PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	ZERANGUE, N; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP				ZERANGUE, N; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP			DIFFERENTIAL MODULATION OF HUMAN GLUTAMATE TRANSPORTER SUBTYPES BY ARACHIDONIC-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GAMMA-AMINOBUTYRIC ACID; SYNAPTIC TRANSMISSION; STRIATAL NEURONS; PRIMARY CULTURES; NMDA RECEPTORS; FATTY-ACIDS; RAT-BRAIN; SYNAPTOSOMES; EXPRESSION; ASTROCYTES	Arachidonic acid has been proposed to be a messenger molecule released following synaptic activation of glutamate receptors and during ischemia. Here we demonstrate that micromolar levels of arachidonic acid inhibit glutamate uptake mediated by EAAT1, a human excitatory amino acid transporter widely expressed in brain and cerebellum, by reducing the maximal transport rate approximately 30%. In contrast, arachidonic acid increased transport mediated by EAAT2, a subtype abundantly expressed in forebrain and midbrain, by causing the apparent affinity for glutamate to increase more than 2-fold. The results demonstrate that the response of different glutamate transporter subtypes to arachidonic acid could influence synaptic transmission and modulate excitotoxicity via positive or negative feedback according to the transporter(s) present in a particular region.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,HOWARD HUGHES MED INST,PORTLAND,OR 97201	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University				Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048709] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48709] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; CHAN PH, 1983, J NEUROCHEM, V40, P309, DOI 10.1111/j.1471-4159.1983.tb11284.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DUMUIS A, 1988, NATURE, V336, P68, DOI 10.1038/336068a0; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; HAUN SE, 1994, SOC NEUR ABSTR, V20, P225; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; LAZAREWICZ JW, 1988, NEUROPHARMACOLOGY, V27, P765, DOI 10.1016/0028-3908(88)90088-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; RHOADS DE, 1982, J NEUROCHEM, V38, P1255, DOI 10.1111/j.1471-4159.1982.tb07898.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; STELLA N, 1994, J NEUROSCI, V14, P568; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; VOLTERRA A, 1992, J NEUROCHEM, V59, P600, DOI 10.1111/j.1471-4159.1992.tb09411.x; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; YU ACH, 1986, J NEUROCHEM, V47, P1181	24	148	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6433	6435		10.1074/jbc.270.12.6433	http://dx.doi.org/10.1074/jbc.270.12.6433			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896776	hybrid, Green Published			2022-12-27	WOS:A1995QQ85500004
J	COPPENS, I; LEVADE, T; COURTOY, PJ				COPPENS, I; LEVADE, T; COURTOY, PJ			HOST PLASMA LOW-DENSITY-LIPOPROTEIN PARTICLES AS AN ESSENTIAL SOURCE OF LIPIDS FOR THE BLOOD-STREAM FORMS OF TRYPANOSOMA-BRUCEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; TRYPANOCIDAL DRUG; CHOLESTEROL; ACID; GLYCOPROTEIN; METABOLISM; HYDROLASES; RECEPTOR; DISEASE	In contrast to mammalian cells, bloodstream forms of Trypanosoma brucei show no activity for fatty acid and sterol synthesis and critically depend on plasma low density lipoprotein (LDL) particles for their rapid growth, We report here that these parasites acquire such lipids by receptor-mediated endocytosis of LDL, subsequent lysosomal degradation of apoprotein B-LDL, and utilization of these lipids, Uptake of LDL-associated [H-3]sphingomyelin and of LDL-associated [H-3]cholesteryl oleate paralleled each other, and that of I-125-apoprotein B-LDL showed saturation and could be inhibited by unlabeled LDL or by anti-LDL receptor antibodies. Metabolism of lipids carried by LDL was abolished by chloroquine and by the thiol protease inhibitor, leupeptin, Sphingomyelin was cleaved by an acid sphingomyelinase to yield ceramide, which was itself split up into sphingosine and fatty acids. The latter were further incorporated into phosphatidylcholine, triacylglycerols, or cholesteryl esters, Similarly, cholesteryl oleate was hydrolyzed by an acid lipase to yield free cholesterol, which was reesterified with fatty acids, presumably in the cytosol. Like free cholesterol, LDL provided substrate for cholesterol esterification. In the culture-adapted procyclic form of T. brucei, which is capable of sterol synthesis, exogenous LDL-cholesterol rather than endogenously synthesized sterol was utilized for sterol esterification. Interference with exogenous supply of lipids via receptor-mediated endocytosis of LDL should be explored to fight against trypanosomiasis.	INT INST CELLULAR & MOLEC PATHOL,B-1200 BRUSSELS,BELGIUM; UNIV CATHOLIQUE LOUVAIN,SCH MED,CELL BIOL UNIT,B-1200 BRUSSELS,BELGIUM; CHU RANGUEIL,INSERM,CJF 9206,BIOCHIM LAB,F-31054 TOULOUSE,FRANCE	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)			Levade, Thierry/O-8948-2014					BASTIN P, 1994, MOL BIOCHEM PARASIT, V63, P193, DOI 10.1016/0166-6851(94)90055-8; BLACK S, 1989, MOL BIOCHEM PARASIT, V37, P201; BRUN R, 1979, ACTA TROP, V36, P286; CARROLL M, 1986, COMP BIOCHEM PHYS B, V83, P647, DOI 10.1016/0305-0491(86)90312-3; COPPENS I, 1991, BIOCHEM BIOPH RES CO, V178, P185, DOI 10.1016/0006-291X(91)91797-G; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; COPPENS I, 1995, MOL BIOCHEM PARASIT, V69, P29, DOI 10.1016/0166-6851(94)00192-P; COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; COPPENS I, 1993, MOL BIOCHEM PARASIT, V58, P223, DOI 10.1016/0166-6851(93)90044-X; DIXON H, 1972, COMP BIOCHEM PHYSIOL, V41, P1, DOI 10.1016/0305-0491(72)90002-8; DIXON H, 1971, COMP BIOCH PHYSL, V398, P247; DOERING TL, 1993, J BIOL CHEM, V268, P9215; FOLCH J, 1957, J BIOL CHEM, V226, P497; GILLETT MPT, 1992, BIOCHIM BIOPHYS ACTA, V1123, P239, DOI 10.1016/0005-2760(92)90002-D; GILLETT MPT, 1987, BIOCHEM SOC T, V15, P258, DOI 10.1042/bst0150258; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1974, P NATL ACAD SCI USA, V71, P4288, DOI 10.1073/pnas.71.11.4288; GRABER D, 1994, J NEUROCHEM, V63, P1060; GRELLIER P, 1991, J CELL BIOL, V112, P267, DOI 10.1083/jcb.112.2.267; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAMBREY PN, 1981, MOL BIOCHEM PARASIT, V2, P177, DOI 10.1016/0166-6851(81)90098-0; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; JACKSON RL, 1976, PHYSIOL REV, V56, P259, DOI 10.1152/physrev.1976.56.2.259; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LEVADE T, 1983, J NEUROCHEM, V40, P1762, DOI 10.1111/j.1471-4159.1983.tb08153.x; LEVADE T, 1993, FEBS LETT, V329, P306, DOI 10.1016/0014-5793(93)80243-N; LONSDALEECCLES JD, 1987, EUR J BIOCHEM, V169, P467, DOI 10.1111/j.1432-1033.1987.tb13634.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MELLORS A, 1989, PARASITOL TODAY, V8, P239; NEGRE A, 1984, BIOCHIM BIOPHYS ACTA, V794, P89, DOI 10.1016/0005-2760(84)90301-1; Opperdoes F.R., 1987, NATO ASI Series Series H Cell Biology, V11, P51; OPPERDOES FR, 1976, EXP PARASITOL, V40, P198, DOI 10.1016/0014-4894(76)90082-5; OPPERDOES FR, 1981, MOL BIOCHEM PARASIT, V4, P311, DOI 10.1016/0166-6851(81)90063-3; OPPERDOES FR, 1982, MOL BIOCHEM PARASIT, V5, P309, DOI 10.1016/0166-6851(82)90038-X; POUMAY Y, 1984, J LIPID RES, V26, P1476; VANDEWEERD V, 1989, MOL BIOCHEM PARASIT, V37, P201, DOI 10.1016/0166-6851(89)90152-7; VANSTERKENBURG ELM, 1993, ACTA TROP, V54, P237, DOI 10.1016/0001-706X(93)90096-T	38	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5736	5741		10.1074/jbc.270.11.5736	http://dx.doi.org/10.1074/jbc.270.11.5736			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890701	hybrid			2022-12-27	WOS:A1995QM94500011
J	NAKAMURA, F; KATO, M; KAMEYAMA, K; NUKADA, T; HAGA, T; KATO, N; TAKENAWA, T; KIKKAWA, U				NAKAMURA, F; KATO, M; KAMEYAMA, K; NUKADA, T; HAGA, T; KATO, N; TAKENAWA, T; KIKKAWA, U			CHARACTERIZATION OF G(Q) FAMILY G-PROTEINS G(L1)ALPHA(G(14)ALPHA), G(L2)ALPHA(G(11)ALPHA), AND G(Q)ALPHA EXPRESSED IN THE BACULOVIRUS-INSECT CELL SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; INHIBITS PHOSPHOINOSITIDE HYDROLYSIS; PHOSPHOLIPASE-C ISOZYMES; ALPHA-SUBUNITS; KINASE-C; REGULATORY PROTEINS; ADENYLATE-CYCLASE; BINDING-PROTEIN; XENOPUS-OOCYTES; SF9 CELLS	The a subunits of G(q) family G proteins, G(L1)alpha(G(14)alpha), G(L2)alpha(G(11)alpha), and G(q) alpha were expressed with G protein beta(1) and gamma(2) subunits in insect cells using a baculovirus system, The trimeric forms of G proteins, G(L1) (G(L1)alpha beta gamma), G(L2) (C(L2)alpha beta gamma), and G(q) (G(q) alpha beta gamma), were solubilized by 1% sodium cholate and purified by sequential chromatography on three kinds of columns, G(L1), G(L2), and G(q) activated phospholipase C-beta purified from bovine brain in the presence of aluminum fluoride to the same extent, Muscarinic acetylcholine receptor m1 subtype stimulated the guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding to G(L1), G(L2) and G(q) in the presence of similar concentrations of carbamylcholine. When m1 receptor, G protein, and phospholipase C-beta were reconstituted in lipid vesicles, each subtype of G(q) family G proteins mediated the activation of phospholipase C-beta by carbamylcholine in the presence of either 1 mu M GTP gamma S or 1 mM GTP. Phospholipase C-beta stimulated the GTPase activity of G(L1), G(L2), and G(q) in the presence of mi receptor and carbamylcholine but did not stimulate the GTPase activity of G(o). Protein kinase C phosphorylated m1 receptor and phospholipase C-beta, but the phosphorylation did not significantly affect the ability of the m1 receptor to stimulate phospholipase C-beta in the reconstitution system of purified proteins.	UNIV TOKYO, FAC MED, INST BRAIN RES, DEPT BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, INST MED SCI, DEPT MOLEC ONCOL, MINATO KU, TOKYO 108, JAPAN; KOBE UNIV, BIOSIGNAL RES CTR, NADA KU, KOBE 657, JAPAN	University of Tokyo; University of Tokyo; Kobe University			Hayashi, Mariko/HHY-7722-2022; Hayashi, Mariko K/L-1187-2013	Hayashi, Mariko/0000-0001-8296-4599; Hayashi, Mariko K/0000-0001-8296-4599				AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; ASHKENAZI A, 1989, TRENDS PHARMACOL SCI, P16; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT DR, 1985, J BIOL CHEM, V260, P266; ELFAKAHANY EE, 1988, FASEB J, V2, P2575, DOI 10.1096/fasebj.2.10.2838363; FELDER CC, 1989, J BIOL CHEM, V264, P20356; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GRABER SG, 1992, J BIOL CHEM, V267, P1271; HAGA K, 1990, J NEUROCHEM, V54, P1639, DOI 10.1111/j.1471-4159.1990.tb01216.x; HAGA K, 1989, MOL PHARMACOL, V35, P286; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; Kitano T, 1986, Methods Enzymol, V124, P349; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; LEE CH, 1992, J BIOL CHEM, V267, P16044; LIPINSKY D, 1992, FEBS LETT, V307, P237, DOI 10.1016/0014-5793(92)80775-C; MA HW, 1993, J BIOL CHEM, V268, P19915; NAKAMURA F, 1991, J BIOL CHEM, V266, P12676; NAKAMURA K, 1994, J PHYSIOL-LONDON, V474, P35, DOI 10.1113/jphysiol.1994.sp020000; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; ORELLANA SA, 1985, J BIOL CHEM, V260, P5236; PARKER EM, 1991, J BIOL CHEM, V266, P519; RHEE SG, 1991, METHOD ENZYMOL, V197, P502; RYU SH, 1990, J BIOL CHEM, V265, P17941; RYU SH, 1987, J BIOL CHEM, V262, P12511; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIOZAKI K, 1992, BIOCHEMISTRY-US, V31, P10634, DOI 10.1021/bi00158a028; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; SUGIMOTO K, 1985, FEBS LETT, V191, P235, DOI 10.1016/0014-5793(85)80015-6; Summers MD, 1987, TEXAS AGR EXPT STATI; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; VANHEESWIJK MPE, 1984, J MEMBRANE BIOL, V79, P19, DOI 10.1007/BF01868523; VICENTINI LM, 1985, BIOCHEM BIOPH RES CO, V127, P310, DOI 10.1016/S0006-291X(85)80160-1; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049	43	69	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6246	6253		10.1074/jbc.270.11.6246	http://dx.doi.org/10.1074/jbc.270.11.6246			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890762	hybrid			2022-12-27	WOS:A1995QM94500080
J	DELGADO, A; SALTO, R; MARQUES, S; RAMOS, JL				DELGADO, A; SALTO, R; MARQUES, S; RAMOS, JL			SINGLE AMINO-ACIDS CHANGES IN THE SIGNAL RECEPTOR DOMAIN OF XYLR RESULTED IN MUTANTS THAT STIMULATE TRANSCRIPTION IN THE ABSENCE OF EFFECTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS TOL PLASMID; INTEGRATION HOST FACTOR; UPPER-PATHWAY OPERON; UPSTREAM REGULATORY SEQUENCE; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; ACTIVATOR PROTEIN; XYLENE METABOLISM; GENE XYLS; PUTIDA	The XylR protein positively controls expression from the Pseudomonas putida TOL plasmid sigma(54)-dependent ''upper'' pathway operon promoter (Pu) and the xylS gene promoter (Ps), in response to the presence of aromatic effecters. Two mutant XylR regulators able to stimulate transcription from Pu and Ps in the absence of effecters were isolated. These mutants exhibited single point mutations, namely Asp(135) --> Asn and Pro(85) --> Ser. Both mutations are located in the amino termini domain of XylR, which is thought to be responsible for interactions with effecters. The effector profile of XylRP85S was similar to that of wild-type XylR protein; however, XylRD135N exhibited an altered pattern of effector recognition: with m-nitrotoluene it stimulated transcription from the Pu promoter above the high basal level, whereas this nitroarene inhibited the wild-type regulator, Previous work (Delgado, A., and Ramos, J. L. (1994) J. Biol, Chem, 269, 8059-8062) showed that residue 172 was involved in effector interactions, as mutant XylRE172K also recognized m-nitrotoluene. However, double mutant XylR135N/E172K did not stimulate transcription in the absence of effector, but retained the ability to stimulate transcription with m-nitrotoluene. Transcription mediated by XylRD135N and XylRP85S from Pu::lacZ was analyzed in detail. Like the wild-type regulator, XylRD135N and XylRP85S required sigma(54) for full transcription activation, but in contrast with the wild-type regulator, XylRD135N, but not XylRP85S, stimulated transcription from Pu in the absence of the integration host factor protein, XylRD135N, also in contrast with XylR and XylRP85S, mediated transcription from a mutant Pu promoter that lacked one of the up stream regulator binding sites (Delta UAS1), but not when both upstream regulator binding sites were deleted, The level of autoregulation of XylRD135N was at least a fold higher than that found with the wild-type XylR regulator and the mutant XylRP85S.	CSIC,DEPT BIOCHEM MOLEC & CELLULAR BIOL PLANTS,ESTAC EXPTL ZAIDIN,E-18008 GRANADA,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)			Marqués, Silvia/B-8079-2012; Salto, Rafael/A-6486-2011; Delgado, Asunción/HGU-5527-2022	Marqués, Silvia/0000-0002-6289-3348; Salto, Rafael/0000-0002-7044-3611; Ramos, Juan L./0000-0002-8731-7435				ABRIL MA, 1993, MOL GEN GENET, V239, P281, DOI 10.1007/BF00281629; ABRIL MA, 1991, J BIOL CHEM, V266, P15832; ABRIL MA, 1989, J BACTERIOL, V171, P6782, DOI 10.1128/jb.171.12.6782-6790.1989; AUSTIN S, 1992, EMBO J, V11, P2219, DOI 10.1002/j.1460-2075.1992.tb05281.x; BIEK DP, 1989, J BACTERIOL, V171, P2056, DOI 10.1128/jb.171.4.2056-2065.1989; BUCK M, 1986, NATURE, V320, P374, DOI 10.1038/320374a0; CLAVERIEMARTIN F, 1992, J MOL BIOL, V227, P996, DOI 10.1016/0022-2836(92)90516-M; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; DELGADO A, 1994, J BIOL CHEM, V269, P8059; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; DIXON R, 1986, MOL GEN GENET, V203, P129, DOI 10.1007/BF00330393; DIXON R, 1991, MOL MICROBIOL, V5, P1657, DOI 10.1111/j.1365-2958.1991.tb01913.x; DRUMMOND M, 1986, EMBO J, V5, P441, DOI 10.1002/j.1460-2075.1986.tb04230.x; GOMADA M, 1992, MOL GEN GENET, V233, P419, DOI 10.1007/BF00265439; HOLTEL A, 1992, NUCLEIC ACIDS RES, V20, P1755, DOI 10.1093/nar/20.7.1755; HOLTEL A, 1990, MOL MICROBIOL, V4, P1551, DOI 10.1111/j.1365-2958.1990.tb02066.x; INOUYE S, 1989, GENE, V85, P145; INOUYE S, 1990, J MOL BIOL, V216, P251, DOI 10.1016/S0022-2836(05)80317-1; INOUYE S, 1987, P NATL ACAD SCI USA, V84, P5182, DOI 10.1073/pnas.84.15.5182; INOUYE S, 1988, GENE, V66, P301; INOUYE S, 1984, P NATL ACAD SCI-BIOL, V81, P1688, DOI 10.1073/pnas.81.6.1688; KEENER J, 1988, P NATL ACAD SCI USA, V85, P4976, DOI 10.1073/pnas.85.14.4976; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; KNOWLES JR, 1987, SCIENCE, V236, P1252; KOHLER T, 1989, J BACTERIOL, V171, P4326; KUSTU S, 1989, MICROBIOL REV, V53, P367, DOI 10.1128/MMBR.53.3.367-376.1989; LEE JH, 1994, J BIOL CHEM, V269, P20401; MACNEIL D, 1981, J BACTERIOL, V146, P260, DOI 10.1128/JB.146.1.260-268.1981; MARQUES S, 1993, MOL MICROBIOL, V9, P923, DOI 10.1111/j.1365-2958.1993.tb01222.x; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; PEREZMARTIN J, 1994, J BIOL CHEM, V269, P22657; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; RAMOS JL, 1987, MOL MICROBIOL, V1, P297; SANDERS DA, 1992, J BACTERIOL, V174, P5117, DOI 10.1128/JB.174.15.5117-5122.1992; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; SHINGLER V, 1993, J BACTERIOL, V175, P1596, DOI 10.1128/JB.175.6.1596-1604.1993; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; WEGLENSKI P, 1989, J BACTERIOL, V171, P4479, DOI 10.1128/JB.171.8.4479-4485.1989; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975	41	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5144	5150		10.1074/jbc.270.10.5144	http://dx.doi.org/10.1074/jbc.270.10.5144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890623	hybrid			2022-12-27	WOS:A1995QL58000031
J	ROTH, DA; WHIRL, ML; VELAZQUEZESTADES, LJ; WALSH, CT; FURIE, B; FURIE, BC				ROTH, DA; WHIRL, ML; VELAZQUEZESTADES, LJ; WALSH, CT; FURIE, B; FURIE, BC			MUTAGENESIS OF VITAMIN-K-DEPENDENT CARBOXYLASE DEMONSTRATES A CARBOXYL TERMINUS-MEDIATED INTERACTION WITH VITAMIN-K HYDROQUINONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPPOSITE FACIAL SPECIFICITY; GAMMA-GLUTAMYL CARBOXYLASE; RECOGNITION SITE; STREPTOMYCES LL-C10037; PROPEPTIDE REGION; ENZYME-ACTIVITY; PROTHROMBIN; SUBSTRATE; IDENTIFICATION; PURIFICATION	The gamma-glutamyl carboxylase and vitamin K epoxidase activities of a series of mutants of bovine vitamin K-dependent carboxylase with progressively larger COOH-terminal deletions have been analyzed. The recombinant wild-type (residues 1-758) and mutant protein carboxylases, Cbx 711, Cbx 676, and Cbx 572, representing residues 1-711, 1-676, and 1-572, respectively, were expressed in baculovirus-infected Sf9 cells, Wild-type carboxylase had a K-m for the substrate Phe-Leu-Glu-Glu-Leu (FLEEL) of 0.87 mM; the carboxylation of FLEEL was stimulated 2.5-fold by proPT18, the propeptide of prothrombin. Its K-m for vitamin K hydroquinone was 23 mu M and the specific epoxidase activity of the carboxylase was 938 pmol vitamin KO/30 min/pmol of carboxylase, Cbx 711, which was also stimulated by proPT18, had a K-m for FLEEL, a K-m for vitamin K hydroquinone, and a specific epoxidase activity that was comparable to the wild-type carboxylase. In contrast Cbx 572 lacked both carboxylase and epoxidase activities, Although Cbx 676 had a normal carboxylase active site in terms of the K-m for FLEEL and its stimulation by proPT18, the K-m for vitamin K hydroquinone was 540 mu M, and the specific epoxidase activity was 97 pmol KO/30 min/pmol of Cbx 676, The catalytic efficiencies of Cbx 676 for glutamate carboxylation and vitamin K epoxidation were decreased 15- and 400-fold, respectively, from wild-type enzyme reflecting the requirement for formation of an activated vitamin K species for carboxylation to occur. These data indicate that the truncation of COOH-terminal segments of the carboxylase had no effect on FLEEL or propeptide recognition, but in the case of Cbx 676, selectively affected the interaction with vitamin K hydroquinone and the generation of epoxidase activity. These data suggest that a vitamin K epoxidase activity domain may reside near the COOH terminus while the carboxylase active site domain resides toward the NH2 terminus.	TUFTS UNIV,SCH MED,DEPT MED,BOSTON,MA 02111; TUFTS UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02111; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Tufts University; Tufts University; Harvard University; Harvard Medical School	ROTH, DA (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR,CTR HEMOSTASIS & THROMBOSIS RES,DIV HEMATOL ONCOL,BOSTON,MA 02111, USA.			Whirl-Carrillo, Michelle/0000-0003-2414-9312	NHLBI NIH HHS [HL02574, HL42443] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002574, P01HL042443] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; CHEUNG A, 1989, ARCH BIOCHEM BIOPHYS, V274, P574, DOI 10.1016/0003-9861(89)90472-4; DOWD P, 1992, J AM CHEM SOC, V114, P7613, DOI 10.1021/ja00046a001; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GOULD SJ, 1991, J AM CHEM SOC, V113, P684, DOI 10.1021/ja00002a052; HAM SW, 1990, J AM CHEM SOC, V112, P1660, DOI 10.1021/ja00160a073; HAROON Y, 1986, CLIN CHEM, V32, P1925; HUBBARD BR, 1989, P NATL ACAD SCI USA, V86, P6893, DOI 10.1073/pnas.86.18.6893; HUBER P, 1990, J BIOL CHEM, V265, P12467; JORGENSEN MJ, 1987, CELL, V48, P185, DOI 10.1016/0092-8674(87)90422-3; KNOBLOCH JE, 1987, J BIOL CHEM, V262, P15334; KULIOPULOS A, 1992, BIOCHEMISTRY-US, V31, P7722, DOI 10.1021/bi00148a037; KULIOPULOS A, 1992, BIOCHEMISTRY-US, V31, P9436, DOI 10.1021/bi00154a016; KULIOPULOS A, 1994, J BIOL CHEM, V269, P21364; KUTKOW KJ, 1993, METHOD ENZYMOL, V222, P435; LARSON AE, 1981, J BIOL CHEM, V256, P1032; MORRIS DP, 1993, J BIOL CHEM, V268, P8735; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D; REHEMTULLA A, 1993, P NATL ACAD SCI USA, V90, P4611, DOI 10.1073/pnas.90.10.4611; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; SHEN B, 1991, BIOCHEMISTRY-US, V30, P8936, DOI 10.1021/bi00101a004; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; SUTTIE JW, 1979, BIOCHEM BIOPH RES CO, V86, P500, DOI 10.1016/0006-291X(79)91742-X; ULRICH MMW, 1988, J BIOL CHEM, V263, P9697; WOOD GM, 1988, J BIOL CHEM, V263, P3234; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; WU SM, 1991, P NATL ACAD SCI USA, V88, P2236, DOI 10.1073/pnas.88.6.2236; YAMADA M, 1995, BIOCHEMISTRY-US, V34, P481, DOI 10.1021/bi00002a012	30	22	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5305	5311		10.1074/jbc.270.10.5305	http://dx.doi.org/10.1074/jbc.270.10.5305			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890642	hybrid, Green Submitted			2022-12-27	WOS:A1995QL58000055
J	SCHWIENTEK, T; LORENZ, C; ERNST, JF				SCHWIENTEK, T; LORENZ, C; ERNST, JF			GOLGI LOCALIZATION IN YEAST IS MEDIATED BY THE MEMBRANE ANCHOR REGION OF RAT-LIVER SIALYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; SIGNAL ANCHOR; PLASMA-MEMBRANE; PROTEIN; RETENTION; APPARATUS; INVERTASE; GLYCOSYLATION	To investigate the function of the membrane anchor region of a mammalian glycosyltransferase in yeast we constructed a fusion gene that encodes the 34 amino terminal residues of rat liver beta-galactoside alpha-2,6-sialyltransferase (EC 2.4.99.1) (ST) fused to the mature form of yeast invertase. Transformants of Saccharomyces cerevisiae expressing the fusion gene produced an intracellular heterogeneously N-glycosylated fusion protein of intermediate molecular weight between the core and fully extended N-glycosylated form of invertase, suggesting a post endoplasmic reticulum (ER) localization. In two types of cell fractionation using sucrose density gradients the ST-invertase fusion protein cofractionated with Golgi marker proteins, whereas a minor fraction (about 30%) comigrated with a vacuolar marker; ST-invertase was not detected in other cell fractions including the ER and the plasma membrane. Consistent with Golgi localization, about 70% of the total amount of the ST-invertase fusion was immunoprecipitated with an antibody directed against alpha-1,6 mannose linkages. The results demonstrate that the membrane anchor region of a mammalian type II glycosyltransferase is able to target a protein to the secretory pathway and to a Golgi compartment of the yeast S. cerevisiae, indicating conservation of targeting mechanisms between higher and lower eukaryotes. Since typical yeast Golgi localization signals are missing in the ST-membrane anchor region the results also suggest that yeast as mammalian cells utilize diverse mechanisms to direct proteins to the Golgi.	UNIV DUSSELDORF, INST MIKROBIOL, D-40225 DUSSELDORF, GERMANY	Heinrich Heine University Dusseldorf								ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; AOKI D, 1992, P NATL ACAD SCI USA, V89, P4319, DOI 10.1073/pnas.89.10.4319; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; BIELEFELD M, 1992, CURR GENET, V21, P265, DOI 10.1007/BF00351680; BOWSER R, 1991, J CELL BIOL, V112, P1117, DOI 10.1083/jcb.112.6.1117; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BURKE J, 1994, J BIOL CHEM, V269, P12049; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHAPMAN RE, 1994, EMBO J, V13, P4896, DOI 10.1002/j.1460-2075.1994.tb06817.x; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; COOPER A, 1992, J CELL BIOL, V119, P1459, DOI 10.1083/jcb.119.6.1459; DAHDAL RY, 1993, J BIOL CHEM, V268, P26310; ERNST JF, 1986, DNA-J MOLEC CELL BIO, V5, P483, DOI 10.1089/dna.1.1986.5.483; ERNST JF, 1992, EUR J BIOCHEM, V203, P663, DOI 10.1111/j.1432-1033.1992.tb16596.x; ESMON PC, 1987, J BIOL CHEM, V262, P4387; FRANZUSOFF A, 1991, METHOD ENZYMOL, V194, P662; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; GELLERFORS P, 1989, J BIOL CHEM, V264, P11444; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; HITZEMAN RA, 1983, SCIENCE, V219, P620, DOI 10.1126/science.6186023; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KREZDORN CH, 1994, EUR J BIOCHEM, V220, P809, DOI 10.1111/j.1432-1033.1994.tb18683.x; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MORMENEO S, 1989, FEMS MICROBIOL LETT, V57, P271, DOI 10.1016/0378-1097(89)90312-1; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; ORLEAN P, 1991, METHOD ENZYMOL, V194, P682; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; ROBERTS CJ, 1992, J CELL BIOL, V119, P69, DOI 10.1083/jcb.119.1.69; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Sherman F., 1986, METHODS YEAST GENETI; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; WALWORTH NC, 1989, METHOD CELL BIOL, V31, P335; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353	47	24	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5483	5489		10.1074/jbc.270.10.5483	http://dx.doi.org/10.1074/jbc.270.10.5483			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890665	hybrid			2022-12-27	WOS:A1995QL58000081
J	SUMNER, JP; DOW, JAT; EARLEY, FGP; KLEIN, U; JAGER, D; WIECZOREK, H				SUMNER, JP; DOW, JAT; EARLEY, FGP; KLEIN, U; JAGER, D; WIECZOREK, H			REGULATION OF PLASMA-MEMBRANE V-ATPASE ACTIVITY BY DISSOCIATION OF PERIPHERAL SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO HORNWORM MIDGUT; MANDUCA-SEXTA MIDGUT; VACUOLAR-TYPE ATPASE; PROTON PUMP; H+-ATPASES; TRANSPORTING EPITHELIA; MAMMALIAN KIDNEY; ULTRASTRUCTURE; PURIFICATION; EVOLUTION	The plasma membrane V-ATPase of Manduca sexta larval midgut is an electrogenic proton pump located in goblet cell apical membranes (GCAM); it energizes, by the voltage component of its proton motive force, an electrophoretic K+/nH(+) antiport and thus K+ secretion (Wieczorek, H., Putzenlechner, M., Zeiske, W., and Klein, U. (1991) J. Biol Chem. 266, 15340-15347). Midgut transepithelial voltage, indicating net active K+ transport, was found to be more than 100 mV during intermoult stages but was abolished during moulting. Simultaneously, ATP hydrolysis and ATP-dependent proton transport in GCAM vesicles were found to be reduced to 10-15% of the intermoult level. Immunocytochemistry of midgut cryosections as well as SDS-polyacrylamide gel electrophoresis and immunoblots of GCAM demonstrated that loss of ATPase activity paralleled the disappearance of specific subunits. The subunits missing were those considered to compose the peripheral V-1 sector, whereas the membrane integral V-0 subunits remained in the GCAM of moulting larvae. The results provide, for the first time, evidence that a V-ATPase activity can be controlled in vivo by the loss of the peripheral V-1 domain.	UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY; ZENECA,AGROCHEM JEALLOLS HILL RES STN,BRACKNELL RG12 6EY,BERKS,ENGLAND; UNIV GLASGOW,DEPT CELL BIOL,GLASGOW G12 8QQ,LANARK,SCOTLAND	University of Munich; University of Glasgow			Dow, Julian/M-2371-2019	Dow, Julian/0000-0002-9595-5146	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022444] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22444] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANRAKU Y, 1992, J EXP BIOL, V172, P67; BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; BELL RA, 1974, ANN ENTOMOL SOC AM, V69, P365; BROWN D, 1991, KIDNEY INT S, V40, P79; CIOFFI M, 1984, AM ZOOL, V24, P139; CIOFFI M, 1983, TISSUE CELL, V15, P781, DOI 10.1016/0040-8166(83)90050-2; DOW JAT, 1992, GENE, V122, P355, DOI 10.1016/0378-1119(92)90226-F; DOW JAT, 1992, J EXP BIOL, V172, P355; DOW JAT, 1984, AM J PHYSIOL, V246, pR633, DOI 10.1152/ajpregu.1984.246.4.R633; DOW JAT, 1990, J EXP BIOL, V150, P247; DOW JAT, 1985, J EXP BIOL, V116, P685; GLUCK SL, 1992, J EXP BIOL, V172, P219; GRAF R, 1994, J BIOL CHEM, V269, P3767; GRAF R, 1992, FEBS LETT, V300, P119, DOI 10.1016/0014-5793(92)80177-I; GRAF R, 1994, BBA-BIOMEMBRANES, V1190, P193, DOI 10.1016/0005-2736(94)90053-1; GRAHAM LA, 1994, J BIOL CHEM, V269, P25974; HARVEY WR, 1992, J EXP BIOL, V172, P1; HARVEY WR, 1964, P NATL ACAD SCI USA, V51, P757; HARVEY WR, 1992, J EXP BIOL, V172; KLEIN U, 1991, J EXP BIOL, V161, P61; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; NELSON H, 1994, J BIOL CHEM, V269, P24150; NELSON N, 1992, J EXP BIOL, V172, P19; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; NOVAK FJS, 1992, BIOCHIM BIOPHYS ACTA, V1132, P67, DOI 10.1016/0167-4781(92)90053-3; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; SCHWEIKL H, 1989, J BIOL CHEM, V264, P11136; TRUMAN JW, 1992, PROG BRAIN RES, V92, P361, DOI 10.1016/S0079-6123(08)61189-9; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; WIECZOREK H, 1992, J EXP BIOL, V172, P335; WIECZOREK H, 1989, J BIOL CHEM, V264, P11143; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; YAMAMOTO RT, 1969, J ECON ENTOMOL, V62, P1427, DOI 10.1093/jee/62.6.1427; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; ZHANG K, 1992, J BIOL CHEM, V267, P14539; ZHANG K, 1992, J BIOL CHEM, V267, P9701; ZHENG XY, 1992, J EXP BIOL, V165, P273	39	280	284	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5649	5653		10.1074/jbc.270.10.5649	http://dx.doi.org/10.1074/jbc.270.10.5649			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890686	hybrid			2022-12-27	WOS:A1995QL58000105
J	BALDWIN, AN; SHOOTER, EM				BALDWIN, AN; SHOOTER, EM			ZONE MAPPING OF THE BINDING DOMAIN OF THE RAT LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR BY THE INTRODUCTION OF NOVEL N-GLYCOSYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY 217C; NGF RECEPTOR; TRK PROTOONCOGENE; CRYSTAL-STRUCTURE; TYROSINE KINASE; LIGAND-BINDING; PC12 CELLS; PROTEINS; HEMAGGLUTININ; CARBOHYDRATE	The binding of NGF (nerve growth factor) to the rat low affinity nerve growth factor receptor (p75(NGFR)) has been studied by site-directed mutagenesis of the receptor. Introduction of non-native N-glycosylation sites within the binding domain indicates that the second of the characteristic cysteine-rich repeats may be particularly important to NGF binding. Two mutants of the second repeat, S42N and S66N, are glycosylated and bind NGF at a drastically reduced level, while still maintaining a conformation recognized by the monoclonal antibody against p75, MC192. Alanine substitution at these sites does not affect NGF binding. Two other mutations that result in local structural changes in the second repeat also greatly decrease binding. One of these altered residues, Ser(50), appears to play an essential structural role, since it cannot be replaced by Asn, Ala, or Thr without loss of both NGF binding and MC192 recognition on a Western. Glycosylation of selected sites in the other repeats has little effect on NGF binding or antibody recognition. The introduction of non-native N-glycosylation sites may provide a generally useful scanning technique for the study of protein-protein interactions.			BALDWIN, AN (corresponding author), STANFORD UNIV,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270] Funding Source: NIH RePORTER; NINDS NIH HHS [NS04270] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALDWIN AN, 1992, J BIOL CHEM, V267, P8352; BALDWIN AN, 1994, J BIOL CHEM, V269, P11456; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BATTLEMAN DS, 1993, J NEUROSCI, V13, P941; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHRAMBACH A, 1976, METHODS PROTEIN SEPA, V2, P27; CUMMINGHAM BC, 1989, SCIENCE, V243, P1330; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; FERRARI G, 1991, EXP NEUROL, V112, P183, DOI 10.1016/0014-4886(91)90068-N; FILIPOVIC I, 1989, J BIOL CHEM, V264, P8815; GALLAGHER P, 1988, J CELL BIOL, V107, P2059, DOI 10.1083/jcb.107.6.2059; GROB PM, 1983, J BIOL CHEM, V258, P4136; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HSU KC, 1993, J BIOL CHEM, V268, P16430; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAHLE P, 1992, J BIOL CHEM, V267, P22707; KERN G, 1992, PROTEIN SCI, V1, P120; KIM HH, 1994, J BIOL CHEM, V269, P12345; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUMAR S, 1990, J NEUROSCI RES, V27, P408, DOI 10.1002/jnr.490270320; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; LEDBETTER JA, 1981, J EXP MED, V153, P1503, DOI 10.1084/jem.153.6.1503; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; MACHAMER CE, 1988, J BIOL CHEM, V263, P5948; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; PENG WW, 1982, SCIENCE, V215, P1102, DOI 10.1126/science.7063842; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; ROVELLI G, 1993, P NATL ACAD SCI USA, V90, P8717, DOI 10.1073/pnas.90.18.8717; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALE RD, 1985, METHOD ENZYMOL, V109, P21; VERDI JM, 1994, P NATL ACAD SCI USA, V91, P3949, DOI 10.1073/pnas.91.9.3949; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VIDAL S, 1989, J VIROL, V63, P892, DOI 10.1128/JVI.63.2.892-900.1989; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P159, DOI 10.1073/pnas.88.1.159; WESTKAMP G, 1991, NEURON, V6, P649; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; YAN H, 1991, J BIOL CHEM, V266, P12099	53	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4594	4602		10.1074/jbc.270.9.4594	http://dx.doi.org/10.1074/jbc.270.9.4594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876230	hybrid			2022-12-27	WOS:A1995QK08400063
J	LEE, J; JAYARAM, M				LEE, J; JAYARAM, M			ROLE OF PARTNER HOMOLOGY IN DNA RECOMBINATION - COMPLEMENTARY BASE-PAIRING ORIENTS THE 5'-HYDROXYL FOR STRAND JOINING DURING FLP SITE-SPECIFIC RECOMBINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA; INTEGRASE FAMILY; HALF-SITE; PROTEIN; SUBSTRATE; CLEAVAGE; MECHANISM; RESOLUTION; CATALYSIS; MUTATIONS	Absolute homology between partner substrates within the strand exchange region is an essential requirement for recombination mediated by the yeast site-specific recombinase Flp. Using combinations of specially designed half- and full-site Flp substrates, we demonstrate that the strand joining step of recombination is exquisitely sensitive to spacer homology. At each exchange point, 2-3 spacer nucleotides adjacent to the nick within the cleaved strand of one substrate must base pair with the corresponding segment of the un-nicked strand from the second substrate for efficient strand joining in the recombinant mode. In accordance with the ''cis-activation/trans-nucleophilic attack'' model for each of the two transesterification steps of Flp recombination (strand cleavage and strand joining), we propose that the limited strand pairing orients the DNA-nucleophile (5'-hydroxyl) for attack on its target diester (3'-phosphotyrosyl-Flp). During one round of recombination, 4-6 terminal base pairs of the spacer (2-3 base pairs at each spacer end) must unpair, following strand cleavage, within a DNA substrate and pair with the partner substrate prior to strand union. In this model, the extent of branch migration of the covalently closed Holliday intermediate is limited to the central core of the spacer. The templated positioning of reactive nucleic acid groups (which is central to the model) may be utilized by other recombination systems and by RNA splicing reactions.	UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin								ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/protein/5.1.87; AMIN A, 1991, MOL CELL BIOL, V11, P4497, DOI 10.1128/MCB.11.9.4497; ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; BAUER CE, 1985, J MOL BIOL, V181, P187, DOI 10.1016/0022-2836(85)90084-1; BAUER CE, 1984, COLD SPRING HARB SYM, V49, P699, DOI 10.1101/SQB.1984.049.01.079; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V2, P1859; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; BROACH JR, 1991, MOL BIOL YEAST SACCH, P297; CHEN JW, 1993, J BIOL CHEM, V268, P14417; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; COWART M, 1991, J MOL BIOL, V220, P621, DOI 10.1016/0022-2836(91)90105-F; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DIXON JE, 1993, J MOL BIOL, V234, P522, DOI 10.1006/jmbi.1993.1608; JAYARAM M, 1988, P NATL ACAD SCI USA, V85, P7902, DOI 10.1073/pnas.85.21.7902; JELTSCH A, 1993, P NATL ACAD SCI USA, V90, P8499, DOI 10.1073/pnas.90.18.8499; KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0; KOWALCZYKOWSKI SC, 1994, EXPERIENTIA, V50, P204, DOI 10.1007/BF01924003; LEE J, 1993, J BIOL CHEM, V268, P17564; LEHMAN IR, 1976, SCIENCE, V186, P790; Maniatis T., 1982, MOL CLONING; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; NASH HA, 1987, P NATL ACAD SCI USA, V84, P4049, DOI 10.1073/pnas.84.12.4049; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; PAN GH, 1993, MOL CELL BIOL, V13, P3167, DOI 10.1128/MCB.13.6.3167; PAN GH, 1992, J BIOL CHEM, V267, P12397; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; QIAN XH, 1992, J BIOL CHEM, V267, P7794; RADDING CM, 1991, J BIOL CHEM, V266, P5355; SADOWSKI PD, 1993, FASEB J, V7, P760, DOI 10.1096/fasebj.7.9.8392474; SENECOFF JF, 1986, J BIOL CHEM, V261, P7380; SERRE MC, 1992, J MOL BIOL, V225, P621, DOI 10.1016/0022-2836(92)90390-6; WEISBERG RA, 1983, J MOL BIOL, V170, P319, DOI 10.1016/S0022-2836(83)80151-X; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131	37	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4042	4052		10.1074/jbc.270.8.4042	http://dx.doi.org/10.1074/jbc.270.8.4042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876153	hybrid			2022-12-27	WOS:A1995QH68800086
J	RIDDERSTRALE, M; DEGERMAN, E; TORNQVIST, H				RIDDERSTRALE, M; DEGERMAN, E; TORNQVIST, H			GROWTH-HORMONE STIMULATES THE TYROSINE PHOSPHORYLATION OF THE INSULIN-RECEPTOR SUBSTRATE-1 AND ITS ASSOCIATION WITH PHOSPHATIDYLINOSITOL 3-KINASE IN PRIMARY ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							3T3-F442A PREADIPOCYTES; KINASE-ACTIVITY; PROTEIN-KINASE; RAT ADIPOCYTES; INTACT-CELLS; IRS-1; IDENTIFICATION; PURIFICATION; ACTIVATION; BINDING	Insulin receptor substrate-1 (IRS-1) is tyrosine-phosphorylated in response to insulin resulting in association with and activation of phosphatidylinositol 3-kinase (PI 3-kinase), thereby initiating some of the effects of insulin, We have recently shown that the insulin-like effects of growth hormone (GH) in adipocytes can be inhibited by the selective PI 3-kinase inhibitor wortmannin (Ridderstrale, M., and Tornqvist, H. (1994) Biochem. Biophys. Res. Commun. 203, 306-310), suggesting a similar role for PI 3-kinase in GH action. Here we show that IRS-1 is tyrosine-phosphorylated in a time- and dose-dependent manner in response to GH in primary rat adipocytes, This phosphorylation coincided with the extent of interaction between IRS-1 and the 85-kDa subunit of PI 3-kinase as evidenced by coimmunoprecipitation. Stimulation with 23 nM GH increased the PI 3-kinase activity associated with IRS-1 4-fold, Our data suggest that GH-induced tyrosine phosphorylation of IRS-1 and the subsequent docking of PI 3-kinase are important postreceptor events in GH action. The mechanism for the phosphorylation of IRS-1 induced by GH is unknown, but involvement of JAK2, the only known GH receptor-associated tyrosine kinase, seems possible.	LUND UNIV, DEPT PEDIAT, S-22100 LUND, SWEDEN	Lund University	RIDDERSTRALE, M (corresponding author), LUND UNIV, DEPT MED & PHYSIOL CHEM, MOLEC SIGNALING SECT, POB 94, S-22100 LUND, SWEDEN.		Ridderstråle, Martin/F-7678-2012					ANDERSON NG, 1992, BIOCHEM J, V284, P649, DOI 10.1042/bj2840649; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; AVRUCH J, 1990, HDB EXPT PHARM, V92, P313; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; ESCOBEDO JA, 1991, CELL, V65, P413; Gliemann J, 1967, Diabetologia, V3, P382, DOI 10.1007/BF02342631; GOLD MR, 1994, J BIOL CHEM, V269, P5403; GOODMAN HM, 1981, ENDOCRINOLOGY, V109, P120, DOI 10.1210/endo-109-1-120; GRICHTING G, 1983, ENDOCRINOLOGY, V113, P1111, DOI 10.1210/endo-113-3-1111; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; ILONDO MM, 1994, ENDOCRINOLOGY, V134, P2397, DOI 10.1210/en.134.6.2397; IZUMI T, 1987, J BIOL CHEM, V262, P1282; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KELLY KL, 1993, J BIOL CHEM, V268, P4391; LAM K, 1994, J BIOL CHEM, V269, P20648; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; MASSAGUE J, 1982, J BIOL CHEM, V257, P5038; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; OKADA T, 1994, J BIOL CHEM, V269, P3568; Panayotou George, 1992, Trends in Cell Biology, V2, P358, DOI 10.1016/0962-8924(92)90042-L; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; RIDDERSTRALE M, 1994, BIOCHEM BIOPH RES CO, V203, P306, DOI 10.1006/bbrc.1994.2182; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROUPAS P, 1994, TRENDS ENDOCRIN MET, V5, P154, DOI 10.1016/1043-2760(94)90012-4; SCHLOOTWEG MC, 1991, J MOL ENDOCRINOL, V6, P179; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TASHIROHASHIMOTO Y, 1989, J BIOL CHEM, V264, P6879; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0	49	119	121	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3471	3474		10.1074/jbc.270.8.3471	http://dx.doi.org/10.1074/jbc.270.8.3471			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876077	hybrid			2022-12-27	WOS:A1995QH68800003
J	SAITOH, H; TAKAGAKI, K; MAJIMA, M; NAKAMURA, T; MATSUKI, A; KASAI, M; NARITA, H; ENDO, M				SAITOH, H; TAKAGAKI, K; MAJIMA, M; NAKAMURA, T; MATSUKI, A; KASAI, M; NARITA, H; ENDO, M			ENZYMATIC RECONSTRUCTION OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDE CHAINS USING THE TRANSGLYCOSYLATION REACTION OF BOVINE TESTICULAR HYALURONIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCURONIDASE; LINKAGE REGION; SULFATE; SUBSTRATE; ASSAY	The reconstruction of glycosaminoglycan chains using the transglycosylation reaction of testicular hyaluronidase was investigated, First, the optimal conditions for the transglycosylation reaction catalyzed by the enzyme were determined by incubation with the enzyme, using hyaluronic acid (M(r) = 800,000) as a donor and pyridylaminated hyaluronic acid hexasaccharide having glucuronic acid at the nonreducing terminal as an acceptor, The carbohydrate chains as reaction products were determined by high performance liquid chromatography and mass spectrometry, The optimal pH for hydrolysis by the enzyme was found to be about 5.0, whereas that for the transglycosylation reaction was about 7.0. Sodium chloride in the reaction medium inhibited the transglycosylation reaction, Under the optimal conditions, the carbohydrate chains were sequentially transferred along with disaccharide units to the nonreducing terminal of the acceptor and elongated up to docosasaccharide from the acceptor, pyridylaminated hexasaccharide. Using a combination of hyaluronic acid, chondroitin, and chondroitin 4- and B-sulfate as an acceptor and a donor, it was possible to reconstruct hybrid chains, which were natural or unnatural types of glycosaminoglycan chains. Therefore, it is highly likely that application of the transglycosylation reaction using testicular hyaluronidase would facilitate artificial reconstruction of glycosaminoglycans having some physiological functions,	HIROSAKI UNIV, SCH MED, DEPT BIOCHEM, HIROSAKI, AOMORI 036, JAPAN; KUSHIRO JR COLL, KUSHIRO 085, JAPAN	Hirosaki University								ABE J, 1988, CARBOHYD RES, V176, P87, DOI 10.1016/0008-6215(88)84060-6; BARDALES RM, 1989, J BIOL CHEM, V264, P19893; BARRETT AJ, 1972, LYSOSOMES LABORATORY, P110; BORDERS CL, 1968, J BIOL CHEM, V243, P3756; DANISHEF.I, 1966, J BIOL CHEM, V241, P143; GORHAM SD, 1975, CONNECT TISSUE RES, V3, P17, DOI 10.3109/03008207509152337; GOTO F, 1993, PURE APPL CHEM, V65, P793, DOI 10.1351/pac199365040793; HIGHSMITH S, 1975, J BIOL CHEM, V250, P7473; HIMENO M, 1974, J BIOCHEM, V76, P1243, DOI 10.1093/oxfordjournals.jbchem.a130677; HOFFMAN P, 1956, J BIOL CHEM, V219, P653; KANTOR TG, 1957, J AM CHEM SOC, V79, P152, DOI 10.1021/ja01558a040; KNUDSEN PJ, 1980, J CHROMATOGR, V187, P373, DOI 10.1016/S0021-9673(00)80469-0; KON A, 1991, J BIOCHEM-TOKYO, V110, P132, DOI 10.1093/oxfordjournals.jbchem.a123531; LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725; LINKER A, 1956, J BIOL CHEM, V219, P13; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAJIMA M, 1985, TOHOKU J EXP MED, V146, P83, DOI 10.1620/tjem.146.83; Meyer K, 1971, ENZYMES, P307; NAKAMURA T, 1990, J BIOL CHEM, V265, P5390; NAKAMURA T, 1990, ANAL BIOCHEM, V191, P21, DOI 10.1016/0003-2697(90)90380-R; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; OTOTANI N, 1972, ANAL BIOCHEM, V45, P462; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Roden L, 1989, CIBA F SYMP, P76; SAITO H, 1968, J BIOL CHEM, V243, P1536; TAKAGAKI K, 1994, BIOCHEMISTRY-US, V33, P6503, DOI 10.1021/bi00187a017; TAKAGAKI K, 1992, GLYCOCONJUGATE J, V9, P174, DOI 10.1007/BF00731162; TAKAGAKI K, 1992, J BIOL CHEM, V267, P18558; TAKAGAKI K, 1990, J BIOL CHEM, V265, P854; TAKAGAKI K, 1988, J BIOL CHEM, V263, P7000; USUI T, 1988, BIOCHIM BIOPHYS ACTA, V953, P179, DOI 10.1016/0167-4838(88)90022-2; WEISSMANN B, 1955, J BIOL CHEM, V216, P783	32	90	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3741	3747		10.1074/jbc.270.8.3741	http://dx.doi.org/10.1074/jbc.270.8.3741			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876114	hybrid			2022-12-27	WOS:A1995QH68800044
J	ARORA, PD; MA, J; MIN, WX; CRUZ, T; MCCULLOCH, CAG				ARORA, PD; MA, J; MIN, WX; CRUZ, T; MCCULLOCH, CAG			INTERLEUKIN-1-INDUCED CALCIUM FLUX IN HUMAN FIBROBLASTS IS MEDIATED THROUGH FOCAL ADHESIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GINGIVAL CREVICULAR FLUID; IL-1 RECEPTOR; SIGNAL TRANSDUCTION; HIGH-AFFINITY; EXTRACELLULAR-MATRIX; TYROSINE PHOSPHORYLATION; ARTICULAR CHONDROCYTES; RAPID PHOSPHORYLATION; INTRACELLULAR CALCIUM	Interleukin-1 (IL-1) is an important mediator of inflammation and also modulates fibroblast metabolism. To assess mechanisms of IL-1-induced signal transduction and calcium flux, early passage human fibroblasts were loaded with fura2/AM. Cells grown on coverslips exhibited dose-dependent [Ca2+](i) responses that were maximal at 10(-8) M IL-1 beta with time to maximum flux of 50 s. Cells incubated with anti-Type 1-IL-1 receptor antibody exhibited a 45 nM increase in [Ca2+](i) above baseline but demonstrated no calcium response after IL-1 beta treatment. Incubation with EGTA (5 mM) or thapsigargin (1 mu M) caused 75% and 37% reductions, respectively, in the IL-1-induced [Ca2+](i) increase, suggesting that extracellular Ca2+ predominates in IL-1-stimulated calcium flux. Cells in suspension did not exhibit [Ca2+](i) responses to IL-1 beta. The relationship between [Ca2+](i) signaling and focal adhesions was examined by plating cells on fibronectin or poly-L-lysine, conditions that either permitted or blocked the formation of focal adhesions. Cells on fibronectin exhibited co-distribution of immunostaining for talin, vinculin, IL-1 receptor, and focal adhesion kinase (pp125(fak)) in focal adhesions and demonstrated [Ca2+](i) responses with 10(-8) M IL-1 beta. Cells on poly-L-lysine or cells in suspension did not exhibit co-distribution of pp125(fak), IL-1 receptor, and focal adhesion proteins and did not exhibit calcium flux. The dependence of IL-1-stimulated [Ca2+](i) responses on tyrosine kinases was examined first by treating cells with genistein, a selective inhibitor of tyrosine kinases. Genistein (100 mu M) completely blocked [Ca2+](i) responses to 10(-8) M IL-1, whereas its inactive analogue genistin was not inhibitory. Second, fibroblast lysates were immunoprecipitated with an antiphosphotyrosine antibody and the lysates were Western-blotted with an anti-pp125(fak) antibody. Cells grown on fibronectin and stimulated with IL-1 exhibited tyrosine phosphorylation of pp125(fak) whereas untreated cells or cells grown on poly-L-lysine and treated with IL-1 showed no reaction. Fibroblasts electroinjected with anti-pp125(fak) monoclonal antibody showed no [Ca2+](i) response, whereas cells treated with an irrelevant antibody exhibited a normal [Ca2+](i) response. Collectively, these data indicate that fibroblasts require substrate attachment and clustering of IL-1 receptors to focal adhesions for IL-1-induced [Ca2+](i) responses. Calcium fluxes are mediated through tyrosine kinases whose substrates include pp125(fak). These studies therefore demonstrate that activation of intracellular signaling pathways by IL-1 is dependent on IL-1 receptor-cytoskeletal protein interactions.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	ARORA, PD (corresponding author), UNIV TORONTO,FAC DENT,MRC,PERIODONTAL PHYSIOL GRP,124 EDWARD ST,TORONTO,ON M5S 1A8,CANADA.							ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; ARORA PD, 1994, J CELL PHYSIOL, V159, P161, DOI 10.1002/jcp.1041590120; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BIRD TA, 1986, NATURE, V324, P263, DOI 10.1038/324263a0; BOCQUET J, 1986, BIOCHEM BIOPH RES CO, V134, P539, DOI 10.1016/S0006-291X(86)80454-5; BOUCHELOUCHE PN, 1988, LEUKEMIA, V2, P691; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CANALIS E, 1986, ENDOCRINOLOGY, V118, P74, DOI 10.1210/endo-118-1-74; CARROLL GJ, 1986, BRIT J RHEUMATOL, V25, P359; CHIN J, 1987, J EXP MED, V165, P70, DOI 10.1084/jem.165.1.70; DEYERLE KL, 1992, J IMMUNOL, V149, P1657; DINARELLO CA, 1991, BLOOD, V77, P1627; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; DOWER SK, 1990, J INVEST DERMATOL, V94, pS68, DOI 10.1111/1523-1747.ep12875154; DURUM SK, 1990, IMMUNOPHYSIOLOGY ROL, P210; GALLIS B, 1989, J IMMUNOL, V143, P3235; GEARING AJH, 1985, IMMUNOL LETT, V10, P297, DOI 10.1016/0165-2478(85)90105-1; GEORGILIS K, 1987, J IMMUNOL, V138, P3403; GLOGAUER M, 1992, EXP CELL RES, V200, P227, DOI 10.1016/0014-4827(92)90168-8; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HULKOWER KI, 1991, AGENTS ACTIONS, V34, P278, DOI 10.1007/BF01993302; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JACONI MEE, 1990, J CELL BIOL, V112, P1249; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KABASHIMA H, 1991, INFECT IMMUN, V59, P4271, DOI 10.1128/IAI.59.11.4271-4274.1991; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; KINANE DF, 1992, ARCH ORAL BIOL, V37, P153, DOI 10.1016/0003-9969(92)90011-V; KORNBERG L, 1991, P NATL ACAD SCI USA, V89, P5192; LICHTMAN AH, 1983, BLOOD, V61, P413; LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MATSUSHIMA K, 1986, J IMMUNOL, V136, P4496; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MIZEL SB, 1990, IMMUNOL TODAY, V11, P390, DOI 10.1016/0167-5699(90)90154-2; OGISO B, 1992, CELL SIGNAL, V4, P627, DOI 10.1016/0898-6568(92)90044-9; ONEILL LAJ, 1990, J BIOL CHEM, V265, P3146; ONEILL LAJ, 1992, J IMMUNOL, V148, P474; PACIFICI R, 1988, J BONE MINER RES, V3, P107; PENDER N, 1991, J CELL SCI, V100, P187; POSTLETHWAITE AE, 1983, J EXP MED, V157, P801, DOI 10.1084/jem.157.2.801; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; QWARNSTROM EE, 1989, J CELL PHYSIOL, V139, P501, DOI 10.1002/jcp.1041390308; RASMUSSEN H, 1986, NEW ENGL J MED, V314, P1164; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; Schaller Michael D., 1993, Trends in Cell Biology, V3, P258, DOI 10.1016/0962-8924(93)90053-4; SCHMIDT JA, 1982, J IMMUNOL, V128, P2177; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SIEGELBAUM SA, 1994, CURR BIOL, V4, P242, DOI 10.1016/S0960-9822(00)00054-3; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; STANTON TH, 1986, J BIOL CHEM, V261, P5699; WIJETUNGE S, 1992, BIOCHEM BIOPH RES CO, V189, P1620, DOI 10.1016/0006-291X(92)90262-J	63	78	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6042	6049		10.1074/jbc.270.11.6042	http://dx.doi.org/10.1074/jbc.270.11.6042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890736	hybrid			2022-12-27	WOS:A1995QM94500052
J	ERNST, A; HELMHOLD, M; BRUNNER, C; PETHOSCHRAMM, A; ARMSTRONG, VW; MULLER, HJ				ERNST, A; HELMHOLD, M; BRUNNER, C; PETHOSCHRAMM, A; ARMSTRONG, VW; MULLER, HJ			IDENTIFICATION OF 2 FUNCTIONALLY DISTINCT LYSINE-BINDING SITES IN KRINGLE-37 AND IN KRINGLES 32-36 OF HUMAN APOLIPOPROTEIN(A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLASMINOGEN KRINGLE-4; RHESUS-MONKEY; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) BINDS; ARTERIAL-WALL; FIBRIN; LP(A); ATHEROSCLEROSIS; PLASMA; HETEROGENEITY	The well documented association between high plasma levels of lipoprotein(a) (Lp(a)) and cardiovascular disease might be mediated by the lysine binding of apolipoprotein(a) (apo(a)), the plasminogen-like, multikringle glycoprotein in Lp(a), We employed a mutational analysis to localize the lysine-binding domains within human apo(a), Recombinant apo(a) (r-apo(a)) with 17 plasminogen kringle IV-like domains, one plasminogen kringle V-like domain, and a protease domain or mutants thereof were expressed in the human hepatocarcinoma cell line HepG2. The lysine binding of plasma Lp(a) and r-apo(a) in the culture supernatants of transfected HepG2 cells was analyzed by lysine-Sepharose affinity chromatography. Wild type recombinant Lp(a) (r-Lp(a)) revealed lysine binding in the range observed for human plasma Lp(a). A single accessible lysine binding site in Lp(a) is indicated by a complete loss of lysine binding observed for r-Lp(a) species that contain either a truncated r-apo(a) lacking kringle IV-37, kringle V, and the protease or a point-mutated r-apo(a) with a Trp 4174 --> Arg substitution in the putative lysine-binding pocket of kringle IV-37, Evidence is also presented for additional lysine-binding sites within kringles 32-36 of apo(a) that are masked in Lp(a) as indicated by an increased lysine binding for the point mutant (Cys-4057 --> Ser), which is unable to assemble into particles, An important role of these lysine-binding site(s) for Lp(a) assembly is suggested by a decreased assembly efficiency for deletion mutants lacking either kringle 32 or kringles 32-35.	BOEHRINGER MANNHEIM GMBH, DEPT BIOL MOLEC, TF MM, D-68305 MANNHEIM, GERMANY; UNIV GOTTINGEN, DEPT CLIN CHEM, D-37075 GOTTINGEN, GERMANY; UNIV INNSBRUCK, INST MED BIOL & HUMAN GENET, A-6020 INNSBRUCK, AUSTRIA	University of Gottingen; University of Innsbruck								ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ARMSTRONG VW, 1990, J LIPID RES, V31, P429; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; BEISIEGEL U, 1990, EUR HEART J, V11, P174, DOI 10.1093/eurheartj/11.suppl_E.174; BROWN MS, 1987, NATURE, V330, P113, DOI 10.1038/330113a0; BRUNNER C, 1993, P NATL ACAD SCI USA, V90, P11643, DOI 10.1073/pnas.90.24.11643; CASTELLINO FJ, 1990, LIPOPROTEIN A, P87; CHIESA G, 1992, J BIOL CHEM, V267, P24369; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037; EATON DL, 1987, P NATL ACAD SCI USA, V84, P3224, DOI 10.1073/pnas.84.10.3224; EZRATTY A, 1993, BIOCHEMISTRY-US, V32, P4628, DOI 10.1021/bi00068a021; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FLEURY V, 1991, BIOCHEMISTRY-US, V30, P7630, DOI 10.1021/bi00244a035; GONZALEZGRONOW M, 1989, BIOCHEMISTRY-US, V28, P2374, DOI 10.1021/bi00432a005; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GUEVARA J, 1992, PROTEINS, V12, P188, DOI 10.1002/prot.340120212; GUEVARA J, 1993, ARTERIOSCLER THROMB, V13, P758, DOI 10.1161/01.ATV.13.5.758; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; HAJJAR KA, 1991, J BIOL CHEM, V266, P21962; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; HERVIO L, 1993, BLOOD, V82, P392; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; KRAFT HG, 1988, ARTERIOSCLEROSIS, V8, P212, DOI 10.1161/01.ATV.8.3.212; KRATZIN H, 1987, BIOL CHEM H-S, V368, P1533, DOI 10.1515/bchm3.1987.368.2.1533; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUSUMI Y, 1993, ATHEROSCLEROSIS, V99, P165, DOI 10.1016/0021-9150(93)90019-Q; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; LEERINK CB, 1991, FIBRINOLYSIS, V5, P233, DOI 10.1016/0268-9499(91)90005-O; LEERINK CB, 1992, THROMB HAEMOSTASIS, V68, P185; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LI ZG, 1992, PROTEIN EXPRES PURIF, V3, P212, DOI 10.1016/1046-5928(92)90017-Q; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; LOGRASSO PV, 1994, J BIOL CHEM, V269, P21820; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029; NACHMAN RL, 1991, ARTERIOSCLER THROMB, V11, P32, DOI 10.1161/01.ATV.11.1.32; PEPIN JM, 1991, J LIPID RES, V32, P317; RATH M, 1989, ARTERIOSCLEROSIS, V9, P579, DOI 10.1161/01.ATV.9.5.579; REJANTE M, 1991, FIBRINOLYSIS, V5, P87, DOI 10.1016/0268-9499(91)90048-9; REJANTE MR, 1991, BIOCHEMISTRY-US, V30, P11081, DOI 10.1021/bi00110a010; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; ROUY D, 1991, ARTERIOSCLER THROMB, V11, P629, DOI 10.1161/01.ATV.11.3.629; ROUY D, 1992, BIOCHEMISTRY-US, V31, P6333, DOI 10.1021/bi00142a024; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANGRAR W, 1994, PROTEIN ENG, V7, P723, DOI 10.1093/protein/7.5.723; SCANU AM, 1990, J LAB CLIN MED, V116, P142; SCANU AM, 1993, J CLIN INVEST, V91, P283, DOI 10.1172/JCI116182; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; THEWES T, 1990, J BIOL CHEM, V265, P3906; THORSEN S, 1975, BIOCHIM BIOPHYS ACTA, V393, P55, DOI 10.1016/0005-2795(75)90216-0; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; TRIEU VN, 1991, J BIOL CHEM, V266, P5480; TULINSKY A, 1988, J MOL BIOL, V202, P885, DOI 10.1016/0022-2836(88)90565-7; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; WILLIAMS JK, 1993, ARTERIOSCLER THROMB, V13, P548, DOI 10.1161/01.ATV.13.4.548; WU TP, 1991, BIOCHEMISTRY-US, V30, P10589, DOI 10.1021/bi00107a030	66	108	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6227	6234		10.1074/jbc.270.11.6227	http://dx.doi.org/10.1074/jbc.270.11.6227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890760	hybrid			2022-12-27	WOS:A1995QM94500077
J	WENDEL, M; SOMMARIN, Y; BERGMAN, T; HEINEGARD, D				WENDEL, M; SOMMARIN, Y; BERGMAN, T; HEINEGARD, D			ISOLATION, CHARACTERIZATION, AND PRIMARY STRUCTURE OF A CALCIUM-BINDING 63-KDA BONE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GEL-ELECTROPHORESIS; POLYACRYLAMIDE GELS; MOLECULAR-CLONING; LEUCINE ZIPPER; MESSENGER-RNA; BOVINE BONE; CARTILAGE; SEQUENCE; MATRIX; IDENTIFICATION	A novel noncollagenous protein of the mineralized matrix of bovine bone was isolated by ion exchange and gel permeation chromatography. The apparent M(r) of the protein is 63,000 as determined by SDS-polyacrylamide gel electrophoresis. The protein is a rather minor constituent in bone and could not be detected in other connective tissues by enzyme-linked immunosorbent assay of guanidine HCl extracts. The 63 kDa protein was detected in the osteoid and around the osteocytes upon immuno-histochemical staining of bovine compact bone. The sequence of the 63-kDa protein was deduced from cDNA clones isolated from a rat calvaria lambda gt11 expression library. The protein contains two centrally located EF-hand Ca2+-binding domains. Seven heptad repeats are present indicating the ability of the protein for coiled-coil interactions. Ability to bind calcium was confirmed by Ca-45(2+) binding to protein blotted onto nitrocellulose membrane. The protein was synthesized in calvaria explants as detected by immunoprecipitation of radiolabeled protein from the culture medium. Although the protein can be detected in biochemical amounts in bone only, varying amounts of mRNA for this protein were detected in several rat tissues by RNase protection assay with highest levels in rat calvaria. This extracellular protein corresponds to a mouse protein called nucleobindin.	LUND UNIV,DEPT MED & PHYSIOL CHEM,S-22100 LUND,SWEDEN; KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,S-17177 STOCKHOLM,SWEDEN	Lund University; Karolinska Institutet								ADAMS ME, 1992, ANAL BIOCHEM, V202, P89, DOI 10.1016/0003-2697(92)90211-O; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; DELMAS PD, 1984, CALCIFIED TISSUE INT, V36, P308, DOI 10.1007/BF02405335; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; ENGEL J, 1992, BIOCHEMISTRY-US, V44, P10643; FISHER LW, 1990, J BIOL CHEM, V265, P2347; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; FRANZEN A, 1984, BIOCHEM J, V224, P47, DOI 10.1042/bj2240047; GORSKI JP, 1990, J BIOL CHEM, V265, P14956; HEINEGARD D, 1981, BIOCHEM J, V197, P355, DOI 10.1042/bj1970355; HEINEGARD D, 1995, STRUCTURE FUNCTION A; Heinegard Dick, 1993, P189; KANAI Y, 1992, IMMUNOL LETT, V32, P43; KRETSINGER RH, 1987, COLD SPRING HARB SYM, V52, P499, DOI 10.1101/SQB.1987.052.01.057; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; LEE CC, 1987, P NATL ACAD SCI USA, V84, P4403, DOI 10.1073/pnas.84.13.4403; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PAULSSON M, 1983, BIOCHEM J, V212, P659, DOI 10.1042/bj2120659; Price P.A., 1987, CALCIUM REGULATION B, V9, P419; PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335; ROBEY PG, 1988, J CELL BIOL, V108, P719; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WENDEL M, 1993, MATRIX, V13, P331, DOI 10.1016/S0934-8832(11)80029-6; YOUNG MF, 1992, CLIN ORTHOPAEDICS, V281, P275	37	50	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6125	6133		10.1074/jbc.270.11.6125	http://dx.doi.org/10.1074/jbc.270.11.6125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890746	hybrid			2022-12-27	WOS:A1995QM94500062
J	CAPLAN, AJ; LANGLEY, E; WILSON, EM; VIDAL, J				CAPLAN, AJ; LANGLEY, E; WILSON, EM; VIDAL, J			HORMONE-DEPENDENT TRANSACTIVATION BY THE HUMAN ANDROGEN RECEPTOR IS REGULATED BY A DNAJ PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; ESCHERICHIA-COLI DNAJ; SACCHAROMYCES-CEREVISIAE; GLUCOCORTICOID RECEPTOR; ENDOPLASMIC-RETICULUM; PROGESTERONE-RECEPTOR; EUKARYOTIC HOMOLOGS; YEAST HOMOLOG; TRANSLOCATION; BINDING	Genetic studies were performed to examine the role of eukaryotic dnaJ protein, Ydj1p, in the regulated activation of human androgen receptor (hAR) after heterologous expression in Saccharomyces cerevisiae. Hormone-dependent activation of hAR was measured as a function of lacZ reporter gene expression, which was defective in ydj1-151 and ydj1-2(Delta) null mutant strains compared to the wild type. This defect was not due to receptor misfolding, since hAR in both wild type and mutant strains had a similar capacity to bind hormone. The target for Ydj1p action was determined to be the hAR hormone binding domain since an N-terminal fragment lacking this region was constitutively active in both wild type and ydj1-151 mutant strains. These data correlate hormone dependence of hAR activation with a requirement for Ydj1p function and are consistent with a role for dnaJ proteins in signal transduction by steroid hormone receptors.	UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	CAPLAN, AJ (corresponding author), MT SINAI MED CTR, DEPT ANAT & CELL BIOL, NEW YORK, NY 10029 USA.		Caplan, Avrom/GPT-0824-2022	Langley, Elizabeth/0000-0001-6180-8036				ATENCIO DP, 1992, MOL CELL BIOL, V12, P283, DOI 10.1128/MCB.12.1.283; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; BRUGGE JS, 1987, MOL CELL BIOL, V7, P2180, DOI 10.1128/MCB.7.6.2180; BRUNT SA, 1990, MOL CELL BIOL, V10, P273, DOI 10.1128/MCB.10.1.273; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; CHELLAIAH A, 1993, BIOCHIM BIOPHYS ACTA, V1174, P111, DOI 10.1016/0167-4781(93)90103-K; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; CYR DM, 1994, J BIOL CHEM, V269, P9798; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DIEHL EE, 1993, BIOCHEMISTRY-US, V32, P13510, DOI 10.1021/bi00212a016; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; MARIVOET S, 1992, MOL CELL ENDOCRINOL, V88, P165, DOI 10.1016/0303-7207(92)90021-W; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Miller J. H, 1972, EXPT MOL GENETICS; OH S, 1993, BIOCHIM BIOPHYS ACTA, V1174, P114, DOI 10.1016/0167-4781(93)90104-L; OMALLEY BW, 1992, MOL ENDOCRINOL, V6, P1359, DOI 10.1210/me.6.9.1359; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; PRATT WB, 1993, J BIOL CHEM, V268, P21455; PURVIS IJ, 1991, GENE, V106, P35, DOI 10.1016/0378-1119(91)90563-Q; RIEHL RM, 1985, BIOCHEMISTRY-US, V24, P6586, DOI 10.1021/bi00344a042; Sambrook J, 1989, MOL CLONING LABORATO; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCIDMORE MA, 1993, MOL BIOL CELL, V4, P1145, DOI 10.1091/mbc.4.11.1145; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SMITH DF, 1992, J BIOL CHEM, V267, P1350; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; WICKNER S, 1991, P NATL ACAD SCI USA, V88, P7903, DOI 10.1073/pnas.88.18.7903; WONG CI, 1993, J BIOL CHEM, V268, P19004; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; [No title captured]	55	103	104	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5251	5257		10.1074/jbc.270.10.5251	http://dx.doi.org/10.1074/jbc.270.10.5251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890635	hybrid, Green Published			2022-12-27	WOS:A1995QL58000047
J	CHANMUGAM, P; FENG, LL; LIOU, SE; JANG, BOC; BOUDREAU, M; YU, G; LEE, JH; KWON, HJ; BEPPU, T; YOSHIDA, M; XIA, YY; WILSON, CB; HWANG, D				CHANMUGAM, P; FENG, LL; LIOU, SE; JANG, BOC; BOUDREAU, M; YU, G; LEE, JH; KWON, HJ; BEPPU, T; YOSHIDA, M; XIA, YY; WILSON, CB; HWANG, D			RADICICOL, A PROTEIN-TYROSINE KINASE INHIBITOR, SUPPRESSES THE EXPRESSION OF MITOGEN-INDUCIBLE CYCLOOXYGENASE IN MACROPHAGES STIMULATED WITH LIPOPOLYSACCHARIDE AND IN EXPERIMENTAL GLOMERULONEPHRITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; MESSENGER-RNA; SIGNAL TRANSDUCTION; COMPLEMENTARY-DNA; G/H SYNTHASE; HERBIMYCIN-A; SRC-FAMILY; GENE; PHOSPHORYLATION; CELLS	Two isoforms of cyclooxygenase (COX) have been identified in eukaryotic cells: a constitutively expressed COX-1 and mitogen-inducible COX-2, which is selectively expressed in response to various inflammatory stimuli. Thus, COX-2 instead of COX-1 is implicated to produce prostanoids mediating inflammatory responses. Major efforts have been focused on identifying nonsteroidal anti inflammatory drugs (NSAIDS) which can selectively inhibit the enzyme activity of COX-2. Such NSAlDS would be more desirable anti-inflammatory agents in comparison to NSAIDS which inhibit both COX-1 and COX-2. Other than glucocorticoids, pharmacological agents which can selectively suppress the expression of COX-2 without affecting that of COX-1 have not been identified. We report here that radicicol, a fungal antibiotic, is a potent protein tyrosine kinase inhibitor, and that it inhibits the expression of COX-2 without affecting COX-1 expression in lipopolysaccharide (LPS)-stimulated macrophages with the IC50 value of 27 nM. Radicicol inhibited tyrosine phosphorylation of p53/56(lyn), a Src family tyrosine kinase and one of the major tyrosine-phosphorylated proteins in LPS-stimulated macrophages. Radicicol also inhibited COX-2 expression in vivo in glomeruli of rats with experimental glomerulonephritis induced by the anti-glomerular basement membrane antibodies, in which COX-2 expression is known to be enhanced. The enzyme activity of COX-1 or COX-2 was not affected by radicicol in macrophages. Radicicol also suppressed the COX-2 expression induced by IL-1(beta) in rat smooth muscle cells. Other protein tyrosine kinase inhibitors suppressed the LPS-induced COX-2 expression in macrophages but at much higher concentrations than needed for radicicol. Radicicol did not inhibit the COX-2 expression induced by phorbol 12-myristate 13-acetate in macrophages. These results suggest that the activation of tyrosine-specific protein kinases is the proximal obligatory step in the LPS-induced signal transduction pathway leading to the induction of COX-2 expression in macrophages. The magnitude of the inhibition of COX-2 protein synthesis by radicicol was much greater than that of the steady state levels of COX-2 mRNA. These results suggest that radicicol inhibits COX-2 expression mainly at post-transcriptional steps.	LOUISIANA STATE UNIV, PENNINGTON BIOMED RES CTR, BATON ROUGE, LA 70808 USA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA; UNIV TOKYO, DEPT BIOTECHNOL, TOKYO 113, JAPAN	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; University of Tokyo			Yoshida, Minoru/C-8049-2014; 권, 호정/AAS-3642-2021; Boudreau, Mary/E-4721-2015	Yoshida, Minoru/0000-0002-4376-5674; 	NIDDK NIH HHS [R01 DK-41868, R01 DK-20043] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041868, R01DK020043] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEDARD PA, 1987, P NATL ACAD SCI USA, V84, P6715, DOI 10.1073/pnas.84.19.6715; BLANTZ RC, 1976, J CLIN INVEST, V58, P899, DOI 10.1172/JCI108543; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; CHANDLER DB, 1987, J IMMUNOL, V139, P893; CHENG HC, 1992, J BIOL CHEM, V267, P9248; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELMOTTE P, 1953, NATURE, V171, P344, DOI 10.1038/171344a0; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; FENG L, 1993, ARCH BIOCHEM BIOPHYS, V307, P361, DOI 10.1006/abbi.1993.1601; Feng L., 1993, Journal of the American Society of Nephrology, V4, P452; FENG L, 1995, IN PRESS J CLIN INVE; GLASER KB, 1993, BIOCHEM PHARMACOL, V45, P711, DOI 10.1016/0006-2952(93)90147-O; GLASER KB, 1990, J BIOL CHEM, V265, P8658; HAN JH, 1993, J BIOL CHEM, V268, P25009; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; JONES DA, 1993, J BIOL CHEM, V268, P9049; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; KWON HJ, 1992, CANCER RES, V52, P6926; LEE SH, 1992, J BIOL CHEM, V267, P25934; McCAPRA FRANK, 1964, TETRAHEDRON LETT, V15/16, P869; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MIRRINGTON RN, 1964, TETRAHEDRON LETT, V7, P365; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; NOZAWA K, 1979, J NAT PROD, V42, P374, DOI 10.1021/np50004a004; OBANION MK, 1991, J BIOL CHEM, V266, P23261; POWELL WS, 1982, METHOD ENZYMOL, V86, P467; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; UEHARA Y, 1989, CANCER RES, V49, P780; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WHITTLE BJR, 1980, NATURE, V284, P271, DOI 10.1038/284271a0; XIE WL, 1993, ARCH BIOCHEM BIOPHYS, V300, P247, DOI 10.1006/abbi.1993.1034; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X	40	123	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5418	5426		10.1074/jbc.270.10.5418	http://dx.doi.org/10.1074/jbc.270.10.5418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890656	hybrid			2022-12-27	WOS:A1995QL58000072
J	KURACHI, S; HITOMI, Y; FURUKAWA, M; KURACHI, K				KURACHI, S; HITOMI, Y; FURUKAWA, M; KURACHI, K			ROLE OF INTRON-I IN EXPRESSION OF THE HUMAN FACTOR-IX GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPHILIA-B LEYDEN; TRANSGENIC MICE; NUCLEOTIDE-SEQUENCE; BINDING-SITE; PLASMID DNA; PROMOTER; CELLS; DISRUPTION; EFFICIENCY; ELEMENT	The first intron (intron I) of the human factor IX gene, which has been previously suggested of having an expression-augmenting activity, was systematically studied for its potential enhancer activity. When tested with the chloramphenicol acetyltransferase expression vector with a minimal factor IX promoter, subregions of intron I showed only marginal enhancing activities (1.7-1.9-fold enhancement at the highest). Smaller subregions encompassing nucleotides 5660-6350 of the intron sequence even showed some weak negative regulatory activities (similar to 50% suppression at the highest), while a cytomegalovirus enhancer sequence, which was used as the positive control, had a 7-fold enhancement. A set of three factor IX minigene expression vectors with the same factor IX promoter were then constructed: p-416FIXc which contained the factor IX cDNA, p-416FIXm1 which contained the factor IX cDNA with a largely truncated intron I, and p-416FIXm2 which contained the factor IX cDNA with the intron I sequence further truncated. The p-416FIXm1 and p-416FIXm2 constructs showed 7-9-fold higher expression activities than p-416FIXc. The elevated factor IX antigen levels agreed well with the grossly elevated factor IX clotting activity and mRNA levels. These results indicate that the expression enhancing activity of intron I is not due to specific enhancer elements present in the intron subsequences, but is due to functional splicing sequences present in the precursor mRNAs produced from the minigene constructs containing intron I. By being efficiently assembled into spliceosome complexes, transcripts with splicing sequences may be better protected in the nucleus from random degradations than those without such sequences.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038644] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00042] Funding Source: Medline; NHLBI NIH HHS [HL38644] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Austen D, 1975, LAB MANUAL BLOOD COA, P59; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; BRIET E, 1982, NEW ENGL J MED, V306, P788, DOI 10.1056/NEJM198204013061306; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; BUSBY S, 1985, NATURE, V316, P271, DOI 10.1038/316271a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; HIROSAWA S, 1990, P NATL ACAD SCI USA, V87, P4421, DOI 10.1073/pnas.87.12.4421; JALLAT S, 1990, EMBO J, V9, P3295, DOI 10.1002/j.1460-2075.1990.tb07529.x; KORB M, 1993, NUCLEIC ACIDS RES, V21, P5901, DOI 10.1093/nar/21.25.5901; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; KURACHI K, 1993, BLOOD COAGUL FIBRIN, V4, P953, DOI 10.1097/00001721-199304060-00013; KURACHI S, 1994, BIOCHEMISTRY-US, V33, P1580, DOI 10.1021/bi00172a039; LAMOND AI, 1993, BIOESSAYS, V15, P595, DOI 10.1002/bies.950150905; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; PICKETTS DJ, 1993, NAT GENET, V3, P175, DOI 10.1038/ng0293-175; REIJNEN MJ, 1993, BLOOD, V82, P151, DOI 10.1182/blood.V82.1.151.bloodjournal821151; RIO DC, 1993, CURR OPIN GENET DEV, V3, P574, DOI 10.1016/0959-437X(93)90093-5; SALIER JP, 1990, J BIOL CHEM, V265, P7062; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; STERNER DA, 1993, MOL CELL BIOL, V13, P2677, DOI 10.1128/MCB.13.5.2677; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; YAO SN, 1992, BIOTECHNIQUES, V12, P525; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	29	82	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5276	5281		10.1074/jbc.270.10.5276	http://dx.doi.org/10.1074/jbc.270.10.5276			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890639	hybrid			2022-12-27	WOS:A1995QL58000051
J	LYNCH, SM; FREI, B				LYNCH, SM; FREI, B			REDUCTION OF COPPER, BUT NOT IRON, BY HUMAN LOW-DENSITY-LIPOPROTEIN (LDL) - IMPLICATIONS FOR METAL ION-DEPENDENT OXIDATIVE MODIFICATION OF LDL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; LIPID-PEROXIDATION; FREE-RADICALS; VITAMIN-E; CHOLESTEROL DEPOSITION; ENDOTHELIAL-CELLS; ALPHA-TOCOPHEROL; SUPEROXIDE; MACROPHAGES; PROOXIDANT	Cell-mediated oxidative modification of human low density lipoprotein (LDL), most likely an important early step in atherosclerosis, requires redox active metal ions such as copper or iron. We have previously shown that iron-dependent, in contrast to copper-dependent, oxidative modification of LDL requires superoxide, a physiological reductant. In the present study, we sought to explain these discrepant results. LDL was incubated at 37 degrees C with Cu2+ (10 mu M) and bathocuproine (BC, 360 mu M), an indicator molecule which specifically complexes Cu+, but not Cu2+, In a time- and concentration-dependent manner, LDL reduced Cu2+ to Cu+. An LDL concentration as low as 10 mu g of protein/ml (about 20 nM) reduced about 7 mu M Cu2+ within 1 h of incubation. Complexation of the Cu+ formed under these conditions with BC significantly inhibited oxidative modification of LDL, as assessed by agarose gel electrophoresis. Preincubation of LDL with N-ethylmaleimide had no effect on the rate and extent of Cu2+ reduction nor LDL oxidation, indicating that free sulfhydryl groups associated with apolipoprotein B are not involved. Addition of either superoxide dismutase or catalase or increasing the cu-tocopherol content of LDL from 11.8 +/- 3.0 to 24.4 +/- 2.8 nmol/mg of protein also had no significant effect on the kinetics of Cu2+ reduction by LDL. In contrast, incubation of LDL with Fe3+ citrate (10 mu M) and the indicator bathophenanthroline (BP, 360 mu M) resulted in no significant Fe2+ formation, even at LDL concentrations as high as 200 mu g of protein/ml. However, incubation of LDL with Fe3+-citrate and an enzymatic source of superoxide led to rapid formation of Fe2+ and consequent oxidative modification of LDL. Addition of BP inhibited iron-mediated LDL oxidation under these conditions. Our results indicate that reduced metal ions are important mediators of LDL oxidation, and that LDL specifically reduces Cu2+, but not Fe3+. These data, therefore, help explain why copper, in addition to being chemically more reactive, is more potent than iron at mediating LDL oxidation.	BOSTON UNIV,SCH MED,WHITAKER CARDIOVASC INST,BOSTON,MA 02118	Boston University			Lynch, Sean M/A-9354-2009		NHLBI NIH HHS [HL-49954] Funding Source: Medline; NIEHS NIH HHS [ES-06593] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006593] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BEDWELL S, 1989, BIOCHEM J, V262, P707, DOI 10.1042/bj2620707; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; ESTERBAUER H, 1991, AM J CLIN NUTR, V53, pS341; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; FREI B, 1988, ANAL BIOCHEM, V175, P120, DOI 10.1016/0003-2697(88)90369-7; GERRITY RG, 1981, AM J PATHOL, V103, P191; GIESEG SP, 1994, FEBS LETT, V343, P188, DOI 10.1016/0014-5793(94)80553-9; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; HEINECKE JW, 1987, J BIOL CHEM, V262, P10098; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; HIRAMATSU K, 1987, ARTERIOSCLEROSIS, V7, P55, DOI 10.1161/01.ATV.7.1.55; INGOLD KU, 1993, P NATL ACAD SCI USA, V90, P45, DOI 10.1073/pnas.90.1.45; JESSUP W, 1993, ATHEROSCLEROSIS, V99, P107, DOI 10.1016/0021-9150(93)90056-Z; JOSELOW M, 1951, J BIOL CHEM, V191, P11; JURGENS G, 1986, BIOCHIM BIOPHYS ACTA, V875, P103, DOI 10.1016/0005-2760(86)90016-0; Kappus H., 1985, OXIDATIVE STRESS, V40, P273, DOI [DOI 10.1016/B978-0-12-642760-8.50016-8, 10.1016/B978-0-12-642760-8.50016-8]; KUZUYA M, 1991, BIOCHIM BIOPHYS ACTA, V1096, P155, DOI 10.1016/0925-4439(91)90054-D; KUZUYA M, 1992, BIOCHIM BIOPHYS ACTA, V1123, P334, DOI 10.1016/0005-2760(92)90015-N; KUZUYA M, 1991, BIOCHIM BIOPHYS ACTA, V1084, P198; LANDERS JW, 1958, AM J CLIN PATHOL, V29, P590; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH SM, 1993, J LIPID RES, V34, P1745; MAIORINO M, 1993, FEBS LETT, V330, P174, DOI 10.1016/0014-5793(93)80267-X; MILLER DM, 1993, ARCH BIOCHEM BIOPHYS, V301, P1, DOI 10.1006/abbi.1993.1107; MINOTTI G, 1987, CHEM PHYS LIPIDS, V44, P191, DOI 10.1016/0009-3084(87)90050-8; MINOTTI G, 1987, J BIOL CHEM, V262, P1098; MINOTTI G, 1992, LIPIDS, V27, P219, DOI 10.1007/BF02536182; MINOTTI G, 1987, FREE RADICAL BIO MED, V3, P379, DOI 10.1016/0891-5849(87)90016-5; PARTHASARATHY S, 1992, PROG LIPID RES, V31, P127, DOI 10.1016/0163-7827(92)90006-5; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; REYFTMANN JP, 1990, BIOCHIM BIOPHYS ACTA, V1042, P159, DOI 10.1016/0005-2760(90)90002-F; SATTLER W, 1991, BIOCHIM BIOPHYS ACTA, V1081, P65, DOI 10.1016/0005-2760(91)90251-C; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, pI1; SPARROW CP, 1993, J LIPID RES, V34, P1219; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; WILKINS GM, 1990, BIOCHEM SOC T, V18, P1170, DOI 10.1042/bst0181170; WONG A, 1984, BIOCHEMISTRY-US, V23, P2939, DOI 10.1021/bi00308a014; WONG A, 1984, BIOCHEMISTRY-US, V23, P2946, DOI 10.1021/bi00308a015; YAMAMOTO Y, 1990, METHOD ENZYMOL, V186, P371; YOSHIDA Y, 1994, BBA-GEN SUBJECTS, V1200, P85, DOI 10.1016/0304-4165(94)90121-X; [No title captured]	49	141	141	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5158	5163		10.1074/jbc.270.10.5158	http://dx.doi.org/10.1074/jbc.270.10.5158			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890625	hybrid			2022-12-27	WOS:A1995QL58000033
J	DREWETT, JG; FENDLY, BM; GARBERS, DL; LOWE, DG				DREWETT, JG; FENDLY, BM; GARBERS, DL; LOWE, DG			NATRIURETIC PEPTIDE RECEPTOR-B (GUANYLYL CYCLASE-B) MEDIATES C-TYPE NATRIURETIC PEPTIDE RELAXATION OF PRECONTRACTED RAT AORTA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP; MICROBIAL ORIGIN; SMOOTH-MUSCLE; 2ND MESSENGER; ATRIAL; ACTIVATION; ANTAGONIST; EXPRESSION; INHIBITION; HS-142-1	The most potent known agonist for the natriuretic peptide receptor-B (NPR-B)/guanylyl cyclase-B is C-type natriuretic peptide (CNP). A homologous ligand-receptor system consists of atrial natriuretic peptide (ANP) and NPR-A/guanylyl cyclase-A A third member of this family is NPR-C, a non-guanylyl cyclase receptor. Monoclonal antibodies were raised against NPR-B by immunizing mice with a purified receptor-IgG fusion protein consisting of the extracellular domain of NPR-B and the Pc portion of human IgG-gamma(1). One monoclonal antibody, 3G12, did not recognize NPR-A or NPR-C and bound to human and rat NPR-B. CNP binding to NPR-B and stimulation of cGMP synthesis were inhibited by 3G12. With cells isolated from either the media or adventitia layers of rat thoracic aorta, 3G12 did not interfere with ANP-stimulated cGMP synthesis, but it inhibited CNP-stimulated cGMP levels in cells from both layers. CNP (IC50 = 10 nM) and ANP (IC50 = 1 nM) caused relaxation of phenylephrine-contracted rat aortic rings. 3G12 caused a marked increase in the IC50 for CNP, from 10 nM to 140 nM, but failed to affect ANP-mediated relaxation. Therefore, our results for the first time demonstrate that CNP relaxes vascular smooth muscle by virtue of its binding to NPR-B.	GENENTECH INC, DEPT CARDIOVASC RES, S SAN FRANCISCO, CA 94080 USA; MED COLL WISCONSIN, DEPT PHARMACOL & TOXICOL, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, CARDIOVASC RES CTR, MILWAUKEE, WI 53226 USA; UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA	Roche Holding; Genentech; Medical College of Wisconsin; Medical College of Wisconsin; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; BOND JS, 1989, PROTEOLYTIC ENZYMES, P241; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHRISMAN TD, 1993, J BIOL CHEM, V268, P3698; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; DEAN AD, 1994, AM J PHYSIOL, V266, pF491, DOI 10.1152/ajprenal.1994.266.3.F491; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DELPORTE C, 1992, EUR J PHARMACOL, V224, P183, DOI 10.1016/0014-2999(92)90803-C; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; DREWETT JG, 1989, J PHARMACOL EXP THER, V248, P135; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURUYA M, 1993, BIOCHEM BIOPH RES CO, V193, P248, DOI 10.1006/bbrc.1993.1616; GUTKOWSKA J, 1989, ENDOCR REV, V10, P519, DOI 10.1210/edrv-10-4-519; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HUANG CL, 1986, P NATL ACAD SCI USA, V83, P8015, DOI 10.1073/pnas.83.20.8015; IMURA R, 1992, MOL PHARMACOL, V42, P982; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KOMATSU Y, 1991, ENDOCRINOLOGY, V129, P1104, DOI 10.1210/endo-129-2-1104; LIGHT DB, 1989, SCIENCE, V243, P383, DOI 10.1126/science.2463673; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1990, NUCLEIC ACIDS RES, V18, P3412, DOI 10.1093/nar/18.11.3412; LOWE DG, 1992, J BIOL CHEM, V267, P21691; LUCAS C, 1990, J IMMUNOL, V145, P1415; MAACK T, 1986, BIOCHEM PHARMACOL, V35, P2057, DOI 10.1016/0006-2952(86)90570-8; MAACK T, 1992, ANNU REV PHYSIOL, V54, P11, DOI 10.1146/annurev.physiol.54.1.11; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MORISHITA Y, 1991, BIOCHEM BIOPH RES CO, V176, P949, DOI 10.1016/0006-291X(91)90374-G; NAKAMURA M, 1994, CIRCULATION, V90, P1210, DOI 10.1161/01.CIR.90.3.1210; OHYAMA Y, 1992, BIOCHEM BIOPH RES CO, V189, P336, DOI 10.1016/0006-291X(92)91563-6; RICHARD V, 1990, AM J PHYSIOL, V259, pH1433, DOI 10.1152/ajpheart.1990.259.5.H1433; SALVESEN G, 1989, PROTEOLYTIC ENZYMES, P98; SANO T, 1992, J PHARMACOL EXP THER, V260, P825; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; STANTON BA, 1991, CAN J PHYSIOL PHARM, V69, P1546, DOI 10.1139/y91-230; STEVENS TL, 1994, HYPERTENSION, V23, P613, DOI 10.1161/01.HYP.23.5.613; STINGO AJ, 1992, AM J PHYSIOL, V262, pH308, DOI 10.1152/ajpheart.1992.262.1.H308; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SUGA SI, 1992, CIRC RES, V71, P34, DOI 10.1161/01.RES.71.1.34; TAWARAGI Y, 1990, BIOCHEM BIOPH RES CO, V172, P627, DOI 10.1016/0006-291X(90)90720-8; VONGELDERN TW, 1990, MOL PHARMACOL, V38, P771; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WEI CM, 1993, AM J PHYSIOL, V264, pH71	49	77	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4668	4674		10.1074/jbc.270.9.4668	http://dx.doi.org/10.1074/jbc.270.9.4668			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876238	hybrid			2022-12-27	WOS:A1995QK08400072
J	FERRO, KL; COLLINS, CA				FERRO, KL; COLLINS, CA			MICROTUBULE-INDEPENDENT PHOSPHOLIPID STIMULATION OF CYTOPLASMIC DYNEIN ATPASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN ATPASE; VESICLE TRANSPORT; ACTIVATED ATPASE; ADP RELEASE; MYOSIN-I; BINDING; PROTEIN; PHOSPHORYLATION; ACTIN; HEAVY	In this study we report that phospholipid vesicles activate ATP hydrolysis by cytoplasmic dynein but not kinesin, consistent with reported differences in the organelle/vesicle binding of these motor proteins, Dynein activation by phospholipids was comparable with that seen in the presence of microtubules but was not sensitive to moderate salt concentrations and was independent of the net charge of the phospholipid, suggesting that the means of interaction between dynein and the lipid vesicle was not strictly ionic in nature, Based on this result, previous data that show that the interaction between dynein and vesicles is not ATP sensitive, and the concentration dependence observed for lipid activation of cytoplasmic dynein, it is likely that the binding interaction between dynein and liposomes is a stable one, In contrast to a previous report, microtubules increased the hydrolysis rate of all naturally occurring nucleotides tested, whereas only ATPase activity was stimulated by phospholipids. As ATP is the physiologically relevant substrate and is the only nucleotide to promote motility, the activation of only the ATPase by phospholipids may represent a means of discriminating between coupled and uncoupled nucleotide hydrolysis in vitro.			FERRO, KL (corresponding author), NORTHWESTERN UNIV, SCH MED, DEPT MOLEC & CELL BIOL, CHICAGO, IL 60611 USA.							ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; COHN SA, 1987, NATURE, V328, P160, DOI 10.1038/328160a0; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GRISSOM PM, 1992, CELL MOTIL CYTOSKEL, V21, P281, DOI 10.1002/cm.970210404; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HISANAGA S, 1989, CELL MOTIL CYTOSKEL, V12, P264, DOI 10.1002/cm.970120407; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P7010, DOI 10.1021/bi00443a034; KOONCE MP, 1990, CELL MOTIL CYTOSKEL, V15, P51, DOI 10.1002/cm.970150108; KUZNETSOV SA, 1989, J BIOL CHEM, V264, P589; LACEY ML, 1992, J BIOL CHEM, V267, P4793; LACEY ML, 1994, CELL MOTIL CYTOSKEL, V28, P205, DOI 10.1002/cm.970280304; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; LIN SXH, 1993, J CELL SCI, V105, P579; LIN SXH, 1992, J CELL SCI, V101, P125; LIN SXH, 1991, J CELL BIOL, V115, P168; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; MATTHIES HJG, 1993, J BIOL CHEM, V268, P11176; NEELY MD, 1990, J BIOL CHEM, V265, P8691; NEELY MD, 1988, J CELL BIOL, V107, P1767, DOI 10.1083/jcb.107.5.1767; PALLINI V, 1983, J SUBMICR CYTOL PATH, V15, P229; PASCHAL BM, 1993, J BIOL CHEM, V268, P15318; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; SADHU A, 1992, J BIOL CHEM, V267, P11352; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SCHROEDER CC, 1990, J CELL BIOL, V111, P2553, DOI 10.1083/jcb.111.6.2553; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; SHIMIZU T, 1992, EUR J BIOCHEM, V206, P911, DOI 10.1111/j.1432-1033.1992.tb17000.x; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; TUMA PL, 1994, J BIOL CHEM, V269, P30842; TUMA PL, 1993, J BIOL CHEM, V268, P17240; VALE RD, 1992, J CELL BIOL, V119, P1589, DOI 10.1083/jcb.119.6.1589; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; YU H, 1992, J BIOL CHEM, V267, P20457; ZOT HG, 1992, J CELL BIOL, V116, P367, DOI 10.1083/jcb.116.2.367	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4492	4496		10.1074/jbc.270.9.4492	http://dx.doi.org/10.1074/jbc.270.9.4492			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876216	hybrid			2022-12-27	WOS:A1995QK08400049
J	YU, G; SHEN, FS; STURCH, S; AQUINO, A; GLAZER, RI; FELSTED, RL				YU, G; SHEN, FS; STURCH, S; AQUINO, A; GLAZER, RI; FELSTED, RL			REGULATION OF HIV-1 GAG PROTEIN SUBCELLULAR TARGETING BY PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MATRIX PROTEIN; STRUCTURAL PROTEINS; MEMBRANE ASSOCIATION; FINE-STRUCTURE; D RETROVIRUSES; LIFE-CYCLE; TYPE-1; CELLS; PRECURSOR	The human immunodeficiency virus type 1 internal structural protein precursor, p55, and its corresponding matrix proteolytic fragment, p17, are phosphorylated at Ser(111) by protein kinase C. COS-7 cells transfected with plasmids encoding either the wild-type or Ser(111) --> Ala mutated human immunodeficiency virus type 1 gag gene matrix domain proteins were treated with phorbol 12-myristate 13-acetate (PMA), and the phosphorylation of the expressed p17 proteins was examined by radioimmunoprecipitation, SDS-polyacrylamide gel electrophoresis, and autoradiography, PMA treatment of transfected cells resulted in a 4-5-fold increase in wild-type p17 (but not mutated p17) phosphorylation; however, mutated p17 exhibited a low basal level of phosphorylation that was not affected by PMA, suggesting that additional sites were phosphorylated, PMA treatment of cells expressing wild-type p17 produced a dramatic shift in the localization of p17 from the cytosol to the membrane fraction within 8-15 min, followed by a slow quantitative dissociation of p17 back into the cytosol by 90 min, The cytosol-to-membrane translocation was dependent on N-myristoylated p17 since cells expressing p17 with a Gly(2) --> Ala mutation did not localize to the membrane, PMA also failed to induce the translocation of fully N-myristoylated Ser(111) --> Ala p17, suggesting that p17 phosphorylation at Ser(111) was responsible for membrane association, This conclusion was confirmed by the finding of phosphorylated wild-type p17 in the membrane fraction only after PMA treatment, These results suggest that a ''myristoyl-protein switch'' regulates the reversible membrane targeting of p17 by protein kinase C-mediated phosphorylation. This signal may provide a mechanism for the cellular regulation of virus development through modulation of gag protein-related developmental steps such as capsid targeting, assembly, encapsidation, budding, and maturation.	NCI,DIV CANC TREATMENT,BIOL CHEM LAB,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BIEMANS R, 1992, AIDS, V6, P541, DOI 10.1097/00002030-199206000-00003; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; BURNETTE B, 1993, J BIOL CHEM, V268, P8698; CANN AJ, 1989, AIDS, V3, pS19, DOI 10.1097/00002030-198901001-00004; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DELCHAMBRE M, 1989, EMBO J, V8, P2653, DOI 10.1002/j.1460-2075.1989.tb08405.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; FELSTED RL, 1989, DEV CANCER CHEMOTHER, V2, P95; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; GELDERBLOM HR, 1988, MICRON MICROSC ACTA, V19, P41, DOI 10.1016/0739-6260(88)90039-1; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GOWDA SD, 1989, J VIROL, V63, P1451, DOI 10.1128/JVI.63.3.1451-1454.1989; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES TA, 1990, J VIROL, V64, P2265, DOI 10.1128/JVI.64.5.2265-2279.1990; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARX PA, 1988, LAB INVEST, V58, P112; MYERS G, 1990, HUMAN RETROVIRUSES A; PAPSIDERO LD, 1989, J VIROL, V63, P267, DOI 10.1128/JVI.63.1.267-272.1989; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; RHEE SS, 1991, EMBO J, V10, P535, DOI 10.1002/j.1460-2075.1991.tb07980.x; RHEE SS, 1990, J VIROL, V64, P4383, DOI 10.1128/JVI.64.9.4383-4389.1990; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; YU XF, 1992, J VIROL, V66, P5667, DOI 10.1128/JVI.66.9.5667-5670.1992; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	39	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4792	4796		10.1074/jbc.270.9.4792	http://dx.doi.org/10.1074/jbc.270.9.4792			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876252	hybrid			2022-12-27	WOS:A1995QK08400088
J	FLORDELLIS, CS; BERGUERAND, M; GOUACHE, P; BARBU, V; GAVRAS, H; HANDY, DE; BEREZIAT, G; MASLIAH, J				FLORDELLIS, CS; BERGUERAND, M; GOUACHE, P; BARBU, V; GAVRAS, H; HANDY, DE; BEREZIAT, G; MASLIAH, J			ALPHA(2) ADRENERGIC-RECEPTOR SUBTYPES EXPRESSED IN CHINESE-HAMSTER OVARY CELLS ACTIVATE DIFFERENTIALLY MITOGEN-ACTIVATED PROTEIN-KINASE BY A P21(RAS) INDEPENDENT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EPIDERMAL GROWTH-FACTOR; ALPHA-2-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; MAP KINASE; ALPHA-2B-ADRENERGIC RECEPTOR; ALPHA(2)-ADRENERGIC RECEPTOR; ADENYLATE-CYCLASE; RAT-TISSUES; FIBROBLASTS; STIMULATION	Epinephrine stimulation of rat alpha(2D), alpha(2B), and alpha(2C) adrenergic receptor subtypes, expressed stably in Chinese hamster ovary (CHO) cells, caused a rapid, transient activation of mitogen-activated protein kinase (MAPK), with subtype-specific different efficiencies. The order of activation was CHO-2B similar to CHO-2D >> CHO-2C. Pertussis toxin blocked the stimulation of MAPK enzymatic activity and the parallel MAPK phosphorylation, demonstrating that these responses are mediated by pertussis toxin-sensitive G(i) proteins. Contrary to what has been reported for the alpha(2A) subtype expressed in rat-1 fibroblasts, epinephrine did not cause any detectable activation of p21(ras) in the CHO transfectants. Furthermore, combined application of epinephrine and phorbol myristate acetate had a potent cooperative but not additive effect in clones CHO-2D and CHO-2B but not in CHO-2C, suggesting that protein kinase C is probably differently involved in the signaling by the three alpha(2) receptor subtypes. These results show that in CHO cells, the different alpha(2) adrenergic receptor subtypes utilize differential pathways to activate MAPK in a p21(ras)-independent way.	CHU ST ANTOINE,BIOCHEM LAB,F-75571 PARIS 12,FRANCE; BOSTON UNIV,SCH MED,HYPERTENS & ATHEROSCLEROSIS SECT,BOSTON,MA 02118	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Boston University	FLORDELLIS, CS (corresponding author), CHU ST ANTOINE,CNRS,URA 1283,27 RUE CHALIGNY,F-75571 PARIS 12,FRANCE.			Handy, Diane/0000-0002-4310-8527				ALBLAS J, 1993, J BIOL CHEM, V268, P22235; BARBU V, 1993, EXP CLIN ENDOCRINOL, V101, P84; BARONDELAGE S, 1994, J BIOL CHEM, V269, P18686; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRESNAHAN MR, 1990, BIOCHIM BIOPHYS ACTA, V1052, P439, DOI 10.1016/0167-4889(90)90153-5; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BYLUND DB, 1992, FASEB J, V6, P832, DOI 10.1096/fasebj.6.3.1346768; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; DUZIC E, 1992, J BIOL CHEM, V267, P24045; EASON MG, 1992, J BIOL CHEM, V267, P15795; FLORDELLIS CS, 1990, HYPERTENSION, V15, P881, DOI 10.1161/01.HYP.15.6.881; FLORDELLIS CS, 1991, P NATL ACAD SCI USA, V88, P1019, DOI 10.1073/pnas.88.3.1019; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HANDY DE, 1993, HYPERTENSION, V21, P861, DOI 10.1161/01.HYP.21.6.861; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HOWE LR, 1993, J BIOL CHEM, V268, P20717; JONES SB, 1990, MOL PHARMACOL, V39, P239; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P537, DOI 10.1016/0076-6879(90)85044-O; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LANIER SM, 1991, J BIOL CHEM, V266, P10470; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LEVISTRE R, 1993, EUR J BIOCHEM, V23, P295; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; LORENZ W, 1990, MOL PHARMACOL, V38, P599; REMAURY A, 1993, BIOCHEM J, V292, P283, DOI 10.1042/bj2920283; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; SETH A, 1992, J BIOL CHEM, V267, P24796; THOMPSON HL, 1993, BIOCHEM J, V290, P483, DOI 10.1042/bj2900483; TOURNIER C, 1995, IN PRESS EUR J BIOCH; VALLAR L, 1990, J BIOL CHEM, V265, P10320; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; WINITZ S, 1993, J BIOL CHEM, V268, P19196; ZENG DW, 1991, MOL BRAIN RES, V10, P219, DOI 10.1016/0169-328X(91)90064-5; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	36	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3491	3494		10.1074/jbc.270.8.3491	http://dx.doi.org/10.1074/jbc.270.8.3491			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876081	hybrid			2022-12-27	WOS:A1995QH68800008
J	KLAMPFER, L; CHENKIANG, S; VILCEK, J				KLAMPFER, L; CHENKIANG, S; VILCEK, J			ACTIVATION OF THE TSG-6 GENE BY NF-IL6 REQUIRES 2 ADJACENT NF-IL6 BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; C/EBP FAMILY; EXPRESSION NF-IL6; HUMAN FIBROBLASTS; INTERLEUKIN-6; PROTEIN; MEMBER	Tumor necrosis factor (TNF)-stimulated gene 6 (TSG-6) encodes a protein expressed during inflammation. We have previously shown that transcription factors of the NF-IL6 and AP-1 families cooperatively modulate activation of the TSG-6 gene by TNF or interleukin I (IL-1) through a promoter region that contains an NF-IL6 site (-106 to -114) and an AP-I element (-126 to -119). In this study we report the identification of an additional NF-IL6 site (NF-IL6*) located at positions -92 to -83. Footprinting and electrophoretic mobility shift assay suggested that NF-IL6 binds with higher affinity to the newly identified NF-IL6* site than to the earlier identified promoter-distal NF-IL6 site and that the two sites cooperate in binding NF-IL6. TNF and IL-I stimulate specific binding of nuclear proteins to the NF-IL6* site more efficiently than to the promoter-distal NF-IL6 site. Moreover, a mutation in the NF-IL6* site abolished transactivation of the TSG-6 promoter by NF-IL6 despite the presence of the intact promoter-distal NF-IL6 site. A mutation in the promoter distal NF-IL6 site also greatly decreased activation of the TSG-6 promoter by NF-IL6. We conclude that the two NF-IL6 sites are functionally interdependent in the activation of the TSG-6 gene.	NYU,MED CTR,DEPT MICROBIOL,NEW YORK,NY 10016; NYU,MED CTR,KAPLAN CANC CTR,NEW YORK,NY 10016; CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029	New York University; New York University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL CANCER INSTITUTE [R35CA049731] Funding Source: NIH RePORTER; NCI NIH HHS [R35-CA49731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1992, INTERLEUKINS MOL BIO, P299; CHENKIANG S, 1993, CURR OPIN IMMUNOL, V5, P124, DOI 10.1016/0952-7915(93)90091-6; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; FENG P, 1993, J BIOL CHEM, V268, P9387; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HSU W, 1993, MOL CELL BIOL, V13, P2515, DOI 10.1128/MCB.13.4.2515; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561, DOI 10.1128/MCB.14.10.6561; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Maxam A M, 1980, Methods Enzymol, V65, P499; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPERGEL JM, 1992, J VIROL, V66, P1021, DOI 10.1128/JVI.66.2.1021-1030.1992; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; TONIATTI C, 1990, EMBO J, V9, P4467, DOI 10.1002/j.1460-2075.1990.tb07897.x; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818; ZHANG Y, 1993, MOL CELL BIOL, V13, P3831, DOI 10.1128/MCB.13.6.3831; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	32	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3677	3682		10.1074/jbc.270.8.3677	http://dx.doi.org/10.1074/jbc.270.8.3677			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876106				2022-12-27	WOS:A1995QH68800035
J	WILSON, BS; KAPP, N; LEE, RJ; PFEIFFER, JR; MARTINEZ, AM; PLATT, Y; LETOURNEUR, F; OLIVER, JM				WILSON, BS; KAPP, N; LEE, RJ; PFEIFFER, JR; MARTINEZ, AM; PLATT, Y; LETOURNEUR, F; OLIVER, JM			DISTINCT FUNCTIONS OF THE FC-EPSILON-R1 GAMMA-SUBUNITS AND BETA-SUBUNITS IN THE CONTROL OF FC-EPSILON-R1-MEDIATED TYROSINE KINASE ACTIVATION AND SIGNALING RESPONSES IN RBL-2H3 MAST-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; T-CELL; ANTIGEN RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; CYTOPLASMIC DOMAINS; IMMUNOGLOBULIN-E; IGE RECEPTOR; PHOSPHORYLATION	In RBL-2H3 rat tumor mast cells, cross-linking the high affinity IgE receptor, Fc epsilon R1, activates the protein-tyrosine kinases Lyn and Syk and initiates a series of responses including protein tyrosine phosphorylation, inositol 1,4,5-trisphosphate synthesis, Ca2+ mobilization, secretion, membrane ruffling, and actin plaque assembly, The development of chimeric receptors containing cytoplasmic domains of individual subunits of the heterotrimeric (alpha beta gamma(2)) Fc epsilon R1 has simplified analyses of early signaling events in RBL-2H3 cells, Here, RBL-2H3 cells were transfected with cDNAs encoding the extracellular and transmembrane domains of the interleukin-2 receptor alpha subunit (the Tac antigen) joined to the C-terminal cytoplasmic domains of the Fc epsilon R1 gamma and beta subunits (TT gamma and TT beta), Both sequences contain tyrosine activation motifs implicated in antigen receptor signal transduction, TT gamma and TT beta are expressed independently of the native Fc epsilon R1, as demonstrated by the ability of Tac cross-linking agents to trigger the clustering and internalization through coated pits of both chimeric receptors without co clustering the Fc epsilon R1. A full range of signaling activities is induced by TT gamma crosslinking; the TT gamma-induced responses are slower and, except for Lyn activation, smaller than the Fc epsilon R1-induced responses, In striking contrast, TT beta cross-linking elicits no tyrosine phosphorylation or signaling responses, it impairs basal activities measured in secretion and anti-PY (anti-phosphotyrosine antibody) immune complex kinase assays, and it antagonizes Fc epsilon R1-induced Lyn and Syk activation, protein-tyrosine phosphorylation, and signaling responses, We hypothesize that the isolated beta subunit binds a specific kinase or coupling protein(s) required for signaling activity, sequestering it from the signal-transducing gamma subunit, Binding the same kinase or coupling protein to the beta subunit of the intact Fc epsilon R1 may serve instead to present it to the adjacent gamma subunit, resulting in enhanced kinase activation and signaling responses.	UNIV NEW MEXICO, SCH MED, DEPT PATHOL, CELL PATHOL LAB, ALBUQUERQUE, NM 87131 USA; UNIV NEW MEXICO, SCH MED, CTR CANC RES & TREATMENT, ALBUQUERQUE, NM 87131 USA; BASEL INST IMMUNOL, CH-4058 BASEL, SWITZERLAND	University of New Mexico; University of New Mexico				Letourneur, Francois/0000-0003-2232-6127	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049814] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49814] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER G, 1991, J BIOL CHEM, V266, P22613; BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; BECKER EL, 1972, J EXP MED, V135, P376, DOI 10.1084/jem.135.2.376; BIEBER T, 1994, IMMUNOL TODAY, V15, P52, DOI 10.1016/0167-5699(94)90132-5; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BURG DL, 1993, J BIOL CHEM, V268, P2304; CAMBIER JC, 1992, FASEB J, V6, P3207, DOI 10.1096/fasebj.6.13.1397843; CHALLISS RAJ, 1988, BIOCHEM BIOPH RES CO, V157, P684, DOI 10.1016/S0006-291X(88)80304-8; DEANIN GG, 1991, BIOCHEM BIOPH RES CO, V179, P551, DOI 10.1016/0006-291X(91)91406-3; EISEMAN E, 1992, J BIOL CHEM, V267, P21027; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HUTCHCROFT JE, 1992, P NATL ACAD SCI USA, V89, P9107, DOI 10.1073/pnas.89.19.9107; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KAMPS MP, 1991, METHOD ENZYMOL, V201, P101; Keller Susanne R., 1994, Trends in Cell Biology, V4, P115, DOI 10.1016/0962-8924(94)90065-5; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LEE RJ, 1992, CYTOMETRY, V13, P127, DOI 10.1002/cyto.990130204; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; LETOURNEUR O, 1991, J IMMUNOL, V147, P2652; LI W, 1992, MOL CELL BIOL, V12, P3176, DOI 10.1128/MCB.12.7.3176; LIU FT, 1980, J IMMUNOL, V124, P2728; MAO SY, 1993, J IMMUNOL, V151, P2760; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MILLARD PJ, 1988, P NATL ACAD SCI USA, V85, P1854, DOI 10.1073/pnas.85.6.1854; OLIVER JM, 1988, PROG ALLERGY, V42, P185; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PARK DJ, 1991, J BIOL CHEM, V266, P24237; PFEIFFER JR, 1994, J IMMUNOL, V152, P270; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; QIAN DP, 1993, P NATL ACAD SCI USA, V90, P11875, DOI 10.1073/pnas.90.24.11875; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RAVETCH JV, 1994, NAT GENET, V7, P117, DOI 10.1038/ng0694-117; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; SAKAMOTO N, 1994, BBA-MOL CELL RES, V1221, P291, DOI 10.1016/0167-4889(94)90253-4; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SEAGRAVE J, 1991, J CELL PHYSIOL, V148, P139, DOI 10.1002/jcp.1041480117; STUMP RF, 1987, J IMMUNOL, V139, P881; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TAYLOR SJ, 1993, CURR OPIN GENET DEV, V3, P26, DOI 10.1016/S0959-437X(05)80337-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B	49	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4013	4022		10.1074/jbc.270.8.4013	http://dx.doi.org/10.1074/jbc.270.8.4013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876149	hybrid			2022-12-27	WOS:A1995QH68800082
J	CHINI, EN; BEERS, KW; DOUSA, TP				CHINI, EN; BEERS, KW; DOUSA, TP			NICOTINATE ADENINE-DINUCLEOTIDE PHOSPHATE (NAADP) TRIGGERS A SPECIFIC CALCIUM-RELEASE SYSTEM IN SEA-URCHIN EGGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; FERTILIZATION; MICROSOMES; BINDING	Transient fluxes of intracellular ionized calcium (Ca2+) from intracellular stores are integral components of regulatory signaling pathways operating in numerous biological regulations, including in early stages of egg fertilization. Therefore, we explored whether NADP, which is rapidly generated by phosphorylation of NAD upon fertilization may, directly or indirectly, exert a regulatory role as a trigger of Ca2+ release from intracellular stores in sea urchin eggs, NADP had no effect, but we found that the deamidated derivative of NADP, nicotinate adenine dinucleotide phosphate (beta-NAADP), is a potent and specific stimulus (ED(50) 16 nM) for Ca2+ release in sea urchin egg homogenates, NAADP triggers the Ca2+ release via a mechanism which is distinct from the well-known Ca2+ release systems triggered either by inositol-1,4,5-triphosphate (IP3) or by cyclic adenosine diphospho-ribose (cADPR), The NAADP-induced release of Ca2+ is not blocked by heparin, an antagonist of IP3, or by procaine or ruthenium red, antagonists of cADPR. However, it is selectively blocked by thionicotinamide-NADP which does not inhibit the actions of IP3 or cADPR, NAADP produced by heating of NADP in alkaline (pH = 12) medium or synthetized enzymatically by nicotinic acid-NADP reaction catalyzed by NAD glycohydrolase have identical properties, The results presented herein thus describe a novel endocellular Ca2+ releasing system controlled by NAADP as a specific stimulus, The NAADP-controlled Ca2+ release system may be an integral component of multiple intracellular regulations occurring in fertilized sea urchin eggs, which are mediated by intracellular Ca2+ release, and may also have similar role(s) in other tissues.	MAYO CLIN & MAYO FDN,MAYO MED SCH,DEPT MED,DIV NEPHROL & INTERNAL MED,NEPHROL RES UNIT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,MAYO MED SCH,DEPT PHYSIOL,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic					NIDDK NIH HHS [DK-07013, DK-30579] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013, R01DK030579] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERNOVSKY C, 1982, METHOD ENZYMOL, V66, P105; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; EPEL D, 1981, CELL, V23, P543, DOI 10.1016/0092-8674(81)90150-1; EPEL D, 1964, BIOCHEM BIOPH RES CO, V17, P62, DOI 10.1016/0006-291X(64)90301-8; EPEL D, 1980, CELL SURFACE MEDIATO, P169; GALIONE A, 1994, MOL CELL ENDOCRINOL, V98, P125, DOI 10.1016/0303-7207(94)90130-9; GALIONE A, 1993, SCIENCE, V261, P348, DOI 10.1126/science.8392748; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; LEE HC, 1991, J BIOL CHEM, V266, P2276; PREISS J, 1958, J BIOL CHEM, V233, P493; SHAPIRO BM, 1981, ANNU REV BIOCHEM, V50, P815, DOI 10.1146/annurev.bi.50.070181.004123; SHOSHANBARMATZ V, 1990, BIOCHEM J, V268, P699, DOI 10.1042/bj2680699	18	126	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3216	3223		10.1074/jbc.270.7.3216	http://dx.doi.org/10.1074/jbc.270.7.3216			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852407	hybrid			2022-12-27	WOS:A1995QG47100051
J	HOOGEWERF, AJ; LEONE, JW; REARDON, IM; HOWE, WJ; ASA, D; HEINRIKSON, RL; LEDBETTER, SR				HOOGEWERF, AJ; LEONE, JW; REARDON, IM; HOWE, WJ; ASA, D; HEINRIKSON, RL; LEDBETTER, SR			CXC CHEMOKINES CONNECTIVE-TISSUE ACTIVATING PEPTIDE-III AND NEUTROPHIL-ACTIVATING PEPTIDE-2 ARE HEPARIN HEPARAN SULFATE-DEGRADING ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; EXTRACELLULAR-MATRIX; CTAP-III; PURIFICATION; BINDING; CELLS; INTERLEUKIN-8; PROTEOGLYCAN; HEPARITINASE; MOLECULES	Heparan sulfate proteoglycans at cell surfaces or in extracellular matrices bind diverse molecules, including growth factors and cytokines, and it is believed that the activities of these molecules may be regulated by the metabolism of heparan sulfate. In this study, purification of a heparan sulfate-degrading enzyme from human platelets led to the discovery that the enzymatic activity resides in at least two members of the platelet basic protein (PBP) family known as connective tissue activating peptide-III (CTAP-III) and neutrophil activating peptide-2. PBP and its N-truncated derivatives, CTAP-III and neutrophil activating peptide-2, are CXC chemokines, a group of molecules involved in inflammation and wound healing. SDS-polyacrylamide gel electrophoresis analysis of the purified heparanase resulted in a single broad band at 8-10 kDa, the known molecular weight of PBP and its truncated derivatives. Gel filtration chromatography of heparanase resulted in peaks of activity corresponding to monomers, dimers, and tetramers; these higher order aggregates are known to form among the chemokines. N-terminaI sequence analysis of the same preparation indicated that only PBP and truncated derivatives were present, and commercial CTAP-III from three suppliers had heparanase activity. Antisera produced in animals immunized with a C-terminal synthetic peptide of PBP inhibited heparanase activity by 95%, compared with activity of the purified enzyme in the presence of the preimmune sera. The synthetic peptide also inhibited heparanase by 95% at 250 mu M, compared to the 33% inhibition of heparanase activity by two other peptides. The enzyme was determined to be an endoglucosaminidase, and it degraded both heparin and heparan sulfate with optimal activity at pH 5.8. Chromatofocusing of the purified heparanase resulted in two protein peaks: an inactive peak at pI 7.3, and an active peak at pI 4.8-5.1. Sequence analysis showed that the two peaks contained identical protein, suggesting that a post-translational modification activates the enzyme.	UPJOHN CO,CANC & INFECT DIS UNIT,KALAMAZOO,MI 49001; UPJOHN CO,BIOCHEM UNIT,KALAMAZOO,MI 49001; UPJOHN CO,COMP CHEM UNIT,KALAMAZOO,MI 49001; UPJOHN CO,ADHES BIOL UNIT,KALAMAZOO,MI 49001	Pfizer; Pfizer; Pfizer; Pfizer								BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Berstein FC, 1997, J MOL BIOL, V112, P535; CASTOR CW, 1983, P NATL ACAD SCI-BIOL, V80, P765, DOI 10.1073/pnas.80.3.765; CASTOR CW, 1992, ARTHRITIS RHEUM-US, V35, P783, DOI 10.1002/art.1780350712; CASTOR CW, 1993, ARTHRITIS RHEUM, V36, P1142, DOI 10.1002/art.1780360816; CHENG CF, 1981, J BIOL CHEM, V256, P2893; Clore G M, 1992, Cytokines, V4, P18; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CONRAD HE, 1980, BIOCHEM J, V191, P355, DOI 10.1042/bj1910355; DEVOUGE MW, 1994, INT J CANCER, V56, P286, DOI 10.1002/ijc.2910560224; GREEN MS, 1986, P SOC EXP BIOL MED, V181, P555; HEDMAN K, 1982, CELL, V28, P663, DOI 10.1016/0092-8674(82)90221-5; HELDIN CH, 1977, EXP CELL RES, V109, P429, DOI 10.1016/0014-4827(77)90023-4; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; JIN L, 1990, INT J CANCER, V45, P1088, DOI 10.1002/ijc.2910450618; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATTERA J, 1980, P NATL ACAD SCI USA, V77, P6662; LEDBETTER SR, 1987, BIOCHEMISTRY-US, V26, P988, DOI 10.1021/bi00378a003; LINDAHL U, 1986, TRENDS BIOCHEM SCI, V11, P221, DOI 10.1016/0968-0004(86)90011-3; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCUS AJ, 1993, FASEB J, V7, P516, DOI 10.1096/fasebj.7.6.8472890; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Mooser G., 1992, ENZYMES, P187; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; NELSON RM, 1993, BLOOD, V82, P3253; OLDBERG A, 1980, BIOCHEMISTRY-US, V19, P5755, DOI 10.1021/bi00566a014; OOSTA GM, 1982, J BIOL CHEM, V257, P1249; REDINI F, 1988, BIOCHEM J, V252, P515, DOI 10.1042/bj2520515; RUCINSKI B, 1979, BLOOD, V53, P47; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; SEWELL RF, 1989, BIOCHEM J, V264, P777, DOI 10.1042/bj2640777; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P8932; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	38	85	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3268	3277		10.1074/jbc.270.7.3268	http://dx.doi.org/10.1074/jbc.270.7.3268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852412	hybrid			2022-12-27	WOS:A1995QG47100058
J	PRIOLA, SA; CAUGHEY, B; WEHRLY, K; CHESEBRO, B				PRIOLA, SA; CAUGHEY, B; WEHRLY, K; CHESEBRO, B			A 60-KDA PRION PROTEIN (PRP) WITH PROPERTIES OF BOTH THE NORMAL AND SCRAPIE-ASSOCIATED FORMS OF PRP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURO-BLASTOMA CELLS; PHYSICAL-PROPERTIES; AGENT; PURIFICATION; RESISTANT; PHOSPHOLIPASE; BIOSYNTHESIS; INFECTIVITY; CONVERSION; FIBRILS	Scrapie is a transmissible spongiform encephalopathy of sheep and other mammals in which disease appears to be caused by the accumulation of an abnormal form of a host protein, prion protein (PrP), in the brain and other tissues. The process by which the normal protease-sensitive form of PrP is converted into the abnormal protease-resistant form is unknown. Several hypotheses predict that oligomeric forms of either the normal or abnormal PrP may act as intermediates in the conversion process. We have now identified a 60-kDa PrP derived from hamster PrP expressed in murine neuroblastoma cells, Peptide mapping studies provided evidence that the 60-kDa PrP was composed solely of PrP and, based on its molecular mass, appeared to be a PrP dimer. The 60-kDa PrP was not dissociated under sev eral harsh denaturing conditions, which indicated that it was covalently linked. It was similar to the disease-associated form of PrP in that it formed large aggre gates. However, it resembled the normal form of PrP in that it was sensitive to proteinase K and had a short metabolic half-life. The 60-kDa PrP, therefore, had characteristics of both the normal and disease-associated forms of PrP. Formation and aggregation of the 60-kDa hamster PrP occurs in uninfected mouse neuroblastoma cells, which suggests that hamster PrP has a predispo sition to aggregate even in the absence of scrapie infec tivity. Similar 60-kDa PrP bands were identified in scrapie-infected hamster brain but not in uninfected brain. Therefore, a 60-kDa molecule might participate in the scrapie-associated conversion of protease-sensitive PrP to protease-resistant PrP.			PRIOLA, SA (corresponding author), NIAID, ROCKY MT LABS, PERSISTENT VIRAL DIS LAB, HAMILTON, MT 59840 USA.							AIKEN JM, 1990, MICROBIOL REV, V54, P242, DOI 10.1128/MMBR.54.3.242-246.1990; ALPER T, 1985, NATURE, V317, P750, DOI 10.1038/317750a0; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; BENDHEIM PE, 1988, J INFECT DIS, V158, P1198, DOI 10.1093/infdis/158.6.1198; BENDHEIM PE, 1986, P NATL ACAD SCI USA, V63, P1212; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BOLTON DC, 1984, BIOCHEMISTRY-US, V23, P5898, DOI 10.1021/bi00320a002; BOLTON DC, 1988, NOVEL INFECTIOUS AGE, P164; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHESEBRO B, 1993, DEV BIOL STAND, V80, P131; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Dickinson AG., 1979, SLOW TRANSMISSIBLE D, P13; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; EKLUND CM, 1963, P SOC EXP BIOL MED, V112, P974, DOI 10.3181/00379727-112-28225; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KASCSAK RJ, 1987, J VIROL, V61, P8688; Kimberlin R.H., 1990, SE VIROL, V1, P153; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OESCH B, 1994, BIOCHEMISTRY-US, V33, P5926, DOI 10.1021/bi00185a033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PATTISON IH, 1967, VET REC, V80, P2, DOI 10.1136/vr.80.1.2; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Rohwer R G, 1991, Curr Top Microbiol Immunol, V172, P195; SAFAR J, 1993, J BIOL CHEM, V268, P20276; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Tarentino A L, 1978, Methods Enzymol, V50, P574; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x	50	79	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3299	3305		10.1074/jbc.270.7.3299	http://dx.doi.org/10.1074/jbc.270.7.3299			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852415	hybrid			2022-12-27	WOS:A1995QG47100062
J	VERGERES, G; RAMSDEN, J; WASKELL, L				VERGERES, G; RAMSDEN, J; WASKELL, L			THE CARBOXYL-TERMINUS OF THE MEMBRANE-BINDING DOMAIN OF CYTOCHROME B(5) SPANS THE BILAYER OF THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOACTIVATABLE PHOSPHOLIPIDS; MICROSOMAL-MEMBRANES; EMBEDDED SEGMENT; CROSS-LINKING; PROTEINS; INSERTION; VESICLES; B5; PARTICIPATION; TRANSLOCATION	Preliminary studies (Vergeres, G., and Waskell, L. (1992) J. Biol. Chem. 267, 12583-12591) have suggested that the carboxyl terminal membrane-binding domain of cytochrome b(5) traverses the membrane and that the carboxyl terminus is in the lumen of the endoplasmic reticulum. In order to confirm and extend these studies, additional experiments were conducted. The gene coding for rat cytochrome b(5) was transcribed and the resulting mRNA was translated in vitro in a rabbit reticulocyte lysate in the presence of microsomes. The binding and topology of cytochrome b(5) were investigated by treating microsomes containing the newly incorporated cytochrome b(5) with carboxypeptidase Y and trypsin. Our studies indicate that cytochrome b(5) is inserted both co- and post-translationally into microsomes in a topology in which the membrane binding domain spans the bilayer with its COOH terminus in the lumen. Cytochrome b(5) is also incorporated into microsomes pretreated with trypsin in a topology indistinguishable from the one resulting from the insertion of the protein into untreated microsomes, reconfirming that cytochrome b(5) does not use the signal recognition particle-dependent translocation machinery. Our results do not allow a distinction to be made between a spontaneous insertion mode or some other trypsin-resistant receptor-mediated mechanism. A role for Pro(115) in the middle of the membrane-binding domain of cytochrome b(5) was also examined by mutating it to an alanine and subsequently characterizing the ability of the mutant protein to be incorporated into membranes. The mutant protein inserted more slowly in vitro into microsomes as well as into pure lipid bilayers by a factor of 2 to 3.	UNIV CALIF SAN FRANCISCO, VET ADM MED CTR, DEPT ANESTHESIA, SAN FRANCISCO, CA 94121 USA; VET ADM MED CTR, DEPT ANESTHESIOL, SAN FRANCISCO, CA 94121 USA; UNIV BASEL, BIOCTR, DEPT BIOPHYS CHEM, CH-4056 BASEL, SWITZERLAND	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Basel					NIGMS NIH HHS [GM 35333] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; ARINC E, 1987, J BIOL CHEM, V262, P15563; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BENDZKO P, 1982, EUR J BIOCHEM, V123, P121, DOI 10.1111/j.1432-1033.1982.tb06507.x; BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; CALABRO MA, 1976, J BIOL CHEM, V251, P2113; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; ENOCH HG, 1979, J BIOL CHEM, V254, P6483; GREENHUT SF, 1993, BIOCHIM BIOPHYS ACTA, V1149, P1, DOI 10.1016/0005-2736(93)90018-U; GRINSTEAD GF, 1982, J BIOL CHEM, V257, P3937; HAUGEN DA, 1976, J BIOL CHEM, V251, P7929; High Stephen, 1993, Trends in Cell Biology, V3, P335, DOI 10.1016/0962-8924(93)90103-8; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; JENNINGS ML, 1989, ANNU REV BIOCHEM, V58, P999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE TC, 1977, BIOCHIM BIOPHYS ACTA, V489, P25, DOI 10.1016/0005-2760(77)90228-4; LETO TL, 1979, J BIOL CHEM, V254, P5015; LITHGOW T, 1993, FEBS LETT, V329, P1, DOI 10.1016/0014-5793(93)80179-X; MATHEWS FS, 1972, J MOL BIOL, V64, P449, DOI 10.1016/0022-2836(72)90510-4; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; MORIMOTO T, 1983, METHOD ENZYMOL, V96, P121; OKADA Y, 1982, EUR J BIOCHEM, V122, P393, DOI 10.1111/j.1432-1033.1982.tb05894.x; OSHINO N, 1982, HEPATIC CYTOCHROME P, P407; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; RACHUBINSKI RA, 1980, J CELL BIOL, V84, P705, DOI 10.1083/jcb.84.3.705; RAMSDEN JJ, 1992, J PHYS CHEM-US, V96, P3388, DOI 10.1021/j100187a038; RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813; RAMSDEN JJ, 1993, BIOCHEMISTRY-US, V32, P523, DOI 10.1021/bi00053a017; RAMSDEN JJ, 1993, J PHYS CHEM-US, V97, P4479, DOI 10.1021/j100119a036; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; ROSEMAN MA, 1977, J BIOL CHEM, V252, P4842; SCHACHTER H, 1980, BIOCH GLYCOPROTEINS, P85; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9128; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; TRETYACHENKOLADOKHINA VG, 1993, BIOCHIM BIOPHYS ACTA, V1153, P163, DOI 10.1016/0005-2736(93)90401-K; VERGERES G, 1992, J BIOL CHEM, V267, P12583; VERGERES G, 1993, J CELL SCI, V106, P249; von Smoluchowski M, 1916, PHYS Z, V17, P557; VONBODMAN SB, 1986, P NATL ACAD SCI USA, V83, P9443; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WASKELL LA, 1991, METHOD ENZYMOL, V206, P523; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001	50	50	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3414	3422		10.1074/jbc.270.7.3414	http://dx.doi.org/10.1074/jbc.270.7.3414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852428	hybrid			2022-12-27	WOS:A1995QG47100078
J	JAMIL, H; DICKSON, JK; CHU, CH; LAGO, MW; RINEHART, JK; BILLER, SA; GREGG, RE; WETTERAU, JR				JAMIL, H; DICKSON, JK; CHU, CH; LAGO, MW; RINEHART, JK; BILLER, SA; GREGG, RE; WETTERAU, JR			MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN - SPECIFICITY OF LIPID-BINDING AND TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; ESTER TRANSFER PROTEIN; DISULFIDE ISOMERASE; SECRETION; LIPASE; HEPATOCYTES; MECHANISM; COMPLEX; ABETALIPOPROTEINEMIA; PHOSPHATIDYLCHOLINE	Microsomal triglyceride transfer protein (MTP) is a lipid transfer protein that is required for the assembly and secretion of very low density lipoproteins by the liver and chylomicrons by the intestine. To further elucidate the nature of the lipid molecule binding and transport site on MTP, we have studied the relative rates at which MTP transports different lipid species. Assay conditions were chosen in which there were minimal changes in the physical properties of the substrate membranes so that transfer rates would reflect MTP-lipid interactions at a membrane surface. Lipid transport rates decreased in order of triglyceride > cholesteryl ester > diglyceride > cholesterol > phosphatidylcholine. Changes in the hydrophobic nature of a lipid molecule by the addition of a fatty acid, modulated the ability of MTP to transport it. Addition of one acyl chain from diglyceride to triglyceride, lysophosphatidylcholine to phosphatidylcholine, or cholesterol to cholesteryl ester increased the rate of MTP-mediated transport 10-fold. In contrast, the lipid transport rate was insensitive to the changes in the structure or charge of the polar head group on phospholipid substrates. Zwitterionic, net negative, or net positive charged phospholipid molecules were all transported at a comparable rate. The ability of MTP to transport lipids is strongly correlated to the binding of these lipids to MTP. Thus, MTP has a specific preference for binding and transporting nonpolar lipid compared with phospholipids, and within a class of lipid molecules, a decrease in polarity increases its tendency to be transported.			JAMIL, H (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT METAB DIS,POB 4000,PRINCETON,NJ 08543, USA.							ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021; ATZEL A, 1993, FASEB J, V7, pA1268; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLLEN IC, 1980, BIOCHEM J, V189, P475, DOI 10.1042/bj1890475; BOREN J, 1991, PROG LIPID RES, V30, P205, DOI 10.1016/0163-7827(91)90017-Y; BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Davis R A, 1993, Subcell Biochem, V21, P169; DECKELBAUM RJ, 1992, BIOCHEMISTRY-US, V31, P8544, DOI 10.1021/bi00151a023; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; GIBBONS GF, 1990, BIOCHEM J, V268, P1; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; HIDE WA, 1992, J LIPID RES, V33, P167; HIGGINS JA, 1984, J LIPID RES, V25, P1295; HUANG C, 1978, P NATL ACAD SCI USA, V75, P388; HUTSON JL, 1982, BIOCHIM BIOPHYS ACTA, V687, P247, DOI 10.1016/0005-2736(82)90553-3; JANERO DR, 1983, J BIOL CHEM, V258, P4496; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIRAI K, 1983, J LIPID RES, V24, P721; SHOULDERS CC, 1994, STRUCTURAL BIOL, V1, P285; SHOULDERS CC, 1993, HUM MOL GENET, V12, P2109; SWENSON TL, 1988, J BIOL CHEM, V263, P5150; VANCE JE, 1985, CAN J BIOCHEM CELL B, V63, P870, DOI 10.1139/o85-108; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P4406, DOI 10.1021/bi00232a006; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; WOOD R, 1969, ARCH BIOCHEM BIOPHYS, V131, P478, DOI 10.1016/0003-9861(69)90420-2; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; [No title captured]	39	145	151	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6549	6554		10.1074/jbc.270.12.6549	http://dx.doi.org/10.1074/jbc.270.12.6549			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896791	Green Submitted, hybrid			2022-12-27	WOS:A1995QQ85500021
J	DEBBURMAN, SK; PTASIENSKI, J; BOETTICHER, E; LOMASNEY, JW; BENOVIC, JL; HOSEY, MM				DEBBURMAN, SK; PTASIENSKI, J; BOETTICHER, E; LOMASNEY, JW; BENOVIC, JL; HOSEY, MM			LIPID-MEDIATED REGULATION OF G-PROTEIN-COUPLED RECEPTOR KINASE-2 AND KINASE-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC CHOLINERGIC RECEPTORS; BETA-GAMMA-SUBUNITS; SIGNALING PROTEINS; CHICK HEART; PH DOMAIN; FAMILY; EXPRESSION; PHOSPHORYLATION; CLONING; MEMBER	G protein coupled receptor-mediated signaling is attenuated by a process referred to as desensitization, wherein agonist-dependent phosphorylation of receptors by G protein-coupled receptor kinases (GRKs) is proposed to be a hey initial event, However, mechanisms that activate GRKs are not fully understood, In one scenario, beta gamma-subunits of G proteins (G(beta gamma)) activate certain GRKs (beta-adrenergic receptor kinases 1 and 2, or GRK2 and GRK3), via a pleckstrin homology domain in the COOH terminus, This interaction has been proposed to translocate cytosolic beta-adrenergic receptor kinases (beta ARKs) to the plasma membrane and facilitate interaction with receptor substrates, Here, we report a novel finding that membrane lipids modulate beta ARK activity in vitro in a manner that is analogous and competitive with G(beta gamma). Several lipids, including phosphatidylserine (PS), stimulated, whereas phosphatidylinositol 4,5-bisphosphate inhibited, the ability of these GRKs to phosphorylate agonist occupied m2 muscarinic acetylcholine receptors. Furthermore, both PS and phosphatidylinositol 4,5-bisphosphate specifically bound to beta ARK1, whereas phosphatidylcholine, a lipid that did not modulate beta ARK activity, did not bind to beta ARK1, The lipid regulation of beta ARKs did not occur via a modulation of its autophosphorylation state, PS- and G(beta gamma)-mediated stimulation of beta ARK1 was compared and found strikingly similar; moreover, their effects together were not additive (except at initial stages of reaction), which suggests that PS and G(beta gamma) employed a common interaction and activation mechanism with the kinase, The effects of these lipids were prevented by two well known G(beta gamma)-binding proteins, phosducin and GST-beta ARK-(466-689) fusion protein, suggesting that the G(beta gamma)-binding domain (possibly the pleckstrin homology domain) of the GRKs is also a site for lipid:protein interaction. We submit the intriguing possibility that both lipids and G proteins co-regulate the function of GRKs.	NORTHWESTERN UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,INST NEUROSCI,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,FEINBERG CARDIOVASC RES INST,CHICAGO,IL 60611; THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Jefferson University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 50121] Funding Source: Medline; NIGMS NIH HHS [GM 44944] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROSE C, 1993, HUM MOL GENET, V1, P697; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GARCIAHIGUERA I, 1994, J BIOL CHEM, V269, P1348; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARGRAVE PA, 1994, REGULATION CELLULAR, P25; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HEKMAN M, 1994, FEBS LETT, V343, P120, DOI 10.1016/0014-5793(94)80302-1; HOSEY MM, 1994, REGULATION SIGNAL TR, P113; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KIM CM, 1993, RECEPTOR, V3, P39; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KWATRA MM, 1986, J BIOL CHEM, V261, P2429; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE RH, 1992, J BIOL CHEM, V267, P25104; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LIGGETT SB, 1994, REGULATION CELLULAR, P71; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PATTERSON SD, 1992, ANAL BIOCHEM, V202, P193, DOI 10.1016/0003-2697(92)90227-X; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Ruiz-Gomez A., 1994, Society for Neuroscience Abstracts, V20, P1066; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SIMONDS WF, 1993, TRENDS BIOCHEM SCI, V18, P315; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WEST MHP, 1984, ELECTROPHORESIS, V5, P133, DOI 10.1002/elps.1150050302; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0	42	81	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5742	5747		10.1074/jbc.270.11.5742	http://dx.doi.org/10.1074/jbc.270.11.5742			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890702	hybrid			2022-12-27	WOS:A1995QM94500012
J	MENDEZ, AJ				MENDEZ, AJ			MONENSIN AND BREFELDIN-A INHIBIT HIGH-DENSITY LIPOPROTEIN-MEDIATED CHOLESTEROL EFFLUX FROM CHOLESTEROL-ENRICHED CELLS - IMPLICATIONS FOR INTRACELLULAR CHOLESTEROL TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE SPHINGOMYELIN; PROTEIN-KINASE-C; CULTURED FIBROBLASTS; GOLGI-APPARATUS; ENDOPLASMIC-RETICULUM; ADIPOSE-CELLS; SMOOTH-MUSCLE; APOLIPOPROTEINS; MACROPHAGES; ESTERIFICATION	Mechanisms and pathways of excess cholesterol removal from intracellular sites of accumulation to extracellular cholesterol accepters remain poorly defined. To gain further insights, compounds known to affect cellular protein transport pathways were tested for their effects on high density lipoprotein (HDL) mediated cholesterol efflux from cultured cells enriched with cholesterol. Monensin, nigericin, and brefeldin A inhibited the ability of HDL to decrease cellular cholesterol esterification, stimulate sterol biosynthesis, and promote the efflux of labeled cholesterol and cholesterol mass from fibroblasts and smooth muscle cells. HDL-mediated decrease in cell cholesterol esterification was inhibited up to 80% by these compounds compared with control incubations over an HDL concentration of 5-100 mu g/ml and up to 18 h of incubation, Up-regulation of sterol biosynthesis after depletion of cell cholesterol by HDL increased over 10- fold; however, inclusion of monensin or brefeldin A during the incubation completely prevented the increase of sterol biosynthesis by HDL. Efflux of [H-3]cholesterol to HDL from prelabeled cells was inhibited up to 40% by these compounds, and this effect persisted when cholesterol esterification was blocked. Similarly, monensin and brefeldin A inhibited up to 50% of HDL-mediated cholesterol mass efflux relative to controls, Treatment of cells with cholesterol oxidase demonstrated an increase of intracellular cholesterol after exposure to monensin or nigericin and to a lesser extent with brefeldin A. These data show that monensin, nigericin, and brefeldin A sequester cholesterol from sites normally available for efflux by HDL. Since these compounds act by disruption of Golgi complex structure and function, a rob for this intracellular organelle in transport of cholesterol between intracellular sites and the plasma membrane for eventual removal by extracellular accepters such as HDL is suggested.			MENDEZ, AJ (corresponding author), MASSACHUSETTS GEN HOSP, CARDIAC UNIT, JACKSON 1422, 32 FRUIT ST, BOSTON, MA 02114 USA.							AZHAR S, 1994, J LIPID RES, V35, P1161; BARKIA A, 1991, ATHEROSCLEROSIS, V87, P135, DOI 10.1016/0021-9150(91)90016-V; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; BERNARD DW, 1991, J BIOL CHEM, V266, P710; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CABAUD PG, 1958, AM J CLIN PATHOL, V30, P234, DOI 10.1093/ajcp/30.3.234; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; ECHEVARRIA F, 1990, J BIOL CHEM, V265, P8484; FIELDING CJ, 1982, MED CLIN N AM, V66, P363, DOI 10.1016/S0025-7125(16)31425-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; HASUMI K, 1993, BIOCHIM BIOPHYS ACTA, V1167, P155, DOI 10.1016/0005-2760(93)90156-4; HOKLAND BM, 1993, J BIOL CHEM, V268, P25343; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KALLEN KJ, 1993, BIOCHEM J, V289, P307, DOI 10.1042/bj2890307; KALLEN KJ, 1993, BIOCHIM BIOPHYS ACTA, V1166, P305, DOI 10.1016/0005-2760(93)90111-L; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LANGE Y, 1983, J BIOL CHEM, V258, P5130; LANGE Y, 1993, J BIOL CHEM, V268, P13838; LEE M, 1992, ARTERIOSCLER THROMB, V12, P1329, DOI 10.1161/01.ATV.12.11.1329; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MORRE DJ, 1983, EUR J CELL BIOL, V30, P25; Oram J F, 1986, Methods Enzymol, V129, P645; ORAM JF, 1983, ARTERIOSCLEROSIS, V3, P420, DOI 10.1161/01.ATV.3.5.420; ORAM JF, 1991, ARTERIOSCLER THROMB, V11, P403, DOI 10.1161/01.ATV.11.2.403; ORCI L, 1981, P NATL ACAD SCI-BIOL, V78, P293, DOI 10.1073/pnas.78.1.293; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; SHIAO YJ, 1993, J BIOL CHEM, V268, P26085; SLOTTE JP, 1990, BIOCHIM BIOPHYS ACTA, V1025, P152; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; STEIN O, 1992, BIOCHIM BIOPHYS ACTA, V1125, P28, DOI 10.1016/0005-2760(92)90151-K; TABAS I, 1988, J BIOL CHEM, V263, P1266; THERET N, 1990, BIOCHEM BIOPH RES CO, V173, P1361, DOI 10.1016/S0006-291X(05)80938-6; URBANI L, 1990, J BIOL CHEM, V265, P1919; VAN MEER G, 1993, J CELL SCI, V104, P833; WATTENBERG BW, 1983, J BIOL CHEM, V258, P2284; WIESGRABER KH, 1980, J LIPID RES, V21, P623; YEAGLE PL, 1986, J BIOL CHEM, V261, P8175	49	69	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5891	5900		10.1074/jbc.270.11.5891	http://dx.doi.org/10.1074/jbc.270.11.5891			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890720	hybrid			2022-12-27	WOS:A1995QM94500032
J	MONSON, EK; DITTA, GS; HELINSKI, DR				MONSON, EK; DITTA, GS; HELINSKI, DR			THE OXYGEN SENSOR PROTEIN, FIXL, OF RHIZOBIUM-MELILOTI - ROLE OF HISTIDINE-RESIDUES IN HEME-BINDING, PHOSPHORYLATION, AND SIGNAL-TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; REGULATOR-II NR(II); ESCHERICHIA-COLI; PHOSPHATASE-ACTIVITIES; PHENOTYPIC SELECTION; KINASE-ACTIVITY; GENE-PRODUCT; NIFA; AUTOPHOSPHORYLATION; TRANSCRIPTION	The two component system sensor/response regulator pair, FixL/FixJ, controls the expression of Rhizobium meliloti nitrogen fixation (nif and fix) genes in response to changes in oxygen concentration. A truncated version of FixL, FixL(*), is an oxygen-binding hemoprotein kinase that phosphorylates and dephosphorylates the nif and fix gene transcriptional activator, FixJ. Phosphorylation of FixJ is required for optimal transcriptional activation, and anaerobic conditions in vitro result in a substantial increase in the level of FixJ-phosphate. In this study, site-directed mutagenesis was carried out at histidine residues in FixL(*). Mutant FixL(*) derivatives were purified and analyzed in vitro for their heme/oxygen binding properties and phosphorylation/dephosphorylation activities. Mutation of histidine 285, the putative autophosphorylation site, to glutamine results in the loss of FixL(*) phosphorylation activities. However, this mutant protein retains a substantial level of FixJ-phosphate dephosphorylation activity. Mutation of histidine 194 to asparagine results in the loss of heme binding and in the failure of FixL(*) to regulate its phosphorylation/dephosphorylation activities in response to changes in oxygen concentration. The FixL(*)H194N mutant protein also exhibits an increased FixJ phosphorylation activity under aerobic conditions. This study provides further evidence for the importance of the heme binding domain of FixL(*) in regulating FixJ phosphorylation and dephosphorylation activities in response to oxygen.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,CTR GENET MOLEC,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044400] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM44400-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRON PG, 1993, P NATL ACAD SCI USA, V90, P3506, DOI 10.1073/pnas.90.8.3506; AGRON PG, 1994, RES MICROBIOL, V145, P454, DOI 10.1016/0923-2508(94)90094-9; AGRON PG, 1993, THESIS U CALIFORNIA; AGUILAR OM, 1987, J BACTERIOL, V169, P5393, DOI 10.1128/jb.169.12.5393-5400.1987; ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; ANTONINI E, 1971, HEMOGLOBIN MYOGLOBIN, P125; ATKINSON MR, 1993, J BACTERIOL, V175, P7016, DOI 10.1128/jb.175.21.7016-7023.1993; BAKER TA, 1984, P NATL ACAD SCI-BIOL, V81, P6779, DOI 10.1073/pnas.81.21.6779; BATUT J, 1989, EMBO J, V8, P1279, DOI 10.1002/j.1460-2075.1989.tb03502.x; BEUZARD Y, 1972, FEBS LETT, V27, P76, DOI 10.1016/0014-5793(72)80413-7; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; DEPHILIP P, 1992, MOL GEN GENET, V235, P49, DOI 10.1007/BF00286180; DEPHILIP P, 1990, J BACTERIOL, V172, P4255, DOI 10.1128/jb.172.8.4255-4262.1990; DITTA G, 1987, J BACTERIOL, V169, P3217, DOI 10.1128/jb.169.7.3217-3223.1987; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; KEENER J, 1988, P NATL ACAD SCI USA, V85, P4976, DOI 10.1073/pnas.85.14.4976; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOIS AF, 1993, J BIOL CHEM, V268, P4370; LOIS AF, 1993, J BACTERIOL, V175, P1103, DOI 10.1128/JB.175.4.1103-1109.1993; MELCHERS LS, 1989, EMBO J, V8, P1919, DOI 10.1002/j.1460-2075.1989.tb03595.x; MONSON EK, 1992, P NATL ACAD SCI USA, V89, P4280, DOI 10.1073/pnas.89.10.4280; Ninfa A J, 1991, Genet Eng (N Y), V13, P39; NINFA AJ, 1986, P NATL ACAD SCI USA, V85, P5492; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; NOONAN B, 1992, MOL GEN GENET, V234, P423, DOI 10.1007/BF00538701; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; REYRAT JM, 1993, J BACTERIOL, V175, P6867, DOI 10.1128/jb.175.21.6867-6872.1993; Sambrook J, 1989, MOL CLONING LABORATO; SHIMODA N, 1990, P NATL ACAD SCI USA, V87, P6684, DOI 10.1073/pnas.87.17.6684; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STUDIER FW, 1985, J MOL BIOL, V189, P113; SZETO WW, 1984, CELL, V36, P1035, DOI 10.1016/0092-8674(84)90053-9; VIERA J, 1987, METHOD ENZYMOL, V153, P3; VIRTS EL, 1988, P NATL ACAD SCI USA, V85, P3062, DOI 10.1073/pnas.85.9.3062; WEINSTEIN M, 1992, MOL MICROBIOL, V6, P2041, DOI 10.1111/j.1365-2958.1992.tb01377.x; WEINSTEIN M, 1993, GENE, V134, P145, DOI 10.1016/0378-1119(93)90088-K; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	48	82	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5243	5250		10.1074/jbc.270.10.5243	http://dx.doi.org/10.1074/jbc.270.10.5243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890634	hybrid			2022-12-27	WOS:A1995QL58000046
J	STRONGIN, AY; COLLIER, I; BANNIKOV, G; MARMER, BL; GRANT, GA; GOLDBERG, GI				STRONGIN, AY; COLLIER, I; BANNIKOV, G; MARMER, BL; GRANT, GA; GOLDBERG, GI			MECHANISM OF CELL-SURFACE ACTIVATION OF 72-KDA TYPE-IV COLLAGENASE - ISOLATION OF THE ACTIVATED FORM OF THE MEMBRANE METALLOPROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLAST COLLAGENASE; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; INTERSTITIAL COLLAGENASE; FUNCTIONAL-ANALYSIS; UROKINASE RECEPTOR; MESSENGER-RNAS; CDNA CLONING; TIMP-2	Matrix metalloproteases are secreted by mammalian cells as zymogens and, upon activation, initiate tissue remodeling by proteolytic degradation of collagens and proteoglycans. Activation of the secreted proenzymes and interaction with their specific inhibitors determine the net enzymatic activity in the extracellular space. We have previously demonstrated that 72T4Cl can be activated by a plasma membrane-dependent mechanism specific for this enzyme. Here, we report purification of the membrane activator of 72T4Cl, which is a new metalloprotease identical to a recently cloned membrane-type matrix metalloprotease (MT-MMP). We demonstrate that activated MT-MMP acts as a cell surface tissue inhibitor of metalloprotease 2 (TIMP-2) receptor with K-d = 2.54 x 10(-9) M. The activator . TLMP-2 complex in turn acts as a receptor for 72T4Cl (K-d = 0.56 x 10(-9) M), binding to the carboxyl-end domain of the enzyme. Activation of 72T4Cl on the cell membrane provides a basic mechanism for spatially regulated extracellular proteolysis and presents a new target for prognosis and treatment of metastatic disease. The activator, purified as a tri-moIecular complex of MT-MMP . TIMPS . carboxyl-end domain of 72T4Cl, is itself an activated form of MT-MMP, posing the following question: what is the mechanism of the activator's activation?	WASHINGTON UNIV,SCH MED,DIV DERMATOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039472, T32AR007284, R01AR040618] Funding Source: NIH RePORTER; NIAMS NIH HHS [T32 AR07284, R01 AR40618, R01 AR39472] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AZZAM HS, 1992, CANCER RES, V52, P4540; BIANCHI E, 1994, CANCER RES, V54, P861; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; BROWN PD, 1993, KIDNEY INT, V43, P163, DOI 10.1038/ki.1993.27; CARMICHAEL DF, 1986, P NATL ACAD SCI USA, V83, P2407, DOI 10.1073/pnas.83.8.2407; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DECLERCK YA, 1993, BIOCHEM J, V289, P65, DOI 10.1042/bj2890065; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EMONARD HP, 1992, CANCER RES, V52, P5845; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; FRISCH SM, 1990, ONCOGENE, V5, P75; FZIOLI F, 1994, TRENDS PHARMACOL SCI, V15, P25; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; GOLDBERG GI, 1991, REGULATORY MECHANISM, P421; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GRANT GA, 1987, J BIOL CHEM, V262, P5886; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HOWARD EW, 1991, J BIOL CHEM, V266, P17972; KARELINA TV, 1993, J INVEST DERMATOL, V100, P159, DOI 10.1111/1523-1747.ep12462791; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KNAUPER V, 1993, BIOCHEM J, V295, P581; KWAAN HC, 1992, CANCER METAST REV, V11, P291, DOI 10.1007/BF01307184; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MEISSAUER A, 1992, EXP CELL RES, V199, P179, DOI 10.1016/0014-4827(92)90423-6; MIYAZAKI K, 1993, J BIOL CHEM, V268, P14387; MONTGOMERY AMP, 1993, CANCER RES, V53, P693; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Nagase H, 1992, Matrix Suppl, V1, P237; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKA T, 1985, P NATL ACAD SCI USA, V82, P7212, DOI 10.1073/pnas.82.21.7212; OSSOWSKI L, 1992, CANCER RES, V52, P6754; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; POLETTE M, 1993, INVAS METAST, V13, P31; POULSOM R, 1992, AM J PATHOL, V141, P389; PYKE C, 1993, AM J PATHOL, V142, P359; PYKE C, 1993, CANCER RES, V53, P1911; PYKE C, 1991, AM J PATHOL, V138, P1059; QUAX PHA, 1991, CELL REGUL, V2, P793, DOI 10.1091/mbc.2.10.793; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; STETLERSTEVENSO.WG, 1993, ANNU REV CELL BIOL, V9, P541; STETLERSTEVENSO.WG, 1989, J BIOL CHEM, V264, P17374; STETLERSTEVENSO.WG, 1993, FASEB J, V7, P1434; STETLERSTEVENSO.WG, 1990, J BIOL CHEM, V265, P13933; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; TRYGGVASON K, 1993, BREAST CANCER RES TR, V24, P209, DOI 10.1007/BF01833261; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; VISSCHER DW, 1994, INT J CANCER, V58, P1; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WELGUS HG, 1979, J BIOL CHEM, V254, P1938	60	1396	1437	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5331	5338		10.1074/jbc.270.10.5331	http://dx.doi.org/10.1074/jbc.270.10.5331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890645	hybrid			2022-12-27	WOS:A1995QL58000059
J	CHAN, D; COLE, WG; ROGERS, JG; BATEMAN, JF				CHAN, D; COLE, WG; ROGERS, JG; BATEMAN, JF			TYPE-X COLLAGEN MULTIMER ASSEMBLY IN-VITRO IS PREVENTED BY A GLY(618) TO VAL MUTATION IN THE ALPHA-1(X) NC1 DOMAIN RESULTING IN SCHMID METAPHYSEAL CHONDRODYSPLASIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERINATAL OSTEOGENESIS IMPERFECTA; CARTILAGE; GENE; SEQUENCE; CHAIN; CHONDROCYTES; LOCALIZATION; ORGANIZATION; METABOLISM; DYSPLASIA	Type X collagen is a homotrimer of alpha 1(X) chains encoded by the COL10A1 gene. It is a highly specialized extracellular matrix component, and its synthesis is restricted to hypertrophic chondrocytes in the calcifying cartilage of the growth plate and in zones of secondary ossification, Our studies on a family with Schmid metaphyseal chondrodysplasia demonstrated that the affected individuals were heterozygous for a single base substitution in the COL10A1 gene, which changed the codon GGC for glycine 618 to GTC for valine in the highly conserved region of the carboxyl-terminal NC1 domain and altered the amino acid sequence in the putative oligosaccharide attachment site. Since hypertrophic cartilage tissue or cell cultures were not available to assess the effect of the mutation, an in vitro cDNA expression system was used to study normal and mutant type X collagen biosynthesis and assembly. Full-length cDNA constructs of the normal type X collagen sequence and also cDNA containing the specific Gly to Val NC1 mutation found in the patient were produced and expressed by in vitro transcription and translation. While the control construct produced type X collagen, which formed trimeric collagen monomers and assembled into larger multimeric assemblies, the mutant col lagen was unable to form these larger aggregates. These experiments demonstrated that the mutation disturbed type X collagen NCI domain interaction and assembly, a finding consistent with the abnormal disorganized cartilage growth plate seen in the patient. These studies provide the first evidence of the effect of a type X colla gen mutation on protein structure and function and directly demonstrate the critical role of interactions between NC1 domains in the formation of type X collagen multimeric structures in vitro.	UNIV MELBOURNE, ROYAL CHILDRENS HOSP, DEPT PAEDIAT, ORTHOPAED MOLEC BIOL RES UNIT, PARKVILLE, VIC 3052, AUSTRALIA; ROYAL CHILDRENS HOSP, MURDOCH INST, PARKVILLE, VIC 3052, AUSTRALIA	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne			; Chan, Danny/C-4203-2009	Bateman, John/0000-0001-8542-0730; Chan, Danny/0000-0003-3824-5778				APTE SS, 1993, MATRIX, V13, P165, DOI 10.1016/S0934-8832(11)80075-2; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BATEMAN JF, 1986, BIOCHEM J, V240, P699, DOI 10.1042/bj2400699; BATEMAN JF, 1988, ANAL BIOCHEM, V168, P171, DOI 10.1016/0003-2697(88)90025-5; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BRASS A, 1992, FEBS LETT, V303, P126, DOI 10.1016/0014-5793(92)80503-9; CHAN D, 1993, J BIOL CHEM, V268, P15238; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DHARMAVARAM RM, 1994, HUM MOL GENET, V3, P507, DOI 10.1093/hmg/3.3.507; DOUGLAS AM, 1992, ANAL BIOCHEM, V201, P362, DOI 10.1016/0003-2697(92)90352-8; GIBSON GJ, 1985, J CELL BIOL, V101, P277, DOI 10.1083/jcb.101.1.277; GOOCHEE CF, 1991, BIO-TECHNOL, V9, P1347, DOI 10.1038/nbt1291-1347; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LACHMAN RS, 1988, PEDIATR RADIOL, V18, P93, DOI 10.1007/BF02387549; LAMANDE SR, 1992, INT CONGR SER, V1002, P409; MCINTOSH I, 1994, HUM MOL GENET, V3, P303, DOI 10.1093/hmg/3.2.303; MIDDLETON RB, 1993, BIOCHEM J, V296, P511, DOI 10.1042/bj2960511; NERLICH AG, 1992, HISTOCHEMISTRY, V98, P275, DOI 10.1007/BF00270010; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; SWEETMAN WA, 1992, AM J HUM GENET, V51, P841; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; THOMAS JT, 1991, BIOCHEM J, V273, P141, DOI 10.1042/bj2730141; VALLE PL, 1988, J BIOL CHEM, V263, P18378; WALLIS GA, 1994, AM J HUM GENET, V54, P169; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424	34	69	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4558	4562		10.1074/jbc.270.9.4558	http://dx.doi.org/10.1074/jbc.270.9.4558			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876225	hybrid			2022-12-27	WOS:A1995QK08400058
J	GRADY, EF; SLICE, LW; BRANT, WO; WALSH, JH; PAYAN, DG; BUNNETT, NW				GRADY, EF; SLICE, LW; BRANT, WO; WALSH, JH; PAYAN, DG; BUNNETT, NW			DIRECT OBSERVATION OF ENDOCYTOSIS OF GASTRIN-RELEASING PEPTIDE AND ITS RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; GUINEA-PIG PANCREAS; MEDIATED ENDOCYTOSIS; DISPERSED ACINI; DOWN-REGULATION; BOMBESIN; INTERNALIZATION; DESENSITIZATION; DEGRADATION; TRANSFERRIN	Endocytosis of the gastrin releasing peptide receptor (GRP-R) may regulate cellular responses to GRP. We observed endocytosis in transfected epithelial cells by confocal microscopy using cyanine 3 GRP (cyanine 3.18-labeled gastrin releasing peptide) and GRP-R antibodies, At 4 degrees C, cy3-GRP and GRP-R were confined to the plasma membrane, After 5 min at 37 degrees C, ligand and receptor were internalized into early endosomes with fluorescein isothiocyanate-transferrin, After 10 min, cy3-GRP and GRP-R were in perinuclear vesicles, and at 60 min cy3-GRP was in large, central vesicles, while GRP-R was at the cell surface. We quantified surface GRP-R using an antibody to an extracellular epitope and an I-125-labeled secondary antibody. After exposure to GRP, there was a loss and subsequent recovery of surface GRP-R. Recovery was unaffected by cycloheximide, and thus independent of new protein synthesis, but was attenuated by acidotropic agents, and therefore required endosomal acidification, Internalization of I-125-GRP, assessed using an acid wash, was maximal after 10-20 min, and was clathrin-mediated since it was inhibited by by perosmolar sucrose and phenylarsine oxide, Thus, GRP and its receptor are rapidly internalized into early endosomes and then dissociate in an acidified compartment, GRP is probably degraded whereas the GRP-R recycles.	UNIV CALIF SAN FRANCISCO,DEPT SURG,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF LOS ANGELES,W LOS ANGELES VET ADM CTR,CTR GASTROENTER BIOL,CURE VA,LOS ANGELES,CA 90073	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles				Bunnett, Nigel W./0000-0003-3367-0644	NIDDK NIH HHS [DK 39957, DK 43207] Funding Source: Medline; NINDS NIH HHS [NS 21710] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039957, R01DK039957, R56DK043207, R01DK043207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021710] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTON PA, 1991, PEPTIDES, V12, P375, DOI 10.1016/0196-9781(91)90029-O; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BERTACCINI G, 1974, BRIT J PHARMACOL, V52, P219, DOI 10.1111/j.1476-5381.1974.tb09703.x; BOWDEN JJ, 1994, P NATL ACAD SCI USA, V91, P8964, DOI 10.1073/pnas.91.19.8964; BROCCARDO M, 1976, BRIT J PHARMACOL, V55, P221; BROWN KD, 1988, BIOCHEM J, V252, P227, DOI 10.1042/bj2520227; BUNNETT N, 1994, GUT PEPTIDES BIOCH P, P423; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; FROST SC, 1985, J BIOL CHEM, V260, P2646; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HANSEN SH, 1993, J CELL BIOL, V123, P89, DOI 10.1083/jcb.123.1.89; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LEE PC, 1980, AM J PHYSIOL, V238, pG213, DOI 10.1152/ajpgi.1980.238.3.G213; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MILLAR JBA, 1990, J BIOL CHEM, V265, P12052; OKAMOTO A, 1994, BIOCHEM J, V299, P683, DOI 10.1042/bj2990683; PANDOL SJ, 1982, J BIOL CHEM, V257, P2024; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; SLICE LW, 1994, J BIOL CHEM, V269, P21755; SPINDEL ER, 1990, MOL ENDOCRINOL, V4, P1956, DOI 10.1210/mend-4-12-1956; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; VIGNA SR, 1994, J NEUROSCI, V14, P834; WAKSHULL EM, 1985, P NATL ACAD SCI USA, V82, P8513, DOI 10.1073/pnas.82.24.8513; WANG LH, 1993, BIOCHIM BIOPHYS ACTA, V1175, P232, DOI 10.1016/0167-4889(93)90028-N; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; YU SS, 1993, J BIOL CHEM, V268, P337; ZACHARY I, 1987, EMBO J, V6, P2233, DOI 10.1002/j.1460-2075.1987.tb02495.x; ZHU WY, 1991, AM J PHYSIOL, V261, pG57, DOI 10.1152/ajpgi.1991.261.1.G57	38	82	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4603	4611		10.1074/jbc.270.9.4603	http://dx.doi.org/10.1074/jbc.270.9.4603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876231	hybrid			2022-12-27	WOS:A1995QK08400064
J	HONDA, Z; TAKANO, T; HIROSE, N; SUZUKI, T; MUTO, A; KUME, S; MIKOSHIBA, K; ITOH, K; SHIMIZU, T				HONDA, Z; TAKANO, T; HIROSE, N; SUZUKI, T; MUTO, A; KUME, S; MIKOSHIBA, K; ITOH, K; SHIMIZU, T			G(Q) PATHWAY DESENSITIZES CHEMOTACTIC RECEPTOR-INDUCED CALCIUM SIGNALING VIA INOSITOL TRISPHOSPHATE RECEPTOR DOWN-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR RECEPTOR; PHOSPHOLIPASE-C; THROMBOXANE-A2 RECEPTOR; G-PROTEINS; EXPRESSION; CLONING; CELLS; LEUKOCYTES; MECHANISMS	Desensitization of a chemotactic receptor is an adaptive process that terminates inflammation, Although homologous desensitization can be well explained by the action of specific receptor kinases, the mechanisms of heterologous desensitization remain elusive. As an approach to evaluate the roles of G(q) pathway in desensitization of calcium signaling, we expressed a constitutively active G(q) alpha mutant (G(q) alpha Q-L) together with platelet-activating factor (PAF) receptor in Xenopus laevis oocytes, G(q) alpha Q-L expression completely attenuated the calcium-sensitive chloride current and the Ca-45 release elicited by PAF. The G(q)-mediated desensitization could not be ascribed to G protein/receptor uncoupling via receptor phosphorylation, because (i) PAF-induced inositol 1,4,5-trisphosphate (IP3) synthesis was only partially suppressed and (ii) a mutated PAF receptor devoid of all Ser and Thr in the third cytoplasmic loop and in the C-terminal tail was also completely desensitized by G(q) alpha Q-L. In G(q) alpha Q-L expressing oocytes, microinjection of IP3 failed to elicit the calcium response, and the IP3, receptor, detected by a specific antibody, disappeared. Thus, the G(q)-mediated desensitization can be most likely explained by IP3 receptor down-regulation. These novel mechanisms may explain in part heterologous desensitization in chemotactic factor-stimulated inflammatory cells.	UNIV TOKYO,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO 108,JAPAN	University of Tokyo; University of Tokyo	HONDA, Z (corresponding author), UNIV TOKYO,FAC MED,DEPT INTERNAL MED & PHYS THERAPY,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Mikoshiba, Katsuhiko/N-7943-2015; Kume, Shoen/M-4356-2016	Kume, Shoen/0000-0002-4292-205X				AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BJORNSON AB, 1993, J INFECT DIS, V168, P120, DOI 10.1093/infdis/168.1.120; DEVIVO M, 1994, J BIOL CHEM, V269, P19671; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; EXTON JH, 1993, ADV SEC MESS PHOSPH, V28, P65; FROELICH CJ, 1989, CLIN IMMUNOL IMMUNOP, V50, P132, DOI 10.1016/0090-1229(89)90228-6; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; KOH YY, 1993, AM J RESP CELL MOL, V8, P493, DOI 10.1165/ajrcmb/8.5.493; KOZASA T, 1993, P NATL ACAD SCI USA, V91, P504; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P413, DOI 10.1016/0165-6147(93)90064-Q; MURACHI T, 1983, TRENDS BIOCHEM SCI, V8, P167, DOI 10.1016/0968-0004(83)90165-2; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; QIAN NX, 1994, J BIOL CHEM, V269, P17417; SHENKER A, 1991, J BIOL CHEM, V266, P9309; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; TAKANO T, 1994, J BIOL CHEM, V269, P22453; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; WOJCIKIEWICZ RJH, 1993, TRENDS PHARMACOL SCI, V14, P279, DOI 10.1016/0165-6147(93)90131-3; WU DQ, 1992, J BIOL CHEM, V267, P1811; ZANOLARI B, 1992, CELL, V71, P755, DOI 10.1016/0092-8674(92)90552-N	31	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4840	4844		10.1074/jbc.270.9.4840	http://dx.doi.org/10.1074/jbc.270.9.4840			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876256	hybrid			2022-12-27	WOS:A1995QK08400093
J	IVANENKO, A; MCKEMY, DD; KENYON, JL; AIREY, JA; SUTKO, JL				IVANENKO, A; MCKEMY, DD; KENYON, JL; AIREY, JA; SUTKO, JL			EMBRYONIC CHICKEN SKELETAL-MUSCLE CELLS FAIL TO DEVELOP NORMAL EXCITATION-CONTRACTION COUPLING IN THE ABSENCE OF THE ALPHA-RYANODINE RECEPTOR - IMPLICATIONS FOR A 2-RYANODINE RECEPTOR SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FOOT PROTEIN ISOFORMS; CALCIUM-RELEASE; EXPRESS; IDENTIFICATION; LOCALIZATION; CHANNELS; CULTURES; FIBERS	Two ryanodine receptor (RyR), sarcoplasmic reticulum Ca2+ release channels, alpha and beta, co-exist in chicken skeletal muscles. To investigate a two-RyR Ca2+ release system, we compared electrically evoked Ca2+ transients in Crooked Neck Dwarf (cn/cn) cultured muscle cells, which do not make alpha RyR, and normal (+/?) cells. At day 3 in culture, Ca2+ release in +/? cells required extracellular Ca2+ (Ca-o(2+)), and Ca2+ transients had slow kinetics. At day 5, Ca2+ release was Ca-o(2+)-independent in 40% of the cells, and transients were more rapid. By day 7, all +/? cells had Ca-o(2+)-independent Ca2+ release. Contractions were observed in +/? cells on all days. Ca2+ transients were observed in cn/cn cells on days 3, 5, and 7, but in each case they were Ca-o(2+)-dependent and exhibited slow kinetics. Localized vesiculations, not contractions, occurred in cn/cn cells. By day 10, Ca2+ transients were no longer observed in cn/cn cells even in Ca-o(2+). Sarcoplasmic reticulum Ca2+ was not depleted, as caffeine induced Ca2+ transients. Thus, in the absence of alpha RyR there is a failure to develop Ca-o(2+)-independent Ca2+ release and contractions and to sustain Ca-o(2+)-dependent release. Moreover, contributions by the alpha RyR cannot be duplicated by the beta RyR alone.	UNIV NEVADA,SCH MED,DEPT PHARMACOL 318,RENO,NV 89557; UNIV NEVADA,SCH MED,DEPT PHYSIOL,RENO,NV 89557	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno				Kenyon, James/0000-0001-8699-4680	PHS HHS [27470] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AIREY JA, 1993, DEV DYNAM, V197, P169, DOI 10.1002/aja.1001970303; AIREY JA, 1993, BIOCHEMISTRY-US, V32, P5739, DOI 10.1021/bi00073a003; AIREY JA, 1993, DEV DYNAM, V197, P189, DOI 10.1002/aja.1001970304; AIREY JA, 1990, J BIOL CHEM, V265, P14187; BANDMAN E, 1982, J CELL BIOL, V93, P698, DOI 10.1083/jcb.93.3.698; BULL R, 1993, FEBS LETT, V331, P223, DOI 10.1016/0014-5793(93)80341-Q; CERNY LC, 1986, J CELL BIOL, V103, P2153, DOI 10.1083/jcb.103.6.2153; COGNARD C, 1992, PFLUG ARCH EUR J PHY, V422, P207, DOI 10.1007/BF00370424; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; GIANNINI G, 1992, SCIENCE, V257, P91, DOI 10.1126/science.1320290; GIANNINI G, 1995, IN PRESS J CELL BIOL; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; JACQUEMOND V, 1991, BIOPHYS J, V60, P867, DOI 10.1016/S0006-3495(91)82120-8; KIDOKORO Y, 1988, P NATL ACAD SCI USA, V85, P1978, DOI 10.1073/pnas.85.6.1978; KIENY M, 1988, Biological Structures and Morphogenesis, V1, P15; LAI FA, 1992, AM J PHYSIOL, V263, pC365, DOI 10.1152/ajpcell.1992.263.2.C365; LEDBETTER MW, 1994, J BIOL CHEM, V269, P31544; MARAYAMA T, 1992, J BIOCH, V112, P514; OBRIEN J, 1993, BIOPHYS J, V65, P2418, DOI 10.1016/S0006-3495(93)81303-1; OLIVARES EB, 1991, BIOPHYS J, V59, P1153, DOI 10.1016/S0006-3495(91)82331-1; OYAMADA H, 1994, J BIOL CHEM, V269, P17206; PAPE PC, 1993, J GEN PHYSIOL, V102, P295, DOI 10.1085/jgp.102.2.295; PERCIVAL AL, 1994, BIOPHYS J, V67, P1834, DOI 10.1016/S0006-3495(94)80665-4; POWELL JA, 1990, FASEB J, V4, P2798, DOI 10.1096/fasebj.4.10.2197156; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; RIOS E, 1988, NEWS PHYSIOL SCI, V3, P223, DOI 10.1152/physiologyonline.1988.3.6.223; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0	29	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4220	4223		10.1074/jbc.270.9.4220	http://dx.doi.org/10.1074/jbc.270.9.4220			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876181	hybrid			2022-12-27	WOS:A1995QK08400011
J	MARZULLO, L; CANNIO, R; GIARDINA, P; SANTINI, MT; SANNIA, G				MARZULLO, L; CANNIO, R; GIARDINA, P; SANTINI, MT; SANNIA, G			VERATRYL ALCOHOL OXIDASE FROM PLEUROTUS-OSTREATUS PARTICIPATES IN LIGNIN BIODEGRADATION AND PREVENTS POLYMERIZATION OF LACCASE-OXIDIZED SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; DEGRADING BASIDIOMYCETE; HYDROGEN-PEROXIDE; PURIFICATION; DEGRADATION; GENES	Oxidative enzymes (laccases and peroxidases) isolated from the culture media of different fungi are involved in the basic mechanism of ligninolysis via radical intermediates, However, experiments aimed at reproducing natural biodegradation in vitro have been unsuccessful so far since the single biocatalysts alone are not able to solubilize lignins because of the simultaneous recondensation of these intermediates, FAD oxidases can prevent this side reaction in lignin depolymerization by reducing quinonoids and radical compounds, This study investigates the possible role of a laccase and a FAD-dependent aryl alcohol oxidase (veratryl alcohol oxidase, VAO) excreted by the basidiomycete Pleurotus ostreatus, In fact, we found that VAO is able to reduce synthetic quinones, laccase-generated quinonoids, and phenoxy radicals with concomitant oxidation of veratryl alcohol to veratryl aldehyde, This cooperative action of laccase and VAO also prevented the polymerization of phenolic compounds and reduced the molecular weight of soluble lignosulfonates to a significant extent.	UNIV NAPLES FEDERICO II,DIPARTIMENTO CHIM ORGAN & BIOL,I-80134 NAPLES,ITALY; IST SUPER SANITA,ULTRASTRUTTURE LAB,I-00161 ROME,ITALY	University of Naples Federico II; Istituto Superiore di Sanita (ISS)			Marzullo, Liberato/C-4408-2008; Giardina, Paola/F-4130-2011	Marzullo, Liberato/0000-0001-6133-4483; Giardina, Paola/0000-0002-5446-8130; SANNIA, Giovanni/0000-0002-7986-6223				BOURBONNAIS R, 1988, BIOCHEM J, V255, P445, DOI 10.1042/bj2550445; CALDWELL ES, 1969, BIOCHIM BIOPHYS ACTA, V184, P420, DOI 10.1016/0304-4165(69)90046-4; DEJONG E, 1992, EUR J BIOCHEM, V208, P651; GALLIANO H, 1991, ENZYME MICROB TECH, V13, P478, DOI 10.1016/0141-0229(91)90005-U; GREEN TR, 1977, NATURE, V268, P78, DOI 10.1038/268078a0; GUILLEN F, 1990, APPL MICROBIOL BIOT, V32, P465, DOI 10.1007/BF00903784; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; HAEMMERLI SD, 1986, FEMS MICROBIOL LETT, V35, P33, DOI 10.1111/j.1574-6968.1986.tb01494.x; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; HUOPONEN K, 1990, GENE, V89, P145, DOI 10.1016/0378-1119(90)90218-G; IWAHARA S, 1980, J FERMENT TECHNOL, V58, P183; KIMURA Y, 1990, APPL MICROBIOL BIOT, V32, P436, DOI 10.1007/BF00903779; KODURI RS, 1994, BIOCHEMISTRY-US, V33, P4425; LEONOWICZ A, 1985, PHYTOCHEMISTRY, V24, P393, DOI 10.1016/S0031-9422(00)80734-7; LUNDQUIST K, 1978, PHYTOCHEMISTRY, V17, P1676, DOI 10.1016/S0031-9422(00)94674-0; MUHEIM A, 1990, ENZYME MICROB TECH, V12, P204, DOI 10.1016/0141-0229(90)90039-S; ODIER E, 1988, BIOCHIMIE, V70, P847, DOI 10.1016/0300-9084(88)90117-4; PALMIERI G, 1993, APPL MICROBIOL BIOT, V39, P632, DOI 10.1007/BF00205066; SAMEJIMA M, 1992, EUR J BIOCHEM, V202, P103; SANNIA G, 1991, BIOCHIM BIOPHYS ACTA, V1073, P114, DOI 10.1016/0304-4165(91)90190-R; SHAH MM, 1993, BIOCHEM BIOPH RES CO, V191, P887, DOI 10.1006/bbrc.1993.1300; SHIMADA M, 1981, ARCH MICROBIOL, V129, P321, DOI 10.1007/BF00414706; SHIN KS, 1993, EUR J BIOCHEM, V215, P747, DOI 10.1111/j.1432-1033.1993.tb18088.x; SKLARZ G, 1986, PHYTOCHEMISTRY, V25, P2537; TONON F, 1988, APPL ENVIRON MICROB, V54, P466, DOI 10.1128/AEM.54.2.466-472.1988; WARIISHI H, 1994, BIOCHEMISTRY-US, V33, P5545, DOI 10.1021/bi00184a025	28	106	110	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3823	3827		10.1074/jbc.270.8.3823	http://dx.doi.org/10.1074/jbc.270.8.3823			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876125	hybrid			2022-12-27	WOS:A1995QH68800055
J	POKALSKY, C; WICK, P; HARMS, E; LYTLE, FE; VANETTEN, RL				POKALSKY, C; WICK, P; HARMS, E; LYTLE, FE; VANETTEN, RL			FLUORESCENCE RESOLUTION OF THE INTRINSIC TRYPTOPHAN RESIDUES OF BOVINE PROTEIN TYROSYL PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE; 2 TRYPTOPHAN; MUTANTS; HEART; REPRESSOR	Fluorescence steady-state and lifetime measurements have been performed that permit the differentiation of the 2 intrinsic tryptophan residues in bovine low molecular weight phosphotyrosyl protein phosphatase (BPTP), Spectral information was obtained by use of two single-tryptophan mutant proteins, W39F and W49F, and the double mutant protein W39,49F, Fluorescence measurements show that Trp(39) is characterized by a large blue shift, a low quantum yield, and a shorter mean lifetime compared to Trp(49). Solute fluorescence quenching studies of W39F reveal that Trp(49) is, highly exposed to the aqueous environment, In contrast, Trp(39) is situated within a hydrophobic core and is only partially accessible to quenching agents such as acrylamide, iodide ion, and cesium ion, The fluorescence contributions of Trp(39),and Trp(49) are additive, and their sum is equivalent to that observed for wild type BPTP, Calculated intramolecular distances between Trp(39) or Trp(49) and, 5-[[C(acetylamino)-ethyl]amino]naphthalene-1-sulfonate group covalently bound at Cys(12) or Cys(17) of the respective protein mutants, place Trp(49) within 10 Angstrom and Trp(39) at least 20 Angstrom from the active site, The fluorescence decay of the single tryptophan mutants and, surprisingly, wild type BPTP were each adequately fitted as biexponential, The latter is a consequence of the imprecision involved in determining actual minima in a three- and four-exponential fitting, Comparison of quenching results of wild type BPTP with those of the single tryptophan mutant proteins indicates that minor fluorescence components, easily resolved using a biexponential fitting for the mutant proteins, are unresolvable for wild type BPTP, These minor components skewed the weighted magnitudes and induced perturbations in lifetimes for the tryptophan fluorescence of wild type BPTP, which directly influenced the calculated values of K-sv and k(q).	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA; PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 27003] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACK MJ, 1983, ANAL BIOCHEM, V135, P233, DOI 10.1016/0003-2697(83)90756-X; BOIVIN P, 1986, BIOCHEM BIOPH RES CO, V134, P557, DOI 10.1016/S0006-291X(86)80456-9; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHERNOFF J, 1985, ARCH BIOCHEM BIOPHYS, V240, P135, DOI 10.1016/0003-9861(85)90016-5; DAVIS JP, 1994, J BIOL CHEM, V269, P8734; Demas J. N., 1983, EXCITED STATE LIFETI; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DRYDEN DTF, 1989, BIOCHIM BIOPHYS ACTA, V997, P313, DOI 10.1016/0167-4838(89)90202-1; EFTINK MR, 1987, BIOCHEMISTRY-US, V26, P8338, DOI 10.1021/bi00399a047; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1993, BIOCHEMISTRY-US, V32, P9189, DOI 10.1021/bi00086a026; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HARRIS JM, 1980, REV SCI INSTRUM, V51, P988, DOI 10.1063/1.1136324; HART KW, 1993, ADV SPECTROSC, V20, P195; HUNTER T, 1989, CELL, V58, P1013, DOI 10.1016/0092-8674(89)90496-0; KASHA M, 1952, J CHEM PHYS, V20, P71, DOI 10.1063/1.1700199; KIRBY EP, 1970, J BIOL CHEM, V245, P6300; KRONMAN MJ, 1970, FINE STRUCTURE PROTE, P00271; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; LEATHERBARROW RJ, 1987, ENZYME MECHANISMS, P83; LOGAN TM, 1994, BIOCHEMISTRY-US, V33, P11087, DOI 10.1021/bi00203a005; MAS MT, 1994, BIOCHEMISTRY-US, V33, P2217; O'Connor D. V., 1984, TIME CORRELATED SING; RAMPONI G, 1989, FEBS LETT, V250, P469, DOI 10.1016/0014-5793(89)80778-1; ROYER CA, 1990, BIOPHYS J, V58, P363, DOI 10.1016/S0006-3495(90)82383-3; SAINI MS, 1981, J BIOL CHEM, V256, P453; STOLE E, 1994, J BIOL CHEM, V269, P7919; STRYJEWSKI W, 1986, EUR J BIOCHEM, V158, P547, DOI 10.1111/j.1432-1033.1986.tb09789.x; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; WAHEED A, 1988, BIOCHEMISTRY-US, V27, P4265, DOI 10.1021/bi00412a010; WALDMAN ADB, 1987, BIOCHIM BIOPHYS ACTA, V913, P66, DOI 10.1016/0167-4838(87)90233-0; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; YOUNG L, 1994, PROTEIN SCI, V3, P717; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; ZHANG ZY, 1990, THESIS PURDUE U	41	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3809	3815		10.1074/jbc.270.8.3809	http://dx.doi.org/10.1074/jbc.270.8.3809			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876123	hybrid			2022-12-27	WOS:A1995QH68800053
J	BRUNO, MD; BOHINSKI, RJ; HUELSMAN, KM; WHITSETT, JA; KORFHAGEN, TR				BRUNO, MD; BOHINSKI, RJ; HUELSMAN, KM; WHITSETT, JA; KORFHAGEN, TR			LUNG CELL-SPECIFIC EXPRESSION OF THE MURINE SURFACTANT PROTEIN-A (SP-A) GENE IS MEDIATED BY INTERACTIONS BETWEEN THE SP-A PROMOTER AND THYROID TRANSCRIPTION FACTOR-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SPECIFICITY; PULMONARY SURFACTANT; PHORBOL ESTER; RAT; IDENTIFICATION; LOCALIZATION; INVITRO; REGIONS; ALPHA	Cis-acting elements determining lung epithelial cell-selective transcription of the murine surfactant protein A (SP-A) gene were identified between nucleotide positions -255 and -57. This region of the murine SP-A gene contained nucleotide sequences consistent with thyroid transcription factor-1 (TTF-1) binding motifs. An SP-A-CAT plasmid containing the TTF-1 binding sites was transcriptionally active in mouse lung epithelial (MLE-15) cells but not in HeLa, 3T3, or H441 cells. However, transcription of the SP-A-CAT construct was activated after cotransfection of HeLa cells with a vector expressing recombinant TTF-1, pCMV-TTF-1. Recombinant TTF-1 homeodomain protein bound to four distinct binding sites located between nucleotides -231 to -168. Proteins in nuclear extracts of MLE-15 cells bound TTF-1 binding sites and were supershifted by TTF-1 antibody. Mutations of three of the TTF-1 binding sites in this region reduced expression of the SP-A-CAT construct in transfected MLE-IB cells and reduced transactivation in HeLa cells. TTF-1 interacts with complex protein/DNA binding sites located in the 5'-flanking region of the murine SP-A gene enhancing lung epithelial cell-specific expression in vitro.	CHILDRENS HOSP,MED CTR,DIV PULM BIOL,CINCINNATI,OH 45229	Cincinnati Children's Hospital Medical Center					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028623, P01HL051832] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28623, HL51832] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALCORN JL, 1993, MOL ENDOCRINOL, V7, P1072, DOI 10.1210/me.7.8.1072; BALLARD PL, 1989, ENDOCR REV, V10, P165, DOI 10.1210/edrv-10-2-165; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; CLEVIDENCE DE, 1994, DEV BIOL, V166, P195, DOI 10.1006/dbio.1994.1307; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; DAMANTE G, 1991, P NATL ACAD SCI USA, V88, P5388, DOI 10.1073/pnas.88.12.5388; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GAO E, 1993, J BIOL CHEM, V268, P19697; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; KHOOR A, 1993, J HISTOCHEM CYTOCHEM, V41, P1311, DOI 10.1177/41.9.8354874; KORFHAGEN TR, 1992, AM J PHYSIOL, V263, pL546, DOI 10.1152/ajplung.1992.263.5.L546; KOURETAS D, 1993, EXP LUNG RES, V19, P485, DOI 10.3109/01902149309064359; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; LACAZEMASMONTEIL T, 1992, EUR J BIOCHEM, V206, P613, DOI 10.1111/j.1432-1033.1992.tb16966.x; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; PRYHUBER GS, 1990, J BIOL CHEM, V265, P20822; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; WHITSETT JA, 1992, AM J PHYSIOL, V262, pL688, DOI 10.1152/ajplung.1992.262.6.L688; WHITSETT JA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P257, DOI 10.1016/0005-2760(92)90004-F; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; WISPE JR, 1990, J CLIN INVEST, V86, P1954, DOI 10.1172/JCI114929	27	234	240	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6531	6536		10.1074/jbc.270.12.6531	http://dx.doi.org/10.1074/jbc.270.12.6531			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896788				2022-12-27	WOS:A1995QQ85500018
J	JAMES, GL; GOLDSTEIN, JL; BROWN, MS				JAMES, GL; GOLDSTEIN, JL; BROWN, MS			POLYLYSINE AND CVIM SEQUENCES OF K-RASB DICTATE SPECIFICITY OF PRENYLATION AND CONFER RESISTANCE TO BENZODIAZEPINE PEPTIDOMIMETIC IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21RAS PROTEIN FARNESYLTRANSFERASE; ALPHA-SUBUNIT; PEPTIDE-BINDING; RAT-BRAIN; FARNESYL; GERANYLGERANYLTRANSFERASE; TRANSFERASE; EXPRESSION; INHIBITORS; PATHWAY	BZA-5B, a benzodiazepine peptidomimetic, inhibits CAAX farnesyltransferase (FTase) and blocks attachment of farnesyl groups to oncogenic and wild-type H-Ras in animal cells. This compound slows the growth of cells transformed with oncogenic H-Ras at concentrations that do not affect the growth of nontransformed cells. This finding suggested that nontransformed cells may produce a form of Ras whose prenylation is resistant to BZA-5B. In the current studies, we found that FTase had a 50-fold higher affinity for K-RasB than for H-Ras in vitro. Farnesylation of K-RasB was inhibited by BZA-2B, the active form of BZA-5B, but only at concentrations that were 8-fold higher than those that inhibited farnesylation of H-Ras, K-RasB, but not H-Ras, was also a substrate for CAAX geranylgeranyltransferase-1 (GGTase-1), and its affinity for the enzyme was equal to that of Rap1B, an authentic leucine-terminated substrate for GGTase-1, Inhibition of the geranylgeranylation of K-RasB occurred only at high concentrations of BZA-2B, All of these properties of K-RasB were traced to the combined effects of its COOH-terminal CVIM sequence and the adjacent polylysine sequence, neither of which is present in H-Ras, These studies provide a potential explanation for the resistance of nontransformed cells to growth inhibition by BZA-5B, Inasmuch as the majority of Ras-related human cancers contain oncogenic versions of K-RasB rather than H-Ras, the current data suggest that in vitro studies of FTase inhibitors with potential anti-cancer activity should use authentic K-RasB as a substrate.			JAMES, GL (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.				NHLBI NIH HHS [HL 20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDRES DA, 1993, J BIOL CHEM, V268, P1383; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BROWN MS, 1993, NATURE, V366, P14, DOI 10.1038/366014a0; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CASEY PJ, 1992, J LIPID RES, V33, P1731; CHEN WJ, 1993, J BIOL CHEM, V268, P9675; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; GIBBS JB, 1989, P NATL ACAD SCI USA, V86, P6630, DOI 10.1073/pnas.86.17.6630; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; JAMES GL, 1994, J BIOL CHEM, V269, P27705; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; KOHL NE, 1994, P NATL ACAD SCI USA, V91, P9141, DOI 10.1073/pnas.91.19.9141; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; MOORES SL, 1991, J BIOL CHEM, V266, P14603; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; POMPLIANO DL, 1993, BIOCHEMISTRY-US, V32, P8341, DOI 10.1021/bi00083a038; POMPLIANO DL, 1992, BIOCHEMISTRY-US, V31, P3800, DOI 10.1021/bi00130a010; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; REISS Y, 1992, J BIOL CHEM, V267, P6403; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SCHAFER WR, 1992, ANNU REV GENET, V30, P209; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; TAMANOI F, 1993, TRENDS BIOCHEM SCI, V18, P349, DOI 10.1016/0968-0004(93)90072-U; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; YOKOYAMA K, 1993, J BIOL CHEM, V268, P4055; ZHANG FL, 1994, J BIOL CHEM, V269, P3175	39	284	325	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6221	6226		10.1074/jbc.270.11.6221	http://dx.doi.org/10.1074/jbc.270.11.6221			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890759				2022-12-27	WOS:A1995QM94500076
J	ZOU, JJ; SCHOENHAUT, DS; CARVAJAL, DM; WARRIER, RR; PRESKY, DH; GATELY, MK; GUBLER, U				ZOU, JJ; SCHOENHAUT, DS; CARVAJAL, DM; WARRIER, RR; PRESKY, DH; GATELY, MK; GUBLER, U			STRUCTURE-FUNCTION ANALYSIS OF THE P35 SUBUNIT OF MOUSE INTERLEUKIN-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL STIMULATORY FACTOR; LYMPHOCYTE MATURATION FACTOR; ACTIVATED HUMAN LYMPHOBLASTS; RECEPTOR-BINDING; FACTOR NKSF; EXPRESSION; PROTEINS; PURIFICATION; MUTAGENESIS; CYTOKINE	Mouse IL-12 acts on both mouse and human cells; human IL-12 acts only on human cells. This species specificity is determined by the p35 subunit of the IL-12 heterodimer. Since mouse and human p35 sequences are 60% identical, the determinants for the species specificity most likely reside in the nonhomologous sequences of mouse p35. To identify the regions on the p35 subunit interacting with the mouse IL-12 receptor, we constructed a series of chimeric mouse-human p35 molecules by replacing mouse sequences with the nonhomologous human counterparts. An IL-12 heterodimer containing a mouse-human p35 chimera with five residues changed in three discontinuous sites had drastically reduced (750-3000-fold) bioactivities on mouse cells. However, the competitive binding activity of the same mutant IL-12 heterodimer on mouse cells was only reduced 30-fold relative to wild-type IL-12. These findings therefore suggest that 1) the mouse p35 subunit participates in both receptor binding and signaling, 2) the mutations introduced into p35 affect signaling to a much greater extent than receptor binding, and 3) the five residues identified on p35 are required for interacting with the mouse, but not with the human IL-12 receptor and as such contribute extensively to the observed species specificity of IL-12.	HOFFMANN LA ROCHE INC,DEPT INFLAMMAT AUTOIMMUNE DIS,NUTLEY,NJ 07110	Roche Holding								BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; CHIZZONITE R, 1991, J IMMUNOL, V147, P1548; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHUA AO, 1994, J IMMUNOL, V153, P128; DANDREA A, 1992, J EXP MED, V176, P1887; DESAI BB, 1992, J IMMUNOL, V148, P3125; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FIORILLO MT, 1992, EUR J IMMUNOL, V22, P2609, DOI 10.1002/eji.1830221021; Gately M K, 1994, Ther Immunol, V1, P187; GATELY MK, 1994, INT IMMUNOL, V6, P157, DOI 10.1093/intimm/6.1.157; GATELY MK, 1992, CURRENT PROTOCOLS IM, V1; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; HOWARD B, 1993, ECL HIGHLIGHTS, V1, P3; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langone J J, 1980, Methods Enzymol, V70, P221; LI XM, 1993, J BIOL CHEM, V268, P22377; LING P, 1995, J IMMUNOL, V154, P116; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; McPherson M. J., 1991, PCR PRACTICAL APPROA; MERBERG DM, 1992, IMMUNOL TODAY, V13, P77, DOI 10.1016/0167-5699(92)90140-3; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; SAVINO R, 1993, P NATL ACAD SCI USA, V90, P4067, DOI 10.1073/pnas.90.9.4067; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Stein S, 1981, Methods Enzymol, V79, P7; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; WOLF SF, 1991, J IMMUNOL, V146, P3074	36	29	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5864	5871		10.1074/jbc.270.11.5864	http://dx.doi.org/10.1074/jbc.270.11.5864			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890716	hybrid			2022-12-27	WOS:A1995QM94500028
J	KOPIN, AS; MCBRIDE, EW; QUINN, SM; KOLAKOWSKI, LF; BEINBORN, M				KOPIN, AS; MCBRIDE, EW; QUINN, SM; KOLAKOWSKI, LF; BEINBORN, M			THE ROLE OF THE CHOLECYSTOKININ-B GASTRIN RECEPTOR TRANSMEMBRANE DOMAINS IN DETERMINING AFFINITY FOR SUBTYPE-SELECTIVE LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; CHROMOSOMAL LOCALIZATION; MORPHINE ANALGESIA; SUBSTANCE-P; HUMAN BRAIN; A RECEPTOR; ANTAGONIST; SPECIFICITY; ANXIETY	We have examined the role of transmembrane domain amino acids in conferring subtype-selective ligand affinity to the human cholecystokinin-B (CCK-B)/gastrin receptor. Fifty-eight residues were sequentially replaced by the corresponding amino acids from the pharmacologically distinct CCK-A receptor subtype. I-125-CCK-8 competition binding experiments were performed to compare all mutant CCK-B/gastrin receptor constructs with the wild type control. Affinities for the nonselective agonist, CCK-8, as well as the subtype-selective peptide (gastrin), peptide derived (PD135,158), and nonpeptide (L365,260 and L364,718) ligands were assessed. Ah of the mutants retained relatively high affinity for CCK-8, suggesting that the tertiary structure of these receptors was well maintained. Only eight of the amino acid substitutions had a significant effect on subtype selective binding. When compared with the wild type, single point mutations in the CCK-B/gastrin receptor decreased affinity for gastrin, L365,260, and PD135;158 up to 17-, 23-, and 61-fold, respectively. In contrast, the affinity for L364,718 increased up to 63-fold. None of the single amino acid substitutions, however, was sufficient to fully account for the subtype selectivity of any tested compound. Rather, CCK-B/gastrin receptor affinity appears to be influenced by multiple residues acting in concert. The 8 pharmacologically important amino acids cluster in the portion of the transmembrane domains adjacent to the cell surface. The spatial orientation of these residues was analyzed with a rhodopsin based three dimensional model of G-protein coupled receptor structure (Baldwin, J. M. (1993) EMBO J. 12, 1693-1703). This model predicts that the 8 crucial residues project into a putative ligand pocket, similar to the one which is well established for biogenic amine receptors (Caron, M. G., and Lefkowitz, R. J. (1993) Recent Prog. Horm. Res. 48, 277-290; Strader, C. D., Sigal, I. S., and Dixon, R. A. (1989) Trends Pharmacol. Sci. 10, Dec. Suppl., 26-30).	TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,GRASP DIGEST DIS CTR,BOSTON,MA 02111; CHILDRENS HOSP,INA SUE PERLMUTTER LAB,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Tufts Medical Center; Tufts University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	KOPIN, AS (corresponding author), TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DIV GASTROENTEROL,BOSTON,MA 02111, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928, K11DK001935, R01DK046767] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30-DK34928, DK01935, DK46767] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; DEWEERTH A, 1993, BIOCHEM BIOPH RES CO, V194, P811, DOI 10.1006/bbrc.1993.1894; DOURISH CT, 1990, EUR J PHARMACOL, V176, P35, DOI 10.1016/0014-2999(90)90129-T; FARIS PL, 1983, SCIENCE, V219, P310, DOI 10.1126/science.6294831; FONG TM, 1994, J BIOL CHEM, V269, P2728; FONG TM, 1992, J BIOL CHEM, V267, P25668; FONG TM, 1992, J BIOL CHEM, V267, P25664; FONG TM, 1994, J BIOL CHEM, V269, P14957; FONG TM, 1993, NATURE, V362, P350; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HUANG RRC, 1994, BIOCHEMISTRY-US, V33, P3007, DOI 10.1021/bi00176a033; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; ITO M, 1993, J BIOL CHEM, V268, P18300; JI H, 1994, J BIOL CHEM, V269, P16533; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; LEE YM, 1992, J BIOL CHEM, V268, P8164; PERLMAN JH, 1994, J BIOL CHEM, V269, P1610; PISEGNA JR, 1992, BIOCHEM BIOPH RES CO, V189, P296, DOI 10.1016/0006-291X(92)91557-7; RAVARD S, 1990, TRENDS PHARMACOL SCI, V11, P271, DOI 10.1016/0165-6147(90)90004-R; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SINGH L, 1991, P NATL ACAD SCI USA, V88, P1130, DOI 10.1073/pnas.88.4.1130; STRADER CD, 1989, TRENDS PHARM SCI S, V10, P26; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; ULRICH CD, 1993, BIOCHEM BIOPH RES CO, V193, P204, DOI 10.1006/bbrc.1993.1610; WALSH JH, 1994, GUT PEPTIDES BIOCH P, P75; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WIERTELAK EP, 1992, SCIENCE, V256, P830, DOI 10.1126/science.1589765; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x; ZHU GC, 1992, J CELL BIOCHEM, V50, P159	34	76	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5019	5023		10.1074/jbc.270.10.5019	http://dx.doi.org/10.1074/jbc.270.10.5019			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890609	hybrid			2022-12-27	WOS:A1995QL58000014
J	LEE, HJ; CHANG, CS				LEE, HJ; CHANG, CS			IDENTIFICATION OF HUMAN TR2 ORPHAN RECEPTOR RESPONSE ELEMENT IN THE TRANSCRIPTIONAL INITIATION SITE OF THE SIMIAN-VIRUS-40 MAJOR LATE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE RECEPTORS; LONG TERMINAL REPEAT; DNA-BINDING DOMAIN; GENE; SUPERFAMILY; DETERMINANTS	A DNA response element (TR2RE-SV40) for the TR2 orphan receptor, a member of the steroid-thyroid hormone receptor superfamily, has been identified in the simian virus 40 (SV40) +55 region (nucleotide numbers 368-389, 5'-GTTAAGGTTCGTAGGTCATGGA-3'). Electrophoretic mobility shift assay, using in vitro translated TR2 orphan receptor with a molecular mass of 67 kilodaltons, showed a specific binding with high affinity (dissociation constant = 9 nM) for this DNA sequence. DNA-swap experiments using chloramphenicol acetyltransferase assay demonstrated that androgen can suppress the transcriptional activities of SV40 early promoter via the interaction between this TR2RE-SV40 and the chimeric receptor AR/TR2/AR with the DNA-binding domain of the TR2 orphan receptor flanked by the N-terminal anal androgen-binding domains of the androgen receptor. In addition, this TR2RE-SV40 can function as a repressor to suppress the transcriptional activities of both SV40 early and late promoters. Together, these data suggest the TR2RE-SV40 may represent the first identified natural DNA response element for the TR2 orphan receptor that may function as a repressor for the SV40 gene expression.	UNIV WISCONSIN,CTR COMPREHENS CANC,DEPT HUMAN ONCOL,MADISON,WI 53792; UNIV WISCONSIN,CTR COMPREHENS CANC,ENDOCRINOL REPROD PHYSIOL PROGRAM,MADISON,WI 53792	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA 55639] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055639, R29CA055639] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; CHANG C, 1989, J STEROID BIOCHEM, V34, P391; CHANG C, 1989, BIOCHEM BIOPH RES CO, V165, P735, DOI 10.1016/S0006-291X(89)80028-2; Chang C, 1993, ENDOCR J, V1, P541; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COONEY AJ, 1991, J VIROL, V65, P2853, DOI 10.1128/JVI.65.6.2853-2860.1991; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GARCIA AD, 1993, J VIROL, V67, P3940, DOI 10.1128/JVI.67.7.3940-3950.1993; GIGUERE V, 1987, NATURE, V331, P91; Kokontis J, 1991, Receptor, V1, P261; KOKONTIS J, 1991, MOLECULAR AND CELLULAR BIOLOGY OF PROSTATE CANCER, P229; LEE HJ, 1993, BIOCHEM BIOPH RES CO, V194, P97, DOI 10.1006/bbrc.1993.1790; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Lydon John P., 1992, Gene Expression, V2, P273; MARTINEZ E, 1991, NUCLEAR HORMONE RECE, P125; MOWSZOWICZ I, 1993, MOL ENDOCRINOL, V7, P861, DOI 10.1210/me.7.7.861; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; OMALLEY BW, 1992, MOL ENDOCRINOL, V6, P1359, DOI 10.1210/me.6.9.1359; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; SAGAMI I, 1986, MOL CELL BIOL, V6, P4259, DOI 10.1128/MCB.6.12.4259; Sambrook J, 1989, MOL CLONING LABORATO; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; TALBOT SJ, 1994, BIOCHEMISTRY-US, V33, P1399, DOI 10.1021/bi00172a016; Tooze J, 1981, MOL BIOL TUMOR VIRUS; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WILEY SR, 1993, GENE DEV, V7, P2206, DOI 10.1101/gad.7.11.2206; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541	31	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5434	5440		10.1074/jbc.270.10.5434	http://dx.doi.org/10.1074/jbc.270.10.5434			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890658	hybrid			2022-12-27	WOS:A1995QL58000074
J	SPARKS, DL; ANANTHARAMAIAH, GM; SEGREST, JP; PHILLIPS, MC				SPARKS, DL; ANANTHARAMAIAH, GM; SEGREST, JP; PHILLIPS, MC			EFFECT OF THE CHOLESTEROL CONTENT OF RECONSTITUTED LPA-I ON LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; LIPID TRANSFER PROTEIN; PLASMA-LIPOPROTEINS; ESTERIFICATION; PARTICLES; CHARGE; ESTER; RECOMBINANTS; METABOLISM	The production of cholesteryl ester (CE) by lecithin: cholesterol acyl transferase (LCAT) is elevated significantly in hyperlipidemic subjects at high risk for coronary artery disease. To elucidate the molecular events involved, the relationship between LCAT activation and apolipoprotein (apo) A-I charge and structure in high density lipoproteins (HDL) has been studied in both native HDL and homogeneous recombinant HDL (Lp2A-I) particles containing apoA-I, palmitoyloleoyl phosphatidylcholine and cholesterol. Increasing the cholesterol content of discoidal Lp2A-I from 4 to 26 molecules/particle raises the maximum rate of cholesterol esterification by LCAT (V-max) from 3.1 to 9.2 nmol CE/h/unit of LCAT and increases the apparent K-m from 0.5 to 3.5 mu M cholesterol. Similarly, increasing the cholesterol content in triolein core-containing Lp2A-I (4-18 molecules/particle) and in native HDL(3) (12-21 molecules/particle) also significantly increases the V-max for LCAT (2.8-7.7 and 0.5-3.6 nmol CE/h, respectively) and raises the K-m values (7.6-36.9 and 7.3-8.5 mu M cholesterol, respectively). In contrast, changes in the cholesterol content of native and recombinant HDL have no significant effect on the apparent K-m values when expressed in terms of the concentration of either apoA-I or palmitoyloleoyl phosphatidylcholine. This appears to indicate that interfacial cholesterol content has no effect on the binding affinity of LCAT to different LpA-I particles but directly affects catalysis by modulating the interaction of cholesterol molecules with the active site of LCAT. Increasing the cholesterol content of the different HDL particles progressively increases the particle net negative charge, and these changes in apoA-I charge are strongly correlated with both the V-max and apparent K-m values for LCAT, This suggests that the conformation and charge of apoA-I play a central role in LCAT activation and that these parameters are influenced by the amount of cholesterol in the surface of HDL particles.	UNIV ALABAMA,MED CTR,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,DEPT BIOCHEM,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,ATHEROSCLEROSIS RES UNIT,BIRMINGHAM,AL 35294; MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Drexel University	SPARKS, DL (corresponding author), UNIV OTTAWA,INST HEART,LIPOPROT & ATHEROSCLEROSIS GRP,1053 CARLING AVE,OTTAWA,ON K1Y 4E9,CANADA.			Phillips, Michael/0000-0002-7147-8007	NHLBI NIH HHS [HL22633, HL34343] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, P01HL022633] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albers J J, 1986, Methods Enzymol, V129, P763; AZEMA C, 1990, BIOCHIM BIOPHYS ACTA, V1046, P73, DOI 10.1016/0005-2760(90)90096-G; BARTER PJ, 1985, ATHEROSCLEROSIS, V58, P97, DOI 10.1016/0021-9150(85)90058-9; BARTER PJ, 1984, BIOCHIM BIOPHYS ACTA, V793, P260, DOI 10.1016/0005-2760(84)90328-X; BOLIN DJ, 1993, J BIOL CHEM, V269, P7429; BREWER HB, 1986, METHOD ENZYMOL, V128, P228; DOBIASOVA M, 1992, J LIPID RES, V33, P1411; DOBIASOVA M, 1983, ADV LIPID RES, V20, P107; DOBIASOVA M, 1991, ARTERIOSCLER THROMB, V11, P64, DOI 10.1161/01.ATV.11.1.64; EISENBERG S, 1984, J LIPID RES, V25, P1017; FURUKAWA Y, 1979, J BIOL CHEM, V254, P7213; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIRZ R, 1970, BIOCHIM BIOPHYS ACTA, V207, P364, DOI 10.1016/0005-2795(70)90029-2; JAUHIAINEN M, 1990, HYPERCHOLESTEROLEMIA, P71; JONAS A, 1986, BIOCHIM BIOPHYS ACTA, V876, P474, DOI 10.1016/0005-2760(86)90034-2; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1985, BIOCHEMISTRY-US, V24, P3508, DOI 10.1021/bi00335a018; JONAS A, 1983, BIOCHIM BIOPHYS ACTA, V794, P361; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; LUNDKATZ S, 1993, BIOCHEMISTRY-US, V269, P4729; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; MATZ CE, 1982, J BIOL CHEM, V257, P4585; MORTON RE, 1988, J BIOL CHEM, V263, P12235; NAKAGAWA M, 1973, BIOCHIM BIOPHYS ACTA, V296, P577; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NISHIDA HI, 1993, J BIOL CHEM, V268, P16352; PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782; RITTER MC, 1977, J BIOL CHEM, V252, P1208; RUTTENBERG HL, 1973, BIOCHIM BIOPHYS ACTA, V326, P419; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SPARKS DL, 1989, J LIPID RES, V30, P1491; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SPARKS DL, 1989, BIOCHEM CELL BIOL, V67, P358, DOI 10.1139/o89-056; SPARKS DL, 1992, J LIPID RES, V33, P128; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4	40	50	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5151	5157		10.1074/jbc.270.10.5151	http://dx.doi.org/10.1074/jbc.270.10.5151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890624	hybrid			2022-12-27	WOS:A1995QL58000032
J	TODD, MJ; LORIMER, GH				TODD, MJ; LORIMER, GH			STABILITY OF THE ASYMMETRIC ESCHERICHIA-COLI CHAPERONIN COMPLEX - GUANIDINE CHLORIDE CAUSES RAPID DISSOCIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; RHODOSPIRILLUM-RUBRUM; MOLECULAR CHAPERONE; ATP HYDROLYSIS; GROEL; PROTEINS; CYCLE; CPN60	The chaperonin proteins, GroEL(14), and GroES(7), inhibit protein aggregation and assist in protein folding in a potassium/ATP-dependent manner. In vitro, assays for chaperonin activity typically involve adding a denatured substrate protein to the chaperonins and measuring the appearance of correctly folded substrate protein. The influence of denaturant is generally ignored. Low concentrations of guanidinium chloride (<100 mM) had a profound effect on the activity/structure of the chaperonins. Guanidinium decreased the ATPase activity of GroEL and attenuated the inhibition of GroEL ATP hydrolysis by GroES. The stable, asymmetric chaperonin complex which forms in the presence of GroES and ADP (GroES(7) . ADP(7) . GroEL(7)-GroEL()) rapidly dissociated upon addition of 80 mM guanidinium chloride. Dissociation was enhanced at high ionic strength, but rapid dissociation was guanidinium-specific. Accelerated release of the GroES from the complex was also demonstrated. Unfolded proteins alone had no effect on complex stability. Residual guanidinium depressed the rate of Rhodospirillum rubrum ribulose-1,5-bisphosphate carboxylase (Rubisco) folding; an increased aggregation rate also decreased the yield of folded Rubisco. Chaperonin-assisted folding is therefore best studied using proteins denatured by means other than guanidinium chloride.			TODD, MJ (corresponding author), DUPONT CO INC,DEPT CENT RES & DEV,EXPTL STN,WILMINGTON,DE 19880, USA.							AZEM A, 1994, BIOCHEMISTRY-US, V33, P6671, DOI 10.1021/bi00187a037; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; ELLIS J, 1992, NATURE, V358, P191, DOI 10.1038/358191a0; GATENBY AA, 1994, ANNU REV PLANT PHYS, V45, P469; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LISSIN NM, 1990, NATURE, V348, P339, DOI 10.1038/348339a0; LORIMER GH, 1993, PHILOS T R SOC B, V339, P297, DOI 10.1098/rstb.1993.0028; LORIMER GH, 1992, CURR OPIN STRUC BIOL, V2, P26; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1993, J BIOL CHEM, V269, P2447; MILLER AD, 1993, BIOCHEM J, V291, P139, DOI 10.1042/bj2910139; MIZOBATA T, 1994, BBA-PROTEIN STRUCT M, V1209, P83, DOI 10.1016/0167-4838(94)90140-6; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; PIERCE J, 1986, APPL ENVIRON MICROB, V49, P1094; PRICE NC, 1993, BIOCHIM BIOPHYS ACTA, V1161, P52, DOI 10.1016/0167-4838(93)90195-W; SCHLOSS JV, 1982, METHOD ENZYMOL, V90, P522; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; ZETTLMEISSL G, 1979, EUR J BIOCHEM, V100, P593, DOI 10.1111/j.1432-1033.1979.tb04206.x	34	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5388	5394		10.1074/jbc.270.10.5388	http://dx.doi.org/10.1074/jbc.270.10.5388			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890652	hybrid			2022-12-27	WOS:A1995QL58000067
J	CHANG, E; GOLDBERG, H				CHANG, E; GOLDBERG, H			REQUIREMENTS FOR TRANSFORMING GROWTH-FACTOR-BETA REGULATION OF THE PRO-ALPHA-2(I) COLLAGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; GENE-EXPRESSION; MESSENGER-RNA; II RECEPTOR; TRANSCRIPTIONAL ACTIVATION; METALLOPROTEINASE GENE; RESPONSIVE ELEMENT; LUNG FIBROBLASTS; TISSUE INHIBITOR; TRANSGENIC MICE	Experiments were designed to clarify the role of several proteins, junB, retinoblastoma protein (RB), and the transforming growth factor-beta (TGF-beta) receptors that are potential intermediates in TGF-beta activation of the alpha 2(I) collagen promoter, Treatment of NIH-3T3 cells with TGF-alpha increased the activity of a transiently transfected murine alpha 2(I) collagen promoter (nucleotides -350 to +54) fused to a luciferase reporter gene 9-fold. Cotransfection of a junB stimulated the basal activity of the alpha 2(I) collagen promoter 93-fold, respectively. Expression of antisense junB RNA attenuated the effect of TGF-beta. Simian virus 40 large T antigen, an inhibitor RE function, did not prevent TGF-beta effects on the alpha 2(I) collagen promoter, A chimeric receptor containing the extracellular domain of the colony-stimulating factor-1 receptor and the intracellular domain of the type I TGF-beta receptor enhanced alpha 2(I) collagen promoter activity 4.8-fold, whereas a similar chimera containing the type II receptor intracellular domain had much weaker effects, Similar results were obtained with a plasminogen activator inhibitor-1 promoter, previously shown to be activated by TGF-beta through AP-1 elements. We conclude that TGF-beta activates the alpha 2(I) collagen and plasminogen activator inhibitor-1 promoters in NIH-3T3 cells through junB and the type I TGF-beta receptor kinase domain.	UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,DIV NEPHROL,TORONTO,ON M5G 1X8,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ARMENDARIZBORUN.J, 1992, J BIOL CHEM, V267, P14313; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BOYLE WJ, 1994, CELL, V64, P573; CAMPBELL CE, 1991, J BIOL CHEM, V266, P7199; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; CURRAN T, 1987, ONCOGENE, V2, P79; DEGROOT RP, 1990, BIOCHEM BIOPH RES CO, V168, P1074, DOI 10.1016/0006-291X(90)91139-J; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; EGHBALI M, 1991, CIRC RES, V69, P483, DOI 10.1161/01.RES.69.2.483; FINE A, 1989, J BIOL CHEM, V264, P16988; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FREEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; GOLDSTEIN RH, 1990, J BIOL CHEM, V265, P13623; HEINO J, 1990, J BIOL CHEM, V265, P10181; HSU JC, 1993, CANCER RES, V53, P3789; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; JONES CL, 1991, KIDNEY INT, V40, P1020, DOI 10.1038/ki.1991.310; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Koskinen PJ, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000292; KURATA S, 1991, J BIOL CHEM, V266, P9997; LAIHO M, 1991, MOL CELL BIOL, V11, P972, DOI 10.1128/MCB.11.2.972; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LI L, 1990, J BIOL CHEM, V265, P1556; LIBOI E, 1988, BIOCHEM BIOPH RES CO, V151, P298, DOI 10.1016/0006-291X(88)90593-1; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; NIEDERREITHER K, 1992, J CELL BIOL, V119, P1361, DOI 10.1083/jcb.119.5.1361; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; PEREZALBUERNE ED, 1993, P NATL ACAD SCI USA, V90, P11960, DOI 10.1073/pnas.90.24.11960; PERONIN M, 1992, INT J CANCER, V51, P980; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; RITZENTHALER JD, 1993, J BIOL CHEM, V268, P13625; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; ROTHWELL VM, 1987, ONCOGENE RES, V1, P311; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; VIARD I, 1993, FEBS LETT, V328, P94, DOI 10.1016/0014-5793(93)80972-W; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WESTERGRENTHORS.G, 1993, J CLIN INVEST, V92, P632; WOOD WM, 1989, J BIOL CHEM, V264, P14840; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; ZENTELLA A, 1991, MOL CELL BIOL, V11, P4952, DOI 10.1128/MCB.11.10.4952; ZHU JY, 1992, J VIROL, V66, P2780, DOI 10.1128/JVI.66.5.2780-2791.1992	58	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4473	4477		10.1074/jbc.270.9.4473	http://dx.doi.org/10.1074/jbc.270.9.4473			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876214	hybrid			2022-12-27	WOS:A1995QK08400046
J	CHU, RY; VARANASI, U; CHU, S; LIN, YL; USUDA, N; RAO, MS; REDDY, JK				CHU, RY; VARANASI, U; CHU, S; LIN, YL; USUDA, N; RAO, MS; REDDY, JK			OVEREXPRESSION AND CHARACTERIZATION OF THE HUMAN PEROXISOMAL ACYL-COA OXIDASE IN INSECT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-OXIDATION ENZYMES; HUMAN-LIVER; NUCLEOTIDE-SEQUENCE; ZELLWEGER SYNDROME; COENZYME-A; RAT-LIVER; ACID; EXPRESSION; HETEROGENEITY; DISORDER	Human liver peroxisomes contain two acyl-CoA oxidases, namely, pahmitoyl-CoA oxidase and a branched chain acyl-CoA oxidase, The palmitoyl-CoA oxidase (ACOX) oxidizes the CoA esters of straight chain fatty acids and prostaglandins and donates electrons directly to molecular oxygen, thereby producing H2O2. The inducibility of this H2O2-generating ACOX in rat and mouse liver by peroxisome proliferators and the postulated role of the resulting oxidative stress in hepatocarcinogenesis generated interest in characterizing the structure and function of human ACOX. We have constructed a full-length cDNA encoding a 660-amino acid residue human ACOX and produced a catalytically active human ACOX protein at high levels in Spodoptera frugiperda (Sf9) insect cells using the baculovirus vector, Immunoblot analysis demonstrated that the full-length 72-kDa polypeptide (component A) was partially processed into its constituent 51-kDa (component B) and 21-kDa (component C) products, respectively, Recombinant protein (similar to 20 mg/l x 10(9) cells) was purified to homogeneity by a single-step procedure on a nickel-nitrilo-triacetic acid affinity column, Using the purified enzyme, K-m and V-max values for palmitoyl-CoA were found to be 10 mu M and 1.4 units/mg of protein, respectively, The maximal activities for saturated fatty acids were observed with C-12-18 substrates. The overexpressed human ACOX protein was identified in the cytoplasm of the insect cells by immunocytochemical staining, individual expression of either the truncated ACOX 51-kDa (component B) or the 21-kDa (component C) revealed lack of enzyme activity, but co-infection of the insect cells with recombinant viruses expressing components B and C resulted in the formation of an enzymatically active heterodimeric B + C complex which could subsequently be inactivated by dissociating with detergent.	NORTHWESTERN UNIV, SCH MED, DEPT PATHOL, CHICAGO, IL 60611 USA	Northwestern University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023750] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM23750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALVARES K, 1992, P NATL ACAD SCI USA, V89, P4908, DOI 10.1073/pnas.89.11.4908; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V198, P1113, DOI 10.1006/bbrc.1994.1158; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONFMAN M, 1979, BIOCHEM BIOPH RES CO, V88, P1030, DOI 10.1016/0006-291X(79)91512-2; CASTEELS M, 1990, J LIPID RES, V31, P1865; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU R, 1994, BIOCHEM BIOPH RES CO, V200, P178, DOI 10.1006/bbrc.1994.1431; Hashimoto T, 1992, Prog Clin Biol Res, V375, P19; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCKOW VA, 1988, VIROLOGY, V167, P56, DOI 10.1016/0042-6822(88)90054-2; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; OSUMI T, 1993, BIOCHIMIE, V75, P243, DOI 10.1016/0300-9084(93)90083-5; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; REDDY JK, 1992, MECHANISM CARCINOGEN, P225; Sambrook J, 1989, MOL CLONING LABORATO; SANTOS MJ, 1992, J CELL PHYSIOL, V151, P103, DOI 10.1002/jcp.1041510115; SANTOS MJ, 1985, P NATL ACAD SCI USA, V82, P6556, DOI 10.1073/pnas.82.19.6556; SUZUKI Y, 1988, CLIN CHIM ACTA, V172, P65, DOI 10.1016/0009-8981(88)90121-0; SUZUKI Y, 1994, AM J HUM GENET, V54, P36; TANAKA K, 1992, PROG CLIN BIOL RES, V375, P95; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANHOVE GF, 1993, J BIOL CHEM, V268, P10335; VARANASI U, 1994, P NATL ACAD SCI USA, V91, P3107, DOI 10.1073/pnas.91.8.3107; WEBB AC, 1991, BIOTECHNIQUES, V11, P512	29	28	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4908	4915		10.1074/jbc.270.9.4908	http://dx.doi.org/10.1074/jbc.270.9.4908			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876265	hybrid			2022-12-27	WOS:A1995QK08400103
J	KOTKOW, KJ; DEITCHER, SR; FURIE, B; FURIE, BC				KOTKOW, KJ; DEITCHER, SR; FURIE, B; FURIE, BC			THE 2ND KRINGLE DOMAIN OF PROTHROMBIN PROMOTES FACTOR VA-MEDIATED PROTHROMBIN ACTIVATION BY PROTHROMBINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; FACTOR-XA; COMPLEX; MEMBRANE; BINDING; PHOSPHOLIPIDS; KINETICS; ABSENCE; PROTEIN; FIBRIN	The incorporation of factor Xa into the prothrombinase complex, factor Xa-factor Va-phospholipid-Ca(II), results in an approximately 10(5)-fold higher rate of substrate activation than that of the enzyme alone, To examine the role of the prothrombin kringle domains in the interaction with prothrombinase we have employed site-directed mutagenesis to produce prothrombin species that lack either the first kringle domain, PT/Delta K1, or the second kringle domain, PT/Delta K2. Previously, we have shown that these proteins are fully carboxylated and that they bind to phospholipid vesicles. In this investigation we demonstrate that cleavage at Arg(271). Thr(272) and Arg(320)-Ile(321) peptide bonds occurs upon activation with prothrombinase to yield normal thrombin from both PT/Delta K1 and PT/Delta K2. In the absence of factor Va, the K-m(app) for the activation of PT/Delta K1, PT/Delta K2, or plasma-derived prothrombin by factor Xa-phospholipid-Ca(II) are equivalent, The K-m(app) for the activation of PT/Delta K2, by prothrombinase is approximately 4-5 fold higher than that obtained for plasma derived prothrombin or PT/Delta K1. These data demonstrate that the prothrombin kringle domains do not contribute significantly to the binding affinity of the substrate-enzyme interaction, In the absence of factor Va, equivalent k(cat) values were obtained for all of the prothrombin species when they were activated by factor Xa-Ca(II)-phospholipid, In contrast, a 7-fold lower k(cat) value was obtained for the activation of PT/Delta K2 by prothrombinase as compared with that obtained for plasma prothrombin or PT/Delta K1. Collectively, these data suggest that determinants within the second prothrombin kringle domain interact with factor Va to elicit a significant acceleration in the catalytic rate of substrate turnover, Indeed, in contrast to plasma derived prothrombin, no direct binding of PT/Delta K2 to factor Va to form the PT/Delta K2-factor Va complex could be demonstrated by 90 degrees Light scattering.	TUFTS UNIV NEW ENGLAND MED CTR, CTR HEMOSTASIS & THROMBOSIS RES, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT MED, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University					NHLBI NIH HHS [HL18834, HL42433] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL018834, R37HL018834] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJAJ SP, 1975, J BIOL CHEM, V250, P2150; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; ESMON CT, 1974, J BIOL CHEM, V249, P7791; HERTZBERG MS, 1992, J BIOL CHEM, V267, P14759; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; JACOBS M, 1994, J BIOL CHEM, V269, P25494; KOTKOW KJ, 1993, J BIOL CHEM, V268, P15633; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN GR, 1988, J BIOL CHEM, V263, P1023; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1981, J BIOL CHEM, V256, P9874; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; ROSING J, 1980, J BIOL CHEM, V255, P274; SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1; URANO S, 1989, P NATL ACAD SCI USA, V86, P2568, DOI 10.1073/pnas.86.8.2568; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; VANZONNEVELD AJ, 1986, P NATL ACAD SCI USA, V83, P4670; WALKER RK, 1992, CIRCULATION S1, V86, P1858	25	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4551	4557		10.1074/jbc.270.9.4551	http://dx.doi.org/10.1074/jbc.270.9.4551			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876224	hybrid			2022-12-27	WOS:A1995QK08400057
J	SOMMERS, CH; MILLER, EJ; DUJON, B; PRAKASH, S; PRAKASH, L				SOMMERS, CH; MILLER, EJ; DUJON, B; PRAKASH, S; PRAKASH, L			CONDITIONAL LETHALITY OF NULL MUTATIONS IN RTH1 THAT ENCODES THE YEAST COUNTERPART OF A MAMMALIAN 5'-EXONUCLEASE TO 3'-EXONUCLEASE REQUIRED FOR LAGGING-STRAND DNA-SYNTHESIS IN RECONSTITUTED SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXCISION-REPAIR GENE; SACCHAROMYCES-CEREVISIAE; RECOMBINATION; MUTANTS; RAD2; ESCHERICHIA-COLI-K12; REPLICATION; DISRUPTION; PROTEINS; SEQUENCE	A 5'- to 3'-exonuclease of about 45 kDa has been purified from various mammalian sources and shown to be required for the completion of lagging strand synthesis in reconstituted DNA replication systems. RTH1 encodes the yeast Saccharomyces cerevisiae counterpart of the mammalian enzyme. To determine the in vivo biological role of RTH1-encoded 5'- to 3'-exonuclease, we have examined the effects of an rth1 Delta mutation on various cellular processes. rth1 Delta mutants grow poorly at 30 degrees C, and a cessation in growth occurs upon transfer of the mutant to 37 degrees C. At the restrictive temperature, the rth1 Delta mutant exhibits a terminal cell cycle morphology similar to that of mutants defective in DNA replication, and levels of spontaneous mitotic recombination are elevated in the rth1 Delta mutant even at the permissive temperature, The rth1 Delta mutation does not affect UV or gamma-ray sensitivity but enhances sensitivity to the alkylating agent methyl methanesulfonate, The role of RTH1 in DNA replication and in repair of alkylation damage is discussed.	UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT BIOPHYS,ROCHESTER,NY 14642; INST PASTEUR,CNRS,URA 1149,UNITE GENET MOLEC LEVURES,F-75724 PARIS 15,FRANCE	University of Rochester; University of Rochester; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Dujon, Bernard/AAL-8410-2021; Dujon, Bernard A/F-4971-2010; Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Dujon, Bernard/0000-0003-4661-3534; Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NATIONAL CANCER INSTITUTE [R01CA041261, R37CA041261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019261] Funding Source: NIH RePORTER; NCI NIH HHS [CA41261] Funding Source: Medline; NIGMS NIH HHS [GM19261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HABRAKEN Y, 1994, NUCLEIC ACIDS RES, V22, P3312, DOI 10.1093/nar/22.16.3312; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; HABRAKEN Y, 1994, J BIOL CHEM, V269, P31342; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARTWELL LH, 1985, GENETICS, V110, P381; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; JACQUIER A, 1992, YEAST, V8, P121, DOI 10.1002/yea.320080207; KONRAD EB, 1973, J MOL BIOL, V77, P519, DOI 10.1016/0022-2836(73)90220-9; KONRAD EB, 1974, P NATL ACAD SCI USA, V71, P2048, DOI 10.1073/pnas.71.5.2048; KONRAD EB, 1977, J BACTERIOL, V130, P167, DOI 10.1128/JB.130.1.167-172.1977; MADURA K, 1986, J BACTERIOL, V166, P914, DOI 10.1128/jb.166.3.914-923.1986; MONTELONE BA, 1981, J BACTERIOL, V147, P517, DOI 10.1128/JB.147.2.517-525.1981; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; PRAKASH L, 1977, GENETICS, V86, P33; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; TURCHI JJ, 1993, J BIOL CHEM, V268, P15136; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803	24	165	170	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4193	4196		10.1074/jbc.270.9.4193	http://dx.doi.org/10.1074/jbc.270.9.4193			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876174	hybrid			2022-12-27	WOS:A1995QK08400004
J	BOULARAND, S; DARMON, MC; MALLET, J				BOULARAND, S; DARMON, MC; MALLET, J			THE HUMAN TRYPTOPHAN-HYDROXYLASE GENE - AN UNUSUAL SPLICING COMPLEXITY IN THE 5'-UNTRANSLATED REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; STRUCTURAL CHARACTERIZATION; PHENYLALANINE-HYDROXYLASE; TYROSINE HYDROXYLASES; FUNCTIONAL DOMAINS; CARCINOID-TUMORS; CDNA LIBRARIES; PINEAL-GLAND; EXPRESSION; SEQUENCE	We report the isolation and the organization of the gene encoding human tryptophan hydroxylase (TPH) and an analysis of the corresponding mRNAs. The gene spans a region of 29 kilobases, which contains at least 11 exons and a variably spliced 5'-untranslated region (5'-UTR). The sequence of the coding region and the majority of the positions of the intron-exon boundaries of human TPH gene are very similar to those encoding human tyrosine hydroxylase and phenylalanine hydroxylase, the other members of the aromatic amino acid hydroxylase family. Phylogenetic analysis evidences the early divergence and the independent evolution of the three hydroxylase types. TPR cDNA cloning and anchored polymerase chain reaction revealed a diversity of the TPH mRNA, which is restricted to the 5'-UTR. Four TPH mRNA species were detected by Northern blot with pineal gland and carcinoid tumor RNAs. These messengers are transcribed from a single transcriptional initiation site, and their diversity results from differential splicing of three intron-like regions and of three exons located in the 5'-UTR Analysis by S1 nuclease protection revealed that the intron-like regions in the 5'-UTR are mostly unspliced and that TPH mRNA species where the three intron-like regions are eliminated are present at low level in pineal gland and not detectable in carcinoid tumors.			BOULARAND, S (corresponding author), CNRS,GENET MOLEC NEUROTRANSMISS & PROC NEURODEGENERATI,F-91198 GIF SUR YVETTE,FRANCE.		Darmon, Michele/F-8708-2011	Darmon, Michele/0000-0001-9730-6273				BIGUET NF, 1986, EMBO J, V5, P287, DOI 10.1002/j.1460-2075.1986.tb04211.x; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BOULARAND S, 1990, NUCLEIC ACIDS RES, V18, P4257, DOI 10.1093/nar/18.14.4257; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CARDINALI DP, 1981, ENDOCR REV, V2, P327, DOI 10.1210/edrv-2-3-327; CIVELLI O, 1982, J BIOL CHEM, V257, P6783; DARMON MC, 1986, FEBS LETT, V206, P43, DOI 10.1016/0014-5793(86)81337-0; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; DELORT J, 1989, NUCLEIC ACIDS RES, V17, P6439, DOI 10.1093/nar/17.16.6439; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUMAS S, 1989, J NEUROSCI RES, V24, P537, DOI 10.1002/jnr.490240412; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; FELDMAN JM, 1986, AM J MED, V81, P41, DOI 10.1016/0002-9343(86)90583-8; FELDMAN JM, 1987, SEMIN ONCOL, V14, P237; GREEN CB, 1994, J NEUROCHEM, V62, P2420; GRENETT HE, 1987, P NATL ACAD SCI USA, V84, P5530, DOI 10.1073/pnas.84.16.5530; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HART R P, 1991, Molecular and Cellular Neuroscience, V2, P71, DOI 10.1016/1044-7431(91)90041-L; IZZO P, 1988, EUR J BIOCHEM, V174, P569, DOI 10.1111/j.1432-1033.1988.tb14136.x; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; Kaufman S., 1974, MOL MECH OXYGEN ACTI, P285; KOSAK M, 1986, P NATL ACAD SCI USA, V83, P2850; KOSAK M, 1992, CRIT REV BIOCHEM MOL, V27, P385; KOSAK M, 1989, J CELL BIOL, V108, P229; KOSAK M, 1991, J CELL BIOL, V115, P887; KUHN DM, 1980, J BIOL CHEM, V255, P4137; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; LEDLEY FD, 1985, SOMAT CELL MOLEC GEN, V13, P575; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; MISAWA H, 1992, J BIOL CHEM, V267, P20392; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; NIELSEN FC, 1990, J BIOL CHEM, V265, P13431; OH SK, 1992, GENE DEV, V9, P1643; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; REYNOLDS GA, 1985, J BIOL CHEM, V260, P369; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SAVAKIS C, 1986, DEV BIOL, V114, P194, DOI 10.1016/0012-1606(86)90395-7; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SHEIN HM, 1971, LIFE SCI, V10, P935, DOI 10.1016/0024-3205(71)90358-4; STOLL J, 1990, GENOMICS, V7, P88, DOI 10.1016/0888-7543(90)90522-V; STOLL J, 1991, J NEUROSCI RES, V28, P457, DOI 10.1002/jnr.490280402; Sussenbach J S, 1989, Prog Growth Factor Res, V1, P33, DOI 10.1016/0955-2235(89)90040-9; VIGNY A, 1982, BIOCHEM BIOPH RES CO, V106, P1, DOI 10.1016/0006-291X(82)92049-6; WEIL D, 1990, MOL CELL BIOL, V10, P5865, DOI 10.1128/MCB.10.11.5865; WURTMAN RJ, 1963, SCIENCE, V141, P277, DOI 10.1126/science.141.3577.277; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; YANG XJ, 1994, P NATL ACAD SCI USA, V91, P6659, DOI 10.1073/pnas.91.14.6659	53	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3748	3756		10.1074/jbc.270.8.3748	http://dx.doi.org/10.1074/jbc.270.8.3748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876115	hybrid			2022-12-27	WOS:A1995QH68800045
J	JOW, L; MUKHERJEE, R				JOW, L; MUKHERJEE, R			THE HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) SUBTYPE NUC1 REPRESSES THE ACTIVATION OF HPPAR-ALPHA AND THYROID-HORMONE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; RETINOIC ACID; FATTY-ACIDS; RESPONSIVE ELEMENT; TRANS-ACTIVATION; IDENTIFICATION; SUPERFAMILY; PROTEINS; DOMAINS; MEMBER	We have cloned two human peroxisome proliferator-activated receptor (PPAR) subtypes, hPPAR alpha and hNUC1. hPPAR alpha is activated by clofibric acid and other PPAR activators. hNUC1 is not activated by these compounds acting instead as a repressor of hPPAR alpha: and human thyroid hormone receptor transcriptional activation. Repression is specific since hNUC1 does not significantly repress activation by the progesterone or retinoic acid receptors. We demonstrate co-operative binding of hNUC1 and hRXR alpha to a PPAR-responsive element and show that in the presence of hRXR alpha, the affinity of hNUC1 for the peroxisome proliferator is comparable to that of hPPAR alpha. Furthermore, repression of hPPAR alpha can be overcome by transfecting excess hPPAR alpha. We propose that hNUC1 represses the activity of hPPAR alpha by titrating out a factor required for activation. Our data further suggests convergence of thyroid hormone- and peroxisome-mediated fatty acid metabolism pathways. Overcoming hNUC1 repression could be a means of increasing the activity of these receptors.	LIGAND PHARMACEUT INC,DEPT MOLEC BIOL,SAN DIEGO,CA 92121	Ligand Pharmaceuticals								ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P1; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BERGER TS, 1992, J STEROID BIOCHEM, V41, P733, DOI 10.1016/0960-0760(92)90414-E; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; DANA SL, 1994, MOL ENDOCRINOL, V8, P1193, DOI 10.1210/me.8.9.1193; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HERTZ R, 1993, BIOCHIMIE, V75, P257, DOI 10.1016/0300-9084(93)90085-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; MUKHERJEE R, 1994, J STEROID BIOCHEM, V51, P157, DOI 10.1016/0960-0760(94)90089-2; NAKAI A, 1988, MOL ENDOCRINOL, V2, P1087, DOI 10.1210/mend-2-11-1087; NESTEL PJ, 1990, ANNU REV NUTR, V10, P149, DOI 10.1146/annurev.nu.10.070190.001053; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V175, P866, DOI 10.1016/0006-291X(91)91645-S; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMSONO K, 1991, CELL, V65, P1255; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244	28	79	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3836	3840		10.1074/jbc.270.8.3836	http://dx.doi.org/10.1074/jbc.270.8.3836			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876127	hybrid			2022-12-27	WOS:A1995QH68800057
J	SHIRE, D; CARILLON, C; KAGHAD, M; CALANDRA, B; RINALDICARMONA, M; LEFUR, G; CAPUT, D; FERRARA, P				SHIRE, D; CARILLON, C; KAGHAD, M; CALANDRA, B; RINALDICARMONA, M; LEFUR, G; CAPUT, D; FERRARA, P			AN AMINO-TERMINAL VARIANT OF THE CENTRAL CANNABINOID RECEPTOR RESULTING FROM ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BETA-2-ADRENERGIC RECEPTORS; MOLECULAR-CLONING; BINDING-SITES; RAT-BRAIN; EXPRESSION; CELLS; IDENTIFICATION; LOCALIZATION; SPECIFICITY	The cDNA sequences encoding the central cannabinoid receptor, CB1, are known for two species, rat and human. However, little information concerning the flanking, noncoding regions is presently available. We have isolated two overlapping clones from a human lung cDNA Library with CB1 cDNA inserts. One of these, cann7, contains a short stretch of the CB1 coding region and 4 kilobase pairs Orb) of the 3'-untranslated region (UTR), including two polyadenylation signals. The other, cann6, is identical to cann7 upstream from the first polyadenylation signal, and in addition, it contains the whole coding region and extends for 1.8 kb into the 5'-UTR. Comparison of cann6 with the published sequence (Gerard, C. M., Mollereau, C., Vassart, G., and Parmentier, M. (1991) Biochem. J. 279, 129-134) shows the coding regions to be identical, but reveals important differences in the flanking regions. Notably, the cann6 sequence appears to be that of an immature transcript, containing 1.8 kb of an intronic sequence in the 5'-UTR. In addition, polymerase chain reaction amplification of the CB1 coding region in the IM-9 cell line cDNA resulted in two fragments, one containing the whole CB1 coding region and the second lacking a 167-base pair intron within the sequence encoding the amino-terminal tail of the receptor. This alternatively spliced form would translate to an NH2-terminal modified isoform (CB1A) of the receptor, shorter than CB1 by 61 amino acids. In addition, the first 28 amino acids of the putative truncated receptor are completely different from those of CB1, containing more hydrophobic residues. Rat CB1 mRNA is similarly alternatively spliced. A study of the distribution of the human CB1 and CB1A mRNAs by reverse transcription-polymerase chain reaction analysis showed the presence of both CB1 and CB1A throughout the brain and in all the peripheral tissues examined, with CB1A being present in amounts of up to 20% of CB1.	SANOFI RECH,F-34184 MONTPELLIER,FRANCE	Sanofi-Aventis; Sanofi France	SHIRE, D (corresponding author), SANOFI RECH,LABEGE INNOPOLE VOIE 1,BP 137,F-31676 LABEGE 04,FRANCE.							BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTTREZ F, 1994, NUCLEIC ACIDS RES, V22, P2712, DOI 10.1093/nar/22.13.2712; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; GERARD CM, 1991, BIOCHEM J, V279, P129, DOI 10.1042/bj2790129; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; HOWLETT AC, 1991, PHARMACOL BIOCHEM BE, V40, P565, DOI 10.1016/0091-3057(91)90364-8; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; JANSEN EM, 1992, BRAIN RES, V575, P93, DOI 10.1016/0006-8993(92)90428-C; KAMINSKI NE, 1992, MOL PHARMACOL, V42, P736; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; MAILLEUX P, 1992, NEUROSCI LETT, V143, P200, DOI 10.1016/0304-3940(92)90265-9; MAILLEUX P, 1992, NEUROSCI LETT, V147, P179, DOI 10.1016/0304-3940(92)90589-Y; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MCLAUGHLIN CR, 1993, DEV BRAIN RES, V76, P75, DOI 10.1016/0165-3806(93)90124-S; MINTY A, 1993, EUR CYTOKINE NETW, V4, P99; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; PETTIT DAD, 1994, BIOCHEM PHARMACOL, V48, P1231, DOI 10.1016/0006-2952(94)90161-9; RANDS E, 1990, J BIOL CHEM, V265, P10759; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341	34	265	283	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3726	3731		10.1074/jbc.270.8.3726	http://dx.doi.org/10.1074/jbc.270.8.3726			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876112	hybrid			2022-12-27	WOS:A1995QH68800042
J	WITHIAMLEITCH, M; RUBIN, RP; KOSHLUKOVA, SE; ALETTA, JM				WITHIAMLEITCH, M; RUBIN, RP; KOSHLUKOVA, SE; ALETTA, JM			IDENTIFICATION AND CHARACTERIZATION OF CARBOXYL ESTER HYDROLASE AS A PHOSPHOLIPID HYDROLYZING ENZYME OF ZYMOGEN GRANULE MEMBRANES FROM RAT EXOCRINE PANCREAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE-POLYACRYLAMIDE GELS; SODIUM DODECYL-SULFATE; GUINEA-PIG PANCREAS; SUBSTRATE-SPECIFICITY; ADRENAL-MEDULLA; PROTEINS; LIPASE; PURIFICATION; BINDING; LYSOPHOSPHOLIPASE	Salt-washed (0.6 M NaCl) zymogen granule membranes (ZGM) of rat pancreatic acinar cells were utilized to identify and characterize membrane protein(s) responsible for phospholipase and lysophospholipase activities. Five major bands were identified in salt-washed ZGM by Coomassie Brilliant Blue. A 70-kDa protein with enzymatic activity was retained in significant quantities after several washes with 0.6 nr NaCl but could be displaced hom ZGM by 2 nz NaCl or by 100 mg/ml heparin. By contrast, GP2, an integral membrane protein, was not displaced under these conditions. These findings suggest that the enzyme is a peripheral membrane protein of ZGM. Renaturation of ZGM proteins following electrophoresis revealed that the 70-kDa protein possessed phospholipase activity. Identification of the 70-kDa protein as a membrane-associated carboxyl ester hydrolase was based upon: (a) the use of a specific polyclonal antiserum, (b) N-terminal sequence, (c) two-dimensional gel analysis, (d) enzymatic characterization, and (e) co-localization to an area of a non-reducing gel containing significant phospholipase activity. Other ZGM proteins, namely GP2 and GP3, could not be demonstrated to possess phospholipase activity under the experimental conditions employed. Our finding that carboxyl ester hydrolase from ZGM exhibits PLA(1) and lysophospholipase activities represents the first identification and characterization of a protein responsible for phospholipase activity in secretory granule membranes.	SUNY BUFFALO, SCH MED & BIOMED SCI, DEPT PHARMACOL & TOXICOL, BUFFALO, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NIADDK NIH HHS [AM-28029] Funding Source: Medline; NIDCR NIH HHS [DE-05764] Funding Source: Medline; NIGMS NIH HHS [GM-07145] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM028029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005764] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSNER MS, 1988, P NATL ACAD SCI USA, V85, P7438, DOI 10.1073/pnas.85.20.7438; BOSNER MS, 1989, J BIOL CHEM, V264, P20261; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CREUTZ CE, 1981, J CELL BIOL, V91, P247, DOI 10.1083/jcb.91.1.247; DEH ME, 1985, ANAL BIOCHEM, V150, P166, DOI 10.1016/0003-2697(85)90456-7; DENNIS EA, 1991, FASEB J, V5, P2068, DOI 10.1096/fasebj.5.7.1901288; ERLANSON C, 1975, SCAND J GASTROENTERO, V10, P401; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GHOSH S, 1991, LIPIDS, V26, P793, DOI 10.1007/BF02536160; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HILDEBRANDT E, 1991, BIOCHEMISTRY-US, V30, P464, DOI 10.1021/bi00216a023; HUSEBYE ES, 1987, BIOCHIM BIOPHYS ACTA, V920, P120, DOI 10.1016/0005-2760(87)90251-7; HYUN J, 1969, J BIOL CHEM, V244, P1937; KISSEL JA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P227, DOI 10.1016/0005-2760(89)90201-4; KRONQUIST KE, 1977, ARCH BIOCHEM BIOPHYS, V182, P188, DOI 10.1016/0003-9861(77)90298-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL D, 1984, BIOCHIM BIOPHYS ACTA, V769, P611, DOI 10.1016/0005-2736(84)90060-9; LEBEL D, 1988, BIOCHEM BIOPH RES CO, V154, P818, DOI 10.1016/0006-291X(88)90213-6; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P136, DOI 10.1016/0005-2744(80)90049-2; MACDONAL.RJ, 1972, BIOCHEM BIOPH RES CO, V49, P377, DOI 10.1016/0006-291X(72)90421-4; MIZUNO M, 1991, BIOCHIM BIOPHYS ACTA, V1084, P21, DOI 10.1016/0005-2760(91)90050-R; MIZUNO NK, 1990, LIPIDS, V25, P760, DOI 10.1007/BF02544048; MOSKOWITZ N, 1982, SCIENCE, V216, P305, DOI 10.1126/science.6278597; MURTHY SK, 1962, BIOCHEM J, V83, P460, DOI 10.1042/bj0830460; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PAQUET MR, 1982, EUR J CELL BIOL, V28, P20; PIND S, 1987, BIOCHIM BIOPHYS ACTA, V901, P78, DOI 10.1016/0005-2736(87)90258-6; POOLE AR, 1970, NATURE, V227, P810, DOI 10.1038/227810a0; REGGIO HA, 1978, J CELL BIOL, V77, P288, DOI 10.1083/jcb.77.2.288; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; RUBIN RP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P245, DOI 10.1016/0005-2760(90)90127-J; RUBIN RP, 1991, BIOCHEM BIOPH RES CO, V177, P22, DOI 10.1016/0006-291X(91)91942-6; RUDD EA, 1984, LIPASES; SCHEELE GA, 1981, METHOD CELL BIOL, V23, P345, DOI 10.1016/S0091-679X(08)61508-3; SCHEELE GA, 1978, J CELL BIOL, V78, P110, DOI 10.1083/jcb.78.1.110; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; VANDENBOSCH H, 1973, BIOCHIM BIOPHYS ACTA, V296, P94, DOI 10.1016/0005-2760(73)90048-9; WAITE M, 1985, J LIPID RES, V26, P1379; WANG CS, 1993, BIOCHIM BIOPHYS ACTA, V1166, P1, DOI 10.1016/0005-2760(93)90277-G; Whittaker VP, 1972, METHODS NEUROCHEMIST, P1; WISHART MJ, 1993, J BIOL CHEM, V268, P10303; WITHIAMLEITCH M, 1993, BIOCHEM BIOPH RES CO, V194, P1167, DOI 10.1006/bbrc.1993.1945	44	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3780	3787		10.1074/jbc.270.8.3780	http://dx.doi.org/10.1074/jbc.270.8.3780			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876119				2022-12-27	WOS:A1995QH68800049
J	ZAKO, M; SHINOMURA, T; UJITA, M; ITO, K; KIMATA, K				ZAKO, M; SHINOMURA, T; UJITA, M; ITO, K; KIMATA, K			EXPRESSION OF PG-M(V3), AN ALTERNATIVELY SPLICED FORM OF PG-M WITHOUT A CHONDROITIN SULFATE ATTACHMENT REGION IN MOUSE AND HUMAN TISSUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX MOLECULES; CORE PROTEIN; CDNA CLONES; PROTEOGLYCAN; BRAIN; CARTILAGE; VERSICAN; ADHESION; SYSTEM; ACID	We showed previously that the alternative splicing of chondroitin sulfate attachment domains (CS alpha and CS beta) yielded multiforms of the PG-M core protein in mouse. A transcript encoding a new short form of the core protein PG-M(V3) was found in various mouse tissues using polymerase chain reaction. DNA sequences of the polymerase chain reaction products suggested that PG-M(V3) had no chondroitin sulfate attachment domain, PG-(V3) was also detected in various human tissues. The presence of a transcript for PG-M(V3) was further supported by Northern blot analysis. Southern blot analysis confirmed that multiforms of the PG-M core protein, including PG-M(V3), were derived hom a single genomic locus by an alternative splicing mechanism. Because PG-M(V3) has no chondroitin sulfate attachment region, which is the most distinctive portion of a proteoglycan molecule, this form may have a unique function.	AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN	Aichi Medical University								BALDWIN CT, 1989, J BIOL CHEM, V264, P15747; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEAK F, 1986, P NATL ACAD SCI USA, V83, P3766, DOI 10.1073/pnas.83.11.3766; DELPECH B, 1993, EUR J CANCER, V7, P1012; DOEGE K, 1987, J BIOL CHEM, V262, P17757; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HENNIG AK, 1993, DEV BRAIN RES, V73, P261, DOI 10.1016/0165-3806(93)90146-2; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; IIJIMA N, 1991, J NEUROCHEM, V56, P706, DOI 10.1111/j.1471-4159.1991.tb08207.x; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; IWATA M, 1993, J NEUROSCI, V13, P195; IWATA M, 1993, J BIOL CHEM, V268, P15061; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; KIMATA K, 1986, J BIOL CHEM, V261, P3517; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; KUSUKAWA N, 1990, BIOTECHNIQUES, V9, P66; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; MAEDA N, 1992, DEV BIOL, V151, P564, DOI 10.1016/0012-1606(92)90194-L; MARRET S, 1994, J NEUROCHEM, V62, P1285; PERIDES G, 1989, J BIOL CHEM, V264, P5981; PERIDES G, 1992, J BIOL CHEM, V267, P23883; PERRIS R, 1990, DEV BIOL, V137, P1, DOI 10.1016/0012-1606(90)90002-Z; RAUCH U, 1992, J BIOL CHEM, V267, P19536; SHINOMURA T, 1992, J BIOL CHEM, V267, P1265; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; UJITA M, J BIOL CHEM, V269, P27603; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1993, ANAT EMBRYOL, V187, P433; YAMAGATA M, 1989, J BIOL CHEM, V264, P8012; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	38	110	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3914	3918		10.1074/jbc.270.8.3914	http://dx.doi.org/10.1074/jbc.270.8.3914			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876137	hybrid			2022-12-27	WOS:A1995QH68800068
J	KIRK, TZ; MARK, ME; CHUA, CC; CHUA, BH; MAYES, MD				KIRK, TZ; MARK, ME; CHUA, CC; CHUA, BH; MAYES, MD			MYOFIBROBLASTS FROM SCLERODERMA SKIN SYNTHESIZE ELEVATED LEVELS OF COLLAGEN AND TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP-1) WITH 2 FORMS OF TIMP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH MUSCLE ACTIN; GROWTH FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; FIBROBLAST-CULTURES; SYSTEMIC-SCLEROSIS; KELOID FIBROBLASTS; DERMAL FIBROBLASTS; CONNECTIVE-TISSUE; MESSENGER-RNAS; EXPRESSION	Cultured fibroblasts derived from skin biopsies from scleroderma patients and normal individuals were examined for the presence of smooth muscle alpha-actin, a marker for myofibroblasts. Six of eight scleroderma cell lines were found to be 50% or more positive for alpha-actin while three of four normal lines and one cell line derived from unaffected skin of a scleroderma patient were less than 10% positive. The cultured fibroblasts from affected scleroderma skin were largely myofibroblasts, a phenotype found in biopsies of scleroderma tissue, as well as other fibrotic lesions, wound healing, and tumor desmoplasia. The data support the hypothesis that a certain activated fibroblast phenotype predominates in scleroderma. The activated fibroblast is the myofibroblast. Both collagen and TIMP (tissue inhibitor of metalloproteinases) were elevated in the alpha-actin positive (myofibroblast enriched) cultures. In addition, the myofibroblast-enriched cultures displayed a more prominent TIMP doublet band pattern on SDS-polyacrylamide gel electrophoresis.	WAYNE STATE UNIV, SCH MED, DEPT INTERNAL MED, DIV RHEUMATOL, DETROIT, MI 48201 USA; WAYNE STATE UNIV, SCH MED, DEPT PATHOL, DETROIT, MI 48201 USA; WAYNE STATE UNIV, SCH MED, DEPT IMMUNOL, DETROIT, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University								[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BORDIN S, 1984, SCIENCE, V223, P171, DOI 10.1126/science.6691142; BOTSTEIN GR, 1982, ARTHRITIS RHEUM, V25, P189, DOI 10.1002/art.1780250212; BUCKINGHAM RB, 1978, J LAB CLIN MED, V92, P5; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CLARK IM, 1991, MATRIX, V11, P76, DOI 10.1016/S0934-8832(11)80211-8; DARBY I, 1990, LAB INVEST, V63, P21; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DIEGELMANN RF, 1979, J CELL PHYSIOL, V98, P341, DOI 10.1002/jcp.1040980210; GILLERY P, 1991, CLIN EXP DERMATOL, V16, P324, DOI 10.1111/j.1365-2230.1991.tb00394.x; GOLDRING SR, 1990, J CLIN INVEST, V85, P798, DOI 10.1172/JCI114506; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HASSELL TM, 1976, P NATL ACAD SCI USA, V73, P2909, DOI 10.1073/pnas.73.8.2909; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; KAHARI VM, 1988, J INVEST DERMATOL, V90, P664, DOI 10.1111/1523-1747.ep12560826; KORN JH, 1983, J CLIN INVEST, V71, P1240, DOI 10.1172/JCI110873; KULOZIK M, 1990, J CLIN INVEST, V86, P917, DOI 10.1172/JCI114793; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; LEFEBVRE P, 1992, J INVEST DERMATOL, V98, P529; LEROY EC, 1972, J EXP MED, V135, P1351, DOI 10.1084/jem.135.6.1351; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; LUDWICKA A, 1992, J RHEUMATOL, V19, P1716; MAYES M D, 1991, Arthritis and Rheumatism, V34, pS111; MAYES M D, 1986, Arthritis and Rheumatism, V29, pS54; MAYES MD, 1988, J RHEUMATOL, V15, P268; MIYAZAKI K, 1993, J BIOL CHEM, V268, P14387; NEEDLEMAN BW, 1990, ARTHRITIS RHEUM, V33, P842, DOI 10.1002/art.1780330611; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RONNOVJESSEN L, 1992, IN VITRO CELL DEV-AN, V28A, P273; RUSSELL SB, 1989, J BIOL CHEM, V264, P13730; SAPPINO AP, 1990, AM J PATHOL, V137, P585; SAPPINO AP, 1990, LAB INVEST, V63, P144; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; TAKEDA K, 1994, J INVEST DERMATOL, V103, P359, DOI 10.1111/1523-1747.ep12394936; UITTO J, 1979, J CLIN INVEST, V64, P921, DOI 10.1172/JCI109558; UITTO J, 1985, P NATL ACAD SCI USA, V82, P5935, DOI 10.1073/pnas.82.17.5935; VYALOV SL, 1993, AM J PATHOL, V143, P1754; WEBSTER DF, 1979, ANAL BIOCHEM, V96, P220, DOI 10.1016/0003-2697(79)90576-1	43	111	112	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3423	3428		10.1074/jbc.270.7.3423	http://dx.doi.org/10.1074/jbc.270.7.3423			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852429	hybrid			2022-12-27	WOS:A1995QG47100079
J	TAKEGAWA, K; TABUCHI, M; YAMAGUCHI, S; KONDO, A; KATO, I; IWAHARA, S				TAKEGAWA, K; TABUCHI, M; YAMAGUCHI, S; KONDO, A; KATO, I; IWAHARA, S			SYNTHESIS OF NEOGLYCOPROTEINS USING OLIGOSACCHARIDE-TRANSFER ACTIVITY WITH ENDO-BETA-N-ACETYLGLUCOSAMINIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; ARTHROBACTER-PROTOPHORMIAE; FLAVOBACTERIUM-MENINGOSEPTICUM; TRANSGLYCOSYLATION ACTIVITY; CHORIONIC-GONADOTROPIN; GLYCOSYLATION SITES; CARBOHYDRATE MOIETY; ENZYMATIC-SYNTHESIS; CHICKEN OVALBUMIN; MOLECULAR-CLONING	We describe a novel method for the enzymatic synthesis of neoglycoproteins. Endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae (Endo-A) had high levels of transglycosylation activity. The enzyme activity of Endo-A was markedly increased by adding 4-L-aspartyl-glycosylamine (GlcNAc-Asn) to the reaction mixture, Digesting (Man)(6)(GlcNAc)(2) with the enzyme in the presence of GlcNAc-Asn gave a mixture of hydrolytic ((Man)(6)GlcNAc) and transglycosylic ((Man)(6)(GlcNAc)(2)Asn) products. By means of transglycosylation, (Man)(6)GlcNAc was transferred en bloc to the partially deglycosylated ovalbumin glycopeptide (EEKYN(GlcNAc) LTSVL) concomitant with the hydrolysis of (Man)(6)(GlcNAc)(2)Asn. The structure of the transglycosylation product was designated as (Man)(6)(GlcNAc)(2)-peptide by amino acid composition and sequence analysis as well as ion mass spectrometry. The enzyme also transferred oligosaccharide to partially deglycosylated ribonuclease B (GlcNAc-protein) during the hydrolysis of (Man)(6)(GlcNAc)(2)Asn. Native ribonuclease B had (Man)(5-9) (GIcNAc)(2) as its heterogeneous N-linked sugar chains. High performance liquid chromatography showed that all of the N-linked sugar chains of the synthetic neoribonuclease of the pyridylamino derivatives were modified to (Man)(6)(GlcNAc)(2).	TAKARA SHUZO CO LTD,BIOTECHNOL RES LABS,OTSU,SHIGA 52021,JAPAN	Takara Holdings Inc.	TAKEGAWA, K (corresponding author), KAGAWA UNIV,FAC AGR,DEPT BIORESOURCE SCI,MIKI,KAGAWA 76107,JAPAN.		Tabuchi, Mitsuaki/E-9544-2010; Tabuchi, Mitsuaki/AAY-7378-2021	Tabuchi, Mitsuaki/0000-0002-2042-691X; Tabuchi, Mitsuaki/0000-0002-2042-691X				BARDALES RM, 1989, J BIOL CHEM, V264, P19893; BRUINS AP, 1987, ANAL CHEM, V59, P2642, DOI 10.1021/ac00149a003; COTE GL, 1990, GLYCOCONJUGATE J, V7, P145, DOI 10.1007/BF01050377; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; GOTO M, 1988, BIO-TECHNOL, V6, P67, DOI 10.1038/nbt0188-67; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; HASE S, 1986, J BIOCHEM-TOKYO, V100, P1; HSIEH P, 1983, J BIOL CHEM, V258, P2548; HUANG CC, 1970, CARBOHYD RES, V13, P127, DOI 10.1016/S0008-6215(00)84902-2; ISHIHARA H, 1981, BIOCHIM BIOPHYS ACTA, V669, P261; ITO S, 1975, ARCH BIOCHEM BIOPHYS, V171, P78, DOI 10.1016/0003-9861(75)90009-0; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIANG CJ, 1980, J BIOCHEM-TOKYO, V88, P51; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; MCREYNOLDS L, 1978, NATURE, V273, P723, DOI 10.1038/273723a0; MENCKE AJ, 1982, J BIOL CHEM, V257, P4799; NILSSON KGI, 1988, TRENDS BIOTECHNOL, V6, P256, DOI 10.1016/0167-7799(88)90058-3; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; SHARES BT, 1986, P NATL ACAD SCI USA, V83, P1993; TAI T, 1977, J BIOL CHEM, V252, P6687; TAKEGAWA K, 1991, BIOCHEM INT, V25, P585; TAKEGAWA K, 1991, BIOCHEM INT, V24, P849; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1991, BIOCHEM INT, V25, P829; TAKEGAWA K, 1991, J FERMENT BIOENG, V71, P278, DOI 10.1016/0922-338X(91)90282-L; TAKEGAWA K, 1991, EUR J BIOCHEM, V202, P175, DOI 10.1111/j.1432-1033.1991.tb16359.x; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TRIMBLE RB, 1986, J BIOL CHEM, V261, P2000; TSUDA E, 1988, BIOCHEMISTRY-US, V27, P5646, DOI 10.1021/bi00415a038; YAMAMOTO K, 1986, AGR BIOL CHEM TOKYO, V50, P421, DOI 10.1080/00021369.1986.10867399; YAMAMOTO K, 1986, J FERMENT BIOENG, V64, P397, DOI 10.1016/0385-6380(86)90026-9; YAN SCB, 1987, METHOD ENZYMOL, V138, P413	39	107	111	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3094	3099		10.1074/jbc.270.7.3094	http://dx.doi.org/10.1074/jbc.270.7.3094			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852391	hybrid			2022-12-27	WOS:A1995QG47100033
J	EHLERT, JE; PETERSEN, F; KUBBUTAT, MHG; GERDES, J; FLAD, HD; BRANDT, E				EHLERT, JE; PETERSEN, F; KUBBUTAT, MHG; GERDES, J; FLAD, HD; BRANDT, E			LIMITED AND DEFINED TRUNCATION AT THE C-TERMINUS ENHANCES RECEPTOR-BINDING AND DEGRANULATION ACTIVITY OF THE NEUTROPHIL-ACTIVATING PEPTIDE-2 (NAP-2) - COMPARISON OF NATIVE AND RECOMBINANT NAP-2 VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING ACTIVITY MGSA; PLATELET BASIC-PROTEIN; HOST DEFENSE CYTOKINES; ESCHERICHIA-COLI; BIOLOGICAL CHARACTERIZATION; INTERLEUKIN-8 RECEPTORS; 3-DIMENSIONAL STRUCTURE; BETA-THROMBOGLOBULIN; EXPRESSION; FACTOR-4	We have previously described a C-terminally truncated variant of the chemokine neutrophil-activating peptide 2 (NAP-2) that exhibited higher neutrophil-stimulating capacity than the full-size poly peptide. To investigate the impact of the NAP-2 C terminus on biological activity and receptor binding, we have now purified the novel molecule to homogeneity. Furthermore, we have cloned, expressed in Escherichia coli, and purified full-size recombinant NAP-2 (rNAP-2-(1-70)) and a series of C-terminally deleted variants (rNAP-2-(1-69) to rNAP-2-(1-64)), Biochemical and immunochemical analyses revealed that the natural NAP-2 variant was structurally identical to the rNAP-2-(1-66) isoform, As compared with their respective native and recombinant full-size counterparts, both molecules exhibited similar to 3-4-fold enhanced potency in the induction of neutrophil degranulation as well as 3-fold enhanced binding affinity for specific receptors on these cells. All other variants were considerably less active. The natural occurrence of a NAP-2 variant truncated by exactly four residues at the C terminus suggests that limited and defined proteolysis at this site plays a role in the regulation of the biological function of the chemokine.	FORSCHUNGSINST BORSTEL,DEPT IMMUNOL & CELL BIOL,D-23845 BORSTEL,GERMANY	Forschungszentrum Borstel								BARONE AD, 1988, J BIOL CHEM, V263, P8710; BRANDT E, 1992, J IMMUNOL, V149, P1356; BRANDT E, 1993, MOL IMMUNOL, V30, P979, DOI 10.1016/0161-5890(93)90123-S; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; BRANDT E, 1992, PLATELETS, V3, P295; CASTOR CW, 1990, J LAB CLIN MED, V116, P516; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLARKLEWIS I, 1991, BIOCHEMISTRY-US, V30, P3128, DOI 10.1021/bi00226a021; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; DERYNCK R, 1990, BIOCHEMISTRY-US, V29, P10225, DOI 10.1021/bi00496a011; DETMERS PA, 1991, J IMMUNOL, V147, P4211; FAIRBROTHER WJ, 1993, FEBS LETT, V330, P302, DOI 10.1016/0014-5793(93)80893-Y; GRASBERGER BL, 1993, J MOL BIOL, V230, P364, DOI 10.1006/jmbi.1993.1152; GUSSOW D, 1989, NUCLEIC ACIDS RES, V17, P4000; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HORUK R, 1993, J BIOL CHEM, V268, P541; JUNGBLUT P, 1994, ELECTROPHORESIS, V15, P685, DOI 10.1002/elps.1150150197; KELVIN DJ, 1993, J LEUKOCYTE BIOL, V54, P604, DOI 10.1002/jlb.54.6.604; LEONARD EJ, 1991, J LEUKOCYTE BIOL, V49, P258, DOI 10.1002/jlb.49.3.258; LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199; MARCHESI SL, 1969, BIOCHIM BIOPHYS ACTA, V181, P20, DOI 10.1016/0005-2795(69)90223-2; MORTZ E, 1994, BIOL MASS SPECTROM, V23, P249, DOI 10.1002/bms.1200230503; MOSER B, 1991, J BIOL CHEM, V266, P10666; MOSER B, 1993, J BIOL CHEM, V268, P7125; Myers J A, 1991, Protein Expr Purif, V2, P136, DOI 10.1016/1046-5928(91)90062-N; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PETERSEN F, 1994, J IMMUNOL, V152, P2467; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; POE M, 1990, J BIOL CHEM, V266, P98; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; SCHOFIELD MJ, 1985, J SOC PERS RELAT, V2, P151, DOI 10.1177/0265407585022003; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; STCHARLES R, 1989, J BIOL CHEM, V264, P2092; TANAKA S, 1988, FEBS LETT, V236, P467, DOI 10.1016/0014-5793(88)80078-4; VANDAMME J, 1990, EUR J IMMUNOL, V20, P2113, DOI 10.1002/eji.1830200933; WALZ A, 1989, BIOCHEM BIOPH RES CO, V159, P969, DOI 10.1016/0006-291X(89)92203-1; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; WALZ A, 1990, J EXP MED, V171, P449, DOI 10.1084/jem.171.2.449; WENGER RH, 1989, BLOOD, V73, P1498	44	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6338	6344		10.1074/jbc.270.11.6338	http://dx.doi.org/10.1074/jbc.270.11.6338			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890771	hybrid			2022-12-27	WOS:A1995QM94500093
J	KIELBASSA, K; MULLER, HJ; MEYER, HE; MARKS, F; GSCHWENDT, M				KIELBASSA, K; MULLER, HJ; MEYER, HE; MARKS, F; GSCHWENDT, M			PROTEIN-KINASE C-DELTA-SPECIFIC PHOSPHORYLATION OF THE ELONGATION-FACTOR EEF-1-ALPHA AND AN EEF-1-ALPHA PEPTIDE AT THREONINE 431	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; TRANSFER RNA-SYNTHETASE; 3 DISTINCT TYPES; SUBSTRATE-SPECIFICITY; ADDITIONAL MEMBERS; RAT FIBROBLASTS; BINDING PROTEIN; FACTOR-I; EXPRESSION; ZETA	Two cytosolic proteins of murine epidermis or porcine spleen with molecular masses of 37 kDa (p37) and 50 kDa (p50) are differentially phosphorylated in vitro by the purified protein kinase C (PKC) isoenzymes alpha, beta, gamma (cPKC) and PKC delta. p37, identified as annexin I, is preferentially phosphorylated by cPKC, whereas p50, identified as elongation factor eEF-1 alpha, is phosphorylated with much greater efficacy by PKC delta than by cPKC. Using the recombinant PKC isoenzymes alpha, beta, gamma, delta, epsilon, eta, and zeta, we could show that purified eEF-1 alpha is indeed a specific substrate of PKC delta. It is not significantly phosphorylated by PKC epsilon, -eta and -zeta and only slightly by PKC alpha, -beta, and -gamma. PKC delta phosphorylates eEF-1 alpha at Thr-431 (based on the murine amino acid sequence). The peptide RFAVRDMRQTVAVGVIKAVDKK with a sequence corresponding to that of 422-443 from murine eEF-1 alpha and containing Thr-431 is an absolutely specific substrate for the delta-type of PKC. The single basic amino acid close to Thr-431 (Arg-429) is essential for recognition of the peptide as a substrate by PKC delta and for the selectivity of this recognition. Substitution of Arg-429 by alanine abolishes the ability of PKC delta to phosphorylate the peptide, and insertion of additional basic amino acids in the vicinity of Thr-431 causes a complete loss of selectivity.	GERMAN CANC RES CTR, D-69120 HEIDELBERG, GERMANY; RUHR UNIV BOCHUM, D-44780 BOCHUM, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum								AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; BACHER N, 1991, MOL CELL BIOL, V11, P126, DOI 10.1128/MCB.11.1.126; BASU A, 1993, PHARMACOL THERAPEUT, V59, P257, DOI 10.1016/0163-7258(93)90070-T; BORNER C, 1991, NATURE, V353, P78, DOI 10.1038/353078a0; BURNS DJ, 1990, J BIOL CHEM, V265, P12044; CACACE AM, 1993, ONCOGENE, V8, P2095; CAVALLIUS J, 1986, EXP GERONTOL, V21, P149, DOI 10.1016/0531-5565(86)90068-9; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DEKKER LV, 1992, FEBS LETT, V312, P195, DOI 10.1016/0014-5793(92)80934-9; DERVENTZI A, 1993, MECH AGEING DEV, V69, P193, DOI 10.1016/0047-6374(93)90023-K; EDMONDS BT, 1993, J CELL BIOCHEM, V52, P134, DOI 10.1002/jcb.240520204; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; GOODE N, 1992, J BIOL CHEM, V267, P16878; GOODNIGHT J, 1992, GENE, V122, P305, DOI 10.1016/0378-1119(92)90219-F; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; GSCHWENDT M, 1992, FEBS LETT, V307, P151, DOI 10.1016/0014-5793(92)80756-7; GSCHWENDT M, 1989, J CELL BIOCHEM, V40, P295, DOI 10.1002/jcb.240400306; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; IDO M, 1987, FEBS LETT, V219, P215, DOI 10.1016/0014-5793(87)81219-X; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KOCHS G, 1993, EUR J BIOCHEM, V216, P597, DOI 10.1111/j.1432-1033.1993.tb18179.x; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; LEIBERSPERGER H, 1990, J BIOL CHEM, V265, P16108; LEIBERSPERGER H, 1991, J BIOL CHEM, V266, P14778; LIYANAGE M, 1992, BIOCHEM J, V283, P781, DOI 10.1042/bj2830781; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; MARAIS RM, 1990, FEBS LETT, V277, P151, DOI 10.1016/0014-5793(90)80831-3; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MEYER HE, 1993, FASEB J, V7, P776, DOI 10.1096/fasebj.7.9.7687226; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MIZUNO K, 1991, EUR J BIOCHEM, V202, P931, DOI 10.1111/j.1432-1033.1991.tb16453.x; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; OHTA K, 1990, J BIOL CHEM, V265, P3240; OLIVIER AR, 1991, EUR J BIOCHEM, V200, P805, DOI 10.1111/j.1432-1033.1991.tb16248.x; ONO Y, 1987, SCIENCE, V236, P1116, DOI 10.1126/science.3576226; ONO Y, 1988, J BIOL CHEM, V263, P6927; ONO Y, 1987, FEBS LETT, V226, P125, DOI 10.1016/0014-5793(87)80564-1; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; OSADA S, 1990, J BIOL CHEM, V265, P22434; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; SAIDO TC, 1992, BIOCHEMISTRY-US, V31, P482, DOI 10.1021/bi00117a026; SCHAAP D, 1990, J BIOL CHEM, V265, P7301; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; SHEU FS, 1990, BIOCHEM BIOPH RES CO, V171, P1236, DOI 10.1016/0006-291X(90)90818-8; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; SOZERI O, 1992, ONCOGENE, V7, P2259; Stabel S., 1993, INTRACELLULAR MESSEN, P167; TURNER RS, 1985, J BIOL CHEM, V260, P1503; VENEMA RC, 1991, J BIOL CHEM, V266, P12574; VENEMA RC, 1991, J BIOL CHEM, V266, P11993; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; ZANG R, 1994, BIOCHEM J, V304, P641, DOI 10.1042/bj3040641	64	69	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6156	6162		10.1074/jbc.270.11.6156	http://dx.doi.org/10.1074/jbc.270.11.6156			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890750	hybrid			2022-12-27	WOS:A1995QM94500066
J	PSHENICHKIN, SP; WISE, BC				PSHENICHKIN, SP; WISE, BC			OKADAIC ACID INCREASES NERVE GROWTH-FACTOR SECRETION, MESSENGER-RNA STABILITY, AND GENE-TRANSCRIPTION IN PRIMARY CULTURES OF CORTICAL ASTROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; BETA-ADRENERGIC-RECEPTOR; C-FOS; HIPPOCAMPAL CULTURES; ASTROGLIAL CULTURES; EXPRESSION; INTERLEUKIN-1; CELLS; ACTIVATION; IDENTIFICATION	Neonatal rat cortical astrocytes ire primary culture synthesize and secrete nerve growth factor (NGF) in response to cytokines, growth factors, and activators of protein kinases. To further implicate a protein phosphorylation mechanism in the regulation of NGF expression, astrocytes were treated with okadaic acid and calyculin A, inhibitors of phosphoprotein phosphatases 1 and 2A. Okadaic acid dramatically increased both NGF mRNA content (50-fold) and NGF secretion (100-fold) in astrocytes, while calyculin A, which has a spectrum of phosphatase inhibitory activity different from okadaic acid, failed to augment NGF expression. The increased mRNA accumulation was due mainly to an increase (4-fold) in the half-life of the NGF mRNA following 9 or 24 h of treatment. Nuclear run on assays indicated that okadaic acid also activated NGF gene transcription, which was preceded by an induction of c-fos and c-jun gene transcription. The induction of NGF expression by okadaic acid appeared independent from protein kinase C activity because down-regulating protein kinase C activity failed to decrease the okadaic acid stimulation. In contrast, interleukin-1 beta acted synergistically with okadaic acid to stimulate NGF secretion. The results indicate that okadaic acid profoundly stimulates NGF expression in astrocytes mainly by enhancing NGF mRNA stability and suggest important roles for phosphoprotein phosphatases in regulating NGF production.	GEORGETOWN UNIV, MED CTR, DEPT PHARMACOL, WASHINGTON, DC 20007 USA; GEORGETOWN UNIV, MED CTR, FIDIA GEORGETOWN INST NEUROSCI, WASHINGTON, DC 20007 USA	Georgetown University; Georgetown University					NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045181] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45181] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CARMANKRZAN M, 1993, J NEUROSCI RES, V34, P225, DOI 10.1002/jnr.490340210; CARMANKRZAN M, 1991, J NEUROCHEM, V56, P636, DOI 10.1111/j.1471-4159.1991.tb08197.x; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; D'MELLO SR, 1991, MOL BRAIN RES, V11, P255, DOI 10.1016/0169-328X(91)90034-U; D'MELLO SR, 1990, J NEUROCHEM, V55, P718, DOI 10.1111/j.1471-4159.1990.tb04192.x; D'MELLO SR, 1991, J NEUROCHEM, V57, P1570, DOI 10.1111/j.1471-4159.1991.tb06353.x; DALTOSO R, 1988, J PHARMACOL EXP THER, V246, P1190; FRIEDMAN WJ, 1990, J NEUROSCI RES, V27, P374, DOI 10.1002/jnr.490270316; FRIEDMAN WJ, 1992, J NEUROSCI RES, V33, P37, DOI 10.1002/jnr.490330106; FURUKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P395, DOI 10.1016/0006-291X(87)90287-7; GUY GR, 1992, J BIOL CHEM, V267, P1846; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; Lindholm D, 1990, Neuroreport, V1, P9; LINDHOLM D, 1992, EUR J NEUROSCI, V4, P404, DOI 10.1111/j.1460-9568.1992.tb00889.x; LU B, 1991, J NEUROSCI, V11, P318; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MOCCHETTI I, 1989, P NATL ACAD SCI USA, V86, P3891, DOI 10.1073/pnas.86.10.3891; NEVEU I, 1992, BRAIN RES, V570, P316, DOI 10.1016/0006-8993(92)90596-2; PSHENICHKIN SP, 1994, J NEUROCHEM, V63, P419; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; SCHONTHAL A, 1991, ONCOGENE, V6, P423; SCHWARTZ JP, 1977, BRAIN RES, V137, P369, DOI 10.1016/0006-8993(77)90349-3; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; SPRINGER JE, 1993, EXP NEUROL, V124, P2, DOI 10.1006/exnr.1993.1166; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; VIGE X, 1991, MOL PHARMACOL, V40, P186; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9; ZAFRA F, 1992, J NEUROSCI, V12, P4793	33	43	44	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5994	5999		10.1074/jbc.270.11.5994	http://dx.doi.org/10.1074/jbc.270.11.5994			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890729	hybrid			2022-12-27	WOS:A1995QM94500044
J	HENNAGER, DJ; WELSH, MJ; DELISLE, S				HENNAGER, DJ; WELSH, MJ; DELISLE, S			CHANGES IN EITHER CYTOSOLIC OR NUCLEOPLASMIC INOSITOL 1,4,5-TRISPHOSPHATE LEVELS CAN CONTROL NUCLEAR CA2+ CONCENTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT-LIVER NUCLEI; XENOPUS-LAEVIS OOCYTES; SMOOTH-MUSCLE CELLS; TRISPHOSPHATE RECEPTOR; INTRACELLULAR CALCIUM; DIACYLGLYCEROL; INCREASES; RELEASE; KINASE	The free nucleoplasmic Ca2+ concentration ([Ca2+](n)) may regulate many nuclear events, such as gene transcription. Since the nucleus may possess the enzymes necessary to generate the second messenger inositol 1,4,5 trisphosphate (Ins(1,4,5)P-3), and because the nuclear envelope may enclose an Ins(1,4,5)P-3-releasable Ca2+ store, we tested the hypothesis that nuclear and/or cytosolic levels of Ins(1,4,5)P-3 can control [Ca2+](n). To assay [Ca2+](n), we measured the fluorescence of the Ca2+ indicator flue 3 in the nucleus of Xenopus oocytes by confocal microscopy. When we injected Ins(1,4,5)P-3 into the cytosol, [Ca2+](n) increased. This increase in [Ca2+](n) still occurred when heparin was present in the nucleus, but was abolished when heparin was present in the cytosol, indicating that cytosolic Ins(1,4,5)P-3 levels could control [Ca2+](n). When we injected Ins(1,4,5)P-3 directly into the nucleus, [Ca2+](n) increased, even when heparin was present in the cytosol, indicating that Ins(1,4,5)P-3 could control [Ca2+](n)fa from within the nucleus. These results provide functional evidence for Ins(1,4,5)P-3 receptors facing the nucleoplasm and raise the possibility that a phosphoinositide cycle situated at the nuclear membranes can control Ca2+-dependent nuclear functions.	UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242; VET ADM MED CTR,IOWA CITY,IA; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; University of Iowa; University of Iowa				Welsh, Michael/0000-0002-1646-6206				ALMOHANNA FA, 1994, NATURE, V367, P745, DOI 10.1038/367745a0; BACHS O, 1992, BIOCHIM BIOPHYS ACTA, V1113, P259, DOI 10.1016/0304-4157(92)90041-8; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; DELISLE S, 1992, J BIOL CHEM, V267, P7963; DELISLE S, 1990, J BIOL CHEM, V265, P11726; DELISLE S, 1992, AM J PHYSIOL, V262, pC1456, DOI 10.1152/ajpcell.1992.262.6.C1456; DIVECHA N, 1993, BIOCHEM J, V289, P617, DOI 10.1042/bj2890617; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; HERNANDEZCRUZ A, 1990, SCIENCE, V247, P858, DOI 10.1126/science.2154851; HIMPENS B, 1992, AM J PHYSIOL, V263, pC95, DOI 10.1152/ajpcell.1992.263.1.C95; HIMPENS B, 1992, AM PHYSL SOC, V92, pC95; LANINI L, 1992, J BIOL CHEM, V267, P11548; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; NEYLON CB, 1990, AM J PHYSIOL, V259, pC675, DOI 10.1152/ajpcell.1990.259.4.C675; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; PAINE PL, 1992, BIOTECHNIQUES, V13, P238; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SMITH CD, 1983, J BIOL CHEM, V258, P32763; SNYDER PM, 1988, J BIOL CHEM, V263, P11048; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; WAHL M, 1992, J CELL PHYSIOL, V150, P593, DOI 10.1002/jcp.1041500321; WAYBILL M, 1991, AM PHYSL SOC, V91, pE49; WILLIAMS DA, 1987, SCIENCE, V235, P1644, DOI 10.1126/science.3103219	29	92	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4959	4962		10.1074/jbc.270.10.4959	http://dx.doi.org/10.1074/jbc.270.10.4959			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890598	hybrid			2022-12-27	WOS:A1995QL58000002
J	SOZZANI, P; CAMBON, C; VITA, N; SEGUELAS, MH; CAPUT, D; FERRARA, P; PIPY, B				SOZZANI, P; CAMBON, C; VITA, N; SEGUELAS, MH; CAPUT, D; FERRARA, P; PIPY, B			INTERLEUKIN-13 INHIBITS PROTEIN-KINASE C-TRIGGERED RESPIRATORY BURST IN HUMAN MONOCYTES - ROLE OF CALCIUM AND CYCLIC-AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN B-CELLS; NADPH OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES; ADENYLATE-CYCLASE; HUMAN-NEUTROPHILS; PLASMA-MEMBRANE; ACTIVATION; CAMP; PHOSPHORYLATION; REDISTRIBUTION	Interleukin 13 (IL-13), a novel cytokine produced by activated lymphocytes modulates some monocyte functions, but no data is available concerning the signal transduction pathway. We show here, the inhibitory effect of IL-13 on 12-O-tetradecanoylphorbol-13-acetate (TPA)-triggered reactive oxygen intermediate production in human monocytes and the signals involved in this response. Our results show that IL-13 produces rapid and transient phosphoinositide hydrolysis and intracellular Ca2+ mobilization. Furthermore, IL-13 induces intracellular cAMP accumulation through inositol 1,4,5-trisphosphate-dependent Ca2+ mobilization. Metabolic inhibitors were used to relate the first steps in signaling pathways to the inhibitory effect of IL-13 on TPA-triggered reactive oxygen intermediate production. Indeed, inhibitors of phospholipase C (neomycin), intracellular Ca2+ mobilization (8-[N,N-diethylamino]-octyl 3,4,5-trimethoxybenzoate hydrochloride), adenylate cyclase (Delta(9)-tetrahydrocannabinol), and protein kinase A (N [2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) impair the IL-13 inhibitory response. Altogether these observations indicate that modulatory effect of IL-13 on the TPA-induced oxidative burst is the result of the intracellular cAMP accumulation through an inositol 1,4,5-trisphosphate-induced Ca2+ mobilization-dependent pathway.	UNIV TOULOUSE 3,CHU RANGUEIL,IFR L BUGNARD,INSERM,CJF 9107,F-31054 TOULOUSE,FRANCE; SANOFI RECH,F-31676 LABEGE INNOPOLE,FRANCE	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sanofi-Aventis				Pipy, Bernard/0000-0001-8060-7029				ABRAMSON SL, 1990, J IMMUNOL, V144, P625; BAUMGOLD J, 1992, LIFE SCI, V50, P1755, DOI 10.1016/0024-3205(92)90058-W; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; DENIS M, 1994, AIDS RES HUM RETROV, V10, P795, DOI 10.1089/aid.1994.10.795; DEWAAL MR, 1993, J IMMUNOL, V151, P1; DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630; DUSI S, 1993, BIOCHEM J, V290, P173, DOI 10.1042/bj2900173; FINNEY M, 1990, EUR J IMMUNOL, V20, P151, DOI 10.1002/eji.1830200122; FORGUE MF, 1991, CARCINOGENESIS, V12, P449, DOI 10.1093/carcin/12.3.449; GENNARO R, 1986, BIOCHEM BIOPH RES CO, V134, P305, DOI 10.1016/0006-291X(86)90563-2; HEBERT JM, 1993, FEBS LETT, V328, P268; ISHITOYA J, 1987, J IMMUNOL, V138, P1201; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Keppel G., 1973, DESIGN ANAL RES HDB; KOHLER I, 1994, FEBS LETT, V345, P187, DOI 10.1016/0014-5793(94)00438-2; KOLB JP, 1993, J IMMUNOL, V150, P4798; LEHN M, 1989, J IMMUNOL, V143, P3020; MACNEIL S, 1985, CELL CALCIUM, V6, P213; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; MITSUYAMA T, 1993, BIOCHIM BIOPHYS ACTA, V1117, P167; MONTANER LJ, 1993, J EXP MED, V178, P743, DOI 10.1084/jem.178.2.743; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; MYERS MA, 1985, J IMMUNOL, V135, P3411; OLIVIER M, 1992, J IMMUNOL, V148, P1188; PENA C, 1980, MOL IMMUNOL, V17, P1487, DOI 10.1016/0161-5890(80)90174-1; PHILLIPS WA, 1992, BIOCHEM BIOPH RES CO, V182, P727, DOI 10.1016/0006-291X(92)91792-O; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; SALIMATH BP, 1992, CELL SIGNAL, V4, P651, DOI 10.1016/0898-6568(92)90046-B; SAVITHA G, 1993, CELL SIGNAL, V5, P107, DOI 10.1016/0898-6568(93)90063-R; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; SINGH VK, 1993, IMMUNOL LETT, V35, P239, DOI 10.1016/0165-2478(93)90189-9; TAKENAWA T, 1986, J BIOL CHEM, V261, P1092; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; VERGHESE MW, 1985, J BIOL CHEM, V260, P6769; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; WOLFSON M, 1985, J IMMUNOL, V135, P2057; WU Z, 1991, J BIOL CHEM, V268, P23766; ZIEGLERHEITBROC.HW, 1992, BLOOD, V79, P503; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	44	58	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5084	5088		10.1074/jbc.270.10.5084	http://dx.doi.org/10.1074/jbc.270.10.5084			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890616	hybrid			2022-12-27	WOS:A1995QL58000023
J	SPILLMANN, D; THOMASOATES, JE; VANKUIK, JA; VLIEGENTHART, JFG; MISEVIC, G; BURGER, MM; FINNE, J				SPILLMANN, D; THOMASOATES, JE; VANKUIK, JA; VLIEGENTHART, JFG; MISEVIC, G; BURGER, MM; FINNE, J			CHARACTERIZATION OF A NOVEL SULFATED CARBOHYDRATE UNIT IMPLICATED IN THE CARBOHYDRATE-CARBOHYDRATE-MEDIATED CELL-AGGREGATION OF THE MARINE SPONGE MICROCIONA-PROLIFERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE; LIQUID-CHROMATOGRAPHY; PORCINE THYROGLOBULIN; H-1-NMR SPECTROSCOPY; OVINE LUTROPIN; BINDING; OLIGOSACCHARIDES; RECOGNITION; GLYCAN; GLYCOPROTEINS	Species-specific cell reaggregation in the marine sponge Microciona prolifera is mediated by an adhesion proteoglycan. Two interactions are involved in the process: a Ca2+-dependent homophilic binding between proteoglycan molecules and a Ca2+-independent binding between the molecule and cells. Both interactions are mediated by the glycan moieties of the proteoglycan. The interaction of the proteoglycan with itself has been characterized as a carbohydrate-carbohydrate interaction of multiple low affinity sites. The monoclonal antibodies Block 1 and Block 2 raised against the purified aggregation proteoglycan and selected for inhibition of aggregation bind to these glycans. In a previous report the structure, Pyr<(6)(4)>Gal beta 1-4GlcNAc beta 1-3Fuc STRUCTURE 1 was assigned to the oligosaccharide reacting with Block 1 antibody (Spillmann, D., Hard, K., Thomas-Gates, J., Vliegenthart, J. F. G., Misevic, G., Burger, M. M., and Finne, J. (1993) J. Biol, Chem. 268, 13378-13387), By the technique of attaching the water-soluble acid-degraded fragments to a lipid carrier for immunochemical detection and by chemical, enzymatic and spectroscopic methods the structure, GlcNAc beta 1-3Fuc\3SO(3) STRUCTURE 2 was assigned to the oligosaccharide reacting with the aggregation- blocking monoclonal antibody Block 2. The structure, Gal alpha 1-2Gal beta 1-4GlcNAc beta 1-3Fuc\3SO(3) was assigned to a major nonreactive oligosaccharide, which outlined the molecular requirements of antibody binding of the two aggregation-associated epitopes. These data demonstrate that two different functional sites with distinct structural characteristics and antibody reactivities are involved in the reaggregation of sponge cells, a model of carbohydrate carbohydrate-mediated cell interactions.	UNIV TURKU, DEPT MED BIOCHEM, SF-20520 TURKU, FINLAND; FRIEDRICH MIESCHER INST, CH-4058 BASEL, SWITZERLAND; UNIV UTRECHT, DEPT MASS SPECTROMETRY, 3508 TB UTRECHT, NETHERLANDS; UNIV UTRECHT, BIJVOET CTR BIOMOLEC RES, DEPT BIOORGAN CHEM, 3508 TB UTRECHT, NETHERLANDS	University of Turku; Friedrich Miescher Institute for Biomedical Research; Utrecht University; Utrecht University			Misevic, Gradimir/D-8294-2016; Finne, Jukka/B-6881-2008	Misevic, Gradimir/0000-0001-5047-2936; Finne, Jukka/0000-0002-8076-3344				ADAMS G. A., 1965, METHOD CARBOHYD CHEM, V5, P269; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9; DELEDERKREMER RM, 1991, J BIOL CHEM, V266, P23670; DELL A, 1991, CARBOHYD RES, V209, P33, DOI 10.1016/0008-6215(91)80143-B; DEWAARD P, 1991, J BIOL CHEM, V266, P4237; EGGENS I, 1989, J BIOL CHEM, V264, P9476; FEIZI T, 1994, METHOD ENZYMOL, V230, P484; Galtsoff PS, 1925, J EXP ZOOL, V42, P223, DOI 10.1002/jez.1400420110; GREEN PJ, 1992, BIOCHEM BIOPH RES CO, V188, P244, DOI 10.1016/0006-291X(92)92376-9; HAKOMORI S, 1993, BIOCHEM SOC T, V21, P583, DOI 10.1042/bst0210583; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HENKART P, 1973, BIOCHEMISTRY-US, V12, P3045, DOI 10.1021/bi00740a016; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; HUMPHREYS T, 1963, DEV BIOL, V8, P27, DOI 10.1016/0012-1606(63)90024-1; JANSSON PE, 1987, CARBOHYD RES, V162, P111, DOI 10.1016/0008-6215(87)80205-7; JUMBLATT JE, 1980, BIOCHEMISTRY-US, V19, P1038, DOI 10.1021/bi00546a032; KAMERLING JP, 1988, FEBS LETT, V241, P246, DOI 10.1016/0014-5793(88)81070-6; KOJIMA N, 1989, J BIOL CHEM, V264, P20159; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; KOJIMA N, 1992, TRENDS GLYCOSCI GLYC, V4, P491; LAMPIO A, 1991, ANAL BIOCHEM, V197, P132, DOI 10.1016/0003-2697(91)90368-4; LEE YC, 1990, ANAL BIOCHEM, V189, P151, DOI 10.1016/0003-2697(90)90099-U; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; MAGNANI JL, 1985, ANAL BIOCHEM, V150, P12; MARION D, 1983, BIOCHEM BIOPH RES CO, V117, P479; MISEVIC GN, 1990, J BIOL CHEM, V265, P20577; MISEVIC GN, 1987, J BIOL CHEM, V262, P5870; MISEVIC GN, 1993, J BIOL CHEM, V268, P4922; MISEVIC GN, 1986, J BIOL CHEM, V261, P2853; MUIR L, 1969, J BIOL CHEM, V244, P2343; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; PARKKINEN J, 1987, METHOD ENZYMOL, V138, P289, DOI 10.1016/0076-6879(87)38024-3; PFEIFFER G, 1992, GLYCOBIOLOGY, V2, P411, DOI 10.1093/glycob/2.5.411; SPILLMANN D, 1993, J BIOL CHEM, V268, P13378; SPILLMANN D, 1994, GLYCOCONJUGATE J, V11, P169, DOI 10.1007/BF00731214; STOLL MS, 1988, BIOCHEM J, V256, P661, DOI 10.1042/bj2560661; TURNER RS, 1973, NATURE, V244, P509, DOI 10.1038/244509a0; VANSTEIJN AMP, 1989, RECL TRAV CHIM PAY B, V108, P374; VARKI A, 1994, P NATL ACAD SCI USA, V94, P7390; WEISSHAAR G, 1990, EUR J BIOCHEM, V192, P741, DOI 10.1111/j.1432-1033.1990.tb19285.x; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204	42	68	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5089	5097		10.1074/jbc.270.10.5089	http://dx.doi.org/10.1074/jbc.270.10.5089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890617	Green Submitted, hybrid			2022-12-27	WOS:A1995QL58000024
J	BUSBY, RW; CHANG, MDT; BUSBY, RC; WIMP, J; TOWNSEND, CA				BUSBY, RW; CHANG, MDT; BUSBY, RC; WIMP, J; TOWNSEND, CA			EXPRESSION AND PURIFICATION OF 2 ISOZYMES OF CLAVAMINATE SYNTHASE AND INITIAL CHARACTERIZATION OF THE IRON-BINDING SITE - GENERAL ERROR ANALYSIS IN POLYMERASE CHAIN-REACTION AMPLIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N-SYNTHASE; CLAVULANIC ACID BIOSYNTHESIS; DEACETOXYCEPHALOSPORIN-C SYNTHETASE; X-RAY-ABSORPTION; ACTIVE-SITE; STREPTOMYCES-CLAVULIGERUS; CEPHALOSPORIUM-ACREMONIUM; SPECTROPHOTOMETRIC ASSAY; ORTHO-PHTHALDIALDEHYDE; REPLICATION ERRORS	Clavaminate synthase is an Fe2+-, O-2-, and alpha-ketoglutarate-dependent oxygenase that catalyzes three transformations in the biosynthesis of the important beta-lactamase inhibitor clavulanic acid, The genes from Streptomyces clavuligerus encoding two isoenzymes of clavaminate synthase have been over-expressed in Escherichia coli to give soluble proteins whose reactions, kinetic properties, and molecular masses are in excellent agreement with the wild-type isozymes, Preliminary investigation of the active site of clavaminate synthase was undertaken using diethyl pyrocarbonate and N-ethylmaleimide. Each was inhibitory to catalytic activity. Protection from inactivation in the presence of these reagents by Fe2+, O-2, and alpha-ketoglutaric acid was thwarted by the rapid self-inactivation of the enzyme in the absence of substrate, However, protection was achieved when Co2+, a potent competitive inhibitor of clavaminate synthase 2 with respect to Fe2+, was substituted. This is consistent with the presence of histidine and cysteine, respectively at or near the active site and possibly involved in iron binding. In the course of constructing the expression vector, a simply applied general error analysis of the polymerase chain reaction was formulated to calculate the proportion of correctly replicated DNA and guide the design of experiments using this method.	JOHNS HOPKINS UNIV, DEPT CHEM, BALTIMORE, MD 21218 USA; NATL TSING HUA UNIV, DEPT LIFE SCI, HSINCHU 30043, TAIWAN; DREXEL UNIV, DEPT MATH & COMP SCI, PHILADELPHIA, PA 19104 USA	Johns Hopkins University; National Tsing Hua University; Drexel University			Houston, Todd A/A-9932-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937, R56AI014937, R01AI014937] Funding Source: NIH RePORTER; NIAID NIH HHS [AI14937] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BALDWIN JE, 1990, J CHEM SOC CHEM COMM, P617, DOI 10.1039/c39900000617; BALDWIN JE, 1987, BIOCHEM J, V245, P831, DOI 10.1042/bj2450831; BALDWIN JE, 1992, J ANTIBIOT, V45, P1378, DOI 10.7164/antibiotics.45.1378; BALDWIN JE, 1993, J CHEM SOC CHEM COMM, P500, DOI 10.1039/c39930000500; BASAK A, 1990, J AM CHEM SOC, V112, P1654, DOI 10.1021/ja00160a069; BERGSEID M, 1991, STRATEGIES, V4, P11; BIRD AE, 1982, ANALYST, V107, P1241, DOI 10.1039/an9820701241; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; DOTZLAF JE, 1987, J BACTERIOL, V169, P1611, DOI 10.1128/jb.169.4.1611-1618.1987; ELSON SW, 1987, J CHEM SOC CHEM COMM, P1736, DOI 10.1039/c39870001736; ELSON SW, 1993, J CHEM SOC CHEM COMM, P1212, DOI 10.1039/c39930001212; ELSON SW, 1987, J CHEM SOC CHEM COMM, P1738; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HASHIMOTO T, 1993, FEBS LETT, V329, P35, DOI 10.1016/0014-5793(93)80187-Y; HAYAISHI O, 1976, ENZYMES, V12, P119; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Kivirikko KI, 1980, ENZYMOLOGY POSTTRANS, P53; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; KOHSAKA M, 1976, BIOCHEM BIOPH RES CO, V70, P465, DOI 10.1016/0006-291X(76)91069-X; KRAWCZAK M, 1989, NUCLEIC ACIDS RES, V17, P2197, DOI 10.1093/nar/17.6.2197; KRIAUCIUNAS A, 1991, J BIOL CHEM, V266, P11779; KROL WJ, 1991, J ORG CHEM, V56, P728, DOI 10.1021/jo00002a045; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLOR EJ, 1994, TETRAHEDRON, V50, P8737, DOI 10.1016/S0040-4020(01)85347-3; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Maniatis T., 1982, MOL CLONING; MARSH EN, 1992, BIOCHEMISTRY-US, V31, P12648, DOI 10.1021/bi00165a015; Miles E W, 1977, Methods Enzymol, V47, P431; MING LJ, 1991, BIOCHEMISTRY-US, V30, P11653, DOI 10.1021/bi00114a007; MYLLYLA R, 1992, BIOCHEM J, V286, P923, DOI 10.1042/bj2860923; NICHOLSON NH, 1994, J CHEM SOC CHEM COMM, P1281, DOI 10.1039/c39940001281; OLINS PO, 1988, GENE, V73, P227, DOI 10.1016/0378-1119(88)90329-0; Ortiz de Montellano P.R., 2015, CYTOCHROME P450 STRU, P912; POPENOE EA, 1969, ARCH BIOCHEM BIOPHYS, V133, P286, DOI 10.1016/0003-9861(69)90456-1; RANDALL CR, 1993, BIOCHEMISTRY-US, V32, P6664, DOI 10.1021/bi00077a020; REISS J, 1990, NUCLEIC ACIDS RES, V18, P973, DOI 10.1093/nar/18.4.973; SALOWE SP, 1990, BIOCHEMISTRY-US, V29, P6499, DOI 10.1021/bi00479a023; SALOWE SP, 1991, BIOCHEMISTRY-US, V30, P2281, DOI 10.1021/bi00222a034; SAMSON SM, 1987, P NATL ACAD SCI USA, V84, P5705, DOI 10.1073/pnas.84.16.5705; SCHEIDEGGER A, 1984, J ANTIBIOT, V37, P522, DOI 10.7164/antibiotics.37.522; SCOTT RA, 1992, BIOCHEMISTRY-US, V31, P4596, DOI 10.1021/bi00134a009; SIEGEL B, 1979, BIOORG CHEM, V8, P219, DOI 10.1016/0045-2068(79)90007-5; STREET IP, 1990, BIOCHEMISTRY-US, V29, P7531, DOI 10.1021/bi00484a023; SVEDAS VJK, 1980, ANAL BIOCHEM, V101, P188, DOI 10.1016/0003-2697(80)90059-7; TOWNSEND CA, 1988, J CHEM SOC CHEM COMM, P1234, DOI 10.1039/c39880001234; TOWNSEND CA, 1993, BIOCHEM SOC T, V21, P208, DOI 10.1042/bst0210208	48	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4262	4269		10.1074/jbc.270.9.4262	http://dx.doi.org/10.1074/jbc.270.9.4262			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876185	hybrid			2022-12-27	WOS:A1995QK08400016
J	FRENCH, AR; TADAKI, DK; NIYOGI, SK; LAUFFENBURGER, DA				FRENCH, AR; TADAKI, DK; NIYOGI, SK; LAUFFENBURGER, DA			INTRACELLULAR TRAFFICKING OF EPIDERMAL GROWTH-FACTOR FAMILY LIGANDS IS DIRECTLY INFLUENCED BY THE PH SENSITIVITY OF THE RECEPTOR-LIGAND INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE FC-RECEPTORS; FACTOR-ALPHA; HUMAN-FIBROBLASTS; INSULIN-RECEPTOR; CELL-LINE; INTERNALIZATION; DEGRADATION; ENDOCYTOSIS; BINDING; COMPARTMENTATION	Using members of the epidermal growth factor (EGF) family as well as site-directed recombinant human EGF mutants, we investigated how ligand binding properties influence endosomal sorting. Mouse EGF (mEGF), human EGF (hEGF), and transforming growth factor alpha (TGF alpha) bind to the human EGF receptor (EGFR) with similar affinities at pH 7.4. However, the binding properties of these ligands have substantially different pH sensitivities resulting in varying degrees of dissociation from the receptors at lower pH levels characteristic of endosomes. we employed a steady-state sorting assay to determine the fraction of Ligand sorted to recycling versus degradation as a function of the number of intracellular ligand molecules in mouse B82 fibroblasts. mEGF, hEGF, and TGF alpha display significantly different steady-state endosomal sorting patterns which correspond to the extent of their dissociation at endosomal pH. Moreover, several recombinant hEGF mutants with differing affinities exhibit altered endosomal sorting compared to hEGF, demonstrating a similar direct relationship between ligand binding properties and endosomal sorting outcomes. Intracellular trafficking of the EGF ligands was also monitored by measuring the observed degradation rate constants. These likewise show marked differences that correlate with the differing pH sensitivities of the ligands' binding properties.	UNIV ILLINOIS, DEPT CELL & STRUCT BIOL, URBANA, IL 61801 USA; UNIV TENNESSEE, GRAD SCH BIOMED SCI, OAK RIDGE NATL LAB, DIV BIOL, OAK RIDGE, TN 37831 USA; OAK RIDGE NATL LAB, PROT ENGN & MOLEC MUTAGENESIS PROGRAM, OAK RIDGE, TN 37831 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	FRENCH, AR (corresponding author), UNIV ILLINOIS, DEPT CHEM ENGN, URBANA, IL 61801 USA.							BRENNER DA, 1989, DNA-J MOLEC CELL BIO, V8, P279, DOI 10.1089/dna.1.1989.8.279; BURGERT HG, 1983, EXP CELL RES, V144, P127, DOI 10.1016/0014-4827(83)90447-0; CAMPION SR, 1992, J CELL BIOCHEM, V50, P35; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CARPENTER G, 1990, PEPTIDE GROWTH FACTO, P69; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; DUNN WA, 1980, J BIOL CHEM, V255, P5971; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; GUILBERT LJ, 1986, J BIOL CHEM, V261, P4024; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; HOPKINS CR, 1992, TRENDS BIOCHEM SCI, V17, P27, DOI 10.1016/0968-0004(92)90423-7; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KORC M, 1989, J BIOL CHEM, V264, P14990; KORC M, 1987, CANCER RES, V47, P4909; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LAUFFENBURGER DA, 1994, IN PRESS HDB BIOMEDI; LINDERMAN JJ, 1988, J THEOR BIOL, V132, P203, DOI 10.1016/S0022-5193(88)80157-7; LOW DA, 1981, P NATL ACAD SCI-BIOL, V78, P2340, DOI 10.1073/pnas.78.4.2340; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MIYAKE Y, 1989, J BIOL CHEM, V264, P16584; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; RAUB TJ, 1986, EXP CELL RES, V165, P73, DOI 10.1016/0014-4827(86)90534-3; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; TADAKI DK, 1993, J BIOL CHEM, V268, P10114; UKKONEN P, 1986, J EXP MED, V163, P952, DOI 10.1084/jem.163.4.952; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1	41	186	192	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4334	4340		10.1074/jbc.270.9.4334	http://dx.doi.org/10.1074/jbc.270.9.4334			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876195	hybrid			2022-12-27	WOS:A1995QK08400026
J	GOMES, XV; WOLD, MS				GOMES, XV; WOLD, MS			STRUCTURAL-ANALYSIS OF HUMAN REPLICATION PROTEIN-A - MAPPING FUNCTIONAL DOMAINS OF THE 70-KDA SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; SIMIAN VIRUS-40 DNA; POLYMERASE-ALPHA-PRIMASE; BINDING-PROTEIN; SV40 ORIGIN; T-ANTIGEN; FACTOR-A; SACCHAROMYCES-CEREVISIAE; INVITRO REPLICATION; PURIFIED PROTEINS	Replication protein A (RPA) is a heterotrimeric single-stranded DNA-binding protein that is essential for DNA metabolism. Human RPA is composed of subunits of 70, 32, and 14 kDa with intrinsic DNA-binding activity localized to the 616-amino acid, 70-kDa subunit (RPA70). We have made a series of C-terminal deletions to map the functional domains of RPA70. Deletion of the C terminus resulted in polypeptides that were significantly more soluble than RPA70 but were unable to form stable complexes with the other two subunits of RPA. These data suggest that the C-terminal region of RPA70 may be important for complex formation. The DNA-binding do main was localized to a region of RPA70 between residues 1 and 441. A mutant containing residues 1-441 bound oligonucleotides with an intrinsic affinity close to wild-type RPA complex. This mutant also appeared to bind with reduced cooperativity. We conclude that the C terminus of RPA70 and the 32- and 14-kDa subunits are not involved directly with interactions with DNA but may have a role in cooperativity of RPA binding. RPA70 deletion mutants were not able to support DNA replication even in the presence of a complex of the 32- and 14-kDa subunits, suggesting that the heterotrimeric complex is essential for DNA replication. The putative zinc finger in the C terminus of RPA70 is not required for single-stranded DNA-binding activity.	UNIV IOWA, SCH MED, DEPT BIOCHEM, IOWA CITY, IA 52242 USA	University of Iowa			Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624	NIGMS NIH HHS [GM44721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1992, J CELL BIOL, V119, P1, DOI 10.1083/jcb.119.1.1; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; ATRAZHEV A, 1992, EUR J BIOCHEM, V210, P855, DOI 10.1111/j.1432-1033.1992.tb17489.x; Ausubel FM, 1988, MOL REPROD DEV; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; BROWN GW, 1994, MOL BIOCHEM PARASIT, V63, P135, DOI 10.1016/0166-6851(94)90016-7; BROWN GW, 1992, P NATL ACAD SCI USA, V89, P10227, DOI 10.1073/pnas.89.21.10227; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; ERDILE LF, 1991, J BIOL CHEM, V266, P12090; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FANG F, 1993, J CELL SCI, V106, P983; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; KAMAKAKA RT, 1994, MOL CELL BIOL, V14, P5114, DOI 10.1128/MCB.14.8.5114; KENNY MK, 1990, J BIOL CHEM, V265, P769; KIM C, 1995, IN PRESS BIOCHEMISTR; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; KORN D, 1979, COLD SPRING HARB SYM, V43, P613, DOI 10.1101/SQB.1979.043.01.068; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1991, J BIOL CHEM, V266, P22707; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; MELENDY T, 1993, J BIOL CHEM, V268, P3389; Melendy T., 1992, V6, P129; MITSIS PG, 1993, BIOCHEMISTRY-US, V32, P5257, DOI 10.1021/bi00070a038; MOORE SP, 1991, P NATL ACAD SCI USA, V88, P9067, DOI 10.1073/pnas.88.20.9067; MURAKAMI Y, 1992, P NATL ACAD SCI USA, V89, P952, DOI 10.1073/pnas.89.3.952; NAKAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4292, DOI 10.1093/nar/19.15.4292; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SEO YS, 1991, J BIOL CHEM, V266, P13161; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STIGGER E, 1994, P NATL ACAD SCI USA, V91, P579, DOI 10.1073/pnas.91.2.579; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMMES P, 1992, J BIOL CHEM, V267, P6063; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; UMBRICHT CB, 1993, J BIOL CHEM, V268, P6131; VILLEMAIN JL, 1993, BIOCHEMISTRY-US, V32, P11235, DOI 10.1021/bi00092a038; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	62	78	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4534	4543		10.1074/jbc.270.9.4534	http://dx.doi.org/10.1074/jbc.270.9.4534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876222	hybrid			2022-12-27	WOS:A1995QK08400055
J	SMITH, KP; LIU, B; SCOTT, C; SHARP, ZD				SMITH, KP; LIU, B; SCOTT, C; SHARP, ZD			PIT-1 EXHIBITS A UNIQUE PROMOTER SPACING REQUIREMENT FOR ACTIVATION AND SYNERGISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GROWTH-HORMONE; CELL-SPECIFIC EXPRESSION; RNA POLYMERASE-II; TRANSCRIPTION FACTOR; PROLACTIN GENE; ELEMENTS; BINDING; INVITRO; DNA; DISTANCE	The developmentally regulated Pit-1 transcription factor is involved in the activation of prolactin, growth hormone, and TSH beta expression. Using templates with spacing mutations to program an in. vitro transcription system, the activity of a single Pit-1 proximal binding site within the rat prolactin promoter was shown to have a unique bimodal distance requirement, Transcription activity rapidly decreased with each 5-base pair (bp) addition to the spacing between the binding site and the TATA box, When positioned 20 bp upstream from its normal -36 position in the prolactin promoter, the activity of the Pit-1 binding site is reduced to basal levels, Placement of the site at a position 30 bp upstream resulted in a return of Pit-1-mediated activation. Using transient transfection assays in GH(3) cells, the prime bimodal sites are also a requirement for optimum expression of chimeric prolactin-luciferase reporter con constructs, interestingly optimal synergism of transcription in vivo by the prolactin distal enhancer, containing four Pit-1 binding sites and an estrogen responsive dement, is also sensitive to the placement of the proximal Pit-1 binding site. These data have important implications for Pit-1 activator function in pituitary cells and for general models of transcription synergism.	UNIV TEXAS,HLTH SCI CTR,CTR MOLEC MED,INST BIOTECHNOL,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78245	University of Texas System; University of Texas Health San Antonio					NIDDK NIH HHS [DK38546] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038546, R29DK038546] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; BARRON EA, 1989, MOL CELL BIOL, V9, P817, DOI 10.1128/MCB.9.2.817; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CAO Z, 1988, MOL CELL BIOL, V8, P5432, DOI 10.1128/MCB.8.12.5432; CAO ZD, 1987, MOL CELL BIOL, V7, P3402, DOI 10.1128/MCB.7.10.3402; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CATANZARO DF, 1987, MOL ENDOCRINOL, V1, P90, DOI 10.1210/mend-1-1-90; CHEN RP, 1990, NATURE, V346, P583, DOI 10.1038/346583a0; CRENSHAW EB, 1989, GENE DEV, V3, P959, DOI 10.1101/gad.3.7.959; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; HARVEY C, 1991, MOL ENDOCRINOL, V5, P836, DOI 10.1210/mend-5-6-836; HE X, 1991, NEURON, V7, P183, DOI 10.1016/0896-6273(91)90257-Z; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LIN SC, 1994, DEVELOPMENT, V120, P515; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; MCKNIGHT SL, 1982, CELL, V31, P355, DOI 10.1016/0092-8674(82)90129-5; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NELSON C, 1986, NATURE, V322, P557, DOI 10.1038/322557a0; PAPE LK, 1990, GENE DEV, V4, P52, DOI 10.1101/gad.4.1.52; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PEERS B, 1990, MOL CELL BIOL, V10, P4690, DOI 10.1128/MCB.10.9.4690; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Sambrook J, 1989, MOL CLONING LABORATO; SMITH KP, 1991, BIOCHEM BIOPH RES CO, V177, P790, DOI 10.1016/0006-291X(91)91858-A; TAKAHASHI K, 1991, NATURE, V319, P121; TANSEY WP, 1993, J BIOL CHEM, V268, P14906; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; WEST BL, 1987, MOL CELL BIOL, V7, P1193, DOI 10.1128/MCB.7.3.1193; WOLF JB, 1990, NUCLEIC ACIDS RES, V18, P4905; WU L, 1988, GENE DEV, V2, P403, DOI 10.1101/gad.2.4.403; YE ZS, 1987, J BIOL CHEM, V262, P6313; ZHOU YH, 1994, EMBO J, V13, P4549, DOI 10.1002/j.1460-2075.1994.tb06776.x	43	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4484	4491		10.1074/jbc.270.9.4484	http://dx.doi.org/10.1074/jbc.270.9.4484			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876215	hybrid			2022-12-27	WOS:A1995QK08400048
J	BROSTROM, MA; PROSTKO, CR; GMITTER, D; BROSTROM, CO				BROSTROM, MA; PROSTKO, CR; GMITTER, D; BROSTROM, CO			INDEPENDENT SIGNALING OF GRP78 GENE-TRANSCRIPTION AND PHOSPHORYLATION OF EUKARYOTIC INITIATION-FACTOR 2-ALPHA BY THE STRESSED ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR SEQUESTERED CALCIUM; GH3 PITUITARY-CELLS; HEAT-SHOCK PROTEINS; TRANSMEMBRANE PROTEIN; CHRONIC DEPRIVATION; MAMMALIAN-CELLS; BREFELDIN-A; EXPRESSION; KINASE; ER	Perturbation of endoplasmic reticular (ER) function signals increased expression of the gene encoding the ER resident chaperone Grp78/BiP and rapid suppression of translational initiation accompanied by phosphorylation of the alpha-subunit of eukaryotic initiation factor 2 (eIF-2). eIF2 alpha phosphorylation and grp78 mRNA induction were measured in GH, pituitary cells subjected to varied degrees of ER stress to ascertain whether activation of an eIF-2 alpha kinase is involved in both events. grp78 mRNA was induced at low concentrations of ionomycin and dithiothreitol that did not provoke eIF-2 alpha phosphorylation or inhibition of amino acid incorporation. Mobilization of the bulk of cell-associated Ca2+ and the induction of grp78 mRNA occurred at comparable low concentrations of ionomycin, whereas phosphorylation of eIF-2 alpha and inhibition of protein synthesis required higher ionophore concentrations. Pretreatment for 1 h with cycloheximide suppressed grp78 mRNA induction and eIF-2 alpha phosphorylation in response to either stressor. Prolonged (17 h) cycloheximide blockade increased eIF-2 alpha phosphorylation without inducing grp78 mRNA Upon release from the blockade, grp78 mRNA was induced and eIF-2 alpha was dephosphorylated. Translational tolerance to ionomycin or dithiothreitol, accompanied by dephosphorylation of eIF-2 alpha, was observed whenever grp78 mRNA was induced. Induction of grp78 mRNA preceded significant eIF-2 alpha phosphorylation during treatment with brefeldin A It is concluded that signaling of grp78 gene transcription can occur independently of eIF-2 alpha phosphorylation or translational repression and that greater degrees of ER stress are required for eIF-2 alpha phosphorylation than for grp78 mRNA induction.			BROSTROM, MA (corresponding author), UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT PHARMACOL, PISCATAWAY, NJ 08854 USA.				NIDDK NIH HHS [DK 35393] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035393] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROSTROM CO, 1983, J BIOL CHEM, V258, P4390; BROSTROM MA, 1990, J BIOL CHEM, V265, P20539; BROSTROM MA, 1993, NUTRITION GENE EXPRE, P117; CHANG SC, 1989, MOL CELL BIOL, V9, P2153, DOI 10.1128/MCB.9.5.2153; CHIN KV, 1987, J BIOL CHEM, V262, P16509; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KIM YK, 1987, J CELL PHYSIOL, V133, P553, DOI 10.1002/jcp.1041330317; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; KUZNETSOV G, 1992, J BIOL CHEM, V267, P3932; KUZNETSOV G, 1993, J BIOL CHEM, V268, P2001; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533; LIU ES, 1992, J BIOL CHEM, V267, P7128; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; LODISH HF, 1992, J BIOL CHEM, V267, P12753; MATTS RL, 1992, J BIOL CHEM, V267, P18160; MATTS RL, 1993, BIOCHEMISTRY-US, V32, P7323, DOI 10.1021/bi00080a001; MATTS RL, 1992, J BIOL CHEM, V267, P18168; MELLOR H, 1994, FEBS LETT, V350, P143, DOI 10.1016/0014-5793(94)00756-X; MORI K, 1993, CELL, V74, P743; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PORUCHYNSKY MS, 1991, J CELL BIOL, V114, P651, DOI 10.1083/jcb.114.4.651; PRICE BD, 1992, J CELL PHYSIOL, V152, P545, DOI 10.1002/jcp.1041520314; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; PROSTKO CR, 1991, J BIOL CHEM, V266, P19790; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; SAMUEL CE, 1992, PHARMACOL THERAPEUT, V54, P307, DOI 10.1016/0163-7258(92)90005-K; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071	41	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4127	4132		10.1074/jbc.270.8.4127	http://dx.doi.org/10.1074/jbc.270.8.4127			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876163				2022-12-27	WOS:A1995QH68800097
J	CAMPBELL, GS; MEYER, DJ; RAZ, R; LEVY, DE; SCHWARTZ, J; CARTERSU, C				CAMPBELL, GS; MEYER, DJ; RAZ, R; LEVY, DE; SCHWARTZ, J; CARTERSU, C			ACTIVATION OF ACUTE-PHASE RESPONSE FACTOR (APRF)/STAT3 TRANSCRIPTION FACTOR BY GROWTH-HORMONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; TYROSINE PHOSPHORYLATION; C-FOS; INTERFERON-ALPHA; BINDING; PROTEIN; PROMOTER; ELEMENT; KINASE; GAMMA	The mechanisms by which the binding of growth hormone (GH) to its cell surface receptor elicits changes in gene transcription are largely unknown. The transcription factor Stat1/p91 has been shown to be activated by GH Here we show that acute phase response factor or Stat3 (or an antigenically related protein), is also activated by GH, Stats has been implicated in the interleukin-6-dependent induction of acute phase response genes, GH promotes in 3T3-F442A fibroblasts the tyrosyl phosphorylation of a protein immunoprecipitated by antibodies to Stats. This protein co-migrates with a tyrosyl phosphorylated protein from cells treated with leukemia inhibitory factor, a cytokine known 60 activate Stat3. Tyrosyl phosphorylated Stats is also observed in response to interferon-gamma. Stat3 is present in GH-inducible DNA-binding complexes that bind the sis-inducible element in the c-fos promoter and the acute phase response element in the alpha(2),-macroglobulin promoter. The ability of GH to activate both Stat1 and Stat3 (i.e. increase their tyrosyl phosphorylation and ability to bind to DNA) suggests that gene regulation by GH involves multiple Stat proteins. Shared transcription factors among hormones and cytokines that activate JAK kinases provide an explanation for shared responses, while the ability of the different Ligands to differentially recruit various Stat family members suggests mechanisms by which specificity in gene regulation could be achieved.	UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109; NYU,SCH MED,DEPT PATHOL,NEW YORK,NY 10016; NYU,SCH MED,KAPLAN COMPREHENS CANC CTR,NEW YORK,NY 10016	University of Michigan System; University of Michigan; New York University; New York University			Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; 	NIAID NIH HHS [R01-AI28900] Funding Source: Medline; NIDDK NIH HHS [R01-DK34171, R01 DK042932, R01 DK034171] Funding Source: Medline; NIGMS NIH HHS [GM07315] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034171, R01DK042932] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; FELDMAN GM, 1994, J BIOL CHEM, V269, P10747; FINBLOOM DS, 1994, MOL CELL BIOL, V14, P2113, DOI 10.1128/MCB.14.3.2113; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GRONOWSKI AM, 1994, J BIOL CHEM, V269, P7874; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; MEYER DJ, 1993, P NATL ACAD SCI USA, V90, P6721, DOI 10.1073/pnas.90.14.6721; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; RAZ R, 1994, J BIOL CHEM, V269, P24391; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; VOGEL J, 1986, MOL CELL BIOL, V6, P3550, DOI 10.1128/MCB.6.10.3550; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657; ZHONG A, 1994, P NATL SCI US, V91, P4806; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	36	172	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3974	3979		10.1074/jbc.270.8.3974	http://dx.doi.org/10.1074/jbc.270.8.3974			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876144	hybrid			2022-12-27	WOS:A1995QH68800077
J	FLYNN, DC; KOAY, TC; HUMPHRIES, CG; GUAPPONE, AC				FLYNN, DC; KOAY, TC; HUMPHRIES, CG; GUAPPONE, AC			AFAP-120 - A VARIANT FORM OF THE SRC SH2/SH3-BINDING PARTNER AFAP-110 IS DETECTED IN BRAIN AND CONTAINS A NOVEL INTERNAL SEQUENCE WHICH BINDS TO A 67-KDA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING RAT-BRAIN; EXPRESS HIGH-LEVELS; GENE-PRODUCT; C-SRC; TYROSINE PHOSPHORYLATION; STABLE ASSOCIATION; MAMMALIAN-CELLS; SH3 DOMAINS; GROWTH CONE; PP60C-SRC	SH2 and SH3 domains have been characterized as functional domains that mediate protein-protein interactions in signal transduction. Recently, the cDNA sequence of a novel Src- and Fyn-binding protein called AFAP-110, for Actin-Filament Associated Protein-110 kDa, was reported. This protein was distinctive in that it is both an SH2 and SH3 binding partner for the nonreceptor tyrosine kinases Src and Fyn. Here, we report the characterization of an alternatively processed form of AFAP-110 that encodes an additional 258 base pair (bp) Of Open reading frame. Transient expression of this full-length clone reveals a molecular mass of 120 kDa. Western blot analysis indicate that a larger 120-kDa variant of AFAP-110 can be detected in brain and is not detectable in any other tissues examined. Northern blot analysis indicate that the novel 258-bp insert can be detected in brain RNA but not chick embryo fibroblast RNA. We propose the name AFAP-120, for Actin Filament-Associated Protein-120 kDa. Expression of the 258-bp novel insert (NINS) as a glutathione S-transferase encoded fusion protein permits adsorption of a 67kDa protein from tissue lysates. Deletion analysis of the NINS indicates that the interaction with p67 can be attributed to a proline-rich motif that resembles an SH3-binding motif. We hypothesize that AFAP-1S0 facilitates interactions in brain between SH2/SH3 signaling proteins and actin filaments and that a proline-rich motif in the NINS may exist to facilitate additional interactions between cellular proteins in brain and actin filaments.	W VIRGINIA UNIV,DEPT MICROBIOL & IMMUNOL,MORGANTOWN,WV 26506	West Virginia University	FLYNN, DC (corresponding author), W VIRGINIA UNIV,MARY BABB RANDOLPH CANC CTR,MORGANTOWN,WV 26506, USA.				NCRR NIH HHS [2S07RR05433-31] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005433] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CARTWRIGHT CA, 1988, P NATL ACAD SCI USA, V85, P3348, DOI 10.1073/pnas.85.10.3348; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; FELICE GR, 1990, EUR J CELL BIOL, V52, P47; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; FLYNN DC, 1992, ONCOGENE, V7, P579; HARLOW E, 1988, ANTIBODIES LABORATOR; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KEMP BE, 1990, TRENDS BIOCHEM SCI, V17, P342; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LEVY BT, 1984, DEV BIOL, V104, P9, DOI 10.1016/0012-1606(84)90031-9; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LYNCH SA, 1986, J NEUROSCI RES, V16, P127; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODAWAY ARF, 1989, NATURE, V342, P624, DOI 10.1038/342624a0; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; ROSEN N, 1986, J BIOL CHEM, V261, P3754; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHALLER MD, 1993, PROG NUCLEIC ACID RE, V44, P205, DOI 10.1016/S0079-6603(08)60221-4; SCHARTL M, 1984, DEV BIOL, V105, P415, DOI 10.1016/0012-1606(84)90298-7; SHORES CG, 1987, J BIOL CHEM, V262, P9477; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBUE K, 1988, BIOCHEM BIOPH RES CO, V157, P1383, DOI 10.1016/S0006-291X(88)81028-3; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; SUGRUE MM, 1990, J NEUROSCI, V10, P2513; WARREN SL, 1987, MOL CELL BIOL, V7, P1326, DOI 10.1128/MCB.7.4.1326; WARREN SL, 1988, MOL CELL BIOL, V8, P632, DOI 10.1128/MCB.8.2.632; WEISTLER OD, 1988, MOL CELL BIOL, V8, P502	50	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3894	3899		10.1074/jbc.270.8.3894	http://dx.doi.org/10.1074/jbc.270.8.3894			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876134	hybrid			2022-12-27	WOS:A1995QH68800065
J	GLATIGNY, A; SCAZZOCCHIO, C				GLATIGNY, A; SCAZZOCCHIO, C			CLONING AND MOLECULAR CHARACTERIZATION OF HXA, THE GENE CODING FOR THE XANTHINE DEHYDROGENASE (PURINE HYDROXYLASE-I) OF ASPERGILLUS-NIDULANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITROGEN METABOLITE REPRESSION; ENCODING NITRATE REDUCTASE; DINUCLEOTIDE-BINDING-SITE; AMINO-ACID-SEQUENCE; IRON-SULFUR CENTERS; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; REGULATORY GENE; ROSY LOCUS; NEUROSPORA-CRASSA	We have cloned and sequenced the hxA gene coding for the xanthine dehydrogenase (purine hydroxylase I) of Aspergillus nidulans. The gene codes for a polypeptide of 1363 amino acids. The sequencing of a nonsense mutation, hxA5, proves formally that the clones isolated correspond to the hxA gene. The gene sequence is interrupted by three introns. Similarity searches reveal two iron-sulfur centers and a NAD/FAD-binding domain and have enabled a consensus sequence to be determined for the molybdenum cofactor-binding domain. The A. nidulans sequence is a useful outclass for the other known sequences, which are all from metazoans. In particular, it gives added significance to the missense mutations sequenced in Drosophila melanogaster and leads to the conclusion that while one of the recently sequenced human genes codes for a xanthine dehydrogenase, the other one must code for a different molybdenum-containing hydroxylase, possibly an aldehyde oxidase. The transcription of the hxA gene is induced by the uric acid analogue 2-thiouric acid and repressed by ammonium. Induction necessitates the product of the uaY regulatory gene.	UNIV PARIS 11, CTR ORSAY, INST MICROBIOL & GENET, CNRS, UA 1354, F-91405 ORSAY, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ALDERSON T, 1967, MUTAT RES, V8, P255; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; ARAMAYO R, 1990, NUCLEIC ACIDS RES, V18, P3415, DOI 10.1093/nar/18.11.3415; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BALLANCE DJ, 1986, YEAST, V2, P229, DOI 10.1002/yea.320020404; BANKS GR, 1993, GENE, V131, P69, DOI 10.1016/0378-1119(93)90670-X; BEARD ME, 1987, P NATL ACAD SCI USA, V84, P7433, DOI 10.1073/pnas.84.21.7433; BERSE B, 1983, GENE, V25, P109, DOI 10.1016/0378-1119(83)90173-7; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BURGER G, 1991, MOL CELL BIOL, V11, P5746, DOI 10.1128/MCB.11.11.5746; BURGER G, 1991, MOL CELL BIOL, V11, P795, DOI 10.1128/MCB.11.2.795; BUXTON FP, 1989, GENE, V84, P329, DOI 10.1016/0378-1119(89)90507-6; CHENG C, 1989, PLANT MOL BIOL, V13, P731; CHENG CL, 1988, EMBO J, V7, P3309, DOI 10.1002/j.1460-2075.1988.tb03201.x; CHOVNICK A, 1990, PROG CLIN BIOL RES, V344, P1; CHOVNICK A, 1977, CELL, V11, P1, DOI 10.1016/0092-8674(77)90312-9; CORRELL CC, 1993, PROTEIN SCI, V2, P2112, DOI 10.1002/pro.5560021212; COTTMAN RE, 1979, J PHYS CHEM-US, V83, P2392; COUGHLAN MP, 1979, P ROY IRISH ACAD B, V79, P169; COUGHLAN MP, 1980, EUR J BIOCHEM, V105, P81, DOI 10.1111/j.1432-1033.1980.tb04476.x; COUGHLAN MP, 1984, ARCH BIOCHEM BIOPHYS, V229, P596, DOI 10.1016/0003-9861(84)90192-9; COUGHLAN MP, 1980, MOLYBDENUM MOLYBDENU, P121; COURTRIGHT JB, 1976, ADV GENET, V18, P249, DOI 10.1016/S0065-2660(08)60440-X; COVE DJ, 1979, BIOL REV, V54, P291, DOI 10.1111/j.1469-185X.1979.tb01014.x; DARLINGTON AJ, 1967, J BACTERIOL, V93, P937, DOI 10.1128/JB.93.3.937-940.1967; DARLINGTON AJ, 1965, NATURE, V206, P599, DOI 10.1038/206599a0; DIOLEZ A, 1993, GENE, V131, P61, DOI 10.1016/0378-1119(93)90669-T; DOYLE WA, 1994, BIOCHEM J, V300, P915, DOI 10.1042/bj3000915; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; FIDEL S, 1988, GENE, V70, P283, DOI 10.1016/0378-1119(88)90200-4; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; FREUDENBERG W, 1988, FEMS MICROBIOL LETT, V52, P13; FU YH, 1990, P NATL ACAD SCI USA, V87, P5331, DOI 10.1073/pnas.87.14.5331; GARRETT RM, 1994, J BIOL CHEM, V269, P272; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY M, 1991, GENETICS, V127, P139; GRUBER H, 1992, GENE, V120, P75, DOI 10.1016/0378-1119(92)90011-D; Gurr S. J., 1987, SPECIAL PUBLICATIONS, P93; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANSELMAN F, 1984, THESIS U ESSEX; HAWKINS AR, 1987, CURR GENET, V11, P491, DOI 10.1007/BF00384611; HIRSCHBERG R, 1972, J BACTERIOL, V112, P392, DOI 10.1128/JB.112.1.392-397.1972; HOUDE M, 1989, GENE, V85, P391, DOI 10.1016/0378-1119(89)90432-0; HUGHES RK, 1992, BIOCHEMISTRY-US, V31, P3073, DOI 10.1021/bi00127a007; HUGHES RK, 1992, BIOCHEM J, V285, P507, DOI 10.1042/bj2850507; ICHIDA K, 1993, GENE, V133, P279; IMHOFF D, 1979, FEMS MICROBIOL LETT, V5, P155; JOHNSTONE IL, 1990, GENE, V90, P181, DOI 10.1016/0378-1119(90)90178-T; KEITH TP, 1987, GENETICS, V116, P67; Kinghorn J. R., 1989, Molecular and genetic aspects of nitrate assimilation., P385; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; KRENITSKY TA, 1974, COMP BIOCHEM PHYSIOL, V49, P687, DOI 10.1016/0305-0491(74)90256-9; KUDLA B, 1990, EMBO J, V9, P1355, DOI 10.1002/j.1460-2075.1990.tb08250.x; LEE CS, 1987, GENETICS, V116, P55; LEWIS NJ, 1978, EUR J BIOCHEM, V91, P311, DOI 10.1111/j.1432-1033.1978.tb20967.x; LEWIS NJ, 1977, EUR J BIOCHEM, V76, P441, DOI 10.1111/j.1432-1033.1977.tb11613.x; LLOYD AT, 1991, MOL GEN GENET, V230, P288, DOI 10.1007/BF00290679; LOCKINGTON RA, 1985, GENE, V33, P137, DOI 10.1016/0378-1119(85)90088-5; LOWE DJ, 1978, BIOCHEM J, V169, P471, DOI 10.1042/bj1690471; LOWE DJ, 1972, BIOCHEM J, V130, P239, DOI 10.1042/bj1300239; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MEHRA RK, 1989, J GEN MICROBIOL, V135, P273; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; NEAME PJ, 1989, J BIOL CHEM, V264, P20894; NELSON MA, 1989, MOL CELL BIOL, V9, P1271, DOI 10.1128/MCB.9.3.1271; NISHINO T, 1989, J BIOL CHEM, V264, P5468; NISHINO T, 1987, BIOCHEMISTRY-US, V26, P3068, DOI 10.1021/bi00385a018; OESTREICHER N, 1993, J BIOL CHEM, V268, P23382; OKAMOTO PM, 1991, MOL GEN GENET, V227, P213, DOI 10.1007/BF00259673; PATEMAN JA, 1964, NATURE, V201, P58, DOI 10.1038/201058a0; PROSSER IM, 1990, PLANT MOL BIOL, V15, P187, DOI 10.1007/BF00017743; RAJAGOPALAN KV, 1991, ADV ENZYMOL RAMB, V64, P215; RILEY MA, 1989, MOL BIOL EVOL, V6, P33; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCAZZOCC.C, 1968, BIOCHIM BIOPHYS ACTA, V166, P557, DOI 10.1016/0005-2787(68)90243-8; SCAZZOCCHIO C, 1973, EUR J BIOCHEM, V36, P428, DOI 10.1111/j.1432-1033.1973.tb02928.x; SCAZZOCCHIO C, 1982, GENETICS, V100, P185; SCAZZOCCHIO C, 1973, MOL GEN GENET, V125, P147, DOI 10.1007/BF00268868; SCAZZOCCHIO C, 1978, EUR J BIOCHEM, V91, P99, DOI 10.1111/j.1432-1033.1978.tb20942.x; SCAZZOCCHIO C, 1994, ASPERGILLUS 50 YEARS, P221; SCAZZOCCHIO C, 1966, THESIS U CAMBRIDGE; SCAZZOCCHIO C, 1980, MOLYBDENUM MOLYBDENU, P489; SCHNORR KM, 1991, MOL GEN GENET, V227, P411, DOI 10.1007/BF00273931; SEALYLEWIS HM, 1979, MOL GEN GENET, V174, P105, DOI 10.1007/BF00433311; SEALYLEWIS HM, 1978, MOL GEN GENET, V164, P303, DOI 10.1007/BF00333161; Sherman F., 1978, METHODS YEAST GENETI; SUAREZ T, 1991, MOL GEN GENET, V230, P369, DOI 10.1007/BF00280293; TAMAKI T, 1989, J BIOCHEM-TOKYO, V106, P541, DOI 10.1093/oxfordjournals.jbchem.a122889; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; THOENES U, 1994, EUR J BIOCHEM, V220, P901, DOI 10.1111/j.1432-1033.1994.tb18693.x; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TOMSETT AB, 1979, GENET RES, V34, P19, DOI 10.1017/S001667230001925X; UPSHALL A, 1986, MOL GEN GENET, V204, P349, DOI 10.1007/BF00425521; VAUCHERET H, 1989, PLANT MOL BIOL, V12, P597, DOI 10.1007/BF00036974; WAHL RC, 1982, J BIOL CHEM, V257, P3958; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; WRIGHT RM, 1993, P NATL ACAD SCI USA, V90, P10690, DOI 10.1073/pnas.90.22.10690; XU P, 1994, BIOCHEM BIOPH RES CO, V199, P998, DOI 10.1006/bbrc.1994.1328; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	103	81	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3534	3550		10.1074/jbc.270.8.3534	http://dx.doi.org/10.1074/jbc.270.8.3534			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876088	hybrid			2022-12-27	WOS:A1995QH68800015
J	SHACKELFORD, RE; MISRA, UK; FLORINECASTEEL, K; THAI, SF; PIZZO, SV; ADAMS, DO				SHACKELFORD, RE; MISRA, UK; FLORINECASTEEL, K; THAI, SF; PIZZO, SV; ADAMS, DO			OXIDIZED LOW-DENSITY-LIPOPROTEIN SUPPRESSES ACTIVATION OF NF-KAPPA-B IN MACROPHAGES VIA A PERTUSSIS-TOXIN-SENSITIVE SIGNALING MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MURINE PERITONEAL-MACROPHAGES; EXPRESSION; TRANSCRIPTION; ATHEROSCLEROSIS; GENE; LIPOPOLYSACCHARIDE; INDUCTION; CELLS; RNA; GRO	The interaction of oxidized low density lipoprotein (ox-LDL) and macrophages is generally believed to be a significant inductive step in atherogenesis. Endocytosis of ox-LDL by scavenger receptors (SR) on macrophages is one result of this interaction, as is suppressed expression of several lipopolysaccharide (LPS)-stimulated, inflammatory genes such as tumor necrosis factor-alpha (TNF-alpha). Events subsequent to SR ligation, including intracellular signaling events if any, have not been established, We report here that ox-LDL initiates rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate 2 (PIP2) and intracellular fluxes of Ca2+ in macrophages, both of which are sensitive to pertussis toxin, ox-LDL also suppresses the LPS-induced binding of macrophage extracts to an NF kappa B sequence oligonucleotide and the LPS-initiated accumulation of RNA specific for TNF-alpha. These latter two effects are pertussis toxin-sensitive. Ligation of SR by ox-LDL thus initiates a pertussis toxin-sensitive signaling pathway in macrophages, which involves hydrolysis of PIP2 and which can suppress expression of the TNF-alpha gene by modulating activation of NF kappa B.	DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Duke University					NATIONAL CANCER INSTITUTE [P01CA029589] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024066, R37HL024066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002922] Funding Source: NIH RePORTER; NCI NIH HHS [CA 29589] Funding Source: Medline; NHLBI NIH HHS [HL 24066] Funding Source: Medline; NIEHS NIH HHS [ES 02922] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ACTON SL, 1994, J BIOL CHEM, V269, P21003; ANDALIBI A, 1993, BIOCHEM SOC T, V21, P651, DOI 10.1042/bst0210651; ANISOWICZ A, 1991, J IMMUNOL, V147, P520; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; COGSWELL JP, 1994, J IMMUNOL, V153, P712; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DROUET C, 1991, J IMMUNOL, V147, P1694; FONG KL, 1973, J BIOL CHEM, V248, P7792; FRAENKELCONRAT H, 1957, METHOD ENZYMOL, V4, P247, DOI 10.1016/0076-6879(57)04059-8; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; Hatch F T, 1968, Adv Lipid Res, V6, P1; INTRONA M, 1987, J IMMUNOL, V138, P3891; JOSHIBARVE SS, 1993, J BIOL CHEM, V268, P18018; KAUFMAN PA, 1992, J CLIN INVEST, V90, P121, DOI 10.1172/JCI115824; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; MALDEN LT, 1991, J BIOL CHEM, V266, P13901; MISRA UK, 1994, J BIOL CHEM, V269, P12541; MISRA UK, 1994, J BIOL CHEM, V269, P18303; MOREL DW, 1986, LAB INVEST, V55, P419; OHMORI Y, 1994, J BIOL CHEM, V269, P17684; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sambrook J, 1989, MOL CLONING LABORATO; STEINBERG D, 1983, ARTERIOSCLEROSIS, V3, P283, DOI 10.1161/01.ATV.3.4.283; TENSEN CP, 1994, P NATL ACAD SCI USA, V91, P4816, DOI 10.1073/pnas.91.11.4816; THAI SF, 1995, IN PRESS J LEUKOCYTE, V57; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; XIE QW, 1994, J BIOL CHEM, V269, P4705	33	80	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3475	3478		10.1074/jbc.270.8.3475	http://dx.doi.org/10.1074/jbc.270.8.3475			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876078				2022-12-27	WOS:A1995QH68800004
J	ZHANG, Q; TECTOR, M; SALTER, RD				ZHANG, Q; TECTOR, M; SALTER, RD			CALNEXIN RECOGNIZES CARBOHYDRATE AND PROTEIN DETERMINANTS OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; ANTIGENS; HLA-A2; GLYCOPROTEINS; MATURATION; CELL	Proper folding of nascent polypeptides is essential for their function and is monitored by intracellular ''quality control'' elements. The molecular chaperone calnexin participates in this process by retaining in the endoplasmic reticulum a variety of unfolded proteins, including class I major histocompatibility complex molecules, We transfected human B cell Lines with genes encoding either wild-type HLA-A2 heavy chains or mutant heavy chains lacking sites for glycosylation or deficient in binding to beta(2)-microglobulin (beta(2)m) In CIR cells, calnexin did not associate detectably with wild-type heavy chains but bound strongly to mutant heavy chains unable to bind beta(2)m Removal of the glycosylation addition site by further mutagenesis prevented binding of mutant heavy chains to calnexin, In Daudi cells, deficient in synthesis of beta(2)m, wild-type HLA-A2 heavy chains, but not a nonglycosylated mutant, bound calnexin. Castanospermine, which blocks trimming of glucose residues from asparagine-linked glycans, inhibited association of calnexin with heavy chains encoded by a second class I gene, HLA-B*0702. Although initiation of calnexin binding appears to depend on the presence of oligosaccharide on the substrate, removal of the glycan from calnexin-associated heavy chains by digestion with endoglycosidase H did not disrupt the interaction, These results suggest that calnexin first recognizes carbohydrate on substrate proteins and then binds more stably to peptide determinants, which disappear upon folding.	UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Salter, Russell/0000-0003-4553-2986				DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; ENNIS PD, 1990, P NATL ACAD SCI USA, V87, P2833, DOI 10.1073/pnas.87.7.2833; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, CURR BIOL, V3, P884; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMB CA, 1992, J IMMUNOL, V148, P3478; ORTMANN E, 1994, NATURE, V368, P864; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; OWEN MJ, 1981, J BIOL CHEM, V256, P8987; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PARHAM P, 1979, J IMMUNOL, V123, P342; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; SALTER RD, 1992, HUM IMMUNOL, V35, P40, DOI 10.1016/0198-8859(92)90093-3; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; TECTOR M, 1994, J BIOL CHEM, V269, P25816; WAYS JP, 1986, J IMMUNOL, V137, P217; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	21	93	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3944	3948		10.1074/jbc.270.8.3944	http://dx.doi.org/10.1074/jbc.270.8.3944			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876141	hybrid			2022-12-27	WOS:A1995QH68800073
J	UTANI, A; NOMIZU, M; SUGIYAMA, S; MIYAMOTO, S; ROLLER, PP; YAMADA, Y				UTANI, A; NOMIZU, M; SUGIYAMA, S; MIYAMOTO, S; ROLLER, PP; YAMADA, Y			A SPECIFIC SEQUENCE OF THE LAMININ ALPHA-2 CHAIN CRITICAL FOR THE INITIATION OF HETEROTRIMER ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE PROTEINS; NEUROMUSCULAR-JUNCTION; MULTIDOMAIN PROTEIN; MECHANISM; REPEATS; FOS	Triple-stranded laminin molecules assemble via an alpha-helical coiled-coil structure spanning approximately 600 amino acid residues of each chain. We reported that the C termini of the beta 1 and gamma 1 chains direct the specific dimer and trimer assembly (Utani, A., Nomizu, M., Timpl, R., Roller, P. P., and Yamada, Y. (1994) J. Biol. Chem. 269, 19167-19175). In this study, we focused on the mechanism of trimer formation of the alpha 2 chain utilizing three different approaches. First, competition assays using mutated recombinant alpha 2 chain defined a 25-amino acid sequence at the C terminus of the long arm as an essential site for assembly with beta 1 and gamma 1 chain. Site-specific mutations and synthetic peptides of this site revealed that both positively charged amino acid residues and the alpha-helical structure within this site were critical. Second, overexpression studies of recombinant alpha 2 chain long arm confirmed that the C-terminal end was critical for the trimer assembly within NIH 3T3 cells. Third, circular dichroism spectroscopic examination of the complexes reconstituted in vitro revealed dynamic conformational changes of the alpha 2 and gamma 1 chains in the process of assembly. These studies also revealed that the proper folding of the extreme C terminus of alpha 2 chain was critical for the stability of trimer. From these data, it is concluded that the C terminus of alpha 2 chain long arm is required for the effective initiation of laminin heterotrimer assembly.	NCI, MED CHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	UTANI, A (corresponding author), NIDR, DEV BIOL LAB, BETHESDA, MD 20892 USA.							BECK K, 1993, J MOL BIOL, V231, P311, DOI 10.1006/jmbi.1993.1284; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BERNIER S, 1994, IN PRESS MATRIX BIOL; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; Engel J., 1993, MOL CELLULAR ASPECTS, P147, DOI [10.1016/B978-0-12-593165-6.50014-0, DOI 10.1016/B978-0-12-593165-6.50014-0]; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; HUNTER I, 1992, J BIOL CHEM, V267, P6006; HUNTER I, 1990, EUR J BIOCHEM, V188, P205, DOI 10.1111/j.1432-1033.1990.tb15391.x; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MARTIN GR, 1988, ADV PROTEIN CHEM, V39, P1; NOMIZU M, 1994, J BIOL CHEM, V269, P30386; NOMIZU M, 1992, INT J PEPT PROT RES, V40, P72; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; PAULSSON M, 1985, EMBO J, V4, P309, DOI 10.1002/j.1460-2075.1985.tb03630.x; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYAN MC, 1994, J BIOL CHEM, V269, P22779; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SCHUERMANN M, 1991, NUCLEIC ACIDS RES, V19, P739, DOI 10.1093/nar/19.4.739; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; UTANI A, 1994, J BIOL CHEM, V269, P19167	29	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3292	3298		10.1074/jbc.270.7.3292	http://dx.doi.org/10.1074/jbc.270.7.3292			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852414	hybrid			2022-12-27	WOS:A1995QG47100061
J	RONG, LA; FEI, YJ; PRASAD, PD; RAMAMOORTHY, S; HAN, H; YANGFENG, TL; HEDIGER, MA; GANAPATHY, V; LEIBACH, FH				RONG, LA; FEI, YJ; PRASAD, PD; RAMAMOORTHY, S; HAN, H; YANGFENG, TL; HEDIGER, MA; GANAPATHY, V; LEIBACH, FH			HUMAN INTESTINAL H+/PEPTIDE COTRANSPORTER - CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER MEMBRANE-VESICLES; PEPTIDE-TRANSPORT; BACILLUS-SUBTILIS; OLIGOPEPTIDES; SPORULATION; BACTERIA; NITRATE; SYSTEM; LOCUS; GENE	In mammalian small intestine, a H+-coupled peptide transporter is responsible for the absorption of small peptides arising from digestion of dietary proteins. Recently a cDNA clone encoding a H+/peptide cotransporter has been isolated from a rabbit intestinal cDNA library (Fei, Y, J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., and Hediger, M. A. (1994) Nature 368, 563-566). Screening of a human intestinal cDNA library with a probe derived from the rabbit H+/peptide cotransporter cDNA resulted in the identification of a cDNA which when expressed in HeLa cells or in Xenopus laevis oocytes induced H+-dependent peptide transport activity. The predicted protein consists of 708 amino acids with 12 membrane-spanning domains and two putative sites for protein kinase C-dependent phosphorylation. The cDNA-induced transport process accepts dipeptides, tripeptides, and amino beta-lactam antibiotics but not free amino acids as substrates. The human H+/peptide cotransporter exhibits a high degree of homology (81% identity and 92% similarity) to the rabbit H+/peptide cotransporter. But surprisingly these transporters show only a weak homology to the H+-coupled peptide transport proteins present in bacteria and yeast. Chromosomal assignment studies with somatic cell hybrid analysis and in situ hybridization have located the gene encoding the cloned human H+/peptide cotransporter to chromosome 13 q33-->q34.	MED COLL GEORGIA,DEPT BIOCHEM & MOLEC BIOL,AUGUSTA,GA 30912; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	University System of Georgia; Augusta University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School				Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028389] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 28389] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLOING G, 1990, MOL MICROBIOL, V4, P633, DOI 10.1111/j.1365-2958.1990.tb00632.x; AMIDON GL, 1994, ANNU REV PHARMACOL, V34, P321; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BRANDSCH M, 1994, BIOCHEM J, V299, P253, DOI 10.1042/bj2990253; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; DANTZIG AH, 1988, BIOCHEM BIOPH RES CO, V155, P1082, DOI 10.1016/S0006-291X(88)80607-7; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; GANAPATHY ME, 1985, AM J OBSTET GYNECOL, V153, P83, DOI 10.1016/0002-9378(85)90600-3; GANAPATHY V, 1985, AM J PHYSIOL, V249, pG153, DOI 10.1152/ajpgi.1985.249.2.G153; GANAPATHY V, 1982, LIFE SCI, V30, P2137, DOI 10.1016/0024-3205(82)90287-9; GANAPATHY V, 1991, Current Opinion in Cell Biology, V3, P695, DOI 10.1016/0955-0674(91)90043-X; GANAPATHY V, 1987, ADV BIOSCI, V65, P91; GANAPATHY V, 1987, AM J PHYSIOL, V251, pF945; GANAPATHY V, 1987, CONTRIB INFUSION THE, V17, P54; GANAPATHY V, 1974, PHYSL GASTROINTESTIN, P1773; HAGTING A, 1994, J BIOL CHEM, V269, P11391; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HIGGINS CF, 1986, METHOD ENZYMOL, V125, P365; KABACK HR, 1992, INT REV CYTOL, V137A, P97; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LOMBARDO YB, 1988, J BIOL CHEM, V263, P12920; MCCLURE PR, 1990, PLANT PHYSIOL, V93, P281, DOI 10.1104/pp.93.1.281; MIYAMOTO Y, 1991, J BIOL CHEM, V266, P4742; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; PERRY JR, 1994, MOL CELL BIOL, V14, P104, DOI 10.1128/MCB.14.1.104; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RAMAMOORTHY S, 1994, BIOCHEM J, V300, P893, DOI 10.1042/bj3000893; RUDNER DZ, 1991, J BACTERIOL, V173, P1388, DOI 10.1128/jb.173.4.1388-1398.1991; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAKUWA N, 1985, BIOCHIM BIOPHYS ACTA, V814, P186, DOI 10.1016/0005-2736(85)90435-3; TIRUPPATHI C, 1990, J BIOL CHEM, V265, P14870; TIRUPPATHI C, 1990, BIOCHEM J, V268, P27, DOI 10.1042/bj2680027; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; TSUJI A, 1987, ADV BIOSCI, V65, P125; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117	38	451	478	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6456	6463		10.1074/jbc.270.12.6456	http://dx.doi.org/10.1074/jbc.270.12.6456			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896779	hybrid			2022-12-27	WOS:A1995QQ85500008
J	WANG, J; ROSS, EM				WANG, J; ROSS, EM			THE CARBOXYL-TERMINAL ANCHORAGE DOMAIN OF THE TURKEY BETA(1)-ADRENERGIC RECEPTOR IS ENCODED BY AN ALTERNATIVELY SPLICED EXON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; AGONIST-INDUCED DESENSITIZATION; 2 ISOFORMS; BETA-2-ADRENERGIC RECEPTORS; DOWN-REGULATION; BINDING; CELLS; GENE; RNA; ERYTHROCYTE	The originally described cDNA of the turkey beta(1)-adrenergic receptor encodes a receptor with a carboxyl-terminal, 59-amino acid extension that was not found in several mammalian beta(1)- adrenergic receptors. This extension blocks agonist-promoted endocytosis and downregulation of the receptor. This carboxyl-terminal domain is encoded by an exon distinct from that which encodes the body of the receptor, and the originally described cDNA results from removal of an 849-nucleotide intron. Unspliced mRNA encodes a shorter open reading frame whose translated carboxyl terminus is identical with that of the mammalian beta(1)-adrenergic receptors. There is no evidence for other introns in the coding region. Splicing of the intron to produce the nonendocytosing receptor is highest in fetal blood cells, is appreciable in adult brain and heart, and is detectable in other tissues. Thus, different tissues use alternative splicing to express beta-adrenergic receptors that either do or do not endocytose and down-regulate in response to agonist.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIGMS NIH HHS [R37GM30355] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030355] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN XH, 1994, J BIOL CHEM, V269, P24810; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DELAPENA P, 1992, J BIOL CHEM, V267, P25703; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FISHMAN PH, 1991, J NEUROCHEM, V56, P596, DOI 10.1111/j.1471-4159.1991.tb08191.x; FREDERICH RC, 1983, J CYCLIC NUCL PROT, V9, P103; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GIROS B, 1989, NATURE, V342, P823; GRANNEMAN JG, 1992, ENDOCRINOLOGY, V130, P109, DOI 10.1210/en.130.1.109; GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964; HANSKI E, 1978, LIFE SCI, V22, P53, DOI 10.1016/0024-3205(78)90411-3; HARDEN TK, 1979, J CYCLIC NUCL PROT, V5, P99; HARDEN TK, 1980, SCIENCE, V210, P441, DOI 10.1126/science.6254143; HERTEL C, 1983, J CYCLIC NUCL PROT, V9, P119; HERTEL C, 1990, J BIOL CHEM, V265, P17988; HOUGH C, 1990, BIOCHEM BIOPH RES CO, V170, P46, DOI 10.1016/0006-291X(90)91238-N; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; Lucas AM, 1961, AGR MONOGRAPH, V25; LUXEMBOURG A, 1991, FEBS LETT, V283, P155, DOI 10.1016/0014-5793(91)80575-N; MINNEMAN KP, 1980, MOL PHARMACOL, V17, P1; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MUNTZ KH, 1994, CIRC RES, V74, P369, DOI 10.1161/01.RES.74.3.369; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; NANOFF C, 1989, J CARDIOVASC PHARM, V13, P198, DOI 10.1097/00005344-198902000-00004; NEGISHI M, 1993, J BIOL CHEM, V268, P9517; NEVE KA, 1986, MOL PHARMACOL, V30, P104; NEVE KA, 1985, J PHARMACOL EXP THER, V235, P657; OMALLEY KL, 1990, BIOCHEMISTRY-US, V29, P1367, DOI 10.1021/bi00458a003; PARKER EM, 1995, J BIOL CHEM, V270, P6482, DOI 10.1074/jbc.270.12.6482; PARKER EM, 1991, J BIOL CHEM, V266, P9987; PERKINS JP, 1990, BETA ADRENERGIC RECE, P73; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; Sambrook J., 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEARLES RP, 1994, DNA SEQUENCE, V4, P231, DOI 10.3109/10425179409020846; SHIMOMURA H, 1990, NUCLEIC ACIDS RES, V18, P4591, DOI 10.1093/nar/18.15.4591; SIMPSON IA, 1980, FEBS LETT, V115, P113, DOI 10.1016/0014-5793(80)80738-1; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SPRONSEN AV, 1993, EUR J BIOCHEM, V23, P1117; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; SUZUKI T, 1992, MOL PHARMACOL, V41, P542; VALET P, 1988, J PHARMACOL EXP THER, V249, P271; WALDO GL, 1983, J BIOL CHEM, V258, P3900; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795; YU SS, 1993, J BIOL CHEM, V268, P337	48	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6488	6495		10.1074/jbc.270.12.6488	http://dx.doi.org/10.1074/jbc.270.12.6488			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896783	hybrid			2022-12-27	WOS:A1995QQ85500013
J	MYERS, SJ; WONG, LM; CHARO, IF				MYERS, SJ; WONG, LM; CHARO, IF			SIGNAL-TRANSDUCTION AND LIGAND SPECIFICITY OF THE HUMAN MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTOR IN TRANSFECTED EMBRYONIC KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; ACTIVATING FACTOR MCAF; FUNCTIONAL EXPRESSION; CHEMOTACTIC PROTEIN-1; MOLECULAR-CLONING; CYTOKINE FAMILY; ALPHA-SUBUNITS; IDENTIFICATION; RANTES; INTERLEUKIN-8	We have examined the ligand specificity and signal transduction pathways of a recently cloned receptor for monocyte chemoattractant protein-1 (MCP-1). In human 293 cells stably transfected with the MCP-1 receptor, MCP-1 bound specifically with high affinity (K-d = 260 pM) and induced a rapid mobilization of calcium from intracellular stores, The closely related chemokines MIP-1 alpha, MIP-1 beta, RANTES, interleukin 8 (IL-8), and Gro-alpha were inactive at concentrations as high as 300 nM. Activation of the MCP-1 receptor potently inhibited adenylyl cyclase with an IC50 = 90 pM. Activation of the MIP-1 alpha/RANTES receptor also mediated inhibition of adenylyl cyclase activity but with a different pharmacological profile: MIP-1 alpha (110 pM, IC50), RANTES (140 pM), MIP-1 beta (10 nM), and MCP-1 (820 nM). Mobilization of intracellular calcium and inhibition of adenylyl cyclase were blocked by pertussis toxin, suggesting that the MCP-1 receptor coupled to G alpha i. These results demonstrate that the MCP-1 receptor binds and signals in response to picomolar concentrations of MCP-1 in a highly specific manner. Signaling was manifested as mobilization of intracellular calcium and inhibition of adenylyl cyclase and was mediated by a pertussis toxin-sensitive G-protein(s).	UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94141; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DAIICHI RES CTR,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052773] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52773] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; ERNST CA, 1994, J IMMUNOL, V152, P3541; FURUTANI Y, 1989, BIOCHEM BIOPH RES CO, V159, P249, DOI 10.1016/0006-291X(89)92430-3; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; GRONENBORN AM, 1991, PROTEIN ENG, V4, P263, DOI 10.1093/protein/4.3.263; HUNG DT, 1992, J BIOL CHEM, V267, P20831; HUNG DT, 1992, J CELL BIOL, V116, P827, DOI 10.1083/jcb.116.3.827; JIANG YL, 1992, J IMMUNOL, V148, P2423; KIMURA T, 1992, NATURE, V356, P526, DOI 10.1038/356526a0; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PUTNEY JW, 1994, TRENDS ENDOCRIN MET, V5, P256, DOI 10.1016/1043-2760(94)P3085-L; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; SAGE SO, 1987, J BIOL CHEM, V262, P16364; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; SOZZANI S, 1993, J IMMUNOL, V150, P1544; SOZZANI S, 1991, J IMMUNOL, V147, P2215; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Thomas A.P., 1991, CELLULAR CALCIUM PRA, P1; VADDI K, 1994, J LEUKOCYTE BIOL, V55, P756, DOI 10.1002/jlb.55.6.756; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; VANRIPER G, 1993, J EXP MED, V177, P851, DOI 10.1084/jem.177.3.851; WANG JM, 1993, J EXP MED, V177, P699, DOI 10.1084/jem.177.3.699; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; WORTHEN GS, 1994, J CLIN INVEST, V94, P815, DOI 10.1172/JCI117401; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YOSHIMURA T, 1990, J IMMUNOL, V145, P292; ZACHARIAE COC, 1990, J EXP MED, V171, P2177, DOI 10.1084/jem.171.6.2177; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	43	155	163	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5786	5792		10.1074/jbc.270.11.5786	http://dx.doi.org/10.1074/jbc.270.11.5786			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890708	hybrid			2022-12-27	WOS:A1995QM94500018
J	NUKAGA, M; NARUTA, S; TANIMOTO, K; KOGURE, K; TANIGUCHI, K; TAMAKI, M; SAWAI, T				NUKAGA, M; NARUTA, S; TANIMOTO, K; KOGURE, K; TANIGUCHI, K; TAMAKI, M; SAWAI, T			MOLECULAR EVOLUTION OF A CLASS-C BETA-LACTAMASE EXTENDING ITS SUBSTRATE-SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITROBACTER-FREUNDII CEPHALOSPORINASE; AMINO-ACID SUBSTITUTION; ACTIVE-SITE; EXTENSION; SPECTRUM; ENZYMES; DNA; MUTAGENESIS; HYDROLYSIS; MECHANISM	Enterobacter cloacae GC1, a clinical strain isolated in 1992 in Japan, was found to produce a chromosomal class C beta-lactamase with extended substrate specificity to oxyimino beta-lactam antibiotics, significantly differing from the known E. cloacae beta-lactamases such as the P99 beta-lactamase. The 1560 nucleotides including the GC1 beta-lactamase gene were sequenced, and the amino acid sequence of the mature enzyme comprising 364 amino acids was deduced. A comparison of the amino acid sequence with those of known E. cloacae beta-lactamases revealed the duplication of three amino acids at positions 208-213, i.e. Ala-Val-Arg-Ala-Val-Arg. This duplication was attributed to a tandem duplication of a 9-nucleotide sequence, The chimeric beta-lactamases produced by the chimeric genes from the GC1 and P99 beta-lactamase genes indicated that the extended substrate specificity is entirely attributed to the 3-amino acid insertion, Two mutant beta-lactamases were prepared from P99 beta-lactamase by site-directed mutagenesis, i.e. an Ala-Ala-Ala sequence was inserted before or after the native Ala-Val-Arg at positions 208-210, These mutant enzymes revealed that the Ala-Val-Arg located from positions 211 to 213 in the GC1 beta-lactamase are the newly inserted residues, and this phenomenon is independent of the characteristics of the amino acids inserted.	CHIBA UNIV,FAC PHARMACEUT SCI,DIV MICROBIAL CHEM,INAGE KU,CHIBA 263,JAPAN	Chiba University				Haruta, Shin/0000-0002-3705-2459				AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; DALE JW, 1985, FEBS LETT, V191, P39, DOI 10.1016/0014-5793(85)80989-3; GALLENI M, 1988, BIOCHEM J, V250, P753, DOI 10.1042/bj2500753; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KNOTTHUNZIKER V, 1982, BIOCHEM J, V207, P315, DOI 10.1042/bj2070315; LAWYER FC, 1989, J BIOL CHEM, V264, P6427; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; MILER JH, 1972, EXPT MOL GENETICS, P433; NOVICK RP, 1962, BIOCHEM J, V83, P236, DOI 10.1042/bj0830236; NUKAGA M, 1994, ANTIMICROB AGENTS CH, V38, P1374, DOI 10.1128/AAC.38.6.1374; NUKAGA M, 1993, FEBS LETT, V332, P93, DOI 10.1016/0014-5793(93)80491-C; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; OWEN RJ, 1987, NUCLEIC ACIDS RES, V15, P3631, DOI 10.1093/nar/15.8.3631; PHILIPPON A, 1989, ANTIMICROB AGENTS CH, V33, P1131, DOI 10.1128/AAC.33.8.1131; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWAI T, 1981, J ANTIBIOT, V34, P1318, DOI 10.7164/antibiotics.34.1318; SAWAI T, 1982, J BACTERIOL, V152, P567; SOWEK JA, 1991, BIOCHEMISTRY-US, V30, P3179, DOI 10.1021/bi00227a004; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8767; TSUKAMOTO K, 1990, J BACTERIOL, V172, P4348, DOI 10.1128/jb.172.8.4348-4351.1990; TSUKAMOTO K, 1990, FEBS LETT, V264, P211, DOI 10.1016/0014-5793(90)80250-M; TSUKAMOTO K, 1992, EUR J BIOCHEM, V207, P1123, DOI 10.1111/j.1432-1033.1992.tb17150.x; TSUKAMOTO K, 1990, EUR J BIOCHEM, V188, P15, DOI 10.1111/j.1432-1033.1990.tb15365.x; YAMAGUCHI A, 1983, ANTIMICROB AGENTS CH, V24, P23, DOI 10.1128/AAC.24.1.23; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	29	76	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5729	5735		10.1074/jbc.270.11.5729	http://dx.doi.org/10.1074/jbc.270.11.5729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890700				2022-12-27	WOS:A1995QM94500010
J	TOULME, F; LECAM, E; TEYSSIER, C; DELAIN, E; SAUTIERE, P; MAURIZOT, JC; CULARD, F				TOULME, F; LECAM, E; TEYSSIER, C; DELAIN, E; SAUTIERE, P; MAURIZOT, JC; CULARD, F			CONFORMATIONAL-CHANGES OF DNA MINICIRCLES UPON THE BINDING OF THE ARCHAEBACTERIAL HISTONE-LIKE PROTEIN MC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; LAC REPRESSOR; METHANOSARCINA-BARKERI; HU; NUCLEOSOME; DEPENDENCE; INVITRO; RINGS	Binding of the archaebacterial histone-like protein MC1 to DNA minicircles has been examined by gel retardation and electron microscopy, MC1 preferentially binds to a 207-base pair relaxed DNA minicircle as compared with the linear fragment. Random binding is observed at very low ionic strength, and a slight increase in salt concentration highly favors the formation of a complex that corresponds to the binding of two MC1 molecules per DNA ring. Measurements of dissociation rates show that this complex is remarkably stable, and electron microscopy reveals that it is characterized by two diametrically opposed kinks. These results are discussed in regard to the mechanisms by which MC1 affects DNA structure.	CTR BIOPHYS MOLEC, F-45071 ORLEANS 2, FRANCE; INST GUSTAVE ROUSSY, MICROSCOPIE CELLULAIRE & MOLEC LAB, CNRS, URA 147, F-94805 VILLEJUIF, FRANCE; INST PASTEUR, F-59019 LILLE, FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille				Le cam, Eric/0000-0002-6832-6117				BAUER WR, 1993, P NATL ACAD SCI USA, V90, P833, DOI 10.1073/pnas.90.3.833; BONNEFOY E, 1994, J MOL BIOL, V242, P116, DOI 10.1006/jmbi.1994.1563; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; CAIRNEY KL, 1982, BIOPOLYMERS, V21, P923, DOI 10.1002/bip.360210506; CHARTIER F, 1988, BIOCHIM BIOPHYS ACTA, V951, P149, DOI 10.1016/0167-4781(88)90035-8; CHARTIER F, 1989, J BIOL CHEM, V264, P17006; CHARTIER F, 1985, FEBS LETT, V183, P119, DOI 10.1016/0014-5793(85)80967-4; CREVEL G, 1989, CR ACAD SCI III-VIE, V309, P1; CULARD F, 1993, FEBS LETT, V315, P335, DOI 10.1016/0014-5793(93)81189-7; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; EISMANN ER, 1990, J MOL BIOL, V213, P763, DOI 10.1016/S0022-2836(05)80262-1; FULLER F, 1982, GENE, V19, P43, DOI 10.1016/0378-1119(82)90187-1; GUALERZI CO, 1986, BACTERIAL CHROMATIN, P101; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; IMBERT M, 1988, CAN J MICROBIOL, V34, P931, DOI 10.1139/m88-165; JOANICOT M, 1987, BIOPOLYMERS, V26, P315, DOI 10.1002/bip.360260211; KAM Z, 1981, BIOPOLYMERS, V20, P2671, DOI 10.1002/bip.1981.360201213; KATOUZIANSAFADI M, 1991, NUCLEIC ACIDS RES, V19, P4937, DOI 10.1093/nar/19.18.4937; KRZYCKI JA, 1990, 6TH P INT S GEN IND, P603; LAINE B, 1990, FEMS SYMP, V54, P291; LAINE B, 1991, NUCLEIC ACIDS RES, V19, P3041, DOI 10.1093/nar/19.11.3041; LAINE B, 1991, CHROMATINE, P37; LECAM E, 1991, J ELECTRON MICR TECH, V18, P375; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; MUZARD G, 1990, EMBO J, V9, P1289, DOI 10.1002/j.1460-2075.1990.tb08238.x; PETTIJOHN DE, 1990, NUCLEIC ACIDS MOL BI, V4, P152; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; SASMOR HM, 1990, BIOCHEMISTRY-US, V29, P9023, DOI 10.1021/bi00490a020; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SROS M, 1994, NUCLEIC ACIDS RES, V22, P1044; TEYSSIER C, 1994, BIOCHEM J, V303, P567, DOI 10.1042/bj3030567; THEVENY B, 1988, STRUCTURE EXPRESSION, V3, P35; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	35	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6286	6291		10.1074/jbc.270.11.6286	http://dx.doi.org/10.1074/jbc.270.11.6286			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890766	hybrid			2022-12-27	WOS:A1995QM94500086
J	BURLEIGH, BA; ANDREWS, NW				BURLEIGH, BA; ANDREWS, NW			A 120-KDA ALKALINE PEPTIDASE FROM TRYPANOSOMA-CRUZI IS INVOLVED IN THE GENERATION OF A NOVEL CA2+-SIGNALING FACTOR FOR MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; FLUOROMETHYL KETONES; CYSTEINE PROTEINASE; EPITHELIAL-CELLS; INVASION; ENTRY; CYTOSKELETON; ATTACHMENT; INHIBITION	Trypomastigotes, the infective stages of the intracellular parasite Trypanosoma cruzi, induce rapid and repetitive cytosolic free Ca2+ transients in fibroblasts. Buffering or depletion of intracellular free Ca2+ inhibits cell entry by trypomastigotes, indicating a role for this signaling event in invasion. We show here that the majority of the Ca2+-signaling activity is associated with the soluble fraction of parasites disrupted by sonication. Distinct cell types from different species are responsive to this soluble factor, and intracellular free Ca2+ transients occur rapidly and reach concentrations comparable to responses induced by thrombin and bombesin. The Ca2+-signaling activity does not bind concanavalin A and is strongly inhibited by a specific subset of protease inhibitors. The only detectable protease in the fractions with Ca2+-signaling activity is an unusual alkaline peptidase of 120 kDa, to which no function had been previously assigned. The activity of the protease and cell invasion by trypomastigotes are blocked by the same specific inhibitors that impair Ca2+-signaling, suggesting that the enzyme is required for generating the response leading to infection. We demonstrate that the 120-kDa peptidase is not sufficient for triggering Ca2+-signaling, possibly being involved in the processing of precursors present only in infective trypomastigotes. These findings indicate a biological function for a previously identified unusual protozoan protease and provide the first example of a proteolytically generated parasite factor with characteristics of a mammalian hormone.			BURLEIGH, BA (corresponding author), YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510, USA.			Andrews, Norma/0000-0002-0611-2412	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032056, R01AI034867] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI32056, R01AI34867] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; ASHALL F, 1990, MOL BIOCHEM PARASIT, V38, P77, DOI 10.1016/0166-6851(90)90207-3; ASHALL F, 1990, BIOCHIM BIOPHYS ACTA, V1035, P293, DOI 10.1016/0304-4165(90)90091-A; BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; BONALDO MC, 1991, EXP PARASITOL, V73, P44, DOI 10.1016/0014-4894(91)90006-I; CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; FISHER JM, 1988, J BIOL CHEM, V263, P16515; FOUBISTER V, 1994, J EXP MED, V179, P993, DOI 10.1084/jem.179.3.993; GINOCCHIO CC, 1994, CELL, V76, P717, DOI 10.1016/0092-8674(94)90510-X; GREIG S, 1990, MOL BIOCHEM PARASIT, V39, P31, DOI 10.1016/0166-6851(90)90005-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; HERRERA EM, 1994, MOL BIOCHEM PARASIT, V65, P73, DOI 10.1016/0166-6851(94)90116-3; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; LESLIE FM, 1987, PHARMACOL REV, V39, P197; LEY V, 1990, J EXP MED, V171, P401, DOI 10.1084/jem.171.2.401; LEY V, 1989, J EXP MED, V168, P649; MANJARREZHERNAN.HA, 1992, LANCET, V339, P521; MEIRELLES MNL, 1986, EUR J CELL BIOL, V41, P198; MEIRELLES MNL, 1992, MOL BIOCHEM PARASIT, V52, P175, DOI 10.1016/0166-6851(92)90050-T; MOULDER JW, 1985, MICROBIOL REV, V49, P298, DOI 10.1128/MMBR.49.3.298-337.1985; MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8; NOGUEIRA N, 1976, J EXP MED, V143, P1402, DOI 10.1084/jem.143.6.1402; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; PIRAS MM, 1985, MOL BIOCHEM PARASIT, V14, P151, DOI 10.1016/0166-6851(85)90034-9; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; RASNICK D, 1985, ANAL BIOCHEM, V149, P461, DOI 10.1016/0003-2697(85)90598-6; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; RUIZ RD, 1993, PARASITE IMMUNOL, V15, P121, DOI 10.1111/j.1365-3024.1993.tb00591.x; SANTANA JM, 1992, BIOCHEM BIOPH RES CO, V187, P1466, DOI 10.1016/0006-291X(92)90467-Y; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1991, INFECT IMMUN, V59, P645, DOI 10.1128/IAI.59.2.645-654.1991; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; TARDIEUX I, 1994, J EXP MED, V179, P1017, DOI 10.1084/jem.179.3.1017; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989; YOUNG VB, 1992, J CELL BIOL, V116, P197, DOI 10.1083/jcb.116.1.197	44	88	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5172	5180		10.1074/jbc.270.10.5172	http://dx.doi.org/10.1074/jbc.270.10.5172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890627	hybrid			2022-12-27	WOS:A1995QL58000035
J	SCHMIDT, HHJ; REMALEY, AT; STONIK, JA; RONAN, R; WELLMANN, A; THOMAS, F; ZECH, LA; BREWER, HB; HOEG, JM				SCHMIDT, HHJ; REMALEY, AT; STONIK, JA; RONAN, R; WELLMANN, A; THOMAS, F; ZECH, LA; BREWER, HB; HOEG, JM			CARBOXYL-TERMINAL DOMAIN TRUNCATION ALTERS APOLIPOPROTEIN-A-I IN-VIVO CATABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; CORONARY HEART-DISEASE; INVIVO METABOLISM; EXCHANGEABLE APOLIPOPROTEINS; AMPHIPATHIC HELIX; APOA-I; PLASMA; DEGRADATION; CONVERSION	Apolipoprotein A-I (apoA-I), the major protein of high density lipoproteins, facilitates reverse cholesterol transport from peripheral tissue to liver. To determine the structural motifs important for modulating the in vivo catabolism of human apoA-I (h-apoA-I), we generated carboxyl-terminal truncation mutants at residues 201 (apoA-I-201), 217 (apoA-I-217), and 226 (apoA-I-226) by site directed mutagenesis. ApoA-I was expressed in Escherichia coli as a fusion protein with the maltose binding protein, which was removed by factor Xa cleavage. The in vivo kinetic analysis of the radioiodinated apoA-I in normolipemic rabbits revealed a markedly increased rate of catabolism for the truncated forms of apoA-I. The fractional catabolic rates (FCR) of 9.10 +/- 1.28/day (+/-S.D.) for apoA-I-201, 6.34 +/- 0.81/day for apoA-I-217, and 4.42 +/- 0.51/day for apoA-I-226 were much faster than the FCR of recombinant intact apoA-I (r-apoA-I, 0.93 +/- 0.07/day) and h-apoA-I (0.91 +/- 0.34/day), All the truncated forms of apoA-I were associated with very high density lipoproteins, whereas the intact recombinant apoA-I (r-apoA-I) and h-apoA-I associated with HDL(2) and HDL(3), Gel filtration chromatography revealed that in contrast to r-apoA-I, the mutant apoA-I-201 associated with a phospholipid-rich rabbit apoA-I containing particle. Analysis by agarose gel electrophoresis demonstrated that the same mutant migrated in the pre-beta position, but not within the alpha position as did r-apoA-I. These results indicate that the carboxyl-terminal region (residue 227-243) of apoA-I is critical in modulating the association of apoA-I with lipoproteins and in vivo metabolism of apoA-I.	NHLBI, CELL BIOL SECT, MOLEC DIS BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								ALLAN CM, 1992, J BIOL CHEM, V267, P13257; ASSMANN G, 1974, P NATL ACAD SCI USA, V71, P989, DOI 10.1073/pnas.71.3.989; BARRANS A, 1994, J BIOL CHEM, V269, P11572; BAUSSERMAN LL, 1984, BIOCHEMISTRY-US, V23, P2241, DOI 10.1021/bi00305a023; BEG ZH, 1989, J BIOL CHEM, V264, P6913; BERMAN M, 1978, DHEW NIH78 PUBL, P180; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; BOJANOVSKI D, 1987, J CLIN INVEST, V80, P1742, DOI 10.1172/JCI113266; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BRINTON EA, 1991, J CLIN INVEST, V87, P536, DOI 10.1172/JCI115028; BYRNE RE, 1983, BIOCHEMISTRY-US, V22, P2894, DOI 10.1021/bi00281a018; CALABRESI L, 1993, BIOCHEMISTRY-US, V32, P6477, DOI 10.1021/bi00076a023; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; CHEUNG P, 1983, NUCLEIC ACIDS RES, V11, P3703, DOI 10.1093/nar/11.11.3703; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; DALTON MB, 1993, J BIOL CHEM, V268, P19274; DEEB SS, 1991, J BIOL CHEM, V266, P13654; EDELSTEIN C, 1983, J BIOL CHEM, V258, P1430; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FORMISANO S, 1978, J BIOL CHEM, V253, P354; FUNKE H, 1991, J CLIN INVEST, V87, P371, DOI 10.1172/JCI114997; GARBER DW, 1992, ARTERIOSCLER THROMB, V12, P886, DOI 10.1161/01.ATV.12.8.886; GLASS C, 1985, J BIOL CHEM, V260, P744; GLASS CK, 1983, J BIOL CHEM, V258, P7161; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON JI, 1983, J BIOL CHEM, V258, P4037; GREGG RE, 1985, CIRCULATION, V72, P364; HARA H, 1991, J BIOL CHEM, V266, P3080; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; IKEWAKI K, 1993, J LIPID RES, V34, P2207; JENG I, 1980, BIOCHEM BIOPH RES CO, V92, P876, DOI 10.1016/0006-291X(80)90784-6; JIA S, 1990, METABOLISM, V39, P155; KHOUW AS, 1993, J LIPID RES, V34, P1483; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; LE NA, 1988, METABOLISM, V37, P614, DOI 10.1016/0026-0495(88)90077-7; LI WH, 1988, J LIPID RES, V29, P245; LIJNEN HR, 1981, THROMB RES, V24, P151, DOI 10.1016/0049-3848(81)90040-2; LINS L, 1993, BIOCHIM BIOPHYS ACTA, V1151, P137, DOI 10.1016/0005-2736(93)90096-I; LIU JN, 1993, BLOOD, V81, P980; MALLORY JB, 1987, J BIOL CHEM, V262, P4241; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; MINNICH A, 1992, J BIOL CHEM, V267, P16553; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; MORRIS BJ, 1992, J HYPERTENS, V10, P209, DOI 10.1097/00004872-199203000-00002; MORRISON J, 1991, J BIOL CHEM, V266, P18780; MORRISON JR, 1992, J BIOL CHEM, V267, P13205; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; ORAM JF, 1990, ATHEROSCLER REV, V20, P103; OSBORNE JC, 1984, J BIOL CHEM, V259, P347; PAN TC, 1987, EUR J BIOCHEM, V170, P99, DOI 10.1111/j.1432-1033.1987.tb13672.x; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; RADER DJ, 1992, J LIPID RES, V33, P755; REMALEY AT, 1993, J BIOL CHEM, V268, P6785; RIEGER KJ, 1993, BIOCHEM J, V296, P373, DOI 10.1042/bj2960373; ROMA P, 1993, J CLIN INVEST, V91, P1445, DOI 10.1172/JCI116349; SAKU K, 1993, BIOCHIM BIOPHYS ACTA, V1167, P257, DOI 10.1016/0005-2760(93)90227-Z; SAKU K, 1984, METABOLISM, V33, P432, DOI 10.1016/0026-0495(84)90143-4; SCANU AM, 1987, ATHEROSCLER REV, V16, P9; SCHAEFER EJ, 1982, ARTERIOSCLEROSIS, V2, P16, DOI 10.1161/01.ATV.2.1.16; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1992, J LIPID RES, V33, P141; SHORE VG, 1978, BIOCHIM BIOPHYS ACTA, V529, P319, DOI 10.1016/0005-2760(78)90075-9; Skidgel R A, 1992, Agents Actions Suppl, V38 ( Pt 1), P359; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SWANEY JB, 1993, J LIPID RES, V24, P245; VADIVELOO PK, 1993, BIOCHEMISTRY-US, V32, P9480, DOI 10.1021/bi00087a028; WARD PE, 1991, BIOCHEM PHARMACOL, V42, P721, DOI 10.1016/0006-2952(91)90028-4; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; ZANNIS VI, 1983, P NATL ACAD SCI-BIOL, V80, P2574, DOI 10.1073/pnas.80.9.2574	75	65	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5469	5475		10.1074/jbc.270.10.5469	http://dx.doi.org/10.1074/jbc.270.10.5469			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890663	hybrid			2022-12-27	WOS:A1995QL58000079
J	NAUSEEF, WM; MCCORMICK, SJ; CLARK, RA				NAUSEEF, WM; MCCORMICK, SJ; CLARK, RA			CALRETICULIN FUNCTIONS AS A MOLECULAR CHAPERONE IN THE BIOSYNTHESIS OF MYELOPEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA HL-60 CELLS; ENDOPLASMIC-RETICULUM MEMBRANE; INTRACELLULAR-TRANSPORT; PROTEIN; CALNEXIN; INDUCTION; HEME; FIBROBLASTS; DEFICIENCY; MATURATION	Myeloperoxidase (MPO), a lysosomal heme protein found exclusively in neutrophils and monocytes, is necessary for-efficient oxygen-dependent microbicidal activity. Acquisition of heme by the heme-free MPO precursor apopro-MPO appears to be a prerequisite for its subsequent proteolytic processing and advancement along the biosynthetic pathway to mature MPO. We present data indicating that calreticulin (CRT), a high capacity calcium-binding protein residing in the lumen of the endoplasmic reticulum of a wide variety of cells, interacts specifically with fully glycosylated apopro-MPO. Biosynthetically radiolabelled CRT (60 kDa) and apopro-MPO (90 kDa) were coprecipitated from PLB 985 cells by monospecific antiserum against CRT when the immunoprecipitations were performed either under nondenaturing conditions or following reversible crosslinking, Nonglycosylated MPO precursors synthesized in the presence of tunicamycin did not interact with CRT, The CRT-apopro-MPO interaction was restricted to an early phase of MPO biosynthesis, and CRT did not interact with the later appearing, heme containing species of MPO, i.e, pro-MPO or the heavy subunit of mature MPO. These data show that CRT participates in the post-translational processing of MPO, perhaps by maintaining apopro-MPO in a conformation competent to accommodate insertion of the heme group, In this general way, CRT shares certain functional properties with the structurally homologous transmembrane calcium-binding endoplasmic reticulum protein calnexin, Both interact with glycosylated biosynthetic precursors of proteins selectively expressed in specialized cells.	VET ADM MED CTR,DEPT MED,IOWA CITY,IA 52242	US Department of Veterans Affairs; Veterans Health Administration (VHA)	NAUSEEF, WM (corresponding author), UNIV IOWA,COLL MED,DEPT MED,200 HAWKINS DR,IOWA CITY,IA 52242, USA.		Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Nauseef, William/0000-0003-4032-757X	BLRD VA [I01 BX000513] Funding Source: Medline; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	BLRD VA; Veterans Affairs(US Department of Veterans Affairs)		AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; AKIN DT, 1987, ARCH BIOCHEM BIOPHYS, V255, P428, DOI 10.1016/0003-9861(87)90411-5; AKIN DT, 1987, ARCH BIOCHEM BIOPHYS, V257, P451, DOI 10.1016/0003-9861(87)90590-X; AKIN DT, 1986, J BIOL CHEM, V261, P8370; ARNLJOTS K, 1987, J BIOL CHEM, V262, P10430; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CASTANEDA VL, 1992, EXP HEMATOL, V20, P916; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DENNING GM, 1993, MOL BIOL CELL, V4, P135; DINAUER MC, 1992, ANNU REV MED, V43, P117, DOI 10.1146/annurev.med.43.1.117; DUPUIS M, 1993, J EXP MED, V177, P1, DOI 10.1084/jem.177.1.1; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Ezekowitz R A, 1992, Curr Top Microbiol Immunol, V181, P283; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GUAN SH, 1991, BIOCHEMISTRY-US, V30, P9892, DOI 10.1021/bi00105a012; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUR SJ, 1989, J BIOL CHEM, V264, P8542; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Johnson K. R., 1991, PEROXIDASES CHEM BIO, P63; Kelley William L., 1992, Current Opinion in Cell Biology, V4, P984, DOI 10.1016/0955-0674(92)90130-5; Klebanoff S. J, 1991, PEROXIDASES CHEM BIO, V1, P1; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; KOEFFLER HP, 1985, BLOOD, V65, P484; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LENTER M, 1994, J BIOL CHEM, V269, P12263; MARGOLESE L, 1993, J BIOL CHEM, V268, P17959; MCCAULIFFE DP, 1992, J BIOL CHEM, V267, P2557; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; NAUSEEF W M, 1990, Hematologic Pathology, V4, P165; NAUSEEF WM, 1986, BLOOD, V67, P865; NAUSEEF WM, 1983, J CLIN INVEST, V71, P1297, DOI 10.1172/JCI110880; NAUSEEF WM, 1990, BLOOD, V76, P2622; NAUSEEF WM, 1987, BLOOD, V70, P1143; NAUSEEF WM, 1992, BLOOD, V80, P2622; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; OFARRELL PH, 1977, J BIOL CHEM, V250, P4007; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; OLSSON I, 1984, BIOCHEM J, V223, P911, DOI 10.1042/bj2230911; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PINNIX IB, 1994, ARCH BIOCHEM BIOPHYS, V312, P447, DOI 10.1006/abbi.1994.1331; POUYSSEGUR J, 1977, CELL, V11, P941, DOI 10.1016/0092-8674(77)90305-1; SARGAN DR, 1986, BIOCHEMISTRY-US, V25, P6252, DOI 10.1021/bi00368a062; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; STROMBERG K, 1986, EUR J CELL BIOL, V39, P424; TAYLOR KL, 1990, BIOCHEMISTRY-US, V29, P1533, DOI 10.1021/bi00458a026; WADA I, 1994, J BIOL CHEM, V269, P7464; WADA I, 1991, J BIOL CHEM, V266, P19599; YAMADA M, 1982, J BIOL CHEM, V257, P5980; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	62	226	228	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4741	4747		10.1074/jbc.270.9.4741	http://dx.doi.org/10.1074/jbc.270.9.4741			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876246	hybrid			2022-12-27	WOS:A1995QK08400082
J	DONATH, MJSH; LENTING, PJ; VANMOURIK, JA; MERTENS, K				DONATH, MJSH; LENTING, PJ; VANMOURIK, JA; MERTENS, K			THE ROLE OF CLEAVAGE OF THE LIGHT-CHAIN AT POSITIONS ARG(1689) OR ARG(1721) IN SUBUNIT INTERACTION AND ACTIVATION OF HUMAN BLOOD-COAGULATION FACTOR-VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FACTOR-VIII; VON-WILLEBRAND FACTOR; SEVERE HEMOPHILIA-A; VONWILLEBRAND-FACTOR; FACTOR-XA; MONOCLONAL-ANTIBODIES; BIOLOGICAL-ACTIVITY; FACTOR-IXA; PROTEIN-C; FACTOR-VA	The role of Factor VIII Light chain cleavage in Factor VIII activation and subunit interaction was investigated. Purified Factor VIII was dissociated into its separate subunits, and the isolated light chain was cleaved by thrombin at position Arg(1689) or by Factor Xa at position Arg(1721). These Factor VIII light chain derivatives then were used for reconstitution with purified Factor VIII heavy chain to obtain heterodimers that were exclusively cleaved within the Light chain, Intact and cleaved light chain could effectively be reassociated with heavy chain, with concomitant regain of Factor VIII cofactor function. The association rate constant of Factor Xa-cleaved light chain was found to be 3-fold lower than that of thrombin-cleaved or intact light chain, suggesting a role of the region Ser(1690)-Arg(1721) in subunit assembly. Dissociation rate constants, however, were independent of Factor VIII light chain cleavage. Low ionic strength was observed to promote association but to destabilize the Factor VIII heterodimer. At high ionic strength, Factor VIII dissociation was extremely slow (k(off) approximate to 10(-5) s(-1)) for all Factor VIII light chain derivatives, indicating that Factor VIII light chain cleavage is not related to Factor VIII dissociation. Furthermore, Factor VIII light chain cleavage does not affect enzyme-cofactor assembly, since the various light chain derivatives proved equally efficient in binding to Factor IXa (K-d approximate to 15 nM). Studies in a purified Factor X-activating system demonstrated that thrombin and Factor Xa activate Factor VIII to the same extent. However, Factor Xa differed from thrombin in that it cleaved at Arg(1721) rather than at Arg(1689). Reassociated heterodimers of Factor VIII heavy chain and intact light chain did not promote Factor X activation. In contrast, heterodimers that contained cleaved light chain exhibited substantial Factor VIIIa activity. These data demonstrate that a single cleavage at either Arg(1689) or Arg(1721) converts the inactive Factor VIII heterodimer into an active cofactor of Factor IXa.	NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT BLOOD COAGULAT,1066 CX AMSTERDAM,NETHERLANDS				Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429				ALY AM, 1992, J CLIN INVEST, V89, P1382, DOI 10.1172/JCI115726; ANDERSSON LO, 1986, P NATL ACAD SCI USA, V83, P2979, DOI 10.1073/pnas.83.9.2979; ARAI M, 1990, BLOOD, V75, P384; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; EATON DL, 1987, J BIOL CHEM, V262, P3285; ESMON CT, 1979, J BIOL CHEM, V254, P964; FAY PJ, 1993, J BIOL CHEM, V268, P17861; FAY PJ, 1993, THROMB HAEMOSTASIS, V70, P63; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; FAY PJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P525, DOI 10.1016/0003-9861(88)90404-3; FESS DN, 1982, BLOOD, V59, P594; GILBERT GE, 1990, J BIOL CHEM, V265, P815; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; JOHNSON DJD, 1994, THROMB HAEMOSTASIS, V71, P428; KAUFMAN RJ, 1992, ANNU REV MED, V43, P325, DOI 10.1146/annurev.med.43.1.325; KOEDAM JA, 1990, EUR J BIOCHEM, V189, P229, DOI 10.1111/j.1432-1033.1990.tb15481.x; KRISHNASWAMY S, 1989, J BIOL CHEM, V264, P3160; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LEYTE A, 1989, BIOCHEM J, V257, P679, DOI 10.1042/bj2570679; LEYTE A, 1991, J BIOL CHEM, V266, P740; LEYTE A, 1989, BIOCHEM J, V263, P187, DOI 10.1042/bj2630187; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1985, BIOCHEMISTRY-US, V24, P8056, DOI 10.1021/bi00348a033; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MAHLER HR, 1967, BIOL CHEM, P220; MANN KG, 1990, BLOOD, V76, P1; MCDONALD M, 1991, THROMB HAEMOSTASIS, V65, P943; MERTENS K, 1984, BIOCHEM J, V223, P607, DOI 10.1042/bj2230607; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; MERTENS K, 1993, BRIT J HAEMATOL, V85, P133, DOI 10.1111/j.1365-2141.1993.tb08656.x; MERTENS K, 1984, BIOCHEM J, V223, P559; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NEUENSCHWANDER P, 1990, ANAL BIOCHEM, V184, P347, DOI 10.1016/0003-2697(90)90692-3; NORDFANG O, 1988, J BIOL CHEM, V263, P1115; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; OBRIEN DP, 1989, BLOOD, V73, P2117; OBRIEN DP, 1990, BLOOD, V75, P1664; PITTMAN DD, 1989, THROMB HAEMOSTASIS, V61, P161; PITTMAN DD, 1988, P NATL ACAD SCI USA, V85, P2429, DOI 10.1073/pnas.85.8.2429; STEL HV, 1984, BLOOD, V63, P1408; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALKER FJ, 1992, J BIOL CHEM, V267, P19896	49	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3648	3655		10.1074/jbc.270.8.3648	http://dx.doi.org/10.1074/jbc.270.8.3648			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876103	hybrid			2022-12-27	WOS:A1995QH68800031
J	DONG, BH; SILVERMAN, RH				DONG, BH; SILVERMAN, RH			2-5A-DEPENDENT RNASE MOLECULES DIMERIZE DURING ACTIVATION BY 2-5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE EXPRESSION; PROTEIN-SYNTHESIS; CROSS-LINKING; INTERFERON; ENDORIBONUCLEASE; ENZYME	2-5A-dependent RNase is an interferon-inducible enzyme that requires 5'-phosphorylated, 2',5'-linked oligoadenylates (2-5A) for its endoribonuclease activity against single-stranded RNAs. We demonstrate here that recombinant, human 2-5A-dependent RNase forms stable homodimers during its stimulation by 2-5A. The protein dimers were observed to form only upon binding to 2-5A, as shown using gel filtration chromatography and chemical cross-linking and after centrifugation in glycerol gradients. A monoclonal antibody to 2-5A-dependent RNase was prepared and used to probe the subunit structure of the enzyme in the presence or absence of 2-5A Using oligoadenylates of different length, structure, and 5'-phosphorylation states we determined that conversion of 2-5A-dependent RNase from its monomeric, inactive form to its homodimeric, active form required the presence of functional 2-5A These results demonstrate that the catalytically active form of 2-5A-dependent RNase is a homodimer.	CLEVELAND CLIN FDN,RES INST,DEPT CANC BIOL,CLEVELAND,OH 44195	Cleveland Clinic Foundation					NATIONAL CANCER INSTITUTE [R01CA044059] Funding Source: NIH RePORTER; NCI NIH HHS [5R01 CA44059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAYARD B, 1994, EUR J BIOCHEM, V223, P403, DOI 10.1111/j.1432-1033.1994.tb19007.x; BISBAL C, 1989, EUR J BIOCHEM, V179, P595, DOI 10.1111/j.1432-1033.1989.tb14588.x; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; DONG BH, 1994, J BIOL CHEM, V269, P14153; FLOYDSMITH G, 1986, METHOD ENZYMOL, V119, P489; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; NILSEN TW, 1981, J BIOL CHEM, V256, P751; REVEL M, 1979, REGULATION MACROMOLE, P341; RYSIECKI G, 1989, J INTERFERON RES, V9, P649, DOI 10.1089/jir.1989.9.649; SALEHZADA T, 1993, J BIOL CHEM, V268, P7733; SILVERMAN RH, 1985, ANAL BIOCHEM, V144, P450, DOI 10.1016/0003-2697(85)90141-1; SLATTERY E, 1979, P NATL ACAD SCI USA, V76, P4778, DOI 10.1073/pnas.76.10.4778; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	17	218	224	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4133	4137		10.1074/jbc.270.8.4133	http://dx.doi.org/10.1074/jbc.270.8.4133			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876164	hybrid			2022-12-27	WOS:A1995QH68800098
J	TSEN, G; HALFTER, W; KROGER, S; COLE, GJ				TSEN, G; HALFTER, W; KROGER, S; COLE, GJ			AGRIN IS A HEPARAN-SULFATE PROTEOGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; N-CAM; ACETYLCHOLINE-RECEPTOR; ORGANIZING PROTEIN; NEURITE OUTGROWTH; SKELETAL-MUSCLES; BINDING DOMAIN; GLYCOSAMINOGLYCANS; IDENTIFICATION; DEPENDS	In the present study we have identified the extracellular matrix protein agrin as a major heparan sulfate proteoglycan (HSPG) in embryonic chick brain. Using monoclonal antibodies and a polyclonal antiserum to the core protein of a previously identified HSPG from embryonic chick brain, our expression screened a random-primed E9 chick brain cDNA library. Twelve cDNAs were isolated that were shown to be identical to the chick extracellular matrix protein agrin. Western blot analysis and immunocytochemistry confirmed that agrin is a HSPG that is identical with the HSPG from embryonic chick brain. A polyclonal antiserum to recombinant agrin protein recognized agrin as a diffuse band of over 400 kDa in extracts from brain and vitreous humor. The agrin immunoreactivity on the blot was shifted to a defined band of approximately 250 kDa after treatment of the samples with heparitinase or nitrous acid, and this banding pattern was indistinguishable from immunoreactivity obtained with antibodies to the brain HSPG. We also show that agrin binds tightly to anion exchange beads, indicating that the molecule is highly negatively charged which is a hallmark of all proteoglycans. Furthermore, the agrin antiserum recognizes the affinity purified HSPG from chick brain and vitreous humor. Immunocytochemistry demonstrated that agrin is expressed in developing brain, and is especially abundant in developing axonal tracts, in a distribution identical to the staining of the brain HSPG with monoclonal antibodies. We also show that the anti-HSPG antibodies stain the synaptic site of the neuromuscular junction, in agreement with agrin expression. Thus, our studies demonstrate that chick agrin is a HSPG that is prominent in the embryonic chick brain. Since previous studies hom our laboratories have shown that this proteoglycan interacts with neural cell adhesion molecule, our studies raise the interesting possibility that neural cell adhesion molecule and agrin are interactive partners that may regulate a variety of cell adhesion processes during neural development, including synaptogenesis.	OHIO STATE UNIV,CTR NEUROBIOTECHNOL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT ANAT CELL BIOL & NEUROBIOL,COLUMBUS,OH 43210; UNIV PITTSBURGH,DEPT NEUROBIOL,PITTSBURGH,PA 15261; MAX PLANCK INST BRAIN RES,DEPT NEUROANAT,D-60528 FRANKFURT,GERMANY	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Max Planck Society				Kroger, Stephan/0000-0002-4626-1690	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029934] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29934] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BURG M, 1990, ARCH BIOCHEM BIOPHYS, V276, P396, DOI 10.1016/0003-9861(90)90738-K; BURG MA, 1994, J NEUROBIOL, V25, P1, DOI 10.1002/neu.480250102; BURG MA, 1995, IN PRESS J NEUROSCI; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CASTELLOT JJ, 1986, J CELL BIOL, V102, P1979, DOI 10.1083/jcb.102.5.1979; COHEN MW, 1994, J NEUROSCI, V14, P3293; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; COLE GJ, 1985, J CELL BIOL, V100, P1192, DOI 10.1083/jcb.100.4.1192; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; COLE GJ, 1986, J CELL BIOL, V99, P1605; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GORDON H, 1993, J NEUROSCI, V13, P586; HAGEN SG, 1993, J BIOL CHEM, V268, P7261; HALFTER W, 1993, J NEUROSCI, V13, P2863; HANTAZAMBROISE D, 1987, J NEUROSCI, V7, P2293; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; HOCH W, 1994, J CELL BIOL, V126, P1, DOI 10.1083/jcb.126.1.1; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KALLAPUR SG, 1992, J NEUROSCI RES, V33, P538, DOI 10.1002/jnr.490330406; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; MA E, 1994, J NEUROSCI, V14, P2943; MA JY, 1993, J BIOL CHEM, V268, P25108; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; PERKINS SJ, 1989, J MOL BIOL, V206, P737, DOI 10.1016/0022-2836(89)90580-9; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; REYES AA, 1990, CELL REGUL, V1, P567, DOI 10.1091/mbc.1.8.567; RIOPELLE RJ, 1990, BRAIN RES, V525, P92, DOI 10.1016/0006-8993(90)91324-A; ROGERS SL, 1985, J NEUROSCI, V5, P369; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUBERT D, 1985, J CELL BIOL, V101, P1071, DOI 10.1083/jcb.101.3.1071; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1990, J NEUROSCI, V10, P3576	51	231	235	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3392	3399		10.1074/jbc.270.7.3392	http://dx.doi.org/10.1074/jbc.270.7.3392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852425	hybrid			2022-12-27	WOS:A1995QG47100075
J	BAO, J; CHEUNG, WY; WU, JY				BAO, J; CHEUNG, WY; WU, JY			BRAIN L-GLUTAMATE DECARBOXYLASE - INHIBITION BY PHOSPHORYLATION AND ACTIVATION BY DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; RAT-BRAIN; TRYPTOPHAN-HYDROXYLASE; TYROSINE-HYDROXYLASE; ACID DECARBOXYLASE; OKADAIC ACID; PHOSPHATASES; CALMODULIN; EXPRESSION	Previously we showed that the activity of the gamma-aminobutyric acid-synthesizing enzyme L-glutamate decarboxylase (GAD) in crude brain extract is inhibited by ATP and protein phosphatase inhibitors. We suggested that GAD activity is regulated by protein phosphorylation. In this paper we further present evidence to support our hypothesis that protein kinase A and calcineurin may be involved in regulation of GAD activity through phosphorylation and dephosphorylation of GAD, respectively. In addition, the effect of neuronal stimulation on GAD activity in cultured neurons is also included. A model to link neuronal excitation and activation of GAD by Ca2+ dependent phosphatase is proposed.	UNIV KANSAS, DEPT PHYSIOL & CELL BIOL, LAWRENCE, KS 66045 USA; ACAD SINICA, INST BIOMED SCI, TAIPEI 11529, TAIWAN	University of Kansas; Academia Sinica - Taiwan			WU, JANG-YEN/I-6424-2013		NINDS NIH HHS [NS 20978, NS 20922] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020978, R01NS020922] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMES MM, 1978, J BIOL CHEM, V253, P27; ARIAS C, 1992, J NEUROCHEM, V58, P369, DOI 10.1111/j.1471-4159.1992.tb09320.x; Bao Jun, 1994, Journal of Biomedical Science, V1, P237, DOI 10.1007/BF02253308; BENSON DL, 1991, J NEUROSCI, V11, P1540; BLUMP, 1991, MOVEMENT DISORD, V6, P12; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; EHRET M, 1989, J NEUROCHEM, V52, P1886, DOI 10.1111/j.1471-4159.1989.tb07272.x; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HARRIS KA, 1993, ANN NEUROL, V33, P77, DOI 10.1002/ana.410330113; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; HORNYKIEWICZ O, 1976, GABA NERVOUS SYSTEM, P479; HUBBARD MJ, 1991, MOL NEUROBIOL, P135; JONES EG, 1994, J NEUROSCI, V14, P611; KRAVITZ EA, 1967, NEUROSCIENCES, P433; KUHN DM, 1980, P NATL ACAD SCI-BIOL, V77, P4688, DOI 10.1073/pnas.77.8.4688; LEE YH, 1994, J NEUROCHEM, V62, P2325; McGeer P.L., 1976, GABA NERVOUS SYSTEM, P487; MILLER LP, 1977, NATURE, V266, P847, DOI 10.1038/266847a0; MILLER LP, 1979, J NEUROCHEM, V33, P533, DOI 10.1111/j.1471-4159.1979.tb05185.x; OGITA K, 1991, METHOD ENZYMOL, V200, P228; Roberts E, 1975, NERVOUS SYSTEM, V1, P541; ROBERTS EUGENE, 1968, BRAIN RES, V8, P1, DOI 10.1016/0006-8993(68)90170-4; SCHMIDT BM, 1993, J NEUROCHEM, V61, P1774, DOI 10.1111/j.1471-4159.1993.tb09815.x; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SHERMAN AD, 1991, NEUROSCI LETT, V121, P77, DOI 10.1016/0304-3940(91)90653-B; TOWER DB, 1976, GABA NERVOUS SYSTEM, P461; WU JY, 1990, NEUROCHEM INT, V17, P449, DOI 10.1016/0197-0186(90)90027-Q; WU JY, 1976, GABA NERVOUS SYSTEM, P7	30	64	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6464	6467		10.1074/jbc.270.12.6464	http://dx.doi.org/10.1074/jbc.270.12.6464			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896780	hybrid			2022-12-27	WOS:A1995QQ85500009
J	BOWRY, VW; MOHR, D; CLEARY, J; STOCKER, R				BOWRY, VW; MOHR, D; CLEARY, J; STOCKER, R			PREVENTION OF TOCOPHEROL-MEDIATED PEROXIDATION IN UBIQUINOL-10-FREE HUMAN LOW-DENSITY-LIPOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BLOOD-PLASMA; HERITABLE HYPERLIPIDEMIC RABBITS; VITAMIN-E CONSUMPTION; ANTIOXIDANT ACTIVITY; ALPHA-TOCOPHEROL; LIPID-PEROXIDATION; INITIATED OXIDATION; FREE-RADICALS; DEGRADATION; PROBUCOL	Oxidation of low density lipoprotein (LDL) may be involved in the development of atherosclerosis. It has recently been shown that alpha-tocopherol (alpha TOH) can act either as an antioxidant or prooxidant for isolated low density lipoprotein (LDL), In the absence of an effective co-antioxidant, alpha-TOH is a prooxidant and this activity is evidently due to reaction of the alpha-tocopheroxyl radical (alpha-TO.) with the LDL's polyunsaturated lipids (Bowry, V. B., and Stocker, R. (1993) J. Am. Chem. Sec. 115, 6029-6045). Herein we examined the effectiveness of selected natural and synthetic radical scavengers as co antioxidants for inhibiting peroxyl radical-induced peroxidation in LDL that is devoid of ubiquinol-10 (an effective endogenous co-antioxidant) hut still contains most of its natural complement of alpha-TOH. Various quinols, catechols, and aminophenols, as well as ascorbate, 6-palmityl ascorbate, and bilirubin, were very effective co-antioxidants under our test conditions, whereas ordinary phenolic antioxidants, including short-tailed alpha-TOH homologues, were less effective, Reduced glutathione, urate, and Probucol were ineffective. These findings confirm that the prooxidant activity of alpha-TOH in LDL relies heavily on the segregation of water-insoluble radicals (particularly alpha-TO.) into individual LDL particles, since it was those compounds that are expected to either irreversibly reduce alpha-TO. or accelerate the diffusion of radicals between particles which most effectively inhibited the tocopherol-mediated phase of peroxidation. Theoretical and practical implications of these findings are discussed, as is their relevance to the ''LDL oxidation'' hypothesis of atherogenesis.	HEART RES INST,BIOCHEM GRP,SYDNEY,NSW 2050,AUSTRALIA	University of Sydney; Heart Research Institute			Stocker, Roland/AAV-4489-2021; Bowry, Vincent/Q-2111-2018	Bowry, Vincent/0000-0002-3462-4562				BARCLAY LRC, 1993, CAN J CHEM, V71, P1, DOI 10.1139/v93-001; BARCLAY LRC, 1988, J BIOL CHEM, V263, P16138; BARNHART RL, 1989, J LIPID RES, V30, P1703; BIELSKI BHJ, 1975, ANN NY ACAD SCI, V258, P231, DOI 10.1111/j.1749-6632.1975.tb29283.x; BISBY RH, 1991, FEBS LETT, V290, P205, DOI 10.1016/0014-5793(91)81260-F; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; BOWRY VW, 1992, BIOCHEM J, V288, P341, DOI 10.1042/bj2880341; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; BUETTNER GR, 1990, METHOD ENZYMOL, V186, P125; BURTON GW, 1986, ACCOUNTS CHEM RES, V19, P194, DOI 10.1021/ar00127a001; BURTON GW, 1981, J AM CHEM SOC, V103, P6472, DOI 10.1021/ja00411a035; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CHRISTEN S, 1994, J CLIN INVEST, V93, P2149, DOI 10.1172/JCI117211; CHRISTEN S, 1992, BIOCHEMISTRY-US, V31, P8090, DOI 10.1021/bi00149a045; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; DOBA T, 1985, BIOCHIM BIOPHYS ACTA, V835, P298, DOI 10.1016/0005-2760(85)90285-1; ESTERBAUER H, 1987, J LIPID RES, V28, P495; FOTI M, 1994, J AM CHEM SOC, V116, P9440, DOI 10.1021/ja00100a005; FREI B, 1991, AM J CLIN NUTR, V54, pS1113, DOI 10.1093/ajcn/54.6.1113s; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOTOH N, 1992, BIOCHIM BIOPHYS ACTA, V1128, P147, DOI 10.1016/0005-2760(92)90300-K; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; HEINECKE JW, 1987, FREE RADICAL BIO MED, V3, P65, DOI 10.1016/0891-5849(87)90040-2; HOFF HF, 1991, ARTERIOSCLER THROMB, V11, P1209, DOI 10.1161/01.ATV.11.5.1209; INGOLD KU, 1993, P NATL ACAD SCI USA, V90, P45, DOI 10.1073/pnas.90.1.45; MAO SJT, 1991, J MED CHEM, V34, P298, DOI 10.1021/jm00105a046; MOHR D, 1992, BIOCHIM BIOPHYS ACTA, V1126, P247, DOI 10.1016/0005-2760(92)90237-P; MOREL I, 1992, FREE RADICAL BIO MED, V13, P499, DOI 10.1016/0891-5849(92)90144-6; MUKAI K, 1991, J ORG CHEM, V56, P4188, DOI 10.1021/jo00013a021; NELAN DR, 1962, J AM CHEM SOC, V84, P2963, DOI 10.1021/ja00874a025; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; NIKI E, 1985, J BIOL CHEM, V260, P2191; NOGUCHI N, 1993, BIOCHIM BIOPHYS ACTA, V1168, P348; OBRIEN K, 1991, ARTERIOSCLER THROMB, V11, P751, DOI 10.1161/01.ATV.11.3.751; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; PRYOR WA, 1985, J ORG CHEM, V30, P281; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; ROGINSKY VA, 1993, CHEM PHYS LIPIDS, V65, P103, DOI 10.1016/0009-3084(93)90043-3; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; SPARROW CP, 1992, J CLIN INVEST, V89, P1885, DOI 10.1172/JCI115793; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; SUARNA C, 1991, LIPIDS, V26, P187, DOI 10.1007/BF02543969; TAKENAKA Y, 1991, ARCH BIOCHEM BIOPHYS, V285, P344, DOI 10.1016/0003-9861(91)90370-X; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	56	185	188	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5756	5763		10.1074/jbc.270.11.5756	http://dx.doi.org/10.1074/jbc.270.11.5756			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890704	hybrid			2022-12-27	WOS:A1995QM94500014
J	HOFFENBERG, S; SANFORD, JC; LIU, SB; DANIEL, DS; TUVIN, M; KNOLL, BJ; WESSLINGRESNICK, M; DICKEY, BF				HOFFENBERG, S; SANFORD, JC; LIU, SB; DANIEL, DS; TUVIN, M; KNOLL, BJ; WESSLINGRESNICK, M; DICKEY, BF			BIOCHEMICAL AND FUNCTIONAL-CHARACTERIZATION OF A RECOMBINANT GTPASE, RAB5, AND 2 OF ITS MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-BINDING; ESCHERICHIA-COLI; GERANYLGERANYL TRANSFERASE; FUSION INVITRO; GENE-PRODUCT; VESICULAR TRANSPORT; ACTIVATING PROTEIN; ENDOCYTIC PATHWAY; COMPONENT-A; GS-ALPHA	Biochemical, structural, and functional properties of Rab5 wild-type (WT) protein were compared with those of Q79L and N133I mutants. The detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate increased guanine nucleotide binding to RabB WT approximate to 10-fold. The single-step catalytic rate of RabB WT exceeded that of Q79L 12.2-fold, but the steady-state GTPase rate was only 2.8-fold greater because GDP dissociation was rate limiting and GDP dissociation was 3.6-fold slower than for Q79L. In contrast, dissociation rates of GTP were indistinguishable. Binding to RabB N133I was not detectable. GTP protected RabB WT and Q79L from any apparent proteolysis by trypsin. A 20-kDa fragment was the major product of digestion in the presence of GDP, and 12- and 8-kDa fragments were the major products in the absence of added guanine nucleotides. RabB N133I underwent no apparent proteolysis with 10 mM GTP or GDP, suggesting a ''triphosphate'' conformation may be induced in Rab5 N133I by either GTP or GDP. Partially geranylgeranylated Rab5 WT stimulated endosome fusion in vitro, whereas unmodified RabB WT did not. Processed RabB Q79L failed to inhibit endosome fusion, and RabB N133I could not be geranylgeranylated. These findings identify biochemical and structural features of RabB proteins, providing data for the interpretation of functional assays.	BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115	Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	HOFFENBERG, S (corresponding author), VET ADM MED CTR,DIV PULM & CRIT CARE MED,BLDG 109,RM 106,2002 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NHLBI NIH HHS [HL43161] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURSTEIN ES, 1992, BIOCHEM J, V282, P387, DOI 10.1042/bj2820387; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; CLANTON DJ, 1986, P NATL ACAD SCI USA, V83, P5076, DOI 10.1073/pnas.83.14.5076; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DEXTER D, 1990, J IMMUNOL, V145, P1845; DICKEY BF, 1993, GTPASES BIOL; FERSHT A, 1984, ENZYME STRUCTURE MEC, P117; GOFFENBERG SI, 1990, BIOCHEMISTRY-MOSCOW+, V55, P653; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRAND RJA, 1989, FEBS LETT, V256, P281; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HALL A, 1986, J BIOL CHEM, V261, P963; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; JOHN J, 1989, J BIOL CHEM, V264, P13086; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KHOSRAVIFAR R, 1992, J BIOL CHEM, V267, P24363; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LI GP, 1993, J BIOL CHEM, V268, P24475; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MAYORGA LS, 1989, SCIENCE, V244, P1475, DOI 10.1126/science.2499930; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NAGATA KI, 1992, J BIOL CHEM, V267, P19600; NEAL SE, 1988, J BIOL CHEM, V263, P19718; NEWMAN CMH, 1992, J BIOL CHEM, V267, P11329; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; POE M, 1985, J BIOL CHEM, V260, P3906; SANFORD JC, 1993, J BIOL CHEM, V268, P23773; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925; STEELEMORTIMER O, 1994, EMBO J, V13, P34, DOI 10.1002/j.1460-2075.1994.tb06232.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; WESSLINGRESNICK M, 1990, J BIOL CHEM, V265, P16751; WESSLINGRESNICK M, 1990, J BIOL CHEM, V265, P690; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; YANG C, 1993, EUR J BIOCHEM, V217, P1027, DOI 10.1111/j.1432-1033.1993.tb18334.x; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	58	53	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5048	5056		10.1074/jbc.270.10.5048	http://dx.doi.org/10.1074/jbc.270.10.5048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890612	hybrid			2022-12-27	WOS:A1995QL58000018
J	STANLEY, MJ; LIEBERSBACH, BF; LIU, W; ANHALT, DJ; SANDERSON, RD				STANLEY, MJ; LIEBERSBACH, BF; LIU, W; ANHALT, DJ; SANDERSON, RD			HEPARAN SULFATE-MEDIATED CELL-AGGREGATION - SYNDECAN-1 AND SYNDECAN-4 MEDIATE INTERCELLULAR-ADHESION FOLLOWING THEIR TRANSFECTION INTO HUMAN B-LYMPHOID-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL MESENCHYMAL INTERACTIONS; INTEGRAL MEMBRANE PROTEOGLYCAN; EMBRYONIC TOOTH MESENCHYME; SURFACE PROTEOGLYCAN; TRANSIENT EXPRESSION; I COLLAGEN; L-SELECTIN; N-CAM; RECEPTOR; BETAGLYCAN	Because syndecans are present at sites of cell-cell contact in vivo it has been hypothesized that they play a role in mediating cell-cell adhesion. However, there has been no direct evidence to support this notion. To address this question, B lymphoid (ARH-77) cells were transfected with the cDNA for murine syndecan-1. Unlike the parental cells, the transfectants form large multicellular aggregates in suspension cultures and stain intensely for syndecan-1 at sites of cell-cell contact. Using rotation-mediated aggregation assays, we find that aggregation of syndecan-1-transfected cells is dependent on divalent cations and is inhibited by the following: (i) addition of heparin and heparin-like glycosaminoglycans, (ii) removal of heparan sulfate from the cell surface, or (iii) addition of exogenous purified syndecan-1. Mixing of syndecan-1-transfected and control-transfected cells results in aggregates containing both cell types indicating that aggregation occurs through a heterophilic adhesion mechanism in which heparan sulfate chains bind to a counter-receptor present on these cells. Importantly, syndecan 4-transfected cells also aggregate in a heparan sulfate dependent manner, while in contrast, betaglycan-transfected cells aggregate poorly, Thus, syndecans may be important mediators of cell-cell adhesion, but this function may not be common to all transmembrane heparan sulfate-bearing proteoglycans.	UNIV ARKANSAS MED SCI HOSP, DEPT PATHOL, LITTLE ROCK, AR 72205 USA; UNIV ARKANSAS MED SCI HOSP, DEPT ANAT, LITTLE ROCK, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences					NATIONAL CANCER INSTITUTE [R29CA055879] Funding Source: NIH RePORTER; NCI NIH HHS [CA55879] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRES JL, 1991, J BIOL CHEM, V266, P23282; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BOUTIN EL, 1991, DEV BIOL, V148, P63, DOI 10.1016/0012-1606(91)90317-V; BURK KH, 1978, CANCER RES, V38, P2508; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; DAVID G, 1992, ADV EXP MED BIOL, V313, P69; DAVID G, 1993, DEVELOPMENT, V119, P841; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; DRACH J, 1991, CLIN EXP IMMUNOL, V83, P418; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRANSSON LA, 1983, J BIOL CHEM, V258, P4342; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GOULD SE, 1992, P NATL ACAD SCI USA, V89, P3271, DOI 10.1073/pnas.89.8.3271; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HORAN PK, 1991, MET CELL BIOL, V33, P469; INKI P, 1992, LAB INVEST, V66, P314; INKI P, 1994, EUR J CELL BIOL, V63, P43; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; KATO M, 1994, J BIOL CHEM, V269, P18881; KODA JE, 1985, J BIOL CHEM, V260, P8157; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; NELSON RM, 1993, BLOOD, V82, P3253; NORGARDSUMNICHT KE, 1993, SCIENCE, V261, P480, DOI 10.1126/science.7687382; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; REYES AA, 1990, CELL REGUL, V1, P567, DOI 10.1091/mbc.1.8.567; RIDLEY RC, 1993, BLOOD, V81, P767; ROHDE LH, 1993, J CELL PHYSIOL, V155, P185, DOI 10.1002/jcp.1041550124; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; SANDERSON RD, 1992, J INVEST DERMATOL, V99, P390, DOI 10.1111/1523-1747.ep12616103; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SOLURSH M, 1990, DEV BIOL, V140, P83, DOI 10.1016/0012-1606(90)90055-N; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; SUN XJ, 1989, J BIOL CHEM, V264, P11288; SUTHERLAND AE, 1991, DEVELOPMENT, V113, P339; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; THESLEFF I, 1988, DEV BIOL, V129, P565, DOI 10.1016/0012-1606(88)90401-0; TRAUTMAN MS, 1991, DEVELOPMENT, V111, P213; VAINIO S, 1989, J CELL BIOL, V108, P1945, DOI 10.1083/jcb.108.5.1945; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; VAINIO S, 1992, DEV BIOL, V152, P221, DOI 10.1016/0012-1606(92)90130-9; VANCAMP B, 1990, BLOOD, V76, P377	56	112	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5077	5083		10.1074/jbc.270.10.5077	http://dx.doi.org/10.1074/jbc.270.10.5077			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890615	hybrid			2022-12-27	WOS:A1995QL58000022
J	ZHANG, XP; COLLINS, KI; GREENBERGER, LM				ZHANG, XP; COLLINS, KI; GREENBERGER, LM			FUNCTIONAL EVIDENCE THAT TRANSMEMBRANE-12 AND THE LOOP BETWEEN TRANSMEMBRANE-11 AND TRANSMEMBRANE-12 FORM PART OF THE DRUG-BINDING DOMAIN IN P-GLYCOPROTEIN ENCODED BY MDR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT HUMAN-CELLS; MULTIDRUG-RESISTANCE; CHLORIDE CHANNEL; MELANOMA-CELLS; GENE; EXPRESSION; VINBLASTINE; COLCHICINE; MUTATIONS; PROTEINS	Human MDR1 encodes an ATP-binding cassette transporter, beta-glycoprotein, that mediates multiple drug resistance (MDR) to antitumor agents. It has been previously shown that photoaffinity drug-labeling sites reside within, or near, the last transmembrane loop of each cassette within beta-glycoprotein (transmembrane domains (TM) 5-6 and 11-12). A genetic approach was used to determine if the drug-labeling site in the second cassette contains functionally important amino acids. Since human MDR3 is 77% identical to MDR1 but does not mediate MDR, the region from TM10 to the C terminus of MDR1 was replaced with the corresponding sequences from MDR3. The resultant chimeric protein was expressed but not functional. By using progressively smaller replacements, we show that replacements limited to TM12 markedly impaired resistance to actinomycin D, vincristine, and doxorubicin, but not to colchicine. The phenotype was associated with an impaired ability to photoaffinity label the chimeric beta-glycoprotein with [I-125]iodoaryl azidoprazosin. In contrast, replacement of the loop between TM11 and 12 appears to create a more efficient drug pump for actinomycin D, colchicine, and doxorubicin, but not vincristine. These results suggest that, similar to voltage-gated ion channels, amino acids within and immediately N-terminal to the last transmembrane domain of beta-glycoprotein compose part of the drug-binding pocket and are in close proximity to photoaffinity drug-labeling domains.	AMER CYANAMID CO, LEDERLE LABS, ONCOL & IMMUNOL RES SECT, PEARL RIVER, NY 10965 USA									ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; AKRIGG A, 1985, VIRUS RES, V2, P107, DOI 10.1016/0168-1702(85)90242-4; ALTENBERG GA, 1994, J BIOL CHEM, V269, P7145; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ARCECI RJ, 1993, CANCER RES, V53, P310; ARCECI RJ, 1993, BLOOD, V81, P2215; BECK WT, 1992, BIOCHEM PHARMACOL, V43, P89, DOI 10.1016/0006-2952(92)90665-6; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; BUSCHMAN E, 1994, CANCER RES, V54, P4892; BUSCHMAN E, 1991, MOL CELL BIOL, V11, P595, DOI 10.1128/MCB.11.2.595; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; DEVINE SE, 1992, P NATL ACAD SCI USA, V89, P4564, DOI 10.1073/pnas.89.10.4564; EWART GD, 1994, J BIOL CHEM, V269, P10370; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; GLOSSMANN H, 1987, TRENDS PHARMACOL SCI, V8, P95, DOI 10.1016/0165-6147(87)90082-4; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GREENBERGER LM, 1994, TRENDS CARDIOVAS MED, V4, P193, DOI 10.1016/1050-1738(94)90057-4; GREENBERGER LM, 1990, J BIOL CHEM, V265, P4394; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; GREENBERGER LM, 1991, J BIOL CHEM, V266, P20744; GREENBERGER LM, 1994, ANTICANCER DRUG RESI, P69; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HSU SIH, 1989, J BIOL CHEM, V264, P12053; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; KAJIJI S, 1993, BIOCHEMISTRY-US, V32, P4185, DOI 10.1021/bi00067a005; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LINCKE CR, 1990, CANCER RES, V50, P1779; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1993, J BIOL CHEM, V268, P19965; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; LOTHSTEIN L, 1989, J BIOL CHEM, V264, P16054; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOORE RE, 1990, NUCLEIC ACIDS RES, V18, P1921, DOI 10.1093/nar/18.7.1921; MORRIS DI, 1994, MOL PHARMACOL, V46, P329; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; ROBINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538; ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003; RUETZ S, 1993, P NATL ACAD SCI USA, V90, P11588, DOI 10.1073/pnas.90.24.11588; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; RUETZ S, 1994, J BIOL CHEM, V269, P12277; SAFA AR, 1990, P NATL ACAD SCI USA, V87, P7225, DOI 10.1073/pnas.87.18.7225; SCHINKEL AH, 1991, CANCER RES, V51, P2628; SHEN DW, 1986, J BIOL CHEM, V261, P7762; SKACH WR, 1993, J BIOL CHEM, V268, P6903; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yang C. H., 1991, SYNERGISM ANTAGONISM, P311; ZANG XP, 1994, ONCOL RES, V6, P291; ZHANG JT, 1993, J BIOL CHEM, V268, P15101; ZHANG JT, 1993, BIOCHIM BIOPHYS ACTA, V1153, P191, DOI 10.1016/0005-2736(93)90405-O	64	92	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5441	5448		10.1074/jbc.270.10.5441	http://dx.doi.org/10.1074/jbc.270.10.5441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890659	hybrid			2022-12-27	WOS:A1995QL58000075
J	LU, HS; HARA, S; WONG, LWI; JONES, MD; KATTA, V; TRAIL, G; ZOU, AH; BRANKOW, D; COLE, S; HU, S; WEN, DZ				LU, HS; HARA, S; WONG, LWI; JONES, MD; KATTA, V; TRAIL, G; ZOU, AH; BRANKOW, D; COLE, S; HU, S; WEN, DZ			POSTTRANSLATIONAL PROCESSING OF MEMBRANE-ASSOCIATED NEU DIFFERENTIATION FACTOR PROISOFORMS EXPRESSED IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; C-ERBB-2 PROTEIN; RECEPTOR; LIGAND; HEREGULIN; ONCOGENE; TISSUES; PROTOONCOGENE; ACTIVATOR; BINDING	Expression vectors constructed from human and rat pro-neu differentiation factor (NDF) cDNAs were transfected in Chinese hamster ovary cells for expression of recombinant NDF molecules. Soluble NDF forms were released into culture medium after post-translational processing of the membrane-bound pro-NDF forms. Different human and rat NDF isoforms, after being purified from the culture medium, were subjected to structural and biochemical characterizations. The isolated human and rat NDF isoforms have been proteolytically processed at a specific site at the N terminus, which is different from that observed for the processing of rat or human MIF molecule prepared from natural origins. The processing of each recombinant NDF isoform at its C terminus was heterogeneous but consistently occurred at nearby peptide bonds. Specific N- and C-terminal processing by Chinese hamster ovary cells has resulted in the production of two types (alpha and beta) of recombinant NDFs containing 222-225 amino acid residues. Both human and rat NDF molecules are heavily glycosylated at two of the three potential Asn-linked glycosylation sites and contain O-linked sugars at 11 of the Thr/Ser sites. Glycosylation occurs at a short, Ser/Thr-rich spacer region that connects the N-terminal immunoglobulin homology unit to the epidermal growth factor domain. Cellular phosphorylation assay indicated that these secreted forms contain similar biological activity in receptor tyrosine autophosphorylation of mammary tumor cells.			LU, HS (corresponding author), AMGEN INC,AMGEN CTR,1840 DEHAVILLAND DR,THOUSAND OAKS,CA 91320, USA.			Jones, Michael/0000-0001-7541-7634				COHEN JA, 1992, J NEUROSCI RES, V31, P622, DOI 10.1002/jnr.490310406; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DOBASHI K, 1991, P NATL ACAD SCI USA, V88, P8582, DOI 10.1073/pnas.88.19.8582; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; HENRICKSON W, 1992, COLD SPRING HARB SYM, V57, P549; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUANG SS, 1992, J BIOL CHEM, V267, P11508; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; JONES MD, 1994, ANAL BIOCHEM, V216, P125; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; LOFTS FJ, 1992, BREAST CANCER CELLUL; LU HS, 1986, J CHROMATOGR, V368, P215, DOI 10.1016/S0021-9673(00)91065-3; LU HS, 1995, J BIOL CHEM, V270, P4784, DOI 10.1074/jbc.270.9.4784; LU HS, 1991, J BIOL CHEM, V266, P8102; LU HS, 1995, IN PRESS J CHROMATOG; LUPU R, 1992, P NATL ACAD SCI USA, V89, P2287, DOI 10.1073/pnas.89.6.2287; MAGUIRE HC, 1989, J INVEST DERMATOL, V92, P786, DOI 10.1111/1523-1747.ep12696796; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; MORI S, 1989, LAB INVEST, V61, P93; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NATALI PG, 1990, INT J CANCER, V45, P457, DOI 10.1002/ijc.2910450314; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PELES E, 1993, EMBO J, V12, P961, DOI 10.1002/j.1460-2075.1993.tb05737.x; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PRESS MF, 1990, ONCOGENE, V5, P953; QUIRKE P, 1989, BRIT J CANCER, V60, P64, DOI 10.1038/bjc.1989.221; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SCHACHTER AL, 1984, NATURE, V312, P513; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; THOMPSON SA, 1994, J BIOL CHEM, V269, P2541; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1991, BIOCHEMISTRY-US, V30, P3543, DOI 10.1021/bi00228a027	41	39	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4775	4783		10.1074/jbc.270.9.4775	http://dx.doi.org/10.1074/jbc.270.9.4775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876250	hybrid			2022-12-27	WOS:A1995QK08400086
J	WOLF, BA; WERTKIN, AM; JOLLY, YC; YASUDA, RP; WOLFE, BB; KONRAD, RJ; MANNING, D; RAVI, S; WILLIAMSON, JR; LEE, VMY				WOLF, BA; WERTKIN, AM; JOLLY, YC; YASUDA, RP; WOLFE, BB; KONRAD, RJ; MANNING, D; RAVI, S; WILLIAMSON, JR; LEE, VMY			MUSCARINIC REGULATION OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR PROTEIN SECRETION AND AMYLOID BETA-PROTEIN PRODUCTION IN HUMAN NEURONAL NT2N CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED PANCREATIC-ISLETS; PHOSPHOLIPASE-C; RAT-BRAIN; DIACYLGLYCEROL ACCUMULATION; INOSITOL TRISPHOSPHATE; CHOLINERGIC RECEPTORS; INSULIN-SECRETION; ARACHIDONIC-ACID; NTERA-2 CELLS; GLUCOSE	The Alzheimer amyloid precursor protein (APP) undergoes complex processing resulting in the production of a 4-kDa amyloid peptide (A beta) which has been implicated in the pathogenesis of Alzheimer's disease, Recent studies have shown that cells can secrete carboxyl ter minus truncated APP derivatives (APP-S) in response to physiological stimulus. We have used human central nervous system neurons (NT2N) derived from a teratocarcinoma cell line (NT2) to study the signal transduction pathways involved in APP-S secretion and AP production. Muscarinic receptors (m2 and m3) as well as the heterotrimeric GTP binding protein G(q) and the beta 1 isoform of phospholipase C were present in NT2N neurons, Stimulation of the muscarinic receptor with carbachol resulted in phospholipase C activation as shown by a transient increase in the second messengers 1,2-diacyl-sn-glycerol and inositol 1,4,5-trisphosphate. Carbachol also caused an increase in intracellular Ca2+ levels measured in single NT2N neurons, Under these conditions, carbachol caused a time-dependent a-fold increase in APP-S secretion into the medium, In contrast, prolonged treatment with carbachol caused a decrease in A beta production into the medium. These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway, Furthermore, activation of this pathway results in dissociation of APP-S secretion and A beta production.	UNIV PENN, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT BIOCHEM & BIOPHYS, PHILADELPHIA, PA 19104 USA; GEORGETOWN UNIV, SCH MED, DEPT PHARMACOL, WASHINGTON, DC 20007 USA	University of Pennsylvania; University of Pennsylvania; Georgetown University	WOLF, BA (corresponding author), UNIV PENN, SCH MED, DEPT PATHOL & LAB MED, 217 JOHN MORGAN, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE ON AGING [P01AG009973, P01AG011542, P30AG010124] Funding Source: NIH RePORTER; NIA NIH HHS [AG-09973, AG-10124, AG-11542] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOTHMER J, 1994, BBA-MOL BASIS DIS, V1225, P111, DOI 10.1016/0925-4439(94)90068-X; BRASS LF, 1993, THROMB HAEMOSTASIS, V70, P217; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; COCKCROFT S, 1992, BIOCHEM J, V288, P1; DYRKS T, 1994, FEBS LETT, V349, P210, DOI 10.1016/0014-5793(94)00671-7; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GAGNON AW, 1991, BLOOD, V78, P1247; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GREENAMYRE JT, 1993, CEREBROVAS BRAIN MET, V5, P61; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HANSEN CA, 1991, J BIOL CHEM, V266, P18573; Harden T. Kendall, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P11; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HOSEY MM, 1992, FASEB J, V6, P845, DOI 10.1096/fasebj.6.3.1740234; HULME EC, 1993, CELL SIGNAL, V5, P687, DOI 10.1016/0898-6568(93)90030-P; HUNG AY, 1993, J BIOL CHEM, V268, P22959; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; KONRAD RJ, 1992, BIOCHEM J, V287, P283, DOI 10.1042/bj2870283; KONRAD RJ, 1993, MOL CELL ENDOCRINOL, V92, P135, DOI 10.1016/0303-7207(93)90084-W; LAW SF, 1991, J BIOL CHEM, V266, P17885; LEWIS JM, 1991, CELL REGUL, V2, P1097, DOI 10.1091/mbc.2.12.1097; LI M, 1991, MOL PHARMACOL, V40, P28; LOUNSBURY KM, 1993, J BIOL CHEM, V268, P3494; MARX J, 1993, SCIENCE, V259, P457, DOI 10.1126/science.8424167; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Price DL, 1991, BRAIN PATHOL, V1, P287, DOI 10.1111/j.1750-3639.1991.tb00672.x; RHEE SG, 1991, METHOD ENZYMOL, V197, P502; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLACK BE, 1993, J BIOL CHEM, V268, P21097; SLOTKIN TA, 1994, J CLIN INVEST, V94, P696, DOI 10.1172/JCI117387; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; TURK J, 1986, BIOCHEM J, V237, P259, DOI 10.1042/bj2370259; WAHLESTEDT C, 1994, TRENDS PHARMACOL SCI, V15, P42, DOI 10.1016/0165-6147(94)90107-4; WALL SJ, 1991, MOL PHARMACOL, V40, P783; WALL SJ, 1991, MOL PHARMACOL, V39, P643; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WOLF BA, 1991, J CLIN INVEST, V87, P31, DOI 10.1172/JCI114988; WOLF BA, 1989, BIOCHEMISTRY-US, V28, P4291, DOI 10.1021/bi00436a026; WOLF BA, 1986, J BIOL CHEM, V261, P3501; WOLF BA, 1989, FEBS LETT, V248, P35, DOI 10.1016/0014-5793(89)80426-0; WOLF BA, 1988, J BIOL CHEM, V263, P3565; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; WURTMAN RJ, 1994, J CLIN INVEST, V94, P470, DOI 10.1172/JCI117356; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; YASUDA RP, 1993, MOL PHARMACOL, V43, P149	68	190	197	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4916	4922		10.1074/jbc.270.9.4916	http://dx.doi.org/10.1074/jbc.270.9.4916			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876266	hybrid			2022-12-27	WOS:A1995QK08400104
J	HATAKEYAMA, T; NAGATOMO, H; YAMASAKI, N				HATAKEYAMA, T; NAGATOMO, H; YAMASAKI, N			INTERACTION OF THE HEMOLYTIC LECTIN CEL-III FROM THE MARINE INVERTEBRATE CUCUMARIA-ECHINATA WITH THE ERYTHROCYTE-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HOLOTHURIA-POLII ECHINODERMATA; PORE-FORMING PROTEIN; CELOMIC FLUID; ANIMAL LECTINS; SEA-URCHIN; PURIFICATION; AFFINITY; RECOGNITION; STIMULATION	GEL-III is one of four Ca2+-dependent galactose/N-acetylgalactosamine (GalNAc)-binding lectins from the marine invertebrate Cucumaria echinata which exhibits hemolytic activity, especially toward rabbit and human erythrocytes. The hemolytic activity of GEL-III was also Ca2+-dependent and was found to be inhibited by galactose or GalNAc-containing carbohydrates, suggesting that the hemolysis was caused by GEL-III binding to specific carbohydrates on the erythrocyte membrane by Ca2+-dependent lectin activity, followed by partial destruction of the membrane. The activity of GEL-III was highest at 10 degrees C and decreased markedly with increasing temperature, unlike usual enzymatic reactions. The hemolytic activity of GEL-III increased with increasing pH from neutral to 10, but almost no hemolysis was observed below pH 6.5. Immunoblotting analysis of proteins from the erythrocyte membrane after treatment with GEL-III indicated that GEL-III aggregates were irreversibly bound to the membrane. When erythrocytes were incubated with GEL-III in the presence of dextran with molecular masses greater than 4 kDa, lysis was impeded considerably, while a concomitant release of ATP was detected from these osmotically protected cells. It was found that GEL-III released carboxyfluorescein from artificial globoside-containing lipid vesicles, and it is suggested that GEL-III is a novel pore-forming protein with the characteristics of a Ca2+-dependent lectin, which may act as a toxic protein to foreign microorganisms.			HATAKEYAMA, T (corresponding author), KYUSHU UNIV, FAC AGR, BIOCHEM LAB, HIGASHI KU, HAKOZAKI 6-10-1, FUKUOKA 812, JAPAN.			Hatakeyama, Tomomitsu/0000-0002-9505-1980				BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BERTHEUSSEN K, 1983, DEV COMP IMMUNOL, V7, P21, DOI 10.1016/0145-305X(83)90051-4; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; CANICATTI C, 1987, EXPERIENTIA, V43, P611, DOI 10.1007/BF02126350; CANICATTI C, 1988, DEV COMP IMMUNOL, V12, P55, DOI 10.1016/0145-305X(88)90024-9; DeLuca M., 1978, METHOD ENZYMOL, V57, P3, DOI DOI 10.1016/0076-6879(78)57003-1; DOERY HM, 1965, J GEN MICROBIOL, V40, P283, DOI 10.1099/00221287-40-2-283; DRICKAMER K, 1993, BIOCHEM SOC T, V21, P456, DOI 10.1042/bst0210456; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; GIGA Y, 1987, J BIOL CHEM, V262, P6197; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; HIMESHIMA T, 1994, J BIOCHEM-TOKYO, V115, P689, DOI 10.1093/oxfordjournals.jbchem.a124397; HIRAYAMA T, 1983, FEBS LETT, V157, P46, DOI 10.1016/0014-5793(83)81113-2; KAISER ET, 1987, ANNU REV BIOPHYS BIO, V16, P561; KOMANO H, 1980, J BIOL CHEM, V255, P2919; KONSKA G, 1994, J BIOCHEM-TOKYO, V116, P519, DOI 10.1093/oxfordjournals.jbchem.a124555; LAZAROVICI P, 1986, J BIOL CHEM, V261, P6704; MacFarlane MG, 1941, BIOCHEM J, V35, P884, DOI 10.1042/bj0350884; MANGEL A, 1992, EUR J BIOCHEM, V210, P499, DOI 10.1111/j.1432-1033.1992.tb17448.x; MURAMOTO K, 1990, BIOCHIM BIOPHYS ACTA, V1039, P42, DOI 10.1016/0167-4838(90)90224-4; NAKAJIMA H, 1982, GANN, V73, P627; PARK NG, 1992, BIOCHEMISTRY-US, V31, P12241, DOI 10.1021/bi00163a038; PARRINELLO N, 1979, DEV COMP IMMUNOL, V3, P45, DOI 10.1016/S0145-305X(79)80005-1; PARRINELLO N, 1981, DEV COMP IMMUNOL, V5, P33, DOI 10.1016/S0145-305X(81)80005-5; RYOYAMA K, 1973, BIOCHIM BIOPHYS ACTA, V320, P157, DOI 10.1016/0304-4165(73)90175-X; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; SHINODA S, 1993, MICROBIOL IMMUNOL, V37, P405, DOI 10.1111/j.1348-0421.1993.tb03229.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; TAKAGI T, 1994, J BIOCHEM-TOKYO, V116, P598, DOI 10.1093/oxfordjournals.jbchem.a124566; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; TEICHBERG VI, 1988, J BIOL CHEM, V263, P14086; WALKER B, 1992, J BIOL CHEM, V267, P21782; YAMAZAKI M, 1983, JPN J CANCER RES, V74, P576; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P5668, DOI 10.1073/pnas.83.15.5668	36	97	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3560	3564		10.1074/jbc.270.8.3560	http://dx.doi.org/10.1074/jbc.270.8.3560			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876091	hybrid			2022-12-27	WOS:A1995QH68800018
J	KELLER, SH; KREIENKAMP, HJ; KAWANISHI, C; TAYLOR, P				KELLER, SH; KREIENKAMP, HJ; KAWANISHI, C; TAYLOR, P			MOLECULAR DETERMINANTS CONFERRING ALPHA-TOXIN RESISTANCE IN RECOMBINANT DNA-DERIVED ACETYLCHOLINE-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BINDING-SITE; MUSCLE-CELLS; AMINO-ACIDS; SUBUNIT; LIGAND; RESIDUES; IDENTIFICATION; BUNGAROTOXIN; EXPRESSION	Sequences of the alpha-subunits of the nicotinic acetylcholine receptor from the snake and mongoose contain several differences in the region between amino acids 183 and 200. Receptors from both of these species reveal resistance to the snake alpha-toxins presumably arising as a protective evolutionary mechanism. Sequence differences include the added glycosylation signals at residue 187 in the mongoose and at residues 189 and 111 in snake. Although previous observations with peptides and fusion proteins either synthesized chemically or in a bacterial expression system indicate that certain amino acid residues may contribute to the resistance, our findings with the intact receptor in an eukaryotic expression system indicate the major role for glycosylation. In this study, we show that addition of glycosylation signals gives rise to virtually complete glycosylation at the added sites, although heterogeneity of oligosaccharide processing is evident. By analysis of combinations of mutants, we document that glycosylation exerts the predominant influence on alpha-toxin binding. Substitutions at other residues are largely without influence as single mutations but appear to decrease affinity further in multiple mutants, particularly where the receptor is glycosylated at the 187 and 189 positions. Glycosylation exerts a major influence on the dissociation as well as the association rates of the alpha-toxin-receptor complex, suggesting that the decrease for cu-toxin affinity is not simply a consequence of restricted diffusional access, rather glycosylation affects the conformation and stability of the bound complex.	YOKOHAMA CITY UNIV, DEPT PSYCHIAT, YOKOHAMA, KANAGAWA 232, JAPAN	Yokohama City University	KELLER, SH (corresponding author), UNIV CALIF SAN DIEGO, DEPT PHARMACOL, 0636, LA JOLLA, CA 92093 USA.			Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	NIGMS NIH HHS [GM24437] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; AYLWIN ML, 1994, FEBS LETT, V349, P99, DOI 10.1016/0014-5793(94)00649-0; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BULLER AL, 1990, J MEMBRANE BIOL, V115, P179, DOI 10.1007/BF01869456; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395, DOI 10.1017/S0033583500004352; CHATURVEDI V, 1993, BIOCHEMISTRY-US, V32, P9570, DOI 10.1021/bi00088a008; CHATURVEDI V, 1992, BIOCHEMISTRY-US, V31, P1370, DOI 10.1021/bi00120a012; COHEN JB, 1991, J BIOL CHEM, V266, P23354; CONTITRONCONI BM, 1991, BIOCHEMISTRY-US, V30, P2575, DOI 10.1021/bi00224a003; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GRIESMANN GE, 1990, J NEUROCHEM, V54, P1541, DOI 10.1111/j.1471-4159.1990.tb01202.x; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; NEUMANN D, 1989, P NATL ACAD SCI USA, V86, P7255, DOI 10.1073/pnas.86.18.7255; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; OHANA B, 1991, BIOCHEM BIOPH RES CO, V179, P648, DOI 10.1016/0006-291X(91)91421-8; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; PETAJAREPO UE, 1993, BIOCHEM J, V292, P839, DOI 10.1042/bj2920839; PRIVES JM, 1980, P NATL ACAD SCI-BIOL, V77, P5263, DOI 10.1073/pnas.77.9.5263; RUSSO D, 1991, MOL ENDOCRINOL, V5, P29, DOI 10.1210/mend-5-1-29; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1991, J BIOL CHEM, V266, P13679; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1	35	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4165	4171		10.1074/jbc.270.8.4165	http://dx.doi.org/10.1074/jbc.270.8.4165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876169	hybrid			2022-12-27	WOS:A1995QH68800103
J	BENDIK, I; PFAHL, M				BENDIK, I; PFAHL, M			SIMILAR LIGAND-INDUCED CONFORMATIONAL-CHANGES OF THYROID-HORMONE RECEPTORS REGULATE HOMODIMERIC AND HETERODIMERIC FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; RESPONSE ELEMENT; DNA-BINDING; ACID RECEPTORS; NUCLEAR RECEPTORS; NEGATIVE REGULATION; ENHANCES BINDING; ALPHA-MYOSIN; VITAMIN-D	Thyroid hormone receptors (TRs) bind specific: thyroid hormone response elements (TREs) as heterodimers with retinoid X receptors (RXRs) and act as transcriptional activators. As homodimers, TRs can bind a distinct set of sequences and function as ligand sensitive repressors. In our study, we compared the natural malic enzyme TRE (ME-TRE) as a model system for the TR/RXR heterodimer pathway to the chicken lysozyme silencer element F2-TRE which is strongly bound and regulated by TR/TR homodimers. Using electrophoretic mobility shift assays, transient transfections with a variety of natural and synthetic triiodothyronine and thyroxine derivatives as well as limited proteolytic analysis, we show that the natural homo and heterodimeric pathways show similar ligand requirements. Furthermore, we observe that the ligand-induced conformational changes in the receptor proteins that either result in a loss of TR/TR homodimer binding and release of transcriptional repression or in transcriptional activation of TR/RXR heterodimers are indistinguishable. Therefore, we propose that in TR/TR homodimers and TR/RXR heterodimers very similar moieties of the receptors are involved in ligand binding and subsequent conformational changes that lead to loss of gene repression (TR/TR homodimer) and gain of gene activation (TR/RXR. heterodimer).	LA JOLLA CANC RES FDN, CANC RES CTR, LA JOLLA, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute					NIDDK NIH HHS [DK 35083] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035083] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; ANDREA TA, 1979, J MED CHEM, V22, P221, DOI 10.1021/jm00189a002; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; BHAT MK, 1993, BIOCHEM BIOPH RES CO, V195, P385, DOI 10.1006/bbrc.1993.2055; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; BURNSIDE J, 1990, J BIOL CHEM, V265, P2500; CARLBERG C, 1993, BIOCHEM BIOPH RES CO, V195, P1345, DOI 10.1006/bbrc.1993.2191; Chin W.W., 1991, NUCL HORMONE RECEPTO, P79; DEGROOT LJ, 1984, THYROID ITS DISEASES; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; DIETRICH SW, 1977, J MED CHEM, V20, P863, DOI 10.1021/jm00217a001; DOWNES M, 1993, CELL GROWTH DIFFER, V4, P901; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GLASS CK, 1990, BIOCHIM BIOPHYS ACTA, V1032, P157, DOI 10.1016/0304-419X(90)90002-I; GRAUPNER G, 1991, BIOCHEM BIOPH RES CO, V179, P1554, DOI 10.1016/0006-291X(91)91750-7; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HARTONG R, 1994, J BIOL CHEM, V269, P13021; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; HUSMANN M, 1991, MOL CELL BIOL, V11, P4097, DOI 10.1128/MCB.11.8.4097; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LAZAR MA, 1990, MOL ENDOCRINOL, V4, P1627, DOI 10.1210/mend-4-11-1627; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LEE MO, 1994, P NATL ACAD SCI USA, V91, P5632, DOI 10.1073/pnas.91.12.5632; LEESON PD, 1988, J MED CHEM, V31, P37, DOI 10.1021/jm00396a008; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LENG XH, 1993, J STEROID BIOCHEM, V46, P643, DOI 10.1016/0960-0760(93)90306-H; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; MUSCAT GEO, 1993, CELL GROWTH DIFFER, V4, P269; MUSCAT GEO, 1994, NUCLEIC ACIDS RES, V22, P583, DOI 10.1093/nar/22.4.583; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PFAHL M, 1990, METHOD ENZYMOL, V189, P256; Pfahl Magnus, 1994, Seminars in Cell Biology, V5, P95, DOI 10.1006/scel.1994.1013; PIEDRAFITA FJ, 1994, INDUCIBLE GENE EXPRE, V2, P157; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; ROSEN ED, 1991, MOL CELL ENDOCRINOL, V78, pC83, DOI 10.1016/0303-7207(91)90175-R; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SCHRADER M, 1994, J BIOL CHEM, V269, P5501; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; TONEY JH, 1993, BIOCHEMISTRY-US, V32, P2, DOI 10.1021/bi00052a001; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG X, 1991, MOL ENDOCRINOL, V5, P1909, DOI 10.1210/mend-5-12-1909; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016; ZHANG XK, 1991, NEW BIOL, V3, P169; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	67	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3107	3114		10.1074/jbc.270.7.3107	http://dx.doi.org/10.1074/jbc.270.7.3107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852392	hybrid			2022-12-27	WOS:A1995QG47100035
J	LI, JF; EASTMAN, A				LI, JF; EASTMAN, A			APOPTOSIS IN AN INTERLEUKIN-2-DEPENDENT CYTOTOXIC T-LYMPHOCYTE CELL-LINE IS ASSOCIATED WITH INTRACELLULAR ACIDIFICATION - ROLE OF THE NA+/H+-ANTIPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ENDONUCLEASE ACTIVATION; DNA FRAGMENTATION; GROWTH-FACTOR; INTERNUCLEOSOMAL FRAGMENTATION; OKADAIC ACID; DEATH; THYMOCYTES; CALCIUM; STIMULATION	Apoptosis is a form of cell death associated with DNA fragmentation and chromatin condensation. We recently established that intracellular acidification occurred during apoptosis following cytotoxic insult. The current studies were designed to determine whether intracellular acidification was more generally associated with apoptosis, specifically in a model of growth factor withdrawal. Upon withdrawal of interleukin-2, CTLL-2 cells accumulated in the G(1) phase of the cell cycle and started to fragment their DNA around 12 h concurrent with both decreased pH and increased Ca2+. Chelation of Ca2+ did not inhibit DNA digestion, whereas incubation with a calcium ionophore pre vented both acidification and DNA digestion Hence,. acidification rather than increased Ca2+ was associated with apoptosis. The acidified cells represented a discrete population up to 0.7 pH units below normal. The extent of acidification depended upon the extracellular pH; above pH 6.3, intracellular pH was significantly below extracellular pH, whereas below pH 6.3, the cells still regulated their pH. inhibition of the Na+/H+-antiport prevented the apoptotic cells from regulating their intracellular pH under these acidic conditions. These results demonstrate that apoptotic cells retain a functional antiport but that its set-point has changed, Many survival factors are known to phosphorylate and activate the antiport, hence apoptosis is likely to be associated with dephosphorylation. Although acidification always occurred during apoptosis, maintaining intracellular pH above 7.2 did not prevent apoptosis, suggesting that an acid pH is not essential for apoptosis, We hypothesize that other critical regulators of apoptosis must be subject to dephosphorylation.	DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755; DARTMOUTH COLL,SCH MED,NORRIS COTTON CANC CTR,HANOVER,NH 03755	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center					NATIONAL CANCER INSTITUTE [R01CA050224, R55CA050224, P30CA023108] Funding Source: NIH RePORTER; NCI NIH HHS [CA50224, CA23108] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER PE, 1979, J EXP MED, V149, P273, DOI 10.1084/jem.149.1.273; BARRY MA, 1993, CANCER RES, V53, P2349; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; BARRY MA, 1992, BIOCHEM BIOPH RES CO, V186, P782, DOI 10.1016/0006-291X(92)90814-2; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; BROWN DG, 1993, J BIOL CHEM, V268, P3037; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; EASTMAN A, 1993, TOXICOL APPL PHARM, V121, P160, DOI 10.1006/taap.1993.1141; EASTMAN A, 1992, CANCER INVEST, V10, P229, DOI 10.3109/07357909209032765; EASTMAN A, 1995, METHOD CELL BIOL, V46, P41; HESKETH TR, 1985, NATURE, V313, P481, DOI 10.1038/313481a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; ISEKI R, 1991, J IMMUNOL, V147, P4286; June C H, 1990, Methods Cell Biol, V33, P37; KAPUS A, 1994, J BIOL CHEM, V269, P23544; MADHUS IH, 1988, BIOCHEM J, V250, P1; MCCONKEY DJ, 1989, FASEB J, V3, P1843, DOI 10.1096/fasebj.3.7.2497041; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; MORANA S, 1994, INT J ONCOL, V5, P153; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; ORMEROD MG, 1993, CYTOMETRY, V14, P595, DOI 10.1002/cyto.990140603; RAJOTTE D, 1992, J BIOL CHEM, V267, P9980; RODRIGUEZTARDUC.G, 1990, EMBO J, V9, P2997; RODRIGUEZTARDUC.G, 1989, BIOCHEM BIOPH RES CO, V164, P1069; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SARDET C, 1991, J BIOL CHEM, V266, P19166; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; SONG QZ, 1992, J CELL PHYSIOL, V153, P550, DOI 10.1002/jcp.1041530316; SONG QZ, 1993, BIOCHEM BIOPH RES CO, V190, P47, DOI 10.1006/bbrc.1993.1009; SORENSON CM, 1988, CANCER RES, V48, P4484; SWANN K, 1985, NATURE, V314, P274, DOI 10.1038/314274a0; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; ZHIVOTOVSKY B, 1993, EXP CELL RES, V207, P163, DOI 10.1006/excr.1993.1176	36	207	215	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3203	3211		10.1074/jbc.270.7.3203	http://dx.doi.org/10.1074/jbc.270.7.3203			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852405	hybrid			2022-12-27	WOS:A1995QG47100049
J	CSERMELY, P; MIYATA, Y; SCHNAIDER, T; YAHARA, I				CSERMELY, P; MIYATA, Y; SCHNAIDER, T; YAHARA, I			AUTOPHOSPHORYLATION OF GRP94 (ENDOPLASMIN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; GLUCOSE-REGULATED PROTEIN; CHAIN BINDING-PROTEIN; ESCHERICHIA-COLI; SENSITIVE METHOD; ATP; CALCIUM; RETICULUM; GRP78; DISSOCIATION	The 94-kDa glucose-regulated protein (endoplasmin, grp94) is an abundant member of the 90-kDa molecular chaperone family in the endoplasmic reticulum, We have found earlier that the 50% homologous 90-kDa heat shock protein, hsp90, has ATP-binding site(s) and auto phosphorylating activity (Csermely, P., and Kahn, C. R. (1991) J. Biol. Chem. 266, 4943-4950), In the present paper we demonstrate that highly purified grp94 is also able to autophosphorylate itself on serine and threonine residues, grp94 can be freed from the co-purifying casein kinase II by concanavalin A affinity chromatography, and its phosphorylation is unaffected by activators and inhibitors of numerous protein kinases known to associate with the homologous hsp90. The autophosphorylation persists in immunoprecipitates and in SDS-polyacrylamide gel-purified and renatured grp94. Autophosphorylation displays a monomolecular kinetics, is activated by micromolar calcium concentrations, has an extreme heat stability, and can utilize both ATP and GTP with relatively high k(m) values of 243 +/- 14 mu M and 116 +/- 23 mu M, respectively. Sequence analysis of grp94 shows the presence of two ATP-binding sites. The major product of limited proteolysis of grp94 by chymotrypsin or papain is an N-terminal 85 kDa fragment that can bind to ATP-agarose but does not show autophosphorylation. Our data suggest that grp94 has an enzymatic function analogous in many respects to the similar activity of hsp70, hsp90, and grp78 (BiP). Autophosphorylation may participate in/regulate the complex formation of these proteins, so it may be involved in their chaperone function.	TOKYO METROPOLITAN INST MED SCI, DEPT CELL BIOL, BUNKYO KU, TOKYO 113, JAPAN	Tokyo Metropolitan Institute of Medical Science	CSERMELY, P (corresponding author), SEMMELWEIS UNIV MED, SCH MED, INST BIOCHEM 1, POB 260, H-1444 BUDAPEST, HUNGARY.		Miyata, Y/X-7111-2019; Csermely, Peter/J-2067-2017	Csermely, Peter/0000-0001-9234-0659				Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; BAUMANN O, 1991, P NATL ACAD SCI USA, V88, P741, DOI 10.1073/pnas.88.3.741; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALA SE, 1994, J BIOL CHEM, V269, P5926; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; CHIN DT, 1988, J BIOL CHEM, V263, P11718; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; DALIE BL, 1990, BIOCHEM BIOPH RES CO, V166, P1284, DOI 10.1016/0006-291X(90)91005-D; DECHERT U, 1994, EUR J BIOCHEM, V225, P805, DOI 10.1111/j.1432-1033.1994.0805b.x; DECHERT U, 1989, J NEUROCHEM, V53, P1268, DOI 10.1111/j.1471-4159.1989.tb07424.x; DORNER AJ, 1990, P NATL ACAD SCI USA, V87, P7429, DOI 10.1073/pnas.87.19.7429; EDWARDS DP, 1984, BIOCHEMISTRY-US, V23, P4427, DOI 10.1021/bi00314a029; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GAUT JR, 1993, J BIOL CHEM, V268, P7248; GAUT JR, 1993, J BIOL CHEM, V268, P12691; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HIGGINS RC, 1979, ANAL BIOCHEM, V93, P257, DOI 10.1016/S0003-2697(79)80077-9; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KIANG JG, 1992, AM J PHYSIOL, V263, pC30, DOI 10.1152/ajpcell.1992.263.1.C30; KOYASU S, 1989, J BIOL CHEM, V264, P15083; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; KULOMAA MS, 1986, BIOCHEMISTRY-US, V25, P6244, DOI 10.1021/bi00368a061; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LEGAGNEUX V, 1991, FEBS LETT, V291, P359, DOI 10.1016/0014-5793(91)81320-8; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; MAKI RG, 1990, P NATL ACAD SCI USA, V87, P5658, DOI 10.1073/pnas.87.15.5658; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; MIYATA Y, 1991, J BIOL CHEM, V266, P8779; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MOORE SK, 1989, J BIOL CHEM, V264, P5343; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NADEAU K, 1992, PROTEIN SCI, V1, P970, DOI 10.1002/pro.5560010802; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; RENNER M, 1993, P NATL ACAD SCI USA, V90, P6493, DOI 10.1073/pnas.90.14.6493; SHERMAN MY, 1992, NATURE, V357, P167, DOI 10.1038/357167a0; SRIVASTAVA PK, 1987, P NATL ACAD SCI USA, V84, P3807, DOI 10.1073/pnas.84.11.3807; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TOLEDO H, 1993, P NATL ACAD SCI USA, V90, P2505, DOI 10.1073/pnas.90.6.2505; VAN PN, 1989, J BIOL CHEM, V264, P17494; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEITZEL G, 1987, EXP CELL RES, V170, P64, DOI 10.1016/0014-4827(87)90117-0; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	54	72	74	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6381	6388		10.1074/jbc.270.11.6381	http://dx.doi.org/10.1074/jbc.270.11.6381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890776	hybrid			2022-12-27	WOS:A1995QM94500098
J	LI, CW; BOOZE, RM; HERSH, LB				LI, CW; BOOZE, RM; HERSH, LB			TISSUE-SPECIFIC EXPRESSION OF RAT NEUTRAL ENDOPEPTIDASE (NEPRILYSIN) MESSENGER-RNAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; LEUKEMIA ANTIGEN CALLA; MOLECULAR-CLONING; ENKEPHALINASE; PROTEIN; MODULATION; PROMOTERS	Neutral endopeptidase is a cell surface zinc metallopeptidase that regulates the action of a variety of physiologically active peptides, The enzyme exhibits a wide tissue distribution, being most abundant in kidney and lung. Three rat neutral endopeptidase cDNAs with unique 5'-untranslated sequences were isolated, Distribution of the corresponding mRNAs in rat tissues was analyzed by RNase protection assays and by in situ hybridization, In kidney, the type 2b transcript was the major species, In lung and testis, type 1 and type 2b transcripts were expressed in approximately equal amounts, while in brain and spinal cord the type 1 mRNA was the major transcript, These findings were extended by in situ hybridization studies. Ah three mRNAs were expressed in the proximal tubule of the kidney, with the type 2b transcript giving the strongest signal, In the frontoparietal cortex, expression of the neutral endopeptidase mRNA subtypes was cell- and region-specific, The type 1 transcript was localized to neurons, type 2b mRNA was not detectable, while type 3 mRNA was localized to the oligodendrocytes of the corpus callosum, These results clearly demonstrate that expression of the three neutral endopeptidase mRNAs can be regulated in a cell-specific manner.	UNIV KENTUCKY,COLL MED,DEPT BIOCHEM,LEXINGTON,KY 40536; UNIV KENTUCKY,COLL MED,DEPT PHARMACOL,LEXINGTON,KY 40536	University of Kentucky; University of Kentucky				Booze, Rosemarie/0000-0003-3908-8313	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009160, R01DA002243, R01DA006638] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 06638, DA 02243, DA 09160] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CASEY ML, 1991, J BIOL CHEM, V266, P23041; CHEN CY, 1992, J IMMUNOL, V148, P2817; DADAMIO L, 1989, P NATL ACAD SCI USA, V86, P7103, DOI 10.1073/pnas.86.18.7103; DJOKIC TD, 1989, J PHARMACOL EXP THER, V248, P7; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; KENNY J, 1986, TRENDS BIOCHEM SCI, V11, P40, DOI 10.1016/0968-0004(86)90231-8; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MALFROY B, 1987, BIOCHEM BIOPH RES CO, V144, P59, DOI 10.1016/S0006-291X(87)80475-8; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SHIPP MA, 1988, P NATL ACAD SCI USA, V85, P4819, DOI 10.1073/pnas.85.13.4819; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; SIMPSON ER, 1993, CLIN CHEM, V39, P317; SOLEILHAC JM, 1992, MOL PHARMACOL, V41, P609; STEFANO GB, 1992, J NEUROIMMUNOL, V41, P9, DOI 10.1016/0165-5728(92)90189-R; STEPHENSON SL, 1987, BIOCHEM J, V243, P183, DOI 10.1042/bj2430183; WAKSMAN G, 1986, P NATL ACAD SCI USA, V83, P1523, DOI 10.1073/pnas.83.5.1523; WERB Z, 1989, J BIOL CHEM, V264, P9111; YOSHIMURA T, 1987, AM J HEMATOL, V55, P47	22	56	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5723	5728		10.1074/jbc.270.11.5723	http://dx.doi.org/10.1074/jbc.270.11.5723			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890699	hybrid			2022-12-27	WOS:A1995QM94500009
J	MORALES, MJ; CASTELLINO, RC; CREWS, AL; RASMUSSON, RL; STRAUSS, HC				MORALES, MJ; CASTELLINO, RC; CREWS, AL; RASMUSSON, RL; STRAUSS, HC			A NOVEL BETA-SUBUNIT INCREASES RATE OF INACTIVATION OF SPECIFIC VOLTAGE-GATED POTASSIUM CHANNEL ALPHA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; HETEROMULTIMERIC K+ CHANNELS; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; SECONDARY-STRUCTURE; XENOPUS OOCYTES; IK(A) CHANNELS; PROTEINS; BRAIN; DNA	Voltage-gated potassium channel beta subunits are cytoplasmic proteins that co-purify with the pore-forming a subunits. One of these subunits, Kv beta 1 from rat brain, was previously demonstrated to increase the rate of inactivation of Kv1.1 and Kv1.4 when co-expressed in Xenopus oocytes, We have cloned and characterized a novel voltage-gated K+ channel beta subunit. The cDNA, designated Kv beta S, has a 408-amino acid open reading frame. It possesses a unique 79-amino acid N-terminal leader, but is identical with rat Kv beta 1 over the 329 C-terminal amino acids. The Kv beta 3 transcript was found in many tissues, but was most abundant in aorta and left ventricle of the heart. Go-expression of Kv beta 3 with K+ channel alpha subunits shows that this beta subunit can increase the rate of inactivation from 4- to 7-fold in a Kv1.4 or Shaker B channel, Kv beta 3 had no effect on Kv1.1, unlike KvP1 which can increase rate of inactivation of this alpha subunit more than 100-fold, Other kinetic parameters were unaffected. This study shows that voltage-gated K+ channel beta subunits are present outside the central nervous system, and that at least one member of this family selectively modulates inactivation of K+ channel alpha subunits.	DUKE UNIV, MED CTR, DEPT PHARMACOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT CELL BIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA; DUKE UNIV, SCH ENGN, DEPT BIOMED ENGN, DURHAM, NC 27708 USA	Duke University; Duke University; Duke University; Duke University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL019216, R01HL019216, R01HL052874] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52874, HL19216] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P3097, DOI 10.1093/nar/21.13.3097; BROWN AM, 1993, ANNU REV BIOPH BIOM, V22, P173, DOI 10.1146/annurev.bb.22.060193.001133; CELI FS, 1993, NUCLEIC ACIDS RES, V21, P1047, DOI 10.1093/nar/21.4.1047; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COMER MB, 1994, AM J PHYSIOL-HEART C, V267, pH1383, DOI 10.1152/ajpheart.1994.267.4.H1383; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; Hille B., 1992, IONIC CHANNELS EXCIT; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; KASS RS, 1993, TRENDS CARDIOVAS MED, V3, P149, DOI 10.1016/1050-1738(93)90016-Y; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MAROM S, 1993, RECEPTOR CHANNEL, V1, P81; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PENNEFATHER P, 1990, CARDIAC ELECTROPHYSI, P17; PETERSON MG, 1993, METHOD ENZYMOL, V218, P493; PO S, 1993, CIRC RES, V72, P1326, DOI 10.1161/01.RES.72.6.1326; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0	45	143	145	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6272	6277		10.1074/jbc.270.11.6272	http://dx.doi.org/10.1074/jbc.270.11.6272			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890764	hybrid			2022-12-27	WOS:A1995QM94500084
J	SHAPIRO, SD; FLISZAR, CJ; BROEKELMANN, TJ; MECHAM, RP; SENIOR, RM; WELGUS, HG				SHAPIRO, SD; FLISZAR, CJ; BROEKELMANN, TJ; MECHAM, RP; SENIOR, RM; WELGUS, HG			ACTIVATION OF THE 92-KDA GELATINASE BY STROMELYSIN AND 4-AMINOPHENYLMERCURIC ACETATE - DIFFERENTIAL PROCESSING AND STABILIZATION OF THE CARBOXYL-TERMINAL DOMAIN BY TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST COLLAGENASE INHIBITOR; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; CYSTEINE SWITCH; SITE; LOCALIZATION; PURIFICATION; DEGRADATION; CLONING; FAMILY	The matrix metalloproteinase 92-kDa gelatinase is a major product of inflammatory cells. Macrophages synthesize and secrete this proteinase as a proenzyme in association with tissue inhibitor of metalloproteinases (TWIP) (92(TIMP)), whereas neutrophils store and release it from secondary granules as a TIMP-free proenzyme (92(TIMP-free)). Metalloproteinase proenzymes can be activated in vitro by a variety of agents, including organomercurials and proteinases, resulting in loss of an 8-10-kDa NH2-terminal domain which disrupts the interaction of a conserved cysteine residue with the catalytic zinc molecule. We report that the activation and processing of 92-kDa gelatinase differs depending on its association with TIMP and the nature of the activating agent. We observed that 92(TIMP) undergoes classic activation to 82 kDa by stromelysin, whereas exposure to 4-aminophenylmercuric acetate (APMA) results in a final product of 83 kDa that still contains the ''prodomain'' cysteine. Association with TIMP appears to stabilize the COOH-terminal domain, whereas 92(TIMP-free) is converted by APMA to a final product of 67 kDa lacking the COOH-terminal portion. In the continued presence of APMA, which maintains cysteine-zinc disruption, the 67-kDa species is at least as active as the classic 82 kDa. In contrast, activation of 92(TIMP-free) by stromelysin initially generates the 82-kDa form which is followed by final conversion to a 50-kDa species that lacks the cata lytic domain of the parent molecule. Therefore, although stromelysin activation of 92(TIMP-free) is initially efficient, the active 82-kDa form is short-lived and is replaced by an inactive 50-kDa product, This complex pattern of activation of the 92-kDa gelatinase may serve to restrict its proteolytic capacity following exposure to stromelysin and may serve to regulate proteinase activity in vivo.	WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,DIV RESP CRIT CARE,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,DIV DERMATOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)					NHLBI NIH HHS [R0-1 HL47328, HL2401] Funding Source: Medline; NIAMS NIH HHS [AR35805] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035805] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BARAGI VM, 1994, J BIOL CHEM, V269, P12692; BIRKEDALHANSEN B, 1988, BIOCHEMISTRY-US, V27, P6751, DOI 10.1021/bi00418a016; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brophy C M, 1991, Ann Vasc Surg, V5, P229, DOI 10.1007/BF02329378; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; BUTTICE G, 1991, NUCLEIC ACIDS RES, V19, P3723, DOI 10.1093/nar/19.13.3723; CARMICHAEL DF, 1986, P NATL ACAD SCI USA, V83, P2407, DOI 10.1073/pnas.83.8.2407; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; MURPHY G, 1992, J BIOL CHEM, V267, P9612; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1992, J BIOL CHEM, V267, P3581; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160, DOI 10.1164/ajrccm/150.6_Pt_2.S160; SHAPIRO SD, 1993, BIOCHEMISTRY-US, V32, P4286, DOI 10.1021/bi00067a018; SIRES UI, 1993, J BIOL CHEM, V268, P2069; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STETLERSTEVENSO.WG, 1989, J BIOL CHEM, V264, P17374; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; VINCENT MP, 1995, IN PRESS J CLIN INVE; WEINGARTEN H, 1985, ANAL BIOCHEM, V147, P437, DOI 10.1016/0003-2697(85)90294-5; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	34	162	164	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6351	6356		10.1074/jbc.270.11.6351	http://dx.doi.org/10.1074/jbc.270.11.6351			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890773	hybrid			2022-12-27	WOS:A1995QM94500095
J	ADLER, P; WOOD, SJ; LEE, YC; LEE, RT; PETRI, WA; SCHNAAR, RL				ADLER, P; WOOD, SJ; LEE, YC; LEE, RT; PETRI, WA; SCHNAAR, RL			HIGH-AFFINITY BINDING OF THE ENTAMOEBA-HISTOLYTICA LECTIN TO POLYVALENT N-ACETYLGALACTOSAMINIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHERENCE LECTIN; CLUSTER GLYCOSIDES; HUMAN-ERYTHROCYTES; COLONIC MUCINS; RECEPTOR; SUBUNIT; RAT; PROTEINS; LIGANDS; LIVER	Entamoeba histolytica trophozoites initiate pathogenic colonization by adherence to host glycoconjugates via an amebic surface lectin which binds to galactose (Gal) and N-acetylgalactosamine (GalNAc) residues. Monovalent and multivalent carbohydrate ligands were screened for inhibition of E. histolytica lectin-mediated human red cell hemagglutination, revealing that: (i) the synthetic multivalent neoglycoprotein GalNAc(39)BSA (having an average of 39 GalNAc residues linked to bovine serum albumin) was 140,000-fold more potent an inhibitor than monovalent GalNAc and 500,000-fold more potent than monovalent Gal; and (ii) small synthetic multivalent ligands which bind with high affinity to the mammalian hepatic Gal/GalNAc lectin do not bind with high affinity to the E. histolytica lectin. Radioligand binding studies revealed saturable binding of I-125-GalNAc(39)BSA to E. histolytica membranes (K-D = 10 +/- 3 nM, B-max = 0.9 +/- 0.08 pmol/mg membrane protein). Maximal binding required the presence of calcium chloride (300 mu M) or sodium chloride (50 mM), and had a broad pH maximum (pH 6-9), GalNAc(39)BSA was 200,000-fold more potent than monovalent GalNAc in blocking radio ligand binding, Among synthetic saccharide-derivatized linear polymers, the GalNAc beta and GalNAc alpha 3Gal beta derivatives were the most potent, with GalNAc alpha and GalNAc alpha 3(Fuc alpha 2)Gal beta derivatives much weaker. The data support a model in which a unique pattern of spaced multiple GalNAc residues are the highest affinity targets for the E. histolytica lectin.	JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; USA,CHEM RES DEV COMMAND,ABERDEEN PROVING GROUND,MD 21010; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218; UNIV VIRGINIA,SCH MED,DEPT MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT PATHOL & MICROBIOL,CHARLOTTESVILLE,VA 22908	Johns Hopkins University; Johns Hopkins University; University of Virginia; University of Virginia			Schnaar, Ronald L/S-8967-2016; Petri, William/AAL-3642-2020; Petri, William A./D-3639-2019	Schnaar, Ronald L/0000-0002-7701-5484; Petri, William/0000-0002-7268-1218; 	NIAID NIH HHS [AI-26649] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI026649, R01AI026649] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOVIN NV, 1993, GLYCOCONJUGATE J, V10, P142, DOI 10.1007/BF00737711; CANOMANCERA R, 1987, Z PARASITENKD, V74, P18; CHADEE K, 1987, J CLIN INVEST, V80, P1245, DOI 10.1172/JCI113199; CHADEE K, 1988, J INFECT DIS, V158, P398, DOI 10.1093/infdis/158.2.398; GRANT DAW, 1986, BIOCHEM J, V234, P131, DOI 10.1042/bj2340131; JOHNSON G, 1975, CARBOHYD RES, V39, P271, DOI 10.1016/S0008-6215(00)86137-6; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KIM YS, 1971, J BIOL CHEM, V246, P5466; LEE RT, 1987, GLYCOCONJUGATE J, V4, P317, DOI 10.1007/BF01048365; LEE RT, 1994, CARBOHYD RES, V251, P69, DOI 10.1016/0008-6215(94)84276-0; LEE RT, 1986, J CARBOHYD CHEM, V5, P343, DOI 10.1080/07328308608058840; LEE RT, 1984, BIOCHEMISTRY-US, V23, P4255, DOI 10.1021/bi00313a037; LEE YC, 1993, BIOCHEM SOC T, V21, P460, DOI 10.1042/bst0210460; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; LEE YC, 1992, FASEB J, V6, P3193, DOI 10.1096/fasebj.6.13.1397841; LEE YC, 1978, CARBOHYD RES, V67, P509; MANN BJ, 1993, INFECT IMMUN, V61, P1772, DOI 10.1128/IAI.61.5.1772-1778.1993; MCCOY JJ, 1993, J BIOL CHEM, V268, P24223; MCCOY JJ, 1994, INFECT IMMUN, V62, P3045, DOI 10.1128/IAI.62.8.3045-3050.1994; PETRI WA, 1987, J CLIN INVEST, V80, P1238, DOI 10.1172/JCI113198; PETRI WA, 1995, IN PRESS METHODS ENZ, V252; PURDY JE, 1993, MOL BIOCHEM PARASIT, V62, P53, DOI 10.1016/0166-6851(93)90177-Y; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; RAY TK, 1970, BIOCHIM BIOPHYS ACTA, V196, P1, DOI 10.1016/0005-2736(70)90159-8; SARKAR M, 1979, J BIOL CHEM, V254, P3170; STAHL P, 1982, J CELL BIOL, V93, P49, DOI 10.1083/jcb.93.1.49; WALSH JA, 1986, REV INFECT DIS, V8, P228; WEIGEL PH, 1979, CARBOHYD RES, V70, P83, DOI 10.1016/S0008-6215(00)83272-3	28	78	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5164	5171		10.1074/jbc.270.10.5164	http://dx.doi.org/10.1074/jbc.270.10.5164			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890626	hybrid			2022-12-27	WOS:A1995QL58000034
J	ALVAREZ, R; DEANDRES, J; YUBERO, P; VINAS, O; MAMPEL, T; IGLESIAS, P; GIRALT, M; VILLARROYA, F				ALVAREZ, R; DEANDRES, J; YUBERO, P; VINAS, O; MAMPEL, T; IGLESIAS, P; GIRALT, M; VILLARROYA, F			A NOVEL REGULATORY PATHWAY OF BROWN FAT THERMOGENESIS - RETINOIC ACID IS A TRANSCRIPTIONAL ACTIVATOR OF THE MITOCHONDRIAL UNCOUPLING PROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; THYROID-HORMONE; ADIPOSE-TISSUE; RESPONSE ELEMENT; BINDING-PROTEIN; ADRENERGIC REGULATION; TRANSGENIC MICE; GROWTH-HORMONE; CELL-CULTURE; BETA	The mitochondrial uncoupling protein (UCP) is responsible for the thermogenic function of brown fat, and it is a molecular marker of the brown adipocyte cell type. Retinoic acid (RA) increased UCP mRNA levels severalfold in brown adipocytes differentiated in culture, This induction was independent of adrenergic pathways or protein synthesis. RA stimulated ucp gene expression regardless of the stage of brown adipocyte differentiation. In transient transfection experiments RA induced the expression of chloramphenicol acetyltransferase vectors driven by 4.5 kilobases of the 5'-noncoding region of the rat ucp gene, and co-transfection of expression vectors for RA receptors enhanced the action of RA. Retinoic acid receptor alpha was more effective than retinoid X receptor in promoting RA action, whereas a mixture of the two was the most effective. The RA-responsive region in the ucp gene was located at -2469/-2318 and contains three motifs (between -2357 and -2330) of the consensus half sites characteristic of retinoic acid response elements. This 27-base pair sequence specifically binds purified retinoic acid receptor alpha as well as related proteins from brown fat nuclei. In conclusion, a novel potential regulatory pathway of brown fat development and thermogenic function has been recognized by identifying RA as a transcriptional activator of the ucp gene.	UNIV BARCELONA,FAC BIOL,DEPT BIOQUIM & FISIOL,UNITAT BIOQUIM & BIOL MOLEC,E-08028 BARCELONA,SPAIN; UNIV BARCELONA,DEPT BIOPHYS SCI,UNITAT BIOQUIM & BIOL MOLEC B,E-08028 BARCELONA,SPAIN	University of Barcelona; University of Barcelona			Giralt, Marta/A-4756-2013; Iglesias, P/AAU-1011-2020; Mampel, Teresa/C-5571-2017; Villarroya, Francesc/K-4357-2014; Iglesias, Roser/C-5561-2017	Giralt, Marta/0000-0001-7968-4190; Iglesias, P/0000-0003-0126-1985; Iglesias, Roser/0000-0002-7107-8097; Villarroya, Francesc/0000-0003-1266-9142				ALBAGLICURIEL O, 1993, DIFFERENTIATION, V52, P201, DOI 10.1111/j.1432-0436.1993.tb00632.x; ANTRAS J, 1991, J BIOL CHEM, V266, P1157; BEDO G, 1989, NATURE, V339, P231, DOI 10.1038/339231a0; BIANCO AC, 1988, J BIOL CHEM, V263, P18168; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOUILLAUD F, 1988, BIOCHEM BIOPH RES CO, V157, P783, DOI 10.1016/S0006-291X(88)80318-8; BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; CASSARD AM, 1990, J CELL BIOCHEM, V43, P255, DOI 10.1002/jcb.240430306; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; CHAMPIGNY O, 1992, MOL CELL ENDOCRINOL, V86, P73, DOI 10.1016/0303-7207(92)90177-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DE LUCA LM, 1991, FASEB J, V5, P2924; DITTMAN WA, 1994, J BIOL CHEM, V269, P16925; ENERBACK S, 1987, GENE AMST, V64, P97; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; GARCIAJIMENEZ C, 1993, ENDOCRINOLOGY, V132, P1537, DOI 10.1210/en.132.4.1537; GIGUERE V, 1987, NATURE, V330, P444; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; GIRALT M, 1990, BIOCHIM BIOPHYS ACTA, V1048, P270, DOI 10.1016/0167-4781(90)90066-B; GIRALT M, 1991, J BIOL CHEM, V266, P21991; GLAICHENHAUS N, 1986, EMBO J, V5, P1261, DOI 10.1002/j.1460-2075.1986.tb04355.x; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; KLAUS S, 1991, J CELL BIOL, V115, P1783, DOI 10.1083/jcb.115.6.1783; KOZAK LP, 1988, J BIOL CHEM, V263, P12274; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MADER S, 1993, J BIOL CHEM, V268, P591; MANEHADO C, 1994, BIOCHEM J, V302, P695; Mangelsdorf D J, 1994, Nutr Rev, V52, pS32, DOI 10.1111/j.1753-4887.1994.tb01385.x; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; NICHOLLS DG, 1986, BROWN ADIPOSE TISSUE, P52; PAPPU HR, 1989, FOCUS, V11, P6; POTHIER F, 1992, DNA CELL BIOL, V11, P83, DOI 10.1089/dna.1992.11.83; REHNMARK S, 1993, FEBS LETT, V318, P235, DOI 10.1016/0014-5793(93)80519-Z; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; RICQUIER D, 1993, EUR J BIOCHEM, V218, P785, DOI 10.1111/j.1432-1033.1993.tb18433.x; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; RICQUIER D, 1992, FEBS LETT, V303, P103, DOI 10.1016/0014-5793(92)80496-4; ROTHWELL NJ, 1986, BROWN ADIPOSE TISSUE, P269; ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814, DOI 10.1128/MCB.11.7.3814; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SJOGREN S, 1977, ACTA ODONTOL SCAND, V35, P311, DOI 10.3109/00016357709064130; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; STUNNENBERG HG, 1993, BIOESSAYS, V15, P309, DOI 10.1002/bies.950150504; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; TEBOUL M, 1992, ENDOCRINOLOGY, V130, P1475, DOI 10.1210/en.130.3.1475; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; WAN YJY, 1992, LAB INVEST, V66, P646; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V204, P867, DOI 10.1006/bbrc.1994.2540	57	166	174	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5666	5673		10.1074/jbc.270.10.5666	http://dx.doi.org/10.1074/jbc.270.10.5666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890689	hybrid			2022-12-27	WOS:A1995QL58000108
J	JELTSCH, A; ALVES, J; URBANKE, C; MAASS, G; ECKSTEIN, H; ZHANG, LS; BAYER, E; PINGOUD, A				JELTSCH, A; ALVES, J; URBANKE, C; MAASS, G; ECKSTEIN, H; ZHANG, LS; BAYER, E; PINGOUD, A			A DODECAPEPTIDE COMPRISING THE EXTENDED CHAIN-ALPHA-4 REGION OF THE RESTRICTION-ENDONUCLEASE ECORI SPECIFICALLY BINDS TO THE ECORI RECOGNITION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; DNA-BINDING; SUBSTRATE RECOGNITION; CLEAVAGE; MUTANTS; OLIGODEOXYNUCLEOTIDES; MUTAGENESIS; SEQUENCES; MECHANISM; CATALYSIS	The restriction endonuclease EcoRI binds and cleaves DNA containing GAATTC sequences with high specificity. According to the crystal structure, most of the specific contacts of the enzyme to the DNA are formed by the extended chain region and the first turn of alpha-helix alpha 4 (amino acids 137-145). Here, we demonstrate that a dodecapeptide (WDGMAAGNAIER), which is identical in the underlined parts of its sequence to EcoRI amino acids 137-145, specifically binds to GAATTC sequences. The peptide inhibits DNA cleavage by EcoRI but not by BamHI, BclI, EcoRV, HindIII, PacI, and XbaI. DNA cleavage by XbaI is slowed down at sites that partially overlap with EcoRI sites. The peptide inhibits cleavage of GAATTC sites by ApoI, which recognizes the sequence RAATTY. It interferes with DNA methylation by the EcoRI methyltransferase but not by the BamHI methyltransferase. It competes with EcoRI for DNA binding. Based on these results, the DNA binding constant of the peptide to GAATTC sequences was calculated to be 3 x 10(4) M(-1). DNA binding is not temperature-dependent, suggesting that binding of the peptide is entropy driven. As the peptide does not show any nonspecific binding to DNA, its DNA binding specificity is similar to that of EcoRI, in spite of the fact that the affinity is much smaller. These results suggest that contacts to the phosphate groups in EcoRI mainly provide binding affinity, whereas the specificity of EcoRI is based to a large ex tent on sequence-specific base contacts.	UNIV GIESSEN,INST BIOCHEM,FB 15,D-35392 GIESSEN,GERMANY; HANNOVER MED SCH,ZENTRUM BIOCHEM,D-30623 HANNOVER,GERMANY; UNIV TUBINGEN,INST ORGAN CHEM,D-72076 TUBINGEN,GERMANY	Justus Liebig University Giessen; Hannover Medical School; Eberhard Karls University of Tubingen			Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290				ALVES J, 1989, BIOCHEMISTRY-US, V28, P2678, DOI 10.1021/bi00432a047; ALVES J, 1989, BIOCHEMISTRY-US, V28, P7879, DOI 10.1021/bi00445a050; BRENNAN CA, 1986, J BIOL CHEM, V261, P7279; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; FISCHER E, 1894, BER DTSCH CHEM GES, V257, P2985; FLIESS A, 1988, NUCLEIC ACIDS RES, V16, P11781, DOI 10.1093/nar/16.24.11781; FLIESS A, 1986, NUCLEIC ACIDS RES, V14, P3463, DOI 10.1093/nar/14.8.3463; FRITZ A, 1994, THESIS U HANNOVER; GARDNER RC, 1982, DNA-J MOLEC CELL BIO, V1, P109, DOI 10.1089/dna.1.1982.1.109; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; GEIGER R, 1989, BIOCHEMISTRY-US, V28, P2667, DOI 10.1021/bi00432a046; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HEITMAN J, 1990, PROTEINS, V7, P185, DOI 10.1002/prot.340070207; HEITMAN J, 1990, EMBO J, V9, P3369, DOI 10.1002/j.1460-2075.1990.tb07538.x; HEITMAN J, 1993, GENETIC ENG, P57; HSU MT, 1978, BIOCHEMISTRY-US, V17, P131, DOI 10.1021/bi00594a019; JELTSCH A, 1994, BIOCHEMISTRY-US, V33, P10215, DOI 10.1021/bi00200a001; JELTSCH A, 1993, P NATL ACAD SCI USA, V90, P8499, DOI 10.1073/pnas.90.18.8499; JELTSCH A, 1993, ANAL BIOCHEM, V213, P234, DOI 10.1006/abio.1993.1415; JELTSCH A, 1993, J MOL BIOL, V229, P221, DOI 10.1006/jmbi.1993.1019; KIM Y, 1993, STRUCTURAL BIOL STAT, V1, P225; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; KING K, 1989, J BIOL CHEM, V264, P11807; KOZIOLKIEWICZ M, 1992, BIOCHEMISTRY-US, V31, P9460, DOI 10.1021/bi00154a019; LANGOWSKI J, 1981, NUCLEIC ACIDS RES, V9, P3483, DOI 10.1093/nar/9.14.3483; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MATTAJ IW, 1994, CELL, V73, P837; MCCLARIN JA, 1986, SCIENCE, V234, P1526, DOI 10.1126/science.3024321; MCLAUGHLIN LW, 1987, BIOCHEMISTRY-US, V26, P7238, DOI 10.1021/bi00397a007; NEEDELS MC, 1989, P NATL ACAD SCI USA, V86, P3579, DOI 10.1073/pnas.86.10.3579; OELGESCHLAGER T, 1990, GENE, V89, P19, DOI 10.1016/0378-1119(90)90201-2; OSUNA J, 1991, GENE, V106, P7, DOI 10.1016/0378-1119(91)90559-T; POWELL MJD, 1965, COMPUT J, V7, P303, DOI 10.1093/comjnl/7.4.303; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; ROBERTS RJ, 1993, NUCLEASES, P439; ROSENBERG JM, 1982, DNA-J MOLEC CELL BIO, V1, P117, DOI 10.1089/dna.1.1982.1.117; Rosenberg JM, 1991, CURR OPIN STRUC BIOL, V1, P104, DOI 10.1016/0959-440X(91)90018-O; Sambrook J, 1989, MOL CLONING LABORATO; SIKSNYS V, 1994, GENE, V142, P1, DOI 10.1016/0378-1119(94)90347-6; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TALANIAN RV, 1992, BIOCHEMISTRY-US, V31, P6871, DOI 10.1021/bi00145a002; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; THIELKING V, 1990, BIOCHEMISTRY-US, V29, P4682, DOI 10.1021/bi00471a024; WATERS TR, 1992, ANAL BIOCHEM, V204, P585; WOLBERGER C, 1993, CURR OPIN STRUC BIOL, V3, P3, DOI 10.1016/0959-440X(93)90194-P; ZHANG L, 1990, PEPTIDES 1990, P196	49	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5122	5129		10.1074/jbc.270.10.5122	http://dx.doi.org/10.1074/jbc.270.10.5122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890621	hybrid			2022-12-27	WOS:A1995QL58000028
J	AMES, JB; PORUMB, T; TANAKA, T; IKURA, M; STRYER, L				AMES, JB; PORUMB, T; TANAKA, T; IKURA, M; STRYER, L			AMINO-TERMINAL MYRISTOYLATION INDUCES COOPERATIVE CALCIUM-BINDING TO RECOVERIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INDUCED CONFORMATIONAL CHANGE; ROD GUANYLATE-CYCLASE; MULTIDIMENSIONAL NMR; GLOBULAR DOMAINS; SKELETAL-MUSCLE; PEPTIDE COMPLEX; CA2+ BINDING; TROPONIN-C; CALMODULIN	Recoverin, a new member of the EF-hand protein superfamily, serves as a Ca2+ sensor in vision, A myristoyl or related N-acyl group covalently attached to the amino terminus of recoverin enables it to bind to disc membranes when the Ca2+ level is elevated. Ca2+-bound recoverin prolongs the lifetime of photoexcited rhodopsin, most likely by blocking its phosphorylation, We report here Ca2+ binding studies of myristoylated and unmyristoylated recombinant recoverin using flow dialysis, fluorescence, and NMR spectroscopy, Unmyristoylated recoverin exhibits heterogeneous and uncooperative binding of two Ca2+ with dissociation constants of 0.11 and 6.9 mu M. In contrast, two Ca2+ bind cooperatively to myristoylated recoverin with a Hill coefficient of 1.75 and an apparent dissociation constant of 17 mu M. Thus, the attached myristoyl group lowers the calcium affinity of the protein and induces cooperativity in Ca2+ binding, One-dimensional H-1 and two-dimensional N-15-H-1 shift correlation NMR spectra of myristoylated recoverin measured as a function of Ca2+ concentration show that a concerted conformational change occurs when two Ca2+ are bound. The Ca2+ binding and NMR data can be fit to a concerted allosteric model in which the two Ca2+ binding sites have different affinities in both the T and R states, The T and R conformational states are defined in terms of the Ca2+-myristoyl switch; in the T state, the myristoyl group is sequestered inside the protein, whereas in the R state, the myristoyl group is extruded, Ca2+ binds to the It state at least 10,000-fold more tightly than to T, In this model, the dissociation constants of the two sites in the It state of the myristoyl ated protein are 0.11 and 6.9 mu M, as in unmyristoylated recoverin, The ratio of the unliganded form of T to that of R is estimated to be 400 for myristoylated and <0.05 for unmyristoylated recoverin, Thus, the attached myristoyl group has two related roles: it shifts the T/R ratio of the unliganded protein more than 8000-fold, and serves as a membrane anchor for the fully Liganded protein.	STANFORD UNIV, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA; ONTARIO CANC INST, DIV MOLEC & STRUCT BIOL, TORONTO, ON M4X 1K9, CANADA; UNIV TORONTO, DEPT MED BIOPHYS, TORONTO, ON M4X 1K9, CANADA	Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto				Ikura, Mitsuhiko/0000-0002-9524-1303	NATIONAL EYE INSTITUTE [F32EY006418, R01EY002005, R37EY002005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024032, R37GM024032] Funding Source: NIH RePORTER; NEI NIH HHS [EY02005, EY06418-02] Funding Source: Medline; NIGMS NIH HHS [GM24032] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKKE M, 1991, J MOL BIOL, V220, P173, DOI 10.1016/0022-2836(91)90389-N; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Dahlquist F W, 1978, Methods Enzymol, V48, P270; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HAIECH J, 1981, BIOCHEMISTRY-US, V20, P3890, DOI 10.1021/bi00516a035; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; IIDA S, 1988, J BIOCHEM-TOKYO, V103, P482, DOI 10.1093/oxfordjournals.jbchem.a122296; IKURA M, 1983, BIOCHEMISTRY-US, V22, P2573, DOI 10.1021/bi00279a039; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KATAOKA M, 1993, J BIOCHEM-TOKYO, V114, P535, DOI 10.1093/oxfordjournals.jbchem.a124212; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLEVIT RE, 1984, EUR J BIOCHEM, V139, P109, DOI 10.1111/j.1432-1033.1984.tb07983.x; Koch K W, 1994, Rev Physiol Biochem Pharmacol, V125, P149, DOI 10.1007/BFb0030910; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MINOWA O, 1984, J BIOCHEM-TOKYO, V96, P1175, DOI 10.1093/oxfordjournals.jbchem.a134935; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OGAWA Y, 1986, J BIOCHEM-TOKYO, V99, P81, DOI 10.1093/oxfordjournals.jbchem.a135482; PORUMB T, 1994, ANAL BIOCHEM, V220, P227, DOI 10.1006/abio.1994.1332; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; THULIN E, 1984, BIOCHEMISTRY-US, V23, P1862, DOI 10.1021/bi00303a043; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TSUDA S, 1988, BIOCHEMISTRY-US, V27, P4120, DOI 10.1021/bi00411a032; WYLIE DC, 1988, CALMODULIN, P1; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; [No title captured]; [No title captured]	42	144	147	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4526	4533		10.1074/jbc.270.9.4526	http://dx.doi.org/10.1074/jbc.270.9.4526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876221	hybrid			2022-12-27	WOS:A1995QK08400054
J	GRIERSON, JP; MELDOLESI, J				GRIERSON, JP; MELDOLESI, J			SHEAR STRESS-INDUCED [CA2+](I) TRANSIENTS AND OSCILLATIONS IN MOUSE FIBROBLASTS ARE MEDIATED BY ENDOGENOUSLY RELEASED ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; LYSOPHOSPHATIDIC ACID; PHOSPHOINOSITIDASE-C; PHOSPHOLIPASE-C; RELAXING FACTOR; FREE CALCIUM; PC12 CELLS; RECEPTOR; FLOW; ACTIVATION	The effects of ATP, U-73122, apyrase, and saline shear stress on [Ca2+](i) homeostasis were studied in fura-2 loaded, mouse fibroblast cells (L929), both in suspension and plated on glass, Release of internal Ca2+ was induced by ATP, via a receptor identified pharmacologically as a P-2U type, In single cells, low concentrations of ATP evoked [Ca2+](i) oscillations, These events were blocked by the putative phospholipase C inhibitor, U-73122 (but not by the inactive analog U-73343) and by the ATP/ADPase, apyrase, In addition, both these agents reduced the [Ca2+](i) of unstimulated cells, especially after stirring, and blocked spontaneously occurring [Ca2+](i) oscillations, which suggested an already activated state of the ATP receptor, independent from exogenous stimulations, Moreover, it was found that stirring of the cells was correlated with a steady accumulation of inositol phosphates, also blockable by apyrase, and that [Ca2+](i) mobilization could be induced by puffs of saline in single cells, The transition to a Ca2+-free environment also provoked [Ca2+](i) oscillations, most likely via the increase in ATP(4-) concentration, This evidence suggests that endogenous ATP is released from L fibroblasts in response to fluid shear stress, and this results in an autocrine, tonic up-regulation of the phosphoinositide signaling system and an ensuing alteration in Ca2+ homeostasis, Up until now, such a response to shear stress was believed to be unique to endothelial cells.	B CECCARELLI CTR,I-20132 MILAN,ITALY; S RAFFAELE SCI INST,DIBIT,I-20132 MILAN,ITALY		GRIERSON, JP (corresponding author), UNIV MILAN,CNR,DEPT PHARMACOL,VIA OLGETTINA 58,I-20132 MILAN,ITALY.							ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; ANDO J, 1991, BIOCHEM BIOPH RES CO, V179, P1192, DOI 10.1016/0006-291X(91)91698-C; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BHAGYALAKSHMI A, 1992, J VASC RES, V29, P443, DOI 10.1159/000158963; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BOEYNAEMS JM, 1990, TRENDS PHARMACOL SCI, V11, P34, DOI 10.1016/0165-6147(90)90039-B; DAVIDSON JS, 1990, ENDOCRINOLOGY, V126, P80, DOI 10.1210/endo-126-1-80; DURIEUX ME, 1993, TRENDS PHARMACOL SCI, V14, P249, DOI 10.1016/0165-6147(93)90021-B; FINE J, 1989, BIOCHEM J, V263, P371, DOI 10.1042/bj2630371; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; GROHOVAZ F, 1991, J CELL BIOL, V113, P1341, DOI 10.1083/jcb.113.6.1341; HAHN K, 1992, NATURE, V359, P736, DOI 10.1038/359736a0; HEBDA PA, 1993, DERMATOL CLIN, V11, P685, DOI 10.1016/S0733-8635(18)30221-3; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; JALINK K, 1990, J BIOL CHEM, V265, P12232; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; KORENAGA R, 1994, BIOCHEM BIOPH RES CO, V198, P213, DOI 10.1006/bbrc.1994.1030; LIN TA, 1993, J NEUROCHEM, V60, P1115, DOI 10.1111/j.1471-4159.1993.tb03262.x; MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571; MILNER P, 1990, BIOCHEM BIOPH RES CO, V170, P649, DOI 10.1016/0006-291X(90)92141-L; MUALLEM S, 1989, J BIOL CHEM, V264, P205; MURRIN RJA, 1992, MOL PHARMACOL, V41, P561; NIEWIAROWSKI S, 1973, J LAB CLIN MED, V82, P605; OCONNOR SE, 1991, TRENDS PHARMACOL SCI, V12, P137, DOI 10.1016/0165-6147(91)90530-6; OIKI S, 1988, J MEMBRANE BIOL, V105, P23, DOI 10.1007/BF01871103; OKADA Y, 1982, J PHYSIOL-LONDON, V327, P449, DOI 10.1113/jphysiol.1982.sp014242; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RUBANYI GM, 1986, AM J PHYSIOL, V250, P1145, DOI 10.1152/ajpheart.1986.250.6.H1145; SHEN J, 1992, AM J PHYSIOL, V262, pC384, DOI 10.1152/ajpcell.1992.262.2.C384; WATSON S, 1993, TRENDS PHARM SCI S, V14, P38; WOJCIKIEWICZ RJH, 1993, TRENDS PHARMACOL SCI, V14, P279, DOI 10.1016/0165-6147(93)90131-3	34	97	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4451	4456		10.1074/jbc.270.9.4451	http://dx.doi.org/10.1074/jbc.270.9.4451			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876211	hybrid			2022-12-27	WOS:A1995QK08400043
J	HII, CST; FERRANTE, A; EDWARDS, YS; HUANG, ZH; HARTFIELD, PJ; RATHJEN, DA; POULOS, A; MURRAY, AW				HII, CST; FERRANTE, A; EDWARDS, YS; HUANG, ZH; HARTFIELD, PJ; RATHJEN, DA; POULOS, A; MURRAY, AW			ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE BY ARACHIDONIC-ACID IN RAT-LIVER EPITHELIAL WB CELLS BY A PROTEIN-KINASE C-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							POLYUNSATURATED FATTY-ACIDS; MAP KINASE; HUMAN-NEUTROPHILS; RECEPTOR; ISLETS; CA-2+; RAF-1	Arachidonic acid (20:4(n-6)), which is released by cells responding to a wide range of stimuli, may play an important role in intracellular signaling. We now report that incubation of WB cells with 20:4(n-6) resulted in the appearance of several tyrosine-phosphorylated cytosolic proteins. Two of the phosphotyrosine-containing proteins, migrating in SDS-polyacrylamide gels of approximately 43 and 45 kDa, corresponded in mobility to phosphorylated species of the 42- and 44-kDa mitogen-activated protein kinase (MAPK) isoforms. Immunoblots of soluble fractions from unstimulated WR cells with anti-MAPK antibodies revealed the presence of the 42- and 44 kDa isoforms of MAPK. Upon incubation with 20:4(n-6), the mobility of both isoforms was retarded, consistent with their activation by phosphorylation. Chromatography of soluble fractions from these cells on Mono Q columns revealed early and late eluting peaks of myelin basic protein kinase activity, which contained the 42- and 44-kDa MAPK isoforms, respectively. Activation of MAPK was transient, peaking at 5 min, and was detectable at 5 mu M 20:4(n-6). Further studies into the mechanisms by which MAPK was activated by 20:4(n-6) strongly suggested the involvement of protein kinase C (PRC). Not only did incubation of WB cells with 20:4(n-6) result in the translocation of PKC alpha, delta, and epsilon to a particulate fraction, it was found that the fatty acid failed to activate MAPK in cells pretreated for 26 h with phorbol la myristate 13-acetate, which depleted WE cells of PKC alpha, delta, and epsilon. In addition, fatty acids of the n-3 series were effective activators of MAPK. The present study, to our knowledge, is the first to report that polyunsaturated fatty acids can cause the activation of MAPK.	WOMENS & CHILDRENS HOSP,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA; FLINDERS UNIV S AUSTRALIA,SCH BIOL SCI,BEDFORD PK,SA 5042,AUSTRALIA	Womens & Childrens Hospital Australia; Flinders University South Australia	HII, CST (corresponding author), WOMENS & CHILDRENS HOSP,DEPT IMMUNOL,ADELAIDE,SA 5006,AUSTRALIA.		Hartfield, Perry/B-1139-2012					ABRAMSON SB, 1991, J IMMUNOL, V147, P231; ANEL A, 1994, J BIOL CHEM, V269, P9506; AYLSWORTH CF, 1986, CANCER RES, V46, P4527; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; BAND AM, 1992, J MOL ENDOCRINOL, V8, P95, DOI 10.1677/jme.0.0080095; BATES EJ, 1992, J LEUKOCYTE BIOL, V53, P420; Bazan NG, 1992, ESSENTIAL FATTY ACID, P107; BELCH JJF, 1992, ESSENTIAL FATTY ACID, P356; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHAO TSO, 1994, J BIOL CHEM, V269, P7337; CHOW SC, 1990, J BIOL CHEM, V265, P902; CLARKE SD, 1993, PROG LIPID RES, V32, P139, DOI 10.1016/0163-7827(93)90013-M; FERRANTE A, 1994, J CLIN INVEST, V93, P1063, DOI 10.1172/JCI117056; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; GOLUBIC M, 1991, EMBO J, V10, P2897, DOI 10.1002/j.1460-2075.1991.tb07839.x; HARDY SJ, 1994, J NEUROCHEM, V62, P1546; HII CST, 1994, BIOCHEM J, V303, P475, DOI 10.1042/bj3030475; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; KHAN WA, 1994, J BIOL CHEM, V269, P9729; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; NAKAMURA K, 1989, EUR J PHARMACOL, V160, P61, DOI 10.1016/0014-2999(89)90654-7; PEPPELENBOSCH MP, 1993, CELL, V74, P565, DOI 10.1016/0092-8674(93)80057-L; SAMIEI M, 1993, BIOCHIM BIOPHYS ACTA, V1176, P287, DOI 10.1016/0167-4889(93)90057-V; WARNER LC, 1993, ONCOGENE, V8, P3249; WOLF BA, 1986, J BIOL CHEM, V261, P3501; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	33	105	105	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4201	4204		10.1074/jbc.270.9.4201	http://dx.doi.org/10.1074/jbc.270.9.4201			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876176	hybrid			2022-12-27	WOS:A1995QK08400006
J	SELBY, CP; SANCAR, A				SELBY, CP; SANCAR, A			STRUCTURE AND FUNCTION OF TRANSCRIPTION-REPAIR COUPLING FACTOR .1. STRUCTURAL DOMAINS AND BINDING-PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-SPECIFIC REPAIR; COLI RNA-POLYMERASE; ESCHERICHIA-COLI; TERNARY COMPLEXES; GENE; PURIFICATION; INVITRO; UVRA	The 130-kDa mfd gene product is required for coupling transcription to repair in Escherichia coli. Mfd displaces E. coli RNA polymerase (Pol) stalled at a lesion, binds to the damage recognition protein UvrA, and increases the template strand repair rate during transcription. Here, the interactions of Mfd (transcription-repair coupling factor, TRCF) with DNA, RNA Pol, and UvrA were investigated, TRCF bound nonspecifically to double stranded DNA; binding to DNA produced alternating DNase I-protected and -hypersensitive regions, suggesting possible wrapping of the DNA around the enzyme. Weaker binding to single stranded DNA and no binding to single stranded RNA were observed. DNA binding required ATP, and hydrolysis of ATP promoted dissociation. Removal of a stalled RNA Pol also requires ATP hydrolysis. Apparently, TRCF recognizes a stalled elongation complex by directly interacting with RNA Pol, since binding to a synthetic transcription bubble was no stronger than binding to double stranded DNA, and binding to free RNA Pol holoenzyme and to initiation and elongation complexes in the absence of adenosine 5'-O-(thiotriphosphate) were observed. Structure-function analysis showed that residues 379-571 are involved in binding to a stalled RNAP. The helicase mo tifs region, residues 571-931, binds to ATP and duplex polynucleotide (DNA:DNA or DNA:RNA). Dissociation of the ternary complex upon hydrolysis of ATP also requires the carboxyl terminus of TRCF, Finally, residues 1-378 bind to UvrA and deliver the damage recognition component of the excision nuclease to the lesion.			SELBY, CP (corresponding author), UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599, USA.				NIGMS NIH HHS [GM32833] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; FORMOSA T, 1991, METHOD ENZYMOL, V208, P24; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; KRUMMEL B, 1992, J MOL BIOL, V225, P221, DOI 10.1016/0022-2836(92)90917-9; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; OLLER AR, 1992, P NATL ACAD SCI USA, V89, P11036, DOI 10.1073/pnas.89.22.11036; REARDON JT, 1993, J BIOL CHEM, V268, P21301; RICHARDSON JP, 1993, CRIT REV BIOCHEM MOL, V281, P1; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; WASHBURN BK, 1991, J BACTERIOL, V173, P2569, DOI 10.1128/jb.173.8.2569-2575.1991; WITKIN EM, 1994, BIOESSAYS, V16, P437, DOI 10.1002/bies.950160613; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345	17	125	126	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4882	4889		10.1074/jbc.270.9.4882	http://dx.doi.org/10.1074/jbc.270.9.4882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876261	hybrid			2022-12-27	WOS:A1995QK08400099
J	SIEMEISTER, G; ALHASANI, H; KLEIN, HW; KELLNER, S; STREICHER, R; KRONE, W; MULLERWIELAND, D				SIEMEISTER, G; ALHASANI, H; KLEIN, HW; KELLNER, S; STREICHER, R; KRONE, W; MULLERWIELAND, D			RECOMBINANT HUMAN INSULIN-RECEPTOR SUBSTRATE-1 PROTEIN - TYROSINE PHOSPHORYLATION AND IN-VITRO BINDING OF INSULIN-RECEPTOR KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; PHOSPHATIDYLINOSITOL 3'-KINASE; SIGNAL TRANSMISSION; SH3 DOMAIN; IRS-1; CELLS; EXPRESSION; POLYMERASE; SUBUNIT; GENE	Insulin receptor substrate-1 (IRS-1) is a major endogenous substrate of the insulin receptor, To study the interaction of the insulin receptor with IRS-1 in vitro, we expressed in Escherichia coli the amino acids 516-777 of human IRS-1 (hIRS-p30) covering five potential tyrosine phosphorylation sites within YXXM motifs, Kinetic data for tyrosine phosphorylation of hIRS-p30 by partially purified insulin receptor and insulin-like growth factor I receptor and by baculovirus-expressed insulin receptor kinase domain were determined, Native insulin receptor demonstrated the highest affinity to hIRS-p30 (K-m = 6.8 +/- 0.6 mu M), followed by the insulin-like growth factor I receptor (K-m = 9.9 +/- 1.0 mu M). We used the soluble recombinant insulin receptor kinase domain, which phosphorylated hIRS-p30 with high affinity (K-m = 11.9 +/- 0.8 mu M), and affinity columns prepared by coupling hIRS-p30 to NHS-activated Sepharose for binding assays, The insulin receptor kinase domain phosphorylated the hIRS-p30 on the column, was bound by the immobilized hIRS-p30, and was eluted with high salt buffer, Autophosphorylated and EDTA-inactivated insulin receptor kinase domain was bound only by immobilized hIRS-p30 protein that had been prephosphorylated, Our results indicate that the recombinant hIRS-p30 protein is a high affinity substrate for insulin receptor and insulin-like growth factor I receptor in vitro, Moreover, we show that only tyrosine-phosphorylated hIRS-p30 is able to bind to the insulin receptor.	UNIV COLOGNE, INNERE MED KLIN & POLIKLIN 2, D-50924 COLOGNE, GERMANY; UNIV DUSSELDORF, DIABET FORSCHUNGSINST, D-40225 DUSSELDORF, GERMANY	University of Cologne; Heinrich Heine University Dusseldorf								ALHASANI H, 1994, FEBS LETT, V349, P17, DOI 10.1016/0014-5793(94)00632-6; ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; HEIDENREICH K, 1994, BIOL CHEM H-S, V375, P99, DOI 10.1515/bchm3.1994.375.2.99; KABURAGI Y, 1993, J BIOL CHEM, V268, P16610; KAHN CR, 1993, HORM RES, V39, P93, DOI 10.1159/000182793; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KASUGA M, 1985, METHOD ENZYMOL, V109, P609; Keller Susanne R., 1994, Trends in Cell Biology, V4, P115, DOI 10.1016/0962-8924(94)90065-5; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; NISHIYAMA M, 1992, BIOCHEM BIOPH RES CO, V183, P280, DOI 10.1016/0006-291X(92)91640-C; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHITE MF, 1987, J BIOL CHEM, V262, P9769; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; YONEZAWA K, 1992, J BIOL CHEM, V267, P25958	36	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4870	4874		10.1074/jbc.270.9.4870	http://dx.doi.org/10.1074/jbc.270.9.4870			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876259	hybrid			2022-12-27	WOS:A1995QK08400097
J	TOMONAGA, T; LEVENS, D				TOMONAGA, T; LEVENS, D			HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-K IS A DNA-BINDING TRANSACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; ESCHERICHIA-COLI; PROTEIN; GENE; PURIFICATION; EXPRESSION; ACID; FMR1	We have previously reported that heterogeneous nuclear ribonucleoprotein K (hnRNP K) binds to the pyrimidine-rich strand of the CT element found in the human c-myc gene and activates CT reporter-driven gene expression in vivo. We now characterize the DNA and protein requirements for the interaction of hnRNP K with the CT element, First, hnRNP K is shown to preferentially bind single-stranded DNA over RNA or native double-stranded DNA Using specific oligoribonucleotide or deoxyribonucleotide probes with specific or nonspecific RNA or DNA competitors, electrophoretic mobility shift assay revealed hnRNP K: to be a DNA-binding protein. Specific binding was not simply a reflection of binding to pyrimidine-rich sequences as the number and arrangement of individual CT elements governed interactions with hnRNP K; at least two CT repeats separated by at least three nucleotides are required for binding, indicating the existence of particular stereochemical constraints regulating CT-hnRNP K complex formation. Deletion analysis showed that hnRNP K possesses several nonoverlapping, DNA binding domains, each capable of specific: binding with the CT element and preferring DNA over RNA. Each sequence recognition domain is composed of at least one K homology motif, while a larger portion of hnRNP It may be required for stable RNA binding, Additional experiments indicate that the N-terminal 35 residues of hnRNP K are necessary for transactivating the CT element. These results indicate that hnRNP K is a RNA-binding protein and transcriptional activator.	NCI,PATHOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Levens, David/C-9216-2009	Levens, David/0000-0002-7616-922X				ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HOBERT O, 1994, J BIOL CHEM, V269, P20225; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; ITO K, 1994, NUCLEIC ACIDS RES, V22, P53, DOI 10.1093/nar/22.1.53; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; PAVLOV AR, 1994, J BIOL CHEM, V269, P12968; PELHAM HRB, 1988, P NATL ACAD SCI USA, V77, P4170; RUSSEL M, 1976, J BIOL CHEM, V251, P7263; SHIMAMOTO N, 1987, NUCLEIC ACIDS RES, V15, P5241, DOI 10.1093/nar/15.13.5241; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; VONHIPPEL PH, 1982, J MOL BIOL, V162, P795, DOI 10.1016/0022-2836(82)90548-4; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L	29	167	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4875	4881		10.1074/jbc.270.9.4875	http://dx.doi.org/10.1074/jbc.270.9.4875			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876260	hybrid			2022-12-27	WOS:A1995QK08400098
J	ANDJELKOVIC, M; JONES, PF; GROSSNIKLAUS, U; CRON, P; SCHIER, AF; DICK, M; BILBE, G; HEMMINGS, BA				ANDJELKOVIC, M; JONES, PF; GROSSNIKLAUS, U; CRON, P; SCHIER, AF; DICK, M; BILBE, G; HEMMINGS, BA			DEVELOPMENTAL REGULATION OF EXPRESSION AND ACTIVITY OF MULTIPLE FORMS OF THE DROSOPHILA RAC PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; SIGNALING PROTEINS; CATALYTIC SUBUNIT; BINDING-PROTEIN; GENE; SEQUENCE; RECEPTOR; ENCODES; FAMILY; LOCUS	We have characterized the Drosophila homologue of the proto-oncogenic RAG protein kinase (DRAG-PH). The DRAG-PH gene gives rise to two transcripts with the same coding potential, generated by the use of two different polyadenylation signals. Each transcript encodes two polypeptides because of the presence of a weaker initiator ACG codon, upstream hom the major AUG, such that the larger protein contains an N-terminal extension. Like the human isoforms, DRAC-PKs possess a novel signaling region, the pleckstrin homology domain. DRAG-PH proteins have a similar expression pattern, being regulated both maternally and zygotically, and are expressed throughout Drosophila development. Antisera specific for recombinant DRAG-PR and for its C terminus detected two polypeptides of 66 and 85 kDa in Drosophila extracts. The antirecombinant antisera also recognized a polypeptide of 120 kDa from Drosophila, which apparently shared an epitope related to DRAG-PH sequences. The role of p120 appears to be restricted compared with that of DRAG-PH, since it was not detected in larvae or adult flies. There was no spatial restriction of DRAG-PH expression during embryogenesis, suggesting that localized activation might be a regulatory mechanism for its function. DRAG-PH possesses an intrinsic kinase activity that is similar to 8-fold higher in adult flies than in 0-3-h embryos undergoing rapid mitotic cycles.	FRIEDRICH MIESCHER INST, CH-4002 BASEL, SWITZERLAND; UNIV BASEL, BIOZENTRUM, CH-4056 BASEL, SWITZERLAND; CIBA GEIGY LTD, BIOTECHNOL, CH-4002 BASEL, SWITZERLAND	Friedrich Miescher Institute for Biomedical Research; University of Basel; Novartis			Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Schier, Alexander Franz/0000-0001-7645-5325				AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; APPEL LF, 1993, P NATL ACAD SCI USA, V90, P4937, DOI 10.1073/pnas.90.11.4937; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BIGS WH, 1992, P NATL ACAD SCI USA, V89, P6295; BOECK R, 1992, J VIROL, V66, P1765, DOI 10.1128/JVI.66.3.1765-1768.1992; BOUROUIS M, 1990, EMBO J, V9, P2877, DOI 10.1002/j.1460-2075.1990.tb07477.x; BOYD L, 1993, P NATL ACAD SCI USA, V90, P9164, DOI 10.1073/pnas.90.19.9164; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESIMONE SM, 1993, MOL CELL BIOL, V13, P3641, DOI 10.1128/MCB.13.6.3641; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRANKE TF, 1994, ONCOGENE, V9, P141; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GROSSNIKLAUS U, 1989, DEVELOPMENT, V107, P189; GUPTA KC, 1994, BIOCHEM BIOPH RES CO, V201, P567, DOI 10.1006/bbrc.1994.1739; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLOW E, 1988, ANTIBODIES LABORATOR; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; INGLEY E, 1994, IN PRESS J CELL BIOC, V56, P436; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KALDERON D, 1988, GENE DEV, V2, P1539, DOI 10.1101/gad.2.12a.1539; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MELNICK MB, 1993, DEVELOPMENT, V118, P127; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; OHSAKO S, 1993, J BIOL CHEM, V268, P2052; OSADA S, 1990, J BIOL CHEM, V265, P22434; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SAVANTBHONSALE S, 1992, GENE DEV, V6, P1927, DOI 10.1101/gad.6.10.1927; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; SHOJI S, 1983, BIOCHEMISTRY-US, V22, P3702, DOI 10.1021/bi00284a025; SIEGFRIED E, 1990, TRENDS GENET, V6, P357, DOI 10.1016/0168-9525(90)90277-D; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; SUGAYA R, 1994, J BIOCHEM, V115, P150, DOI 10.1093/oxfordjournals.jbchem.a124292; SUGIHARA H, 1990, J BIOL CHEM, V265, P21714; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WINICK J, 1993, DEVELOPMENT, V119, P1055; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160	72	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4066	4075		10.1074/jbc.270.8.4066	http://dx.doi.org/10.1074/jbc.270.8.4066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876156	hybrid			2022-12-27	WOS:A1995QH68800089
J	CHEN, ZQ; LEFEBVRE, D; BAI, XH; REAUME, A; ROSSANT, J; LYE, SJ				CHEN, ZQ; LEFEBVRE, D; BAI, XH; REAUME, A; ROSSANT, J; LYE, SJ			IDENTIFICATION OF 2 REGULATORY ELEMENTS WITHIN THE PROMOTER REGION OF THE MOUSE CONNEXIN-43 GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTION PROTEIN; MAMMALIAN-CELLS; MESSENGER-RNA; EXPRESSION; RAT; COMMUNICATION; TRANSCRIPTION; PROGESTERONE; PREGNANCY; ESTROGEN	To define the minimal sequences required for expression of the connexin 43 gene (cx43) in myometrial cells, we generated 5' deletion constructs of a fragment extending 1686 base pairs upstream and 162 base pairs downstream of the transcription start site and determined their ability to drive expression of the chloramphenicol acetyltransferase reporter gene in transfected myometrial cell lines, Our investigation revealed two cis-acting regulatory elements within this fragment, Deletion of a region extending from -102 to -92 led to an increase of the promoter activity by greater than 10-fold, indicating a presence of a repressor element, Deletion of a region extending from -72 to -62 caused a decrease of the promoter activity of a similar extent, implying the existence of a positive element, Electrophoretic mobility shift assays demonstrated that synthetic oligonucleotides derived from these two small regions can each bind with a nuclear protein(s) prepared from myometrial cells, and an introduction of three and two base substitutions into each of these oligomers was sufficient to abolish their protein binding capability, These same mutations, when incorporated in the chloramphenicol acetyltransferase constructs, diminished regulatory functions of the negative and positive elements, and the protein(s) that bind to these functional elements was found in several tissues known to express cx43 gene,	UNIV TORONTO, DEPT OBSTET & GYNAECOL, TORONTO, ON M5S 1A8, CANADA; UNIV TORONTO, DEPT MED & MOLEC GENET, TORONTO, ON M5S 1A8, CANADA	University of Toronto; University of Toronto	CHEN, ZQ (corresponding author), MT SINAI HOSP, SAMUEL LUNENFELD RES INST, PROGRAM DEV & FETAL HLTH, 600 UNIV AVE, TORONTO, ON M5G 1X5, CANADA.		Lye, Stephen J/E-7269-2013	Lye, Stephen J/0000-0002-3305-4406				BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; CHOW L, 1994, AM J OBSTET GYNECOL, V170, P788, DOI 10.1016/S0002-9378(94)70284-5; DELEON JR, 1994, J MOL CELL CARDIOL, V26, P379, DOI 10.1006/jmcc.1994.1047; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; GARFIELD RE, 1988, ONSET LABOR CELLULAR, P55; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM F, 1978, VIROLOGY, V52, P456; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KIRKMAN H, 1970, CANCER RES, V30, P794; LANG LM, 1991, AM J PHYSIOL, V260, pE787, DOI 10.1152/ajpendo.1991.260.5.E787; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; LI ZY, 1993, AM J PHYSIOL, V265, pG911, DOI 10.1152/ajpgi.1993.265.5.G911; LOK S, 1989, NUCLEIC ACIDS RES, V17, P3563, DOI 10.1093/nar/17.9.3563; LYE SJ, 1993, ENDOCRINOLOGY, V132, P2380, DOI 10.1210/en.132.6.2380; MCNUTT CM, 1994, J ENDOCRINOL, V141, P195, DOI 10.1677/joe.0.1410195; MEAKIN SO, 1989, EXP EYE RES, V48, P131, DOI 10.1016/0014-4835(89)90026-2; MEHTA PP, 1992, MOL BIOL CELL, V3, P839, DOI 10.1091/mbc.3.8.839; PEREZREYES N, 1992, P NATL ACAD SCI USA, V89, P1224, DOI 10.1073/pnas.89.4.1224; PETROCELLI T, 1993, ENDOCRINOLOGY, V133, P284, DOI 10.1210/en.133.1.284; RISEK B, 1990, J CELL BIOL, V110, P269, DOI 10.1083/jcb.110.2.269; RISEK B, 1991, DEVELOPMENT, V113, P165; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SULLIVAN R, 1993, GENE, V130, P191, DOI 10.1016/0378-1119(93)90419-4; VALDIMARSSON G, 1991, MOL REPROD DEV, V30, P18, DOI 10.1002/mrd.1080300103; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WIESEN JF, 1993, ENDOCRINOLOGY, V133, P741, DOI 10.1210/en.133.2.741; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WINTERHAGER E, 1991, EUR J CELL BIOL, V55, P133; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018	30	83	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3863	3868		10.1074/jbc.270.8.3863	http://dx.doi.org/10.1074/jbc.270.8.3863			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876131	hybrid			2022-12-27	WOS:A1995QH68800061
J	PAN, M; STEVENS, BR				PAN, M; STEVENS, BR			DIFFERENTIATION-DEPENDENT AND PROTEIN KINASE-C-DEPENDENT REGULATION OF ALANINE TRANSPORT VIA SYSTEM-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-TRANSPORT; BORDER MEMBRANE-VESICLES; CELL-LINE CACO-2; INTESTINE; COLON; POTENT	The regulation of sodium-dependent L-alanine transport is described for the first time in intestinal cells, Substrate analogue inhibition patterns and Dixon analyses indicated that uptake occurred via transport system B, an epithelial cell variant of systems B-0,B-+ and ASC. System B served > 95% of the Na+-dependent alanine uptake in both undifferentiated (2 days postpassaging) and differentiated (> 9 days postpassaging) states of the human Caco-2 cultured intestinal cell line. (Methylamino)isobutyric acid-inhibitable system A transport accounted for < 5% of total alanine uptake. System B activity was greater in undifferentiated cells compared with the differentiated state, and activity at any differentiation state was stimulated by 12-O-tetradecanoylphorbol-13-acetate (TPA), The maximal stimulation, determined by TPA dose-response/exposure time data, was attributable to a change in cell transport capacity (V-max), with K-m unaffected. The V-max of system B was greater in 9-day-old cells (2.79 +/- 0.21 nmol min(-1) mg of protein(-1); K-m = 164 +/- 26 mu M alanine), decreasing to V-max = 0.51 +/- 0.03 nmol min(-1) mg of protein(-1) (K-m = 159 +/- 14 mu M) in 9-day-old cells. Regardless of differentiation status, the sodium-activation Hill coefficient was 1.06 +/- 0.10, and the alanine passive diffusion permeability coefficient was 0.53 +/- 0.08 mu l min(-1) mg of protein(-1). Phorbol ester up-regulated the V-max of system B in 2-day-old cells to V-max = 6.32 +/- 0.37 nmol min(-1) mg of protein(-1) (K-m = 169 +/- 18 mu M), and in 9-day-old cells to V-max = 1.42 +/- 0.05 nmole min(-1) mg of protein(-1) (K-m = 180 +/- 10 mu M). Phorbol ester stimulation of transport occurred after at least 6 h of continual exposure, and was blocked by the protein kinase C inhibitors chelerythrine or photoactivated calphostin C. Protein synthesis inhibitors cycloheximide and actinomycin D each blocked the phorbol ester upregulation of system B activity. It is concluded that Caco-2 cells regulate carrier-mediated sodium-dependent transport of L-alanine by changing the membrane capacity to transport alanine via system B and that this regulation involves de novo protein synthesis under the control of protein kinase C.	UNIV FLORIDA,COLL MED,DEPT PHYSIOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida								BERTRAN J, 1994, CELL PHYSIOL BIOCHEM, V4, P217, DOI 10.1159/000154728; BLAIS A, 1987, J MEMBRANE BIOL, V99, P113, DOI 10.1007/BF01871231; BRANDSCH M, 1994, BIOCHEM J, V299, P253, DOI 10.1042/bj2990253; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; BUDDINGTON RK, 1990, AM J PHYSIOL, V259, pG544, DOI 10.1152/ajpgi.1990.259.4.G544; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; DIAMOND J, 1991, NEWS PHYSIOL SCI, V6, P92, DOI 10.1152/physiologyonline.1991.6.2.92; GERENCSER GA, 1994, J EXP BIOL, V196, P59; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; KARASOV WH, 1989, ADAPTATION DEV GASTA, P157; KILBERG MS, 1993, ANNU REV NUTR, V13, P137, DOI 10.1146/annurev.nu.13.070193.001033; KOEPSELL H, 1994, CELL PHYSIOL BIOCHEM, V4, P206, DOI 10.1159/000154727; KONG CT, 1993, J BIOL CHEM, V268, P1509; MACKENZIE B, 1994, J BIOL CHEM, V269, P22488; MAENZ DD, 1992, J BIOL CHEM, V267, P22079; MAILLIARD M, 1995, IN PRESS GASTROENTER; MALO C, 1991, GASTROENTEROLOGY, V100, P1644, DOI 10.1016/0016-5085(91)90664-7; PINTO M, 1983, BIOL CELL, V47, P323; SALLOUM RM, 1991, AM J PHYSIOL, V261, pG22, DOI 10.1152/ajpgi.1991.261.1.G22; SALLOUM RM, 1990, J SURG RES, V48, P635, DOI 10.1016/0022-4804(90)90244-V; SEGAL IH, 1976, BIOCH CALCULATIONS, P441; SOUBA WW, 1992, BIOCHEM BIOPH RES CO, V188, P746, DOI 10.1016/0006-291X(92)91119-B; STEVENS BR, 1984, ANNU REV PHYSIOL, V46, P417; STEVENS BR, 1992, AM J PHYSIOL, V263, pR458, DOI 10.1152/ajpregu.1992.263.3.R458; STEVENS BR, 1992, MAMMALIAN AMINO ACID; TAMAOKI T, 1990, BIO-TECHNOL, V8, P732, DOI 10.1038/nbt0890-732; VANWINKLE LJ, 1988, BIOCHIM BIOPHYS ACTA, V947, P173, DOI 10.1016/0304-4157(88)90024-X	28	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3582	3587		10.1074/jbc.270.8.3582	http://dx.doi.org/10.1074/jbc.270.8.3582			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876094	hybrid			2022-12-27	WOS:A1995QH68800021
J	POKRYWKA, NJ; GOLDFARB, DS				POKRYWKA, NJ; GOLDFARB, DS			NUCLEAR EXPORT PATHWAYS OF TRANSFER-RNA AND 40-S RIBOSOMES INCLUDE BOTH COMMON AND SPECIFIC INTERMEDIATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BINDING-PROTEIN; XENOPUS-OOCYTES; PORE COMPLEX; TRANSPORT; SIGNALS; TRANSLOCATION; IMPORT; CELL	Different classes of RNAs are exported from Xenopus laevis oocyte nuclei by facilitated pathways. We have performed kinetic competition analyses to investigate the relationship between the export pathways of microinjected tRNA and ribosomal subunits. Saturating concentrations of ribosomal subunits do not compete tRNA export. Thus, the saturable factor in the ribosomal subunit export pathway is not limiting for tRNA export. The co-microinjection of ribosomal subunits did, however, stimulate the rate of tRNA export. Co-injected mRNA also stimulated tRNA export. tRNA export itself displays positive cooperative export kinetics that are abrogated by saturating concentrations of rRNA. These results are consistent with the existence of common high affinity RNA-binding sites that can be titrated with tRNA, rRNA or ribosomal subunits, and mRNA. Furthermore, high concentrations of tRNA are also shown to have moderate inhibitory effects on 40 S subunit export, indicating a lower affinity common intermediate also shared by mRNA.	UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627	University of Rochester								ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; BATAILLE N, 1990, J CELL BIOL, V111, P1571, DOI 10.1083/jcb.111.4.1571; CALZONE FJ, 1982, NUCLEIC ACIDS RES, V10, P2145, DOI 10.1093/nar/10.6.2145; DARGEMONT C, 1992, J CELL BIOL, V118, P1, DOI 10.1083/jcb.118.1.1; DELPOZZO G, 1994, J MOL BIOL, V240, P193, DOI 10.1006/jmbi.1994.1435; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; FISCHER U, 1991, J CELL BIOL, V113, P705, DOI 10.1083/jcb.113.4.705; FORBES DJ, 1992, ANNU REV CELL BIOL, V8, P495, DOI 10.1146/annurev.cb.08.110192.002431; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; HASELBECK RC, 1993, BIOCHEMISTRY-US, V32, P8575, DOI 10.1021/bi00084a026; HE XP, 1994, J CELL SCI, V107, P903; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Izaurralde E, 1992, Semin Cell Biol, V3, P279, DOI 10.1016/1043-4682(92)90029-U; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; KHANNAGUPTA A, 1989, P NATL ACAD SCI USA, V86, P1791, DOI 10.1073/pnas.86.6.1791; Krug RM, 1993, CURR OPIN CELL BIOL, V5, P944, DOI 10.1016/0955-0674(93)90074-Z; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Maquat LE, 1991, CURR OPIN CELL BIOL, V3, P1004, DOI 10.1016/0955-0674(91)90121-E; MELCHIOR F, 1993, J CELL BIOL, V269, P9289; MICHAUD N, 1993, EXP CELL RES, V208, P128, DOI 10.1006/excr.1993.1230; MICHAUD N, 1992, J CELL BIOL, V116, P851, DOI 10.1083/jcb.116.4.851; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; Sambrook J, 1989, MOL CLONING LABORATO; SCHEER U, 1988, NUCLEOCYTOPLASMIC TR, P5; SCHMIDTZACHMANN MS, 1993, CELL, V74, P493, DOI 10.1016/0092-8674(93)80051-F; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; TERNS MP, 1993, GENE DEV, V7, P1898, DOI 10.1101/gad.7.10.1898; TOBIAN JA, 1985, CELL, V43, P415, DOI 10.1016/0092-8674(85)90171-0; ZACHAR Z, 1993, J CELL BIOL, V121, P729, DOI 10.1083/jcb.121.4.729; ZASLOFF M, 1983, P NATL ACAD SCI-BIOL, V80, P6436, DOI 10.1073/pnas.80.21.6436	38	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3619	3624		10.1074/jbc.270.8.3619	http://dx.doi.org/10.1074/jbc.270.8.3619			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876098	hybrid			2022-12-27	WOS:A1995QH68800026
J	YEO, EJ; EXTON, JH				YEO, EJ; EXTON, JH			STIMULATION OF PHOSPHOLIPASE-D BY EPIDERMAL GROWTH-FACTOR REQUIRES PROTEIN-KINASE-C ACTIVATION IN SWISS 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE-DERIVED DIACYLGLYCEROL; PHORBOL 12-MYRISTATE 13-ACETATE; INOSITOL-LIPID HYDROLYSIS; GTP-BINDING PROTEIN; HUMAN-NEUTROPHILS; PERTUSSIS TOXIN; FACTOR RECEPTOR; ALPHA-THROMBIN; FATTY-ACIDS; D PATHWAY	The proposal that epidermal growth factor (EGF) activates phospholipase D (PLD) by a mechanism(s) not involving phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) hydrolysis was examined in Swiss 3T3 fibroblasts. EGF, basic fibroblast growth factor (bFGF), bombesin, and platelet-derived growth factor (PDGF) activated PLD as measured by transphosphatidylation of butanol to phosphatidylbutanol. The increase in inositol phosphates induced by bFGF, EGF, or bombesin was significantly enhanced by Re-31-8220, an inhibitor of protein kinase C (PKC), suggesting that PtdIns(4,5)P-2-hydrolyzing phospholipase is coupled to the receptors for these agonists but that the response is downregulated by PI(C. Activation of PLD by EGF was inhibited dose dependently by the PKC inhibitors bisindolylnaleimide and Re-31-8220, which also inhibited the effects of bFGF, bombesin, and PDGF. Downregulation of PRC by prolonged treatment with 4 beta-phorbol 12-myristate 13-acetate also abolished EGF- and PDGF-stimulated phosphatidylbutanol formation. EGF and bombesin induced biphasic translocations of PKC delta and epsilon to the membrane that were detectable at 15 s. In the presence of Re-31-8220, translocation of PKC alpha became evident, and membrane association of the delta- and E-isozymes was enhanced and/or sustained in response to the two agonists. The inhibitor also enhanced EGF-stimulated [H-3]diacylglycerol formation in cells preincubated with [H-3]arachidonic acid, which labeled predominantly phosphatidylinositol, but inhibited [H-3]diacylglycerol production in cells preincubated with [H-3]myristic acid, which labeled mainly phosphatidylcholine. These data support the conclusion that EGF can stimulate diacylglycerol formation from PtdIns(4,5)P-2 and that PKC performs the dual role of down-regulating this response as well as mediating phosphatidylcholine hydrolysis. In summary, all of the results of the study indicate that PLD activation by EGF is downstream of PtdIns(4,5)P-2-hydrolyzing phospholipase and is dependent upon subsequent PKC activation.	VANDERBILT UNIV,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT PHYSIOL & MOLEC BIOPHYS,NASHVILLE,TN 37232	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040919] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-40919] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGWU DE, 1991, J IMMUNOL, V146, P3895; AHMED A, 1994, AM J PHYSIOL, V266, pC206, DOI 10.1152/ajpcell.1994.266.1.C206; BALBOA MA, 1994, J BIOL CHEM, V269, P10511; BALBOA MA, 1992, J EXP MED, V176, P9, DOI 10.1084/jem.176.1.9; BENAV P, 1993, EUR J BIOCHEM, V215, P455, DOI 10.1111/j.1432-1033.1993.tb18054.x; BESTERMAN JM, 1986, J BIOL CHEM, V261, P723; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BRISCOE CP, 1994, BIOCHEM J, V298, P61, DOI 10.1042/bj2980061; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURNS DJ, 1990, J BIOL CHEM, V265, P12044; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; CONRICODE KM, 1994, FEBS LETT, V342, P149, DOI 10.1016/0014-5793(94)80490-7; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; COOK SJ, 1990, BIOCHEM J, V265, P617, DOI 10.1042/bj2650617; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; COOK SJ, 1991, BIOCHIM BIOPHYS ACTA, V1092, P265, DOI 10.1016/0167-4889(91)90166-U; COOK SJ, 1992, BIOCHEM J, V285, P247, DOI 10.1042/bj2850247; DAVIS PD, 1989, FEBS LETT, V259, P61, DOI 10.1016/0014-5793(89)81494-2; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DAVIS RJ, 1984, J BIOL CHEM, V259, P8545; ELDAR H, 1993, J BIOL CHEM, V268, P12560; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; EXTON JH, 1990, J BIOL CHEM, V265, P1; HA KS, 1993, J BIOL CHEM, V268, P10534; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HUANG CF, 1992, J BIOL CHEM, V267, P16859; HUANG CF, 1990, J BIOL CHEM, V265, P14858; JOHNSON RM, 1987, J BIOL CHEM, V262, P17285; KANAHO Y, 1992, J BIOL CHEM, V267, P23554; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LALLEMAIN G, 1986, FEBS LETT, V197, P344, DOI 10.1016/0014-5793(86)80354-4; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; LEE LS, 1979, P NATL ACAD SCI USA, V76, P5168, DOI 10.1073/pnas.76.10.5168; LEEBLUNDBERG LMF, 1985, P NATL ACAD SCI USA, V82, P5651, DOI 10.1073/pnas.82.17.5651; LYNCH CJ, 1985, J BIOL CHEM, V260, P2844; MCKINNON M, 1994, BBA-MOL CELL RES, V1222, P109, DOI 10.1016/0167-4889(94)90031-0; MOEHREN G, 1994, J BIOL CHEM, V269, P838; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PACHTER JA, 1992, J BIOL CHEM, V267, P9826; PAI JK, 1991, CELL REGUL, V2, P897, DOI 10.1091/mbc.2.11.897; PFEILSCHIFTER J, 1993, FEBS LETT, V331, P267, DOI 10.1016/0014-5793(93)80350-4; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; PLEVIN R, 1991, BIOCHEM J, V279, P559, DOI 10.1042/bj2790559; PRICE BD, 1989, BIOCHEM J, V264, P509, DOI 10.1042/bj2640509; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SIMPSON CMF, 1987, NEUROCHEMISTRY PRACT, P193; SONG JG, 1993, BIOCHEM J, V294, P711, DOI 10.1042/bj2940711; SONG JG, 1994, CELL GROWTH DIFFER, V5, P79; SWENDSEN CL, 1987, BIOCHIM BIOPHYS ACTA, V919, P79, DOI 10.1016/0005-2760(87)90220-7; TAKAYAMA H, 1987, BIOCHIM BIOPHYS ACTA, V922, P314; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WAHL M, 1988, J BIOL CHEM, V263, P7581; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WRIGHT TM, 1990, BIOCHEM J, V267, P501, DOI 10.1042/bj2670501; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374; YEO EJ, 1994, J BIOL CHEM, V269, P27823	64	143	143	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3980	3988		10.1074/jbc.270.8.3980	http://dx.doi.org/10.1074/jbc.270.8.3980			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876145	hybrid			2022-12-27	WOS:A1995QH68800078
J	YOUNG, EC; BERLINER, E; MAHTANI, HK; PEREZRAMIREZ, B; GELLES, J				YOUNG, EC; BERLINER, E; MAHTANI, HK; PEREZRAMIREZ, B; GELLES, J			SUBUNIT INTERACTIONS IN DIMERIC KINESIN HEAVY-CHAIN DERIVATIVES THAT LACK THE KINESIN ROD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE BRAIN KINESIN; DROSOPHILA KINESIN; ELECTRON-MICROSCOPY; EXPRESSION; IDENTIFICATION; MICROTUBULES; MOTILITY; SEQUENCE; MOVEMENT; PROTEIN	The N-terminal residues of the two heavy chains of the motor enzyme kinesin form two globular ''heads''; the heads are attached to a ''rod'' domain which is a two-stranded cu-helical colied-coli, Interaction between the heads is thought to be important to kinesin function, The rod may not be necessary for head-head interactions because a heavy chain N-terminal fragment containing only residues from the head and adjacent region forms dimers (Huang, T,-G,, Suhan, J,, and Hackney, D, D, (1994) J, Biol. Chem. 269, 16502-16507), However, the nature and stability of the subunit-subunit interactions in such derivatives are unclear, To examine the physical properties of heavy chain interaction in and near the head domains, we characterized the self-association behavior of two dimeric kinesin derivatives predicted (Lupas, k, van Dyke, Ri., and Stock, J, (1991) Science 252, 1162-1164) to lack the rod, Derivative K448-BIO contains the 448 N-terminal residues of Drosophila kinesin heavy chain fused at the C terminus to a a-residue Linker and a C-terminal fragment from Escherichia coli biotin carboxyl carrier protein; derivative K448-L is the same except that it lacks the biotin carboxyl carrier protein fragment, Both derivatives expressed in insect cells display microtubule-stimulated ATPase activity; K448-BIO also displays microtubule motility, Equilibrium sedimentation and gel filtration indicate that purified K448-BIO and H448-L at 0.02-0.4 mg/ml form homogeneous solutions of homodimers with no detectable formation of monomers or higher order oligomers, Derivative self-association is non covalent but extremely stable with an association constant greater than or equal to 2 x 10(8) M(-1). Stable subunit-subunit association induced by structures in and near the kinesin heads may be necessary for full mechanochemical function.	BRANDEIS UNIV, GRAD DEPT BIOCHEM, WALTHAM, MA 02254 USA; BRANDEIS UNIV, BIOPHYS PROGRAM, WALTHAM, MA 02254 USA; BRANDEIS UNIV, CTR COMPLEX SYST, WALTHAM, MA 02254 USA	Brandeis University; Brandeis University; Brandeis University				Young, Edgar C./0000-0002-8453-088X				AMOS LA, 1987, J CELL SCI, V87, P105; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BERLINER E, 1995, IN PRESS NATURE; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGLANDER SW, 1965, ANAL BIOCHEM, V12, P579, DOI 10.1016/0003-2697(65)90225-3; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GELLES J, 1995, IN PRESS BIOPHYS J; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; HENRIKSON KP, 1979, ANAL BIOCHEM, V94, P366, DOI 10.1016/0003-2697(79)90374-9; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HUANG TG, 1994, J BIOL CHEM, V269, P16502; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; KATO K, 1990, EUR J NEUROSCI, V2, P704, DOI 10.1111/j.1460-9568.1990.tb00460.x; KOSIK KS, 1990, J BIOL CHEM, V265, P3278; KUZNETSOV SA, 1989, J BIOL CHEM, V264, P589; KUZNETSOV SA, 1988, EMBO J, V7, P353, DOI 10.1002/j.1460-2075.1988.tb02820.x; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; PATEL N, 1993, P NATL ACAD SCI USA, V90, P9181, DOI 10.1073/pnas.90.19.9181; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; SAXTON WM, 1988, P NATL ACAD SCI USA, V85, P1109, DOI 10.1073/pnas.85.4.1109; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VANHOLDE KE, 1985, PHYSICAL BIOCH, P124; WRIGHT BD, 1991, J CELL BIOL, V113, P817, DOI 10.1083/jcb.113.4.817; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	47	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3926	3931		10.1074/jbc.270.8.3926	http://dx.doi.org/10.1074/jbc.270.8.3926			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876139	hybrid			2022-12-27	WOS:A1995QH68800070
J	HANADA, K; NISHIJIMA, M; AKAMATSU, Y; PAGANO, RE				HANADA, K; NISHIJIMA, M; AKAMATSU, Y; PAGANO, RE			BOTH SPHINGOLIPIDS AND CHOLESTEROL PARTICIPATE IN THE DETERGENT INSOLUBILITY OF ALKALINE-PHOSPHATASE, A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN, IN MAMMALIAN MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; GLYCOSYL-PHOSPHATIDYLINOSITOL; INTRACELLULAR-TRANSPORT; CULTURED-CELLS; SURFACE; GLYCOPROTEINS; BIOSYNTHESIS; ASSOCIATION; METABOLISM; REDUCTASE	SPB-1, a Chinese hamster ovary cell variant defective in serine palmitoyltransferase activity for sphingolipid synthesis, provides a useful system for studying the effects of sphingolipids and/or cholesterol deprivation on cellular functions and membrane properties. To investigate whether there was an interaction among sphingolipids, cholesterol, and glycosylphosphatidylinositol (GPI)-anchored proteins in biological membranes, we introduced human placental alkaline phosphatase (FLAP) in SPB-1 and in wild type cells by stable transfection and examined the effects of sphingolipid and/or cholesterol deprivation on the solubility of FLAP in Triton X-100. Although the FLAP solubility of the membranes isolated from the control cells in Triton X-100 was only 10%, deprivation of sphingolipid and cholesterol further enhanced the solubility, which reached 50% when both sphingolipids and cholesterol were deprived. The enhanced solubility was suppressed to the control level by metabolic complementation with exogenous sphingosine and cholesterol. The sphingolipid and cholesterol content of the isolated membranes changed independently, eliminating the possibility that sphingolipid deprivation induced a reduction in cellular cholesterol and enhanced FLAP solubility and vice versa. It was also unlikely that the enhanced solubility was due to structural changes in FLAP molecules since, regardless of sphingolipid and cholesterol deprivations, almost all FLAP had the GPI-anchor moiety and there were no differences in the apparent molecular weight of the protein in supernatant and precipitate fractions of the detergent-treated membranes. In addition, the expression level of caveolin in the isolated membranes was not significantly affected by sphingolipids and/or cholesterol depletion. These results indicated that both sphingolipids and cholesterol were involved in the FLAP insolubility and suggested that these lipids coordinately played a role in formation of Triton X-100-resistant complexes.	CARNEGIE INST WASHINGTON,DEPT EMBRYOL,BALTIMORE,MD 21210	Carnegie Institution for Science	HANADA, K (corresponding author), NATL INST HLTH,DEPT BIOCHEM & CELL BIOL,SHINJUKU KU,1-23-1 TOYAMA,TOKYO 162,JAPAN.			Hanada, Kentaro/0000-0003-1383-2781				BERGER J, 1989, P NATL ACAD SCI USA, V86, P1457, DOI 10.1073/pnas.86.5.1457; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRILES EB, 1977, J BIOL CHEM, V252, P1107; BROWN AG, 1976, J CHEM SOC PERK T 1, P1165, DOI 10.1039/p19760001165; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CINEK T, 1992, J IMMUNOL, V149, P2262; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DRABEROVA L, 1993, P NATL ACAD SCI USA, V90, P3611, DOI 10.1073/pnas.90.8.3611; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; GAMBLE W, 1978, J LIPID RES, V19, P1068; GARCIA M, 1993, J CELL SCI, V104, P1281; GLASER M, 1993, CURR OPIN STRUC BIOL, V3, P475, DOI 10.1016/0959-440X(93)90070-2; HANADA K, 1993, J BIOL CHEM, V268, P13820; HANADA K, 1992, J BIOL CHEM, V267, P23527; HANADA K, 1990, J BIOL CHEM, V265, P22137; HOESSLI D, 1985, EXP CELL RES, V156, P239, DOI 10.1016/0014-4827(85)90278-2; HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865; Ikezawa H, 1981, METHODS ENZYMOLOGY C, P731, DOI [10.1016/0076-6879(81)71086-3, DOI 10.1016/0076-6879(81)71086-3]; ITO M, 1993, EUR J BIOCHEM, V218, P637, DOI 10.1111/j.1432-1033.1993.tb18417.x; KANEKO I, 1978, EUR J BIOCHEM, V87, P313; KARLSSON KA, 1970, CHEM PHYS LIPIDS, V5, P6, DOI 10.1016/0009-3084(70)90008-3; KIM HS, 1983, J MEMBRANE BIOL, V75, P115, DOI 10.1007/BF01995631; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MCCOMB RB, 1972, CLIN CHEM, V18, P97; NAKAMURA K, 1984, ANAL BIOCHEM, V142, P406, DOI 10.1016/0003-2697(84)90484-6; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SLOTTE JP, 1994, CURR TOP MEMBR, V40, P483, DOI 10.1016/S0070-2161(08)60993-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VAZ WLC, 1993, CURR OPIN STRUC BIOL, V3, P482, DOI 10.1016/0959-440X(93)90071-R; WARNOCK DE, 1993, J BIOL CHEM, V268, P10145; White D.A., 1973, FORM FUNCTION PHOSPH; YOGEESWARAN G, 1974, BIOCHEM BIOPH RES CO, V56, P1010, DOI 10.1016/S0006-291X(74)80289-5; ZURZOLO C, 1994, EMBO J, V13, P42, DOI 10.1002/j.1460-2075.1994.tb06233.x	42	188	189	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6254	6260		10.1074/jbc.270.11.6254	http://dx.doi.org/10.1074/jbc.270.11.6254			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890763	hybrid			2022-12-27	WOS:A1995QM94500081
J	GAO, B; SPECTOR, MS; KUNOS, G				GAO, B; SPECTOR, MS; KUNOS, G			THE RAT ALPHA(1B) ADRENERGIC-RECEPTOR GENE MIDDLE PROMOTER CONTAINS MULTIPLE BINDING-SITES FOR SEQUENCE-SPECIFIC PROTEINS INCLUDING A NOVEL UBIQUITOUS TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR PROTEINS; MESSENGER-RNAS; KINASE-C; TISSUE; LIVER; CELLS; EXPRESSION; ALBUMIN; ELEMENT; PURIFICATION	Transcription of the rat alpha(1B) adrenergic receptor (alpha(1B)AR) gene in the liver is controlled by three promoters that generate three mRNAs. The middle promoter (P2), located between -432 and -813 base pairs upstream from the translation start codon and lacking a TATA box, is responsible for generating the major, 2.7-kilobase mRNA species expressed in many tissues (Gao, B., and Kunos, G. (1994) J. Biol. Chem. 269, 15762-15767). DNase I footprinting using rat liver nuclear extracts identified three protected regions in P2: footprint I (-432 to -452), footprint II(-490 to -540), and footprint III (-609 to -690). Putative response elements in footprints I and III were not analyzed except the AP2 binding site in footprint III, which could be protected by purified AP2 protein. Footprint II contains four sites corresponding to half of the NF-I consensus sequence, but DNA mobility shift assays indicate that this footprint binds two proteins distinct from NF-I: a ubiquitous CP1-related factor and another novel factor, termed alpha-Adrenergic Receptor Transcription Factor (alpha ARTF), which binds to two separate sites in this region. The alpha ARTF is widely distributed, with the highest amounts found in brain, followed by liver, kidney, lung, and spleen, but no detectable activity in heart. Deletions of alpha ARTF binding sites nearly abolished P2 promoter activity, which suggests that the alpha ARTF is essential for the transcription of the alpha(1B)AR gene in most tissues.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT PHARMACOL, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT TOXICOL, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT MED, RICHMOND, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University					NHLBI NIH HHS [HL49938] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049938] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; COSTA RH, 1988, P NATL ACAD SCI USA, V85, P3840, DOI 10.1073/pnas.85.11.3840; DUSSERRE Y, 1992, MOL CELL BIOL, V12, P5228, DOI 10.1128/MCB.12.11.5228; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; FORD APDW, 1994, TRENDS PHARMACOL SCI, V15, P167, DOI 10.1016/0165-6147(94)90136-8; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GAO B, 1993, GENE, V131, P243, DOI 10.1016/0378-1119(93)90300-R; GAO B, 1994, J BIOL CHEM, V269, P15762; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HARRISON JK, 1991, TRENDS PHARMACOL SCI, V12, P62, DOI 10.1016/0165-6147(91)90499-I; HU ZW, 1993, J BIOL CHEM, V268, P3610; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; IANNELLO RC, 1991, J BIOL CHEM, V266, P3309; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; LAZARWESLEY E, 1991, ENDOCRINOLOGY, V129, P1116, DOI 10.1210/endo-129-2-1116; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; Maxam A M, 1980, Methods Enzymol, V65, P499; MCGEHEE RE, 1990, MOL CELL ENDOCRINOL, V74, P1, DOI 10.1016/0303-7207(90)90200-R; MCGEHEE RE, 1991, J RECEPTOR RES, V11, P773, DOI 10.3109/10799899109064679; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RAWLINS DR, 1984, CELL, V37, P309, DOI 10.1016/0092-8674(84)90327-1; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROY RJ, 1991, BIOTECHNIQUES, V11, P770; Sambrook J, 1989, MOL CLONING LABORATO; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; YANAGIDA A, 1990, MOL CELL BIOL, V10, P1470, DOI 10.1128/MCB.10.4.1470	39	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5614	5619		10.1074/jbc.270.10.5614	http://dx.doi.org/10.1074/jbc.270.10.5614			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890681	hybrid			2022-12-27	WOS:A1995QL58000099
J	JEONG, JM; MURTHY, SNP; RADEK, JT; LORAND, L				JEONG, JM; MURTHY, SNP; RADEK, JT; LORAND, L			THE FIBRONECTIN-BINDING DOMAIN OF TRANSGLUTAMINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; COLD-INSOLUBLE GLOBULIN; ERYTHROCYTE TRANSGLUTAMINASE; PLASMA FIBRONECTIN; PURIFICATION; EXPRESSION; AFFINITY; PROTEINS	Guinea pig liver transglutaminase (EC 2.3.2.13) displays a Ca2+-independent binding (K-a = 10(7) M(-1)) to the same gelatin-binding domain of human plasma fibronectin that is known to form a very tight complex with the human red cell enzyme. The fibronectin-combining site of the liver transglutaminase was investigated by testing fragments obtained from the parent protein by controlled digestion with endoproteinase Lys-C. Overlay assays, probed with anti-fibronectin antibody, revealed that the fibronectin binding ability of the transglutaminase was encoded in a linear sequence in its 28-kDa N-terminal domain. Removal of the first 7 residues by further digestion of the purified 28-kDa material with endoproteinase Glu-C generated a 27-kDa fragment that, however, showed no binding activity. Thus, residues 1-7 in the liver enzyme seem to be of particular importance for influencing its ability to bind to fibronectin.	NORTHWESTERN UNIV,SCH MED,DEPT CELL & MOLEC BIOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,FEINBERG CARDIOVASC RES INST,CHICAGO,IL 60611	Northwestern University; Northwestern University					NHLBI NIH HHS [HL02212, HL45168] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045168] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; CHURCHICH JE, 1967, BIOCHIM BIOPHYS ACTA, V147, P511, DOI 10.1016/0005-2795(67)90010-4; CROALL DE, 1986, CELL CALCIUM, V7, P29, DOI 10.1016/0143-4160(86)90028-X; FOLK JE, 1966, J BIOL CHEM, V241, P5518; GENTILE V, 1991, J BIOL CHEM, V266, P478; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; INGHAM KC, 1989, J BIOL CHEM, V264, P16977; KLOTZ IM, 1986, INTRO BIOMOLECULAR E, P103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER GL, 1959, ANAL CHEM, V31, P964, DOI 10.1021/ac60149a611; MOLNAR J, 1979, BIOCHEMISTRY-US, V18, P3909, DOI 10.1021/bi00585a010; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; TAKEUCHI Y, 1992, FEBS LETT, V307, P177, DOI 10.1016/0014-5793(92)80762-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; WERAARCHAKULBOONMA, 1992, P NATL ACAD SCI USA, V89, P9804, DOI 10.1073/PNAS.89.20.9804	24	64	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5654	5658		10.1074/jbc.270.10.5654	http://dx.doi.org/10.1074/jbc.270.10.5654			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890687	hybrid			2022-12-27	WOS:A1995QL58000106
J	LEWIS, WS; CODY, V; GALITSKY, N; LUFT, JR; PANGBORN, W; CHUNDURU, SK; SPENCER, HT; APPLEMAN, JR; BLAKLEY, RL				LEWIS, WS; CODY, V; GALITSKY, N; LUFT, JR; PANGBORN, W; CHUNDURU, SK; SPENCER, HT; APPLEMAN, JR; BLAKLEY, RL			METHOTREXATE-RESISTANT VARIANTS OF HUMAN DIHYDROFOLATE-REDUCTASE WITH SUBSTITUTIONS OF LEUCINE-22 - KINETICS, CRYSTALLOGRAPHY, AND POTENTIAL AS SELECTABLE MARKERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSIENT-STATE; BONE-MARROW; GENE; EXPRESSION; BINDING; DRUG; TRIMETHOPRIM	Although substitution of tyrosine, phenylalanine, tryptophan, or arginine for leucine 22 in human dihydrofolate reductase greatly slows hydride transfer, there is little loss in overall activity (k(cat)) at pH 7.65 (except for the arginine 22 variant), but K-m for dihydrofolate and NADPH are increased significantly. The greatest effect, decreased binding of methotrexate to the enzyme NADPH complex by 740- to 28,000-fold due to a large increase in the rate of methotrexate dissociation, makes these variants suitable to act as selectable markers. Affinities for four other inhibitors are also greatly decreased. Binding of methotrexate to apoenzyme is decreased much less (decreases as much as 120-fold), binding of tetrahydrofolate is decreased as much as 23-fold, and binding of dihydrofolate is decreased little or increased. Crystal structures of ternary complexes of three of the variants show that the mutations cause little perturbation of the protein backbone, of side chains of other active site residues, or of bound inhibitor. The largest structural deviations occur in the ternary complex of the arginine variant at residues 21-27 and in the orientation of the methotrexate. Tyrosine 22 and arginine 22 relieve short contacts to methotrexate and NADPH by occupying low probability conformations, but this is unnecessary for phenylalanine 22 in the piritrexim complex.	ST JUDE CHILDRENS RES HOSP, DEPT MOLEC PHARMACOL, MEMPHIS, TN 38101 USA; HAUPTMAN WOODWARD MED RES INST INC, BUFFALO, NY 14203 USA; GENSIA PHARMACEUT INC, SAN DIEGO, CA 92121 USA	St Jude Children's Research Hospital; Hauptman Woodward Medical Research Institute					NCI NIH HHS [R01 CA 31922, P30 CA 21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA031922] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		APPLEMAN JR, 1988, J BIOL CHEM, V263, P10304; APPLEMAN JR, 1990, J BIOL CHEM, V265, P2740; APPLEMAN JR, 1988, J BIOL CHEM, V263, P9187; APPLEMAN JR, 1989, J BIOL CHEM, V264, P2625; APPLEMAN JR, 1992, BIOCHEMISTRY-US, V31, P3709, DOI 10.1021/bi00129a021; BANERJEE D, 1994, GENE, V139, P269, DOI 10.1016/0378-1119(94)90768-4; BEARD WA, 1991, BIOCHEMISTRY-US, V30, P1432, DOI 10.1021/bi00219a038; BLAKLEY RL, 1993, ADV EXP MED BIOL, V338, P473; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDLER JP, 1972, COMPUT BIOMED RES, V5, P515, DOI 10.1016/0010-4809(72)90058-4; CHEN YQ, 1994, BIOCHEMISTRY-US, V33, P7021, DOI 10.1021/bi00189a001; CHUNDURU SK, 1994, J BIOL CHEM, V269, P9547; CLINE MJ, 1980, NATURE, V284, P422, DOI 10.1038/284422a0; CODY V, 1992, ANTI-CANCER DRUG DES, V7, P483; COREY CA, 1990, BLOOD, V75, P337; DICKER AP, 1993, P NATL ACAD SCI USA, V90, P11797, DOI 10.1073/pnas.90.24.11797; ERCIKAN E, 1993, ADV EXP MED BIOL, V338, P515; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; HABER DA, 1981, J BIOL CHEM, V256, P9501; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HOCK RA, 1986, NATURE, V320, P275, DOI 10.1038/320275a0; HUSSAIN A, 1992, GENE, V112, P179, DOI 10.1016/0378-1119(92)90374-X; HUSSAIN A, 1992, ARCH BIOCHEM BIOPHYS, V296, P539, DOI 10.1016/0003-9861(92)90608-Y; ISOLA LM, 1986, P NATL ACAD SCI USA, V83, P9621, DOI 10.1073/pnas.83.24.9621; KWOK WW, 1986, P NATL ACAD SCI USA, V83, P4552, DOI 10.1073/pnas.83.12.4552; LI M, 1992, HUM GENE THER, V3, P381, DOI 10.1089/hum.1992.3.4-381; LI MX, 1994, BLOOD, V83, P3403; MARGOSIAK SA, 1993, ARCH BIOCHEM BIOPHYS, V305, P499, DOI 10.1006/abbi.1993.1453; MATTHEWS DA, 1985, J BIOL CHEM, V260, P381; MCIVOR RS, 1990, NUCLEIC ACIDS RES, V18, P7025, DOI 10.1093/nar/18.23.7025; MCTIGUE MA, 1992, BIOCHEMISTRY-US, V31, P7264, DOI 10.1021/bi00147a009; MILLER AD, 1985, MOL CELL BIOL, V5, P431, DOI 10.1128/MCB.5.3.431; MORRIS JA, 1994, BIOCHEM PHARMACOL, V47, P1207, DOI 10.1016/0006-2952(94)90393-X; NAKANO Y, 1994, BIOCHEMISTRY-US, V33, P9945; OEFNER C, 1988, EUR J BIOCHEM, V246, P2211; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; SPENCER HT, 1994, BLOOD S, V84, pA1588; SRIMATKANDADA S, 1989, J BIOL CHEM, V264, P3524; STUBER D, 1986, P839; THILLET J, 1988, J BIOL CHEM, V263, P12500; TSAY JT, 1990, BIOCHEMISTRY-US, V29, P6428, DOI 10.1021/bi00479a014; VINH DBN, 1993, J PHARMACOL EXP THER, V267, P989; WILLIAMS DA, 1987, J EXP MED, V166, P210, DOI 10.1084/jem.166.1.210; WU YD, 1987, J AM CHEM SOC, V109, P2226, DOI 10.1021/ja00241a074; YU MH, 1993, CANCER RES, V53, P6031	46	110	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5057	5064		10.1074/jbc.270.10.5057	http://dx.doi.org/10.1074/jbc.270.10.5057			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890613	hybrid			2022-12-27	WOS:A1995QL58000019
J	JORDAN, R; MCMACKEN, R				JORDAN, R; MCMACKEN, R			MODULATION OF THE ATPASE ACTIVITY OF THE MOLECULAR CHAPERONE DNAK BY PEPTIDES AND THE DNAJ AND GRPE HEAT-SHOCK PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIALIZED NUCLEOPROTEIN STRUCTURES; LAMBDA-P-PROTEIN; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; REPLICATION; INITIATION; ORIGIN; GROEL; BINDING	Previous studies have demonstrated that the Escherichia coli DnaK, DnaJ, and GrpE heat shock proteins participate in the initiation of bacteriophage A DNA replication by mediating the required disassembly of a preinitiation nucleoprotein structure that is formed at the phage replication origin, To gain some understanding in a simpler system of how the DnaJ and GrpE cochaperonins influence the activity of DnaK, we have examined the effect of the cochaperonins on the weak intrinsic ATPase activity of the molecular chaperone DnaK in the presence and absence of peptide effecters, We have found that random sequence peptide chains of 8 or 9 amino acid residues in length yield optimal (10-fold) activation of the DnaK ATPase, whereas peptides with 5 or fewer residues fail to stimulate the ATPase of this bacterial hsp70 homologue, Furthermore, we have discovered that those peptides that interact best with DnaK, as judged by their K-A as activators of ATP hydrolysis by DnaK, also act as strong inhibitors of lambda DNA replication in vitro, The inhibitory effect of peptides on lambda DNA replication was overcome by increasing the concentration of DnaK in the replication system, Diminished inhibition was also found when the replication system was supplemented with GrpE cochaperonin, a protein known to increase the effectiveness of DnaK action in lambda DNA replication, These and other results suggest that the peptide-binding site of DnaK is required for its function in lambda DNA replication, Apparently, peptides sequester free DnaK protein and block X DNA replication by reducing the amount of DnaK: that is free to mediate disassembly of nucleoprotein preinitiation structures, In related studies, we have found that DnaJ, like short peptides, activates the intrinsic ATPase activity of DnaK, DnaJ, however, is substantially more potent in this regard, since it activates DnaK at concentrations 1000-fold below those required for a peptide of random sequence, By itself, the GrpE cochaperonin has no effect on the peptide-independent ATPase activity of DnaK, but GrpE does vigorously stimulate the peptide-dependent ATPase of the DnaK chaperone, Under steady-state conditions, the V-max of ATP hydrolysis by DnaK was elevated approximately 40-fold by the presence of GrpE and saturating level of peptides.	JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT BIOCHEM, BALTIMORE, MD 21205 USA	Johns Hopkins University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; ALFANO C, 1989, J BIOL CHEM, V264, P10699; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CYR DM, 1992, J BIOL CHEM, V267, P20927; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GROSS CA, 1990, STRESS PROTEINS BIOL, P167; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENSAWILMOT K, 1989, J BIOL CHEM, V264, P2853; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SCIDMORE MA, 1993, MOL BIOL CELL, V4, P1145, DOI 10.1091/mbc.4.11.1145; WALL D, 1994, J BIOL CHEM, V269, P5446; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437	31	118	119	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4563	4569		10.1074/jbc.270.9.4563	http://dx.doi.org/10.1074/jbc.270.9.4563			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876226	hybrid			2022-12-27	WOS:A1995QK08400059
J	KEDISHVILI, NY; BOSRON, WF; STONE, CL; HURLEY, TD; PEGGS, CF; THOMASSON, HR; POPOV, KM; CARR, LG; EDENBERG, HJ; LI, TK				KEDISHVILI, NY; BOSRON, WF; STONE, CL; HURLEY, TD; PEGGS, CF; THOMASSON, HR; POPOV, KM; CARR, LG; EDENBERG, HJ; LI, TK			EXPRESSION AND KINETIC CHARACTERIZATION OF RECOMBINANT HUMAN STOMACH ALCOHOL-DEHYDROGENASE - ACTIVE-SITE AMINO-ACID-SEQUENCE EXPLAINS SUBSTRATE-SPECIFICITY COMPARED WITH LIVER ISOZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-PROPERTIES; PURIFICATION; ISOENZYMES; PROTEINS; METABOLISM; BINDING; CLONING; ETHANOL; CDNA	A full-length 1966-base pair clone of the human class IV alcohol dehydrogenase (sigma-ADH) was isolated from a human stomach cDNA library. The 373-amino acid sigma-ADH encoded by this cDNA was expressed in Escherichia coli, The specific activity of the recombinant enzyme for ethanol oxidation at pH 7.5 and 25 degrees C, calculated from active-site titration of NADH binding, was 92 +/- 9 units/mg, Kinetic analysis of the catalytic efficiency (k(cat)/K-M) of recombinant sigma-ADH for oxidation of primary alcohols indicated broad substrate specificity, Recombinant human sigma-ADH exhibited high catalytic efficiency for oxidation of all-trans-retinol to all-trans-retinal. This pathway is important in the synthesis of the transcriptional regulator all-trans-retinoic acid, Secondary alcohols and 3 beta-hydroxysteroids were inactive with sigma-ADH or were oxidized with very low efficiency, The K-M of a-ADH for ethanol was 25 mM, and the K-M for primary straight chain alcohols decreased substantially as chain length increased. There are important amino acid differences in the alcohol-binding site between the human class IV (sigma) and human class I (beta) alcohol dehydrogenases that appear to explain the high catalytic efficiency for all-trans-retinol, the high k(cat) for ethanol, and the low catalytic efficiency for secondary alcohols of sigma-ADH relative to beta(1)-ADH, For example, modeling the binding of all-trans-retinol in the human beta(1)-ADH structure suggested that coordination of retinol to the active-site zinc is hindered by a loop from residues 114 to 120 that is at the entrance to the alcohol-binding site, The deletion of Gly-117 in human sigma-ADH and a substitution of Leu for the bulky Tyr-110 appear to facilitate retinol access to the active-site zinc.	INDIANA UNIV, SCH MED, DEPT MED, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	KEDISHVILI, NY (corresponding author), INDIANA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, 635 BARNHILL DR, MS 405, INDIANAPOLIS, IN 46202 USA.			HURLEY, THOMAS/0000-0002-5942-1163; Edenberg, Howard/0000-0003-0344-9690; Kedishvili, Natalia/0000-0001-6917-4891	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA007117, K21AA000148, R37AA002342] Funding Source: NIH RePORTER; NIAAA NIH HHS [R37-AA07117, R37-AA02342, K21-AA00148] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; BOSRON WF, 1979, BIOCHEMISTRY-US, V18, P1101, DOI 10.1021/bi00573a026; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BOSRON WF, 1993, SEMIN LIVER DIS, V13, P126, DOI 10.1055/s-2007-1007344; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; Cleland W W, 1979, Methods Enzymol, V63, P103; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; FARRES J, 1994, EUR J BIOCHEM, V224, P549, DOI 10.1111/j.1432-1033.1994.00549.x; FENG DF, 1990, METHOD ENZYMOL, V183, P375; GENTRY RT, 1994, J LAB CLIN MED, V123, P21; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HOOG JO, 1992, EUR J BIOCHEM, V205, P519, DOI 10.1111/j.1432-1033.1992.tb16808.x; HOOG JO, 1987, BIOSCIENCE REP, V7, P969, DOI 10.1007/BF01122131; HURLEY TD, 1991, P NATL ACAD SCI USA, V88, P8149, DOI 10.1073/pnas.88.18.8149; HURLEY TD, 1994, J MOL BIOL, V239, P415, DOI 10.1006/jmbi.1994.1382; HURLEY TD, 1995, ENZYMOLOGY MOL BIOL, V5; IKUTA T, 1985, P NATL ACAD SCI USA, V82, P2703, DOI 10.1073/pnas.82.9.2703; KEDISHVILI NY, 1995, ENZYMOLOGY MOL BIOL, V5; MORENO A, 1991, J BIOL CHEM, V266, P1128; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PARES X, 1990, METHOD ENZYMOL, V189, P436; PARES X, 1994, P NATL ACAD SCI USA, V91, P1893, DOI 10.1073/pnas.91.5.1893; PARES X, 1985, ALCOHOL, V2, P43, DOI 10.1016/0741-8329(85)90013-8; PARK DH, 1992, J BIOL CHEM, V267, P5527; PARK DH, 1991, J BIOL CHEM, V266, P13296; SATRE MA, 1994, J BIOL CHEM, V269, P15606; STONE CL, 1989, J BIOL CHEM, V264, P11112; STONE CL, 1993, J BIOL CHEM, V268, P892; STONE CL, 1993, ALCOHOL CLIN EXP RES, V17, P911, DOI 10.1111/j.1530-0277.1993.tb00863.x; YANG ZN, 1994, ALCOHOL CLIN EXP RES, V18, P587, DOI 10.1111/j.1530-0277.1994.tb00914.x; YIN SJ, 1993, ALCOHOL CLIN EXP RES, V17, P376, DOI 10.1111/j.1530-0277.1993.tb00779.x; YIN SJ, 1990, BIOCHEM INT, V22, P829; YOKOYAMA H, 1994, BIOCHEM BIOPH RES CO, V203, P219, DOI 10.1006/bbrc.1994.2170; YONETANI T, 1962, ARCH BIOCHEM BIOPHYS, V99, P433, DOI 10.1016/0003-9861(62)90291-6	39	79	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3625	3630		10.1074/jbc.270.8.3625	http://dx.doi.org/10.1074/jbc.270.8.3625			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876099	hybrid			2022-12-27	WOS:A1995QH68800027
J	MURAD, AO; DECOCK, J; BROWN, D; SMERDON, MJ				MURAD, AO; DECOCK, J; BROWN, D; SMERDON, MJ			VARIATIONS IN TRANSCRIPTION-REPAIR COUPLING IN MOUSE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOBUTANE PYRIMIDINE DIMERS; STRAND-SPECIFIC REPAIR; TUMOR VIRUS PROMOTER; NUCLEOSOME CORE DNA; GLUCOCORTICOID RECEPTOR; YEAST MINICHROMOSOME; ACTIVE GENE; GROUP-C; SEQUENCE; CHROMATIN	Formation and repair of W-induced cyclobutane pyrimidine dimers (CPDs) was examined in three different genes in mouse L cells: 1) a stably integrated insert (called LTL), consisting of a herpes simplex virus thymidine kinase gene (th) fused to a hormone inducible promotor (LTR); 2) the constitutively expressed protooncogene c-abl; and 3) the inactive immunoglobulin J chain gene, Transcription of the tk gene is induced >50-fold by dexamethasone. There is a nonuniform distribution of CPDs in LTL DNA irradiated in vitro, being 4-fold higher in the LTR than in the th gene, indicating the LTR may be damaged preferentially in irradiated cells, Repair of CPDs occurs efficiently in both strands of LTL and is unaffected by hormone induction of th gene transcription. Transcription of tit mRNA is very sensitive to UV damage and follows single hit kinetics with UV dose. Furthermore, tit mRNA expression rapidly recovers during repair incubation, Transcription-coupled repair occurs in these cells, however, since only the transcribed strand of c-abl is efficiently repaired of CPDs; the nontranscribed strand as well as both strands of the J chain gene are inefficiently repaired. Thus, repair in the LTL construct may reflect a lack of transcription-coupled repair in either the LTR promotor or the LTL insertion region of chromatin.	WASHINGTON STATE UNIV, DEPT BIOCHEM & BIOPHYS, PULLMAN, WA 99164 USA	Washington State University					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04106] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BEATO M, 1991, NUCLEAR HORMONE RECE, P197; BECKER MM, 1989, J BIOL CHEM, V264, P4163; BEDOYAN J, 1992, J BIOL CHEM, V267, P5996; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BOHR VA, 1988, DNA REPAIR LABORATOR, P347; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; CANN GM, 1982, P NATL ACAD SCI-BIOL, V79, P6656, DOI 10.1073/pnas.79.21.6656; DECOCK JGR, 1991, NUCLEIC ACIDS RES, V19, P3289, DOI 10.1093/nar/19.12.3289; DECOCK JGR, 1992, MUTAT RES, V293, P11, DOI 10.1016/0921-8777(92)90003-L; DECOCK JGR, 1992, MUTAT RES, V274, P85, DOI 10.1016/0921-8777(92)90055-8; DRAPKIN R, 1994, CELL, V77, P9, DOI 10.1016/0092-8674(94)90228-3; EVANS MK, 1993, J BIOL CHEM, V268, P4839; FRANKLIN WA, 1986, MUTAT RES, V165, P1, DOI 10.1016/0167-8817(86)90002-7; FREIFELDER D, 1982, PHYSICAL CHEM STUDEN, P700; FRIEDBERG EC, 1994, MUTAT RES, V307, P5, DOI 10.1016/0027-5107(94)90272-0; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GALE JM, 1988, J MOL BIOL, V204, P949, DOI 10.1016/0022-2836(88)90054-X; GORDON LK, 1982, RADIAT RES, V89, P99, DOI 10.2307/3575688; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; MADHANI HD, 1986, CELL, V45, P417, DOI 10.1016/0092-8674(86)90327-2; Maniatis T., 1982, MOL CLONING; MAULDIN SK, 1994, MUTAT RES, V314, P187, DOI 10.1016/0921-8777(94)90082-5; MITCHELL DL, 1992, NUCLEIC ACIDS RES, V20, P225, DOI 10.1093/nar/20.2.225; MITCHELL DL, 1990, RADIAT RES, V123, P299, DOI 10.2307/3577736; MURAD AO, 1991, THESIS WASHINGTON ST; Patrick MH., 1976, PHOTOCHEM PHOTOBIOL, V2, P35, DOI [10.1016/B978-0-12-734602-1.50008-3, DOI 10.1016/B978-0-12-734602-1.50008-3]; PFEIFER GP, 1992, MOL CELL BIOL, V12, P1798, DOI 10.1128/MCB.12.4.1798; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PINA B, 1990, J MOL BIOL, V216, P975, DOI 10.1016/S0022-2836(99)80015-1; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; PROTICSABLJIC M, 1985, P NATL ACAD SCI USA, V82, P6622, DOI 10.1073/pnas.82.19.6622; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RUVEN HJT, 1994, MUTAT RES-DNA REPAIR, V315, P189, DOI 10.1016/0921-8777(94)90018-3; SAUERBIER W, 1976, ADV RADIAT BIOL, V6, P49; SELBY CP, 1990, J BIOL CHEM, V265, P21330; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1979, BIOCHEMISTRY-US, V18, P3732, DOI 10.1021/bi00584a014; SMERDON MJ, 1993, ALFRED BENZON SYMP S, V35, P258; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SMITH CA, 1987, J CELL SCI, P225; SMITH CA, 1981, DNA REPAIR LABORAT B, V1, P289; TANG MS, 1991, BIOCHEMISTRY-US, V30, P7021, DOI 10.1021/bi00242a030; TRUSS M, 1990, P NATL ACAD SCI USA, V87, P7180, DOI 10.1073/pnas.87.18.7180; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	49	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3949	3957		10.1074/jbc.270.8.3949	http://dx.doi.org/10.1074/jbc.270.8.3949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876142	hybrid			2022-12-27	WOS:A1995QH68800074
J	STEINMAN, HM				STEINMAN, HM			THE BCL-2 ONCOPROTEIN FUNCTIONS AS A PROOXIDANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; OXIDATIVE STRESS; SUPEROXIDE DISMUTASES; KAPPA-B; OXYGEN; MANGANESE; CATALASES; CELLS	The mechanism by which the bcl-2 oncogene exerts its anti-apoptotic and antioxidant action is unknown. We found that expression of bcl-2 in superoxide dismutase-deficient (SOD-) Escherichia coli resulted in increased transcription of the KatG catalase-peroxidase, a 13-fold increase in KatG activity and a 100-fold increase in resistance to hydrogen peroxide. In addition, mutation rate was increased 3-fold, and katG and oxyR, a transcriptional regulator of katG induction, were required for aerobic survival. These data indicate that Bcl-2 acts as a pro-oxidant in E. coli, i.e. Bcl-2 generates reactive oxygen intermediates. In support of a pro-oxidant mechanism in eukaryotic cells, we found a 73% increase in superoxide dismutase activity in a murine B-cell line overexpressing Bcl-2. Increases in reduced glutathione and in oxyradical damage to DNA, previously observed in other overexpressing cell lines, are additional evidence for a pro-oxidant mechanism. Thus, Bcl-2 does not appear to be an antioxidant. Instead, Bcl-2 appears to influence levels of reactive oxygen intermediates that induce endogenous cellular antioxidants. This activity of Bcl-2 may control, entry into apoptosis.			STEINMAN, HM (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, 1300 MORRIS PK AVE, BRONX, NY 10461 USA.				NIGMS NIH HHS [GM 40468] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; GONZALEZFLECHA B, 1994, J BACTERIOL, V176, P2293; GREEN MJ, 1984, METHOD ENZYMOL, V105, P3; HEIMBERGER A, 1988, BIOCHEM BIOPH RES CO, V154, P392, DOI 10.1016/0006-291X(88)90698-5; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; LOEWEN PC, 1985, ARCH BIOCHEM BIOPHYS, V243, P144, DOI 10.1016/0003-9861(85)90782-9; LOEWEN PC, 1992, MOL BIOL FREE RADICA, P97; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOODY CS, 1982, P NATL ACAD SCI-BIOL, V79, P2855, DOI 10.1073/pnas.79.9.2855; RAY S, 1994, P NATL ACAD SCI USA, V91, P5548, DOI 10.1073/pnas.91.12.5548; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SCHWEIZER H, 1983, MOL GEN GENET, V192, P293, DOI 10.1007/BF00327683; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P99; STEINMAN HM, 1992, MOL GEN GENET, V232, P427, DOI 10.1007/BF00266247; STEINMAN HM, 1985, J BACTERIOL, V162, P1255, DOI 10.1128/JB.162.3.1255-1260.1985; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; TARTAGLIA LA, 1989, J MOL BIOL, V210, P709, DOI 10.1016/0022-2836(89)90104-6; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; ZEHAVA CL, 1990, J BIOL CHEM, V265, P4929	29	136	146	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3487	3490						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876080				2022-12-27	WOS:A1995QH68800007
J	TANNER, JW; CHEN, W; YOUNG, RL; LONGMORE, GD; SHAW, AS				TANNER, JW; CHEN, W; YOUNG, RL; LONGMORE, GD; SHAW, AS			THE CONSERVED BOX-1 MOTIF OF CYTOKINE RECEPTORS IS REQUIRED FOR ASSOCIATION WITH JAK KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GAMMA SIGNAL-TRANSDUCTION; POLYMERASE CHAIN-REACTION; GROWTH-FACTOR RECEPTOR; AMINO-TERMINAL DOMAIN; ERYTHROPOIETIN RECEPTOR; INTERFERON-ALPHA/BETA; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; GLYCOPROTEIN	The JAK2 tyrosine kinase is known to associate with the receptors for growth hormone (GH) and erythropoietin (EPO) and with the interleukin-6 receptor signal transducing protein, gp130. Here we demonstrate that chimeric cytokine receptors which contain the cytoplasmic domain of the receptors for GH and EPO or for gp130 can form complexes with JAK2 when transiently co expressed in HeLa cells. Mutational analyses of chimeras for the the GH and EPO receptors and gp130 demonstrated that box 1, a motif critical for cytokine receptor signal transduction, was required for the association of JAK2. Although JAK2 was capable of associating with all three of the chimeras, JAK1 co-precipitated only with the gp130 chimera. Association of JAK1 and JAK2 with cytokine receptor proteins, therefore, requires the highly conserved box 1 domain, but other sequences within the receptor proteins may influence the specificity of JAK binding. Mutational analysis of JAK2 revealed that multiple or complex protein sequences within JAK2 are required for association with cytokine receptors.	WASHINGTON UNIV, SCH MED, CTR IMMUNOL, DEPT PATHOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)								AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAUMANN H, 1994, MOL CELL BIOL, V14, P138, DOI 10.1128/MCB.14.1.138; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; ERNST M, 1994, EMBO J, V13, P1574, DOI 10.1002/j.1460-2075.1994.tb06420.x; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GOUJON L, 1994, P NATL ACAD SCI USA, V91, P957, DOI 10.1073/pnas.91.3.957; HARPUR AG, 1992, ONCOGENE, V7, P1347; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Higuchi R., 1989, PCR TECHNOLOGY PRINC; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; LEFRANCOIS L, 1982, VIROLOGY, V121, P168, DOI 10.1016/0042-6822(82)90126-X; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUI H, 1994, J BIOL CHEM, V269, P5364; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; SOTIROPOULOS A, 1994, ENDOCRINOLOGY, V135, P1292, DOI 10.1210/en.135.4.1292; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WILKS AF, 1991, METHOD ENZYMOL, V200, P533; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384, DOI 10.1128/MCB.13.4.2384	53	218	223	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6523	6530		10.1074/jbc.270.12.6523	http://dx.doi.org/10.1074/jbc.270.12.6523			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896787	hybrid			2022-12-27	WOS:A1995QQ85500017
J	GUAGLIARDI, A; DEPASCALE, D; CANNIO, R; NOBILE, V; BARTOLUCCI, S; ROSSI, M				GUAGLIARDI, A; DEPASCALE, D; CANNIO, R; NOBILE, V; BARTOLUCCI, S; ROSSI, M			THE PURIFICATION, CLONING, AND HIGH-LEVEL EXPRESSION OF A GLUTAREDOXIN-LIKE PROTEIN FROM THE HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS-FURIOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; THIOREDOXIN-F; ESCHERICHIA-COLI; THIOLTRANSFERASE; ARCHAEBACTERIUM; ORGANISMS; BACTERIA; LIVER	A protein has been purified to homogeneity from crude extracts of the hyperthermophilic archaeon Pyrococcus furiosus based on its ability to catalyze the reduction of insulin disulfides in the presence of dithiothreitol; the protein has a molecular mass of 24.8 kDa and a pi of 4.9, and it is highly heat-stable. The first 29 amino acid residues at the N terminus of the P. furiosus protein were determined by Edman degradation, and its gene was cloned in Escherichia coli, The amino acid sequence derived from the DNA sequence contains the CPYC sequence, which is typical of the active site of glutaredoxin (also called thioltransferase), The C-terminal portion of the P. furiosus protein, containing the conserved sequence, shows sequence similarity with glutaredoxins from different sources. The P. furiosus protein can reduce disulfide bonds in L-cystine in the presence of GSH (the thioltransferase activity) with an optimum pH of 8.0, The expression of the P. furiosus protein, with full activity, in E. coli at a very high level (21% of total soluble protein) is described; the recombinant protein was purified to homogeneity by merely two successive heat treatments and gel filtration chromatography. The features of the P. furiosus protein here described are discussed in light of the current knowledge about the ubiquitous family of protein disulfide oxidoreductases.	CNR,IST BIOCHIM PROT & ENZIMOL,I-80125 NAPLES,ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	GUAGLIARDI, A (corresponding author), UNIV NAPLES,DIPARTIMENTO CHIM ORGAN & BIOL,VIA MEZZOCANNONE 16,I-80134 NAPLES,ITALY.			Bartolucci, Simonetta/0000-0002-1968-2959				ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; ADAMS MWW, 1994, IN PRESS FEMS MICROB; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; AXELSSON K, 1978, BIOCHEMISTRY-US, V17, P2978, DOI 10.1021/bi00608a006; BARDWELL JCA, 1993, CELL, V74, P769, DOI 10.1016/0092-8674(93)90455-Y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNIO R, 1994, EUR J BIOCHEM, V222, P345, DOI 10.1111/j.1432-1033.1994.tb18873.x; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Freedman Robert B., 1992, P455; GAN ZR, 1990, BIOCHEM BIOPH RES CO, V168, P944, DOI 10.1016/0006-291X(90)91120-H; GAN ZR, 1987, J BIOL CHEM, V262, P6699; GUAGLIARDI A, 1994, INT J BIOCHEM, V26, P375, DOI 10.1016/0020-711X(94)90057-4; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HOOG JO, 1983, EUR J BIOCHEM, V136, P223, DOI 10.1111/j.1432-1033.1983.tb07730.x; HOPPER S, 1989, J BIOL CHEM, V264, P20438; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGLOTZ P, 1986, Z NATURFORSCH C, V41, P275; LANGLOTZ P, 1987, Z NATURFORSCH C, V42, P1364; LOFERER H, 1994, TRENDS BIOCHEM SCI, V19, P169, DOI 10.1016/0968-0004(94)90279-8; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; MINAKUCHI K, 1994, FEBS LETT, V337, P157, DOI 10.1016/0014-5793(94)80264-5; PAPAYANNOPOULOS IA, 1989, BIOCHEM BIOPH RES CO, V159, P1448, DOI 10.1016/0006-291X(89)92272-9; REITER WD, 1988, NUCLEIC ACIDS RES, V16, P1, DOI 10.1093/nar/16.1.1; RIGHETTI PE, 1976, LAB TECHNIQUES BIOCH, V5, P562; SAIKI RK, 1990, PCR PROTOCOLS GUIDE; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLICHT F, 1985, NATURWISSENSCHAFTEN, V72, P328, DOI 10.1007/BF00454779; SJOBERG BM, 1972, J BIOL CHEM, V247, P8063; WHITTAKER MM, 1984, J BIOL CHEM, V259, P4088; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	34	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5748	5755		10.1074/jbc.270.11.5748	http://dx.doi.org/10.1074/jbc.270.11.5748			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890703				2022-12-27	WOS:A1995QM94500013
J	YAMASHIRO, S; HARAGUCHI, M; FURUKAWA, K; TAKAMIYA, K; YAMAMOTO, A; NAGATA, Y; LLOYD, KO; SHIKU, H; FURUKAWA, K				YAMASHIRO, S; HARAGUCHI, M; FURUKAWA, K; TAKAMIYA, K; YAMAMOTO, A; NAGATA, Y; LLOYD, KO; SHIKU, H; FURUKAWA, K			SUBSTRATE-SPECIFICITY OF BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE IN-VITRO AND IN CDNA-TRANSFECTED CELLS - G(M2)/G(D2) SYNTHASE EFFICIENTLY GENERATES ASIALO-G(M2) IN CERTAIN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BREFELDIN-A; RAT-LIVER; GANGLIOSIDE; GLYCOSYLATION; EXPRESSION; MELANOMA; CANCER; GM2; GLYCOSYLTRANSFERASES	The substrate specificity of beta 1,4-N-acetylgalactosaminyltransferase has been analyzed using a fusion enzyme which consisted of the catalytic domain of the enzyme and the IgG binding domain of protein A, and also by extracts from cDNA transfectants, Both enzyme sources were capable of producing not only G(M2) and G(D2), but also asialo-G(M2), GalNAc-sialylparagloboside, and Gal-NAc-G(D1a) from appropriate accepters, although the efficiencies were at most 1-3% of those of G(M2)/G(D2). The biological significance of these low specificities was studied with transient and stable transfectant cells. From the results of transient expression of the cDNA, asialo-G(M2) expression appeared to inversely correlate with G(M3) synthase levels in those lines. Consequently, G(M2) seemed to be preferentially synthesized when both G(M3) and lactosylceramide are available, and asialo-G(M2) is synthesized in the absence of G(M3) synthesis. However, the results of double immunostaining of CHO transfectants with anti-G(M2) and anti-asialo-G(M2) antibodies indicated that another factor may be involved in asialo-G(M2) synthesis. From the in vitro assay using mixed acceptors, it was concluded that the presence of certain levels of G(M2) might enhance the asialo-G(M2) synthesis. These results suggest that even accepters showing low efficiencies in vitro might be used in certain cells depending on the availability of precursors, expression levels of other gangliosides, as well as the kinetic properties of tile enzyme, and the compartmentation of the glycosylation machineries in the cells.	NAGASAKI UNIV,SCH MED,DEPT ONCOL,NAGASAKI 852,JAPAN; NAGASAKI UNIV,SCH DENT,DEPT PROSTHODONT,NAGASAKI 852,JAPAN; MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021	Nagasaki University; Nagasaki University; Memorial Sloan Kettering Cancer Center				Takamiya, Kogo/0000-0001-7240-6307	NATIONAL CANCER INSTITUTE [R01CA060680] Funding Source: NIH RePORTER; NCI NIH HHS [CA 60680] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; DOHI T, 1990, J BIOL CHEM, V265, P7880; FURUKAWA K, 1985, BIOCHEMISTRY-US, V24, P7820, DOI 10.1021/bi00347a047; FURUKAWA K, 1988, J BIOL CHEM, V263, P14939; HASHIMOTO Y, 1993, J BIOL CHEM, V268, P25857; HIRABAYASHI Y, 1985, J BIOL CHEM, V260, P3328; KALISIAK A, 1991, GLYCOCONJUGATE J, V8, P55, DOI 10.1007/BF00731643; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; NATOLI EJ, 1986, CANCER RES, V46, P4116; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P7044, DOI 10.1073/pnas.85.19.7044; RUAN S, 1992, CANCER RES, V52, P5725; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; SMITH PL, 1994, J BIOL CHEM, V269, P15162; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; THAMPOE IJ, 1989, CANCER RES, V49, P6258; TRINCHERA M, 1989, J BIOL CHEM, V264, P15766; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; WARREN L, 1959, J BIOL CHEM, V234, P1971; YAMASHIRO S, 1993, CANCER RES, V53, P5395; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; YOUNG WW, 1979, J EXP MED, V150, P1008, DOI 10.1084/jem.150.4.1008	23	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6149	6155		10.1074/jbc.270.11.6149	http://dx.doi.org/10.1074/jbc.270.11.6149			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890749	hybrid			2022-12-27	WOS:A1995QM94500065
J	COSO, OA; CHIARIELLO, R; KALINEC, G; KYRIAKIS, JM; WOODGETT, J; GUTKIND, JS				COSO, OA; CHIARIELLO, R; KALINEC, G; KYRIAKIS, JM; WOODGETT, J; GUTKIND, JS			TRANSFORMING G-PROTEIN-COUPLED RECEPTORS POTENTLY ACTIVATE JNK (SAPK) - EVIDENCE FOR A DIVERGENCE FROM THE TYROSINE KINASE SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; JUN; PHOSPHORYLATION; TRANSDUCTION; RAS	The expression of human muscarinic acetylcholine receptors (mAChRs) in NIH 3T3 cells has been used as a model for studying proliferative signaling through G protein-coupled receptors. In this biological system, the mi class of mAChRs can effectively transduce mitogenic signals (Stephens, E. V., Kalinec, G., Brann, M. R., and Gutkind, J. S. (1993) Oncogene 8, 19-26) and induce malignant transformation if persistently activated (Gutkind, J. S., Novotny, E. A., Brann, M. R., and Robbins, K. C. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4703-4708). Moreover, available evidence suggests that the mi-signaling pathway converges at the level of p21(ras) with that emerging from tyrosine kinase receptors (Crespo, P., Xu, N., Simonds, W. F., and Gutkind, J. S. (1994) Nature 369, 418-420). To explore nuclear events involved in growth regulation by G protein-coupled receptors in this setting, we compared the effect of platelet-derived growth factor (PDGF) and the cholinerse agonist, carbachol, on the expression of mRNA for members of the jun and fos family of nuclear proto-oncogenes. We found that activation of m1 receptors by carbachol induces the expression of a distinct set of nuclear transcription factors. In particular, carbachol caused a much greater induction of c-jun mRNA and AP-1 activity. These responses did not correlate with protein kinase C stimulation nor with the activation of mitogen-activated protein (MAP) kinases. Recently, it has been shown that a novel family of kinases structurally related to MAP kinases, stress-activated protein kinases, or Jun kinases (JNKs), phospho rylate in vivo the amino-terminal transactivating domain of the c-Jun protein, thereby increasing its transcriptional activity. In view of our results, this observation prompted us to ask whether m1 and PDGF can differentially activate JNKs. Here, we show that m1 mAChRs can induce a remarkable increase in JNK activity, which was temporally distinct from that of MAP kinase and was entirely protein kinase C independent. In contrast, PDGF failed to activate JNK in these cells, although it stimulated MAP kinase to an extent even greater than that for carbachol. These findings demonstrate that G protein-coupled receptors can signal through pathways leading to the activation of JNK, thus diverging at this level with those signaling routes utilized by tyrosine kinase receptors.	NIDR,CELLULAR DEV & ONCOL LAB,MOLEC SIGNALING UNIT,BETHESDA,MD 20892; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DIABET UNIT,BOSTON,MA 02129; PRINCESS MARGARET HOSP,ONTARIO CANC INST,TORONTO,ON M4X 1K9,CANADA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre			Gutkind, J. Silvio/J-1201-2016; Woodgett, Jim/F-1087-2010; Gutkind, J. Silvio/A-1053-2009; Chiariello, Mario/O-3642-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Woodgett, Jim/0000-0003-3731-5797; Chiariello, Mario/0000-0001-8434-5177				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRAVO R, 1990, CELL GROWTH DIFFER, V1, P305; CRESPO P, 1994, J BIOL CHEM, V269, P21103; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HER JH, 1991, NUCLEIC ACIDS RES, V19, P3743, DOI 10.1093/nar/19.13.3743; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HIPSKIND R, 1992, NATURE, V354, P19; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PELECH SL, 1993, CURR BIOL, V3, P513, DOI 10.1016/0960-9822(93)90043-N; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; STEPHENS EV, 1993, ONCOGENE, V8, P19; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396	28	215	216	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5620	5624		10.1074/jbc.270.10.5620	http://dx.doi.org/10.1074/jbc.270.10.5620			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890682	hybrid			2022-12-27	WOS:A1995QL58000100
J	GITT, MA; WISER, MF; LEFFLER, H; HERRMANN, J; XIA, YR; MASSA, SM; COOPER, DNW; LUSIS, AJ; BARONDES, SH				GITT, MA; WISER, MF; LEFFLER, H; HERRMANN, J; XIA, YR; MASSA, SM; COOPER, DNW; LUSIS, AJ; BARONDES, SH			SEQUENCE AND MAPPING OF GALECTIN-5, A BETA-GALACTOSIDE-BINDING LECTIN, FOUND IN RAT ERYTHROCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-LAC LECTIN; ENDOGENOUS LECTIN; MASS-SPECTROMETRY; MUSCLE LECTIN; GENE FAMILY; 2 MEMBERS; PROTEIN; RECEPTOR; MOUSE; ORGANIZATION	A monomeric rat beta-galactoside-binding lectin previously purified from extracts of rat lung has been localized to erythrocytes, and the cDNA encoding it has been isolated from a rat reticulocyte cDNA library. The deduced amino acid sequence of the cDNA predicts a protein with a M(r) of 16,199, with no evidence of a signal peptide. The deduced sequence is identical to the sequences of seven proteolytic peptides derived from the purified lectin. Peptide analysis by mass spectrometry indicates that the N terminal methionine is cleaved and that serine 2 is acetylated. The lectin shares all the strictly conserved amino acid residues of other members of the mammalian galectin family and is designated galectin-5 (GenBank(TM) accession number L36862). Galectin-5 is a weak agglutinin of rat erythrocytes, despite its monomeric structure. The gene encoding galectin-5 (LGALS5) has been mapped in mouse to chromosome 11, similar to 50 centimorgans from the centromere and 1.8 +/- 1.8 centimorgans from the polymorphic marker D11Mit34n, a region syntenic with human chromosome 17q11.	UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; TULANE UNIV,MED CTR,SCH PUBL HLTH & TROP MED,DEPT TROP MED & PARASITOL,NEW ORLEANS,LA 70112; UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & MOLEC GENET,LOS ANGELES,CA 90024	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tulane University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Leffler, Hakon/A-2416-2019; Wiser, Mark/GPK-5489-2022	Leffler, Hakon/0000-0003-4482-8945	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031083] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01614] Funding Source: Medline; NHLBI NIH HHS [HL38627] Funding Source: Medline; NIAID NIH HHS [AI31083] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBRANDT K, 1987, P NATL ACAD SCI USA, V84, P6859, DOI 10.1073/pnas.84.19.6859; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BUCKWALTER MS, 1991, GENOMICS, V10, P515, DOI 10.1016/0888-7543(91)90430-M; CERRA RF, 1985, J BIOL CHEM, V260, P10474; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; FALICK AM, 1989, ANAL BIOCHEM, V182, P165, DOI 10.1016/0003-2697(89)90736-7; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; GITT MA, 1992, J BIOL CHEM, V267, P10601; GITT MA, 1991, BIOCHEMISTRY-US, V30, P82, DOI 10.1021/bi00215a013; HARRISON FL, 1984, J CELL SCI, V72, P147; HARRISON FL, 1986, J CELL SCI, V84, P201; HARRISON FL, 1980, NATURE, V286, P502, DOI 10.1038/286502a0; HOGAN A, 1991, DEVELOPMENT, V113, P363; HSU DK, 1992, J BIOL CHEM, V267, P14167; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; JOSHI N, 1993, ANN NEUROL, V34, P385, DOI 10.1002/ana.410340313; KAROLYI IJ, 1992, MAMM GENOME, V3, P184, DOI 10.1007/BF00352466; LEFFLER H, 1986, J BIOL CHEM, V261, P119; LEFFLER H, 1989, BIOCHEMISTRY-US, V28, P9222, DOI 10.1021/bi00449a039; LEVI G, 1981, J BIOL CHEM, V256, P5735; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MEDZIHRADSZKY KF, 1992, EUR J BIOCHEM, V203, P327, DOI 10.1111/j.1432-1033.1992.tb16553.x; MEHRABIAN M, 1993, GENOMICS, V15, P418, DOI 10.1006/geno.1993.1078; ODA Y, 1993, JBIOL CHEM, V268, P5292; RAZ A, 1991, CANCER RES, V51, P2173; ROSE K, 1988, BIOCHEM J, V252, P191; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; SEARLE AG, 1961, GENET RES, V2, P122, DOI 10.1017/S0016672300000604; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VANBELKUM A, 1990, UCLA SYM BI, V130, P7; WALLS FC, 1990, BIOLOGICAL MASS SPECTROMETRY /, P197; WEN PZ, 1993, GENOMICS, V15, P458, DOI 10.1006/geno.1993.1091; WHITNEY P, 1988, Journal of Cell Biology, V107, p639A; WISER MF, 1988, MOL BIOCHEM PARASIT, V27, P11, DOI 10.1016/0166-6851(88)90020-5	43	107	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5032	5038		10.1074/jbc.270.10.5032	http://dx.doi.org/10.1074/jbc.270.10.5032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890611	hybrid			2022-12-27	WOS:A1995QL58000016
J	HEINRICH, JN; BRAVO, R				HEINRICH, JN; BRAVO, R			THE ORPHAN MOUSE RECEPTOR INTERLEUKIN (IL)-8R-BETA BINDS N51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CLONING	We have demonstrated that the orphan receptor representing the putative mouse (mu) homolog of the human (hu) interleukin-8 receptor beta (IL-8R beta) binds the mouse N51 cytokine, also known as KC. The muIL-8R beta gene was constitutively expressed in NIH 3T3 cells (NIH-muIL-8R beta), Cells and plasma membranes from the NIH-muIL-8R beta clone showed binding of I-125-N51 that was displaced by unlabeled N51. Other related cytokines were assayed for their ability to displace I-125-N51. MIP-2 and GRO alpha/MGSA competed as well as N51 for the receptor, but huIL-8 and NAP-2 did not compete at all. Chimeric molecules between IL-8 and N51 were used to extend the binding analysis. The segment between the conserved cysteines 2 and 3, named domain I; cysteines 3 and 4, domain II; and cysteine 4 and the C terminus, domain III of IL-8 were replaced by the corresponding domains of N51 and vice versa. When studying the binding of I-125-N51 and the hybrid molecules to the receptor, we observed that chimeras of N51 containing either domain I, II, or III of IL-8 were agonists of N51, and chimeras of IL-8 containing domain II or III of N51 were partial agonists of N51. These results demonstrate that domain I of N51 does not confer binding specificity and suggest that the region from the third cysteine to the C terminus of the N51 molecule is more important for binding to muIL-8R beta.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543	Bristol-Myers Squibb								CACALANO G, 1994, SCIENCE, V256, P682; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; HARADA A, 1994, GENE, V142, P297, DOI 10.1016/0378-1119(94)90278-X; HEINRICH JN, 1994, MOL CELL BIOL, V14, P2849, DOI 10.1128/MCB.14.5.2849; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1992, J BIOL CHEM, V267, P16283; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; RYSECK RP, 1989, EXP CELL RES, V180, P266, DOI 10.1016/0014-4827(89)90230-9; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; van der Eb A J, 1980, Methods Enzymol, V65, P826	16	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4987	4989		10.1074/jbc.270.10.4987	http://dx.doi.org/10.1074/jbc.270.10.4987			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890604	hybrid			2022-12-27	WOS:A1995QL58000009
J	LOMAS, DA; ELLIOTT, PR; CHANG, WSW; WARDELL, MR; CARRELL, RW				LOMAS, DA; ELLIOTT, PR; CHANG, WSW; WARDELL, MR; CARRELL, RW			PREPARATION AND CHARACTERIZATION OF LATENT ALPHA(1)-ANTITRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; PLASMINOGEN-ACTIVATOR INHIBITOR; CRYSTAL-STRUCTURE; ENDOTHELIAL-CELLS; ANTITHROMBIN-III; REACTIVE CENTER; ALPHA-1-ANTITRYPSIN; SERPINS; RESOLUTION; MODEL	Members of the serine proteinase inhibitor or serpin superfamily have a common molecular architecture based on a dominant five-membered A beta-pleated sheet and a mobile reactive center loop. The reactive center loop has been shown to adopt a range of conformations from the three turn alpha-helix of ovalbumin to the cleaved or latent inhibitor in which the reactive center loop is fully inserted into the A sheet of the molecule. While the cleaved state can be achieved in all inhibitory serpins only plasminogen activator inhibitor-1 and, more recently, antithrombin have been shown to adopt the latent conformation. We show here that the archetypal serpin, alpha(1)-antitrypsin, can also be induced to adopt the latent conformation by heating at high temperatures in 0.7 M citrate for 12 h. The resulting species elutes at a lower sodium chloride concentration on an anion exchange column and has a more cathodal electrophoretic mobility on non-denaturing polyacrylamide gel electrophoresis and isoelectric focusing than native M antitrypsin. Latent antitrypsin is inactive as an inhibitor of bovine alpha-chymotrypsin, is stable to unfolding with 8 M urea, and is more resistant to heat-induced loop-sheet polymerization than native but less resistant than cleaved antitrypsin. The reactive center loop of latent antitrypsin is inaccessible to proteolytic cleavage, and its occupancy of the A sheet prevents the molecule accepting an exogenous reactive center loop peptide. The activity of latent antitrypsin may be increased from <1% to approximately 35% by refolding from 6 M guanidinium chloride.			LOMAS, DA (corresponding author), UNIV CAMBRIDGE, CTR MRC, DEPT HAEMATOL, HILLS RD, CAMBRIDGE CB2 2QH, ENGLAND.		Chang, Wun-Shaing Wayne/C-1202-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AULAK KS, 1993, J BIOL CHEM, V268, P18088; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; Bode W, 1991, CURR OPIN STRUC BIOL, V1, P45, DOI 10.1016/0959-440X(91)90010-Q; BRUCE D, 1994, J CLIN INVEST, V94, P2265, DOI 10.1172/JCI117589; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; CARRELL RW, 1993, NATURE, V364, P737, DOI 10.1038/364737a0; Carrell RW, 1992, CURR OPIN STRUC BIOL, V2, P438; ELDERING E, 1994, J CELL BIOCH S18D, V154, pS319; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P3634, DOI 10.1021/bi00410a017; Goldenberg D.P, 1989, PROTEIN STRUCTURE PR, P225; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; KATAGIRI K, 1988, EUR J BIOCHEM, V176, P81, DOI 10.1111/j.1432-1033.1988.tb14253.x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; LEVIN EG, 1987, BLOOD, V70, P1090; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; LOMAS DA, 1993, AM J PHYSIOL, V265, pL211, DOI 10.1152/ajplung.1993.265.3.L211; LONGSTAFF C, 1991, BIOCHEMISTRY-US, V30, P979, DOI 10.1021/bi00218a014; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; MATHESON NR, 1991, J BIOL CHEM, V266, P13489; MIKUS P, 1993, EUR J BIOCHEM, V218, P1071, DOI 10.1111/j.1432-1033.1993.tb18467.x; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; MUNCH M, 1991, FEBS LETT, V295, P102, DOI 10.1016/0014-5793(91)81395-O; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; POWELL LM, 1992, J MOL BIOL, V224, P241, DOI 10.1016/0022-2836(92)90587-A; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; TRAVIS J, 1981, METHOD ENZYMOL, V80, P754; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251	45	142	151	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5282	5288		10.1074/jbc.270.10.5282	http://dx.doi.org/10.1074/jbc.270.10.5282			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890640	hybrid			2022-12-27	WOS:A1995QL58000052
J	MAKLER, V; CUKIERMAN, E; ROTMAN, M; ADMON, A; CASSEL, D				MAKLER, V; CUKIERMAN, E; ROTMAN, M; ADMON, A; CASSEL, D			ADP-RIBOSYLATION FACTOR-DIRECTED GTPASE-ACTIVATING PROTEIN - PURIFICATION AND PARTIAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI MEMBRANES; ADENYLATE-CYCLASE; BINDING-PROTEIN; PHOSPHOLIPASE-D; CHOLERA-TOXIN; BOVINE BRAIN; COFACTOR; ARF; COP; RAS	The small GTP-binding protein ARF plays an established role in the control of vesicular traffic and in the regulation of phospholipase D activity. Like other GTP binding proteins, ARF becomes activated upon the binding of GTP, whereas GTP hydrolysis acts as a turn-off signal. The fact that purified ARF proteins have negligible GTPase activity has suggested that GTP hydrolysis by ARFs is dependent on a GTPase-activating protein (GAP). Here we report the complete purification of an ARF GAP from rat liver cytosol. Advanced stages in the purification were carried out in the presence of denaturing agents, making use of an unusual conformational stability, or refolding capacity, of the GAP. The GAP was purified about 15,000-fold and was identified as a protein of 49 kDa. Partial amino acid sequence analysis showed that the GAP is a previously uncharacterized protein Both crude and purified GAP migrated on a Superdex 200 column as a 200-kDa complex, suggesting a tet rameric structure. The purified ARF GAP was stimulated by phosphoinositides and was inhibited by phosphatidylcholine, similar to the results previously reported for a preparation from brain (Randazzo, P. A., and Kahn, R. A. (1994) J. Biol. Chem. 269, 10758). The availability of the ARF GAP molecule will advance the understanding of the regulation of the cellular processes in which ARF proteins participate.	TECHNION ISRAEL INST TECHNOL, DEPT BIOL, IL-32000 HAIFA, ISRAEL	Technion Israel Institute of Technology			cukierman, edna/AAU-8932-2020	cukierman, edna/0000-0002-1452-9576; Admon, Arie/0000-0003-0504-3950				BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DAYLE AH, 1980, ANAL BIOCHEM, V109, P76; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANSER E, 1992, J BIOL CHEM, V267, P16025; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; TSAI C, 1994, P NATL ACAD SCI USA, V91, P3063; TSAI SC, 1988, J BIOL CHEM, V263, P1768; TSUCHIYA M, 1991, J BIOL CHEM, V266, P2772; WEISS O, 1989, J BIOL CHEM, V264, P21066; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9	30	72	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5232	5237		10.1074/jbc.270.10.5232	http://dx.doi.org/10.1074/jbc.270.10.5232			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890632	hybrid			2022-12-27	WOS:A1995QL58000044
J	KRISTIE, TM; POMERANTZ, JL; TWOMEY, TC; PARENT, SA; SHARP, PA				KRISTIE, TM; POMERANTZ, JL; TWOMEY, TC; PARENT, SA; SHARP, PA			THE CELLULAR C1 FACTOR OF THE HERPES-SIMPLEX VIRUS ENHANCER COMPLEX IS A FAMILY OF POLYPEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS DNA-REPLICATION; NUCLEAR FACTOR-III; HISTONE H2B GENE; OCTAMER-BINDING PROTEINS; OCT-1 HOMEO DOMAIN; RNA POLYMERASE-III; TRANSCRIPTION FACTOR; HELA-CELLS; U2 SNRNA; TRANSACTIVATOR VP16	The alpha/immediate early genes of herpes simplex virus are regulated by the specific assembly of a multiprotein enhancer complex containing the Oct-1 POU domain protein, the viral alpha-transinduction factor alpha TIF, (VP16, ICP25), and the C1 cellular factor, The C1 factor from mammalian cells is a heterogeneous but related set of polypeptides that interact directly with the alpha-transinduction factor to form a heteromeric protein complex, The isolation of cDNAs encoding the polypeptides of the C1 factor suggests that these proteins are proteolytic products of a novel precursor. The sequence of the amino termini of these polypeptide products indicate that the proteins are generated by site-specific cleavages within a reiterated 20-amino acid sequence. Although the C1 factor appears to be ubiquitously expressed, it is localized to subnuclear structures in specific cell types.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; HARVARD UNIV,MIT,DIV HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Merck & Company	KRISTIE, TM (corresponding author), NIAID,VIRAL DIS LAB,BLDG 4,RM 133,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.			Pomerantz, Joel L./0000-0002-5030-1018	NCI NIH HHS [P30-CA14051, P01-CA42063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARES M, 1987, GENE DEV, V1, P808, DOI 10.1101/gad.1.8.808; BARK C, 1987, NATURE, V328, P356, DOI 10.1038/328356a0; BEVERLY S, 1987, CURRENT PROTOCOLS MO; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; DEJONG J, 1993, GENE DEV, V7, P2220, DOI 10.1101/gad.7.11.2220; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FERREIRA JA, 1994, J CELL BIOL, V126, P11, DOI 10.1083/jcb.126.1.11; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; GILMAN M, 1987, CURRENT PROTOCOLS MO; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Harlow E, 1988, IMMUNIZATION ANTIBOD, P53; HARLOW E, 1988, CELL STAINING ANTIBO, P359; HASSAN AB, 1994, J CELL SCI, V107, P425; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464; KATAN M, 1990, NUCLEIC ACIDS RES, V18, P6871, DOI 10.1093/nar/18.23.6871; KRISTIE TM, 1984, P NATL ACAD SCI-BIOL, V81, P4065, DOI 10.1073/pnas.81.13.4065; KRISTIE TM, 1993, J BIOL CHEM, V268, P6525; KRISTIE TM, 1989, EMBO J, V8, P4229, DOI 10.1002/j.1460-2075.1989.tb08608.x; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; KRISTIE TM, 1988, J VIROL, V62, P1145, DOI 10.1128/JVI.62.4.1145-1157.1988; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LABELLA F, 1989, GENE DEV, V3, P1982, DOI 10.1101/gad.3.12a.1982; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; MA DM, 1993, GENE DEV, V7, P2246, DOI 10.1101/gad.7.11.2246; MCKNIGHT JLC, 1987, P NATL ACAD SCI USA, V84, P7061, DOI 10.1073/pnas.84.20.7061; MIZUSHIMASUGANO J, 1986, P NATL ACAD SCI USA, V83, P8511, DOI 10.1073/pnas.83.22.8511; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; MULLERIMMERGLUC.MM, 1990, EMBO J, V9, P1625; MURPHY S, 1989, CELL, V59, P1071, DOI 10.1016/0092-8674(89)90763-0; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; ONEILL EA, 1988, J BIOL CHEM, V263, P931; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; POMERANTZ JL, 1992, GENE DEV, V6, P2047, DOI 10.1101/gad.6.11.2047; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; PRUIJN GJM, 1986, NATURE, V322, P656, DOI 10.1038/322656a0; PRUIJN GJM, 1987, EMBO J, V6, P3771, DOI 10.1002/j.1460-2075.1987.tb02712.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO R, 1994, J BIOL CHEM, V269, P17267; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SIVE HL, 1986, MOL CELL BIOL, V6, P3329, DOI 10.1128/MCB.6.10.3329; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; VERRIJZER CP, 1990, GENE DEV, V4, P1964, DOI 10.1101/gad.4.11.1964; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; WERSTUCK G, 1989, J VIROL, V63, P5509, DOI 10.1128/JVI.63.12.5509-5513.1989; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; XIAO P, 1990, MOL CELL BIOL, V10, P4974, DOI 10.1128/MCB.10.9.4974; YANG J, 1991, EMBO J, V10, P2291, DOI 10.1002/j.1460-2075.1991.tb07765.x; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235	64	93	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4387	4394		10.1074/jbc.270.9.4387	http://dx.doi.org/10.1074/jbc.270.9.4387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876203	hybrid			2022-12-27	WOS:A1995QK08400034
J	VAITHILINGAM, IS; MCDONALD, W; MALOTT, DW; DELMAESTRO, RF				VAITHILINGAM, IS; MCDONALD, W; MALOTT, DW; DELMAESTRO, RF			AN EXTRACELLULAR PROTEASOME-LIKE STRUCTURE FROM C6 ASTROCYTOMA-CELLS WITH SERINE COLLAGENASE-IV ACTIVITY AND METALLO-DEPENDENT ACTIVITY ON ALPHA-CASEIN AND BETA-INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; PROTEOLYTIC ACTIVITY; TISSUE INHIBITOR; TUMOR-CELLS; METALLOPROTEINASES; LOCALIZATION; METASTASIS; GROWTH	An extracellular proteasome-like (EP) structure has been isolated from serum-free media conditioned by C6 astrocytoma cells, EP has a native molecular mass of 1000 kDa and is composed of three subunits, two isoelectric variants at 70 kDa and one at 65 kDa, The extracellular proteasome degraded collagen TV, alpha-casein, beta-insulin, and certain synthetic peptide substrates. A 68-kDa type IV collagenase, identified as the activated form of gelatinase A, was also isolated from this medium, The type IV collagenase activity of the proteasome was sensitive to serine protease inhibitors, while the 68-kDa collagenase IV represented the matrix metalloprotease gelatinase A. The general protease activity of the proteasome was sensitive to metalloprotease inhibitors, Western blot analysis indicates a sequence relationship between the 68-kDa type IV collagenase and either one or both of the 70-kDa isoelectric variants of the proteasome; however, the two enzymes appear to be distinct functionally, Comparison with known proteasomes indicates that EP represents a novel proteasome. The complexity of degradative enzymes in the extracellular microenvironment implies that complete inhibition of tumor growth requires at least a combination of serine and metalloprotease inhibitors.	UNIV WESTERN ONTARIO,VICTORIA HOSP,DEPT CLIN NEUROL SCI,DIV NEUROSURG,BRAIN RES LABS,LONDON,ON N6A 4G5,CANADA; VICTORIA HOSP,DEPT PATHOL,LONDON,ON N6A 4G5,CANADA	University of Victoria; Western University (University of Western Ontario); University of Victoria; Western University (University of Western Ontario)								ALVAREZ OA, 1990, J NATL CANCER I, V82, P589, DOI 10.1093/jnci/82.7.589; AMSTERDAM A, 1989, P NATL ACAD SCI USA, V90, P99; BEYETTE JR, 1992, MUSCLE NERVE, V15, P1023, DOI 10.1002/mus.880150907; BOSMAN FT, 1989, HISTOCHEM J, V21, P629, DOI 10.1007/BF01002481; DAHLMANN B, 1992, EUR J BIOCHEM, V208, P789, DOI 10.1111/j.1432-1033.1992.tb17249.x; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DECLERCK YA, 1992, CANCER RES, V52, P701; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; HEWITT RE, 1991, INT J CANCER, V49, P666, DOI 10.1002/ijc.2910490507; HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3; KRAMER SP, 1968, J SURG RES, V8, P253, DOI 10.1016/0022-4804(68)90095-4; LYUBLINSKAYA LA, 1974, ANAL BIOCHEM, V62, P371, DOI 10.1016/0003-2697(74)90169-9; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OZAKI M, 1992, J BIOL CHEM, V267, P21678; PALMER A, 1994, EUR J CELL BIOL, V64, P163; RAJABI M, 1987, OBSTET GYNECOL, V69, P179; RIVETT AJ, 1993, BIOCHEM J, V291, P1; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; TANAKA K, 1992, NEW BIOL, V4, P173; TSUDA TT, 1993, FEBS LETT, V319, P35, DOI 10.1016/0014-5793(93)80032-P; VAITHILINGAM I, 1989, BIOCHEM INT, V19, P1297; VAITHILINGAM IS, 1992, J NEUROSURG, V77, P595, DOI 10.3171/jns.1992.77.4.0595; VAITHILINGAM IS, 1991, J NEURO-ONCOL, V10, P203, DOI 10.1007/BF00177532; VAITHILINGAM IS, 1992, CAN J NEUROL SCI, V19, P17, DOI 10.1017/S0317167100042487; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; WADA M, 1993, J LAB CLIN MED, V121, P215; WEITMAN D, 1992, J BIOL CHEM, V267, P6977; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210	31	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4588	4593		10.1074/jbc.270.9.4588	http://dx.doi.org/10.1074/jbc.270.9.4588			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876229	hybrid			2022-12-27	WOS:A1995QK08400062
J	BENO, DWA; BRADY, LM; BISSONNETTE, M; DAVIS, BH				BENO, DWA; BRADY, LM; BISSONNETTE, M; DAVIS, BH			PROTEIN-KINASE-C AND MITOGEN-ACTIVATED PROTEIN-KINASE ARE REQUIRED FOR 1,25-DIHYDROXYVITAMIN D-3-STIMULATED EGR INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PHOSPHOINOSITIDE TURNOVER; RAT HEPATIC LIPOCYTES; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; CELL ACTIVATION; RETINOIC ACID; MUSCLE-CELLS; MAP KINASES; RAF-1; PHOSPHORYLATION	Recent studies have demonstrated that 1,25-dihydroxyvitamin D-3 (D3) can activate Raf kinase and induce Egr expression in cultured rat hepatic Ito cells (Lissoos, T, W,, Beno, D, W, A, and Davis, B, EI. (1993) J. Biol, Chem, 268, 25132-25138), Since Raf is an upstream activator of mitogen-activated protein kinase (MAPK), the current study evaluated the ability of D3 to activate MAPK, D3-activated MAPK and induced its cytoplasmic to perinuclear translocation in Ito cells, MAPK activation was found to be protein kinase C-dependent, which was analogous to previous studies of D3 and Raf activation. To further explore the D3 cascade, a series of transient transfections were performed using dominant negative raf and MAPK mutant plasmids which effectively block Ras-induced Raf and MAPK activity, respectively, D3 induced a marked increase in the expression of a chloramphenicol acetyltransferase reporter gene linked to the Egr promoter (egr-CAT). When the dominant negative Raf plasmid was co-transfected, there was no significant reduction in egr-CAT. In contrast, when the dominant negative MAPK plasmid was co-transfected, egr-CAT induction was completely abolished, These results suggest that 1) D3 stimulates MAPK via a protein kinase C-dependent pathway, 2) D3-induced Egr expression can occur via a pathway independent of Ras-induced Raf, and 3) D3 absolutely requires MAPK activity for Egr expression.	UNIV CHICAGO,DEPT MED,GASTROENTEROL SECT,CHICAGO,IL 60637	University of Chicago					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040223, K08DK002022, P30DK042086] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 40223, DK 02022, DK 42086] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON NG, 1991, BIOCHEM J, V277, P573, DOI 10.1042/bj2770573; BENO DWA, 1994, BBA-MOL CELL RES, V1222, P292, DOI 10.1016/0167-4889(94)90181-3; BISSONNETTE M, 1994, AM J PHYSIOL, V267, pG465, DOI 10.1152/ajpgi.1994.267.3.G465; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CHAO TSO, 1994, J BIOL CHEM, V269, P7337; CLEMENS TL, 1988, ENDOCRINOLOGY, V122, P1224, DOI 10.1210/endo-122-4-1224; DAVIS BH, 1993, BIOCHEM J, V294, P785, DOI 10.1042/bj2940785; DAVIS BH, 1991, BIOCHEM J, V278, P43, DOI 10.1042/bj2780043; DAVIS BH, 1987, J BIOL CHEM, V262, P10280; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DRITTANTI L, 1989, BIOCHIM BIOPHYS ACTA, V1014, P112, DOI 10.1016/0167-4889(89)90022-0; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; FRIEDMAN SL, 1992, HEPATOLOGY, V16, pA143; HALLINE AG, 1994, ENDOCRINOLOGY, V134, P1710, DOI 10.1210/en.134.4.1710; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JURUTKA PW, 1993, J BIOL CHEM, V268, P6791; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KHALIL RA, 1993, AM J PHYSIOL, V265, pC406, DOI 10.1152/ajpcell.1993.265.2.C406; KOBAYASHI Y, 1992, HEPATOLOGY, V16, pA143; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LISSOOS TW, 1993, J BIOL CHEM, V268, P25132; LISSOOS TW, 1993, HEPATOLOGY, V18, pA161; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PINZANI M, 1990, ENDOCRINOLOGY, V127, P2343, DOI 10.1210/endo-127-5-2343; RAPP UR, 1991, ONCOGENE, V6, P495; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROUET P, 1992, BIOTECHNIQUES, V13, P700; RUPPRECHT HD, 1993, AM J PHYSIOL, V265, pF351, DOI 10.1152/ajprenal.1993.265.3.F351; Sambrook J, 1989, MOL CLONING LABORATO; SCHAAP D, 1993, J BIOL CHEM, V268, P20232; SEGER R, 1992, J BIOL CHEM, V267, P14373; SETH A, 1992, J BIOL CHEM, V267, P24796; SOZERI O, 1992, ONCOGENE, V7, P2259; TIEN XY, 1993, AM J PHYSIOL, V265, pG143, DOI 10.1152/ajpgi.1993.265.1.G143; WALI RK, 1990, J CLIN INVEST, V85, P1296, DOI 10.1172/JCI114567; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	48	90	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3642	3647		10.1074/jbc.270.8.3642	http://dx.doi.org/10.1074/jbc.270.8.3642			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876102	hybrid			2022-12-27	WOS:A1995QH68800030
J	ODA, T; CHEN, CH; WU, HC				ODA, T; CHEN, CH; WU, HC			CERAMIDE REVERSES BREFELDIN-A (BFA) RESISTANCE IN BFA-RESISTANT CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PERIPHERAL MEMBRANE-PROTEIN; GOLGI-APPARATUS; INTRACELLULAR TRANSLOCATION; ADP-RIBOSYLTRANSFERASE; NUCLEOTIDES MODULATE; CULTURED FIBROBLASTS; SECRETORY PROTEINS; PSEUDOMONAS TOXIN; RAT HEPATOCYTES	We have found that C-6 ceramide, a cell-permeable ceramide analog, partially restored the brefeldin A (BFA) sensitivity in a BFA-resistant mutant of Vero cells (BER-40) and in the naturally BFA-resistant Madin-Darby canine kidney (MDCK) cells. Incubation of BER-40 and MDCK cells with low concentrations of C-6 ceramide resulted in (i) a pronounced increase in BFA cytotoxicity as measured by the inhibition of [H-3]thymidine incorporation and the inhibition of colony formation by BFA, (ii) a significant protection by BFA against ricin cytotoxicity, and (iii) an inhibition of bulk protein secretion by BFA in BER-40 and MDCK: cells. Related sphingolipids including sphingosine, sphingomyelin, and lactosylceramide and other unrelated Lipid second messengers such as arachidonic acid and 1,2-diacylglycerol did not elicit the protection of BER-40 and MDCK cells against ricin cytotoxicity by BFA. C-6 ceramide was the most effective among the ceramides with different acyl chain lengths. Interestingly, dihydro-C-6 ceramide, which lacks the trans double bond in the sphingoid base, had no effect. On the other hand, C-6 ceramide did not enhance BFA sensitivity in BFA-sensitive Vero cells. The LD(50) of C-6 ceramide were similar in Vero and BER-40 cells. Fluorescence microscopic studies revealed that C-6 ceramide induced the redistribution of P-COP from the Golgi membranes to a more dispersed localization in both BFA-sensitive and BFA-resistant cell Lines, mimicking the effect of BFA. Suboptimal concentration of C-6 ceramide also restored the effect of BFA on the beta-COP distribution in BER-40 and MDCK cells. These results indicate that C-6 ceramide restores the BFA sensitivity in BFA-resistant BER-40 and MDCK cells.	UNIFORMED SERV UNIV HLTH SCI, DEPT IMMUNOL & MICROBIOL, BETHESDA, MD 20814 USA	Uniformed Services University of the Health Sciences - USA					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028810] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28810] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; CHEN C, 1992, EXP CELL RES, V203, P321, DOI 10.1016/0014-4827(92)90005-S; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; HAKOMORI SI, 1983, HDB LIPID RES, V3, P327; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; ITO M, 1986, J BIOL CHEM, V261, P14278; KIM MY, 1991, J BIOL CHEM, V266, P484; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KOLESNICK RN, 1989, J BIOL CHEM, V264, P7617; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; KTISTAKIS NT, 1992, NATURE, V356, P344, DOI 10.1038/356344a0; LINARDIC CM, 1992, J BIOL CHEM, V267, P14909; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; LOW SH, 1991, J BIOL CHEM, V266, P17729; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; NAKAMURA K, 1984, ANAL BIOCHEM, V142, P406, DOI 10.1016/0003-2697(84)90484-6; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; ODA T, 1993, J BIOL CHEM, V268, P12596; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; ORCI L, 1991, CELL, V64, P1183; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; PAGANO RE, 1988, BIOCHEMISTRY-US, V27, P4439, DOI 10.1021/bi00412a034; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; ROSENWALD AG, 1993, J BIOL CHEM, V268, P4577; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SUGAI M, 1992, P NATL ACAD SCI USA, V89, P8903, DOI 10.1073/pnas.89.19.8903; SUGAI M, 1992, J BIOL CHEM, V267, P21297; TAKATSUKI A, 1985, AGR BIOL CHEM TOKYO, V49, P899, DOI 10.1080/00021369.1985.10866826; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z; YOSHIDA T, 1990, EXP CELL RES, V190, P11, DOI 10.1016/0014-4827(90)90137-Y; ZEUZEM S, 1991, FEBS LETT, V288, P143, DOI 10.1016/0014-5793(91)81021-Y; ZIZI M, 1991, J BIOL CHEM, V266, P18443	45	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4088	4092		10.1074/jbc.270.8.4088	http://dx.doi.org/10.1074/jbc.270.8.4088			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876158	hybrid			2022-12-27	WOS:A1995QH68800091
J	WRAY, JW; ABELES, RH				WRAY, JW; ABELES, RH			THE METHIONINE SALVAGE PATHWAY IN KLEBSIELLA-PNEUMONIAE AND RAT-LIVER - IDENTIFICATION AND CHARACTERIZATION OF 2 NOVEL DIOXYGENASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-METHYLTHIORIBOSE KINASE; MICROBIAL-METABOLISM; CARBON-MONOXIDE; ENZYME; QUINOLINE	The 5-methylthio-D-ribose moiety of 5'-(methylthio)adenosine is converted to methionine in a wide variety of organisms, 1,2-Dihydroxy-3-keto-5-methylthiopentene anion (an aci-reductone) is an advanced intermediate in the methionine salvage pathway present in the Gram-negative bacterium Klebsiella pneumoniae and rat liver, This metabolite is oxidized spontaneously in air to formate and 2-keto-4-methylthiobutyric acid (the alpha-keto acid precursor of methionine), Previously, we had purified an enzyme (E2) from Klebsiella which catalyzes the oxidative degradation of the aci-reductone to formate, CO, and methylthiopropionic acid. To further characterize the reactions of the aci-reductone we used its desthio analog, 1-2-dihydroxy-3-ketohexene anion (III), which was described previously, This molecule undergoes the analogous enzymatic and non-enzymatic reactions of the natural substrate, namely the formation of formate, CO, and butyrate from III, Experiments with O-18(2) show that E2 is a dioxygenase which incorporates one molecule of O-18 into formate and butyric acid, No cofactor has been identified, We were unable to find an enzyme which catalyzes the conversion of 1,2-dihydroxy-3-keto-5-methylthiopentane to a keto acid precursor of methionine, The keto acid is probably produced non enzymically in Klebsiella. We have, however, identified and purified an enzyme (E3) from rat liver, which catalyzes the formation of formate and 2-oxopentanoic acid from III, This enzyme has a monomeric molecular mass of 28,000 daltons, and no chromophoric cofactor has been identified, Experiments with O-18(2) show that E3 is a dioxygenase which incorporates an O-18 molecule into formate and the alpha-keto acid, In rat liver CO formation was not detected,	UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97403	University of Oregon					NIGMS NIH HHS [GM07596] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELL LM, 1991, BIOCHEMISTRY-US, V30, P7883, DOI 10.1021/bi00246a002; BARTON, 1965, J CHEM SOC 3, P3563; BAUER L, 1994, FEMS MICROBIOL LETT, V117, P299; BOTT G, 1990, BIOL CHEM H-S, V371, P999, DOI 10.1515/bchm3.1990.371.2.999; DEBEYER A, 1993, BIOL CHEM H-S, V374, P101, DOI 10.1515/bchm3.1993.374.1-6.101; DUERRE JA, 1962, J BIOL CHEM, V237, P3737; FERRO AJ, 1978, J BIOL CHEM, V253, P6021; FERRO AJ, 1976, BIOCHIM BIOPHYS ACTA, V438, P487, DOI 10.1016/0005-2744(76)90264-3; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; GERSMANN HR, 1971, J CHEM SOC C, V12, P2230; GIANOTTI AJ, 1990, J BIOL CHEM, V265, P831; HUTCHINSON CR, 1977, J LABELLED COMPD RAD, V13, P571, DOI 10.1002/jlcr.2580130415; Maxwell J C, 1978, Methods Enzymol, V54, P302; MYERS RW, 1993, J BIOL CHEM, V268, P24785; OKA T, 1971, BIOCHEM BIOPH RES CO, V43, P1, DOI 10.1016/S0006-291X(71)80076-1; RUSSELL GA, 1968, ADV CHEM SER, V75, P174; SIMPSON FJ, 1960, BIOCHEM BIOPH RES CO, V2, P15, DOI 10.1016/0006-291X(60)90255-2; STARK BP, 1967, EXTRUSION REACTIONS, P16; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TRACKMAN PC, 1981, BIOCHEM BIOPH RES CO, V103, P1238, DOI 10.1016/0006-291X(81)90255-2; Tsuji J., 1969, SYNTHESIS-STUTTGART, P157, DOI DOI 10.1055/S-1969-34197; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Waterman M R, 1978, Methods Enzymol, V52, P456; WESTLAKE DWS, 1959, CAN J MICROBIOL, V5, P621, DOI 10.1139/m59-076; WRAY JW, 1993, J BIOL CHEM, V268, P21466	25	100	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3147	3153		10.1074/jbc.270.7.3147	http://dx.doi.org/10.1074/jbc.270.7.3147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852397	hybrid			2022-12-27	WOS:A1995QG47100040
J	THOMAS, D; HANLEY, MR				THOMAS, D; HANLEY, MR			EVALUATION OF CALCIUM INFLUX FACTORS FROM STIMULATED JURKAT T-LYMPHOCYTES BY MICROINJECTION INTO XENOPUS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INTRACELLULAR CA2+ STORES; ENTRY; THAPSIGARGIN; DEPLETION; INHIBITION; MESSENGER; CELLS	Acid extracts of thapsigargin-activated Jurkat cells have been shown to have intracellular activity in inducing a dose-dependent rapid chloride current upon microinjection in Xenopus laevis oocytes. The extracts act by elevation of calcium through calcium entry. The factor(s) responsible for this activity have been termed calcium influx factor (CIF) and have been found to be small, relatively polar molecules (<1000 daltons) whose activity is abolished by alkaline phosphatase treatment and potentiated by co-injection of okadaic acid (a protein phosphatase inhibitor). CIF is produced in a time-dependent manner following thapsigargin treatment of Jurkat cells, being first elevated above basal levels by 2 min. Intracellular CIF activity is completely absent from NG115-401L neuronal cells, which lack capacitative entry. On this basis, it appears that Jurkat cells, activated by stimuli that deplete internal calcium stores, produce one or more CIF activities acting intracellularly, and Xenopus oocytes may be a powerful tool to purify and characterize CIFs.	UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	University of California System; University of California Davis								ALVAREZ J, 1992, FASEB J, V6, P786, DOI 10.1096/fasebj.6.2.1537469; BAHNSON TD, 1993, J BIOL CHEM, V268, P10808; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRD GS, 1993, J BIOL CHEM, V268, P21486; BREITTMAYER JP, 1994, J BIOL CHEM, V269, P5054; FERGUSON JE, 1992, ARCH BIOCHEM BIOPHYS, V297, P388, DOI 10.1016/0003-9861(92)90689-T; GRYNKIEWICZ G, 1985, J BIOL CHEM, V60, P3440; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; LEE KM, 1993, J BIOL CHEM, V268, P9945; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PREMACK BA, 1994, J IMMUNOL, V152, P5226; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; SASAKAWA N, 1994, FEBS LETT, V347, P181, DOI 10.1016/0014-5793(94)00532-X; THOMAS D, 1994, METHOD CELL BIOL, V40, P65; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	19	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6429	6432		10.1074/jbc.270.12.6429	http://dx.doi.org/10.1074/jbc.270.12.6429			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896775	hybrid			2022-12-27	WOS:A1995QQ85500003
J	HAASS, C; CAPELL, A; CITRON, M; TEPLOW, DB; SELKOE, DJ				HAASS, C; CAPELL, A; CITRON, M; TEPLOW, DB; SELKOE, DJ			THE VACUOLAR H+-ATPASE INHIBITOR BAFILOMYCIN A1 DIFFERENTIALLY AFFECTS PROTEOLYTIC PROCESSING OF MUTANT AND WILD-TYPE BETA-AMYLOID PRECURSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CULTURED-CELLS; PC12 CELLS; PEPTIDE; MUTATION; CLEAVAGE; IDENTIFICATION; PATHWAY; GENE; DERIVATIVES	We analyzed the effect of the vacuolar H+-ATPase inhibitor bafilomycin A1 (bafA1) on the processing of beta-amyloid precursor protein (beta APP). In kidney 293 cells stably transfected with the wild-type beta APP cDNA, bafA1 caused a stabilization of mature beta APP and its 10-kDa COOH-terminal fragment. Moreover, it caused a 2-3-fold increase in secretion of soluble APP and amyloid-beta protein (A beta). Interestingly, bafA1 treatment of cells transfected with a mutant beta APP isoform that occurs in a Swedish kindred with familial Alzheimer's disease resulted in a decrease of A beta production and no increase of soluble APP secretion. Identical results were obtained when the effect of bafA1 was analyzed on fibroblasts derived from affected versus unaffected members of the Swedish family. These data demonstrate a differential effect of bafA1 on the production of A beta derived from wild-type or Swedish mutant beta APP. Radiosequencing of A beta derived from bafA1-treated cells expressing wild-type beta APP revealed a marked increase of A beta peptides starting at amino acids phenylalanine 4 and valine -3 and a relative decrease of A beta molecules beginning at the typical NH2 terminus of aspartate 1. Cells transfected with the Swedish mutation and treated with bafA1 did not produce these alternative A beta peptides, so that bafA1 treatment resulted in a decrease of A beta starting at aspartate 1. Our data indicate that multiple proteases are able to cleave A beta at or near its NH2 terminus. Inhibition of the protease cleaving at aspartate 1 by bafA1 and perhaps other similar agents can result in an increase of alternatively cleaved peptides.	HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	HAASS, C (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE ON AGING [P50AG005134, RF1AG006173, R37AG006173, R01AG006173] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05134, AG 06173] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CARPORASO GL, 1994, J NEUROSCI, V14, P3123; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CITRON M, 1995, IN PRESS NEURON; COLE GM, 1989, NEUROCHEM RES, V14, P933, DOI 10.1007/BF00965926; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOWING E, 1994, J BIOL CHEM, V269, P10987; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1994, J BIOL CHEM, V269, P17741; HAASS C, 1991, J NEUROSCI, V11, P3783; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; HAASS C, 1995, IN PRESS J CELL BIOL; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; HARDY J, 1992, NAT GENET, V1, P233, DOI 10.1038/ng0792-233; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOO EH, 1994, J BIOL CHEM, V269, P17386; LE ACY, 1994, J BIOL CHEM, V269, P30966; LUKACS GL, 1992, J BIOL CHEM, V266, P24540; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SUZUKI N, 1994, SCIENCE, V262, P1336; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; UMATA T, 1990, J BIOL CHEM, V265, P21940; WEIDEMANN A, 1989, CELL, V7, P115; XU HX, 1994, J BIOL CHEM, V269, P22875; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	50	92	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6186	6192		10.1074/jbc.270.11.6186	http://dx.doi.org/10.1074/jbc.270.11.6186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890753	hybrid			2022-12-27	WOS:A1995QM94500070
J	IIRI, T; HOMMA, Y; OHOKA, Y; ROBISHAW, JD; KATADA, T; BOURNE, HR				IIRI, T; HOMMA, Y; OHOKA, Y; ROBISHAW, JD; KATADA, T; BOURNE, HR			POTENTIATION OF G(I)-MEDIATED PHOSPHOLIPASE-C ACTIVATION BY RETINOIC ACID IN HL-60 CELLS - POSSIBLE ROLE OF G(GAMMA-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; CHEMOTACTIC PEPTIDE RECEPTORS; NUCLEOTIDE-BINDING PROTEIN; PERTUSSIS TOXIN; ALPHA-SUBUNIT; SIGNAL TRANSDUCTION; RAT-BRAIN; EXPRESSION; DIFFERENTIATION; FORMS	Differentiated HL-60 cells acquire responsiveness to fMet-Leu-Phe (fMLP), which activates phospholipase C and O-2(-) generation in a pertussis toxin-sensitive manner. Addition of retinoic acid (RA) for the last 24 h during dimethyl sulfoxide (Me(2)SO)-induced differentiation enhanced fMLP dependent signals and interaction between fMLP receptor and G(i). RA modifies both the function and subunit composition of G(i2), the predominant G(i) of HL-60 membranes, as shown by comparing purified G(i2) from membranes of Me(2)SO-treated cells (D-G(i2)) to G(i) from membranes of cells treated with both Me(2)SO and RA (DR-G(i2)). As compared to D-G(i2), DR-G(i2) induced more fMLP binding when added to membranes of pertussis toxin treated HL-60 cells and, in the presence of GTP gamma S, stimulated beta gamma-sensitive phospholipase C in extracts of HL-60 cells to a much greater extent and at lower concentrations. Immunoblots revealed that RA induced expression of the gamma(2) subunit, which was otherwise undetectable in G(i2) purified from HL-60 cells or in HL-60 membranes. Possibly by inducing expression of gamma(2), RA alters two functions of the G(i) beta gamma subunit, modulation of fMLP receptor-G(i2) coupling and activation of the effector, phospholipase C.	UNIV CALIF SAN FRANCISCO, MED CTR, DEPT PHARMACOL, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, CELL BIOL PROGRAM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; TOKYO METROPOLITAN GERIATR HOSP & INST GERENTOL, DEPT BIOSIGNAL RES, TOKYO 173, JAPAN; GEISINGER MED CLIN, WEIS CTR RES, DANVILLE, PA 17822 USA; UNIV TOKYO, FAC PHARMACEUT SCI, DEPT PHYS CHEM, BUNKYO KU, TOKYO 113, JAPAN	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Geisinger Medical Center; University of Tokyo					NCI NIH HHS [CA54427] Funding Source: Medline; NIGMS NIH HHS [GM 39867, GM27800] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039867, R01GM039867, R37GM027800, R01GM027800] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; ASANO T, 1993, J BIOL CHEM, V268, P20512; BLANK JL, 1993, J BIOL CHEM, V268, P25184; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOYER JL, 1994, J BIOL CHEM, V269, P2814; BRABET P, 1990, J NEUROCHEM, V54, P1310, DOI 10.1111/j.1471-4159.1990.tb01964.x; BRANDT SJ, 1985, P NATL ACAD SCI USA, V82, P3277, DOI 10.1073/pnas.82.10.3277; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CHAN SDH, 1990, J BIOL CHEM, V265, P20081; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; COLLINS SJ, 1987, BLOOD, V70, P1233; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FAURE M, 1994, J BIOL CHEM, V269, P7821; FAWZI AB, 1991, J BIOL CHEM, V266, P12194; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GIERSCHIK P, 1989, EUR J BIOCHEM, V183, P97, DOI 10.1111/j.1432-1033.1989.tb14901.x; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; IIRI T, 1991, EUR J BIOCHEM, V202, P635, DOI 10.1111/j.1432-1033.1991.tb16417.x; IIRI T, 1992, J BIOL CHEM, V267, P1020; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; KATADA T, 1986, J BIOL CHEM, V261, P8182; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KIKUCHI A, 1986, J BIOL CHEM, V261, P1558; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEE SB, 1993, J BIOL CHEM, V268, P25952; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; MURPHY PM, 1987, FEBS LETT, V221, P81, DOI 10.1016/0014-5793(87)80356-3; OINUMA M, 1987, J BIOL CHEM, V262, P8347; PARK DG, 1993, J BIOL CHEM, V268, P4573; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; PEREZ HD, 1992, J BIOL CHEM, V267, P358; RAO KMK, 1988, CANCER RES, V48, P6721; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; ROBISHAW JD, 1993, ANAL BIOCHEM, V208, P283, DOI 10.1006/abio.1993.1047; SEISHIMA M, 1988, BIOCHEM BIOPH RES CO, V156, P1077, DOI 10.1016/S0006-291X(88)80742-3; SIMCHOWITZ L, 1979, J LAB CLIN MED, V93, P583; SKUBITZ KM, 1982, BLOOD, V59, P586; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STERNWEIS PC, 1994, CURR OPIN CELL BIOL, V6, P198, DOI 10.1016/0955-0674(94)90136-8; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; TOHKIN M, 1991, EUR J BIOCHEM, V195, P527, DOI 10.1111/j.1432-1033.1991.tb15733.x; UEDA N, 1994, J BIOL CHEM, V269, P4388; UHING RJ, 1987, J BIOL CHEM, V262, P15575; VONWEIZSACKER E, 1992, BIOCHEM BIOPH RES CO, V183, P350, DOI 10.1016/0006-291X(92)91650-F; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	61	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5901	5908		10.1074/jbc.270.11.5901	http://dx.doi.org/10.1074/jbc.270.11.5901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890721	hybrid			2022-12-27	WOS:A1995QM94500033
J	INAGAKI, N; TSUURA, Y; NAMBA, N; MASUDA, K; GONOI, T; HORIE, M; SEINO, Y; MIZUTA, M; SEINO, S				INAGAKI, N; TSUURA, Y; NAMBA, N; MASUDA, K; GONOI, T; HORIE, M; SEINO, Y; MIZUTA, M; SEINO, S			CLONING AND FUNCTIONAL-CHARACTERIZATION OF A NOVEL ATP-SENSITIVE POTASSIUM CHANNEL UBIQUITOUSLY EXPRESSED IN RAT-TISSUES, INCLUDING PANCREATIC-ISLETS, PITUITARY, SKELETAL-MUSCLE, AND HEART	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							K+ CHANNELS; B-CELLS; BETA-CELLS	ATP-sensitive K+ (K-ATP) channels play a crucial role in coupling metabolic energy to the membrane potential of cells. We have isolated a cDNA encoding a novel member (uK(ATP)-1) of the inward rectifier K+ channel family from a rat pancreatic islet cDNA library, Rat uK(ATP)-1 is a 424-amino acid residue protein (M(r) = 47,960), Electrophysiological studies of uK(ATP)-1 expressed in Xenopus laevis oocytes show that uK(ATP)-1 is a weak rectifier and is blocked with Ba2+ ions, Single-channel patch clamp study of clonal human kidney epithelial cells (HEK293) transfected with uK(ATP)-1 cDNA reveals that uK(ATP)-1 closes in response to 1 mM ATP and has a single channel conductance of 70 +/- 2 picosiemens (n = 6), indicating that uK(ATP)-1 is an ATP-sensitive inward rectifier K+ channel. In addition, uK(ATP)-1 is activated by the K-ATP channel opener, diazoxide. RNA blot analysis shows that uK(ATP)-1 mRNA is expressed ubiquitously in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart, suggesting that uK(ATP)-1 may play a physiological role as a link between the metabolic state and membrane K+ permeability of cells in almost every normal tissue. Since uK(ATP)-1 shares only 43-46% amino acid identity with members of previously reported inward rectifier K+ channel subfamilies, including ROMK1, IRK1, GIRK1, and cK(ATP)-1, uK(ATP)-1 is not an isoform of these subfamilies and, therefore, represents a new subfamily of the inward rectifier K+ channel family having two transmembrane segments.	CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC MED,CHUO KU,CHIBA 260,JAPAN; KYOTO UNIV,SCH MED,DEPT INTERNAL MED 3,SAKYO KU,KYOTO 606,JAPAN; KYOTO UNIV,SCH MED,DEPT METAB & CLIN NUTR,SAKYO KU,KYOTO 606,JAPAN; CHIBA UNIV,PATHOGEN FUNGI & MICROBIAL TOXICOSES RES CTR,CHUO KU,CHIBA 260,JAPAN	Chiba University; Kyoto University; Kyoto University; Chiba University			, gonoi/GRS-0648-2022; Horie, Minoru/ABG-7128-2020; gonoi, tohru/AAC-5181-2021	, gonoi/0000-0003-3655-7911; gonoi, tohru/0000-0003-3655-7911; Inagaki, Nobuya/0000-0001-8261-2593				ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; BERNARDI H, 1993, P NATL ACAD SCI USA, V90, P1340, DOI 10.1073/pnas.90.4.1340; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; COOK NS, 1988, TRENDS PHARMACOL SCI, V9, P21, DOI 10.1016/0165-6147(88)90238-6; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; FAN Z, 1990, J PHYSIOL-LONDON, V430, P273, DOI 10.1113/jphysiol.1990.sp018291; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5343; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INGAKI N, 1994, P NATL ACAD SCI USA, V91, P2679; JAN LY, 1994, NATURE, V371, P119, DOI 10.1038/371119a0; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MAKHINA EN, 1994, J BIOL CHEM, V269, P20468; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; MORISHIGE KI, 1994, FEBS LETT, V346, P251, DOI 10.1016/0014-5793(94)00483-8; NICHOLS CG, 1993, TRENDS PHARMACOL SCI, V14, P320; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; TAN W, 1994, FEBS LETT, V348, P239; TSUURA Y, 1992, DIABETES, V41, P861, DOI 10.2337/diabetes.41.7.861; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251	31	346	360	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5691	5694		10.1074/jbc.270.11.5691	http://dx.doi.org/10.1074/jbc.270.11.5691			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890693	hybrid			2022-12-27	WOS:A1995QM94500002
J	KIM, YM; BERGONIA, HA; MULLER, C; PITT, BR; WATKINS, WD; LANCASTER, JR				KIM, YM; BERGONIA, HA; MULLER, C; PITT, BR; WATKINS, WD; LANCASTER, JR			LOSS AND DEGRADATION OF ENZYME-BOUND HEME INDUCED BY CELLULAR NITRIC-OXIDE SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT HEPATOCYTES; CYTOCHROME-P-450 HEME; SERUM-ALBUMIN; OXYGENASE; IRON; INDUCTION; LIVER; OXIDATION; PROTEIN; CELLS	We report here that, like nonheme iron, protein-bound intracellular heme iron is also a target for destruction by endogenously produced nitric oxide ((NO)-N-.). In isolated rat hepatocytes (NO)-N-. synthesis results in substantial (approximately 60%) and comparable loss of catalase and cytochrome P450 as well as total microsomal heme, and decreased heme synthetic (delta-aminolevulinate synthetase and ferrochelatase) and increased degradative (heme oxygenase) enzymatic activities, The effect is reversible, and intact cytochrome P450 apoproteins are still present, as judged by heme reconstitution of isolated microsomes. The effects on delta-aminolevulinate synthetase and heme oxygenase are likely to be secondary to heme liberation, while the effects on ferrochelatase appear to be a direct effect of (NO)-N-., perhaps destruction of its nonheme iron-sulfur center.	UNIV PITTSBURGH, SCH MED, DEPT SURG, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT ANESTHESIOL & CRIT CARE MED, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NHLBI NIH HHS [HL32154] Funding Source: Medline; NIDDK NIH HHS [DK46935] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046935] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BILLIAR TR, 1989, SURGERY, V106, P364; BISSELL DM, 1976, ARCH BIOCHEM BIOPHYS, V176, P91, DOI 10.1016/0003-9861(76)90144-2; BISSELL DM, 1976, ARCH BIOCHEM BIOPHYS, V176, P103, DOI 10.1016/0003-9861(76)90145-4; BONKOVSKY HL, 1990, EUR J BIOCHEM, V189, P155, DOI 10.1111/j.1432-1033.1990.tb15472.x; BONKOVSKY HL, 1984, BIOCHEM J, V222, P453, DOI 10.1042/bj2220453; Bonkovsky HL, 1982, HEPATOLOGY TXB LIVER, P351; BONNETT R, 1978, J CHEM SOC PERK T 1, P974, DOI 10.1039/p19780000974; BORNHEIM LM, 1986, ARCH BIOCHEM BIOPHYS, V246, P63, DOI 10.1016/0003-9861(86)90449-2; CABLE EE, 1991, BIOCHIM BIOPHYS ACTA, V1080, P245, DOI 10.1016/0167-4838(91)90009-O; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; Estabrook R W, 1978, Methods Enzymol, V52, P212; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FUCHS D, 1991, EUR J HAEMATOL, V46, P65; FUKUDA Y, 1993, BIOCHEM BIOPH RES CO, V193, P297, DOI 10.1006/bbrc.1993.1623; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522; Grisham MB, 1992, REACTIVE METABOLITES; GUENGERICH FP, 1992, FASEB J, V6, P667, DOI 10.1096/fasebj.6.2.1537453; HELQVIST S, 1991, DIABETOLOGIA, V34, P150, DOI 10.1007/BF00418268; HENRY Y, 1993, FASEB J, V7, P1124, DOI 10.1096/fasebj.7.12.8397130; HIBBS JB, 1990, INT CONGR SER, V897, P189; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; KIM YM, 1993, FEBS LETT, V332, P255, DOI 10.1016/0014-5793(93)80644-A; KRAEMER MJ, 1982, PEDIATRICS, V69, P476; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; MARDEN MC, 1989, BIOCHEMISTRY-US, V28, P4422, DOI 10.1021/bi00436a045; McDonald W., 1985, CRC HDB METHODS OXYG, P291; MITANI K, 1992, BLOOD, V79, P1255; MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NUSSLER AK, 1993, BIOCHEM BIOPH RES CO, V194, P826, DOI 10.1006/bbrc.1993.1896; OKEEFFE DH, 1978, J BIOL CHEM, V253, P3509; PIKULEVA IA, 1992, J BIOL CHEM, V267, P1438; RADI R, 1991, J BIOL CHEM, V266, P4244; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; STADLER J, 1994, P NATL ACAD SCI USA, V91, P3559, DOI 10.1073/pnas.91.9.3559; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; TAKETANI S, 1981, J BIOL CHEM, V256, P2748; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; WINK DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P115, DOI 10.1006/abbi.1993.1016; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; YU CA, 1974, J BIOL CHEM, V249, P107	47	229	239	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5710	5713		10.1074/jbc.270.11.5710	http://dx.doi.org/10.1074/jbc.270.11.5710			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890697	hybrid			2022-12-27	WOS:A1995QM94500007
J	MERCHANT, JL; SHIOTANI, A; MORTENSEN, ER; SHUMAKER, DK; ABRACZINSKAS, DR				MERCHANT, JL; SHIOTANI, A; MORTENSEN, ER; SHUMAKER, DK; ABRACZINSKAS, DR			EPIDERMAL GROWTH-FACTOR STIMULATION OF THE HUMAN GASTRIN PROMOTER REQUIRES SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; ZINC-FINGER PROTEIN; C-FOS GENE; DNA-BINDING; EXPRESSION; CELLS; SITE; ACTIVATION; RECEPTORS; SEQUENCES	Growth factors coordinately regulate a variety of different genes to stimulate cellular proliferation. In the stomach, gastrin, epidermal growth factor (EGF), and transforming growth factor-a all mediate gastric mucosal homeostasis by promoting cell renewal, We have previously shown that EGF and phorbol esters stimulate the human gastrin promoter through a novel GC-rich DNA element 5'-(-68)GGGGCGGGGTGGGGGG-53 called gERE (gastrin EGF response element). In this report, we show that three factors bind to this element, the transcription factor Sp1 and two fast migrating complexes designated gastrin EGF response proteins (gERP 1 and 2). To understand how these factors bind and confer EGF responsiveness, mutations of gERE were tested in vitro for protein binding and in vivo for promoter activation. Both gel shift assays and UV cross-linking studies revealed that the factors bind to overlapping domains, Sp1 to the 5' half-site and gERP 1 and 2 to the 3' half-site. Placing either the 5' or 3' mutations upstream of a minimal gastrin promoter abolished EGF induction. Therefore both the 5' and 3' domains were required to confer EGF induction. Collectively, these results demonstrate that complex interactions between Spl and other factors binding to overlapping gERE half-sites confer EGF responsiveness to the gastrin promoter.	UNIV MICHIGAN,DEPT PHYSIOL,ANN ARBOR,MI 48109; HOWARD HUGHES MED INST,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; Howard Hughes Medical Institute	MERCHANT, JL (corresponding author), UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109, USA.		Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533, R01DK045729, R37DK045729] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-45729, DK-34533] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMAN SL, 1993, P NATL ACAD SCI USA, V88, P7523; BORELLINI F, 1991, J BIOL CHEM, V266, P15850; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; BURGESS AW, 1989, BRIT MED BULL, V45, P401, DOI 10.1093/oxfordjournals.bmb.a072331; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN XR, 1992, ONCOGENE, V7, P1805; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, P743; ELSHOLTZ HP, 1986, SCIENCE, V234, P1552, DOI 10.1126/science.3491428; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GODLEY JM, 1989, P NATL ACAD SCI USA, V86, P3036, DOI 10.1073/pnas.86.9.3036; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HUANG HC, 1990, GENE DEV, V4, P287, DOI 10.1101/gad.4.2.287; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KITADAI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1342, DOI 10.1016/0006-291X(92)90221-6; KUTOH E, 1993, BIOCHEM BIOPH RES CO, V194, P1475, DOI 10.1006/bbrc.1993.1991; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LEMAIGRE FP, 1990, MOL CELL BIOL, V10, P1811, DOI 10.1128/MCB.10.4.1811; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LEWIS EJ, 1987, MOL CELL BIOL, V7, P3332, DOI 10.1128/MCB.7.9.3332; MERCHANT JL, 1991, MOL CELL BIOL, V11, P2686, DOI 10.1128/MCB.11.5.2686; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; NEHLS MC, 1992, DNA CELL BIOL, V11, P443, DOI 10.1089/dna.1992.11.443; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; PYRC JJ, 1992, BIOCHEMISTRY-US, V31, P4102, DOI 10.1021/bi00131a029; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SCHMIDT MC, 1989, MOL CELL BIOL, V9, P3299, DOI 10.1128/MCB.9.8.3299; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHIN TH, 1992, MOL CELL BIOL, V12, P3998, DOI 10.1128/MCB.12.9.3998; THIESEN HJ, 1991, BIOCHEM BIOPH RES CO, V176, P551, DOI 10.1016/S0006-291X(05)80219-0; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; WALSH JH, 1975, NEW ENGL J MED, V292, P1324, DOI 10.1056/NEJM197506192922505; WESTIN G, 1988, NUCLEIC ACIDS RES, V16, P5771, DOI 10.1093/nar/16.13.5771	40	79	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6314	6319		10.1074/jbc.270.11.6314	http://dx.doi.org/10.1074/jbc.270.11.6314			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890769	hybrid			2022-12-27	WOS:A1995QM94500090
J	CHO, MJ; CUMMINGS, RD				CHO, MJ; CUMMINGS, RD			GALECTIN-1, A BETA-GALACTOSIDE-BINDING LECTIN IN CHINESE-HAMSTER OVARY CELLS .2. LOCALIZATION AND BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLLACTOSAMINE CHAINS; S-TYPE LECTIN; CALF HEART; EXTRACELLULAR-MATRIX; MUSCLE LECTIN; LUNG; AGGLUTININ; DEFICIENT; MECHANISM; ADHESION	In the accompanying study (Cho, M., and Cummings, R. D. (1995) J. Biol. Chem. 270, 5198-5206), we reported that Chinese hamster ovary (CHO) cells synthesize galectin-1. We have now used several approaches to define the subcellular location and biosynthesis of galectin-1 in these cells. Galectin-1 was present on the cell surface, as assessed by immunofluorescent staining with monospecific antibody to the protein. Quantitation of the surface localized galectin-1 was achieved by metabolically radiolabeling cells with [S-35]Met/Cys and measuring the amount of lectin (i) sensitive to trypsin, (ii) accessible to biotinylating reagents, and (iii) accessible to the haptenic disaccharide lactose. By all three procedures, approximate to 1/2 of the radiolabeled galectin-1 associated with cells was shown to be on the cell surface with the remainder intracellular. The kinetics of externalization of galectin-1 was monitored by pulse-chase radiolabeling, and it was shown that cells secrete the protein with a t(1/2) approximate to 20 h. The cell surface form of galectin-1 in CHO cells was active and bound to surface glycoconjugates, but lectin accumulating in the culture media was inactive. Lectin synthesized by mutant Lec8 CHO cells, which are unable to galactosylate glycoproteins, was not found on the surface and quantitatively accumulated in the media in an inactive form. Taken together, our results demonstrate that galectin-1 is quantitatively externalized by CHO cells and can associate with surface glycoconjugates where the lectin activity is stabilized.			CHO, MJ (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CTR MOLEC MED, OKLAHOMA CITY, OK 73190 USA.				NATIONAL CANCER INSTITUTE [R01CA037626] Funding Source: NIH RePORTER; NCI NIH HHS [CA37626] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN HJ, 1990, J CELL BIOCHEM, V43, P43, DOI 10.1002/jcb.240430105; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BRILES EB, 1977, J BIOL CHEM, V252, P1107; BRILES EB, 1979, J CELL BIOL, V81, P528, DOI 10.1083/jcb.81.3.528; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEWAARD A, 1976, J BIOL CHEM, V251, P7581; DO KY, 1990, BIOCHEM BIOPH RES CO, V173, P1123, DOI 10.1016/S0006-291X(05)80902-7; GITT MA, 1986, P NATL ACAD SCI USA, V83, P7603, DOI 10.1073/pnas.83.20.7603; HARRISON FL, 1992, J CELL SCI, V101, P635; HIRABAYASHI J, 1987, J BIOCHEM-TOKYO, V101, P775, DOI 10.1093/jb/101.3.775; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; ORR GA, 1981, J BIOL CHEM, V256, P761; QUN Z, 1993, ARCH BIOCHEM BIOPHYS, V300, P6, DOI 10.1006/abbi.1993.1002; SMITH DF, 1990, J BIOL CHEM, V265, P6225; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; WHITNEY PL, 1986, BIOCHEM J, V238, P683, DOI 10.1042/bj2380683; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q	25	120	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5207	5212		10.1074/jbc.270.10.5207	http://dx.doi.org/10.1074/jbc.270.10.5207			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890631	hybrid			2022-12-27	WOS:A1995QL58000040
J	FARRENS, DL; KHORANA, HG				FARRENS, DL; KHORANA, HG			STRUCTURE AND FUNCTION IN RHODOPSIN .11. MEASUREMENT OF THE RATE OF METARHODOPSIN-II DECAY BY FLUORESCENCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE RHODOPSIN; CONFORMATIONAL-CHANGES; PATHWAYS	An increase in fluorescence is observed upon light activation of bovine rhodopsin. The rate of increase is monoexponential (t(1/2) = 15.5 min) at 20 degrees C in 0.1% lauryl maltoside, pH 6.0, and parallels the rate of decay of metarhodopsin II. We show that the increase in fluorescence is due to the release of free retinal, which no longer quenches the tryptophan fluorescence. An extrinsic fluorescence reporter group, pyrene maleimide, attached to bovine rhodopsin also shows an increase in pyrene fluorescence on illumination. The rate of increase in pyrene fluorescence matches the rate of increase in tryptophan fluorescence. This result has been used to develop a micromethod, requiring on the order of 1 mu g of rhodopsin, for measurement of metarhodopsin II decay. An Arrhenius plot derived from the fluorescence assay shows the energy of activation barrier for retinal release from rhodopsin to be 20.2 kcal/mol in 0.1% dodecyl maltoside at pH 6.0.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)					NATIONAL EYE INSTITUTE [F32EY006465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028289, R01GM028289] Funding Source: NIH RePORTER; NEI NIH HHS [1-F32-EY06465] Funding Source: Medline; NIGMS NIH HHS [GM28289] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT N, 1982, EUR J BIOCHEM, V127, P97, DOI 10.1111/j.1432-1033.1982.tb06842.x; BLAZYNSKI C, 1984, VISION RES, V24, P459, DOI 10.1016/0042-6989(84)90043-9; BLAZYNSKI C, 1981, VISION RES, V21, P833, DOI 10.1016/0042-6989(81)90183-8; BOROCHOVNEORI H, 1983, BIOCHEMISTRY-US, V22, P197, DOI 10.1021/bi00270a029; BOWNDS D, 1965, NATURE, V205, P254, DOI 10.1038/205254a0; CHIBA T, 1978, BIOCHEM BIOPH RES CO, V85, P551, DOI 10.1016/0006-291X(78)91198-1; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P197; EBREY TG, 1968, VISION RES, V8, P965, DOI 10.1016/0042-6989(68)90071-0; EBREY TG, 1971, P NATL ACAD SCI USA, V68, P713, DOI 10.1073/pnas.68.4.713; EBREY TG, 1972, PHOTOCHEM PHOTOBIOL, V15, P585, DOI 10.1111/j.1751-1097.1972.tb06269.x; FARRENS DL, 1992, PHOTOCHEM PHOTOBIOL, V54, P313; HUBBARD R, 1965, COLD SPRING HARB SYM, V30, P301, DOI 10.1101/SQB.1965.030.01.032; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KROFP A, 1967, VISION RES, V7, P811, DOI 10.1016/0042-6989(67)90001-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; RESEK JF, 1994, P NATL ACAD SCI USA, V91, P7643, DOI 10.1073/pnas.91.16.7643; SAKAMOTO T, 1995, P NATL ACAD SCI USA, V92, P249, DOI 10.1073/pnas.92.1.249; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	22	170	170	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5073	5076		10.1074/jbc.270.10.5073	http://dx.doi.org/10.1074/jbc.270.10.5073			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890614	hybrid			2022-12-27	WOS:A1995QL58000021
J	FREEMAN, NL; CHEN, ZX; HORENSTEIN, J; WEBER, A; FIELD, J				FREEMAN, NL; CHEN, ZX; HORENSTEIN, J; WEBER, A; FIELD, J			AN ACTIN MONOMER BINDING-ACTIVITY LOCALIZES TO THE CARBOXYL-TERMINAL HALF OF THE SACCHAROMYCES-CEREVISIAE CYCLASE-ASSOCIATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLYL CYCLASE; RAS PROTEINS; PROFILIN; YEAST; GENE; CAP; THYMOSIN-BETA-4; POLYMERIZATION; NUCLEATION; SEQUENCE	The Saccharomyces cerevisiae adenylyl cyclase complex contains at least two subunits, a 200-kDa catalytic subunit and a 70-kDa cyclase-associated protein, CAP (also called Srv2p). Genetic studies suggested two roles for CAP, one as a positive regulator of cAMP levels in yeast and a second role as a cytoskeletal regulator. We present evidence showing that CAP sequesters monomeric actin (K-d in the range of 0.5-5 mu M), decreasing actin incorporation into actin filaments. Anti-CAP monoclonal antibodies co-immunoprecipitate a protein with a molecular size of about 46 kDa. When CAP was purified from yeast using an anti-CAP monoclonal antibody column, the 46-kDa protein co-purified with a stoichiometry of about 1:1 with CAP. Western blots identified the 46-kDa protein as yeast actin. CAP also bound to muscle actin in vitro in immunoprecipitation assays and falling ball viscometry assays. Experiments with pyrene-labeled actin demonstrated that CAP sequesters actin monomers. The actin monomer binding activity is localized to the carboxyl-terminal half of CAP. Together, these data suggest that yeast CAP regulates the yeast cytoskeleton by sequestering actin monomers.	UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	University of Pennsylvania; University of Pennsylvania; Columbia University					NIGMS NIH HHS [R01-GM-48241, R01 GM048241] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048241] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYAN J, 1988, J CELL BIOL, V106, P1553, DOI 10.1083/jcb.106.5.1553; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; COHEN CM, 1979, NATURE, V279, P163, DOI 10.1038/279163a0; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GALLWITZ D, 1980, P NATL ACAD SCI-BIOL, V77, P2546, DOI 10.1073/pnas.77.5.2546; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; GOLDSCHMIDTCLER.PJ, 1992, MOL BIOL CELL, V3, P1015; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; MATVIW H, 1992, MOL CELL BIOL, V12, P5033, DOI 10.1128/MCB.12.11.5033; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; MURRAY JM, 1981, BIOCHEMISTRY-US, V20, P641, DOI 10.1021/bi00506a030; NEFSKY B, 1992, EUR J BIOCHEM, V206, P949, DOI 10.1111/j.1432-1033.1992.tb17005.x; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; NORTHROP J, 1986, J BIOL CHEM, V261, P9274; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; POLLARD TD, 1982, METHOD ENZYMOL, V85, P211; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Rose MD., 1990, METHODS YEAST GENETI; SAFER D, 1991, J BIOL CHEM, V266, P4029; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; WANG J, 1992, MOL CELL BIOL, V12, P4937, DOI 10.1128/MCB.12.11.4937; WEBER A, 1987, BIOCHEMISTRY-US, V26, P2528, DOI 10.1021/bi00383a019; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; ZECHEL K, 1980, EUR J BIOCHEM, V110, P343, DOI 10.1111/j.1432-1033.1980.tb04873.x; ZELICOF A, 1993, J BIOL CHEM, V268, P13448	41	117	117	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5680	5685		10.1074/jbc.270.10.5680	http://dx.doi.org/10.1074/jbc.270.10.5680			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890691	hybrid			2022-12-27	WOS:A1995QL58000110
J	YANG, B; JUNG, D; RAFAEL, JA; CHAMBERLAIN, JS; CAMPBELL, KP				YANG, B; JUNG, D; RAFAEL, JA; CHAMBERLAIN, JS; CAMPBELL, KP			IDENTIFICATION OF ALPHA-SYNTROPHIN BINDING TO SYNTROPHIN TRIPLET, DYSTROPHIN, AND UTROPHIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; POINT MUTATIONS; PROTEIN; TORPEDO; DEFICIENCY; ASSOCIATION; SARCOLEMMA; TISSUE	Syntrophin represents three cytoplasmic components of the dystrophin-glycoprotein complex that links the cytoskeleton to the extracellular matrix in skeletal muscle. alpha-Syntrophin has now been translated in vitro and shown to associate directly with all three components of the syntrophin triplet and with dystrophin. The in vitro translated 71-kDa non-muscle dystrophin isoform, containing the cysteine-rich/C-terminal domain, can also interact with the syntrophin triplet. The syntrophin binding motif in dystrophin was localized to exons 73 and 74 including amino acids 3447-3481 by comparing the interactions of alpha-syntrophin and seven overlapping human dystrophin fusion proteins. More than one syntrophin interaction site in this binding motif was suggested. alpha-Syntrophin also interacts directly with a C-terminal utrophin fusion protein. alpha-Syntrophin is localized to the muscle sarcolemma as well as to the neuromuscular junction in control mouse muscle. However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent. Our data suggest that alpha-syntrophin binds all syntrophin isoforms, and syntrophin directly interacts with dystrophin through more than one binding site in dystrophin exons 73 and 74 including amino acids 3447-3481.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,CTR HUMAN GENOME,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Rafael-Fortney, Jill/E-3909-2011	Campbell, Kevin/0000-0003-2066-5889; Chamberlain, Jeffrey/0000-0001-5299-0059				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; ANDERSON MS, 1992, TRENDS BIOCHEM SCI, V17, P289, DOI 10.1016/0968-0004(92)90437-E; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARTAUD A, 1993, J BIOL CHEM, V268, P13019; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GREENBERG DS, 1994, NAT GENET, V8, P340, DOI 10.1038/ng1294-340; Harian J. E., 1994, NATURE, V371, P168, DOI 10.1038/371168a0; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAMARCY NR, 1994, J BIOL CHEM, V269, P2870; LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; YANG B, 1994, J BIOL CHEM, V269, P6040; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	37	115	119	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4975	4978		10.1074/jbc.270.10.4975	http://dx.doi.org/10.1074/jbc.270.10.4975			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890602	hybrid			2022-12-27	WOS:A1995QL58000006
J	ALI, MS; SHENOY, BC; ESWARAN, D; ANDERSSON, LA; ROCHE, TE; PATEL, MS				ALI, MS; SHENOY, BC; ESWARAN, D; ANDERSSON, LA; ROCHE, TE; PATEL, MS			IDENTIFICATION OF THE TRYPTOPHAN RESIDUE IN THE THIAMIN PYROPHOSPHATE BINDING-SITE OF MAMMALIAN PYRUVATE-DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOACID DEHYDROGENASE; MAGNETIC CIRCULAR-DICHROISM; BETA-SUBUNIT; 3-DIMENSIONAL STRUCTURE; ACID DEHYDROGENASE; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; CDNA CLONES; COMPLEX; COMPONENT	The pyruvate dehydrogenase (E1) component of the mammalian pyruvate dehydrogenase complex catalyzes the oxidative decarboxylation of pyruvate with the formation of an acetyl residue and reducing equivalents, which are transferred sequentially to the dihydrolipoyl acetyltransferase and dihydrolipoamide dehydrogenase components, To examine the role of tryptophanyl residue(s) in the active site of E1, the enzyme was modified with the tryptophan-specific reagent N-bromosuccinimide. Modification of 2 tryptophan residues/mol of bovine E1 (out of 12 in a tetramer alpha(2) beta(2)) resulted in complete inactivation of the enzyme. The inactivation was prevented by preincubation with thiamin pyrophosphate (TPP), indicating that the modified tryptophan residue(s) is a part of the active site of this enzyme. Fluorescence studies showed that thiamin pyrophosphate interacts with tryptophan residue(s) of E1, The magnetic circular dichroism (MCD) spectral intensity at similar to 292 nm was decreased by similar to 15% for E1 + TPP relative to the intensity for E1 alone, Because this MCD band is uniquely sensitive to and quantitative for tryptophan, the simplest interpretation is that 1 out of 6 tryptophan residues present in E1 (alpha beta dimer) interacts with TPP. The natural circular dichroism (CD) spectrum of E1 is dramatically altered upon binding TPP, with concomitant induction of optical activity at similar to 263 nm for the nonchiral TPP macrocyle, From CD Studies, it is also inferred that loss of activity following N-bromosuccinimide treatment occurred without significant changes in the overall secondary structure of the protein, A single peptide was isolated by differential peptide mapping in the presence and absence of thiamin pyrophosphate following modification with N-bromosuccinimide. This peptide generated from human E1 was found to correspond to amino acid residues 116-143 in the deduced sequence of human E1 beta, suggesting that the tryptophan residue 135 in the beta subunit of human E1 functions in the active site of E1. The amino acid sequences surrounding this tryptophan residue are conserved in E1 beta from several species, suggesting that this region may constitute a structurally and/or functionally essential part of the enzyme.	SUNY BUFFALO, DEPT BIOCHEM, BUFFALO, NY 14214 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT BIOCHEM, CLEVELAND, OH 44106 USA; KANSAS STATE UNIV AGR & APPL SCI, DEPT BIOCHEM, MANHATTAN, KS 66506 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Case Western Reserve University; Kansas State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018320, R01DK020478, R55DK018320] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20478, DK18320] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBINSSON B, 1989, J PHYS CHEM-US, V93, P6646, DOI 10.1021/j100355a016; BARTH G, 1972, J AM CHEM SOC, V94, P1293, DOI 10.1021/ja00759a041; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DIEFENBACH RJ, 1991, BIOCHEM J, V276, P439, DOI 10.1042/bj2760439; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; HAWKINS CF, 1990, EUR J BIOCHEM, V191, P337, DOI 10.1111/j.1432-1033.1990.tb19128.x; HO L, 1989, P NATL ACAD SCI USA, V86, P5330, DOI 10.1073/pnas.86.14.5330; HO L, 1990, GENE, V86, P297, DOI 10.1016/0378-1119(90)90294-2; HOLMES CFB, 1986, EUR J BIOCHEM, V155, P173, DOI 10.1111/j.1432-1033.1986.tb09473.x; HOLMQUIS.B, 1973, BIOCHEMISTRY-US, V12, P4409, DOI 10.1021/bi00746a018; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; KHAILOVA LS, 1989, ANN NY ACAD SCI, V573, P36, DOI 10.1111/j.1749-6632.1989.tb14985.x; KHAILOVA LS, 1982, BIOCHEM INT, V5, P525; KOCHETOV GA, 1970, BIOCHEM BIOPH RES CO, V41, P1134, DOI 10.1016/0006-291X(70)90203-2; KOROCHKINA LG, 1984, BIOCHEM INT, V9, P491; KOROTCHKINA LG, 1995, IN PRESS PROTEIN EXP; LINDQVIST Y, 1992, EMBO J, V11, P2373, DOI 10.1002/j.1460-2075.1992.tb05301.x; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; MATUDA S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P1, DOI 10.1016/0167-4781(91)90076-X; OBRIEN TA, 1980, J BIOL CHEM, V255, P3302; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; ROCHE TE, 1972, BIOCHEM BIOPH RES CO, V48, P840, DOI 10.1016/0006-291X(72)90684-5; ROCHE TE, 1977, ARCH BIOCHEM BIOPHYS, V183, P664, DOI 10.1016/0003-9861(77)90400-3; Spande T.F., 1967, DETERMINATION TRYPTO, P498; STEPP LR, 1985, BIOCHEMISTRY-US, V24, P7187, DOI 10.1021/bi00346a026; STRICKLAND EH, 1970, BIOCHEMISTRY-US, V9, P4914, DOI 10.1021/bi00827a013; SUNDSTROM M, 1992, FEBS LETT, V313, P229, DOI 10.1016/0014-5793(92)81197-T; URATA Y, 1991, J NUTR SCI VITAMINOL, V37, P257; WEXLER ID, 1991, FEBS LETT, V282, P209, DOI 10.1016/0014-5793(91)80479-M; WHEELOCK MJ, 1991, MOL BIOCHEM PARASIT, V45, P9, DOI 10.1016/0166-6851(91)90022-X; ZHAO Y, 1992, BIOCHIM BIOPHYS ACTA, V1132, P207, DOI 10.1016/0167-4781(92)90014-Q	32	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4570	4574		10.1074/jbc.270.9.4570	http://dx.doi.org/10.1074/jbc.270.9.4570			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876227	hybrid			2022-12-27	WOS:A1995QK08400060
J	CHEN, LX; ZHANG, ZP; SCAFONAS, A; CAVALLI, RC; GABRIEL, JL; SOPRANO, KJ; SOPRANO, DR				CHEN, LX; ZHANG, ZP; SCAFONAS, A; CAVALLI, RC; GABRIEL, JL; SOPRANO, KJ; SOPRANO, DR			ARGININE-132 OF CELLULAR RETINOIC ACID-BINDING PROTEIN (TYPE-II) IS IMPORTANT FOR BINDING OF RETINOIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; P2 MYELIN PROTEIN; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; CRABP-I; DIFFERENTIAL PATTERN; MOLECULAR-CLONING; RAT; EXPRESSION; RECEPTORS	Cellular retinoic acid binding protein type II (CRABP-II) is one of two small molecular weight, cytosolic proteins which specifically bind retinoic acid (RA). Crystallographic and site-directed mutagenesis studies of several related proteins have indicated that either one or two conserved amino acid residues, homologous to positions Arg(111) and Arg(132) of CRABP-II are important for the binding of the hydrophobic ligand. In this report we have prepared site-directed mutations of these two positions of CRABP-II, Arg(111) and Arg(132), as well as Lys(82) to determine the role of these residues in the binding of Rk Recombinant wild type and mutant CRABP-II proteins were expressed and purified, and the affinity for retinoids was determined by fluorometric titration and binding of H-3-labeled compounds. K82A displayed an identical K-d for all-trans-RA as wild type CRABP-II and the K-d for all-trans-RA of R111A was only slightly higher, On the other hand, the two Arg(132) mutants, R132A and R132Q, of CRABP-II demonstrated undetectable binding of all-trans-RA. Taken together these data demonstrate that Arg(132) is a critical amino acid residue for the binding of RA by CRABP-II.	TEMPLE UNIV, SCH MED, DEPT BIOCHEM, PHILADELPHIA, PA 19140 USA; TEMPLE UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, PHILADELPHIA, PA 19140 USA; TEMPLE UNIV, SCH MED, FELS INST CANC RES & MOLEC BIOL, PHILADELPHIA, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044841, R01DK044517, T32DK007162] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 T32DK07162, DK44841, DK44517] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASTROM A, 1991, J BIOL CHEM, V266, P17662; BAILEY JS, 1988, J BIOL CHEM, V263, P9326; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; CHENG L, 1991, J BIOL CHEM, V266, P24404; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DOLLE P, 1990, DEVELOPMENT, V110, P1133; EADS J, 1993, J BIOL CHEM, V268, P26375; ELLER MS, 1992, EXP CELL RES, V198, P328, DOI 10.1016/0014-4827(92)90387-N; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; FIORELLA PD, 1993, J BIOL CHEM, V268, P21545; GIGUERE V, 1990, P NATL ACAD SCI USA, V87, P6233, DOI 10.1073/pnas.87.16.6233; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gudas Lorraine J., 1994, P443; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JAKOBY MG, 1993, BIOCHEMISTRY-US, V32, P872, DOI 10.1021/bi00054a019; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KAKKAD BP, 1988, J BIOL CHEM, V263, P12916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; Mangelsdorf David J., 1994, P319; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MULLERFAHRNOW A, 1991, EUR J BIOCHEM, V199, P271, DOI 10.1111/j.1432-1033.1991.tb16120.x; Ong David E., 1994, P283; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1992, DEVELOPMENT, V115, P973; SACCHETTINI JC, 1988, J BIOL CHEM, V263, P5815; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCAPIN G, 1992, J BIOL CHEM, V267, P4253; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SIEGENTHALER G, 1986, J INVEST DERMATOL, V86, P42, DOI 10.1111/1523-1747.ep12283788; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUMP DG, 1991, J BIOL CHEM, V266, P4622; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; XU ZH, 1992, BIOCHEMISTRY-US, V31, P3484, DOI 10.1021/bi00128a024; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG JH, 1992, PROTEINS, V13, P87, DOI 10.1002/prot.340130202	41	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4518	4525		10.1074/jbc.270.9.4518	http://dx.doi.org/10.1074/jbc.270.9.4518			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876220	hybrid			2022-12-27	WOS:A1995QK08400053
J	JOKLIK, WK; RONER, MR				JOKLIK, WK; RONER, MR			WHAT REASSORTS WHEN REOVIRUS GENOME SEGMENTS REASSORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOUBLE-STRANDED-RNA; REPLICASE PARTICLE; INFLUENZA-VIRUS; IN-VITRO; PROTEIN; SEROTYPE-3; SEQUENCES; BACTERIOPHAGE-PHI-6; MECHANISM; MUTANTS				JOKLIK, WK (corresponding author), DUKE UNIV, MED CTR, DEPT MICROBIOL, DURHAM, NC 27710 USA.		Roner, Michael/Q-9253-2019		NCI NIH HHS [T32 CA 09111] Funding Source: Medline; NIAID NIH HHS [R01 AI 08909, T32 AI 07148] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007148, R01AI008909] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACS G, 1971, J VIROL, V8, P684, DOI 10.1128/JVI.8.5.684-689.1971; ANTCZAK JB, 1992, VIROLOGY, V187, P760, DOI 10.1016/0042-6822(92)90478-8; BAMFORD DH, 1980, VIROLOGY, V107, P222, DOI 10.1016/0042-6822(80)90287-1; BORSA J, 1973, J VIROL, V11, P552, DOI 10.1128/JVI.11.4.552-564.1973; CASHDOLLAR LW, 1985, P NATL ACAD SCI USA, V82, P24, DOI 10.1073/pnas.82.1.24; CROSS RK, 1976, VIROLOGY, V74, P345, DOI 10.1016/0042-6822(76)90341-X; ENAMI M, 1991, VIROLOGY, V185, P291, DOI 10.1016/0042-6822(91)90776-8; FIELDS BN, 1969, VIROLOGY, V37, P335, DOI 10.1016/0042-6822(69)90217-7; FRILANDER M, 1992, J VIROL, V66, P5013, DOI 10.1128/JVI.66.8.5013-5017.1992; GAILLARD RK, 1982, VIROLOGY, V123, P152, DOI 10.1016/0042-6822(82)90302-6; GAILLARD RK, 1985, VIROLOGY, V147, P336, DOI 10.1016/0042-6822(85)90136-9; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; HUISMANS H, 1976, VIROLOGY, V70, P411, DOI 10.1016/0042-6822(76)90282-8; JAYASURIYA AK, 1988, VIROLOGY, V163, P591, DOI 10.1016/0042-6822(88)90300-5; KRUG RM, 1989, VIRUSES, V6; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LARSON SM, 1994, VIROLOGY, V201, P303, DOI 10.1006/viro.1994.1295; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; MINDICH L, 1980, VIROLOGY, V103, P386, DOI 10.1016/0042-6822(80)90197-X; MINDICH L, 1976, VIROLOGY, V75, P218, DOI 10.1016/0042-6822(76)90020-9; MOODY MD, 1989, VIROLOGY, V173, P437, DOI 10.1016/0042-6822(89)90556-4; MORGAN EM, 1977, VIROLOGY, V77, P421, DOI 10.1016/0042-6822(77)90440-8; MORGAN EM, 1975, VIROLOGY, V68, P455, DOI 10.1016/0042-6822(75)90286-X; PATTON JT, 1988, VIROLOGY, V166, P358, DOI 10.1016/0042-6822(88)90506-5; PATTON JT, 1990, J GEN VIROL, V71, P1087, DOI 10.1099/0022-1317-71-5-1087; RAMIG RF, 1983, VIROLOGY, V125, P299, DOI 10.1016/0042-6822(83)90203-9; RAMIG RF, 1983, REOVIRIDAE, P197; RONER MR, 1990, VIROLOGY, V179, P845, DOI 10.1016/0042-6822(90)90153-I; SAKUMA S, 1971, J VIROL, V8, P190, DOI 10.1128/JVI.8.2.190-196.1971; SAKUMA S, 1972, J VIROL, V10, P943, DOI 10.1128/JVI.10.5.943-950.1972; SAKUMA S, 1972, J VIROL, V10, P628, DOI 10.1128/JVI.10.4.628-638.1972; SILVERSTEIN SC, 1968, J CELL BIOL, V36, P197, DOI 10.1083/jcb.36.1.197; SPENDLOVE RS, 1970, J GEN VIROL, V8, P83, DOI 10.1099/0022-1317-8-2-83; WARD RL, 1990, J VIROL, V64, P3219, DOI 10.1128/JVI.64.7.3219-3225.1990; WIENER JR, 1987, VIROLOGY, V161, P332, DOI 10.1016/0042-6822(87)90125-5; WIENER JR, 1988, VIROLOGY, V163, P603, DOI 10.1016/0042-6822(88)90301-7; WIENER JR, 1989, VIROLOGY, V170, P340, DOI 10.1016/0042-6822(89)90392-9; WIENER JR, 1989, VIROLOGY, V169, P194, DOI 10.1016/0042-6822(89)90055-X; ZWEERINK HJ, 1976, VIROLOGY, V73, P442, DOI 10.1016/0042-6822(76)90405-0; ZWEERINK HJ, 1974, NATURE, V247, P313, DOI 10.1038/247313a0	43	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4181	4184		10.1074/jbc.270.9.4181	http://dx.doi.org/10.1074/jbc.270.9.4181			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876171	hybrid			2022-12-27	WOS:A1995QK08400001
J	NISSEN, MS; REEVES, R				NISSEN, MS; REEVES, R			CHANGES IN SUPERHELICITY ARE INTRODUCED INTO CLOSED CIRCULAR DNA BY BINDING OF HIGH-MOBILITY GROUP PROTEIN I/Y	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE INTERLEUKIN-2 CDNA; MINOR-GROOVE BINDERS; HMG-I; CHROMOSOMAL-PROTEINS; SATELLITE DNA; SUPERCOILED DNA; GENE-REGULATION; BETA GENE; SEQUENCE; CELLS	Mammalian high mobility group HMG-YY chromatin proteins bind to the minor groove of AT-rich DNA sequences with high affinity both in vivo and in vitro. Topoisomerase I-mediated relaxation assays, analyzed by one and two dimensional agarose gel electrophoresis, indicate that binding of recombinant human HMG-I/Y to closed circular DNA introduces positive supercoils at low protein to nucleotide molar ratios and negative supercoils at higher ratios, This is interpreted to mean that HMG-I/Y binding initially causes bending of the DNA helix followed by unwinding of the helix. In contrast, binding of another minor groove binding Ligand, netropsin, introduces positive supercoils only, An in vitro produced mutant HMG-I/Y protein lacking the negatively charged carboxyl-terminal domain binds Mammalian high mobility group HMG-YY chromatin proteins bind to the minor groove of AT-rich DNA sequences with high affinity both in vivo and in vitro. Topoisomerase I-mediated relaxation assays, analyzed by one and two dimensional agarose gel electrophoresis, indicate that binding of recombinant human HMG-I/Y to closed circular DNA introduces positive supercoils at low protein to nucleotide molar ratios and negative supercoils at higher ratios, This is interpreted to mean that HMG-I/Y binding initially causes bending of the DNA helix followed by unwinding of the helix. In contrast, binding of another minor groove binding Ligand, netropsin, introduces positive supercoils only, An in vitro produced mutant HMG-I/Y protein lacking the negatively charged carboxyl-terminal domain binds A . T-rich DNA approximately 1.4-fold better than the native protein, yet it is estimated to be 8-10-fold more effective at introducing negative supercoils. This finding suggests that the highly acidic C-terminal region of the HMG-I/Y protein may function as a regulatory domain influencing the amount of topological change induced in DNA substrates by binding of the protein. Footprinting of HMG-I/Y on negatively supercoiled A . T-rich DNA using diethylpyrocarbonate suggests that the protein is able to recognize, bind to, and alter the conformation of non-B-form DNA.	WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164; WASHINGTON STATE UNIV,DEPT GENET & CELL BIOL,PULLMAN,WA 99164	Washington State University; Washington State University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026356] Funding Source: NIH RePORTER; NIAID NIH HHS [5-R01-AI26356] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BATES AD, 1993, DNA TOPOLOGY, P114; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BUSSEMAKERS MJG, 1991, CANCER RES, V51, P606; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CHURCHILL MEA, 1990, BIOCHEMISTRY-US, V29, P6043, DOI 10.1021/bi00477a023; CHUVPILO S, 1994, NUCLEIC ACIDS RES, V21, P5694; COLL M, 1989, BIOCHEMISTRY-US, V28, P310, DOI 10.1021/bi00427a042; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; ELTON TS, 1987, BIOCHEM BIOPH RES CO, V143, P260, DOI 10.1016/0006-291X(87)90659-0; EVANS JNS, 1992, B MAG RESON, V14, P171; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; GIANCOTTI V, 1989, EXP CELL RES, V184, P538, DOI 10.1016/0014-4827(89)90352-2; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; JACOBSEN K, 1990, PLANT CELL, V2, P85, DOI 10.1105/tpc.2.1.85; JOHN S, 1994, IN PRESS MOL CELL BI; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; KAPLAN DJ, 1988, NUCLEIC ACIDS RES, V16, P10375, DOI 10.1093/nar/16.21.10375; KOPKA ML, 1985, J MOL BIOL, V183, P553, DOI 10.1016/0022-2836(85)90171-8; KOPKA ML, 1992, NUCLEIC ACID TARGETE, P303; LEHN DA, 1988, BIOCHEM INT, V16, P963; LEVINGER L, 1982, P NATL ACAD SCI-BIOL, V79, P7152, DOI 10.1073/pnas.79.23.7152; LUND T, 1987, BIOCHEM BIOPH RES CO, V146, P725, DOI 10.1016/0006-291X(87)90589-4; LUND T, 1985, FEBS LETT, V180, P275, DOI 10.1016/0014-5793(85)81085-1; LUND T, 1983, FEBS LETT, V152, P163, DOI 10.1016/0014-5793(83)80370-6; MANFIOLETTI G, 1992, NUCLEIC ACIDS RES, V19, P6793; MCLEAN MJ, 1994, DNA PROTEIN INTERACT, P89; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; PFAFFLE P, 1990, J BIOL CHEM, V265, P16821; PULLEYBLANK DE, 1975, J MOL BIOL, V91, P1, DOI 10.1016/0022-2836(75)90368-X; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; RAM T, 1992, GENETICS MOL BIOL BR, P65; RAM TG, 1993, CANCER RES, V53, P2655; REEVES R, 1993, J BIOL CHEM, V268, P21137; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Sambrook J, 1989, MOL CLONING LABORATO; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SHURE M, 1977, NUCLEIC ACIDS RES, V4, P1183, DOI 10.1093/nar/4.5.1183; SNOUNOU G, 1983, J MOL BIOL, V167, P211, DOI 10.1016/S0022-2836(83)80043-6; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; SOTELONIETO J, 1994, PLANT CELL, V6, P287; STORL K, 1993, FEBS LETT, V334, P49, DOI 10.1016/0014-5793(93)81678-S; STORL K, 1993, FEBS LETT, V317, P157, DOI 10.1016/0014-5793(93)81513-Y; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; THOMPSON EM, 1994, MOL CELL BIOL, V14, P4694, DOI 10.1128/MCB.14.7.4694; TJADEN G, 1994, PLANT CELL, V6, P107, DOI 10.1105/tpc.6.1.107; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WANG JC, 1974, J MOL BIOL, V89, P783, DOI 10.1016/0022-2836(74)90053-9; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; WINTER E, 1989, EMBO J, V8, P1867, DOI 10.1002/j.1460-2075.1989.tb03583.x; ZHOA K, 1993, EMBO J, V12, P3237; ZIMMER C, 1989, NUCLEIC ACIDS RES, V10, P1721	61	82	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4355	4360		10.1074/jbc.270.9.4355	http://dx.doi.org/10.1074/jbc.270.9.4355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876198	hybrid			2022-12-27	WOS:A1995QK08400029
J	GARY, JD; CLARKE, S				GARY, JD; CLARKE, S			PURIFICATION AND CHARACTERIZATION OF AN ISOASPARTYL DIPEPTIDASE FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; ASPARTYL RESIDUES; DIHYDROOROTASE; SEQUENCE; SURVIVAL; PEPTIDE; SITE; GENE; K-12; ACCUMULATION	We have identified a gene (iadA) in Escherichia coli encoding a 41-kDa polypeptide that catalyzes the hydrolytic cleavage of L-isoaspartyl, or L-beta-aspartyl, dipeptides. We demonstrate at least a 3000-fold purification of the enzyme to homogeneity from crude cytosol. From the amino-terminal amino acid sequence obtained hom this preparation, we designed an oligonucleotide that allowed us to map the gene to the 98-min region of the chromosome and to clone and obtain the DNA sequence of the gene. Examination of the deduced amino acid sequence revealed no similarities to other peptidases or proteases, while a marked similarity was found with several dihydroorotases and imidases, reflecting the similarity in the structures of the substrates for these enzymes. Using an E. coli strain containing a plasmid overexpressing this gene, me were able to purify sufficient amounts of the dipeptidase to characterize its substrate specificity. We also examined the phenotype of two E. coli strains where this isoaspartyl dipeptidase gene was deleted. We inserted a chloramphenicol cassette into the disrupted coding region of iadA in both a parent strain (MC1000) and a derivative strain (CL1010) lacking pcm, the gene encoding the L-isoaspartyl methyltransferase involved in the repair of isomerized proteins. We found that the iadA deletion does not result in reduced stationary phase or heat shock survival. Analysis of isoaspartyl dipeptidase activity in the deletion strain revealed a second activity of lower native molecular weight that accounts for approximately 31% of the total activity in the parent strain MC1000. The presence of this second activity may account for the absence of an observable phenotype in the iadA mutant cells.	UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07185, GM26020] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JL, 1967, TECHNIQUES PROTEIN C, P340; BLATTNER FR, 1993, NUCLEIC ACIDS RES, V21, P5408; BROWN DC, 1991, J BIOL CHEM, V266, P1597; BRUNAUER LS, 1986, J BIOL CHEM, V261, P2538; BUCHANAN DL, 1966, BIOCHEMISTRY-US, V5, P3240, DOI 10.1021/bi00874a026; BUCKHOLZ RG, 1991, YEAST, V7, P913, DOI 10.1002/yea.320070903; BURTON EG, 1989, J NUTR, V119, P713, DOI 10.1093/jn/119.5.713; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; CLARKE S, 1992, STABILITY PROTEIN PH, P1; CONLIN CA, 1994, J BACTERIOL, V176, P1552, DOI 10.1128/jb.176.5.1552-1553.1994; DODD IB, 1987, J MOL BIOL, V194, P557, DOI 10.1016/0022-2836(87)90681-4; DORER FE, 1968, ARCH BIOCHEM BIOPHYS, V127, P490, DOI 10.1016/0003-9861(68)90253-1; FU JC, 1991, J BIOL CHEM, V266, P14562; GHIM SY, 1994, MICROBIOL-UK, V140, P479, DOI 10.1099/00221287-140-3-479; HALEY EE, 1966, BIOCHEMISTRY-US, V5, P3229, DOI 10.1021/bi00874a024; HALEY EE, 1968, J BIOL CHEM, V243, P5748; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; JENKINS DE, 1988, J BACTERIOL, V170, P3910, DOI 10.1128/jb.170.9.3910-3914.1988; JIN SF, 1994, J BACTERIOL, V176, P4669, DOI 10.1128/JB.176.15.4669-4679.1994; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOINTE G, 1994, APPL ENVIRON MICROB, V60, P888, DOI 10.1128/AEM.60.3.888-895.1994; LI C, 1992, P NATL ACAD SCI USA, V89, P9885, DOI 10.1073/pnas.89.20.9885; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; MANDELSTAM J, 1958, BIOCHEM J, V69, P110, DOI 10.1042/bj0690110; MANDELSTAM J, 1960, BACTERIOL REV, V24, P289, DOI 10.1128/MMBR.24.3.289-308.1960; Miller J.H., 1972, EXPT MOL GENETICS; MOORE S, 1968, J BIOL CHEM, V243, P6281; MURRAY ED, 1984, J BIOL CHEM, V259, P722; PAYNE JW, 1972, J GEN MICROBIOL, V71, P267, DOI 10.1099/00221287-71-2-267; PLANCOT MT, 1969, B SOC CHIM BIOL, V51, P1111; QUINN CL, 1991, J BIOL CHEM, V266, P9113; REEVE CA, 1984, J BACTERIOL, V160, P1041, DOI 10.1128/JB.160.3.1041-1046.1984; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; REYNOLDS TR, 1992, BIOTECHNIQUES, V12, P518; RUDD KE, 1992, SHORT COURSE BACTERI; Sambrook J, 1989, MOL CLONING LABORATO; Scharf SJ, 1990, PCR PROTOCOLS GUIDE, P84; SETLOW P, 1975, J BACTERIOL, V122, P642, DOI 10.1128/JB.122.2.642-649.1975; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Silhavy T. J., 1984, EXPT GENE FUSIONS; SIMMONDS S, 1976, BIOCHEMISTRY-US, V15, P261, DOI 10.1021/bi00647a004; SLATER S, 1993, J BACTERIOL, V175, P4260, DOI 10.1128/JB.175.13.4260-4262.1993; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; SUNG YC, 1992, J BACTERIOL, V174, P3645, DOI 10.1128/JB.174.11.3645-3650.1992; SUZUKI H, 1993, J BACTERIOL, V175, P6038, DOI 10.1128/JB.175.18.6038-6040.1993; TABOR S, 1989, J BIOL CHEM, V264, P6447; WASHABAUGH MW, 1984, J BIOL CHEM, V259, P3293; WASHABAUGH MW, 1986, J BIOL CHEM, V261, P5920; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; YANG YS, 1993, J BIOL CHEM, V268, P10870; YEN C, 1980, J MOL BIOL, V143, P35, DOI 10.1016/0022-2836(80)90123-0	59	39	43	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4076	4087		10.1074/jbc.270.8.4076	http://dx.doi.org/10.1074/jbc.270.8.4076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876157	hybrid			2022-12-27	WOS:A1995QH68800090
J	SOYAL, SM; SEELOS, C; LINLEE, YC; SANDERS, S; GOTTO, AM; HACHEY, DL; PATSCH, W				SOYAL, SM; SEELOS, C; LINLEE, YC; SANDERS, S; GOTTO, AM; HACHEY, DL; PATSCH, W			THYROID-HORMONE INFLUENCES THE MATURATION OF APOLIPOPROTEIN-A-I MESSENGER-RNA IN RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; C-III; SUCROSE DIET; TRANSCRIPTION; SEQUENCES; TRIIODOTHYRONINE; AMPLIFICATION; CHOLESTEROL; METABOLISM; PRECURSOR	Chronic administration of thyroid hormone (T-3) increases apolipoprotein (ape) A-I gene expression in rat liver, That transcriptional activity of the apoA-I gene is reduced to 50% of control, whereas abundance levels of nuclear and total cellular apoA-I mRNA are increased 3-fold, implies more effective apoA-I mRNA maturation. To study hormonal effects on apoA-I RNA processing, we quantified mRNA precursors in control and T-3-treated rats (50 mu g/100 g body weight for 7 days). Northern blotting, amplification of reverse-transcribed RNA, and ribonuclease protection assays showed that the splicing pathway is branched, in that either intron 1 or intron 2 is removed first from the primary transcript, whereas intron 3 is removed last. In T-3-treated rats, abundance levels of the primary transcript, the intron 1-containing precursor devoid of intron 2, the intron 2 containing precursor devoid of intron 1, the intron S-containing precursor lacking both introns 1 and 2, and nuclear mRNA were 65, 183, 78, 195, and 268% of controls, Compared with control rats, the half-life of the intron 1-containing precursor, measured after injection of actinomycin D, was increased 2-fold in T-3-treated rats. In contrast, half-lives of the primary transcript and the intron 2-containing precursor were similar in control and T-3-treated rats. Ribonuclease protection assays revealed an RNA species extending from the transcription start site close to the 3' end of intron 1. The abundance of this RNA fragment, probably representing a degradation product, was 2.5-fold higher in control than in T-3-treated animals (p < 0.001). Sequences of apoA-I mRNA precursors were identical in control and T-3-treated rats which excluded hormonal effects on splice-site selection or post-transcriptional editing of apoA-I transcripts. Compartmental modeling of apoA-I mRNA processing suggested that chronic thyroid hormone administration enhances apoA-I mRNA maturation more than 7-fold by protecting the intron 1-containing precursor devoid of intron 2 from degradation and by facilitating the splicing of intron 1 from this precursor.	BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Baylor College of Medicine					NHLBI NIH HHS [HL27341, R01 HL34457] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL027341, R01HL034457, P60HL027341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANIELLO F, 1991, P NATL ACAD SCI USA, V88, P4035, DOI 10.1073/pnas.88.9.4035; APOSTOLOPOULOS JJ, 1988, BIOCHEM BIOPH RES CO, V154, P997, DOI 10.1016/0006-291X(88)90238-0; APOSTOLOPOULOS JJ, 1987, J LIPID RES, V28, P642; BADIMON JJ, 1990, J CLIN INVEST, V353, P265; BIERMAN EL, 1991, ADV EXP MED BIOL, V285, P81; BINGHAM PM, 1988, TRENDS GENET, V4, P134, DOI 10.1016/0168-9525(88)90136-9; BOSTON RC, 1981, COMPUT PROG BIOMED, V13, P111, DOI 10.1016/0010-468X(81)90089-1; CAFFARELLI E, 1987, EMBO J, V6, P3493, DOI 10.1002/j.1460-2075.1987.tb02674.x; DAVIDSON NO, 1988, J LIPID RES, V29, P1511; DAVIDSON NO, 1988, J BIOL CHEM, V263, P13482; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FOSTER DM, 1983, COMPARTMENTAL DISTRI, P73; Gelfand D.H., 1990, PC PRO, P129; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; HORN GT, 1989, NUCLEIC ACIDS RES, V17, P2140, DOI 10.1093/nar/17.5.2140; KILEDJIAN M, 1991, J BIOL CHEM, V266, P4207; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; LINLEE YC, 1993, J LIPID RES, V34, P249; LINLEE YC, 1993, CIRCULATION, V88, P421; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MCNALLY MT, 1991, VIROLOGY, V185, P99, DOI 10.1016/0042-6822(91)90758-4; MILLER GJ, 1975, LANCET, V1, P16; NORTHEMANN W, 1985, J BIOL CHEM, V260, P6200; NOWICKA G, 1990, J LIPID RES, V31, P1947; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OPPENHEIMER JH, 1975, ENDOCR RES COMMUN, V2, P309, DOI 10.1080/07435807509089004; PATSCH W, 1993, CIRCULATION, V88, P73; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; PILDER S, 1986, MOL CELL BIOL, V6, P470, DOI 10.1128/MCB.6.2.470; RADOSAVLJEVIC M, 1992, ATHEROSCLEROSIS, V95, P147, DOI 10.1016/0021-9150(92)90018-C; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASTRY KN, 1988, MOL CELL BIOL, V8, P605, DOI 10.1128/MCB.8.2.605; SHEMER R, 1990, J BIOL CHEM, V265, P1010; SORCITHOMAS M, 1988, J BIOL CHEM, V263, P5183; STROBL W, 1989, J BIOL CHEM, V264, P1190; STROBL W, 1990, J CLIN INVEST, V85, P659, DOI 10.1172/JCI114489; STROBL W, 1993, J CLIN INVEST, V92, P1766, DOI 10.1172/JCI116765; TAM SP, 1985, J BIOL CHEM, V260, P1670; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WILCOX HG, 1982, J LIPID RES, V23, P1159; WU AL, 1979, J BIOL CHEM, V254, P7316	47	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3996	4004		10.1074/jbc.270.8.3996	http://dx.doi.org/10.1074/jbc.270.8.3996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876147	hybrid			2022-12-27	WOS:A1995QH68800080
J	HADARI, YR; PAZ, K; DEKEL, R; MESTROVIC, T; ACCILI, D; ZICK, Y				HADARI, YR; PAZ, K; DEKEL, R; MESTROVIC, T; ACCILI, D; ZICK, Y			GALECTIN-8 - A NEW RAT LECTIN, RELATED TO GALECTIN-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING-PROTEIN; CARBOHYDRATE-RECOGNITION; MUSCLE LECTIN; GROWTH-FACTOR; RECEPTOR; LAMININ; IDENTIFICATION; SPECIFICITY; EXPRESSION; SECRETION	A protein of 35 kDa which has the characteristic properties of galectins (S-type lectins) was cloned from rat liver cDNA expression library. Since names for galectins 1-7 were already assigned, this new protein was named galectin-8. Three lines of evidence demonstrate that galectin-8 is indeed a novel galectin: (i) its deduced amino acid sequence contains two domains with conserved motifs that are implicated in the carbohydrate binding of galectins, (ii) in vitro translation products of galectin-8 cDNA or bacterially expressed recombinant galectin-8 are biologically active and possess sugar binding and hemagglutination activity, and (iii) a protein of the expected size (34 kDa) that binds to lactosyl-Sepharose and reacts with galectin-8-specific antibodies is present in rat liver and comprises similar to 0.025% of the total Triton X-100-soluble hepatic proteins. Overall, galectin-8 is structurally related (34% identity) to galectin-4, a soluble rat galectin with two carbohydrate-binding domains in the same polypeptide chain, joined by a link peptide. Nonetheless, several important features distinguish these two galectins: (i) Northern blot analysis revealed that, unlike galectin-4 that is confined to the intestine and stomach, galectin-8 is expressed in liver, kidney, cardiac muscle, lung, and brain; (ii) unlike galectin-4, but similar to galectins-1 and -2, galectin-8 contains 4 Cys residues; (iii) the link peptide of galectin-8 is unique and bears no similarity to any known protein; (iv) the N-terminal carbohydrate-binding region of galectin-8 contains a unique WG-E-I motif instead of the consensus WG-E-R/K motif implicated as playing an essential role in sugar-binding of all galectins. Together with galectin-4, galectin-8 therefore represents a subfamily of galectins consisting of a tandem repeat of structurally different carbohydrate recognition domains within a single polypeptide chain.	WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL; TECHNION ISRAEL INST TECHNOL, SCH MED, IL-31096 HAIFA, ISRAEL; UNIV ZAGREB, SCH MED, ZAGREB 41000, CROATIA; NIH, DIABET BRANCH, BETHESDA, MD 20892 USA	Weizmann Institute of Science; Technion Israel Institute of Technology; University of Zagreb; National Institutes of Health (NIH) - USA			Zick, Yehiel/K-1479-2012					ALBRANDT K, 1987, P NATL ACAD SCI USA, V84, P6859, DOI 10.1073/pnas.84.19.6859; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; Colin Hughes R., 1992, CURR OPIN STRUC BIOL, V2, P687, DOI 10.1016/0959-440X(92)90202-I; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; COURAUD PO, 1989, J BIOL CHEM, V264, P1310; DOUGLAS N, 1990, J CELL BIOL, V110, P1681; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; GINSBERG D, 1990, ONCOGENE, V5, P1285; GITT MA, 1992, J BIOL CHEM, V267, P10601; HADARI YR, 1992, J BIOL CHEM, V267, P17483; HADARI YR, 1993, MOL CELL ENDOCRINOL, V97, P9, DOI 10.1016/0303-7207(93)90206-Y; HARRISON FL, 1991, J CELL SCI, V100, P9; HEFFETZ D, 1991, METHOD ENZYMOL, V201, P44; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAING JG, 1988, BIOCHEMISTRY-US, V27, P5329, DOI 10.1021/bi00414a057; LAMPHERE L, 1992, ENDOCRINOLOGY, V131, P2196, DOI 10.1210/en.131.5.2196; LEVI G, 1981, J BIOL CHEM, V256, P5735; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; LIS N., 1972, METHODS ENZIMOL, V28, P360, DOI [10.1016/0076-6879(72)28046-6., DOI 10.1016/0076-6879(72)28046-6]; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; MIGNATTI P, 1991, J CELL BIOCHEM, V47, P201, DOI 10.1002/jcb.240470303; OCHIENG J, 1993, BIOCHEMISTRY-US, V32, P4455, DOI 10.1021/bi00067a038; ODA Y, 1993, J BIOL CHEM, V268, P5929; POIRIER F, 1992, DEVELOPMENT, V115, P143; RAZ A, 1987, CANCER METAST REV, V6, P433, DOI 10.1007/BF00144274; Sambrook J, 1989, MOL CLONING LABORATO; SANFORD GL, 1990, FASEB J, V4, P2912, DOI 10.1096/fasebj.4.11.2379767; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO S, 1994, J BIOL CHEM, V269, P4424; SHARON N, 1993, TRENDS BIOCHEM SCI, V18, P221, DOI 10.1016/0968-0004(93)90193-Q; SIDERS WM, 1993, J BIOL CHEM, V268, P22170; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; WANG J L, 1991, Glycobiology, V1, P243, DOI 10.1093/glycob/1.3.243; WELLS V, 1991, CELL, V64, P91, DOI 10.1016/0092-8674(91)90211-G; YAMAOKA K, 1991, BIOCHEM BIOPH RES CO, V179, P272, DOI 10.1016/0006-291X(91)91365-J; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q	45	166	173	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3447	3453		10.1074/jbc.270.7.3447	http://dx.doi.org/10.1074/jbc.270.7.3447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852431	hybrid			2022-12-27	WOS:A1995QG47100083
J	MCCORMACK, AL; MONONEN, I; KAARTINEN, V; YATES, JR				MCCORMACK, AL; MONONEN, I; KAARTINEN, V; YATES, JR			LOCALIZATION OF THE DISULFIDE BOND INVOLVED IN POSTTRANSLATIONAL PROCESSING OF GLYCOSYLASPARAGINASE AND DISRUPTED BY A MUTATION IN THE FINNISH-TYPE ASPARTYLGLYCOSAMINURIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTYLGLUCOSAMINURIA; GLYCOASPARAGINASE; SUBUNITS	The heavy chain of human glycosylasparaginase (N-4-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26)) has five cysteinyl residues (Cys-61, Cys-64, Cys-69, Cys-163, and Cys-179). A Cys-163 to serine substitution due to a point mutation in the glycosylasparaginase gene causes the most common disorder of glycoprotein degradation, the Finnish-type aspartylglycosaminuria. To localize the potential disulfide bonds, the isolated heavy chain of human leukocyte glycosylasparaginase was treated with the enzyme alpha-chymotrypsin, and the resulting peptides were separated by high performance liquid chromatography prior to and after reduction and S-carboxymethylation. The peptide containing the Cys-163 residue and the peptide to which it is connected with a disulfide were structurally characterized by mass spectrometry. The disulfide bond crucial for catalytic activity, subunit processing, and biological transport of glycosylasparaginase was located close to the carboxyl terminus of the heavy chain at positions 163 and 179.	UNIV WASHINGTON,DEPT MOLEC BIOTECHNOL,SEATTLE,WA 98195; KUOPIO UNIV HOSP,DEPT CLIN CHEM,SF-70211 KUOPIO,FINLAND; UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,SCH MED,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90054	University of Washington; University of Washington Seattle; Kuopio University Hospital; University of Eastern Finland; Children's Hospital Los Angeles; University of Southern California			Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X				FISHER KJ, 1990, FEBS LETT, V269, P440, DOI 10.1016/0014-5793(90)81211-6; FISHER KJ, 1993, FEBS LETT, V323, P271, DOI 10.1016/0014-5793(93)81355-4; FISHER KJ, 1991, J BIOL CHEM, V266, P12105; GRIFFIN PR, 1991, INT J MASS SPECTROM, V111, P131, DOI 10.1016/0168-1176(91)85052-N; HUNT DF, 1986, P NATL ACAD SCI USA, V84, P620; KAARTINEN V, 1992, J BIOL CHEM, V267, P6855; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; MONONEN I, 1991, P NATL ACAD SCI USA, V88, P2941, DOI 10.1073/pnas.88.7.2941; MONONEN I, 1993, FASEB J, V7, P1247, DOI 10.1096/fasebj.7.13.8405810; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X	10	9	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3212	3215		10.1074/jbc.270.7.3212	http://dx.doi.org/10.1074/jbc.270.7.3212			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852406	hybrid			2022-12-27	WOS:A1995QG47100050
J	FUCHS, A; DAGHER, MC; VIGNAIS, PV				FUCHS, A; DAGHER, MC; VIGNAIS, PV			MAPPING THE DOMAINS OF INTERACTION OF P40(PHOX) WITH BOTH P47(PHOX) AND P67(PHOX) OF THE NEUTROPHIL OXIDASE COMPLEX USING THE 2-HYBRID SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CELL-FREE SYSTEM; RESPIRATORY BURST OXIDASE; PROTEIN; COMPONENTS; RAS	The superoxide generating NADPH oxidase complex in phagocytic cells is constituted of a heterodimeric flavocytochrome b and cytosolic factors, p67(phox), p47(phox) and p40(phox) as well as a small G protein Rac (for review, see Refs. 1-3). A truncated form of the p40(phox) cDNA was isolated by a two hybrid screen of a B lymphocyte library using a full length clone of p47(phox) as target, This truncated form of p40(phox) consisting of the Src Homology 3 (SH3) domain to the 3' stop codon was also shown to interact with p67(phox) in the same system. A Library of smaller fragments of the truncated p40 cDNA was constructed and screened against either p47(phox) or p67(phox). Results show that the SH3 domain of p40(phox) is sufficient for interaction with p47(phox), whereas the C terminus of p40(phox) but not its SH3 domain is involved in the interaction with p67(phox).			FUCHS, A (corresponding author), CEN GRENOBLE, CEA,DEPT BIOL MOLEC & STRUCT,BIOCHIM LAB,CNRS, URA 1130, 17 RUE MARTYRS, F-38054 GRENOBLE 09, FRANCE.			DAGHER, Marie-Claire/0000-0001-6878-3169; Fuchs, Alexandra/0000-0001-5536-8716				ABO A, 1992, J BIOL CHEM, V267, P16767; BABIOR B, 1982, ADV ENZYMOL RELAT AR, V65, P49; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINAN P, 1994, J BIOL CHEM, V269, P13752; FUCHS A, 1994, EUR J BIOCHEM, V226, P587, DOI 10.1111/j.1432-1033.1994.tb20084.x; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; IYER SS, 1994, J BIOL CHEM, V269, P22405; JOUAN A, 1993, BIOCHEM BIOPH RES CO, V197, P1296, DOI 10.1006/bbrc.1993.2618; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; MALY FE, 1988, J IMMUNOL, V140, P2334; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; PARK JW, 1992, J BIOL CHEM, V267, P17327; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SOMEYA A, 1993, FEBS LETT, V330, P215, DOI 10.1016/0014-5793(93)80276-Z; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; TSUNAWAKI S, 1994, BIOCHEM BIOPH RES CO, V199, P1378, DOI 10.1006/bbrc.1994.1383; UHLINGER DJ, 1993, J BIOL CHEM, V268, P8624; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	27	103	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5695	5697		10.1074/jbc.270.11.5695	http://dx.doi.org/10.1074/jbc.270.11.5695			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890694	hybrid			2022-12-27	WOS:A1995QM94500003
J	MARECHAL, E; MIEGE, C; BLOCK, MA; DOUCE, R; JOYARD, J				MARECHAL, E; MIEGE, C; BLOCK, MA; DOUCE, R; JOYARD, J			THE CATALYTIC SITE OF MONOGALACTOSYLDIACYLGLYCEROL SYNTHASE FROM SPINACH CHLOROPLAST ENVELOPE MEMBRANES - BIOCHEMICAL ANALYSIS OF THE STRUCTURE AND OF THE METAL CONTENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL GALACTOSYLTRANSFERASE ACTIVITY; UDP-GALACTOSE; PARTIAL-PURIFICATION; N-ACETYLGLUCOSAMINE; BINDING-SITE; ZINC; MOTIFS; 1,10-PHENANTHROLINE; PHOSPHOTRIESTERASE	We have analyzed the structure of the active site of monogalactosyldiacylglycerol (MGDG) synthase from spinach chloroplast envelope. Since purification of this membrane-embedded enzyme yielded such low amounts of protein that analyses of the amino acid sequence were so far impossible, we used indirect strategies. Analyses of the inhibition of MGDG synthase by UDP and of its inactivation by citraconic anhydride first indicated that the enzyme contained two functionally independent and topologically distinct binding sites for each substrate, Whereas MGDG synthase binds both the nucleotidic part of UDP-Gal and the acyl chains of 1,2-diacylglycerol, UDP is a competitive inhibitor relatively to UDP-Gal, while it does not compete with 1,2-diacylglycerol for binding on the enzyme, The UDP-Gal-binding site contains lysine residues, as demonstrated for UDP-Gal-binding sites from all galactosyltransferases studied so far, Radiolabeling of MGDG synthase by sulfur labeling reagent, a S-35-labeled lysine-blocking reagent, confirmed that MGDG synthase was a polypeptide with a low molecular mass (around 20 kDa), The 1,2-diacylglycerol-binding site contains reduced cysteines and at least one metal, The divalent cation(s) associated to apo-MGDG synthase was not unambiguously identified, but the results suggest that it could be zinc, Therefore, MGDG synthase presents some structural features in common with diacylglycerol-manipulating enzymes, such as protein kinase C and 1,2-diacylglycerol kinase, which are characterized by the presence of a ubiquitous Cys(6)His(2) domain involved in zinc coordination in their 1,2-diacylglycerol-binding domains.	CEN GRENOBLE,CEA,DEPT BIOL MOLEC & STRUCT,PHYSIOL CELLULAIRE VEGETALE LAB,CNRS,UA 576,F-38054 GRENOBLE 9,FRANCE; UNIV GRENOBLE 1,F-38041 GRENOBLE,FRANCE	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)								[Anonymous], METHODS CHLOROPLAST; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BARKER R, 1972, J BIOL CHEM, V247, P7135; BENSON AA, 1964, ANN REV PLANT PHYSIO, V15, P1, DOI 10.1146/annurev.pp.15.060164.000245; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; COVES J, 1986, FEBS LETT, V208, P401, DOI 10.1016/0014-5793(86)81057-2; COVES J, 1988, P NATL ACAD SCI USA, V85, P4966, DOI 10.1073/pnas.85.14.4966; COVES J, 1987, PLANT MEMBRANES STRU, P103; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DOERING TL, 1989, J BIOL CHEM, V264, P11168; Douce, 1987, BIOCH PLANTS, P215, DOI 10.1016/B978-0-12-675409-4.50015-0; DOUCE R, 1974, SCIENCE, V183, P852, DOI 10.1126/science.183.4127.852; Douce R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 4. Lipids: structure and function., P321; DRUM DE, 1969, BIOCHEMISTRY-US, V8, P3792, DOI 10.1021/bi00837a045; DRUM DE, 1969, BIOCHEMISTRY-US, V8, P3783, DOI 10.1021/bi00837a044; DRUM DE, 1970, BIOCHEMISTRY-US, V21, P4078; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; FERRARI RA, 1961, ARCH BIOCHEM BIOPHYS, V93, P185, DOI 10.1016/0003-9861(61)90248-X; FREEMAN HC, 1973, INORGANIC BIOCH, P121; FUJIKAWA K, 1993, BIOCHEM J, V294, P443, DOI 10.1042/bj2940443; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; HANNUN YA, 1991, J BIOL CHEM, V260, P10039; HEEMSKERK JWM, 1986, THESIS U NIJMEGEN NE; HUBBARD SR, 1991, SCIENCE, V254, P1776; KANOH H, 1981, ARCH BIOCHEM BIOPHYS, V209, P266, DOI 10.1016/0003-9861(81)90280-0; KITCHEN BJ, 1974, BIOCHEM J, V143, P587, DOI 10.1042/bj1430587; LITTLE C, 1975, BIOCHIM BIOPHYS ACTA, V391, P326, DOI 10.1016/0005-2744(75)90256-9; LOOMIS CR, 1985, J BIOL CHEM, V260, P4091; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARECHAL E, 1994, J BIOL CHEM, V269, P5788; MARECHAL E, 1994, FEBS LETT, V352, P307, DOI 10.1016/0014-5793(94)00978-3; MARECHAL E, 1991, CR ACAD SCI III-VIE, V313, P521; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P133, DOI 10.1093/oxfordjournals.pcp.a076508; MURATA N, 1987, BIOCH PLANTS, V9, P315; NEUFELD EF, 1964, BIOCHEM BIOPH RES CO, V14, P503, DOI 10.1016/0006-291X(64)90259-1; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; POWELL JT, 1976, J BIOL CHEM, V251, P3645; POWERS JC, 1986, RES MONOGRAPHS CELL, V12, P219; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; SALIER JP, 1980, ANAL BIOCHEM, V109, P273, DOI 10.1016/0003-2697(80)90649-1; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; SCHMIDTSCHULTZ T, 1994, J NEUROCHEM, V62, P1578; SCRUTTON MC, 1973, INORGANIC BIOCH, P381; SEGEL IH, 1975, ENZYME KINETICS, P957; STEINBUCH M, 1976, METHOD ENZYMOL, V19, P760; TEUCHER T, 1991, PLANTA, V184, P319, DOI 10.1007/BF00195332; VALLEE BL, 1993, ACCOUNTS CHEM RES, V26, P543, DOI 10.1021/ar00034a005; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANBESOUW A, 1979, FEBS LETT, V102, P33; WANG ZX, 1992, BIOCHEM J, V281, P285, DOI 10.1042/bj2810285; WISSING JB, 1992, PLANT PHYSIOL, V98, P1148, DOI 10.1104/pp.98.3.1148; WU HB, 1993, BIOCHEM J, V296, P435, DOI 10.1042/bj2960435; YADAV S, 1990, J BIOL CHEM, V265, P14163; YADAV SP, 1991, J BIOL CHEM, V266, P698	60	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5714	5722		10.1074/jbc.270.11.5714	http://dx.doi.org/10.1074/jbc.270.11.5714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890698	hybrid			2022-12-27	WOS:A1995QM94500008
J	NYSTEDT, S; LARSSON, AK; ABERG, H; SUNDELIN, J				NYSTEDT, S; LARSSON, AK; ABERG, H; SUNDELIN, J			THE MOUSE PROTEINASE-ACTIVATED RECEPTOR-2 CDNA AND GENE - MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-RECEPTOR; TETHERED LIGAND; SEQUENCE; MECHANISM; PEPTIDES; CLEAVAGE; RELEASE; SIGNAL	We have reported the cloning from mouse genomic DNA of a fragment encoding a G-protein-coupled receptor related to the receptor for the blood clotting enzyme thrombin. Like the thrombin receptor this receptor is activated by proteolytic cleavage of its extracellular amino terminus, Because the physiological agonist at the receptor was unknown, we provisionally named it proteinase-activated receptor 2 (PAR-2). Here we present a PAR-2 cDNA of 2729 nucleotides that differs from the published genomic sequence at the 5' end, including a part of the protein coding region. The differences do not affect the peptide sequence of the activating proteinase cleavage site proper, but may include amino acid residues important for enzyme-substrate recognition. Analysis of the PAR-2 gene structure showed that the cDNA 5' end is derived from a separate exon located about 10 kilobases away from the 3' exon. Results from a primer extension experiment indicate that transcription starts at a unique site around nucleotide -203 respective to the translation initiation ATC, Chinese hamster ovary cells transfected with either the PAR-2 cDNA or a construct made from the published PAR-2 genomic sequence responded with intracellular calcium mobilization to stimulation with 1 nM trypsin, 10 mu M PAR-2-activating peptide (SLIGRL), or 1 mu M thrombin receptor-activating peptide (SFLLRN). Untransfected cells responded only to stimulation with thrombin receptor activating peptide. Only transcripts corresponding to the PAR-2 cDNA could be detected in three mouse tissues examined.	LUND UNIV,WALLENBERG LAB,DIV MOLEC NEUROBIOL,S-22007 LUND,SWEDEN	Lund University								AUCH D, 1991, NUCLEIC ACIDS RES, V18, P6743; BAHOU W, 1992, BLOOD S1, V80, pA265; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHANG WC, 1993, AM J PHYSIOL, V264, pC271, DOI 10.1152/ajpcell.1993.264.2.C271; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HERBERT JM, 1994, J BIOL CHEM, V269, P3076; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; NORTON KJ, 1993, BLOOD, V82, P2125; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Sambrook J, 1989, MOL CLONING LABORATO; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WACHTFOGEL YT, 1986, BLOOD, V67, P1731; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; ZHONG CZ, 1992, J BIOL CHEM, V267, P16975	24	157	162	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5950	5955		10.1074/jbc.270.11.5950	http://dx.doi.org/10.1074/jbc.270.11.5950			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890726				2022-12-27	WOS:A1995QM94500039
J	YAMADA, T; SONG, H; INAKA, K; SHIMADA, Y; KIKUCHI, M; MATSUSHIMA, M				YAMADA, T; SONG, H; INAKA, K; SHIMADA, Y; KIKUCHI, M; MATSUSHIMA, M			STRUCTURE OF A CONFORMATIONALLY CONSTRAINED ARG-GLY-ASP SEQUENCE INSERTED INTO HUMAN LYSOZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMINO-ACID SEQUENCE; CELL-ADHESION; FIBRONECTIN; REFINEMENT; INTEGRINS; SECRETION; RGD	To examine the effect of a conformational constraint introduced into the Arg-Gly-Asp (RGD) sequence on cell adhesion activity, we constructed a mutant protein by inserting an RGD-containing sequence flanked by two Cys residues between Val(74) and Asn(75) of human lysozyme, The CRGDSC-inserted lysozyme was expressed in yeast, purified, and designated as Cys-RGD4, Using baby hamster kidney cells, Cys-RGD4 was shown to possess even higher cell adhesion activity than that of the RGDS-inserted lysozyme, RGD4. The Cys-RGD4 protein was co-crystallized with a lysozyme inhibitor, tri-N-acetylchitotriose, and the three-dimensional structure was determined at 1.6-Angstrom resolution by x-ray crystallography. In contrast to RGD4, the inserted RGD-containing region of Cys-RGD4 was well defined, The structural analysis revealed that the two inserted Cys residues form a new disulfide bond in Cys-RGD4, as expected, and that the RGD region assumes a type II' beta-turn conformation of Gly-Asp with a hydrogen bond between the C=O of Arg and the H-N of Ser. In addition, it was confirmed that two more hydrogen bonds are present in the RGD region of the Cys-RGD4 lysozyme, These results suggest that the conformation of the RGD-containing region is rigid and stable in the Cys-RGD4 molecule and that the type II' beta-turn structure of RGD is essential for binding to integrins with high affinity.			YAMADA, T (corresponding author), PROT ENGN RES INST,6-2-3 FURUEDAI,SUITA,OSAKA 565,JAPAN.		song, haiwei/H-6082-2011					ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; HEMLER ME, 1991, RECEPTORS EXTRACELLU, P255; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; INAKA K, 1991, J BIOL CHEM, V266, P12599; KREZEL AM, 1994, SCIENCE, V264, P1944, DOI 10.1126/science.8009227; KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; MAEDA T, 1989, J BIOL CHEM, V264, P1515; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MIYAHARA J, 1986, NUCL INSTRUM METH A, V246, P572, DOI 10.1016/0168-9002(86)90156-7; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7639; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; TANIYAMA Y, 1990, J BIOL CHEM, V265, P7570; WATT KWK, 1979, BIOCHEMISTRY-US, V18, P5410, DOI 10.1021/bi00591a024; YAMADA T, 1994, BIOCHEMISTRY-US, V33, P3885, DOI 10.1021/bi00179a013; YAMADA T, 1993, J BIOL CHEM, V268, P10588; YOSHIMURA K, 1987, BIOCHEM BIOPH RES CO, V145, P712, DOI 10.1016/0006-291X(87)91023-0	24	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5687	5690		10.1074/jbc.270.11.5687	http://dx.doi.org/10.1074/jbc.270.11.5687			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890692	hybrid			2022-12-27	WOS:A1995QM94500001
J	CAO, W; DOUGLAS, MG				CAO, W; DOUGLAS, MG			BIOGENESIS OF ISP6, A SMALL CARBOXYL-TERMINAL ANCHORED PROTEIN OF THE RECEPTOR COMPLEX OF THE MITOCHONDRIAL OUTER-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IMPORT MACHINERY; ADP/ATP CARRIER; YEAST; TRANSLOCATION; SEQUENCES; MOM19	To study the biogenesis of ISP6, an outer membrane component of the mitochondrial protein translocation complex, two fusion proteins have been made by fusing ISP6 to either the carboxyl- or amino-terminal end of the mouse dihydrofolate reductase (DHFR), In vitro import experiments showed that when DHFR was placed at the carboxyl-terminal end of ISP6, the resulting fusion protein 6-DHFR inserted into mitochondrial membrane less efficiently than the other form of the fusion proteins. In vivo this fusion protein lost its ability to suppress the temperature-sensitive phenotype of an isp42 mutant, while the other fusion protein DHFR-6, which was found targeted correctly to mitochondria, suppressed the mutant as well as the wild-type ISP6. Further analysis showed that the binding and insertion of DHFR-6 to mitochondrial outer membrane was not affected by deletion of either of the two mitochondrial protein receptors or by the predigestion of mitochondrial surface proteins prior to import. Additional data indicated that ISP42, which closely associates with ISP6 in the translocation complex, does not likely play the role of a targeting partner for ISP6. In summary, these data suggest that ISP6 may target to mitochondria by sequences at its carboxyl terminus and that the import process of ISP6 is most likely distinct from that of most other mitochondrial precursors, which are recognized by protein receptors on mitochondrial surface.	UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine				Cao, Wei/0000-0002-8952-9159				CYR DM, 1991, J BIOL CHEM, V266, P21700; DAUN G, 1982, J BIOL CHEM, V257, P13028; DOBBERSTEIN B, 1994, NATURE, V367, P599, DOI 10.1038/367599a0; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HURT EC, 1984, EMBO J, V3, P3149, DOI 10.1002/j.1460-2075.1984.tb02272.x; JANIAK F, 1994, J BIOL CHEM, V269, P9842; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; SCHATZ G, 1993, PROTEIN SCI, V2, P141; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SEGUI RB, 1993, EMBO J, V12, P2211; SIKORSKI RS, 1989, GENETICS, V122, P19; SMAGULA C, 1988, J BIOL CHEM, V263, P6783; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Stuart R A, 1993, Trends Cell Biol, V3, P135, DOI 10.1016/0962-8924(93)90176-2	27	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5674	5679		10.1074/jbc.270.10.5674	http://dx.doi.org/10.1074/jbc.270.10.5674			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890690	Green Published, hybrid			2022-12-27	WOS:A1995QL58000109
J	KOLEY, AP; BUTERS, JTM; ROBINSON, RC; MARKOWITZ, A; FRIEDMAN, FK				KOLEY, AP; BUTERS, JTM; ROBINSON, RC; MARKOWITZ, A; FRIEDMAN, FK			CO BINDING-KINETICS OF HUMAN CYTOCHROME-P450 3A4 - SPECIFIC INTERACTION OF SUBSTRATES WITH KINETICALLY DISTINGUISHABLE CONFORMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LIVER; MICROSOMAL CYTOCHROME-P-450; DRUG-METABOLISM; ENZYME; IDENTIFICATION; PURIFICATION; OXIDATION; PROTEIN; ACID	The kinetics of CO binding to human cytochrome P450 3A4 was examined by the flash photolysis technique, employing the membrane-bound P450 expressed in baculovirus-infected SF9 insect cells, Triexponential kinetics was observed, indicating that P450 3A4 is composed of multiple, kinetically distinguishable conformers. To define the substrate specificity of individual P450 3A4 conformers we evaluated the effect of a series of substrates of varying sizes and structures on the CO binding kinetics. The rate of CO binding to the total mixture of P450 3A4 conformers was increased in the presence of nifedipine and erythromycin, decreased by quinidine, testosterone, and warfarin, and unaffected by cimetidine and 17 alpha-ethynylestradiol. A recently developed kinetic difference method (Koley, A. P., Robinson, R. C., Markowitz, A., and Friedman, F. K. (1994) Biochemistry 33, 2484-2489) was used to define the kinetic parameters of individual P450 3A4 conformers. The results showed that different conformers have distinct substrate specificities. The substrates had markedly variable effects on the CO binding kinetics of their target P450 3A4 conformers and thus differentially modulate their conformations. These results demonstrate that the interaction of a particular substrate with a specific P450 3A4 conformer can be assessed in the presence of multiple conformers.	NCI,MOLEC CARCINOGENESIS LAB,BETHESDA,MD 20892; NIH,BIOMED ENGN & INSTRUMENTAT PROGRAM,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA			Friedman, Fred/O-6173-2019; BUTERS, JEROEN/AAF-6949-2020; Friedman, Fred K/D-4208-2016; Buters, Jeroen T/G-5070-2011	Friedman, Fred/0000-0002-0284-7067; Buters, Jeroen/0000-0003-3581-5472				ALBEN JO, 1993, BIOPHYS J, V65, P1357, DOI 10.1016/S0006-3495(93)81183-4; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; BRIAN WR, 1990, BIOCHEMISTRY-US, V29, P11280, DOI 10.1021/bi00503a018; BUTERS TJM, 1994, DRUG METAB DISPOS, V22, P688; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287; GUENGERICH FP, 1990, CHEM RES TOXICOL, V3, P363, DOI 10.1021/tx00016a015; JOHNSON EF, 1988, J BIOL CHEM, V263, P17672; KOLEY AP, 1994, BIOCHEMISTRY-US, V33, P2484, DOI 10.1021/bi00175a017; KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87; LU AYH, 1980, PHARMACOL REV, V31, P277; MARKOWITZ A, 1992, ANAL INSTRUM, V20, P213; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P.R., 2015, CYTOCHROME P450 STRU, P912; RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; SHET MS, 1993, P NATL ACAD SCI USA, V90, P11748, DOI 10.1073/pnas.90.24.11748; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319	24	87	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5014	5018		10.1074/jbc.270.10.5014	http://dx.doi.org/10.1074/jbc.270.10.5014			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890608	hybrid			2022-12-27	WOS:A1995QL58000013
J	ORKIN, SH				ORKIN, SH			TRANSCRIPTION FACTORS AND HEMATOPOIETIC DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GATA-BINDING PROTEINS; BETA-GLOBIN LOCUS; TRANSGENIC MICE; DNA-BINDING; NF-M; EXPRESSION; GENE; CONTAINS; CLONING; CELLS		HOWARD HUGHES MED INST,BOSTON,MA 02115	Howard Hughes Medical Institute	ORKIN, SH (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115, USA.							ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; ANDREWS NC, 1993, NATURE, P722; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BLOBEL GA, 1995, MOL CELL BIOL, V15, P626; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; OOSTERWEGEL M, 1991, J EXP MED, V173, P1133, DOI 10.1084/jem.173.5.1133; PEVNY L, 1995, IN PRESS DEVELOPMENT; PHILIPSEN S, 1993, EMBO J, V12, P1077, DOI 10.1002/j.1460-2075.1993.tb05749.x; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; VISVADER J, 1993, BLOOD, V82, P1493; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; VISVADER JE, 1992, EMBO J, V11, P4577; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WONG PMC, 1994, IMMUNITY, V1, P571, DOI 10.1016/1074-7613(94)90047-7; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642; ZON LI, 1993, BLOOD, V81, P3234	53	209	210	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4955	4958		10.1074/jbc.270.10.4955	http://dx.doi.org/10.1074/jbc.270.10.4955			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890597	hybrid			2022-12-27	WOS:A1995QL58000001
J	SANDONA, D; GASTALDELLO, S; RIZZUTO, R; BISSON, R				SANDONA, D; GASTALDELLO, S; RIZZUTO, R; BISSON, R			EXPRESSION OF CYTOCHROME-C-OXIDASE DURING GROWTH AND DEVELOPMENT OF DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; TISSUE-SPECIFIC REGULATION; SUBUNIT-V; DISCOIDEUM; OXYGEN; GENES; ISOFORMS; COMPLEX; ENZYME; FORMS	In the slime mold Dictyostelium discoideum, the subunit composition of cytochrome c oxidase depends on oxygen that inversely regulates the concentrations of two alternative isoforms of the smallest enzyme subunit (Schiavo, G., and Bisson, R, (1989) J, Biol, Chem, 264, 7129-7134). In order to investigate their role in the Dictyostelium life cycle, the expression of the oxidase subunits was monitored during cell growth and development. The results obtained demonstrate that exponentially growing amoebae respond rapidly and precisely to hypoxia by switching the expression of the two isoforms and also by increasing the levels of the mRNAs of the different oxidase subunits in a highly coordinated process. During normal development the ''hypoxic'' subunit is not synthesized, but its level of expression appears to parallel the sensitivity to oxygen of development, rising steeply below 10% oxygen when the differentiation program is virtually blocked. Under these conditions, the expression of the alternative subunit isoform is essentially oxygen-insensitive. These findings suggest that the physiological relevance of the subunit switching concerns primarily the vegetative phase of growth, possibly as part of a more general mechanism evolved in order to evade conditions that do not allow development. Taken together, the data obtained offer an intriguing example of the fine control exerted on the expression of a key respiratory enzyme in a strictly aerobic organism.	UNIV PADUA,DIPARTIMENTO SCI BIOMED SPERIMENTALI,CNR,STUDY PHYSIOL UNIT,I-35121 PADUA,ITALY; UNIV PADUA,DIPARTIMENTO SCI BIOMED SPERIMENTALI,MOLEC BIOL & PATHOL LAB,I-35121 PADUA,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua			Gastaldello, Stefano/AAM-6768-2020; Rizzuto, Rosario/B-6312-2008; sandona, dorianna/AAB-9480-2020; Gastaldello, Stefano/AAD-3788-2020	Gastaldello, Stefano/0000-0001-7369-8452; Rizzuto, Rosario/0000-0001-7044-5097	Fondazione Telethon Funding Source: Custom	Fondazione Telethon(Fondazione Telethon)		ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; BISSON R, 1985, BIOCHEMISTRY-US, V24, P7845, DOI 10.1021/bi00347a051; BISSON R, 1986, J BIOL CHEM, V261, P4373; BONNE G, 1993, EUR J BIOCHEM, V217, P1099, DOI 10.1111/j.1432-1033.1993.tb18342.x; BONNER JT, 1982, AM NAT, V119, P530, DOI 10.1086/283930; BURKE P, 1994, YEAST GENETICS MOL B, pA225; CALHOUN MW, 1994, TRENDS BIOCHEM SCI, V19, P325, DOI 10.1016/0968-0004(94)90071-X; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CAPALDI RA, 1990, FEBS LETT, V261, P158, DOI 10.1016/0014-5793(90)80660-B; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; CUMSKY MG, 1987, MOL CELL BIOL, V7, P3511, DOI 10.1128/MCB.7.10.3511; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; HUDIG H, 1987, ARCH MICROBIOL, V149, P12, DOI 10.1007/BF00423129; IUCHI S, 1991, CELL, V66, P5, DOI 10.1016/0092-8674(91)90130-Q; JERMYN KA, 1987, DEVELOPMENT, V100, P745; KADENBACH B, 1987, CURR TOP BIOENERG, V15, P113; KADENBACH B, 1990, BIOCHIM BIOPHYS ACTA, V1015, P368, DOI 10.1016/0005-2728(90)90042-3; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LIDDEL GU, 1961, DEV BIOL, V3, P265, DOI 10.1016/0012-1606(61)90047-1; LIGHTOWLERS RN, 1990, J BIOL CHEM, V266, P19752; LOOMIS WF, 1982, DEV DICTYOSTELIUM DI; Loomis WF., 1975, DICTYOSTELIUM DISCOI; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; RIZZUTO R, 1990, NUCLEIC ACIDS RES, V18, P6711, DOI 10.1093/nar/18.22.6711; RIZZUTO R, 1991, BIOCHIM BIOPHYS ACTA, V1129, P100, DOI 10.1016/0167-4781(91)90220-G; ROHDICH F, 1993, BIOCHEMISTRY-US, V32, P8499, DOI 10.1021/bi00084a015; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANDONA D, 1994, EUR J BIOCHEM, V219, P1053, DOI 10.1111/j.1432-1033.1994.tb18588.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SCHIAVO G, 1989, J BIOL CHEM, V264, P7129; SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x; SEELAN RS, 1991, J BIOL CHEM, V266, P19752; STERNFELD J, 1977, P NATL ACAD SCI USA, V74, P268, DOI 10.1073/pnas.74.1.268; STERNFELD J, 1981, J CELL SCI, V50, P9; Stryer L., 1988, BIOCHEMISTRY-US; TAANMAN JW, 1993, J BIOL CHEM, V268, P18754; TROLL H, 1993, J BIOL CHEM, V268, P25469; WALLET V, 1990, J NATL CANCER I, V80, P1199; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180	41	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5587	5593		10.1074/jbc.270.10.5587	http://dx.doi.org/10.1074/jbc.270.10.5587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890678	hybrid			2022-12-27	WOS:A1995QL58000095
J	SHAO, HN; PANDEY, A; OSHEA, KS; SELDIN, M; DIXIT, VM				SHAO, HN; PANDEY, A; OSHEA, KS; SELDIN, M; DIXIT, VM			CHARACTERIZATION OF B61, THE LIGAND FOR THE ECK RECEPTOR PROTEIN-TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED LINKAGE GROUP; GENE	B61 was originally described as a novel secreted tumor necrosis factor-alpha-inducible gene product in endothelial cells (Holzman, L. B., Marks, R. M., and Dixit, V. M. (1990) Mol. Cell. Biol. 10, 5830-5838). It was recently discovered that soluble recombinant B61 could serve as a ligand for the Eck receptor protein-tyrosine kinase, a member of the Eph/Eck subfamily of receptor protein tyrosine kinases (Bartley, T. D., Hunt, R. W., Welcher, A. A., Boyle, W. J,, Parker, V. P., Lindberg, R. A, Lu, H. S., Colombero, A. M., Elliott, R. L., Guthrie, R. A., Holst, P. L., Shrine, J. D., Toso, R. J., Zhang, M., Fernandez, E., Trail, G., Yarnum, B., Yarden, Y., Hunter, T., and Fox, G. M. (1994) Nature 368, 558-560). We now show that B61 can also exist as a cell surface glycosylphosphatidylinositol-linked protein that is capable of activating the Eck receptor protein-tyrosine kinase, the first such report of a receptor protein-tyrosine kinase ligand that is glycosylphosphatidylinositol-linked. In addition, the expression patterns of B61 and Eck during mouse ontogeny were determined by in situ hybridization. Both were found to be highly expressed in the developing lung and gut, while Eck was preferentially expressed in the thymus. Finally, the gene for B61 was localized to a specific position on mouse chromosome 3 by interspecific backcross analysis.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109; DUKE UNIV,MED CTR,DEPT MED & MICROBIOL,DURHAM,NC 27710	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University			dixit, vishva m/A-4496-2012; Pandey, Akhilesh/B-4127-2009	dixit, vishva m/0000-0001-6983-0326; Pandey, Akhilesh/0000-0001-9943-6127	NHLBI NIH HHS [HL45351] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045351] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Green EL, 1981, GENETICS PROBABILITY, P77; HENNER DJ, 1988, NUCLEIC ACIDS RES, V16, P10383, DOI 10.1093/nar/16.21.10383; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6314; MOSELEY WS, 1989, GENOMICS, V5, P899, DOI 10.1016/0888-7543(89)90132-8; OAKEY RJ, 1992, IMMUNOGENETICS, V35, P279, DOI 10.1007/BF00166834; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS AM, 1990, GENOMICS, V8, P524; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WATSON MA, 1990, DEVELOPMENT, V110, P173; WOLF FW, 1994, J BIOL CHEM, V269, P3633	17	57	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5636	5641		10.1074/jbc.270.10.5636	http://dx.doi.org/10.1074/jbc.270.10.5636			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890684	hybrid			2022-12-27	WOS:A1995QL58000103
J	LU, HS; CHANG, D; PHILO, JS; ZHANG, K; NARHI, LO; LIU, NL; ZHANG, M; SUN, JL; WEN, J; YANAGIHARA, D; KARUNAGARAN, D; YARDEN, Y; RATZKIN, B				LU, HS; CHANG, D; PHILO, JS; ZHANG, K; NARHI, LO; LIU, NL; ZHANG, M; SUN, JL; WEN, J; YANAGIHARA, D; KARUNAGARAN, D; YARDEN, Y; RATZKIN, B			STUDIES ON THE STRUCTURE AND FUNCTION OF GLYCOSYLATED AND NONGLYCOSYLATED NEU DIFFERENTIATION FACTORS - SIMILARITIES AND DIFFERENCES OF THE ALPHA-ISOFORM AND BETA-ISOFORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY-STRUCTURE; INFRARED-SPECTRA; PROTEIN; HEREGULIN; LIGAND; FORMS; BANDS	Comparative analyses of both glycosylated and non glycosylated neu differentiation factor (NDF) isoforms revealed significant similarities and differences of their overall structures and functions. Biophysical analyses confirmed that all NDF isoforms are monomeric, but have an extended ellipsoidal shape in solution. All full-length NDFs are similar in secondary and tertiary structures and they contain no alpha-helix but are abundant in beta-strand structures. A small NDF fragment containing only the epidermal growth factor domain is also rich in beta-strand structures, but exhibits tertiary structure different from the long NDF forms. Monoclonal antibodies that selectively recognize epidermal growth factor domains of human NDF-alpha or NDF-beta can specifically bind the respective NDF-alpha and -beta isoforms independent of NDF origins. Western blot analysis and quantitative binding assays further identify that an NDF preparation produced naturally from Rat1-EJ cells contains both alpha and beta isoforms in a 3 to 2 ratio. In receptor binding competition experiments, human and rat NDF-beta isoforms have higher affinity than NDF-alpha isoforms. NDF-beta isoforms can dramatically enhance the stimulation of DNA synthesis for transfected NIH3T3 cells that overexpress HER-3 and HER-4 receptors, while NDF-alpha isoforms can only stimulate proliferation of HER-4-transfected cells with lower activity. Taken together, NDF-alpha and -beta isoforms share similar gross protein conformations but are biologically distinct.	WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science	LU, HS (corresponding author), AMGEN INC,AMGEN CTR,1840 DEHAVILLAND DR,THOUSAND OAKS,CA 91320, USA.		Philo, John S/A-8804-2009; Karunagaran, Devarajan/A-8148-2010; YARDEN, YOSEF/K-1467-2012	Philo, John S/0000-0003-3418-0356; Karunagaran, Devarajan/0000-0001-9331-8947; 				ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; ARAKAWA T, 1994, ARCH BIOCHEM BIOPHYS, V308, P267, DOI 10.1006/abbi.1994.1037; ARNOLD GE, 1992, BIOCHEMISTRY-US, V31, P7948, DOI 10.1021/bi00149a028; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; HENDRICKSON WA, 1992, COLD SPRING HARB SYM, V57, P549, DOI 10.1101/SQB.1992.057.01.060; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HUNTER T, 1992, COLD SPRING HARB SYM, V57, P25, DOI 10.1101/SQB.1992.057.01.005; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LU HS, 1995, IN PRESS J CHROMATOG; LU HS, 1994, J BIOL CHEM, V270, P4775; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; NAGATA K, 1994, EMBO J, V13, P3517, DOI 10.1002/j.1460-2075.1994.tb06658.x; NARHI LO, 1992, BIOCHEMISTRY-US, V31, P182; NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PHILO JS, 1993, BIOCHEMISTRY-US, V32, P10812, DOI 10.1021/bi00091a036; PHILO JS, 1995, IN PRESS MODERN ANAL; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PRESTRELSKI SJ, 1992, J BIOL CHEM, V267, P319; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; PRESTRELSKI SJ, 1991, BIOCHEMISTRY-US, V30, P133, DOI 10.1021/bi00215a020; SHIRE SJ, 1992, DS837 BECKM INSTR TE; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M	32	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4784	4791		10.1074/jbc.270.9.4784	http://dx.doi.org/10.1074/jbc.270.9.4784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876251	hybrid			2022-12-27	WOS:A1995QK08400087
J	MUKHERJEE, B; BURMA, S; HASNAIN, SE				MUKHERJEE, B; BURMA, S; HASNAIN, SE			THE 30-KDA PROTEIN-BINDING TO THE INITIATOR OF THE BACULOVIRUS POLYHEDRIN PROMOTER ALSO BINDS SPECIFICALLY TO THE CODING STRAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE GENE-EXPRESSION; RNA POLYMERASE-II; DNA-BINDING; TRANSCRIPTION; IDENTIFICATION; ELEMENT; SITE; SEQUENCES; VIRUS	We previously reported the purification and characterization of the polyhedrin promoter-binding protein (PPBP), an unusual DNA-binding protein that interacts with transcriptionally important motifs of the baculovirus polyhedrin gene promoter (S, Burma, B, Mukherjee, A. Jain, S. Habib, and S.E, Hasnain, J, Biol. Chem, (1994) 269, 2750-2757, PPBP also exhibits a sequence-specific single-stranded DNA-binding activity. Gel retardations and competition analyses with double- and single-stranded oligonucleotides indicated that PPBP binds the coding strand and not the noncoding strand of the promoter, This was further confirmed by UV crosslinking and Southwestern blotting experiments, Gel retardations with mutated oligonucleotides indicated that both dsDNA and ssDNA binding involve common AATA-AATAAGTATT motifs, However, ssDNA binding is dependent upon ionic interactions unlike dsDNA binding, which is mainly through nonionic interactions, The affinity of PPBP for the coding strand appears to be higher than that for duplex promoter DNA, Interestingly, the PPBP-coding strand complex has a longer half-life (similar to 60 min) than the PPBP-duplex promoter complex (similar to 15 min), PPBP represents a unique example of an ''initiator'' promoter-binding protein with dual dsDNA and ssDNA binding activities, and this reconciles very well with the unusual binding characteristics displayed by it, The formation of the PPBP-coding strand complex in vivo may be a crucial step for the exceptionally high and repeated rounds of transcriptional activity of the baculovirus polyhedrin gene promoter.	NATL INST IMMUNOL,EUKARYOT GENE EXPRESS LAB,NEW DELHI 110067,INDIA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)			HASNAIN, SEYED/C-1492-2009	Hasnain, Seyed/0000-0002-2967-0791				BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; BURMA S, 1994, J BIOL CHEM, V269, P2750; CHODOSH L, 1988, CURRENT PROTOCOLS MO, V2; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; CRICK F, 1971, NATURE, V234, P25, DOI 10.1038/234025a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GRAYHACK EJ, 1992, MOL CELL BIOL, V12, P3573, DOI 10.1128/MCB.12.8.3573; JARVIS DL, 1992, RECOMBINANT DNA VACC, P265; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; KUMAR A, 1986, J BIOL CHEM, V261, P1266; LANNIGAN DA, 1989, P NATL ACAD SCI USA, V86, P863, DOI 10.1073/pnas.86.3.863; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; LI YH, 1993, J VIROL, V67, P5260, DOI 10.1128/JVI.67.9.5260-5268.1993; Luckow V. A, 1991, Recombinant DNA technology and applications., P97; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MOLLEGAARD NE, 1994, P NATL ACAD SCI USA, V91, P3892, DOI 10.1073/pnas.91.9.3892; MORRIS TD, 1994, GENE, V140, P147, DOI 10.1016/0378-1119(94)90538-X; MORRIS TD, 1994, VIROLOGY, V200, P360; NORDSTROM LA, 1993, J BIOL CHEM, V268, P13193; OOI BG, 1989, J MOL BIOL, V210, P721, DOI 10.1016/0022-2836(89)90105-8; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; PASSARELLI AL, 1993, J VIROL, V67, P3481, DOI 10.1128/JVI.67.6.3481-3488.1993; PASSARELLI AL, 1993, VIROLOGY, V197, P704, DOI 10.1006/viro.1993.1646; POSSEE RD, 1987, NUCLEIC ACIDS RES, V15, P10233, DOI 10.1093/nar/15.24.10233; POSSEE RD, 1991, VIROLOGY, V185, P229, DOI 10.1016/0042-6822(91)90770-C; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RANKIN C, 1988, GENE, V70, P39, DOI 10.1016/0378-1119(88)90102-3; SANTORO IM, 1991, MOL CELL BIOL, V11, P1944, DOI 10.1128/MCB.11.4.1944; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; STARK HC, 1992, P NATL ACAD SCI USA, V89, P2180, DOI 10.1073/pnas.89.6.2180; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WILUSZ J, 1990, MOL CELL BIOL, V10, P6397, DOI 10.1128/MCB.10.12.6397; ZENTGRAF U, 1992, NUCLEIC ACIDS RES, V20, P3685, DOI 10.1093/nar/20.14.3685	35	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4405	4411		10.1074/jbc.270.9.4405	http://dx.doi.org/10.1074/jbc.270.9.4405			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876205	hybrid			2022-12-27	WOS:A1995QK08400037
J	LATHAM, KA; TAYLOR, JS; LLOYD, RS				LATHAM, KA; TAYLOR, JS; LLOYD, RS			T4 ENDONUCLEASE-V PROTECTS THE DNA STRAND OPPOSITE A THYMINE DIMER FROM CLEAVAGE BY THE FOOTPRINTING REAGENTS DNASE-I AND 1,10-PHENANTHROLINE-COPPER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; COLI RNA-POLYMERASE; BETA-ELIMINATION REACTION; ALDEHYDIC ABASIC SITES; X-RAY STRUCTURE; ESCHERICHIA-COLI; NUCLEASE ACTIVITY; PYRIMIDINE DIMER; CIS-SYN; DUPLEX D(GCGTTGCG).D(CGCAACGC)	The glycosylase/abasic lyase T4 endonuclease V initiates the repair of ultraviolet light-induced pyrimidine dimers. This enzyme forms an imino intermediate between its N-terminal alpha-NH2 group and C-1' of the 5'-residue within the dimer. Sodium borohydride was used to covalently trap endonuclease V to a 49-base pair oligodeoxynucleotide containing a site-specific cyclobutane thymine dimer. The bound and free oligonucleotides were then subjected to nuclease protection assays using DNase I and a complex of I,10-phenanthroline-copper. There was a large region of protection from both nucleases produced by endonuclease V evident on the strand opposite and asymmetrically opposed to the dimer. Little protection was seen on the dimer-containing strand, The existence of a footprint with the 1,10-phenanthroline-copper cleavage agent indicated that endonuclease V was interacting with the DNA predominantly via the minor groove, Methylation by dimethyl sulfate yielded no areas of protection when endonuclease V was covalently attached to the DNA, indicating that the protein may closely approach the DNA without direct contact with the bases near the thymine dimer, The Escherichia coli proteins Fpg and photolyase display a very different pattern of nuclease protection on their respective substrates, implying that endonuclease V recognizes pyrimidine dimers by a novel mechanism.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77555; VANDERBILT UNIV,DEPT BIOCHEM,NASHVILLE,TN 37232; VANDERBILT UNIV,CTR MOLEC TOXICOL,NASHVILLE,TN 37232; WASHINGTON UNIV,DEPT CHEM,ST LOUIS,MO 63130	University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Vanderbilt University; Washington University (WUSTL)			Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257; Lloyd, R. Stephen/0000-0001-7273-372X	NATIONAL CANCER INSTITUTE [R37CA040463, R01CA040463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004091] Funding Source: NIH RePORTER; NCI NIH HHS [CA40463] Funding Source: Medline; NIEHS NIH HHS [ES04091] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AUGUSTINE ML, 1991, BIOCHEMISTRY-US, V30, P8052, DOI 10.1021/bi00246a025; BAER M, 1989, MOL CELL BIOL, V9, P4777, DOI 10.1128/MCB.9.11.4777; BAILLY V, 1989, BIOCHEM J, V259, P751, DOI 10.1042/bj2590751; Brenowitz M., 1989, CURRENT PROTOCOLS MO; DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; DOI T, 1992, P NATL ACAD SCI USA, V89, P9420, DOI 10.1073/pnas.89.20.9420; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; DOWD DR, 1989, J MOL BIOL, V208, P701, DOI 10.1016/0022-2836(89)90160-5; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GANESAN AK, 1986, BIOCHEMISTRY-US, V25, P5751, DOI 10.1021/bi00367a060; GORDON LK, 1980, J BIOL CHEM, V255, P2047; GRUSKIN EA, 1988, J BIOL CHEM, V263, P12728; GRUSKIN EA, 1986, J BIOL CHEM, V261, P9607; HORI N, 1992, NUCLEIC ACIDS RES, V20, P4761, DOI 10.1093/nar/20.18.4761; IWAI S, 1994, BIOCHEMISTRY-US, V33, P5581, DOI 10.1021/bi00184a029; JOHNSRUD L, 1978, P NATL ACAD SCI USA, V75, P5314, DOI 10.1073/pnas.75.11.5314; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KEMMINK J, 1987, EUR J BIOCHEM, V162, P37, DOI 10.1111/j.1432-1033.1987.tb10538.x; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; KUWABARA M, 1986, BIOCHEMISTRY-US, V25, P7401, DOI 10.1021/bi00371a023; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LAHM A, 1991, J MOL BIOL, V221, P645; LEE BJ, 1994, BIOCHEMISTRY-US, V33, P57, DOI 10.1021/bi00167a008; LLOYD RS, 1980, NUCLEIC ACIDS RES, V8, P5113, DOI 10.1093/nar/8.21.5113; MANOHARAN M, 1988, J AM CHEM SOC, V110, P2690, DOI 10.1021/ja00216a074; MARSHALL LE, 1981, BIOCHEMISTRY-US, V20, P244, DOI 10.1021/bi00505a003; Maxam A M, 1980, Methods Enzymol, V65, P499; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MAZUMDER A, 1989, J AM CHEM SOC, V111, P8029, DOI 10.1021/ja00202a062; MCMILLAN S, 1981, J VIROL, V40, P211, DOI 10.1128/JVI.40.1.211-223.1981; MORIKAWA K, 1992, SCIENCE, V256, P523, DOI 10.1126/science.1575827; PRINCE MA, 1991, J BIOL CHEM, V266, P10686; RECINOS A, 1988, BIOCHEMISTRY-US, V27, P1832, DOI 10.1021/bi00406a006; SCHROCK RD, 1991, J BIOL CHEM, V266, P17631; SCHROCK RD, 1993, J BIOL CHEM, V268, P880; SEAWELL PC, 1980, BIOCHEMISTRY-US, V19, P1685, DOI 10.1021/bi00549a026; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SIGMAN DS, 1991, METHOD ENZYMOL, V208, P414; SIGMAN DS, 1986, ACCOUNTS CHEM RES, V19, P180, DOI 10.1021/ar00126a004; SMITH CA, 1993, J BIOL CHEM, V268, P11143; STUMP DG, 1988, BIOCHEMISTRY-US, V27, P1839, DOI 10.1021/bi00406a007; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P8858, DOI 10.1021/bi00489a049; TCHOU J, 1993, J BIOL CHEM, V268, P26738; WEISS B, 1987, ADV ENZYMOL RAMB, V60, P1; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V	47	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3765	3771		10.1074/jbc.270.8.3765	http://dx.doi.org/10.1074/jbc.270.8.3765			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876117	hybrid			2022-12-27	WOS:A1995QH68800047
J	MACDONALD, GH; ITOHLINDSTROM, Y; TING, JPY				MACDONALD, GH; ITOHLINDSTROM, Y; TING, JPY			THE TRANSCRIPTIONAL REGULATORY PROTEIN, YB-1, PROMOTES SINGLE-STRANDED REGIONS IN THE DRA PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER FACTOR-I; BINDING-PROTEIN; ESCHERICHIA-COLI; MESSENGER-RNA; Y-BOX; EXPRESSION; GENE; FAMILY; CELLS; SITE	YB-1 is a member of a newly defined family of DNA- and RNA-binding proteins, the Y box factors. These proteins have been shown to affect gene expression at both the transcriptional and translational levels. Recently, we showed that YB-1 represses interferon-gamma-induced transcription of class II human major histocompatibility (MHC) genes (1). Studies in this report characterize the DNA binding properties of purified, recombinant YB-1 on the MRC class II DRA promoter. The generation of YE-l-specific antibodies further permitted an analysis of the DNA binding properties of endogenous YB-1. YB-1 specifically binds single-stranded templates of the DRA promoter with greater affinity than double-stranded templates. The single-stranded DNA binding sites of YB-1 were mapped to the X box, whereas the double-stranded binding sites were mapped to the Y box of the DRA promoter, by methylation interference analysis. Most significantly, YB-1 can induce or stabilize single-stranded regions in the X and Y elements of the DRA promoter, as revealed by mung bean nuclease analysis. In concert with the findings that YB-1 represses DRA transcription, this study of YB-1 binding properties suggests a model of repression in which YB-1 binding results in single-stranded regions within the promoter, thus preventing loading and/or function of other DRA-specific transactivating factors.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	MACDONALD, GH (corresponding author), UNIV N CAROLINA,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599, USA.				NCI NIH HHS [R01 CA-48185, CA-37172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA048185] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; CHEN LL, 1993, CELL GROWTH DIFFER, V4, P975; COGSWELL JP, 1990, P NATL ACAD SCI USA, V87, P7703, DOI 10.1073/pnas.87.19.7703; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; FABER M, 1990, J BIOL CHEM, V265, P22243; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; GRAUMANN P, 1994, FEBS LETT, V338, P157, DOI 10.1016/0014-5793(94)80355-2; GREUEL BT, 1990, VIROLOGY, V177, P33, DOI 10.1016/0042-6822(90)90457-3; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P4915, DOI 10.1093/nar/19.18.4915; HORWITZ EM, 1994, J BIOL CHEM, V269, P14130; KANDALA JC, 1994, VIROLOGY, V198, P514, DOI 10.1006/viro.1994.1062; KASHANCHI F, 1994, J VIROL, V68, P561, DOI 10.1128/JVI.68.1.561-565.1994; Kato M, 1991, Nucleic Acids Symp Ser, P35; KERR D, 1994, J VIROL, V68, P7637, DOI 10.1128/JVI.68.11.7637-7643.1994; KOLLURI R, 1992, NUCLEIC ACIDS RES, V20, P111, DOI 10.1093/nar/20.1.111; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIN XH, 1992, J BIOL CHEM, V267, P25614; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Maxam A M, 1980, Methods Enzymol, V65, P499; MURRAY MT, 1993, P NATL ACAD SCI USA, V89, P11; OZER J, 1993, GENE, V133, P187, DOI 10.1016/0378-1119(93)90637-I; RANJAN M, 1993, GENE DEV, V7, P1725, DOI 10.1101/gad.7.9.1725; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; SANTRA M, 1994, J BIOL CHEM, V269, P579; SHEIDEREIT L, 1984, P NATL ACAD SCI USA, V66, P3029; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPITKOVSKY DD, 1992, NUCLEIC ACIDS RES, V20, P797, DOI 10.1093/nar/20.4.797; TAFURI SR, 1993, J BIOL CHEM, V268, P24255; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1993, BIOESSAYS, V16, P245; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; ZELEZNIKLE NJ, 1991, P NATL ACAD SCI USA, V88, P1873, DOI 10.1073/pnas.88.5.1873	36	125	130	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3527	3533		10.1074/jbc.270.8.3527	http://dx.doi.org/10.1074/jbc.270.8.3527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876087	Green Published, hybrid			2022-12-27	WOS:A1995QH68800014
J	MCINTOSH, JM; GHOMASHCHI, F; GELB, MH; DOOLEY, DJ; STOEHR, SJ; GIORDANI, AB; NAISBITT, SR; OLIVERA, BM				MCINTOSH, JM; GHOMASHCHI, F; GELB, MH; DOOLEY, DJ; STOEHR, SJ; GIORDANI, AB; NAISBITT, SR; OLIVERA, BM			CONODIPINE-M, A NOVEL PHOSPHOLIPASE-A(2) ISOLATED FROM THE VENOM OF THE MARINE SNAIL CONUS-MAGUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; CALCIUM-CHANNEL ANTAGONISTS; PRODUCT-CONTAINING VESICLES; INTERFACIAL CATALYSIS; COMPETITIVE INHIBITORS; OMEGA-CONOTOXIN; GAMMA-CARBOXYGLUTAMATE; POLYPEPTIDE TOXIN; BETA-BUNGAROTOXIN; BILAYER INTERFACE	We describe the purification and first biochemical characterization of an enzymatic activity in venom from the marine snail Conus magus. This enzyme, named conodipine-M, is a novel phospholipase A(2) with a molecular mass of 13.6 kDa and is comprised of two polypeptide chains linked by one or more disulfide bonds. The amino acid sequence of conodipine-M shows little if any homology to other previously sequenced phospholipase A(2) enzymes (PLA(2)s). Conodipine-M thus represents a new group of PLA(2)s. This is remarkable, since conodipine-M displays a number of properties that are similar to those of previously characterized 14-kDa PLA(2)s. The enzyme shows little, if any, phospholipase A(1), diacylglycerol lipase, triacylglycerol lipase, or lysophospholipase activities. Conodipine-M hydrolyzes the sn-2 ester of various preparations of phospholipid only in the presence of calcium and with specific activities that are comparable to those of well known 14-kDa snake venom and pancreatic PLA(2)s. The Conus enzyme binds tightly to vesicles of the negatively charged phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphomethanol and catalyzes the hydrolysis of this substrate in a processive fashion. Conodipine-M does not significantly discriminate against phospholipids with unsaturated versus saturated fatty acids at the sn-2 position or with different polar head groups. Linoleoyl amide and a phospholipid analog containing an alkylphosphono group at the sn-2 position are potent inhibitors of conodipine-M. We suggest that the functional resemblance of conodipine-M to other PLA(2)s might be explained by the utilization of similar catalytic residues.	UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA; UNIV WASHINGTON, DEPT CHEM, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, DEPT NEUROSCI, ANN ARBOR, MI 48106 USA; WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, DEPT CHEM, ANN ARBOR, MI 48106 USA	Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pfizer; Pfizer	MCINTOSH, JM (corresponding author), UNIV UTAH, DEPT PSYCHIAT, 201 S BIOL, SALT LAKE CITY, UT 84112 USA.			gelb, michael/0000-0001-7000-5219	NHLBI NIH HHS [HL36235] Funding Source: Medline; NIGMS NIH HHS [P01 GM 48677] Funding Source: Medline; NIMH NIH HHS [K20 MH00929] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036235, R23HL036235, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH000929] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABE T, 1977, EUR J BIOCHEM, V80, P1, DOI 10.1111/j.1432-1033.1977.tb11849.x; [Anonymous], 1987, PHOSPHOLIPASES; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; BENISHIN CG, 1990, MOL PHARMACOL, V38, P164; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BOTES DP, 1974, J BIOL CHEM, V249, P3827; CHANG C C, 1985, Proceedings of the National Science Council Republic of China Part B Life Sciences, V9, P126; CLARK C, 1981, TOXICON, V19, P691, DOI 10.1016/0041-0101(81)90106-9; CRUZ LJ, 1985, J TOXICOL-TOXIN REV, V4, P107, DOI 10.3109/15569548509014416; CRUZ LJ, 1978, ARCH BIOCHEM BIOPHYS, V190, P539, DOI 10.1016/0003-9861(78)90308-9; CRUZ LJ, 1986, J BIOL CHEM, V261, P6230; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1983, ENZYMES, P307; DOOLEY DJ, 1987, J NEUROCHEM, V49, P900, DOI 10.1111/j.1471-4159.1987.tb00978.x; EVENBERG A, 1977, J BIOL CHEM, V252, P1189; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; FRAENKELCONRAT H, 1983, J TOXICOL-TOXIN REV, V1, P205; GELB MH, 1992, BIOORG MED CHEM LETT, V2, P1335, DOI 10.1016/S0960-894X(00)80508-9; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; GHOMASHCHI F, 1991, BIOCHEMISTRY-US, V30, P7318, DOI 10.1021/bi00243a037; GONOI T, 1987, MOL PHARMACOL, V32, P691; GRAY WR, 1981, J BIOL CHEM, V256, P4734; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HALPERT J, 1975, J BIOL CHEM, V250, P6990; HAMMERLAND LG, 1992, EUR J PHARM-MOLEC PH, V226, P239, DOI 10.1016/0922-4106(92)90067-6; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HOWARD BD, 1980, ANNU REV PHARMACOL, V20, P307, DOI 10.1146/annurev.pa.20.040180.001515; JAIN MK, 1992, J MED CHEM, V35, P3584, DOI 10.1021/jm00097a018; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7340, DOI 10.1021/bi00243a039; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; JAIN MK, 1989, BIOCHEMISTRY-US, V28, P4135, DOI 10.1021/bi00436a002; JAIN MK, 1995, IN PRESS METHODS ENZ; KERR LM, 1984, NATURE, V308, P282, DOI 10.1038/308282a0; KOBAYASHI J, 1985, TOXICON, V23, P783, DOI 10.1016/0041-0101(85)90009-1; KOBAYASHI J, 1982, BIOCHEM BIOPH RES CO, V105, P1389, DOI 10.1016/0006-291X(82)90941-X; KONDO K, 1978, J BIOCHEM-TOKYO, V83, P101, DOI 10.1093/oxfordjournals.jbchem.a131881; KUCHLER K, 1989, EUR J BIOCHEM, V184, P249, DOI 10.1111/j.1432-1033.1989.tb15014.x; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MCINTOSH JM, 1993, TOXICON, V31, P1561, DOI 10.1016/0041-0101(93)90340-O; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; MYERS RA, 1991, BIOCHEMISTRY-US, V30, P9370, DOI 10.1021/bi00102a034; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Nieuwenhuizen W, 1974, Methods Enzymol, V32, P147; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; RAMILO CA, 1992, BIOCHEMISTRY-US, V31, P9919, DOI 10.1021/bi00156a009; RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402; ROSENBERG P, 1990, PHOSPHOLIPASES, P67; SAXENA VK, 1992, NEUROCHEM INT, V20, P69, DOI 10.1016/0197-0186(92)90127-D; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; Stoehr S. J., 1992, Society for Neuroscience Abstracts, V18, P971; STRONG PN, 1976, P NATL ACAD SCI USA, V73, P178, DOI 10.1073/pnas.73.1.178; SUPAVILAI P, 1984, J NEURAL TRANSM, V60, P149, DOI 10.1007/BF01249091; VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404; VOLWERK JJ, 1974, BIOCHEMISTRY-US, V13, P1446, DOI 10.1021/bi00704a020; YUAN W, 1990, BIOCHEMISTRY-US, V29, P6082, DOI 10.1021/bi00477a028; YUAN W, 1990, THESIS U WASHINGTON; ZAFARALLA GC, 1988, BIOCHEMISTRY-US, V27, P7102, DOI 10.1021/bi00418a065	67	87	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3518	3526		10.1074/jbc.270.8.3518	http://dx.doi.org/10.1074/jbc.270.8.3518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876086	hybrid			2022-12-27	WOS:A1995QH68800013
J	RAMPAL, AL; JHUN, BH; KIM, S; LIU, HZ; MANKA, M; LACHAAL, M; SPANGLER, RA; JUNG, CY				RAMPAL, AL; JHUN, BH; KIM, S; LIU, HZ; MANKA, M; LACHAAL, M; SPANGLER, RA; JUNG, CY			OKADAIC ACID STIMULATES GLUCOSE-TRANSPORT IN RAT ADIPOCYTES BY INCREASING THE EXTERNALIZATION RATE-CONSTANT OF GLUT4 RECYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE CELL; PROTEIN-PHOSPHORYLATION; APPARENT TRANSLOCATION; PLASMA-MEMBRANE; INSULIN; METABOLISM; INHIBITOR; MECHANISM; KINETICS; VANADATE	GLUT4, the major insulin-responsive glucose transporter isoform in rat adipocytes, rapidly recycles between the cell surface and an intracellular pool with two first order rate constants, one for internalization (k(in)) and the other for externalization (k(ex)). Insulin decreases k(in) by 2.8-fold and increases h(ex) by 3.3-fold, thus increasing the steady-state cell surface GLUT4 level by approximately 8-fold (Jhun, B, H,, Rampal, k L., Liu, H., Lachaal, M., and Jung, C, (1992) J. Biol. Chem. 267, 17710-17715), To gain an insight into the biochemical mechanisms that modulate these rate constants, we studied the effects upon them of okadaic acid (OKA), a phosphatase inhibitor that exerts a insulin-like effect on glucose transport in adipocytes, OKA stimulated 3-O-methylglucose transport maximally 3.1-fold and increased the cell surface GLUT4 level 3.4-fold. When adipocytes were pulse-labeled with an impermeant, covalently reactive glucose analog, [H-3]1,3-bis-(3-deoxy-D-glucopyranose-3-yloxy)-2 -propyl 4-benzoylbenzoate, and the time course of labeled CfLUT4 recycling was followed, the k(in) was found to increase 2.8-fold upon maximal stimulation by OKA, whereas the k(in), remained unchanged within experimental error, These findings demonstrate that ORA mimics the insulin effect on only GLUT4 externalization and suggest that insulin stimulates GLUT4 externalization by increasing the phosphorylation state of a serine/threonine phosphoprotein, probably by inhibiting protein phosphatase 1 or 2A.	VET ADM MED CTR,BIOPHYS LAB,BUFFALO,NY 14215; SUNY BUFFALO,DEPT BIOPHYS SCI,BUFFALO,NY 14215	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo			Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668	NIDDK NIH HHS [DK13376] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013376] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDINI G, 1992, J BIOL CHEM, V266, P4037; BEGUM N, 1993, J BIOL CHEM, V268, P3352; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIRMBAUM MJ, 1992, INT REV CYTOL A, V137, P239; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CORMONT M, 1993, J BIOL CHEM, V268, P19491; CORVERA S, 1991, J BIOL CHEM, V266, P9271; CUSHMAN SW, 1984, FED PROC, V43, P2251; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DUBYAK GR, 1980, J BIOL CHEM, V255, P5306; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JHUN BH, 1992, J BIOL CHEM, V267, P17710; JHUN BH, 1991, J BIOL CHEM, V266, P22260; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; LAWRENCE JC, 1992, ANNU REV PHYSIOL, V54, P177, DOI 10.1146/annurev.ph.54.030192.001141; MARTZ A, 1986, J BIOL CHEM, V261, P3606; MAY JM, 1979, J BIOL CHEM, V254, P9017; ROBINSON LJ, 1992, AM J PHYSIOL, V263, P383; SHISHEVA A, 1991, ENDOCRINOLOGY, V129, P2279; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TANTI JF, 1991, J BIOL CHEM, V266, P2099; TOYODA N, 1986, J BIOL CHEM, V261, P2117; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	30	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3938	3943		10.1074/jbc.270.8.3938	http://dx.doi.org/10.1074/jbc.270.8.3938			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876140	hybrid			2022-12-27	WOS:A1995QH68800072
J	RAO, SS; KOHTZ, DS				RAO, SS; KOHTZ, DS			POSITIVE AND NEGATIVE REGULATION OF D-TYPE CYCLIN EXPRESSION IN SKELETAL MYOBLASTS BY BASIC FIBROBLAST GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR-BETA - A ROLE FOR CYCLIN D1 IN CONTROL OF MYOBLAST DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR GENES; MYOGENIC DIFFERENTIATION; CELL-CYCLE; G1 PHASE; DNA-BINDING; FAMILY; MYOD; PROLIFERATION; MEMBER; G(1)	Differentiation of skeletal myoblasts in culture is negatively regulated by certain growth factors, including basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF beta). We investigated the effects of bFGF and TGF beta on D-type cyclin expression in skeletal myoblasts. When myoblasts were induced to differentiate in low mitogen medium, expression of cyclin D1 rapidly fell below detectable levels. In contrast, expression of cyclin D3 increased to levels exceeding those present in myoblasts. Expression of cyclin D1 was induced iii myoblasts by bFGF and TGF beta (albeit with different kinetics for each factor), while induction of cyclin D3 expression was inhibited by these growth factors. Although these results are consistent with other reports showing induction of cyclin D1 by growth factors, induction of cyclin D3 expression during terminal differentiation of myoblasts and inhibition of this induction by growth factors is surprising. These results suggest that cyclin D3, previously thought to be only a positive regulator of cell cycle progression, may also function in the cellular context of terminal differentiated muscle. Stable expression of cyclin D1 from an ectopic viral promoter inhibits C2C12 myoblast differentiation, but only in those clones where the level of cyclin D1 expression does not significantly exceed that present in control myoblasts stimulated by bFGF. Together, these result suggest that cyclin D1 expression functions in the inhibition of myoblast differentiation by certain growth factors.			RAO, SS (corresponding author), CUNY MT SINAI SCH MED, DEPT PATHOL 1194, NEW YORK, NY 10029 USA.							BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; COCKS BG, 1992, J BIOL CHEM, V267, P12307; COLE F, 1993, J BIOL CHEM, V268, P1580; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; INABA T, 1992, GENOMICS, V13, P565, DOI 10.1016/0888-7543(92)90126-D; KATO JY, 1993, P NATL ACAD SCI USA, V90, P11513, DOI 10.1073/pnas.90.24.11513; KOPPE RI, 1989, J BIOL CHEM, V264, P14327; LATHROP B, 1985, J CELL BIOL, V103, P1799; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MATSUSHIME H, 1991, COLD SPRING HARB SYM, V56, P69; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Sambrook J, 1989, MOL CLONING LABORATO; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	46	130	132	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4093	4100		10.1074/jbc.270.8.4093	http://dx.doi.org/10.1074/jbc.270.8.4093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876159	hybrid			2022-12-27	WOS:A1995QH68800092
J	BOURGOIN, S; HARBOUR, D; DESMARAIS, Y; TAKAI, Y; BEAULIEU, A				BOURGOIN, S; HARBOUR, D; DESMARAIS, Y; TAKAI, Y; BEAULIEU, A			LOW-MOLECULAR-WEIGHT GTP-BINDING PROTEINS IN HL-60 GRANULOCYTES - ASSESSMENT OF THE ROLE OF ARF AND OF A 50-KDA CYTOSOLIC PROTEIN IN PHOSPHOLIPASE-D ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; CELL-FREE SYSTEM; HUMAN NEUTROPHILS; RHO GDI; RABBIT NEUTROPHILS; PHOSPHATIDIC-ACID; NADPH OXIDASE; P21; DIRADYLGLYCEROL; INVOLVEMENT	Phospholipase D (PLD) activation by guanine nucleotides requires protein cofactors in both the plasma membrane and the cytosol, HL-60 cytosol was fractionated by ammonium sulfate and gel-permeation chromotography, Two cytosolic protein fractions were found to reconstitute the GTP gamma S (guanosine 5'-3-O-(thio)triphosphate) stimulated PLD in a reconstitution assay consisting of H-3-labeled HL-60 membranes and eluted column fractions. The major peak of reconstituting activity was in the region of 50 kDa, and a second discrete peak of PLD reconstitution activity was observed in the region of 18 kDa, Rho GDP/GTP exchange inhibitor, Rho GDI, comigrated with Rac2 and RhoA, but not Rad. RhoA and Rac2 were entirely complexed with Rho GDI and eluted with an apparent molecular mass of 43 kDa by gel filtration chromatography, The partial overlap between cytosolic Rac2 and RhoA with the 50-kDa peak of reconstituting activity was not consistent with the participation of cytosolic Rho-related GTPases in the activation of PLD by guanine nucleotides. However, recombinant Rho GDI, which inhibits nucleotide exchange on the Rho family of small GTP binding proteins, reduced GTP gamma S-stimulated PLD activity in HL-60 homogenates. The stimulatory exchange factor, Smg GDS, which is active on Rho and Rac, could be partially separated from the PLD-stimulating factor(s) by gel-permeation chromatography. Moreover, recombinant Smg GDS failed to stimulate GTP dependent PLD activity, Cytosolic ADP-ribosylation factor (ARF) was exclusively located in the 18-kDa peak of reconstitution activity, Faint amounts of membrane-bound ARF were also detected using the monoclonal antibody 1D9, The effects of the 50-kDa and 18-kDa PLD inducing factors on the salt-extracted PLD activity were synergistic. The weak stimulatory effect of ARF alone suggested that the GTP gamma S stimulated PLD activity is dependent on the presence of another protein(s), presumably ARF-regulatory proteins. We propose that a membrane-bound GTP-binding protein, possibly ARF, may be involved in the activation of PLD when combined with the component(s) of the 50 kDa fraction.	KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN	Kobe University	BOURGOIN, S (corresponding author), CHUL,CTR RECH,CTR RECH RHUMATOL & IMMUNOL,2705 BLVD LAURIER,ST FOY,PQ G1V 4G2,CANADA.			Bourgoin, Sylvain/0000-0001-9779-0368				AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOKOCH GM, 1988, J BIOL CHEM, V263, P16744; BOKOCH GM, 1993, FASEB J, V7, P750, DOI 10.1096/fasebj.7.9.8330683; BONSER RW, 1989, BIOCHEM J, V264, P617, DOI 10.1042/bj2640617; BOURGOIN S, 1990, J EXP MED, V172, P767, DOI 10.1084/jem.172.3.767; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CHUANG TH, 1993, J BIOL CHEM, V268, P775; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; FABIATO A, 1989, J PHYSL, V75, P464; GENY B, 1993, EUR J BIOCHEM, V215, P389, DOI 10.1111/j.1432-1033.1993.tb18045.x; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; KANAHO Y, 1991, J IMMUNOL, V146, P3536; KANAHO Y, 1991, FEBS LETT, V279, P249, DOI 10.1016/0014-5793(91)80160-5; KELVIN DJ, 1993, J LEUKOCYTE BIOL, V54, P604, DOI 10.1002/jlb.54.6.604; KUSNER DJ, 1993, J BIOL CHEM, V268, P19973; KWONG CH, 1993, BIOCHEMISTRY-US, V32, P5711, DOI 10.1021/bi00072a029; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MIURA Y, 1993, J BIOL CHEM, V268, P510; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MULLMANN TJ, 1993, J LEUKOCYTE BIOL, V53, P630, DOI 10.1002/jlb.53.6.630; NAKAMURA K, 1984, ANAL BIOCHEM, V142, P406, DOI 10.1016/0003-2697(84)90484-6; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PAI JK, 1988, J BIOL CHEM, V263, P12472; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; SASAKI T, 1993, J BIOL CHEM, V268, P23959; STAI SC, 1994, P NATL ACAD SCI USA, V91, P3063; STUTCHFIELD J, 1993, BIOCHEM J, V293, P649, DOI 10.1042/bj2930649; TAKAI Y, 1992, INT REV BIOL, V119, P178; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; THOMPSON NT, 1990, BIOCHEM J, V271, P209, DOI 10.1042/bj2710209; TSHUCHIYA M, 1991, J BIOL CHEM, V266, P2772; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; XIE MS, 1991, BIOCHEM J, V278, P81, DOI 10.1042/bj2780081; XIE MS, 1991, J CLIN INVEST, V88, P45, DOI 10.1172/JCI115303; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289	45	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3172	3178		10.1074/jbc.270.7.3172	http://dx.doi.org/10.1074/jbc.270.7.3172			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852400	hybrid			2022-12-27	WOS:A1995QG47100044
J	EVDOKIMOVA, VM; WEI, CL; SITIKOV, AS; SIMONENKO, PN; LAZAREV, OA; VASILENKO, KS; USTINOV, VA; HERSHEY, JWB; OVCHINNIKOV, LP				EVDOKIMOVA, VM; WEI, CL; SITIKOV, AS; SIMONENKO, PN; LAZAREV, OA; VASILENKO, KS; USTINOV, VA; HERSHEY, JWB; OVCHINNIKOV, LP			THE MAJOR PROTEIN OF MESSENGER-RIBONUCLEOPROTEIN PARTICLES IN SOMATIC-CELLS IS A MEMBER OF THE Y-BOX BINDING TRANSCRIPTION FACTOR FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; RABBIT RETICULOCYTES; RNA-BINDING; POLY(A)-BINDING PROTEIN; CYTOPLASMIC MRNP; TRANSLATION; PURIFICATION; INITIATION; CLONING; INVITRO	A cDNA encoding the major core protein, p50, of cytoplasmic messenger ribonucleoprotein particles (mRNPs) of somatic cells was cloned from a rabbit reticulocyte cDNA library. From the derived 324-amino acid sequence, p50 is identified as a member of the Y-box binding transcription factor family. The protein was earlier described as a repressor of globin mRNA translation. These findings suggest that p50 may affect protein biosynthesis at two levels: mRNA transcription in the nucleus and mRNA translation in the cytoplasm. Together with recently published results showing that masked mRNA in germ cells also is associated with proteins of the Y-box binding protein family, the present finding indicates that these proteins are universal core proteins responsible for the formation of cytoplasmic mRNPs in eukaryotes. Highly purified p50 forms large 18 S homomultimeric complexes with a molecular mass of about 800 kilodaltons and melts RNA secondary structure. This suggests that p50 may affect translation by changing the overall structure of the mRNA.	UNIV CALIF DAVIS, SCH MED, DEPT BIOL CHEM, DAVIS, CA 95616 USA; RUSSIAN ACAD SCI, INST PROT RES, PUSHCHINO 142292, RUSSIA	University of California System; University of California Davis; Russian Academy of Sciences			Ustinov, Valentin/J-6301-2018; Vassilenko, Konstantin S/M-4187-2015; Ovchinnikov, Lev/L-2397-2015	Vassilenko, Konstantin S/0000-0003-3393-3109; 	NIGMS NIH HHS [GM22135] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022135] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; ADAMSON SD, 1968, ARCH BIOCHEM BIOPHYS, V125, P671, DOI 10.1016/0003-9861(68)90625-5; BLOBEL G, 1973, P NATL ACAD SCI USA, V70, P924, DOI 10.1073/pnas.70.3.924; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; DE SA MFG, 1988, EUR J BIOCHEM, V176, P521; DESCHAMPS S, 1991, FEBS LETT, V282, P110, DOI 10.1016/0014-5793(91)80456-D; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; ENGLAND TE, 1978, NATURE, V275, P560, DOI 10.1038/275560a0; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; JAIN SK, 1979, FEBS LETT, V97, P84, DOI 10.1016/0014-5793(79)80058-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MINICH WB, 1993, EUR J BIOCHEM, V212, P633, DOI 10.1111/j.1432-1033.1993.tb17701.x; MINICH WB, 1989, FEBS LETT, V258, P227, DOI 10.1016/0014-5793(89)81659-X; MINICH WB, 1990, MOL BIOL REP, V14, P65, DOI 10.1007/BF00360418; MINICH WB, 1992, BIOCHIMIE, V74, P477, DOI 10.1016/0300-9084(92)90088-V; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; MURRAY MT, 1991, J CELL BIOL, V112, P1, DOI 10.1083/jcb.112.1.1; OVCHINNIKOV LP, 1978, EUR J BIOCHEM, V90, P517, DOI 10.1111/j.1432-1033.1978.tb12631.x; RANJAN M, 1993, GENE DEV, V7, P1725, DOI 10.1101/gad.7.9.1725; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; SCHMID HP, 1982, J CELL BIOL, V93, P893, DOI 10.1083/jcb.93.3.893; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; SPIRIN AS, 1969, EUR J BIOCHEM, V10, P20; SPIRIN AS, 1965, FED PROC, V24, pT907; TAFURI SR, 1993, J BIOL CHEM, V268, P12213; TAFURI SR, 1992, NEW BIOL, V4, P349; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; VYSOTSKAYA V, 1994, EUR J BIOCHEM, V223, P437, DOI 10.1111/j.1432-1033.1994.tb19011.x; WOLFFE AP, 1992, NEW BIOL, V4, P290; ZELUS BD, 1989, MOL CELL BIOL, V9, P2756, DOI 10.1128/MCB.9.6.2756	33	150	158	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3186	3192		10.1074/jbc.270.7.3186	http://dx.doi.org/10.1074/jbc.270.7.3186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852402	hybrid			2022-12-27	WOS:A1995QG47100046
J	HSU, SC; DEFRANCO, DB				HSU, SC; DEFRANCO, DB			SELECTIVITY OF CELL-CYCLE REGULATION OF GLUCOCORTICOID RECEPTOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; C-JUN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; HORMONE RECEPTORS; BINDING ACTIVITY; GENE-EXPRESSION; DOWN-REGULATION; DNA-BINDING; PHOSPHORYLATION	The restricted expression of some genes to distinct stages of the cell cycle is often brought about through alterations in the activity and/or abundance of specific transcription factors. Many cells have been shown to be unresponsive to glucocorticoid hormone action during the G(2) phase of the mammalian cell cycle, suggesting that some activities of the glucocorticoid receptor (GR), a ligand-activated transcription factor, are subjected to cell cycle control. We show here that GR insensitivity in G(2) is selective, affecting receptor-mediated transactivation from a simple glucocorticoid response element, but not repression from a composite glucocorticoid response element. Since glucocorticoid-dependent down-regulation of GR protein levels is also unaffected in G(2), distinct activities of the receptor that participate in this homologous down-regulation must be operating as effectively in G(2)-synchronized cells as in asynchronous cells. Finally, the phosphorylation state of the GR is altered in G(2)-synchronized cells reflecting, in part, both site-specific phosphorylation and dephosphorylation events. These results suggest that, while GR may be a target for cell cycle regulated kinases and phosphatases, the resulting changes in receptor phosphorylation have an impact only on selected GR functions.	UNIV PITTSBURGH,DEPT BIOL SCI,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCI NIH HHS [CA43037] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043037] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALAM T, 1993, J BIOL CHEM, V268, P15681; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENOR S, 1993, MOL CELL BIOL, V13, P331, DOI 10.1128/MCB.13.1.331; BERKOFLINT Y, 1994, EMBO J, V13, P646, DOI 10.1002/j.1460-2075.1994.tb06303.x; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; BURNSTEIN KL, 1991, STEROIDS, V56, P52, DOI 10.1016/0039-128X(91)90124-E; DANIELSEN M, 1984, MOL CELL BIOL, V4, P449, DOI 10.1128/MCB.4.3.449; DEFRANCO D, 1986, MOL CELL BIOL, V6, P993, DOI 10.1128/MCB.6.4.993; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FANGER BO, 1986, ARCH BIOCHEM BIOPHYS, V249, P116, DOI 10.1016/0003-9861(86)90566-7; GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274; HAFFAR OK, 1987, MOL CELL BIOL, V7, P1508, DOI 10.1128/MCB.7.4.1508; Hall FL, 1991, CURR OPIN CELL BIOL, V3, P176, DOI 10.1016/0955-0674(91)90136-M; HOECK W, 1989, J BIOL CHEM, V264, P14396; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KILMARTIN JV, 1993, J CELL BIOL, V123, P10952; KIM YK, 1991, MOL CELL BIOL, V11, P2296, DOI 10.1128/MCB.11.4.2296; LABELLA F, 1989, GENE DEV, V3, P1982, DOI 10.1101/gad.3.12a.1982; MARODER M, 1993, MOL ENDOCRINOL, V7, P570, DOI 10.1210/me.7.4.570; MARTIN DW, 1970, P NATL ACAD SCI USA, V65, P1064, DOI 10.1073/pnas.65.4.1064; MCKINNEY JD, 1991, TRENDS BIOCHEM SCI, V16, P430, DOI 10.1016/0968-0004(91)90170-Z; MENDEL DB, 1986, NATURE, V324, P478, DOI 10.1038/324478a0; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MOYER ML, 1993, J BIOL CHEM, V268, P22933; Nigg EA, 1993, CURR OPIN CELL BIOL, V5, P187, DOI 10.1016/0955-0674(93)90101-U; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; ORTI E, 1989, J BIOL CHEM, V264, P9728; PETERSEN DD, 1989, P NATL ACAD SCI USA, V86, P7800, DOI 10.1073/pnas.86.20.7800; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; QI M, 1989, MOL ENDOCRINOL, V3, P1279, DOI 10.1210/mend-3-8-1279; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; REIK A, 1994, MOL ENDOCRINOL, V8, P490, DOI 10.1210/me.8.4.490; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SETH A, 1993, MOL CELL BIOL, V13, P4125, DOI 10.1128/MCB.13.7.4125; Solomon MJ, 1993, CURR OPIN CELL BIOL, V5, P180, DOI 10.1016/0955-0674(93)90100-5; SOMERS JP, 1992, MOL ENDOCRINOL, V7, P26; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; TOBEY RA, 1990, P NATL ACAD SCI USA, V87, P5104, DOI 10.1073/pnas.87.13.5104; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZHANG YX, 1994, MOL ENDOCRINOL, V8, P577, DOI 10.1210/me.8.5.577; Zolnierowicz S, 1994, Trends Cell Biol, V4, P61, DOI 10.1016/0962-8924(94)90012-4	59	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3359	3364		10.1074/jbc.270.7.3359	http://dx.doi.org/10.1074/jbc.270.7.3359			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852422	hybrid			2022-12-27	WOS:A1995QG47100070
J	SOTO, C; CASTANO, EM; FRANGIONE, B; INESTROSA, NC				SOTO, C; CASTANO, EM; FRANGIONE, B; INESTROSA, NC			THE ALPHA-HELICAL TO BETA-STRAND TRANSITION IN THE AMINO-TERMINAL FRAGMENT OF THE AMYLOID BETA-PEPTIDE MODULATES AMYLOID FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; FIBRIL FORMATION; DUTCH-TYPE; PROTEIN; AGGREGATION; INVITRO; DEPOSITION	Amyloid-beta peptide (A beta) consists of a hydrophobic C-terminal domain (residues 29-42) that adopts beta-strand coniformation and an N-terminal domain (amino acids 10-24) whose sequence permits the existence of a dynamic equilibrium between an alpha-helix and a beta-strand, In this paper we analyzed the effect of the alternate N-terminal conformations on amyloid fibril formation through the study of the analogous A beta peptides containing single amino acidic substitutions, The single mutation of valine 18 to alanine induces a significant increment of the alpha-helical content of A beta, determined by Fourier transform infrared spectroscopy and circular dichroism and dramatically diminishes fibrillogenesis, measured by turbidity, thioflavine T binding, Congo red staining, and electron microscopic examination, In hereditary Dutch cerebral hemorrhage with amyloidosis (a variant of Alzheimer's disease), the substitution of glutamine for glutamic acid at position 22 decreased the propensity of the A beta N-terminal domain to adopt an alpha-helical structure, with a concomitant increase in amyloid formation, We propose that A beta exists in an equilibrium between two species: one ''able'' and another ''unable'' to form amyloid, depending on the secondary structure adopted by the N-terminal domain, Thus, manipulation of the A beta secondary structure with therapeutical compounds that promote the alpha-helical conformation may provides a tool to control the amyloid deposition observed in Alzheimer's disease patients.	PONTIFICIA UNIV CATOLICA CHILE,FAC CIENCIAS BIOL,DEPT BIOL CELULAR & MOLEC,MOLEC NEUROBIOL UNIT,SANTIAGO,CHILE; NYU,MED CTR,DEPT PATHOL,NEW YORK,NY 10016	Pontificia Universidad Catolica de Chile; New York University					NIA NIH HHS [AG10953, AG05891] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005891, R35AG010953, R37AG005891] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BRANDAN E, 1993, GEN PHARMACOL, V24, P1063, DOI 10.1016/0306-3623(93)90350-7; BURDICK D, 1992, J BIOL CHEM, V267, P546; CASTANO EM, 1986, BIOCHEM BIOPH RES CO, V141, P782, DOI 10.1016/S0006-291X(86)80241-8; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; FABIAN H, 1993, BIOCHEM BIOPH RES CO, V191, P232, DOI 10.1006/bbrc.1993.1207; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOREVIC PD, 1987, BIOCHEM BIOPH RES CO, V147, P854, DOI 10.1016/0006-291X(87)91008-4; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; Inestrosa N C, 1992, Biol Res, V25, P63; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MULLERHILL B, 1989, ANNU REV BIOCHEM, V58, P287; NAIKI H, 1991, LAB INVEST, V65, P104; NELSON JW, 1989, BIOCHEMISTRY-US, V28, P5256, DOI 10.1021/bi00438a050; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SORIMACHI K, 1994, EUR J BIOCHEM, V219, P237, DOI 10.1111/j.1432-1033.1994.tb19935.x; SOTO C, 1994, J NEUROCHEM, V63, P1191; TOBIAS DJ, 1991, BIOCHEMISTRY-US, V30, P6059, DOI 10.1021/bi00238a033; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; ZAGORSKI MG, 1992, BIOCHEMISTRY-US, V31, P5621, DOI 10.1021/bi00139a028	37	287	315	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3063	3067		10.1074/jbc.270.7.3063	http://dx.doi.org/10.1074/jbc.270.7.3063			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852387	hybrid			2022-12-27	WOS:A1995QG47100028
J	SUZUKI, H; KANAZAWA, T				SUZUKI, H; KANAZAWA, T			THE TRYPTOPHAN FLUORESCENCE CHANGE UPON CONFORMATIONAL TRANSITION OF THE PHOSPHOENZYME INTERMEDIATE IN SARCOPLASMIC-RETICULUM CA2+-ATPASE IS REVEALED IN THE ABSENCE OF K+ AND THE PRESENCE OF LASALOCID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; INTRINSIC FLUORESCENCE; CATALYTIC CYCLE; CA-2+-ATPASE; CALCIUM; ATPASE; HYDROLYSIS; CA-2+; STATE; SITE	ATP-induced changes in the tryptophan fluorescence of the Ca2+-ATPase were determined with sarcoplasmic reticulum vesicles at pH 7.0 and 0 degrees C by steady-state measurements in the presence of Ca2+ and the absence of K+ with and without added lasalocid (a carboxylic ionophore, 50 mu m), which was previously shown to cause a predominant accumulation of the ADP-insensitive form of the phosphoenzyme intermediate (EP) (Kawashima, T., Hare, H., and Kanazawa, T. (1990) J. Biol, Chem. 265, 10993-10999), When ATP was added in the absence of lasalocid, the fluorescence decreased by 1.7%. The addition of lasalocid quenched 71% of the fluorescence but did not reduce the ATP-induced fluorescence drop. The fluorescence drop and the EP formation were also determined in the presence of lasalocid by stopped-flow spectrometry and continuous-flow rapid quenching. The observed fluorescence drop was biphasic, The first phase coincided with the formation of EP, which was largely ADP-sensitive in this early stage of the reaction, The second phase was much slower than the first phase and coincided with the accumulation of ADP-insensitive EP. When the transition of EP from the ADP-sensitive form to the ADP-insensitive form was blocked by N-ethylmaleimide treatment, the second phase disappeared, and the fluorescence drop entirely coincided with the formation of ADP sensitive EP. These findings demonstrate that the first phase of the fluorescence drop is attributed to the formation of ADP-sensitive EP, the second phase being attributed to the transition of EP from the ADP sensitive form to the ADP-insensitive form, The present results reveal the conditions that definitely discriminate these two phases.			SUZUKI, H (corresponding author), ASAHIKAWA MED COLL,DEPT BIOCHEM,ASAHIKAWA 078,HOKKAIDO,JAPAN.							ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; BASTIDE F, 1973, Journal of Biological Chemistry, V248, P8385; BRANDL CJ, 1986, CELL, V55, P597; CHAMPEIL P, 1986, FEBS LETT, V206, P93, DOI 10.1016/0014-5793(86)81347-3; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DEFORESTA B, 1990, EUR J BIOCHEM, V194, P383; DEGANI C, 1973, J BIOL CHEM, V248, P8222; DUPONT Y, 1980, EUR J BIOCHEM, V109, P231, DOI 10.1111/j.1432-1033.1980.tb04788.x; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; DUPONT Y, 1985, STRUCTURE FUNCTION S, P225; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; HARA H, 1986, J BIOL CHEM, V261, P6584; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V68, P593, DOI 10.1093/oxfordjournals.jbchem.a129392; KAWAKITA M, 1980, J BIOCHEM, V87, P609, DOI 10.1093/oxfordjournals.jbchem.a132785; KAWASHIMA T, 1990, J BIOL CHEM, V265, P10993; KUBO K, 1990, BIOCHIM BIOPHYS ACTA, V1040, P251, DOI 10.1016/0167-4838(90)90084-S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKINOSE M, 1967, PFLUGERS ARCH, V294, P82; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; OBARA M, 1988, J BIOL CHEM, V263, P3690; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; SUZUKI H, 1994, BIOCHEMISTRY-US, V33, P8240, DOI 10.1021/bi00193a010; TAKAKUWA Y, 1979, BIOCHEM BIOPH RES CO, V88, P1209, DOI 10.1016/0006-291X(79)91108-2; TAKISAWA H, 1981, NATURE, V290, P271, DOI 10.1038/290271a0; VERJOVSKIALMEID.S, 1981, J BIOL CHEM, V256, P2662; YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706	30	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3089	3093		10.1074/jbc.270.7.3089	http://dx.doi.org/10.1074/jbc.270.7.3089			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852390	hybrid			2022-12-27	WOS:A1995QG47100032
J	WIESE, RJ; MASTICK, CC; LAZAR, DF; SALTIEL, AR				WIESE, RJ; MASTICK, CC; LAZAR, DF; SALTIEL, AR			ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE AND PHOSPHATIDYLINOSITOL 3'-KINASE IS NOT SUFFICIENT FOR THE HORMONAL-STIMULATION OF GLUCOSE-UPTAKE, LIPOGENESIS, OR GLYCOGEN-SYNTHESIS IN 3T3-L1 ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; TYROSINE-PHOSPHORYLATION; ENDOGENOUS SUBSTRATE; PHOSPHATASE INHIBITOR; SIGNALING PATHWAYS; RAT ADIPOCYTES; OKADAIC ACID; INTACT RAT; IRS-1; CELLS	The precise mechanism by which insulin regulates glucose metabolism is not fully understood. However, it is known that insulin activates two enzymes, phosphatidylinositol 3'-kinase (PI 3'-K) and mitogen-activated protein kinase (MAPK), which may be involved in stimulating the metabolic effects of insulin. The role of these enzymes in glucose metabolism was examined by comparing the effects of insulin, platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) in 3T3-L1 adipocytes. Treatment of the cells with PDGF or EGF for 5 min increased the MAPK activity 3-5-fold, while insulin treatment produced a 2.5-fold increase. The MAPK activity remained elevated for 1 h after either PDGF or insulin treatment. PDGF and insulin, but not EGF, caused a transient increase in the amount PI 3'-K activity coprecipitated with tyrosine phosphorylated proteins. Although PDGF and insulin caused a similar increase in the activities of these two enzymes, only insulin caused substantial increases in glucose utilization. Insulin increased the transport of glucose and the synthesis of lipid 4- and 17-fold, respectively, while PDGF did not affect these processes significantly. Glycogen synthesis was increased 15-fold in response to insulin and only 3-fold in response to PDGF. Thus, the activation of MAPK and PI 3'-K are not sufficient for the complete stimulation of glucose transport, lipid synthesis, or glycogen synthesis by hormones in 3T3-L1 adipocytes, suggesting a requirement for other signaling mechanisms that may be uniquely responsive to insulin.	WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,DEPT SIGNAL TRANDSUCT,ANN ARBOR,MI 48105	Pfizer			Mastick, Cynthia/G-9841-2017; Saltiel, Alan/L-3632-2019	Mastick, Cynthia/0000-0003-4769-5412; Saltiel, Alan/0000-0002-9726-9828				BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BERNIER M, 1987, P NATL ACAD SCI USA, V84, P1844, DOI 10.1073/pnas.84.7.1844; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CORVERA S, 1991, J BIOL CHEM, V266, P9271; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; FINGAR DC, 1994, ENDOCRINOLOGY, V134, P728, DOI 10.1210/en.134.2.728; FOLLI F, 1992, J BIOL CHEM, V267, P22171; HARING HU, 1987, P NATL ACAD SCI USA, V84, P113, DOI 10.1073/pnas.84.1.113; HESS SL, 1991, J CELL BIOCHEM, V45, P374, DOI 10.1002/jcb.240450411; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HOFFMANN RD, 1988, P NATL ACAD SCI USA, V85, P8835; IZUMI T, 1987, J BIOL CHEM, V262, P1282; JHUN BH, 1994, MOL CELL BIOL, V14, P7466, DOI 10.1128/MCB.14.11.7466; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LAVAN BE, 1993, J BIOL CHEM, V268, P5921; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MACHICAO F, 1987, BIOCHEM J, V243, P797, DOI 10.1042/bj2430797; MARGOLIS RN, 1988, P NATL ACAD SCI USA, V85, P7256, DOI 10.1073/pnas.85.19.7256; MASTICK CC, 1994, ENDOCRINOLOGY, V135, P214, DOI 10.1210/en.135.1.214; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MOLLER DE, 1991, J BIOL CHEM, V266, P10995; MOMOMURA K, 1988, BIOCHEM BIOPH RES CO, V155, P1181, DOI 10.1016/S0006-291X(88)81264-6; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; OHMICHI M, 1993, ENDOCRINOLOGY, V133, P46, DOI 10.1210/en.133.1.46; OHMICHI M, 1992, NEURON, V9, P769, DOI 10.1016/0896-6273(92)90039-G; OKADA T, 1994, J BIOL CHEM, V269, P3568; OSTEROP APRM, 1992, J BIOL CHEM, V267, P14647; PANG L, 1993, BIOCHEM BIOPH RES CO, V196, P301, DOI 10.1006/bbrc.1993.2249; PANG L, 1994, J BIOL CHEM, V269, P10604; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; REESJONES RW, 1985, J BIOL CHEM, V260, P4461; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SALTIEL AR, 1990, DIABETES CARE, V13, P244, DOI 10.2337/diacare.13.3.244; SALTIEL AR, 1994, FASEB J, V8, P1034, DOI 10.1096/fasebj.8.13.7926368; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SEDOUL JC, 1985, BIOCHEM J, V227, P887; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAKATA Y, 1992, J BIOL CHEM, V267, P9065; TAKATA Y, 1991, J BIOL CHEM, V266, P9135; TOBE K, 1993, J BIOL CHEM, V268, P11167; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; WATERS SB, 1993, J BIOL CHEM, V268, P22231; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	58	148	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3442	3446		10.1074/jbc.270.7.3442	http://dx.doi.org/10.1074/jbc.270.7.3442			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852430	hybrid			2022-12-27	WOS:A1995QG47100082
J	XIAO, JH; DURAND, B; CHAMBON, P; VOORHEES, JJ				XIAO, JH; DURAND, B; CHAMBON, P; VOORHEES, JJ			ENDOGENOUS RETINOIC-ACID RECEPTOR (RAR) RETINOID-X RECEPTOR (RXR) HETERODIMERS ARE THE MAJOR FUNCTIONAL FORMS REGULATING RETINOID-RESPONSIVE ELEMENTS IN ADULT HUMAN KERATINOCYTES - BINDING OF LIGANDS TO RAR ONLY IS SUFFICIENT FOR RAR-RXR HETERODIMERS TO CONFER LIGAND-DEPENDENT ACTIVATION OF HRAR-BETA-2/RARE (DR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE; HUMAN SKIN; TERMINAL DIFFERENTIATION; TOPICAL TRETINOIN; NUCLEAR RECEPTORS; PHOTODAMAGED SKIN; DIRECT REPEAT; BETA-GENE; VITAMIN-D; MOUSE	We have examined how retinoic acid receptors (RARs) and retinoid X receptors (RXRs) at physiological concentrations regulate distinct retinoid-responsive elements, hRAR beta 2/beta RARE (DR5) and rCRBPII/RXRE (DR1), in keratinocytes from human skin, a major retinoid target. In vitro, endogenous RAR gamma and RXRs bound to these elements as heterodimers (RAR-RXR) but not homodimers (RAR.RAR or RXR.RXR). In cultured keratinocytes, all-trans retinoic acid, 9-cis retinoic acid, and CD367 activated beta RARE but not RXRE via endogenous RAR.RXR (ED(50) = 2.3, 3.8, and 0.3 nM respectively) whereas SR11237 showed no significant effect. All-trans retinoic acid, 9-cis retinoic acid, and SR11237 activated RXRE via overexpressed RXR.RXR (ED(50) = 110, 120, and 11 nM, respectively), indicating interconversion between retinoic acid isomers, whereas co-overexpression of RAR alpha or RAR gamma suppressed this activation. Unlike 9cRA, CD367 neither induced formation of nor activated RXR.RXR. Overexpression of RAR or RXR mutated in transactivation domain AF-2 suppressed endogenous receptor activity over beta RARE. Our data suggest that 1) in keratinocytes, RAR.RXR-mediated pathway dominates over that mediated by RXR.RXR; 2) RAR-selective CD367 and RXR-selective SR11237 can be used to identify these two distinct pathways, respectively; 3) beta RARE is mainly regulated by RAR.RXR, in which RAR alone confers ligand inducibility whereas AF-2 of unliganded RXR is required for transactivation by liganded RAR AF-2; 4) lack of RXRE activity in keratinocytes is due to low endogenous levels of RXR.RXR and inhibition by RAR.RXR; and 5) interaction among RXRs is much lower than that between RAR and RXR.	INST GENET & BIOL MOLEC & CELLULAIRE,GENET MOLEC EUCARYOTES LAB,CNRS,INSERM,U184,F-67404 ILLKIRCH GRAFFENS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	XIAO, JH (corresponding author), UNIV MICHIGAN,DEPT DERMATOL,KRESGE I,RM 6558,1301 E CATHERINE ST,ANN ARBOR,MI 48109, USA.		DURAND, Beatrice C/J-6387-2015; Voorhees, John/AAM-9966-2020	DURAND, Beatrice C/0000-0002-0047-288X; Voorhees, John/0000-0003-1856-785X				ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; ANESKIEVICH BJ, 1992, MOL CELL BIOL, V12, P4862, DOI 10.1128/MCB.12.11.4862; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; BOYCE ST, 1986, IN VITRO MODELS CANC, V3, P245; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BULENGORANSBY SM, 1993, NEW ENGL J MED, V328, P1438, DOI 10.1056/NEJM199305203282002; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; ELDER JT, 1992, J INVEST DERMATOL, V98, P673, DOI 10.1111/1523-1747.ep12499896; ELDER JT, 1991, J INVEST DERMATOL, V96, P425, DOI 10.1111/1523-1747.ep12469889; ELDER JT, 1992, J INVEST DERMATOL, V98, pS36, DOI 10.1111/1523-1747.ep12462180; FISCHER GJ, 1994, J BIOL CHEM, V269, P20629; FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0; GENDIMENICO GJ, 1994, J INVEST DERMATOL, V102, P676, DOI 10.1111/1523-1747.ep12374092; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KASTNER P, 1990, P NATL ACAD SCI USA, V87, P2700, DOI 10.1073/pnas.87.7.2700; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOPAN R, 1987, J CELL BIOL, V105, P427, DOI 10.1083/jcb.105.1.427; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEIDM, 1902, CELL, V68, P377; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; MADER S, 1993, J BIOL CHEM, V268, P591; MANGELSDORF DJ, 1993, RECENT PROG HORM RES, V48, P99; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MARTIN B, 1992, SKIN PHARMACOL, V5, P57; MENDELSOHN C, 1994, MECH DEVELOP, V45, P227, DOI 10.1016/0925-4773(94)90010-8; NAGPAL S, 1993, EMBO J, V2, P2349; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; OLSEN EA, 1992, J AM ACAD DERMATOL, V26, P215, DOI 10.1016/0190-9622(92)70030-J; PECK GL, 1994, RETINOIDS BIOL CHEM, P209; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PREDKI PF, 1994, MOL ENDOCRINOL, V8, P31, DOI 10.1210/me.8.1.31; RAFAL ES, 1992, NEW ENGL J MED, V326, P368, DOI 10.1056/NEJM199202063260603; REDFERN CPF, 1992, J CELL SCI, V102, P113; ROCHETTEEGLY C, 1991, J CELL BIOL, V115, P535, DOI 10.1083/jcb.115.2.535; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; RUBERTE E, 1990, DEVELOPMENT, V108, P213; RUBERTE E, 1991, DEVELOPMENT, V111, P45; SAMBROOK J, 1989, MOL CLONING LAORATOR; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; TATE BF, 1994, MOL CELL BIOL, V14, P2323, DOI 10.1128/MCB.14.4.2323; UNDERHILL TM, 1994, MOL ENDOCRINOL, V8, P274, DOI 10.1210/me.8.3.274; VOLLBERG TM, 1992, MOL ENDOCRINOL, V6, P667, DOI 10.1210/mend.6.5.1318502; VOORHEES JJ, 1972, ARCH DERMATOL, V105, P695, DOI 10.1001/archderm.105.5.695; WEINSTEIN GD, 1991, ARCH DERMATOL, V127, P659, DOI 10.1001/archderm.127.5.659; XIAO JH, 1987, EMBO J, V6, P3005, DOI 10.1002/j.1460-2075.1987.tb02606.x; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; ZELENT A, 1991, EMBO J, V10, P71, DOI 10.1002/j.1460-2075.1991.tb07922.x; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG XK, 1994, MOL CELL BIOL, V14, P4311, DOI 10.1128/MCB.14.6.4311; ZHANG XK, 1993, RECEPTOR, V3, P183; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	73	84	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3001	3011		10.1074/jbc.270.7.3001	http://dx.doi.org/10.1074/jbc.270.7.3001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852380	Green Submitted			2022-12-27	WOS:A1995QG47100020
J	DAVIS, CM; BUSTAMANTE, PL; LOACH, PA				DAVIS, CM; BUSTAMANTE, PL; LOACH, PA			RECONSTITUTION OF THE BACTERIAL CORE LIGHT-HARVESTING COMPLEXES OF RHODOBACTER-SPHAEROIDES AND RHODOSPIRILLUM-RUBRUM WITH ISOLATED ALPHA-POLYPEPTIDES AND BETA-POLYPEPTIDES, BACTERIOCHLOROPHYLL-A, AND CAROTENOID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT-PROTEIN COMPLEXES; PURPLE PHOTOSYNTHETIC BACTERIA; RAMAN-SCATTERING SPECTROSCOPY; AMINO-ACID-SEQUENCE; RHODOPSEUDOMONAS-SPHAEROIDES; ENERGY-TRANSFER; REACTION CENTERS; RESONANCE RAMAN; CIRCULAR-DICHROISM; STRUCTURAL SUBUNIT	Methodology has been developed to reconstitute carotenoids and bacteriochlorophyll a with isolated light-harvesting complex I (LHI) polypeptides of both Rhodobacter sphaeroides and Rhodospirillum rubrum, Reconstitution techniques first developed in this laboratory using the LHI polypeptides of R. rubrum, R. sphaeroides, and Rhodobacter capsulatus reproduced bacteriochlorophyll a spectral properties characteristic of LHI complexes lacking carotenoids. In this study, carotenoids are supplied either as organic-solvent extracts of chromatophores or as thin-layer chromatography or high performance liquid chromatography-purified species. The resulting LHI complexes exhibit carotenoid and bacteriochlorophyll a spectral properties characteristic of native LHI complexes of carotenoid-containing bacteria. Absorption and circular dichroism spectra support the attainment of a native-like carotenoid environment in the reconstituted LHI complexes. For both R. sphaeroides- and R. rubrum-reconstituted systems, fluorescence excitation spectra reveal appropriate carotenoid to bacteriochlorophyll a energy-transfer efficiencies based on comparisons with the in vivo systems. In the case of R, rubrum reconstitutions, carotenoids afford protection from photodynamic degradation. Thus, carotenoids reconstituted into LHI exhibit spectral and functional characteristics associated with native pigments. Heterologous reconstitutions demonstrate the applicability of the developed assay in dissecting the molecular environment of carotenoids in Light-harvesting complexes.	NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC BIOL & CELL BIOL,EVANSTON,IL 60208	Northwestern University					NIGMS NIH HHS [GM 11741] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGALIDIS I, 1980, BIOCHIM BIOPHYS ACTA, V589, P264, DOI 10.1016/0005-2728(80)90043-2; ANDERSSON PO, 1991, PHOTOCHEM PHOTOBIOL, V54, P353, DOI 10.1111/j.1751-1097.1991.tb02027.x; ANGERHOFER A, 1986, BIOCHIM BIOPHYS ACTA, V848, P333, DOI 10.1016/0005-2728(86)90208-2; BOLT J, 1979, BIOCHIM BIOPHYS ACTA, V546, P54, DOI 10.1016/0005-2728(79)90169-5; BOLT JD, 1981, BIOCHIM BIOPHYS ACTA, V635, P535, DOI 10.1016/0005-2728(81)90112-2; BOLT JD, 1981, PHOTOCHEM PHOTOBIOL, V34, P653, DOI 10.1111/j.1751-1097.1981.tb09418.x; BOUCHER F, 1977, BIOCHIM BIOPHYS ACTA, V461, P339, DOI 10.1016/0005-2728(77)90224-9; BRETON J, 1974, BIOCHEM BIOPH RES CO, V59, P1011, DOI 10.1016/S0006-291X(74)80080-X; BROGLIE RM, 1980, P NATL ACAD SCI-BIOL, V77, P87, DOI 10.1073/pnas.77.1.87; BRUNISHOLZ RA, 1984, H-S Z PHYSIOL CHEM, V365, P675, DOI 10.1515/bchm2.1984.365.2.675; BRUNISHOLZ RA, 1981, FEBS LETT, V129, P150, DOI 10.1016/0014-5793(81)80778-8; BRUNISHOLZ RA, 1992, J PHOTOCH PHOTOBIO B, V15, P113, DOI 10.1016/1011-1344(92)87010-7; BUSTAMANTE PL, 1994, BIOCHEMISTRY-US, V33, P13329, DOI 10.1021/bi00249a020; CHADWICK BW, 1986, BIOCHIM BIOPHYS ACTA, V851, P257, DOI 10.1016/0005-2728(86)90133-7; CHANG MC, 1990, PHOTOCHEM PHOTOBIOL, V52, P873, DOI 10.1111/j.1751-1097.1990.tb08696.x; CHANG MC, 1990, BIOCHEMISTRY-US, V29, P421, DOI 10.1021/bi00454a017; COGDELL RJ, 1981, BIOCHIM BIOPHYS ACTA, V634, P191, DOI 10.1016/0005-2728(81)90138-9; COGDELL RJ, 1987, BIOCHIM BIOPHYS ACTA, V895, P63, DOI 10.1016/S0304-4173(87)80008-3; COGDELL RJ, 1978, BIOCHIM BIOPHYS ACTA, V502, P409, DOI 10.1016/0005-2728(78)90074-9; COGDELL RJ, 1985, PHOTOCHEM PHOTOBIOL, V42, P669, DOI 10.1111/j.1751-1097.1985.tb01629.x; COGDELL RJ, 1976, BIOCHIM BIOPHYS ACTA, V430, P83, DOI 10.1016/0005-2728(76)90224-3; COGDELL RJ, 1992, J PHOTOCH PHOTOBIO B, V15, P105, DOI 10.1016/1011-1344(92)87009-X; COHENBAZIRE G, 1958, NATURE, V181, P250, DOI 10.1038/181250a0; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DAVIDSON E, 1981, BIOCHIM BIOPHYS ACTA, V635, P295, DOI 10.1016/0005-2728(81)90028-1; Davies B., 1976, CAROTENOIDS CHEM BIO, P38, DOI [DOI 10.1590/S0101-20612001000200017, 10.1007/978-3-642-66632-2_11, DOI 10.1007/978-3-642-66632-2_11]; DECOSTER B, 1992, BIOCHIM BIOPHYS ACTA, V1102, P107, DOI 10.1016/0167-4838(92)90504-7; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; DIRKS G, 1980, PHOTOCHEM PHOTOBIOL, V32, P277, DOI 10.1111/j.1751-1097.1980.tb04022.x; DRATZ EA, 1967, BROOKHAVEN SYM BIOL, V19, P303; FRANK HA, 1993, PHOTOCHEM PHOTOBIOL, V57, P49, DOI 10.1111/j.1751-1097.1993.tb02254.x; GILLBRO T, 1993, PHOTOCHEM PHOTOBIOL, V57, P44, DOI 10.1111/j.1751-1097.1993.tb02253.x; GINGRAS G, 1990, P NATL ACAD SCI USA, V87, P3405, DOI 10.1073/pnas.87.9.3405; GODIK VI, 1979, BIOCHIM BIOPHYS ACTA, V548, P296, DOI 10.1016/0005-2728(79)90137-3; GOEDHEER JC, 1959, BIOCHIM BIOPHYS ACTA, V35, P1, DOI 10.1016/0006-3002(59)90328-2; GOODWIN MG, 1993, BIOCHIM BIOPHYS ACTA, V1144, P191, DOI 10.1016/0005-2728(93)90172-C; GOODWIN TW, 1955, BIOCHEM J, V59, P491, DOI 10.1042/bj0590491; GOODWIN TW, 1956, BIOCHEM J, V64, P486, DOI 10.1042/bj0640486; GRIFFITHS M, 1955, NATURE, V176, P1211, DOI 10.1038/1761211a0; GUST D, 1993, PHOTOSYNTHETIC REACT, V2, P419; Hunter CN., 1981, PHOTOSYNTHESIS, V3, P539; IBA K, 1988, J BACTERIOL, V170, P1843, DOI 10.1128/jb.170.4.1843-1847.1988; IWATA K, 1985, BIOCHIM BIOPHYS ACTA, V810, P269, DOI 10.1016/0005-2728(85)90141-0; JIRSAKOVA V, 1993, BIOCHIM BIOPHYS ACTA, V1183, P301, DOI 10.1016/0005-2728(93)90231-4; JONES MR, 1992, MOL MICROBIOL, V6, P1173, DOI 10.1111/j.1365-2958.1992.tb01556.x; KAKITANI T, 1982, BIOPHYS J, V39, P57, DOI 10.1016/S0006-3495(82)84490-1; KLUG G, 1984, ARCH MICROBIOL, V139, P319, DOI 10.1007/BF00408373; KOYAMA Y, 1993, CHEM PHYS LETT, V208, P479, DOI 10.1016/0009-2614(93)87176-4; KOYAMA Y, 1990, PHOTOCHEM PHOTOBIOL, V51, P119, DOI 10.1111/j.1751-1097.1990.tb01692.x; KOYAMA Y, 1982, BIOCHIM BIOPHYS ACTA, V680, P109, DOI 10.1016/0005-2728(82)90001-9; KRAMER HJM, 1984, BIOCHIM BIOPHYS ACTA, V767, P335, DOI 10.1016/0005-2728(84)90204-4; KRINSKY NI, 1979, PURE APPL CHEM, V51, P649, DOI 10.1351/pac197951030649; KUKI M, 1994, PHOTOCHEM PHOTOBIOL, V59, P116; LEE JK, 1989, J BACTERIOL, V171, P3391, DOI 10.1128/jb.171.6.3391-3405.1989; LEUKING DR, 1978, J BIOL CHEM, V253, P451; LOACH PA, 1963, PHOTOCHEM PHOTOBIOL, V2, P443, DOI 10.1111/j.1751-1097.1963.tb08901.x; LOACH PA, 1966, BIOCHEMISTRY-US, V5, P592, DOI 10.1021/bi00866a028; LOACH PA, 1994, PHOTOSYNTH RES, V40, P231, DOI 10.1007/BF00034773; LOZANO RM, 1990, BIOCHEM J, V270, P469, DOI 10.1042/bj2700469; LOZANO RM, 1989, BIOCHIM BIOPHYS ACTA, V976, P196, DOI 10.1016/S0005-2728(89)80230-0; LUTZ M, 1978, BIOCHIM BIOPHYS ACTA, V503, P287, DOI 10.1016/0005-2728(78)90189-5; MEADOWS KA, 1995, BIOCHEMISTRY-US, V34, P1559, DOI 10.1021/bi00005a012; MIGUEL MD, 1989, BIOCHEMISTRY-US, V28, P8921, DOI 10.1021/bi00448a035; MILLER JF, 1987, BIOCHEMISTRY-US, V26, P5055, DOI 10.1021/bi00390a026; NOGUCHI T, 1990, BIOCHIM BIOPHYS ACTA, V1017, P280, DOI 10.1016/0005-2728(90)90194-9; PARKESLOACH PS, 1994, PHOTOSYNTH RES, V40, P247, DOI 10.1007/BF00034774; PARKESLOACH PS, 1990, BIOCHEMISTRY-US, V29, P2951, DOI 10.1021/bi00464a010; PARKESLOACH PS, 1988, BIOCHEMISTRY-US, V27, P2718, DOI 10.1021/bi00408a011; PICOREL R, 1988, J BIOL CHEM, V263, P4374; PICOREL R, 1990, BIOCHEMISTRY-US, V29, P707, DOI 10.1021/bi00455a017; Polgar A., 1944, ARCH BIO CHEM, V5, P243; RICHTER P, 1992, J BACTERIOL, V174, P3030, DOI 10.1128/JB.174.9.3030-3041.1992; SHNEOUR EA, 1962, BIOCHIM BIOPHYS ACTA, V62, P534, DOI 10.1016/0006-3002(62)90235-4; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; SISTROM WR, 1956, J CELL COMPAR PHYSL, V48, P473, DOI 10.1002/jcp.1030480309; STERLING C, 1964, ACTA CRYSTALLOGR, V17, P1224, DOI 10.1107/S0365110X64003152; STURGIS JN, 1988, PHOTOCHEM PHOTOBIOL, V48, P243, DOI 10.1111/j.1751-1097.1988.tb02817.x; SYMONS M, 1983, BIOCHIM BIOPHYS ACTA, V723, P454, DOI 10.1016/0005-2728(83)90052-X; THEILER R, 1984, H-S Z PHYSIOL CHEM, V365, P703, DOI 10.1515/bchm2.1984.365.2.703; THRASH RJ, 1979, PHOTOCHEM PHOTOBIOL, V29, P1049, DOI 10.1111/j.1751-1097.1979.tb07814.x; VANDERREST M, 1974, J BIOL CHEM, V249, P6446; VANGRONDELLE R, 1982, BIOCHIM BIOPHYS ACTA, V682, P208, DOI 10.1016/0005-2728(82)90100-1; VISSCHERS RW, 1992, BIOCHIM BIOPHYS ACTA, V1100, P259, DOI 10.1016/0167-4838(92)90480-2; ZUBER H, 1991, CHLOROPHYLLS, P627; ZURDO J, 1993, BIOCHEM J, V290, P531, DOI 10.1042/bj2900531	85	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5793	5804		10.1074/jbc.270.11.5793	http://dx.doi.org/10.1074/jbc.270.11.5793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890709	hybrid			2022-12-27	WOS:A1995QM94500019
J	MIYOSHI, E; NISHIKAWA, A; IHARA, Y; SAITO, H; UOZUMI, N; HAYASHI, N; FUSAMOTO, H; KAMADA, T; TANIGUCHI, N				MIYOSHI, E; NISHIKAWA, A; IHARA, Y; SAITO, H; UOZUMI, N; HAYASHI, N; FUSAMOTO, H; KAMADA, T; TANIGUCHI, N			TRANSFORMING GROWTH-FACTOR-BETA UP-REGULATES EXPRESSION OF THE N-ACETYLGLYCOSAMINYLTRANSFERASE-V GENE IN MOUSE MELANOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; MESSENGER-RNA STABILITY; HAMSTER-KIDNEY CELLS; HUMAN LYMPHOCYTES-T; ACETYLGLUCOSAMINYLTRANSFERASE-V; PHASEOLUS-VULGARIS; FACTOR-BETA-1; TISSUES; GLYCOPROTEINS; TRANSCRIPTION	beta-1,6-N acetylglucosaminyltransferase V (GnT-V) (EC 2.4.1.155) that catalyzes beta-1,6 branching in asparaginelinked oligosaccharides is activated on viral or oncogenic transformation and is associated with tumor metastasis. To study the molecular mechanisms involved in regulation of expression of the GnT-V gene, we cloned cDNA and genomic DNA for the enzyme (Saito, H., Nishikawa, A., Gu, J., Ihara, Y., Soejima, Y., Sekiya, C., Niikawa, N., and Taniguchi, N. (1994) Biochem. Biophys. Res. Commun. 198, 318-327). We found that transforming growth factor beta (TGF beta) specifically induced GnT-V expression in mouse melanoma cells. The activity of GnT-V was increased 24 h after the addition of TGF beta and remained at high levels up to 72 h. Northern blot analysis showed that the mRNA levels of GnT-V were consistent with the increased activity. To further investigate the nature of the induction, mRNA stability and transcriptional activity were assayed. The enhancement of the GnT-V mRNA expression resulted from prolonged mRNA stability, not from increased transcription. Consequently, elevated mRNA levels were observed even 72 h after the addition of TGF beta. Lectin blot analysis involving leukoagglutinin showed newly synthesized beta-1,6 branching structures in the sugar chains of a protein of approximately 130 kDa at 48 h after TGF beta treatment. These results suggested that TGF beta caused changes in the sugar chains of proteins in melanoma cells by upregulating GnT-V expression.	OSAKA UNIV,SCH MED,DEPT BIOCHEM,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT MED 1,SUITA,OSAKA 565,JAPAN	Osaka University; Osaka University			Nishikawa, Atsushi/E-6766-2013; Taniguchi, Naoyuki/I-4182-2014	Nishikawa, Atsushi/0000-0003-4325-1160; Taniguchi, Naoyuki/0000-0001-5889-5968				ANZANO MA, 1985, MOL CELL BIOL, V5, P242, DOI 10.1128/MCB.5.1.242; ARANGO J, 1988, J CELL BIOCHEM, V37, P225, DOI 10.1002/jcb.240370209; AYANLARBATUMAN O, 1991, J CLIN INVEST, V88, P1574, DOI 10.1172/JCI115469; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DENNIS JW, 1989, CANCER RES, V49, P945; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DERYNCK R, 1987, CANCER RES, V47, P707; DODGE GR, 1990, J BIOL CHEM, V265, P18023; FILDER IJ, 1987, ADV CANCER RES, V28, P149; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; HAHN TJ, 1992, J BIOL CHEM, V267, P23982; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HEFFERNAN M, 1993, J BIOL CHEM, V268, P1242; Herlyn M, 1990, Adv Cancer Res, V54, P213, DOI 10.1016/S0065-230X(08)60812-X; KAHARI VM, 1992, LAB INVEST, V66, P580; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MIYOSHI E, 1993, CANCER RES, V53, P3899; MOORADIAN DL, 1992, J NATL CANCER I, V84, P523, DOI 10.1093/jnci/84.7.523; NEVINS JR, 1987, METHOD ENZYMOL, V152, P238; NEWMAN MJ, 1990, P NATL ACAD SCI USA, V87, P5543, DOI 10.1073/pnas.87.14.5543; NIITSU Y, 1988, BLOOD, V71, P263; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; NISHIURA T, 1990, CANCER RES, V50, P5345; OLSEN AS, 1989, MATRIX, V9, P73, DOI 10.1016/S0934-8832(89)80024-1; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; PIERCE M, 1986, J BIOL CHEM, V261, P772; PITTELKOW MR, 1989, J CELL PHYSIOL, V140, P565, DOI 10.1002/jcp.1041400323; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; RODECK U, 1991, CANCER METAST REV, V10, P89, DOI 10.1007/BF00049407; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; Sambrook J, 1989, MOL CLONING LABORATO; Schwarz LC, 1990, GROWTH FACTORS, V3, P115, DOI 10.3109/08977199009108274; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; STEINER MS, 1992, MOL ENDOCRINOL, V6, P15, DOI 10.1210/me.6.1.15; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; YAMASHITA K, 1985, J BIOL CHEM, V260, P3963	44	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6216	6220		10.1074/jbc.270.11.6216	http://dx.doi.org/10.1074/jbc.270.11.6216			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890758	hybrid			2022-12-27	WOS:A1995QM94500075
J	PALM, L; ANDERSEN, J; RAHBEKNIELSEN, H; HANSEN, TS; KRISTIANSEN, K; HOJRUP, P				PALM, L; ANDERSEN, J; RAHBEKNIELSEN, H; HANSEN, TS; KRISTIANSEN, K; HOJRUP, P			THE PHOSPHORYLATED RIBOSOMAL-PROTEIN S7 IN TETRAHYMENA IS HOMOLOGOUS WITH MAMMALIAN S4 AND THE PHOSPHORYLATED RESIDUES ARE LOCATED IN THE C-TERMINAL REGION - STRUCTURAL CHARACTERIZATION OF PROTEINS SEPARATED BY 2-DIMENSIONAL POLYACRYLAMIDE-GEL ELECTROPHORESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; RAT-LIVER RIBOSOMES; PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID-SEQUENCE; S6 PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; CROSS-LINKING; 3T3 CELLS; IDENTIFICATION; PEPTIDES	A single basic ribosomal protein, protein S7, can be multiply phosphorylated in the ciliated protozoan Tetrahymena. Induction of phosphorylation is highly regulated, and the phosphorylation proceeds in a strictly sequential manner. The first site to be phosphorylated is a serine residue and the second a threonine. In this paper we report the complete primary structure of Tetrahymena thermophila ribosomal protein S7 including identification of the phosphorylated serine and threonine residues. Most of the sequence information was obtained from peptides generated by in situ digestion of S7 in two-dimensional gels using an approach that combined traditional protein chemistry with mass spectrometry. T. thermophila ribosomal protein S7 has a molecular mass of 29,459 Da and contains 259 amino acid residues. Phosphorylation takes place on Ser(258) and Thr(248) in the C-terminal region of the protein. Alignment of T. thermophila ribosomal protein S7 with known ribosomal proteins yielded the surprising result that T. thermophila 57 is homologous, not with mammalian ribosomal protein S6, but with mammalian ribosomal protein S4. These findings clearly distinguish the pattern of phosphorylation of ribosomal proteins in Tetrahymena from all other eukaryotes analyzed to date.	ODENSE UNIV,DEPT MOLEC BIOL,DK-5230 ODENSE M,DENMARK	University of Southern Denmark			Højrup, Peter/ABG-8477-2020; Kristiansen, Karsten/J-5148-2014; Andersen, Jens S/L-2100-2015	Kristiansen, Karsten/0000-0002-6024-0917; Andersen, Jens S/0000-0002-6091-140X; Hojrup, Peter/0000-0002-7838-6180				BANDI HR, 1993, J BIOL CHEM, V268, P4530; BOMMER UA, 1980, FEBS LETT, V111, P171, DOI 10.1016/0014-5793(80)80785-X; BRATHOLM PS, 1986, THESIS U ODENSE; BYLUND DB, 1976, ANAL BIOCHEM, V73, P477, DOI 10.1016/0003-2697(76)90197-4; CHOLI T, 1989, J CHROMATOGR, V476, P59, DOI 10.1016/S0021-9673(01)93856-7; CUNY M, 1985, J CELL PHYSIOL, V124, P349, DOI 10.1002/jcp.1041240227; DREISIG H, 1984, EUR J BIOCHEM, V140, P469, DOI 10.1111/j.1432-1033.1984.tb08126.x; FERRARI S, 1991, J BIOL CHEM, V266, P22770; GHRIST BFD, 1990, HPLC BIOL MACROMOLEC, P403; HALL SC, 1993, P NATL ACAD SCI USA, V90, P1927, DOI 10.1073/pnas.90.5.1927; HALLBERG RL, 1981, CELL, V26, P47, DOI 10.1016/0092-8674(81)90032-5; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JOHNSON GP, 1986, ANAL CHEM, V58, P1084; JOHNSON SP, 1987, MOL CELL BIOL, V7, P1338, DOI 10.1128/MCB.7.4.1338; KARWAN R, 1988, J PROTEIN CHEM, V7, P244; KAWASAKI H, 1990, ANAL BIOCHEM, V186, P264, DOI 10.1016/0003-2697(90)90077-M; KAWASAKI H, 1990, ANAL BIOCHEM, V191, P332, DOI 10.1016/0003-2697(90)90227-Z; KRIEG J, 1988, J BIOL CHEM, V263, P11473; KRISTIANSEN K, 1978, EUR J BIOCHEM, V83, P395, DOI 10.1111/j.1432-1033.1978.tb12105.x; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; LEER RJ, 1982, NUCLEIC ACIDS RES, V10, P5869, DOI 10.1093/nar/10.19.5869; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; MARTINPEREZ J, 1983, P NATL ACAD SCI-BIOL, V80, P926, DOI 10.1073/pnas.80.4.926; MARVALDI J, 1977, BIOCHEMISTRY-US, V16, P4320, DOI 10.1021/bi00638a030; MIKKELSEN J, 1987, BIOCHEM J, V245, P857, DOI 10.1042/bj2450857; NYGARD O, 1982, EMBO J, V1, P357, DOI 10.1002/j.1460-2075.1982.tb01174.x; Palm Lisbeth, 1993, NATO ASI (Advanced Science Institute) Series Series H Cell Biology, V76, P321; PLOUG M, 1989, ANAL BIOCHEM, V181, P33, DOI 10.1016/0003-2697(89)90390-4; ROACH PJ, 1991, METHOD ENZYMOL, V201, P202; TERAO K, 1979, J BIOCHEM-TOKYO, V86, P605, DOI 10.1093/oxfordjournals.jbchem.a132564; THOMAS G, 1980, CELL, V19, P1015, DOI 10.1016/0092-8674(80)90092-6; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; UCHIUMI T, 1986, J BIOL CHEM, V261, P9663; VANONI M, 1991, EUR J CELL BIOL, V55, P179; WARD LD, 1990, J CHROMATOGR, V519, P199, DOI 10.1016/0021-9673(90)85148-O; WELINDER BS, 1991, J CHROMATOGR, V537, P181, DOI 10.1016/S0021-9673(01)88894-4; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443	37	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6000	6005		10.1074/jbc.270.11.6000	http://dx.doi.org/10.1074/jbc.270.11.6000			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890730	hybrid			2022-12-27	WOS:A1995QM94500045
J	WARNER, GJ; STOUDT, G; BAMBERGER, M; JOHNSON, WJ; ROTHBLAT, GH				WARNER, GJ; STOUDT, G; BAMBERGER, M; JOHNSON, WJ; ROTHBLAT, GH			CELL TOXICITY INDUCED BY INHIBITION OF ACYL-COENZYME A-CHOLESTEROL ACYLTRANSFERASE AND ACCUMULATION OF UNESTERIFIED CHOLESTEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; MACROPHAGE FOAM CELLS; ATHEROSCLEROTIC LESIONS; CULTURED-CELLS; ESTER CYCLE; COA; METABOLISM; ESTERIFICATION; CYTOTOXICITY; FIBROBLASTS	Considerable evidence supports the involvement of acyl-CoA:cholesterol acyltransferase (ACAT) in the maintenance of intracellular cholesterol homeostasis, A number of recently developed ACAT inhibitors may have potential use as pharmacological agents to reduce the development of atherosclerosis, Recently, however, reports arose describing cytotoxic effects following administration of a specific ACAT inhibitor to experimental animals, In order to address the specific intracellular mechanisms involved with the cytotoxic effect, we examined the consequences of ACAT inhibition in cholesterol-enriched mouse peritoneal macrophages, Mouse peritoneal macrophages were cholesterol-enriched by incubation with acetylated low density lipoprotein and free cholesterol:phospholipid dispersions prior to the addition of an ACAT inhibitor, either Sandoz 58-035 or Pfizer CP-113,818, The adenine pool of the macrophages was radiolabeled prior to addition of the ACAT inhibitors, in order to monitor the release of radiolabeled adenine, a technique shown to be a sensitive method to monitor drug-induced toxicity, The ACAT inhibitors were added for up to 48 h and at concentrations up to 2 mu g/ml, These conditions resulted in an approximately a-fold increase in adenine release, The increase in cell toxicity paralleled an increase in the cellular free cholesterol content, Reducing the cellular free cholesterol content, by the addition of extracellular accepters, decreased the cytotoxic effects of the ACAT inhibitors, Addition of an intracellular cholesterol transport inhibitor, either progesterone or U18666A, together with CP-113,818 blocked the toxic effect of CP-113,818, These results suggest that ACAT inhibition of cholesterol-enriched macrophages increases cell toxicity due to the buildup of cellular free cholesterol, Removal of free cholesterol by the addition of extracellular cholesterol accepters or by blocking intracellular sterol transport relieves the ACAT inhibitor-induced toxicity.	MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129; PFIZER INC,CENT RES,GROTON,CT 06340	Drexel University; Pfizer					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007443, P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07443, HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELMAN SJ, 1984, J BIOL CHEM, V259, P3844; ARBOGAST LY, 1976, P NATL ACAD SCI USA, V73, P3680, DOI 10.1073/pnas.73.10.3680; BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BERNARD DW, 1990, ARTERIOSCLEROSIS, V10, P135, DOI 10.1161/01.ATV.10.1.135; BOCAN TMA, 1993, ATHEROSCLEROSIS, V99, P175, DOI 10.1016/0021-9150(93)90020-U; BROWN BG, 1993, CIRCULATION, V87, P1781, DOI 10.1161/01.CIR.87.6.1781; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; CARR TP, 1995, J LIPID RES, V36, P25; CIANFLONE KM, 1990, J LIPID RES, V31, P2045; CONSTANTINIDES P, 1966, J ATHEROSCLER RES, V61, P1; DOMINICK MA, 1993, TOXICOL PATHOL, V21, P54, DOI 10.1177/019262339302100107; DOMINICK MA, 1993, FUND APPL TOXICOL, V20, P217, DOI 10.1006/faat.1993.1029; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; Hatch F T, 1968, Adv Lipid Res, V6, P1; ISHIKAWA TT, 1974, J LIPID RES, V15, P286; LANGE Y, 1994, J BIOL CHEM, V269, P3411; LENDON CL, 1991, ATHEROSCLEROSIS, V87, P87, DOI 10.1016/0021-9150(91)90235-U; LISCUM L, 1989, J BIOL CHEM, V264, P11796; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCLOSKEY HM, 1987, BIOCHIM BIOPHYS ACTA, V921, P320, DOI 10.1016/0005-2760(87)90033-6; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; MIDDLETON B, 1987, BIOCHEM BIOPH RES CO, V145, P350, DOI 10.1016/0006-291X(87)91328-3; REID VC, 1992, ATHEROSCLEROSIS, V92, P251, DOI 10.1016/0021-9150(92)90285-O; ROSS AC, 1984, J BIOL CHEM, V259, P815; ROTHBLAT GH, 1982, J BIOL CHEM, V257, P4775; SHIRATORI Y, 1994, J BIOL CHEM, V269, P11337; SHIRHATTI V, 1985, ANAL BIOCHEM, V147, P410, DOI 10.1016/0003-2697(85)90290-8; SLISKOVIC DR, 1991, TRENDS PHARMACOL SCI, V12, P194, DOI 10.1016/0165-6147(91)90546-5; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SUCKLING KE, 1985, J LIPID RES, V26, P647; TANAKA H, 1994, ATHEROSCLEROSIS, V107, P187, DOI 10.1016/0021-9150(94)90020-5; VERNETTI LA, 1993, TOXICOL APPL PHARM, V118, P30, DOI 10.1006/taap.1993.1005; YANCEY PG, 1991, ARTERIOSCLER THER, V12, P1291	41	227	230	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5772	5778		10.1074/jbc.270.11.5772	http://dx.doi.org/10.1074/jbc.270.11.5772			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890706	hybrid			2022-12-27	WOS:A1995QM94500016
J	WEI, CL; MACMILLAN, SE; HERSHEY, JWB				WEI, CL; MACMILLAN, SE; HERSHEY, JWB			PROTEIN-SYNTHESIS INITIATION-FACTOR EIF-1A IS A MODERATELY ABUNDANT RNA-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; TRANSLATIONAL CONTROL; RABBIT RETICULOCYTES; EXPRESSION; CELLS; PHOSPHORYLATION; MECHANISM; SEQUENCES; CLONING; SUBUNIT	Eukaryotic initiation factor (eIF) 1A (formerly called eIF-4C) is a small protein that promotes dissociation of 80 S ribosomes into subunits, stabilizes methionyl-tRNA binding to 40 S ribosomal subunits, and is required for the binding of mRNA to ribosomes. The sequence of eIF-1A derived from its cloned cDNA possesses a high frequency of basic residues and acidic residues at its N and C termini, respectively. Northwestern blotting with a fragment of mRNA indicates that eIF-1A binds RNA. Overexpression of the human eIF-1A cDNA in Escherichia coli and subsequent purification enabled us to prepare large quantities of active factor. The level of eIF-1A in HeLa cells determined by Western immunoblotting is 0.01% of total protein, which corresponds to 0.2 molecules of eIF-1A/ribosome. The moderate abundance means that eIF-1A is equal to or in excess of native 40 S subunits and suggests that the factor may not be limiting for protein synthesis, a conclusion reinforced by the failure of overproduced eIF-1A to stimulate translation rates in transiently transfected COS-1 cells. S1 nuclease protection and primer extension analyses show that eIF-1A mRNA possesses an unusually long 5'-untranslated leader that is very G/C-rich (72%), Unexpectedly, the mRNA is efficiently translated in HeLa cells as judged by polysome profile analyses.	UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	University of California System; University of California Davis					NIGMS NIH HHS [GM22135] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022135] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNE R, 1978, J BIOL CHEM, V253, P3078; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; DEVER TE, 1994, J BIOL CHEM, V269, P3212; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; DUNCAN R, 1987, J BIOL CHEM, V262, P380; ERNST H, 1987, J BIOL CHEM, V262, P1206; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Maniatis T., 1982, MOL CLONING; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MILBURN SC, 1990, EMBO J, V9, P2783, DOI 10.1002/j.1460-2075.1990.tb07466.x; SMITMCBRIDE Z, 1989, J BIOL CHEM, V264, P18527; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THOMAS A, 1979, EUR J BIOCHEM, V98, P329, DOI 10.1111/j.1432-1033.1979.tb13192.x; THOMAS A, 1980, EUR J BIOCHEM, V107, P39, DOI 10.1111/j.1432-1033.1980.tb04621.x; THOMAS AAM, 1981, FEBS LETT, V128, P177, DOI 10.1016/0014-5793(81)80076-2; TIMMER RT, 1993, J BIOL CHEM, V268, P24863; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	25	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5764	5771		10.1074/jbc.270.11.5764	http://dx.doi.org/10.1074/jbc.270.11.5764			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890705				2022-12-27	WOS:A1995QM94500015
J	ZHAO, JM; LAST, RL				ZHAO, JM; LAST, RL			IMMUNOLOGICAL CHARACTERIZATION AND CHLOROPLAST LOCALIZATION OF THE TRYPTOPHAN BIOSYNTHETIC-ENZYMES OF THE FLOWERING PLANT ARABIDOPSIS-THALIANA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE-BETA-SUBUNIT; AROMATIC AMINO-ACIDS; SPINACH-CHLOROPLASTS; ESCHERICHIA-COLI; ANTHRANILATE SYNTHASE; MUTANTS; GENE; PURIFICATION; TRANSFERASE; RESISTANT	In order to study the tryptophan biosynthetic enzymes of the plant Arabidopsis thaliana, polyclonal antibodies were raised against five of the tryptophan biosynthetic pathway proteins: anthranilate synthase a subunit, phosphoribosylanthranilate transferase, phosphoribosylanthranilate isomerase, and the tryptophan synthase alpha and beta subunits. Immunoblot analysis of Arabidopsis leaf protein extracts revealed that the antibodies identify the corresponding proteins that are enriched in Arabidopsis chloroplast fractions. Precursors of phosphoribosylanthranilate isomerase and tryptophan synthase alpha subunit were synthesized by in vitro translation. The precursors were efficiently imported and processed by isolated spinach chloroplasts, and the cleavage sites within the precursors were determined. These results provide the first direct evidence that the tryptophan biosynthetic enzymes from Arabidopsis are synthesized as higher molecular weight precursors and then imported into chloroplasts and processed into their mature forms.	CORNELL UNIV,GENET & DEV SECT,ITHACA,NY 14853	Cornell University	ZHAO, JM (corresponding author), CORNELL UNIV,BOYCE THOMPSON INST PLANT RES,TOWER RD,ITHACA,NY 14853, USA.		Last, Robert L/D-9197-2011	Last, Robert/0000-0001-6974-9587	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043134, R01GM043134] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43134] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F. M., 1993, CURRENT PROTOCOLS MO, V1; BERLYN MB, 1989, P NATL ACAD SCI USA, V86, P4604, DOI 10.1073/pnas.86.12.4604; BERNASCONI P, 1994, PLANT PHYSIOL, V106, P353, DOI 10.1104/pp.106.1.353; BICKEL H, 1978, PHYTOCHEMISTRY, V17, P119, DOI 10.1016/S0031-9422(00)89691-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HERRMANN KM, 1991, NATO ADV SCI I A-LIF, V212, P729; HINNEBUSCH AG, 1992, MOL CELLULAR BIOL YE, V2, P321; KREPS JA, 1992, PLANT PHYSIOL, V99, P269, DOI 10.1104/pp.99.1.269; LAST RL, 1991, PLANT CELL, V3, P345, DOI 10.1105/tpc.3.4.345; LAST RL, 1988, SCIENCE, V240, P305, DOI 10.1126/science.240.4850.305; LI J, 1995, IN PRESS PLANT PHYSL; MISHKIND ML, 1987, METHOD ENZYMOL, V148, P274; NIYOGI KK, 1993, PLANT CELL, V5, P1011, DOI 10.1105/tpc.5.9.1011; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; ROSE AB, 1992, PLANT PHYSIOL, V100, P582, DOI 10.1104/pp.100.2.582; ROSE AB, 1994, ARABIDOPSIS, P835; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; SCHULZESIEBERT D, 1989, PLANT SCI, V59, P167, DOI 10.1016/0168-9452(89)90134-9; SINGH B, 1992, PLANT PHYSIOL, V99, P812, DOI 10.1104/pp.99.3.812; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; WEAVER LM, 1993, BIOORG MED CHEM LETT, V3, P1421, DOI 10.1016/S0960-894X(01)80423-6; YANOFSKY C, 1987, ESCHERICHIA COLI SAL, V2, P1453	25	58	78	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6081	6087		10.1074/jbc.270.11.6081	http://dx.doi.org/10.1074/jbc.270.11.6081			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890741	hybrid			2022-12-27	WOS:A1995QM94500057
J	LAZO, JS; KONDO, Y; DELLAPIAZZA, D; MICHALSKA, AE; CHOO, KHA; PITT, BR				LAZO, JS; KONDO, Y; DELLAPIAZZA, D; MICHALSKA, AE; CHOO, KHA; PITT, BR			ENHANCED SENSITIVITY TO OXIDATIVE STRESS IN CULTURED EMBRYONIC-CELLS FROM TRANSGENIC MICE DEFICIENT IN METALLOTHIONEIN-I AND METALLOTHIONEIN-II GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; SUPEROXIDE-DISMUTASE; RENDERED RESISTANT; ANTICANCER DRUGS; CADMIUM; EXPRESSION; VITRO; DNA; GLUTATHIONE; INDUCTION	Embryonic cells from transgenic mice with targeted disruption of metallothionein I and II genes expressed no detectable metallothionein either constitutively or after treatment with cadmium, in contrast to cultured cells that were wild type or heterozygous for the loss of the metallothionein genes. Metallothionein null cells were most sensitive to the cytotoxic effects of cadmium, the membrane permeant oxidant tert-butylhydroperoxide, and the redox cycling toxin paraquat. No marked differences were seen among the wild type, heterozygous, or metallothionein null cells in glutathione levels or in the activity of CuZn-superoxide dismutase, glutathione peroxidase, or catalase. Nevertheless, metallothionein null cells were more sensitive to tert-butylhydroperoxide-induced oxidation as ascertained by confocal microscopic imaging of dichlorofluoroscein fluorescence. These results indicate basal metallothionein levels can function to regulate intracellular redox status in mammalian cells.	ROYAL CHILDRENS HOSP,MURDOCH INST RES BIRTH DEFECTS,MELBOURNE,VIC 3052,AUSTRALIA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	LAZO, JS (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,E1340 BIOMED SCI TOWER,PITTSBURGH,PA 15261, USA.				NCI NIH HHS [CA 66197] Funding Source: Medline; NHLBI NIH HHS [HL 32154] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032154] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASU A, 1990, TOXICOL LETT, V50, P123, DOI 10.1016/0378-4274(90)90002-4; BAUMAN JW, 1991, TOXICOL APPL PHARM, V110, P647; CHUBATSU LS, 1992, CHEM-BIOL INTERACT, V82, P99, DOI 10.1016/0009-2797(92)90017-F; CHUBATSU LS, 1993, BIOCHEM J, V291, P193, DOI 10.1042/bj2910193; DE SK, 1990, J BIOL CHEM, V265, P15267; Gunzler WA, 1985, CRC HDB METHODS OXYG, P285; HAINAUT P, 1993, CANCER RES, V53, P4469; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HART BA, 1990, TOXICOL APPL PHARM, V103, P255, DOI 10.1016/0041-008X(90)90228-M; HARVEY M, 1993, ONCOGENE, V8, P2457; HIDLAGO J, 1988, AM J PHYSIOL, V255, pE518; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KAINA B, 1990, P NATL ACAD SCI USA, V87, P2710, DOI 10.1073/pnas.87.7.2710; KARIN M, 1985, CELL, V41, P9, DOI 10.1016/0092-8674(85)90051-0; KELLEY SL, 1988, SCIENCE, V241, P1813, DOI 10.1126/science.3175622; KOROPATNICK J, 1993, MOL PHARMACOL, V44, P44; KOROPATNICK J, 1989, RADIAT RES, V119, P356, DOI 10.2307/3577626; KUO SM, 1994, TOXICOL APPL PHARM, V125, P104, DOI 10.1006/taap.1994.1054; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; LEIBBRANDT MEI, 1994, CELL GROWTH DIFFER, V5, P17; LEYSHONSORLAND K, 1993, CANCER RES, V53, P4874; MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V269, P390, DOI 10.1016/0003-9861(89)90122-7; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MELLOFILHO AC, 1988, BIOCHEM J, V256, P475, DOI 10.1042/bj2560475; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; MURPHY BJ, 1994, CANCER RES, V54, P5808; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SCHROEDER JJ, 1990, P NATL ACAD SCI USA, V87, P3137, DOI 10.1073/pnas.87.8.3137; SCHWARZ MA, 1994, J BIOL CHEM, V269, P15238; SPERANZA MJ, 1993, J BIOL CHEM, V268, P19039; TAMAI KT, 1993, P NATL ACAD SCI USA, V90, P8013, DOI 10.1073/pnas.90.17.8013; THOMAS JP, 1986, BIOCHIM BIOPHYS ACTA, V884, P448, DOI 10.1016/0304-4165(86)90195-9; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; VENESSMEEHAN KA, 1991, AM J RESP CELL MOL, V5, P516, DOI 10.1165/ajrcmb/5.6.516; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y	38	289	297	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5506	5510		10.1074/jbc.270.10.5506	http://dx.doi.org/10.1074/jbc.270.10.5506			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890668	hybrid			2022-12-27	WOS:A1995QL58000084
J	MANNO, S; TAKAKUWA, Y; NAGAO, K; MOHANDAS, N				MANNO, S; TAKAKUWA, Y; NAGAO, K; MOHANDAS, N			MODULATION OF ERYTHROCYTE-MEMBRANE MECHANICAL FUNCTION BY BETA-SPECTRIN PHOSPHORYLATION AND DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; INDUCED SHAPE CHANGES; RED-CELL; CASEIN KINASE; CYTOSKELETAL PROTEINS; SKELETAL PROTEINS; SELF-ASSOCIATION; PLASMA-MEMBRANE; OKADAIC ACID; 4.1 BINDING	The mechanical properties of human erythrocyte membrane are largely regulated by submembranous protein skeleton whose principal components are alpha- and beta-spectrin, actin, protein 4.1, adducin, and dematin, All of these proteins, except for actin, are phosphorylated by various kinases present in the erythrocyte. In vitro studies with purified skeletal proteins and various kinases has shown that while phosphorylation of these proteins can modify some of the binary and ternary protein interactions, it has no effect on certain other interactions between these proteins. Most importantly, at present there is no direct evidence that phosphorylation of skeletal protein(s) alters the function of the intact membrane. To explore this critical issue, we have developed experimental strategies to determine the functional consequences of phosphorylation of beta-spectrin on mechanical properties of intact erythrocyte membrane. We have been able to document that membrane mechanical stability is exquisitely regulated by phosphorylation of beta-spectrin by membrane-bound casein kinase I. Increased phosphorylation of beta-spectrin decreases membrane mechanical stability while decreased phosphorylation increases membrane mechanical stability. Our data for the first time demonstrate that phosphorylation of a skeletal protein in situ can modulate physiological function of native erythrocyte membrane.	UNIV CALIF BERKELEY, DIV LIFE SCI, LAWRENCE BERKELEY LAB, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	MANNO, S (corresponding author), TOKYO WOMENS MED COLL, DEPT BIOCHEM, SHINJUKU KU, 8-1 KAWADA CHO, TOKYO 162, JAPAN.				NIDDK NIH HHS [DK26263] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON JM, 1980, J BIOL CHEM, V255, P1259; ANDERSON JM, 1979, J BIOL CHEM, V254, P939; AVRUCH J, 1974, BIOCHEMISTRY-US, V13, P5507, DOI 10.1021/bi00724a009; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BESSIS N, 1977, BLOOD CELLS BERL, V3, P209; BIRCHMEIER W, 1977, J CELL BIOL, V73, P647, DOI 10.1083/jcb.73.3.647; BOIVIN P, 1980, BIOCHEM BIOPH RES CO, V93, P24, DOI 10.1016/S0006-291X(80)80240-3; BOIVIN P, 1981, BIOCHIM BIOPHYS ACTA, V647, P1, DOI 10.1016/0005-2736(81)90289-3; BRENNER SL, 1979, J BIOL CHEM, V254, P8620; CHAO TS, 1991, BIOCHEMISTRY-US, V30, P10529, DOI 10.1021/bi00107a023; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CLARI G, 1981, BIOCHIM BIOPHYS ACTA, V640, P240, DOI 10.1016/0005-2736(81)90549-6; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; COHEN CM, 1986, J BIOL CHEM, V261, P7701; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; DEKOWSKI SA, 1983, J BIOL CHEM, V258, P2750; DUNBAR JC, 1978, BIOCHIM BIOPHYS ACTA, V510, P283, DOI 10.1016/0005-2736(78)90028-7; EDER PS, 1986, BIOCHEMISTRY-US, V25, P1764, DOI 10.1021/bi00355a047; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FRIEDMAN DL, 1985, BIOCHIM BIOPHYS ACTA, V847, P165, DOI 10.1016/0167-4889(85)90017-5; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; HARRIS HW, 1980, J BIOL CHEM, V255, P1521; HARRIS HW, 1980, J BIOL CHEM, V255, P1512; HOSEY MM, 1977, BIOCHIM BIOPHYS ACTA, V482, P348; HOSEY MM, 1977, J BIOL CHEM, V252, P102; HOSEY MM, 1976, BIOCHEMISTRY-US, V15, P1561, DOI 10.1021/bi00652a029; HUSAINCHISHTI A, 1988, NATURE, V334, P718, DOI 10.1038/334718a0; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KUMAR R, 1975, BIOCHIM BIOPHYS ACTA, V410, P87, DOI 10.1016/0005-2744(75)90209-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LING E, 1988, J BIOL CHEM, V263, P2209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU PW, 1985, J BIOL CHEM, V260, P4958; LUTZ HU, 1984, FEBS LETT, V169, P323, DOI 10.1016/0014-5793(84)80343-9; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1982, BLOOD, V59, P768; PALFREY HC, 1985, J BIOL CHEM, V260, P6021; PLUT DA, 1978, EUR J BIOCHEM, V82, P333, DOI 10.1111/j.1432-1033.1978.tb12027.x; SHAHBAKHTI F, 1986, BIOCHEMISTRY-US, V25, P5969, DOI 10.1021/bi00368a020; SHEETZ MP, 1977, J CELL BIOL, V73, P638, DOI 10.1083/jcb.73.3.638; SIMONS TJB, 1979, NATURE, V281, P337, DOI 10.1038/281337a0; SOONG CJ, 1987, ARCH BIOCHEM BIOPHYS, V254, P509, DOI 10.1016/0003-9861(87)90131-7; TAO M, 1980, J BIOL CHEM, V255, P2563; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; UNGEWICKELL E, 1979, NATURE, V280, P811, DOI 10.1038/280811a0; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; USUI H, 1983, J BIOL CHEM, V258, P455; USUI H, 1988, J BIOL CHEM, V263, P3752; WAXMAN L, 1979, ARCH BIOCHEM BIOPHYS, V195, P300, DOI 10.1016/0003-9861(79)90356-4; WEI TQ, 1993, ARCH BIOCHEM BIOPHYS, V307, P206, DOI 10.1006/abbi.1993.1580; YAN TFJ, 1982, J BIOL CHEM, V257, P7037	52	123	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5659	5665		10.1074/jbc.270.10.5659	http://dx.doi.org/10.1074/jbc.270.10.5659			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890688	hybrid			2022-12-27	WOS:A1995QL58000107
J	MARCHAND, P; TANG, J; JOHNSON, GD; BOND, JS				MARCHAND, P; TANG, J; JOHNSON, GD; BOND, JS			COOH-TERMINAL PROTEOLYTIC PROCESSING OF SECRETED AND MEMBRANE FORMS OF THE ALPHA-SUBUNIT OF THE METALLOPROTEASE MEPRIN-A - REQUIREMENT OF THE I-DOMAIN FOR PROCESSING IN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; COS-1 CELLS; EXPRESSION; HYDROLASE; CLONING; RAT; PURIFICATION; RECEPTORS; PROTEASES; KIDNEY	Cell surface isoforms of meprin A (EC 3.4.24.18) from mice and rats contain beta subunits that are type I integral membrane proteins and alpha subunits that are disulfide linked to or noncovalently associated with membrane-anchored meprin subunits. Both alpha and beta subunits are synthesized with COOH-terminal domains predicted to be cytoplasmic, transmembrane, and epidermal growth factor-like; these domains are retained in beta subunits but are removed from alpha during maturation. The present studies establish that an inserted 56-amino acid domain (the ''I'' domain), present in alpha but not in beta, is necessary and sufficient for COOH-terminal proteolytic processing of the alpha subunit. This was demonstrated by expression of mutant meprin subunits (deletion mutants, chimeric alpha beta subunits, and beta mutants containing the I domain) in COS-1 cells. Mutations of two common processing sites present in the I domain (a dibasic site and a furin site) did not prevent COOH-terminal proteolytic processing, indicating that the proteases responsible for cleavage are distinct from those having these specificities, Deletion of the I domain from the alpha subunit resulted in accumulation of unprocessed subunits in a preGolgi compartment. Furthermore, COOH-terminal proteolytic processing of wild-type alpha subunits occurred before acquisition of endoglycosidase H resistance. Pulse chase experiments and expression of an alpha subunit transcript containing a c-myc epitope tag, confirmed that proteolytic lytic processing at the COOH terminus occurs in the endoplasmic reticulum. This work identifies the region of the alpha subunit that is essential for COOH-terminal processing and demonstrates that the differential processing of the evolutionarily-related subunits of meprin A that results in a structurally unique tetrameric protease begins in the endoplasmic reticulum.	PENN STATE UNIV, COLL MED, DEPT BIOCHEM & MOLEC BIOL, HERSHEY, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK019691, R37DK019691, R01DK019691] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 19691] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKUSJARVI G, 1987, MOL CELL BIOL, V7, P549, DOI 10.1128/MCB.7.1.549; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; BOND JS, 1994, IN PRESS ZINC METALL; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BREWER JW, 1994, J BIOL CHEM, V269, P17338; CORBEIL D, 1993, FEBS LETT, V335, P361, DOI 10.1016/0014-5793(93)80420-Y; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GARDNER AM, 1993, J BIOL CHEM, V268, P25940; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; GORBEA CM, 1991, ARCH BIOCHEM BIOPHYS, V290, P549, DOI 10.1016/0003-9861(91)90580-C; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBURG G, 1994, J BIOL CHEM, V269, P25354; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; HAMMOND SA, 1993, NATURE, V364, P158, DOI 10.1038/364158a0; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JIANG WP, 1992, J BIOL CHEM, V267, P9185; JOHNSON GD, 1994, J BIOL CHEM, V269, P7682; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; KENNY AJ, 1987, BIOCHEM J, V245, P515, DOI 10.1042/bj2450515; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LAKE RA, 1991, GENE TRANSFER EXPRES, P23; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; MILHIET PE, 1994, BIOCHEM J, V300, P37, DOI 10.1042/bj3000037; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; URADE R, 1992, FEBS LETT, V312, P83, DOI 10.1016/0014-5793(92)81415-I; URADE R, 1993, J BIOL CHEM, V268, P22004; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; WIKSTROM L, 1993, J BIOL CHEM, V268, P14412; WILEMAN T, 1991, CELL REGUL, V2, P753, DOI 10.1091/mbc.2.9.753; YANG B, 1993, J BIOL CHEM, V268, P7435	46	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5449	5456		10.1074/jbc.270.10.5449	http://dx.doi.org/10.1074/jbc.270.10.5449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890660	hybrid			2022-12-27	WOS:A1995QL58000076
J	MILNE, DM; CAMPBELL, LE; CAMPBELL, DG; MEEK, DW				MILNE, DM; CAMPBELL, LE; CAMPBELL, DG; MEEK, DW			P53 IS PHOSPHORYLATED IN-VITRO AND IN-VIVO BY AN ULTRAVIOLET RADIATION-INDUCED PROTEIN-KINASE CHARACTERISTIC OF THE C-JUN KINASE, JNK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; ACTIVATION DOMAIN; BINDING PROTEIN; 3T3 CELLS; MOUSE P53; T-ANTIGEN; TRANSCRIPTION; MUTATION; SITE; IDENTIFICATION	The p53 tumor suppressor protein is thought to play a major role in the defense of the cell against agents that damage DNA. In this report, we describe the identification and characterization of a protein kinase that phosphorylates mouse p53 at a single site, serine 34, a major site of phosphorylation in the cell. The protein kinase is activated strikingly following treatment of cells with ultraviolet radiation, has a native molecular weight of approximately 45,000, and can be resolved from mitogen-activated protein (MAP) kinase by chromatography on Superose 6 and DEAE cellulose. The p53 kinase activity co-purifies with UV-activated c-Jun kinase activity on heparin Sepharose and on a c-Jun (but not a v-Jun-) affinity column. Treatment of the partially purified kinase with CL100, a protein phosphatase that specifically dephosphorylates MAP kinase homologues, inhibits its activity. Taken together, the data suggest that this p53 kinase is likely to be activated by phosphorylation and may be a member of the stress-activated protein kinase subfamily of MAP kinases. UV irradiation of SV3T3 cells leads to increased phosphorylation of p53 at serine 34, indicating that phosphorylation of p53 by this kinase is likely to be physiological. Phosphorylation of p53 by this protein kinase may be a key event in a signal transduction mechanism that coordinately controls key nuclear proteins in response to oxidative stress or DNA damaging agents.	UNIV DUNDEE,NINEWELLS HOSP & MED SCH,BIOMED RES CTR,DUNDEE DD1 9SY,SCOTLAND; UNIV DUNDEE,DEPT BIOCHEM,MRC,PROT PHOSPHORYLAT UNIT,DUNDEE DD1 4HN,SCOTLAND	University of Dundee; University of Dundee			Campbell, David G/K-1874-2015	Campbell, David G/0000-0003-2278-2149				ADDISON C, 1990, ONCOGENE, V5, P423; ADLER V, 1992, J BIOL CHEM, V267, P17001; ALESSI DR, 1993, ONCOGENE, V8, P2015; ANDERSON CW, 1994, IN PRESS SEMIN CELL; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BLACK EJ, 1991, ONCOGENE, V6, P1949; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DEMERS GW, 1994, P NATL ACAD SCI USA, V91, P4382, DOI 10.1073/pnas.91.10.4382; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1993, BIOCHIM BIOPHYS ACTA, V1155, P181, DOI 10.1016/0304-419X(93)90004-V; DOVER R, 1994, J CELL SCI, V107, P1181; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FISCELLA M, 1993, ONCOGENE, V8, P1519; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; HARPER JW, 1993, CELL, V75, P805; HERRMANN CPE, 1991, ONCOGENE, V6, P877; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KASTAN MB, 1991, CANCER RES, V51, P6304; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MEEK DW, 1990, J VIROL, V64, P1734, DOI 10.1128/JVI.64.4.1734-1744.1990; MEEK DW, 1994, SEMIN CANCER BIOL, V5, P203; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MILNE DM, 1992, NUCLEIC ACIDS RES, V20, P5565, DOI 10.1093/nar/20.21.5565; MILNE DM, 1992, ONCOGENE, V7, P1361; MILNE DM, 1994, J BIOL CHEM, V269, P9253; RAGIMOV N, 1993, ONCOGENE, V8, P1183; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; SCHARER E, 1992, NUCLEIC ACIDS RES, V20, P1539, DOI 10.1093/nar/20.7.1539; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; TACK LC, 1992, J VIROL, V66, P1312, DOI 10.1128/JVI.66.3.1312-1320.1992; VAIDYA AB, 1978, VIROLOGY, V90, P12, DOI 10.1016/0042-6822(78)90328-8; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231; WEINTRAUB H, 1991, P NATL ACAD SCI USA, V88, P4570, DOI 10.1073/pnas.88.11.4570; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143	60	251	258	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5511	5518		10.1074/jbc.270.10.5511	http://dx.doi.org/10.1074/jbc.270.10.5511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890669	hybrid			2022-12-27	WOS:A1995QL58000085
J	RUBINFELD, B; SOUZA, B; ALBERT, I; MUNEMITSU, S; POLAKIS, P				RUBINFELD, B; SOUZA, B; ALBERT, I; MUNEMITSU, S; POLAKIS, P			THE APC PROTEIN AND E-CADHERIN FORM SIMILAR BUT INDEPENDENT COMPLEXES WITH ALPHA-CATENIN, BETA-CATENIN, AND PLAKOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; CELL-ADHESION MOLECULE; SEGMENT POLARITY GENE; CYTOPLASMIC DOMAIN; MUTATIONS; IDENTIFICATION; LOCUS; CHROMOSOME-5Q21; ASSOCIATION; EXPRESSION	The tumor suppressor APC protein associates with the cadherin binding proteins alpha- and beta-catenin. To examine the relationship between cadherin, catenins, and APC, we have tested combinatorial protein-protein interactions in vivo, using a yeast two-hybrid system, and in vitro, using purified proteins. beta-Catenin directly binds to APC at high and low affinity sites. alpha-Catenin cannot directly bind APC but associates with it by binding to beta-catenin. Plakoglobin, also known as gamma-catenin, directly binds to both APC and alpha-catenin and also to the APC beta-catenin complex, but not directly to beta-catenin. beta-Catenin binds to multiple independent regions of APC, some of which include a previously identified consensus motif and others which contain the centrally located 20 amino acid repeat sequences. The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the aminoterminal half independently binds alpha-catenin. The catenins bind to APC and E-cadherin in a similar fashion, but APC and E-cadherin do not associate with each other either in the presence or absence of catenins. Thus, APC forms distinct heteromeric complexes containing combinations of alpha catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.	ONYX PHARMACEUT,RICHMOND,CA 94806					Rubinfeld, Bonnee/0000-0001-9861-6775				BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; FERNANDEZSARABI.MJ, 1993, NATURE, V366, P274; FRANKE WW, 1989, P NATL ACAD SCI USA, V86, P4027, DOI 10.1073/pnas.86.11.4027; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; KORMAN NJ, 1989, NEW ENGL J MED, V321, P631, DOI 10.1056/NEJM198909073211002; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NAKAMURA Y, 1993, ADV CANCER RES, V62, P65, DOI 10.1016/S0065-230X(08)60315-2; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; PEIFER M, 1993, SCIENCE, V262, P1667, DOI 10.1126/science.8259511; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; POLAKIS P, 1995, IN PRES CURR OPIN GE, V5; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; SPAARGAREN M, 1994, BIOCHEM J, V300, P303, DOI 10.1042/bj3000303; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; UTSUNOMIYA J, 1990, HEREDITARY COLORECTA, P3	40	294	301	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5549	5555		10.1074/jbc.270.10.5549	http://dx.doi.org/10.1074/jbc.270.10.5549			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890674	hybrid			2022-12-27	WOS:A1995QL58000090
J	SHIMOIKE, T; TAURA, T; KIHARA, A; YOSHIHISA, T; AKIYAMA, Y; CANNON, K; ITO, K				SHIMOIKE, T; TAURA, T; KIHARA, A; YOSHIHISA, T; AKIYAMA, Y; CANNON, K; ITO, K			PRODUCT OF A NEW GENE, SYD, FUNCTIONALLY INTERACTS WITH SECY WHEN OVERPRODUCED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN EXPORT; BACTERIOPHAGE-LAMBDA; MEMBRANE COMPONENT; MACHINERY; MUTATION; SYSTEM; DNA	A mutant form of SecY, SecY(-d)1, was previously suggested to sequester a component(s) of the protein translocator complex. Its synthesis from a plasmid leads to interference with protein export in Escherichia coli. SecE is a target of this sequestration, and its overproduction cancels the export interference. We now report that overexpression of another gene, termed syd, also suppresses secY(-d)1. The nucleotide sequence of syd predicted that it encodes a protein of 181 amino acid residues, which has been identified by overproduction, purification, and determination of the amino terminal sequence. Cell fractionation experiments suggested that Syd is loosely associated with the cytoplasmic surface of the cytoplasmic membrane. SecY may be involved in the membrane association of Syd since the association is saturable, the extent of which depends on the overproduction of SecY. SecY is rapidly degraded in vivo unless its primary partner, SecE, is sufficiently available. Overproduction of Syd was found to stabilize oversynthesized SecY. However, Syd cannot stabilize the SecY(-d)1 form of SecY. Thus, in the presence of both secY(+) and secY(-d)1, Syd increases the effective SecY(+)/SecY(-d)1 ratio in the cell and cancels the dominant interference by the latter. We also found that overproduction of Syd dramatically inhibits protein export in the secY24 mutant cell in which SecY-SecE interaction has been weakened. These results indicate that Syd, especially when it is overproduced, has abilities to interact with SecY. Possible significance of such interactions is discussed in conjunction with the apparent lack of phenotypic consequences of genetic disruption of syd.	KYOTO UNIV, INST VIRUS RES, DEPT CELL BIOL, KYOTO 60601, JAPAN	Kyoto University			KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788				AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; BABA T, 1994, P NATL ACAD SCI USA, V91, P4539, DOI 10.1073/pnas.91.10.4539; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; DOUVILLE K, 1994, J BIOL CHEM, V269, P18705; ITO K, 1992, MOL MICROBIOL, V6, P2423; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; JOLY JC, 1994, P NATL ACAD SCI USA, V91, P4703, DOI 10.1073/pnas.91.11.4703; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KLECKNER N, 1978, GENETICS, V90, P427; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; MATSUYAMA S, 1990, FEBS LETT, V269, P96, DOI 10.1016/0014-5793(90)81128-B; Miller J.H., 1972, EXPT MOL GENETICS; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; MURPHY CK, 1994, P NATL ACAD SCI USA, V91, P2557, DOI 10.1073/pnas.91.7.2557; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Osborn M J, 1974, Methods Enzymol, V31, P642; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RIGGS PD, 1988, GENETICS, V118, P571; RUDD KE, 1993, ASM NEWS, V59, P335; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; SHIMOIKE T, 1992, MOL MICROBIOL, V6, P1205, DOI 10.1111/j.1365-2958.1992.tb01559.x; Silhavy T. J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; STAHL FW, 1986, GENETICS, V113, P215; TAURA T, 1993, J BACTERIOL, V175, P7771, DOI 10.1128/JB.175.24.7771-7775.1993; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; UEGUCHI C, 1992, J BACTERIOL, V174, P1454, DOI 10.1128/jb.174.5.1454-1461.1992; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; YAMATO I, 1975, J BIOCHEM, V77, P705, DOI 10.1093/oxfordjournals.jbchem.a130774	37	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5519	5526		10.1074/jbc.270.10.5519	http://dx.doi.org/10.1074/jbc.270.10.5519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890670	hybrid			2022-12-27	WOS:A1995QL58000086
J	BIESINGER, B; TSYGANKOV, AY; FICKENSCHER, H; EMMRICH, F; FLECKENSTEIN, B; BOLEN, JB; BROKER, BM				BIESINGER, B; TSYGANKOV, AY; FICKENSCHER, H; EMMRICH, F; FLECKENSTEIN, B; BOLEN, JB; BROKER, BM			THE PRODUCT OF THE HERPESVIRUS-SAIMIRI OPEN READING FRAME-1 (TIP) INTERACTS WITH T-CELL-SPECIFIC KINASE P56(LCK) IN TRANSFORMED-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PROTEIN-KINASE; HUMAN LYMPHOCYTES-T; VIRUS TYPE-I; SIGNAL-TRANSDUCTION; SRC-FAMILY; RECEPTOR; GROWTH; CLONES; LINES; IMMORTALIZATION	Subgroup C strains of Herpesvirus saimiri, a leukemogenic virus of non human primates, transform human T cells to permanent growth in culture, These cells retain their antigen specificity, and they are becoming widely used as a model for activated human T cells, Though a variety of human cell types can be infected by H. saimiri, transformation appears to be specific for CD4+ and CD8+ T cells, Our investigation of early signaling events in H. saimiri-transformed T cells revealed a novel 40-kDa phosphoprotein complexed with the T cell-specific tyrosine protein kinase p56(lck). This protein, termed Tip (tyrosine kinase interacting protein), is identified as a viral protein encoded by the open reading frame 1 (ORF1), In the transformed cells Tip is expressed together with the gene product of ORF2, the viral onco protein StpC, which acts on epithelial cells, The H. saimiri genome has 75 ORFs, but only ORF1 and ORF2 are transcribed in transformed human cells, Tip is phosphorylated on tyrosine in cell-free systems containing Lck, indicating that the viral protein is a substrate for this T cell-specific kinase, Alteration of T cell signaling pathways by Tip may be the second event complementing the action of StpC in a new mechanism of T cell transformation.	UNIV ERLANGEN NURNBERG, INST KLIN & MOLEK VIROL, D-91054 ERLANGEN, GERMANY; BRISTOL MYERS SQUIBB CO, DEPT MOLEC BIOL, SIGNAL TRANSDUCT LAB, PRINCETON, NJ 08543 USA; UNIV ERLANGEN NURNBERG, MAX PLANCK GESELL, INST KLIN IMMUNOL, ARBEITSGRP RHEUMATOL, D-91054 ERLANGEN, GERMANY	University of Erlangen Nuremberg; Bristol-Myers Squibb; Max Planck Society; University of Erlangen Nuremberg			Fickenscher, Helmut/A-3004-2010; Tsygankov, Alexander Y/K-6205-2017; Bröker, Barbara M/O-4850-2015; Fickenscher, Helmut/J-9655-2019	Bröker, Barbara M/0000-0002-5020-8542; Fickenscher, Helmut/0000-0003-0043-1153				ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ADAM D, 1993, J BIOL CHEM, V268, P19882; ADLER HT, 1992, ONCOGENE, V7, P1191; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; BEVERLEY P, 1986, HDB EXPT IMMUNOLOGY, V2; BIESINGER B, 1990, VIROLOGY, V176, P505, DOI 10.1016/0042-6822(90)90020-R; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BROKER BM, 1994, EUR J IMMUNOL, V24, P843, DOI 10.1002/eji.1830240411; BROKER BM, 1993, J IMMUNOL, V151, P1184; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; COHEN BD, 1993, J VIROL, V67, P5303, DOI 10.1128/JVI.67.9.5303-5311.1993; DECARLI M, 1993, J IMMUNOL, V151, P5022; DESEAU V, 1987, J CELL BIOCHEM, V35, P113, DOI 10.1002/jcb.240350205; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; ELLINGER S, 1989, J CLIN MICROBIOL, V27, P971, DOI 10.1128/JCM.27.5.971-976.1989; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; INATSUKI A, 1989, J IMMUNOL, V143, P1327; JUNG JU, 1991, J VIROL, V65, P6953, DOI 10.1128/JVI.65.12.6953-6960.1991; JUNG JU, 1991, P NATL ACAD SCI USA, V88, P7051, DOI 10.1073/pnas.88.16.7051; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KASCHKADIERICH C, 1982, J VIROL, V44, P295, DOI 10.1128/JVI.44.1.295-310.1982; KLAGES S, 1993, ONCOGENE, V8, P713; LONGNECKER R, 1993, J VIROL, V67, P5068, DOI 10.1128/JVI.67.8.5068-5074.1993; MEDVECZKY MM, 1993, VIROLOGY, V196, P402, DOI 10.1006/viro.1993.1495; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MITTRUCKER HW, 1993, INT IMMUNOL, V5, P985, DOI 10.1093/intimm/5.8.985; MITTRUCKER HW, 1992, J EXP MED, V176, P909, DOI 10.1084/jem.176.3.909; MURPHY C, 1994, ONCOGENE, V9, P221; MURTHY SCS, 1989, J VIROL, V63, P3307, DOI 10.1128/JVI.63.8.3307-3314.1989; NICK S, 1993, VIROLOGY, V194, P875, DOI 10.1006/viro.1993.1334; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SEE YP, 1990, PROTEIN STRUCTURE PR, P1; SIMMER B, 1991, J GEN VIROL, V72, P1953, DOI 10.1099/0022-1317-72-8-1953; SPANA C, 1993, PROTEIN EXPRES PURIF, V4, P390, DOI 10.1006/prep.1993.1051; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; WEBER F, 1993, P NATL ACAD SCI USA, V90, P11049, DOI 10.1073/pnas.90.23.11049; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; YSSEL H, 1989, J IMMUNOL, V142, P2279	43	119	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4729	4734		10.1074/jbc.270.9.4729	http://dx.doi.org/10.1074/jbc.270.9.4729			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876245	hybrid			2022-12-27	WOS:A1995QK08400080
J	CREIGHTON, S; GOODMAN, MF				CREIGHTON, S; GOODMAN, MF			GEL KINETIC-ANALYSIS OF DNA-POLYMERASE FIDELITY IN THE PRESENCE OF PROOFREADING USING BACTERIOPHAGE-T4 DNA-POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC ACID POLYMERASES; 5' EXONUCLEASE ACTIVITY; SPONTANEOUS MUTATION; BIOCHEMICAL BASIS; REVERSE-TRANSCRIPTASE; REPLICATION FIDELITY; WILD-TYPE; TRANSIENT MISALIGNMENT; INSERTION FIDELITY; KLENOW FRAGMENT	A gel fidelity assay, previously used in the analysis of DNA polymerases having no associated 3' to 5' exonuclease activity, has been generalized for use with polymerases that contain exonucleolytic proofreading. The main purpose of this study was the development of a general analysis, using a standard Markov model, to convert experimentally observed DNA primer gel bands arising from insertion and proofreading of right and wrong deoxyribonucleotides, into nucleotide incorporation velocities and, most importantly, fidelities. The model has been applied primarily to an analysis of polymerase kinetics and fidelity in the presence of a next correct rescue dNTP, but the model can be conveniently modified to investigate other experimental designs, In the presence of rescue dNTP, direct competition occurs between excision or extension of a mismatch. At concentrations of rescue dNTP sufficient to suppress the gel band intensity at the mismatch target site, nucleotide incorporation and misincorporation rates can be ob obtained from the ratios of gel band intensities 3' (downstream) and 5' (upstream) to the target site, measured as a function dNTP concentration for ''wrong'' and ''right'' dNTP substrates. The polymerase misincorporation efficiency, in the presence of proofreading, is given by the ratio of wrong to right incorporation efficiencies, V-max/K-m, obtained from the gel band ratios. The bacteriophage T4 polymerase with a highly active 3'-exonuclease activity was used to illustrate the assay, Nucleotide misincorporation efficiencies measured at several template sites were dCMP . A similar or equal to 10(-6), dGMP . A similar or equal to 10(-5), dTMP . T similar or equal to 2 x 10(-4), and dAMP . A < 10(-7). Proofreading of the dGMP . A mispair was suppressed by about 3-fold in the presence of high concentrations of next correct ''rescue'' dNTP causing a concomitant reduction in the fidelity of dGMP . A to about 3 x 10(-5).	UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089	University of Southern California					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042554, R37GM021422, R01GM021422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011398] Funding Source: NIH RePORTER; NIA NIH HHS [AG11398] Funding Source: Medline; NIGMS NIH HHS [GM42554, GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMAN RA, 1993, Q REV BIOPHYS, V26, P225, DOI 10.1017/S0033583500002869; BERNARDI F, 1979, J MOL BIOL, V129, P93, DOI 10.1016/0022-2836(79)90062-7; BESSMAN MJ, 1974, J MOL BIOL, V88, P409, DOI 10.1016/0022-2836(74)90491-4; BESSMAN MJ, 1977, J MOL BIOL, V116, P115, DOI 10.1016/0022-2836(77)90122-X; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; BLOOM LB, 1993, BIOCHEMISTRY-US, V32, P11247, DOI 10.1021/bi00092a039; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CAI H, 1993, J BIOL CHEM, V268, P23567; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CLAYTON LK, 1979, J BIOL CHEM, V254, P1902; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P347; FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4946, DOI 10.1073/pnas.76.10.4946; GALAS DJ, 1978, J MOL BIOL, V88, P653; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; GOODMAN R, 1988, INTRO STOCHASTIC MOD, P127; HALL ZW, 1968, J MOL BIOL, V36, P321, DOI 10.1016/0022-2836(68)90158-7; HERSHFIELD MS, 1972, J BIOL CHEM, V247, P3393; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; KUNKEL TA, 1984, J BIOL CHEM, V259, P1539; LASKEN RS, 1985, P NATL ACAD SCI USA, V82, P1301, DOI 10.1073/pnas.82.5.1301; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; NOSSAL NG, 1973, DNA SYNTHESIS IN VIT; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; PETRUSKA J, 1985, J BIOL CHEM, V260, P7533; PLESS RC, 1983, BIOCHEMISTRY-US, V22, P4905, DOI 10.1021/bi00290a006; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; REDDY MK, 1992, J BIOL CHEM, V267, P14157; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; RONEN A, 1976, MUTAT RES, V34, P21, DOI 10.1016/0027-5107(76)90258-X; SINHA NK, 1987, P NATL ACAD SCI USA, V84, P915, DOI 10.1073/pnas.84.4.915; TRAUTNER TA, 1962, P NATL ACAD SCI USA, V48, P449, DOI 10.1073/pnas.48.3.449; VANKAMPEN NG, 1992, STOCHASTIC PROCESSES, P73; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; YU H, 1992, J BIOL CHEM, V267, P10888	45	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4759	4774		10.1074/jbc.270.9.4759	http://dx.doi.org/10.1074/jbc.270.9.4759			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876249	hybrid			2022-12-27	WOS:A1995QK08400085
J	GUALBERTO, A; LOWRY, J; SANTORO, IM; WALSH, K				GUALBERTO, A; LOWRY, J; SANTORO, IM; WALSH, K			PARAMETERS THAT INFLUENCE THE EXTENT OF SITE OCCUPANCY BY A CANDIDATE TELOMERE END-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; LAC REPRESSOR; TRANSCRIPTION FACTOR; RNA-POLYMERASE; SYNTHETIC DNA; 3' TERMINUS; SEQUENCE; SUBUNIT; GENES; IDENTIFICATION	The MF3 protein specifically recognizes telomeric and non-telomeric DNA probes that can form G.G base-paired structures (Gualberto, A., Patrick, R. M., and Walsh, K. (1992) Genes & Dev, 6, 815-824). Here we further characterize the nucleic acid recognition properties of MF3 and present a mathematical analysis that evaluates the potential extent of telomere site occupancy by this factor. The substitution of dI at dG positions in telomeric DNA probes revealed that a single dG at any position within the internal repeat was sufficient for high affinity binding to MF3, The RNA analogs of high affinity DNA sites were not bound specifically by MF3, but the substitution of dU for dT in a DNA probe had little or no effect on binding These data demonstrate that ribose ring structure is a critical feature of nucleoprotein complex formation, and this ribose specificity may enable MF3 to occupy sites of unusual DNA structure while minimizing interactions with cellular RNAs. Collectively, the nucleic acid binding properties of MF3 suggest that it may occupy a significant fraction of sites at telomere ends or other G-rich regions of altered DNA structure in vivo.	TUFTS UNIV,ST ELIZABETHS MED CTR,SCH MED,DIV CARDIOVASC RES,BOSTON,MA 02135; CASE WESTERN RESERVE UNIV,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106; UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599	St. Elizabeth's Medical Center; Tufts University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill				Gualberto, Antonio/0000-0002-6590-839X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040197] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50692] Funding Source: Medline; NIAMS NIH HHS [AR40197] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CARDENAS ME, 1993, GENE DEV, V7, P883, DOI 10.1101/gad.7.5.883; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; FANG GW, 1991, NUCLEIC ACIDS RES, V19, P5515, DOI 10.1093/nar/19.20.5515; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GOLDE A, 1962, VIROLOGY, V16, P9, DOI 10.1016/0042-6822(62)90197-6; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; GUALBERTO A, 1992, GENE DEV, V6, P815, DOI 10.1101/gad.6.5.815; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; HICKE BJ, 1990, P NATL ACAD SCI USA, V87, P1481, DOI 10.1073/pnas.87.4.1481; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; LIU ZP, 1993, P NATL ACAD SCI USA, V90, P3157, DOI 10.1073/pnas.90.8.3157; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P1387, DOI 10.1093/nar/20.6.1387; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; RAGHURAMAN MK, 1989, NUCLEIC ACIDS RES, V17, P4235, DOI 10.1093/nar/17.11.4235; RAGHURAMAN MK, 1990, NUCLEIC ACIDS RES, V18, P4543, DOI 10.1093/nar/18.15.4543; Saenger W., 1984, PRINCIPLES NUCL ACID, P51; SANTORO IM, 1991, MOL CELL BIOL, V11, P1944, DOI 10.1128/MCB.11.4.1944; VESELKOV AG, 1993, NATURE, V364, P496, DOI 10.1038/364496a0; WALSH K, 1992, J BIOL CHEM, V267, P13714; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7	30	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4509	4517		10.1074/jbc.270.9.4509	http://dx.doi.org/10.1074/jbc.270.9.4509			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876219	hybrid, Green Published			2022-12-27	WOS:A1995QK08400052
J	ZHU, JH; REYNET, C; CALDWELL, JS; KAHN, CR				ZHU, JH; REYNET, C; CALDWELL, JS; KAHN, CR			CHARACTERIZATION OF RAD, A NEW MEMBER OF RAS/GTPASE SUPERFAMILY, AND ITS REGULATION BY A UNIQUE GTPASE-ACTIVATING PROTEIN (GAP)-LIKE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; MUTATIONAL ANALYSIS; CATALYTIC DOMAIN; BINDING PROTEIN; XENOPUS-OOCYTES; PHOSPHORYLATION; P21; LOCALIZATION; PROTEOLYSIS; ADIPOCYTES	We have recently identified a new member of the Ras/GTPase superfamily termed Rad which has unique sequence features and is overexpressed in the skeletal muscle of humans with type II diabetes (Reynet, C., and Kahn, C. R. (1993) Science, 262, 1441-1444), When expressed in bacteria as a glutathione S-transferase fusion protein, Rad bound [alpha(32)P]GTP quickly and saturably, Binding was specific for guanine nucleotides and displayed unique magnesium dependence such that both GTP and GDP binding were optimal at relatively high Mg2+ concentrations (1-10 mM), Rad had low intrinsic GTPase activity which was greatly enhanced by a GTPase-activating protein (GAP) activity present in various tissues and cell lines. Several known GAPs had no stimulatory effect toward Rad, Conversion of Ser to Asn at position 66 in Rad (equivalent to position 12 in Ras) resulted in a total loss of GTP binding. Mutation of pro(61) (equivalent to Gly(12) in Ras) or Gln(109) (equivalent to Gln(61) in Ras) had no effect on Rad GTPase activity, whereas creation of a double mutation at these positions resulted in exceptionally high intrinsic GTPase activity, lit vitro, Rad was phosphorylated by the catalytic subunit of cAMP-dependent protein kinase (PK). Phosphopeptide mapping indicated two PKA phosphorylation sites near the C-OOH terminus. Rad also coprecipitated a serine/threonine kinase activity from extracts of various tissues and cell lines which catalyzed phosphorylation on Rad but was not inhibited by PKA inhibitor. Thus, Rad is a GTP-binding protein and a GTPase which has some structure/function similarities to Ras, but displays unique features. Rad may also be phosphorylated on serine/threonine residues by PHA and other kinases, as well as regulated by its own GAP which is present in many tissues and cell types.	JOSLIN DIABET CTR,DIV RES,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02215	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School			Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK045935] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 36836, DK 45935] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BHULLAR RP, 1987, BIOCHEM J, V245, P617, DOI 10.1042/bj2450617; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CHUANG LM, 1993, P NATL ACAD SCI USA, V90, P5172, DOI 10.1073/pnas.90.11.5172; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; CORMONT M, 1993, J BIOL CHEM, V268, P19491; DOWNWARD J, 1992, BIOESSAYS, V14, P177, DOI 10.1002/bies.950140308; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; GIBBS JB, 1989, P NATL ACAD SCI USA, V86, P6630, DOI 10.1073/pnas.86.17.6630; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HALL A, 1986, J BIOL CHEM, V261, P963; HATA Y, 1991, J BIOL CHEM, V266, P6571; KAELIN WG, 1993, CELL, V64, P521; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MURRAY RK, 1990, HARPERS BIOCH, P441; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUNYER T, 1984, J BIOL CHEM, V259, P5447; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; VANDERSLUIJS P, 1992, EMBO J, V11, P4379, DOI 10.1002/j.1460-2075.1992.tb05538.x; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; ZIMMERMANN P, 1990, AM J PHYSIOL, V263, pG396	37	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4805	4812		10.1074/jbc.270.9.4805	http://dx.doi.org/10.1074/jbc.270.9.4805			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876254	hybrid			2022-12-27	WOS:A1995QK08400090
J	CHAI, XY; BOERMAN, MHEM; ZHAI, Y; NAPOLI, JL				CHAI, XY; BOERMAN, MHEM; ZHAI, Y; NAPOLI, JL			CLONING OF A CDNA FOR LIVER MICROSOMAL RETINOL DEHYDROGENASE - A TISSUE-SPECIFIC, SHORT-CHAIN ALCOHOL-DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING PROPERTIES; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; CORTICOSTEROID 11-BETA-DEHYDROGENASE; ESCHERICHIA-COLI; RAT-TISSUES; VITAMIN-A; CRABP-I; ACID; PROTEINS; EXPRESSION	Retinoic acid, a hormone biosynthesized hom retinol, controls numerous biological systems by regulating eukaryotic gene expression hom conception through death. This work reports the cloning and expression of a Liver cDNA encoding a microsomal retinol dehydrogenase (RoDH), which catalyzes the primary and rate-limiting step in retinoic acid synthesis. The predicted amino acid sequence and biochemical data obtained from the recombinant enzyme verify it as a short-chain alcohol dehydrogenase. Like microsomal RoDH, the recombinant enzyme recognized as substrate retinol bound to cellular retinol-binding protein, had higher activity with NADP rather than NAD, was stimulated by ethanol or phosphatidylcholine, was not inhibited by 4-methylpyrazole, was inhibited by phenylarsine oxide and carbenoxolone and localized to microsomes. RoDH recognized the physiological form of retinol, holocellular retinol-binding protein, with a K-m of 0.9 mu M, a value lower than the similar to 5 mu M concentration of holocellular retinol binding protein in liver. Northern and Western blot analyses revealed RoDH expression only in rat Liver, despite enzymatic activity in liver, brain, kidney, lung, and testes. These data suggest that tissue specific isozyme(s) of short chain alcohol dehydrogenases catalyze the first step in retinoic acid biogenesis and further strengthen the evidence that the ''cassette'' of retinol bound to cellular retinol-binding protein serves as a physiological substrate.	SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NIDDK NIH HHS [DK36870] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI N, 1981, J BIOL CHEM, V256, P9471; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; BERLETH ES, 1992, J BIOL CHEM, V267, P16403; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCHILL P, 1992, BIOCHEMISTRY-US, V31, P3793, DOI 10.1021/bi00130a009; CHYTIL F, 1987, ANNU REV NUTR, V7, P321, DOI 10.1146/annurev.nu.07.070187.001541; CHYTIL F, 1990, Critical Reviews in Eukaryotic Gene Expression, V1, P61; CLARKE SD, 1989, FASEB J, V3, P2480, DOI 10.1096/fasebj.3.13.2680704; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; EDWARDS CRW, 1993, J STEROID BIOCHEM, V45, P1, DOI 10.1016/0960-0760(93)90114-C; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FESUS L, 1991, EUR J CELL BIOL, V56, P170; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUSTAFSON AL, 1993, DEVELOPMENT, V117, P451; HOFFMAN RD, 1992, J BIOL CHEM, V267, P14005; JAUHIAINEN M, 1988, J BIOL CHEM, V263, P6525; KROOK M, 1990, BIOCHEMISTRY-US, V29, P738, DOI 10.1021/bi00455a021; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; LI E, 1991, J BIOL CHEM, V266, P3622; LOHNES D, 1992, J CELL SCI S, V16, P69; Lotan R, 1988, Prog Clin Biol Res, V259, P261; MARKS AR, 1992, J BIOL CHEM, V267, P15459; MONDER C, 1989, ENDOCRINOLOGY, V125, P1046, DOI 10.1210/endo-125-2-1046; NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0; NAPOLI JL, 1991, BIOMED PHARMACOTHER, V45, P131, DOI 10.1016/0753-3322(91)90101-X; NAPOLI JL, 1992, BIOCHIM BIOPHYS ACTA, V1120, P183, DOI 10.1016/0167-4838(92)90267-H; NAPOLI JL, 1990, METHOD ENZYMOL, V189, P470; NAPOLI JL, 1994, BASIC SCI CLIN ASPEC, P135; ONG DE, 1982, J BIOL CHEM, V257, P13385; ONG DE, 1994, NUTR REV, V52, pS24; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; PETKOVICH M, 1992, ANNU REV NUTR, V12, P443, DOI 10.1146/annurev.nu.12.070192.002303; POSCH KC, 1992, J BIOL CHEM, V267, P19676; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; POSCH KC, 1989, ARCH BIOCHEM BIOPHYS, V274, P171, DOI 10.1016/0003-9861(89)90428-1; RUBERTE E, 1992, DEVELOPMENT, V115, P973; SIEGENTHALER G, 1990, BIOCHEM J, V268, P371, DOI 10.1042/bj2680371; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; WERMUTH B, 1992, PROSTAGLANDINS, V44, P5, DOI 10.1016/0090-6980(92)90102-Y; WU L, 1993, J BIOL CHEM, V268, P12964	46	128	137	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3900	3904		10.1074/jbc.270.8.3900	http://dx.doi.org/10.1074/jbc.270.8.3900			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876135	hybrid			2022-12-27	WOS:A1995QH68800066
J	CHAUDHARY, S; TORA, L; DAVIDSON, I				CHAUDHARY, S; TORA, L; DAVIDSON, I			CHARACTERIZATION OF A HELA-CELL FACTOR WHICH NEGATIVELY REGULATES TRANSCRIPTIONAL ACTIVATION IN-VITRO BY TRANSCRIPTIONAL ENHANCER FACTOR-I (TEF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; DNA TOPOISOMERASE-I; TATA-LESS PROMOTER; TFIID COMPLEX; MEDIATED INHIBITION; PROTEIN-BINDING; SIMIAN VIRUS-40; SV40 ENHANCER; DISTINCT; SEQUENCE	A novel negatively acting factor has been identified and partially purified from HeLa and BJA-B cell extracts by chromatographic fractionation. Addition of this factor to HeLa cell extracts or to a reconstituted HeLa cell transcription system repressed transcriptional activation by a chimeric activator, GAL-TEF-1, containing the activation function of transcriptional enhancer factor-1 (TEF-1), In contrast, this factor did not repress transactivation by the chimeric GAL-VP16 activator, Repression of transactivation by GAL-TEF-1 could be alleviated by the addition of immunopurified HeLa cell TFIID, but not by increased quantities of GAL-TEF-1, These observations suggest that this negatively acting factor represses transactivation by interfering with the function of, or competing for, the TATA-binding protein-associated coactivators which mediate the activity TEF-1.	UNIV LOUIS PASTEUR STRASBOURG 1,COLL FRANCE,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Davidson, Irwin/0000-0001-5533-1171				BOYER TG, 1993, GENE DEV, V7, P1810, DOI 10.1101/gad.7.9.1810; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; BROU C, 1993, NUCLEIC ACIDS RES, V21, P4011, DOI 10.1093/nar/21.17.4011; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CAHILL MA, 1994, FEBS LETT, V334, P105; CHAUDHARY S, 1994, MOL CELL BIOL, V14, P5290, DOI 10.1128/MCB.14.8.5290; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; DAVIDSON I, 1986, NATURE, V323, P544, DOI 10.1038/323544a0; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Drapkin R, 1993, CURR OPIN CELL BIOL, V5, P469, DOI 10.1016/0955-0674(93)90013-G; GERARD M, 1991, J BIOL CHEM, V266, P20940; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GILL G, 1994, P NATL SCI US, V72, P192; Gill G, 1992, CURR OPIN GENET DEV, V2, P236, DOI 10.1016/S0959-437X(05)80279-5; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; INOSTROZA JA, 1991, CELL, V70, P477; ISHIJI T, 1992, EMBO J, V6, P2271; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; KRETZSCHMAR M, 1994, MOL CELL BIOL, V14, P3927, DOI 10.1128/MCB.14.6.3927; LESCURE A, 1994, EMBO J, V13, P116; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PUGH BF, 1992, J BIOL CHEM, V267, P679; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; WALKER S, 1993, MOL CELL BIOL, V13, P5233, DOI 10.1128/MCB.13.9.5233; WEINZEIRL RO, 1993, NATURE, V862, P511; WHITE JH, 1991, P NATL ACAD SCI USA, V88, P7674, DOI 10.1073/pnas.88.17.7674; WHITE JH, 1992, EMBO J, V6, P2229; WILDEMAN AG, 1986, MOL CELL BIOL, V6, P2098, DOI 10.1128/MCB.6.6.2098; XIAO JH, 1987, EMBO J, V6, P3005, DOI 10.1002/j.1460-2075.1987.tb02606.x; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	52	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3631	3637		10.1074/jbc.270.8.3631	http://dx.doi.org/10.1074/jbc.270.8.3631			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876100	hybrid			2022-12-27	WOS:A1995QH68800028
J	DELAPENA, P; DELCAMINO, D; PARDO, LA; DOMINGUEZ, P; BARROS, F				DELAPENA, P; DELCAMINO, D; PARDO, LA; DOMINGUEZ, P; BARROS, F			G(S) COUPLES THYROTROPIN-RELEASING-HORMONE RECEPTORS EXPRESSED IN XENOPUS OOCYTES TO PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEINS; ANTERIOR-PITUITARY-CELLS; PERTUSSIS TOXIN; ALPHA-SUBUNIT; MOLECULAR-CLONING; SEQUENCE DETERMINATION; ADENYLYL CYCLASE; LAEVIS OOCYTES; BETA-SUBUNITS; CDNA	Coupling of thyrotropin-releasing hormone (TRH) receptors to individual G-proteins has been studied in Xenopus oocytes injected with receptor cRNA and antisense oligonucleotides to mRNA encoding different G-protein alpha- and beta-subunits. Injection of antisenses which target mRNA sequences shared by several G-protein alpha or beta gamma polypeptides effectively blocked Ca2+-dependent Cl- currents induced by TRH through activation of phospholipase C. Three different alpha(s)-specific antisense oligonucleotides complementary to sequences located in different positions along the coding region of the alpha(s) protein mRNA were highly effective in inhibiting TRH-induced responses. Anti-alpha(o), -alpha(q), -alpha(i), or -alpha(z) oligonucleotides were not able to modify the TRH-evoked response. In contrast, anti-alpha(o), but not anti-alpha(s), oligonucleotides blocked the response to serotonin in oocytes injected with serotonin 5-HT1(c) receptor cRNA. Cholera toxin catalyzed the [P-32]ADP-ribosylation of 40-42- and 50-52-kDa proteins in GH(3) cell plasma membranes, [P-32]ADP-ribosylation of oocyte membranes with the toxin labeled several proteins. These include a single 50-55-kDa substrate, which is clearly diminished in membranes from anti-alpha(s)-injected oocytes. Amplification of oocyte RNA in a polymerase chain reaction system and sequencing of the amplified products demonstrated that anti-alpha(s) oligonucleotides selectively recognize the message for the Xenopus alpha(s) polypeptide. It is concluded that G(s), but not G(o), G(q), G(i), or G(z), couples TRH receptors expressed in oocytes to activation of phospholipase C and subsequent inositol 1,4,5-trisphosphate-dependent stimulation of Ca2+-dependent Cl- currents.			DELAPENA, P (corresponding author), UNIV OVIEDO,FAC MED,DEPT BIOL FUNC,AREA BIOQUIM & BIOL MOLEC,E-33006 OVIEDO,SPAIN.		Dominguez, Pedro/A-8266-2012; Pardo, Luis/C-5066-2013; De-la-Pena-Cortines, Pilar/B-1453-2012; Barros, Francisco/H-3297-2015; Barros, Francisco/O-6647-2019	Dominguez, Pedro/0000-0003-4788-1071; Pardo, Luis/0000-0003-1375-4349; De-la-Pena-Cortines, Pilar/0000-0002-3915-730X; Barros, Francisco/0000-0001-9040-1948; Barros, Francisco/0000-0001-9040-1948				ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; BARROS F, 1994, PFLUG ARCH EUR J PHY, V426, P221, DOI 10.1007/BF00374775; BARROS F, 1993, FEBS LETT, V336, P433, DOI 10.1016/0014-5793(93)80851-K; BARROS F, 1991, FEBS LETT, V279, P33, DOI 10.1016/0014-5793(91)80243-V; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLITZER RD, 1993, J BIOL CHEM, V268, P7532; CHABRE O, 1992, MOL ENDOCRINOL, V6, P551, DOI 10.1210/me.6.4.551; CODINA J, 1988, J BIOL CHEM, V263, P6746; CODINA J, 1986, FEBS LETT, V207, P187, DOI 10.1016/0014-5793(86)81486-7; CRUCIANI RA, 1993, P NATL ACAD SCI USA, V90, P3019, DOI 10.1073/pnas.90.7.3019; DELAPENA P, 1992, BIOCHEM J, V284, P891, DOI 10.1042/bj2840891; DELAPENA P, 1992, J BIOL CHEM, V267, P25703; DELGADO LM, 1992, FEBS LETT, V311, P411; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; GAO B, 1987, P NATL ACAD SCI USA, V84, P6122, DOI 10.1073/pnas.84.17.6122; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; GOLLASCH M, 1993, P NATL ACAD SCI USA, V90, P6265, DOI 10.1073/pnas.90.13.6265; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; HUNG DT, 1992, J BIOL CHEM, V267, P20831; ITOH H, 1988, J BIOL CHEM, V263, P6656; JOUNEAUX C, 1994, J BIOL CHEM, V269, P1845; KANEKO S, 1992, FEBS LETT, V299, P179, DOI 10.1016/0014-5793(92)80242-9; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; MA HW, 1993, J BIOL CHEM, V268, P19915; MATSUOKA M, 1990, J BIOL CHEM, V265, P13215; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P239, DOI 10.1016/0165-6147(93)90019-G; MOLLARD P, 1990, BIOCHEM J, V268, P345, DOI 10.1042/bj2680345; MORIARTY TM, 1990, NATURE, V343, P79, DOI 10.1038/343079a0; MORIARTY TM, 1989, J BIOL CHEM, V264, P13524; MORIARTY TM, 1990, G PROTEINS, P479; MUNSHI R, 1991, J BIOL CHEM, V266, P22285; OLATE J, 1989, FEBS LETT, V244, P188, DOI 10.1016/0014-5793(89)81190-1; OLATE J, 1990, FEBS LETT, V268, P27, DOI 10.1016/0014-5793(90)80964-K; OLATE J, 1984, FEBS LETT, V175, P25; OZAWA S, 1986, PHYSIOL REV, V66, P887, DOI 10.1152/physrev.1986.66.4.887; SADLER SE, 1984, MOL PHARMACOL, V26, P526; SHAPIRO RA, 1993, J BIOL CHEM, V268, P21734; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; TAYLOR CW, 1990, BIOCHEM J, V272, P1; VONWEIZSACKER E, 1992, BIOCHEM BIOPH RES CO, V183, P350, DOI 10.1016/0006-291X(92)91650-F; WU DQ, 1992, J BIOL CHEM, V267, P25798; ZHAO DY, 1992, ENDOCRINOLOGY, V130, P3529, DOI 10.1210/en.130.6.3529	45	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3554	3559		10.1074/jbc.270.8.3554	http://dx.doi.org/10.1074/jbc.270.8.3554			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876090	hybrid			2022-12-27	WOS:A1995QH68800017
J	FOUNTOULAKIS, M; MESA, C; SCHMID, G; GENTZ, R; MANNEBERG, M; ZULAUF, M; DEMBIC, Z; GAROTTA, G				FOUNTOULAKIS, M; MESA, C; SCHMID, G; GENTZ, R; MANNEBERG, M; ZULAUF, M; DEMBIC, Z; GAROTTA, G			INTERFERON-GAMMA RECEPTOR EXTRACELLULAR DOMAIN EXPRESSED AS IGG FUSION PROTEIN IN CHINESE-HAMSTER OVARY CELLS - PURIFICATION, BIOCHEMICAL-CHARACTERIZATION, AND STOICHIOMETRY OF BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; IFN-GAMMA; ACCESSORY FACTOR; BIOLOGICAL-ACTIVITY; SOLUBLE HUMAN; SIGNAL; ANTIBODIES; INTERACTS; INHIBITOR; COMPLEX	Agents that antagonize the functions of interferon gamma (IFN gamma) are potential pharmaceuticals against several immunological and inflammatory disorders. IFN gamma receptor-immunoglobulin G fusion proteins (IFN gamma R-IgG) function as antagonists of endogenous IFN gamma and have longer half-lives in vivo in comparison with soluble IFN gamma receptors (sIFN gamma R), consisting of the extracellular region of the native sequence. A fusion protein comprising the extracellular domain of the human LFN gamma receptor and the hinge, CH2 and CH3 domains of the human IgG3 constant region, was expressed in Chinese hamster ovary cells. The IFN gamma R-IgG3 fusion protein was secreted into the culture medium as a 175-kDa glycoprotein and was purified over Protein G-Sepharose, DEAE-Sepharose, and size exclusion chromatography. IFN gamma R-IgG3 bound IFN gamma in solid phase assays and ligand blots, competed for the binding of radiolabeled IFN gamma to the cell surface receptor of Raji cells, and inhibited the IFN gamma-mediated antiviral activity with an efficiency at least one order of magnitude higher than that of the soluble receptor produced in the same expression system. Two IFN gamma R-IgG3 fusion proteins bound two IFN gamma dimers forming a complex of approximately 380 kDa. In immunodiffusion assays, the IFN gamma R-IgG3 fusion protein did not precipitate IFN gamma. Dissociation of bound IFN gamma from IFN gamma R-IgG3 was 2-fold slower than from the sIFN gamma R produced in insect cells.	F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,DEPT BIOTECHNOL,CH-4002 BASEL,SWITZERLAND; F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,DEPT PHYS,CH-4002 BASEL,SWITZERLAND	Roche Holding; Roche Holding	FOUNTOULAKIS, M (corresponding author), F HOFFMANN LA ROCHE & CO LTD,PRPG,PHARMACEUT RES,DEPT GENE TECHNOL,BLDG 15-16,CH-4002 BASEL,SWITZERLAND.		Dembic, Zlatko/A-1833-2008	Dembic, Zlatko/0000-0002-9970-6497				AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; ANTONI G, 1989, ANAL BIOCHEM, V179, P158, DOI 10.1016/0003-2697(89)90217-0; AXELROD A, 1994, J BIOL CHEM, V269, P15533; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DOBELI H, 1988, J BIOTECHNOL, V7, P199, DOI 10.1016/0168-1656(88)90052-1; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; Evans T. J., 1994, European Cytokine Network, V5, P203; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FOUNTOULAKIS M, 1989, J IMMUNOL, V143, P3266; FOUNTOULAKIS M, 1993, ANAL BIOCHEM, V208, P270, DOI 10.1006/abio.1993.1045; FOUNTOULAKIS M, 1991, EUR J BIOCHEM, V198, P441, DOI 10.1111/j.1432-1033.1991.tb16034.x; FOUNTOULAKIS M, 1990, J BIOL CHEM, V265, P13268; FOUNTOULAKIS M, 1992, BIO-TECHNOL, V10, P1143, DOI 10.1038/nbt1092-1143; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; FOUNTOULAKIS M, 1992, J BIOL CHEM, V267, P7095; FOUNTOULAKIS M, 1992, J BIOCHEM BIOPH METH, V24, P265, DOI 10.1016/0165-022X(94)90078-7; FOUNTOULAKIS M, 1995, IN PRESS J CHEM TECH; GAROTTA G, 1989, PHARMACOL RES, V21, P5, DOI 10.1016/S1043-6618(89)80013-1; GAROTTA G, 1990, J BIOL CHEM, V265, P6908; GENTZ R, 1992, EUR J BIOCHEM, V210, P545, DOI 10.1111/j.1432-1033.1992.tb17453.x; GIBBS VC, 1991, MOL CELL BIOL, V11, P5860, DOI 10.1128/MCB.11.12.5860; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HIBINO Y, 1992, J BIOL CHEM, V267, P3741; KALINA U, 1993, J VIROL, V67, P1702, DOI 10.1128/JVI.67.3.1702-1706.1993; KURSCHNER C, 1992, J IMMUNOL, V149, P4096; KURSCHNER C, 1992, J BIOL CHEM, V267, P9354; LANDOLFO S, 1991, J IMMUNOL RES, V3, P81; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; MONTMINY M, 1993, SCIENCE, V261, P1694, DOI 10.1126/science.8397444; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NICOLETTI F, 1990, LANCET, V336, P319, DOI 10.1016/0140-6736(90)91860-D; OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347; OZMEN L, 1993, J IMMUNOL, V150, P2698; OZMEN L, 1993, INT REV EXP PATHOL, V34, P137; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; SCHMID G, 1994, ANIMAL CELL TECHNOLO, P625; SEN GC, 1992, J BIOL CHEM, V267, P5017; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SOH J, 1993, P NATL ACAD SCI USA, V90, P8737, DOI 10.1073/pnas.90.18.8737; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; STUBER D, 1993, BIOCHEMISTRY-US, V32, P2423; TRAUNECKER A, 1991, TRENDS BIOTECHNOL, V9, P109, DOI 10.1016/0167-7799(91)90038-J; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462	50	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3958	3964		10.1074/jbc.270.8.3958	http://dx.doi.org/10.1074/jbc.270.8.3958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876143	hybrid			2022-12-27	WOS:A1995QH68800075
J	HARELBRONSTEIN, M; DIBROV, P; OLAMI, Y; PINNER, E; SCHULDINER, S; PADAN, E				HARELBRONSTEIN, M; DIBROV, P; OLAMI, Y; PINNER, E; SCHULDINER, S; PADAN, E			MH1, A 2ND-SITE REVERTANT OF ALL ESCHERICHIA-COLI MUTANT LACKING NA+/H+ ANTIPORTERS (DELTA-NHAA-DELTA-NHAB), REGAINS NA+ RESISTANCE AND A CAPACITY TO EXCRETE NA+ IN A DELTA-MU(H)+-INDEPENDENT FASHION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTIVE RESPIRATORY-CHAIN; ION-TRANSPORT; SODIUM; GENE; PROTON; CLONING; ENERGETICS; EXPRESSION; CELLS; ANT	The Escherichia coli mutant Delta nhaA Delta nhaB (EP432), which lacks the two specific Na+/H+ antiporter genes, is incapable of efficiently excreting Na+. Accordingly at low K+ (6 mM) medium, its intracellular Na+ concentration is only slightly lower (1,5-2x) than the extracellular concentration (50 mM), explaining the high sensitivity to Na+ (less than or equal to 30 mM) of the mutant, This Na+ sensitivity is shown to be a powerful selection for spontaneous second-site suppressor mutations that allow growth on high Na+ (less than or equal to 0.6 M) with a rate similar to that of the wild type. One such mutation, MH1, maps at 25.7 min on the E, coli chromosome. It confers Na+ but not Li+ resistance upon Delta nhaA Delta nhaB cells and exposes a Nac-excreting capacity, maintaining a Na+ gradient of about 8-10 (at 50 mM extracellular Na+), which is similar to that of the wild type, Although lower, Na+ excretion capacity is also observed in the Delta nhaA Delta nhaB mutant when grown in medium containing higher K+ (70 mM). This capacity is accompanied with a shift in the sensitivity of the mutant to higher Na+ concentrations (greater than or equal to 300 mar). Whereas Na+ excretion by a wild type carrying Delta unc is uncoupler sensitive, that of MH1 Delta unc is dependent on respiration in an uncoupler-insensitive fashion. It is concluded that under some conditions (high HC in the medium or in MH1-Like mutants), a primary pump driven by respiration is responsible for Na+ extrusion when the Na+/H+ antiporters are not active.			HARELBRONSTEIN, M (corresponding author), HEBREW UNIV JERUSALEM,INST LIFE SCI,DIV MICROBIAL & MOLEC ECOL,IL-91904 JERUSALEM,ISRAEL.		Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237				AVETISYAN AV, 1989, FEBS LETT, V254, P17, DOI 10.1016/0014-5793(89)81000-2; AVETISYAN AV, 1992, FEBS LETT, V306, P199, DOI 10.1016/0014-5793(92)80999-W; AVETISYAN AV, 1993, FEBS LETT, V3, P267; BOOS W, 1987, J BIOL CHEM, V262, P13212; BORBOLLA MG, 1984, ARCH BIOCHEM BIOPHYS, V229, P98, DOI 10.1016/0003-9861(84)90134-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS LK, 1991, METHOD ENZYMOL, V204, P43; BROSIUS J, 1992, METHOD ENZYMOL, V216, P469; CASTLE AM, 1986, J BIOL CHEM, V261, P7797; DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950; DIBROV PA, 1991, BIOCHIM BIOPHYS ACTA, V1056, P209, DOI 10.1016/S0005-2728(05)80052-0; DIMROTH P, 1992, ALKALI CATION TRANSP, P77; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HEEFNER DL, 1982, P NATL ACAD SCI-BIOL, V79, P2798, DOI 10.1073/pnas.79.9.2798; IVEY DM, 1993, J BIOL CHEM, V268, P11296; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KARPEL R, 1991, J BIOL CHEM, V266, P21753; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller J. H., 1992, SHORT COURSE BACTERI, P263; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; PADAN E, 1989, J BIOL CHEM, V264, P20297; PADAN E, 1994, BBA-BIOENERGETICS, V1185, P129, DOI 10.1016/0005-2728(94)90204-6; PADAN E, 1992, ALKALI CATION TRANSP, P3; PAN JW, 1990, J BIOL CHEM, V265, P9247; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; ROSEN BP, 1986, ANNU REV MICROBIOL, V40, P263, DOI 10.1146/annurev.mi.40.100186.001403; SKULACHEV VP, 1984, TRENDS BIOCHEM SCI, V9, P483, DOI 10.1016/0968-0004(84)90317-7; SKULACHEV VP, 1988, MEMBRANE BIOENERGETI, P293; TAKASE K, 1993, J BIOL CHEM, V268, P11610; TOKUDA H, 1985, MICROBIOL SCI, V2, P65; Walderhaug M.O., 1987, ION TRANSPORT PROKAR, P85; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087	35	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3816	3822		10.1074/jbc.270.8.3816	http://dx.doi.org/10.1074/jbc.270.8.3816			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876124	hybrid			2022-12-27	WOS:A1995QH68800054
J	RORDORFNIKOLIC, T; VANHORN, DJ; CHEN, DX; WHITE, MF; BACKER, JM				RORDORFNIKOLIC, T; VANHORN, DJ; CHEN, DX; WHITE, MF; BACKER, JM			REGULATION OF PHOSPHATIDYLINOSITOL 3'-KINASE BY TYROSYL PHOSPHOPROTEINS - FULL ACTIVATION REQUIRES OCCUPANCY OF BOTH SH2 DOMAINS IN THE 85-KDA REGULATORY SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR KINASE INSERT; PDGF RECEPTOR; SIGNAL TRANSDUCTION; INSULIN-RECEPTOR; GROWTH-FACTOR; INTACT-CELLS; PHOSPHOINOSITIDE 3-KINASE; PI 3-KINASE; PHOSPHORYLATION; BINDING	Phosphatidylinositol 3'-kinase (PI 3'-kinase) is activated in insulin-stimulated cells by the binding of the SH2 domains in its 85-kDa regulatory subunit to insulin receptor substrate-1 (IRS-1). We have previously shown that both tyrosyl-phosphorylated IRS-l and mono-phosphopeptides containing a single YXXM motif activate PI 3'-kinase in vitro. However, activation by the monophosphopeptides was significantly less potent than activation by the multiply phosphorylated IRS-1. We now show that the increased potency of PI 3'-kinase activation by IRS-1 relative to phosphopeptide is not due to tertiary structural features IRS-l, as PI 3'-kinase is activated normally by denatured, reduced, and carboxymethylated IRS-1. Furthermore, activation of PI 3'-kinase by bis-phosphorylated peptides containing two YXXM motifs is 100-fold more potent than the corresponding mono-phosphopeptides and similar to activation by IRS-1. These data suggest that tyrosyl-phosphorylated IRS-1 or bis-phosphorylated peptides bind simultaneously to both SH2 domains of p85. However, these data cannot differentiate between an activation mechanism that requires two-site occupancy for maximal activity as opposed to one in which bivalent binding enhances the occupancy of a single activating site. To distinguish between these possibilities, we produced recombinant PI 3'-kinase containing either wild-type p85 or p85 mutated in its N-terminal, C-terminal, or both SH2 domains. We find that mutation of either SH2 domains significantly reduced phosphopeptide binding and decreased PI 3'-kinase activation by 50%, whereas mutation of both SH2 domains completely blocked binding and activation. These data provide the first direct evidence that full activation of PI 3'-kinase by tyrosylphosphorylated proteins requires occupancy of both SH2 domains in p85.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,BRONX,NY 10461; BRIGHAM & WOMENS HOSP,JOSLIN DIABET CTR,DEPT MED,DIV RES,BOSTON,MA 02215; HARVARD UNIV,SCH MED,BOSTON,MA 02215	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School					NIDDK NIH HHS [DK-44541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BACKER JM, 1993, J BIOL CHEM, V268, P8204; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; HERBST JJ, 1994, BIOCHEMISTRY-US, V33, P9376, DOI 10.1021/bi00198a002; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HOLT KH, 1994, MOL CELL BIOL, V14, P42, DOI 10.1128/MCB.14.1.42; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; HU P, 1994, MOL CELL BIOL, V14, P2577, DOI 10.1128/MCB.14.4.2577; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LING LE, 1992, J VIROL, V66, P1702, DOI 10.1128/JVI.66.3.1702-1708.1992; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; PANAYOTOU G, 1992, EMBO J, V11, P4261, DOI 10.1002/j.1460-2075.1992.tb05524.x; PARKER PJ, 1993, CELL GROWTH DIFFER, V3, P747; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; VANHORN DJ, 1994, J BIOL CHEM, V269, P29; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; YU JC, 1991, MOL CELL BIOL, V11, P3780, DOI 10.1128/MCB.11.7.3780	35	210	210	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3662	3666		10.1074/jbc.270.8.3662	http://dx.doi.org/10.1074/jbc.270.8.3662			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876105	hybrid			2022-12-27	WOS:A1995QH68800033
J	BORCHELT, DR; GUARNIERI, M; WONG, PC; LEE, MK; SLUNT, HS; XU, ZS; SISODIA, SS; PRICE, DL; CLEVELAND, DW				BORCHELT, DR; GUARNIERI, M; WONG, PC; LEE, MK; SLUNT, HS; XU, ZS; SISODIA, SS; PRICE, DL; CLEVELAND, DW			SUPEROXIDE-DISMUTASE-1 SUBUNITS WITH MUTATIONS LINKED TO FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS DO NOT AFFECT WILD-TYPE SUBUNIT FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS	Mutations in superoxide dismutase 1 (SOD1) have been linked to familial amyotrophic lateral sclerosis, a dominantly inherited motor neuron disorder of midlife. Because SOD1 is a homodimeric enzyme, dimerization of mutant and wild-type SOD1 subunits could dominantly alter the activity, stability, or localization of wild-type SOD1 subunits. To explore these possibilities, we used transient and stable gene transfection to express high levels of either of two mutant human SOD1 subunits in the presence of limited levels of wild-type mouse and/or human SOD1 subunits. Although both mutant subunits displayed diminished half-lives and free radical scavenging activities, their presence caused no change in the half-life or activity of wild-type SOD1 subunits. Our data indicate that mutant subunits do not dominantly affect the function of wild-type SOD1 subunits. These findings, together with observations that many mutant SOD1 subunits retain significant stability and activity, suggest that motor neuron damage in familial amyotrophic lateral sclerosis is caused by the acquisition of injurious properties by mutant SOD1 subunits.	JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Cleveland, Don/AAN-9783-2021; Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682; Cleveland, Don/0000-0002-1934-3682	NIA NIH HHS [AG 05146] Funding Source: Medline; NINDS NIH HHS [NS 20471, NS 27036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471, R37NS027036, R01NS027036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; ELSHAFEY A, 1994, HUM MOL GENET, V3, P363, DOI 10.1093/hmg/3.2.363; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALINOWSKI DP, 1979, BIOCHEMISTRY-US, V18, P237, DOI 10.1021/bi00568a037; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; NAKANO R, 1994, BIOCHEM BIOPH RES CO, V200, P695, DOI 10.1006/bbrc.1994.1506; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; RAINERO I, 1994, NEUROLOGY, V44, P347, DOI 10.1212/WNL.44.2.347; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; SHERMAN L, 1983, P NATL ACAD SCI-BIOL, V80, P5465, DOI 10.1073/pnas.80.18.5465; SIDDIQUE T, 1989, NEUROLOGY, V39, P919, DOI 10.1212/WNL.39.7.919; WEISSMANN C, 1994, SCIENCE, V264, P528, DOI 10.1126/science.7909168; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	26	137	140	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3234	3238		10.1074/jbc.270.7.3234	http://dx.doi.org/10.1074/jbc.270.7.3234			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852409	hybrid			2022-12-27	WOS:A1995QG47100053
J	GONG, ZY; HUI, CC; HEW, CL				GONG, ZY; HUI, CC; HEW, CL			PRESENCE OF ISL-1-RELATED LIM DOMAIN HOMEOBOX GENES IN TELEOST AND THEIR SIMILAR PATTERNS OF EXPRESSION IN BRAIN AND SPINAL-CORD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH INTESTINAL PROTEIN; ZINC FINGER PROTEIN; MESSENGER-RNAS; INSULIN GENE; CELL; ISL-1; HOMEODOMAIN; BINDING; DELETION; FAMILY	Three novel LIM domain homeobox cDNAs encoding proteins structurally related to the Isl-1 protein were isolated from a chinook salmon pituitary cDNA library. Southern blot analysis of genomic DNA indicate that they are derived from three distinct genes, designated as isl-2a, isl-2b, and isl-3 genes. Nucleotide sequence analysis of reverse transcriptase-polymerase chain reaction amplified products reveal that the isl gene family contains two members (a and b) each of both isl-1 and isl-2 genes, and one member of isl-3 gene in the two tetraploid salmonid species, chinook salmon and rainbow trout, and only one member each of isl-1, isl-2, and isl-3 genes in the diploid zebrafish. The expression of the three isl genes in the rainbow trout were studied by reverse transcriptase-polymerase chain reaction analysis of embryonic and adult RNAs, and by in situ hybridization analysis of 8-week-old hatchlings. The transcripts of all three genes could be detected as early as 4 weeks postfertilization (the eye stage) and increased dramatically in 5-week-old embryos. In the adult, the three isl mRNAs appear to be differentially distributed in various tissues. The level of isl-1 mRNA is generally higher than those of isl-2 and isl-3 mRNAs. In situ hybridization analysis indicates that the transcripts of all three genes are localized in subsets of neurons in the brain and spinal cord. In the retina, isl-1 mRNA could be found in both the ganglion and inner nuclear layers while isl-2 and isl-3 mRNAs could only be detected in the ganglion layer. High level of isl-1 mRNA could also be found in mid-gut and interrenal organ where endocrine cells are densely populated. Based on these observations, we speculate that the three structurally related isl genes may play similar roles in cell determination and differentiation in the developing nervous system.	HOSP SICK CHILDREN,RES INST,TORONTO,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON M5G 1L5,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	GONG, ZY (corresponding author), UNIV TORONTO,DEPT CLIN BIOCHEM,100 COLL ST,TORONTO,ON M5G 1L5,CANADA.		Hew, Choy Leong/I-1501-2012; Gong, Zhiyuan/H-8794-2012	Hew, Choy Leong/0000-0002-9441-0064; Gong, Zhiyuan/0000-0002-9660-5260				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ARCHER VEV, 1994, P NATL ACAD SCI USA, V91, P316, DOI 10.1073/pnas.91.1.316; BALTZ R, 1992, PLANT J, V2, P713, DOI 10.1046/j.1365-313X.1992.t01-13-00999.x; BIRKENMEIER EH, 1986, P NATL ACAD SCI USA, V83, P2516, DOI 10.1073/pnas.83.8.2516; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; DANDOYDRON F, 1993, EXP CELL RES, V209, P58, DOI 10.1006/excr.1993.1285; DONG JL, 1991, MOL ENDOCRINOL, V5, P1633, DOI 10.1210/mend-5-11-1633; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FERGUSON EL, 1987, NATURE, V326, P260; FERMALD RD, 1990, VISUAL SYSTEM FISH, P443; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Galea E, 1992, PCR Methods Appl, V2, P66; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gong Zhiyuan, 1994, Molecular Marine Biology and Biotechnology, V3, P243; GONG ZY, 1987, MOL CELL BIOL, V7, P4238, DOI 10.1128/MCB.7.12.4238; GONG ZY, 1992, CAN J ZOOL, V70, P810, DOI 10.1139/z92-114; GONG ZY, 1994, BIOCHEMISTRY-US, V33, P15149, DOI 10.1021/bi00254a026; HEMPE JM, 1991, P NATL ACAD SCI USA, V88, P9671, DOI 10.1073/pnas.88.21.9671; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KORZH V, 1993, DEVELOPMENT, V118, P417; KOSA JL, 1994, BIOCHEMISTRY-US, V33, P468, DOI 10.1021/bi00168a011; LI PM, 1991, P NATL ACAD SCI USA, V88, P9210, DOI 10.1073/pnas.88.20.9210; LI X, 1993, NATURE, V367, P83; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MICHELSEN JW, 1993, P NATL ACAD SCI USA, V90, P4404, DOI 10.1073/pnas.90.10.4404; MIZUNO K, 1994, ONCOGENE, V9, P1605; OHLSSON H, 1991, MOL ENDOCRINOL, V5, P897, DOI 10.1210/mend-5-7-897; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; SIEBERT PD, 1992, NATURE, V359, P577; TAIRA M, 1993, DEV BIOL, V159, P245, DOI 10.1006/dbio.1993.1237; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; WANG M, 1994, ENDOCRINOLOGY, V134, P1416, DOI 10.1210/en.134.3.1416; WANG XK, 1992, J BIOL CHEM, V267, P9176; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	47	29	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3335	3345		10.1074/jbc.270.7.3335	http://dx.doi.org/10.1074/jbc.270.7.3335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852419	hybrid			2022-12-27	WOS:A1995QG47100067
J	KOJRO, E; FAHRENHOLZ, F				KOJRO, E; FAHRENHOLZ, F			LIGAND-INDUCED CLEAVAGE OF THE V-2 VASOPRESSIN RECEPTOR BY A PLASMA-MEMBRANE METALLOPROTEINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; BINDING-SITE; IDENTIFICATION; EXPRESSION; PROTEIN; HORMONE; SUBUNIT; KIDNEY; RAT	The proteolytic cleavage of a G protein-coupled peptide hormone receptor, the renal V-2 vasopressin receptor, by a plasma membrane proteinase was investigated. In the absence of protease inhibitors during incubation of bovine kidney membranes with a photoreactive vasopressin agonist, V-2 receptor truncation leads to a labeled receptor fragment with M(r) 30,000. The V-2 receptor-degrading enzyme could be completely inhibited by zinc ions yielding the native V-2 receptor glycoprotein with M(r) 58,000. Studies with inhibitors of metalloendopeptidases involved in peptide hormone metabolism and with peptide substrates spanning the V-2 receptor cleavage site classify the receptor protease as metalloendoproteinase with specificity for longer substrates. Comparison of the NH2-terminal protein sequence of the truncated M(r) 30,000 V-2 receptor with the sequence deduced from the cDNA of the cloned bovine V-2 receptor shows that cleavage occurs between Gln(92) and Val(93) of the second transmembrane helix close to an extracellular agonist binding site. V-2 receptor proteolysis was dependent on the presence of a hormonal ligand. It occurred rapidly after hormone binding and led to a loss of ligand binding properties of the truncated V-2 receptor. The data suggest that the endogenous V-2 receptor-degrading metalloendoproteinase regulates V-2 receptor function. The novel pathway may contribute to the termination of signal transmission.	MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY	Max Planck Society								BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BOEGE F, 1987, BIOCHEMISTRY-US, V26, P2418, DOI 10.1021/bi00383a004; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; CHASE LR, 1968, SCIENCE, V159, P545, DOI 10.1126/science.159.3814.545; CRAUSE P, 1982, MOL CELL ENDOCRINOL, V28, P529, DOI 10.1016/0303-7207(82)90144-7; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; FAHRENHOLZ F, 1985, EUR J BIOCHEM, V152, P589, DOI 10.1111/j.1432-1033.1985.tb09236.x; FAHRENHOLZ F, 1988, J RECEPTOR RES, V8, P283, DOI 10.3109/10799898809048993; FAHRENHOLZ F, 1986, ENDOCRINOLOGY, V118, P1026, DOI 10.1210/endo-118-3-1026; FAHRENHOLZ F, 1984, EUR J PHARMACOL, V100, P47, DOI 10.1016/0014-2999(84)90314-5; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; GORBULEV V, 1993, EUR J BIOCHEM, V215, P1, DOI 10.1111/j.1432-1033.1993.tb18000.x; HECHTER O, 1978, J BIOL CHEM, V253, P3219; KIMURA T, 1992, NATURE, V356, P526, DOI 10.1038/356526a0; KOJRO E, 1993, BIOCHEMISTRY-US, V32, P13537, DOI 10.1021/bi00212a020; KOZUKA M, 1991, J BIOL CHEM, V26, P16892; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN KS, 1991, BIOCHEMISTRY-US, V30, P2613, DOI 10.1021/bi00224a007; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; MAIRE J, 1988, MOL PHARMACOL, V33, P432; MOREL A, 1992, NATURE, V356, P523, DOI 10.1038/356523a0; ORLOFF J, 1967, AM J MED, V42, P757, DOI 10.1016/0002-9343(67)90093-9; ORLOWSKI M, 1988, BIOCHEMISTRY-US, V27, P597, DOI 10.1021/bi00402a015; OSTROWSKI J, 1992, ANNU REV PHARMACOL, V32, P167, DOI 10.1146/annurev.pharmtox.32.1.167; PRICE JS, 1991, BRIT J PHARMACOL, V104, P321, DOI 10.1111/j.1476-5381.1991.tb12429.x; SAITO Y, 1991, J BIOL CHEM, V266, P23433; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; WESCH D, 1984, ANAL BIOCHEM, V138, P141; WILLIAMS CH, 1993, BIOCHEM J, V294, P681, DOI 10.1042/bj2940681	32	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6476	6481		10.1074/jbc.270.12.6476	http://dx.doi.org/10.1074/jbc.270.12.6476			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896781	hybrid			2022-12-27	WOS:A1995QQ85500011
J	BELKIN, AM; BURRIDGE, K				BELKIN, AM; BURRIDGE, K			ASSOCIATION OF ACICULIN WITH DYSTROPHIN AND UTROPHIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; TISSUE DISTRIBUTION; SUBCELLULAR-DISTRIBUTION; ACETYLCHOLINE-RECEPTORS; ELECTRIC TISSUE; TERMINAL DOMAIN; SMOOTH-MUSCLE; GENE-PRODUCT; PROTEIN	Aciculin is a recently identified 60-kDa cytoskeletal protein, highly homologous to the glycolytic enzyme phosphoglucomutase type 1, (Belkin, A. M., Klimanskaya, I. V., Lukashev, M. E., Lilley, K., Critchley, D., and Koteliansky, V.E. (1994) J. Cell Sci. 107, 159-173). Aciculin expression in skeletal muscle is developmentally regulated, and this protein is particularly enriched at cell-matrix adherens junctions of muscle cells (Belkin, A. M., and Burridge, K. (1994) J. Cell Sci. 107, 1993-2003). The purpose of our study was to identify cytoskeletal protein(s) interacting with aciculin in various cell types. Using immunoprecipitation from cell lysates of metabolically labeled differentiating C2C12 muscle cells with anti-aciculin-specific antibodies, we detected a high molecular weight band (M(r) similar to 400,000), consistently coprecipitating with aciculin. We showed that this 400 kDa band comigrated with dystrophin and immunoblotted with anti-dystrophin antibodies. The association between aciculin and dystrophin in C2C12 cells was shown to resist Triton X-100 extraction and the majority of the complex could be extracted only in the presence of ionic detergents. In the reverse immunoprecipitation experiments, aciculin was detected in the precipitates with different anti-dystrophin antibodies. Immunodepletion experiments with lysates of metabolically labeled C2C12 myotubes showed that aciculin is a major dystrophin-associated protein in cultured skeletal muscle cells. Double immunostaining of differentiating and mature C2C12 myotubes with antibodies against aciculin and dystrophin revealed precise colocalization of these two cytoskeletal proteins throughout the process of myodifferentiation in culture. In skeletal muscle tissue, both proteins are concentrated at the sarcolemma and at myotendinous junctions. In contrast, utrophin, an autosomal homologue of dystrophin, was not codistributed with aciculin in muscle cell cultures and in skeletal muscle tissues. Analytical gel filtration experiments with purified aciculin and dystrophin showed interaction of these proteins in vitro, indicating that their association in skeletal muscle is due to direct binding. Whereas dystrophin was shown to be a major aciculin-associated protein in skeletal muscle, immunoblotting of anti-aciculin immunoprecipitates with antibodies against utrophin showed that aciculin is associated with utrophin in cultured A7r5 smooth muscle cells and REF52 fibroblasts. Immunodepletion experiments performed with lysates of metabolically labeled A7r5 cells demonstrated that aciculin is a major utrophin-binding protein in this cell type. Taken together, our data show that aciculin is a novel dystrophin- and utrophin-binding protein. Association of aciculin with dystrophin (utrophin) in various cell types might provide an additional cytoskeletal-matrix transmembrane link at sites where actin filaments terminate at the plasma membrane.			BELKIN, AM (corresponding author), UNIV N CAROLINA,DEPT CELL BIOL & ANAT,CHAPEL HILL,NC 27599, USA.				NIGMS NIH HHS [GM 29860] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; BELKIN AM, 1994, J CELL SCI, V107, P159; BELKIN AM, 1994, J CELL SCI, V107, P1993; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARTAUD A, 1993, J BIOL CHEM, V268, P13019; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; DAVISON MD, 1988, CELL, V52, P159, DOI 10.1016/0092-8674(88)90503-X; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FABBRIZIO E, 1993, BIOCHEMISTRY-US, V32, P10457, DOI 10.1021/bi00090a023; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1987, SCIENCE, V238, P347, DOI 10.1126/science.3659917; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; KELLY T, 1987, J BIOL CHEM, V262, P17189; KHURANA TS, 1992, J CELL BIOL, V119, P357, DOI 10.1083/jcb.119.2.357; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAMARCY NR, 1994, J BIOL CHEM, V269, P2870; KRAMARCY NR, 1990, FEBS LETT, V272, P171; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKONISHOK M, 1992, DEV BIOL, V152, P209, DOI 10.1016/0012-1606(92)90129-5; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEMAIRE C, 1988, EMBO J, V7, P4157, DOI 10.1002/j.1460-2075.1988.tb03311.x; LEV AA, 1987, J BIOL CHEM, V262, P15817; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; MASUDA T, 1992, J CELL BIOL, V119, P543, DOI 10.1083/jcb.119.3.543; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1993, FEBS LETT; MATSUMURA K, 1992, NATURE, V320, P276; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NOURSADEGHI M, 1993, FEBS LETT, V320, P155, DOI 10.1016/0014-5793(93)80082-6; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PORTER GA, 1992, J CELL BIOL, V117, P997, DOI 10.1083/jcb.117.5.997; RAPAPORT D, 1992, DIFFERENTIATION, V49, P187, DOI 10.1111/j.1432-0436.1992.tb00666.x; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; STRAUB V, 1992, J CELL BIOL, V119, P1183, DOI 10.1083/jcb.119.5.1183; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; TANAKA H, 1991, HISTOCHEMISTRY, V96, P1, DOI 10.1007/BF00266753; THIMAN N, 1992, FEBS LETT, V308, P154; THIMAN N, 1991, J CELL BIOL, V115, P1695; TIDBALL JG, 1991, AM J PATHOL, V138, P17; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; WAY M, 1992, FEBS LETT, V301, P243, DOI 10.1016/0014-5793(92)80249-G; YANG B, 1994, J BIOL CHEM, V269, P6040; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; ZYBRYCKAGAARN EE, 1988, NATURE, V333, P466	69	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6328	6337		10.1074/jbc.270.11.6328	http://dx.doi.org/10.1074/jbc.270.11.6328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890770	hybrid, Green Published			2022-12-27	WOS:A1995QM94500092
J	NESSI, C; ALBERTINI, AM; SPERANZA, ML; GALIZZI, A				NESSI, C; ALBERTINI, AM; SPERANZA, ML; GALIZZI, A			THE OUTB GENE OF BACILLUS-SUBTILIS CODES FOR NAD SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; GERMINATION; EXPRESSION; CLONING; SPORES	The outB gene of Bacillus subtilis is involved in spore germination and outgrowth and is essential for growth, The OutB protein was obtained by expression in Escherichia coli and purified to apparent homogeneity, Here we report experiments showing that OutB is a NH3-dependent NAD synthetase, the enzyme that catalyzes the final reaction in the biosynthesis of NAD. The enzyme is composed of two identical subunits of 30,240 Da and is NH3-dependent, whereas glutamine is inefficient as an amide donor, The NAH synthetase is highly resistant to heat, with a half-time of inactivation at 100 degrees C of 13 min. A mutant NAD synthetase was purified from a B. subtilis strain temperature-sensitive during spore germination and outgrowth, The mutant enzyme was 200 times less active than the wild-type one, with a lower temperature optimum and a non-hyperbolic kinetic versus NH4+. The time course of synthesis of OutB showed that synthesis of the enzyme started during germination and outgrowth, and reached the highest level at the end of exponential growth, The enzyme could be recovered from dormant spores.	UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL,I-27100 PAVIA,ITALY; UNIV PAVIA,DIPARTMENTO BIOCHIM,I-27100 PAVIA,ITALY; UNIV PAVIA,CTR INTERUNIV STUDIO MACROMOLEC INFORMAZ,I-27100 PAVIA,ITALY	University of Pavia; University of Pavia; University of Pavia								ALBERTINI AM, 1988, GENE DEV, V2, P1381, DOI 10.1101/gad.2.11.1381; ALBERTINI AM, 1990, J BACTERIOL, V172, P5482, DOI 10.1128/jb.172.9.5482-5485.1990; ALBERTINI AM, 1975, J BACTERIOL, V124, P14, DOI 10.1128/JB.124.1.14-25.1975; ALBERTINI AM, 1987, J BACTERIOL, V169, P1480, DOI 10.1128/jb.169.4.1480-1484.1987; ALLIBERT P, 1987, J BACTERIOL, V169, P260, DOI 10.1128/jb.169.1.260-271.1987; Anagnostopoulos C., 1993, P425; BERGMEYER U, 1974, METHOD ENZYMAT AN, V4, P2048; CARAMORI T, 1993, J GEN MICROBIOL, V139, P31, DOI 10.1099/00221287-139-1-31; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HUGHES KT, 1988, J BACTERIOL, V170, P2113, DOI 10.1128/jb.170.5.2113-2120.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MITCHELL C, 1992, J BACTERIOL, V174, P2474, DOI 10.1128/jb.174.8.2474-2477.1992; Sambrook J, 1989, MOL CLONING LABORATO; SAXTON RE, 1968, BIOCHIM BIOPHYS ACTA, V156, P77, DOI 10.1016/0304-4165(68)90106-2; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P701; SETLOW B, 1977, J BACTERIOL, V129, P857, DOI 10.1128/JB.129.2.857-865.1977; SETLOW P, 1975, J BIOL CHEM, V250, P8168; SICCARDI AG, 1975, J BACTERIOL, V121, P13, DOI 10.1128/JB.121.1.13-19.1975; SPENCER RL, 1967, J BIOL CHEM, V242, P385; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; SUN DX, 1991, J BACTERIOL, V173, P3831, DOI 10.1128/JB.173.12.3831-3845.1991; TRITZ GJ, 1987, ESCHERICHIA COLI SAL, P557; WILLISON JC, 1994, J BACTERIOL, V176, P3400, DOI 10.1128/jb.176.11.3400-3402.1994; YU CK, 1972, J BIOL CHEM, V247, P4794	24	44	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6181	6185		10.1074/jbc.270.11.6181	http://dx.doi.org/10.1074/jbc.270.11.6181			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890752	hybrid			2022-12-27	WOS:A1995QM94500069
J	EGAN, MG; SIRLIN, S; RUMBERGER, BG; GARROW, TA; SHANE, B; SIROTNAK, FM				EGAN, MG; SIRLIN, S; RUMBERGER, BG; GARROW, TA; SHANE, B; SIROTNAK, FM			RAPID DECLINE IN FOLYLPOLYGLUTAMATE SYNTHETASE-ACTIVITY AND GENE-EXPRESSION DURING MATURATION OF HL-60 CELLS - NATURE OF THE EFFECT, IMPACT ON FOLATE COMPOUND POLYGLUTAMATE POOLS, AND EVIDENCE FOR PROGRAMMED DOWN-REGULATION DURING MATURATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTO-TOXICITY; TUMOR-CELLS; METHOTREXATE; TRANSPORT; LEUKEMIA; MOUSE; DIFFERENTIATION; PURIFICATION; RESISTANCE; ANALOGS	These studies in HL-60 cells examined the regulation of folylpolyglutamate synthetase (FPGS) activity at the level of gene expression during terminal maturation. Following addition of 210 mM Me(2)SO to cultures of HL-60 cells at a concentration that induces maturation of 85-90% of the cells, FPGS activity, but not folylpolyglutamate hydrolase (FPGH) activity, was reduced 2-7-fold within 1-5 days. The initial decline in FPGS activity preceded any effect of Me(2)SO on rate of growth and the increase in appearance of nitro blue tetrazolium-positive cells, a marker of cellular maturation, and the decrease after 5 days of exposure to Me(2)SO was solely accounted for by a 7-fold decrease in value for V-max. The same time and concentration dependence for Me(2)SO was shown for the decline in FPGS activity, increase in nitro blue tetrazolium-positive cells, and decline in the level of a 2.1-kilobase FPGS mRNA during exposure to this inducer. This decline in FPGS mRNA was reversible when Me(2)SO was removed from the culture medium but only until that time when an appreciable number of cells were committed to terminal maturation. Following growth of HL-60 cells with [H-3]MTX, used as a model folate compound, a large reduction in its intracellular polyglutamate pools was shown during maturation which quantitatively reflected the decline in FPGS activity as well as folate transport inward (Sirotnak, F. M., Jacobson, D. M., and Yang, C-H. (1986) J. Biol. Chem. 261, 11150-11156). Other data showed that folate status or obviation of the folate requirement during growth of these cells strongly influenced the rapidity of the onset of maturation following exposure to inducer. Overall, these results show that FPGS activity in HL 60 cells is a marker for proliferative capacity and that the underlying basis for the decline in FPGS activity during maturation is altered cognate gene expression which is manifested as early reversible and late irreversible phases. They also suggest that the coordinate reduction observed in folate transport, FPGS activity, dihydrofolate reductase, and probably other folate related enzymes by limiting macromolecular biosynthesis may be early programmed events in the maturation process that influence the switch from proliferation to senescence in these cells.	MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL & THERAPEUT, NEW YORK, NY 10021 USA; CORNELL UNIV, GRAD SCH MED SCI, NEW YORK, NY 10021 USA; UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Berkeley					NATIONAL CANCER INSTITUTE [P30CA008748, R01CA022764, R35CA056517] Funding Source: NIH RePORTER; NCI NIH HHS [CA22764, CA08748, CA56517] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BARREDO J, 1992, MOL PHARMACOL, V42, P687; BARRUECO JR, 1992, J BIOL CHEM, V267, P15356; BLOCH A, 1993, LEUKEMIA, V7, P1219; CHELLO PL, 1982, BIOCHEM PHARMACOL, V31, P1527, DOI 10.1016/0006-2952(82)90376-8; CORIN RE, 1984, J BIOL CHEM, V259, P206; Egan M. G., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P275; FABRE I, 1984, CANCER RES, V44, P3190; FANUCCHI MP, 1987, CANCER RES, V47, P2334; GALLAGHER R, 1979, BLOOD, V54, P713; GARROW TA, 1992, P NATL ACAD SCI USA, V89, P9151, DOI 10.1073/pnas.89.19.9151; GOLDMAN ID, 1986, INT ENCY PHARM THERA, P283; GRINDEY GB, 1984, FOLATE ANTAGONISTS T, V1, P290; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; KISLIUK RL, 1981, MOL CELL BIOCHEM, V39, P331, DOI 10.1007/BF00232583; KISLIUK RL, 1984, FOLATE ANTAGONISTS T, V1, P2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; MORAN RG, 1985, MOL PHARMACOL, V27, P156; MORAN RG, 1984, BIOCHEMISTRY-US, V23, P4580, DOI 10.1021/bi00315a011; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POSER RG, 1981, CANCER RES, V41, P4441; PRIEST DG, 1991, J NATL CANCER I, V83, P1806, DOI 10.1093/jnci/83.24.1806; RHEE MS, 1993, CANCER RES, V53, P2227; RUMBERGER BG, 1990, CANCER COMMUN, V2, P305; RUMBERGER BG, 1990, CANCER RES, V50, P4639; SAMUELS LL, 1986, CANCER RES, V46, P2230; SAMUELS LL, 1985, CANCER RES, V45, P1488; SHANE B, 1989, VITAM HORM, V45, P263; SIROTNAK FM, 1988, BIOCHEM PHARMACOL, V37, P4239, DOI 10.1016/0006-2952(88)90122-0; SIROTNAK FM, 1985, CANCER RES, V45, P3992; SIROTNAK FM, 1986, J BIOL CHEM, V261, P1150; SIROTNAK FM, 1984, FOLATE ANTAGONISTS T, V2, P43; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; YANG CH, 1992, J BIOL CHEM, V267, P6628	38	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5462	5468		10.1074/jbc.270.10.5462	http://dx.doi.org/10.1074/jbc.270.10.5462			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890662	hybrid			2022-12-27	WOS:A1995QL58000078
J	HU, YM; KOHLHAW, GB				HU, YM; KOHLHAW, GB			ADDITIVE ACTIVATION OF YEAST LEU4 TRANSCRIPTION BY MULTIPLE CIS-ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ISOPROPYLMALATE SYNTHASE; AMINO-ACID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; RESPONSIVE ELEMENTS; GENERAL CONTROL; NUCLEOTIDE-SEQUENCE; HIS4 TRANSCRIPTION; REGULATORY GENE; GCN4 PROTEIN; PROMOTER	The LEU4 gene of Saccharomyces cerevisiae and the enzyme encoded by LEU4, alpha-isopropylmalate synthase, occupy a special position in amino acid metabolism. alpha-Isopropylmalate synthase catalyzes the first committed step in leucine biosynthesis. However, the reaction product alpha-isopropylmalate is not only an intermediate in the leucine biosynthetic pathway, but also functions as co activator of at least six genes, both within and outside of the leucine pathway. The metabolic importance of alpha-isopropylmalate appears to be reflected in the surprisingly multifaceted regulation of LEU4 expression. This report describes an analysis of functional cis elements in the LEU4 promoter. Five such elements were identified. Three distal elements, designated UAS(LEU), GCE-A, and GCE-B, are responsible for regulation by the regulatory proteins Leu3p and Gcn4p, respectively. The incremental activation of LEU4 by these elements is additive and independent. In addition, two proximal elements were localized. One of these con forms to the TATA consensus sequence and exhibits high affinity for TATA binding protein. The other element shows strong sequence identity with the Bas2p binding site and appears to be involved in basal and phosphate-mediated regulation of LEU4.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIGMS NIH HHS [GM15102] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; BAI YL, 1991, NUCLEIC ACIDS RES, V19, P5991, DOI 10.1093/nar/19.21.5991; BAICHWAL VR, 1983, CURR GENET, V7, P369, DOI 10.1007/BF00445877; BELTZER JP, 1988, J BIOL CHEM, V263, P368; BELTZER JP, 1986, J BIOL CHEM, V261, P5160; BRANDL CJ, 1989, P NATL ACAD SCI USA, V86, P2652, DOI 10.1073/pnas.86.8.2652; BRISCO PRG, 1990, J BIOL CHEM, V265, P11667; CHANG LFL, 1984, GENETICS, V108, P91; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; DAVIS LG, 1986, BASIC METHODS MOL BI, P250; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; EMAMI KH, 1992, EMBO J, V11, P5005, DOI 10.1002/j.1460-2075.1992.tb05607.x; FALCO SC, 1985, NUCLEIC ACIDS RES, V13, P4011, DOI 10.1093/nar/13.11.4011; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FRIDEN P, 1988, MOL CELL BIOL, V8, P2690, DOI 10.1128/MCB.8.7.2690; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAMPSEY DM, 1981, J BIOL CHEM, V256, P3791; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HU YM, 1995, MOL CELL BIOL, V15, P52, DOI 10.1128/MCB.15.1.52; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LITSKE JG, 1986, NUCLEIC ACIDS RES, V14, P9631, DOI 10.1093/nar/14.24.9631; LOPES JM, 1993, J BACTERIOL, V175, P4235, DOI 10.1128/JB.175.13.4235-4238.1993; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; LUCHE RM, 1990, MOL CELL BIOL, V10, P3884, DOI 10.1128/MCB.10.8.3884; MOSCH HU, 1990, EMBO J, V9, P2951, DOI 10.1002/j.1460-2075.1990.tb07487.x; MOSCH HU, 1991, J BIOL CHEM, V266, P20453; OSHIMA H, 1993, J BIOL CHEM, V268, P26858; PELLMAN D, 1990, NATURE, V348, P82, DOI 10.1038/348082a0; PETERS MH, 1990, ARCH BIOCHEM BIOPHYS, V276, P294, DOI 10.1016/0003-9861(90)90041-V; REMBOUTSIKA E, 1994, MOL CELL BIOL, V14, P5547, DOI 10.1128/MCB.14.8.5547; REMBOUTSIKA E, 1994, THESIS PURDUE U W LA; RUBIN GM, 1974, EUR J BIOCHEM, V41, P197, DOI 10.1111/j.1432-1033.1974.tb03260.x; SCHMIDHEINI T, 1990, MOL GEN GENET, V224, P57, DOI 10.1007/BF00259451; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; STRUHL K, 1987, MOL CELL BIOL, V7, P104, DOI 10.1128/MCB.7.1.104; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; ZHOU K, 1990, J BIOL CHEM, V265, P17409	45	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5270	5275		10.1074/jbc.270.10.5270	http://dx.doi.org/10.1074/jbc.270.10.5270			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890638	hybrid			2022-12-27	WOS:A1995QL58000050
J	RIIKONEN, A; TIKKANEN, R; JALANKO, A; PELTONEN, L				RIIKONEN, A; TIKKANEN, R; JALANKO, A; PELTONEN, L			IMMEDIATE INTERACTION BETWEEN THE NASCENT SUBUNITS AND 2 CONSERVED AMINO-ACIDS TRP(34) AND THR(206) ARE NEEDED FOR THE CATALYTIC ACTIVITY OF ASPARTYLGLUCOSAMINIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATION; LIVER; COMPLEX; DISEASE; CDNA	Aspartylglucosaminidase (AGA, EC 3.5.1.26) is a dimeric lysosomal hydrolase involved in the degradation of glycoproteins, The synthesized precursor polypeptide of AGA is rapidly activated in the endoplasmic reticulum by proteolysis into two subunits, Expression of the alpha- and beta-subunits of AGA in separate cDNA constructs showed that independently folded subunits totally lack enzyme activity, and even when co-expressed in vitro they fail to produce an active heterodimer of the enzyme, Both of the subunits are required for the enzyme activity, and the immediate interaction of the subunits in the endoplasmic reticulum is necessary for the correct folding of the dimeric enzyme molecule. The specific amino acid residues essential for the active site of the AGA enzyme were further analyzed by site directed mutagenesis and in vitro expression of mutagenized constructs, Replacement of Thr(206), the most aminoterminal residue of the beta-subunit, with Ser resulted in a complete loss of enzyme activity without influencing intracellular processing or transport of the mutant polypeptide to the lysosomes, Analogously, replacement of the most amino-terminal tryptophan, Trp(34) with Phe or Ser in the alpha-subunit, resulted in a totally inactive enzyme without influencing the intracellular processing or stability of the polypeptide, These results suggest that the catalytic center of this amidase is formed by the interaction of the amino-terminal parts of two subunits and requires both Trp(34) in the alpha-subunit and Thr(206) in the beta-subunit.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND	Finland National Institute for Health & Welfare				Tikkanen, Ritva/0000-0002-8393-1825				AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; Autio S, 1972, J Ment Defic Res, V1, P1; BROWN CA, 1993, AM J HUM GENET, V53, P497; DUGAL B, 1977, BIOCHEM J, V165, P497, DOI 10.1042/bj1650497; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FISHER KJ, 1993, FEBS LETT, V323, P271, DOI 10.1016/0014-5793(93)81355-4; HALILA R, 1991, BIOCHEM J, V276, P251, DOI 10.1042/bj2760251; IKONEN E, 1993, EMBO J, V12, P295, DOI 10.1002/j.1460-2075.1993.tb05656.x; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; IKONEN E, 1991, GENOMICS, V11, P206, DOI 10.1016/0888-7543(91)90120-4; IKONEN E, 1991, P NATL ACAD SCI USA, V88, P11222, DOI 10.1073/pnas.88.24.11222; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; KOHNO M, 1972, BIOCHIM BIOPHYS ACTA, V258, P600, DOI 10.1016/0005-2744(72)90252-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINO M, 1966, BIOCHEM BIOPH RES CO, V24, P961, DOI 10.1016/0006-291X(66)90344-5; MAKINO M, 1968, J BIOCHEM, V63, P186, DOI 10.1093/oxfordjournals.jbchem.a128760; MAURY P, 1980, J LAB CLIN MED, V96, P838; POLLITT RJ, 1968, LANCET, V2, P253; RIIKONEN A, 1994, DNA CELL BIOL, V13, P257, DOI 10.1089/dna.1994.13.257; SAVOLAINEN H, 1976, BIOCHEM J, V153, P749, DOI 10.1042/bj1530749; Spande T.F., 1967, DETERMINATION TRYPTO, P498; STACEY A, 1990, NUCLEIC ACIDS RES, V18, P2829, DOI 10.1093/nar/18.9.2829; TIKKANEN R, 1995, IN PRESS DNA CELL BI; TOLLERSRUD OK, 1992, BIOCHEM J, V282, P891, DOI 10.1042/bj2820891; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P	25	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4903	4907		10.1074/jbc.270.9.4903	http://dx.doi.org/10.1074/jbc.270.9.4903			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876264	hybrid			2022-12-27	WOS:A1995QK08400102
J	ZGOMBICKNIGHT, M; FOGLIO, MH; DUESTER, G				ZGOMBICKNIGHT, M; FOGLIO, MH; DUESTER, G			GENOMIC STRUCTURE AND EXPRESSION OF THE ADH7 GENE ENCODING HUMAN CLASS-IV ALCOHOL-DEHYDROGENASE, THE FORM MOST EFFICIENT FOR RETINOL METABOLISM IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; BINDING-PROTEIN; TRANSCRIPTION INITIATION; NUCLEOTIDE-SEQUENCE; MOLECULAR ANALYSIS; MOUSE EPIDERMIS; MESSENGER-RNAS; HUMAN STOMACH; BETA-SUBUNIT; ACID	Human alcohol dehydrogenase (ADH) consists of a family of five evolutionarily related classes of enzymes that collectively function in the metabolism of a wide variety of alcohols including ethanol and retinol, Class TV ADH has been found to be the most active as a retinol dehydrogenase, thus it may participate in retinoic acid synthesis, The gene encoding class IV ADH (ADH7) has now been cloned and subjected to molecular examination, Southern blot analysis indicated that class TV ADH is encoded by a single unique gene and has no related pseudogenes. The class TV ADH gene is divided into nine exons, consistent with the highly conserved intron/exon structure of other mammalian ADH genes, The predicted amino acid sequence of the exon coding regions indicates that a protein of 373 amino acids, excluding the amino-terminal methionine, would be translated, sharing greater sequence identity with class I ADH (69%) than with classes II, III, or V (59-61%), Expression of class Pr ADH mRNA was detected in human stomach but not liver, This correlates with previous protein studies, which have indicated that class IV ADH is the major stomach ADH but unlike other ADHs is absent from liver, Primer extension studies using human stomach RNA were performed to identify the transcription initiation site lying 100 base pairs upstream of the ATG translation start codon. Nucleotide sequence analysis of the promoter region indicated the absence of a TATA box sequence often located about 25 base pairs upstream of the start site as well as the absence of GC boxes, which are quite often seen in promoters lacking a TATA box. The class TV ADH promoter thus differs from the other ADH promoters, which contain either a TATA box (classes I and II) or CC-boxes (class III), suggesting a fundamentally different form of transcriptional regulation.	LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037	Sanford Burnham Prebys Medical Discovery Institute				Duester, Gregg/0000-0003-4335-3650	NIAAA NIH HHS [AA07261] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007261] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AUSUBEL FM, 1989, CURRENT PROTOTOCOLS, V2; BILANCHONE V, 1986, NUCLEIC ACIDS RES, V14, P3911, DOI 10.1093/nar/14.9.3911; BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CARCAMO J, 1990, GENE DEV, V4, P1611, DOI 10.1101/gad.4.9.1611; CECI JD, 1987, GENE, V59, P171, DOI 10.1016/0378-1119(87)90325-8; CONNOR MJ, 1987, BIOCHEM J, V244, P489, DOI 10.1042/bj2440489; CONNOR MJ, 1988, CANCER RES, V48, P7038; CRABB DW, 1989, GENOMICS, V5, P906, DOI 10.1016/0888-7543(89)90133-X; DANIELSSON O, 1994, P NATL ACAD SCI USA, V91, P4980, DOI 10.1073/pnas.91.11.4980; DANIELSSON O, 1992, P NATL ACAD SCI USA, V89, P9247, DOI 10.1073/pnas.89.19.9247; DE LUCA LM, 1991, FASEB J, V5, P2924; DESIMONE V, 1992, BIOCHIM BIOPHYS ACTA, V1132, P119, DOI 10.1016/0167-4781(92)90001-G; DUESTER G, 1991, MOL CELL BIOL, V11, P1638, DOI 10.1128/MCB.11.3.1638; DUESTER G, 1986, J BIOL CHEM, V261, P2027; FARRES J, 1994, EUR J BIOCHEM, V224, P549, DOI 10.1111/j.1432-1033.1994.00549.x; GIRI PR, 1989, BIOCHEM BIOPH RES CO, V164, P453, DOI 10.1016/0006-291X(89)91741-5; HEDEN LO, 1986, FEBS LETT, V194, P327, DOI 10.1016/0014-5793(86)80111-9; HOOG JO, 1987, BIOCHEMISTRY-US, V26, P1926, DOI 10.1021/bi00381a021; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; HUR MW, 1992, GENE, V121, P305, DOI 10.1016/0378-1119(92)90135-C; IKUTA T, 1986, BIOCHEM BIOPH RES CO, V140, P1020, DOI 10.1016/0006-291X(86)90737-0; JORNVALL H, 1987, P NATL ACAD SCI USA, V84, P2580, DOI 10.1073/pnas.84.9.2580; JORNVALL H, 1993, ADV EXP MED BIOL, V328, P533; KIM CI, 1992, ARCH BIOCHEM BIOPHYS, V294, P388, DOI 10.1016/0003-9861(92)90700-7; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MATSUO Y, 1989, FEBS LETT, V243, P57, DOI 10.1016/0014-5793(89)81217-7; MATSUO Y, 1990, AM J HUM GENET, V46, P85; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORENO A, 1991, J BIOL CHEM, V266, P1128; PARES X, 1994, P NATL ACAD SCI USA, V91, P1893, DOI 10.1073/pnas.91.5.1893; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; Sambrook J, 1989, MOL CLONING LABORATO; SATRE MA, 1994, J BIOL CHEM, V269, P15606; STEWART MJ, 1990, GENE, V90, P271, DOI 10.1016/0378-1119(90)90190-3; STONE CL, 1993, ALCOHOL CLIN EXP RES, V17, P911, DOI 10.1111/j.1530-0277.1993.tb00863.x; VANBAHRLINDSTRO.H, 1986, BIOCHEMISTRY-US, V25, P2465; VANOOIJ C, 1992, MOL CELL BIOL, V12, P3023, DOI 10.1128/MCB.12.7.3023; VONBAHRLINDSTROM H, 1991, GENE, V103, P269, DOI 10.1016/0378-1119(91)90285-J; YANG ZN, 1994, ALCOHOL CLIN EXP RES, V18, P587, DOI 10.1111/j.1530-0277.1994.tb00914.x; YASUNAMI M, 1991, P NATL ACAD SCI USA, V88, P7610, DOI 10.1073/pnas.88.17.7610; YIN SJ, 1993, ALCOHOL CLIN EXP RES, V17, P376, DOI 10.1111/j.1530-0277.1993.tb00779.x; YIN SJ, 1990, BIOCHEM INT, V22, P829; YIN SJ, 1988, BIOCHEM GENET, V26, P343; YOKOYAMA H, 1994, BIOCHEM BIOPH RES CO, V203, P219, DOI 10.1006/bbrc.1994.2170; ZHANG K, 1987, GENE, V57, P27, DOI 10.1016/0378-1119(87)90173-9	48	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4305	4311		10.1074/jbc.270.9.4305	http://dx.doi.org/10.1074/jbc.270.9.4305			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876191	hybrid			2022-12-27	WOS:A1995QK08400022
J	BUSCH, AE; WALDEGGER, S; HERZER, T; RABER, G; GULBINS, E; TAKUMI, T; MORIYOSHI, H; NAKANISHI, S; LANG, F				BUSCH, AE; WALDEGGER, S; HERZER, T; RABER, G; GULBINS, E; TAKUMI, T; MORIYOSHI, H; NAKANISHI, S; LANG, F			MOLECULAR-BASIS OF I-SK PROTEIN-REGULATION BY OXIDATION OR CHELATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; XENOPUS-OOCYTES; INDUCED ARRHYTHMIAS; MEMBRANE-PROTEIN; MINK CHANNELS; KINASE-C; ISK; K+; MUTATIONS; CLONING	Slowly activating I-sK channels were expressed in Xenopus oocytes and exposed to oxidative agents. Oxidative treatment reduced the resulting current I-sK, while no inhibition was observed for I-sK protein mutants carrying a Ser mutation instead of a highly conserved Cys residue in the intracellular domain. In contrast, Hg2+, which may not only oxidize thiol groups but also form chelates with dibasic amino acids, caused a use-dependent, positive regulation of I-sK. This effect was reversed in an I-sK protein mutant with a deletion in the extracellular domain. These data suggest opposite effects of peroxides and Hg2+ on I-sK, a peroxide-mediated I-sK inhibition by intracellular oxidation and a Hg2+-mediated I-sK increase, caused by extracellular Hg2+ chelation of the I-sK protein.	OSAKA UNIV,FAC MED,DEPT PHARMACOL,SUITA,OSAKA 565,JAPAN; KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN	Osaka University; Kyoto University	BUSCH, AE (corresponding author), UNIV TUBINGEN,INST PHYSIOL 1,D-72076 TUBINGEN,GERMANY.		Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342				ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; BUSCH AE, 1992, J PHYSIOL-LONDON, V450, P491, DOI 10.1113/jphysiol.1992.sp019138; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; BUSCH AE, 1994, BIOCHEM BIOPH RES CO, V202, P265, DOI 10.1006/bbrc.1994.1922; BUSCH AE, 1994, MOL PHARMACOL, V46, P750; BUSCH AE, 1993, CELL PHYSIOL BIOCHEM, V3, P270, DOI 10.1159/000154692; BUSCH AE, 1993, FEBS LETT, V334, P221, DOI 10.1016/0014-5793(93)81715-C; BUSCH AE, 1993, BIOCHEM BIOPH RES CO, V197, P473, DOI 10.1006/bbrc.1993.2503; CERBAI E, 1991, CIRCULATION, V84, P1773, DOI 10.1161/01.CIR.84.4.1773; FREEMAN LC, 1993, CIRC RES, V73, P968, DOI 10.1161/01.RES.73.5.968; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; HICE RE, 1994, PFLUG ARCH EUR J PHY, V426, P139, DOI 10.1007/BF00374681; HONORE E, 1992, EMBO J, V10, P2805; MURAI T, 1989, BIOCHEM BIOPH RES CO, V161, P176, DOI 10.1016/0006-291X(89)91577-5; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; VARNUM MD, 1993, P NATL ACAD SCI USA, V90, P11528, DOI 10.1073/pnas.90.24.11528; VARNUM MD, 1993, BIOPHYS J, V64, pA198; WOODWARD B, 1985, J MOL CELL CARDIOL, V17, P485, DOI 10.1016/S0022-2828(85)80053-5	20	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3638	3641		10.1074/jbc.270.8.3638	http://dx.doi.org/10.1074/jbc.270.8.3638			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876101	hybrid			2022-12-27	WOS:A1995QH68800029
J	CHEN, H; LEIPPRANDT, JR; TRAVISS, CE; SOPHER, BL; JONES, MZ; CAVANAGH, KT; FRIDERICI, KH				CHEN, H; LEIPPRANDT, JR; TRAVISS, CE; SOPHER, BL; JONES, MZ; CAVANAGH, KT; FRIDERICI, KH			MOLECULAR-CLONING AND CHARACTERIZATION OF BOVINE BETA-MANNOSIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORAGE DISEASE; MESSENGER-RNA; THYROID STRUCTURE; FEMALE-PATIENT; DEFICIENCY; PURIFICATION; HEXOSAMINIDASE; ACCUMULATION; FIBROBLASTS; EXPRESSION	Deficiency of lysosomal beta-mannosidase activity results in a severe neurodegenerative disease in goats and cattle and a relatively milder phenotype in humans. A cDNA coding for the entire beta-mannosidase protein is described, Mixed oligonucleotides derived from bovine beta-mannosidase peptide sequences were used to screen a bovine thyroid cDNA library, Clones covering about 80% of the C-terminal region were recovered, The missing 5'-region was obtained using the technique of 5'-rapid amplification of cDNA ends. The composite cDNA contains 3852 nucleotides, encoding 879 amino acids. The N-terminal methionine is followed by 16 amino acids displaying the characteristics of a typical signal peptide sequence. The deduced amino acid sequence is colinear with all peptide sequences determined by protein microsequencing, Northern blot analysis demonstrates a single 4.2-kilobase transcript in various tissues from both normal and affected goats and calves, The mRNA level is decreased in tissues of affected beta-mannosidosis animals, The gene encoding beta-mannosidase is localized to human chromosome 4 as shown by Southern analysis of rodent/human somatic cell hybrids, This is the first report of cloning of lysosomal beta-mannosidase.	MICHIGAN STATE UNIV,DEPT PATHOL,E LANSING,MI 48824	Michigan State University					NINDS NIH HHS [NS16886] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016886] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBITT B, 1991, J AM VET MED ASSOC, V198, P109; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BOLE PJ, 1981, BOLE VET J, V57, P504; BOYER PJ, 1990, LAB INVEST, V63, P100; BRYAN L, 1990, BIOCHEM BIOPH RES CO, V173, P491, DOI 10.1016/S0006-291X(05)80060-9; CAVANAGH K, 1982, AM J VET RES, V48, P1058; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; COOPER A, 1986, NEW ENGL J MED, V315, P1231; COOPER A, 1991, J INHERIT METAB DIS, V14, P18, DOI 10.1007/BF01804383; COOPER A, 1988, J INHERIT METAB DIS, V11, P17, DOI 10.1007/BF01800054; DORLAND L, 1988, J INHERIT METAB DIS, V11, P255, DOI 10.1007/BF01804251; FISHER R A, 1987, American Journal of Human Genetics, V41, pA165; FREI JI, 1988, BIOCHEM J, V249, P871, DOI 10.1042/bj2490871; HARTLEY WJ, 1973, ACTA NEUROPATHOL, V25, P325, DOI 10.1007/BF00691760; IWASAKI Y, 1989, J BIOCHEM-TOKYO, V106, P331, DOI 10.1093/oxfordjournals.jbchem.a122853; JOLLY RD, 1990, NEW ZEAL VET J, V38, P102, DOI 10.1080/00480169.1990.35628; JONES MZ, 1981, J BIOL CHEM, V256, P5185; JONES MZ, 1981, J BIOL CHEM, V256, P5181; JONES MZ, 1983, J NEUROPATH EXP NEUR, V42, P268, DOI 10.1097/00005072-198305000-00005; JONES MZ, 1992, J INHERIT METAB DIS, V15, P57, DOI 10.1007/BF01800344; JONES MZ, 1984, J INHERIT METAB DIS, V7, P80, DOI 10.1007/BF01805811; KLEIJER WJ, 1990, J INHERIT METAB DIS, V13, P867, DOI 10.1007/BF01800211; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYOSAKA S, 1985, CHEM PHARM BULL, V33, P256; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEVADE T, 1994, ANN NEUROL, V35, P116, DOI 10.1002/ana.410350119; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; LOVELL KL, 1991, J INHERIT METAB DIS, V14, P228, DOI 10.1007/BF01800594; LOVELL KL, 1983, ACTA NEUROPATHOL, V62, P121, DOI 10.1007/BF00684928; LUNDIN LG, 1987, BIOCHEM GENET, V25, P603, DOI 10.1007/BF00554361; MAHURAN DJ, 1988, J BIOL CHEM, V263, P4612; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; POENARU L, 1992, CLIN GENET, V41, P331; Sambrook J, 1989, MOL CLONING LABORATO; SOPHER BL, 1993, BIOCHEM J, V289, P343, DOI 10.1042/bj2890343; SOPHER BL, 1992, J BIOL CHEM, V267, P6178; STEIN C, 1989, J BIOL CHEM, V264, P1252; STOLTZFUS LJ, 1992, J BIOL CHEM, V267, P6570; VANPELT J, 1990, CLIN CHIM ACTA, V187, P55, DOI 10.1016/0009-8981(90)90261-P; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WENGER DA, 1986, NEW ENGL J MED, V315, P1201, DOI 10.1056/NEJM198611063151906; WIJBURG H, 1992, EUR J PEDIATR, V151, P311, DOI 10.1007/BF02072238; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139	46	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3841	3848		10.1074/jbc.270.8.3841	http://dx.doi.org/10.1074/jbc.270.8.3841			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876128	hybrid			2022-12-27	WOS:A1995QH68800058
J	COPELAND, WC; TAN, XH				COPELAND, WC; TAN, XH			ACTIVE-SITE MAPPING OF THE CATALYTIC MOUSE PRIMASE SUBUNIT BY ALANINE SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INITIATION; YEAST; RNA; REPLICATION; CELLS; PURIFICATION	In the eukaryotic cell, DNA synthesis is initiated by DNA primase associated with DNA polymerase alpha. The eukaryotic primase is composed of two subunits, p49 and p58, where the p49 subunit contains the catalytic active site, Mutagenesis of the cDNA for the p49 subunit was initiated to demonstrate a functional correlation of conserved residues among the eukaryotic primases and DNA polymerases, Fourteen invariant charged residues in the smaller catalytic mouse primase subunit, p49, were changed to alanine, These mutant proteins were expressed, purified, and enzymatically characterized for primer synthesis, Analyses of the mutant proteins indicate that residues 104-111 are most critical for primer synthesis and form part of the active site, Alanine substitution in residues Glu(105), Asp(109) and Asp(111) produced protein with no detectable activity in direct primase assays, indicating that these residues may form part of a conserved carboxylic triad also observed in the active sites of DNA polymerases and reverse transcriptases, Ah other mutant proteins showed a dramatic decrease in catalysis, while mutation of two residues, Arg(162) and Arg(163), caused an increase in K-m(NTP). Analysis of these mutant proteins in specific assays designed to separately investigate dinucleotide formation (initiation) and elongation of primer indicates that these two activities utilize the same active site within the p49 subunit, Finally, mutations in three active site codons produced protein with reduced affinity with the p58 subunit, suggesting that p58 may interact directly with active site residues.			COPELAND, WC (corresponding author), NIEHS,MOLEC GENET LAB,POB 12233,RES TRIANGLE PK,NC 27709, USA.		Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953				BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; CONWAY RC, 1982, P NATL ACAD SCI USA, V79, P2523; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; GRONOSTAJSKI RM, 1984, J BIOL CHEM, V259, P9479; KAGUNI LS, 1983, J BIOL CHEM, V258, P9037; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KORNBERG A, 1992, DNA REPLICATION, P275; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LONGHESE MP, 1993, GENETICS, V133, P183; MIYAZAWA H, 1993, J BIOL CHEM, V268, P8111; PANDEY VN, 1994, J BIOL CHEM, V269, P13259; PATRA D, 1992, J MOL BIOL, V224, P307, DOI 10.1016/0022-2836(92)90996-W; PLEVANI P, 1987, NUCLEIC ACIDS RES, V15, P7975; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; PRUSSAK CE, 1989, J BIOL CHEM, V264, P4957; ROTH YF, 1987, EUR J BIOCHEM, V165, P473, DOI 10.1111/j.1432-1033.1987.tb11463.x; SANTOCANALE C, 1993, J BIOL CHEM, V268, P1343; SANTOCANALE C, 1992, GENE, V113, P199, DOI 10.1016/0378-1119(92)90396-7; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SCHERZINGER E, 1977, NUCLEIC ACIDS RES, V4, P4151, DOI 10.1093/nar/4.12.4151; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; SHEAFF RJ, 1994, J BIOL CHEM, V269, P19225; SHIODA M, 1982, P NATL ACAD SCI-BIOL, V79, P7209, DOI 10.1073/pnas.79.23.7209; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; STADLBAUER F, 1994, EUR J BIOCHEM, V222, P781, DOI 10.1111/j.1432-1033.1994.tb18925.x; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TSENG BY, 1979, J MOL BIOL, V129, P531, DOI 10.1016/0022-2836(79)90467-4; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; ZHANG SS, 1990, J MOL BIOL, V216, P475, DOI 10.1016/0022-2836(90)90370-2	39	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3905	3913		10.1074/jbc.270.8.3905	http://dx.doi.org/10.1074/jbc.270.8.3905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876136	hybrid			2022-12-27	WOS:A1995QH68800067
J	THOMAS, PQ; JOHNSON, BV; RATHJEN, J; RATHJEN, PD				THOMAS, PQ; JOHNSON, BV; RATHJEN, J; RATHJEN, PD			SEQUENCE, GENOMIC ORGANIZATION, AND EXPRESSION OF THE NOVEL HOMEOBOX GENE HESX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION INHIBITING ACTIVITY; EMBRYONIC STEM-CELLS; MYELOID-LEUKEMIA; MOUSE EMBRYOS; HOMEODOMAIN; INVITRO; ANTENNAPEDIA; DROSOPHILA; BRAIN; FORMS	Extensive analyses of homeobox gene expression and function during murine embryogenesis have demonstrated that homeobox gene products are key components in the establishment of pattern formation and regional identity during development. In this paper we report the molecular characterization and expression of a novel murine homeobox sequence, Hesx1, isolated from pluripotent embryonic stem cells, Hesx1 is expressed as two transcripts of 1.0 and 1.2 kilobases which encode an identical 185 amino acid open reading frame, The transcripts differ in the 3'-untranslated region due to the differential utilization of a weak splice donor site located immediately downstream of the translation termination codon. The Hesx1 homeodomain shared 80% identity with the Xenopus homeoprotein XANF-1 and was less than 50% related to other homeodomain sequences, Hesx1 and XANF-1 therefore constitute the founder members of a new homeodomain class, Hesx1 expression was down-regulated during embryonic stem cell differentiation and was detected in tissue-specific RNA samples derived from the embryonic liver, and at lower levels in viscera, amnion, and yolk sac, Expression in adult mice was not detected, These sites of expression are consistent with a role for Hesx1 in the regulation of developmental decisions in the early mouse embryo and during fetal hematopoiesis.	UNIV ADELAIDE,DEPT BIOCHEM,ADELAIDE,SA 5005,AUSTRALIA	University of Adelaide			Thomas, Paul Q/K-4497-2012	Johnson, Brett/0000-0003-3883-3158				BEDFORD FK, 1993, NUCLEIC ACIDS RES, V21, P1245, DOI 10.1093/nar/21.5.1245; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Burglin T., 1994, GUIDEBOOK HOMEOBOX G; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DEJONG R, 1993, DEV BIOL, V157, P133, DOI 10.1006/dbio.1993.1118; DIETRICH W, 1992, GENETICS, V131, P423; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EDWARDS DR, 1985, MOL CELL BIOL, V5, P3280, DOI 10.1128/MCB.5.11.3280; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; HUNT P, 1992, ANNU REV CELL BIOL, V8, P227, DOI 10.1146/annurev.cb.08.110192.001303; KAPPEN C, 1993, GENOMICS, V18, P54, DOI 10.1006/geno.1993.1426; Kaufman M.H., 1992, ATLAS MOUSE DEV; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LINTS TJ, 1993, DEVELOPMENT, V119, P419; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURTHA MT, 1991, P NATL ACAD SCI USA, V88, P10711, DOI 10.1073/pnas.88.23.10711; PAPALOPULU N, 1991, NUCLEIC ACIDS RES, V19, P5497, DOI 10.1093/nar/19.20.5497; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; ROBERTSON M, 1993, DEV GENET, V14, P165, DOI 10.1002/dvg.1020140303; Sambrook J, 1989, MOL CLONING LABORATO; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Smith A G, 1992, Semin Cell Biol, V3, P385, DOI 10.1016/1043-4682(92)90010-S; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; THOMAS PQ, 1992, NUCLEIC ACIDS RES, V20, P5840, DOI 10.1093/nar/20.21.5840; TONISSEN KF, 1994, DEV BIOL, V162, P325, DOI 10.1006/dbio.1994.1089; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; ZARAISKY AG, 1992, DEV BIOL, V152, P373, DOI 10.1016/0012-1606(92)90144-6	44	95	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3869	3875		10.1074/jbc.270.8.3869	http://dx.doi.org/10.1074/jbc.270.8.3869			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876132	hybrid			2022-12-27	WOS:A1995QH68800062
J	BURSTEIN, ES; SPALDING, TA; HILLEUBANKS, D; BRANN, MR				BURSTEIN, ES; SPALDING, TA; HILLEUBANKS, D; BRANN, MR			STRUCTURE-FUNCTION OF MUSCARINIC RECEPTOR COUPLING TO G-PROTEINS - RANDOM SATURATION MUTAGENESIS IDENTIFIES A CRITICAL DETERMINANT OF RECEPTOR AFFINITY FOR G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVELY ACTIVATING MUTATION; 3RD CYTOPLASMIC LOOP; ACETYLCHOLINE-RECEPTOR; EXPRESSION; CLONING; GENES; CELLS; PHOSPHOINOSITIDE; SUBSTITUTIONS; SUBTYPES	To derive structure-function relationships for receptor-G protein coupling, libraries were created of human m5 muscarinic acetylcholine receptors (m5) randomly mutated in the C-terminal region of the third intracellular loop. Functional receptors were identified based on their ability to amplify NIH 3T3 cells in a ligand-dependent manner, These receptors either had wildtype phenotypes (Group 1) or were functionally impaired (Group 2). No ''activated receptors'' were identified, Tolerated substitutions in Group 2 receptors were randomly distributed and frequently included prolines and glycines. In contrast, tolerated substitutions in Group 1 receptors exhibited a periodicity proximal to transmembrane domain 6 where proline and glycine substitutions were not observed. These observations are consistent with a short alpha-helical extension of the C-terminal region of the third intracellular loop from transmembrane domain 6. Mutations at Ala-441 were most commonly associated with impaired function of Group 2 receptors. Twelve point mutations at Ala-441 were tested, and all caused marked increases in EC(50) values with little effect on maximal response or agonist binding affinity. These results indicate that Ala-441 is a key determinant of m5 receptor affinity for G proteins and exists within the structural context of a short alpha-helix.	UNIV VERMONT,DEPT PHARMACOL,BURLINGTON,VT 05405; UNIV VERMONT,VERMONT REG CANC CTR,BURLINGTON,VT 05405; RECEPTOR TECHNOL INC,WINOOSKI,VT 05404	University of Vermont; University of Vermont	BURSTEIN, ES (corresponding author), UNIV VERMONT,DEPT PSYCHIAT,MOLEC NEUROPHARMACOL SECT,BURLINGTON,VT 05405, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009436] Funding Source: NIH RePORTER; NINDS NIH HHS [F32NS09436] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN LF, 1991, P NATL ACAD SCI USA, V88, P11354, DOI 10.1073/pnas.88.24.11354; ARDEN JR, 1992, BIOCHEM BIOPH RES CO, V188, P1111, DOI 10.1016/0006-291X(92)91346-R; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BRANN MR, 1992, MOL BIOL G PROTEIN C; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; JONES SVP, 1992, MOL BIOL G PROTEIN C, P170; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; KUNKEL MT, 1993, EMBO J, V12, P3809, DOI 10.1002/j.1460-2075.1993.tb06059.x; LECHLEITER J, 1991, EMBO J, V9, P4381; LEMEH J, 1992, J BIOL CHEM, V267, P13406; LIM K, 1989, BIOTECHNIQUES, V7, P576; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OLIPHANT AR, 1989, P NATL ACAD SCI USA, V86, P9094, DOI 10.1073/pnas.86.23.9094; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; REN Q, 1993, J BIOL CHEM, V268, P16483; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; WESS J, 1990, MOL PHARMACOL, V38, P517; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; YAGHMAI R, 1992, P NATL ACAD SCI USA, V89, P7890, DOI 10.1073/pnas.89.17.7890	32	80	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3141	3146		10.1074/jbc.270.7.3141	http://dx.doi.org/10.1074/jbc.270.7.3141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852396				2022-12-27	WOS:A1995QG47100039
J	ELLISON, V; GERTON, J; VINCENT, KA; BROWN, PO				ELLISON, V; GERTON, J; VINCENT, KA; BROWN, PO			AN ESSENTIAL INTERACTION BETWEEN DISTINCT DOMAINS OF HIV-1 INTEGRASE MEDIATES ASSEMBLY OF THE ACTIVE MULTIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; ESCHERICHIA-COLI; RETROVIRAL DNA; ZINC-BINDING; PROTEIN; INVITRO; COMPLEX; TYPE-1; FINGER	Integrase mediates integration of the retroviral genome into a host cell chromosome, an essential step in the viral life cycle. In vitro, a stable complex containing only purified human immunodeficiency virus (HIV) integrase and a model viral DNA substrate processively executes the S'-end processing and DNA joining steps in the integration reaction. We examined the relationship of three essential components of the HIV integrase: the HHCC domain, a putative zinc-finger near the N terminus; the phylogenetically conserved ''DD35E'' motif, which defines the catalytic domain; and a feature recognized by its sensitivity to the alkylating agent N-ethylmaleimide (NEM). HIV integrase is a multimer, and these three components can be distributed among at least two subunits of the multimeric enzyme. The components function asymmetrically in the active multimer; the DD35E motif and NEM-sensitive site are required in trans to the HHCC region. A divalent cation-dependent interaction involving the NEM-sensitive site of one integrase subunit and the HHCC region of another subunit points to a role for these two features of integrase in multimer assembly. Deletion of the HHCC domain, or modification of integrase with NEM, impaired the assembly of a stable complex between integrase and viral DNA, suggesting that this initial step in the integration pathway requires assembly of the active integrase multimer.	STANFORD UNIV,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,DEPT BIOCHEM,STANFORD,CA 94305; STANFORD UNIV,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University					NIAID NIH HHS [AI27205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027205] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERG JM, 1990, ANNU REV BIOPHYS BIO, V19, P405; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; CHEN JD, 1993, EMBO J, V12, P2075, DOI 10.1002/j.1460-2075.1993.tb05856.x; CHOW SA, 1994, J VIROL, V68, P3896, DOI 10.1128/JVI.68.6.3896-3907.1994; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; COLICELLI J, 1985, CELL, V42, P573, DOI 10.1016/0092-8674(85)90114-X; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; DELRIO S, 1993, P NATL ACAD SCI USA, V90, P168, DOI 10.1073/pnas.90.1.168; DONEHOWER LA, 1984, P NATL ACAD SCI-BIOL, V81, P6461, DOI 10.1073/pnas.81.20.6461; ECHOLS H, 1990, J BIOL CHEM, V265, P14697; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; ELLISON V, 1990, J VIROL, V64, P2711, DOI 10.1128/JVI.64.6.2711-2715.1990; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; ENGELMAN A, 1992, J VIROL, V66, P6363; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; HUGHES RE, 1990, CELL, V63, P1331, DOI 10.1016/0092-8674(90)90428-H; JONES KS, 1992, J BIOL CHEM, V267, P16037; JONSSON CB, 1993, J VIROL, V67, P5562, DOI 10.1128/JVI.67.9.5562-5571.1993; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; LOEBER G, 1991, J VIROL, V65, P3167, DOI 10.1128/JVI.65.6.3167-3174.1991; MARKBY DW, 1991, P NATL ACAD SCI USA, V88, P10568, DOI 10.1073/pnas.88.23.10568; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; PUGH BF, 1988, J BIOL CHEM, V263, P76; SCHWARTZBERG P, 1984, CELL, V37, P1043, DOI 10.1016/0092-8674(84)90439-2; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; VANGENT DC, 1992, P NATL ACAD SCI USA, V89, P9598, DOI 10.1073/pnas.89.20.9598; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VARMUS H, 1989, RETROVIRUSES; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419	40	124	126	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3320	3326		10.1074/jbc.270.7.3320	http://dx.doi.org/10.1074/jbc.270.7.3320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852418	hybrid			2022-12-27	WOS:A1995QG47100065
J	SCHAEFFER, P; LAPLACE, MC; SAVI, P; PFLIEGER, AM; GULLY, D; HERBERT, JM				SCHAEFFER, P; LAPLACE, MC; SAVI, P; PFLIEGER, AM; GULLY, D; HERBERT, JM			HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS EXPRESS HIGH-AFFINITY NEUROTENSIN RECEPTORS COUPLED TO INTRACELLULAR CALCIUM-RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHATES; SMOOTH-MUSCLE; NITRIC-OXIDE; CYCLIC-GMP; BINDING; RATS; PEPTIDES; N1E-115; SITES; BRAIN	The binding of I-125-neurotensin (NT) to human umbilical vein endothelial cell monolayers was studied. At 20 degrees C, I-125-NT bound to a single class of binding sites with a dissociation constant of 0.23 +/- 0.08 nM and a binding site density of 5500 +/- 1300 sites/cell (n = 3). I-125-NT also bound to human aortic endothelial cells with a dissociation constant of 0.6 +/- 0.26 nM and a binding site density of 32000 +/- 1700 sites/cell. Association and dissociation kinetics were of a pseudo-first order ana gave association and dissociation rate constant values of 1.6 x 10(6) M(-1) s(-1) and 3.5 x 10(-4) s(-1), respectively. I-125-NT binding was inhibited by NT analogues with a rank order of potency similar to that characterizing brain high affinity NT binding sites (K-0.5, nM): NT8-13 (0.11) > NT (0.35) > acetyl-NT8-13 (1.5) > [Phe(11)]NT (12) > [D-Tyr(11)]NT (> 1000). I-125-NT binding was also inhibited by the non-peptide NT antagonist SR 48692 (K-i = 16 nM) but was not affected by levocabastine, an inhibitor of low affinity brain NT binding sites. NT had no effect on cGMP levels in endothelial cells but NT and its analogues increased Ca-45(2+) efflux from endothelial cells at nanomolar concentrations with a rank order of potency which was identical to that observed in binding experiments. This effect was inhibited by SR 48692 (IC50 = 8 nM). NT was able to increase phosphoinositide turnover in these cells, and this effect was blocked by SR 48692. The correlation between dissociation constants of NT analogues in binding experiments and IC50 values in Ca-45(2+) efflux experiments was very high (r = 0.997) with a slope near unity, indicating that I-125-NT binding sites ard functional NT receptors coupled to phosphoinositide hydrolysis and Ca2+ release in human umbilical vein endothelial cells.	SANOFI RECH,HAEMOBIOL RES DEPT,F-31036 TOULOUSE,FRANCE	Sanofi-Aventis; Sanofi France			Schaeffer, Paul/D-7069-2014; Schaeffer, Paul/AAZ-9961-2020	Schaeffer, Paul/0000-0002-2835-1801; Schaeffer, Paul/0000-0002-2835-1801				AHMAD S, 1987, BIOCHIM BIOPHYS ACTA, V896, P224, DOI 10.1016/0005-2736(87)90183-0; AMADH S, 1991, PEPTIDES, V12, P623; AMAR S, 1985, BIOCHEM BIOPH RES CO, V129, P117, DOI 10.1016/0006-291X(85)91411-1; BACHELARD H, 1992, BRIT J PHARMACOL, V105, P191, DOI 10.1111/j.1476-5381.1992.tb14234.x; BARSHAVIT Z, 1982, NEUROPEPTIDES, V2, P325, DOI 10.1016/0143-4179(82)90070-1; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BOUABOULA M, 1992, J BIOL CHEM, V267, P21830; BOZOU JC, 1989, BIOCHEM J, V264, P871, DOI 10.1042/bj2640871; BUHNER S, 1989, CAN J PHYSIOL PHARM, V67, P1534, DOI 10.1139/y89-247; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CARRAWAY RE, 1991, PEPTIDES, V12, P1105, DOI 10.1016/0196-9781(91)90066-X; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DIPAOLA ED, 1990, EUR J PHARMACOL, V175, P279, DOI 10.1016/0014-2999(90)90565-N; DORLEANSJUSTE P, 1985, EUR J PHARMACOL, V114, P9, DOI 10.1016/0014-2999(85)90515-1; FORSTERMANN U, 1990, MOL PHARMACOL, V38, P7; GILBERT JA, 1984, EUR J PHARMACOL, V99, P245, DOI 10.1016/0014-2999(84)90248-6; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; HE P, 1990, AM J PHYSIOL, V258, pH1366; HELMSTAEDTER V, 1977, CELL TISSUE RES, V184, P445; KEOURAC R, 1981, LIFE SCI, V28, P2477; KITABGI P, 1985, Reviews in Clinical and Basic Pharmacology, V5, P397; KITABGI P, 1984, PEPTIDES, V5, P917, DOI 10.1016/0196-9781(84)90117-7; KOMORI S, 1992, BRIT J PHARMACOL, V107, P790, DOI 10.1111/j.1476-5381.1992.tb14525.x; LAZARUS LH, 1977, J BIOL CHEM, V252, P7180; LAZARUS LH, 1977, J BIOL CHEM, V252, P7174; MAZELLA J, 1988, J BIOL CHEM, V263, P144; MONCADA S, 1991, PHARMACOL REV, V43, P109; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OBARA H, 1989, PEPTIDES, V10, P241, DOI 10.1016/0196-9781(89)90100-9; QUIRION R, 1980, LIFE SCI, V27, P1889, DOI 10.1016/0024-3205(80)90435-X; RIOUX F, LIFE SCI, V27, P259; SCHOTTE A, 1986, N-S ARCH PHARMACOL, V333, P400, DOI 10.1007/BF00500016; SUMNERS C, 1982, HYPERTENSION, V4, P888, DOI 10.1161/01.HYP.4.6.888; SUNDLER F, 1977, HISTOCHEMISTRY, V53, P24; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; WATSON MA, 1992, J NEUROCHEM, V59, P1967, DOI 10.1111/j.1471-4159.1992.tb11035.x; [No title captured]	37	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3409	3413		10.1074/jbc.270.7.3409	http://dx.doi.org/10.1074/jbc.270.7.3409			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852427	hybrid			2022-12-27	WOS:A1995QG47100077
J	WU, YJ; FRAIZER, GC; SAUNDERS, GF				WU, YJ; FRAIZER, GC; SAUNDERS, GF			GATA-1 TRANSACTIVATES THE WT1 HEMATOPOIETIC SPECIFIC ENHANCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILMS-TUMOR GENE; TRANSCRIPTION FACTOR GATA-1; NUCLEAR FACTOR; EXPRESSION; BINDING; DELETION; CELLS; DIFFERENTIATION; MUTATION; PROMOTER	The Wilms' tumor gene, WT1, is believed to play a role in hematopoiesis as it is expressed in the spleen and in immature leukemias in addition to the developing genitourinary system. WT1 is down-regulated in differentiated leukemia cells both in vivo and in vitro and is upregulated in fetal spleen and immature leukemia cells. The modulation of WT1 expression was examined in many cell types, and a hematopoietic-specific enhancer element has been identified. Here we describe the transcriptional response of this enhancer to hematopoietic-specific transcription factors. We found co-expression of WT1 and GATA-1 mRNA in K562 cells and in mouse spleen, suggesting potential interactions between these two transcription factors. We find that the activity of the 3' WT1 enhancer is positively correlated with the expression of GATA-1. Gel shift competition experiments and transactivation studies revealed that this functional activity is mediated via binding at a GATA-binding site in the WT1 enhancer. The transactivation of the WT1 enhancer by GATA-1 implies that GATA-1 plays a role in the regulation of WT1 during hematopoiesis.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NCI NIH HHS [CA 34936, CA 16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA034936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; FRAIZER GC, 1994, J BIOL CHEM, V269, P8892; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; HOFMANN W, 1993, ONCOGENE, V8, P3123; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; HUFF V, 1991, AM J HUM GENET, V48, P997; KIDD JM, 1984, WILMS TUMOR, P265; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P4299, DOI 10.1093/nar/16.10.4299; MIWA H, 1992, LEUKEMIA, V6, P405; MIYAGI T, 1993, LEUKEMIA, V7, P970; OKA T, 1991, ONCOGENE, V6, P2077; ORKIN SH, 1992, BLOOD, V80, P575; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PHELAN SA, 1994, CELL GROWTH DIFFER, V5, P677; PRITCHARDJONES K, 1994, HUM MOL GENET, V3, P1633, DOI 10.1093/hmg/3.9.1633; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; SEKIYA M, 1994, BLOOD, V83, P1876; SHIMAMOTO T, 1994, P AM ASSOC CANC RES, V35, P3554; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; TSAI SF, 1990, NATURE, V339, P446; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	37	51	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5944	5949		10.1074/jbc.270.11.5944	http://dx.doi.org/10.1074/jbc.270.11.5944			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890725	hybrid			2022-12-27	WOS:A1995QM94500038
J	CASTRO, E; MATEO, J; TOME, AR; BARBOSA, RM; TERESA, M; MIRASPORTUGAL, MT; ROSARIO, LM				CASTRO, E; MATEO, J; TOME, AR; BARBOSA, RM; TERESA, M; MIRASPORTUGAL, MT; ROSARIO, LM			CELL-SPECIFIC PURINERGIC RECEPTORS COUPLED TO CA2+ ENTRY AND CA2+ RELEASE FROM INTERNAL STORES IN ADRENAL CHROMAFFIN CELLS - DIFFERENTIAL SENSITIVITY TO UTP AND SURAMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP RECEPTOR; PC12 CELLS; CATECHOLAMINE SECRETION; CALCIUM-CONCENTRATION; CYTOSOLIC CALCIUM; ENDOTHELIAL-CELLS; PATCH-CLAMP; INFLUX; STIMULATION; AGONIST	We have assessed the relative contribution of Ca2+ entry and Ca2+ release from internal stores to the [Ca2+](i) transients evoked by purinergic receptor activation in bovine adrenal chromaffin cells. The [Ca2+](i) was recorded from single cells using ratiometric fura-2 microfluorometry. Two discrete groups of ATP-sensitive cells could be distinguished on the basis of their relative capacity to respond to ATP in the virtual absence of extracellular Ca2+. One group of cells (group I) failed to respond to ATP in the absence of Ca2+, was completely insensitive 60 UTP, and displayed suramin-blockable [Ca2+](i) transients when challenged with ATP in the presence of external Ca2+. ATP activated a prominent and rapidly inactivating Mn2+ influx pathway in group I cells, as assessed by monitoring Mn2+ quenching of fura-2 fluorescence. In contrast, a second group of ATP-sensitive cells (group II) exhibited pronounced [Ca2+](i) rises when challenged with ATP and UTP in the absence of Ca2+ and was completely insensitive to suramin, ATP and UTP activated a delayed and less prominent Mn2+ influx pathway in group II cells, Contrary to the nicotinic receptor agonist DMPP, which evoked a preferential release of epinephrine, ATP evoked a preferential release of norepinephrine, and UTP had no effect on secretion. Suramin nearly suppressed ATP-evoked norepinephrine release. We conclude that chromaffin cells contain two distinct and cell-specific purinoceptor subtypes. Although some cells express a P-2U-type purinoceptor coupled to Ca2+ release from internal stores and to the associated slow Ca2+ refilling mechanism, other cells express a suramin-sensitive and UTP insensitive purinoceptor exclusively coupled to Ca2+ influx, probably an ATP gated channel. It is suggested that the ATP-gated channel is preferentially localized to norepinephrine-secreting chromaffin cells and supports specifically hormone output from these cells. Thus, the biochemical pathways involved in the exocytotic release of the two major stress-related hormones appear to be regulated by distinct signaling systems.	FAC SCI & TECHNOL COIMBRA,CTR NEUROSCI,DEPT ZOOL,COIMBRA,PORTUGAL; FAC SCI & TECHNOL COIMBRA,DEPT BIOCHEM,COIMBRA,PORTUGAL; UNIV COIMBRA,FAC PHARM,INSTRUMENTAL ANAL LAB,P-3049 COIMBRA,PORTUGAL; FCTUC,DEPT BIOCHEM,P-3049 COIMBRA,PORTUGAL	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	CASTRO, E (corresponding author), UNIV COMPLUTENSE MADRID,FAC VET SCI,DEPT BIOCHEM & MOLEC BIOL,E-28040 MADRID,SPAIN.		Miras-Portugal, Maria Teresa/L-7137-2014; de Castro, Jesus Mateo/N-4434-2014; Tome, Angelo Jose Ribeiro/AAL-1963-2020; Barbosa, Rui/A-7742-2016; Barbosa, Rui M./U-7117-2019	de Castro, Jesus Mateo/0000-0003-4459-7083; Tome, Angelo Jose Ribeiro/0000-0001-8671-989X; Barbosa, Rui/0000-0002-1604-6324; Barbosa, Rui M./0000-0002-1604-6324; Rosario, Luis/0000-0001-8329-2333				AUGISTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247; BARNARD EA, 1994, TRENDS PHARMACOL SCI, V15, P67, DOI 10.1016/0165-6147(94)90280-1; BEAN BP, 1990, J NEUROSCI, V10, P1; CASTRO E, 1990, BRIT J PHARMACOL, V100, P360, DOI 10.1111/j.1476-5381.1990.tb15809.x; CASTRO E, 1994, PFLUG ARCH EUR J PHY, V426, P524, DOI 10.1007/BF00378530; CASTRO E, 1989, J NEUROSCI RES, V23, P290, DOI 10.1002/jnr.490230307; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; DUARTE CB, 1993, J NEUROCHEM, V60, P908, DOI 10.1111/j.1471-4159.1993.tb03236.x; DUARTE CB, 1993, EUR J PHARM-MOLEC PH, V244, P259, DOI 10.1016/0922-4106(93)90151-X; DUBYAK GR, 1993, AM J PHYSIOL, V255, pC577; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; FASOLATO C, 1993, PFLUG ARCH EUR J PHY, V423, P225, DOI 10.1007/BF00374399; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FASOLATO C, 1990, J BIOL CHEM, V265, P20351; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GRUNKIEWICZ G, 1985, J BIOL CHEM, V250, P3440; HALLAM TJ, 1988, BIOCHEM J, V255, P179, DOI 10.1042/bj2550179; HILLARP NA, 1953, ACTA PHYSIOL SCAND, V30, P55; HOYLE CHV, 1990, BRIT J PHARMACOL, V99, P617, DOI 10.1111/j.1476-5381.1990.tb12979.x; JACOB R, 1990, J PHYSIOL-LONDON, V421, P55, DOI 10.1113/jphysiol.1990.sp017933; KELNER KL, 1985, NEUROCHEM INT, V7, P373, DOI 10.1016/0197-0186(85)90128-7; KIM KT, 1989, P NATL ACAD SCI USA, V86, P9881, DOI 10.1073/pnas.86.24.9881; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; MACONOCHIE DJ, 1992, J PHYSIOL-LONDON, V454, P129, DOI 10.1113/jphysiol.1992.sp019257; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; MORO MA, 1991, J NEUROCHEM, V57, P363, DOI 10.1111/j.1471-4159.1991.tb03761.x; NAKAZAWA K, 1990, NEUROSCI LETT, V119, P5, DOI 10.1016/0304-3940(90)90741-Q; NAKAZAWA K, 1990, J PHYSIOL-LONDON, V428, P257, DOI 10.1113/jphysiol.1990.sp018211; NAKAZAWA K, 1994, PFLUG ARCH EUR J PHY, V427, P129, DOI 10.1007/BF00585951; OCONNOR SE, 1991, TRENDS PHARMACOL SCI, V12, P137, DOI 10.1016/0165-6147(91)90530-6; OSULLIVAN AJ, 1989, BIOSCIENCE REP, V9, P243, DOI 10.1007/BF01116001; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; ROBINSON IM, 1992, BIOCHEM J, V288, P457, DOI 10.1042/bj2880457; ROJAS E, 1985, FEBS LETT, V185, P323, DOI 10.1016/0014-5793(85)80931-5; Role L W, 1992, Curr Opin Neurobiol, V2, P254, DOI 10.1016/0959-4388(92)90112-X; SASAKAWA N, 1989, J NEUROCHEM, V52, P441, DOI 10.1111/j.1471-4159.1989.tb09140.x; SELA D, 1991, J BIOL CHEM, V266, P17990; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; SILINSKY EM, 1992, BRIT J PHARMACOL, V106, P762, DOI 10.1111/j.1476-5381.1992.tb14408.x; STAUDERMAN KA, 1990, CELL REGUL, V1, P683, DOI 10.1091/mbc.1.9.683; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I	43	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5098	5106		10.1074/jbc.270.10.5098	http://dx.doi.org/10.1074/jbc.270.10.5098			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890618	hybrid			2022-12-27	WOS:A1995QL58000025
J	OMALLEY, SM; SATTAR, AKM; WILLIAMS, KR; SPICER, EK				OMALLEY, SM; SATTAR, AKM; WILLIAMS, KR; SPICER, EK			MUTAGENESIS OF THE COOH-TERMINAL REGION OF BACTERIOPHAGE-T4 REGA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID INTERACTIONS; GENE-44 MESSENGER-RNA; FACTOR-RHO; BINDING; SEQUENCE; IDENTIFICATION; EXPRESSION; INTERFACE; RESIDUES	The bacteriophage T4 regA protein is a translational repressor that regulates the synthesis of >12 T4 proteins. Earlier studies demonstrated that photo-cross-linking of the 122-residue regA protein to (dT)(16) occurs at two sites, with the major site occurring at Phe-106. Amino acid substitutions were introduced at Phe-106 to evaluate its role in nucleic acid binding. Binding affinities of mutants F106C, F106V, and F106Y for nonspecific and specific RNA ligands indicated little difference between the K-app of the mutants and wild type regA protein, for either poly(U) or for a specific gene 44 oligoribonucleotide. Thus, Phe-106 does not contribute measurably to the overall free energy of binding. Partial proteolysis of regA protein was carried out to further probe its domain structure, Chymotryptic cleavage produced a fragment of 11,095 Da that has reduced affinity for poly(U) and that contains the first 93 residues of regA protein. Interestingly, proteolysis of regA protein is reduced in the presence of the specific target, gene 44 RNA. Two deletion mutants, 1-->94 and 1-->109, have also been cloned and purified. The binding affinities of these deletion mutants indicated a 100-1000-fold reduction in their affinities for poly(U). These studies indicate the last 13 amino acids in regA protein make a significant contribution to RNA binding.	MED UNIV S CAROLINA,DEPT BIOCHEM & MOLEC BIOL,CHARLESTON,SC 29425; YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	Medical University of South Carolina; Yale University; Howard Hughes Medical Institute; Yale University			Williams, Kenneth/B-5986-2016	Williams, Kenneth/0000-0001-7792-9588	NIGMS NIH HHS [GM31539] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031539] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADARI H Y, 1986, Proteins Structure Function and Genetics, V1, P116, DOI 10.1002/prot.340010203; ADARI HY, 1985, P NATL ACAD SCI USA, V82, P1901, DOI 10.1073/pnas.82.7.1901; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BUJALOWSKI W, 1987, BIOCHEMISTRY-US, V26, P3099, DOI 10.1021/bi00385a023; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; JOZWIK CE, 1992, P NATL ACAD SCI USA, V89, P5053, DOI 10.1073/pnas.89.11.5053; KELLY RC, 1976, J BIOL CHEM, V251, P7240; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MILLER ES, 1994, MOL BIOL BACTERIOP T, V4, P193; MOTT JE, 1985, P NATL ACAD SCI USA, V82, P88, DOI 10.1073/pnas.82.1.88; NADLER SG, 1992, J BIOL CHEM, V267, P3750; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; ROSENBERG M, 1983, METHOD ENZYMOL, V101, P123; Sambrook J, 1989, MOL CLONING LABORATO; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; SZEWCZAK AA, 1991, J BIOL CHEM, V266, P17832; UNNITHAN S, 1990, NUCLEIC ACIDS RES, V18, P7083, DOI 10.1093/nar/18.23.7083; WEBSTER KR, 1992, J BIOL CHEM, V267, P26097; WEBSTER KR, 1989, NUCLEIC ACIDS RES, V17, P10047, DOI 10.1093/nar/17.23.10047; WEBSTER KR, 1991, BIOTECHNIQUES, V11, P658; WEBSTER KR, 1990, J BIOL CHEM, V265, P19007; WILLIAMS KR, 1991, METHOD ENZYMOL, V208, P516; WINTER RB, 1987, P NATL ACAD SCI USA, V84, P7822, DOI 10.1073/pnas.84.22.7822	25	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5107	5114		10.1074/jbc.270.10.5107	http://dx.doi.org/10.1074/jbc.270.10.5107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890619	hybrid			2022-12-27	WOS:A1995QL58000026
J	PFEIFFER, DR; GUDZ, TI; NOVGORODOV, SA; ERDAHL, WL				PFEIFFER, DR; GUDZ, TI; NOVGORODOV, SA; ERDAHL, WL			THE PEPTIDE MASTOPARAN IS A POTENT FACILITATOR OF THE MITOCHONDRIAL PERMEABILITY TRANSITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; RAT-LIVER MITOCHONDRIA; FREEZE-THAW EXTRUSION; WASP VENOM PEPTIDE; CYCLOSPORINE-A; MEMBRANE-PERMEABILITY; HEART-MITOCHONDRIA; INNER MEMBRANE; CA-2+ RELEASE; OXIDATIVE STRESS	Mastoparan facilitates opening of the mitochondrial permeability transition pore through an apparent bimodal mechanism of action, In the submicromolar concentration range, the action of mastoparan is dependent upon the medium Ca2+ and phosphate concentration and is subject to inhibition by cyclosporin A, At concentrations above 1 mu M, pore induction by mastoparan occurs without an apparent Ca2+ requirement and in a cyclosporin A insensitive manner, Studies utilizing phospholipid vesicles show that mastoparan perturbs bilayer membranes across both concentration ranges, through a mechanism which is strongly dependent upon transmembrane potential, However, solute size exclusion studies suggest that the pores formed in mitochondria in response to both low and high concentrations of mastoparan are the permeability transition pore, It is proposed that low concentrations of mastoparan influence the pore per se, with higher concentrations having the additional effect of depolarizing the mitochondrial inner membrane through an action exerted upon the lipid phase. It may be the combination of these effects which allow pore opening in the absence of Ca2+ and in the presence of cyclosporin A, although other interpretations remain viable, A comparison of the activities of mastoparan and its analog, MP14, on mitochondria and phospholipid vesicles provides an initial indication that a G-protein may participate in regulation of the permeability transition pore, These studies draw attention to peptides, in a broad sense, as potential pore regulators in cells, under both physiological and pathological conditions.	UNIV MINNESOTA,HORMEL INST,AUSTIN,MN 55912	University of Minnesota System	PFEIFFER, DR (corresponding author), OHIO STATE UNIV,COLL MED,DEPT BIOCHEM MED,310A HAMILTON HALL,1645 NEIL AVE,COLUMBUS,OH 43210, USA.				NHLBI NIH HHS [HL 36124, HL 49181, HL 49182] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049182, R01HL049181, R01HL036124] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARGIOLAS A, 1983, J BIOL CHEM, V258, P3697; Barlett G.R., 1959, J BIOL CHEM, V234, P466; BEAVIS AD, 1985, J BIOL CHEM, V260, P3424; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; BROEKEMEIER KM, 1992, FEBS LETT, V304, P192, DOI 10.1016/0014-5793(92)80616-O; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; BROEKEMEIER KM, 1991, J BIOL CHEM, V266, P20700; BROEKEMEIER KM, 1989, BIOCHEM BIOPH RES CO, V163, P561, DOI 10.1016/0006-291X(89)92174-8; BROEKEMEIER KM, 1988, J BIOL CHEM, V264, P7826; CHAPMAN CJ, 1991, CHEM PHYS LIPIDS, V60, P201, DOI 10.1016/0009-3084(91)90042-A; CHAPMAN CJ, 1990, CHEM PHYS LIPIDS, V55, P73, DOI 10.1016/0009-3084(90)90068-3; COLOMBINI M, 1980, J MEMBRANE BIOL, V53, P79, DOI 10.1007/BF01870576; CROMPTON M, 1988, BIOCHEM J, V255, P357; DANILENKO M, 1993, BIOCHEM BIOPH RES CO, V196, P1296, DOI 10.1006/bbrc.1993.2393; DANILENKO M, 1991, BIOCHEM BIOPH RES CO, V196, P1296; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; FRY DW, 1978, ANAL BIOCHEM, V90, P809, DOI 10.1016/0003-2697(78)90172-0; GLAVINOVIC MI, 1992, NEUROSCIENCE, V50, P675, DOI 10.1016/0306-4522(92)90456-C; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P12655; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIRAI Y, 1981, BIOMED RES-TOKYO, V2, P447, DOI 10.2220/biomedres.2.447; HIRAI Y, 1980, BIOMED RES-TOKYO, V1, P185, DOI 10.2220/biomedres.1.185; HIRAI Y, 1979, CHEM PHARM BULL, V27, P1945; HIRAI Y, 1979, CHEM PHARM BULL, V27, P1942; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; IGBAVBOA U, 1991, BIOCHIM BIOPHYS ACTA, V1059, P339, DOI 10.1016/S0005-2728(05)80219-1; IMBERTI R, 1993, J PHARMACOL EXP THER, V265, P392; JOYCEBRADY M, 1991, J BIOL CHEM, V266, P6859; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KATSU T, 1990, BIOCHIM BIOPHYS ACTA, V1027, P185, DOI 10.1016/0005-2736(90)90083-Z; KINNALLY KW, 1992, J BIOENERG BIOMEMBR, V24, P99, DOI 10.1007/BF00769536; KOMATSU M, 1993, J BIOL CHEM, V268, P23297; LATORRE R, 1981, PHYSIOL REV, V61, P77, DOI 10.1152/physrev.1981.61.1.77; LENARTOWICZ E, 1991, J BIOENERG BIOMEMBR, V23, P679, DOI 10.1007/BF00785817; LEQUOC K, 1985, J BIOL CHEM, V260, P7422; LITHGOW T, 1991, BIOCHEM BIOPH RES CO, V180, P1453, DOI 10.1016/S0006-291X(05)81359-2; NAZARETH W, 1991, J MOL CELL CARDIOL, V23, P1351, DOI 10.1016/0022-2828(91)90181-K; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; NOVGORODOV SA, 1994, ARCH BIOCHEM BIOPHYS, V311, P219, DOI 10.1006/abbi.1994.1230; NOVGORODOV SA, 1993, BIOPHYS J, V64, pA107; OZAKI Y, 1990, BIOCHEM BIOPH RES CO, V170, P779, DOI 10.1016/0006-291X(90)92159-W; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; PERIANIN A, 1989, J IMMUNOL, V143, P1669; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; RAYNOR RL, 1992, FEBS LETT, V307, P275, DOI 10.1016/0014-5793(92)80694-C; RILEY WW, 1985, J BIOL CHEM, V260, P2416; SCHILLER LR, 1988, GASTROENTEROLOGY, V94, P933, DOI 10.1016/0016-5085(88)90550-1; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; TAKEDA S, 1993, J BIOCHEM-TOKYO, V114, P684, DOI 10.1093/oxfordjournals.jbchem.a124237; TANIMURA A, 1991, BIOCHEM BIOPH RES CO, V177, P802, DOI 10.1016/0006-291X(91)91860-F; VERCESI AE, 1984, ARCH BIOCHEM BIOPHYS, V232, P86, DOI 10.1016/0003-9861(84)90523-X; VODYANOY I, 1993, BIOPHYS J, V65, P2097, DOI 10.1016/S0006-3495(93)81245-1; WALLACE MA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P311, DOI 10.1016/0005-2760(89)90018-0; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; YOKOKAWA N, 1989, BIOCHEM BIOPH RES CO, V158, P712, DOI 10.1016/0006-291X(89)92779-4; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739	68	184	191	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4923	4932		10.1074/jbc.270.9.4923	http://dx.doi.org/10.1074/jbc.270.9.4923			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876267	hybrid			2022-12-27	WOS:A1995QK08400105
J	POWELL, BS; COURT, DL; INADA, T; NAKAMURA, Y; MICHOTEY, V; CUI, XW; REIZER, A; SAIER, MH; REIZER, J				POWELL, BS; COURT, DL; INADA, T; NAKAMURA, Y; MICHOTEY, V; CUI, XW; REIZER, A; SAIER, MH; REIZER, J			NOVEL PROTEINS OF THE PHOSPHOTRANSFERASE SYSTEM ENCODED WITHIN THE RPON OPERON OF ESCHERICHIA-COLI - ENZYME IIA(NTR) AFFECTS GROWTH ON ORGANIC NITROGEN AND THE CONDITIONAL LETHALITY OF AN ERA(TS) MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GRAM-POSITIVE BACTERIA; SITE-SPECIFIC MUTAGENESIS; RHIZOBIUM-MELILOTI NTRA; AMINO-ACID SEQUENCE; SIGMA-FACTOR GENE; NUCLEOTIDE-SEQUENCE; SALMONELLA-TYPHIMURIUM; PHOSPHOCARRIER PROTEIN; BACILLUS-SUBTILIS; STAPHYLOCOCCUS-CARNOSUS	Two rpoN-linked Delta Tn10-kan insertions suppress the conditionally lethal era(ts) allele. One truncates rpoN while the second disrupts another gene (ptsN) in the rpoN operon and does not affect classical nitrogen regulation. Neither alter expression of era indicating that suppression is post-translational. Plasmid clones of ptsN prevent suppression by either disruption mutation indicating that this gene is important for lethality caused by era(ts). rpoN and six neighboring genes were sequenced and compared with sequences in the database. Two of these genes encode proteins homologous to Enzyme IIA(Fru) and HPr of the phosphoenolpyruvate:sugar phosphotransferase system. We designate these proteins IIA(Ntr) (ptsN) and NPr (npr). Purified IIA(Ntr) and NPr exchange phosphate appropriately with Enzyme I, HPr, and Enzyme IIA proteins of the phosphoenolpyruvate: sugar phosphotransferase system. Several sugars and tricarboxylic acid cycle intermediates inhibited growth of the ptsN disruption mutant on medium containing an amino acid or nucleoside base as a combined source of nitrogen, carbon, and energy. This growth inhibition was relieved by supplying the ptsN gene or ammonium salts but was not aleviated by altering levels of exogenously supplied cAMP. These results support our previous proposal of a novel mechanism linking carbon and nitrogen assimilation and relates IIA(Ntr) to the unknown process regulated by the essential GTPase Era.	NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, CHROMOSOME BIOL LAB, FREDERICK, MD 21702 USA; UNIV TOKYO, INST MED SCI, DEPT TUMOR BIOL, TAKANAWA 108, JAPAN; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Tokyo; University of California System; University of California San Diego			Michotey, Valerie/AAA-4397-2021	Michotey, Valerie/0000-0001-6639-2877	NCI NIH HHS [N01-CO74101] Funding Source: Medline; NIAID NIH HHS [5RO1AI 21702, 2RO1AI 14176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021702, R01AI014176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBRIGHT LM, 1989, J BACTERIOL, V171, P1932, DOI 10.1128/jb.171.4.1932-1941.1989; ALIAS A, 1989, NUCLEIC ACIDS RES, V17, P5377, DOI 10.1093/nar/17.13.5377; BACHMANN BJ, 1990, MICROBIOL REV, V54, P130, DOI 10.1128/MMBR.54.2.130-197.1990; BACKMAN K, 1981, P NATL ACAD SCI-BIOL, V78, P3743, DOI 10.1073/pnas.78.6.3743; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; BALBAS P, 1993, GENE, V136, P211, DOI 10.1016/0378-1119(93)90466-G; BERGER DK, 1990, J BACTERIOL, V172, P4399, DOI 10.1128/jb.172.8.4399-4406.1990; BLATTNER FR, 1993, NUCLEIC ACIDS RES, V21, P5408; BOYD DA, 1994, INFECT IMMUN, V62, P1156, DOI 10.1128/IAI.62.4.1156-1165.1994; BRUN YV, 1992, GENE DEV, V6, P2395, DOI 10.1101/gad.6.12a.2395; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASTANO I, 1984, MOL GEN GENET, V195, P228, DOI 10.1007/BF00332751; CHEN SM, 1990, J BIOL CHEM, V265, P2888; CONTESSE G, 1969, LACTOSE OPERON, P401; DEBARBOUILLE M, 1991, P NATL ACAD SCI USA, V88, P9092, DOI 10.1073/pnas.88.20.9092; DEREUSE H, 1985, GENE, V35, P199; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1986, BIOCHEMISTRY-US, V25, P6543, DOI 10.1021/bi00369a031; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIXON RA, 1984, J GEN MICROBIOL, V130, P2745; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; EHRT S, 1994, J BACTERIOL, V176, P3493, DOI 10.1128/JB.176.12.3493-3499.1994; EISERMANN R, 1991, EUR J BIOCHEM, V197, P9, DOI 10.1111/j.1432-1033.1991.tb15875.x; FENG DF, 1990, METHOD ENZYMOL, V183, P375; FISCHER R, 1991, J BACTERIOL, V173, P3709, DOI 10.1128/JB.173.12.3709-3715.1991; FISCHER R, 1989, GENE, V82, P249, DOI 10.1016/0378-1119(89)90050-4; GAGNON G, 1992, Journal of Dental Research, V72, P733; GAVINI N, 1990, J BIOL CHEM, V265, P21532; GEERSE RH, 1989, MOL GEN GENET, V216, P517, DOI 10.1007/BF00334399; GONZYTREBOUL G, 1989, MOL MICROBIOL, V3, P103, DOI 10.1111/j.1365-2958.1989.tb00109.x; GRISAFI PL, 1989, J BACTERIOL, V171, P2719, DOI 10.1128/jb.171.5.2719-2727.1989; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HONEYMAN AL, 1992, INFECT IMMUN, V60, P3369, DOI 10.1128/IAI.60.8.3369-3375.1992; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; IMAISHI H, 1993, J BACTERIOL, V175, P1550, DOI 10.1128/JB.175.5.1550-1551.1993; INADA T, 1989, J BACTERIOL, V171, P5017, DOI 10.1128/jb.171.9.5017-5024.1989; INADA T, 1992, FUNCTIONAL STUDY RNC; INOUYE S, 1989, GENE, V85, P145; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; JIN SG, 1994, J BACTERIOL, V176, P1316, DOI 10.1128/jb.176.5.1316-1322.1994; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; JONES R, 1989, MOL GEN GENET, V215, P507, DOI 10.1007/BF00427050; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOHLER T, 1989, NUCLEIC ACIDS RES, V17, P10125, DOI 10.1093/nar/17.23.10125; KOHLER T, 1994, FEMS MICROBIOL LETT, V115, P177, DOI 10.1016/0378-1097(94)90010-8; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUNDIG W, 1971, J BIOL CHEM, V246, P1393; KUSTU S, 1989, MICROBIOL REV, V53, P367, DOI 10.1128/MMBR.53.3.367-376.1989; KUSTU S, 1986, REGULATION GENE EXPR, P139; LEE CA, 1983, J BIOL CHEM, V258, P761; LERNER CG, 1991, MOL MICROBIOL, V5, P951, DOI 10.1111/j.1365-2958.1991.tb00770.x; LONDON J, 1983, J BACTERIOL, V156, P611, DOI 10.1128/JB.156.2.611-619.1983; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; MAGASANIK B, 1987, ESCHERICHIA COLI SAL, P302; MAGASANIK B, 1987, ESCHERICHIA COLI SAL, P1318; MARCH PE, 1988, ONCOGENE, V2, P539; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MATTOO RL, 1983, ANAL BIOCHEM, V128, P245, DOI 10.1016/0003-2697(83)90372-X; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; MEIJER WG, 1992, J BACTERIOL, V174, P3855, DOI 10.1128/jb.174.12.3855-3866.1992; MERRICK M, 1987, MOL GEN GENET, V210, P323, DOI 10.1007/BF00325701; Merrick M. J., 1988, The Nitrogen and Sulphur Cycles. Proceedings of the 42nd Symposium of the Society for General Microbiology. Southampton, UK, January 1988., P331; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; MERRICK MJ, 1985, NUCLEIC ACIDS RES, V13, P7607, DOI 10.1093/nar/13.21.7607; MERRICK MJ, 1989, MOL MICROBIOL, V3, P1765, DOI 10.1111/j.1365-2958.1989.tb00162.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; ORCHARD LMD, 1990, P ROY SOC B-BIOL SCI, V242, P87, DOI 10.1098/rspb.1990.0108; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POPHAM D, 1991, J BIOL CHEM, V266, P19510; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POWERS DA, 1984, J BIOL CHEM, V259, P5212; PRIES A, 1991, J BACTERIOL, V173, P5843, DOI 10.1128/jb.173.18.5843-5853.1991; REDDY P, 1989, NUCLEIC ACIDS RES, V17, P10473, DOI 10.1093/nar/17.24.10473; REICHE B, 1988, BIOCHEMISTRY-US, V27, P6512, DOI 10.1021/bi00417a047; REIZER J, 1992, J BIOL CHEM, V267, P9158; REIZER J, 1989, EMBO J, V8, P2111, DOI 10.1002/j.1460-2075.1989.tb03620.x; REIZER J, 1993, J CELL BIOCHEM, V51, P19, DOI 10.1002/jcb.240510105; REIZER J, 1992, PROTEIN SCI, V1, P722, DOI 10.1002/pro.5560010604; REIZER J, 1994, FEMS MICROBIOL LETT, V118, P159, DOI 10.1111/j.1574-6968.1994.tb06819.x; REIZER J, 1984, J BACTERIOL, V160, P333, DOI 10.1128/JB.160.1.333-340.1984; REIZER J, 1994, PROTEIN SCI, V3, P440; REIZER J, 1988, CRC CR REV MICROBIOL, V15, P297, DOI 10.3109/10408418809104461; REIZER J, 1993, PROTEIN SCI, V2, P506; REIZER J, 1994, METHODS MOL BIOL COM, P319; RONSON CW, 1987, J BACTERIOL, V169, P2424, DOI 10.1128/jb.169.6.2424-2431.1987; RUDD KE, 1992, SHORT COURSE BACTERI; SAFFEN DW, 1987, J BIOL CHEM, V262, P16241; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Sambrook J, 1989, MOL CLONING LABORATO; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SCHNEIDER BL, 1991, J BACTERIOL, V173, P6355, DOI 10.1128/jb.173.20.6355-6363.1991; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHATTERS RG, 1989, J BACTERIOL, V171, P5087, DOI 10.1128/jb.171.9.5087-5094.1989; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SINGER M, 1989, MICROBIOL REV, V53, P1; SMITH DW, 1988, COMPUT APPL BIOSCI, V4, P212; SMITH GR, 1971, J BIOL CHEM, V246, P3320; SOOD P, 1994, MOL MICROBIOL, V12, P201, DOI 10.1111/j.1365-2958.1994.tb01009.x; SPRENGER GA, 1993, BIOCHIM BIOPHYS ACTA, V1158, P103, DOI 10.1016/0304-4165(93)90103-F; STIGTER J, 1993, MOL PLANT MICROBE IN, V6, P238, DOI 10.1094/MPMI-6-238; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; SUTRINA SL, 1988, J BIOL CHEM, V263, P5061; SUTRINA SL, 1990, J BIOL CHEM, V265, P18581; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; TIGEMEYER F, 1990, NUCLEIC ACIDS RES, V18, P1898, DOI 10.1093/nar/18.7.1898; ULLMANN A, 1969, P FOGARTY INT CTR, V4, P215; VANSLOOTEN JC, 1990, J BACTERIOL, V172, P5563, DOI 10.1128/jb.172.10.5563-5574.1990; VANWEEGHEL RP, 1991, BIOCHEMISTRY-US, V30, P1768, DOI 10.1021/bi00221a006; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WARRELMANN J, 1992, ARCH MICROBIOL, V158, P107, DOI 10.1007/BF00245213; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; WENG QP, 1992, J BIOL CHEM, V267, P19529; WU LF, 1990, J MOL BIOL, V213, P687, DOI 10.1016/S0022-2836(05)80256-6; YE JJ, 1994, P NATL ACAD SCI USA, V91, P3102, DOI 10.1073/pnas.91.8.3102; YE JJ, 1994, J BIOL CHEM, V269, P11837; ZHU PP, 1993, J BIOL CHEM, V268, P26531; ZUBER M, 1987, P NATL ACAD SCI USA, V84, P4514, DOI 10.1073/pnas.84.13.4514	123	187	198	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4822	4839		10.1074/jbc.270.9.4822	http://dx.doi.org/10.1074/jbc.270.9.4822			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876255	hybrid			2022-12-27	WOS:A1995QK08400092
J	ROUQUIER, S; LOWE, JB; KELLY, RJ; FERTITTA, AL; LENNON, GG; GIORGI, D				ROUQUIER, S; LOWE, JB; KELLY, RJ; FERTITTA, AL; LENNON, GG; GIORGI, D			MOLECULAR-CLONING OF A HUMAN GENOMIC REGION CONTAINING THE H-BLOOD-GROUP ALPHA(1,2)FUCOSYLTRANSFERASE GENE AND 2 H-LOCUS-RELATED DNA RESTRICTION FRAGMENTS - ISOLATION OF A CANDIDATE FOR THE HUMAN SECRETOR BLOOD-GROUP LOCUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; HUMAN ALPHA(1,3)FUCOSYLTRANSFERASE GENE; INTERPHASE CELL-NUCLEI; HUMAN CHROMOSOME-19; ALU-PCR; DETERMINES EXPRESSION; STRUCTURAL GENE; LEWIS-X; SEQUENCES; ASSIGNMENT	We have used the human H blood group alpha(1,2)fucosyltransferase (FUT1) cDNA to screen chromosome 19 cosmid libraries in a search for the human Secretor (Se) blood group gene (FUT2), One cosmid has been isolated that contains two distinct segments that cross-hybridize with FUT1. We have assembled a 100-kilobase (kb) cosmid contig, localized to 19q13,3, encompassing FUT1 and the two FUT1-related sequences, termed Sec1 and Sec2, for Secretor candidate 1 and 2, Sec1 and Sec2 are separated by 12 kb and are 65.5 kb and 35 kb apart, respectively, from the FUT1 gene, We used a cosmid-dependent direct cDNA selection method to clone a cDNA corresponding to a transcript that emanates from Sec2. This cDNA detects a 3.35-kb transcript in human tissues known to express the Se locus, Together with sequence and expression data reported in the accompanying article (Kelly, R, J., Rouquier, S., Giorgi, D., Lennon, G. G., and Lowe, J. B. (1995) J. Biol. Chem. 270, 4640-4649), these data demonstrate that Sec2 corresponds to the human Se blood group locus (FUT2), Our results further more define the physical relationship between the LT and Se loci and confirm a hypothesis that these two loci represent distinct but closely linked alpha(1,2)fucosyltransferase genes	LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA 94550; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48105; UNIV MICHIGAN,MED CTR,DEPT PATHOL,ANN ARBOR,MI 48105	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Lennon, Greg/T-4717-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048859] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R01HL48859] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASLANIDIS C, 1991, P NATL ACAD SCI USA, V88, P6765, DOI 10.1073/pnas.88.15.6765; BALL S, 1984, CYTOGENET CELL GENET, V37, P411; BALL SP, 1991, ANN HUM GENET, V55, P225, DOI 10.1111/j.1469-1809.1991.tb00417.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BLASZCZYKTHURIN M, 1988, BIOCHEM BIOPH RES CO, V151, P100, DOI 10.1016/0006-291X(88)90564-5; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; COLE CG, 1991, GENOMICS, V10, P816, DOI 10.1016/0888-7543(91)90468-T; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; EIBERG H, 1983, CLIN GENET, V24, P159; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEMMILL RM, 1987, GENE ANAL TECH, V4, P119, DOI 10.1016/0735-0651(87)90010-0; GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; KUIJPERS TW, 1993, BLOOD, V81, P873; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; LEPENDU J, 1985, AM J HUM GENET, V37, P749; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; LOWE JB, 1991, J BIOL CHEM, V266, P17467; MOHR J, 1951, ACTA PATHOL MIC SC, V28, P339; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NISHIHARA S, 1993, BIOCHEM BIOPH RES CO, V190, P42, DOI 10.1006/bbrc.1993.1008; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1990, J IMMUNOGENET, V17, P235; ORIOL R, 1984, CYTOGENET CELL GENET, V37, P564; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PONTAROTTI P, 1988, NUCLEIC ACIDS RES, V16, P6767, DOI 10.1093/nar/16.14.6767; ROUQUIER S, 1994, CYTOGENET CELL GENET, V66, P70, DOI 10.1159/000133668; ROUQUIER S, 1993, GENOMICS, V17, P330, DOI 10.1006/geno.1993.1329; Sadler J. E., 1984, BIOL CARBOHYDRATES, V2, P199; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SHUTLER G, 1992, GENOMICS, V13, P518, DOI 10.1016/0888-7543(92)90119-D; SICILIANO MJ, 1986, MUTAT RES, V174, P303, DOI 10.1016/0165-7992(86)90051-5; SMITH DF, 1990, J BIOL CHEM, V265, P6225; TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; TRASK B, 1992, GENOMICS, V14, P162, DOI 10.1016/S0888-7543(05)80299-X; TRASK BJ, 1991, AM J HUM GENET, V48, P1; TUCKER JD, 1988, CYTOGENET CELL GENET, V48, P103, DOI 10.1159/000132600; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; Watkins W M, 1980, Adv Hum Genet, V10, P1; WESTON BW, 1992, J BIOL CHEM, V267, P4152; WESTON BW, 1992, J BIOL CHEM, V267, P24575; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021	55	152	169	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4632	4639		10.1074/jbc.270.9.4632	http://dx.doi.org/10.1074/jbc.270.9.4632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876234	hybrid			2022-12-27	WOS:A1995QK08400068
J	BUBB, MR; SPECTOR, I; BERSHADSKY, AD; KORN, ED				BUBB, MR; SPECTOR, I; BERSHADSKY, AD; KORN, ED			SWINHOLIDE-A IS A MICROFILAMENT DISRUPTING MARINE TOXIN THAT STABILIZES ACTIN DIMERS AND SEVERS ACTIN-FILAMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SPONGE THEONELLA-SWINHOEI; F-ACTIN; CYTOCHALASIN-D; POLYMERIZATION; GELSOLIN; BINDING; MACROLIDE; DEPOLYMERIZATION; PENTOXIFYLLINE; ORGANIZATION	Swinholide A, isolated from the marine sponge Theonella swinhoei, is a 44-carbon ring dimeric dilactone macrolide with a 2-fold axis of symmetry. Recent studies have elucidated its unusual structure and shown that it has potent cytotoxic activity, We now report that swinholide A disrupts the actin cytoskeleton of cells grown in culture, sequesters actin dimers in vitro in both polymerizing and non-polymerizing buffers with a binding stoichiometry of one swinholide A molecule per actin dimer, and rapidly severs F-actin in vitro with high cooperativity, These unique properties are sufficient to explain the cytotoxicity of swinholide A. They also suggest that swinholide A might be a model for studies of the mechanism of action of F-actin severing proteins and be therapeutically useful in conditions where filamentous actin contributes to pathologically high viscosities.	NHLBI,CELL BIOL LAB,BETHESDA,MD 20892; SUNY STONY BROOK,HLTH SCI CTR,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science			Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295; Bershadsky, Alexander/0000-0002-9571-7375				BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CARMELY S, 1985, TETRAHEDRON LETT, V26, P511, DOI 10.1016/S0040-4039(00)61925-1; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DOI M, 1991, J ORG CHEM, V56, P3629, DOI 10.1021/jo00011a033; ELZINGA M, 1984, P NATL ACAD SCI-BIOL, V81, P6599, DOI 10.1073/pnas.81.21.6599; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; GODDETTE DW, 1985, BIOCHEM BIOPH RES CO, V128, P1087, DOI 10.1016/0006-291X(85)91051-4; HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; KOBAYASHI M, 1990, CHEM PHARM BULL, V38, P2409; KOBAYASHI M, 1994, CHEM PHARM BULL, V42, P19; KORTHUIS RJ, 1991, J APPL PHYSIOL, V71, P1261, DOI 10.1152/jappl.1991.71.4.1261; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; MARUYAMA K, 1980, BIOCHIM BIOPHYS ACTA, V626, P494; MIHASHI K, 1964, ARCH BIOCHEM BIOPHYS, V107, P441, DOI 10.1016/0003-9861(64)90300-5; MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785; MORRIS A, 1980, NATURE, V287, P638; NORTHROP J, 1986, J BIOL CHEM, V261, P9274; PATERSON I, 1994, J AM CHEM SOC, V116, P9391, DOI 10.1021/ja00099a091; PATTERSON GML, 1993, CELL MOTIL CYTOSKEL, V24, P39, DOI 10.1002/cm.970240105; PORTUGAL J, 1988, BIOCHIM BIOPHYS ACTA, V949, P158, DOI 10.1016/0167-4781(88)90079-6; RAO KMK, 1988, J CELL PHYSIOL, V137, P577, DOI 10.1002/jcp.1041370326; Senderowicz A. M. J., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P409; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPUDICH JA, 1971, J BIOL CHEM, V246, P4865; SUN HQ, 1994, J BIOL CHEM, V269, P9473; TODD JS, 1992, TETRAHEDRON LETT, V33, P441, DOI 10.1016/S0040-4039(00)93962-5; VANLEENEN D, 1993, J IMMUNOL, V151, P2318; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; WALLING EA, 1988, ARCH BIOCHEM BIOPHYS, V264, P321, DOI 10.1016/0003-9861(88)90600-5; WODNICKA M, 1992, FOLIA HISTOCHEM CYTO, V30, P107; YIN HL, 1981, J BIOL CHEM, V256, P9693	37	153	159	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3463	3466		10.1074/jbc.270.8.3463	http://dx.doi.org/10.1074/jbc.270.8.3463			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876075	hybrid			2022-12-27	WOS:A1995QH68800001
J	DESTROOPER, B; CRAESSAERTS, K; DEWACHTER, I; MOECHARS, D; GREENBERG, B; VANLEUVEN, F; VANDENBERGHE, H				DESTROOPER, B; CRAESSAERTS, K; DEWACHTER, I; MOECHARS, D; GREENBERG, B; VANLEUVEN, F; VANDENBERGHE, H			BASOLATERAL SECRETION OF AMYLOID PRECURSOR PROTEIN IN MADIN-DARBY CANINE KIDNEY-CELLS IS DISTURBED BY ALTERATIONS OF INTRACELLULAR PH AND BY INTRODUCING A MUTATION ASSOCIATED WITH FAMILIAL ALZHEIMERS-DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; BETA-PROTEIN; HIPPOCAMPAL-NEURONS; CULTURED-CELLS; MDCK CELLS; H+-ATPASE; NEXIN-II; GENE; CLEAVAGE; PEPTIDE	The analysis of potential sorting signals in amyloid precursor protein (APP) by site-directed mutagenesis and the disturbance of metabolic pathways by drugs is used here to define the parameters that determine polarized secretion of APP in Madin-Darby canine kidney cells. Endogenously produced APP751/770 and APP695 produced from transfected constructs are secreted almost exclusively into the basolateral compartment. The sorting mechanism is highly dependent on intracellular pH as demonstrated by its sensitivity to primary amines and inhibitors of the acidifying vacuolar proton ATPase. The role of potential basolateral sorting signals in the cytoplasmic, transmembrane, and beta A4 amyloid region of APP was investigated. Neither deletion of the endocytosis and putative basolateral sorting signal GY.NPTY nor complete deletion of the cytoplasmic domain causes apical secretion of soluble APP. Further deletion of the transmembrane domain and of the beta A4 amyloid region confirmed that the major basolateral sorting determinant resides in the extracellular domain of APP. Increased beta-secretase cleavage of APP after introduction of the ''swedish'' double mutation causes apical missorting of about 20% of beta-secretase-cleaved APP. The data underline the complexity of processing and sorting APP in polarized cells and suggest a possible problem of protein sorting in Alzheimer's Disease.	KATHOLIEKE UNIV LEUVEN,CTR HUMAN GENET,DEPT HUMAN GENET,EXPTL GENET GRP,B-3000 LOUVAIN,BELGIUM; CEPHALON INC,W CHESTER,PA 19380	KU Leuven; Teva Pharmaceutical Industries; Cephalon Inc.			de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; , Ilse Dewachter/0000-0001-7202-515X				BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLARK RF, 1993, ARCH NEUROL-CHICAGO, V50, P1164, DOI 10.1001/archneur.1993.00540110044004; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DESTROOPER B, 1991, EUR J BIOCHEM, V199, P25; DESTROOPER B, 1992, FEBS LETT, V308, P50, DOI 10.1016/0014-5793(92)81048-Q; DESTROOPER B, 1991, BIOCHIM BIOPHYS ACTA, V1129, P141, DOI 10.1016/0167-4781(91)90231-A; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; DYRKS T, 1993, FEBS LETT, V335, P89, DOI 10.1016/0014-5793(93)80446-2; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GILLESPIE SL, 1992, BIOCHEM BIOPH RES CO, V187, P1285, DOI 10.1016/0006-291X(92)90442-N; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; HAASS C, 1995, IN PRESS J CELL BIOL; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MARTIN GM, 1990, NATURE, V347, P124, DOI 10.1038/347124a0; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V179, P1670, DOI 10.1016/0006-291X(91)91767-7; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; PIKE CJ, 1993, J NEUROSCI, V13, P1676; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SEILER N, 1993, NEUROCHEM RES, V18, P235, DOI 10.1007/BF00969079; SHOJI M, 1992, SCIENCE, V253, P126; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANLEUVEN F, 1980, CELL, V20, P37, DOI 10.1016/0092-8674(80)90232-9; VANLEUVEN F, 1982, TRENDS BIOCHEM SCI, V7, P185, DOI 10.1016/0968-0004(82)90135-9; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619; ZEUZEM S, 1992, J MEMBRANE BIOL, V125, P231; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	52	66	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4058	4065		10.1074/jbc.270.8.4058	http://dx.doi.org/10.1074/jbc.270.8.4058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876155	hybrid			2022-12-27	WOS:A1995QH68800088
J	JIANG, SW; SHEPARD, AR; EBERHARDT, NL				JIANG, SW; SHEPARD, AR; EBERHARDT, NL			AN INITIATOR ELEMENT IS REQUIRED FOR MAXIMAL HUMAN CHORIONIC SOMATOMAMMOTROPIN GENE PROMOTER AND ENHANCER FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLACENTAL-LACTOGEN; RNA POLYMERASE-II; TRANSCRIPTION FACTOR; TATA BOX; INVITRO FUNCTION; BINDING; SEQUENCES; PREGNANCY; COMPLEX; SP1	Previous studies have indicated that cell-specific expression of the human chorionic somatomammotropin (hCS) gene may be mediated by a placental-specific enhancer (CSEn). In the current studies, we have analyzed the promoter elements that are required for enhancer and promoter function in choriocarcinoma cells (BeWo). Mutation of both hCS GHF1 sites had no effect on promoter or enhancer activity. In contrast, mutation of the Spl site diminished basal and CSEn-stimulated transcription by approximate to 75% and approximate to 56%, respectively, indicating that Spl was necessary but not sufficient for maximal basal and enhancer-mediated transcription. Deletion and site-specific mutation of the proximal promoter region indicated that the TATA box and an initiator site (InrE) located between nucleotides -15/+1 of the hCS promoter were required for maximal promoter and enhancer function. Mutations of the InrE were associated with reduced basal and enhancer-stimulated activities and altered transcription initiation sites. A protein of 70-kDa mass, that was preferentially expressed in human choriocarcinoma cells (BeWo and JEG-3), bound specifically to the InrE. The data suggest that an initiator present in high concentrations in placental cells contributes to the control of cell-specific hCS gene expression at the promoter level and is required for maximal enhancer function.	MAYO CLIN & MAYO FDN,SMH,DEPT MED,ENDOCRINE RES UNIT,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT BIOCHEM MOLEC BIOL,ENDOCRINE RES UNIT,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041206] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41206] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; BORODY IB, 1981, BRIT J OBSTET GYNAEC, V88, P447, DOI 10.1111/j.1471-0528.1981.tb01011.x; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; CARCAMO J, 1991, P NATL ACAD SCI USA, V88, P8052, DOI 10.1073/pnas.88.18.8052; CONAWAY JW, 1990, J BIOL CHEM, V265, P7564; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; FITZPATRICK SL, 1990, MOL ENDOCRINOL, V4, P1815, DOI 10.1210/mend-4-12-1815; FREEMARK M, 1989, J CLIN INVEST, V83, P883, DOI 10.1172/JCI113972; FREEMARK M, 1993, ENDOCRINOLOGY, V133, P1830, DOI 10.1210/en.133.4.1830; HANDWERGER S, 1991, ENDOCR REV, V12, P329, DOI 10.1210/edrv-12-4-329; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HIRT H, 1987, DNA-J MOLEC CELL BIO, V6, P59, DOI 10.1089/dna.1987.6.59; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JACQUEMIN P, 1994, MOL CELL BIOL, V14, P93, DOI 10.1128/MCB.14.1.93; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; JIANG SW, 1994, J BIOL CHEM, V269, P10384; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; MANTOVANI R, 1993, NUCLEIC ACIDS RES, V21, P4873, DOI 10.1093/nar/21.21.4873; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MILLER WL, 1983, ENDOCR REV, V4, P97, DOI 10.1210/edrv-4-2-97; NACHTIGAL MW, 1989, NUCLEIC ACIDS RES, V17, P4327, DOI 10.1093/nar/17.11.4327; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; NIELSEN PV, 1979, AM J OBSTET GYNECOL, V135, P322, DOI 10.1016/0002-9378(79)90698-7; POGULIS RJ, 1993, J BIOL CHEM, V268, P2493; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; PURNELL BA, 1993, MOL CELL BIOL, V13, P2593, DOI 10.1128/MCB.13.4.2593; ROGERS BL, 1986, NUCLEIC ACIDS RES, V14, P7647, DOI 10.1093/nar/14.19.7647; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SEGAL R, 1991, J BIOL CHEM, V266, P20406; SELBY MJ, 1984, J BIOL CHEM, V259, P3131; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SHEPARD AR, 1994, J BIOL CHEM, V269, P1804; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Snedecor G. W., 1980, STATISTICAL METHODS, P116; SUN JM, 1992, NUCLEIC ACIDS RES, V20, P6385, DOI 10.1093/nar/20.23.6385; TALKINGTON CA, 1982, NATURE, V298, P192, DOI 10.1038/298192a0; TOKUNAGA K, 1984, NUCLEIC ACIDS RES, V12, P1543, DOI 10.1093/nar/12.3.1543; VACCARO M, 1990, P NATL ACAD SCI USA, V87, P3047, DOI 10.1073/pnas.87.8.3047; WALKER WH, 1990, J BIOL CHEM, V265, P12940; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; XIE W, 1991, BIOTECHNIQUES, V11, P325; ZENZIEGREGORY B, 1992, J BIOL CHEM, V267, P2823	50	29	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3683	3692		10.1074/jbc.270.8.3683	http://dx.doi.org/10.1074/jbc.270.8.3683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876107	hybrid			2022-12-27	WOS:A1995QH68800036
J	ROUSSEAU, A; MICHAUD, A; CHAUVET, MT; LENFANT, M; CORVOL, P				ROUSSEAU, A; MICHAUD, A; CHAUVET, MT; LENFANT, M; CORVOL, P			THE HEMOREGULATORY PEPTIDE N-ACETYL-SER-ASP-LYS-PRO IS A NATURAL AND SPECIFIC SUBSTRATE OF THE N-TERMINAL ACTIVE-SITE OF HUMAN ANGIOTENSIN-CONVERTING ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL PROLIFERATION; 2 HOMOLOGOUS DOMAINS; NEGATIVE REGULATOR; MOLECULAR-CLONING; BONE-MARROW; PLASMA; ACSDKP; BRADYKININ; EXPRESSION; HYDROLYSIS	Angiotensin I-converting enzyme (ACE) is a zinc-dipeptidyl carboxypeptidase, which contains two similar domains, each possessing a functional active site, Respective involvement of each active site in the degradation of the circulating peptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP), a negative regulator of hematopoietic stem cell proliferation, was studied by using wild-type recombinant ACE and two full-length mutants containing a single functional site, Both the N- and C-active sites of ACE exhibit dipeptidyl activity toward AcSDKP, with K-m values of 31 and 39 mu M, respectively, However, the N-active site hydrolyzes the peptide 50 times faster compared with the C-active site, with k(cat)/K-m values of 0.5 and 0.01 mu M(-1).s(-1), respectively, The predominant role of the N-active site in AcSDKP hydrolysis was confirmed by the inhibition of hydrolysis using a monoclonal antibody specifically directed against the N-active site, The N-domain specificity for AcSDKP will aid the identification of specific inhibitors for this domain. This is the first report of a highly specific substrate for the N-active site of ACE, with kinetic constants in the range of physiological substrates, suggesting that ACE might be involved via its N-terminal active site in the in vivo regulation of the local concentration of this hemoregulatory peptide.	COLL FRANCE,INSERM,U36,F-75005 PARIS,FRANCE; CNRS,INST CHIM SUBST NAT,F-91198 GIF SUR YVETTE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; ALHENCGELAS F, 1988, J LAB CLIN MED, V101, P83; BELDENT V, 1993, J BIOL CHEM, V268, P26428; BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945; BOGDEN AE, 1991, ANN NY ACAD SCI, V628, P126, DOI 10.1111/j.1749-6632.1991.tb17230.x; BONNET D, 1993, BLOOD, V82, P3307; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DANILOV S, 1994, J BIOL CHEM, V269, P26806; DANILOV SM, 1987, BIOTECHNOL APPL BIOC, V9, P319; DORER FE, 1976, BIOCHIM BIOPHYS ACTA, V429, P220, DOI 10.1016/0005-2744(76)90045-0; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; EHLERS MRW, 1988, BIOCHEMISTRY-US, V27, P5538, DOI 10.1021/bi00415a023; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; FRINDEL E, 1977, EXP HEMATOL, V5, P74; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; HUBERT C, 1991, J BIOL CHEM, V268, P15377; JASPARD E, 1993, J BIOL CHEM, V268, P9496; KUMAR RS, 1991, J BIOL CHEM, V266, P3854; KUMAR RS, 1989, J BIOL CHEM, V264, P16754; LANZILLO JJ, 1985, J BIOL CHEM, V260, P4938; LATTION AL, 1989, FEBS LETT, V252, P99, DOI 10.1016/0014-5793(89)80897-X; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; LIOZON E, 1993, LEUKEMIA, V7, P808; LORD BI, 1977, BIOMED EXPRESS, V27, P223; OFFORD RE, 1966, NATURE, V211, P591, DOI 10.1038/211591a0; PERSSON A, 1977, ANAL BIOCHEM, V83, P296, DOI 10.1016/0003-2697(77)90538-3; PRADELLES P, 1990, BIOCHEM BIOPH RES CO, V170, P986, DOI 10.1016/0006-291X(90)90489-A; RIEGER KJ, 1993, BIOCHEM J, V296, P373, DOI 10.1042/bj2960373; ROBINSON S, 1992, CELL PROLIFERAT, V25, P623, DOI 10.1111/j.1365-2184.1992.tb01464.x; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; SKIDGEL RA, 1985, P NATL ACAD SCI USA, V82, P1025, DOI 10.1073/pnas.82.4.1025; SOTTY D, 1991, PEPTIDES 1990, P309; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WDZIECZAKBAKALA J, 1983, BIOMED PHARMACOTHER, V9, P467; WEI L, 1992, J BIOL CHEM, V267, P13398; WEI L, 1991, J BIOL CHEM, V266, P9002; WEI L, 1991, J BIOL CHEM, V266, P5540; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6	40	272	286	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3656	3661		10.1074/jbc.270.8.3656	http://dx.doi.org/10.1074/jbc.270.8.3656			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876104	hybrid			2022-12-27	WOS:A1995QH68800032
J	MARSISCHKY, GT; WILSON, BA; COLLIER, RJ				MARSISCHKY, GT; WILSON, BA; COLLIER, RJ			ROLE OF GLUTAMIC-ACID-988 OF HUMAN POLY-ADP-RIBOSE POLYMERASE IN POLYMER FORMATION - EVIDENCE FOR ACTIVE-SITE SIMILARITIES TO THE ADP-RIBOSYLATING TOXINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); HUMAN POLY(ADP-RIBOSE) POLYMERASE; NAD-BINDING-SITE; FULL-LENGTH CDNA; DIPHTHERIA-TOXIN; ESCHERICHIA-COLI; PERTUSSIS TOXIN; ENZYMATIC-ACTIVITY; CHOLERA-TOXIN	Sequence similarities between the enzymatic region of poly-ADP-ribose polymerase and the corresponding region of mono-ADP-ribosylating bacterial toxins suggest similarities in active site structure and catalytic mechanism. Glu(988) Of the human polymerase aligns with the catalytic glutamic acid of the toxins, and replacement of this residue with Gln, Asp, or Ala caused major reductions in synthesis of enzyme-linked poly-ADP-ribose. Replacement of any of 3 other nearby Glu residues had little effect. The Glu(988) mutations produced similar changes in activity in the carboxyl-terminal 40-kDa catalytic fragment fused to maltose binding protein: E988Q and E988A reduced polymer elongation > 2000-fold, and E988D similar to 20-fold. Smaller changes were seen in chain initiation. The mutations had little effect on the K-m of NAD, indicating a predominantly catalytic function for Glu(988). The results support the concept of similar active sites of the polymerase and the ADP-ribosylating toxins, Glu(988) may function in polymer elongation similarly to the toxins' active site glutamate, as a general base to activate the attacking nucleophile (in the case of the polymerase, the 2'-OH of the terminal adenosine group of a nascent poly-ADP-ribose chain).			MARSISCHKY, GT (corresponding author), HARVARD UNIV, SCH MED, SHIPLEY INST MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA.			Collier, R John/0000-0002-2427-4239	NIAID NIH HHS [AI 22848, AI 22021] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021, R01AI022848, R37AI022021] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABOULELA N, 1988, ANAL BIOCHEM, V174, P239, DOI 10.1016/0003-2697(88)90541-6; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; CARROLL SF, 1984, P NATL ACAD SCI-BIOL, V81, P3307, DOI 10.1073/pnas.81.11.3307; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1985, P NATL ACAD SCI USA, V82, P7237, DOI 10.1073/pnas.82.21.7237; CARROLL SF, 1988, MOL MICROBIOL, V2, P293, DOI 10.1111/j.1365-2958.1988.tb00031.x; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; CIEPLAK W, 1990, BIOCHEM J, V268, P547, DOI 10.1042/bj2680547; CLEAVER JE, 1991, MUTAT RES, V257, P1, DOI 10.1016/0165-1110(91)90016-O; COBURN J, 1992, CURR TOP MICROBIOL, V175, P133; COCKLE SA, 1989, FEBS LETT, V249, P329, DOI 10.1016/0014-5793(89)80652-0; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; DEMURCIA G, 1991, BIOESSAYS, V13, P455, DOI 10.1002/bies.950130905; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOMENIGHINI M, 1991, MOL MICROBIOL, V5, P23, DOI 10.1111/j.1365-2958.1991.tb01822.x; DOUGLAS CM, 1987, J BACTERIOL, V169, P4967, DOI 10.1128/jb.169.11.4967-4971.1987; DOUGLAS CM, 1990, BIOCHEMISTRY-US, V29, P5043, DOI 10.1021/bi00473a007; FITZMAURICE WP, 1989, MOL GEN GENET, V218, P340, DOI 10.1007/BF00331287; GILL DM, 1987, BIOCHEMISTRY-US, V26, P6364, DOI 10.1021/bi00394a009; GUAN C, 1988, GENE, V67, P21; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; HUPPI K, 1989, NUCLEIC ACIDS RES, V17, P3387, DOI 10.1093/nar/17.9.3387; IKEJIMA M, 1989, BIOCHEM BIOPH RES CO, V163, P739, DOI 10.1016/0006-291X(89)92285-7; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; IKEJIMA M, 1987, J BIOL CHEM, V262, P17641; ITTEL ME, 1991, GENE, V102, P157, DOI 10.1016/0378-1119(91)90073-K; JUNG M, 1993, J BIOL CHEM, V268, P23215; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KAWAICHI M, 1981, J BIOL CHEM, V256, P9483; KEITH G, 1990, ANAL BIOCHEM, V191, P309, DOI 10.1016/0003-2697(90)90224-W; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; LUKAC M, 1988, INFECT IMMUN, V56, P3095, DOI 10.1128/IAI.56.12.3095-3098.1988; LUKAC M, 1988, J BIOL CHEM, V263, P6146; MADHUSUDAN T, 1994, PROTEIN SCI, V3, P176; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Maniatis T., 1982, MOL CLONING; MARSISCHKY GT, 1992, ADP RIBOSYLATION REA, P47; MARSISCHKY GT, 1993, THESIS TUFTS U SCH M; MASUTANI M, 1994, EUR J BIOCHEM, V220, P607, DOI 10.1111/j.1432-1033.1994.tb18662.x; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; MENNELLA MRF, 1992, ADP RIBOSYLATION REA, P369; MIWA M, 1979, P NATL ACAD SCI USA, V76, P595, DOI 10.1073/pnas.76.2.595; MIWA M, 1981, J BIOL CHEM, V256, P2916; MIWA M, 1977, NUCLEIC ACIDS RES, V4, P3997, DOI 10.1093/nar/4.11.3997; MOSS J, 1991, MOL MICROBIOL, V5, P2621, DOI 10.1111/j.1365-2958.1991.tb01971.x; OPPENHEIMER NJ, 1981, J BIOL CHEM, V256, P8579; PIZZA M, 1988, P NATL ACAD SCI USA, V85, P7521, DOI 10.1073/pnas.85.20.7521; POIRIER GG, 1982, EUR J BIOCHEM, V127, P437; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; SAITO I, 1990, GENE, V90, P249, DOI 10.1016/0378-1119(90)90187-V; SASTRY SS, 1988, J BIOL CHEM, V263, P1505; SIMONIN F, 1993, J BIOL CHEM, V268, P13454; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Sinnott M. L., 1987, ENZYME MECHANISMS, P259; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P3481, DOI 10.1073/pnas.90.8.3481; UCHIDA T, 1971, NATURE-NEW BIOL, V233, P8, DOI 10.1038/newbio233008a0; UEDA K, 1979, J BIOL CHEM, V254, P679; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; USHIRO H, 1987, J BIOL CHEM, V262, P2352; WERNER E, 1984, EUR J BIOCHEM, V139, P81, DOI 10.1111/j.1432-1033.1984.tb07979.x; WILSON BA, 1994, J BIOL CHEM, V269, P23296; WILSON BA, 1994, ZBL BAKT S, V24, P402; WILSON BA, 1992, CURR TOP MICROBIOL, V175, P27; WILSON BA, 1990, BIOCHEMISTRY-US, V29, P8648	75	120	123	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3247	3254		10.1074/jbc.270.7.3247	http://dx.doi.org/10.1074/jbc.270.7.3247			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852410	hybrid			2022-12-27	WOS:A1995QG47100055
J	DOMPENCIEL, RE; GARNEPUDI, VR; SCHOENBERG, DR				DOMPENCIEL, RE; GARNEPUDI, VR; SCHOENBERG, DR			PURIFICATION AND CHARACTERIZATION OF AN ESTROGEN-REGULATED XENOPUS LIVER POLYSOMAL NUCLEASE INVOLVED IN THE SELECTIVE DESTABILIZATION OF ALBUMIN MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; 3' UNTRANSLATED REGION; BINDING PROTEIN; ENDONUCLEOLYTIC CLEAVAGE; GENE-TRANSCRIPTION; IN-VITRO; SEQUENCE; LAEVIS; DEGRADATION; INSTABILITY	A previous report from this laboratory described an estrogen-regulated endoribonuclease activity on Xenopus liver polysomes which had properties one might expect for a messenger ribonuclease involved in the regulated destabilization of albumin mRNA (Pastori, R. L., Moskaitis, J. E., and Schoenberg, D. R. (1991) Biochemistry 30, 10490-10498). This report describes the purification and properties of this ribonuclease. The purified nuclease fraction contained a doublet of 62 and 64 kDa and a small amount of a 40-kDa peptide, In situ analysis on both denaturing and nondenaturing gels using an albumin transcript as substrate showed all three proteins possess nuclease activity. Peptide mapping and Western blot with a polyclonal antiserum showed the 62- and 64-kDa peptides to be isoforms, and the 40-kDa peptide to be a degradation product of the larger species. Two-dimensional gel electrophoresis further separated the 62- and 64-kDa species into three pairs of proteins, with isoelectric points of 9.6, 9.8, and 9.8. The purified ribonuclease rapidly degraded a full-length albumin transcript, yet had no effect on either a full-length albumin antisense transcript or full-length ferritin transcript, A number of properties of the purified nuclease were characterized, including the effects of salt, divalent cations, EDTA, sulfhydryl reagents, and temperature. Treatment of the polysomal nuclease with micrococcal nuclease had no effect, indicating that this enzyme does not require an RNA cofactor for activity. Finally, primer extension mapped the major cleavage site to an overlapping repeated sequence APyrUGA, with cleavage between and adjacent to the two pyrimidine residues generating fragments with 5'-hydroxyls.	UNIFORMED SERV UNIV HLTH SCI, SCH MED, DEPT PHARMACOL, BETHESDA, MD 20814 USA	Uniformed Services University of the Health Sciences - USA			Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038277] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BANDYOPADHYAY R, 1990, MOL CELL BIOL, V10, P2060, DOI 10.1128/MCB.10.5.2060; BEINTEMA JJ, 1988, PROG BIOPHYS MOL BIO, V51, P165, DOI 10.1016/0079-6107(88)90001-6; Belasco J.G., 2012, CONTROL MESSENGER RN; BINDER R, 1989, J BIOL CHEM, V264, P16910; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BOHJANEN PR, 1992, J BIOL CHEM, V267, P6302; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; BROWN BD, 1993, GENE DEV, V7, P1620, DOI 10.1101/gad.7.8.1620; BROWN BD, 1990, GENE DEV, V4, P1925, DOI 10.1101/gad.4.11.1925; CALVERT R, 1978, FEBS LETT, V86, P247, DOI 10.1016/0014-5793(78)80572-9; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COUTTS M, 1993, BIOCHIM BIOPHYS ACTA, V1173, P57, DOI 10.1016/0167-4781(93)90242-6; GREENBERG ME, 1993, CONTROL MESSENGER RN; HAEFLIGER DN, 1989, J MOL EVOL, V29, P344, DOI 10.1007/BF02103621; HARFORD JB, 1993, CONTROL MESSENGER RN; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HUA J, 1993, NUCLEIC ACIDS RES, V21, P155, DOI 10.1093/nar/21.1.155; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KARWAN R, 1993, FEBS LETT, V319, P1, DOI 10.1016/0014-5793(93)80025-P; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWELL JE, 1992, GENE DEV, V6, P2088, DOI 10.1101/gad.6.11.2088; MARTIN MB, 1986, J BIOL CHEM, V261, P2355; MCLAREN RS, 1993, J BIOL CHEM, V268, P14637; MOSKAITIS JE, 1991, BIOCHEM BIOPH RES CO, V174, P825, DOI 10.1016/0006-291X(91)91492-U; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; MULLER WEG, 1992, J MOL BIOL, V226, P721, DOI 10.1016/0022-2836(92)90628-W; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; NIELSEN FC, 1992, J BIOL CHEM, V267, P19404; PASTORI RL, 1993, ARCH BIOCHEM BIOPHYS, V305, P313, DOI 10.1006/abbi.1993.1428; PASTORI RL, 1991, BIOCHEMISTRY-US, V30, P10490, DOI 10.1021/bi00107a018; PASTORI RL, 1991, MOL ENDOCRINOL, V5, P461, DOI 10.1210/mend-5-4-461; PASTORI RL, 1990, BIOCHEMISTRY-US, V29, P2599, DOI 10.1021/bi00462a024; REDINBAUGH MG, 1985, ANAL BIOCHEM, V147, P144, DOI 10.1016/0003-2697(85)90020-X; RIEGEL AT, 1987, MOL ENDOCRINOL, V1, P160, DOI 10.1210/mend-1-2-160; ROSS J, 1986, J MOL BIOL, V188, P579, DOI 10.1016/S0022-2836(86)80008-0; ROSS J, 1987, J BIOL CHEM, V262, P9374; ROSS J, 1993, CONTROL MESSENGER RN; SCHOENBERG DR, 1981, NUCLEIC ACIDS RES, V9, P6669, DOI 10.1093/nar/9.24.6669; SHAPIRO DJ, 1989, RECENT PROG HORM RES, V45, P29; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	48	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6108	6118		10.1074/jbc.270.11.6108	http://dx.doi.org/10.1074/jbc.270.11.6108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890744				2022-12-27	WOS:A1995QM94500060
J	FRANK, DJ; TYREE, CM; GEORGE, CP; KADONAGA, JT				FRANK, DJ; TYREE, CM; GEORGE, CP; KADONAGA, JT			STRUCTURE AND FUNCTION OF THE SMALL-SUBUNIT OF TFIIF (RAP30) FROM DROSOPHILA-MELANOGASTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; TRANSCRIPTION INITIATION-FACTOR; ESCHERICHIA-COLI SIGMA-70; ACCURATE INITIATION; PREINITIATION COMPLEX; MINIMAL SET; CDNA; PROTEINS; SEQUENCE; RAP74	To study the mechanism of basal transcription by RNA polymerase II, a cDNA encoding the Drosophila homologue of the small subunit of TFIIF (also referred to as TFIIF30, RAP30, factor 5b, and gamma) was isolated. The Drosophila TFIIF30 gene is located at region 86C on the right arm of the third chromosome. The protein encoded by the cDNA, termed dTFIIF30, was synthesized in Escherichia coli and purified to greater than 95% homogeneity. In reconstituted transcription reactions with purified basal factors, the specific activity of dTFIIF30 was identical to that of its human homologue. Moreover, a carboxyl-terminal fragment, designated dF30(119-276), which contains the carboxyl-terminal 158 amino acid residues of dTFIIF30, was found to possess approximately 50% of the transcriptional activity as full-length dTFIIF30. The interaction of dTFIIF30 with the large subunit of TFIIF (also referred to as TFIIF74, RAP74, factor 5a, and beta) was investigated by glycerol gradient sedimentation analyses. In these experiments, dTFIIF30, but not dF30(119-276), assembled into a stable heteromeric complex with TFIIF74. These results, combined with those of previous work on TFIIF, support a model for TFIIF30 function in which the carboxyl-terminal region constitutes a functional domain that can interact with RNA polymerase II to mediate basal transcription, whereas the amino terminus comprises a domain that interacts with TFIIF74.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	FRANK, DJ (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.				NIGMS NIH HHS [GM 41249] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASO T, 1992, NATURE, V355, P461, DOI 10.1038/355461a0; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; BURTON ZF, 1986, EMBO J, V5, P2923, DOI 10.1002/j.1460-2075.1986.tb04588.x; CHANG CH, 1993, J BIOL CHEM, V268, P20482; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CONAWAY RC, 1990, J BIOL CHEM, V265, P7559; Drapkin R, 1993, CURR OPIN CELL BIOL, V5, P469, DOI 10.1016/0955-0674(93)90013-G; FINKELSTEIN A, 1992, NATURE, V355, P464, DOI 10.1038/355464a0; FLORES O, 1989, J BIOL CHEM, V264, P8913; FLORES O, 1990, J BIOL CHEM, V265, P5629; FLORES O, 1988, J BIOL CHEM, V263, P10812; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; FLORES O, 1992, J BIOL CHEM, V267, P2786; GARRETT KP, 1992, J BIOL CHEM, V26, P23942; GEORGE CP, 1995, MOL CELL BIOL, V15, P1049; GONG DW, 1993, NUCLEIC ACIDS RES, V21, P1492, DOI 10.1093/nar/21.6.1492; GONG DW, 1992, NUCLEIC ACIDS RES, V20, P6414, DOI 10.1093/nar/20.23.6414; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GREENBLATT J, 1991, TRENDS BIOCHEM SCI, V16, P408, DOI 10.1016/0968-0004(91)90165-R; HENRY NL, 1992, J BIOL CHEM, V267, P23388; HORIKOSHI M, 1991, NUCLEIC ACIDS RES, V19, P5436, DOI 10.1093/nar/19.19.5436; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; KEPHART DD, 1993, NUCLEIC ACIDS RES, V21, P1319, DOI 10.1093/nar/21.5.1319; KILLEEN M, 1992, J BIOL CHEM, V267, P9463; KILLEEN MT, 1992, MOL CELL BIOL, V12, P30, DOI 10.1128/MCB.12.1.30; KOBAYASHI Y, 1992, NUCLEIC ACIDS RES, V20, P1994, DOI 10.1093/nar/20.8.1994; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; PRICE DH, 1987, J BIOL CHEM, V262, P3244; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; TAN SY, 1994, J BIOL CHEM, V269, P25684; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; WANG BQ, 1993, PROTEIN EXPRES PURIF, V4, P207, DOI 10.1006/prep.1993.1027; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; ZAWEL L, 1995, IN PRESS ANN REV BIO, V64	42	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6292	6297		10.1074/jbc.270.11.6292	http://dx.doi.org/10.1074/jbc.270.11.6292			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890767	hybrid			2022-12-27	WOS:A1995QM94500087
J	GREEN, T; STAUFFER, KA; LUMMIS, SCR				GREEN, T; STAUFFER, KA; LUMMIS, SCR			EXPRESSION OF RECOMBINANT HOMOOLIGOMERIC 5-HYDROXYTRYPTAMINE(3) RECEPTORS PROVIDES NEW INSIGHTS INTO THEIR MATURATION AND STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; INFECTED INSECT CELLS; FUNCTIONAL EXPRESSION; GLYCINE RECEPTOR; LIGAND-BINDING; NCB20 CELLS; SUBUNIT; PURIFICATION; CHANNELS; SITES	A recombinant baculovirus containing a mouse 5-hydroxytryptamine(3) (5-HT3) receptor subunit cDNA under the control of the polyhedrin promoter was shown to direct the production of large amounts of functional 5-HT3 receptor in insect cells, as assayed by Western blotting and ligand binding, After solubilization, the receptor was purified to homogeneity by affinity chromatography and characterized pharmacologically. The ligand binding characteristics of the recombinant receptor were essentially identical to those of the native receptor, both before and after purification, Only fully glycosylated receptors bound to the ligand affinity resin, although subsequent removal of the sugar did not affect ligand binding, Visualization of the purified receptor using electron microscopy showed that the receptor preparation contained a homogeneous population of pentameric doughnut shaped particles, The general appearance of the recombinant homooligomeric channels was indistinguishable from that of native 5-HT3 receptors. Yields of purified receptor were of the order of 200 mu g/3 liters of original culture. The amount and homogeneity of the purified receptor are sufficient to begin preliminary crystallization trials.	UNIV CAMBRIDGE,CTR MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge	GREEN, T (corresponding author), UNIV CAMBRIDGE,CTR MRC,CTR PROT ENGN,CAMBRIDGE CB2 2QH,ENGLAND.							BOESS FG, 1992, J NEUROCHEM, V59, P1692, DOI 10.1111/j.1471-4159.1992.tb11000.x; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; CARTER DB, 1992, BIO-TECHNOL, V10, P679, DOI 10.1038/nbt0692-679; CASCIO M, 1993, J BIOL CHEM, V268, P22135; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; HOPE AG, 1993, EUR J PHARM-MOLEC PH, V245, P187, DOI 10.1016/0922-4106(93)90128-V; IIZUKA M, 1993, J BIOCHEM, V114, P140, DOI 10.1093/oxfordjournals.jbchem.a124129; JOYCE KA, 1993, FEBS LETT, V335, P61, DOI 10.1016/0014-5793(93)80439-2; KLAIBER K, 1990, NEURON, V5, P221, DOI 10.1016/0896-6273(90)90311-3; LANE MD, 1987, J RECEPTOR RES, V7, P321, DOI 10.3109/10799898709054992; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LUMMIS SCR, 1992, MOL PHARMACOL, V41, P18; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MCKERNAN RM, 1990, J BIOL CHEM, V265, P13572; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAYEEM N, 1994, J NEUROCHEM, V62, P815; NELSON DR, 1989, BIOCHEM PHARMACOL, V38, P1693, DOI 10.1016/0006-2952(89)90319-5; NORRIS GE, 1989, J MOL BIOL, V209, P329, DOI 10.1016/0022-2836(89)90283-0; RAFTERY MA, 1980, SCIENCE, V280, P1454; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMIEDEN V, 1993, SCIENCE, V262, P256, DOI 10.1126/science.8211147; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; SUMMERS MD, 1987, TEXAS AGR STATION B, V1555; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turton S., 1993, Molecular Neuropharmacology, V3, P167; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107	33	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6056	6061		10.1074/jbc.270.11.6056	http://dx.doi.org/10.1074/jbc.270.11.6056			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890738	hybrid			2022-12-27	WOS:A1995QM94500054
J	CHARY, P; LATHAM, GJ; ROBBERSON, DL; KIM, SJ; HAN, S; HARRIS, CM; HARRIS, TM; LLOYD, RS				CHARY, P; LATHAM, GJ; ROBBERSON, DL; KIM, SJ; HAN, S; HARRIS, CM; HARRIS, TM; LLOYD, RS			IN-VIVO AND IN-VITRO REPLICATION CONSEQUENCES OF STEREOISOMERIC BENZO[A]PYRENE-7,8-DIHYDRODIOL 9,10-EPOXIDE ADDUCTS ON ADENINE N-6 AT THE 2ND POSITION OF N-RAS CODON-61	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DNA ADDUCT; ESCHERICHIA-COLI; DIOL EPOXIDE; BENZO<A>PYRENE 7,8-DIOL-9,10-EPOXIDES; ACTIVATED BENZO<A>PYRENE; SOLUTION CONFORMATION; CYCLOBUTANE DIMER; SITE; MUTAGENESIS; CELLS	Benzo[a]pyrene-7,8 dihydrodiol 9,10-epoxide (BPDE), a metabolite of the widespread environmental pollutant benzo[a]pyrene, is mutagenic in both bacterial and mammalian systems. Toward understanding the mutagenic effects of different stereoisomers of BPDE at specific sites in DNA, six stereochemically defined BPDE adducts were constructed on adenine N-6 at position 2 of the human N-ras 61 codon within an 11-base oligonucleotide fragment. Both the nonadducted and BPDE-adducted N-ras 61 11-mers were inserted into a unique EcoRI site in single-stranded M13mp7L2 DNA and utilized for in vivo studies. The ligation efficiencies of BPDE-adducted 11-mers into the single-stranded vector were determined by Southern hybridization and confirmed by electron microscopy. Repair-deficient AB2480 E. coli cells were transformed with adducted and non-adducted DNA samples. The resultant plaque-forming abilities were used to evaluate the replication competence of the various BPDE adducts with respect to the nonadducted 11-mer, Point mutations due to aberrant replication at the adducted site were identified by the technique of differential DNA hybridization. All of the six BPDE adducts examined were mutagenic in vivo, generating exclusively A-->G mutations at frequencies ranging from 0.26 to 1.20%. In vitro replication studies using these BPDE adducted 11-mers involved primer extension assays with Klenow fragment. All of the BPDE-modified templates demonstrated distinct blockage at the adducted site and/or 1 base 3' to the adducted site, allowing essentially no translesion synthesis to form fully extended polymerization products in vitro.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555; VANDERBILT UNIV,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37235; VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37235; VANDERBILT UNIV,SCH MED,DEPT CHEM,NASHVILLE,TN 37235; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center				Lloyd, R. Stephen/0000-0001-7273-372X	NIEHS NIH HHS [ES05355] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES005355] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BANERJEE SK, 1990, J BACTERIOL, V172, P2105, DOI 10.1128/jb.172.4.2105-2112.1990; BASU AK, 1993, BIOCHEMISTRY-US, V32, P4708, DOI 10.1021/bi00069a004; BASU AK, 1993, BIOCHEMISTRY-US, V32, P12793, DOI 10.1021/bi00210a031; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BENASUTTI M, 1988, CHEM RES TOXICOL, V1, P160, DOI 10.1021/tx00003a006; BERNELOTMOENS C, 1990, CARCINOGENESIS, V11, P781, DOI 10.1093/carcin/11.5.781; BISHOP RE, 1991, CHEM RES TOXICOL, V4, P647, DOI 10.1021/tx00024a009; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BRADLEY LJN, 1993, BIOCHEMISTRY-US, V32, P982, DOI 10.1021/bi00054a031; BROOKES P, 1982, CARCINOGENESIS, V3, P1223, DOI 10.1093/carcin/3.10.1223; BURNOUF D, 1990, P NATL ACAD SCI USA, V87, P6087, DOI 10.1073/pnas.87.16.6087; CAROTHERS AM, 1990, CARCINOGENESIS, V11, P189; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; CHRISTNER DF, 1993, P AM ASSOC CANC RES, V32, P142; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P4145, DOI 10.1021/bi00067a001; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; DELOSSANTOS C, 1992, BIOCHEMISTRY-US, V31, P5245, DOI 10.1021/bi00138a002; DIPPLE A, 1984, CHEM CARCINOGENS, V1, P41; EISENSTADT E, 1982, P NATL ACAD SCI-BIOL, V79, P1945, DOI 10.1073/pnas.79.6.1945; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FENG B, 1993, J CELL BIOCHEM, V17, P262; GIBBS PEM, 1993, J BACTERIOL, V175, P2607, DOI 10.1128/JB.175.9.2607-2612.1993; HARRIS CM, 1991, J AM CHEM SOC, V113, P4328, DOI 10.1021/ja00011a044; Harvey RG, 1991, POLYCYCL AROMAT COMP, P1; HRUSZKEWYCZ A, 1992, CARCINOGENESIS, V13, P2347, DOI 10.1093/carcin/13.12.2347; JEFFREY AM, 1977, NATURE, V269, P348, DOI 10.1038/269348a0; JENNETTE KW, 1977, BIOCHEMISTRY-US, V16, P932, DOI 10.1021/bi00624a019; KIM SJ, 1992, J AM CHEM SOC, V114, P5480, DOI 10.1021/ja00039a101; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; LATHAM GJ, 1993, J BIOL CHEM, V268, P23427; LAWRENCE CW, 1990, NUCLEIC ACIDS RES, V18, P2153, DOI 10.1093/nar/18.8.2153; LINDAHL T, 1982, EMBO J, V1, P1359, DOI 10.1002/j.1460-2075.1982.tb01323.x; LOECHLER EL, 1989, BIOPOLYMERS, V28, P909, DOI 10.1002/bip.360280502; MACKAY W, 1992, CARCINOGENESIS, V13, P1415, DOI 10.1093/carcin/13.8.1415; MAO B, 1993, BIOCHEMISTRY-US, V33, P11785; MEEHAN T, 1979, NATURE, V277, P410, DOI 10.1038/277410a0; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; SAID B, 1991, NUCLEIC ACIDS RES, V19, P1311, DOI 10.1093/nar/19.6.1311; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P7531, DOI 10.1021/bi00080a027; SINGER B, 1991, CARCINOGENESIS, V12, P949; SINGER B, 1983, MOL BIOL MUTAGENS CA, P150; SLAZA T, 1979, CANCER RES, V39, P67; Strauss B S, 1989, Ann Ist Super Sanita, V25, P177; TAKKER DR, 1977, J BIOL CHEM, V252, P6328; TAKKER DR, 1976, P NATL ACAD SCI USA, V73, P3381; TAKKER DR, 1977, CHEM-BIOL INTERACT, V16, P281; TANG MS, 1992, BIOCHEMISTRY-US, V31, P8429, DOI 10.1021/bi00151a006; THRALL BD, 1992, CARCINOGENESIS, V13, P1529, DOI 10.1093/carcin/13.9.1529; VOUSDEN KH, 1986, P NATL ACAD SCI USA, V83, P1222, DOI 10.1073/pnas.83.5.1222; WEI SJC, 1993, CANCER RES, V53, P3294; WOOD AW, 1977, BIOCHEM BIOPH RES CO, V77, P1389, DOI 10.1016/S0006-291X(77)80133-2; YANG SK, 1976, BIOCHEM PHARMACOL, V25, P2221, DOI 10.1016/0006-2952(76)90138-6; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070	57	92	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4990	5000		10.1074/jbc.270.10.4990	http://dx.doi.org/10.1074/jbc.270.10.4990			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890605	hybrid			2022-12-27	WOS:A1995QL58000010
J	FINNEGAN, JM; WIGHTMAN, RM				FINNEGAN, JM; WIGHTMAN, RM			CORRELATION OF REAL-TIME CATECHOLAMINE RELEASE AND CYTOSOLIC CA2+ AT SINGLE BOVINE CHROMAFFIN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMITTER RELEASE; ADRENAL-MEDULLA; CALCIUM INFLUX; SECRETION; CA-2+; MOBILIZATION; EXOCYTOSIS; STORES; FURA-2; MODEL	Previous investigations of the role of Ca2+ in stimulus-secretion coupling have been undertaken in populations of adrenal chromaffin cells. In the present study, the simultaneous detection of intracellular Ca2+, with the fluorescent probe fura-2, and catecholamine release, using a carbon-fiber microelectrode, are examined at single chromaffin cells in culture. Results from classic depolarizing stimuli, high potassium (30-140 mM) and 1,1-dimethyl-4-phenylpiperazinium (3-50 mu M), show a dependence of peak cytosolic Ca2+ concentration and catecholamine release on secretagogue concentration. Catecholamine release induced by transient high K+ stimulation increases logarithmically with K+ concentration. Continuous exposure to veratridine (50 mu M) induces oscillations in intracellular Ca2+ and at higher concentrations (100 mu M) concomitant fluctuation of cytosolic Ca2+ and catecholamine secretion. Mobilization of both caffeine- and inositol trisphosphate-sensitive intracellular Ca2+ stores is found to elicit secretion with or without extracellular Ca2+. Caffeine-sensitive intracellular Ca2+ stores can be depleted, refilled, and cause exocytosis in medium without Ca2+. Single cell measurement of exocytosis and the increase in cytosolic Ca2+ induced by bradykinin-activated intracellular stores reveal cell to cell variability in exocytotic responses which is masked in populations of cells. Taken together, these results show that exocytosis of catecholamines can be induced by an increase in cytosolic Ca2+ either as a result of transmembrane entry or by release of internal stores.	UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill								ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V369, P163; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P617, DOI 10.1113/jphysiol.1975.sp010950; BURGOYNE RD, 1989, NATURE, V342, P72, DOI 10.1038/342072a0; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; CARMICHAEL SW, 1993, ADRENAL MEDULLA, P145; CHEEK TR, 1989, FEBS LETT, V247, P429, DOI 10.1016/0014-5793(89)81385-7; CHEEK TR, 1994, BIOCHEM J, V301, P879, DOI 10.1042/bj3010879; CHEEK TR, 1989, CELL CALCIUM, V10, P213, DOI 10.1016/0143-4160(89)90004-3; CHEEK TR, 1990, FEBS LETT, V266, P91, DOI 10.1016/0014-5793(90)81514-O; CHEEK TR, 1993, J EXP BIOL, V184, P183; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; DOUGLAS WW, 1975, HDB PHYSL 7, V6, P366; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; JANKOWSKI JA, 1992, J BIOL CHEM, V267, P18329; JANKOWSKI JA, 1994, J NEUROCHEM, V63, P1739; KAO LS, 1986, J BIOL CHEM, V261, P4881; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KILPATRICK DL, 1982, J NEUROCHEM, V38, P427, DOI 10.1111/j.1471-4159.1982.tb08647.x; KIM KT, 1989, P NATL ACAD SCI USA, V86, P9881, DOI 10.1073/pnas.86.24.9881; KRISTENSEN EW, 1988, BRAIN RES, V461, P44, DOI 10.1016/0006-8993(88)90723-8; LESZCZYSZYN DJ, 1991, J NEUROCHEM, V56, P1855, DOI 10.1111/j.1471-4159.1991.tb03441.x; LIU PS, 1991, J NEUROCHEM, V56, P172, DOI 10.1111/j.1471-4159.1991.tb02577.x; MARTIN PT, 1991, J BIOL CHEM, V266, P7388; MORO MA, 1990, ANAL BIOCHEM, V185, P243, DOI 10.1016/0003-2697(90)90287-J; NACHSHEN DA, 1987, J PHYSIOL-LONDON, V387, P415, DOI 10.1113/jphysiol.1987.sp016581; NACHSHEN DA, 1980, J GEN PHYSIOL, V76, P709, DOI 10.1085/jgp.76.6.709; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; OHTA M, 1973, J PHARMACOL EXP THER, V154, P143; OSULLIVAN AJ, 1989, BIOSCIENCE REP, V9, P243, DOI 10.1007/BF01116001; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; OWEN PJ, 1989, J PHARMACOL EXP THER, V248, P1231; POISNER AM, 1973, P SOC EXP BIOL MED, V142, P103; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHROEDER TJ, 1992, ANAL CHEM, V64, P3077, DOI 10.1021/ac00048a003; SCHROEDER TJ, 1994, J BIOL CHEM, V269, P17215; SORIMACHI M, 1989, JPN J PHYSIOL, V39, P687, DOI 10.2170/jjphysiol.39.687; STAUDERMAN KA, 1991, BIOCHEM J, V278, P643, DOI 10.1042/bj2780643; STOEHR SJ, 1986, J NEUROCHEM, V46, P637, DOI 10.1111/j.1471-4159.1986.tb13014.x; SUI AL, 1994, NEUROCHEM RES, V19, P753, DOI 10.1007/BF00967716; TERAOKA H, 1991, J NEUROCHEM, V57, P1884, DOI 10.1111/j.1471-4159.1991.tb06399.x; TERAOKA H, 1990, BRIT J PHARMACOL, V101, P67, DOI 10.1111/j.1476-5381.1990.tb12090.x; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; TSIEN RY, 1994, CHEM ENG NEWS, V72, P34, DOI 10.1021/cen-v072n029.p034; Viveros OH, 1975, HDB PHYSIOLOGY, V6, P389; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6	56	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5353	5359		10.1074/jbc.270.10.5353	http://dx.doi.org/10.1074/jbc.270.10.5353			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890648	hybrid, Green Published			2022-12-27	WOS:A1995QL58000062
J	VADLAMUDI, RK; WEBER, E; JI, IH; JI, TH; BULLA, LA				VADLAMUDI, RK; WEBER, E; JI, IH; JI, TH; BULLA, LA			CLONING AND EXPRESSION OF A RECEPTOR FOR AN INSECTICIDAL TOXIN OF BACILLUS-THURINGIENSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; DELTA-ENDOTOXINS; CELL-ADHESION; SPECIFICITY; MIDGUT; PROTEINS; SEQUENCES; MECHANISM	Environmentally friendly toxins of Bacillus thuringiensis are effective in controlling agriculturally and biomedically harmful insects. However, little is known about the insect receptor molecules that bind these toxins and the mechanism of insecticidal activity. We report here for the first time the cloning and expression of a cDNA that encodes a receptor (BT-R(1)) of the tobacco hornworm Manduca sexta for an insecticidal toxin of B. thuringiensis. The receptor is a 210-kDa membrane glycoprotein that specifically binds the cryIA(b) toxin of B, thuringiensis subsp. berliner and leads to death of the hornworm. BT-R(1) shares sequence similarity with the cadherin superfamily of proteins.	UNIV WYOMING, DEPT MOLEC BIOL, LARAMIE, WY 82071 USA	University of Wyoming				Bulla, Lee/0000-0003-1789-7021	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018702] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-18702] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; ELSHOURBAGY NA, 1993, J BIOL CHEM, V268, P3873; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GIORDANA B, 1993, COMP BIOCHEM PHYS C, V106, P403, DOI 10.1016/0742-8413(93)90153-C; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOFTE H, 1989, MICROBIOL REV, V53, P242; JI I, 1980, P NATL ACAD SCI-BIOL, V77, P7167, DOI 10.1073/pnas.77.12.7167; JI IH, 1993, J BIOL CHEM, V268, P22971; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maniatis T, 1989, MOL CLONING; MANLEY JL, 1985, MOL CELL BIOL, V5, P373, DOI 10.1128/MCB.5.2.373; MARTINEZRAMIREZ AC, 1994, BIOCHEM BIOPH RES CO, V201, P782, DOI 10.1006/bbrc.1994.1769; ODDOU P, 1991, EUR J BIOCHEM, V202, P673, DOI 10.1111/j.1432-1033.1991.tb16422.x; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; SACCHI VF, 1986, FEBS LETT, V204, P213, DOI 10.1016/0014-5793(86)80814-6; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; VANRIE J, 1990, APPL ENVIRON MICROB, V56, P1378, DOI 10.1128/AEM.56.5.1378-1385.1990; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C	31	276	319	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5490	5494		10.1074/jbc.270.10.5490	http://dx.doi.org/10.1074/jbc.270.10.5490			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890666	hybrid			2022-12-27	WOS:A1995QL58000082
J	EICHLER, J; SILMAN, I				EICHLER, J; SILMAN, I			THE ACTIVITY OF AN ENDOPLASMIC RETICULUM-LOCALIZED POOL OF ACETYLCHOLINESTERASE IS MODULATED BY HEAT-SHOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK MUSCLE CULTURES; MONOMERIC ACETYLCHOLINESTERASE; MOLECULAR-FORMS; GOLGI-APPARATUS; COATED VESICLES; PROTEIN; CHOLINESTERASE; METABOLISM; TRANSPORT; CELLS	Primary cultures prepared from embryonic chick pectoral muscle were subjected to heat shock, and the effect on acetylcholinesterase activity in the cultures was examined. A rapid recovery in enzyme activity was observed soon after an initial heat shock-induced drop and was shown to be independent of de novo synthesis of protein, since it could occur in the presence of an inhibitor of protein synthesis. Lectin binding and sucrose gradient centrifugation studies suggested that molecular monomers and dimers found in the endoplasmic reticulum are involved in the observed recovery of acetylcholinesterase activity. Enhanced activation of a preexisting pool of inactive enzyme was clearly not the main agent of the recovery in enzymic activity. Recovery relied principally on restoration of the activity of previously active, heat-denatured acetylcholinesterase molecules found in the endoplasmic reticulum. Possible agents involved in the recovery of enzymatic activity might be heat shock proteins acting as molecular chaperones.	WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science			EICHLER, JERRY/F-2351-2012	EICHLER, JERRY/0000-0001-9409-8026				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BROCKMAN SK, 1986, J BIOL CHEM, V261, P1201; CHATEL JM, 1994, J NEUROCHEM, V63, P1111; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; EICHLER J, 1991, FEBS LETT, V293, P16, DOI 10.1016/0014-5793(91)81142-U; Ellis R J, 1990, Semin Cell Biol, V1, P1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hahn GM, 1990, STRESS PROTEINS BIOL, P79; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAZAR M, 1984, J BIOL CHEM, V259, P3703; LYLES JM, 1979, J NEUROCHEM, V33, P727, DOI 10.1111/j.1471-4159.1979.tb05218.x; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MORIMOTO R I, 1990, P1; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1980, CELL, V22, P595, DOI 10.1016/0092-8674(80)90369-4; ROTUNDO RL, 1980, CELL, V22, P583, DOI 10.1016/0092-8674(80)90368-2; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; STIEGER S, 1987, J NEUROCHEM, V49, P460, DOI 10.1111/j.1471-4159.1987.tb02887.x; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAVITIAN B, 1991, CHOLINESTERASES STRU, P125; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; VALLETTE FM, 1991, CHOLINESTERASES STRU, P98; WALKER CR, 1976, NEUROSCIENCE, V1, P509, DOI 10.1016/0306-4522(76)90103-2; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; WILSON BW, 1974, P NATL ACAD SCI USA, V71, P3194, DOI 10.1073/pnas.71.8.3194	34	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4466	4472		10.1074/jbc.270.9.4466	http://dx.doi.org/10.1074/jbc.270.9.4466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876213	hybrid			2022-12-27	WOS:A1995QK08400045
J	ERB, L; GARRAD, R; WANG, YJ; QUINN, T; TURNER, JT; WEISMAN, GA				ERB, L; GARRAD, R; WANG, YJ; QUINN, T; TURNER, JT; WEISMAN, GA			SITE-DIRECTED MUTAGENESIS OF P-2U PURINOCEPTORS - POSITIVELY CHARGED AMINO-ACIDS IN TRANSMEMBRANE HELIX-6 AND HELIX-7 AFFECT AGONIST POTENCY AND SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							VASCULAR ENDOTHELIAL-CELLS; EXTRACELLULAR ATP; FUNCTIONAL EXPRESSION; PROLINE RESIDUES; CYSTIC-FIBROSIS; RECEPTOR; NUCLEOTIDES; MECHANISMS; CLONING; TRANSDUCTION	Two subtypes of G protein coupled receptors for nucleotides (P-2U and P-2Y purinoreceptors) contain several conserved positively charged amino acids in the third, sixth, and seventh putative transmembrane helices (TMHs). Since the fully ionized form of nucleotides has been shown to be an activating ligand for both P-2U and P-2Y purinoceptors (P(2U)R and P(2Y)R), we postulated that some of these positively charged amino acids are involved in binding of the negatively charged phosphate groups of nucleotides. To investigate the role of the conserved positively charged amino acids in purinoceptor function, a series of mutant P(2U)R cDNAs were constructed so that lysine 107 and arginine 110 in TMH 3, histidine 262 and arginine 265 in TMH 6, and arginine 292 in TMH 7 were changed to the neutral amino acid leucine or isoleucine, The mutated P(2U)R cDNAs were stably expressed in 1321N1 astrocytoma cells and receptor activity was monitored by quantitating changes in the concentration of intracellular Ca2+ upon stimulation with full (ATP, UTP) or partial (ADP, UDP) P(2U)R agonists, Neutralization of His(262), Arg(265), or Arg(292) caused a 100-850-fold decrease in the potency of ATP and UTP relative to the unmutated P(2U)R and rendered ADP and UDP ineffective, In contrast, neutralization of Lys(107) or Arg(110) did not alter the agonist potency or specificity of the P(2U)R. Neutralization of Lys(289) in the P(2U)R, which is expressed as a glutamine residue in the P-2Y subtype, did not alter receptor activity; however, a consersubtype, did not alter receptor activity; however, a conservative change from lysine to arginine at this position altered the rank order of agonist potency so that ADP and UDP were approximately 100-fold more potent than ATP and UTP, A three-dimensional model of the P(2U)R indicates the feasibility of His(262), Arg(265), and Arg(292) interactions with the phosphate groups of nucleotides.	UNIV MISSOURI,DEPT PHARMACOL,COLUMBIA,MO 65212	University of Missouri System; University of Missouri Columbia	ERB, L (corresponding author), UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65212, USA.			Erb, Laurie/0000-0001-6372-3378	NIDCR NIH HHS [R01-DE07389] Funding Source: Medline; NIGMS NIH HHS [R01-GM36887] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036887] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALONSOTORRE SR, 1993, J BIOL CHEM, V268, P18640; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; BARNARD EA, 1994, TRENDS PHARMACOL SCI, V15, P67, DOI 10.1016/0165-6147(94)90280-1; BOEYNAEMS JM, 1990, TRENDS PHARMACOL SCI, V11, P34, DOI 10.1016/0165-6147(90)90039-B; BOUTHERINFALSON O, 1990, BIOCHEM BIOPH RES CO, V172, P306, DOI 10.1016/S0006-291X(05)80210-4; CLARKE LL, 1992, AM J PHYSIOL, V263, pC348, DOI 10.1152/ajpcell.1992.263.2.C348; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; ERB L, 1993, P NATL ACAD SCI USA, V90, P10449, DOI 10.1073/pnas.90.22.10449; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GACHET C, 1991, NOUV REV FR HEMATOL, V33, P347; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; HIBERT MF, 1991, MOL PHARMACOL, V40, P8; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; LOUBATIERESMARI.MM, 1979, EUR J PHARMACOL, V59, P277; LUSTIG KD, 1992, BIOCHEM J, V284, P733, DOI 10.1042/bj2840733; LUSTIG KD, 1992, BIOCHIM BIOPHYS ACTA, V1134, P61, DOI 10.1016/0167-4889(92)90028-A; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MOTTE S, 1993, BRIT J PHARMACOL, V109, P967, DOI 10.1111/j.1476-5381.1993.tb13715.x; OLAH ME, 1992, J BIOL CHEM, V267, P10764; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P215; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TURNER JT, 1990, J PHARMACOL EXP THER, V253, P1049; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; YU HX, 1991, J PHARMACOL EXP THER, V259, P1344	30	140	141	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4185	4188		10.1074/jbc.270.9.4185	http://dx.doi.org/10.1074/jbc.270.9.4185			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876172	hybrid			2022-12-27	WOS:A1995QK08400002
J	JAIN, SK; COX, MM; INMAN, RB				JAIN, SK; COX, MM; INMAN, RB			OCCURRENCE OF 3-STRANDED DNA WITHIN A RECA PROTEIN FILAMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; 3-STRANDED DNA; ATP HYDROLYSIS; HOMOLOGOUS RECOGNITION; GENETIC-RECOMBINATION; NUCLEOSIDE TRIPHOSPHATE; PARANEMIC JOINTS; HELICAL DNA; EXCHANGE; COMPLEXES	A RecA protein-generated triple-stranded DNA species can be observed by electron microscopy, within narrowly defined conditions, Three stranded DNA is detected only when initiation of normal DNA strand exchange is precluded by heterologous sequences within the duplex DNA substrate, when ATP is hydrolyzed, and when the DNA is cross-linked with a psoralen derivative prior to removal of RecA filaments. When adenosine 5'-O-(thiotriphosphate) is used, only the product hybrid duplex DNA can be cross linked within the RecA filament, The third strand is either displaced or interwound in a conformation that does not permit crosslinking, When ATP is hydrolyzed by RecA, all three strands are cross-linked within the filament in a complex pattern that suggests a dynamic structure, This structure is altered when RecA protein is removed be fore cross-linking, Hsieh ct al, (1990) and Rao ct al, (1991, 1993) have proposed, on the basis of nuclease protection and chemical modification studies, that a stable triple-stranded DNA species can persist after removal of RecA protein, We have been unable to visualize these triple-stranded structures by the methods used in the present investigation, When RecA removal was followed immediately by interstrand cross-linking, only the two strands of the hybrid duplex DNA were cross linked.	UNIV WISCONSIN, COLL AGR & LIFE SCI, DEPT BIOCHEM, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison					NIGMS NIH HHS [GM14711, GM32335] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM014711, R01GM032335] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; BEDALE WA, 1993, J BIOL CHEM, V268, P15004; BIANCHI M, 1983, CELL, V34, P931, DOI 10.1016/0092-8674(83)90550-0; BORTNER C, 1990, J MOL BIOL, V215, P623, DOI 10.1016/S0022-2836(05)80173-1; BURNETT B, 1994, J MOL BIOL, V238, P540, DOI 10.1006/jmbi.1994.1313; CHIU SK, 1993, BIOCHEMISTRY-US, V32, P13146, DOI 10.1021/bi00211a025; CHOW SA, 1988, J BIOL CHEM, V263, P3335; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; COX MM, 1981, J BIOL CHEM, V256, P4676; COX MM, 1994, TRENDS BIOCHEM SCI, V19, P217, DOI 10.1016/0968-0004(94)90025-6; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DAVIS RW, 1980, ADV BACTERIAL GENET, P116; DICAPUA E, 1987, EMBO J, V6, P2493, DOI 10.1002/j.1460-2075.1987.tb02531.x; DOMBROSKI DF, 1983, NUCLEIC ACIDS RES, V11, P7487, DOI 10.1093/nar/11.21.7487; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; HSIEH P, 1990, GENE DEV, V4, P1951, DOI 10.1101/gad.4.11.1951; INMAN RB, 1970, J MOL BIOL, V49, P93, DOI 10.1016/0022-2836(70)90378-5; ISAACS ST, 1977, BIOCHEMISTRY-US, V16, P1058, DOI 10.1021/bi00625a005; JAIN SK, 1992, J BIOL CHEM, V267, P4215; JAIN SK, 1994, J BIOL CHEM, V269, P20653; JAIN SK, 1994, THESIS U WISCONSIN M; KANNE D, 1982, J AM CHEM SOC, V104, P6754, DOI 10.1021/ja00388a046; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; KONFORTI BB, 1992, J MOL BIOL, V227, P38, DOI 10.1016/0022-2836(92)90680-I; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KUBISTA M, 1990, J BIOL CHEM, V265, P18891; LEAHY MC, 1986, J BIOL CHEM, V261, P6954; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; PUGH BF, 1987, J BIOL CHEM, V262, P1326; PUGH BF, 1987, J BIOL CHEM, V262, P1337; RADDING CM, 1991, J BIOL CHEM, V266, P5355; RAO BJ, 1991, P NATL ACAD SCI USA, V88, P2984, DOI 10.1073/pnas.88.8.2984; RAO BJ, 1993, J MOL BIOL, V229, P328, DOI 10.1006/jmbi.1993.1038; RAO BJ, 1993, P NATL ACAD SCI USA, V90, P6646, DOI 10.1073/pnas.90.14.6646; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; SCHNOS M, 1987, J MOL BIOL, V193, P377; SCHUTTE BC, 1988, BIOCHEMISTRY-US, V27, P7886, DOI 10.1021/bi00420a046; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; SHCHYOLKINA AK, 1994, FEBS LETT, V339, P113, DOI 10.1016/0014-5793(94)80396-X; STASIAK A, 1992, MOL MICROBIOL, V6, P3267, DOI 10.1111/j.1365-2958.1992.tb02194.x; TAKAHASHI M, 1989, J MOL BIOL, V205, P137, DOI 10.1016/0022-2836(89)90371-9; TAKAHASHI M, 1994, BIOCHIMIE PARIS, V73, P219; UMLAUF S, 1990, THESIS U WISCONSIN M; UMLAUF SW, 1990, J BIOL CHEM, V265, P16898; ZHURKIN VB, 1994, J MOL BIOL, V239, P181, DOI 10.1006/jmbi.1994.1362	54	23	24	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4943	4949		10.1074/jbc.270.9.4943	http://dx.doi.org/10.1074/jbc.270.9.4943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876269	hybrid			2022-12-27	WOS:A1995QK08400107
J	ORTIZ, DF; RUSCITTI, T; MCCUE, KF; OW, DW				ORTIZ, DF; RUSCITTI, T; MCCUE, KF; OW, DW			TRANSPORT OF METAL-BINDING PEPTIDES BY HMT1, A FISSION YEAST ABC-TYPE VACUOLAR MEMBRANE-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADMIUM-SULFIDE CRYSTALLITES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MULTIDRUG RESISTANCE; P-GLYCOPROTEINS; IN-VITRO; GLUTATHIONE; VESICLES; PHYTOCHELATINS; ATP	The Schizosaccharomyces pombe hmt1 gene encodes an ABC (ATP-binding cassette)-type protein essential for Cd2+ tolerance. Immunoblot analysis of subcellular fractions indicates that the native HMT1 polypeptide is associated with the vacuolar membrane, Vacuolar membrane vesicles were purified from strains that hyperproduce, or are deficient in, the HMT1 protein, In vitro transport of radiolabeled substrates by these vesicles indicates that HMT1 is an ATP-dependent transporter of phytochelatins, the metal-chelating peptides involved in heavy metal tolerance of plants and certain fungi, Vacuolar vesicles containing HMT1 are capable of taking up both apo-phytochelatins and phytochelatin-Cd2+ complexes, HMT1 activity is sensitive to antibodies directed against this protein and to vanadate, but not to inhibitors affecting the vacuolar proton ATPase or ionophores that abolish the pH gradient across the vacuolar membrane. Vacuolar uptake of Cd2+ and of a glutathione conjugate were also observed, but are not attributable to HMT1. These studies highlight the importance of the yeast vacuole in detoxification of xenobiotics.	USDA ARS, CTR PLANT GENE EXPRESS, ALBANY, CA 94710 USA; UNIV CALIF BERKELEY, DEPT PLANT BIOL, BERKELEY, CA 94720 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley			McCue, Kent/A-8973-2009	McCue, Kent/0000-0003-1914-4971				ABRAHAMSON SL, 1992, ANAL BIOCHEM, V200, P239, DOI 10.1016/0003-2697(92)90459-K; Ackrell B A, 1978, Methods Enzymol, V53, P466; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; AWASTHI YC, 1981, BLOOD, V58, P733; BALZI E, 1994, J BIOL CHEM, V269, P2206; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; COOPER A, 1992, J CELL BIOL, V119, P1459, DOI 10.1083/jcb.119.6.1459; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; DAMERON CT, 1989, NATURE, V338, P596, DOI 10.1038/338596a0; DAMERON CT, 1989, J BIOL CHEM, V264, P17355; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; GRILL E, 1986, FEBS LETT, V197, P115, DOI 10.1016/0014-5793(86)80309-X; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HORTENSTEINER S, 1993, J BIOL CHEM, V268, P18446; JUANG RH, 1993, ARCH BIOCHEM BIOPHYS, V304, P392, DOI 10.1006/abbi.1993.1367; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIMOTO Y, 1989, J BIOL CHEM, V264, P11693; KANE SE, 1990, J BIOENERG BIOMEMBR, V22, P593, DOI 10.1007/BF00762963; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KNEER R, 1992, PHYTOCHEMISTRY, V31, P2663, DOI 10.1016/0031-9422(92)83607-Z; KONDO T, 1980, P NATL ACAD SCI-BIOL, V77, P6359, DOI 10.1073/pnas.77.11.6359; LELONG IH, 1992, FEBS LETT, V304, P256, DOI 10.1016/0014-5793(92)80632-Q; MARTINOIA E, 1993, NATURE, V364, P247, DOI 10.1038/364247a0; MURASUGI A, 1983, J BIOCHEM-TOKYO, V93, P661, DOI 10.1093/oxfordjournals.jbchem.a134222; NISHI K, 1992, MOL MICROBIOL, V6, P761, DOI 10.1111/j.1365-2958.1992.tb01526.x; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; Ow David W., 1994, V11, P339; PLOCKE DJ, 1992, EUR J BIOCHEM, V207, P201, DOI 10.1111/j.1432-1033.1992.tb17038.x; REESE RN, 1992, PLANT PHYSIOL, V98, P225, DOI 10.1104/pp.98.1.225; REESE RN, 1988, J BIOL CHEM, V263, P12832; ROBERTS CJ, 1992, J CELL BIOL, V119, P69, DOI 10.1083/jcb.119.1.69; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SALT DE, 1993, J BIOL CHEM, V268, P12297; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; SPEISER DM, 1992, MOL CELL BIOL, V12, P5301, DOI 10.1128/MCB.12.12.5301; SPEISER DM, 1992, PLANT PHYSIOL, V99, P817, DOI 10.1104/pp.99.3.817; STEFFENS JC, 1986, J BIOL CHEM, V261, P13879; THUMANN J, 1991, FEBS LETT, V284, P66, DOI 10.1016/0014-5793(91)80763-S; VOGELILANGE R, 1990, PLANT PHYSIOL, V92, P1086, DOI 10.1104/pp.92.4.1086; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; ZEREZ CR, 1986, J BIOL CHEM, V261, P8877; ZHANG JT, 1991, J BIOL CHEM, V266, P18224	51	344	371	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4721	4728		10.1074/jbc.270.9.4721	http://dx.doi.org/10.1074/jbc.270.9.4721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876244	hybrid			2022-12-27	WOS:A1995QK08400079
J	ROTTINGEN, JA; ENDEN, T; CAMERER, E; IVERSEN, JG; PRYDZ, H				ROTTINGEN, JA; ENDEN, T; CAMERER, E; IVERSEN, JG; PRYDZ, H			BINDING OF HUMAN FACTOR VIIA TO TISSUE FACTOR INDUCES CYTOSOLIC CA2+ SIGNALS IN J82 CELLS, TRANSFECTED COS-1 CELLS, MADIN-DARBY CANINE KIDNEY-CELLS AND IN HUMAN ENDOTHELIAL-CELLS INDUCED TO SYNTHESIZE TISSUE FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM-CONCENTRATION; CYTOPLASMIC FREE CALCIUM; PROTEIN-KINASE-C; INOSITOL TRISPHOSPHATE; IFN-GAMMA; OSCILLATIONS; CDNA; COAGULATION; EXPRESSION; MONOLAYERS	Tissue factor (TF) is the most potent trigger of blood clotting known, It activates factor VII (FVII) thereby initiating a cascade of proteolytic reactions resulting in thrombin production, The cloning of TF revealed its structural characteristics to be those of a receptor related to the class 2 cytokine receptor superfamily, but until now no intracellular signal has been discovered related to binding of the ligand (FVIIa) to the putative receptor, We have studied possible intracellular signaling effects of the FVIIa-TF interaction by measuring cytosolic free Ca2+ in single fura-2-loaded cells and found that 200 nM FVIIa caused Ca2+ transients in about 30% of human umbilical vein endothelial cells treated with interleukin-1 beta to express TF, compared to below 5% in uninduced cells, A gradual increase of the basal Ca2+ level was also caused by binding of FVIIa, In the human bladder carcinoma cell line J82, which has a high constitutive TF activity, similar results were found, An antibody neutralizing TF activity decreased the response rate to control levels, COS-1 cells which do not make TF did not respond to FVIIa as opposed to COS-1 cells expressing TF after transfection with a human TF cDNA construct, The canine kidney cell line MDCK, a constitutive TF producer, responded especially well; up to 100% of the cells examined showed Ca2+ oscillations which were dose dependent with regard to frequency, latency, maximal amplitude, and recruitment of responding cells, The frequency was reduced by inhibition of Ca2+ influx with 100 mu M LaCl3, In confluent MDCK cells the Ca2+ oscillations were synchronous, constituting the first evidence of a synchronous cytosolic Ca2+ oscillator generated by global application of agonist, Thus, TF mediates a cytosolic Ca2+ signal upon interaction with its ligand FVIIa, thereby suggesting a more complex biological role for TF.	UNIV OSLO,BIOTECHNOL CTR OSLO,N-0371 OSLO,NORWAY; UNIV OSLO,INST BASIC MED SCI,DEPT PATHOL,INTRACELLULAR SIGNALLING LAB,N-0371 OSLO,NORWAY	University of Oslo; University of Oslo			Camerer, Eric/K-4161-2017	Camerer, Eric/0000-0002-6271-7125				ANDOH K, 1990, THROMB HAEMOSTASIS, V63, P298; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEVILACQUA MP, 1985, AM J PATHOL, V121, P393; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; BJORKLID E, 1973, BIOCHEM BIOPH RES CO, V55, P969, DOI 10.1016/0006-291X(73)91237-0; BODE HP, 1994, FEBS LETT, V339, P307, DOI 10.1016/0014-5793(94)80436-2; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; CARLSEN E, 1988, TRANSPLANTATION, V46, P575, DOI 10.1097/00007890-198810000-00022; CARSON SD, 1993, BLOOD COAGUL FIBRIN, V4, P281, DOI 10.1097/00001721-199304000-00010; DANDREA P, 1993, J BIOL CHEM, V268, P15213; DRAKE TA, 1989, J CELL BIOL, V109, P389, DOI 10.1083/jcb.109.1.389; EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67; FISHER KL, 1987, THROMB RES, V48, P89, DOI 10.1016/0049-3848(87)90349-5; GLADHAUG A, 1970, BIOCHIM BIOPHYS ACTA, V215, P105, DOI 10.1016/0304-4165(70)90392-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; HJORT PF, 1957, SCAND J CLIN LAB S27, V9, P183; HVATUM M, 1966, BIOCHIM BIOPHYS ACTA, V130, P92, DOI 10.1016/0304-4165(66)90012-2; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KLEIN JB, 1990, J IMMUNOL, V144, P4305; LASKEY RE, 1992, P NATL ACAD SCI USA, V89, P1690, DOI 10.1073/pnas.89.5.1690; LE DT, 1992, J BIOL CHEM, V267, P15447; LOESSBERG PA, 1993, J BIOL CHEM, V268, P19769; MASON MJ, 1992, AM J PHYSL CELL PHYS, V264, pC654; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; NARAHARA N, 1994, ARTERIOSCLER THROMB, V14, P1815, DOI 10.1161/01.ATV.14.11.1815; NATHANSON MH, 1992, MOL BIOL CELL, V3, P113, DOI 10.1091/mbc.3.1.113; NEZU N, 1990, J IMMUNOL, V145, P3126; NGEZAHAYO A, 1993, PFLUG ARCH EUR J PHY, V422, P413, DOI 10.1007/BF00374302; OSADA S, 1994, HEPATOLOGY, V19, P514; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; PICKLES RJ, 1991, P ROY SOC B-BIOL SCI, V245, P53, DOI 10.1098/rspb.1991.0087; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; REUNING U, 1993, THROMB HAEMOSTASIS, V69, P197; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROTNES JS, 1994, CELL CALCIUM, V15, P467, DOI 10.1016/0143-4160(94)90111-2; ROTNES JS, 1992, CELL CALCIUM, V13, P487, DOI 10.1016/0143-4160(92)90017-M; ROTNES JS, 1994, EUR J HAEMATOL, V53, P65; SAGE SO, 1989, J BIOL CHEM, V264, P6; Sambrook J, 1989, MOL CLONING LABORATO; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; SCARPATI EM, 1987, BIOCHEMISTRY-US, V26, P5234, DOI 10.1021/bi00391a004; SCHWARZ G, 1994, CELL CALCIUM, V15, P45, DOI 10.1016/0143-4160(94)90103-1; SPICER EK, 1987, P NATL ACAD SCI USA, V84, P5148, DOI 10.1073/pnas.84.15.5148; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0	50	184	188	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4650	4660		10.1074/jbc.270.9.4650	http://dx.doi.org/10.1074/jbc.270.9.4650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876236	hybrid			2022-12-27	WOS:A1995QK08400070
J	YU, X; INESI, G				YU, X; INESI, G			VARIABLE STOICHIOMETRIC EFFICIENCY OF CA2+ AND SR2+ TRANSPORT BY THE SARCOPLASMIC-RETICULUM ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; ENERGY INTERCONVERSION; PHOSPHORYL TRANSFER; TRANSIENT STATE; CALCIUM ATPASE; VESICLES; BINDING; STRONTIUM; PUMP; CONSEQUENCES	In comparative experiments with Ca2+ ATPase in native sarcoplasmic reticulum vesicles and reconstituted proteoliposomes, we find that a variable stoichiometry of Ca2+ or Sr2+ transport per ATPase cycle is observed in the absence of passive leak through independent channels. The observed ratio is commonly lower than the optimal value of 2 and depends on the composition of the reaction mixture. In all cases, a progressive rise in the lumenal concentration of Ca2+ and Sr2+ is accompanied by a parallel reduction of coupling ratios. Significant cant ATPase activity remains even after asymptotic levels of Ca2+ accumulation are reached. This residual activity subsides if the Ca2+ concentration in the outer medium is reduced below activating levels (as it would following Ca2+ transients in muscle fibers), The reduction of stoichiometric coupling is explained with a reaction scheme, including a branched pathway for hydrolytic cleavage of phosphorylated intermediate before release of Ca2+ into the lumen of the vesicles. Flux through this pathway is favored when net lumenal Ca2+ dissociation from the phosphoenzyme is impeded and results in P-i production accompanied by lumenal and medium Ca2+ exchange. Occurrence of reactions through branched pathways may have general implications for the stoichiometric efficiency of energy-transducing enzymes.			YU, X (corresponding author), UNIV MARYLAND, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21201 USA.				NHLBI NIH HHS [HL27867-13] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL027867] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERMAN MC, 1990, BIOCHIM BIOPHYS ACTA, V1029, P235, DOI 10.1016/0005-2736(90)90159-L; de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FROEHLICH JP, 1975, J BIOL CHEM, V250, P2013; FUJIMORI T, 1992, J BIOL CHEM, V267, P18475; FUJIMORI T, 1992, J BIOL CHEM, V267, P18466; GUIMARAESMOTTA H, 1984, J BIOL CHEM, V259, P8699; HASSELBACH W, 1964, PROGR BIOPHYS MOL BI, V14, P169; HILL T, 1991, STATISTICAL THERMODY; HORGAN DJ, 1972, ANAL BIOCHEM, V48, P147, DOI 10.1016/0003-2697(72)90178-9; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; INESI G, 1988, METHOD ENZYMOL, V157, P154; JOHNSON EA, 1985, P NATL ACAD SCI USA, V82, P5352, DOI 10.1073/pnas.82.16.5352; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTONOSI A, 1964, J BIOL CHEM, V239, P659; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P906, DOI 10.1016/0005-2736(73)90395-7; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; ORLOWSKI S, 1993, FEBS LETT, V328, P296, DOI 10.1016/0014-5793(93)80947-S; PENEFSKY ZJ, 1991, ADV ENZYMOL, V64, P173; PETITHORY JR, 1986, BIOCHEMISTRY-US, V25, P4493, DOI 10.1021/bi00364a006; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Scarpa A, 1979, Methods Enzymol, V56, P301; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; SOLER F, 1990, EUR J BIOCHEM, V192, P347, DOI 10.1111/j.1432-1033.1990.tb19233.x; TAKAKUWA Y, 1981, J BIOL CHEM, V256, P2696; VERJOVSKIALMEIDA S, 1977, BIOCHEMISTRY-US, V16, P329, DOI 10.1021/bi00621a026; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656	34	82	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4361	4367		10.1074/jbc.270.9.4361	http://dx.doi.org/10.1074/jbc.270.9.4361			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876199	hybrid			2022-12-27	WOS:A1995QK08400030
J	LAROSE, L; GISH, G; PAWSON, T				LAROSE, L; GISH, G; PAWSON, T			CONSTRUCTION OF AN SH2 DOMAIN-BINDING SITE WITH MIXED SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE KINASES; PHOSPHOLIPASE-C-GAMMA; PDGF BETA-RECEPTOR; SIGNAL TRANSDUCTION; V-SRC; PHOSPHATIDYLINOSITOL-3 KINASE; PHOSPHORYLATION SITES; PHOSPHOTYROSINE; ASSOCIATION	SH2 domains bind to specific phosphotyrosine-containing sites in a fashion dictated by the amino acids flanking the phosphotyrosine. Attention has focused on the role of the three COOH-terminal positions (+1 to +3) in generating specificity. Autophosphorylation of Tyr(1021) in the tail of the beta-receptor for platelet-derived growth factor creates a specific binding site for the COOH-terminal SH2 domain of phospholipase C (PLC)-gamma 1. We show that the residues 4 and 5 amino acids COOH-terminal to Tyr(1021) (+4 Leu and +5 Pro) are required for efficient PLC-yl binding, and that their replacement with the corresponding residues from a phosphatidylinositol 3'-kinase binding site abrogates stable association with PLC-gamma 1. In contrast, replacement of the +3 Pro with Met produces a Tyr(1021) Site with mixed specificity that binds both PLC-gamma 1 and phosphatidylinositol 3'-kinase. This motif is rendered specific for phosphatidylinositol 3'-kinase by further substitution of the +4 Leu. These results indicate that the +4 and +5 residues are important for the selective binding of specific SH2 domains. This study suggests that phosphotyrosine sites can be tailored to bind one or more SH2 domains with high affinity, depending on the combination of residues in the +1 to +5 positions.	MT SINAI HOSP, SAMUEL LUNENFELD RES INST, PROGRAMME MOLEC BIOL & CANC, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON M5S 1A8, CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto			Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013					CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; COUGHLIN SR, 1989, SCIENCE, V243, P1191; DECKER SJ, 1990, J BIOL CHEM, V265, P7009; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GISH G, 1995, IN PRESS METHODS ENZ; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KAMPS MP, 1988, ONCOGENE, V2, P305; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KASHISHIAN A, 1993, MOL BIOL CELL, V4, P49, DOI 10.1091/mbc.4.1.49; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOCH CA, 1992, MOL CELL BIOL, V12, P1366, DOI 10.1128/MCB.12.3.1366; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAROSE L, 1993, ONCOGENE, V8, P2493; LAVAN BE, 1992, J BIOL CHEM, V267, P11631; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; LHOTAK V, 1991, MOL CELL BIOL, V11, P2496, DOI 10.1128/MCB.11.5.2496; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; Payne G, 1994, Chem Biol, V1, P99, DOI 10.1016/1074-5521(94)90047-7; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SULTZMAN L, 1991, MOL CELL BIOL, V11, P2018, DOI 10.1128/MCB.11.4.2018; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	41	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3858	3862		10.1074/jbc.270.8.3858	http://dx.doi.org/10.1074/jbc.270.8.3858			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876130	hybrid			2022-12-27	WOS:A1995QH68800060
J	SCHONHORN, JE; AKOMPONG, T; WESSLINGRESNICK, M				SCHONHORN, JE; AKOMPONG, T; WESSLINGRESNICK, M			MECHANISM OF TRANSFERRIN RECEPTOR DOWN-REGULATION IN K562 CELLS IN RESPONSE TO PROTEIN-KINASE-C ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-CELLS; MEDIATED ENDOCYTOSIS; PHORBOL ESTERS; MEGAKARYOBLASTIC DIFFERENTIATION; GENE-EXPRESSION; GROWTH-FACTOR; IRON UPTAKE; PHOSPHORYLATION; SERINE-24; BINDING	Treatment with phorbol esters increases endocytosis of the transferrin receptor in K562 cells (Klausner, R, D,, Harford, J,, and van Renswoude, J, (1984) Proc. Natl. Acad, Sci, U, S. A. 81, 3005-3009), In this report, we demonstrate that this effect is reversible within early times of protein kinase C activation (<2 h) but that prolonged exposure to phorbol esters results in a net loss of receptors, These effects are not due to the differentiation response of K562 cells to phorbol esters since bryostatin-1 also down-regulates the endocytosis of the transferrin receptor and shut downs receptor synthesis, but does not induce differentiation (Hocevar, B, A., Morrow, D, M,, Tykocinski, M, L,, and Fields, A. P, (1992) J. Cell Sci, 101, 671-679), We have characterized the early stages of receptor down-regulation which occur due to stimulation of receptor internalization from the cell surface, The fact that fluid-phase pinocytosis is also enhanced upon protein kinase C activation indicates that this effect is not specific for the transferrin receptor itself, but is a rather general cellular response to tumor-promoting phorbol esters, The fate of down-regulated transferrin receptors was followed in morphological and subcellular fractionation studies that demonstrate localization of this pool of receptors in early endocytic and recycling compartments, Our results exclude the possibility that transferrin receptor down-regulation results in trafficking of the receptor to lysosomal compartments for degradation, This idea is consistent with the observations that the time course of transferrin receptor degradation is not enhanced in stimulated K562 cells, while transferrin receptor synthesis is shut down, Our results rigorously demonstrate that activation of protein kinase C down-regulates the K562 cell transferrin receptor in two stages: acute regulation of early steps in endocytosis that results in an immediate reduction of similar to 40% in cell surface number of receptors and a more chronic reduction in transferrin receptor synthesis upon prolonged exposure to phorbol esters (>15 h).	HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health								ALITALO R, 1988, BLOOD, V71, P899; ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; BACKER JM, 1991, BIOCHEM PHARMACOL, V41, P1267, DOI 10.1016/0006-2952(91)90097-O; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS RJ, 1987, J BIOL CHEM, V262, P16041; DAVIS RJ, 1986, J BIOL CHEM, V261, P9034; DICKSON RB, 1983, BIOCHEMISTRY-US, V22, P5667, DOI 10.1021/bi00293a033; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; HO PTC, 1989, CANCER RES, V49, P1989; HOCEVAR BA, 1992, J CELL SCI, V101, P671; KLAUSNER RD, 1984, P NATL ACAD SCI-BIOL, V81, P3005, DOI 10.1073/pnas.81.10.3005; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KRAFT AS, 1987, ONCOGENE, V1, P111; KRAFT AS, 1986, P NATL ACAD SCI USA, V84, P8438; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; LUCOCQ J, 1991, J CELL SCI, V100, P753; MAY WS, 1984, P NATL ACAD SCI-BIOL, V81, P2016, DOI 10.1073/pnas.81.7.2016; MCCLELLAND A, 1984, CELL, V39, P267, DOI 10.1016/0092-8674(84)90004-7; MCGRAW TE, 1988, J CELL BIOL, V106, P1061, DOI 10.1083/jcb.106.4.1061; MULFORD CA, 1988, J BIOL CHEM, V263, P5455; PELICCI PG, 1984, LEUKEMIA RES, V8, P597, DOI 10.1016/0145-2126(84)90008-0; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; ROVERA G, 1982, ANN NY ACAD SCI, V397, P211, DOI 10.1111/j.1749-6632.1982.tb43428.x; SCHONHORN JE, 1994, MOL CELL BIOCHEM, V135, P159, DOI 10.1007/BF00926519; SUTHERLAND JA, 1986, J BIOL RESP MODIF, V5, P250; TESTA U, 1984, CANCER RES, V44, P4981; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; WATTS C, 1985, J CELL BIOL, V100, P633, DOI 10.1083/jcb.100.2.633; WESSLINGRESNICK M, 1990, J BIOL CHEM, V265, P690; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WOODMAN PG, 1992, J CELL BIOL, V116, P331, DOI 10.1083/jcb.116.2.331; ZERIAL M, 1987, EMBO J, V6, P2661, DOI 10.1002/j.1460-2075.1987.tb02557.x	33	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3698	3705		10.1074/jbc.270.8.3698	http://dx.doi.org/10.1074/jbc.270.8.3698			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876109	hybrid			2022-12-27	WOS:A1995QH68800038
J	SIBBESEN, O; KOCH, B; HALKIER, BA; MOLLER, BL				SIBBESEN, O; KOCH, B; HALKIER, BA; MOLLER, BL			CYTOCHROME P-450(TYR) IS A MULTIFUNCTIONAL HEME-THIOLATE ENZYME CATALYZING THE CONVERSION OF L-TYROSINE TO P-HYDROXYPHENYLACETALDEHYDE OXIME IN THE BIOSYNTHESIS OF THE CYANOGENIC GLUCOSIDE DHURRIN IN SORGHUM-BICOLOR (L) MOENCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-PLANTS; INVITRO BIOSYNTHESIS; N-HYDROXYTYROSINE; LINN MOENCH; PURIFICATION; INTERMEDIATE; INVOLVEMENT; REDUCTASE; CULTURES	Cytochrome P-450(TYR), which catalyzes the N-hydroxylation of L-tyrosine in the biosynthesis of the cyanogenic glucoside dhurrin in Sorghum bicolor (L.) Moench has recently been isolated (Sibbesen, O., Koch, B., Halkier, B. A., and Moller, B. L. (1994) Proc. Natl. Acad. Sci. U. S. A. 92, 9740-9744). Reconstitution of the enzyme activity in lipid micelles containing cytochrome P-450, and NADPH-cytochrome P-450 oxidoreductase demonstrates that cytochrome P-450(TYR) catalyzes the conversion of L-tyrosine into p-hydroxyphenylacetaldehyde oxime. Earlier studies with microsomes have demonstrated that this conversion involves two N-hydroxylation reactions of which the first produces N-hydroxytyrosine. We propose that the product of the second N-hydroxylation reaction is N,N-dihydroxytyrosine. N,N-dihydroxytyrosine is dehydrated to 2-nitroso-3-(p-hydroxyphenyl) propionic acid which decarboxylates to p-hydroxyphenylacetaldehyde oxime. The dehydration and decarboxylation reactions may proceed non-enzymatically. The E/Z ratio of the p-hydroxyphenylacetaldehyde oxime produced by reconstituted cytochrome P-450(TYR) is 69:31. Lipid micelles made from L-alpha-dilauroyl phosphatidylcholine are more than twice as effective in reconstituting cytochrome P-450(TYR) activity as compared to other lipids. The K-m and turnover number of the enzyme is 0.14 mM and 200 min(-1), respectively, when assayed in the presence of 15 mM NaCl whereas the values are 0.21 mM and 230 min(-1) when assayed in the absence of added salt. The multifunctional nature cytochrome P-450(TYR) is confirmed by demonstrating that binding of L-tyrosine or N-hydroxytyrosine mutually excludes binding of the other substrate. These results explain why the conversion of tyrosine to p-hydroxyphenylacetaldehyde oxime as earlier reported (Moller, B. L., and Conn, E. E. (1980) J. Biol. Chem. 255, 3049-3056) shows the phenomenon of catalytic facilitation (''channeling''). Cytochrome P-450(TYR) is the first isolated multifunctional heme-thiolate enzyme from plants. N-Hydroxylases of the cytochrome P-450 type with high substrate specificity have not previously been reported.	ROYAL VET & AGR UNIV,DEPT PLANT BIOL,PLANT BIOCHEM LAB,DK-1871 FREDERIKSBERG C,DENMARK	University of Copenhagen			Møller, Birger Lindberg/H-2657-2014; Halkier, Barbara A/H-3196-2014; Møller, Birger Lindberg/GQI-1792-2022	Møller, Birger Lindberg/0000-0002-3252-3119; Halkier, Barbara A/0000-0002-3742-702X; Møller, Birger Lindberg/0000-0002-3252-3119; Koch, Birgit/0000-0002-4006-2690				AKAZAWA T, 1960, PLANT PHYSIOL, V35, P535, DOI 10.1104/pp.35.4.535; BENVENISTE I, 1986, BIOCHEM J, V235, P365, DOI 10.1042/bj2350365; EBERHART DC, 1991, ARCH BIOCHEM BIOPHYS, V291, P231, DOI 10.1016/0003-9861(91)90128-6; FARNDEN KJF, 1973, PHYTOCHEMISTRY, V12, P2673, DOI 10.1016/0031-9422(73)85078-2; FUKUDA H, 1994, BIOCHEM BIOPH RES CO, V201, P516, DOI 10.1006/bbrc.1994.1732; HALKIER BA, 1991, P NATL ACAD SCI USA, V88, P487, DOI 10.1073/pnas.88.2.487; HALKIER BA, 1990, J BIOL CHEM, V265, P21114; HALKIER BA, 1989, J BIOL CHEM, V264, P19487; HALKIER BA, 1991, PLANT PHYSIOL, V96, P10, DOI 10.1104/pp.96.1.10; HOSEL W, 1985, PLANTA, V166, P176, DOI 10.1007/BF00397345; IKUSHIRO S, 1989, BIOCHIM BIOPHYS ACTA, V984, P50, DOI 10.1016/0005-2736(89)90341-6; JEFCOATE CR, 1978, METHOD ENZYMOL, V27, P258; KOCHS G, 1989, ARCH BIOCHEM BIOPHYS, V273, P543, DOI 10.1016/0003-9861(89)90514-6; KOUKOL J, 1962, J BIOL CHEM, V237, P3223; MCFARLANE IJ, 1975, J BIOL CHEM, V250, P4708; MEIJER AH, 1993, J CHROMATOGR, V635, P237, DOI 10.1016/0021-9673(93)80366-G; MOLLER BL, 1977, ACTA CHEM SCAND B, V31, P343, DOI 10.3891/acta.chem.scand.31b-0343; MOLLER BL, 1979, J BIOL CHEM, V254, P8575; MOLLER BL, 1980, J BIOL CHEM, V255, P3049; OMURA T, 1964, J BIOL CHEM, V239, P2379; REAY PF, 1974, J BIOL CHEM, V249, P5826; SHIMADA M, 1977, ARCH BIOCHEM BIOPHYS, V180, P199, DOI 10.1016/0003-9861(77)90026-1; SIBBESEN O, 1994, SOC EXP BIOL SEMIN S, V56, P227; SIBBESEN O, 1994, P NATL ACAD SCI USA, V92, P9740; VOZNESENSKY AI, 1992, J BIOL CHEM, V267, P14669; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531	26	122	127	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3506	3511		10.1074/jbc.270.8.3506	http://dx.doi.org/10.1074/jbc.270.8.3506			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876084	hybrid			2022-12-27	WOS:A1995QH68800011
J	STANLEY, SL; TIAN, KR; KOESTER, JP; LI, E				STANLEY, SL; TIAN, KR; KOESTER, JP; LI, E			THE SERINE-RICH ENTAMOEBA-HISTOLYTICA PROTEIN IS A PHOSPHORYLATED MEMBRANE-PROTEIN CONTAINING O-LINKED TERMINAL N-ACETYLGLUCOSAMINE RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; ESCHERICHIA-COLI; ADHERENCE LECTIN; GLYCOPROTEINS; GLYCOSYLATION; EXPRESSION; THREONINE; GALACTOSE; CLONING; ANTIGEN	Previously, we described the isolation of a cDNA clone and the gene encoding a protective antigen of the protozoan parasite Entamoeba histolytica, the serine-rich Entamoeba histolytica protein (SREHP). The derived amino acid sequence of the SREHP cDNA clone was remarkable for a high serine content (52/233 amino acids), a putative signal sequence, multiple hydrophilic dodecapeptide and octapeptide tandem repeats, and a hydrophobic C-terminal putative membrane-spanning region. Here, we show that SREHP is modified by the addition of phosphate at serine residues, O-linked terminal N-acetylglucosamine residues, and by acylation. When the SREHP gene is expressed in baculovirus transformed Sf-9 cells, the product is also phosphorylated and glycosylated and is localized to the plasma membrane of the insect cells, The native SREHP molecule also serves as a potent chemoattractant for amebic trophozoites. The data presented here suggest that SREHP is a unique membrane protein with phosphorylation and glycosylation patterns usually associated with nuclear or cytoplasmic proteins.	WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	STANLEY, SL (corresponding author), WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA.				NIAID NIH HHS [AI30084, AI01231] Funding Source: Medline; NIDDK NIH HHS [DK02072] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K04AI001231, R01AI030084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K04DK002072] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABEIJON C, 1988, P NATL ACAD SCI USA, V85, P1010, DOI 10.1073/pnas.85.4.1010; AMES BN, 1966, METHOD ENZYMOL, V8, P155; BAILEY GB, 1985, J PROTOZOOL, V32, P341; BIZZOZERO OA, 1994, J NEUROCHEM, V62, P1163; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; DIN NU, 1992, BIOCH INT, V27, P55; FERGUSON MAJ, 1988, POST TRANSLATIONAL M, P1; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; HOLDER AA, 1988, PROGR ALLERGY, V41, P148; HOLT GD, 1986, J BIOL CHEM, V261, P8049; LI E, 1988, J EXP MED, V167, P1725, DOI 10.1084/jem.167.5.1725; LI E, 1992, MOL BIOCHEM PARASIT, V50, P355, DOI 10.1016/0166-6851(92)90234-B; LI E, 1989, INFECT IMMUN, V57, P8, DOI 10.1128/IAI.57.1.8-12.1989; LI E, 1987, J BIOL CHEM, V262, P13773; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Lushbaugh W.B., 1988, P41; MAGEE AI, 1984, BIOCHIM BIOPHYS ACTA, V798, P156, DOI 10.1016/0304-4165(84)90298-8; MCCOY JJ, 1993, J BIOL CHEM, V268, P24223; MYUNG K, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P285; NYAME K, 1987, J BIOL CHEM, V262, P7990; PETRI WA, 1989, J BIOL CHEM, V264, P3007; QUE XC, 1994, MOL BIOCHEM PARASIT, V66, P111, DOI 10.1016/0166-6851(94)90041-8; QUE XH, 1993, MOL BIOCHEM PARASIT, V60, P161, DOI 10.1016/0166-6851(93)90128-K; STANLEY SL, 1990, P NATL ACAD SCI USA, V87, P4976, DOI 10.1073/pnas.87.13.4976; STANLEY SL, 1992, MOL BIOCHEM PARASIT, V50, P127, DOI 10.1016/0166-6851(92)90250-N; STANLEY SL, 1991, JAMA-J AM MED ASSOC, V266, P1984, DOI 10.1001/jama.266.14.1984; STANLEY SL, 1988, MOL IMMUNOL, V25, P285, DOI 10.1016/0161-5890(88)90020-X; STANLEY SL, 1993, SEMIN GASTROINTEST D, V4, P214; STOFFEL W, 1983, H-S Z PHYSIOL CHEM, V364, P1455, DOI 10.1515/bchm2.1983.364.2.1455; TORRES CR, 1984, J BIOL CHEM, V259, P3308; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; ZHANG TH, 1994, PARASITE IMMUNOL, V16, P225, DOI 10.1111/j.1365-3024.1994.tb00344.x; ZHANG TH, 1994, INFECT IMMUN, V62, P1166, DOI 10.1128/IAI.62.4.1166-1170.1994	35	57	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4121	4126		10.1074/jbc.270.8.4121	http://dx.doi.org/10.1074/jbc.270.8.4121			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876162	hybrid			2022-12-27	WOS:A1995QH68800096
J	TOWATARI, M; MAY, GE; MARAIS, R; PERKINS, GR; MARSHALL, CJ; COWLEY, S; ENVER, T				TOWATARI, M; MAY, GE; MARAIS, R; PERKINS, GR; MARSHALL, CJ; COWLEY, S; ENVER, T			REGULATION OF GATA-2 PHOSPHORYLATION BY MITOGEN-ACTIVATED PROTEIN-KINASE AND INTERLEUKIN-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR; MAP KINASE; ERYTHROID-DIFFERENTIATION; GROWTH-FACTORS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; STEEL FACTOR; CELL-LINE; FAMILY	GATA-2 is a member of a family of transcription factors which bind a common DNA sequence motif (WGA-TAR) through an evolutionarily conserved zinc finger domain, An essential role for GATA-2 in the development of hematopoietic stem cells has recently been shown in gene targeting experiments in mice, Here we show that GATA-2 exists in hematopoietic progenitor cells as a phosphoprotein, Stimulation of progenitors with interleukin-3 (IL-3) results in enhanced phosphorylation of GATA-2 which occurs within 5 min. IL-3 is known to signal in part through mitogen-activated protein (MAP) kinase, and evidence for MAP kinase signaling in the control of GATA-2 phosphorylation was obtained by genetically manipulating the MAP kinase pathway in COS cells using either constitutively activating or interfering mutants of MAP kinase kinase, Furthermore, using an interfering mutant of MAP kinase kinase, we directly demonstrated a critical role for the MAP kinase pathway in the IL-3-dependent phosphorylation of GATA-2 in hematopoietic progenitor cells. Finally, in vitro phosphorylation experiments using recombinant GATA-2 raise the possibility that MAP kinase itself may phosphorylate GATA-2, Our results provide evidence for phosphorylation via the MAP kinase pathway constituting a cytoplasmic link between GATA-2 and growth factor receptors and are consistent with the hypothesis that GATA-2 is involved in the growth factor responsiveness and proliferation control of hematopoietic progenitor cells,	INST CANC RES,CHESTER BEATTY LABS,LEUKAEMIA RES FUND CTR,LONDON SW3 6JB,ENGLAND; INST CANC RES,CHESTER BEATTY LABS,CELL & MOLEC BIOL SECT,LONDON SW3 6JB,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK				Marais, Richard/0000-0001-7484-4183; Cowley, Sally/0000-0003-0297-6675				ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRIEGEL K, 1993, GENE DEV, V7, P1097, DOI 10.1101/gad.7.6.1097; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; CROSS MA, 1994, ONCOGENE, V9, P3013; CROSSLEY M, 1994, J BIOL CHEM, V269, P16589; DEXTER TM, 1979, NATURE, V277, P471, DOI 10.1038/277471a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; EVANS T, 1991, MOL CELL BIOL, V11, P843, DOI 10.1128/MCB.11.2.843; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LEONARD M, 1993, BLOOD, V82, P1071; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MARVEL J, 1994, ONCOGENE, V9, P1117; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MIYAJIMA A, 1993, BLOOD, V82, P1960; MOUTHON MA, 1993, BLOOD, V81, P647; NAGAI T, 1994, BLOOD, V84, P1074, DOI 10.1182/blood.V84.4.1074.bloodjournal8441074; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OKUDA K, 1992, BLOOD, V79, P2880; ORKIN SH, 1992, BLOOD, V80, P575; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PERKINS GR, 1993, J EXP MED, V178, P1429, DOI 10.1084/jem.178.4.1429; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; SETH A, 1991, J BIOL CHEM, V266, P23521; SPOONCER E, 1984, NATURE, V310, P228, DOI 10.1038/310228a0; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VISVADER J, 1993, BLOOD, V82, P1493; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; Whetton AD, 1993, CURR OPIN CELL BIOL, V5, P1044, DOI 10.1016/0955-0674(93)90090-D; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650	51	98	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4101	4107		10.1074/jbc.270.8.4101	http://dx.doi.org/10.1074/jbc.270.8.4101			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876160	hybrid, Green Submitted			2022-12-27	WOS:A1995QH68800093
J	YAMASHIRO, S; YAMAKITA, Y; YOSHIDA, KS; TAKIGUCHI, K; MATSUMURA, F				YAMASHIRO, S; YAMAKITA, Y; YOSHIDA, KS; TAKIGUCHI, K; MATSUMURA, F			CHARACTERIZATION OF THE COOH TERMINUS OF NONMUSCLE CALDESMON MUTANTS LACKING MITOSIS-SPECIFIC PHOSPHORYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEINS; SMOOTH-MUSCLE; NONMUSCLE CALDESMON; CA-2+ REGULATION; ATPASE ACTIVITY; P34CDC2 KINASE; THIN-FILAMENTS; TROPOMYOSIN; ACTOMYOSIN; MICROFILAMENTS	Phosphorylation of rat non muscle caldesmon by cdc2 kinase causes reduction in most of caldesmon's properties, including caldesmon's binding to actin, myosin, and calmodulin, as well as its inhibition of actomyosin ATPase, We have generated and characterized the COOH terminus of caldesmon mutants lacking mitosis-specific phosphorylation sites, because the COOH-terminal half of caldesmon contains all ? putative Ser or Thr sites for cdc2 kinase. Codons for the 7 putative Ser or Thr residues have been mutated to Ala, and resultant mutants were bacterially expressed. Analyses of the phosphopeptide maps of these mutants have identified 6 sites, including Ser-249, Ser-462, Thr-468, Ser-491, Ser-497, and Ser-527 as the mitosis-specific phosphorylation sites, whereas the phosphorylation of the remaining site, Thr-377, is not detected by this assay method. Actin binding experiments have suggested that 5 sites including Ser-249, Ser-462, Thr-468, Ser-491, and Ser-497 are important for the phosphorylation-dependent reduction in actin binding. Characterization of a mutant lacking all 7 Ser or Thr sites (7-fold mutant) has revealed that 7-fold mutation eliminates all phosphorylation sites by cdc2 kinase, While the in vitro properties of the 7-fold mutant, including actin, myosin, and calmodulin binding and inhibition of actomyosin ATPase, are very similar to those of nonmutated protein, such properties are not affected by the treatment with cdc2 kinase in contrast to nonmutated protein. This mutant should thus be useful to explore the functions of the mitosis-specific phosphorylation of caldesmon.			YAMASHIRO, S (corresponding author), RUTGERS STATE UNIV,DEPT MOLEC BIOL & BIOCHEM,NELSON HALL,PISCATAWAY,NJ 08855, USA.		Yamakita, Yoshihiko/A-3003-2016	Yamashiro, Shigeko/0000-0001-7207-9406	NATIONAL CANCER INSTITUTE [R37CA042742] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA42742] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; BRYAN J, 1989, J BIOL CHEM, V264, P13873; CRAIG SW, 1982, TRENDS BIOCHEM SCI, V7, P88, DOI 10.1016/0968-0004(82)90153-0; DABROWSKA R, 1985, BIOCHIM BIOPHYS ACTA, V842, P70, DOI 10.1016/0304-4165(85)90295-8; GALAZKIEWICZ B, 1989, EUR J BIOCHEM, V181, P607, DOI 10.1111/j.1432-1033.1989.tb14767.x; GALAZKIEWICZ B, 1991, EUR J BIOCHEM, V195, P543, DOI 10.1111/j.1432-1033.1991.tb15735.x; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; HORIUCHI KY, 1986, BIOCHEM BIOPH RES CO, V136, P962, DOI 10.1016/0006-291X(86)90426-2; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; ISHIKAWA R, 1989, J BIOL CHEM, V264, P16764; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; KORN ED, 1982, METHOD ENZYMOL, V85, P357; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; LOHKA MJ, 1989, J CELL SCI, V92, P131; MAK AS, 1991, J BIOL CHEM, V266, P19971; MAK AS, 1991, J BIOL CHEM, V266, P6678; MARSTON SB, 1991, BIOCHEM J, V279, P1; Matsumura F, 1993, CURR OPIN CELL BIOL, V5, P70, DOI 10.1016/S0955-0674(05)80010-9; NOVY RE, 1991, J BIOL CHEM, V266, P16917; PRITCHARD K, 1989, BIOCHEM J, V257, P839, DOI 10.1042/bj2570839; REDWOOD CS, 1993, FEBS LETT, V327, P85, DOI 10.1016/0014-5793(93)81045-2; SANGER JW, 1976, CELL MOTILITY, P1295; SCHROEDER TE, 1976, CELL MOTILITY, P265; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; WANG CLA, 1991, J BIOL CHEM, V266, P9166; WEEDS A, 1982, NATURE, V296, P811, DOI 10.1038/296811a0; YAMAKITA Y, 1982, J BIOL CHEM, V267, P12022; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; YAMASHIROMATSUM.S, 1988, J CELL BIOL, V106, P1973	34	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4023	4030		10.1074/jbc.270.8.4023	http://dx.doi.org/10.1074/jbc.270.8.4023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876150	hybrid			2022-12-27	WOS:A1995QH68800083
J	BENYA, RV; KUSUI, T; BATTEY, JF; JENSEN, RT				BENYA, RV; KUSUI, T; BATTEY, JF; JENSEN, RT			CHRONIC DESENSITIZATION AND DOWN-REGULATION OF THE GASTRIN-RELEASING PEPTIDE RECEPTOR ARE MEDIATED BY A PROTEIN-KINASE C-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED DESENSITIZATION; BOMBESIN-LIKE PEPTIDES; GROWTH-FACTOR RECEPTOR; GUINEA-PIG PANCREAS; SWISS 3T3 CELLS; MUSCARINIC RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; HOMOLOGOUS DESENSITIZATION; MOLECULAR MECHANISMS; SIGNAL TRANSDUCTION	The cellular basis of down-regulation and desensitization in phospholipase C-linked receptors is unclear. Recent studies with some receptors suggest that elements in the carboxyl terminus of the receptor are important in mediating these processes. Three mutant gastrin-releasing peptide receptors (GRP-R) were studied: one whose last 37 carboxyl-terminal amino acids were eliminated (construct MGT346); one that replaced all of the carboxyl-terminal Ser and Thr eliminated in MGT346 with Ala, Asn, or Gly (construct JF1); and one that selectively replaced the Ser and Thr of the protein kinase C consensus sequence (PKC-CS) located within the same region with alanine (construct TS360AA). Desensitization was assessed by measuring the ability to activate phospholipase C and increase cellular [H-3]inositol phosphates, or increase [Ca2+](i), after pre-exposure to 3 nM bombesin for 24 h. Wild-type GRP-R was maximally desensitized and down-regulated after a 24-h exposure to 3 nM bombesin, and removal of the PKC-CS alone markedly attenuated each process. Elimination of additional serines and threonines by truncation (MGT346) or replacement (JF1) did not decrease down-regulation or desensitization further. To coli firm the necessity of sec ond messenger activation in mediating down-regulation, we further investigated two additional mutant GRP-R that bound agonist with high affinity but fail to activate phospholipase C (constructs R139G and A263E). Neither construct underwent significant down-regulation. Removal of all GRP-R carboxyl-terminal Ser or Thr, either by MGT346 or JF1, reduced internalization by > 80%, whereas elimination of the PKC-CS in TS360AA only attenuated internalization by 21 +/- 2%. These data suggest that activation of the distal carboxyl-terminal PKC-CS is essential for chronic desensitization and down-regulation of the GRP-R, and provide no evidence for involvement of second messenger-independent processes. In contrast, internalization is equally regulated by both second messenger-dependent and independent processes.	NIDDK, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA; NCI, BIOL CHEM LAB, DEV THERAPEUT PROGRAM, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ALBERS HE, 1991, J NEUROSCI, V11, P846; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENYA RV, 1994, MOL PHARMACOL, V46, P495; BENYA RV, 1992, MOL PHARMACOL, V42, P1058; BENYA RV, 1994, MOL PHARMACOL, V46, P235; BENYA RV, 1994, J BIOL CHEM, V269, P11721; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BLANCHARD LM, 1990, PANCREAS, V5, P50, DOI 10.1097/00006676-199001000-00007; BOLOGNA M, 1989, CANCER, V63, P1714; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BROWN MR, 1988, ANN NY ACAD SCI, V547, P174, DOI 10.1111/j.1749-6632.1988.tb23885.x; COCHET C, 1984, J BIOL CHEM, V259, P2553; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; ERSPAMER GF, 1988, REGUL PEPTIDES, V21, P1; EVA C, 1990, J PHARMACOL EXP THER, V253, P257; FRANKEL A, 1993, EXP CELL RES, V209, P398, DOI 10.1006/excr.1993.1327; GHATEI MA, 1982, J CLIN ENDOCR METAB, V54, P980, DOI 10.1210/jcem-54-5-980; GIACCHETTI S, 1990, INT J CANCER, V46, P293, DOI 10.1002/ijc.2910460226; GLENNEY JR, 1992, BIOCHIM BIOPHYS ACTA, V1134, P113, DOI 10.1016/0167-4889(92)90034-9; GOLARD A, 1993, J NEUROPHYSIOL, V70, P1639, DOI 10.1152/jn.1993.70.4.1639; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUPTA SK, 1993, J MOL NEUROSCI, V4, P117, DOI 10.1007/BF02782124; HAGA K, 1990, J NEUROCHEM, V54, P1639, DOI 10.1111/j.1471-4159.1990.tb01216.x; HAGA T, 1993, LIFE SCI, V52, P421, DOI 10.1016/0024-3205(93)90297-G; ISHII K, 1994, J BIOL CHEM, V269, P1125; Jensen Robert T., 1994, P1377; JENSEN RT, 1988, ANN NY ACAD SCI, V547, P138, DOI 10.1111/j.1749-6632.1988.tb23882.x; KANBA S, 1990, BIOCHEM PHARMACOL, V40, P1005, DOI 10.1016/0006-2952(90)90486-5; KANETO A, 1978, METABOLISM, V27, P549, DOI 10.1016/0026-0495(78)90021-5; KUSUI T, 1994, BIOCHEMISTRY-US, V33, P12968, DOI 10.1021/bi00248a005; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI WS, 1990, BIOCHEM J, V267, P23, DOI 10.1042/bj2670023; LEE PC, 1980, AM J PHYSIOL, V238, pG213, DOI 10.1152/ajpgi.1980.238.3.G213; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; MASTERS SB, 1985, MOL PHARMACOL, V27, P325; MILLAR JBA, 1990, J BIOL CHEM, V265, P12052; MOODY TW, 1988, ANN NY ACAD SCI, V547, P351; MORRISON WJ, 1988, MOL PHARMACOL, V33, P58; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PANDOL SJ, 1982, J BIOL CHEM, V257, P2024; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; PROLL MA, 1993, MOL PHARMACOL, V44, P569; ROZENGURT E, 1988, ANN NY ACAD SCI, V547, P277, DOI 10.1111/j.1749-6632.1988.tb23896.x; RUFF M, 1985, CLIN IMMUNOL IMMUNOP, V37, P387, DOI 10.1016/0090-1229(85)90108-4; SEVERI C, 1991, AM J PHYSIOL, V260, pG683, DOI 10.1152/ajpgi.1991.260.5.G683; SLICE LW, 1994, J BIOL CHEM, V269, P21755; SWOPE SL, 1990, MOL PHARMACOL, V37, P758; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; UPP JR, 1988, PANCREAS, V3, P193, DOI 10.1097/00006676-198804000-00014; WALSH JH, 1993, J CELL PHYSIOL, V156, P333, DOI 10.1002/jcp.1041560216; WANG LH, 1993, BIOCHIM BIOPHYS ACTA, V1175, P232, DOI 10.1016/0167-4889(93)90028-N; YANG J, 1993, MOL PHARMACOL, V44, P1158; YU SS, 1993, J BIOL CHEM, V268, P337	57	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3346	3352		10.1074/jbc.270.7.3346	http://dx.doi.org/10.1074/jbc.270.7.3346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852420	hybrid			2022-12-27	WOS:A1995QG47100068
J	CHEN, XJ; CURTISS, A; ALCANTARA, E; DEAN, DH				CHEN, XJ; CURTISS, A; ALCANTARA, E; DEAN, DH			MUTATIONS IN DOMAIN-I OF BACILLUS-THURINGIENSIS DELTA-ENDOTOXIN CRYIAB REDUCE THE IRREVERSIBLE BINDING OF TOXIN TO MANDUCA-SEXTA BRUSH-BORDER MEMBRANE-VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECTICIDAL CRYSTAL PROTEINS; BUTTERFLY PIERIS-BRASSICAE; BOMBYX-MORI; HELIOTHIS-VIRESCENS; RECEPTOR-BINDING; SPECIFICITY; TOXICITY; LOCATION; REGIONS; MUTAGENESIS	Site-directed mutagenesis was used to generate CryIAb mutants at the selected N-terminal positions to study the function of domain I. Structurally stable mutant proteins were tested for toxicity, receptor binding kinetics, and pore function. Substitutions of tyrosine at position 153 with arginine (Y153R) or alanine (Y153A) did not affect toxicity appreciably, whereas replacing this tyrosine with aspartic acid (Y153D) resulted in a great loss of toxicity. Mutation of alanine at position 92 to glutamic acid (A92E) almost completely abolished toxicity. The initial receptor binding was unchanged as measured by competition binding assays among all mutant proteins, Reduced pore function, however, was observed for mutants A92E and Y153D as tested by voltage clamping, Further studies with specially designed asso ciation and dissociation binding assays showed that irreversible binding of these two mutant toxins to Manduca sexta brush border membrane vesicles was significantly reduced. The decrease in irreversible binding was correlated with the changes in toxicity and may reflect a severely disturbed membrane insertion process in these two mutant toxins, leading to reduced pore function and toxicity, The results support the model that domain I is involved in membrane integration and pore formation.	OHIO STATE UNIV, DEPT BIOCHEM, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029092] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI29092-04A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMAD W, 1990, FEMS MICROBIOL LETT, V68, P97, DOI 10.1111/j.1574-6968.1990.tb04130.x; CHEN XJ, 1993, P NATL ACAD SCI USA, V90, P9041, DOI 10.1073/pnas.90.19.9041; ENGLISH L, 1992, INSECT BIOCHEM MOLEC, V22, P1, DOI 10.1016/0965-1748(92)90093-T; FEITELSON JS, 1992, BIO-TECHNOL, V10, P271, DOI 10.1038/nbt0392-271; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; GE AZ, 1989, P NATL ACAD SCI USA, V86, P4037, DOI 10.1073/pnas.86.11.4037; GE AZ, 1991, J BIOL CHEM, V266, P17954; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; Hodgman T. C, 1990, J DNA SEQU MAPPING, V1, P97; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOFMANN C, 1988, EUR J BIOCHEM, V173, P85, DOI 10.1111/j.1432-1033.1988.tb13970.x; HOFTE H, 1989, MICROBIOL REV, V53, P242; HONEE G, 1991, MOL MICROBIOL, V5, P2799, DOI 10.1111/j.1365-2958.1991.tb01988.x; IHARA H, 1993, BIOSCI BIOTECH BIOCH, V57, P200, DOI 10.1271/bbb.57.200; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1993, BIOESSAYS, V15, P469, DOI 10.1002/bies.950150706; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MK, 1992, J BIOL CHEM, V267, P3115; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LU H, 1994, J BACTERIOL, V176, P5554, DOI 10.1128/JB.176.17.5554-5559.1994; MACINTOSH SC, 1991, P NATL ACAD SCI USA, V88, P8930, DOI 10.1073/pnas.88.20.8930; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OPPERT B, 1994, BIOCHEM BIOPH RES CO, V198, P940, DOI 10.1006/bbrc.1994.1134; Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SCHNEPF HE, 1990, J BIOL CHEM, V265, P20923; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; WIDNER WR, 1990, J BACTERIOL, V172, P2826, DOI 10.1128/jb.172.6.2826-2832.1990; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WOLFERSBERGER MG, 1990, EXPERIENTIA, V46, P475; WOLFERSBERGER MG, 1986, BACTERIAL PROTEIN TO, P237; WU D, 1992, J BIOL CHEM, V267, P2311	36	73	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6412	6419		10.1074/jbc.270.11.6412	http://dx.doi.org/10.1074/jbc.270.11.6412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890779	hybrid			2022-12-27	WOS:A1995QM94500102
J	DIAZ, E; TIMMIS, KN				DIAZ, E; TIMMIS, KN			IDENTIFICATION OF FUNCTIONAL RESIDUES IN A 2-HYDROXYMUCONIC SEMIALDEHYDE HYDROLASE - A NEW MEMBER OF THE ALPHA/BETA HYDROLASE-FOLD FAMILY OF ENZYMES WHICH CLEAVES CARBON-CARBON BONDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCHLORINATED BIPHENYL DEGRADATION; PSEUDOMONAS-PUTIDA; HALOALKANE DEHALOGENASE; META-CLEAVAGE; 2-HYDROXY-6-OXOHEPTA-2,4-DIENOATE HYDROLASE; SECONDARY STRUCTURE; MORAXELLA TA144; SEQUENCE; GENE; MECHANISM	The 2-hydroxymuconic semialdehyde hydrolase, XylF, of the Pseudomonas putida TOL plasmid-encoded pathway for the catabolism of toluene and xylenes, catalyzes one of the rarest types of enzyme reaction (EC 3.7.1.9), the hydrolysis of a carbon-carbon bond in its substrate, the ring-fission product of 3-alkyl-substitutedd catechols. In this study, amino acid sequence comparisons between XylF and other hydrolases, and analysis of the similarity between the predicted secondary structure of XylF and the known secondary structure of the haloalkane dehalogenase from Xanthobacter autotrophicus strain GJ10, led us to identify several conserved residues likely to have a functional role in the catalytic center of XylF, Three amino acids, Ser(107), Asp(228), and His(256), were found to be arranged in a sequential order similar to that in alpha/beta hydrolase-fold enzymes. Investigations of the potential functional role of these and other residues through amino acid modification and in vitro site directed mutagenesis experiments provided evidence in support of the hypothesis that XylF is a serine hydrolase of the alpha/beta hydrolase-fold family of enzymes, and pointed to the residues identified above as the catalytic triad of XylF. These studies also provided information on other conserved residues in XylF-related enzymes. Interestingly, the substitution of Phe by Met in position 108 of XylF created an enzyme with increased thermostability and altered substrate specificity.			DIAZ, E (corresponding author), GBF,NATL RES CTR BIOTECHNOL,DEPT MICROBIOL,MASCHERODER WEG 1,D-38124 BRAUNSCHWEIG,GERMANY.		Diaz, Eduardo/F-8605-2016	Diaz, Eduardo/0000-0002-9731-6524				ARAND M, 1994, FEBS LETT, V338, P251, DOI 10.1016/0014-5793(94)80278-5; ATLAN D, 1994, MICROBIOL-UK, V140, P527, DOI 10.1099/00221287-140-3-527; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; DUGGLEBY CJ, 1986, J GEN MICROBIOL, V132, P717; FELLER G, 1991, BIOCHIM BIOPHYS ACTA, V1088, P323, DOI 10.1016/0167-4781(91)90073-U; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; FURUKAWA K, 1993, J BACTERIOL, V175, P5224, DOI 10.1128/JB.175.16.5224-5232.1993; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; HARAYAMA S, 1992, MET IONS BIOL SYST, V28, P99; HARAYAMA S, 1987, J BACTERIOL, V169, P558, DOI 10.1128/jb.169.2.558-564.1987; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; HAYASE N, 1990, J BACTERIOL, V172, P1160, DOI 10.1128/jb.172.2.1160-1164.1990; HAYASHI R, 1975, J BIOL CHEM, V250, P5221; HESSING JGM, 1983, THESIS U LEIDEN HOLL; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOFER B, 1993, GENE AMST, V13, P47; HORN JM, 1991, MOL MICROBIOL, V5, P2459, DOI 10.1111/j.1365-2958.1991.tb02091.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGIN D, 1993, P NATL ACAD SCI USA, V90, P4897, DOI 10.1073/pnas.90.11.4897; MARQUES S, 1993, MOL MICROBIOL, V9, P923, DOI 10.1111/j.1365-2958.1993.tb01222.x; MENN FM, 1991, GENE, V104, P91, DOI 10.1016/0378-1119(91)90470-V; Miles E W, 1977, Methods Enzymol, V47, P431; MINAMIKAWA T, 1970, Biochemical Journal, V116, P889; MONDELLO FJ, 1989, J BACTERIOL, V171, P1725, DOI 10.1128/jb.171.3.1725-1732.1989; NORDLUND I, 1990, BIOCHIM BIOPHYS ACTA, V1049, P227, DOI 10.1016/0167-4781(90)90046-5; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PATHAK D, 1991, PROTEINS, V9, P267, DOI 10.1002/prot.340090405; POLGAR L, 1991, EUR J BIOCHEM, V197, P441, DOI 10.1111/j.1432-1033.1991.tb15930.x; Powers J.C., 1986, PROTEINASE INHIBITOR; PRIES F, 1994, J BIOL CHEM, V269, P17490; SALATREPAT JM, 1972, EUR J BIOCHEM, V28, P347, DOI 10.1111/j.1432-1033.1972.tb01920.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALONI A, 1994, J BIOL CHEM, V269, P15076; SHIMADA Y, 1993, BIOCHIM BIOPHYS ACTA, V1174, P79, DOI 10.1016/0167-4781(93)90095-U; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; VERSCHUEREN KHG, 1993, J MOL BIOL, V232, P856, DOI 10.1006/jmbi.1993.1436; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; WEBB EC, 1992, ENZYME NOMENCLATURE, P417; WITKOWSKI A, 1992, J BIOL CHEM, V267, P18488; ZHOU XY, 1991, EMBO J, V10, P4041, DOI 10.1002/j.1460-2075.1991.tb04980.x	46	69	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6403	6411		10.1074/jbc.270.11.6403	http://dx.doi.org/10.1074/jbc.270.11.6403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890778	hybrid			2022-12-27	WOS:A1995QM94500101
J	LIPKA, G; SCHULTHESS, G; THURNHOFER, H; WACKER, H; WEHRLI, E; ZEMAN, K; WEBER, FE; HAUSER, H				LIPKA, G; SCHULTHESS, G; THURNHOFER, H; WACKER, H; WEHRLI, E; ZEMAN, K; WEBER, FE; HAUSER, H			CHARACTERIZATION OF LIPID EXCHANGE PROTEINS ISOLATED FROM SMALL-INTESTINAL BRUSH-BORDER MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL CARRIER PROTEIN-2; AMINO-ACID-SEQUENCE; RAT-LIVER; SUBCELLULAR-DISTRIBUTION; VESICLES; EXPRESSION; CHOLESTEROL; TISSUES; CLONING; PHOSPHATIDYLCHOLINE	Subjecting rabbit small intestinal brush border membrane vesicles (BBMV) to freeze-thaw cycles releases water-soluble lipid exchange (transfer) proteins into the supernatant. They differ widely in apparent molecular weight and catalyze cholesterol, phosphatidylcholine, and phosphatidylinositol exchange between two populations of small unilamellar lipid vesicles. In order to determine their interrelations, the smallest water-soluble lipid exchange protein was purified to homogeneity by gel filtration on Sephadex G-75 and cation exchange chromatography on Mono S. It is a basic protein of apparent molecular mass of 13 +/- 0.5 kDa. The purified protein was used to raise polyclonal antibodies, Polyclonal antibodies were also produced against a lipid exchange protein of apparent molecular mass of 100-120 kDa. By comparing lipid exchange, lipid binding, and immunological properties of the water soluble lipid exchange proteins it can be shown that the 13-kDa (peak 3) protein is related to the 100-120 kDa (peak 1) protein; the properties of these two proteins are different from those of the peak 2 lipid exchange protein of apparent molecular mass of 22 kDa. Based on the immunological cross-reactivity observed between the 13 and 100-120 kDa and the lipid binding properties of these two proteins, a working hypothesis is proposed: both proteins are probably part of an intergral membrane protein of the brush border membrane that facilitates cholesterol and phosphatidylcholine absorption in this membrane. Evidence derived from immunogold labeling of BBMV supports the notion that this protein is located on the external (luminal) side of the brush border membrane. The analogous behavior of rabbit and human small intestinal brush border membrane in terms of lipid absorption and the release of water-soluble lipid exchange proteins is discussed.	ETH ZENTRUM,BIOCHEM LAB,CH-8092 ZURICH,SWITZERLAND; UNIV ZURICH HOSP,MED POLIKLIN,DEPT INNERE MED,CH-8091 ZURICH,SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital			Weber, Franz E./I-7831-2019	Weber, Franz E./0000-0003-1670-2296				[Anonymous], 1976, THEORY APPL SPIN LAB; BAUM CL, 1993, J LIPID RES, V34, P729; BEHNKE O, 1986, EUR J CELL BIOL, V41, P326; BRUNNER J, 1979, J BIOL CHEM, V254, P1821; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; GAINS N, 1981, BIOCHIM BIOPHYS ACTA, V646, P211, DOI 10.1016/0005-2736(81)90327-8; GAINS N, 1984, BIOCHIM BIOPHYS ACTA, V772, P161, DOI 10.1016/0005-2736(84)90039-7; GEE AP, 1979, J IMMUNOL METHODS, V30, P119, DOI 10.1016/0022-1759(79)90086-3; HAASE W, 1978, BIOCHEM J, V172, P57, DOI 10.1042/bj1720057; HAUSER H, 1982, BIOCHEMISTRY-US, V21, P5621, DOI 10.1021/bi00265a036; HAUSER H, 1980, BIOCHIM BIOPHYS ACTA, V602, P567, DOI 10.1016/0005-2736(80)90335-1; HYATT AD, 1989, COLLOIDAL GOLD PRINC, V2, P19; KHARROUBI A, 1988, J LIPID RES, V29, P287; KLIP A, 1979, FEBS LETT, V99, P91, DOI 10.1016/0014-5793(79)80256-2; LIPKA G, 1991, BIOCHEMISTRY-US, V30, P11828, DOI 10.1021/bi00115a013; LIPKA G, 1992, STRUCTURAL DYNAMIC P, P7; MCKAY HAC, 1983, NATURE, V142, P997; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; MONCECCHI D, 1991, J BIOL CHEM, V266, P9885; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; MUTSCH B, 1986, BIOCHEMISTRY-US, V25, P2134; OSSENDORP BC, 1991, EUR J BIOCHEM, V201, P233, DOI 10.1111/j.1432-1033.1991.tb16279.x; OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347; REINHART MP, 1993, BIOCHEM J, V295, P787, DOI 10.1042/bj2950787; RIGHETTI PG, 1990, GEL ELECTROPHORESIS, P149; SCHULTHESS G, 1994, BIOCHEMISTRY-US, V33, P4500, DOI 10.1021/bi00181a009; SEEDORF U, 1991, J BIOL CHEM, V266, P630; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THURNHOFER H, 1990, BIOCHIM BIOPHYS ACTA, V1024, P249, DOI 10.1016/0005-2736(90)90351-N; THURNHOFER H, 1991, BIOCHIM BIOPHYS ACTA, V1064, P275, DOI 10.1016/0005-2736(91)90312-V; THURNHOFER H, 1990, BIOCHEMISTRY-US, V29, P2142, DOI 10.1021/bi00460a026; THURNHOFER H, 1991, EUR J BIOCHEM, V201, P273, DOI 10.1111/j.1432-1033.1991.tb16284.x; VANHEUSDEN GPH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P315, DOI 10.1016/0005-2760(90)90247-U; VANHEUSDEN GPH, 1992, METHOD ENZYMOL, V209, P535; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; WESTERMAN J, 1985, BIOCHEM BIOPH RES CO, V127, P333, DOI 10.1016/S0006-291X(85)80163-7; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; YAMAMOTO R, 1991, P NATL ACAD SCI USA, V88, P463, DOI 10.1073/pnas.88.2.463	38	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5917	5925		10.1074/jbc.270.11.5917	http://dx.doi.org/10.1074/jbc.270.11.5917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890723	hybrid			2022-12-27	WOS:A1995QM94500035
J	TELLAM, JT; MCINTOSH, S; JAMES, DE				TELLAM, JT; MCINTOSH, S; JAMES, DE			MOLECULAR-IDENTIFICATION OF 2 NOVEL MUNC-18 ISOFORMS EXPRESSED IN NONNEURONAL TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNC-18 GENE ENCODES; SACCHAROMYCES-CEREVISIAE; VESICULAR TRANSPORT; SECRETORY PATHWAY; MEMBRANE-PROTEIN; GOLGI-COMPLEX; YEAST; FUSION; FAMILY; MACHINERY	Munc-18, also known as n-Sec1 or rbSec1, is a syntaxin-binding protein thought to play a role in regulating synaptic vesicle exocytosis. Although a gene family of syntaxins has been identified, only a limited subset bind to Munc-18. This implicates the existence of other mammalian Munc-18 homologues that may be involved in a range of vesicle transport reactions. The purpose of the present study was to identify other members of the Munc-18 family by cDNA cloning, Three distinct Munc-18 isoforms, Munc-18a, previously identified in neuronal tissue, and two novel isoforms, Munc-18b and Munc-18c, were isolated from a 3T3-L1 adipocyte cDNA library by screening with a rat brain Munc-18 DNA probe, Munc-18a is identical to Munc-18 and by Northern analysis is expressed predominantly in brain and to a lesser extent in testis and 3T3-L1 cells, Munc-18b is 62% identical to Munc-18 at the amino acid level and is expressed in testis, intestine, kidney, rat adipose tissue, and 3T3-L1 cells, Munc-18c is 51% identical to Munc-18 and is ubiquitously expressed. It is likely, based on these findings, that unique Munc-18/syntaxin interactions may play an important role in generating a combinatorial mechanism for the regulation of vesicle transport in mammalian cells.	UNIV QUEENSLAND,CTR MOLEC BIOL & BIOTECHNOL,BRISBANE,QLD 4072,AUSTRALIA; UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,BRISBANE,QLD 4072,AUSTRALIA	University of Queensland; University of Queensland			mcintosh, shane/AAL-4279-2021	James, David/0000-0001-5946-5257; mcintosh, shane/0000-0003-2835-7936				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; EGERTON M, 1993, YEAST, V9, P703, DOI 10.1002/yea.320090704; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HIGGINS DG, 1991, CABIOS, V8, P189; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; JONES E, 1976, GENETICS, V85, P23; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; NEWMAN AP, 1990, MOL CELL BIOL, V10, P3405, DOI 10.1128/MCB.10.7.3405; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1993, CELL, V75, P1; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214	28	157	166	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5857	5863		10.1074/jbc.270.11.5857	http://dx.doi.org/10.1074/jbc.270.11.5857			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890715	hybrid			2022-12-27	WOS:A1995QM94500027
J	JANC, JW; EGAN, LA; TOWNSEND, CA				JANC, JW; EGAN, LA; TOWNSEND, CA			PURIFICATION AND CHARACTERIZATION OF CLAVAMINATE SYNTHASE FROM STREPTOMYCES-ANTIBIOTICUS - A MULTIFUNCTIONAL ENZYME OF CLAVAM BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLAVULANIC ACID BIOSYNTHESIS; SPECTROPHOTOMETRIC ASSAY; ORTHO-PHTHALDIALDEHYDE; AMINO-ACIDS; CLAVULIGERUS; IDENTIFICATION; INTERMEDIATE; PRODUCT; ORIGIN; GENES	Clavaminate synthase (CS), a key enzyme in the clavulanic acid biosynthetic pathway, has been purified to electrophoretic homogeneity from Streptomyces antibioticus (Tu 1718), a species that does not produce clavulanic acid. A comparison of the physical and kinetic properties of clavaminate synthase from S. antibioticus (CS3) and the two isozymes from Streptomyces clavulgerus (CS1 and CS2) has been conducted. In oxidative reactions requiring the co-substrates O-2, alpha-ketoglutaric acid, and catalytic Fe2+, both CS1 and CS2 catalyze three distinct transformations, the hydroxylation of deoxyguanidinoproclavaminic acid to guanidinoproclavaminic acid, and the cyclization and desaturation of proclavaminic acid to clavaminic acid. We have demonstrated that CS3 from S. antibioticus also catalyzes these three oxidations. The apparent molecular mass of CS3 from matrix-assisted laser desorption mass spectrometry is 35,839 +/- 36 Da. The enzyme is a monomer in solution as determined by gel filtration chromatography. Analysis of the four possible proclavaminic acid diastereomers confirmed the absolute configuration of the substrate to be 2S,3R. Based upon N-terminal sequence comparisons among the three proteins, CS3 possesses the higher degree of homology with the CS1 isozyme from S. clavuligerus. Although previously associated solely with clavulanic acid biosynthesis, we propose these findings and recent precursor incorporation data support the view that clavaminate synthase plays a critical role in the biosynthesis of the clavam metabolites.	JOHNS HOPKINS UNIV,DEPT CHEM,BALTIMORE,MD 21218	Johns Hopkins University					NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937, R56AI014937, R01AI014937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015174] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 04794] Funding Source: Medline; NIAID NIH HHS [AI 14937] Funding Source: Medline; NIGMS NIH HHS [GM 15174] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGGALEY KH, 1988, J CHEM SOC CHEM COMM, P567, DOI 10.1039/c39880000567; BALDWIN JE, 1993, TETRAHEDRON LETT, V34, P5645, DOI 10.1016/S0040-4039(00)73905-0; BALDWIN JE, 1990, J CHEM SOC CHEM COMM, P617, DOI 10.1039/c39900000617; BALDWIN JE, 1994, TETRAHEDRON LETT, V35, P2783, DOI 10.1016/S0040-4039(00)77032-8; BALDWIN JE, 1993, J CHEM SOC CHEM COMM, P500, DOI 10.1039/c39930000500; BEUTLER HO, 1985, METHOD ENZYMAT AN, V7, P25; BIRD AE, 1982, ANALYST, V107, P1241, DOI 10.1039/an9820701241; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN D, 1979, J CHEM SOC CHEM COMM, P282, DOI 10.1039/c39790000282; Cleland W W, 1979, Methods Enzymol, V63, P103; COTTER RJ, 1992, ANAL CHEM, V64, pA1027, DOI 10.1021/ac00045a002; ELSON SW, 1987, J CHEM SOC CHEM COMM, P1736, DOI 10.1039/c39870001736; ELSON SW, 1993, J CHEM SOC CHEM COMM, P1212, DOI 10.1039/c39930001212; EVANS RH, 1983, J ANTIBIOT, V36, P213, DOI 10.7164/antibiotics.36.213; HOWARTH TT, 1976, J CHEM SOC CHEM COMM, P266; IWATAREUYL D, 1992, J AM CHEM SOC, V114, P2762, DOI 10.1021/ja00033a086; JANE JW, 1993, BIOMED CHEM LETT, V3, P2213; JENSEN SE, 1993, INDUSTRIAL MICROORGANISMS: BASIC AND APPLIED MOLECULAR GENETICS, P169; KLAPPER MH, 1977, BIOCHEM BIOPH RES CO, V78, P1018, DOI 10.1016/0006-291X(77)90523-X; KROL WJ, 1991, J ORG CHEM, V56, P728, DOI 10.1021/jo00002a045; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLOR EJ, 1994, TETRAHEDRON, V50, P8737, DOI 10.1016/S0040-4020(01)85347-3; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; MARSH EN, 1992, BIOCHEMISTRY-US, V31, P12648, DOI 10.1021/bi00165a015; MOORE S, 1954, J BIOL CHEM, V211, P907; NICHOLSON NH, 1994, J CHEM SOC CHEM COMM, P1281, DOI 10.1039/c39940001281; ROHL F, 1987, ARCH MICROBIOL, V147, P315, DOI 10.1007/BF00406126; SALOWE SP, 1990, BIOCHEMISTRY-US, V29, P6499, DOI 10.1021/bi00479a023; SALOWE SP, 1991, BIOCHEMISTRY-US, V30, P2281, DOI 10.1021/bi00222a034; Segel IH, 1975, ENZYME KINETICS, P346; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SVEDAS VJK, 1980, ANAL BIOCHEM, V101, P188, DOI 10.1016/0003-2697(80)90059-7; TOWNSEND CA, 1988, J CHEM SOC CHEM COMM, P1234, DOI 10.1039/c39880001234; WANNING M, 1981, TETRAHEDRON LETT, V22, P2539, DOI 10.1016/S0040-4039(01)90514-3; WANNING M, 1980, THESIS U TUBINGEN FR; WARD JM, 1993, FEMS MICROBIOL LETT, V110, P239; WRIGHT F, 1992, GENE, V113, P55, DOI 10.1016/0378-1119(92)90669-G	37	32	32	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5399	5404		10.1074/jbc.270.10.5399	http://dx.doi.org/10.1074/jbc.270.10.5399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890654	hybrid			2022-12-27	WOS:A1995QL58000069
J	KATAGIRI, H; TERASAKI, J; MURATA, T; ISHIHARA, H; OGIHARA, T; INUKAI, K; FUKUSHIMA, Y; ANAI, M; KIKUCHI, M; MIYAZAKI, J; YAZAKI, Y; OKA, Y				KATAGIRI, H; TERASAKI, J; MURATA, T; ISHIHARA, H; OGIHARA, T; INUKAI, K; FUKUSHIMA, Y; ANAI, M; KIKUCHI, M; MIYAZAKI, J; YAZAKI, Y; OKA, Y			A NOVEL ISOFORM OF SYNTAXIN-BINDING PROTEIN HOMOLOGOUS TO YEAST SEC1 EXPRESSED UBIQUITOUSLY IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INTEGRAL MEMBRANE-PROTEIN; UNC-18 GENE ENCODES; VESICULAR TRANSPORT; SYNAPTIC VESICLES; INSULIN-SECRETION; GLUCOSE-TRANSPORT; PLASMA-MEMBRANE; FUSION; TRANSLOCATION; METABOLISM	munc-18/n-Sec1/rbSec1, a brain homologue of the yeast Seclp protein, is thought to participate in regulating the docking and fusion of synaptic vesicles. We have screened the mouse cDNA library of an MIN6 cell line, derived from pancreatic beta cells, for its novel isoform and have identified a cDNA encoding a 593-amino acid protein having 63, 53, and 30% identity with munc-18/nSec1/rbSec1, Caenorhabditis elegans unc18, and Saccharomyces cerevisiae Sec1p, respectively. While munc-18/nSec1/rbSec1 expression has been reported to be neural-specific, RNA blot analysis has revealed that the novel isoform, which we refer to as mused (mammalian ubiquitous Sec1), is expressed ubiquitously. We have also identified mouse munc-18/n-Sec1/rbSec1 from the MIN6 cDNA library, indicating that different isoforms of a protein participating in vesicular transport exist in a single cell. muSec1 bound to glutathione S-transferase-syntaxin 1A and, although with lower affinity, to glutathione S-transferase-syntaxin 4 fusion protein. These findings suggest that muSec1 is, via its binding to the syntaxin family, involved in the protein trafficking from the Golgi apparatus to the plasma membrane and that the fundamental mechanisms of protein trafficking have been conserved from yeast through virtually all mammalian cells.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT DIS RELATED GENE REGULAT RES SANDOZ,TOKYO 113,JAPAN; ASAHI LIFE FDN,INST ADULT DIS,SHINJUKU KU,TOKYO 160,JAPAN	University of Tokyo; Novartis; Sandoz; University of Tokyo; Asahi Life Foundation			Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CAIN CC, 1991, J BIOL CHEM, V267, P11681; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HODEL A, 1994, J BIOL CHEM, V269, P8623; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; OKA Y, 1984, J BIOL CHEM, V259, P8125; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PELHAM HRB, 1993, NATURE, V364, P582, DOI 10.1038/364582a0; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1993, CELL, V75, P1; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538	26	65	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4963	4966		10.1074/jbc.270.10.4963	http://dx.doi.org/10.1074/jbc.270.10.4963			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890599	hybrid			2022-12-27	WOS:A1995QL58000003
J	LAMBEAU, G; ANCIAN, P; NICOLAS, JP; BEIBOER, SHW; MOINIER, D; VERHEIJ, H; LAZDUNSKI, M				LAMBEAU, G; ANCIAN, P; NICOLAS, JP; BEIBOER, SHW; MOINIER, D; VERHEIJ, H; LAZDUNSKI, M			STRUCTURAL ELEMENTS OF SECRETORY PHOSPHOLIPASES A(2) INVOLVED IN THE BINDING TO M-TYPE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC PHOSPHOLIPASE-A2; TRANSITION-STATE ANALOG; AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; ENZYMATIC-ACTIVITY; TOXIC PHOSPHOLIPASES-A2; VENOM PHOSPHOLIPASE-A2; CATALYTIC MECHANISM; MANNOSE RECEPTOR; SKELETAL-MUSCLE	Specific membrane receptors for secretory phospholipases A(2) (sPL(2)s) have been initially identified with novel snake venom sPL(2)s called OS1 and OS2. One of these sPLA(2) receptors (muscle (M) type, 180 kDa) has a very high affinity for OS1 and OS2 and a high affinity for pancreatic and inflammatory-type mammalian sPL(2)s, which might be the natural endogenous ligands of PLA(2) receptors. Primary structures of OS1, and OS2 were determined and compared with sequences of other sPL(2)s that bind less tightly or do not bind to the M-type receptor. In addition, the binding properties of pancreatic sPLA(2) mutants to the M-type receptor have been analyzed. Residues within or close to the Ca2+-binding loop of pancreatic sPLA(2) are crucially involved in the binding step, although the presence of Ca2+ that is essential for the enzymatic activity is not required for binding to the receptor. These residues include Gly-30 and Asp-49, which are conserved in all sPL(2)s. Leu-31 is also essential for binding of pancreatic sPLA(2) to its receptor. Many other mutations have been considered. Those occurring in the N-terminal alpha helices and the pancreatic loop do not change binding to the M-type receptor. Conversion of pancreatic prophospholipase to phospholipase is essential for the acquisition of binding properties to the M-type receptor.	CNRS,INST PHARMACOL MOLEC & CELLULAIRE,F-06560 VALBONNE,FRANCE; UNIV UTRECHT,CTR BIOMEMBRANES & LIPID ENZYMOL,DEPT ENZYMOL & PROT ENGN,3508 TB UTRECHT,NETHERLANDS	Centre National de la Recherche Scientifique (CNRS); Utrecht University			Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X				ARITA H, 1991, J BIOL CHEM, V266, P19139; BEKKERS ACAPA, 1991, BIOCHIM BIOPHYS ACTA, V1076, P374, DOI 10.1016/0167-4838(91)90479-J; CHEN J, 1994, J BIOL CHEM, V269, P2365; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P103, DOI 10.1016/0005-2744(68)90248-9; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DIJKSTRA BW, 1984, BIOCHEMISTRY-US, V23, P2759, DOI 10.1021/bi00307a035; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1981, NATURE, V289, P604, DOI 10.1038/289604a0; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; DIJKSTRA BW, 1982, ACTA CRYSTALLOGR B, V38, P793, DOI 10.1107/S0567740882004099; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FINZEL BC, 1991, ACTA CRYSTALLOGR B, V47, P814, DOI 10.1107/S0108768191004226; FRANKEN PA, 1992, EUR J BIOCHEM, V203, P89, DOI 10.1111/j.1432-1033.1992.tb19832.x; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; GLASER KB, 1993, TRENDS PHARMACOL SCI, V14, P92, DOI 10.1016/0165-6147(93)90071-Q; Hawgood B., 1991, HDB NATURAL TOXINS R, V5, P3; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; JOUBERT FJ, 1977, BIOCHIM BIOPHYS ACTA, V493, P216, DOI 10.1016/0005-2795(77)90275-6; KANEMASA T, 1992, FEBS LETT, V303, P217, DOI 10.1016/0014-5793(92)80523-J; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1117, P217; KUIPERS OP, 1990, BIOCHEMISTRY-US, V29, P6094, DOI 10.1021/bi00477a029; KUIPERS OP, 1989, SCIENCE, V244, P82, DOI 10.1126/science.2704992; KUIPERS OP, 1990, PROTEIN ENG, V3, P599, DOI 10.1093/protein/3.7.599; KUIPERS OP, 1991, BIOCHEMISTRY-US, V30, P8771, DOI 10.1021/bi00100a008; KUIPERS OP, 1989, PROTEIN ENG, V2, P467, DOI 10.1093/protein/2.6.467; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; LAMBEAU G, 1989, J BIOL CHEM, V264, P11503; LAMBEAU G, 1991, FEBS LETT, V293, P29, DOI 10.1016/0014-5793(91)81145-X; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; LAMBEAU G, 1991, NEUROCHEM RES, V16, P651, DOI 10.1007/BF00965551; LUGTIGHEID RB, 1993, EUR J BIOCHEM, V216, P519, DOI 10.1111/j.1432-1033.1993.tb18170.x; MAYER RJ, 1993, FASEB J, V7, P339, DOI 10.1096/fasebj.7.2.8440410; MUKHERJEE AB, 1992, DNA CELL BIOL, V11, P233, DOI 10.1089/dna.1992.11.233; MULHERKAR R, 1993, BIOCHEM BIOPH RES CO, V195, P1254, DOI 10.1006/bbrc.1993.2179; NEVALAINEN TJ, 1993, CLIN CHEM, V39, P2453; NIEUWENHUIZEN W, 1974, METHOD ENZYMOL, V323, P147; PRUZANSKI W, 1993, J LIPID MEDIATOR, V8, P161; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; PUIJK WC, 1977, BIOCHIM BIOPHYS ACTA, V492, P254, DOI 10.1016/0005-2795(77)90076-9; PUIJK WC, 1977, BIOCHIM BIOPHYS ACTA, V580, P411; RENETSEDER R, 1985, J BIOL CHEM, V260, P1627; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SEILHAMER JJ, 1986, DNA-J MOLEC CELL BIO, V5, P519, DOI 10.1089/dna.1.1986.5.519; SOMMERS CD, 1992, EUR J PHARMACOL, V216, P87, DOI 10.1016/0014-2999(92)90213-N; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TOJO H, 1988, J BIOL CHEM, V263, P5724; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; VANDENBERGH CJ, 1989, EUR J BIOCHEM, V182, P307; VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404; VANDENBERGH CJ, 1988, EUR J BIOCHEM, V176, P353; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; WEISS J, 1991, J BIOL CHEM, V266, P4162; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; YING Z, 1993, EUR J BIOCHEM, V215, P91, DOI 10.1111/j.1432-1033.1993.tb18010.x	60	94	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5534	5540		10.1074/jbc.270.10.5534	http://dx.doi.org/10.1074/jbc.270.10.5534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890672	hybrid			2022-12-27	WOS:A1995QL58000088
J	SURYA, A; FOSTER, RW; KNOX, BE				SURYA, A; FOSTER, RW; KNOX, BE			TRANSDUCIN ACTIVATION BY THE BOVINE OPSIN APOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; LIGHT-DEPENDENT PHOSPHORYLATION; CYCLIC-NUCLEOTIDE CASCADE; METARHODOPSIN-II; PHOTORECEPTOR-MEMBRANES; SCHIFF-BASE; PHOTOEXCITED RHODOPSIN; VISUAL-PIGMENT; PROTON UPTAKE; BEHAVIOR	The interaction of the bovine opsin apoprotein with transducin in rod outer segment membranes was investigated using a guanyl nucleotide exchange assay. In exhaustive binding experiments, opsin activates transducin, with half-maximal exchange activity occurring at 0.8 mol of opsin/mol of transducin. The opsin activity was light insensitive, hydroxylamine-resistant, unaffected by stoichiometric concentrations of retinaloxime, and more heat labile than rhodopsin. The t1/2 of transducin activation in the presence of excess opsin was 8.5 min, compared with 0.7 min for metarhodopsin(II). The second-order rate constants were determined to be 0.012 pmol of guanosine 5'-(gamma-thio)triphosphate (GTP gamma S) bound per min/nM opsin and 0.35 pmol of GTP gamma S bound per min/nM metarhodopsin(II). Opsin was able to activate more than one transducin, although there appeared to be a turnover-dependent inactivation of the apoprotein. Opsin showed a broad pH range (5.8-7.4) for optimal activity, with no activity in buffers of pH >9, whereas metarhodopsin(II) exhibited activity at pH >9. Regulation of opsin activity by stoichiometric amounts of retinal was observed, with inhibition by 11-cis-retinal and stimulation by all-trans-retinal. A model for opsin activity is proposed.	SUNY HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,SYRACUSE,NY 13210; SYRACUSE UNIV,DEPT PHYS,SYRACUSE,NY 13244	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University					NATIONAL EYE INSTITUTE [R55EY009409, R01EY009409] Funding Source: NIH RePORTER; NEI NIH HHS [EY09409] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; BARLOW HB, 1964, VISION RES, V4, P47, DOI 10.1016/0042-6989(64)90031-8; BENNETT N, 1982, EUR J BIOCHEM, V127, P97, DOI 10.1111/j.1432-1033.1982.tb06842.x; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; BRIN KP, 1977, J GEN PHYSIOL, V69, P97, DOI 10.1085/jgp.69.1.97; BRUCKERT F, 1988, EUR BIOPHYS J BIOPHY, V16, P207; BUBIS J, 1990, J BIOL CHEM, V265, P12995; CALHOON RD, 1985, BIOCHEMISTRY-US, V24, P6446, DOI 10.1021/bi00344a021; CATT M, 1982, BIOCHEM SOC T, V10, P343, DOI 10.1042/bst0100343; CLACK JW, 1982, J GEN PHYSIOL, V80, P863, DOI 10.1085/jgp.80.6.863; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; CORSON DW, 1990, P NATL ACAD SCI USA, V87, P6823, DOI 10.1073/pnas.87.17.6823; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FUKADA Y, 1982, BIOCHIM BIOPHYS ACTA, V708, P12; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HOFMANN KP, 1983, BIOCHIM BIOPHYS ACTA, V725, P60, DOI 10.1016/0005-2728(83)90224-4; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; JIN J, 1993, NEURON, V11, P513, DOI 10.1016/0896-6273(93)90155-K; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; KHAN SMA, 1991, EUR J BIOCHEM, V200, P53, DOI 10.1111/j.1432-1033.1991.tb21047.x; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; KNOX B E, 1991, Biophysical Journal, V59, p328A; KOHRANA HG, 1992, J BIOL CHEM, V267, P1; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KOUTALOS Y, 1992, BIOPHYS J, V61, P272, DOI 10.1016/S0006-3495(92)81833-7; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LONGSTAFF C, 1986, P NATL ACAD SCI USA, V83, P4209, DOI 10.1073/pnas.83.12.4209; MATHEWS RG, 1963, J GEN PHYSIOL, V47, P215; MILJANICH GP, 1985, J MEMBRANE BIOL, V85, P79, DOI 10.1007/BF01872007; OKADA D, 1989, PHOTOCHEM PHOTOBIOL, V49, P197, DOI 10.1111/j.1751-1097.1989.tb04096.x; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; PEPPERBERG DR, 1987, EXP EYE RES, V45, P141, DOI 10.1016/S0014-4835(87)80085-4; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RUSHTON WAH, 1961, J PHYSL, V156, P195; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SHICHI H, 1978, J BIOL CHEM, V253, P7040; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WEIGAND RD, 1982, METHOD ENZYMOL, V81, P297; WEITZ CJ, 1992, NEURON, V8, P465, DOI 10.1016/0896-6273(92)90274-H; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P12444; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; WONG JK, 1973, ARCH BIOCHEM BIOPHYS, V154, P1, DOI 10.1016/0003-9861(73)90028-3; YOSHIZAWA T, 1983, BIOPHYS STRUCT MECH, V9, P245, DOI 10.1007/BF00535660	56	81	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5024	5031		10.1074/jbc.270.10.5024	http://dx.doi.org/10.1074/jbc.270.10.5024			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890610	hybrid			2022-12-27	WOS:A1995QL58000015
J	CHUNG, SO; KUBO, T; NATORI, S				CHUNG, SO; KUBO, T; NATORI, S			MOLECULAR-CLONING AND SEQUENCING OF ARYLPHORIN-BINDING PROTEIN IN PROTEIN GRANULES OF THE SARCOPHAGA FAT-BODY - IMPLICATION OF A POSTTRANSLATIONAL PROCESSING MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORAGE PROTEIN; PEREGRINA; RECEPTOR; GENE; 20-HYDROXYECDYSONE; IDENTIFICATION; ACTIVATION; DROSOPHILA; CECROPIA; MEMBRANE	Previously, we identified an arylphorin-binding protein of Sarcophaga peregrina (flesh fly) with a molecular mass of 120 kDa and suggested its participation in the selective uptake of arylphorin from the hemolymph into the pupal fat body at metamorphosis (Ueno, K, and Natori, S. (1984) J, Biol, Chem, 259, 12107-12111). This paper reports the isolation and sequencing of cDNA for the 120-kDa protein. This protein consists of 1146 amino acid residues. Immunoblotting and RNA blotting experiments revealed that this protein is present as two fragments of 76 kDa (695 residues) and 53 kDa (451 residues) in the larval fat body. When larvae pupate, the 120-kDa protein gene is further activated and the complete 120-kDa protein is synthesized without fragmentation, This suggests a novel mechanism for the production of the 120-kDa protein regulated by a proteinase depending upon the stage of development of Sarcophaga. Ah of these proteins were found to be localized in protein granules in the adipocytes.	UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo				Kubo, Takeo/0000-0002-5914-5269				BOWEN B, 1980, NUCLEIC ACIDS RES, V8, P1, DOI 10.1093/nar/8.1.1; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; HOMMA K, 1994, J BIOL CHEM, V269, P16258; KINNEAR JF, 1975, INSECT BIOCHEM, V5, P531, DOI 10.1016/0020-1790(75)90036-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE M, 1981, P NATL ACAD SCI-BIOL, V78, P2417, DOI 10.1073/pnas.78.4.2417; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASCHAT F, 1990, J MOL BIOL, V214, P359, DOI 10.1016/0022-2836(90)90186-P; MIYACHI Y, 1972, J CLIN ENDOCR METAB, V34, P23, DOI 10.1210/jcem-34-1-23; MUNN EA, 1969, J INSECT PHYSIOL, V15, P1935, DOI 10.1016/0022-1910(69)90023-7; NAKANISHI Y, 1983, P NATL ACAD SCI-BIOL, V80, P2971, DOI 10.1073/pnas.80.10.2971; NATORI S, 1986, ARCH INSECT BIOCHEM, P105, DOI 10.1002/arch.940030712; Natori S., 1989, P426; OHTAKI T, 1966, JPN J MED SCI BIOL, V19, P97, DOI 10.7883/yoken1952.19.97; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SGARAMELLA V, 1972, J MOL BIOL, V72, P427, DOI 10.1016/0022-2836(72)90155-6; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAHARA T, 1982, BIOCHEM J, V203, P571, DOI 10.1042/bj2030571; TELFER WH, 1983, INSECT BIOCHEM, V13, P601, DOI 10.1016/0020-1790(83)90034-3; TOJO S, 1978, J CELL BIOL, V78, P823, DOI 10.1083/jcb.78.3.823; UENO K, 1987, J BIOL CHEM, V262, P12780; UENO K, 1982, INSECT BIOCHEM, V12, P185, DOI 10.1016/0020-1790(82)90007-5; UENO K, 1984, J BIOL CHEM, V259, P2107; UENO K, 1983, J BIOL CHEM, V258, P2210; WEINSTOCK R, 1978, P NATL ACAD SCI USA, V75, P1299, DOI 10.1073/pnas.75.3.1299; WYATT GR, 1978, ANNU REV BIOCHEM, V47, P779, DOI 10.1146/annurev.bi.47.070178.004023	28	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4624	4631		10.1074/jbc.270.9.4624	http://dx.doi.org/10.1074/jbc.270.9.4624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876233	hybrid			2022-12-27	WOS:A1995QK08400067
J	NIGHTINGALE, K; WOLFFE, AP				NIGHTINGALE, K; WOLFFE, AP			METHYLATION AT CPG SEQUENCES DOES NOT INFLUENCE HISTONE-H1 BINDING TO A NUCLEOSOME INCLUDING A XENOPUS-BOREALIS 5-S-RIBOSOMAL RNA GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							THYMIDINE KINASE GENE; RNA POLYMERASE-II; DNA METHYLATION; CHROMATIN STRUCTURE; LINKER HISTONES; GLOBIN GENE; TRANSCRIPTION; PROTEIN; H-1; REPRESSION	We demonstrate that methylation of the 12 dinucleotide CpGs within a GC-rich DNA fragment containing a Xenopus borealis 5 S rRNA gene does not influence histone ill binding to naked or nucleosomal 5 S DNA. Thus a simple mechanism in which histone ill selectively associates with nucleosomes containing methylated CpG cannot explain the repressive effects of methylation on gene activity.	NICHHD,MOLEC EMBRYOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								BALL DJ, 1983, P NATL ACAD SCI-BIOL, V80, P5490, DOI 10.1073/pnas.80.18.5490; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOULIKAS T, 1980, P NATL ACAD SCI-BIOL, V77, P127, DOI 10.1073/pnas.77.1.127; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; BUSCHHAUSEN G, 1985, NUCLEIC ACIDS RES, V13, P5503, DOI 10.1093/nar/13.15.5503; BUSSLINGER M, 1993, NUCLEIC ACIDS RES, V11, P3559; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; DREW HR, 1987, J MOL BIOL, V197, P485, DOI 10.1016/0022-2836(87)90560-2; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; ENGLANDER EW, 1993, J BIOL CHEM, V268, P19565; FELSENFELD G, 1982, COLD SPRING HARB SYM, V47, P577; HAYES JJ, 1994, P NATL ACAD SCI USA, V91, P7817, DOI 10.1073/pnas.91.16.7817; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; HIGURASHI M, 1991, J BIOL CHEM, V266, P8619; HOELLER M, 1988, Genes and Development, V2, P1127; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JOST JP, 1992, P NATL ACAD SCI USA, V89, P9499, DOI 10.1073/pnas.89.20.9499; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LEVINE A, 1993, J BIOL CHEM, V268, P21754; Maxam A M, 1980, Methods Enzymol, V65, P499; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; MURRAY EJ, 1987, EMBO J, V6, P2329, DOI 10.1002/j.1460-2075.1987.tb02508.x; SALUZ HP, 1989, ANAL BIOCHEM, V176, P201, DOI 10.1016/0003-2697(89)90296-0; SCHLISSEL MS, 1984, CELL, V37, P903, DOI 10.1016/0092-8674(84)90425-2; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; SINGER DS, 1976, NUCLEIC ACIDS RES, V3, P2531, DOI 10.1093/nar/3.10.2531; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; URA K, 1994, J BIOL CHEM, V269, P27171; WOLFFE AP, 1989, EMBO J, V8, P527, DOI 10.1002/j.1460-2075.1989.tb03407.x; WOLFFE AP, 1986, CELL, V44, P381, DOI 10.1016/0092-8674(86)90459-9; WOLFFE AP, 1993, METH MOL G, V2, P314; YISRAELI J, 1988, P NATL ACAD SCI USA, V85, P4638, DOI 10.1073/pnas.85.13.4638	41	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4197	4200		10.1074/jbc.270.9.4197	http://dx.doi.org/10.1074/jbc.270.9.4197			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876175	hybrid			2022-12-27	WOS:A1995QK08400005
J	MCLENNAN, AG; MAYERS, E; WALKERSMITH, I; CHEN, HJ				MCLENNAN, AG; MAYERS, E; WALKERSMITH, I; CHEN, HJ			LANTERNS OF THE FIREFLY PHOTINUS-PYRALIS CONTAIN ABUNDANT DIADENOSINE 5',5'''-P-1,P-4-TETRAPHOSPHATE PYROPHOSPHOHYDROLASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DINUCLEOSIDE POLYPHOSPHATES; TETRAPHOSPHATE AP4A; ESCHERICHIA-COLI; MAMMALIAN-CELLS; TUMOR-CELLS; 5',5'''-P1,P4-TETRAPHOSPHATE; APPPPA; PURIFICATION; LUCIFERASE; SYNTHETASES	The enzyme diadenosine 5',5'''-P-1,P-4-tetraphosphate (Ap(4)A) pyrophosphohydrolase has been purified to homogeneity from firefly lanterns. It is a single polypeptide of M(r) 16,000 with a K-m for Ap(4)A of 1.9 mu M and k(cat) = 3.6 s(-1). It is inhibited competitively by adenosine 5'-tetraphosphate (K-i = 7.5 nM) and non-competitively by fluoride ions (K-i = 50 mu M). The specific activity of the enzyme in crude extracts of at least 20 milliunits/mg protein is 10-100 times higher than in any other eukaryote so far examined. Interestingly, firefly luciferase is known to synthesize Ap(4)A and related adenine-containing dinucleoside tetraphosphates in vitro. The high activity of Ap,A hydrolase in lanterns may be related to this ability and could be relevant to the use of the luciferase gene as a reporter gene.			MCLENNAN, AG (corresponding author), UNIV LIVERPOOL,DEPT BIOCHEM,CELLULAR & METAB REGULAT GRP,POB 147,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.							BAKER JC, 1984, ANAL BIOCHEM, V141, P451, DOI 10.1016/0003-2697(84)90070-8; BAKER JC, 1986, P NATL ACAD SCI USA, V83, P2350, DOI 10.1073/pnas.83.8.2350; BARNES LD, 1982, BIOCHEMISTRY-US, V21, P6123, DOI 10.1021/bi00267a015; BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0; BREVET A, 1985, J BIOL CHEM, V260, P5566; CAMESELLE JC, 1982, BIOCHEM J, V201, P405, DOI 10.1042/bj2010405; DANG CV, 1989, J BIOL CHEM, V264, P5861; FARR SB, 1989, P NATL ACAD SCI USA, V86, P5010, DOI 10.1073/pnas.86.13.5010; Garrison PN, 1992, AP4A OTHER DINUCLEOS, P29; GILSON G, 1988, EXP CELL RES, V177, P143, DOI 10.1016/0014-4827(88)90032-8; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; GURANOWSKI A, 1990, FEBS LETT, V271, P215, DOI 10.1016/0014-5793(90)80409-C; GURANOWSKI A, 1985, J BIOL CHEM, V260, P3542; GURANOWSKI A, 1990, FEBS LETT, V262, P205, DOI 10.1016/0014-5793(90)80190-T; GURANOWSKI A, 1992, AP4A OTHER DINUCLEOS, P81; JAKUBOWSKI H, 1983, J BIOL CHEM, V258, P9982; JOHNSTON DJ, 1990, BIOCHEM J, V268, P791, DOI 10.1042/bj2680791; KELLER GA, 1987, P NATL ACAD SCI USA, V84, P3264, DOI 10.1073/pnas.84.10.3264; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZEWSKA D, 1993, PROTEIN EXPRES PURIF, V4, P45, DOI 10.1006/prep.1993.1007; MANNAERTS GP, 1987, PEROXISOMES BIOL MED, P169; MCELROY WD, 1962, ENZYMES, V6, P433; MCLENNAN AG, 1994, BIOCHEM J, V300, P183, DOI 10.1042/bj3000183; MORENO A, 1982, INT J BIOCHEM, V14, P629, DOI 10.1016/0020-711X(82)90047-7; MORIS G, 1987, BIOCHIMIE, V69, P1217, DOI 10.1016/0300-9084(87)90149-0; OGILVIE A, 1983, J BIOL CHEM, V258, P4105; ORTIZ B, 1993, EUR J BIOCHEM, V212, P263, DOI 10.1111/j.1432-1033.1993.tb17658.x; PETERSON GL, 1982, METHOD ENZYMOL, V91, P95; PLATEAU P, 1981, BIOCHEMISTRY-US, V20, P4654, DOI 10.1021/bi00519a021; PLATEAU P, 1992, AP4A OTHER DINUCLEOS, P63; PRESCOTT M, 1989, BIOCHEM J, V259, P831, DOI 10.1042/bj2590831; ROBINSON AK, 1993, BIOCHIM BIOPHYS ACTA, V1161, P139, DOI 10.1016/0167-4838(93)90207-8; SILLERO MAG, 1991, EUR J BIOCHEM, V202, P507; VALLEJO CG, 1989, INT J BIOCHEM, V21, P1223, DOI 10.1016/0020-711X(89)90007-4; YAMAGUCHI N, 1985, GASTROENTEROLOGY, V89, P732	35	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3706	3709		10.1074/jbc.270.8.3706	http://dx.doi.org/10.1074/jbc.270.8.3706			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876110	hybrid			2022-12-27	WOS:A1995QH68800039
J	MOLL, T; CZYZ, M; HOLZMULLER, H; HOFERWARBINEK, R; WAGNER, E; WINKLER, H; BACH, FH; HOFER, E				MOLL, T; CZYZ, M; HOLZMULLER, H; HOFERWARBINEK, R; WAGNER, E; WINKLER, H; BACH, FH; HOFER, E			REGULATION OF THE TISSUE FACTOR PROMOTER IN ENDOTHELIAL-CELLS - BINDING OF NF-KAPPA-B-LIKE, AP-1-LIKE, AND SP1-LIKE TRANSCRIPTION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR MESSENGER-RNA; COAGULATION PROTEASE CASCADE; THP-1 MONOCYTIC CELLS; FACTOR GENE; ADHESION MOLECULE-1; PROCOAGULANT RESPONSE; CELLULAR RECEPTOR; PHORBOL ESTER; EXPRESSION	Tissue factor is up-regulated on endothelial cells and monocytes in response to cytokines and endotoxin and is the main trigger of the extrinsic pathway of the coagulation cascade. We have isolated the porcine tissue factor gene and studied the regulation of the promoter, which has not been investigated previously in endothelial cells. Comparison of the promoter sequences with the respective human and murine genes reveals short stretches of homology, which encompass potential binding sites for AP-1, NF kappa B, and Spl transcription factors. Using DNase I footprinting, we detect binding of nuclear factors to these promoter elements. Transfection experiments demonstrate that a 300-base pair fragment containing the conserved elements can mediate induced transcription and that the NF kappa B-like element is essential, In accordance, electrophoretic mobility shift assays show a strong increase in the binding of factors to the NF kappa B-like site following induction. We further provide evidence that RelA (p65), c-Rel, and possibly novel polypeptides bind to the tissue factor NF kappa B element, In addition, we show constitutive binding of members of the Fos/Jun and Spl families to the AP-1 and Spl sites, respectively, We propose a concerted action of AP-1-, NF kappa B-, and Spl-like factors in transcription from the tissue factor promoter in endothelial cells,	VIENNA INT RES COOPERAT CTR,DEPT TRANSPLANTAT IMMUNOL,A-1230 VIENNA,AUSTRIA; HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,SANDOZ CTR IMMUNOBIOL,BOSTON,MA 02215; BENDER & CO GESMBH,A-1121 VIENNA,AUSTRIA	Harvard University; Harvard Medical School; Novartis; Sandoz			Wagner, Ernst/ABB-5976-2020; Czyz, Malgorzata/AAD-1869-2020; Wagner, Ernst/A-7435-2012	Wagner, Ernst/0000-0001-8413-0934; Czyz, Malgorzata/0000-0002-8279-4742; Wagner, Ernst/0000-0001-8413-0934				AHERN SM, 1993, J BIOL CHEM, V268, P2154; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Brenowitz M., 1989, CURRENT PROTOCOLS MO; CHENG Q, 1994, J BIOL CHEM, V269, P13551; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CLAUSS M, 1990, J BIOL CHEM, V265, P7078; COLLINS T, 1991, J BIOL CHEM, V266, P2466; CONWAY EM, 1989, THROMB RES, V53, P231, DOI 10.1016/0049-3848(89)90098-4; COTTEN M, 1992, P NATL ACAD SCI USA, V89, P6094, DOI 10.1073/pnas.89.13.6094; COTTEN M, 1993, METHOD ENZYMOL, V217, P618; CROSS SL, 1989, SCIENCE, V244, P466, DOI 10.1126/science.2497520; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; CROSSMAN DC, 1990, ENDOTHELIUM INTRO CU, P119; DEMARTIN R, 1993, GENE, V124, P137, DOI 10.1016/0378-1119(93)90776-Y; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONOVANPELUSO M, 1994, J BIOL CHEM, V269, P1361; DRAKE TA, 1989, AM J PATHOL, V134, P1087; EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GREGORY SA, 1989, MOL CELL BIOL, V9, P2752, DOI 10.1128/MCB.9.6.2752; GRILLI M, 1993, INT REV CYTOL, V143, P1; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HOFER E, 1994, TRANSPLANT P, V26, P1322; IADEMARCO MF, 1993, P NATL ACAD SCI USA, V90, P3943, DOI 10.1073/pnas.90.9.3943; ISHII H, 1992, BLOOD, V80, P2556; KADANOGA JT, 1986, P NATL ACAD SCI USA, V83, P5889; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; KAUFMAN PA, 1992, J CLIN INVEST, V90, P121, DOI 10.1172/JCI115824; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LANDO PA, 1986, J IMMUNOL METHODS, V89, P131, DOI 10.1016/0022-1759(86)90041-4; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; MACKMAN N, 1992, ARTERIOSCLER THROMB, V12, P474, DOI 10.1161/01.ATV.12.4.474; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; NEMERSON Y, 1988, BLOOD, V71, P1; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Sambrook J, 1989, MOL CLONING LABORATO; SCARPATI EM, 1989, J BIOL CHEM, V264, P20705; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; VANHUIJSDUIJNEN RH, 1992, J BIOL CHEM, V267, P22385; WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099, DOI 10.1073/pnas.89.13.6099; WARREN JB, 1990, ENDOTHELIUM INTRO CU, P263; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839	56	140	141	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3849	3857		10.1074/jbc.270.8.3849	http://dx.doi.org/10.1074/jbc.270.8.3849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876129				2022-12-27	WOS:A1995QH68800059
J	VITA, N; LEFORT, S; LAURENT, P; CAPUT, D; FERRARA, P				VITA, N; LEFORT, S; LAURENT, P; CAPUT, D; FERRARA, P			CHARACTERIZATION AND COMPARISON OF THE INTERLEUKIN-13 RECEPTOR WITH THE INTERLEUKIN-4 RECEPTOR ON SEVERAL CELL-TYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; HIGH-AFFINITY; HUMAN-MONOCYTES; IGE SYNTHESIS; GAMMA-CHAIN; B-CELLS; IL-4; EXPRESSION; COMPONENT; BINDING	We describe here the characterization of the interleukin (IL) 13 receptor and a comparison with the IL-4 receptor on different cell types. Several, but not all, of the IL-4 receptor-positive cells showed specific IL-13 binding, which was always completely displaced by IL-4. In the IL-13 receptor-positive cells, the IL-13 either completely or partially displaced the labeled IL-4. Further characterization of the IL-13 receptor in two cell Lines, COS-3 and A431, representative of the groups of complete and partial displacement of IL-4 by IL-13, respectively, showed that the IL-13 binds with high affinity (K-d approximate to 300 pM) to both cells and that the number of binding sites is, in COS-3 cells, equivalent to that for IL-4 and, in A431 cells, is smaller than that for IL-4. Cross-linking of labeled IL-13 yielded, on COS-3 cells, two affinity-labeled complexes of 220 and 70 kDa, and on A431 cells, one complex of 70 kDa; labeled IL-4 yielded on both cells the same pattern of three complexes of 220, 145, and 70 kDa. Altogether, these results suggest that the IL-13 receptor may be constituted by a subset of the IL-4 receptor complex associated with at least one additional protein.	SANOFI RECH,F-31676 LABEGE,FRANCE	Sanofi-Aventis; Sanofi France								AARDEN LA, 1987, EUR J IMMUNOL, V17, P1411, DOI 10.1002/eji.1830171004; AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; CABRILLAT H, 1987, BIOCHEM BIOPH RES CO, V149, P995, DOI 10.1016/0006-291X(87)90507-9; CALVO JC, 1983, BIOCHEM J, V212, P259, DOI 10.1042/bj2120259; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; DEROCQ JM, 1994, FEBS LETT, V343, P32, DOI 10.1016/0014-5793(94)80601-2; DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630; FANSLOW WC, 1993, BLOOD, V81, P2998; FERRARA P, 1987, FEBS LETT, V226, P47, DOI 10.1016/0014-5793(87)80548-3; GALIZZI JP, 1990, J BIOL CHEM, V265, P439; GALIZZI JP, 1990, INT IMMUNOL, V2, P669, DOI 10.1093/intimm/2.7.669; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HERBERT JM, 1993, FEBS LETT, V328, P268, DOI 10.1016/0014-5793(93)80941-M; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; JACOBSEN SEW, 1994, IN PRESS J EXP MED; KEEGAN AD, 1991, J IMMUNOL, V16, P2272; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRUSE N, 1992, EMBO J, V11, P3237, DOI 10.1002/j.1460-2075.1992.tb05401.x; KRUSE N, 1993, EMBO J, V12, P5121, DOI 10.1002/j.1460-2075.1993.tb06207.x; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MINTY A, 1993, EUR CYTOKINE NETW, V4, P99; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; MONTANER LJ, 1993, J EXP MED, V178, P743, DOI 10.1084/jem.178.2.743; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUZIO M, 1994, BLOOD, V83, P1738, DOI 10.1182/blood.V83.7.1738.bloodjournal8371738; PARK LS, 1987, J EXP MED, V166, P476, DOI 10.1084/jem.166.2.476; PAUL WE, 1991, BLOOD, V77, P1859; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Roth J, 1975, Methods Enzymol, V37, P223; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; VITA N, 1993, EUR CYTOKINE NETW, V4, P197; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	37	93	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3512	3517		10.1074/jbc.270.8.3512	http://dx.doi.org/10.1074/jbc.270.8.3512			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876085				2022-12-27	WOS:A1995QH68800012
J	KOZAROV, E; VANDERWEL, H; FIELD, M; GRITZALI, M; BROWN, RD; WEST, CM				KOZAROV, E; VANDERWEL, H; FIELD, M; GRITZALI, M; BROWN, RD; WEST, CM			CHARACTERIZATION OF FP21, A CYTOSOLIC GLYCOPROTEIN FROM DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; DISCOIDEUM; PROTEINS; ACID; GLYCOSYLATION; SEQUENCES; MEMBRANES; NUCLEUS; BINDING; PEPTIDE	FP21 is a glycoprotein which, when tracked by radio-activity in its fucosyl moiety, was previously detected in the cytosol, of Dictyostelium cells after cell fractionation. This compartmentalization is confirmed by SDS-polyacrylamide gel electrophoresis/Western blotting of cell fractions using three different antibodies. Although a substantial fraction of FP21 is also detected in the particulate fraction using these new antibodies, particulate FP21 is released by disrupting protein-protein interactions, but not membrane disruption. Since purified FP21 is susceptible to aggregation, and purified nuclei do not contain FP21, particulate FP21 is also part of the cytosol. Additional compositional and structural information provides strong evidence that FP21 does not at any time traverse the rough endoplasmic reticulum. First, cDNAs spanning the entire coding region of the FP21 gene predict no hydrophobic motifs expected to promote membrane insertion, but do predict an NH2-terminal coiled coil domain which could explain aggregation. Second, monosaccharide composition analysis of the predominant glycoform of FP21 yields 2 mol of galactose, 1 mol of xylose, and 1 mol of fucose/mol of polypep tide; FP21 from a fucosylation-defective mutant contains 1 additional mol of xylose in place of fucose. Thus the N-glycosylation sequon present in FP21 is not utilized by oligosaccharyl transferase, which resides in the rough endoplasmic reticulum. These findings indicate that nascent FP21 remains in the cytosol after synthesis and is therefore glycosylated by unusual cytosolic xylosyl-, galactosyl-, and fucosyltransferases.	UNIV FLORIDA,COLL MED,DEPT ANAT & CELL BIOL,GAINESVILLE,FL 32610; UNIV FLORIDA,INST FOOD & AGR SCI,DEPT FOOD SCI & HUMAN NUTR,GAINESVILLE,FL 32610	State University System of Florida; University of Florida; State University System of Florida; University of Florida					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER; NHLBI NIH HHS [2-T35-HL07489] Funding Source: Medline; NIGMS NIH HHS [R01-GM37539] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; AUSEBEL FM, 1992, CURRENT PROTOCOLS MO; BERLOT C, 1987, METHOD CELL BIOL, V28, P333; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; ELWOOD PC, 1988, ANAL BIOCHEM, V175, P202, DOI 10.1016/0003-2697(88)90379-X; FECHHEIMER M, 1984, J BIOL CHEM, V259, P4514; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GONZALEZYANES B, 1992, J BIOL CHEM, V267, P9595; GONZALEZYANES B, 1989, DEV BIOL, V133, P576, DOI 10.1016/0012-1606(89)90060-2; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Harlow E, 1988, ANTIBODIES LAB MANUA; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; JAHNEN W, 1990, BIOCHEM BIOPH RES CO, V166, P139, DOI 10.1016/0006-291X(90)91922-F; JOZIASSE DH, 1992, GLYCOBIOLOGY, V2, P271, DOI 10.1093/glycob/2.4.271; LOMAKO J, 1988, FASEB J, V2, P3097, DOI 10.1096/fasebj.2.15.2973423; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACLEAN N, 1984, EXPERIENTIA, V40, P1207, DOI 10.1007/BF01946648; MARCHASE RB, 1993, J BIOL CHEM, V268, P8341; MCROBBIE SJ, 1983, BIOCHEM BIOPH RES CO, V115, P351, DOI 10.1016/0006-291X(83)91011-2; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; PLOUG M, 1989, ANAL BIOCHEM, V181, P33, DOI 10.1016/0003-2697(89)90390-4; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sambrook J, 1989, MOL CLONING LABORATO; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schachter H, 1992, GLYCOCONJUGATES COMP, P263; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHAPER JH, 1992, CURR OPIN STRUC BIOL, V2, P701; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEEL LF, 1991, DEV GENET, V12, P98, DOI 10.1002/dvg.1020120117; STEINBUCH M, 1969, ARCH BIOCHEM BIOPHYS, V134, P279, DOI 10.1016/0003-9861(69)90285-9; SUTTON GW, 1993, TECHNIQUES PROTEIN C, V4, P109; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WARRICK HM, 1988, NUCLEIC ACIDS RES, V16, P6617, DOI 10.1093/nar/16.14.6617; WEITZHANDLER M, 1993, J BIOL CHEM, V268, P5121	38	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3022	3030		10.1074/jbc.270.7.3022	http://dx.doi.org/10.1074/jbc.270.7.3022			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852383				2022-12-27	WOS:A1995QG47100023
J	BUSE, P; WOO, PL; ALEXANDER, DB; CHA, HH; REZA, A; SIROTA, ND; FIRESTONE, GL				BUSE, P; WOO, PL; ALEXANDER, DB; CHA, HH; REZA, A; SIROTA, ND; FIRESTONE, GL			TRANSFORMING GROWTH-FACTOR-ALPHA ABROGATES GLUCOCORTICOID-STIMULATED TIGHT JUNCTION FORMATION AND GROWTH SUPPRESSION IN RAT MAMMARY EPITHELIAL TUMOR-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; PROTEIN-KINASE-C; TGF-ALPHA; GENE-EXPRESSION; DOWN-REGULATION; INVITRO; COMMUNICATION; ESTROGEN; DIFFERENTIATION; OVEREXPRESSION	The glucocorticoid and transforming growth factor-alpha (TGF-alpha) regulation of growth and cell-cell contact was investigated in the Con8 mammary epithelial tumor cell line derived from a 7,12-dimethylbenz(alpha)anthracene-induced rat mammary adenocarcinoma. In Con8 cell monolayers cultured on permeable filter supports, the synthetic glucocorticoid, dexamethasone, coordinately suppressed [H-3]thymidine incorporation, stimulated monolayer transepithelial electrical resistance (TER), and decreased the paracellular leakage of [H-3]inulin or [C-14]mannitol across the monolayer. These processes dose dependently correlated with glucocorticoid receptor occupancy and function. Constitutive production of TGF-alpha in transfected cells or exogenous treatment with TGF-alpha prevented the glucocorticoid growth suppression response and disrupted tight junction formation without affecting glucocorticoid responsiveness. Treatment with hydroxyurea or araC demonstrated that de novo DNA synthesis is not a requirement for the growth factor disruption of tight junctions. Immunofluorescence analysis revealed that the ZO-1 tight junction protein is localized exclusively at the cell periphery in dexamethasone treated cells and that TGF-alpha caused ZO-1 to relocalize from the cell periphery back to a cytoplasmic compartment. Taken together, our results demonstrate that glucocorticoids can coordinately regulate growth inhibition and cell-cell contact of mammary tumor cells and that TGF-alpha, can override both effects of glucocorticoids. These results have uncovered a novel functional ''cross-talk'' between glucocorticoids and TGF-alpha which potentially regulates the proliferation and differentiation of mammary epithelial cells.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NIDDK NIH HHS [DK-42799] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042799, R01DK042799] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER DB, 1993, CANCER RES, V53, P1808; ARTEAGA CL, 1988, MOL ENDOCRINOL, V2, P1064, DOI 10.1210/mend-2-11-1064; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUNER T, 1990, INVAS METAST, V10, P31; BRAUNER T, 1990, INVAS METAST, V10, P18; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CIARDIELLO F, 1990, CELL GROWTH DIFFER, V1, P407; CIARDIELLO F, 1991, ANN ONCOL, V2, P169; CITI S, 1993, J CELL BIOL, V121, P485, DOI 10.1083/jcb.121.3.485; CITI S, 1992, J CELL BIOL, V117, P169, DOI 10.1083/jcb.117.1.169; CLARKE R, 1989, MOL ENDOCRINOL, V3, P372, DOI 10.1210/mend-3-2-372; Dembinski T. C., 1987, The mammary gland. Development, regulation, and function., P355; DENEKAMP J, 1993, BRIT J RADIOL, V66, P181, DOI 10.1259/0007-1285-66-783-181; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DICKSON RB, 1987, ENDOCR REV, V8, P29, DOI 10.1210/edrv-8-1-29; ELLIS B, 1992, AM J PHYSIOL, V263, pF293, DOI 10.1152/ajprenal.1992.263.2.F293; FULLER PJ, 1991, FASEB J, V5, P3092, DOI 10.1096/fasebj.5.15.1743440; GOYA L, 1993, CANCER RES, V53, P1816; GOYA L, 1993, MOL ENDOCRINOL, V7, P1121, DOI 10.1210/me.7.9.1121; GRONEMEYER H, 1992, FASEB J, V6, P2524, DOI 10.1096/fasebj.6.8.1592204; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Haslam S. Z., 1987, The mammary gland. Development, regulation, and function., P499; IMAGAWA W, 1990, ENDOCR REV, V11, P494, DOI 10.1210/edrv-11-4-494; JANECKI A, 1991, MOL CELL ENDOCRINOL, V82, P61, DOI 10.1016/0303-7207(91)90009-H; Jones JCR, 1991, CURR OPIN CELL BIOL, V3, P127, DOI 10.1016/0955-0674(91)90175-X; KLIJN JGM, 1992, ENDOCR REV, V13, P3, DOI 10.1210/er.13.1.3; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; LIPPMAN ME, 1989, RECENT PROG HORM RES, V45, P383; LIU SC, 1987, MOL ENDOCRINOL, V1, P683, DOI 10.1210/mend-1-10-683; MADARA JL, 1993, AM J PHYSIOL, V264, pC1096, DOI 10.1152/ajpcell.1993.264.5.C1096; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; MCDONAGH D, 1991, MODERN PATHOL, V4, P436; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; MURRAY PA, 1993, BRIT J CANCER, V67, P1408, DOI 10.1038/bjc.1993.261; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NIGAM SK, 1992, P NATL ACAD SCI USA, V89, P6162, DOI 10.1073/pnas.89.13.6162; NOGUCHI S, 1993, CANCER, V72, P131, DOI 10.1002/1097-0142(19930701)72:1<131::AID-CNCR2820720125>3.0.CO;2-Z; OKA T, 1974, J BIOL CHEM, V249, P3586; PAWSON T, 1993, PHILOS T R SOC B, V340, P279, DOI 10.1098/rstb.1993.0069; Pitelka D. R., 1978, Anderson, R. R. : Lactation. A comprehensive treatise. Vol. IV., P41; REN J, 1990, CANCER RES, V50, P358; RIUS C, 1992, J CELL SCI, V101, P395; SALOMON DS, 1992, CURRENT PERSPECTIV B, V1, P211; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; SCHOENENBERGER CA, 1991, J CELL BIOL, V112, P873, DOI 10.1083/jcb.112.5.873; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; Segaloff A, 1966, Recent Prog Horm Res, V22, P351; SINGER KL, 1994, J BIOL CHEM, V269, P16108; SNEDEKER SM, 1991, P NATL ACAD SCI USA, V88, P276, DOI 10.1073/pnas.88.1.276; TOMITA K, 1979, CANCER RES, V39, P4407; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; TSUKITA S, 1993, J CELL BIOL, V123, P1049, DOI 10.1083/jcb.123.5.1049; VONDERHAAR BK, 1988, CANCER TREAT RES, V40, P252; WAHLI W, 1991, FASEB J, V5, P2243, DOI 10.1096/fasebj.5.9.1860615; WEBSTER MK, 1990, J BIOL CHEM, V265, P4831; WEBSTER MK, 1991, CANCER RES, V51, P6031; WELSCH CW, 1985, CANCER RES, V45, P3415; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; ZETTL KS, 1992, P NATL ACAD SCI USA, V89, P9069, DOI 10.1073/pnas.89.19.9069	64	54	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6505	6514		10.1074/jbc.270.12.6505	http://dx.doi.org/10.1074/jbc.270.12.6505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896785	hybrid			2022-12-27	WOS:A1995QQ85500015
J	YAKOVLEV, AG; KRUEGER, KE; FADEN, AI				YAKOVLEV, AG; KRUEGER, KE; FADEN, AI			STRUCTURE AND EXPRESSION OF A RAT KAPPA-OPIOID RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOLECULAR-CLONING; DELTA; BRAIN; MU; PEPTIDES; BINDING; MOUSE	A gene encoding the rat kappa opioid receptor (KOR) was cloned and characterized. Results of rat genomic library screening and genomic Southern blot analysis show the gene represented at one copy/haploid genome. Three introns are present within the gene; however, polymerase chain reaction using different sets of primers specifying neighboring exons indicates that alternative splicing does not occur. Using reverse transcription polymerase chain reaction and primer extension techniques, we are able to demonstrate that two species of transcripts are differentially produced from the KOR gene in a tissue specific manner. The first transcript that we designate as KOR1 is equivalent to the cDNA sequence reported by other groups and is believed to correspond to KOR subtype 1. KOR1 beans with exon 1 just downstream of two TATA boxes, whereas the second transcript, which we refer to as KORx, begins in intron I and thereby retains this intronic sequence in the mature mRNA. Within this intronic sequence there are two potential translation initiation codons that are in-frame with the proposed initiation codon of KOR. The potential open reading frame that starts further upstream in KORx may lead to the translation of a variant KOR protein having a novel peptide sequence at its amino terminus.	GEORGETOWN UNIV,MED CTR,DEPT NEUROL,WASHINGTON,DC 20007; GEORGETOWN UNIV,MED CTR,DEPT PHARMACOL,WASHINGTON,DC 20007; GEORGETOWN UNIV,MED CTR,DEPT CELL BIOL,WASHINGTON,DC 20007	Georgetown University; Georgetown University; Georgetown University					PHS HHS [R49/CCR 306634] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BLOOM FE, 1983, ANNU REV PHARMACOL, V23, P151, DOI 10.1146/annurev.pa.23.040183.001055; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; CHEN Y, 1993, BIOCHEM J, V295, P625, DOI 10.1042/bj2950625; CHENG J, 1992, EUR J PHARM-MOLEC PH, V226, P15, DOI 10.1016/0922-4106(92)90077-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EIDNE KA, 1989, NATURE, V342, P865, DOI 10.1038/342865a0; FADEN AI, 1993, HDB EXPT PHARM, P325; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LI SX, 1993, BIOCHEM J, V295, P629, DOI 10.1042/bj2950629; MACK KJ, 1984, LIFE SCI, V34, P281, DOI 10.1016/0024-3205(84)90600-3; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; MENG F, 1993, P NATL ACAD SCI USA, V90, P9954, DOI 10.1073/pnas.90.21.9954; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; MINAMI M, 1993, FEBS LETT, V329, P291, DOI 10.1016/0014-5793(93)80240-U; NISHI M, 1993, FEBS LETT, V330, P770; REISINE T, 1993, TRENDS NEUROSCI, V16, P506, DOI 10.1016/0166-2236(93)90194-Q; Sambrook J, 1989, MOL CLONING LABORATO; SIMON EJ, 1991, MED RES REV, V11, P357, DOI 10.1002/med.2610110402; SPAIN JW, 1985, J NEUROSCI, V5, P584; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736; ZAITSEV IZ, 1983, B EXP BIOL MED, V10, P84; ZUKIN RS, 1988, P NATL ACAD SCI USA, V85, P4061, DOI 10.1073/pnas.85.11.4061	22	26	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6421	6424		10.1074/jbc.270.12.6421	http://dx.doi.org/10.1074/jbc.270.12.6421			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896774	hybrid			2022-12-27	WOS:A1995QQ85500001
J	HOOPER, LV; BERANEK, MC; MANZELLA, SM; BAENZIGER, JU				HOOPER, LV; BERANEK, MC; MANZELLA, SM; BAENZIGER, JU			DIFFERENTIAL EXPRESSION OF GALNAC-4-SULFOTRANSFERASE AND GALNAC-TRANSFERASE RESULTS IN DISTINCT GLYCOFORMS OF CARBONIC-ANHYDRASE-VI IN PAROTID AND SUBMAXILLARY-GLANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PITUITARY GLYCOPROTEIN HORMONES; N-ACETYLGALACTOSAMINE-TRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; ACETYL-D-GALACTOSAMINE; STRUCTURAL ELUCIDATION; CARBOHYDRATE CHAINS; SUGAR CHAINS; SIALYLATED OLIGOSACCHARIDES; LUTROPIN OLIGOSACCHARIDES	Differential expression of glycosyltransferases has the potential to generate functionally distinct glycoforms of otherwise identical proteins. We have previously demonstrated the presence of unique oligosaccharides terminating with GalNAc-4-SO4 on the pituitary glycoproteins lutropin (LH), thyroid stimulating hor mone (TSH), and pro-opiomelanocortin (POMC). A glycoprotein hormone:GalNAc-transferase and a GalNAc-4-sulfotransferase are present in the pituitary and can account for the synthesis of these unique oligosaccharides on specific glycoproteins. Both transferases are coordinately expressed in a number of tissues in addition to pituitary, including submaxillary gland, lacrimal gland, and kidney, suggesting that additional glycoproteins bearing oligosaccharides terminating with GalNAc-4-SO4 are synthesized in these tissues. In this study we show that while the glycoprotein hormone:GalNAc-transferase and the GaLNAc-4-sulfotransferase are coordinately expressed in bovine submaxillary gland, the GalNAc-transferase is expressed in the parotid gland in the absence of the GalNAc-4-sulfotransferase. The relative expression of these two transferases in submaxillary and parotid glands correlates with the presence of unique Asn-linked oligosaccharides on carbonic anhydrase VI (CA VI) synthesized in each of these tissues. The majority of Asn-linked oligosaccharides on CA VI synthesized in submaxillary gland terminate with GalNAc-4-SO,, In contrast, CA VI which is synthesized in bovine parotid gland bears oligosaccharides which terminate predominantly with beta 1,4-linked GalNAc which is not sulfated. The presence of different terminal residues on the Asn-linked oligosaccharides of submaxillary and parotid CA VI thus correlates with the complement of transferases in these glands and suggests differing biological roles for submaxillary and parotid CA VI.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Washington University (WUSTL)			Baenziger, Jacques U/E-9430-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41738] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALDRED P, 1991, BIOCHEMISTRY-US, V30, P569, DOI 10.1021/bi00216a035; ANSON DS, 1993, BIOCHEM J, V294, P657, DOI 10.1042/bj2940657; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1994, METHOD ENZYMOL, V230, P237; BAENZIGER JU, 1993, GUIDE TECHNIQUES GLY, P237; BAENZIGER JU, 1991, BIOL CARBOHYDRATES, V3, P1; BERGWERFF AA, 1992, FEBS LETT, V314, P389, DOI 10.1016/0014-5793(92)81512-K; CHAN A L, 1991, Glycobiology, V1, P173, DOI 10.1093/glycob/1.2.173; CODDEVILLE B, 1992, CARBOHYD RES, V236, P145, DOI 10.1016/0008-6215(92)85013-P; COLBURN P, 1988, IN VITRO CELL DEV B, V24, P1133; DHARMESH SM, 1993, P NATL ACAD SCI USA, V90, P11127, DOI 10.1073/pnas.90.23.11127; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; FELDSTEIN JB, 1984, J BIOL CHEM, V259, P5447; FERNLEY RT, 1989, BIOCHEM J, V259, P91, DOI 10.1042/bj2590091; FERNLEY RT, 1988, BIOCHEMISTRY-US, V27, P2815, DOI 10.1021/bi00408a023; FERNLEY RT, 1988, BIOCHEM J, V249, P201, DOI 10.1042/bj2490201; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; FREEZE HH, 1986, J BIOL CHEM, V261, P127; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1985, J BIOL CHEM, V260, P5631; GREEN ED, 1985, P NATL ACAD SCI USA, V82, P7850, DOI 10.1073/pnas.82.23.7850; GREEN ED, 1984, P NATL ACAD SCI-BIOL, V81, P5320, DOI 10.1073/pnas.81.17.5320; GREEN ED, 1986, ANAL BIOCHEM, V158, P42, DOI 10.1016/0003-2697(86)90585-3; GREEN ED, 1986, MOL CELL BIOCHEM, V72, P81; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HARTREE AS, 1992, BIOCHEM J, V287, P665, DOI 10.1042/bj2870665; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; LITJENS T, 1991, BIOCHEM INT, V24, P209; MELLIS SJ, 1983, ANAL BIOCHEM, V134, P442, DOI 10.1016/0003-2697(83)90320-2; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; MENGELING BJ, 1995, J NATL ACAD SCI US, V92, P502; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; NAKATA N, 1993, BIOCHEMISTRY-US, V32, P4369, DOI 10.1021/bi00067a029; NEMANSKY M, 1992, BIOCHEM J, V287, P311, DOI 10.1042/bj2870311; NYAME K, 1989, J BIOL CHEM, V264, P3235; OGAWA Y, 1992, J HISTOCHEM CYTOCHEM, V40, P807, DOI 10.1177/40.6.1588027; PARKKILA S, 1990, J HISTOCHEM CYTOCHEM, V38, P941, DOI 10.1177/38.7.2113069; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; ROUX L, 1988, J BIOL CHEM, V263, P8879; SATO T, 1993, J BIOCHEM-TOKYO, V114, P890, DOI 10.1093/oxfordjournals.jbchem.a124273; SICILIANO RA, 1993, GLYCOBIOLOGY, V3, P225, DOI 10.1093/glycob/3.3.225; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1991, J BIOL CHEM, V266, P17142; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, J BIOL CHEM, V267, P19140; SMITH PL, 1993, J BIOL CHEM, V268, P795; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; SPIRO RG, 1988, J BIOL CHEM, V263, P14351; SRIVASTAVA V, 1989, CARBOHYD RES, V185, P163, DOI 10.1016/0008-6215(89)84031-5; SRIVATSAN J, 1992, GLYCOBIOLOGY, V2, P445, DOI 10.1093/glycob/2.5.445; SUNDARAM V, 1986, AM J HUM GENET, V38, P125; TABAK LA, 1982, J ORAL PATHOL MED, V11, P1, DOI 10.1111/j.1600-0714.1982.tb00138.x; TANAKA N, 1992, J BIOCHEM-TOKYO, V112, P68, DOI 10.1093/oxfordjournals.jbchem.a123867; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TOMIYA N, 1993, J BIOL CHEM, V268, P113; VANDANA HO, 1987, CAN J CHEM, V65, P1645; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VEROSTEK MF, 1993, J BIOL CHEM, V268, P12095; WARNCRAMER BJ, 1991, THROMB RES, V61, P215; YAMASHITA K, 1983, J BIOL CHEM, V258, P4144; YAN SB, 1993, GLYCOBIOLOGY, V3, P597, DOI 10.1093/glycob/3.6.597	67	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5985	5993		10.1074/jbc.270.11.5985	http://dx.doi.org/10.1074/jbc.270.11.5985			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890728	hybrid			2022-12-27	WOS:A1995QM94500043
J	JIA, ZC; HASNAIN, S; HIRAMA, T; LEE, X; MORT, JS; TO, R; HUBER, CP				JIA, ZC; HASNAIN, S; HIRAMA, T; LEE, X; MORT, JS; TO, R; HUBER, CP			CRYSTAL-STRUCTURES OF RECOMBINANT RAT CATHEPSIN-B AND A CATHEPSIN B-INHIBITOR COMPLEX - IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STABILIZATION; PAPAIN; BINDING; SPECIFICITY; RESOLUTION; POTENT; REFINEMENT; REACTIVITY; FORM	The lysosomal cysteine proteinase cathepsin B (EC 3.4.22.1) plays an important role in protein catabolism and has also been implicated in various disease states. The crystal structures of two forms of native recombinant rat cathepsin B have been determined. The overall folding of rat cathepsin B was shown to be very similar to that of the human liver enzyme. The structure of the native enzyme containing an underivatized active site cysteine (Cys(29)) showed the active enzyme conformation to be similar to that determined previously for the oxidized form. In a second structure Cys(29) was derivatized with the reversible blocking reagent pyridyl disulfide. In this structure large side chain conformational changes were observed for the two key catalytic residues Cys(29) and His(199), demonstrating the potential flexibility of these side chains. In addition the structure of the complex between rat cathepsin B and the inhibitor benzyloxycarbonyl-Arg-Ser(O-Bzl) chloromethylketone was determined. The complex structure showed that very little conformational change occurs in the enzyme upon inhibitor binding. It also allowed visualization of the interaction between the enzyme and inhibitor, In particular the interaction between Glu(245) and the P-2 Arg residue was clearly demonstrated, and it was found that the benzyl group of the P-1 substrate residue occupies a large hydrophobic pocket thought to represent the S'(1) subsite, This may have important implications for structure-based design of cathepsin B inhibitors.	NATL RES COUNCIL CANADA, INST BIOL SCI, BIOTECHNOL RES INST, OTTAWA, ON K1A 0R6, CANADA; NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, MONTREAL, PQ H4P 2R2, CANADA; MCGILL UNIV, SHRINERS HOSP CRIPPLED CHILDREN, JOINT DIS LAB, MONTREAL, PQ H3G 1A6, CANADA; MCGILL UNIV, DEPT SURG, MONTREAL, PQ H3G 1A6, CANADA	National Research Council Canada; National Research Council Canada; McGill University; McGill University								BAKER EN, 1980, J MOL BIOL, V141, P441, DOI 10.1016/0022-2836(80)90255-7; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1992, X PLOR VERSION 3 0 M; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; BUTTLE DJ, 1993, ARTHRITIS RHEUM, V36, P1709, DOI 10.1002/art.1780361210; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; ESSER RE, 1994, ARTHRITIS RHEUM, V37, P236, DOI 10.1002/art.1780370213; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; FUJINAGA M, 1987, J APPL CRYSTALLOGR, V20, P517, DOI 10.1107/S0021889887086102; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; HASNAIN S, 1993, J BIOL CHEM, V268, P235; HEINEMANN U, 1982, J MOL BIOL, V161, P591, DOI 10.1016/0022-2836(82)90410-7; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KATUNUMA N, 1987, REV PHYSIOL BIOCH P, V108, P1, DOI 10.1007/BFb0034070; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOWLESSUR D, 1989, BIOCHEM J, V258, P755, DOI 10.1042/bj2580755; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LEE X, 1990, J BIOL CHEM, V265, P5950; MATSUMOTO K, 1989, FEBS LETT, V245, P177, DOI 10.1016/0014-5793(89)80216-9; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; PICKERSGILL RW, 1991, ACTA CRYSTALLOGR B, V47, P766, DOI 10.1107/S0108768191003191; RICH DH, 1986, BIOCHEM J, V235, P731, DOI 10.1042/bj2350731; ROWAN AD, 1993, BIOCHEM J, V294, P923, DOI 10.1042/bj2940923; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; SEGUNDO BS, 1985, P NATL ACAD SCI USA, V82, P2320, DOI 10.1073/pnas.82.8.2320; SHAW E, 1983, ARCH BIOCHEM BIOPHYS, V222, P424, DOI 10.1016/0003-9861(83)90540-4; SHIPTON M, 1978, BIOCHEM J, V171, P385, DOI 10.1042/bj1710385; Sloane B F, 1990, Semin Cancer Biol, V1, P137; SMITH RA, 1988, BIOCHEM BIOPH RES CO, V155, P1201, DOI 10.1016/S0006-291X(88)81267-1; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; WANG J, 1994, PROTEIN ENG, V7, P75, DOI 10.1093/protein/7.1.75; 1979, SUITE PROGRAMS PROTE; 1993, RELEASE 3 3 REFERENC	40	111	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5527	5533		10.1074/jbc.270.10.5527	http://dx.doi.org/10.1074/jbc.270.10.5527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890671	hybrid			2022-12-27	WOS:A1995QL58000087
J	ALNEMRI, ES; FERNANDESALNEMRI, T; LITWACK, G				ALNEMRI, ES; FERNANDESALNEMRI, T; LITWACK, G			CLONING AND EXPRESSION OF 4 NOVEL ISOFORMS OF HUMAN INTERLEUKIN-1-BETA CONVERTING-ENZYME WITH DIFFERENT APOPTOTIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH GENE CED-3; CELL-DEATH; PROTEASE; ENCODES	To understand the mechanism of interleukin-1 beta converting enzyme (ICE) activation in apoptosis, we analyzed the expression of ICE mRNA in two human cell lines by reverse transcription-polymerase chain reaction technique. This resulted in the identification and cloning of four alternatively spliced ICE mRNA isoforms. Although all the alternative splicing events were within the coding sequence of ICE, the four ICE isoforms maintained open reading frames and were designated as ICE beta, gamma, delta and epsilon. In ICE gamma, most of the propeptide (amino acids 20-112) is deleted, which suggests that it may function as a catalyst for ICE autoprocessing in vivo. In ICE delta, amino acids 288-335, which contain the cleavage sites between the p20 and p10 subunits of ICE, are deleted thus resulting in its inactivation. Intriguingly, in ICE epsilon amino acids 20-335, which encompass most of the propeptide and the p20 subunit, are deleted resulting in the formation of a molecule that is homologous to the p10 subunit. Examination of the ability of these four ICE isoforms to cause apoptosis revealed that only the parental ICE alpha and isoforms beta and gamma, but not isoforms delta and epsilon, can induce apoptosis when overexpressed in Sf9 insect cells. In addition, coexpression of the p20 and p10 but not the p20 and ICE epsilon in Sf9 cells results in apoptosis. Interestingly, expression of ICE epsilon and to a lesser degree ICE delta resulted in extension of the survival of baculovirus-infected cells in a manner similar to expression of BCL2. The ability of ICE epsilon to extend the survival of Sf9 cells suggests that baculovirus-induced apoptosis in these cells is mediated by an ICE-like protease. We show that ICE epsilon can bind to the p20 subunit of ICE and potentially may compete with the p10 subunit to form an inactive ICE complex. Therefore, by acting as a dominant inhibitor of ICE activity, ICE epsilon may regulate ICE activation in vivo.	THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107	Jefferson University	ALNEMRI, ES (corresponding author), THOMAS JEFFERSON UNIV,DEPT PHARMACOL,BLUEMLE LIFE SCI BLDG,233 S 10TH ST,PHILADELPHIA,PA 19107, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035035] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 35035-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; ALNEMRI ES, 1991, J BIOL CHEM, V266, P3925; BLACK RA, 1989, FEBS LETT, V247, P386, DOI 10.1016/0014-5793(89)81376-6; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CERRETTI DP, 1994, GENOMICS, V20, P468, DOI 10.1006/geno.1994.1202; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; FATH I, 1994, NATURE, V264, P971; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HOWARD AD, 1991, J IMMUNOL, V147, P2964; HUDIG D, 1993, CURR OPIN IMMUNOL, V5, P90, DOI 10.1016/0952-7915(93)90086-8; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	22	138	163	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4312	4317		10.1074/jbc.270.9.4312	http://dx.doi.org/10.1074/jbc.270.9.4312			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876192	hybrid			2022-12-27	WOS:A1995QK08400023
J	RUAN, YM; CHEN, C; CAO, YX; GAROFALO, RS				RUAN, YM; CHEN, C; CAO, YX; GAROFALO, RS			THE DROSOPHILA INSULIN-RECEPTOR CONTAINS A NOVEL CARBOXYL-TERMINAL EXTENSION LIKELY TO PLAY AN IMPORTANT ROLE IN SIGNAL-TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; JUXTAMEMBRANE REGION; BINDING-SPECIFICITY; LIGAND SPECIFICITY; PROMOTER REGION; GENE; SEQUENCE; PROTEIN; CELLS; CDNA	The nucleic acid and deduced amino acid sequence of the Drosophila insulin receptor homologue (dir) has been determined, The coding sequence of dir is contained within 10 exons spanning less than 8 kilobase pairs of genomic DNA. The deduced amino acid sequence of the dir encodes a protein of 2148 amino acids, larger than the human insulin receptor due to amino- and carboxyl-terminal extensions, The overall level of amino acid identity between the DIR and human insulin and insulin like growth factor-I receptors is 32.5 and 33.3%, respectively, Higher levels of identity are found in exon 2 (45 and 43%, respectively) and in the beta subunit (50 and 48%, respectively), and the positions of most cysteine residues in the ct subunit cysteine rich domain are conserved, A novel, 400-amino acid, carboxyl-terminal extension contains 9 tyrosine residues, four of which are present in YXXM or YXXL motifs, suggesting that they function as binding sites for SH2 domain-containing signaling proteins, The presence of multiple putative SH2 domain binding sites in the DIR represents a significant difference from its mammalian homologues and suggests that, unlike the human insulin and insulinlike growth factor-I receptors, the DIR forms stable complexes with signaling molecules as part of its signal transduction mechanism.	SUNY HLTH SCI CTR, DEPT ANAT & CELL BIOL, BROOKLYN, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center								ABBOTT AM, 1992, J BIOL CHEM, V267, P10759; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BACKER JM, 1991, BIOCHEMISTRY-US, V30, P6366, DOI 10.1021/bi00240a003; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BIRCHMEIER C, 1990, P NATL ACAD SCI USA, V87, P4799, DOI 10.1073/pnas.87.12.4799; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; COOKE DW, 1991, BIOCHEM BIOPH RES CO, V177, P1113, DOI 10.1016/0006-291X(91)90654-P; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; FEENER EP, 1993, J BIOL CHEM, V268, P11256; FERNANDEZALMONA.R, THESIS CORNELL U MED; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; MAMULA PW, 1992, DNA CELL BIOL, V11, P43, DOI 10.1089/dna.1992.11.43; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; NISHIDA Y, 1986, BIOCHEM BIOPH RES CO, V141, P474, DOI 10.1016/S0006-291X(86)80197-8; PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; PETRUZZELLI L, 1985, CANCER CELL, V3, P115; RAFAELOFF R, 1989, J BIOL CHEM, V264, P15900; Sambrook J, 1989, MOL CLONING LABORATO; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SHIER P, 1989, J BIOL CHEM, V264, P14605; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TEWARI DS, 1989, J BIOL CHEM, V264, P16238; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	45	81	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4236	4243		10.1074/jbc.270.9.4236	http://dx.doi.org/10.1074/jbc.270.9.4236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876183	hybrid			2022-12-27	WOS:A1995QK08400013
J	WILCOX, MD; DINGUS, J; BALCUEVA, EA; MCINTIRE, WE; MEHTA, ND; SCHEY, KL; ROBISHAW, JD; HILDEBRANDT, JD				WILCOX, MD; DINGUS, J; BALCUEVA, EA; MCINTIRE, WE; MEHTA, ND; SCHEY, KL; ROBISHAW, JD; HILDEBRANDT, JD			BOVINE BRAIN G(O) ISOFORMS HAVE DISTINCT GAMMA-SUBUNIT COMPOSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GUANINE-NUCLEOTIDE-BINDING; AMINO-ACID-SEQUENCE; G-PROTEINS; ALPHA-SUBUNIT; ADENYLATE-CYCLASE; BETA-GAMMA; 2 FORMS; SIGNAL TRANSDUCTION; MESSENGER-RNA; IDENTIFICATION	The gamma subunit composition of the major bovine brain G(O) and G(i) proteins (G(OA), G(OB), G(OC), G(i1), and G(i2)) was characterized using antibodies against specific gamma isoforms. Each of the purified Gr protein heterotrimers contained a heterogeneous population of gamma subunits, and the profiles of the gamma subunits found with G(i1), G(i2), and G, were similar. In contrast, each G(O) isoform had a distinct pattern of associated gamma subunits, These differences were surprising given that all three alpha(O) isoforms are thought to share a common amino-terminal sequence important for the binding of beta gamma dimers and that the alpha(CO) and alpha(OC) proteins may come from the same alpha(O1) mRNA. The free alpha(OA) and alpha(OC) subunits had unique elution behaviors during MonoQ chromatography, compatible with differences in their post-translational processing, These results indicate that both the alpha and gamma subunit compositions of heterotrimers define the structure of an intact G protein, Furthermore, the exact subunit composition of G protein heterotrimers may depend upon regulated expression of different subunit isoforms or upon cellular processing of alpha subunits.	MED UNIV S CAROLINA, DEPT PHARMACOL, CHARLESTON, SC 29464 USA; GEISINGER MED CLIN, WEIS CTR RES, DANVILLE, PA 17822 USA	Medical University of South Carolina; Geisinger Medical Center					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039867, R01GM039867] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37219] Funding Source: Medline; NIGMS NIH HHS [GM39867] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASANO T, 1992, J NEUROCHEM, V58, P2176, DOI 10.1111/j.1471-4159.1992.tb10961.x; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CARTY DJ, 1990, J BIOL CHEM, V265, P6268; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; DINGUS J, 1994, METHOD ENZYMOL, V237, P457; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; GIERSCHIK P, 1985, P NATL ACAD SCI USA, V82, P727, DOI 10.1073/pnas.82.3.727; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLDSMITH P, 1988, BIOCHEMISTRY-US, V27, P7085, DOI 10.1021/bi00418a062; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HILDEBRANDT JD, 1984, J BIOL CHEM, V259, P2039; HSU WH, 1990, J BIOL CHEM, V265, P11220; INANOBE A, 1990, FEBS LETT, V263, P369, DOI 10.1016/0014-5793(90)81416-L; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KOBAYASHI I, 1989, FEBS LETT, V257, P177, DOI 10.1016/0014-5793(89)81815-0; KOHNKEN RE, 1989, J BIOL CHEM, V264, P20688; KROLL SD, 1992, J BIOL CHEM, V267, P23183; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; MORISHITA R, 1992, EUR J BIOCHEM, V210, P1061, DOI 10.1111/j.1432-1033.1992.tb17512.x; MORISHITA R, 1994, FEBS LETT, V337, P23, DOI 10.1016/0014-5793(94)80622-5; MURTAGH JJ, 1991, MOL CELL BIOL, V11, P1146, DOI 10.1128/MCB.11.2.1146; MURTAGH JJ, 1994, NUCLEIC ACIDS RES, V22, P842, DOI 10.1093/nar/22.5.842; NEER EJ, 1988, J BIOL CHEM, V263, P8996; NEER EJ, 1984, J BIOL CHEM, V259, P4222; OVCHINNIKOV YA, 1987, FEBS LETT, V226, P91, DOI 10.1016/0014-5793(87)80557-4; PADRELL E, 1991, J BIOL CHEM, V266, P9771; PRICE SR, 1990, BIOCHEMISTRY-US, V29, P5069, DOI 10.1021/bi00473a011; RAHMATULLAH M, 1994, J BIOL CHEM, V269, P3574; RAHMATULLAH M, 1995, J BIOL CHEM, V270, P2946, DOI 10.1074/jbc.270.7.2946; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; ROBISHAW JD, 1993, ANAL BIOCHEM, V208, P283, DOI 10.1006/abio.1993.1047; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIBASAKI H, 1991, FEBS LETT, V285, P268, DOI 10.1016/0014-5793(91)80814-J; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPICHER K, 1991, BIOCHEM BIOPH RES CO, V175, P473, DOI 10.1016/0006-291X(91)91588-4; SPIEGEL AM, 1991, TRENDS BIOCHEM SCI, V16, P338, DOI 10.1016/0968-0004(91)90139-M; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUKAMOTO T, 1991, P NATL ACAD SCI USA, V88, P2974, DOI 10.1073/pnas.88.8.2974; UEDA N, 1994, J BIOL CHEM, V269, P4388; VANMEURS KP, 1987, P NATL ACAD SCI USA, V84, P3107, DOI 10.1073/pnas.84.10.3107; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	51	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4189	4192		10.1074/jbc.270.9.4189	http://dx.doi.org/10.1074/jbc.270.9.4189			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876173	hybrid			2022-12-27	WOS:A1995QK08400003
J	DURNER, J; BOGER, P				DURNER, J; BOGER, P			UBIQUITIN IN THE PROKARYOTE ANABAENA-VARIABILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; GEL-ELECTROPHORESIS; SYSTEM; CYANOBACTERIUM; CONJUGATION; CELLS; GENE; POLYPEPTIDE; EXPRESSION; CALMODULIN	The ubiquitin-dependent pathway for protein degradation has been found to play a major role in controlling protein turnover in the cell. Ubiquitin is one of the most conserved proteins yet identified, and up until now it has been thought to be present only in eukaryotes and archaebacteria. This is the first report on the detection and purification of ubiquitin from a eubacterium, the cyanobacterium Anabaena variabilis. The purification procedure included a heat denaturing step, fractionated ammonium sulfate precipitation, two gel filtration runs (Sephadex G-50 and Superose 12), and a final hydroxylapatite chromatography. Comparisons with bovine ubiquitin showed a high similarity with respect to antigenicity to anti-ubiquitin (bovine), molecular mass (M(r) = 6,000), isoelectric point (pi 6.5), and NH2-terminal sequence. The existence of ubiquitin in A. variabilis was confirmed by Southern hybridization. In in vitro experiments both cyanobacterial and bovine ubiquitin were covalently attached to several target proteins from A. variabilis, respectively. Data are presented which suggest ubiquitination of dinitrogenase reductase, the Fe-protein subunit of nitrogenase, Our findings imply that ubiquitination equivalent to the eukaryotic system is instrumental in this organism.	UNIV KONSTANZ,LEHRSTUHL PHYSIOL & BIOCHEM PFLANZEN,D-78434 CONSTANCE,GERMANY	University of Konstanz								ANDERSEN MW, 1981, FEBS LETT, V132, P210, DOI 10.1016/0014-5793(81)81162-3; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BOND U, 1988, J BIOL CHEM, V263, P2384; BORTHAKUR D, 1990, MOL GEN GENET, V221, P227, DOI 10.1007/BF00261725; BRASS S, 1994, APPL ENVIRON MICROB, V60, P2575, DOI 10.1128/AEM.60.7.2575-2583.1994; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1989, TRENDS BIOCHEM SCI, V14, P483, DOI 10.1016/0968-0004(89)90180-1; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; DURNER J, 1994, EUR J BIOCHEM, V220, P125, DOI 10.1111/j.1432-1033.1994.tb18606.x; ELHAI J, 1991, 6 INT S PHOT PROK AM, pB114; FERGUSON DL, 1990, PLANT PHYSIOL, V92, P740, DOI 10.1104/pp.92.3.740; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GALLON JR, 1992, NEW PHYTOL, V122, P571; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; GOMEN H, 1994, P NATL ACAD SCI USA, V91, P7648; HASELKORN R, 1978, ANNU REV PLANT PHYS, V29, P319, DOI 10.1146/annurev.pp.29.060178.001535; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILL DR, 1994, J BIOL CHEM, V269, P7726; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; KOK K, 1993, P NATL ACAD SCI USA, V90, P6071, DOI 10.1073/pnas.90.13.6071; MULLIGAN ME, 1994, J MOL BIOL, V235, P1162, DOI 10.1006/jmbi.1994.1070; MURRY MA, 1983, CAN J MICROBIOL, V29, P1286, DOI 10.1139/m83-201; ONEK LA, 1994, ARCH MICROBIOL, V161, P352, DOI 10.1007/s002030050066; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; PETTERSSON A, 1989, FEMS MICROBIOL LETT, V60, P95, DOI 10.1016/0378-1097(89)90084-0; POTTS M, 1993, J BIOL CHEM, V268, P7632; POTTS M, 1992, SCIENCE, V256, P1690, DOI 10.1126/science.256.5064.1690; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SHANKLIN J, 1987, P NATL ACAD SCI USA, V84, P359, DOI 10.1073/pnas.84.2.359; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VEIERSKOV B, 1991, PLANT PHYSIOL, V96, P4, DOI 10.1104/pp.96.1.4; VIERSTRA RD, 1987, PLANT PHYSIOL, V84, P332, DOI 10.1104/pp.84.2.332; VIERSTRA RD, 1985, J BIOL CHEM, V260, P2015; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; VIJAYKUMAR S, 1987, J MOL BIOL, V195, P531; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; WOLF S, 1993, FEBS LETT, V326, P42, DOI 10.1016/0014-5793(93)81757-Q; WONG S, 1993, MOL CELL BIOL, V13, P207, DOI 10.1128/MCB.13.1.207; XU MQ, 1990, SCIENCE, V250, P1566, DOI 10.1126/science.2125747; ZHANG CC, 1993, P NATL ACAD SCI USA, V90, P11840, DOI 10.1073/pnas.90.24.11840	47	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3720	3725		10.1074/jbc.270.8.3720	http://dx.doi.org/10.1074/jbc.270.8.3720			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876111	hybrid			2022-12-27	WOS:A1995QH68800041
J	SONG, HY; DUNBAR, JD; ZHANG, YX; GUO, DQ; DONNER, DB				SONG, HY; DUNBAR, JD; ZHANG, YX; GUO, DQ; DONNER, DB			IDENTIFICATION OF A PROTEIN WITH HOMOLOGY TO HSP90 THAT BINDS THE TYPE-1 TUMOR-NECROSIS-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR; MOLECULAR-CLONING; CELL; SHOCK; ACTIVATION; CYTOTOXICITY; STIMULATION; ANTIBODIES; EXPRESSION; SIGNALS	The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC). The TNF receptor-associated protein, TRAP-1, shows strong homology to members of the 90-kDa family of heat shock proteins. After in vitro transcription/translation and S-35 labeling, TRAP-1 was precipitated using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact. The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system. This showed that the amino acid sequences that mediate binding are diffusely distributed outside of the domain in the C terminus of TNFR-1IC that signals cytotoxicity. The 2.4-kilobase TRAP-1 mRNA was variably expressed in skeletal muscle, Liver, heart, brain, kidney, pancreas, lung, and placenta. TRAP-1 mRNA was also detected in each of eight different transformed cell Lines. Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein tyrosine kinase activity, transmits its message to signal transduction pathways.	INDIANA UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute								AELST LV, 1993, P NATL ACAD SCI USA, V90, P6213; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; BAGLIONI C, 1985, J BIOL CHEM, V260, P3395; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DARNAY BG, 1994, J BIOL CHEM, V269, P20299; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ESPEVIK T, 1989, J EXP MED, V171, P415; FERNANDEZSARABI.MJ, 1993, NATURE, V366, P274; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GEHR G, 1992, J IMMUNOL, V149, P911; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRELL M, 1993, LYMPHOKINE CYTOK RES, V12, P143; HELLER RA, 1992, CELL, V70, P47; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; JACOBSEN FW, 1994, P NATL ACAD SCI USA, V91, P10695, DOI 10.1073/pnas.91.22.10695; KULL FC, 1985, P NATL ACAD SCI USA, V82, P5756, DOI 10.1073/pnas.82.17.5756; KUSHER DI, 1990, J IMMUNOL, V145, P2925; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Miller J.H., 1972, EXPT MOL GENETICS; MOORE SK, 1989, J BIOL CHEM, V264, P5343; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROBAYE B, 1989, BIOCHEM BIOPH RES CO, V163, P301, DOI 10.1016/0006-291X(89)92135-9; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SIDHU RS, 1993, PHARMACOL THERAPEUT, V57, P79, DOI 10.1016/0163-7258(93)90037-E; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SONG HY, 1994, J BIOL CHEM, V269, P22492; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; TARTAGLIA LA, 1993, CELL, V73, P213, DOI 10.1016/0092-8674(93)90222-C; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TARTAGLIA LA, 1993, J IMMUNOL, V151, P4637; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7226; VANARSDALE TL, 1994, J IMMUNOL, V153, P3043; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WONG GHW, 1992, J IMMUNOL, V149, P3550; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074	49	187	204	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3574	3581		10.1074/jbc.270.8.3574	http://dx.doi.org/10.1074/jbc.270.8.3574			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876093	hybrid			2022-12-27	WOS:A1995QH68800020
J	TORRI, AF; ENGLUND, PT				TORRI, AF; ENGLUND, PT			A DNA-POLYMERASE-BETA IN THE MITOCHONDRION OF THE TRYPANOSOMATID CRITHIDIA-FASCICULATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							KINETOPLAST DNA; REPLICATION; MINICIRCLES; NETWORKS; TOPOISOMERASE; COMPILATION; ALIGNMENT; SITES	We previously purified a Crithidia fasciculata mitochondrial DNA polymerase that has unusual properties. Unlike a conventional mitochondrial DNA polymerase gamma, this enzyme is small, non-processive, deficient in 3'-exonuclease activity, and error prone (Torri, A. F., Kunkel, T. A., and Englund, P. T. (1994) J. Biol. Chem. 269, 8165-8171), In all of these characteristics, the enzyme resembles DNA polymerase beta, a nuclear enzyme thought to be involved in DNA repair, We have now cloned and sequenced the gene for this enzyme. The mitochondrial polymerase has significant homology, about 33% identity at the amino acid level, with human DNA polymerase beta. However, sequence analysis of the clone revealed the presence of a cleaved N-terminal presequence, presumably a mitochondrial import signal, which resembles presequences on other C. fasciculata mitochondrial proteins, The polymerase's function may be to repair the many gaps in newly replicated kinetoplast (mitochondrial) DNA minicircles in this parasite, This enzyme is the first example of a mitochondrial DNA polymerase beta.			TORRI, AF (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.				NIGMS NIH HHS [GM 27608] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027608, R01GM027608] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; EFFRON PN, 1993, MOL BIOCHEM PARASIT, V59, P191, DOI 10.1016/0166-6851(93)90217-L; ENGLUND PT, 1978, CELL, V14, P157, DOI 10.1016/0092-8674(78)90310-0; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; KITCHIN PA, 1984, J BIOL CHEM, V259, P5532; Kornberg A., 1992, DNA REPLICATION; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; PASION SG, 1992, MOL BIOCHEM PARASIT, V50, P57, DOI 10.1016/0166-6851(92)90244-E; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PEREZMORGA DL, 1993, CELL, V74, P703, DOI 10.1016/0092-8674(93)90517-T; RAY DS, 1987, PLASMID, V17, P177, DOI 10.1016/0147-619X(87)90026-6; RYAN KA, 1988, ANNU REV MICROBIOL, V42, P339, DOI 10.1146/annurev.mi.42.100188.002011; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SHLOMAI J, 1994, PARASITOL TODAY, V10, P341, DOI 10.1016/0169-4758(94)90244-5; TORRI AF, 1992, J BIOL CHEM, V267, P4786; TORRI AF, 1994, J BIOL CHEM, V269, P8165; XU CX, 1993, P NATL ACAD SCI USA, V90, P1786, DOI 10.1073/pnas.90.5.1786	19	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3495	3497		10.1074/jbc.270.8.3495	http://dx.doi.org/10.1074/jbc.270.8.3495			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876082	hybrid			2022-12-27	WOS:A1995QH68800009
J	BUKI, KG; BAUER, PI; HAKAM, A; KUN, E				BUKI, KG; BAUER, PI; HAKAM, A; KUN, E			IDENTIFICATION OF DOMAINS OF POLY(ADP-RIBOSE) POLYMERASE FOR PROTEIN-BINDING AND SELF-ASSOCIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE DIPHOSPHORIBOSYL TRANSFERASE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; ADP-RIBOSYLATION; EUKARYOTE CHROMATIN; CELLULAR-REGULATION; DNA TOPOISOMERASE; CALF THYMUS; CELLS; INHIBITION; SEPARATION	Cellular proteins extracted from normal and cancer cells bind polymerizing ADP-ribose transferase (pADPRT) on nitrocellulose membrane transblots. Histones at 1 mg/ml concentration completely prevent the binding of pADPRT to cellular proteins, indicating that the binding of histones to pADPRT sites competitively blocks the association of pADPRT to proteins other than histones. The direct binding of pADPRT to histones is shown by cross-linking with glutaraldehyde. The COOH-terminal basic histone H1 tail binds to the basic polypeptide domain of pADPRT. The basic domain present in the NH2-terminal part of core histones is the probable common structural feature of all core histones that accounts for their binding to pADPRT. Two polypeptide domains of pADPRT were identified, by way of CNBr fragments, to bind histones. These two domains are located within the 64-kDa fragment of pADPRT and are contiguous with the polypeptide domains that were shown to participate in self-association of pADPRT, ending at the 606th amino acid residue. The polypeptide domains of pADPRT which participate in DNA binding are thus shown to associate also with other proteins. Intact pADPRT binds to both the zinc-free or zinc-reconstituted basic polypeptide fragments of pADPRT. Histones activate auto-poly(ADP)-ribosylation of pADPRT by increasing the number of short oligomers on pADPRT. This reaction is also dependent in a biphasic manner on the concentration of pADPRT. Histones in solution are only marginally poly(ADP)-ribosylated but are good polymer accepters when incorporated into artificial nucleosome structures.	SAN FRANCISCO STATE UNIV,ROMBERG TIBURON CTR,ENVIRONM & TOXICOL CHEM LAB,TIBURON,CA 94920; SAN FRANCISCO STATE UNIV,ROMBERG TIBURON CTR,OCTAMER RES FDN,TIBURON,CA 94920	California State University System; San Francisco State University; California State University System; San Francisco State University								ALTHAUS FR, 1992, J CELL SCI, V102, P663; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BAUER PI, 1986, FEBS LETT, V195, P331, DOI 10.1016/0014-5793(86)80188-0; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; BAUER PL, 1985, ADP RIBOSYLATION PRO, P63; BOULIKAS T, 1988, EMBO J, V7, P57, DOI 10.1002/j.1460-2075.1988.tb02783.x; BRADBURY EM, 1975, EUR J BIOCHEM, V57, P521, DOI 10.1111/j.1432-1033.1975.tb02327.x; BUKI KG, 1991, BIOCHEM BIOPH RES CO, V180, P496, DOI 10.1016/S0006-291X(05)81092-7; BUKI KG, 1987, ANAL BIOCHEM, V167, P160, DOI 10.1016/0003-2697(87)90147-3; BUKI KG, 1991, FEBS LETT, V290, P181, DOI 10.1016/0014-5793(91)81255-7; BUKI KG, 1988, BIOCHEMISTRY-US, V27, P5990, DOI 10.1021/bi00416a024; COLE GA, 1991, BIOCHEM BIOPH RES CO, V180, P504, DOI 10.1016/S0006-291X(05)81093-9; DARBY MK, 1985, EMBO J, V4, P2129, DOI 10.1002/j.1460-2075.1985.tb03903.x; FERRO AM, 1984, J BIOL CHEM, V259, P547; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; HAKAM A, 1987, FEBS LETT, V212, P73, DOI 10.1016/0014-5793(87)81559-4; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; HULETSKY A, 1985, EUR J BIOCHEM, V146, P277, DOI 10.1111/j.1432-1033.1985.tb08650.x; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; IKEJIMA M, 1987, J BIOL CHEM, V262, P17641; ISENBERG I, 1979, ANN REV BIOCH, V48, P151; JACKOWSKI G, 1983, J BIOL CHEM, V258, P2587; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KASID UN, 1989, J BIOL CHEM, V264, P18687; KIRSTEN E, 1991, EXP CELL RES, V194, P1, DOI 10.1016/0014-4827(91)90122-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUDWIG A, 1988, J BIOL CHEM, V263, P6993; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; MINAGA T, 1979, J BIOL CHEM, V254, P9663; MOLINETE M, 1992, SEP OJ INT SEM ADP R; NAEGELI H, 1991, J BIOL CHEM, V266, P10596; OHASHI Y, 1986, BIOCH BIOPHYS COMMUN, V140, P667; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; RICE WG, 1993, NATURE, V361, P473, DOI 10.1038/361473a0; RICE WG, 1992, P NATL ACAD SCI USA, V89, P7703, DOI 10.1073/pnas.89.16.7703; SAITO I, 1990, GENE, V90, P249, DOI 10.1016/0378-1119(90)90187-V; SASTRY SS, 1989, BIOCHEMISTRY-US, V28, P5670, DOI 10.1021/bi00439a050; SASTRY SS, 1990, BIOCHEM BIOPH RES CO, V167, P842, DOI 10.1016/0006-291X(90)92102-6; SATOH MS, 1993, J BIOL CHEM, V268, P5480; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIZUTA Y, 1985, P52; SIMBULAN CMG, 1993, J BIOL CHEM, V268, P93; SIMONIN F, 1993, J BIOL CHEM, V268, P13454; SIMONIN F, 1991, ANAL BIOCHEM, V195, P226, DOI 10.1016/0003-2697(91)90321-J; SIMONIN F, 1990, J BIOL CHEM, V256, P19249; SOOKITOTH A, 1989, EXP CELL RES, V184, P44, DOI 10.1016/0014-4827(89)90362-5; STEIN A, 1987, J BIOL CHEM, V262, P3872; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P3481, DOI 10.1073/pnas.90.8.3481; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; WOLFFE AP, 1994, CELL, V77, P13, DOI 10.1016/0092-8674(94)90229-1; YAMANAKA H, 1988, J BIOL CHEM, V263, P3879; YOSHIHARA K, 1975, P NATL ACAD SCI USA, V72, P289, DOI 10.1073/pnas.72.1.289; YOSHIHARA K, 1972, BIOCHEM BIOPH RES CO, V47, P119, DOI 10.1016/S0006-291X(72)80018-4; YOSHIHARA K, 1985, BIOCHEM BIOPH RES CO, V128, P61, DOI 10.1016/0006-291X(85)91644-4; YOUNG LJT, 1994, 11TH INT S ADP RIB D	57	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3370	3377		10.1074/jbc.270.7.3370	http://dx.doi.org/10.1074/jbc.270.7.3370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852424	hybrid			2022-12-27	WOS:A1995QG47100072
J	MOSSMAN, K; UPTON, C; MCFADDEN, G				MOSSMAN, K; UPTON, C; MCFADDEN, G			THE MYXOMA VIRUS-SOLUBLE INTERFERON-GAMMA RECEPTOR HOMOLOG, M-T7, INHIBITS INTERFERON-GAMMA IN A SPECIES-SPECIFIC MANNERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOPE FIBROMA VIRUS; INVERTED TERMINAL REPEAT; VACCINIA VIRUS; IFN-GAMMA; BIOCHEMICAL-CHARACTERIZATION; TUMORIGENIC POXVIRUSES; PROTEIN-SYNTHESIS; NITRIC-OXIDE; DNA-SEQUENCE; EXPRESSION	The myxoma virus M-T7 protein contains significant sequence similarity to the ligand binding domain of the mammalian interferon-gamma receptors, and functions as a soluble homolog which can bind and inhibit the biological activities of rabbit interferon-gamma (Upton, C., Mossman, K., and McFadden, G. (1992) Science 258: 1369-1372). M-T7, the most abundantly secreted protein from myxoma virus-infected cells, was shown to be expressed in significant biological amounts as a typical poxvirus early gene product, efficiently secreted at early times of infection to levels that exceed 5 x 10(7) molecules/cell, and function as a stable inhibitory protein in infected cell supernatants until late times of infection. M-T7 was specific in binding and inhibiting rabbit interferon-gamma, and did not bind either human or murine interferon-gamma. Scatchard analysis of rabbit interferon-gamma binding curves yielded a single high affinity binding site on M-T7, with a K-d of 1.2 x 10(-9) M, which is comparable to the affinity between soluble forms of cellular interferon-gamma receptors and their cognate ligands. In comparison, rabbit interferon-gamma was shown to bind its cellular receptor with a K-d of 5.9 x 10(-10) M, again comparable to the affinity of membrane bound forms of other mammalian interferon-gamma receptors for interferon-gamma. Thus, the myxoma virus M-T7 protein is a functional soluble interferon-gamma receptor homolog which binds and inhibits interferon-gamma with high affinity in a species-specific manner.	UNIV ALBERTA,DEPT BIOCHEM,EDMONTON,AB T6G 2H7,CANADA	University of Alberta			Upton, Chris/A-4670-2008	Upton, Chris/0000-0002-9019-8967				AGUET M, 1988, CELL, V5, P273; BASHAM TY, 1983, J IMMUNOL, V130, P1492; BASHAM TY, 1985, J INTERFERON RES, V5, P23, DOI 10.1089/jir.1985.5.23; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; DING AH, 1988, J IMMUNOL, V141, P2407; EPSTEIN LB, 1984, INTERFERONS IMMUNE S, P185; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FENNER F, 1965, MYXOMATOSIS; FISCHER DG, 1993, SCIENCE, V262, P250, DOI 10.1126/science.8211145; FOUNTOULAKIS M, 1991, EUR J BIOCHEM, V198, P441, DOI 10.1111/j.1432-1033.1991.tb16034.x; FOUNTOULAKIS M, 1990, J BIOL CHEM, V265, P13268; GAROTTA G, 1990, J BIOL CHEM, V265, P6908; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GOODING LR, 1992, CELL, V71, P5; GRAY PW, 1989, P NATL ACAD SCI USA, V86, P8497, DOI 10.1073/pnas.86.21.8497; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KERR IM, 1992, J INTERFERON RES, V12, P237, DOI 10.1089/jir.1992.12.237; KERR IM, 1991, FEBS LETT, V285, P194, DOI 10.1016/0014-5793(91)80802-A; KOHONENCORISH MRJ, 1990, EUR J IMMUNOL, V20, P157, DOI 10.1002/eji.1830200123; KUNG HF, 1986, METHOD ENZYMOL, V119, P296; LIEW FY, 1990, J IMMUNOL, V145, P4306; MACAULAY C, 1987, VIROLOGY, V158, P381, DOI 10.1016/0042-6822(87)90210-8; MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MASSUNG RF, 1993, VIROLOGY, V197, P511, DOI 10.1006/viro.1993.1625; MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288; MCFADDEN G, 1994, ADV CANCER RES, V63, P117, DOI 10.1016/S0065-230X(08)60400-5; MCFADDEN G, 1994, IN PRESS SEMIN VIROL; MCNAIR ANB, 1993, PHARMACOL THERAPEUT, V56, P79; MELKOVA Z, 1994, VIROLOGY, V198, P731, DOI 10.1006/viro.1994.1087; MOSSMAN K, 1995, VIROCEPTORS VIROKINE, P41; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; OZMEN L, 1993, INT REV EXP PATHOL, V34, P137; Pestka S, 1981, Methods Enzymol, V78, P3; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; RUBY J, 1991, LYMPHOKINE CYTOK RES, V10, P353; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHREIBER M, 1994, VIROLOGY, V204, P692, DOI 10.1006/viro.1994.1585; SCHREIBER RD, 1983, J IMMUNOL, V131, P826; SCHREIBER RD, 1985, LYMPHOKINES, V11, P87; SHCHELKUNOV SN, 1993, FEBS LETT, V319, P80, DOI 10.1016/0014-5793(93)80041-R; Smith Geoffrey L., 1994, Trends in Microbiology, V2, P81, DOI 10.1016/0966-842X(94)90539-8; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; SPRIGGS MK, 1994, VIRUS RES, V33, P1, DOI 10.1016/0168-1702(94)90013-2; UPTON C, 1986, VIROLOGY, V152, P308, DOI 10.1016/0042-6822(86)90134-0; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; UPTON C, 1994, METH MOL G, V4, P383; VILCEK J, 1985, LYMPHOKINES, V11, P1; WILLIAMS BRG, 1991, EUR J BIOCHEM, V200, P1, DOI 10.1111/j.1432-1033.1991.tb21041.x; ZOON KC, 1986, METHOD ENZYMOL, V119, P312; [No title captured]	64	89	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3031	3038		10.1074/jbc.270.7.3031	http://dx.doi.org/10.1074/jbc.270.7.3031			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852384	hybrid			2022-12-27	WOS:A1995QG47100024
J	DIRKSEN, WP; SUN, QA; ROTTMAN, FM				DIRKSEN, WP; SUN, QA; ROTTMAN, FM			MULTIPLE SPLICING SIGNALS CONTROL ALTERNATIVE INTRON RETENTION OF BOVINE GROWTH-HORMONE PRE-MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GENE-EXPRESSION; EXON SEQUENCES; SR PROTEINS; DROSOPHILA; BINDING; VARIANT; MUTANTS; SITES	A fraction of bovine growth hormone (bGH) pre-mRNA undergoes alternative splicing in which the last intron is retained and transported to the cytoplasm. Our goal was to characterize the cis-acting signals in bGH pre-mRNA that collectively determine the distribution between intron splicing and intron retention. We now demonstrate that the balance between splicing and intron retention in cytoplasmic mRNA is primarily determined by the interaction of three splicing signals and the degree to which these signals deviate from consensus splicing signals. Intron retention requires the presence of both suboptimal 5'- and 3'-splice sites. Mutation of either splice site toward consensus leads to complete splicing of the intron. In the presence of both wild-type, suboptimal splice sites, efficient splicing of this intron is ensured by the presence of a third splicing element, a purine rich exonic splicing enhancer (ESE). Although strong ESEs can be contained within very small sequences, the bGH ESE activity appears to be composed of multiple sequences spread throughout a 115-nucleotide region of exon 5. Consequently, the final ratio of splicing to intron retention depends on the balance between the relative strengths of each of these three splicing signals, which still allow intron containing coding sequences to be transported to the cytoplasm.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT MOLEC BIOL & MICROBIOL,CLEVELAND,OH 44106	Case Western Reserve University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032770] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32770] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; COOKE NE, 1988, J BIOL CHEM, V263, P9001; CRABTREE GR, 1982, CELL, V31, P159, DOI 10.1016/0092-8674(82)90415-9; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; GRABOWSKI PJ, 1991, MOL CELL BIOL, V11, P5919, DOI 10.1128/MCB.11.12.5919; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; HAMPSON RK, 1987, P NATL ACAD SCI USA, V84, P2673, DOI 10.1073/pnas.84.9.2673; HAMPSON RK, 1989, MOL CELL BIOL, V9, P1604, DOI 10.1128/MCB.9.4.1604; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; MANIATIS T, 1991, SCIENCE, V251, P33, DOI 10.1126/science.1824726; Maniatis T., 1982, MOL CLONING; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; McKeown M, 1990, Genet Eng (N Y), V12, P139; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; NEEL H, 1993, GENE DEV, V7, P2194, DOI 10.1101/gad.7.11.2194; NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Sambrook J, 1989, MOL CLONING LABORATO; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SIEBEL CW, 1990, SCIENCE, V248, P1200, DOI 10.1126/science.2161558; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; SUN Q, 1993, J BIOL CHEM, V268, P15659; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; WEIL D, 1990, MOL CELL BIOL, V10, P5865, DOI 10.1128/MCB.10.11.5865; WOYCHIK RP, 1984, P NATL ACAD SCI-BIOL, V81, P3944, DOI 10.1073/pnas.81.13.3944; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	36	54	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5346	5352		10.1074/jbc.270.10.5346	http://dx.doi.org/10.1074/jbc.270.10.5346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890647	hybrid			2022-12-27	WOS:A1995QL58000061
J	GAN, T; MUNOZ, A; SHAW, CF; PETERING, DH				GAN, T; MUNOZ, A; SHAW, CF; PETERING, DH			REACTION OF CD-111(7)-METALLOTHIONEIN WITH EDTA - A REAPPRAISAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEINS	The ligand substitution reaction of EDTA with Cd-7-metallothionein (Cd-7-MT) has been reinvestigated, NMR titration of the Cd-111-protein with EDTA showed that the ligand interacts preferentially and cooperatively with Cd2+ ions in the beta-domain cluster. NMR and ultra-filtration kinetic analysis of this reaction using 5.6 mM Cd2+ as Cd-111(7)-MT and 56 mM EDTA indicated that cadmium-EDTA formed less rapidly than Cd-111 peak intensity declined. Spectrophotometric and gel filtration studies of the reaction with 20 mu M Cd2+ as Cd-7-MT with various concentrations of EDTA revealed biphasic kinetics with much larger rate constants than observed in the NMR experiments. The fraction of total ligand substitution occurring in each kinetic step varied with EDTA concentration. The EDTA concentration depend of both kinetic steps was consistent with the initial formation of protein EDTA adducts, followed by their breakdown into products. Kinetic measurements were also made for the reactions of the isolated Cd-4-alpha- and Cd-3-beta-domains with EDTA. The Cd-4 domain reacted with EDTA with biphasic kinetics, in which one Cd2+ was removed rapidly with first-order kinetics, which were zero-order in EDTA. The other three reacted with kinetics like those for the slower step of the holoprotein, Cd-3-beta reacted with EDTA like the faster rate process associated with the Cd-7-protein, The observed rate constants for the reaction of Cd7-metallothionein with EDTA and the fraction of reaction in the faster rate process were sensitive to protein concentration. These results are consistent with the hypothesis that the monomer-dimer equilibrium of the protein controls its kinetic reactivity with EDTA.	UNIV WISCONSIN, DEPT CHEM, MILWAUKEE, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee				Munoz, Amalia/0000-0002-1858-0379	NIEHS NIH HHS [ES-04026] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004026] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BUHLER RHO, 1979, METALLOTHIONEIN, P211; CARR JD, 1967, INORG CHEM, V6, P1083, DOI 10.1021/ic50052a003; DALGARNO DC, 1986, ADV INORG BIOCHEM, V6, P113; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GALE GR, 1985, RES COMMUN CHEM PATH, V49, P423; LI TY, 1980, P NATL ACAD SCI-BIOL, V77, P6334, DOI 10.1073/pnas.77.11.6334; MINKEL DT, 1980, BIOCHEM J, V191, P475, DOI 10.1042/bj1910475; NICHOLSON JK, 1987, METALLOTHIONEIN, V2, P191; OH SH, 1978, AM J PHYSIOL, V243, pE252; Otvos J. D., 1989, COMMENTS INORG CHEM, V9, P1, DOI DOI 10.1080/02603598908035801; OTVOS JD, 1993, METALLOTHIONEIN, V3, P57; PATTANAIK A, 1992, J BIOL CHEM, V267, P16121; RIVERA M, 1991, CHEM RES TOXICOL, V4, P572, DOI 10.1021/tx00023a014; ROBBINS AH, 1991, J MOL BIOL, V221, P1269, DOI 10.1016/0022-2836(91)90933-W; VAZQUEZ F, 1988, BIOCHEM J, V253, P611, DOI 10.1042/bj2530611; WINGE DR, 1991, METHOD ENZYMOL, V205, P438; WINGE DR, 1978, ARCH BIOCHEM BIOPHYS, V188, P466, DOI 10.1016/S0003-9861(78)80031-9	17	56	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5339	5345		10.1074/jbc.270.10.5339	http://dx.doi.org/10.1074/jbc.270.10.5339			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890646	hybrid			2022-12-27	WOS:A1995QL58000060
J	HEMMING, NJ; ANSTEE, DJ; STARICOFF, MA; TANNER, MJA; MOHANDAS, N				HEMMING, NJ; ANSTEE, DJ; STARICOFF, MA; TANNER, MJA; MOHANDAS, N			IDENTIFICATION OF THE MEMBRANE ATTACHMENT SITES FOR PROTEIN-4.1 IN THE HUMAN ERYTHROCYTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELL; SIALOGLYCOPROTEIN-BETA; GLYCOPHORIN-C; SKELETON; BINDING; PURIFICATION; KINASE	The nature of the membrane attachment site(s) for protein 4.1 in the human erythrocyte membrane has yet to be fully elucidated. In this paper we show that the major attachment site is glycophorin (GP) C/D, and that purified protein 4.1 can bind to two distinct sites on glycophorin C/D. One of these interactions is direct, involving residues 82-98 on glycophorin C (61-77 on glycophorin D), while the other interaction is mediated by p55. We have localized the binding site for p55 on glycophorin C to residues 112-128 (glycophorin D 91-107). We also provide evidence that band 3 is an additional, minor, protein 4.1 binding site. The binding sites for band 3, glycophorin C/D, and p55 are all located within the 30-kDa domain of protein 4.1. We estimate that the relative utilization of the three sites in normal membranes comprises 40% to p55, 40% to GPC/D, and 20% to band 3. The same region of protein 4.1 binds GPC/D and band 3, while the p55 binding site is distinct. The interactions involving protein 4.1 with p55 and p55 with GPC/D are of high affinity (nM), while those involving GPC/D and band 3 are 100 fold lower (mu M). These results suggest that the most significant interactions between protein 4.1 and the membrane are those involving p55.	UNIV BRISTOL,DEPT BIOCHEM,BRISTOL B58 1TD,AVON,ENGLAND; UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,BERKELEY,CA 94720	University of Bristol; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	HEMMING, NJ (corresponding author), INT BLOOD GRP REFERENCE LAB,SOUTHMEAD RD,BRISTOL BS10 5ND,AVON,ENGLAND.		Anstee, David/AAE-9231-2020					ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; ALLOISIO N, 1985, BIOCHIM BIOPHYS ACTA, V816, P57, DOI 10.1016/0005-2736(85)90392-X; ANSTEE DJ, 1984, BIOCHEM J, V218, P615, DOI 10.1042/bj2180615; COHEN AM, 1988, BIOCHEMISTRY-US, V276, P614; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; DISCHER D, 1993, BLOOD, V82, pA309; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; GASCARD P, 1994, BLOOD, V83, P1102; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; HUSAINCHISHTI A, 1989, J BIOL CHEM, V264, P8985; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; LETO TL, 1984, J BIOL CHEM, V259, P4603; LIU SC, 1992, SEMIN HEMATOL, V29, P231; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LOVRIEN RE, 1980, J CELL BIOL, V85, P534, DOI 10.1083/jcb.85.3.534; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALLINSON G, 1986, BIOCHEM J, V234, P649, DOI 10.1042/bj2340649; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MUELLER TJ, 1981, ERYTHROCYTE MEMBRANE, V2; OKUBO Y, 1988, VOX SANG, V54, P107, DOI 10.1111/j.1423-0410.1988.tb01626.x; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; PINDER JC, 1993, BLOOD, V82, P3482; REID ME, 1990, BLOOD, V75, P2229; REID ME, 1990, TRANSFUS MED S1, V1, P66; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; SATO SB, 1983, EUR J BIOCHEM, V130, P19; SCOTT ML, 1992, Patent No. 111764; SHIFFER KA, 1984, P NATL ACAD SCI-BIOL, V81, P4404, DOI 10.1073/pnas.81.14.4404; SMYTHE J, 1994, BLOOD, V83, P1668; TANNER MJA, 1988, BIOCHEM J, V250, P407, DOI 10.1042/bj2500407; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	34	88	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5360	5366		10.1074/jbc.270.10.5360	http://dx.doi.org/10.1074/jbc.270.10.5360			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890649	hybrid			2022-12-27	WOS:A1995QL58000063
J	HORTON, JD; CUTHBERT, JA; SPADY, DK				HORTON, JD; CUTHBERT, JA; SPADY, DK			REGULATION OF HEPATIC 7-ALPHA-HYDROXYLASE EXPRESSION AND RESPONSE TO DIETARY-CHOLESTEROL IN THE RAT AND HAMSTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY LIPOPROTEIN TRANSPORT; BILE-ACID EXCRETION; HMG-COA REDUCTASE; STEROL BALANCE; PLASMA-CHOLESTEROL; FATTY-ACIDS; TRANSCRIPTIONAL REGULATION; RHESUS-MONKEYS; MESSENGER-RNA; ABSORPTION	Although dietary cholesterol raises plasma total and low density lipoprotein (LDL) cholesterol concentrations, the response to a given intake of cholesterol varies enormously among different species and even among individuals of the same species. The mechanisms responsible for differing sensitivity to dietary cholesterol were examined by comparing the rat, which is able to adapt to large fluctuations in sterol intake or loss with little change in plasma LDL levels, with the hamster, where changes in sterol balance strongly influence plasma LDL concentrations. When fed the same cholesterol-free diet, hepatic 7 alpha-hydroxylase activity was 16-fold higher in the rat than in the hamster. As a consequence, rates of hepatic cholesterol synthesis were 20-fold higher in the rat than in the hamster, In both species, hepatic cholesterol synthesis was suppressed >90% in response to increasing loads of dietary cholesterol. However, the quantitative importance of this adaptive mechanism was much greater in the rat since the absolute reduction in hepatic cholesterol synthesis in the rat (2,110 nmol/h/g) was much larger than in the hamster (103 nmol/h/g). In the rat, the high basal level of 7 alpha-hydroxylase expression was further induced by substrate (cholesterol) allowing these animals to convert excess dietary cholesterol to bile acids efficiently. In contrast, the low basal level of enzyme expression in the hamster was not induced by dietary cholesterol. Thus, the low basal rates of bile acid and cholesterol synthesis coupled with a lack of 7 alpha-hydroxylase induction by cholesterol render the hamster much more sensitive than the rat to the cholesterolemic effects of dietary cholesterol.			HORTON, JD (corresponding author), UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047551, R01HL038049] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38049, HL-47551] Funding Source: Medline; NIADDK NIH HHS [AM-07100] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKERLUND JE, 1990, J LIPID RES, V31, P2159; ARMSTRONG ML, 1974, CIRC RES, V34, P447, DOI 10.1161/01.RES.34.4.447; BEHER WT, 1977, STEROIDS, V29, P695, DOI 10.1016/0039-128X(77)90020-4; BELLENTANI S, 1987, J LIPID RES, V28, P1021; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080; BEYNEN AC, 1987, ADV LIPID RES, V22, P115; BEYNEN AC, 1989, ATHEROSCLEROSIS, V77, P151, DOI 10.1016/0021-9150(89)90076-2; BHATTACHARYYA AK, 1980, J LIPID RES, V21, P518; BJORKHEM I, 1991, BIOCHIM BIOPHYS ACTA, V1085, P329, DOI 10.1016/0005-2760(91)90137-7; BJORKHEM I, 1992, J LIPID RES, V33, P455; BJORKHEM I, 1978, J LIPID RES, V19, P359; Carey M.C., 1988, LIVER BIOL PATHOBIOL, V2nd, P573; CASTEELS M, 1988, J BIOL CHEM, V263, P4654; CHIANG JYL, 1994, J BIOL CHEM, V269, P17502; CHIANG JYL, 1991, METHOD ENZYMOL, V206, P483; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIGHETTI G, 1983, LIFE SCI, V33, P2483, DOI 10.1016/0024-3205(83)90156-X; CLARKSON TB, 1971, ARCH PATHOL, V92, P37; COHEN BI, 1992, LIPIDS, V27, P526, DOI 10.1007/BF02536135; COHEN BI, 1977, J LIPID RES, V18, P223; CROUSE JR, 1982, METABOLISM, V31, P733, DOI 10.1016/0026-0495(82)90206-2; DAGGY BP, 1992, GASTROENTEROLOGY, V102, P797; DAVIS RA, 1983, J BIOL CHEM, V258, P3661; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; DUELAND S, 1993, J LIPID RES, V34, P923; GLASS CK, 1983, J BIOL CHEM, V258, P7161; HO KJ, 1975, AM J PHYSIOL, V229, P1427, DOI 10.1152/ajplegacy.1975.229.5.1427; HOEKMAN MFM, 1993, GENE, V130, P217, DOI 10.1016/0378-1119(93)90422-Y; HORTON JD, 1993, J CLIN INVEST, V92, P743, DOI 10.1172/JCI116645; HORTON JD, 1994, J CLIN INVEST, V93, P2084, DOI 10.1172/JCI117203; JONES MP, 1993, J LIPID RES, V34, P885; KERN F, 1991, NEW ENGL J MED, V324, P896, DOI 10.1056/NEJM199103283241306; KESANIEMI YA, 1987, EUR J CLIN INVEST, V17, P391, DOI 10.1111/j.1365-2362.1987.tb01132.x; KUSHWAHA RS, 1993, METABOLISM, V42, P714, DOI 10.1016/0026-0495(93)90238-J; LIN DS, 1980, J LIPID RES, V21, P1042; LOFLAND HB, 1972, J LIPID RES, V13, P39; MARANHAO RC, 1983, J LIPID RES, V24, P167; MCMURRY MP, 1985, AM J CLIN NUTR, V41, P1289, DOI 10.1093/ajcn/41.6.1289; MYANT NB, 1977, J LIPID RES, V18, P135; NESTEL PJ, 1976, METABOLISM, V25, P1591, DOI 10.1016/0026-0495(76)90112-8; OVERTURF ML, 1990, J LIPID RES, V31, P2019; PERTSEMLIDIS D, 1973, J CLIN INVEST, V52, P2353, DOI 10.1172/JCI107424; QUINTAO E, 1971, J LIPID RES, V12, P233; RAICHT RF, 1975, BIOCHIM BIOPHYS ACTA, V388, P374, DOI 10.1016/0005-2760(75)90096-X; RAMIREZ MI, 1994, MOL CELL BIOL, V14, P2809, DOI 10.1128/MCB.14.4.2809; RUDEL L, 1994, J CLIN INVEST, V93, P2463, DOI 10.1172/JCI117255; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SHEKELLE RB, 1989, LANCET, V1, P1177; SHODA J, 1993, HEPATOLOGY, V17, P395; SPADY DK, 1983, J LIPID RES, V24, P303; SPADY DK, 1986, J CLIN INVEST, V77, P1474, DOI 10.1172/JCI112460; SPADY DK, 1992, J BIOL CHEM, V267, P5584; SPADY DK, 1988, J CLIN INVEST, V81, P300, DOI 10.1172/JCI113321; SPADY DK, 1992, SEMIN LIVER DIS, V12, P373, DOI 10.1055/s-2008-1040407; SPADY DK, 1994, CIRCULATION, V90, P90; TURLEY SD, 1983, GASTROENTEROLOGY, V84, P253; WONG MH, 1994, J BIOL CHEM, V269, P1340; ZUCKER I, 1973, PHYSIOL BEHAV, V11, P239, DOI 10.1016/0031-9384(73)90356-9	58	138	140	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5381	5387		10.1074/jbc.270.10.5381	http://dx.doi.org/10.1074/jbc.270.10.5381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890651	hybrid			2022-12-27	WOS:A1995QL58000066
J	JARRETT, HW; FOSTER, JL				JARRETT, HW; FOSTER, JL			ALTERNATE BINDING OF ACTIN AND CALMODULIN TO MULTIPLE SITES ON DYSTROPHIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; GLYCOPROTEIN COMPLEX; PROTEIN-KINASE; PURIFICATION; BRAIN; MEMBRANE; DOMAIN	Mouse dystrophin protein sequence 1-385 and various deletion mutants were expressed in Escherichia coli as fusion proteins, and the binding of actin, calmodulin, and troponin C were characterized. The fusion protein-containing sequence 1-385 bound actin with an apparent dissociation constant of 129 +/- 65 nM as measured using a solid-phase immunoassay. High affinity was also observed with ultracentrifuge cosedimentation assays and biotinylated-actin binding assays. Results with deletion mutants and analysis based upon sequence homology were consistent with two or three high affinity F-actin-binding sequences within this region of dystrophin at sequence positions 18-37 (ABS 1), 128-149 (ABS 2), and potentially at a new region called ABS 3 (86-120), A fusion protein lacking these sequences but containing dystrophin triple helix sequences also bound actin but with reduced affinity. Calmodulin binds to dystrophin sequence 1-385 in a Ca2+-dependent manner and competitively inhibits F-actin binding. Results were consistent with two Ca2+ calmodulin-binding sites in this region of dystrophin at approximate sequence positions 18-42 (CBS 1) and 104-125 (CBS 2) with calmodulin affinities of 2.1 +/- 1 and 1.6 +/- 1.2 mu M, respectively. Troponin C can substitute for calmodulin, although it binds with about 2-fold lower affinity. These results suggest that calmodulin (or troponin C) binding alternates with and may regulate F-actin binding by dystrophin much as has been postulated for other cytoskeletal proteins which are homologous to dystrophin.			JARRETT, HW (corresponding author), UNIV TENNESSEE,CTR HLTH SCI,DEPT BIOCHEM,MEMPHIS,TN 38163, USA.							BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORRADO K, 1994, FEBS LETT, V344, P255, DOI 10.1016/0014-5793(94)00397-1; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FABBRIZIO E, 1993, BIOCHEMISTRY-US, V32, P10457, DOI 10.1021/bi00090a023; FRANZA BR, 1987, NATURE, V330, P391, DOI 10.1038/330391a0; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GRAF E, 1980, ARCH BIOCHEM BIOPHYS, V203, P719, DOI 10.1016/0003-9861(80)90231-3; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; JARRETT HW, 1986, J BIOL CHEM, V261, P4967; JARRETT HW, 1979, J BIOL CHEM, V254, P8237; JARRETT HW, 1991, J BIOL CHEM, V266, P362; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; KAKIUCHI S, 1981, FEBS LETT, V132, P144, DOI 10.1016/0014-5793(81)80449-8; KAKIUCHI S, 1985, CALCIUM BIOL SYSTEMS, P275; KARINCH AM, 1990, J BIOL CHEM, V265, P11833; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE BA, 1992, FEBS LETT, V298, P44, DOI 10.1016/0014-5793(92)80019-D; LUISE M, 1993, BIOCHEM J, V293, P243, DOI 10.1042/bj2930243; MADHAVAN R, 1994, BIOCHEMISTRY-US, V33, P5797, DOI 10.1021/bi00185a018; MADHAVAN R, 1992, BIOCHEM BIOPH RES CO, V185, P753, DOI 10.1016/0006-291X(92)91690-R; MEZGUELDI M, 1994, J BIOL CHEM, V269, P12824; MILNER RE, 1993, J BIOL CHEM, V268, P21901; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SENTER L, 1993, BIOCHEM BIOPH RES CO, V192, P899, DOI 10.1006/bbrc.1993.1500; SOBUE K, 1981, BIOCHEM BIOPH RES CO, V100, P1063, DOI 10.1016/0006-291X(81)91931-8; TAKIO K, 1986, BIOCHEMISTRY-US, V25, P8049, DOI 10.1021/bi00372a038; VERMA AK, 1988, J BIOL CHEM, V263, P14152; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; WAY M, 1992, FEBS LETT, V301, P243, DOI 10.1016/0014-5793(92)80249-G	37	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5578	5586		10.1074/jbc.270.10.5578	http://dx.doi.org/10.1074/jbc.270.10.5578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890677	hybrid			2022-12-27	WOS:A1995QL58000094
J	SEKSEK, O; BIWERSI, J; VERKMAN, AS				SEKSEK, O; BIWERSI, J; VERKMAN, AS			DIRECT MEASUREMENT OF TRANS-GOLGI PH IN LIVING CELLS AND REGULATION BY 2ND MESSENGERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE-A; CHLORIDE CONDUCTANCE; ELECTRON-MICROSCOPY; ACIDIFICATION; MEMBRANE; FIBROBLASTS; APPARATUS; ORGANELLES; VESICLES; NETWORK	In the endocytic compartment, an acidic pH plays a key role in receptor and ligand sorting, vesicular transport, and protein degradation. In the secretory compartment, indirect estimates of trans-Golgi pH based on partitioning of weak bases and following viral infection suggest a mildly acidic pH of >6.0. We developed a liposome microinjection method to introduce fluorescent indicators into the aqueous compartment of trans-Golgi in living cells. In the presence of ATP and at 37 degrees C, 70-nm diameter liposomes delivered their fluid-phase contents selectively into the trans-Golgi compartment as assessed by colocalization with the trans-Golgi stain N-{6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]caproyl}-sphingosine (C-6-NBD-ceramide). Liposome fusion was ATP- and temperature-dependent and blocked by N-ethylmaleimide but not by guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S). trans-Golgi pH in skin fibroblasts was 6.17 +/- 0.02 (S.E., n = 174) as measured by ratio imaging confocal microscopy using fluorescein and rhodamine based indicators and an in vivo calibration procedure. trans-Gels pH increased to 6.8 +/- 0.1 by cAMP agonists and to 6.5 +/- 0.1 by protein kinase C activation. These results provide the first direct measurement of trans-Golgi pH in living cells and demonstrate pH regulation by second messengers.	UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco			Seksek, Olivier/AAO-1837-2020	Seksek, Olivier/0000-0002-3053-3022	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043840] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42368] Funding Source: Medline; NIDDK NIH HHS [DK43840] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; BAE HR, 1990, NATURE, V348, P637, DOI 10.1038/348637a0; BARASCH J, 1988, J CELL BIOL, V107, P2137, DOI 10.1083/jcb.107.6.2137; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; BRADBURY NA, 1992, BIOCHEM BIOPH RES CO, V184, P1173, DOI 10.1016/S0006-291X(05)80006-3; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; FREEDMAN SD, 1993, BIOCHEM BIOPH RES CO, V197, P992, DOI 10.1006/bbrc.1993.2577; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HAUGLAND RP, 1992, HDB FLUORESCENT PROB, P159; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUWAHARA M, 1988, BIOPHYS J, V54, P595, DOI 10.1016/S0006-3495(88)82994-1; LEE GM, 1989, J CELL SCI, V94, P443; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MULBERG AE, 1991, J BIOL CHEM, V266, P20590; NELSON N, 1992, Current Opinion in Cell Biology, V4, P654, DOI 10.1016/0955-0674(92)90086-R; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; PARK J, 1990, BIOL CELL, V70, P177, DOI 10.1016/0248-4900(90)90375-D; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Salzman N H, 1993, Subcell Biochem, V19, P95; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; WARREN G, 1985, TRENDS BIOCHEM SCI, V10, P439, DOI 10.1016/0968-0004(85)90027-1; WHITE J, 1983, Q REV BIOPHYS, V16, P151, DOI 10.1017/S0033583500005072; WILSON DW, 1993, J BIOL CHEM, V268, P7465; XU HX, 1994, J BIOL CHEM, V269, P22875; YILLA M, 1993, J BIOL CHEM, V268, P19092; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	32	114	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4967	4970		10.1074/jbc.270.10.4967	http://dx.doi.org/10.1074/jbc.270.10.4967			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890600	hybrid			2022-12-27	WOS:A1995QL58000004
J	DIMENT, S; EIDELMAN, M; RODRIGUEZ, GM; ORLOW, SJ				DIMENT, S; EIDELMAN, M; RODRIGUEZ, GM; ORLOW, SJ			LYSOSOMAL HYDROLASES ARE PRESENT IN MELANOSOMES AND ARE ELEVATED IN MELANIZING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NORMAL HUMAN MELANOCYTES; BIOSYNTHESIS; PROTEIN-1; MUTATIONS; BROWN	Melanosomes, the subcellular site of melanin synthesis and deposition, may be related to the endolysosomal lineage of organelles, To determine if melanosomes contain lysosomal hydrolases, we examined the subcellular distribution of five of these enzymes in melanocytes cultured from C57BL/6J mice, Analyses of Percoll gradient density centrifugations demonstrated that beta-hexosaminidase, beta-galactosidase, beta-glucuronidase, and cathepsins B and L all co-sedimented with tyrosinase-rich densely sedimenting melanosomes. The melanosomal distribution of these enzymes was confirmed in studies of melanocytes cultured from albino mice and of melanocytes rendered amelanotic by transfection with the v-ras(Ha) oncogene (which lack dense, melanized melanosomes). In these cells, only a less dense peak of activity for each hydrolase was present, The level of each hydrolase was elevated in black cells when compared with albino cells. Metabolic labeling studies confirmed that the increase in beta-glucuronidase in black versus albino cells resulted mainly from increased synthesis of this enzyme. The data suggest that melanosomes represent specialized lysosomes present within melanocytes, that they contain a broad array of lysosomal hydrolases, and that the levels of these hydrolases are elevated in cells actively engaged in pigment production.	NYU, MED CTR, SCH MED, RONALD O PERELMAN DEPT DERMATOL, NEW YORK, NY 10016 USA; NYU, SCH MED, DEPT PATHOL, NEW YORK, NY 10016 USA; NYU, SCH MED, DEPT CELL BIOL, NEW YORK, NY 10016 USA	New York University; New York University; New York University				Orlow, Seth/0000-0003-2548-7380; Diment, Stephanie/0000-0003-0673-2862	NIAMS NIH HHS [AR41880] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041880, R55AR041880] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BENNETT DC, 1989, DEVELOPMENT, V105, P379; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Gorlin RJ, 1990, SYNDROMES HEAD NECK, P124; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5; LEPOOLE IC, 1993, EXP CELL RES, V205, P388, DOI 10.1006/excr.1993.1102; LUO D, 1994, EXP CELL RES, V213, P231, DOI 10.1006/excr.1994.1195; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Moellmann G, 1988, PIGMENT CELL RES, V1, P79, DOI DOI 10.1111/J.1600-0749.1988.TB00798.X; NOVAK EK, 1979, GENETICS, V92, P189; ORLOW SJ, 1993, J INVEST DERMATOL, V100, P55, DOI 10.1111/1523-1747.ep12354138; ORLOW SJ, 1994, CURR PROBL DERMATOL, V6, P157; SEIJI M, 1969, J INVEST DERMATOL, V52, P212, DOI 10.1038/jid.1969.33; SMIT NPM, 1993, BIOCHIM BIOPHYS ACTA, V1181, P1, DOI 10.1016/0925-4439(93)90082-C; TSUKAMOTO K, 1992, PIGM CELL RES, P181; VARKI A, 1982, AM J HUM GENET, V34, P717; VIJAYASARADHI S, 1991, EXP CELL RES, V196, P233, DOI 10.1016/0014-4827(91)90256-T; WINDER AJ, 1993, J CELL SCI, V106, P153; WOLFF K, 1971, ARCH DERMATOL FORSCH, V241, P255, DOI 10.1007/BF00595442; ZHOU BK, 1993, J INVEST DERMATOL, V100, P110, DOI 10.1111/1523-1747.ep12462775	21	89	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4213	4215		10.1074/jbc.270.9.4213	http://dx.doi.org/10.1074/jbc.270.9.4213			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876179	hybrid			2022-12-27	WOS:A1995QK08400009
J	SELBY, CP; SANCAR, A				SELBY, CP; SANCAR, A			STRUCTURE AND FUNCTION OF TRANSCRIPTION-REPAIR COUPLING FACTOR .2. CATALYTIC PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; NUCLEOTIDE EXCISION REPAIR; TERMINATION FACTOR-RHO; STRAND-SPECIFIC REPAIR; ESCHERICHIA-COLI; ECORI ENDONUCLEASE; (A)BC EXCINUCLEASE; CLEAVAGE CENTER; DNA STRAND; INVITRO	The transcription repair coupling factor (TRCF) of Escherichia coli has the so-called helicase motifs, is a DNA-, RNA Pol-, and UvrA-binding protein, and is required for the coupling of repair to transcription, We investigated the potential helicase, transcription termination, and transcription-repair coupling activities of TRCF on various substrates, We found that TRCF does not have a helicase activity on any of the substrates tested, However, the TRCF releases both RNA Pol and the truncated transcript from a transcriptional road block caused by a lesion, a ''missing base,'' or a DNA-bound protein, It does not have any effect on rho-dependent or rho-independent transcriptional termination, However, some premature terminations were induced by TRCF at other sites, The coupling of transcription to repair occurs with supercolied and relaxed circular DNA and with linear DNA. However, the coupling with linear DNA is strongly affected by the length of the DNA and does not occur with fragments in which the lesion is closer than 90 nucleotides to the 5' terminus of the template strand, Under transcription conditions the repair of lesions in the promoter region and up to the eleventh transcribed base is inhibited even in the presence of TRCF, Stimulation of repair in the transcribed strand starts at lesions at +15 nucleotides, Stimulation of repair occurs via facilitating the delivery of the A(2)B(1) complex to the lesion site by the TCRF and can be inhibited by excess UvrA which binds to the TRCF off DNA. In vitro, strand-specific repair is not dependent on the MutL and MutS proteins which have recently been implicated in preferential repair in vivo.			SELBY, CP (corresponding author), UNIV N CAROLINA, SCH MED, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; GAMPER HB, 1982, CELL, V29, P81, DOI 10.1016/0092-8674(82)90092-7; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; KING K, 1989, J BIOL CHEM, V264, P11807; LIN JJ, 1992, MOL MICROBIOL, V6, P2219, DOI 10.1111/j.1365-2958.1992.tb01398.x; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; MULLIGAN ME, 1985, J BIOL CHEM, V260, P3529; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; OH EY, 1987, P NATL ACAD SCI USA, V84, P3638, DOI 10.1073/pnas.84.11.3638; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; ORREN DK, 1990, J BIOL CHEM, V265, P15796; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; RICHARDSON JP, 1993, CRIT REV BIOCHEM MOL, V28, P1, DOI 10.3109/10409239309082571; RUTESHOUSER EC, 1989, J MOL BIOL, V208, P23, DOI 10.1016/0022-2836(89)90085-5; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; THOMAS DC, 1985, J BIOL CHEM, V260, P9875; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; ZOU LL, 1991, J BIOL CHEM, V266, P10201	26	99	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4890	4895		10.1074/jbc.270.9.4890	http://dx.doi.org/10.1074/jbc.270.9.4890			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876262	hybrid			2022-12-27	WOS:A1995QK08400100
J	SAUNIER, B; TOURNIER, C; JACQUEMIN, C; PIERRE, M				SAUNIER, B; TOURNIER, C; JACQUEMIN, C; PIERRE, M			STIMULATION OF MITOGEN-ACTIVATED PROTEIN-KINASE BY THYROTROPIN IN PRIMARY CULTURED HUMAN THYROID-FOLLICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; MAP KINASE; CYCLIC-AMP; PHOSPHOLIPASE-C; TSH RECEPTOR; CELLS; PHOSPHORYLATION; INHIBITION; PATHWAY; PROLIFERATION	In the thyroid, thyrotropin (TSH) stimulates both growth and function, and stimulates the production of cAMP which reproduces most of the effects of TSH, Here, we report evidence that TSH stimulates the mitogen-activated protein (MAP) kinase cascade through a cAMP-independent pathway, in human thyroid. TSH stimulated MAP kinase activity (4-9-fold the basal level) measured in the cytosolic fractions of primary cultured thyroid follicles. Maximal activity was reached after 20 min and remained sustained for 1-3 h, TSH being as potent as EGF; EC(50) was 1.5 nM TSH. Only a single isoform of MAP kinase (p42) was detected in the follicles. p42 was phosphorylated on tyrosine residues and showed a reduced electrophoretic mobility in follicles stimulated by TSH, All these effects on MAP kinase were decreased by preincubation of the follicles with human anti-TSH receptor antibodies. The stimulation of MAP kinase by TSH was neither blocked by pertussis toxin nor reproduced by forskolin, cholera toxin, or 8-bromo-cAMP. In conclusion, in human thyroid cells, in contrast with previous observations on dog thyroid cells, TSH stimulates strongly MAP kinase through a pertussis toxin-insensitive and cAMP-independent pathway.			SAUNIER, B (corresponding author), INSERM,U96,80 RUE GEN LECLERC,F-94276 LE KREMLIN BICETR,FRANCE.			Saunier, Bertrand/0000-0002-0700-3082				ALBLAS J, 1993, J BIOL CHEM, V268, P22235; ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COOK S, 1994, NATURE, V369, P361, DOI 10.1038/369361a0; CORDA D, 1988, HORIZONS ENDOCRINOLO, P169; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DERWAHL M, 1993, BIOCHEM BIOPH RES CO, V191, P1131, DOI 10.1006/bbrc.1993.1334; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; FAURE M, 1994, J BIOL CHEM, V269, P7851; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GRAFF I, 1987, FEBS LETT, V210, P204, DOI 10.1016/0014-5793(87)81338-8; GRANOT Y, 1993, J BIOL CHEM, V268, P9564; HAYE B, 1973, FEBS LETT, V30, P253, DOI 10.1016/0014-5793(73)80664-7; HOWE LR, 1993, J BIOL CHEM, V268, P20717; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KUPPERMAN E, 1993, MOL CELL BIOL, V13, P4477, DOI 10.1128/MCB.13.8.4477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMY F, 1993, J BIOL CHEM, V268, P8398; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; MADEC AM, 1988, ENDOCRINOLOGY, V123, P2062, DOI 10.1210/endo-123-4-2062; MISRAHI M, 1994, EUR J BIOCHEM, V222, P711, DOI 10.1111/j.1432-1033.1994.tb18916.x; NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P151; ORGIAZZI JJ, 1990, THYROID GLAND, P405; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; QIAN NX, 1993, P NATL ACAD SCI USA, V90, P4077, DOI 10.1073/pnas.90.9.4077; ROGER PP, 1982, FEBS LETT, V144, P209, DOI 10.1016/0014-5793(82)80639-X; ROGER PP, 1987, BIOCHEM BIOPH RES CO, V149, P707, DOI 10.1016/0006-291X(87)90425-6; SAUNIER B, 1993, EUR J BIOCHEM, V218, P1091, DOI 10.1111/j.1432-1033.1993.tb18469.x; TOURNIER C, 1995, IN PRESS EUR J BIOCH; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; VILLONE G, 1993, MOL CELL ENDOCRINOL, V95, P85, DOI 10.1016/0303-7207(93)90032-F; WESTERMARK K, 1982, EXP CELL RES, V138, P47, DOI 10.1016/0014-4827(82)90089-1; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	42	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3693	3697		10.1074/jbc.270.8.3693	http://dx.doi.org/10.1074/jbc.270.8.3693			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876108	hybrid			2022-12-27	WOS:A1995QH68800037
J	LIN, RT; GEWERT, D; HISCOTT, J				LIN, RT; GEWERT, D; HISCOTT, J			DIFFERENTIAL TRANSCRIPTIONAL ACTIVATION IN-VITRO BY NF-KAPPA-B/REL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-INTERFERON GENE; VIRUS-INDUCIBLE ENHANCER; DNA-BINDING SUBUNIT; B PROTEINS; REGULATORY ELEMENTS; NUCLEAR FACTOR; PROTO-ONCOGENE; REL ONCOGENE; C-REL; IFN	Distinct NF-kappa B subunit combinations contribute to the specificity of NF-kappa B-mediated transcriptional activation and to the induction of multiple cytokine genes including interferon-beta (IFN-beta). To evaluate the regulatory influence of different homo- and heterodimers, NF-kappa B subunits were analyzed for transcriptional activity in vitro using test templates containing two types of NF-kappa B recognition elements (the human immunodeficiency virus type 1 enhancer and the IFN-beta-positive regulatory domain II (PRDII)) as well as IFN-beta PRDIII-PRDI-PRDII linked to the -56 minimal promoter of rabbit beta-globin. Recombinant NF-kappa B subunits (p50, p65, c-Rel, p52, and I kappa B alpha) and interferon regulatory factor 1 were produced from either Escherichia coli or baculovirus expression systems, Transcriptional analysis in vitro demonstrated that 1) various dimeric complexes of NF-kappa B differentially stimulated transcription through the human immunodeficiency virus enhancer or PRDII up to 20-fold; 2) recombinant I kappa B alpha specifically inhibited NF-kappa B-dependent transcription in vitro; and 3) different NF-kappa B complexes and interferon regulatory factor 1 cooperated to stimulate transcription in vitro through the PRDIII-PRDI-PRDII virus-inducible regulatory domains of the IFN-beta promoter. These results demonstrate the role of NF-kappa B protein dimerization in differential transcriptional activation in vitro and emphasize the role of cooperativity between transcription factor families as an additional regulatory level to maintain transcriptional specificity.	MCGILL UNIV, JEWISH GEN HOSP, LADY DAVIS INST MED RES, TERRY FOX MOLEC ONCOL GRP, MONTREAL, PQ H3T 1E2, CANADA; MCGILL UNIV, DEPT MICROBIOL & IMMUNOL, MONTREAL, PQ H3T 1E2, CANADA; MCGILL UNIV, DEPT MED, MONTREAL, PQ H3T 1E2, CANADA; WELLCOME FDN LTD, DEPT CELL BIOL, BECKENHAM BR3 3BS, KENT, ENGLAND	Lady Davis Institute; McGill University; McGill University; McGill University; GlaxoSmithKline			Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503				BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOURS V, 1992, MOL CELL BIOL, V12, P685, DOI 10.1128/MCB.12.2.685; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; BROWNELL E, 1989, ONCOGENE, V4, P935; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CHANG CC, 1994, ONCOGENE, V9, P923; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN L, 1992, VIROLOGY, V191, P589, DOI 10.1016/0042-6822(92)90234-G; COHEN L, 1992, J CELL PHYSIOL, V152, P10, DOI 10.1002/jcp.1041520103; COHEN L, 1991, CELL GROWTH DIFFER, V2, P3233; CROSTON GE, 1992, GENE DEV, V6, P2270, DOI 10.1101/gad.6.12a.2270; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1991, TRENDS GENET, V7, P318, DOI 10.1016/0168-9525(91)90200-A; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; HANSEN SK, 1994, MOL CELL BIOL, V14, P2593, DOI 10.1128/MCB.14.4.2593; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; HISCOTT J, 1989, J VIROL, V63, P2557, DOI 10.1128/JVI.63.6.2557-2566.1989; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; KAUFMAN PA, 1992, J CLIN INVEST, V90, P121, DOI 10.1172/JCI115824; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KRETZSCHMAR M, 1992, GENE DEV, V6, P761, DOI 10.1101/gad.6.5.761; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LANOIX J, 1994, ONCOGENE, V9, P841; LEBAIL O, 1993, EMBO J, V12, P5042; LEBLANC JF, 1990, MOL CELL BIOL, V10, P3987, DOI 10.1128/MCB.10.8.3987; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Leveillard Thierry, 1993, Gene Expression, V3, P135; LIN RT, 1994, J BIOL CHEM, V269, P17542; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MANIATIS T, 1992, TRANSCRIPTIONAL REGU, P1193; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MIYAMOTO M, 1994, MOL CELL BIOL, V14, P3276; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; XU X, 1993, MOL CELL BIOL, V13, P6733, DOI 10.1128/MCB.13.11.6733; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	75	100	100	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3123	3131		10.1074/jbc.270.7.3123	http://dx.doi.org/10.1074/jbc.270.7.3123			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852394	hybrid			2022-12-27	WOS:A1995QG47100037
J	BUCHHOLZ, D; SCOTT, P; SHASTRI, N				BUCHHOLZ, D; SCOTT, P; SHASTRI, N			PRESENTATION WITHOUT PROTEOLYTIC CLEAVAGE OF ENDOGENOUS PRECURSORS IN THE MHC CLASS-I ANTIGEN-PROCESSING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DROSOPHILA-MELANOGASTER CELLS; PROTEASOME-RELATED GENE; T-CELLS; VIRAL PEPTIDES; LYMPHOCYTES-T; LINKED LMP; MOLECULES; RECOGNITION; SUBUNITS	The antigen presentation pathway yields peptide-MHC class I complexes on the antigen presenting cell (APC) surface for recognition by appropriate T-cells. Expression of the peptide MHC complex on APC surface is preceded by several steps that include the generation of peptide fragments in the cytoplasm and their assembly with MHC molecules in the endoplasmic reticulum. It is now clear that MHC binding to optimally processed peptides in the endoplasmic reticulum is obligatory for their stable expression on the cell surface. However, whether a similar obligatory relationship exists between generation of processed peptides and their expression as peptide-MHC on APC surface is not known. Here, we addressed this question by analyzing the processing of ovalbumin (aa257-264, SL8) or influenza nucleoprotein (aa366-374, AM9) analogs. We examined the generation of naturally processed peptides using pre cursors that did, or did not, contain residues flanking the optimal MHC binding peptides. By characterizing the peptides generated from these precursors by T-cell stimulation assays and by high performance liquid chromatography analysis, we established that intracellular assembly of peptide-MHC complexes and their expression on the cell surface can occur with peptides that lack flanking residues. The presentation of these endogenously synthesized perfect fit peptides demonstrates that the cleavage of precursor polypeptides is an independent step in the antigen presentation pathway.	UNIV CALIF BERKELEY,DEPT MOLEC CELL BIOL,DIV IMMUNOL,BERKELEY,CA 94720	University of California System; University of California Berkeley					NIAID NIH HHS [AI-26604] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026604, R21AI026604] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BACIK I, 1994, J IMMUNOL, V152, P381; BLUESTONE JA, 1992, J EXP MED, V176, P1757, DOI 10.1084/jem.176.6.1757; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CATIPOVIC B, 1992, J EXP MED, V176, P1611, DOI 10.1084/jem.176.6.1611; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DICK LR, 1994, J IMMUNOL, V152, P3884; EISENLOHR LC, 1909, CELL, V71, P963; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FALK K, 1993, CELL IMMUNOL, V150, P447, DOI 10.1006/cimm.1993.1212; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HEATH WR, 1989, NATURE, V341, P749, DOI 10.1038/341749a0; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; JOYCE S, 1994, P NATL ACAD SCI USA, V91, P4145, DOI 10.1073/pnas.91.10.4145; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAPHAM CK, 1993, J EXP MED, V177, P1633, DOI 10.1084/jem.177.6.1633; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MALARKANNAN S, 1995, J IMMUNOL, V154, P585; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V1, P213; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHASTRI N, 1993, J IMMUNOL, V150, P2724; SHASTRI N, 1995, J BIOL CHEM, V270, P1088, DOI 10.1074/jbc.270.3.1088; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TOWNSEND ARM, 1984, CELL, V39, P13, DOI 10.1016/0092-8674(84)90187-9; UDAKA K, 1993, P NATL ACAD SCI USA, V90, P11272, DOI 10.1073/pnas.90.23.11272; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VANBLEEK GM, 1990, NATURE, V348, P213; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; YEWDELL J, 1994, J IMMUNOL, V152, P1163; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	66	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6515	6522		10.1074/jbc.270.12.6515	http://dx.doi.org/10.1074/jbc.270.12.6515			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896786	hybrid			2022-12-27	WOS:A1995QQ85500016
J	KNAB, AM; FERTALA, J; BJORNSTI, MA				KNAB, AM; FERTALA, J; BJORNSTI, MA			A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I MUTANT EXHIBITS ALTERED SENSITIVITIES TO OTHER DNA TOPOISOMERASE POISONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE TYROSINE; ANTITUMOR AGENT; CYTO-TOXICITY; CELL-CYCLE; CLEAVAGE; YEAST; INDUCTION; ANALOGS; REPLICATION; DERIVATIVES	The cytotoxic plant alkaloid camptothecin promotes DNA topoisomerase I-linked nicks in DNA by stabilizing a covalently bound enzyme-DNA complex. In the yeast Saccharomyces cerevisiae, substitution of Arg and Ala for the amino acid residues immediately N-terminal to the active site tyrosine in the yeast and human DNA topoisomerase I mutants, top1 vac, results in camptothecin resistance. To examine the mechanism of drug resistance, we assessed the sensitivity of these enzymes to several classes of DNA topoisomerase poisons, Yeast cells expressing the camptothecin-resistant top1 vac mutants were resistant to all of the camptothecin derivatives cytotoxic to wild-type TOP1-expressing cells. This correlated with a significant reduction in drug-induced DNA cleavage in vitro. However, the yeast and human mutant enzymes differed in their responses to the minor groove binding ligand netropsin and to saintopin, a DNA intercalator that targets both DNA topoisomerase I and II. The yeast mutant enzyme demonstrated enhanced sensitivity to the action of saintopin but was resistant to the inhibitory effects of netropsin. In contrast, the human Top1 vac enzyme was resistant to saintopin and indistinguishable from the wild-type enzyme in its response to the netropsin, These results are discussed in terms of enzyme function and the different modes of action of these DNA topoisomerase poisons.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University					NCI NIH HHS [CA58755] Funding Source: Medline; NIGMS NIH HHS [GM44810] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058755] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSEN AH, 1985, NUCLEIC ACIDS RES, V13, P1543, DOI 10.1093/nar/13.5.1543; BENEDETTI P, 1993, CANCER RES, V53, P4343; BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; BJORNSTI MA, 1989, CANCER RES, V49, P6318; BJORNSTI MA, 1994, CANCER CHEMOTHER PHA, V34, P51; Bjornsti MA, 1991, CURR OPIN STRUC BIOL, V1, P99, DOI 10.1016/0959-440X(91)90017-N; BOROS I, 1984, GENE, V30, P257, DOI 10.1016/0378-1119(84)90130-6; CHAMPOUX JJ, 1989, J BIOL CHEM, V264, P1010; Champoux JJ, 1990, DNA TOPOLOGY ITS BIO, P217; CHEN AY, 1993, CANCER RES, V53, P1332; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; DARPA P, 1990, CANCER RES, V50, P6919; DELBINO G, 1990, CANCER RES, V50, P5746; ENG WK, 1988, MOL PHARMACOL, V34, P755; FUJII N, 1993, J BIOL CHEM, V268, P13160; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; GUPTA M, 1992, J BIOL CHEM, V269, P573; HERTZBERG RP, 1990, J BIOL CHEM, V265, P19287; HOLM C, 1989, CANCER RES, V49, P6365; HORWITZ MS, 1971, BIOCHEM BIOPH RES CO, V45, P723; HOUGHTON PJ, 1993, CANCER RES, V53, P2823; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; HSIANG YH, 1989, CANCER RES, V49, P4385; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAXEL C, 1991, J BIOL CHEM, V266, P20418; KINGSBURY WD, 1991, J MED CHEM, V34, P98, DOI 10.1021/jm00105a017; KNAB AM, 1993, J BIOL CHEM, V268, P22322; LETEURTRE F, 1994, J BIOL CHEM, V269, P28702; LEVIN NA, 1993, GENETICS, V133, P799; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; PODDEVIN B, 1993, MOL PHARMACOL, V44, P767; POTMESIL M, 1994, CANCER RES, V54, P1431; POTMESIL M, 1991, DNA TOPOISOMERASES C, P299; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P9793, DOI 10.1073/pnas.86.24.9793; SNOUNOU G, 1983, J MOL BIOL, V167, P211, DOI 10.1016/S0022-2836(83)80043-6; WALL ME, 1991, DNA TOPOISOMERASES C, P93; Wang J. C., 1990, DNA TOPOLOGY ITS BIO, P321; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WANI MC, 1987, J MED CHEM, V30, P1774, DOI 10.1021/jm00393a016; YAMASHITA Y, 1991, BIOCHEMISTRY-US, V30, P5838, DOI 10.1021/bi00238a005; YAMASHITA Y, 1992, BIOCHEMISTRY-US, V31, P12069, DOI 10.1021/bi00163a015	45	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6141	6148		10.1074/jbc.270.11.6141	http://dx.doi.org/10.1074/jbc.270.11.6141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890748	hybrid			2022-12-27	WOS:A1995QM94500064
J	MATLACK, KES; WALTER, P				MATLACK, KES; WALTER, P			THE 70 CARBOXYL-TERMINAL AMINO-ACIDS OF NASCENT SECRETORY PROTEINS ARE PROTECTED FROM PROTEOLYSIS BY THE RIBOSOME AND THE PROTEIN TRANSLOCATION APPARATUS OF THE ENDOPLASMIC-RETICULUM MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION PARTICLE RECEPTOR; IMMUNOGLOBULIN LIGHT-CHAINS; MICROSOMAL MEMBRANE; PHOTOCROSS-LINKING; SIGNAL SEQUENCE; ER; INSERTION; COMPLEX; SEC61P; IDENTIFICATION	We have used proteolysis to examine the environment through which nascent secretory proteins are translocated across the membrane of the endoplasmic reticulum. After solubilization of rough microsomes with detergent, fragments comprised of the approximately 70 carboxyl-terminal amino acids of translocating nascent chains initiated and targeted in vivo were protected from digestion by added proteases. About 40 amino acids of nascent chains were protected from proteolysis by the ribosome; thus, membrane-derived components protect an additional 30 amino acids, Under conditions in which those 30 additional amino acids are protected, only a small set of integral membrane proteins remained associated with the ribosome. These proteins include the Sec61 complex previously identified as the core component of the membrane-bound protein translocation apparatus, These results support the concept of a translocation pore that makes intimate contact with the ribosome and thereby protects nascent chains from proteolytic digestion for an additional, constant length.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco								BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; GLABE CG, 1980, J BIOL CHEM, V255, P9236; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; HIGH S, 1993, J BIOL CHEM, V268, P26745; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; KUHN LA, 1985, BIOCHIM BIOPHYS ACTA, V828, P351, DOI 10.1016/0167-4838(85)90316-4; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; MAURER HR, 1972, Z KLIN CHEM KLIN BIO, V10, P220; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; MUSCH A, 1992, CELL, V69, P343, DOI 10.1016/0092-8674(92)90414-8; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; SCHEELE G, 1980, J CELL BIOL, V87, P611, DOI 10.1083/jcb.87.3.611; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; TAJIMA S, 1986, J CELL BIOL, V103, P1167, DOI 10.1083/jcb.103.4.1167; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WIEDMANN M, 1989, FEBS LETT, V257, P263, DOI 10.1016/0014-5793(89)81549-2; YOSHIDA H, 1987, BIOCHEM J, V245, P811, DOI 10.1042/bj2450811	36	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6170	6180		10.1074/jbc.270.11.6170	http://dx.doi.org/10.1074/jbc.270.11.6170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890751	hybrid			2022-12-27	WOS:A1995QM94500068
J	PEREZSALA, D; COLLADOESCOBAR, D; MOLLINEDO, F				PEREZSALA, D; COLLADOESCOBAR, D; MOLLINEDO, F			INTRACELLULAR ALKALINIZATION SUPPRESSES LOVASTATIN-INDUCED APOPTOSIS IN HL-60 CELLS THROUGH THE INACTIVATION OF A PH-DEPENDENT ENDONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PROTEIN-KINASE-C; TUMOR-NECROSIS-FACTOR; NA+/H+ ANTIPORT; ISOPRENOID METABOLISM; SIGNAL-TRANSDUCTION; DNA FRAGMENTATION; U937 CELLS; ACTIVATION; DEATH	Protein isoprenylation is a post-translational modification essential for the biological activity of G-proteins. Inhibition of protein isoprenylation by lovastatin (LOV) induces apoptosis in HL-60 cells, a process of active cell death characterized by the internucleosomal degradation of genomic DNA. In this article we show that LOV-induced apoptosis is associated with intracellular acidification and that activation of the Na+/H+ antiporter induces a raise in pH(i) which is sufficient to prevent or arrest DNA digestion. First, LOV induced a decrease in pH(i) which was dose-dependent and correlated with the extent of DNA degradation, Flow cytometry analysis revealed that this acidification was due to the appearance of a subpopulation of cells whose pH(i) was 0.9 pH units below control values, Cell sorting experiments demonstrated that DNA degradation had occurred only in those cells which had suffered intracellular acidification, LOV-induced apoptosis could be suppressed by me valonate supplementation, inhibition of protein synthesis, and protein kinase C activation by phorbol myristate acetate, In all three cases, intracellular acidification was abolished. Inhibition of the Na+/H+ antiporter by 5-N-ethyl-N-isopropyl amiloride induced DNA degradation in HL-60 cells per se and suppressed the protective effect of phorbol myristate acetate, LOV-induced intracellular acidification was not due to a complete inhibition of the Na+/H+ antiporter, In fact, LOV-treated cells were able to respond to phorbol myristate acetate stimulation of the Na+/H+ antiporter with a marked increase in pH,. This effect was accompanied by a rapid arrest of DNA digestion, These observations illustrate the strong pH dependence of LOV-induced DNA degradation, thus providing a connection between the activation of the Na+/H+ antiporter and the suppression of apoptosis.	CSIC,INST LOPEZ NEYRA,GRANADA,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	PEREZSALA, D (corresponding author), CSIC,CTR INVEST BIOL,C VELAZQUEZ 144,E-28006 MADRID,SPAIN.		Perez-Sala, Dolores/L-5969-2014	Perez-Sala, Dolores/0000-0003-0600-665X				AIHARA H, 1991, P NATL ACAD SCI USA, V88, P11062, DOI 10.1073/pnas.88.24.11062; ALVAREZ J, 1989, EUR J BIOCHEM, V183, P709, DOI 10.1111/j.1432-1033.1989.tb21102.x; ARELLANO R, 1993, FEBS LETT, V332, P247, DOI 10.1016/0014-5793(93)80642-8; BARBER DL, 1992, J BIOL CHEM, V267, P20607; BARRY MA, 1993, CANCER RES, V53, P2349; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; BARRY MA, 1992, BIOCHEM BIOPH RES CO, V186, P782, DOI 10.1016/0006-291X(92)90814-2; BOKOCH GM, 1992, J CLIN INVEST, V89, P402, DOI 10.1172/JCI115599; CACERESCORTES J, 1994, J BIOL CHEM, V269, P12084; CASEY PJ, 1992, J LIPID RES, V33, P1731; COHEN JJ, 1984, J IMMUNOL, V132, P38; COLLINS MKL, 1993, TRENDS BIOCHEM SCI, V18, P307, DOI 10.1016/0968-0004(93)90042-L; CUTTS JL, 1989, J CELL PHYSIOL, V139, P550, DOI 10.1002/jcp.1041390314; DEANIN GG, 1991, J IMMUNOL, V146, P3528; DHANASEKARAN N, 1994, J BIOL CHEM, V269, P11802; FENTON RG, 1992, J CELL BIOL, V117, P347, DOI 10.1083/jcb.117.2.347; FLIEGEL L, 1993, BIOCHEM J, V296, P273, DOI 10.1042/bj2960273; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GONG JP, 1993, J CELL PHYSIOL, V157, P263; GREENBLATT MS, 1992, BLOOD, V80, P1339; JAKOBISIAK M, 1991, P NATL ACAD SCI USA, V88, P3628, DOI 10.1073/pnas.88.9.3628; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; LADOUX A, 1988, EUR J BIOCHEM, V175, P455, DOI 10.1111/j.1432-1033.1988.tb14216.x; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lee S, 1993, CURR OPIN CELL BIOL, V5, P286, DOI 10.1016/0955-0674(93)90118-A; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LI GD, 1993, BIOCHEM J, V289, P379, DOI 10.1042/bj2890379; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; MCCONKEY DJ, 1989, FASEB J, V3, P1843, DOI 10.1096/fasebj.3.7.2497041; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MOLENAAR WH, 1983, NATURE, V304, P645; MUSGROVE E, 1986, CYTOMETRY, V7, P347, DOI 10.1002/cyto.990070409; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; NG LL, 1991, AM J PHYSIOL, V261, pC780, DOI 10.1152/ajpcell.1991.261.5.C780; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAJOTTE D, 1992, J BIOL CHEM, V267, P9980; RESTREPO D, 1988, J GEN PHYSIOL, V92, P489, DOI 10.1085/jgp.92.4.489; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SIFFERT W, 1990, J BIOL CHEM, V265, P15441; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VAIRO G, 1992, J BIOL CHEM, V267, P19043; VALLANCE SJ, 1990, BIOCHEM J, V265, P359, DOI 10.1042/bj2650359; VAUX DL, 1993, MOL CELL BIOL, V13, P7000, DOI 10.1128/MCB.13.11.7000; VIGNE P, 1983, BIOCHEM BIOPH RES CO, V116, P86, DOI 10.1016/0006-291X(83)90384-4; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G	50	292	302	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6235	6242		10.1074/jbc.270.11.6235	http://dx.doi.org/10.1074/jbc.270.11.6235			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890761	Green Submitted, hybrid			2022-12-27	WOS:A1995QM94500078
J	SPITZNER, JR; CHUNG, IK; MULLER, MT				SPITZNER, JR; CHUNG, IK; MULLER, MT			DETERMINATION OF 5' AND 3' DNA TRIPLEX INTERFERENCE BOUNDARIES REVEALS THE CORE DNA-BINDING SEQUENCE FOR TOPOISOMERASE-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED DNA; DOUBLE-HELICAL DNA; EUKARYOTIC TOPOISOMERASE; ANTITUMOR DRUGS; CLEAVAGE SITES; GENOMIC DNA; SINGLE-SITE; INHIBITION; YEAST; TRANSCRIPTION	Previous studies have shown that formation of intermolecular DNA triplexes at sequences that overlap protein binding sites inhibits DNA binding by these proteins. We show that DNA cleavage by eukaryotic topoisomerase II is blocked by tripler formation at sites overlapping and adjacent to the triple binding site. To map precisely the boundaries of tripler interference, we constructed a vector containing enzyme binding sites of different lengths and flanked both 5' and 3' by DNA triplexes. We call this method Tripler Interference Mapping by Binding Element Replacement (TIMBER). Triplex regions within 3 bases 5' or 7 bases 3' of cleavage sites blocked DNA cleavage; tripler formation outside of this region had no effect upon cleavage activity. We conclude that topoisomerase II binding requires unhindered access to the major groove of a duplex DNA binding site in this 10-base region. In addition, the inclusion of topoisomerase II inhibitors yielded the same results for the tripler interference assays despite alterations in DNA cleavage site selection. The statistical analyses of over 500 topoisomerase II cleavage sites (in the presence or absence of inhibitors) suggest a model consistent with the region spanning -3 to +7 (relative to the cleavage site) containing most of the base-specific contacts for topoisomerase II. This tripler interference assay may prove valuable in the characterization of DNA binding sites for other proteins as well, particularly in conjunction with deletion analysis.	OHIO STATE UNIV, DEPT MOLEC GENET, COLUMBUS, OH 43210 USA	Ohio State University					NIAID NIH HHS [AI128362] Funding Source: Medline; NIGMS NIH HHS [GM-14335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI128362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM014335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOOTHMAN DA, 1989, CANCER RES, V49, P605; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P6611, DOI 10.1093/nar/18.22.6611; CAPRANICO G, 1990, BIOCHEMISTRY-US, V29, P562, DOI 10.1021/bi00454a033; CAPRANICO G, 1994, J MOL BIOL, V235, P1218, DOI 10.1006/jmbi.1994.1075; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CHUNG IK, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P105; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; DIDONATO JA, 1991, J MOL BIOL, V219, P451, DOI 10.1016/0022-2836(91)90186-A; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DUVALVALENTIN G, 1992, P NATL ACAD SCI USA, V89, P504, DOI 10.1073/pnas.89.2.504; FOSSE P, 1991, NUCLEIC ACIDS RES, V19, P2861, DOI 10.1093/nar/19.11.2861; FRANCOIS JC, 1989, J BIOL CHEM, V264, P5891; Gootz Thomas D., 1993, P139; HANVEY JC, 1990, NUCLEIC ACIDS RES, V18, P157, DOI 10.1093/nar/18.1.157; HARTMAN DA, 1992, J BIOL CHEM, V267, P5488; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HUANG CC, 1992, BIOCHEMISTRY-US, V31, P993, DOI 10.1021/bi00119a007; KIESSLING LL, 1992, BIOCHEMISTRY-US, V31, P2829, DOI 10.1021/bi00125a026; LEDOAN T, 1987, NUCLEIC ACIDS RES, V15, P8643, DOI 10.1093/nar/15.21.8643; LEE MP, 1989, J BIOL CHEM, V264, P21779; LUND K, 1990, J BIOL CHEM, V265, P13856; LYAMICHEV VI, 1988, NUCLEIC ACIDS RES, V16, P2165, DOI 10.1093/nar/16.5.2165; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; MULLER MT, 1988, BIOCHEMISTRY-US, V27, P8369, DOI 10.1021/bi00422a012; NELSON EM, 1984, P NATL ACAD SCI-BIOL, V81, P1361, DOI 10.1073/pnas.81.5.1361; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; POMMIER Y, 1991, J MOL BIOL, V222, P909, DOI 10.1016/0022-2836(91)90585-T; POVSIC TJ, 1990, J AM CHEM SOC, V112, P9428, DOI 10.1021/ja00181a075; PRASEUTH D, 1988, P NATL ACAD SCI USA, V85, P1349, DOI 10.1073/pnas.85.5.1349; RAJAGOPAL P, 1989, BIOCHEMISTRY-US, V28, P7859, DOI 10.1021/bi00445a048; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; ROY C, 1993, NUCLEIC ACIDS RES, V21, P2845, DOI 10.1093/nar/21.12.2845; Sambrook J, 1989, MOL CLONING LABORATO; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; SPITZLEY T, 1989, RATIO, V2, P63, DOI 10.1111/j.1467-9329.1989.tb00127.x; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; STORMO GD, 1990, METHOD ENZYMOL, V183, P211; STORMO GD, 1988, ANNU REV BIOPHYS BIO, V17, P241; STROBEL SA, 1991, NATURE, V350, P172, DOI 10.1038/350172a0; STROBEL SA, 1988, J AM CHEM SOC, V110, P7927, DOI 10.1021/ja00231a082; STROBEL SA, 1990, SCIENCE, V249, P73, DOI 10.1126/science.2195655; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	49	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5932	5943		10.1074/jbc.270.11.5932	http://dx.doi.org/10.1074/jbc.270.11.5932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890724	hybrid			2022-12-27	WOS:A1995QM94500037
J	BENZ, DJ; MOL, M; EZAKI, M; MORIITO, N; ZELAN, I; MIYANOHARA, A; FRIEDMANN, T; PARTHASARATHY, S; STEINBERG, D; WITZTUM, JL				BENZ, DJ; MOL, M; EZAKI, M; MORIITO, N; ZELAN, I; MIYANOHARA, A; FRIEDMANN, T; PARTHASARATHY, S; STEINBERG, D; WITZTUM, JL			ENHANCED LEVELS OF LIPOPEROXIDES IN LOW-DENSITY-LIPOPROTEIN INCUBATED WITH MURINE FIBROBLASTS EXPRESSING HIGH-LEVELS OF HUMAN 15-LIPOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; POLYMERASE CHAIN-REACTION; SMOOTH-MUSCLE CELLS; OXIDATIVE MODIFICATION; MESSENGER-RNA; LIPID-PEROXIDATION; HUMAN-MONOCYTES; SUPEROXIDE; LIPOXYGENASE; RECEPTOR	There is strong experimental evidence that oxidized low density lipoprotein (Ox-LDL) plays an important role in atherosclerosis. However, the mechanisms by which Ox-LDL is formed in vivo are unknown. To test whether 15 lipoxygenase (15-LO) could play a role in oxidation of LDL by cells, we expressed 15-LO activity in murine fibroblasts, which do not normally have 15-LO activity, and tested their ability to modify LDL. Using a retroviral vector, we prepared fibroblasts that expressed 2- to more 15-LO activity than 20-fold control fibroblasts infected with a vector containing beta-galactosidase (lacZ). Compared with LDL incubated with lacZ cells, LDL incubated with 15-LO-containing cells were enriched with lipid hydroperoxides. When these LDL samples were subsequently subjected to oxidative stress, they were more susceptible to further oxidative modification, as judged by increased conjugated diene formation and by increased ability to compete with I-125-Ox-LDL for uptake by macrophages. These findings establish that cellular 15-LO can contribute to oxidative modification of LDL, but the quantitative significance of these findings to the in vivo oxidation of LDL remains to be established.	UNIV CALIF SAN DIEGO, DEPT MED, DIV ENDOCRINOL METAB, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego			Parthasarathy, Sampath/AAP-3361-2020; Parthasarathy, Sampath/G-5602-2011		NHLBI NIH HHS [5 P50 HL14197-23] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014197] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON KM, 1992, CLIN BIOCHEM, V25, P1, DOI 10.1016/0009-9120(92)80038-I; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CATHCART MK, 1989, J IMMUNOL, V142, P1963; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; DERIAN CK, 1992, PROSTAG LEUKOTR ESS, V45, P49, DOI 10.1016/0952-3278(92)90102-O; FUNK CD, 1991, J BIOL CHEM, V266, P12508; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; HEINECKE JW, 1987, J BIOL CHEM, V262, P10098; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; HIRAMATSU K, 1987, ARTERIOSCLEROSIS, V7, P55, DOI 10.1161/01.ATV.7.1.55; JIALAL I, 1991, ARTERIOSCLER THROMB, V11, P482, DOI 10.1161/01.ATV.11.3.482; KHOUW AS, 1993, J LIPID RES, V34, P1483; KUHN H, 1992, EICOSANOIDS, V5, P17; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; LEAKE DS, 1990, BIOCHEM J, V270, P741, DOI 10.1042/bj2700741; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH SM, 1993, J LIPID RES, V34, P1745; MCNALLY AK, 1990, J IMMUNOL, V145, P254; MIYANOHARA A, 1988, P NATL ACAD SCI USA, V85, P6538, DOI 10.1073/pnas.85.17.6538; NOGUCHI N, 1992, BIOCHEM PHARMACOL, V44, P39, DOI 10.1016/0006-2952(92)90035-H; O'Leary Vanessa, 1993, Biochemical Society Transactions, V21, p89S; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; PARTHASARATHY S, 1987, BIOCHIM BIOPHYS ACTA, V917, P337, DOI 10.1016/0005-2760(87)90139-1; PHILISTAIMIKAS A, 1995, IN PRESS ARTERIOSCLE; RANKIN SM, 1991, J LIPID RES, V32, P449; SATTLER W, 1994, ARCH BIOCHEM BIOPHYS, V309, P214, DOI 10.1006/abbi.1994.1105; SHARKEY MF, 1990, J LIPID RES, V31, P2167; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; SIGAL E, 1994, ANN NY ACAD SCI, V714, P211, DOI 10.1111/j.1749-6632.1994.tb12046.x; SIMON TC, 1989, THROMB RES, V55, P171, DOI 10.1016/0049-3848(89)90433-7; SPARROW CP, 1992, P NATL ACAD SCI USA, V89, P128, DOI 10.1073/pnas.89.1.128; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1988, BIOCHIM BIOPHYS ACTA, V959, P20, DOI 10.1016/0005-2760(88)90145-2; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; YLAHERTTULA S, 1994, CIRCULATION, V90, P135	40	99	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5191	5197		10.1074/jbc.270.10.5191	http://dx.doi.org/10.1074/jbc.270.10.5191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890629	hybrid, Green Published			2022-12-27	WOS:A1995QL58000038
J	BHANDARI, B; WENZEL, UO; MARRA, F; ABBOUD, HE				BHANDARI, B; WENZEL, UO; MARRA, F; ABBOUD, HE			A NUCLEAR-PROTEIN IN MESANGIAL CELLS THAT BINDS TO THE PROMOTER REGION OF THE PLATELET-DERIVED GROWTH FACTOR-A CHAIN GENE - INDUCTION BY PHORBOL ESTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NF-KAPPA-B; MAJOR HISTOCOMPATIBILITY COMPLEX; GLUTAMINE-SYNTHETASE GENE; VIRUS TYPE-1 ENHANCER; SMOOTH-MUSCLE CELLS; TRANSCRIPTION FACTOR; MESSENGER-RNAS; EXPRESSION; SEQUENCE	Mesangial cells predominantly express platelet-derived growth factor (PDGF)-A chain mRNA and release PDGF. Mesangial cell PDGF-A chain mRNA abundance is regulated by several agents including phorbol esters. We have recently demonstrated that induction of PDGF-A chain mRNA abundance in response to phorbol 12-myristate 13-acetate is primarily due to gene transcription. We have now analyzed the 5'-flanking region of the PDGF-A chain promoter to identify DNA binding protein(s) which have the potential to regulate PDGF-A chain gene transcription in human mesangial cells. DNase I footprint analysis of the 5'-flanking region of the PDGF-A chain promoter identifies a DNase I protected region at the location -82 to -102 corresponding to the sequence 5'-GGCCCGGAATCCGGGGGAGGC-3'. Therefore, nuclear extracts from human mesangial cells contain a protein, PDGF-A-BP-1, that binds to a DNA sequence (-82 to -102) in the promoter region of the PDGF-A chain gene. Gel mobility shift analysis using labeled oligomer corresponding to the binding site for PDGF-A-BP-1 indicates that PDGF-A-BP-1 is induced by phorbol ester in mesangial cells as well as fat-storing cells (>20 fold). Egr-1. protein does not bind to labeled PDGF-A-BP-1 oligomer and does not compete with the binding of PDGF-A-BP-1. In addition, SP-1 binding sequence does not compete with the binding sequence of the mesangial cell protein. PDGF-A-BP-1 appears to represent a novel protein which is induced by phorbol ester and thus has the potential for an important role in the transcriptional regulation of the PDGF-A chain gene in mesangial cells and other vascular pericytes.	AUDIE L MURPHY MEM VET ADM MED CTR,SAN ANTONIO,TX 78284	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	BHANDARI, B (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV NEPHROL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.		Marra, Fabio/K-7263-2016	Marra, Fabio/0000-0001-8629-0878	NIDDK NIH HHS [DK 43988] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043988] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; BHANDARI B, 1993, MOL CELL ENDOCRINOL, V91, P185, DOI 10.1016/0303-7207(93)90271-K; BHANDARI B, 1988, P NATL ACAD SCI USA, V85, P5789, DOI 10.1073/pnas.85.16.5789; BHANDARI B, 1991, J BIOL CHEM, V266, P7784; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; DAYNES RA, 1991, J EXP MED, V174, P1323, DOI 10.1084/jem.174.6.1323; DESCHEEMAEKER KA, 1992, J BIOL CHEM, V267, P15086; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; GALLINARI P, 1989, MOL CELL BIOL, V9, P1566, DOI 10.1128/MCB.9.4.1566; GASHLER AL, 1992, P NATL ACAD SCI USA, V89, P10984, DOI 10.1073/pnas.89.22.10984; HAHN AWA, 1993, J VASC RES, V30, P192, DOI 10.1159/000158994; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; HENSELING U, 1990, MOL CELL BIOL, V10, P4100, DOI 10.1128/MCB.10.8.4100; HUTCHINS JB, 1992, DEV BRAIN RES, V67, P121, DOI 10.1016/0165-3806(92)90213-G; KAVANAUGH WM, 1988, J BIOL CHEM, V263, P8470; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KNAUSS TC, 1990, J BIOL CHEM, V265, P14457; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LENARDO M, 1989, EMBO J, V8, P3351, DOI 10.1002/j.1460-2075.1989.tb08497.x; MAEKAWA T, 1989, J BIOL CHEM, V264, P14591; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; MERCOLA M, 1990, DEV BIOL, V138, P114, DOI 10.1016/0012-1606(90)90181-H; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; RUSTGI AK, 1990, P NATL ACAD SCI USA, V87, P8707, DOI 10.1073/pnas.87.22.8707; Sambrook J, 1989, MOL CLONING LABORATO; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P959, DOI 10.1128/MCB.9.3.959; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; SILVER BJ, 1989, P NATL ACAD SCI USA, V85, P1056; STARKSEN NF, 1987, J BIOL CHEM, V262, P14381; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SUVA LJ, 1991, MOL CELL BIOL, V11, P2503, DOI 10.1128/MCB.11.5.2503; TAKIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P1686, DOI 10.1073/pnas.88.5.1686; WANG ZY, 1992, J BIOL CHEM, V267, P13669; WANG ZY, 1992, J BIOL CHEM, V267, P17022; WU FK, 1988, EMBO J, V7, P2117, DOI 10.1002/j.1460-2075.1988.tb03051.x; YEB HJ, 1991, CELL, V64, P209; ZWIJSEN RML, 1992, BIOCHEM BIOPH RES CO, V186, P1410, DOI 10.1016/S0006-291X(05)81563-3	44	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5541	5548		10.1074/jbc.270.10.5541	http://dx.doi.org/10.1074/jbc.270.10.5541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890673	hybrid			2022-12-27	WOS:A1995QL58000089
J	HALL, A; HAKANSSON, K; MASON, RW; GRUBB, A; ABRAHAMSON, M				HALL, A; HAKANSSON, K; MASON, RW; GRUBB, A; ABRAHAMSON, M			STRUCTURAL BASIS FOR THE BIOLOGICAL SPECIFICITY OF CYSTATIN-C - IDENTIFICATION OF LEUCINE-9 IN THE N-TERMINAL BINDING REGION AS A SELECTIVITY-CONFERRING RESIDUE IN THE INHIBITION OF MAMMALIAN CYSTEINE PEPTIDASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE CYSTATIN; RAY CRYSTAL-STRUCTURE; HUMAN GAMMA-TRACE; PROTEINASE-INHIBITOR; CHICKEN CYSTATIN; ESCHERICHIA-COLI; CATHEPSIN-S; GEL ELECTROPHORESIS; MOLECULAR-CLONING; SEQUENCE-ANALYSIS	The structural basis for the biological specificity of human cystatin C has been investigated. Cystatin C and other inhibitors belonging to family 2 of the cystatin superfamily interact reversibly with target peptidases, seemingly by independent affinity contributions from a wedge-shaped binding region built from two loop-forming inhibitor segments and a binding region corresponding to the N-terminal segment of the inhibitor. Human cystatin C variants with Gly substitutions for residues Arg-8, Leu-9, and/or Val-10 of the N-terminal binding region, and/or the evolutionarily conserved Trp-106 in the wedge shaped binding region, were produced by site-directed mutagenesis and Escherichia coli expression. A total of 10 variants were isolated, structurally verified, and compared to wild-type cystatin C with respect to inhibition of the mammalian cysteine peptidases, cathepsins B, H, L, and S. Varying contributions from the N-terminal binding region and the wedge-shaped binding region to cystatin C affinity for the four target peptidases were observed. Interactions from the side chains of residues in the N-terminal binding region and Trp-106 are jointly responsible for the major part of cystatin C affinity for cathepsin L and are also of considerable importance for cathepsin B and H affinity. In contrast, for cathepsin S inhibition these interactions are of lesser significance, as reflected by a K-i value of 10(-8) M. for the cystatin C variant devoid of Arg-8, Leu-9, Val-10, and Trp 106 side chains. The side chain of Val-10 is responsible for most of the affinity contribution from the N terminal binding region, for all four enzymes. The contribution of the Arg-8 side chain is minor, but significant for cystatin C interaction with cathepsin B. The Leu-9 side chain confers selectivity to the inhibition of the target peptidases; it contributes to cathepsin B and L affinity by factors of 200 and 50, respectively, to cathepsin S binding by a factor of 5 only, and results in a 10-fold decreased affinity between cystatin C and cathepsin H.	ALFRED I DUPONT INST,NEMOURS RES PROGRAMS,DEPT MED CELL BIOL,WILMINGTON,DE 19803; UNIV LUND HOSP,DEPT CLIN CHEM,S-22185 LUND,SWEDEN	Nemours Alfred I. duPont Hospital for Children; Lund University; Skane University Hospital			Abrahamson, Magnus/CAG-9507-2022	Grubb, Anders/0000-0002-0125-3662				ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; ABRAHAMSON M, 1987, FEBS LETT, V216, P229, DOI 10.1016/0014-5793(87)80695-6; ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; AUERSWALD EA, 1992, EUR J BIOCHEM, V209, P837, DOI 10.1111/j.1432-1033.1992.tb17355.x; BALBIN M, 1994, J BIOL CHEM, V269, P23156; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BJORCK L, 1990, J VIROL, V64, P941; BJORK I, 1994, BIOCHEM J, V299, P219, DOI 10.1042/bj2990219; BJORK I, 1992, FEBS LETT, V299, P66, DOI 10.1016/0014-5793(92)80102-M; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BODE W, 1990, BIOL CHEM H-S, V371, P111; BROMME D, 1991, BIOMED BIOCHIM ACTA, V50, P631; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; COLLINS AR, 1991, ANTIMICROB AGENTS CH, V35, P2444, DOI 10.1128/AAC.35.11.2444; DALBOGE H, 1989, GENE, V79, P325, DOI 10.1016/0378-1119(89)90214-X; DIECKMANN T, 1993, J MOL BIOL, V234, P1048, DOI 10.1006/jmbi.1993.1658; FREIJE JP, 1993, J BIOL CHEM, V268, P15737; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; HALL A, 1992, J ENZYM INHIB, V6, P113, DOI 10.3109/14756369209040742; HALL A, 1993, BIOCHEM J, V291, P123, DOI 10.1042/bj2910123; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; ISEMURA S, 1991, J BIOCHEM, V110, P648, DOI 10.1093/oxfordjournals.jbchem.a123634; ISEMURA S, 1986, FEBS LETT, V198, P145, DOI 10.1016/0014-5793(86)81201-7; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; KEPPLER D, 1994, BIOCHEM SOC T, V22, P43, DOI 10.1042/bst0220043; KORANT BD, 1985, BIOCHEM BIOPH RES CO, V127, P1072, DOI 10.1016/S0006-291X(85)80054-1; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; LINDAHL P, 1994, BIOCHEMISTRY-US, V33, P4384, DOI 10.1021/bi00180a036; LINDAHL P, 1992, BIOCHEM J, V286, P165, DOI 10.1042/bj2860165; LUACES AL, 1988, BIOCHEM J, V250, P903, DOI 10.1042/bj2500903; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MASON RW, 1986, BIOCHEM J, V240, P285, DOI 10.1042/bj2400285; MASON RW, 1986, BIOMED BIOCHIM ACTA, V45, P1433; MASON RW, 1993, ADV CELL MOL BIOL M, V1, P81; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; NICKLIN MJH, 1984, BIOCHEM J, V223, P245, DOI 10.1042/bj2230245; NORTH MJ, 1990, PARASITOL TODAY, V6, P270, DOI 10.1016/0169-4758(90)90189-B; OLAFSSON I, 1990, SCAND J CLIN LAB INV, V50, P85, DOI 10.3109/00365519009091569; RAWLINGS ND, 1990, COMPUT APPL BIOSCI, V6, P118; Sambrook J, 1989, MOL CLONING LABORATO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHI GP, 1992, J BIOL CHEM, V267, P7258; XIN XQ, 1992, ARCH BIOCHEM BIOPHYS, V299, P334, DOI 10.1016/0003-9861(92)90283-3	53	112	123	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5115	5121		10.1074/jbc.270.10.5115	http://dx.doi.org/10.1074/jbc.270.10.5115			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890620	hybrid			2022-12-27	WOS:A1995QL58000027
J	LI, CY; SUARDET, L; LITTLE, JB				LI, CY; SUARDET, L; LITTLE, JB			POTENTIAL ROLE OF WAF1/CIP1/P21 AS A MEDIATOR OF TGF-BETA CYTOINHIBITORY EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							COLORECTAL-CANCER; INHIBITION; PROTEIN; KINASES; P21; G1	Transforming growth factor-beta (TGF-beta) inhibits cell cycle progression of many types of human cells by arresting them in the G(1) phase of the cell cycle, The arrest is mediated through interactions of various cyclin-dependent protein kinases (CDKs) and their inhibitors, We demonstrate that treatment with TGF-beta induces increased levels of WAF1/Cip1/p21, a potent inhibitor of various cyclin-CDK kinase activities, in two colon cancer cell lines (LS1034 and LS513), which are sensitive to TGF-beta-induced growth arrest. The induction in at least one of these cells lines (LS1034, p53-) is p53-independent. No WAF1 induction was observed after TGF-beta treatment in a third cell line (HT-29), which is completely insensitive to the cytoinhibitory effect of TGB-beta. In both LS513 and LS1034, WAF1 induction correlated with reduced cyclin E-associated kinase activity in vitro and suppression of the retinoblastoma susceptibility gene (Rb) protein phosphorylation in vivo. In addition, WAF1 was physically associated with cyclin E in the two sensitive cell lines. These results suggest that WAF1/Cip1/p21 is a mediator of cellular sensitivity to TGF-beta.			LI, CY (corresponding author), HARVARD UNIV, SCH PUBL HLTH, RADIOBIOL LAB, 665 HUNTINGTON AVE, BOSTON, MA 02115 USA.		Li, Chuan-Yuan/H-4148-2013		NCI NIH HHS [CA-47542] Funding Source: Medline; NIEHS NIH HHS [ES0002] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		DANEILPOUR D, 1990, J IMMUNOL METHODS, V158, P17; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KASTAN MB, 1991, CANCER RES, V51, P6304; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PIENTENPOL JA, 1990, CELL, V61, P777; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; SUARDET L, 1992, CANCER RES, V52, P3705; TOGUCHIDA J, 1992, CANCER RES, V52, P6194; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YAMASHITA K, 1990, EMBO J, V9, P4331, DOI 10.1002/j.1460-2075.1990.tb07882.x	26	239	243	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4971	4974		10.1074/jbc.270.10.4971	http://dx.doi.org/10.1074/jbc.270.10.4971			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890601	hybrid			2022-12-27	WOS:A1995QL58000005
J	JANNATIPOUR, M; ROKEACH, LA				JANNATIPOUR, M; ROKEACH, LA			THE SCHIZOSACCHAROMYCES-POMBE HOMOLOG OF THE CHAPERONE CALNEXIN IS ESSENTIAL FOR VIABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SCHISTOSOMA-MANSONI ANTIGEN; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEINS; UNFOLDED PROTEINS; BINDING PROTEIN; BIP GENE; CALRETICULIN; YEAST; SEQUENCE	We have cloned a Schizosaccharomyces pombe gene, here designated cnx1, encoding the homologue of the endoplasmic reticulum molecular chaperone calnexin. Disruption of the cnx1 gene was lethal, demonstrating that it has an essential cellular function. Transcription of cnx1 mRNA is initiated at multiple sites, and it can be induced by various stress treatments that lead to the accumulation of unfolded and/or misfolded proteins in the endoplasmic reticulum. The encoded Cnx1p protein more closely resembles its plant and animal calnexin homologues than that of Saccharomyces cerevisiae. Cnx1p is acidic and migrates aberrantly on SDS-polyacrylamide gel electrophoresis, similar to its mammalian counterparts. Cnx1p contains the hallmark KPEDWD motifs that are found in all members of the calnexin/calreticulin family of proteins. Using an in vitro translation-processing system, we have shown that Cnx1p has the characteristic type I topology of calnexin proteins. Unlike its higher eukaryotic homologues, Cnx1p has a site for N-glycosylation that was modified in an in vitro translation-processing assay.	UNIV MONTREAL, DEPT BIOCHIM, MONTREAL, PQ H3C 3J7, CANADA	Universite de Montreal								AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; ARMSTRONG J, 1993, MOL BIOL CELL, V4, P583, DOI 10.1091/mbc.4.6.583; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BROWN DJ, 1988, J VIROL, V62, P3824, DOI 10.1128/JVI.62.10.3824-3831.1988; Burns K, 1994, Trends Cell Biol, V4, P152; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CALA SE, 1993, J BIOL CHEM, V268, P2969; CHAPPELL TG, 1989, J CELL BIOL, V109, P2693, DOI 10.1083/jcb.109.6.2693; CHEN FQ, 1994, PLANT CELL, V6, P835, DOI 10.1105/tpc.6.6.835; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DEDHAR S, 1994, TRENDS BIOCHEM SCI, V19, P269, DOI 10.1016/0968-0004(94)90001-9; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVIRGILIO C, 1993, YEAST, V9, P185, DOI 10.1002/yea.320090209; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1993, CURR BIOL, V3, P884, DOI 10.1016/0960-9822(93)90226-E; HAWN TR, 1993, J BIOL CHEM, V268, P7692; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUANG LQ, 1993, J BIOL CHEM, V268, P6560; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Johnson B.F, 1989, MOL BIOL FISSION YEA, P243; KENNEDY TE, 1992, NEURON, V9, P1013, DOI 10.1016/0896-6273(92)90062-I; KHALIFE J, 1993, MOL BIOCHEM PARASIT, V57, P193, DOI 10.1016/0166-6851(93)90195-4; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; MERTINS P, 1987, NUCLEIC ACIDS RES, V15, P7369, DOI 10.1093/nar/15.18.7369; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1985, ARCH MICROBIOL, V142, P370, DOI 10.1007/BF00491906; MORI K, 1993, CELL, V74, P743; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PARTALEDIS JA, 1993, P NATL ACAD SCI USA, V90, P5450, DOI 10.1073/pnas.90.12.5450; PIDOUX AL, 1992, EMBO J, V11, P1583, DOI 10.1002/j.1460-2075.1992.tb05203.x; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; ROKEACH LA, 1994, INFECT IMMUN, V62, P3696, DOI 10.1128/IAI.62.9.3696-3704.1994; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; ROKEACH LA, 1991, PROTEIN ENG, V4, P981, DOI 10.1093/protein/4.8.981; ROKEACH LA, 1991, J IMMUNOL, V147, P3031; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ RT, 1977, J VIROL, V23, P217, DOI 10.1128/JVI.23.2.217-226.1977; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Smith M.J., 1992, DNA Sequence, V2, P235, DOI 10.3109/10425179209020808; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; STEINER S, 1973, Cancer Research, V33, P2402; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; UNNASCH TR, 1988, J CLIN INVEST, V82, P262, DOI 10.1172/JCI113581; WADA I, 1991, J BIOL CHEM, V266, P19599; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145	63	56	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4845	4853		10.1074/jbc.270.9.4845	http://dx.doi.org/10.1074/jbc.270.9.4845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876257	hybrid			2022-12-27	WOS:A1995QK08400094
J	ARAR, C; CARPENTIER, V; LECAER, JP; MONSIGNY, M; LEGRAND, A; ROCHE, AC				ARAR, C; CARPENTIER, V; LECAER, JP; MONSIGNY, M; LEGRAND, A; ROCHE, AC			ERGIC-53, A MEMBRANE-PROTEIN OF THE ENDOPLASMIC RETICULUM-GOLGI INTERMEDIATE COMPARTMENT, IS IDENTICAL TO MR60, AN INTRACELLULAR MANNOSE-SPECIFIC LECTIN OF MYELOMONOCYTIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; RESOLUTION; RECEPTOR; SEQUENCE; COMPLEX; L-14-II; LACTOSE; ER	A mannose specific membrane lectin (MR60) isolated from human myelomonocytic HL60 cells by affinity chromatography is expressed in intracellular organelles of immature monocytes (Pimpaneau, V., Midoux, P., Monsigny, M., and Roche, A. C. (1991) Carbohydr. Res. 213, 95-108). It is not present at the cell surface and is immunochemically and structurally distinct from the M(r) 175,000 mannose receptor of mature macrophages. MR60 cDNA was isolated and characterized; on the basis of its sequence, MR60 is not related to any known mammalian lectins. Surprisingly, MR60 was found to be identical to ERGIC-53 (Schindler, R., Itin, C., Zerial, M., Lottspeich, F., and Hauri, H. P. (1993) Eur. J. Cell Biol. 61, 1-9), a type I integral membrane protein, defined as a marker of the intermediate compartment that recycles between the Golgi apparatus and endoplasmic reticulum; MR60/ERGIC-53 shares with VIP-36 significant homologies with leguminous plant lectins (Fiedler, K., and Simmons, R. (1994) Cell 77, 625-626). We extend these findings in evidencing a structural homology between MR60/ERGIC-53 and mammalian galectins (soluble beta galactose binding proteins). MR60/ERGIC-53 is the first lectin characterized as an endoplasmic reticulum-Golgi protein. Accordingly, this intracellular mannose binding protein could be involved in the traffic of glycoproteins between endoplasmic reticulum and the Golgi apparatus.	UNIV ORLEANS,BIOCHIM GLYCOCANJUGUES & LECTINES ENDOGENES LAB,F-45071 ORLEANS 02,FRANCE; CNRS,CTR BIOPHYS MOLEC,F-45071 ORLEANS 02,FRANCE; INST ALFRED H FESSARD,CNRS,F-91198 GIF SUR YVETTE,FRANCE	Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay			Monsigny, Michel/AAZ-6728-2020					AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; CARPENTIER V, 1994, GLYCOCONJUGATE J, V11, P333, DOI 10.1007/BF00731206; CARPENTIER V, 1992, THESIS U ORLEANS; EINSPAHR H, 1986, J BIOL CHEM, V261, P6518; FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x; FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GITT MA, 1992, J BIOL CHEM, V267, P10601; GITT MA, 1991, BIOCHEMISTRY-US, V30, P82, DOI 10.1021/bi00215a013; HAURI H-P, 1992, Current Opinion in Cell Biology, V4, P600, DOI 10.1016/0955-0674(92)90078-Q; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIPPINCOTTSCHWA.J, 1990, CELL, V60, P821; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; MOORE SEH, 1993, J BIOL CHEM, V268, P3809; PIMPANEAU V, 1991, CARBOHYD RES, V213, P95, DOI 10.1016/S0008-6215(00)90601-3; SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; STAHL P, 1982, J CELL BIOL, V93, P49, DOI 10.1083/jcb.93.1.49	21	98	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3551	3553		10.1074/jbc.270.8.3551	http://dx.doi.org/10.1074/jbc.270.8.3551			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876089	hybrid			2022-12-27	WOS:A1995QH68800016
J	ARNER, ESJ; BJORNSTEDT, M; HOLMGREN, A				ARNER, ESJ; BJORNSTEDT, M; HOLMGREN, A			1-CHLORO-2,4-DINITROBENZENE IS AN IRREVERSIBLE INHIBITOR OF HUMAN THIOREDOXIN REDUCTASE - LOSS OF THIOREDOXIN DISULFIDE REDUCTASE-ACTIVITY IS ACCOMPANIED BY A LARGE INCREASE IN NADPH OXIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							IMMUNOHISTOCHEMICAL LOCALIZATION; RAT-LIVER; KAPPA-B; PURIFICATION; INVOLVEMENT; GLUTATHIONE; SKIN; SELENODIGLUTATHIONE; MUTAGENESIS; ACTIVATION	Human thioredoxin reductase is a dimeric enzyme that catalyzes reduction of the disulfide in oxidized thioredoxin by a mechanism involving transfer of electrons from NADPH via FAD to a redox-active disulfide. 1-Chloro-2,4-dinitrobenzene (DNCB) is an alkylating agent used for depleting intracellular GSH and also showing distinct immunomodulatory properties, We have discovered that low concentrations of DNCB completely inactivated human or bovine thioredoxin reductase, with a second order rate constant in excess of 200 M(-1) S-1, which is almost 10,000-fold faster than alkylation of GSH. Total inactivation of 50 nM reduced thioredoxin reductase was obtained by 100 mu M DNCB after 5 min of incubation at 20 degrees C also in the presence of 1 mM GSH, The inhibition occurred with enzyme only in the presence of NADPH and persisted after removal of DNCB, suggesting alkylation of the active site nascent thiols as the mechanism of inactivation, Thioredoxin reductase modified by DNCB lacked reducing activity with oxidized thioredoxin, 5,5'-dithiobis-(2-nitrobenzoic acid), or sodium selenite, However, the DNCB-modified enzyme oxidized NADPH at a rate of 4.7 nmol/min/nmol of enzyme in the presence of atmospheric oxygen, This activity was not dependent on the presence of DNCB in solution and constituted a 34-fold increase of the inherent low NADPH oxidase activity of the native enzyme. DNCB is a specific inhibitor of mammalian thioredoxin reductase, which reacted 100-fold faster than glutathione reductase, The inactivation of the disulfide reducing activity of thioredoxin reductase and thioredoxin with a concomitant large increase of the NADPH oxidase activity producing reactive oxygen intermediates may mediate effects of DNCB on cells in vivo.	KAROLINSKA INST, MED NOBEL INST BIOCHEM, DEPT MED BIOCHEM & BIOPHYS, S-17177 STOCKHOLM, SWEDEN	Karolinska Institutet			Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114				AHMED AR, 1983, ARCH DERMATOL, V119, P934, DOI 10.1001/archderm.119.11.934; BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; ERICSON ML, 1992, LYMPHOKINE CYTOK RES, V11, P201; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HANSSON HA, 1986, CELL TISSUE RES, V245, P189; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1980, P NATL ACAD SCI-BIOL, V77, P5149, DOI 10.1073/pnas.77.9.5149; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HOLMGREN A, 1988, PLASMA MEMBRANE OXID, P295; Ifversen Peter, 1993, Human Antibodies and Hybridomas, V4, P115; JAKOBSSON PJ, 1992, P NATL ACAD SCI USA, V89, P3521, DOI 10.1073/pnas.89.8.3521; KULKARNI AP, 1990, BIOCHEM BIOPH RES CO, V166, P417, DOI 10.1016/0006-291X(90)91961-Q; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; OBLONG JE, 1993, BIOCHEMISTRY-US, V32, P7271, DOI 10.1021/bi00079a025; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; SCHALLREUTER KU, 1991, INT J CANCER, V48, P15; SCHALLREUTER KU, 1992, BIOCHIM BIOPHYS ACTA, V1160, P127, DOI 10.1016/0167-4838(92)90046-G; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; SCHMIDT RJ, 1992, ARCH DERMATOL RES, V284, P400, DOI 10.1007/BF00372070; STRICKER RB, 1993, IMMUNOL LETT, V36, P1, DOI 10.1016/0165-2478(93)90060-F; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; TONISSEN K, 1993, J BIOL CHEM, V268, P22485; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; YODOI J, 1991, ADV CANCER RES, V57, P381	33	155	157	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3479	3482		10.1074/jbc.270.8.3479	http://dx.doi.org/10.1074/jbc.270.8.3479			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876079	hybrid			2022-12-27	WOS:A1995QH68800005
J	GARTNER, F; VOOS, W; QUEROL, A; MILLER, BR; CRAIG, EA; CUMSKY, MG; PFANNER, N				GARTNER, F; VOOS, W; QUEROL, A; MILLER, BR; CRAIG, EA; CUMSKY, MG; PFANNER, N			MITOCHONDRIAL IMPORT OF SUBUNIT VA OF CYTOCHROME-C-OXIDASE CHARACTERIZED WITH YEAST MUTANTS - INDEPENDENCE FROM RECEPTORS, BUT REQUIREMENT FOR MATRIX HSP70 TRANSLOCASE FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN-70; INTERMEMBRANE SPACE; INNER MEMBRANE; PRECURSOR PROTEINS; HEME LYASE; MOM19; PREPROTEINS; SEQUENCES; MECHANISM; PATHWAY	We have investigated the unusual import pathway of cytochrome c oxidase subunit Va (COXVa) into the yeast mitochondrial inner membrane by use of mutants that lack import receptors or are defective in matrix hsp70. (i) Mitochondria lacking the receptor MOM72 are not impaired in import of COXVa. Mitochondria lacking the main receptor MOM19 are moderately reduced in import of COXVa; this, however, is caused by a reduction of the inner membrane potential and not by a lack of specific receptor functions. (ii) Mitochondria defective in the unfoldase function of matrix hsp70 efficiently import COXVa, whereas mitochondria defective in the translocase function of the hsp70 are blocked in import of COXVa. A COXVa construct where the internal hydrophobic sorting signal is placed close to the presequence does not require either hsp70 function. These results demonstrate that import of COXVa does not require MOM19 or MOM72, but they unexpectedly reveal a strong dependence on the translocase function of matrix hsp70. Two important implications about the characterization of mitochondrial protein import in general are obtained. First, the interpretation of import results with mutants lacking MOM19 have to consider effects on the membrane potential. Second, the distance between a matrix targeting sequence and a hydrophobic sorting sequence within a precursor appears to determine if the inner membrane sorting machinery can substitute for the translocase function of hsp70 or not.	UNIV FREIBURG, INST BIOCHEM, D-79104 FREIBURG, GERMANY; UNIV CALIF IRVINE, DEPT MOLEC BIOL & BIOCHEM, IRVINE, CA 92717 USA; UNIV WISCONSIN, DEPT BIOMOLEC CHEM, MADISON, WI 53706 USA	University of Freiburg; University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison			Querol, Amparo/H-3782-2012; Querol, Amparo/AAW-7469-2020; Pfanner, Nikolaus/AAV-7878-2021	Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845; 				BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BLOM J, 1993, MOL CELL BIOL, V13, P7364, DOI 10.1128/MCB.13.12.7364; BRINKS S, 1994, J BIOL CHEM, V269, P16478; DAUM G, 1982, J BIOL CHEM, V257, P3028; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; DUMONT ME, 1991, MOL CELL BIOL, V11, P5487, DOI 10.1128/MCB.11.11.5487; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; GLASER SM, 1990, MOL CELL BIOL, V10, P1873, DOI 10.1128/MCB.10.5.1873; GLICK BS, 1993, PROTEIN SCI, V2, P1901, DOI 10.1002/pro.5560021112; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Horwich A, 1990, CURR OPIN CELL BIOL, V2, P625, DOI 10.1016/0955-0674(90)90103-L; JORDI W, 1992, EUR J BIOCHEM, V204, P841, DOI 10.1111/j.1432-1033.1992.tb16703.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MILLER BR, 1993, J CELL BIOL, V121, P1021, DOI 10.1083/jcb.121.5.1021; MILLER BR, 1991, J CELL BIOL, V112, P833, DOI 10.1083/jcb.112.5.833; MOCZKO M, 1993, FEBS LETT, V326, P251, DOI 10.1016/0014-5793(93)81801-6; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; NICHOLSON DW, 1988, J BIOL CHEM, V263, P19034; PFALLER R, 1989, J BIOL CHEM, V264, P34; PFANNER N, 1994, TRENDS BIOCHEM SCI, V19, P368, DOI 10.1016/0968-0004(94)90113-9; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119	37	67	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3788	3795						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876120				2022-12-27	WOS:A1995QH68800050
J	PILON, M; WIENK, H; SIPS, W; DESWAAF, M; TALBOOM, I; VANTHOF, R; DEKORTEKOOL, G; DEMEL, R; WEISBEEK, P; DEKRUIJFF, B				PILON, M; WIENK, H; SIPS, W; DESWAAF, M; TALBOOM, I; VANTHOF, R; DEKORTEKOOL, G; DEMEL, R; WEISBEEK, P; DEKRUIJFF, B			FUNCTIONAL DOMAINS OF THE FERREDOXIN TRANSIT SEQUENCE INVOLVED IN CHLOROPLAST IMPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEINS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; SECONDARY STRUCTURE; ENVELOPE MEMBRANE; PEPTIDE; TRANSPORT; BINDING; MITOCHONDRIAL; TRANSLOCATION; CLEAVAGE	In order to analyze the information content of a chloroplast transit sequence, we have constructed and analyzed by in vitro assays seven substitution and 20 deletion mutants of the ferredoxin transit sequence. The N-terminal part and the C-terminal part are important for targeting, and in addition the C-terminal region is required for processing. A third region is important for translocation but not for the initial interaction with the envelope. A fourth region is less essential for in vitro import. Purified precursors were tested for their ability to compete for the in vitro import of radiolabeled wildtype precursor, which confirmed the important role in chloroplast recognition of both the N- and the C-terminal domain of the transit sequence. Monolayer experiments showed that the N terminus was mainly involved in the insertion into mono-galactolipid-containing lipid surfaces whereas the C terminus mediates the recognition of negatively charged lipids. A sequence comparison to other transit sequences suggests that the domain structure of the ferredoxin transit sequence can be extended to these sequences and thus reveals a general structural design of transit sequences.	UNIV UTRECHT,INST BIOMEMBRANES,3584 CH UTRECHT,NETHERLANDS; UNIV UTRECHT,CTR BIOMEMBRANES & LIPID ENZYMOL,DEPT MEMBRANE BIOCHEM,3584 CH UTRECHT,NETHERLANDS; UNIV CALIF BERKELEY,DEPT MOLEC CELL BIOL,BERKELEY,CA 94720	Utrecht University; Utrecht University; University of California System; University of California Berkeley			Wienk, Hans/P-8929-2015	Wienk, Hans/0000-0001-9577-0064				ARCHER EK, 1993, PLANT MOL BIOL, V23, P1105, DOI 10.1007/BF00042345; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHUA NH, 1979, J CELL BIOL, V81, P461, DOI 10.1083/jcb.81.3.461; CHUPIN V, 1994, RECL TRAV CHIM PAY B, V113, P237; CLARK SE, 1991, J CELL BIOL, V114, P681, DOI 10.1083/jcb.114.4.681; CLINE K, 1985, J BIOL CHEM, V260, P3691; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; DEBOER AD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P221, DOI 10.1016/0304-4157(91)90015-O; DEBOER D, 1991, EMBO J, V10, P2765, DOI 10.1002/j.1460-2075.1991.tb07825.x; DEKRUIJFF B, 1994, FEBS LETT, V346, P78, DOI 10.1016/0014-5793(94)00404-8; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; DOUCE R, 1990, ANNU REV CELL BIOL, V6, P173, DOI 10.1146/annurev.cb.06.110190.001133; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; HAGEMAN J, 1990, PLANT CELL, V2, P479, DOI 10.1105/tpc.2.5.479; HORNIAK L, 1993, FEBS LETT, V334, P241, DOI 10.1016/0014-5793(93)81720-K; HUANG JT, 1990, PLANT CELL, V2, P1249, DOI 10.1105/tpc.2.12.1249; KARLINNEUMANN GA, 1986, EMBO J, V5, P9, DOI 10.1002/j.1460-2075.1986.tb04170.x; KEEGSTRA K, 1989, CELL, V56, P247, DOI 10.1016/0092-8674(89)90898-2; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHENY EA, 1994, PLANT CELL, V6, P427, DOI 10.2307/3869762; Margulis L, 1970, ORIGIN EUKARYOTIC CE; OBLONG JE, 1992, EMBO J, V11, P4401, DOI 10.1002/j.1460-2075.1992.tb05540.x; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; OSTREM JA, 1989, J BIOL CHEM, V264, P3662; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; PERRY SE, 1991, J BIOL CHEM, V266, P11882; PILON M, 1990, J BIOL CHEM, V265, P3358; PILON M, 1992, J BIOL CHEM, V267, P2548; PILON M, 1992, J BIOL CHEM, V267, P19907; RAVEN PH, 1970, SCIENCE, V169, P641, DOI 10.1126/science.169.3946.641; REISS B, 1987, MOL GEN GENET, V209, P116, DOI 10.1007/BF00329845; REISS B, 1989, P NATL ACAD SCI USA, V86, P886, DOI 10.1073/pnas.86.3.886; ROBINSON C, 1984, EUR J BIOCHEM, V142, P337, DOI 10.1111/j.1432-1033.1984.tb08291.x; ROISE D, 1988, J BIOL CHEM, V263, P4509; Sambrook J., 1989, MOL CLONING; SCHNELL DJ, 1991, J BIOL CHEM, V266, P3335; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; SMEEKENS S, 1989, MOL GEN GENET, V216, P178, DOI 10.1007/BF00332249; SMEEKENS S, 1987, PLANT MOL BIOL, V9, P377, DOI 10.1007/BF00014912; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THEG SM, 1989, J BIOL CHEM, V264, P6730; VANDEENEN LLM, 1964, ADV LIPID RES, V2, P167; VANTHOF R, 1991, FEBS LETT, V291, P350, DOI 10.1016/0014-5793(91)81318-3; VANTHOF R, 1993, J BIOL CHEM, V268, P4037; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1991, PLANT MOL BIOL REP, V9, P104	53	77	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3882	3893		10.1074/jbc.270.8.3882	http://dx.doi.org/10.1074/jbc.270.8.3882			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876133	hybrid			2022-12-27	WOS:A1995QH68800064
J	ZOLOTARJOVA, N; PERIYASAMY, SM; HUANG, WH; ASKARI, A				ZOLOTARJOVA, N; PERIYASAMY, SM; HUANG, WH; ASKARI, A			FUNCTIONAL COUPLING OF PHOSPHORYLATION AND NUCLEOTIDE-BINDING SITES IN THE PROTEOLYTIC FRAGMENTS OF NA+/K+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; K+)-DEPENDENT ADENOSINE-TRIPHOSPHATASE; ISOTHIOCYANATE REACTIVE SITE; AMINO-ACID-SEQUENCE; ALPHA-SUBUNIT; FLUORESCEIN ISOTHIOCYANATE; ACTIVE-SITE; CHYMOTRYPTIC CLEAVAGE; INORGANIC-PHOSPHATE; LIGAND-BINDING	Cleavage of the alpha-subunit of Na+/K+-ATPase by trypsin at Arg(438)-Ala(439) causes enzyme inhibition which has been suggested to be due to altered alignment of phosphorylation site on the 48-kDa N-terminal fragment with nucleotide binding site on the 64-kDa C-terminal fragment. Our aims were to test this hypothesis and to assess the effect of the cleavage on the enzyme's two ATP sites. Na+-dependent phosphorylation of the partially cleaved enzyme by ATP showed that K-0.5 values of ATP for phosphorylations of intact alpha and 48-kDa peptide were the same (0.4 mu M). Unchanged interactions among the residues across the cleavage site were also indicated by data showing that reaction of fluorescein isothiocyanate with the 64-kDa peptide blocked phosphorylation of the 48-kDa peptide by ATP. ATP is known to block the reaction of fluorescein isothiocyanate with the enzyme, Experiments on the partially cleaved enzyme showed that K-0.5 of ATP for protection of alpha was 30-60 mu M, and the value for the protection of interacting 48-kDa and 64-kDa peptides was 1-3 mM. Evidently, while the cleavage does not affect the high affinity catalytic site, it disrupts the allosteric low affinity ATP site. Experiments on reconstituted preparations showed that the cleavage abolished ATP-dependent Na+/K+ exchange, P-i + ATP-dependent Rb+/Rb+ exchange, ATP-dependent Na+/Na+ exchange, and ADP + ATP-dependent Na+/Na+ exchange activities, Selective disruption of the low affinity ATP site accounts for the inhibitions of all functions involving K+(Rb+), based on the established role of this site in the control of K+ access channels. Cleavage-induced inhibitions of other activities, however, suggest additional roles of the low affinity ATP site in the reaction cycle.			ZOLOTARJOVA, N (corresponding author), MED COLL OHIO, DEPT PHARMACOL, POB 10008, TOLEDO, OH 43699 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36573] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT AJ, 1991, BIOCHEMISTRY-US, V30, P1692, DOI 10.1021/bi00220a035; ASKARI A, 1984, J BIOL CHEM, V259, P4169; ASKARI A, 1988, J BIOL CHEM, V263, P235; ASKARI A, 1983, J BIOL CHEM, V258, P3453; Askari A, 1988, Prog Clin Biol Res, V268A, P149; ASKARI A, 1987, J BIOENERG BIOMEMBR, V19, P359, DOI 10.1007/BF00768539; BLOSTEIN R, 1975, J BIOL CHEM, V250, P6118; CAMPOS M, 1994, J BIOL CHEM, V269, P18028; CARILLI CT, 1982, J BIOL CHEM, V257, P5601; CORNELIUS F, 1987, BIOCHIM BIOPHYS ACTA, V904, P353, DOI 10.1016/0005-2736(87)90385-3; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P19, DOI 10.1016/0304-4157(91)90011-K; CORNELIUS F, 1985, BIOCHIM BIOPHYS ACTA, V818, P211, DOI 10.1016/0005-2736(85)90572-3; Dzhandzhugazyan K N, 1988, Prog Clin Biol Res, V268A, P181; ESMANN M, 1988, METHOD ENZYMOL, V156, P72; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; GARNER MH, 1987, DIABETES, V36, P716, DOI 10.2337/diabetes.36.6.716; HASENAUER J, 1993, J BIOL CHEM, V268, P3289; HENDERSON GR, 1977, ARCH BIOCHEM BIOPHYS, V182, P221, DOI 10.1016/0003-9861(77)90302-2; HUANG WH, 1990, BIOCHIM BIOPHYS ACTA, V1030, P65, DOI 10.1016/0005-2736(90)90239-K; JORGENSEN PL, 1977, BIOCHIM BIOPHYS ACTA, V466, P97, DOI 10.1016/0005-2736(77)90211-5; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P291; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1982, ANN NY ACAD SCI, V402, P207, DOI 10.1111/j.1749-6632.1982.tb25743.x; JORGENSEN PL, 1985, BIOCHIM BIOPHYS ACTA, V821, P319, DOI 10.1016/0005-2736(85)90102-6; KAKAR SS, 1985, BIOCHEM INT, V11, P611; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KENNEDY BG, 1986, J GEN PHYSIOL, V87, P47, DOI 10.1085/jgp.87.1.47; KIRLEY TL, 1984, BIOCHEM BIOPH RES CO, V125, P767, DOI 10.1016/0006-291X(84)90605-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NORBY JG, 1983, J GEN PHYSIOL, V82, P725, DOI 10.1085/jgp.82.6.725; NORBY JG, 1988, METHOD ENZYMOL, V156, P191; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PELUFFO RD, 1992, J BIOL CHEM, V267, P6596; PELUFFO RD, 1994, J BIOL CHEM, V269, P1051; PLESNER IW, 1985, BIOCHIM BIOPHYS ACTA, V818, P235, DOI 10.1016/0005-2736(85)90564-4; PLESNER IW, 1987, BIOPHYS J, V51, P69, DOI 10.1016/S0006-3495(87)83312-X; POST RL, 1972, J BIOL CHEM, V247, P6530; ROBINSON JD, 1976, BIOCHIM BIOPHYS ACTA, V440, P711, DOI 10.1016/0005-2728(76)90053-0; SCHEINERBOBIS G, 1993, BIOCHEMISTRY-US, V32, P9592, DOI 10.1021/bi00088a011; SEN PC, 1981, ARCH BIOCHEM BIOPHYS, V211, P652, DOI 10.1016/0003-9861(81)90501-4; TRAN CM, 1994, J BIOL CHEM, V269, P6558; WIERZBICKI W, 1993, P NATL ACAD SCI USA, V90, P70, DOI 10.1073/pnas.90.1.70; WINTER CG, 1978, BIOCHEM BIOPH RES CO, V84, P474, DOI 10.1016/0006-291X(78)90193-6; XIE ZJ, 1994, SODIUM PUMP, P49; XU KY, 1989, BIOCHEMISTRY-US, V28, P5764, DOI 10.1021/bi00440a010; YODA A, 1984, BIOCHIM BIOPHYS ACTA, V778, P332, DOI 10.1016/0005-2736(84)90377-8	47	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3989	3995		10.1074/jbc.270.8.3989	http://dx.doi.org/10.1074/jbc.270.8.3989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876146	hybrid			2022-12-27	WOS:A1995QH68800079
J	HERNANDEZ, MC; ERKMAN, L; MATTERSADZINSKI, L; ROZTOCIL, T; BALLIVET, M; MATTER, JM				HERNANDEZ, MC; ERKMAN, L; MATTERSADZINSKI, L; ROZTOCIL, T; BALLIVET, M; MATTER, JM			CHARACTERIZATION OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR BETA-3 GENE - ITS REGULATION WITHIN THE AVIAN NERVOUS-SYSTEM IS EFFECTED BY A PROMOTER 143 BASE-PAIRS IN LENGTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; MOLECULAR-CLONING; GOLDFISH RETINA; BINDING-SITE; SUBUNIT; BRAIN; RAT; EXPRESSION; SUBTYPES; NEURONS	Genomic and cDNA clones encoding the chicken neuronal nicotinic acetylcholine receptor beta 3 subunit were isolated and sequenced. The beta 3 gene consists of six protein encoding exons and the deduced protein has the structural features found in all other members of the neuronal nicotinic acetylcholine receptor subunit family. Although they are undetectable in most brain compartments, beta 3 mRNAs are relatively abundant in the developing retina and in the trigeminal ganglion. In situ hybridization and immunohistochemical analysis demonstrated that in retina, beta 3 transcripts and protein are confined to subpopulations of cells in the inner nuclear and ganglion cell. layers. beta 3 is expressed in the proximal and distal regions of the developing trigeminal ganglion, i.e. in both placode and neural crest-derived neurons. Transient transfection assays in cells freshly dissociated from selected regions of the central nervous system at different developmental stages allowed the identification of genetic elements involved in the neuronal-selective expression of the beta 3 gene. A promoter fragment 143 base pairs in length and containing TATA, CAAT, and other consensus sequences is sufficient to restrict reporter gene expression to a subpopulation of retinal neurons. This promoter is totally inactive upon transfection into neuronal and non-neuronal cells from other regions of the central nervous system.	UNIV GENEVA, DEPT BIOCHEM, CH-1211 GENEVA 4, SWITZERLAND	University of Geneva								ANAND R, 1991, J BIOL CHEM, V266, P11192; AUBRY JM, 1993, NEUROSCIENCE, V53, P417, DOI 10.1016/0306-4522(93)90205-T; BALLIVET M, 1983, COLD SPRING HARB SYM, V48, P83, DOI 10.1101/SQB.1983.048.01.011; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BEYER HS, 1991, BIOTECHNIQUES, V11, P746; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOYD RT, 1991, J NEUROBIOL, V22, P1, DOI 10.1002/neu.480220102; BOYD RT, 1988, NEURON, V1, P495; CAULEY K, 1989, J CELL BIOL, V108, P637, DOI 10.1083/jcb.108.2.637; CAULEY K, 1990, J NEUROSCI, V10, P670; CHANGEUX JP, 1992, TRENDS PHARMACOL SCI, V13, P299, DOI 10.1016/0165-6147(92)90094-M; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; GALZI JL, 1991, ANNU REV PHARMACOL, V31, P37, DOI 10.1146/annurev.pa.31.040191.000345; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; HILL JA, 1993, J NEUROSCI, V13, P1551; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KEYSER KT, 1993, J NEUROSCI, V13, P442; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; Maniatis T., 1982, MOL CLONING; MATTER JM, 1990, EMBO J, V9, P1021, DOI 10.1002/j.1460-2075.1990.tb08205.x; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; MORRIS BJ, 1990, MOL BRAIN RES, V7, P305, DOI 10.1016/0169-328X(90)90081-N; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Role L W, 1992, Curr Opin Neurobiol, V2, P254, DOI 10.1016/0959-4388(92)90112-X; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SEGUELA P, 1993, J NEUROSCI, V13, P596; STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8	51	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3224	3233		10.1074/jbc.270.7.3224	http://dx.doi.org/10.1074/jbc.270.7.3224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852408	hybrid			2022-12-27	WOS:A1995QG47100052
J	MORI, K; DWEK, RA; DOWNING, AK; OPDENAKKER, G; RUDD, PM				MORI, K; DWEK, RA; DOWNING, AK; OPDENAKKER, G; RUDD, PM			THE ACTIVATION OF TYPE-1 AND TYPE-2 PLASMINOGEN BY TYPE-I AND TYPE-II TISSUE-PLASMINOGEN ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED OLIGOSACCHARIDE UNIT; CARBOHYDRATE SIDE-CHAINS; HAMSTER OVARY CELLS; N-GLYCOSYLATION; BINDING-SITE; VARIANTS; FIBRINOLYSIS; PURIFICATION; DEGRADATION; MECHANISM	Tissue plasminogen activator (tPA) was fractionated using lysine-Sepharose affinity chromatography. Type I, type II, and a minor peak with high affinity for lysine (designated type D) tPA were recovered. In an indirect amidolytic assay involving native human Glu-plasminogem and fibrin, type II tPA showed a 2-fold higher activity than type I. To explore the combinatorial effect of the variable glycosylation status of both tPA and plasminogen, kinetic constants for fibrin-dependent plasminogen activation were determined for combinations of type I, II, and D tPA with type 1 and 2 plasminogen. Within a 4-fold range, the fastest rate was achieved from the combination of type D* (type II + D) tPA and type 2 plasminogen. N-Glycosylation of plasminogen increased the K-m value for activation by all tPA variants; N-glycosylation of type I tPA at Asn(184) decreased the k(cat) (turnover) values for the fibrin-dependent activation of plasminogen over type II tPA, while type D* tPA showed the highest turnover rate, In the presence of fibrinogen fragments, N-glycosylation of plasminogen at site 289 modulates the kinetics of association of enzyme and substrate, while N-glycosylation at site 184 on tPA modulates the turnover rate of the enzyme.	UNIV OXFORD,INST GLYCOBIOL,DEPT BIOCHEM,OXFORD OX1 3QU,ENGLAND; CATHOLIC UNIV LEUVEN,REGA INST MED RES,B-3000 LOUVAIN,BELGIUM	University of Oxford; KU Leuven			Opdenakker, Ghislain/V-8562-2019; Opdenakker, Ghislain/Q-3130-2017	Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294				ASTRUP T, 1947, NATURE, V159, P681, DOI 10.1038/159681b0; BERG DT, 1993, BLOOD, V81, P1312; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; COLLEN D, 1991, BLOOD, V78, P3114; COLLEN D, 1993, LANCET, V342, P34, DOI 10.1016/0140-6736(93)91888-S; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIDSON DJ, 1993, J CLIN INVEST, V92, P249, DOI 10.1172/JCI116557; DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037; EDELBERG JM, 1990, J CLIN INVEST, V86, P107, DOI 10.1172/JCI114671; ERINARSSON M, 1985, BIOCHIM BIOPHYS ACTA, V830, P1; GEPPERT AG, 1992, ARCH BIOCHEM BIOPHYS, V297, P205, DOI 10.1016/0003-9861(92)90663-H; GONZALEZGRONOW M, 1989, BIOCHEMISTRY-US, V28, P2374, DOI 10.1021/bi00432a005; HAJJAR KA, 1993, J CLIN INVEST, V93, P703; HALL SW, 1990, J CELL BIOCHEM, V43, P213, DOI 10.1002/jcb.240430303; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HARRIS RJ, 1991, BIOCHEMISTRY-US, V30, P2311, DOI 10.1021/bi00223a004; HAYES ML, 1979, J BIOL CHEM, V254, P8768; HAYES ML, 1979, J BIOL CHEM, V254, P8772; HAYES ML, 1979, J BIOL CHEM, V254, P8777; HENDERSON PJF, 1992, ENZYME ASSAYS PRACTI, P278; HOWARD S C, 1991, Glycobiology, V1, P411, DOI 10.1093/glycob/1.4.411; OPDENAKKER G, 1986, P SOC EXP BIOL MED, V182, P248; OPDENAKKER G, 1992, CYTOKINE, V4, P251, DOI 10.1016/1043-4666(92)90064-X; OPDENAKKER G, 1988, FEBS LETT, V238, P129, DOI 10.1016/0014-5793(88)80241-2; PAREKH RB, 1989, BIOCHEMISTRY-US, V28, P7670, DOI 10.1021/bi00445a023; PAREKH RB, 1989, BIOCHEMISTRY-US, V28, P7644, DOI 10.1021/bi00445a021; POHL G, 1984, BIOCHEMISTRY-US, V23, P3701, DOI 10.1021/bi00311a020; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; RIJKEN DC, 1979, BIOCHIM BIOPHYS ACTA, V580, P140, DOI 10.1016/0005-2795(79)90205-8; RIJKEN DC, 1981, J BIOL CHEM, V256, P7035; ROCHE PC, 1993, BIOCHIM BIOPHYS ACTA, V745, P82; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; SPELLMAN MW, 1989, J BIOL CHEM, V264, P14100; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; VERHEIJEN JH, 1982, THROMB HAEMOSTASIS, V48, P266; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; ZAMARRON C, 1984, J BIOL CHEM, V259, P2080	38	37	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3261	3267		10.1074/jbc.270.7.3261	http://dx.doi.org/10.1074/jbc.270.7.3261			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852411				2022-12-27	WOS:A1995QG47100057
J	ASHANI, Y; RADIC, Z; TSIGELNY, I; VELLOM, DC; PICKERING, NA; QUINN, DM; DOCTOR, BP; TAYLOR, P				ASHANI, Y; RADIC, Z; TSIGELNY, I; VELLOM, DC; PICKERING, NA; QUINN, DM; DOCTOR, BP; TAYLOR, P			AMINO-ACID-RESIDUES CONTROLLING REACTIVATION OF ORGANOPHOSPHONYL CONJUGATES OF ACETYLCHOLINESTERASE BY MONOQUATERNARY AND BISQUATERNARY OXIMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEREOSPECIFIC REACTIVATION; SOMAN; INVITRO; BUTYRYLCHOLINESTERASE; SPECIFICITY; TORPEDO; BINDING; BRAIN; SITE; EEL	Single and multiple site mutants of recombinant mouse acetylcholinesterase (rMoAChE) were inhibited with racemic 7-(methylethoxyphosphinyloxy)-1-methylquinolinium iodide (MEPQ) and the resulting mixture of two enantiomers, CH3PR,S(O)(OC2H5)-AChE(EMP(R,S)-AChE), were subjected to reactivation with 2-(hydroxyiminomethyl)-1-methylpyridinium methanesulfonate (P2S) and 1-(2'-hydroxyiminomethyl-1'-pyridinium)-3-(4''-carbamoyl-1''-pyridinium)-2-oxapropane dichloride (HI-6), Kinetic analysis of the reactivation profiles revealed biphasic behavior with an approximate 1:1 ratio of two presumed reactivatable enantiomeric components. Equilibrium dissociation and kinetic rate constants for reactivation of site-specific mutant enzymes were compared with those obtained for wild-type rMoAChE, tissue-derived Torpedo AChE and human plasma butyrylcholinesterase. Substitution of key amino acid residues at the entrance to the active-site gorge (Trp-286, Tyr-124, Tyr-72, and Asp-74) had a greater influence on the reactivation kinetics of the bisquaternary reactivator HI-6 compared with the monoquaternary reactivator P2S, Replacement of Phe-295 by Leu enhanced reactivation by HI-6 but not by P2S, Of residues forming the choline-binding subsite, the E202Q mutation had a dominant influence where reactivation by both oximes was decreased 16- to 33-fold, Residues Trp-86 and Tyr-337 in this subsite showed little involvement, These kinetic findings, together with energy minimization of the oxime complex with the phosphonylated enzyme, provide a model for differences in the reactivation potencies of P2S and HI-6, The two kinetic components of oxime reactivation of MEPQ-inhibited AChEs arise from the chirality of O-ethyl methylphosphonyl moieties conjugated with Ser-203 and may be attributable to the relative stability of the phosphonyl oxygen of the two enantiomers in the oxyanion hole,	WALTER REED ARMY INST RES,DIV BIOCHEM,WASHINGTON,DC 20307; UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Diego								Albert A., 1962, IONIZATION CONSTANTS; Aldridge W. N., 1972, ENZYME INHIBITORS SU; ASHANI Y, 1970, J MED CHEM, V13, P471, DOI 10.1021/jm00297a031; BARAK D, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P195; BARAK D, 1994, J BIOL CHEM, V269, P6296; BEDFORD CD, 1986, J MED CHEM, V29, P2174, DOI 10.1021/jm00161a008; BERMAN HA, 1989, J BIOL CHEM, V264, P3951; BISMUTH C, 1992, CLIN EXPT TOXICOLOGY, P555; CARLSTROM D, 1966, ACTA CHEM SCAND, V20, P1240, DOI 10.3891/acta.chem.scand.20-1240; CYGLER M, 1993, PROTEIN SCI, V2, P366; CYGLER M, 1994, J AM CHEM SOC, V116, P3180, DOI 10.1021/ja00087a002; DEJONG LPA, 1985, BIOCHIM BIOPHYS ACTA, V830, P345, DOI 10.1016/0167-4838(85)90294-8; DEJONG LPA, 1984, BIOCHEM PHARMACOL, V33, P1119, DOI 10.1016/0006-2952(84)90523-9; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V1, P88; ERDMANN WD, 1969, N-S ARCH PHARMAKOL, V263, P61, DOI 10.1007/BF00549443; HACKLEY B. E., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P211, DOI 10.1016/0003-9861(59)90359-5; HALL CR, 1980, TETRAHEDRON, V36, P2059, DOI 10.1016/0040-4020(80)80096-2; HANKE DW, 1991, J TOXICOL ENV HEALTH, V34, P141, DOI 10.1080/15287399109531554; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HAREL M, 1992, P NATL ACAD SCI USA, V89, P10827, DOI 10.1073/pnas.89.22.10827; HARVEY B, 1986, BIOCHEM PHARMACOL, V35, P745, DOI 10.1016/0006-2952(86)90241-8; KAMENAR B, 1986, ACTA CRYSTALLOGR C, V42, P1818, DOI 10.1107/S010827018609042X; LEE SL, 1982, J BIOL CHEM, V257, P2302; LEVY D, 1986, BIOCHEM PHARMACOL, V35, P1079, DOI 10.1016/0006-2952(86)90142-5; LUNDY PM, 1992, TOXICOLOGY, V72, P99, DOI 10.1016/0300-483X(92)90089-W; NAIR HK, 1994, BIOCHEMISTRY-US, V33, P8566, DOI 10.1021/bi00194a023; OLDIGES H, 1970, ARCH TOXIKOL, V26, P293; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; POZIOMEK EJ, 1958, J ORG CHEM, V23, P714, DOI 10.1021/jo01099a019; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P2465, DOI 10.1016/0006-2952(93)90228-O; SEGALL Y, 1993, BIOCHEMISTRY-US, V32, P13441, DOI 10.1021/bi00212a009; Segel IH, 1976, BIOCH CALCULATIONS; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; VANHAVERE W, 1982, ACTA CRYSTALLOGR B, V38, P2516, DOI 10.1107/S0567740882009248; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; WILSON IB, 1955, BIOCHIM BIOPHYS ACTA, V18, P168, DOI 10.1016/0006-3002(55)90040-8	39	86	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6370	6380		10.1074/jbc.270.11.6370	http://dx.doi.org/10.1074/jbc.270.11.6370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890775	hybrid			2022-12-27	WOS:A1995QM94500097
J	KUMBLE, KD; KORNBERG, A				KUMBLE, KD; KORNBERG, A			INORGANIC POLYPHOSPHATE IN MAMMALIAN-CELLS AND TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PHOSPHOTRANSFERASE; GLUCOKINASE	Inorganic polyphosphate (polyP), a linear polymer of hundreds of orthophosphate (P-i) residues linked by high-energy, phosphoanhydride bonds, has been identified and measured in a variety of mammalian cell lines and tissues by unambiguous enzyme methods, Subpicomole amounts of polyP (0.5 pmol/100 mu g of protein) were determined by its conversion to ATP by Escherichia coli polyphosphate kinase and, alternatively, to P-i by Saccharomyces cerevisiae exopolyphosphatase, Levels of 25 to 120 mu M (in terms of P-i residues), in chains 50 to 800 residues long, were found in rodent tissues (brain, heart, kidneys, liver, and lungs) and in subcellular fractions (nuclei, mitochondria, plasma membranes, and microsomes). PolyP in brain was predominantly near 800 residues and found at similar levels pre- and postnatally, Conversion of P-i into polyP by cell lines of fibroblasts, T-cells, kidney, and adrenal cells attained levels in excess of 10 pmol per mg of cell protein per h. Synthesis of polyP from P-i in the medium bypasses intracellular P-i and ATP pools suggesting the direct involvement of membrane component(s). In confluent PC12 (adrenal pheochromocytoma) cells, polyP turnover was virtually complete in an hour, whereas in fibroblasts there was little turnover in four hours, The ubiquity of polyP and variations in its size, location, and metabolism are indicative of a multiplicity of functions for this polymer in mammalian systems.			KUMBLE, KD (corresponding author), STANFORD UNIV, SCH MED, BECKMAN CTR, DEPT BIOCHEM, STANFORD, CA 94305 USA.							AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; ANSEVIN AT, 1975, J BIOL CHEM, V250, P281; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V215, P589, DOI 10.1016/0003-9861(82)90120-5; BONTING CFC, 1991, J BACTERIOL, V173, P6484, DOI 10.1128/jb.173.20.6484-6488.1991; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COWLING RT, 1994, J BIOL CHEM, V269, P9480; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Fleischer S, 1974, Methods Enzymol, V31, P6; GABEL NW, 1971, J NEUROCHEM, V18, P1229, DOI 10.1111/j.1471-4159.1971.tb00222.x; GEZELIUS K, 1973, CR ACAD SCI D NAT, V276, P117; GRIFFIN JB, 1965, J BIOL CHEM, V240, P4427; HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012; Kulaev IS, 1979, BIOCH INORGANIC POLY; LYNN WS, 1963, BIOCHEM BIOPH RES CO, V11, P367, DOI 10.1016/0006-291X(63)90124-4; MANSUROVA SE, 1975, DOKL AKAD NAUK SSSR+, V225, P717; OFFENBACHER S, 1984, ARCH BIOCHEM BIOPHYS, V231, P114, DOI 10.1016/0003-9861(84)90368-0; PHILLIPS NFB, 1993, ARCH BIOCHEM BIOPHYS, V300, P309, DOI 10.1006/abbi.1993.1043; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; PISONI RL, 1992, J BIOL CHEM, V267, P3626; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; VANVEEN HW, 1993, J BIOL CHEM, V268, P19377; WEINSTEIN BI, 1976, ARCH BIOCHEM BIOPHYS, V175, P114, DOI 10.1016/0003-9861(76)90489-6; WOOD HG, 1988, ANNU REV BIOCHEM, V57, P235, DOI 10.1146/annurev.bi.57.070188.001315; WURST H, 1994, J BIOL CHEM, V269, P10996	25	240	248	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5818	5822		10.1074/jbc.270.11.5818	http://dx.doi.org/10.1074/jbc.270.11.5818			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890711	hybrid			2022-12-27	WOS:A1995QM94500022
J	RIGGS, DL; PETERSON, CL; WICKHAM, JQ; MILLER, LM; CROWELL, JA; SERGERE, JC				RIGGS, DL; PETERSON, CL; WICKHAM, JQ; MILLER, LM; CROWELL, JA; SERGERE, JC			CHARACTERIZATION OF THE COMPONENTS OF RECONSTITUTED SACCHAROMYCES-CEREVISIAE RNA-POLYMERASE-I TRANSCRIPTION COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; WHOLE-CELL EXTRACT; FACTOR TIF-IA; EUKARYOTIC TRANSCRIPTION; DEPENDENT TRANSCRIPTION; HORMONAL-REGULATION; INITIATION; YEAST; RDNA; GENE	We have reconstituted specific RNA polymerase I transcription from three partially purified chromatographic fractions (termed A, B, and C). Here, we present the chromatographic scheme and the initial biochemical characterization of these fractions, The A fraction contained the RNA polymerase I transcription factor(s), which was necessary and sufficient to form stable preinitiation complexes at the promoter. Of the three fractions, only fraction A contained a significant amount of the TATA binding factor, The B fraction contributed RNA polymerase I, and it contained an essential RNA polymerase I transcription factor that was specifically inactivated in response to a significant decrease in growth rate, The function of the C fraction remains unclear, This reconstituted transcription system provides a starting point for the biochemical dissection of the yeast RNA polymerase I transcription complex, thus allowing in vitro experiments designed to elucidate the molecular mechanisms controlling rRNA synthesis.			RIGGS, DL (corresponding author), UNIV OKLAHOMA,DEPT BOT & MICROBIOL,NORMAN,OK 73019, USA.			Wickham, John/0000-0001-9057-9973	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047881] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47881] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; BRUN RP, 1994, MOL CELL BIOL, V14, P5010, DOI 10.1128/MCB.14.7.5010; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; CULOTTA VC, 1985, MOL CELL BIOL, V5, P1582, DOI 10.1128/MCB.5.7.1582; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; HU CH, 1994, MOL CELL BIOL, V14, P2871, DOI 10.1128/MCB.14.5.2871; KERMEKCHIEV M, 1993, NUCLEIC ACIDS RES, V21, P447, DOI 10.1093/nar/21.3.447; KUHN A, 1992, P NATL ACAD SCI USA, V89, P7340, DOI 10.1073/pnas.89.16.7340; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; LUE NF, 1990, J BIOL CHEM, V265, P18091; MAHAJAN PB, 1990, J BIOL CHEM, V265, P16244; MAHAJAN PB, 1990, J BIOL CHEM, V265, P16225; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; PIKAARD CS, 1989, GENE DEV, V3, P1779, DOI 10.1101/gad.3.11.1779; POON D, 1993, J BIOL CHEM, V268, P15325; PUTNAM CD, 1994, MOL CELL BIOL, V14, P6476, DOI 10.1128/MCB.14.10.6476; REEDER RH, 1992, TRANSCRIPTIONAL REGU, V1, P315; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; RIGGS DL, 1990, J BIOL CHEM, V265, P7596; SCHNAPP A, 1990, NUCLEIC ACIDS RES, V18, P1385, DOI 10.1093/nar/18.6.1385; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; SCHULTZ LD, 1976, P NATL ACAD SCI USA, V73, P1029, DOI 10.1073/pnas.73.4.1029; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SCHULTZ MC, 1991, P NATL ACAD SCI USA, V88, P1004, DOI 10.1073/pnas.88.3.1004; Smith S. David, 1993, Gene Expression, V3, P229; SMITH SD, 1990, MOL CELL BIOL, V10, P3105, DOI 10.1128/MCB.10.6.3105; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; TOWER J, 1987, CELL, V50, P873, DOI 10.1016/0092-8674(87)90514-9; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; WOONTNER M, 1990, J BIOL CHEM, V265, P8979	38	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6205	6210		10.1074/jbc.270.11.6205	http://dx.doi.org/10.1074/jbc.270.11.6205			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890756	hybrid			2022-12-27	WOS:A1995QM94500073
J	TROTTER, PJ; PEDRETTI, J; YATES, R; VOELKER, DR				TROTTER, PJ; PEDRETTI, J; YATES, R; VOELKER, DR			PHOSPHATIDYLSERINE DECARBOXYLASE-2 OF SACCHAROMYCES-CEREVISIAE - CLONING AND MAPPING OF THE GENE, HETEROLOGOUS EXPRESSION, AND CREATION OF THE NULL ALLELE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ESCHERICHIA-COLI; MEMBRANE LIPIDS; YEAST; BIOGENESIS; DNA; COMPLEMENTATION; MITOCHONDRIA; MUTANTS; BINDING	The yeast Saccharomyces cerevisiae expresses two phosphatidylserine decarboxylase (PSD) activities which are responsible for conversion of phosphatidylserine to phosphatidylethanolamine, and either enzyme alone is sufficient for normal cellular growth, However, strains containing a PSD1 null allele and a mutation leading to loss of PSD2 activity (psd1-Delta 1::TRP1 psd2) are auxotrophic for ethanolamine, This nutritional requirement was utilized to isolate the gene encoding the PSD2 enzyme by complementation. The PSD2 gene encodes a protein of 1138 amino acids with a predicted molecular mass of 130 kDa. The deduced amino acid sequence shows significant identity (34%) to a PSD-like sequence from Clostridium pasteurianum and the yeast PSD1 (19%) at the carboxyl end of the protein, Of particular interest is the presence of a sequence, GGST, which may be involved in post-translational processing and pros thetic group formation similar to other PSD enzymes, The PSD2 amino acid sequence also shows significant homology to the C-2 regions of protein kinase C and synaptotagmin. Physical mapping experiments demonstrate that the PSD2 is located on chromosome 7. The PSD2 gene was heterologously expressed by infection of Sf-9 insect cells with recombinant baculovirus, resulting in a 10-fold increase in PSD activity. The null allele of PSD2 was introduced into yeast strains by one-step gene deletion/disruption with a HIS3 marker gene, Strains expressing wild type PSD1 and the psd2-Delta 1::HIS3 allele show a small decrease in overall PSD activity, but no noticeable effect upon [H-3] serine incorporation into aminophospholipids. Strains containing both the psd1-Delta 1::TRP1 and psd2-Delta 1::HIS3 null alleles, however, express no detectable PSD activity, are ethanolamine auxotrophs and show a severe deficit in the conversion of [H-3] serine-labeled phosphatidylserine to phosphatidylethanolamine. These data indicate that the gene isolated is the structural gene for PSD2 and that the PSD1 and PSD2 enzymes account for all yeast PSD activity.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, LORD & TAYLOR LAB LUNG BIOCHEM, DENVER, CO 80206 USA; NATL JEWISH CTR IMMUNOL & RESP MED, ANNA PERAHIA ADATTO CLIN RES CTR, DENVER, CO 80206 USA	National Jewish Health; National Jewish Health					NIGMS NIH HHS [GM32453, GM16701] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, F32GM016701, R01GM032453] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRANOFF BW, 1963, BIOCHEM PREP, V10, P46; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ATKINSON KD, 1984, GENETICS, V108, P533; AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; COBRINIK D, 1992, TRENDS BIOCHEM SCI, V17, P312, DOI 10.1016/0968-0004(92)90443-D; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DENNIS EA, 1972, J LIPID RES, V13, P263; FATTAEY AR, 1993, ONCOGENE, V8, P3149; GARDINER K, 1991, ANAL CHEM, V63, P658, DOI 10.1021/ac00007a003; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HINNEBUSCH AG, 1991, MOL CELLULAR BIOL YE, V1, P627; HUBSCHER G, 1962, BIOCHIM BIOPHYS ACTA, V56, P555; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KANFER J, 1964, J BIOL CHEM, V239, P1720; KANFER JN, 1980, CAN J BIOCHEM CELL B, V58, P1370, DOI 10.1139/o80-186; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; KRUGER KE, 1991, J NEUROSCI, V11, P2303; KUGE O, 1991, J BIOL CHEM, V266, P6370; LI QX, 1988, J BIOL CHEM, V263, P11516; LI QX, 1990, J BIOL CHEM, V265, P4111; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; MORTIMER RK, 1991, METHOD ENZYMOL, V194, P827; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; O'Reilly D., 1992, BACULOVIRUS EXPRESSI, P109; OHTA A, 1981, J BIOL CHEM, V256, P2219; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; ONO Y, 1988, NUCLEIC ACIDS RES, V16, P5199, DOI 10.1093/nar/16.11.5199; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; REZA F, 1994, FEBS LETT, V339, P229, DOI 10.1016/0014-5793(94)80421-4; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATRE M, 1978, J BIOL CHEM, V253, P479; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STRATHERN JN, 1991, METHOD ENZYMOL, V194, P319; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; TROTTER PJ, 1994, BBA-LIPID LIPID MET, V1213, P241, DOI 10.1016/0005-2760(94)00073-5; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032; [No title captured]	51	138	139	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6071	6080		10.1074/jbc.270.11.6071	http://dx.doi.org/10.1074/jbc.270.11.6071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890740	hybrid			2022-12-27	WOS:A1995QM94500056
J	HAUCKE, V; LITHGOW, T; ROSPERT, S; HAHNE, K; SCHATZ, G				HAUCKE, V; LITHGOW, T; ROSPERT, S; HAHNE, K; SCHATZ, G			THE YEAST MITOCHONDRIAL PROTEIN IMPORT RECEPTOR MAS20P BINDS PRECURSOR PROTEINS THROUGH ELECTROSTATIC INTERACTION WITH THE POSITIVELY CHARGED PRESEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; MACHINERY; INSERTION; COMPLEX	Protein import into yeast mitochondria is mediated by the four outer membrane receptors Mas70p, Mas37p, Mas20p, and Mas22p, These receptors may function as two subcomplexes: a Mas37p/Mas70p heterodimer and an acidic complex consisting of Mas20p and Mas22p. To assess the relative contribution of these subcomplexes to precursor binding, we allowed different precursors to bind to the surface of deenergized mitochondria, then reenergized the mitochondria and measured the chase of the bound precursors into the organelles. Productive binding of several precursors with a positively charged amino-terminal matrix targeting sequence, such as SU9-DHFR, hsp60, and mitochondrial cpn10, was strongly inhibited by salt, by low concentrations of a mitochondrial presequence peptide, and by a deletion of Mas20p, but was independent of Mas37p/Mas70p. In contrast, productive binding of the ADP/ATP carrier was not inhibited by salt, the presequence peptide, or a deletion of Mas20p, but was strongly dependent on Mas37p/Mas70p. The precursors of alcohol dehydrogenase III and the Rieske iron sulfur protein had binding properties between these two extremes. The productively bound precursor of cpn10 could be cross-linked to Mas20p. We conclude that Mas20p binds mitochondrial precursor proteins through electrostatic interactions with the positively charged presequence, whereas Mas37p/Mas70p may recognize some feature(s) of the mature part of precursor proteins.	UNIV BASEL, BIOCTR, CH-4056 BASEL, SWITZERLAND	University of Basel			Lithgow, Trevor J/H-5925-2017	Lithgow, Trevor J/0000-0002-0102-7884; Rospert, Sabine/0000-0002-3089-9614; Haucke, Volker/0000-0003-3119-6993				ALLISON DS, 1986, P NATL ACAD SCI USA, V83, P9011, DOI 10.1073/pnas.83.23.9011; BEASLEY E M, 1992, Current Opinion in Cell Biology, V4, P646, DOI 10.1016/0955-0674(92)90084-P; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; GLASER SM, 1990, J BIOL CHEM, V265, P8808; GLICK BS, 1991, METHOD CELL BIOL, V34, P389; GLICK BS, 1995, IN PRESS METHODS ENZ; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; LITHGOW T, 1994, J BIOL CHEM, V269, P15325; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; PERALTA D, 1993, EUR J BIOCHEM, V211, P881, DOI 10.1111/j.1432-1033.1993.tb17621.x; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; RIEZMAN H, 1983, EMBO J, V2, P1113, DOI 10.1002/j.1460-2075.1983.tb01554.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; ROSPERT S, 1993, FEBS LETT, V335, P358, DOI 10.1016/0014-5793(93)80419-U; SCHATZ G, 1993, PROTEIN SCI, V2, P141; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; VALLETTE FM, 1994, J BIOL CHEM, V269, P13367; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; WACHTER C, 1994, MOL BIOL CELL, V5, P465, DOI 10.1091/mbc.5.4.465	30	91	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5565	5570		10.1074/jbc.270.10.5565	http://dx.doi.org/10.1074/jbc.270.10.5565			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890675	hybrid			2022-12-27	WOS:A1995QL58000092
J	IWASAKI, S; TSURUOKA, N; HATTORI, A; SATO, M; TSUJIMOTO, M; KOHNO, M				IWASAKI, S; TSURUOKA, N; HATTORI, A; SATO, M; TSUJIMOTO, M; KOHNO, M			DISTRIBUTION AND CHARACTERIZATION OF SPECIFIC CELLULAR-BINDING PROTEINS FOR BONE MORPHOGENETIC PROTEIN-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; OSTEOGENIC PROTEIN; II RECEPTOR; EMBRYONIC-DEVELOPMENT; MESSENGER-RNA; DIFFERENTIATION; FIBROBLASTS; EXPRESSION; INVITRO; CLONING	Bone morphogenetic proteins (BMPs), which were originally identified by their novel ability to induce de novo cartilage and bone formation in vivo, are multifunctional proteins structurally related to transforming growth factor-beta s, activins, and inhibins. As a first step to elucidate the precise physiological function as well as the action mechanism of BMPs, we have examined the distribution of the specific cellular binding proteins for BMP-2 on a wide variety of cell types. A single class of high affinity-specific binding sites for BMP-2 were identified not only on osteoblastic cells but also on major types of non hematopoietic cells in a rather ubiquitous fashion (1,200 similar to 60,000 receptors/cell, K-d = 35 similar to 230 pM); these cells included fibroblasts, keratinocytes, astrocytes, kidney epithelial cells, and tumor cells of bone, muscle, lung, liver, kidney, stomach, colon, prostate, and neuronal tissue. Other growth factors including transforming growth factor-beta(1), activin A, and inhibin A did not compete for the binding of I-125-labeled BMP-2 to the cells. Affinity cross-linking of radiolabeled BMP showed five components with apparent molecular masses of 170, 105, 90, 80, and 70 kDa common to all three fibroblast cell lines analyzed. On the other hand, no specific binding sites for BMP-2 were identified on vascular endothelial cells or on hematopoietic cells including RPMI 1788 and RPMI 8226 (B-lymphocyte lineage), MOLT-3 and MOLT-4 (T-lymphocyte lineage), HL-60 (myeloid lineage), and K-562 (erythroid lineage). These results suggest that major types of cells other than hematopoietic cells and vascular endothelial cells may be potential targets for BMP-2 action.	GIFU PHARMACEUT UNIV,DEPT BIOL,GIFU 502,JAPAN; SUNTORY INST BIOORGAN RES,OSAKA 618,JAPAN	Gifu Pharmaceutical University; Suntory Holdings Ltd								BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740; DALE L, 1992, DEVELOPMENT, V115, P573; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FROLIK CA, 1984, J BIOL CHEM, V259, P995; ISHIDA N, 1994, J BIOCHEM-TOKYO, V115, P279, DOI 10.1093/oxfordjournals.jbchem.a124329; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Lin Herbert Y., 1993, Trends in Cell Biology, V3, P14, DOI 10.1016/0962-8924(93)90195-7; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LUYTEN FP, 1994, EXP CELL RES, V210, P224, DOI 10.1006/excr.1994.1033; LYONS KM, 1990, DEVELOPMENT, V109, P833; LYONS KM, 1991, TRENDS GENET, V7, P408, DOI 10.1016/0168-9525(91)90265-R; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MURASE K, 1993, BIOCHEM MOL BIOL INT, V30, P615; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; PARALKAR VM, 1991, P NATL ACAD SCI USA, V88, P3397, DOI 10.1073/pnas.88.8.3397; PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; STEINMAN RM, 1974, J CELL BIOL, V63, P949, DOI 10.1083/jcb.63.3.949; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	42	61	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5476	5482		10.1074/jbc.270.10.5476	http://dx.doi.org/10.1074/jbc.270.10.5476			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890664	hybrid			2022-12-27	WOS:A1995QL58000080
J	VIEIRA, L; SLOTKI, I; CABANTCHIK, ZI				VIEIRA, L; SLOTKI, I; CABANTCHIK, ZI			CHLORIDE CONDUCTIVE PATHWAYS WHICH SUPPORT ELECTROGENIC H+ PUMPING BY LEISHMANIA-MAJOR PROMASTIGOTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED MACROPHAGES; TRYPANOSOMA-BRUCEI; MEMBRANE; PH; TRANSPORT; DONOVANI; GRADIENT; EXCHANGE; GLUCOSE; ATPASE	The proton extrusion mechanisms of Leishmania promastigotes were studied in terms of electrogenic movements of protons and anions (Cl- and HCO3-). Changes in membrane potential (V-m) and intracellular pH (pH(i)) were monitored fluorimetrically with the potential sensitive dye bis oxonol and the pH-sensitive dye tetraacethoxymethyl 2',7'-bis-(carboxyethyl)-5,6 carboxyfluorescein, respectively. In nominal bicarbonate-free medium (pH(e) 7.4, 28 degrees C), V-m and pH(i) of Leishmania promastigotes were maintained at -113 +/- 4 mV and 6.75 +/- 0.02, respectively. In Cl- free (gluconate based) medium, cells underwent a time dependent acidification (0.3 pH units) and a long term membrane hyperpolarization (7-10 mV), both of which were greatly enhanced in the presence of. the anion blocker, 4,4'-diisothiocyanodihydrostilbene-2,2'-disulfonic acid (H2DIDS). Cells in Cl--free medium underwent a marked depolarization upon treatment with the H+-ATPase inhibitor dicyclohexylcarbodiimide (DCCD), but hyperpolarized after repletion with Cl-. In Cl--depleted cells, replenishment of Cl- led to a H2DIDS-sensitive cytoplasmic alkalinization and a small initial hyperpolarization. Cells exposed either to DCCD or to the H+ uncoupler carbonylcyanide chloraphenylhydrazone caused a marked cytoplasmic acidification and membrane depolarization. In the presence of 25 mM HCO3-, promastigotes maintained an almost neutral cytosol, irrespective of H+ pump action or ionic composition of the medium, The present observations provide evidence for the operation of a DCCD-sensitive electrogenic H+ ATPase which contributes to the maintenance of a highly hyperpolarized plasma membrane in Leishmania promastigotes. H+ pump activity required a parallel pathway of Cl- ions in order to dissipate the pump generated electrical potential, In nominally CO2-free media, the two electrogenic systems are implicated in the maintenance of cell pH and indirectly in electrochemically driven nutrient uptake, In physiological CO2/HCO3-, containing media, the H+ pump and Cl- channel play a role only secondary to that of HCO3-, in pH(i) homeostasis.	HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL; SHAARE ZEDEK MED CTR,RENAL UNIT,IL-91931 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020342, R22AI020342] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-20342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; BLUM JJ, 1993, PARASITOL TODAY, V9, P118, DOI 10.1016/0169-4758(93)90168-F; BOYARSKY G, 1990, P NATL ACAD SCI USA, V87, P5921, DOI 10.1073/pnas.87.15.5921; BUSH DR, 1993, ANNU REV PLANT PHYS, V44, P513, DOI 10.1146/annurev.pp.44.060193.002501; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; CASSEL D, 1985, J CELL PHYSIOL, V122, P178, DOI 10.1002/jcp.1041220203; GLASER TA, 1992, MOL BIOCHEM PARASIT, V51, P9, DOI 10.1016/0166-6851(92)90195-P; GLASER TA, 1988, P NATL ACAD SCI USA, V85, P7602, DOI 10.1073/pnas.85.20.7602; HEYTLER P, 1978, METHOD ENZYMOL, V55, P435; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; JIANG SP, 1994, J CELL PHYSIOL, V159, P60, DOI 10.1002/jcp.1041590109; KABACK HR, 1983, J MEMBRANE BIOL, V76, P95; KANAANI J, 1989, J BIOL CHEM, V264, P3194; KRASNE S, 1978, MEMBRANE PHYSL, P217; MIKKELSEN RB, 1986, MOL BIOCHEM PARASIT, V21, P83, DOI 10.1016/0166-6851(86)90082-4; POOLE RJ, 1978, ANNU REV PLANT PHYS, V29, P437, DOI 10.1146/annurev.pp.29.060178.002253; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; RINK TJ, 1992, J CELL BIOL, V95, P189; RUSSELL DG, 1992, J CELL SCI, V103, P1193; SCHLEIN Y, 1993, PARASITOL TODAY, V9, P255, DOI 10.1016/0169-4758(93)90070-V; SCHMID A, 1989, J MEMBRANE BIOL, V11, P265; SPANSWICK RM, 1981, ANNU REV PLANT PHYS, V32, P267, DOI 10.1146/annurev.pp.32.060181.001411; STEVENS TH, 1992, J EXP BIOL, V172, P47; TERKUILE BH, 1993, PARASITOL TODAY, V9, P206, DOI 10.1016/0169-4758(93)90009-5; TERKUILE BH, 1993, MOL BIOCHEM PARASIT, V60, P313, DOI 10.1016/0166-6851(93)90142-K; TERKUILE BH, 1992, MOL BIOCHEM PARASIT, V55, P21, DOI 10.1016/0166-6851(92)90123-2; THISSEN JA, 1991, EXP PARASITOL, V72, P243, DOI 10.1016/0014-4894(91)90143-K; VIEIRA L, 1994, J BIOL CHEM, V269, P16254; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; XIE XS, 1989, J BIOL CHEM, V264, P18870; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	32	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5299	5304		10.1074/jbc.270.10.5299	http://dx.doi.org/10.1074/jbc.270.10.5299			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890641	hybrid			2022-12-27	WOS:A1995QL58000054
J	CATERINA, MJ; HERELD, D; DEVREOTES, PN				CATERINA, MJ; HERELD, D; DEVREOTES, PN			OCCUPANCY OF THE DICTYOSTELIUM CAMP RECEPTOR, CAR1, INDUCES A REDUCTION IN AFFINITY WHICH DEPENDS UPON COOH-TERMINAL SERINE RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; ADENOSINE 3'-5'-MONOPHOSPHATE RECEPTOR; CYCLIC-AMP RECEPTOR; INDUCED DESENSITIZATION; ADENYLATE-CYCLASE; DOWN-REGULATION; LIGAND-BINDING; DISCOIDEUM; INTERNALIZATION; CELLS	Many G-protein coupled receptors display a rapid decrease in ligand binding following pretreatment with agonist, cAR1, a cAMP receptor expressed early in the developmental program of Dictyostelium, mediates chemotaxis, activation of adenylyl cyclase, and gene expression changes that bring about the aggregation of 10(5) amoebae to form a multicellular structure. Occupancy of cAR1 by cAMP initiates multiple desensitization processes, one of which is an apparent reduction in binding sites. In transformed cells expressing cAR1 constitutively, Scatchard analyses revealed that this apparent loss of ligand binding is largely due to a significant reduction in the affinity of cAR1 for cAMP, A parallel increase in the dose dependence of cAR1-mediated cAMP uptake was observed, Consistent with these findings, proteolysis of intact cells and immunofluorescence suggested that cAR1 remains on the cell-surface following cAMP treatment, Finally, agonist-induced loss of ligand binding is impaired in cAR1 mutants lacking a cluster of cytoplasmic serine residues, which are targets of cAMP-induced phosphorylation.	JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21205 USA	Johns Hopkins University					NIGMS NIH HHS [GM 34933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK LS, 1994, J BIOL CHEM, V269, P2790; BRENNER M, 1984, DEV BIOL, V101, P136, DOI 10.1016/0012-1606(84)90124-6; CATERINA MJ, 1994, J BIOL CHEM, V269, P1523; CATERINA MJ, 1991, FASEB J, V5, P3078, DOI 10.1096/fasebj.5.15.1743439; CHEUNG AH, 1988, MOL PHARMACOL, V34, P132; CHUANG DM, 1979, P NATL ACAD SCI USA, V76, P3024, DOI 10.1073/pnas.76.6.3024; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; DEVREOTES PN, 1985, J BIOL CHEM, V260, P6378; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HENDERSON EJ, 1975, J BIOL CHEM, V250, P4730; HERELD D, 1994, J BIOL CHEM, V269, P7036; HERTEL C, 1983, BIOCHEM J, V216, P669, DOI 10.1042/bj2160669; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; JULIANI MH, 1981, J BIOL CHEM, V256, P613; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; KLEIN C, 1977, CELL, V10, P329, DOI 10.1016/0092-8674(77)90227-6; KLEIN C, 1979, J BIOL CHEM, V254, P2573; KLEIN P, 1987, J BIOL CHEM, V262, P358; KLEIN P, 1985, J BIOL CHEM, V260, P1757; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LOUIS JM, 1994, GENE DEV, V8, P2086, DOI 10.1101/gad.8.17.2086; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P6566, DOI 10.1073/pnas.82.19.6566; MORO O, 1993, J BIOL CHEM, V268, P22273; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ROOS W, 1977, NATURE, V266, P259, DOI 10.1038/266259a0; SAXE CL, 1993, GENE DEV, V7, P262, DOI 10.1101/gad.7.2.262; SNAARJAGALSKA BE, 1988, J BIOL CHEM, V263, P897; TAO YP, 1990, J BIOL CHEM, V265, P15584; TOEWS ML, 1984, J BIOL CHEM, V259, P1844; VANHAASTERT PJM, 1987, J BIOL CHEM, V262, P7700; VANHAASTERT PJM, 1985, BIOCHIM BIOPHYS ACTA, V845, P254, DOI 10.1016/0167-4889(85)90184-3; VANHAASTERT PJM, 1984, BIOCHEM BIOPH RES CO, V124, P597, DOI 10.1016/0006-291X(84)91596-1; VANHAASTERT PJM, 1992, MOL BIOL CELL, V3, P603, DOI 10.1091/mbc.3.6.603; VAUGHAN RA, 1988, J BIOL CHEM, V263, P14538; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WANG HY, 1989, BIOCHEM J, V263, P533, DOI 10.1042/bj2630533; WANG M, 1988, DEV BIOL, V128, P72, DOI 10.1016/0012-1606(88)90268-0; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; YU SS, 1993, J BIOL CHEM, V268, P337	49	27	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4418	4423		10.1074/jbc.270.9.4418	http://dx.doi.org/10.1074/jbc.270.9.4418			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876207	hybrid			2022-12-27	WOS:A1995QK08400039
J	CONROY, WG; BERG, DK				CONROY, WG; BERG, DK			NEURONS CAN MAINTAIN MULTIPLE CLASSES OF NICOTINIC ACETYLCHOLINE-RECEPTORS DISTINGUISHED BY DIFFERENT SUBUNIT COMPOSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY GANGLION NEURONS; MONOCLONAL-ANTIBODIES; BINDING-SITES; MESSENGER-RNA; BRAIN; SUBTYPES; LOCALIZATION; EXPRESSION; COMPONENT; GENES	Although 10 genes have been cloned encoding putative subunits of neuronal nicotinic acetylcholine receptors, little is known about the variety or subunit composition of such receptors expressed by individual neurons, Chick ciliary ganglion neurons express five of the known genes and assemble a class of synaptic-type receptors collectively containing gene products from three of them: alpha 3, beta 4, and alpha 5. Using subunit-specific monoclonal antibodies, we show here that all of the synaptic-type acetylcholine receptors having alpha 3 also have beta 4 subunits and vice versa. In addition, most, if not all, of the alpha 5 gene product present in fully assembled receptors is associated with both alpha 3 and beta 4 subunits, Although the receptors may be homogeneous in these respects, only about 20% of them also contain the fourth gene product, beta 2, newly identified in the ganglion; essentially all of the neurons express the beta 2 gene, No beta 2 subunits are found coassembled with the fifth acetylcholine receptor gene product expressed by the neurons, alpha 7, which has been shown previously to comprise a class of abundant, nonsynaptic receptors on the cells, The identification of three acetylcholine receptor subtypes distinguished by subunit composition on the same neurons provokes questions about their individual physiological roles.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego					NINDS NIH HHS [R01 NS12601, P01 NS25916] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, P01NS025916] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANAND R, 1991, J BIOL CHEM, V266, P11192; BOYD RT, 1991, J NEUROBIOL, V22, P1, DOI 10.1002/neu.480220102; BOYD RT, 1988, NEURON, V1, P495; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; HALVORSEN SW, 1987, J NEUROSCI, V7, P2547; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; LINDSTROM J, 1981, METHOD ENZYMOL, V74, P452; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LORING RH, 1987, J NEUROSCI, V7, P2153; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; RAVDIN PM, 1979, P NATL ACAD SCI USA, V76, P2072, DOI 10.1073/pnas.76.4.2072; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SMITH MA, 1985, J NEUROSCI, V5, P2726; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; WHITING P, 1987, FEBS LETT, V219, P459, DOI 10.1016/0014-5793(87)80272-7; WHITING P, 1991, MOL PHARMACOL, V40, P463; WHITING PJ, 1991, MOL BRAIN RES, V10, P61, DOI 10.1016/0169-328X(91)90057-5; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; WHITING PJ, 1987, J NEUROSCI, V7, P4005; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9	31	253	254	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4424	4431		10.1074/jbc.270.9.4424	http://dx.doi.org/10.1074/jbc.270.9.4424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876208	hybrid			2022-12-27	WOS:A1995QK08400040
J	DENU, JM; ZHOU, GC; WU, L; ZHAO, R; YUVANIYAMA, JD; SAPER, MA; DIXON, JE				DENU, JM; ZHOU, GC; WU, L; ZHAO, R; YUVANIYAMA, JD; SAPER, MA; DIXON, JE			THE PURIFICATION AND CHARACTERIZATION OF A HUMAN DUAL-SPECIFIC PROTEIN-TYROSINE-PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDC25 PROTEIN; VACCINIA VIRUS; DEPHOSPHORYLATION; ACTIVATION; KINASE; PEPTIDES; P34CDC2; SYSTEM; YEAST	An expression and purification method was developed to obtain the recombinant human dual specific protein tyrosine phosphatase (PTPase) VHR in quantities suitable for both kinetic studies and crystallization. Physical characterization of the homogeneous recombinant protein verified the mass to be 20,500 +/- 100 by matrix-assisted laser desorption mass spectrometry, confirmed the anticipated NH2-terminal amino acid sequence and demonstrated that the protein exists as a monomer. Conditions were developed to obtain crystals which were suitable for x-ray structure determination. Using synthetic diphosphorylated peptides corresponding to MAP(177-189) (mitogen-activated protein) kinase (DHTGFLpTEpYVATR), an assay was devised which permitted the determination of the rate constants for dephosphorylation of the diphosphorylated peptide on threonine and tyrosine residues. The diphosphorylated peptides are preferred over the singly phosphorylated on tyrosine by 3-8-fold. The apparent second-order rate constant k(cat)/K-m for dephosphorlyation of phosphotyrosine on DHTGFLpTEpYVATR was 32,000 M(-1) s(-1) while dephosphorylation of phosphothreonine was 14 M(-1) s(-1) (pH 6). The reaction of DHTGFLpTEpYVATR with VHR is ordered, with rapid dephosphorylation on tyrosine occurring first followed by slow dephosphorylation on threonine. Similar results were obtained with F(NLe) (NLe)pTPpYVVTR, a peptide corresponding to a MAP kinase-like protein (JNK1(180-189)) which is involved in the stress response signaling pathway.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,DIV BIOPHYS RES,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan				Yuvaniyama, Jirundon/0000-0002-6800-8944	NIAMS NIH HHS [P560 AR20557] Funding Source: Medline; NIDDK NIH HHS [NIDDKD 18849, NIDDKD 18024] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R01DK018849, R37DK018024] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS DM, 1991, INT J PEPT PROT RES, V38, P469; CHO HJ, 1991, BIOCHEMISTRY-US, V30, P6210, DOI 10.1021/bi00239a019; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KITAS EA, 1991, 12TH AM PEPT S BOST; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; MILLAR JBA, 1991, EMBO J, V10, P4302; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; ZHENG CF, 1993, J BIOL CHEM, V268, P16116; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	27	98	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3796	3803		10.1074/jbc.270.8.3796	http://dx.doi.org/10.1074/jbc.270.8.3796			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876121	hybrid			2022-12-27	WOS:A1995QH68800051
J	LAI, A; SISODIA, SS; TROWBRIDGE, IS				LAI, A; SISODIA, SS; TROWBRIDGE, IS			CHARACTERIZATION OF SORTING SIGNALS IN THE BETA-AMYLOID PRECURSOR PROTEIN CYTOPLASMIC DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID-PHOSPHATASE; HUMAN TRANSFERRIN RECEPTOR; ALZHEIMERS-DISEASE; INTERNALIZATION SIGNALS; INSULIN-RECEPTOR; CELL-SURFACE; ENDOCYTOSIS; SEQUENCE; CLEAVAGE; MEMBRANE	The beta-amyloid precursor protein (APP) is proteolytically processed to generate beta-amyloid protein, the principal protein component of neuropathological lesions characteristic of Alzheimer's disease. To investigate potential sorting signals in the cytoplasmic tail of APP, we transplanted APP cytoplasmic tail sequences into the cytoplasmic tail of the human transferrin receptor (TR) and showed that two sequence moths from the APP cytoplasmic tail promote TR internalization. One sequence, GYENPTY, is related to the low density lipoprotein receptor internalization signal, FDNPVY, but also involves a critical glycine residue; the other, YTSI, conforms to the 4-residue tyrosine based internalization signal consensus sequence. Furthermore, a chimeric molecule (APP-TR) consisting of the cytoplasmic domain of APP and the transmembrane and external domains of TR was rapidly internalized enabling the transport of iron into the cell at similar to 50% the rate of wild-type TR. Alanine scanning mutations indicated that the two sequences identified in transplantation experiments were required for internalization of the chimera. Metabolic pulse-chase experiments showed that the APP-TR chimeras were degraded in a post-Golgi membrane compartment within 2-4 h following normal glycosylation. Degradation was partially dependent upon the two internalization signals and was inhibited by ammonium chloride. A fraction of APP-TR chimeras traffic to a degradative endocytic compartment after appearing on the cell surface. Comparison of soluble APP released from cells expressing either full-length human APP or mutant APP with the sequence YENPTY deleted indicated that this sequence is required for sorting of full-length APP along similar trafficking pathways as the APP-TR chimera.	SALK INST, DEPT CANC BIOL, SAN DIEGO, CA 92186 USA; UNIV CALIF SAN DIEGO, BIOMED SCI GRAD PROGRAM, LA JOLLA, CA 92037 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA	Salk Institute; University of California System; University of California San Diego; Johns Hopkins University					NIGMS NIH HHS [GM07198] Funding Source: Medline; NINDS NIH HHS [NSAG05146, NS20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020471, P01NS020471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1991, EMBO J, V10, P3247, DOI 10.1002/j.1460-2075.1991.tb04888.x; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GARIPPA RJ, 1994, J CELL BIOL, V124, P705, DOI 10.1083/jcb.124.5.705; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HUGHES SH, 1990, J REPROD FERTIL, P39; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; JADOT M, 1992, J BIOL CHEM, V267, P11069; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JING SQ, 1990, J BIOL CHEM, V265, P11555; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; NORSTEDT C, 1993, J BIOL CHEM, V268, P608; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; OMARY MB, 1981, J BIOL CHEM, V256, P2888; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUBRAMANI S, 1981, MOL CELL BIOL, V7, P2745; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TANNER LI, 1987, J BIOL CHEM, V262, P8975; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	44	169	173	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3565	3573		10.1074/jbc.270.8.3565	http://dx.doi.org/10.1074/jbc.270.8.3565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876092				2022-12-27	WOS:A1995QH68800019
J	YANO, M; ELHAYEK, R; IKEMOTO, N				YANO, M; ELHAYEK, R; IKEMOTO, N			CONFORMATIONAL-CHANGES IN THE JUNCTIONAL FOOT PROTEIN CA2+ RELEASE CHANNEL MEDIATE DEPOLARIZATION-INDUCED CA2+ RELEASE FROM SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKINNED MUSCLE-FIBERS; SKELETAL-MUSCLE; CALCIUM-RELEASE; RYANODINE RECEPTOR; TRANSVERSE TUBULE; DIHYDROPYRIDINE RECEPTORS; CHARGE MOVEMENT; PURIFICATION; VESICLES; TOAD	In an attempt to monitor the kinetic events occurring in the junctional foot protein (JFP) during excitation-contraction coupling, the JFP moiety of isolated triads was covalently labeled in a site-directed manner with methylcoumarin acetate (MCA) using a recently developed technique (Kang, J. J., Tarcsafalvi, A., Carlos, A. D., Fujimoto, E., Shahrokh, Z., Thevenin, B. J. M., Shohet, S. B., and Ikemoto, N. (1992) Biochemistry 31, 3288-3293). Chemical depolarization of the transverse tubular system (T-tubule) moiety of labeled triads after appropriate priming induced first a rapid increase of the fluorescence intensity of the JFP-bound MCA probe, and then sarcoplasmic reticulum (SR) Ca2+ release. Upon increasing the magnitude of T-tubule depolarization by increasing the degree of ionic replacement, both the amplitude of the MCA fluorescence change and the amount of released Ca2+ increased in parallel. Blockers of T-tubuleto-SR communication, such as nimodipine and low concentration of neomycin, inhibited both the MCA fluorescence change and the SR Ca2+ release. In contrast, the release blocking concentration of Mg2+ (2 mM) inhibited only SR Ca2+ release without affecting the fluorescence change. These results suggest that upon T-tubule depolarization the original state of the JFP (R) isomerizes to an activated state with higher MCA fluorescence (*R), which in turn changes into a subsequent state in which the release channel is open (*R(0)):R-->R-->R(0).	BOSTON BIOMED RES INST, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA	Boston Biomedical Research Institute; Harvard University; Harvard Medical School					NIAMS NIH HHS [AR 16922] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR016922] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BIANCHI CP, 1968, FED PROC, V27, P126; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; CALVIELLO G, 1989, BIOCHEMISTRY-US, V28, P1301, DOI 10.1021/bi00429a053; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; CHANDLER WK, 1976, J PHYSIOL-LONDON, V254, P285, DOI 10.1113/jphysiol.1976.sp011233; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; IKEMOTO N, 1994, BIOCHEMISTRY-US, V33, P10961, DOI 10.1021/bi00202a015; IKEMOTO N, 1988, METHOD ENZYMOL, V157, P469; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; INUI M, 1987, J BIOL CHEM, V262, P1740; KANG JJ, 1992, BIOCHEMISTRY-US, V31, P3288, DOI 10.1021/bi00127a034; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LAMB GD, 1990, J PHYSIOL-LONDON, V423, P519, DOI 10.1113/jphysiol.1990.sp018037; LAMB GD, 1990, J PHYSIOL-LONDON, V423, P495, DOI 10.1113/jphysiol.1990.sp018036; LU XY, 1994, J BIOL CHEM, V269, P6511; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; PALADE P, 1987, J BIOL CHEM, V262, P6149; PESSAH IN, 1986, J BIOL CHEM, V261, P8643; RIOS E, 1992, ANNU REV PHYSIOL, V54, P109, DOI 10.1146/annurev.ph.54.030192.000545; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; YANOS M, 1994, FEBS LETT, V351, P346	27	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3017	3021		10.1074/jbc.270.7.3017	http://dx.doi.org/10.1074/jbc.270.7.3017			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852382	hybrid			2022-12-27	WOS:A1995QG47100022
J	SMITH, MM; SHI, LH; NAVRE, M				SMITH, MM; SHI, LH; NAVRE, M			RAPID IDENTIFICATION OF HIGHLY-ACTIVE AND SELECTIVE SUBSTRATES FOR STROMELYSIN AND MATRILYSIN USING BACTERIOPHAGE PEPTIDE DISPLAY LIBRARIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN FIBROBLAST STROMELYSIN; MONOVALENT PHAGE DISPLAY; MATRIX METALLOPROTEINASES; SEQUENCE SPECIFICITIES; SYNTHETIC PEPTIDES; ENZYME SPECIFICITY; CLEAVAGE SITES; LIGANDS; COLLAGENASE	The discovery of useful peptide substrates for proteases that recognize many amino acids in their active sites is often a slow process due to the lack of initial substrate data and the expense of analyzing large numbers of peptide substrate. To overcome these obstacles, we have made use of bacteriophage peptide display libraries. We prepared a random hexamer library in the fd-derived vector fAFF-1 and included a ''tether'' sequence that could be recognized by monoclonal antibodies. We chose the matrix metalloproteinases stromelysin and matrilysin as the targets for our studies, as they are known to require at least 6 amino acids in a peptide substrate for cleavage. The phage library was treated in solution with protease and cleaved phage separated from uncleaved phage using a mixture of tether-binding monoclonal antibodies and Protein A-bearing cells followed by precipitation. Clones were screened by the use of a rapid screening assay that identified phage encoding peptide sequences susceptible to cleavage by the enzymes. The nucleotide sequence of the random hexamer region of 43 such clones was determined for stromelysin and 23 for matrilysin. Synthetic peptides were prepared whose sequences were based on some of the positive clones, as well as consensus sequences built from the positive clones. Many of the peptides have k(cat)/K-M values as good or better than those of previously reported substrates, and in fact, we were able to produce stromelysin and matrilysin substrates that are both the most active and smallest reported to date. In addition, the phage data predicted selectivity in the P-2 and P'(1) positions of the two enzymes that were supported by the kinetic analysis of the peptides. This work demonstrates that the phage selection techniques enable the rapid identification of highly active and selective protease substrates without making any a priori assumptions about the specificity or the ''physiological substrate'' of the protease under study.	AFFYMAX RES INST, DEPT BIOCHEM, SANTA CLARA, CA 95051 USA				Smith, Matthew M./AAL-1697-2020					BARRETT RW, 1992, ANAL BIOCHEM, V204, P357, DOI 10.1016/0003-2697(92)90252-3; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BAUM EZ, 1990, P NATL ACAD SCI USA, V87, P10023, DOI 10.1073/pnas.87.24.10023; BERMAN J, 1992, J BIOL CHEM, V267, P1434; BIRKETT AJ, 1991, ANAL BIOCHEM, V196, P137, DOI 10.1016/0003-2697(91)90129-H; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DASMAHAPATRA B, 1992, P NATL ACAD SCI USA, V89, P4159, DOI 10.1073/pnas.89.9.4159; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Fersht A, 1985, ENZYME STRUCTURE MEC, P105; FIELDS GB, 1990, BIOCHEMISTRY-US, V29, P6670, DOI 10.1021/bi00480a017; GRAMSCH C, 1983, J NEUROCHEM, V40, P1220, DOI 10.1111/j.1471-4159.1983.tb13560.x; GRIFFITHS JT, 1992, BIOCHEMISTRY-US, V31, P5193, DOI 10.1021/bi00137a015; HELLEN CUT, 1989, BIOCHEMISTRY-US, V28, P9881, DOI 10.1021/bi00452a001; HOESS RH, 1993, CURR OPIN STRUC BIOL, V3, P572, DOI 10.1016/0959-440X(93)90085-Y; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Model P., 1988, BACTERIOPHAGES, P375; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; NETZELARNETT S, 1991, ANAL BIOCHEM, V195, P86, DOI 10.1016/0003-2697(91)90299-9; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; NIEDZWIECKI L, 1992, BIOCHEMISTRY-US, V31, P12618, DOI 10.1021/bi00165a011; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; PETITHORY JR, 1991, P NATL ACAD SCI USA, V88, P11510, DOI 10.1073/pnas.88.24.11510; POORMAN RA, 1991, J BIOL CHEM, V266, P14554; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; SCOTT JK, 1992, TRENDS BIOCHEM SCI, V17, P241, DOI 10.1016/0968-0004(92)90401-T; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; SMITH TA, 1991, P NATL ACAD SCI USA, V88, P5159, DOI 10.1073/pnas.88.12.5159; STACK MS, 1989, J BIOL CHEM, V264, P4277; TEAHAN J, 1989, BIOCHEMISTRY-US, V28, P8497, DOI 10.1021/bi00447a034; TOMASSELLI AG, 1991, J BIOL CHEM, V266, P14548; TOZSER J, 1992, BIOCHEMISTRY-US, V31, P4793, DOI 10.1021/bi00135a008	37	133	160	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6440	6449		10.1074/jbc.270.12.6440	http://dx.doi.org/10.1074/jbc.270.12.6440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896777	hybrid			2022-12-27	WOS:A1995QQ85500006
J	KIM, HY; KLAUSNER, RD; ROUAULT, TA				KIM, HY; KLAUSNER, RD; ROUAULT, TA			TRANSLATIONAL REPRESSOR ACTIVITY IS EQUIVALENT AND IS QUANTITATIVELY PREDICTED BY IN-VITRO RNA-BINDING FOR 2 IRON-RESPONSIVE ELEMENT-BINDING PROTEINS, IRP1 AND IRP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FERRITIN MESSENGER-RNA; PURIFICATION; REGION	Iron regulatory proteins (IRPs) bind to specific RNA stem-loop structures known as iron-responsive elements (IREs) which mediate the post-transcriptional regulation of many genes of iron metabolism. Most studies have focused on the role of IRP1, which has previously been shown to bind with high affinity to IREs and mediate repression of in vitro translation of ferritin mRNAs. More recently, a second IRP has been identified that is expressed in all tissues and that binds IREs (Rouault, T. A., Haile, D. H., Downey, W. E., Philpott, C. C., Tang, C., Samaniego, F., Chin, J., Paul, I., Orloff, D., Harford, J. B., and Klausner, R. D. (1992) BioMetals 5, 131-140; Henderson, B. R., Seiser, C., and Kuhn, L. C. (1993) J. Biol. Chem. 268, 27327-27334; Guo, B., Yu, Y., and Leibold, E. A. (1994) J. Biol. Chem. 269, 24252-24260; Samaniego, F., Chin, J., Iwai, K., Rouault, T. A., and Klausner, R. D. (1994) J. Biol. Chem. 269, 30904-30910). Here we report that purified recombinant IRP2 inhibits translation of ferritin mRNAs with a molar efficacy equal to that of recombinant IRP1. There is a quantitative correlation between binding to isolated RNA target motifs, as judged by gel retardation assays, and translational repressor function as assayed in an in vitro translation system. In contrast to IRP1, IRP2 is not inactivated for RNA binding by alkylation with N-ethylmaleimide or phenylmaleimide, and as we would therefore predict, IRP2 treated with N-ethyhmaleimide remains an effective repressor of ferritin translation. As IRP1 and IRP2 clearly have equal capability of mediating translational repression in vitro, the contributions of both IRPs to overall regulation must be considered in describing the pathways of iron regulated gene expression in individual cells.			KIM, HY (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892, USA.							BARTON HA, 1990, J BIOL CHEM, V265, P7000; BASILION JP, 1994, ARCH BIOCHEM BIOPHYS, V311, P517, DOI 10.1006/abbi.1994.1270; CAIRO G, 1994, J BIOL CHEM, V269, P6405; DICKEY LF, 1988, J BIOL CHEM, V263, P3071; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; ROUAULT TA, 1992, BIOMETALS, V5, P131, DOI 10.1007/BF01061319; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; STRIPECKE R, 1994, MOL CELL BIOL, V14, P5898, DOI 10.1128/MCB.14.9.5898; WALDEN WE, 1988, P NATL ACAD SCI USA, V85, P9503, DOI 10.1073/pnas.85.24.9503; WALDEN WE, 1989, J BIOL CHEM, V264, P13765	24	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					4983	4986		10.1074/jbc.270.10.4983	http://dx.doi.org/10.1074/jbc.270.10.4983			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890603	hybrid			2022-12-27	WOS:A1995QL58000008
J	SALINAS, F; JIANG, H; KODADEK, T				SALINAS, F; JIANG, H; KODADEK, T			HOMOLOGY DEPENDENCE OF UVSX PROTEIN-CATALYZED JOINT MOLECULE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; RECA PROTEIN; RECOMBINATION PROTEIN; 3-STRANDED DNA; BACTERIOPHAGE-T4; PHAGE-T4; OLIGONUCLEOTIDES; PURIFICATION; POLYMERASE	The bacteriophage UvsX protein is a ''strand transferase'' that promotes the pairing of homologous single and double-stranded DNAs. The efficiency of UvsX protein-mediated joint molecule formation between supercoiled duplex DNA and oligonucleotides is shown to have a sharp dependence on the degree of homology. The reaction proceeded efficiently with oligonucleotides containing 32 homologous positions but not with oligonucleotides containing only 24 homologous bases. This was shown to reflect an intrinsic homology requirement for the formation of stable joint molecules and was not caused by poor binding of the protein to short single-stranded DNAs. Even a single mismatch located in the middle of a region of 40 homologous nucleotides had a detectable effect on the efficiency of pairing. An in vitro recombinationally initiated DNA synthesis reaction that mimics the ''secondary mode'' of phage T4 DNA replication exhibited the same homology dependence.	UNIV TEXAS,DEPT CHEM & BIOCHEM,AUSTIN,TX 78712	University of Texas System; University of Texas Austin					NIGMS NIH HHS [GM-39393] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039393] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1984, COLD SPRING HARB SYM, V49, P1; BITTNER M, 1979, J BIOL CHEM, V254, P9565; CAMERINIOTERO RD, 1993, CELL, V73, P217, DOI 10.1016/0092-8674(93)90224-E; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; GOLUB EI, 1992, NUCLEIC ACIDS RES, V20, P3121, DOI 10.1093/nar/20.12.3121; HINTON DM, 1986, J BIOL CHEM, V261, P5663; HSIEH P, 1990, GENE DEV, V4, P1951, DOI 10.1101/gad.4.11.1951; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; JIANG H, 1993, J BIOL CHEM, V268, P7904; KAHN R, 1984, J BIOL CHEM, V259, P7495; KODADEK T, 1990, BIOCHEM BIOPH RES CO, V169, P302, DOI 10.1016/0006-291X(90)91468-8; KODADEK T, 1989, J BIOL CHEM, V264, P16451; KODADEK T, 1991, J BIOL CHEM, V266, P9712; KODADEK T, 1990, BIOCHEM BIOPH RES CO, V172, P804, DOI 10.1016/0006-291X(90)90746-A; KODADEK T, 1987, NATURE, V326, P312, DOI 10.1038/326312a0; KODADEK T, 1990, J BIOL CHEM, V265, P20966; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LIN TC, 1987, P NATL ACAD SCI USA, V84, P7000, DOI 10.1073/pnas.84.20.7000; MOSIG G, 1983, BACTERIOPHAGE T4, P120; RAO BJ, 1991, P NATL ACAD SCI USA, V88, P2984, DOI 10.1073/pnas.88.8.2984; RAO BJ, 1993, J MOL BIOL, V229, P328, DOI 10.1006/jmbi.1993.1038; RUSH J, 1989, J BIOL CHEM, V264, P10943; SHEN P, 1986, GENETICS, V112, P441; SINGER BS, 1982, CELL, V31, P25, DOI 10.1016/0092-8674(82)90401-9; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; YONESAKI T, 1985, EMBO J, V4, P3321, DOI 10.1002/j.1460-2075.1985.tb04083.x; YU X, 1993, J MOL BIOL, V232, P1, DOI 10.1006/jmbi.1993.1363	30	6	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5181	5186		10.1074/jbc.270.10.5181	http://dx.doi.org/10.1074/jbc.270.10.5181			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890628	hybrid			2022-12-27	WOS:A1995QL58000036
J	UEMURA, H; MIZOKAMI, A; CHANG, CS				UEMURA, H; MIZOKAMI, A; CHANG, CS			IDENTIFICATION OF A NEW ENHANCER IN THE PROMOTER REGION OF HUMAN TR3 ORPHAN RECEPTOR GENE - A MEMBER OF STEROID-RECEPTOR SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE ELEMENTS; C-FOS; TRANSCRIPTION FACTOR; BINDING DOMAINS; GROWTH-FACTORS; EXPRESSION; UPSTREAM; REQUIRES; CELLS; STIMULATION	Human TR3 orphan receptor is a member of the steroid/thyroid hormone receptor superfamily and is the human homologue of the proteins encoded by the rat NGFI-B and mouse nur77 genes. These genes are induced rapidly by androgens/growth factors and may have functions related to cell proliferation, differentiation, and apoptosis. To investigate the TR3 orphan receptor gene transcriptional regulation, a 2,3-kilobase genomic DNA fragment containing the TR3 orphan receptor gene promoter region was isolated, sequenced, and characterized, Sequence homology search within this promoter region revealed some potential cis-acting elements such as cAMP response element, interleukin-6 response element, estrogen response element, and GC box. Deletion analysis and chloramphenicol acetyltransferase assay also showed a novel cis acting element of TR3 orphan receptor gene (NCAE-TR3), 200-181 base pairs upstream of the transcriptional start site. Gel retardation assay further demonstrated that some nuclear factors can bind to this NCAE-TR3. Together, our data suggest that NCAE-TR3 could be a new enhancer element associated with the transcription of an early response gene for mitogenesis and apoptosis.	UNIV WISCONSIN, CTR COMPREHENS CANC, DEPT HUMAN ONCOL, MADISON, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA 55639] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA055639, R01CA055639] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOULDEN AM, 1992, MOL CELL BIOL, V12, P4769, DOI 10.1128/MCB.12.10.4769; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; CHANG C, 1989, J STEROID BIOCHEM, V34, P391; CHANG C, 1989, BIOCHEM BIOPH RES CO, V165, P735, DOI 10.1016/S0006-291X(89)80028-2; Chang C, 1993, ENDOCR J, V1, P541; Chang C. P., 1989, Special Publication - Taichung District Agricultural Improvement Station, P183; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; DESCHAMPS J, 1985, SCIENCE, V230, P1174, DOI 10.1126/science.3865371; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRETER RR, 1992, MOL CELL BIOL, V12, P5288, DOI 10.1128/MCB.12.12.5288; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HUCKABY CS, 1987, P NATL ACAD SCI USA, V84, P8380, DOI 10.1073/pnas.84.23.8380; Kokontis J, 1991, Receptor, V1, P261; KOKONTIS J, 1991, MOLECULAR AND CELLULAR BIOLOGY OF PROSTATE CANCER, P229; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE HJ, 1993, BIOCHEM BIOPH RES CO, V194, P97, DOI 10.1006/bbrc.1993.1790; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Lydon John P., 1992, Gene Expression, V2, P273; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; MIZOKAMI A, 1994, J BIOL CHEM, V269, P25655; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; QURESHI SA, 1991, J BIOL CHEM, V266, P10802; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SHAW PE, 1989, EMBO J, V8, P2567, DOI 10.1002/j.1460-2075.1989.tb08395.x; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; VRIES E, 1987, EMBO J, V6, P161; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861	44	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5427	5433		10.1074/jbc.270.10.5427	http://dx.doi.org/10.1074/jbc.270.10.5427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890657	hybrid			2022-12-27	WOS:A1995QL58000073
J	EASON, MG; MOREIRA, SP; LIGGETT, SB				EASON, MG; MOREIRA, SP; LIGGETT, SB			4 CONSECUTIVE SERINES IN THE 3RD INTRACELLULAR LOOP ARE THE SITES FOR BETA-ADRENERGIC-RECEPTOR KINASE-MEDIATED PHOSPHORYLATION AND DESENSITIZATION OF THE ALPHA(2A)-ADRENERGIC RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED DESENSITIZATION; ALPHA-2-ADRENERGIC RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; DOWN-REGULATION; EXPRESSION; CELLS; ALPHA-2C10; MECHANISM; CLONING; DRUGS	During short term agonist exposure, the alpha(2A)-adrenergic receptor (alpha(2A)AR) undergoes rapid functional desensitization caused by phosphorylation of the receptor by the beta-adrenergic receptor kinase (beta ARK), This signal quenching is similar in nature to that found with a number of G-protein coupled receptors in which agonist-promoted desensitization is due to beta ARK phosphorylation; like these other receptors, the precise molecular determinants of the receptor required for beta ARK phosphorylation are not known. To delineate such a motif in the human alpha(2A)AR(alpha C10), we constructed six mutated receptors consisting of deletions or substitutions of Ser-296-299 in the EESSSS sequence of the third intracellular loop of the receptor, These were expressed in Chinese hamster ovary and COS-7 cells, and agonist-promoted desensitization and receptor phosphorylation were assessed, Deletion of the EESSSS sequence and substitution of alanine for all four serines resulted in a total loss of phosphorylation and desensitization. Mutant receptors that retained two of the original serines (AASS and SSAA) underwent agonist-promoted phosphorylation of 55 +/- 7% and 57 +/- 8% of the phosphorylation found for wild type alpha(2)C10, Additional substitution mutants (SSSA and SAAA) underwent 77 +/- 1% and 27 +/- 4% of wild type phosphorylation, respectively. Thus, substitution of alanine for each additional serine decreased overall phosphorylation as compared with wild type alpha(2)C10 by similar to 25%, which is consistent with all 4 serines being phosphorylated, Mutated receptors that only partially phosphorylated (as compared with wild type) failed to undergo agonist-promoted desensitization. Thus, beta ARK-mediated phosphorylation of alpha(2)C10 occurs at Ser-296-299 in the third intracellular loop, and this represents the critical step in rapid agonist-promoted desensitization. A number of other G-protein coupled receptors that undergo desensitization have a sequence motif similar to that which we have found for beta ARK-mediated phosphorylation of alpha(2)C10, suggesting that these receptors may also be substrates far beta ARK.	UNIV CINCINNATI, COLL MED, DEPT PULM MED, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, COLL MED, DEPT MOLEC GENET, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, COLL MED, DEPT PHARMACOL, CINCINNATI, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati			liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669				BARTON AC, 1990, MOL PHARMACOL, V38, P531; BARTON AC, 1991, MOL PHARMACOL, V39, P650; BATES MD, 1991, MOL PHARMACOL, V39, P55; BATES MD, 1992, AM J PHYSIOL, V260, pF937; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1987, J BIOL CHEM, V262, P17251; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BLAXALL HS, 1994, MOL PHARMACOL, V45, P176; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELEAN A, 1981, MOL PHARMACOL, V21, P5; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EASON MG, 1992, J BIOL CHEM, V267, P15795; EASON MG, 1994, MOL PHARMACOL, V45, P696; EASON MG, 1992, J BIOL CHEM, V267, P25473; EASON MG, 1993, BIOCHEM BIOPH RES CO, V193, P318, DOI 10.1006/bbrc.1993.1626; FREEDMAN NJ, 1994, CIRCULATION, V90, P1; GARCIASEVILLA JA, 1986, BRIT J PHARMACOL, V89, P673, DOI 10.1111/j.1476-5381.1986.tb11171.x; GORDON YKN, 1994, EUR J PHARMACOL, V267, P7; HAMILTON CA, 1990, BRIT J CLIN PHARMACO, V30, pS131, DOI 10.1111/j.1365-2125.1990.tb05484.x; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; INGLESE J, 1993, J BIOL CHEM, V268, P23735; ISHII K, 1984, J PHARMACOL EXP THER, V231, P685; ISHII K, 1994, J BIOL CHEM, V269, P1125; JONES SB, 1990, J PHARMACOL EXP THER, V254, P294; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUROSE H, 1994, J BIOL CHEM, V269, P10093; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; LIGGETT SB, 1992, J BIOL CHEM, V267, P4740; LIGGETT SB, 1993, BAILLIERE CLIN ENDOC, V7, P279, DOI 10.1016/S0950-351X(05)80178-8; LIGGETT SB, 1994, REGULATION CELLULAR, V3, P71; LIMBIRD LE, 1985, RECEPTORS, V2, P281; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; RAMKUMAR V, 1993, BIOCHIM BIOPHYS ACTA, V1179, P89, DOI 10.1016/0167-4889(93)90075-Z; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; THOMAS JM, 1986, ENDOCRINOLOGY, V119, P1305, DOI 10.1210/endo-119-3-1305	41	112	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4681	4688		10.1074/jbc.270.9.4681	http://dx.doi.org/10.1074/jbc.270.9.4681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876239	hybrid			2022-12-27	WOS:A1995QK08400074
J	EDWARDS, SL; DAVIDSON, VL; HYUN, YL; WINGFIELD, PT				EDWARDS, SL; DAVIDSON, VL; HYUN, YL; WINGFIELD, PT			SPECTROSCOPIC EVIDENCE FOR A COMMON ELECTRON-TRANSFER PATHWAY FOR 2 TRYPTOPHAN TRYPTOPHYLQUINONE ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOPROTEIN METHYLAMINE DEHYDROGENASE; C-TYPE CYTOCHROMES; PARACOCCUS-DENITRIFICANS; ALCALIGENES-FAECALIS; CRYSTAL-STRUCTURE; METHYLOTROPHIC BACTERIA; 3-DIMENSIONAL STRUCTURE; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; QUINONE COFACTOR	Aromatic amine dehydrogenase (AADH) and methylamine dehydrogenase (MADH) are the only two enzymes known to use the cofactor tryptophan tryptophylquinone (TTQ). Each catalyzes oxidative deamination of a distinct class of primary amines. A detailed comparison of their circular dichroic spectra indicates that both proteins share a similar fold with their TTQ cofactors residing in similar environments and that this may be a useful diagnostic probe for TTQ enzymes. Alcaligenes faecalis cells induced to express AADH also express a large amount of the blue copper protein, azurin. Oxidized azurin is rapidly reduced by a catalytic amount of AADH in the presence of the substrate, tyramine. Three A. faecalis cytochromes-c and three other cytochromes-c were tested for electron transfer activity with AADH. Azurin markedly facilitated electron transfer from AADH to each cytochrome. This suggests that AADH and azurin may form an electron transfer complex with a c-type cytochrome, analogous to the crystallographically determined MADH-amicyanin-cytochrome c-551i complex (Chen, L., Durley, R. C. E., Matthews, F. S., and Davidson, V. L. (1994) Science 264, 86-90). The similarities of MADH and AADH plus the demonstration of azurin and multiple cytochromes as functional electron-transfer partners suggest that both TTQ-bearing enzymes share common mechanisms for oxidative deamination and subsequent electron transfer.	NIAMSD,STRUCT BIOL RES LAB,BETHESDA,MD 20892; UNIV MISSISSIPPI,MED CTR,DEPT BIOCHEM,JACKSON,MS 39216; NIH,OFF DIRECTOR,PROT EXPRESS LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA				Wingfield, Paul/0000-0002-9515-4752; Davidson, Victor/0000-0002-1966-7302	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041574, R01GM041574] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41574] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; AMBLER RP, 1971, RECENT DEV CHEM STUD, P289; ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; BACKES G, 1991, BIOCHEMISTRY-US, V30, P9201, DOI 10.1021/bi00102a011; BAIOCCHI M, 1993, BIOCHEM MOL BIOL INT, V31, P389; BAKER EN, 1988, J MOL BIOL, V203, P1071, DOI 10.1016/0022-2836(88)90129-5; BOSSARTWHITAKER P, 1993, J MOL BIOL, V232, P1069, DOI 10.1006/jmbi.1993.1461; BROOKS HB, 1993, BIOCHEMISTRY-US, V32, P2725, DOI 10.1021/bi00061a034; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CHEN LY, 1993, PROTEIN SCI, V2, P147; CHEN LY, 1992, BIOCHEMISTRY-US, V31, P4959, DOI 10.1021/bi00136a006; CHEN LY, 1991, FEBS LETT, V287, P163, DOI 10.1016/0014-5793(91)80041-Z; CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419; CHEN LY, 1992, PROTEINS, V14, P288, DOI 10.1002/prot.340140214; CHISTOSERDOV AY, 1990, BIOCHEM BIOPH RES CO, V172, P211, DOI 10.1016/S0006-291X(05)80195-0; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; DAVIDSON VL, 1990, METHOD ENZYMOL, V188, P241; DAVIDSON VL, 1993, PRINCIPLES APPL QUIN, P73; DURLEY R, 1993, PROTEIN SCI, V2, P739, DOI 10.1002/pro.5560020506; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; GOVINDARAJ S, 1994, J BACTERIOL, V176, P2922, DOI 10.1128/JB.176.10.2922-2929.1994; HUIZINGA EG, 1992, BIOCHEMISTRY-US, V31, P9789, DOI 10.1021/bi00155a036; HUSAIN M, 1986, J BIOL CHEM, V261, P8577; HUSAIN M, 1985, J BIOL CHEM, V260, P4626; HUSAIN M, 1987, J BACTERIOL, V169, P1712, DOI 10.1128/jb.169.4.1712-1717.1987; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; IWAKI M, 1983, ARCH BIOCHEM BIOPHYS, V220, P253, DOI 10.1016/0003-9861(83)90408-3; KAKUTANI T, 1981, J BIOCHEM-TOKYO, V89, P463, DOI 10.1093/oxfordjournals.jbchem.a133221; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; ROSEN P, 1981, EUR J BIOCHEM, V120, P339, DOI 10.1111/j.1432-1033.1981.tb05709.x; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VELLIEUX FMD, 1986, EUR J BIOCHEM, V154, P383, DOI 10.1111/j.1432-1033.1986.tb09409.x; VELLIEUX FMD, 1989, EMBO J, V8, P2171, DOI 10.1002/j.1460-2075.1989.tb08339.x; WHERLAND S, 1978, BIOCHEMISTRY-US, V17, P2585, DOI 10.1021/bi00606a020; XIA ZX, 1992, J BIOL CHEM, V267, P22289	39	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4293	4298		10.1074/jbc.270.9.4293	http://dx.doi.org/10.1074/jbc.270.9.4293			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876189	hybrid			2022-12-27	WOS:A1995QK08400020
J	BYRNES, WM; HU, WJ; YOUNATHAN, ES; CHANG, SH				BYRNES, WM; HU, WJ; YOUNATHAN, ES; CHANG, SH			A CHIMERIC BACTERIAL PHOSPHOFRUCTOKINASE EXHIBITS COOPERATIVITY IN THE ABSENCE OF HETEROTROPIC REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PHOSPHOFRUCTOKINASE; SITE-DIRECTED MUTAGENESIS; ALLOSTERIC PHOSPHOFRUCTOKINASE; BACILLUS-STEAROTHERMOPHILUS; SUBSTRATE-BINDING; NUCLEOTIDE-SEQUENCE; ACTIVE-SITE; DISSOCIATION; FLUORESCENCE; MECHANISM	The phosphofructokinases (PFKs) hom the bacteria Escherichia coli and Bacillus stearothermophilus differ markedly in their regulation by ATP. Whereas E. coli PFK (EcPFK) is profoundly inhibited by ATP, B. stearothermophilus PFH (BsPFH) is only slightly inhibited. The structural basis for this difference could be closure of the active site via a conformational transition that occurs in the ATP-binding domain of EcPFK but is absent in BsPFK To investigate the role of this transition in ATP inhibition of EcPFK we have constructed a chimeric enzyme that contains the ''rigid'' ATP-binding domain of BsPFK grafted onto the remainder of the EcPFK subunit. The chimeric PFH has the following characteristics: (i) tetrameric structure and kinetic parameters similar to those of the native enzymes, (ii) insensitivity to regulation by the effector phosphoenolpyruvate despite its ability to bind to the enzyme, and (iii) a sigmoidal (n(H) around 2) fructose B-phosphate saturation curve. From the results, it is concluded that the active site regions of the two native enzymes are remarkably similar, but their effector sites and their mechanisms of heterotropic regulation are different. The chimeric subunit is locked in a structure resembling that of activated E. coli PFK yet the enzyme can exist in two different conformational states. Mechanisms for its sigmoidal kinetics are discussed.	LOUISIANA STATE UNIV,DEPT BIOCHEM,BATON ROUGE,LA 70803	Louisiana State University System; Louisiana State University					NIDDK NIH HHS [DK 31676] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031676] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; AUZAT I, 1994, P NATL ACAD SCI USA, V91, P5242, DOI 10.1073/pnas.91.12.5242; BERGER SA, 1992, BIOCHEMISTRY-US, V31, P9237, DOI 10.1021/bi00153a017; BERGER SA, 1990, NATURE, V343, P575, DOI 10.1038/343575a0; BERGER SA, 1991, BIOCHEMISTRY-US, V30, P8477, DOI 10.1021/bi00098a027; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; BYRNES M, 1994, BIOCHEMISTRY-US, V33, P3424, DOI 10.1021/bi00177a036; Cleland W W, 1979, Methods Enzymol, V63, P103; DEVILLEBONNE D, 1991, FEBS LETT, V290, P173, DOI 10.1016/0014-5793(91)81253-5; DEVILLEBONNE D, 1991, BIOCHEMISTRY-US, V30, P5750, DOI 10.1021/bi00237a017; DEVILLEBONNE D, 1992, BIOCHEMISTRY-US, V31, P1695, DOI 10.1021/bi00121a017; DEVILLEBONNE D, 1989, BIOCHEMISTRY-US, V28, P1917, DOI 10.1021/bi00430a073; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; EVANS PR, 1992, P RA WELCH F C CHEM, V36, P39; FERDINAND W, 1966, BIOCHEM J, V98, P278, DOI 10.1042/bj0980278; FRENCH BA, 1987, GENE, V54, P65, DOI 10.1016/0378-1119(87)90348-9; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; JOHNSON JL, 1992, BIOCHEMISTRY-US, V31, P11510, DOI 10.1021/bi00161a032; KIM SJ, 1993, BIOPHYS J, V65, P215, DOI 10.1016/S0006-3495(93)81070-1; KOTLARZ D, 1982, METHOD ENZYMOL, V90, P60; KUNDROT CE, 1991, BIOCHEMISTRY-US, V30, P1478, DOI 10.1021/bi00220a005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU FTK, 1989, BIOCHEMISTRY-US, V28, P6841, DOI 10.1021/bi00443a010; LEBRAS G, 1982, BIOCHEMISTRY-US, V21, P6656, DOI 10.1021/bi00269a007; LEBRAS G, 1989, BIOCHEMISTRY-US, V28, P6836, DOI 10.1021/bi00443a009; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MONOD J, 1965, J MOL BIOL, V3, P318; Neet K E, 1980, Methods Enzymol, V64, P192; Segel IH, 1975, ENZYME KINETICS, P460; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; SHIRMER T, 1990, NATURE, V343, P140; TESCHNER W, 1990, FEBS LETT, V267, P96, DOI 10.1016/0014-5793(90)80297-V; VALDEZ BC, 1989, J BIOL CHEM, V264, P131; YOUNT RG, 1971, BIOCHEMISTRY-US, V10, P2484, DOI 10.1021/bi00789a009; ZHENG RL, 1994, J BIOL CHEM, V269, P18475; ZHENG RL, 1992, J BIOL CHEM, V267, P23640	36	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3828	3835		10.1074/jbc.270.8.3828	http://dx.doi.org/10.1074/jbc.270.8.3828			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876126	hybrid			2022-12-27	WOS:A1995QH68800056
J	ISHIKAWA, Y; MUKAIDA, N; KUNO, K; RICE, N; OKAMOTO, S; MATSUSHIMA, K				ISHIKAWA, Y; MUKAIDA, N; KUNO, K; RICE, N; OKAMOTO, S; MATSUSHIMA, K			ESTABLISHMENT OF LIPOPOLYSACCHARIDE-DEPENDENT NUCLEAR FACTOR KAPPA-B ACTIVATION IN A CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-TYROSINE PHOSPHORYLATION; MESSENGER-RNA EXPRESSION; FACTOR-ALPHA; BACTERIAL LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR; INTERLEUKIN-8 GENE; BINDING PROTEIN; INFLAMMATORY CYTOKINES; MURINE MACROPHAGES	Nuclear factor kappa B (NF-kappa B), consisting of p50 and p65, is bound to a cytoplasmic retention protein, I kappa B, in a resting state, and the stimulation of cells with a variety of inflammatory stimuli induces the dissociation of NF-kappa B from I kappa B and the nuclear translocation of NF-kappa B, thereby activating several genes involved in inflammatory responses, such as interleukin (IL)-6, IL-8, and tumor necrosis factor alpha. In order to elucidate the precise mechanism of NE-kappa B activation, we have established Lipopolysaccharide (LPS)-dependent NF-kappa B activation in a cell-free system using plasma membrane-enriched, cytosol, and nuclear fractions extracted from a human monocytic cell Line, THP-1, by disruption with sonication followed by a differential centrifugation. The combination of plasma membrane enriched fraction and cytosol was sufficient to activate NF-kappa B in a LPS/CD14-dependent manner only in the presence of ATP as judged by the binding of NF-kappa B to the IL-8 gene kappa B site on an electrophoretic mobility shift assay. LPS-dependent NP-kappa B activation was inhibited by protein kinase inhibitors, such as staurosporine, herbimycin A, tyrphostin, and genistein, but not mitogen-activated protein kinase substrate, cGMP-dependent protein kinase, cAMP-dependent protein kinase, protein kinase C, and calmodulin-dependent protein kinase II inhibitory peptides, suggesting that staurosporine-sensitive kinase(s) as well as tyrosine kinase(s) are involved in LPS-mediated NF-kappa B activation. In addition, LPS induced the phosphorylation of I kappa B-alpha, starting at 5 min after the stimulation in a cell-free system. Moreover, the phosphorylation was inhibited by herbimycin A and tyrphostin, but not staurosporine, suggesting that these protein kinase inhibitors act at distinct steps of signal transmission. Establishment of ligand-dependent activation of NF-kappa B in a cell-free system will facilitate identification of protein kinase(s) and its substrate(s) involved in LPS-mediated NF-kappa B activation.	KANAZAWA UNIV,CANC RES INST,DEPT PHARMACOL,KANAZAWA,ISHIKAWA 920,JAPAN; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21702	Kanazawa University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Mukaida, Naofumi/D-7623-2011; KUNO, Kouji/D-8439-2015	Mukaida, Naofumi/0000-0002-4193-1851; 				BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAGASRA O, 1992, P NATL ACAD SCI USA, V89, P6285, DOI 10.1073/pnas.89.14.6285; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BROWNELL E, 1989, ONCOGENE, V4, P935; CAVAILLON J-M, 1990, Cytokine, V2, P313, DOI 10.1016/1043-4666(90)90061-W; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; COUTURIER C, 1992, EUR J IMMUNOL, V22, P1461, DOI 10.1002/eji.1830220619; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DING A, 1993, J IMMUNOL, V151, P5596; DONG ZY, 1993, J EXP MED, V177, P1071, DOI 10.1084/jem.177.4.1071; ENDO H, 1991, LYMPHOKINE CYTOK RES, V10, P245; GENG Y, 1993, J IMMUNOL, V151, P6692; HAN JH, 1993, J BIOL CHEM, V268, P25009; HARADA A, 1993, INT IMMUNOL, V5, P681, DOI 10.1093/intimm/5.6.681; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HEUMANN D, 1992, J IMMUNOL, V148, P3505; KOVACS EJ, 1989, J IMMUNOL, V143, P3532; KOVACS EJ, 1988, J IMMUNOL, V141, P3101; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MAHE Y, 1991, J BIOL CHEM, V266, P13759; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; OLIVEIRA IC, 1994, MOL CELL BIOL, V147, P5300; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PRABHAKAR U, 1993, EUR CYTOKINE NETW, V4, P31; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; TAN TH, 1992, MOL CELL BIOL, V12, P4067, DOI 10.1128/MCB.12.9.4067; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	42	79	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4158	4164		10.1074/jbc.270.8.4158	http://dx.doi.org/10.1074/jbc.270.8.4158			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876168	hybrid			2022-12-27	WOS:A1995QH68800102
J	MATSUDA, T; SAIJO, M; KURAOKA, I; KOBAYASHI, T; NAKATSU, Y; NAGAI, A; ENJOJI, T; MASUTANI, C; SUGASAWA, K; HANAOKA, F; YASUI, A; TANAKA, K				MATSUDA, T; SAIJO, M; KURAOKA, I; KOBAYASHI, T; NAKATSU, Y; NAGAI, A; ENJOJI, T; MASUTANI, C; SUGASAWA, K; HANAOKA, F; YASUI, A; TANAKA, K			DNA-REPAIR PROTEIN XPA BINDS REPLICATION PROTEIN-A (RPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; NUCLEOTIDE EXCISION REPAIR; PIGMENTOSUM GROUP-F; XERODERMA-PIGMENTOSUM; POLYMERASE-ALPHA; DAMAGED DNA; FACTOR-A; GENE; INVITRO; COMPLEMENTATION	XPA is a zinc finger DNA-binding protein, which is missing or altered in group A xeroderma pigmentosum cells and known to be involved in the damage-recognition step of the nucleotide excision repair (NER) processes. Using the yeast two-hybrid system to search for proteins that interact with XPA, we obtained the 34-kDa subunit of replication protein A (RPA, also known as HSSB and RFA). RPA is a stable complex of three polypeptides of 70, 34, 11 kDa and has been shown to be essential in the early steps of NER as well as in replication and recombination. We also demonstrate here that the RPA complex associates with XPA. These results suggest that RPA may cooperate with XPA in the early steps of the NER processes.	OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN; INST PHYS & CHEM RES,WAKO,SAITAMA 35101,JAPAN; TOHOKU UNIV,INST DEV AGING & CANC,AOBA KU,SENDAI,MIYAGI 980,JAPAN	Osaka University; RIKEN; Tohoku University			Masutani, Chikahide/I-6160-2014	Masutani, Chikahide/0000-0002-8600-8227; Kuraoka, Isao/0000-0001-6391-3411; Nakatsu, Yoshimichi/0000-0001-7408-7071				ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DEWEERDKASTELEI, 1972, NATURE NEW BIOL, V238, P80; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; HOEIJMAKERS JHJ, 1990, CANCER CELL-MON REV, V2, P311; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; LEE SH, 1991, J BIOL CHEM, V266, P22707; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MIURA N, 1991, J BIOL CHEM, V266, P19786; ODONOVAN A, 1993, NATURE, V363, P185, DOI 10.1038/363185a0; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SCHERLY D, 1993, NATURE, V363, P182, DOI 10.1038/363182a0; SHIMAMOTO T, 1991, BIOCHEM BIOPH RES CO, V181, P1231, DOI 10.1016/0006-291X(91)92070-Z; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; TANAKA K, 1994, TRENDS BIOCHEM SCI, V19, P83, DOI 10.1016/0968-0004(94)90040-X; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523	45	162	165	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4152	4157		10.1074/jbc.270.8.4152	http://dx.doi.org/10.1074/jbc.270.8.4152			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876167	hybrid			2022-12-27	WOS:A1995QH68800101
J	XU, WH; SATO, Y; IKEDA, M; YAMASHITA, O				XU, WH; SATO, Y; IKEDA, M; YAMASHITA, O			STAGE-DEPENDENT AND TEMPERATURE-CONTROLLED EXPRESSION OF THE GENE ENCODING THE PRECURSOR PROTEIN OF DIAPAUSE HORMONE AND PHEROMONE BIOSYNTHESIS ACTIVATING NEUROPEPTIDE IN THE SILKWORM, BOMBYX-MORI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENTS; SEQUENCE; MOTH	Embryonic diapause and sex pheromone biosynthesis in the silkworm, Bombyx mori, are, respectively, induced by diapause hormone (DH) and pheromone biosynthesis activating neuropeptide (PBAN), which are produced in the subesophageal ganglion from a common polyprotein precursor (DH-PBAN precursor) encoded by a single gene (DH-PBAN gene). Using DH-PBAN cDNA as a probe, we quantitatively measured DH-PBAN mRNA content throughout embryonic and postembryonic development and observed the effects of incubation temperature, which is a key factor for determination of diapause, on DH-PBAN gene expression, The silkworm, which is programmed to lay diapause eggs by being incubated at 25 degrees C, showed peaks of DH-PBAN mRNA content at five different stages throughout the Life cycle: at the late embryonic stage, at the middle of the fourth and the fifth larval instars, and at early and late stages of pupal-adult development. In the non-diapause type silkworms programmed by a 15 degrees C incubation, only the last peak of DH-PBAN mRNA in pupal-adult development was found, and the other peaks were absent. Furthermore, interruption of the incubation period at 25 degrees C by incubation at 15 degrees C decreased both DH-PEAN mRNA content in mature embryos and in subesophageal ganglia of day 3 pupae and the incidence of diapause eggs, Thus, there were two types of regulatory mechanisms for DH-PBAN gene expression, One is a temperature-controlled expression that is responsible for diapause induction, and the other is a temperature-independent, stage dependent expression related to pheromone production.	NAGOYA UNIV,SCH AGR SCI,SERICULTURAL SCI & ENTOMORESOURCES LAB,CHIKUSA KU,NAGOYA,AICHI 46401,JAPAN; NAGOYA UNIV,RADIOISOTOPE RES CTR,CHIKUSA KU,NAGOYA,AICHI 46401,JAPAN	Nagoya University; Nagoya University								ANDO T, 1988, AGR BIOL CHEM TOKYO, V52, P473; ARIMA R, 1991, APPL ENTOMOL ZOOL, V26, P137, DOI 10.1303/aez.26.137; CHENG JF, 1986, J BIOL CHEM, V261, P839; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COULONBUBLEX M, 1991, ROUX ARCH DEV BIOL, V199, P469, DOI 10.1007/BF01705783; DALLMAN MJ, 1991, PCR PRACTICAL APPROA, P215; Denlinger D.L., 1985, P353; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HASEGAWA K, 1964, J EXP BIOL, V41, P855; IKEDA M, 1993, J INSECT PHYSIOL, V39, P889, DOI 10.1016/0022-1910(93)90122-8; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; KOGURE MAKITA, 1933, JOUR DEPT AGRIC KYUSHU IMP UNIV, V4, P1; KOSEGAWA E, 1992, Journal of Sericultural Science of Japan, V61, P180; KOSEGAWA E, 1991, Journal of Sericultural Science of Japan, V60, P511; MOUNIER N, 1986, BIOCHIMIE, V68, P1053, DOI 10.1016/S0300-9084(86)80179-1; PEARSE V, 1987, LIVING INVERTEBRATES, P573; Sambrook J, 1989, MOL CLONING LABORATO; SATO Y, 1992, P JPN ACAD B-PHYS, V68, P75, DOI 10.2183/pjab.68.75; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; SATO Y, 1994, GEN COMP ENDOCR, V96, P27, DOI 10.1006/gcen.1994.1156; SAUNDERS DS, 1982, INSECT CLOCKS, P156; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SU ZH, 1994, BBA-GENE STRUCT EXPR, V1218, P366, DOI 10.1016/0167-4781(94)90190-2; Watanabe K., 1924, Bulletin of the Imperial Sericultural Experiment Station, V6, P411; XU WH, IN PRESS BIOCH BIOPH; Yamashita O., 1991, P424; Yamashita O., 1985, P407; YAMASHITA O, 1991, MORPHOGENIC HORMONES, P82	28	60	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3804	3808		10.1074/jbc.270.8.3804	http://dx.doi.org/10.1074/jbc.270.8.3804			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876122	hybrid			2022-12-27	WOS:A1995QH68800052
J	FERRARI, G; ANDERSON, BL; STEPHENS, RM; KAPLAN, DR; GREENE, LA				FERRARI, G; ANDERSON, BL; STEPHENS, RM; KAPLAN, DR; GREENE, LA			PREVENTION OF APOPTOTIC NEURONAL DEATH BY G(M1) GANGLIOSIDE - INVOLVEMENT OF TRK NEUROTROPHIN RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; DEPENDENT PROTEIN-KINASE; CYTOPLASMIC FREE CA2+; AMINO-ACID RECEPTORS; FACTOR DEPRIVATION; GM1 GANGLIOSIDE; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; SYMPATHETIC NEURONS; NEURITE OUTGROWTH	We have used serum-deprived cultures of wild type and genetically modified PC12 cells to investigate the molecular mechanisms by which monosialoganglioside (G(M1)) rescues neuronal cells from apoptotic death elicited by withdrawal of trophic support, Our findings indicate that G(M1)-promoted survival can be mediated in part by the Trk NGF receptor as well as by TrkB, and potentially by tyrosine kinase receptors for additional neurotrophic growth factors. Experiments employing K-252a, an inhibitor of Trk kinases, and PC12 cells overexpressing a dominant inhibitory form of Trk both indicate that a portion of the survival-promoting activity of G(M1) is evoked by receptor dimerization and autophosphorylation, In consonance with this we find that G(M1) stimulates Trk tyrosine autophosphorylation and Trk-associated protein kinase activity, These observations may provide a mechanism to account for the reported in vitro and in vivo trophic actions of G(M1).	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21702	Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick					NCI NIH HHS [N0I-CO-7410I] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; ARGENTINO C, 1989, STROKE, V20, P1143, DOI 10.1161/01.STR.20.9.1143; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; BERG MM, 1992, J BIOL CHEM, V267, P13; BREMER EG, 1984, J BIOL CHEM, V259, P6818; CHANG JY, 1990, J NEUROCHEM, V55, P436, DOI 10.1111/j.1471-4159.1990.tb04155.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CUELLO AC, 1989, P NATL ACAD SCI USA, V86, P2056, DOI 10.1073/pnas.86.6.2056; DEERAUSQUIN GA, 1990, P NATL ACAD SCI USA, V87, P8017, DOI 10.1073/pnas.87.20.8017; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; FACCI L, 1984, J NEUROCHEM, V42, P299, DOI 10.1111/j.1471-4159.1984.tb02678.x; FACCI L, 1990, NEUROSCIENCE, V37, P709, DOI 10.1016/0306-4522(90)90101-9; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; FERRARI G, 1983, DEV BRAIN RES, V8, P215, DOI 10.1016/0165-3806(83)90006-8; FERRARI G, 1993, J NEUROSCI, V13, P1879; FERRARI G, 1992, DEV BRAIN RES, V65, P35, DOI 10.1016/0165-3806(92)90005-H; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; GHIDONI R, 1986, BIOCHEM J, V237, P147, DOI 10.1042/bj2370147; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1991, CULTURING NERVE CELL, P207; HAMBURGER V, 1982, NEUROSCI COMMENT, V1, P39; HASHIMOTO S, 1988, J CELL BIOL, V107, P1531, DOI 10.1083/jcb.107.4.1531; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; IP NY, 1993, NEURON, V10, P1; JING S, 1992, NEURON, V9, P1076; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KARPIAK SE, 1990, CRIT REV NEUROBIOL, V5, P221; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KREUTTER D, 1987, J BIOL CHEM, V262, P1633; LEDEEN R, 1985, TRENDS NEUROSCI, V8, P169, DOI 10.1016/0166-2236(85)90064-5; LEON A, 1988, J NEUROSCI, V8, P746; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOEB DM, 1994, J BIOL CHEM, V269, P8901; LOEB DM, 1993, J NEUROSCI, V13, P2919; MANEV H, 1990, FASEB J, V4, P2789, DOI 10.1096/fasebj.4.10.2165013; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MILANI D, 1991, J NEUROSCI RES, V28, P434, DOI 10.1002/jnr.490280317; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; NAKAMURA K, 1992, J NEUROSCI RES, V31, P245, DOI 10.1002/jnr.490310205; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Purves D, 1985, PRINCIPLES NEURAL DE, P131; RICH KM, 1990, SCIENCE, V248, P1419, DOI 10.1126/science.2356470; RUKENSTEIN A, 1961, J NEUROSCI, V11, P2552; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; SEREN MS, 1990, STROKE, V21, P1607, DOI 10.1161/01.STR.21.11.1607; SKAPER SD, 1989, MOL NEUROBIOL, V3, P173, DOI 10.1007/BF02935630; SKAPER SD, 1989, EXP NEUROL, V106, P297, DOI 10.1016/0014-4886(89)90163-5; SKAPER SD, 1993, J NEUROSCI RES, V33, P330; SKAPER SD, 1985, DEV BRAIN RES, V398, P19; SOTO AM, 1985, J STEROID BIOCHEM, V23, P87, DOI 10.1016/0022-4731(85)90265-1; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; TOMASI M, 1980, EUR J BIOCHEM, V111, P315, DOI 10.1111/j.1432-1033.1980.tb04944.x; TSUJI S, 1985, J BIOCHEM-TOKYO, V97, P969, DOI 10.1093/oxfordjournals.jbchem.a135140; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1992, NEURON, V9, P1067; VACCARINO F, 1987, P NATL ACAD SCI USA, V84, P8707, DOI 10.1073/pnas.84.23.8707; VANBUSKIRK R, 1985, MOL CELL BIOL, V5, P1984, DOI 10.1128/MCB.5.8.1984; VANTINI G, 1988, BRAIN RES, V448, P252, DOI 10.1016/0006-8993(88)91262-0; YATES AJ, 1989, J NEUROCHEM, V53, P162, DOI 10.1111/j.1471-4159.1989.tb07308.x	73	191	205	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3074	3080		10.1074/jbc.270.7.3074	http://dx.doi.org/10.1074/jbc.270.7.3074			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852388	hybrid			2022-12-27	WOS:A1995QG47100030
J	UCHIDA, Y; IHARA, Y				UCHIDA, Y; IHARA, Y			THE N-TERMINAL PORTION OF GROWTH-INHIBITORY FACTOR IS SUFFICIENT FOR BIOLOGICAL-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; CEREBRAL CORTICAL-NEURONS; MOLECULAR-CLONING; BASAL NUCLEUS; METAL-BINDING; FACTOR CDNA; METALLOTHIONEIN; DEMENTIA; PROTEINS; DEGENERATION	To determine its active site, growth inhibitory factor (GIF), a central nervous system-specific metallothionein-like protein, was digested with trypsin followed by Staphylococcus aureus protease V8 digestion. Of 5 peptide fragments separated from trypsin-digested GIF by reverse-phase high pressure liquid chromatography and gel filtration, only GIF1-26 or longer peptides showed growth inhibitory activity on cortical neurons in culture. A shorter peptide, GIF5-23, which was obtained by further digestion of GIF1-26 with V8 protease, also showed growth inhibitory activity. However, a synthetic peptide corresponding to GIF5-23 did not show growth inhibitory activity. Metal-free GIF1-26 prepared by acid treatment showed a similar level of growth inhibitory activity to that of metal-containing GIF1-26, indicating that metal in the peptide does not affect the activity. Treatment of metal-free GIF1-26 with beta-mercaptoethanol resulted in the loss of activity. The CD spectrum of beta-mercaptoethanol-treated metal-free GIF1-26 was different from that of nontreated metal-free GIF1-26. These results indicate that the N-terminal portion of GIF is required for growth inhibitory activity and that folding of the peptide via S-metal bonding is critical for biological activity.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo	UCHIDA, Y (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT NEUROPATHOL,ITABASHI KU,35-2 SAKAECHO,TOKYO 173,JAPAN.							APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; ARENDT T, 1986, NEUROSCIENCE, V19, P1265, DOI 10.1016/0306-4522(86)90141-7; ARENDT T, 1992, NEUROSCI LETT, V148, P63, DOI 10.1016/0304-3940(92)90805-H; BRIGGS RW, 1982, J BIOL CHEM, V257, P1259; FERRER I, 1983, ACTA NEUROPATHOL, V59, P167, DOI 10.1007/BF00703200; FERRER I, 1990, NEUROSCI LETT, V114, P11, DOI 10.1016/0304-3940(90)90420-E; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; KILLE P, 1992, J BIOL CHEM, V267, P8042; KOBAYASHI H, 1993, MOL BRAIN RES, V19, P188, DOI 10.1016/0169-328X(93)90025-K; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; NIELSON KB, 1983, J BIOL CHEM, V258, P3063; NUKINA N, 1983, P JPN ACAD B-PHYS, V59, P288, DOI 10.2183/pjab.59.288; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; PAULABARBOSA MM, 1980, J NEUROL SCI, V45, P129, DOI 10.1016/S0022-510X(80)80014-1; POUNTNEY DL, 1994, FEBS LETT, V345, P193, DOI 10.1016/0014-5793(94)00452-8; PROBST A, 1983, BRAIN RES, V268, P249, DOI 10.1016/0006-8993(83)90490-0; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V533, P209, DOI 10.1016/0005-2795(78)90565-2; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; SUZUKI KT, 1981, BIOCHEM J, V199, P289, DOI 10.1042/bj1990289; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1988, BIOCHEM BIOPH RES CO, V150, P1263, DOI 10.1016/0006-291X(88)90765-6; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	26	59	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3365	3369		10.1074/jbc.270.7.3365	http://dx.doi.org/10.1074/jbc.270.7.3365			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852423	hybrid			2022-12-27	WOS:A1995QG47100071
J	DAVIDSON, WS; GILLOTTE, KL; LUNDKATZ, S; JOHNSON, WJ; ROTHBLAT, GH; PHILLIPS, MC				DAVIDSON, WS; GILLOTTE, KL; LUNDKATZ, S; JOHNSON, WJ; ROTHBLAT, GH; PHILLIPS, MC			THE EFFECT OF HIGH-DENSITY-LIPOPROTEIN PHOSPHOLIPID ACYL-CHAIN COMPOSITION ON THE EFFLUX OF CELLULAR FREE-CHOLESTEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; FATTY-ACID COMPOSITION; AMPHIPATHIC HELIX; LPA-I; MEMBRANE; PARTICLES; MECHANISM; CELLS; FIBROBLASTS; COMPLEXES	High density lipoprotein (HDL) phospholipid (PL) fatty acyl chain composition has been proposed to affect the ability of HDL to participate in the first step of reverse cholesterol transport. To examine the effects of PL fatty acid chain length and degree of unsaturation in this process, reconstituted HDL (rHDL) particles were made with human apolipoprotein (apo) A-I and PL containing fatty acid chains from 14 to 18 carbons in length, which were either fully saturated or unsaturated in one or both chains. These particles were characterized structurally and for their ability to promote free (unesterified) cholesterol (FC) efflux from cells growing in culture, The discoidal rHDL particles were homogeneous and exhibited similar hydrodynamic diameters (10.4 +/- 1.0 nm) indicating that apoA-I forms similarly sized discs with a variety of PL. Measurements of particle surface charge, apoA-I alpha-helix content, and conformational stability indicated that the conformation of apoA-I varies among the particles. These conformational effects on apoA-I are consistent with the PL fluidity influencing the interaction between the amphipathic Lu-helical segments and FL acyl chains. Differential scanning calorimetry demonstrated that the physical state of the rHDL PL at 37 degrees C varied according to acyl chain length and degree of unsaturation; the FC efflux efficiencies for particles with PL in either the gel or liquid crystal states were determined. The ability of the rHDL to accept cellular FC depended on the physical state of the PL in the rHDL. Liquid crystal PL formed the most efficient FC acceptor particles exhibiting a maximal efflux velocity (V-max) of 12-14% release of total cellular FC per h. Gel-phase PL formed inefficient rHDL acceptors with a V-max of about 3%/h. A similar hierarchy of FC efflux efficiency was noted when either mouse L-cells or rat Fu5AH hepatoma cells were used as the FC donors. Furthermore, this hierarchy was found to be due to the characteristics of the PL and not due to variable apoA-I conformation because protein-free, small unilamellar vesicles made with the same PL exhibited similar relative efflux capabilities. Generally, the ability of a given rHDL particle to accept cellular FC was related to rHDL PL acyl chain length and degree of unsaturation; decreases in FL acyl chain length and increases in chain unsaturation tended to result in more efficient FC acceptor particles. These results suggest that rHDL acceptor particles that contain highly fluid surfaces sequester FC molecules that have diffused from the cell plasma membrane at a significantly faster rate than those containing highly organized lipid surfaces with restricted FL acyl chain mobility, This information forms a basis for understanding the role of lipid content in the structural and functional diversity of HDL.	MED COLL PENN, DEPT BIOCHEM, PHILADELPHIA, PA 19129 USA	Drexel University				Phillips, Michael/0000-0002-7147-8007; Davidson, William/0000-0003-2756-2989	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGNANI G, 1993, BIOCHEMISTRY-US, V32, P2643, DOI 10.1021/bi00061a024; AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; BARENHOLZ Y, 1984, PHYSL MEMBRANE FLUID, V1, P134; BARRY PH, 1984, PHYSIOL REV, V64, P763, DOI 10.1152/physrev.1984.64.3.763; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BOJESEN E, 1982, NATURE, V299, P276, DOI 10.1038/299276a0; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHRISTENSEN HN, 1974, ENZYME KINETICS, P50; CHUNG BH, 1985, J BIOL CHEM, V260, P256; DAVIDSON WS, 1994, J BIOL CHEM, V269, P22975; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; FIEVET C, 1991, DIABETES METAB REV, V7, P155, DOI 10.1002/dmr.5610070304; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; GERASIMOVA E, 1991, LIPIDS, V26, P261, DOI 10.1007/BF02537134; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONES JD, 1990, BIOCHEMISTRY-US, V29, P1593, DOI 10.1021/bi00458a034; KILSDONK EPC, 1992, J LIPID RES, V33, P1373; KUDCHODKAR BJ, 1983, ATHEROSCLEROSIS, V46, P535; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; MAHLBERG F, 1993, MED SCI SYMP SER, V2, P493; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NICHOLS JW, 1982, BIOCHEMISTRY-US, V32, P12218; ORAM JF, 1990, CURR OPIN LIPIDOL, V1, P416; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; RADER DJ, 1991, J LIPID RES, V32, P1849; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SEGREST JP, 1992, J LIPID RES, V33, P141; SMALL DM, 1986, PHYSICAL CHEM LIPIDS, P627; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SOLA R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P43, DOI 10.1016/0005-2760(90)90108-A; SOLA R, 1993, ARTERIOSCLER THROMB, V13, P958, DOI 10.1161/01.ATV.13.7.958; SPARKS DL, 1992, J LIPID RES, V33, P123; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SPECTOR AA, 1985, J LIPID RES, V26, P1015; STECK TL, 1988, J BIOL CHEM, V263, P13023; SWANEY JB, 1983, J BIOL CHEM, V258, P1254; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; TALL AR, 1977, J BIOL CHEM, V252, P4701; VOSSEN RCRM, 1991, BIOCHIM BIOPHYS ACTA, V1083, P243, DOI 10.1016/0005-2760(91)90078-V; WALD JH, 1990, J BIOL CHEM, V265, P20037; WALD JH, 1990, J BIOL CHEM, V265, P20044; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; WESTERGAARD H, 1974, J CLIN INVEST, V54, P718, DOI 10.1172/JCI107810; YANG EY, 1993, BIOCHEMISTRY-US, V32, P12218, DOI 10.1021/bi00096a035; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	53	137	144	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5882	5890		10.1074/jbc.270.11.5882	http://dx.doi.org/10.1074/jbc.270.11.5882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890719	hybrid			2022-12-27	WOS:A1995QM94500031
J	MARCHINI, D; MANETTI, AGO; ROSETTO, M; BERNINI, LF; TELFORD, JL; BALDARI, CT; DALLAI, R				MARCHINI, D; MANETTI, AGO; ROSETTO, M; BERNINI, LF; TELFORD, JL; BALDARI, CT; DALLAI, R			CDNA SEQUENCE AND EXPRESSION OF THE CERATOTOXIN GENE ENCODING AN ANTIBACTERIAL SEX-SPECIFIC PEPTIDE FROM THE MEDFLY CERATITIS-CAPITATA (DIPTERA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRODUCTIVE ACCESSORY-GLANDS; TWO-DIMENSIONAL NMR; ANTIBIOTIC PEPTIDES; HYALOPHORA-CECROPIA; DROSOPHILA-MELANOGASTER; ANTIMICROBIAL PEPTIDES; SOLUTION CONFORMATION; INNATE IMMUNITY; INSECT IMMUNITY; XENOPUS-LAEVIS	Ceratotoxins are antibacterial 3-kDa molecular mass amphiphilic peptides isolated from the female reproductive accessory glands of the medfly Ceratitis capitata, They are physiologically related to bee melittin and show amino acid sequence homology with magainin peptides,In this paper, we report the complete sequence of cDNA coding for ceratotoxin A and the expression of the gene during the life cycle of the insect, Experimental data show that the ceratotoxin is a gene expressed exclusively in the imaginal stages and that it is female-specific, related to sexual maturity, and stimulated by mating, Differently from most antibacterial insect hemolymph peptides, it is not induced by microbial infection, Western blot analysis using an anti-ceratotoxin antibody indicates the female accessory glands as the only site where the production of the ceratotoxin peptide occurs.	LEIDEN UNIV, DEPT HUMAN GENET, 2333 AL LEIDEN, NETHERLANDS; IMMUNOBIOL RES INST SIENA, I-53100 SIENA, ITALY	Leiden University; Leiden University - Excl LUMC	MARCHINI, D (corresponding author), UNIV SIENA, DEPT EVOLUTIONARY BIOL, VIA P A MATTIOLI 4, I-53100 SIENA, ITALY.		Telford, John Laird/ABG-8144-2020; MARCHINI, DANIELA/ABF-9139-2020	MARCHINI, DANIELA/0000-0002-8380-7453; Dallai, Romano/0000-0002-2258-8891; Baldari, Cosima/0000-0002-4414-6744				ADIYODI KG, 1975, INT REV CYTOL, V43, P353; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BOMAN HG, 1989, FEBS LETT, V259, P103, DOI 10.1016/0014-5793(89)81505-4; BOMAN HG, 1989, J BIOL CHEM, V264, P5852; BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; BOMAN HG, 1982, ZENTRALBL BAKTERIO S, V12, P211; BOROVSKY D, 1994, INSECT BIOCHEM MOLEC, V24, P437, DOI 10.1016/0965-1748(94)90038-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCIANCICH S, 1994, PARASITOL TODAY, V10, P132, DOI 10.1016/0169-4758(94)90260-7; COCIANCICH S, 1993, BIOCHEM BIOPH RES CO, V194, P17, DOI 10.1006/bbrc.1993.1778; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; DALLAI R, 1988, J CELL SCI, V91, P563; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; GABAY JE, 1994, SCIENCE, V264, P373, DOI 10.1126/science.8153623; Gilbert LI., 1985, COMPREHENSIVE INSECT, P15; GUDMUNDSSON GH, 1991, J BIOL CHEM, V266, P11510; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; INAGAKI F, 1989, BIOCHEMISTRY-US, V28, P5985, DOI 10.1021/bi00440a040; IWAI H, 1993, EUR J BIOCHEM, V217, P639, DOI 10.1111/j.1432-1033.1993.tb18287.x; KANAI A, 1989, FEBS LETT, V258, P199, DOI 10.1016/0014-5793(89)81652-7; KREIL G, 1980, EUR J BIOCHEM, V111, P49, DOI 10.1111/j.1432-1033.1980.tb06073.x; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER RI, 1990, BLOOD, V76, P2169; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; MARCHINI D, 1993, INSECT BIOCHEM MOLEC, V23, P591, DOI 10.1016/0965-1748(93)90032-N; MARCHINI D, 1989, INSECT BIOCHEM, V19, P549, DOI 10.1016/0020-1790(89)90020-6; MARCHINI D, 1991, INSECT BIOCHEM, V21, P597, DOI 10.1016/0020-1790(91)90029-E; MARION D, 1988, FEBS LETT, V227, P21, DOI 10.1016/0014-5793(88)81405-4; MATSUYAMA K, 1988, J BIOL CHEM, V263, P17117; MOORE KS, 1991, J BIOL CHEM, V266, P19851; MOR A, 1991, BIOCHEMISTRY-US, V30, P8824, DOI 10.1021/bi00100a014; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; OKADA M, 1985, BIOCHEM J, V229, P453, DOI 10.1042/bj2290453; POSTLETHWAIT JH, 1988, J INSECT PHYSIOL, V34, P91, DOI 10.1016/0022-1910(88)90159-X; RABOSSI A, 1991, ENTOMOL EXP APPL, V60, P135, DOI 10.1007/BF00177034; REDDY ESP, 1979, NATURE, V279, P725, DOI 10.1038/279725a0; RICHTER K, 1986, J BIOL CHEM, V261, P3676; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; SAMAKOVLIS C, 1991, EMBO J, V10, P163, DOI 10.1002/j.1460-2075.1991.tb07932.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUL DJ, 1990, APPL ENVIRON MICROB, V56, P3117, DOI 10.1128/AEM.56.10.3117-3124.1990; SCHMIDT T, 1993, J INSECT PHYSIOL, V39, P361, DOI 10.1016/0022-1910(93)90023-K; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; THOMPSON SA, 1986, SCIENCE, V233, P341, DOI 10.1126/science.233.4761.341; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; ZANETTI M, 1990, J CELL BIOL, V111, P1363, DOI 10.1083/jcb.111.4.1363; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	61	47	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6199	6204		10.1074/jbc.270.11.6199	http://dx.doi.org/10.1074/jbc.270.11.6199			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890755	hybrid			2022-12-27	WOS:A1995QM94500072
J	ZHANG, LX; MILLS, KJ; DAWSON, MI; COLLINS, SJ; JETTEN, AM				ZHANG, LX; MILLS, KJ; DAWSON, MI; COLLINS, SJ; JETTEN, AM			EVIDENCE FOR THE INVOLVEMENT OF RETINOIC ACID RECEPTOR RAR-ALPHA-DEPENDENT SIGNALING PATHWAY IN THE INDUCTION OF TISSUE TRANSGLUTAMINASE AND APOPTOSIS BY RETINOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; LUNG-CARCINOMA CELLS; GENE-EXPRESSION; NUCLEAR RECEPTORS; EPIDERMAL-CELLS; HL-60 CELLS; DEATH; RXR; DIFFERENTIATION; IDENTIFICATION	In this study, we show that all-trans-retinoic acid (RA) is a potent inducer of tissue transglutaminase (TGase II) and apoptosis in the rat tracheobronchial epithelial cell line SPOC-1. We demonstrate that these cells express the retinoid receptors RAR alpha, RAR gamma, and RXR beta. To identify which of these receptors are involved in regulating these processes, we analyzed the effects of several receptor-selective agonists, an antagonist, and a dominant-negative RAR alpha. We show that the RAR-selective retinoid SRI-6751-84 strongly increased TGase II expression at both the protein and mRNA levels, whereas the RXR-selective retinoid SR11217 had little effect. The RAR alpha-selective retinoid Ro40-6055 was also able to induce TGase II, whereas the RAR gamma-selective retinoid CD437 was inactive. The induction of TGase II by the RAR-selective retinoid was completely inhibited by the RAR alpha-antagonist Ro41-5253. Overexpression of a truncated RAR alpha gene with dominant-negative activity also inhibited the induction of TGase II expression. The increase in TGase II is associated with an induction of apoptosis as revealed by DNA fragmentation and the generation of apoptotic cells. We demonstrate that apoptosis is affected by retinoids in a manner similar to TGase II. Our results suggest that the induction of TGase II expression and apoptosis in SPOC-1 cells are mediated through an RAR alpha-dependent signaling pathway.	NIEHS,PULM PATHOBIOL LAB,CELL BIOL SECT,RES TRIANGLE PK,NC 27709; SRI INT,BIOORGAN CHEM LAB,MENLO PK,CA 94025; FRED HUTCHINSON CANC RES CTR,PROGRAM MOLEC MED,SEATTLE,WA 98104	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRI International; Fred Hutchinson Cancer Center			Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	NATIONAL CANCER INSTITUTE [R01CA055397] Funding Source: NIH RePORTER; NCI NIH HHS [CA-55397] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; BIRCKBICHLER PJ, 1985, HYBRIDOMA, V4, P179, DOI 10.1089/hyb.1985.4.179; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; CHIOCCA EA, 1988, J BIOL CHEM, V263, P11584; DAMM K, 1990, P NATL ACAD SCI USA, V90, P2989; DAVIES PJA, 1985, J BIOL CHEM, V260, P5166; DAVIES PJA, 1992, RETINOIDS NORMAL DEV, P249; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DENNING MF, 1991, BIOCHEM BIOPH RES CO, V175, P344, DOI 10.1016/S0006-291X(05)81241-0; DOHERTY MM, 1995, IN PRESS AM J RESPIR; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; EITAN S, 1993, SCIENCE, V261, P106, DOI 10.1126/science.8100369; FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1; FLOYD EE, 1989, MOL CELL BIOL, V9, P4846, DOI 10.1128/MCB.9.11.4846; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GEORGE MD, 1990, J BIOL CHEM, V265, P11098; GORMAN CM, 1982, MOL CELL BIOL, V2, P1041; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; Jetten A M, 1992, J Natl Cancer Inst Monogr, P93; Jetton A. M., 1994, Retinoids: from basic science to clinical applications., P243; JIANG H, 1992, TERATOLOGY, V46, P333, DOI 10.1002/tera.1420460404; KOJIMA S, 1993, J CELL BIOL, V121, P439, DOI 10.1083/jcb.121.2.439; LEHMANN JM, 1991, CANCER RES, V51, P4804; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARTIN B, 1992, SKIN PHARMACOL, V5, P57; MARTIN SJ, 1990, CLIN EXP IMMUNOL, V79, P448; MARVIN KW, 1992, P NATL ACAD SCI USA, V89, P11026, DOI 10.1073/pnas.89.22.11026; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; NERVI C, 1991, EXP CELL RES, V195, P163, DOI 10.1016/0014-4827(91)90512-S; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PIACENTINI M, 1992, INT J CANCER, V52, P271, DOI 10.1002/ijc.2910520220; PIACENTINI M, 1993, FEBS LETT, V320, P150, DOI 10.1016/0014-5793(93)80081-5; PRESTON GA, 1994, CANCER RES, V54, P4214; ROSAMUND LK, 1993, EUR J CELL BIOL, V60, P210; RUBIN AL, 1986, CANCER RES, V46, P21356; SCHRADER M, 1993, J BIOL CHEM, V268, P17830; SCOTT KFF, 1982, P NATL ACAD SCI-BIOL, V79, P4093, DOI 10.1073/pnas.79.13.4093; SPORN MB, 1994, RETINOIDS BIOL MED; TARCSA E, 1992, J BIOL CHEM, V267, P25648; TATE BF, 1994, MOL CELL BIOL, V14, P2323, DOI 10.1128/MCB.14.4.2323; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TOMEI LD, 1994, APOPTOSIS, V2, P147; TSAI S, 1992, GENE DEV, V6, P2258, DOI 10.1101/gad.6.12a.2258; VOLLBERG TM, 1992, AM J RESP CELL MOL, V7, P10, DOI 10.1165/ajrcmb/7.1.10; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; YUSPA SH, 1982, J BIOL CHEM, V257, P9906; ZHANG LX, 1992, CANCER RES, V52, P5707; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	54	130	135	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6022	6029		10.1074/jbc.270.11.6022	http://dx.doi.org/10.1074/jbc.270.11.6022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890733	hybrid			2022-12-27	WOS:A1995QM94500049
J	FUKUDOME, K; ESMON, CT				FUKUDOME, K; ESMON, CT			MOLECULAR-CLONING AND EXPRESSION OF MURINE AND BOVINE ENDOTHELIAL-CELL PROTEIN C/ACTIVATED PROTEIN-C RECEPTOR (EPCR) - THE STRUCTURAL AND FUNCTIONAL CONSERVATION IN HUMAN, BOVINE, AND MURINE EPCR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-DERIVED MICROPARTICLES; THROMBIN-THROMBOMODULIN COMPLEX; ESCHERICHIA-COLI; BINDING; COAGULATION; ANTICOAGULANT; ANTIBODIES	Recently, we identified and cloned a human endothelial cell protein C/activated protein C receptor (EPCR), EPCR was predicted to be a type 1 transmembrane glycoprotein and a novel member of the CD1/major histocompatibility complex superfamily with 28% identity with CD1d. Even greater homology (62% identity) was detected with the murine protein, CCD41, which was previously characterized as a centrosome associated, cell cycle-dependent protein. This raised the possibility that CCD41 was the murine homologue of EPCR. To address this possibility, to better understand structure-function relationships, and to facilitate physiological experiments on EPCR function, we cloned and sequenced murine and bovine EPCR from endothelial cell cDNA libraries. The nucleotide sequence of murine EPCR and CCD41 exhibited five differences corresponding to one base change, three single-base insertions, and one base deletion in the protein coding region. As a result, the predicted structures of EPCR and CCD41 differed in their amino and carboxyl termini but were identical in the central portion of the coding sequence. Based on comparison of the murine, bovine, and human EPCR sequences and the regions where discrepancies between murine EPCR and CCD41 were detected, we believe that CCD41 is probably identical to murine EPCR and that the reported sequence differences are likely the result of compression on the sequencing gel. Compared with human EPCR, the murine and bovine sequences were 69 and 73% identical, respectively, and 57% of the residues were identical between all three species, Both bovine and murine EPCR could bind human activated protein C when the cDNA clones were transfected into 293T cells. Like human EPCR, of the cell Lines tested, the murine EPCR message was restricted to endothelium, Cloning of the murine and bovine homologue of EPCR will facilitate in vivo and in vitro studies of the role of EPCR in the protein C pathway.	OKLAHOMA MED RES FDN,HOWARD HUGHES MED INST,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,HOWARD HUGHES MED INST,DEPT PATHOL,OKLAHOMA CITY,OK 73190; UNIV OKLAHOMA,HLTH SCI CTR,HOWARD HUGHES MED INST,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73190	Howard Hughes Medical Institute; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center								ARUFFO A, 1989, J IMMUNOL, V143, P1723; BANGALORE N, 1994, THROMB HAEMOSTASIS, V72, P465; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DEBAULT LE, 1984, CYTOMETRY, V5, P386, DOI 10.1002/cyto.990050415; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; GERSON WT, 1993, PEDIATRICS, V91, P418; GREY ST, 1994, J IMMUNOL, V153, P3664; GRINNELL BW, 1994, GLYCOBIOLOGY, V4, P221, DOI 10.1093/glycob/4.2.221; HACKENG TM, 1993, J BIOL CHEM, V268, P3993; HARRIS KW, 1985, J BIOL CHEM, V260, P2007; HESSING M, 1989, THROMB HAEMOSTASIS, V62, P467; HYMAN R, 1991, IMMUNOGENETICS, V33, P392, DOI 10.1007/BF00216699; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LU RL, 1989, J BIOL CHEM, V264, P12956; Maniatis T., 1982, MOL CLONING; MARUYAMA I, 1985, J BIOL CHEM, V260, P5432; MITCHELL CA, 1987, J CLIN INVEST, V79, P374, DOI 10.1172/JCI112822; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; RIVARD GE, 1993, THROMB HAEMOSTASIS, V69, P2338; ROTHBARTH K, 1993, J CELL SCI, V104, P19; SEITZ R, 1993, INT J CANCER, V53, P514, DOI 10.1002/ijc.2910530326; STERN DM, 1986, J BIOL CHEM, V261, P713; TANS G, 1991, BLOOD, V77, P2641; TAYLOR F, 1991, BLOOD, V78, P357, DOI 10.1182/blood.V78.2.357.357; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902	28	78	91	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5571	5577		10.1074/jbc.270.10.5571	http://dx.doi.org/10.1074/jbc.270.10.5571			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890676	hybrid			2022-12-27	WOS:A1995QL58000093
J	PERTILE, P; LISCOVITCH, M; CHALIFA, V; CANTLEY, LC				PERTILE, P; LISCOVITCH, M; CHALIFA, V; CANTLEY, LC			PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE SYNTHESIS IS REQUIRED FOR ACTIVATION OF PHOSPHOLIPASE-D IN U937 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-NEUTROPHILS; PHOSPHATIDYLCHOLINE BREAKDOWN; SIGNAL TRANSDUCTION; PHOSPHATIDIC-ACID; HUMAN PLATELETS; 3T3 CELLS; PROTEIN; HYDROLYSIS; INHIBITION; KINASE	Phospholipase D (PLD) has been implicated in signal transduction and membrane traffic. We have previously shown that phosphatidylinositol 4,5-bisphosphate (PtdIns-4,5-P-2) stimulates in vitro partially purified brain membrane PLD activity, defining a novel function of PtdIns-4,5-P-2 as a PLD cofactor. In the present study we extend these observations to permeabilized U937 cells. In these cells, the activation of PLD by guanosine 5'-3-O-(thio)triphosphate (GTP gamma S) is greatly potentiated by MgATP. We have utilized this experimental system to test the hypothesis that MgATP potentiates PLD activation by G proteins because it is required for PtdIns-4,5-P-2 synthesis by phosphoinositide kinases. As expected, MgATP was absolutely required for maintaining elevated phosphatidylinositol 4-phosphate (PtdIns-4-P) and PtdIns-4,5-P-2 levels in the permeabilized cells. In the presence of MgATP, GTP gamma S further elevated the levels of the phosphoinositides. The importance of PtdIns-4,5-P-2 for PLD activation was examined by utilizing a specific inhibitory antibody directed against phosphatidylinositol 4 kinase (PtdIns 4-kinase), the enzyme responsible for the first step in the synthesis of PtdIns-4,5-P-2. Anti-PtdIns 4-kinase completely inhibited PtdIns 4-kinase activity in vitro and reduced by 75-80% PtdIns-4-P and PtdIns-4,5-P-2 levels in the permeabilized cells. In parallel, the anti-PtdIns 4-kinase fully inhibited the activation of PLD by GTP gamma S and caused a 60% inhibition of PLD activation by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate, indicating that elevated PtdIns-4,5-P-2 levels are required for PLD activation. This conclusion is supported by the fact that neomycin, a high affinity ligand of PtdIns-4,5-P-2, also blocked PLD activation. Furthermore, the activity of PLD in U937 cell lysate was stimulated by PtdIns-4,5-P-2 in a dose-dependent manner. The current results indicate that PtdIns-4,5-P-2 synthesis is required for PLD activation in permeabilized U937 cells and strongly support the proposed function of PtdIns-4,5-P-2 as a cofactor for PLD. In addition, the results further establish PtdIns-4,5-P-2 as a key component in the generation of second messengers via multiple pathways including phosphoinositide-phospholipase C, phosphoinositide 3-kinase and PLD.	HARVARD UNIV, BETH ISRAEL HOSP, SCH MED, DIV SIGNAL TRANSDUCT, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT CELL BIOL, BOSTON, MA 02115 USA; WEIZMANN INST SCI, DEPT HORMONE RES, IL-76100 REHOVOT, ISRAEL	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Weizmann Institute of Science			Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Chalifa-Caspi, Vered/0000-0001-6030-5816	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036624] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 36624] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUGER KR, 1991, CANCER CELLS, V8, P268; BALBOA MA, 1992, J EXP MED, V176, P9, DOI 10.1084/jem.176.1.9; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; BURGOYNE RD, 1994, TRENDS BIOCHEM SCI, V19, P55, DOI 10.1016/0968-0004(94)90032-9; CANO E, 1992, EUR J IMMUNOL, V22, P1883, DOI 10.1002/eji.1830220731; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CHAHWALA SB, 1987, BIOCHEMISTRY-US, V26, P612, DOI 10.1021/bi00376a037; COCKCROFT S, 1992, BIOCHIM BIOPHYS ACTA, V1113, P135, DOI 10.1016/0304-4157(92)90036-A; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; COOK SJ, 1992, BIOCHEM J, V285, P247, DOI 10.1042/bj2850247; COORSSEN JR, 1993, FEBS LETT, V316, P170, DOI 10.1016/0014-5793(93)81209-I; DUBYAK GR, 1993, BIOCHEM J, V292, P121, DOI 10.1042/bj2920121; ENDEMANN G, 1987, BIOCHEMISTRY-US, V26, P6845, DOI 10.1021/bi00395a039; ENDEMANN GC, 1991, BIOCHEM J, V273, P63, DOI 10.1042/bj2730063; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; GRUCHALLA RS, 1990, J IMMUNOL, V144, P2334; HEISS SG, 1991, BIOCHEMISTRY-US, V30, P8753, DOI 10.1021/bi00100a006; HUANG CF, 1992, J BIOL CHEM, V267, P16859; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; KANAHO Y, 1991, J IMMUNOL, V146, P3536; KANOH H, 1993, NEUROSCI LETT, V151, P146, DOI 10.1016/0304-3940(93)90007-8; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KISS Z, 1990, J BIOL CHEM, V265, P7345; KUSNER DJ, 1993, J BIOL CHEM, V268, P19973; LASSING I, 1988, J CELL BIOCHEM, V37, P255, DOI 10.1002/jcb.240370302; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LISCOVITCH M, 1989, J BIOL CHEM, V264, P11762; LISCOVITCH M, 1991, BIOCHEM J, V279, P319, DOI 10.1042/bj2790319; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; LISCOVITCH M, 1991, CELL REGUL, V2, P1011, DOI 10.1091/mbc.2.12.1011; LISCOVITCH M, 1994, SIGNAL ACTIVATED PHO, P31; MACNULTY EE, 1992, J BIOL CHEM, V267, P2149; MORITZ A, 1992, J BIOL CHEM, V267, P7207; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MULLMANN TJ, 1990, BIOCHEM BIOPH RES CO, V170, P1197, DOI 10.1016/0006-291X(90)90520-W; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; OZAKI Y, 1993, BIOCHEM PHARMACOL, V46, P395; PERRY DK, 1992, J IMMUNOL, V149, P2749; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RHEE SG, 1994, SIGNAL ACTIVATED PHO, P1; SCHACHT J, 1978, J LIPID RES, V19, P1063; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; STEWART SJ, 1991, CELL REGUL, V2, P841, DOI 10.1091/mbc.2.10.841; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TOKER A, 1994, J BIOL CHEM, V269, P32358; VANDERBEND RL, 1992, BIOCHEM J, V285, P235, DOI 10.1042/bj2850235; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; WANG BM, 1984, BIOCHEM PHARMACOL, V33, P3257, DOI 10.1016/0006-2952(84)90087-X; WANG P, 1991, J BIOL CHEM, V266, P14877; WONG K, 1994, J BIOL CHEM, V269, P28878; XIE MS, 1991, BIOCHEM J, V278, P81, DOI 10.1042/bj2780081; XIE MS, 1991, J CLIN INVEST, V88, P45, DOI 10.1172/JCI115303; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	63	110	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5130	5135		10.1074/jbc.270.10.5130	http://dx.doi.org/10.1074/jbc.270.10.5130			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890622	hybrid			2022-12-27	WOS:A1995QL58000029
J	CHO, HS; CRONAN, JE				CHO, HS; CRONAN, JE			DEFECTIVE EXPORT OF A PERIPLASMIC ENZYME DISRUPTS REGULATION OF FATTY-ACID SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; GENE	Escherichia coli thioesterase I (TesA) encoded by the tesA gene is located in the cellular periplasm. The tesA gene was modified by deletion of the leader sequence such that the mature enzyme was instead localized to the cellular cytosol. Production of thioesterase I in the cytosol results in striking changes in the pattern of E. coli lipid synthesis. In contrast to normal E. coli cells, cells producing cytosolic TesA synthesize large amounts of free fatty acid at all stages of growth. Moreover, cultures of the cytosolic TesA-producing strain continue lipid synthesis (as free fatty acid) in stationary phase whereas lipid synthesis is normally strongly inhibited in such cultures. Surprisingly, production of cytosolic thioesterase I gave only modest inhibition of membrane phospholipid synthesis. These results demonstrate that internalization of a normally secreted enzyme can disrupt normal cellular regulatory mechanisms.	UNIV ILLINOIS,DEPT MICROBIOL,URBANA,IL 61801; UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign			Cronan, John/V-6626-2019		NIAID NIH HHS [AI15650] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMSON L, 1970, LACTOSE OPERON, P317; ALPERS DH, 1965, P NATL ACAD SCI USA, V68, P3720; BOWDEN GA, 1993, J BACTERIOL, V174, P3407; CHO H, 1994, J BACTERIOL, V176, P1793, DOI 10.1128/jb.176.6.1793-1795.1994; CHO HS, 1993, J BIOL CHEM, V268, P9238; Christie W.W., 2003, LIPID ANAL; CRONAN JE, 1968, J BACTERIOL, V95, P2054, DOI 10.1128/JB.95.6.2054-2061.1968; DEMAIN AI, 1993, SCIENCE, V262, P1744; DEMAIN AI, 1993, EMBO J, V12, P879; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; HEATH RJ, 1994, J BIOL CHEM, V269, P26584; HIREL P, 1989, P NATL ACAD SCI USA, V91, P8247; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; KEPES A, 1967, BIOCHIM BIOPHYS ACTA, V138, P107, DOI 10.1016/0005-2787(67)90591-6; KNOLL LJ, 1993, J BIOL CHEM, V268, P4281; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; PEYPOUX F, 1970, Biochimica et Biophysica Acta, V218, P453, DOI 10.1016/0005-2760(70)90008-1; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; Reid T.W., 1971, ENZYMES, V4, P373; Sambrook J, 1989, MOL CLONING LABORATO; SCHULMAN RG, 1979, SCIENCE, V205, P160; STUDIER FW, 1990, METHOD ENZYMOL, V185, P61	24	125	159	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4216	4219		10.1074/jbc.270.9.4216	http://dx.doi.org/10.1074/jbc.270.9.4216			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876180	hybrid			2022-12-27	WOS:A1995QK08400010
J	KLODOS, I; FEDOSOVA, NU; PLESNER, L				KLODOS, I; FEDOSOVA, NU; PLESNER, L			INFLUENCE OF INTRAMEMBRANE ELECTRIC CHARGE ON NA,K-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; SODIUM-POTASSIUM PUMP; ATP-ADP EXCHANGE; CONFORMATIONAL TRANSITIONS; ADENOSINE-TRIPHOSPHATASE; PHOSPHOLIPID-VESICLES; NA+/K+-ATPASE; NA,K PUMP; OX BRAIN; K+	Effects of lipophilic ions, tetraphenylphosphonium (TPP+) and tetraphenylboron (TPB-), on interactions of Na+ and K+ with Na,K-ATPase were studied with membrane-bound enzyme from bovine brain, pig kidney, and shark rectal gland. Na+ and K+ interactions with the inward-facing binding sites, monitored by eosin fluorescence and phosphorylation, were not influenced by lipophilic ions. Phosphoenzyme interactions with extracellular cations were evaluated through K+-, ADP-, and Na+-dependent dephosphorylation. TPP+ decreased: 1) the rate of transition of ADP-insensitive to ADP-sensitive phosphoenzyme, 2) the K+ affinity and the rate coefficient for dephosphorylation of the K-sensitive phosphoenzyme, 3) the Na+ affinity and the rate coefficient for Na+-dependent dephosphorylation, Pre steady state phosphorylation experiments indicate that the subsequent occlusion of extracellular cations was prevented by TPP+, TPB- had opposite effects. Effects of lipophilic ions on the transition between phosphoenzymes were significantly diminished when Na+ was replaced by N methyl-D-glucamine or Tris(+), but were unaffected by the replacement of Cl- by other anions. Lipophilic ions affected Na-ATPase, Na,K-ATPase, and p-nitrophenylphosphatase activities in accordance with their effects on the partial reactions. Effects of lipophilic ions appear to be due to their charge indicating that Na+ and K+ access to their extracellular binding sites is modified by the intramembrane electric field.			KLODOS, I (corresponding author), AARHUS UNIV, INST BIOPHYS, OLE WORMS ALLE 185, DK-8000 AARHUS C, DENMARK.			Fedosova, Natalya U./0000-0002-1706-6108				ANDERSEN OS, 1978, BIOPHYS J, V21, P35, DOI 10.1016/S0006-3495(78)85507-6; APELL HJ, 1989, J MEMBRANE BIOL, V110, P103, DOI 10.1007/BF01869466; BEAUGE L, 1983, BIOCHIM BIOPHYS ACTA, V727, P336, DOI 10.1016/0005-2736(83)90419-4; BERBERIAN G, 1985, BIOCHIM BIOPHYS ACTA, V821, P17, DOI 10.1016/0005-2736(85)90148-8; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; DRAPEAU P, 1980, J BIOL CHEM, V255, P7827; ESMANN M, 1992, BIOCHIM BIOPHYS ACTA, V1110, P20, DOI 10.1016/0005-2736(92)90289-X; FEDOSOVA NU, 1994, SODIUM PUMP, P565; FLASCHKA H, 1960, ADV ANALYT CHEM INST, V1, P1; FLEWELLING RF, 1986, BIOPHYS J, V49, P541, DOI 10.1016/S0006-3495(86)83664-5; FLEWELLING RF, 1986, BIOPHYS J, V49, P531, DOI 10.1016/S0006-3495(86)83663-3; GADSBY DC, 1992, ACTA PHYSIOL SCAND, V146, P111; GADSBY DC, 1991, SOC GEN PHY, V46, P355; Glynn I M, 1988, Prog Clin Biol Res, V268A, P435; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GLYNN IM, 1976, J PHYSIOL-LONDON, V256, P465, DOI 10.1113/jphysiol.1976.sp011333; GLYNN IM, 1987, J PHYSIOL-LONDON, V383, P477; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; GLYNN IM, 1982, MEMBRANES TRANSPORT, V1, P529; GOLDSHLEGER DM, 1994, SODIUM PUMP STRUCTUR, P309; GOLDSHLEGGER R, 1987, J PHYSIOL-LONDON, V387, P331, DOI 10.1113/jphysiol.1987.sp016576; HARA Y, 1981, J BIOCHEM, V90, P923, DOI 10.1093/oxfordjournals.jbchem.a133580; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; JENSEN J, 1983, CURR TOP MEMBR TRANS, V19, P223; JENSEN J, 1984, J PHYSIOL-LONDON, V346, P219, DOI 10.1113/jphysiol.1984.sp015018; JENSEN J, 1983, BIOCHIM BIOPHYS ACTA, V731, P282, DOI 10.1016/0005-2736(83)90020-2; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; JORGENSEN PL, 1991, SOC GEN PHY, V46, P189; JORGENSEN PL, 1994, SODIUM PUMP, P297; KAPLAN JH, 1982, J GEN PHYSIOL, V80, P915, DOI 10.1085/jgp.80.6.915; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; KLODOS I, 1981, BIOCHIM BIOPHYS ACTA, V643, P463, DOI 10.1016/0005-2736(81)90089-4; KLODOS I, 1975, ANAL BIOCHEM, V67, P397, DOI 10.1016/0003-2697(75)90311-5; KLODOS I, 1987, BIOCHIM BIOPHYS ACTA, V897, P302, DOI 10.1016/0005-2736(87)90426-3; KLODOS I, 1994, J BIOL CHEM, V269, P1734; KLODOS I, 1992, ACTA PHYSIOL SCAND, V146, P235; KLODOS I, 1985, SODIUM PUMP, P383; KLODOS I, 1979, NA K ATPASE STRUCTUR, P331; LANGER P, 1991, SODIUM PUMP STRUCTUR, P303; LAUGER P, 1991, ELECTROGENIC ION PUM, P177; LINDBERG O, 1956, METHODS BIOCHEMICAL, V3, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARDH S, 1975, BIOCHIM BIOPHYS ACTA, V391, P464; Norby J G, 1988, Prog Clin Biol Res, V268A, P249; NORBY JG, 1971, BIOCHIM BIOPHYS ACTA, V233, P104, DOI 10.1016/0005-2736(71)90362-2; NORBY JG, 1983, J GEN PHYSIOL, V82, P725, DOI 10.1085/jgp.82.6.725; OTTOLENGHI P, 1975, BIOCHEM J, V151, P61, DOI 10.1042/bj1510061; POST RL, 1975, J SUPRAMOL STR CELL, V3, P479, DOI 10.1002/jss.400030508; POST RL, 1991, SOC GEN PHY, V46, P201; POST RL, 1972, J BIOL CHEM, V247, P6530; RAKOWSKI RF, 1991, J MEMBRANE BIOL, V121, P177, DOI 10.1007/BF01870531; RAKOWSKI RF, 1991, SOC GEN PHY, V46, P339; REPHAELI A, 1986, J BIOL CHEM, V261, P2437; REPHAELI A, 1986, J BIOL CHEM, V261, P6248; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; SCHWARZ W, 1991, SOC GEN PHY, V46, P327; SKOU JC, 1979, BIOCHIM BIOPHYS ACTA, V567, P436, DOI 10.1016/0005-2744(79)90129-3; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V746, P101, DOI 10.1016/0167-4838(83)90016-X; STEINBERG M, 1989, J BIOL CHEM, V264, P2726; STIMERS JR, 1993, J MEMBRANE BIOL, V135, P39; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; VASILETS LA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P201, DOI 10.1016/0304-4157(93)90012-D; VASILETS LA, 1991, J BIOL CHEM, V266, P16285; YODA A, 1987, J BIOL CHEM, V262, P110	68	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4244	4254		10.1074/jbc.270.9.4244	http://dx.doi.org/10.1074/jbc.270.9.4244			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876184	hybrid			2022-12-27	WOS:A1995QK08400014
J	KUMAR, AP; MAR, PK; ZHAO, BW; MONTGOMERY, RL; KANG, DC; BUTLER, AP				KUMAR, AP; MAR, PK; ZHAO, BW; MONTGOMERY, RL; KANG, DC; BUTLER, AP			REGULATION OF RAT ORNITHINE DECARBOXYLASE PROMOTER ACTIVITY BY BINDING OF TRANSCRIPTION FACTOR SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRANS-ACTING FACTOR; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; HEPATOMA-CELLS; STIMULATION; CLONING; GROWTH; FIBROBLASTS	Ornithine decarboxylase (ODC) is the rate-limiting enzyme of polyamine biosynthesis, We investigated the transcriptional regulation of the rat ODC gene using transient expression assays, The 5'-flanking region (-1156 to +13) of the ODC gene was sufficient to mediate strong basal expression of a luciferase reporter. Sequences between -345 and -93 contributed to basal promoter activity. This region, containing five potential Sp1 binding sites, was analyzed by electrophoretic mobility shift assays. Three specific DNA-protein complexes were identified using H35 nuclear extracts and the -345/-93 ODC probe, Binding to all three was eliminated by competition with an oligonucleotide containing an Sp1 binding site, but not by a mutant Sp1 oligonucleotide. Preincubation with an antibody against Sp1 supershifted complexes associated with one or more of Sp1 binding sites 1-4 as well as with site 5, DNase I footprinting revealed two protected regions: PR-I (-92 to -130) and PR-II (-304 to -332), PR-I contains a putative binding site for Sp1 that was protected by recombinant Sp1 protein, Transfection studies in Schneider SL2 cells demonstrated that the ODC promoter is trans-activated up to 350-fold by Sp1 and that this trans-activation is dependent on the presence of Sp1 binding sites 1-4. Thus, although the ODC promoter binds multiple nuclear proteins, Sp1 or a related protein appears to be a critical determinant of ODC transcription, possibly through cooperative interactions between Sp1 and additional transcription factors.	UNIV TEXAS, MD ANDERSON CANC CTR, DIV SCI PK RES, SMITHVILLE, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center					NATIONAL CANCER INSTITUTE [R01CA046629] Funding Source: NIH RePORTER; NCI NIH HHS [CA-46629] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAMSEN MS, 1990, MOL CELL BIOL, V10, P5525, DOI 10.1128/MCB.10.10.5525; ABRAHAMSEN MS, 1992, J BIOL CHEM, V267, P18866; ABRAHAMSEN MS, 1991, PERSPECTIVES CELL RE, P107; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ausubel FM, 1988, MOL REPROD DEV; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BERGER FG, 1984, J BIOL CHEM, V259, P7941; BORELLINI F, 1990, MOL CELL BIOL, V10, P5541, DOI 10.1128/MCB.10.10.5541; BRABANT M, 1988, P NATL ACAD SCI USA, V85, P2200, DOI 10.1073/pnas.85.7.2200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BUTLER AP, 1987, BIOCHEM BIOPH RES CO, V147, P809, DOI 10.1016/0006-291X(87)91002-3; BUTLER AP, 1991, EXP CELL RES, V194, P56, DOI 10.1016/0014-4827(91)90129-I; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FARNHAM PJ, 1993, BIOCHIM BIOPHYS ACTA, V1155, P125, DOI 10.1016/0304-419X(93)90001-S; FEINSTEIN SC, 1985, P NATL ACAD SCI USA, V82, P5761, DOI 10.1073/pnas.82.17.5761; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GEISER AG, 1993, GENE, V129, P223, DOI 10.1016/0378-1119(93)90272-5; GILMOUR SK, 1989, CARCINOGENESIS, V10, P157, DOI 10.1093/carcin/10.1.157; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HOVIS JG, 1986, J BIOL CHEM, V261, P380; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; IYER RR, 1991, GENE, V105, P97, DOI 10.1016/0378-1119(91)90518-G; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KATZ A, 1987, MOL CELL BIOL, V7, P2641, DOI 10.1128/MCB.7.7.2641; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; KIM YJ, 1994, MOL CARCINOGEN, V10, P169, DOI 10.1002/mc.2940100308; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; MANZELLA JM, 1990, J BIOL CHEM, V265, P11817; MOSHIER JA, 1993, CANCER RES, V53, P2618; MOSHIER JA, 1990, J BIOL CHEM, V265, P4884; MOSHIER JA, 1992, NUCLEIC ACIDS RES, V20, P2581, DOI 10.1093/nar/20.10.2581; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; OBRIEN TG, 1975, CANCER RES, V35, P1662; PALVIMO JJ, 1991, NUCLEIC ACIDS RES, V19, P3921, DOI 10.1093/nar/19.14.3921; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PENA A, 1993, J BIOL CHEM, V268, P27277; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; Sambrook J, 1989, MOL CLONING LABORATO; SCALABRINO G, 1981, ADV CANCER RES, V35, P151, DOI 10.1016/S0065-230X(08)60911-2; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; STEGLICH C, 1985, SOMAT CELL MOLEC GEN, V11, P11, DOI 10.1007/BF01534730; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TSENG CP, 1994, CARCINOGENESIS, V15, P707, DOI 10.1093/carcin/15.4.707; VANSTEEG H, 1989, NUCLEIC ACIDS RES, V17, P8855, DOI 10.1093/nar/17.21.8855; VANSTEEG H, 1990, GENE, V93, P249, DOI 10.1016/0378-1119(90)90232-G; VANSTEEG H, 1988, NUCLEIC ACIDS RES, V16, P8173, DOI 10.1093/nar/16.16.8173; WRIGHTON C, 1993, MOL CELL BIOL, V13, P4657, DOI 10.1128/MCB.13.8.4657	63	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4341	4348		10.1074/jbc.270.9.4341	http://dx.doi.org/10.1074/jbc.270.9.4341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876196	hybrid			2022-12-27	WOS:A1995QK08400027
J	TAMAKI, T; OHNISHI, K; HARTL, C; LEROY, EC; TROJANOWSKA, M				TAMAKI, T; OHNISHI, K; HARTL, C; LEROY, EC; TROJANOWSKA, M			CHARACTERIZATION OF A GC-RICH REGION CONTAINING SP1 BINDING SITE(S) AS A CONSTITUTIVE RESPONSIVE ELEMENT OF THE ALPHA-2(I) COLLAGEN GENE IN HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NUCLEAR FACTOR-I; TRANSCRIPTIONAL ACTIVATION; PROMOTER; EXPRESSION; ALPHA-1(I); INTERACT; CELLS	To analyze regulatory elements in the human alpha 2(I) collagen gene (COL1A2) promoter, a series of deletion mutants from -323 to -186 base pairs was tested in transient transfection assays in human fibroblasts. A strong positive responsive element was mapped to a GC-rich region located between base pairs -303 and -271. This region contains three binding sites (GC-boxes) resembling recognition sites for the transcription factor Sp1. Substitution mutations in the GC-boxes abolished binding to the GC-rich region in gel shift analyses and resulted in 90% reduction of promoter activity in transient transfection assays. We demonstrated that transcription factor Sp1 is essential for binding based on the following observations, 1) Sp1 consensus binding site alone competes by binding to the GC-rich region in the DNase I protection assay; 2) both Sp1 consensus binding site and Sp1 antibodies prevent the formation of a DNA-protein complex in the mobility shift assay; 3) anti-Sp1 antibodies recognize a component of the complex competed for by Sp1 consensus binding site.	MED UNIV S CAROLINA,DEPT MED,DIV RHEUMATOL & IMMUNOL,CHARLESTON,SC 29425	Medical University of South Carolina				Trojanowska, Maria/0000-0001-9550-7178				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BOAST S, 1990, J BIOL CHEM, V265, P13351; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; DEMCZUK S, 1993, P NATL ACAD SCI USA, V90, P2574, DOI 10.1073/pnas.90.7.2574; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; KING SL, 1994, J BIOL CHEM, V269, P13156; LEROY EC, 1992, CECIL TXB MED, P1530; Liska Deann J., 1992, Gene Expression, V2, P379; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; NEHLS MC, 1992, DNA CELL BIOL, V11, P443, DOI 10.1089/dna.1992.11.443; RAMIREZ F, 1990, FASEB J, V4, P1616, DOI 10.1096/fasebj.4.6.2180769; RITZENTHALER JD, 1993, J BIOL CHEM, V268, P13625; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; Tamaki T., 1993, Molecular Biology of the Cell, V4, p65A; VOGELI G, 1981, P NATL ACAD SCI-BIOL, V78, P5334, DOI 10.1073/pnas.78.9.5334; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201	23	107	108	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4299	4304		10.1074/jbc.270.9.4299	http://dx.doi.org/10.1074/jbc.270.9.4299			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876190	hybrid			2022-12-27	WOS:A1995QK08400021
J	KALAFATIS, M; BERTINA, RM; RAND, MD; MANN, KG				KALAFATIS, M; BERTINA, RM; RAND, MD; MANN, KG			CHARACTERIZATION OF THE MOLECULAR DEFECT IN FACTOR V-R506Q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; POOR ANTICOAGULANT RESPONSE; COAGULATION FACTOR-V; INACTIVATION; THROMBOPHILIA; MECHANISM; COFACTOR; MEMBRANE; ANTIBODY; THROMBIN	A poor anticoagulant response of plasma to activated protein C is correlated with a single mutation in the factor V molecule (Arg(506) --> Gln), Factor V was purified to homogeneity from plasma of two unrelated patients (patient I, factor V-I, and patient II, factor V-II), who are homozygous for this mutation, The factor V molecule from both patients has normal procoagulant activity when compared with factor V isolated from normal plasma in both a clotting time-based assay and in an assay measuring alpha-thrombin formation, The cleavage and subsequent inactivation by activated protein C (APC) of the alpha-thrombin-activated membrane-bound cofactor (factor Va) from both patients were analyzed and compared with the cleavage and inactivation of normal human factor Va, In normal factor Va, cleavage at Arg(506) generates a M(r) = 75,000 fragment and a M(r) = 28,000/26,000 doublet and is necessary for the optimum exposure of the sites for subsequent cleavage at Arg(306) and Arg(679), Proteolysis at these sites leads to the appearance of M(r) = 45,000 and 30,000 fragments and a M(r) = 22,000/20,000 doublet. Cleavage at Arg(306) is membrane-dependent and is required for complete inactivation, Following 5 min of incubation with APC (5.4 nM) membrane-bound normal factor Va (280 nM) has virtually no cofactor activity whereas under similar experimental conditions factor Va(I) and factor Va(II) retain approximately 50% of their initial activity, After 1 h of incubation with APC, factor Va(I) retains 20% of its initial cofactor activity whereas factor Va(II) has 10% remaining cofactor activity, The initial loss in cofactor activity (similar to 70%) of membrane-bound factor Va(I) and factor Va(II) during the first 10 min of the inactivation reaction is correlated with cleavage at Arg(306) and appearance of a M(r) = 45,000 fragment and a M(r) = 62,000/60,000 doublet, Subsequently, the M(r) = 62,000/60,000 doublet is cleaved at Arg(679) to generate a M(r) = 56,000/54,000 doublet resulting in complete loss of cofactor activity. Both procofactors, factor V-I and factor V-II were inactivated following cleavage at Arg(306) and Arg(679), With APC inactivation rates equivalent to those observed for normal factor V. Our data demonstrate that; 1) cleavage of Arg(506) is required for optimum exposure of the cleavage sites at Arg(306) and Arg(679) and rapid inactivation of membrane-bound factor Va; and 2) cleavage at Arg(306) by APC On membrane-bound factor V occurs at the same rate in both normal and APC-resistant individuals, Thus cleavage at Arg(306) and Arg(679) and subsequent inactivation of the membrane-bound procofactor, factor V, does not require prior cleavage at Arg(506) for optimum exposure.	UNIV VERMONT,COLL MED,DEPT BIOCHEM,BURLINGTON,VT 05405; UNIV LEIDEN HOSP,HEMOSTASIS & THROMBOSIS RES CTR,2300 RC LEIDEN,NETHERLANDS	University of Vermont; Leiden University; Leiden University Medical Center (LUMC)			Bertina, Rogier/AGQ-5246-2022		NHLBI NIH HHS [R37 HL34575] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034575] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALHENCGELAS M, 1994, LANCET, V343, P555; BAJAJ SP, 1973, J BIOL CHEM, V248, P7729; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BOKAREWA M, 1994, THROMB RES, V75, P395, DOI 10.1016/0049-3848(94)90254-2; CHURCH WR, 1988, J BIOL CHEM, V263, P6259; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; DAHLBACK B, 1994, P NATL ACAD SCI USA, V91, P1396, DOI 10.1073/pnas.91.4.1396; GIROLAMI A, 1994, LANCET, V343, P1288, DOI 10.1016/S0140-6736(94)92177-6; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; GRIFFIN JH, 1993, BLOOD, V82, P1989; HALBMAYER WM, 1994, BLOOD COAGUL FIBRIN, V5, P51, DOI 10.1097/00001721-199402000-00008; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JH, 1994, J BIOL CHEM, V269, P23357; LEGNANI C, 1994, LANCET, V343, P1289; LEGNANI C, 1994, LANCET, V343, P541, DOI 10.1016/S0140-6736(94)91494-X; LU DS, 1994, BLOOD, V84, P687; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; ROSENDAAL FR, 1994, LANCET, V343, P1289; ROSENDAAL FR, 1995, IN PRESS BLOOD; SHEN L, 1994, J BIOL CHEM, V269, P18735; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; SUN X, 1994, BLOOD, V83, P3120; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOORBERG J, 1994, LANCET, V343, P1535, DOI 10.1016/S0140-6736(94)92939-4	36	244	251	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4053	4057		10.1074/jbc.270.8.4053	http://dx.doi.org/10.1074/jbc.270.8.4053			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876154	hybrid			2022-12-27	WOS:A1995QH68800087
J	SLEPAK, VZ; KATZ, A; SIMON, MI				SLEPAK, VZ; KATZ, A; SIMON, MI			FUNCTIONAL-ANALYSIS OF A DOMINANT-NEGATIVE MUTANT OF G-ALPHA(I2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; GTP-BINDING PROTEINS; ADENYLYL-CYCLASE; ALPHA-SUBUNIT; NUCLEOTIDE-BINDING; PHOSPHOLIPASE-C; SIGNAL TRANSDUCTION; RECEPTOR; STIMULATION; INHIBITION	The key event in receptor-catalyzed activation of heterotrimeric G proteins is binding of GTP, which leads to subunit dissociation generating GTP-bound alpha subunits and free beta gamma complexes, We have previously identified a mutation that abolished GTP binding in G alpha(o) (S47C) and demonstrated that the mutant retained the ability to bind beta gamma and could act in a dominant negative fashion when expressed in Xenopus oocytes (Slepak, V, Z,, Quick, M, W,, Aragay, A. M,, Davidson, N,, Lester, H. A., and Simon, M. I, (1993) J, Biol, Chem, 268, 21889-21894), In the current work, we investigated the effects of the homologous mutant of G alpha(i2) (S48C) upon signaling pathways reconstituted in transiently transfected COS-7 cells, We found that expression of the G alpha(i2), S48C mutant prevented stimulation of phospholipase C (PLC) beta 2 by free beta gamma subunit complexes, This effect of G alpha(i) S48C was not readily reversible in contrast to the inhibitory effect of wild-type G alpha(i2), which could be reversed upon activation of the cotransfected muscarinic M2 receptor, presumably by release of beta gamma from the G protein heterotrimer, Coexpression of G alpha(i) S48C or the wild-type G alpha(i) also dramatically decreased G(16)-mediated stimulation of PLC by C5a in the cells transfected with cDNAs encoding C5a receptor and G alpha(16). Activation of PLC via endogenous G(q) or G(11) in the presence of alpha 1C adrenergic receptors was similarly attenuated by coexpression of G alpha(i) or G alpha(i) S48C, Pertussis toxin treatment of the transfected cells enhanced the inhibition of the receptor-stimulated PLC by wild-type G alpha(i) subunits but did not influence the effects of the dominant negative mutant, The enhancement of the wild-type G alpha(i) inhibitory effect by pertussis toxin can be explained by stabilization of G alpha(i) binding to beta gamma as a result of ADP-ribosylation, while G alpha(i) S48C mutant binds beta gamma irreversibly even without pertussis toxin treatment, Therefore, a feasible mechanism to rationalize the attenuation of the G alpha(16) and G(q/11)-mediated activation of PLC by cotransfected G alpha(i) is the competition between G alpha(i) and G alpha(16) or G(q/11) for the beta gamma complexes, which are necessary for the G protein coupling with receptors, These experiments provide new evidence for the role of beta gamma in the integration of signals controlling phosphoinositide release through different G alpha families.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology			Katz, Arieh/F-5836-2012					AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CARREL F, 1994, MOL BIOL CELL, V5, P7, DOI 10.1091/mbc.5.1.7; COWEN DS, 1990, J BIOL CHEM, V265, P16181; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HIGUCHI R, 1989, NUCLEIC ACIDS RES, V16, P7351; HUFF RM, 1986, J BIOL CHEM, V261, P1105; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KATADA T, 1987, J BIOL CHEM, V262, P11897; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KIKUCHI A, 1986, J BIOL CHEM, V261, P1558; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; OSAWA S, 1991, J BIOL CHEM, V266, P4673; PITHCER JA, 1992, SCIENCE, V257, P1264; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; SMRCKA AV, 1992, J BIOL CHEM, V268, P9667; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WU DQ, 1992, J BIOL CHEM, V267, P25798; WU DQ, 1992, J BIOL CHEM, V267, P1811	39	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4037	4041		10.1074/jbc.270.8.4037	http://dx.doi.org/10.1074/jbc.270.8.4037			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876152	hybrid, Green Accepted			2022-12-27	WOS:A1995QH68800085
J	VANDIJL, JM; DEJONG, A; VENEMA, G; BRON, S				VANDIJL, JM; DEJONG, A; VENEMA, G; BRON, S			IDENTIFICATION OF THE POTENTIAL ACTIVE-SITE OF THE SIGNAL PEPTIDASE SIPS OF BACILLUS-SUBTILIS - STRUCTURAL AND FUNCTIONAL SIMILARITIES WITH LEXA-LIKE PROTEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; YEAST SEC11 PROTEIN; ESCHERICHIA-COLI; CATALYTIC MECHANISM; POLYACRYLAMIDE GELS; SECRETORY PROTEINS; PLASMA-MEMBRANE; RECA PROTEIN; CLEAVAGE; SEQUENCE	Signal peptidases remove signal peptides from secretory proteins. By comparing the type I signal peptidase, SipS, of Bacillus subtilis with signal peptidases from prokaryotes, mitochondria, and the endoplasmic reticular membrane, patterns of conserved amino acids were discovered. The conserved residues of SipS were altered by site-directed mutagenesis. Replacement of methionine 44 by alanine yielded an enzyme with increased activity. Two residues (aspartic acid 146 and arginine 84) appeared to be conformational determinants; three other residues (serine 43, lysine 83, and aspartic acid 153) were critical for activity. Comparison of SipS with other proteases requiring serine, lysine, or aspartic acid residues in catalysis revealed sequence similarity between the region of SipS around serine 43 and lysine 83 and the active-site region of LexA-like proteases. Furthermore, self-cleavage sites of LexA-like proteases closely resembled signal peptidase cleavage sites. Together with the finding that serine and lysine residues are critical for activity of the signal peptidase of Escherichia coli (Tschantz, W. R., Sung, M., Delgado-Partin, V. M., and Dalbey, R. E. (1993) J. Biol. Chem. 268, 27349-27354), our data indicate that type I signal peptidases and LexA-like proteases are structurally and functionally related serine proteases. A model envisaging a catalytic serine-lysine dyad in prokaryotic type I signal peptidases is proposed to accommodate our observations.	GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST, DEPT GENET, 9751 NN HAREN, NETHERLANDS	University of Groningen			van Dijl, Jan Maarten/G-1205-2013					BEHRENS M, 1991, MOL GEN GENET, V228, P167, DOI 10.1007/BF00282462; BLACK MT, 1992, BIOCHEM J, V282, P539, DOI 10.1042/bj2820539; BLACK MT, 1993, J BACTERIOL, V175, P4957, DOI 10.1128/JB.175.16.4957-4961.1993; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; DEV IK, 1990, J BIOENERG BIOMEMBR, V22, P271, DOI 10.1007/BF00763168; DEV IK, 1990, J BIOL CHEM, V265, P20069; DIERSTEIN R, 1986, EMBO J, V5, P427, DOI 10.1002/j.1460-2075.1986.tb04228.x; DOBBERSTEIN B, 1994, NATURE, V367, P599, DOI 10.1038/367599a0; DRIJFHOUT JW, 1990, ANAL BIOCHEM, V187, P349, DOI 10.1016/0003-2697(90)90468-O; DUFFAUD G, 1988, J BIOL CHEM, V263, P10224; Dunn BM, 1989, PROTEOLYTIC ENZYMES; GIMBLE FS, 1986, J MOL BIOL, V192, P39, DOI 10.1016/0022-2836(86)90462-6; GREENBURG G, 1989, J BIOL CHEM, V264, P15762; HORII T, 1981, CELL, V27, P515, DOI 10.1016/0092-8674(81)90393-7; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; KUO DW, 1993, ARCH BIOCHEM BIOPHYS, V303, P274, DOI 10.1006/abbi.1993.1283; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Pero Janice, 1993, P939; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; ROLAND KL, 1990, J BIOL CHEM, V265, P12828; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SCHNEIDER A, 1994, J BIOL CHEM, V269, P8635; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SUNG M, 1992, J BIOL CHEM, V267, P13154; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; VANDIJL JM, 1991, MOL GEN GENET, V227, P40, DOI 10.1007/BF00260704; VANDIJL JM, 1992, EMBO J, V11, P2819, DOI 10.1002/j.1460-2075.1992.tb05349.x; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; VANDIJL JM, 1990, MOL GEN GENET, V223, P233, DOI 10.1007/BF00265059; VANDIJL JM, 1993, DNA TRANSFER GENE EX, P251; VEHMAANPERA J, 1993, FEMS MICROBIOL LETT, V114, P207, DOI 10.1111/j.1574-6968.1993.tb06575.x; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; WOLFE PB, 1983, J BIOL CHEM, V258, P2073; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301	50	89	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3611	3618		10.1074/jbc.270.8.3611	http://dx.doi.org/10.1074/jbc.270.8.3611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876097				2022-12-27	WOS:A1995QH68800025
J	KUNTZWEILER, TA; WALLICK, ET; JOHNSON, CL; LINGREL, JB				KUNTZWEILER, TA; WALLICK, ET; JOHNSON, CL; LINGREL, JB			GLUTAMIC-ACID-327 IN THE SHEEP ALPHA-1 ISOFORM OF NA+,K+-ATPASE STABILIZES A K+-INDUCED CONFORMATIONAL CHANGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CONFERS OUABAIN RESISTANCE; SODIUM-CALCIUM EXCHANGE; SARCOPLASMIC-RETICULUM; TRANSMEMBRANE SEGMENT; KIDNEY NA+,K+-ATPASE; NA,K-ATPASE ALPHA-1; CARDIAC-GLYCOSIDES; SUBUNIT; BINDING	By combining the tools of site-directed mutagenesis and [H-3]ouabain binding, the functional role of glutamic acid 327 in the fourth transmembrane domain of the sheep al isoform of Na(+)k(+)-ATPase was examined with respect to its interactions with ouabain, Na+, K+, Mg2+, and inorganic phosphate. Using site-directed mutagenesis, this glutamic acid was substituted with alanine, aspartic acid, glutamine, and leucine. The mutant proteins were constructed in a sheep al protein background such that [H-3]ouabain binding could be utilized as a highly specific probe of the exogenous protein expressed in NIH 3T3 cells. Na+ competition of [H-3]ouabain binding to the mutant forms of Na+,K+-ATPase revealed only slight alterations in their affinities for Na+ and in their abilities to undergo Na+-induced conformational changes which inhibit ouabain binding: In contrast, K+ competition of [H-3]ouabain binding to all four mutant forms of Na+,K+-ATPase displayed severely altered interactions between these proteins and K+. Interestingly, [H-3]ouabain binding to the mutant E327Q was not inhibited by the presence of K+. This mutant was previously reported to be functionally able to support cation transport with a 5-fold reduced K-0.5 for K+-dependent ATPase activity (Jewell-Motz, E. A., and Lingrel, J. E. (1993) Biochemistry 32, 13523-13530; Vilsen, B. (1993) Biochemistry 32, 13340-13349). Thus, it appears that this glutamic acid in the fourth transmembrane domain may be important for stabilizing a K+ induced conformation within the catalytic cycle of Na+,K+-ATPase that is not rate-limiting in the overall ATPase cycle but that displays a greatly reduced affinity for ouabain.	UNIV CINCINNATI, COLL MED, DEPT MOLEC GENET BIOCHEM & MICROBIOL, CINCINNATI, OH 45267 USA; UNIV CINCINNATI, COLL MED, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA	University of Cincinnati; University of Cincinnati					NHLBI NIH HHS [HL 50613, HL 28573, HL 08612-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028573, R01HL050613, F32HL008612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; ASKARI A, 1988, J BIOL CHEM, V263, P235; BALL WJ, 1982, BIOCHIM BIOPHYS ACTA, V719, P413, DOI 10.1016/0304-4165(82)90228-8; BALL WJ, 1988, METHOD ENZYMOL, V156, P87; BLOSTEIN R, 1991, SOC GEN PHY, V46, P289; CANESSA CM, 1993, J BIOL CHEM, V268, P17722; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1990, J BIOL CHEM, V265, P17405; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORNELIUS F, 1991, BIOCHIM BIOPHYS ACTA, V1071, P59; DUNHAM ET, 1961, J PHYSIOL-LONDON, V156, P274, DOI 10.1113/jphysiol.1961.sp006675; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; GOLDSHLEGER R, 1992, P NATL ACAD SCI USA, V89, P6911, DOI 10.1073/pnas.89.15.6911; HANSEN O, 1973, BIOCHIM BIOPHYS ACTA, V311, P51, DOI 10.1016/0005-2736(73)90254-X; HANSEN O, 1984, PHARMACOL REV, V36, P143; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; JOHNSON CL, 1995, IN PRESS ARCH BIOCH; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANGER GA, 1982, ANNU REV PHYSIOL, V44, P435, DOI 10.1146/annurev.ph.44.030182.002251; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; OVCHINNIKOV YA, 1986, FEBS LETT, V201, P237, DOI 10.1016/0014-5793(86)80616-0; PHILIPSON KD, 1985, ANNU REV PHYSIOL, V47, P561; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; SCHATZMANN HJ, 1965, BIOCHIM BIOPHYS ACTA, V94, P89, DOI 10.1016/0926-6585(65)90011-7; SCHULTHEIS PJ, 1993, J BIOL CHEM, V268, P22686; SCHULTHEIS PJ, 1993, BIOCHEMISTRY-US, V32, P544, DOI 10.1021/bi00053a020; SEN PC, 1981, ARCH BIOCHEM BIOPHYS, V211, P652, DOI 10.1016/0003-9861(81)90501-4; SHANISEKLER M, 1988, J BIOL CHEM, V263, P19331; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8129; STAUFFER CE, 1975, ANAL BIOCHEM, V69, P646, DOI 10.1016/0003-2697(75)90172-4; ULRICH KJ, 1979, ANNU REV PHYSIOL, V41, P181; VANHUYSSE JW, 1993, BIOCHEMISTRY-US, V32, P819, DOI 10.1021/bi00054a012; VILSEN B, 1992, J BIOL CHEM, V267, P25739; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; WALLICK ET, 1988, METHOD ENZYMOL, V156, P201; WALLICK ET, 1994, P LIFE SCI DRUG DEV, P145	40	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2993	3000		10.1074/jbc.270.7.2993	http://dx.doi.org/10.1074/jbc.270.7.2993			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852379	hybrid			2022-12-27	WOS:A1995QG47100019
J	LADANT, D				LADANT, D			CALCIUM AND MEMBRANE-BINDING PROPERTIES OF BOVINE NEUROCALCIN-DELTA EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; MOLECULAR-CLONING; CA2+-BINDING PROTEIN; MODULATED PROTEINS; NERVOUS-SYSTEM; RETINAL RODS; S-MODULIN; RECOVERIN; FAMILY; VISININ	Neurocalcins are brain-specific proteins that belong to a new subclass of the EF-hand superfamily of calcium binding proteins, defined by the photoreceptor cell-specific protein, recoverin, Recoverin, which regulates the desensitization of photo-excited rhodopsin, is myristoylated and exhibits a calcium myristoyl switch. Like recoverin, neurocalcins have a signal for N-myristoylation and possess four EF-hands, although the first one lacks some residues critical for calcium binding. In this work, I have examined the calcium and membrane binding properties of recombinant myristoylated and unmyristoylated neurocalcin delta. I show that neurocalcin, like recoverin, binds to biological membranes in a calcium- and myristoyl-dependent manner. Both myristoylated and unmyristoylated proteins bind three calcium ions. However, the unmyristoylated form exhibits a higher affinity for calcium than the myristoylated protein but shows a lower cooperativity in binding calcium. These data support the model for the calcium-myristoyl switch mechanism proposed for recoverin (Zozulya, S, and Stryer, L. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 11569-11573; Dizhoor, A. M., Chen, C. IL, Olshevskaya, E., Sinelnikova, V. V., and Hurley, J. B. (1993) Science 259, 829-832). Using point mutations, I have investigated the relative importance of each of the three functional EF hands (EF2, EF3, and EF4) in the calcium and membrane binding properties of neurocalcin. Calcium and membrane binding properties of the mutant-myristoylated proteins suggest that binding of calcium to EF2 is critical in triggering the binding of the protein to membranes.	STANFORD UNIV, MED CTR, SCH MED, DEPT NEUROBIOL, STANFORD, CA 94305 USA	Stanford University				LADANT, Daniel/0000-0003-1955-548X	NIGMS NIH HHS [GM24032] Funding Source: Medline; NIMH NIH HHS [MH45324] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024032, R01GM024032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045324] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HAIECH J, 1991, J BIOL CHEM, V266, P3427; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENZ SE, 1992, MOL BRAIN RES, V15, P133, DOI 10.1016/0169-328X(92)90160-D; MCGINNIS JF, 1992, FEBS LETT, V302, P172, DOI 10.1016/0014-5793(92)80433-H; MEYER T, 1990, BIOCHEMISTRY-US, V29, P32, DOI 10.1021/bi00453a004; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; NAKANO A, 1993, J ENDOCRINOL, V138, P283, DOI 10.1677/joe.0.1380283; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TERASAWA M, 1992, J BIOL CHEM, V267, P19596; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; WIECHMANN AF, 1993, EXP EYE RES, V56, P463, DOI 10.1006/exer.1993.1059; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; ZOZULYA S, 1995, IN PRESS METHODS ENZ	31	116	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3179	3185						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852401				2022-12-27	WOS:A1995QG47100045
J	MESEGUER, I; TORREBLANCA, M; KONISHI, T				MESEGUER, I; TORREBLANCA, M; KONISHI, T			SPECIFIC-INHIBITION OF THE HALOBACTERIAL NA+/H+ ANTIPORTER BY HALOCIN H6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE VESICLES; MEMBRANE-VESICLES; DELTA-PSI; HALOBIUM; PH; EXCHANGE; CELLS; TRANSPORT; H-4; NOV	Halocins H6 and H4 are bacteriocin-like substances capable of killing sensitive halobacterial cells by affecting the bioenergetic steady state across the membrane, The effect of either halocin on living cells is similar, but the primary target of each is different. Halocin H6 inhibited light induced Na+ out-flow in membrane vesicles of Halobacterium halobium. H4 did not, but instead slowed the H+ return-flow in the dark after illumination. Halocin H6 adsorbs firmly to both whole cells and membrane vesicles, The conclusion is that the primary target of halocin H6 is the Na+/H+ antiporter. This is important not only insofar as it outlines the mechanism by which a halocin works, but also for the fact that it is the first specific physiological inhibitor of the halobacterial Na+/H+ antiporter to be described.	NIIGATA COLL PHARM, DEPT RADIOCHEM BIOPHYS, NIIGATA 95021, JAPAN		MESEGUER, I (corresponding author), UNIV ALICANTE, FAC MED, DEPT GENET & MICROBIOL, CAMPUS SAN JUAN, APARTADO 374, E-03080 ALACANT, SPAIN.							BAKKER EP, 1976, BIOCHIM BIOPHYS ACTA, V440, P557, DOI 10.1016/0005-2728(76)90042-6; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; DUNDAS ID, 1963, CAN J MICROBIOL, V9, P619, DOI 10.1139/m63-079; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HELGERSON SL, 1983, BIOCHEMISTRY-US, V22, P5746, DOI 10.1021/bi00294a011; KAGAN BL, 1983, NATURE, V302, P709, DOI 10.1038/302709a0; KONISHI T, 1988, FEBS LETT, V226, P270, DOI 10.1016/0014-5793(88)81437-6; KONISHI T, 1992, BIOCHIM BIOPHYS ACTA, V1140, P1, DOI 10.1016/0005-2728(92)90012-Q; KRULWICH TA, 1983, BIOCHIM BIOPHYS ACTA, V726, P245, DOI 10.1016/0304-4173(83)90011-3; LANYI JK, 1978, MICROBIOL REV, V42, P682, DOI 10.1128/MMBR.42.4.682-706.1978; LANYI JK, 1976, BIOCHEMISTRY-US, V15, P4608, DOI 10.1021/bi00666a010; MACDONALD RE, 1977, BIOCHEMISTRY-US, V16, P3227, DOI 10.1021/bi00633a029; MESEGUER I, 1986, FEMS MICROBIOL LETT, V36, P177; MESEGUER I, 1985, FEMS MICROBIOL LETT, V28, P177; MESEGUER I, 1986, J GEN MICROBIOL, V132, P3061; MESEGUER I, 1991, NATO ADV SCI I A-LIF, V201, P157; MURAKAMI N, 1987, BIOCHEM INT, V15, P215; MURAKAMI N, 1990, ARCH BIOCHEM BIOPHYS, V281, P13, DOI 10.1016/0003-9861(90)90406-O; MURAKAMI N, 1988, J BIOCHEM-TOKYO, V103, P231, DOI 10.1093/oxfordjournals.jbchem.a122253; MURAKAMI N, 1985, J BIOCHEM-TOKYO, V98, P897, DOI 10.1093/oxfordjournals.jbchem.a135369; MURAKAMI N, 1989, ARCH BIOCHEM BIOPHYS, V271, P515, DOI 10.1016/0003-9861(89)90303-2; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; RODRIGUEZVALERA F, 1982, CAN J MICROBIOL, V28, P151, DOI 10.1139/m82-019; RODRIGUEZVALERA F, 1983, SYST APPL MICROBIOL, V4, P369, DOI 10.1016/S0723-2020(83)80021-6; SAHL HG, 1985, J BACTERIOL, V162, P833, DOI 10.1128/JB.162.2.833-836.1985; TORREBLANCA M, 1990, BIOCHEM CELL BIOL, V68, P396, DOI 10.1139/o90-056; TORREBLANCA M, 1989, J GEN MICROBIOL, V135, P2655; TORREBLANCA M, 1986, SYST APPL MICROBIOL, V8, P89, DOI 10.1016/S0723-2020(86)80155-2; WEISS MJ, 1978, P NATL ACAD SCI USA, V75, P2483, DOI 10.1073/pnas.75.5.2483; YANG CC, 1984, J BACTERIOL, V158, P757, DOI 10.1128/JB.158.2.757-759.1984	32	35	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6450	6455		10.1074/jbc.270.12.6450	http://dx.doi.org/10.1074/jbc.270.12.6450			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896778	hybrid			2022-12-27	WOS:A1995QQ85500007
J	DESARNAUD, F; CADAS, H; PIOMELLI, D				DESARNAUD, F; CADAS, H; PIOMELLI, D			ANANDAMIDE AMIDOHYDROLASE ACTIVITY IN RAT-BRAIN MICROSOMES - IDENTIFICATION AND PARTIAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTOR; LOCALIZATION; AGONIST; BINDS	An amidohydrolase activity present in rat brain microsomes catalyzes the hydrolysis of N-arachidonoyl-[H-3]ethanolamine ([H-3]anandamide), an endogenous cannabimimetic substance, forming [H-3]ethanolamine and arachidonic acid. Amidohydrolase activity is maximal at pH 6 and 8, is independent of divalent cations, has an apparent K-m for [H-3]anandamide of 12.7 +/- 1.8 mu M, and has a V-max of 5630 +/- 200 pmol/min/mg of protein. Phenylmethylsulfonyl fluoride, a serine protease inhibitor, and p-bromophenacyl bromide, a histidine-alkylating reagent, inhibit the activity, whereas N-ethyhnaleimide and various nonselective peptidase inhibitors (EDTA, o-phenanthroline, bacitracin) have no effect. Brain amidohydrolase activity exhibits high substrate specificity for [H-3]anandamide; N-gamma-linolenoyl-, N-homo-gamma-linolenoyl-, and N-11,14-eicosadienoyl- are hydrolyzed at markedly slower rates. Moreover, N-11-eicosaenoyl- and N-palmitoyl-[H-3]ethanolamine are not hydrolyzed. [H-3]Anandamide hydrolysis is inhibited competitively by nonradioactive anandamide and by other N-acylethanolamines with the following rank order of potency: anandamide > N-linoleoyl- = N-cis-linolenoyl- = N-gamma-linolenoyl- = N-homo-gamma-linolenoyl- > N-11,14-eicosadienoyl- > N-oleoyl- > N-docosahexaenoyl- > N-docosatetraenoyl > N-linoelaidoyl- > N-eicosaenoyl- > N-palmitoyl greater than or equal to N-elaidoyl- = N-eicosanoyl-ethanolamine = no effect. Amidohydrolase activity is high in liver and brain and low in heart, kidney, intestine, stomach, lung, spleen, and skeletal muscle. Within the central nervous system, highest activity is found in globus pallidus and hippocampus, two regions rich in cannabinoid receptors, and lowest activity is found in brainstem and medulla, where cannabinoid receptors are sparse. The results, showing that brain amidohydrolase activity is selective for anandamide and enriched in areas of the central nervous system with high density of cannabinoid receptors, suggest that this activity may participate in the inactivation of anandamide at its sites of action.	CTR PAUL BROCA,INSERM,UNITE NEUROBIOL & PHARMACOL,F-75014 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)								ABADJI V, 1994, J MED CHEM, V37, P1889, DOI 10.1021/jm00038a020; BORNHEIM LM, 1993, BIOCHEM BIOPH RES CO, V197, P740, DOI 10.1006/bbrc.1993.2541; BUTCHER LL, 1984, HDB CHEM NEURONATOMY, V3, P1; CHILDERS SR, 1994, BIOCHEM PHARMACOL, V47, P711, DOI 10.1016/0006-2952(94)90134-1; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; HANUS L, 1993, J MED CHEM, V36, P3032, DOI 10.1021/jm00072a026; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HOWLETT AC, 1990, TRENDS NEUROSCI, V13, P420, DOI 10.1016/0166-2236(90)90124-S; KRUSZKA KK, 1994, J BIOL CHEM, V269, P14345; MACKIE K, 1993, MOL PHARMACOL, V44, P498; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; PERTWEE R, 1994, EUR J PHARMACOL, V259, P115, DOI 10.1016/0014-2999(94)90499-5; SCHMID HHO, 1990, PROG LIPID RES, V29, P1, DOI 10.1016/0163-7827(90)90004-5; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; VOGEL Z, 1993, J NEUROCHEM, V61, P352, DOI 10.1111/j.1471-4159.1993.tb03576.x; WEIDENFELD J, 1994, NEUROENDOCRINOLOGY, V59, P110, DOI 10.1159/000126646	23	310	323	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6030	6035		10.1074/jbc.270.11.6030	http://dx.doi.org/10.1074/jbc.270.11.6030			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890734	hybrid			2022-12-27	WOS:A1995QM94500050
J	GORDON, PB; HOLEN, I; SEGLEN, PO				GORDON, PB; HOLEN, I; SEGLEN, PO			PROTECTION BY NARINGIN AND SOME OTHER FLAVONOIDS OF HEPATOCYTIC AUTOPHAGY AND ENDOCYTOSIS AGAINST INHIBITION BY OKADAIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT CHAIN KINASE; CITRUS FLAVONOIDS; PLANT FLAVONOIDS; PHOSPHORYLATION; GENISTEIN; MECHANISMS; INVITRO; CELLS; DEGRADATION	In isolated rat hepatocytes, the protein phosphatase inhibitor okadaic acid exerts a strong inhibitory effect on autophagy, which can be partially overcome by certain protein kinase inhibitors like the isoflavone genistein, To see if other, more specific okadaic acid antagonists could be found among the flavonoids, 55 different flavonoids were tested for their effect on okadaic acid-inhibited autophagy, measured as the sequestration of electroinjected [H-3]raffinose, Naringin (naringenin 7-hesperidoside) and several other flavanone and flavone glycosides (prunin, neoeriocitrin, neohesperidin, apiin, rhoifolin, kaempferol 3-rutinoside) offered virtually complete protection against the autophagy-inhibitory effect of okadaic acid, Unlike genistein, these compounds had little or no autophagy-inhibitory effect of their own, Their innocuousness appeared to be related to glycosylation, because the corresponding aglycones (naringenin, eriodictyol, hesperetin, apigenin, kaempferol) were all inhibitory, in particular apigenin (80% inhibition at 100 mu M). Naringin, the most potent okadaic acid-antagonistic flavonoid, gave half-maximal protection at 5 mu M and maximal effect at 100 mu M. Naringin also prevented the okadaic acid-induced inhibition of endogenous, autophagic lysosomal protein degradation and of receptor-mediated asialoglycoprotein uptake and degradation, Naringin and other okadaic acid-antagonistic flavonoids may be useful tools in the study of intracellular protein phosphorylation and could have potential therapeutic value as protectants against pathological hyperphosphorylations, environmental toxins, or side effects of chemotherapeutic drugs.	NORWEGIAN RADIUM HOSP, INST CANC RES, DEPT TISSUE CULTURE, N-0310 OSLO 3, NORWAY	University of Oslo				Holen, Ingunn/0000-0002-8759-6913				ABLER A, 1992, J BIOL CHEM, V267, P3946; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; AUSTIN CA, 1992, BIOCHEM J, V282, P883, DOI 10.1042/bj2820883; BALLARD FJ, 1987, LYSOSOMES THEIR ROLE, P285; BAUMANN J, 1980, ARCH PHARM, V313, P330, DOI 10.1002/ardp.19803130409; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; BENNETT JP, 1981, ARZNEIMITTEL-FORSCH, V31-1, P433; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BRACKE M, 1991, CLIN EXP METASTAS, V9, P13, DOI 10.1007/BF01831706; BRANDI ML, 1992, BONE MINER, V19, pS3, DOI 10.1016/0169-6009(92)90861-7; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; CHEN YT, 1990, FREE RADICAL BIO MED, V9, P19, DOI 10.1016/0891-5849(90)90045-K; COCHET C, 1982, BIOCHEM PHARMACOL, V31, P1357, DOI 10.1016/0006-2952(82)90028-4; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; FRANCIS AR, 1989, CARCINOGENESIS, V10, P1953, DOI 10.1093/carcin/10.10.1953; GRAZIANI Y, 1983, EUR J BIOCHEM, V135, P583, DOI 10.1111/j.1432-1033.1983.tb07692.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUENGERICH FP, 1990, CARCINOGENESIS, V11, P2275, DOI 10.1093/carcin/11.12.2275; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; HOROWITZ RM, 1963, TETRAHEDRON, V19, P773, DOI 10.1016/S0040-4020(01)99211-7; HUANG JM, 1992, J BIOL CHEM, V267, P15511; JINSART W, 1992, BIOL CHEM H-S, V373, P205, DOI 10.1515/bchm3.1992.373.1.205; JINSART W, 1991, BIOL CHEM H-S, V372, P819, DOI 10.1515/bchm3.1991.372.2.819; JUNG G, 1983, MOL PHARMACOL, V23, P698; KIMMICH GA, 1978, MEMBRANE BIOCHEM, V1, P221, DOI 10.3109/09687687809063849; KROYER G, 1986, Z ERNAHRUNGSWISS, V25, P63, DOI 10.1007/BF02023620; LAMBEV I, 1980, Eksperimentalna Meditsina i Morfologiya, V19, P207; LEE H, 1994, MUTAGENESIS, V9, P101, DOI 10.1093/mutage/9.2.101; LINASSIER C, 1990, BIOCHEM PHARMACOL, V39, P187, DOI 10.1016/0006-2952(90)90664-7; LIU J, 1994, J BIOL CHEM, V269, P3047; MARIDONNEAUPARINI I, 1986, PHARMACOL RES, V18, P61, DOI 10.1016/0031-6989(86)90159-1; MORTIMORE GE, 1987, LYSOSOMES THEIR ROLE, P415; NAMGOONG SY, 1994, LIFE SCI, V54, P313, DOI 10.1016/0024-3205(94)00787-X; NGUYEN TD, 1993, J NUTR, V123, P259; OGAWARA H, 1989, J ANTIBIOT, V42, P340, DOI 10.7164/antibiotics.42.340; ROGERS JC, 1989, BIOCHEM BIOPH RES CO, V164, P419, DOI 10.1016/0006-291X(89)91736-1; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SEGLEN PO, 1986, EXP CELL RES, V162, P273, DOI 10.1016/0014-4827(86)90446-5; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Seglen PO, 1992, ENDOCYTOSIS, P247; SEGLEN PO, 1993, MOL MECHANISMS MEMBR, P339; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; VALLANO ML, 1986, ANN NY ACAD SCI, V466, P357, DOI 10.1111/j.1749-6632.1986.tb38406.x; ZU YL, 1994, BIOCHEM BIOPH RES CO, V200, P1118, DOI 10.1006/bbrc.1994.1566	51	68	71	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5830	5838		10.1074/jbc.270.11.5830	http://dx.doi.org/10.1074/jbc.270.11.5830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890712	hybrid			2022-12-27	WOS:A1995QM94500024
J	PIRIESHEPHERD, SR; JETT, EA; ANDON, NL; PIZZO, SV				PIRIESHEPHERD, SR; JETT, EA; ANDON, NL; PIZZO, SV			SIALIC-ACID CONTENT OF PLASMINOGEN-2 GLYCOFORMS AS A REGULATOR OF FIBRINOLYTIC-ACTIVITY - ISOLATION, CARBOHYDRATE ANALYSIS, AND KINETIC CHARACTERIZATION OF 6 GLYCOFORMS OF PLASMINOGEN-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PHASE RESPONSE; SIDE-CHAINS; BINDING; GLYCOSYLATION; ACTIVATOR; ALPHA-2-ANTIPLASMIN; OLIGOSACCHARIDES; GLYCOPROTEINS; INHIBITOR; PROTEIN	Six glycoforms of plasminogen 2 were isolated using a combination of lectin affinity chromatography and chromatofocussing, and the sialic acid content of each glycoform was determined. The kinetics of activation of each glycoform by tissue-type plasminogen activator were analyzed on a fibrin surface and in solution. The second-order rate constant (measured on a fibrin surface) decreased from 1.65 x 10(6) M(-1) s(-1) to 3.77 x 10(4) M(-1) as the sialic acid content of the glycoforms increased from 1.3 mol/mol of protein to 13.65 mol/mol of protein. A similar correlation was noted for activation in solution, Each glycoform was converted to plasmin, and the inhibition constants for the reaction between alpha(2)-antiplasmin and plasmin glycoforms were determined. All overall K-i values, reflecting the final essentially irreversible complex, were in the picomolar range. Sialic acid does not affect inhibition of plasmin by alpha 2-antiplasmin; however, hypersialylated plasmin does not appear to have a kringle dependent component to inhibition.			PIRIESHEPHERD, SR (corresponding author), DUKE UNIV,MED CTR,DEPT PATHOL,BOX 3712,DURHAM,NC 27710, USA.				NHLBI NIH HHS [HL 31932] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031932] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGLESCANO E, 1986, ANAL BIOCHEM, V153, P201, DOI 10.1016/0003-2697(86)90082-5; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CASTELLINO FJ, 1984, SEMIN THROMB HEMOST, V10, P18, DOI 10.1055/s-2007-1004404; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHRISTENSEN S, 1994, BIOCHEM J, V305, P97; DANG CV, 1989, J BIOL CHEM, V264, P15104; DAVIDSON DJ, 1991, BIOCHEMISTRY-US, V30, P6689, DOI 10.1021/bi00241a008; EDALMAN GM, 1986, ANN REV CELL BIOL, V2, P81; EDELBERG JM, 1990, J CLIN INVEST, V86, P107, DOI 10.1172/JCI114671; GONZALEZGRONOW M, 1990, BIOCHIM BIOPHYS ACTA, V1039, P269, DOI 10.1016/0167-4838(90)90259-I; GONZALEZGRONOW M, 1989, BIOCHEMISTRY-US, V28, P2374, DOI 10.1021/bi00432a005; HALL SW, 1990, J CELL BIOCHEM, V43, P213, DOI 10.1002/jcb.240430303; HAYES ML, 1979, J BIOL CHEM, V254, P8768; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; LAMMERS G, 1990, COMP BIOCHEM PHYS B, V95, P327, DOI 10.1016/0305-0491(90)90084-7; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; LIJNEN HR, 1981, EUR J BIOCHEM, V120, P149, DOI 10.1111/j.1432-1033.1981.tb05682.x; LONGSTAFF C, 1991, BIOCHEMISTRY-US, V30, P979, DOI 10.1021/bi00218a014; PIRIESHEPHERD SR, 1991, J BIOL CHEM, V266, P17314; POHL G, 1984, BIOCHEMISTRY-US, V23, P3701, DOI 10.1021/bi00311a020; ROSENFELD L, 1984, ARCH BIOCHEM BIOPHYS, V229, P359, DOI 10.1016/0003-9861(84)90163-2; SARUBBI E, 1989, THROMB HAEMOSTASIS, V62, P927; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIBUYA N, 1987, ARCH BIOCHEM BIOPHYS, V254, P1, DOI 10.1016/0003-9861(87)90074-9; SIEFRING GE, 1974, J BIOL CHEM, V249, P7742; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; STACK MS, 1992, BIOCHEM J, V284, P81, DOI 10.1042/bj2840081; WIMAN B, 1980, BIOCHEM J, V191, P229, DOI 10.1042/bj1910229; WITTWER AJ, 1990, BIOCHEMISTRY-US, V29, P4175, DOI 10.1021/bi00469a021; WOHL RC, 1980, J BIOL CHEM, V255, P2005	30	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5877	5881		10.1074/jbc.270.11.5877	http://dx.doi.org/10.1074/jbc.270.11.5877			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890718	hybrid			2022-12-27	WOS:A1995QM94500030
J	XU, JM; MCKEEHAN, K; MATSUZAKI, K; MCKEEHAN, WL				XU, JM; MCKEEHAN, K; MATSUZAKI, K; MCKEEHAN, WL			INHIBIN ANTAGONIZES INHIBITION OF LIVER-CELL GROWTH BY ACTIVIN BY A DOMINANT-NEGATIVE MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE KINASE; TGF-BETA; II RECEPTOR; EXPRESSION CLONING; SPECIFICITY; HEPATOCYTES; AUTOCRINE; BINDING; GENE; RAT	The beta:beta activin homodimer and alpha:beta inhibin heterodimer are mutual antagonists which share a common beta subunit. Recently, it has been shown that, similar to transforming growth factor-beta 1, activin is an inhibitor of hepatocyte DNA synthesis, The activin receptor appears to be an obligatory complex of genetically distinct type I and II transmembrane serine/threonine kinases. Activin type I receptors, SKR1 and SKR2, were first cloned from well differentiated human hepatoma cells (HepG2). This prompted us to investigate the binding of activin and inhibin to receptors from HepG2 cells and the effect of the two ligands on DNA synthesis. Here we show that beta:beta activin binds to the activin type II receptor kinase (ActRII) which induces activin binding to the type I receptor kinase SKR2 to form ActRII .beta:beta . SKR2 complexes in which an activin beta chain occupies each receptor subunit, Inhibin also binds to ActRII through its beta subunit, competes with the binding of activin to ActRII, but fails to form the ActRII . SKR2 complex. No specific binding site for inhibin could be demonstrated in HepG2 cells. Inhibin, which had no activity of its own, antagonized the inhibitory effect of activin on DNA synthesis, The results suggest that inhibin may be a natural antagonist of assembly of the heterodimeric activin receptor complex through a dominant-negative mechanism.	TEXAS A&M UNIV,ALBERT B ALKEK INST BIOSCI & TECHNOL,DEPT BIOCHEM & BIOPHYS,HOUSTON,TX 77030	Texas A&M University System					NATIONAL CANCER INSTITUTE [R01CA059971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038639, R01DK035310] Funding Source: NIH RePORTER; NCI NIH HHS [CA59971] Funding Source: Medline; NIDDK NIH HHS [DK38639, DK35310] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; HE WW, 1993, DEV DYNAM, V196, P133, DOI 10.1002/aja.1001960207; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MATSUZAKI K, 1993, J BIOL CHEM, V268, P12719; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MCCARTHY SA, 1994, J BIOL CHEM, V269, P3909; MERCOLA M, 1990, GENE DEV, V4, P2333, DOI 10.1101/gad.4.12b.2333; ROBERTS VJ, 1994, ENDOCRINOLOGY, V134, P914, DOI 10.1210/en.134.2.914; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; SHI E, 1993, MOL CELL BIOL, V13, P3907, DOI 10.1128/MCB.13.7.3907; SPORN MB, 1990, PEPTIDE GROWTH FACTO, V2, P211; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; XU JM, 1992, J BIOL CHEM, V267, P17792; XU JM, 1994, P NATL ACAD SCI USA, V91, P7957, DOI 10.1073/pnas.91.17.7957; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727	26	115	121	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6308	6313		10.1074/jbc.270.11.6308	http://dx.doi.org/10.1074/jbc.270.11.6308			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890768	hybrid			2022-12-27	WOS:A1995QM94500089
J	CHENG, HF; JIANG, MJ; CHEN, CL; LIU, SM; WONG, LP; LOMASNEY, JW; KING, K				CHENG, HF; JIANG, MJ; CHEN, CL; LIU, SM; WONG, LP; LOMASNEY, JW; KING, K			CLONING AND IDENTIFICATION OF AMINO-ACID-RESIDUES OF HUMAN PHOSPHOLIPASE C-DELTA-1 ESSENTIAL FOR CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C ISOZYMES; SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNITS; BOVINE BRAIN; ACTIVATION; PROTEIN; GQ; BINDING; GENE; SEQUENCE	In vitro single point mutagenesis, inositol phospholipid hydrolysis, and substrate protection experiments were used to identify catalytic residues of human phosphatidylinositide-specific phospholipase C delta 1 (PLC delta 1) isolated from a human aorta cDNA library, Invariant amino acid residues containing a functional side chain in the highly conserved X region were changed by in vitro mutagenesis. Most of the mutant enzymes were still able to hydrolyze inositol phospholipid with activity ranging from 10 to 100% of levels in the wild type enzyme. Exceptions were mutants with the conversion of Arg(398) to Leu (R338L), Glu(341) to Gly (E341G), or His(356) to Leu (H356L), which made the enzyme severely defective in hydrolyzing inositol phospholipid. Phospholipid vesicle binding experiments showed that these three cleavage-defective mutant forms of PLC delta 1 could specifically bind to phosphatidylinositol 4,5-bisphosphate (PIP2) with an affinity similar to that of wild type enzyme. Western blotting analysis of trypsin-treated enzyme-PIP2 complexes revealed that a 67-kDa major protein fragment survived trypsin digestion if the wild type enzyme, E341G, or H356L mutant PLC delta 1 was preincubated with 7.5 mu M PIP2, whereas if it was preincubated with 80 mu M PIP2, the size of major protein surviving was comparable to that of intact enzyme. However, mutant enzyme R338L was not protected from trypsin degradation by PIP2 binding. These observations suggest that PLC delta 1 can recognize PIP2 through a high affinity and a low affinity binding site and that residues Glu(541), and His(356) are not involved in either high affinity or low affinity PIP2 binding but rather are essential for the Ca2+-dependent cleavage activity of PLC.	ACAD SINICA, INST BIOMED SCI, TAIPEI 115, TAIWAN; NATL LABS FOODS & DRUGS, DEPT HLTH, TAIPEI 115, TAIWAN; NORTHWESTERN UNIV, SCH MED, FEINBERG CARDIOVASC RES INST, CHICAGO, IL 60611 USA	Academia Sinica - Taiwan; Northwestern University								BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISTOL A, 1988, COLD SPRING HARB SYM, V53, P915, DOI 10.1101/SQB.1988.053.01.105; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; ELLIS MV, 1993, EUR J BIOCHEM, V213, P339, DOI 10.1111/j.1432-1033.1993.tb17767.x; EMORI Y, 1989, J BIOL CHEM, V264, P21885; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KATO H, 1992, J BIOL CHEM, V267, P6483; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KRIZ R, 1990, CIBA F SYMP, V150, P112; KUPPE A, 1989, J BACTERIOL, V171, P6077, DOI 10.1128/jb.171.11.6077-6083.1989; Lee Sang Bong, 1994, Society for Neuroscience Abstracts, V20, P928; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; MELDRUM E, 1991, EUR J BIOCHEM, V196, P159, DOI 10.1111/j.1432-1033.1991.tb15799.x; MUELLER P, 1983, BIOPHYS J, V44, P375, DOI 10.1016/S0006-3495(83)84311-2; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; PARK D, 1992, J BIOL CHEM, V267, P16048; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; PAWELCZYK T, 1993, BIOCHEM J, V291, P693, DOI 10.1042/bj2910693; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RATH HM, 1990, J BIOL CHEM, V265, P3080; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, J BIOL CHEM, V263, P14497; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; YAGISAWA H, 1991, J HYPERTENS, V9, P997, DOI 10.1097/00004872-199111000-00004; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804	47	74	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5495	5505		10.1074/jbc.270.10.5495	http://dx.doi.org/10.1074/jbc.270.10.5495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890667	hybrid			2022-12-27	WOS:A1995QL58000083
J	CHO, MJ; CUMMINGS, RD				CHO, MJ; CUMMINGS, RD			GALECTIN-1, A BETA-GALACTOSIDE-BINDING LECTIN IN CHINESE-HAMSTER OVARY CELLS .1. PHYSICAL AND CHEMICAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TYPE LECTIN; CARBOHYDRATE RECOGNITION DOMAIN; N-ACETYLLACTOSAMINE CHAINS; NEGATIVE GROWTH-FACTOR; CALF HEART; MUSCLE LECTIN; LUNG; PROTEIN; ACID; MUTAGENESIS	We report our studies on the characterization of an similar to 14-kDa lectin, termed galectin-1, that we have found to be expressed by Chinese hamster ovary (CHO) cells. cDNA for galectin-1 from CHO cells was prepared and sequenced, and a recombinant form (rGal-1) was expressed in Escherichia coli. A mutated form of the protein that fully retained activity was also constructed (termed C2SrGal-1) in which Cys-2 was changed to Ser-2. rGal-1 was stable in the presence of reducing agent, but it quickly lost all activity in the absence of reducing agent. In contrast, glycoprotein ligands, such as base ment membrane laminin, stabilized the activity of rGal-1 in the absence of reducing agent (t(1/2) = 2 weeks). C2SrGal-1 was stable in the presence or absence of either ligand or reducing agent. Unexpectedly, galectin-1 was found to exist in a reversible and active monomer-dimer equilibrium with a K-d approximate to 7 mu M and an equilibration time of t(1/2) approximate to 10 h. Addition of haptenic sugars did not affect this equilibrium. Galectin-1 isolated from the cytosol of CHO cells was found to exist as monomers and dimers. These studies demonstrate that galectin-1 binding to a biological ligand stabilizes its activity and that the monomer/dimer state of the protein is regulated by lectin concentration.			CHO, MJ (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, OKLAHOMA CTR MOLEC MED, OKLAHOMA CITY, OK 73190 USA.				NCI NIH HHS [CA37626] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037626] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABBOTT WM, 1991, J BIOL CHEM, V266, P5552; AGRWAL N, 1993, J BIOL CHEM, V268, P14932; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; BEYER EC, 1980, J BIOL CHEM, V255, P4236; BRILES EB, 1977, J BIOL CHEM, V252, P1107; BRILES EB, 1979, J CELL BIOL, V81, P528, DOI 10.1083/jcb.81.3.528; CERRA RF, 1984, J CELL BIOL, V98, P1580, DOI 10.1083/jcb.98.4.1580; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207; CHO MJ, 1994, BIOCHEM SOC T, V22, P378, DOI 10.1042/bst0220378; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEWAARD A, 1976, J BIOL CHEM, V251, P7581; DO KY, 1990, BIOCHEM BIOPH RES CO, V173, P1123, DOI 10.1016/S0006-291X(05)80902-7; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; GITT MA, 1986, P NATL ACAD SCI USA, V83, P7603, DOI 10.1073/pnas.83.20.7603; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; HIRABAYASHI J, 1992, J BIOCHEM-TOKYO, V111, P553, DOI 10.1093/oxfordjournals.jbchem.a123794; LEE RT, 1990, J BIOL CHEM, V265, P7864; LEFFLER H, 1986, J BIOL CHEM, V261, P119; LEVI G, 1981, J BIOL CHEM, V256, P5735; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; MERKLE RK, 1989, ARCH BIOCHEM BIOPHYS, V274, P404, DOI 10.1016/0003-9861(89)90453-0; MOREMEN KW, 1989, P NATL ACAD SCI USA, V86, P5276, DOI 10.1073/pnas.86.14.5276; PFEIFER K, 1993, GLYCOBIOLOGY, V3, P179, DOI 10.1093/glycob/3.2.179; QUN Z, 1993, ARCH BIOCHEM BIOPHYS, V300, P6, DOI 10.1006/abbi.1993.1002; ROFF CF, 1983, J BIOL CHEM, V258, P657; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383; TRACEY BM, 1992, J BIOL CHEM, V267, P10342; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WELLS V, 1992, BIOCHIM BIOPHYS ACTA, V1121, P239, DOI 10.1016/0167-4838(92)90152-4; WELLS V, 1991, CELL, V64, P91, DOI 10.1016/0092-8674(91)90211-G; WILSON TJG, 1989, BIOCHEM J, V261, P847, DOI 10.1042/bj2610847; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q	43	161	163	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5198	5206		10.1074/jbc.270.10.5198	http://dx.doi.org/10.1074/jbc.270.10.5198			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890630	hybrid			2022-12-27	WOS:A1995QL58000039
J	FRECH, C; SCHMID, FX				FRECH, C; SCHMID, FX			DSBA-MEDIATED DISULFIDE BOND FORMATION AND CATALYZED PROLYL ISOMERIZATION IN OXIDATIVE PROTEIN-FOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; ESCHERICHIA-COLI; CONFORMATIONAL STABILITY; ENZYMATIC CATALYSIS; INITIATION SITES; FORMATION INVIVO; REDOX PROPERTIES; PEPTIDE MODELS; CYTOCHROME-C; RIBONUCLEASE-T1	The interrelationship between the acquisition of ordered structure, prolyl isomerization, and the formation of the disulfide bonds in assisted protein folding was investigated by using a variant of ribonuclease T1 (C2S/C10N-RNase T1) with a single disulfide bond and two cis-prolyl bonds as a model protein. The thiol disulfide oxidoreductase DsbA served as the oxidant for forming the disulfide bond and prolyl isomerase A as the catalyst of prolyl isomerization. Both enzymes are from the periplasm of Escherichia coli. Reduced C2S/C1ON-RNase T1 is unfolded in 0 M NaCl, but native-like folded in greater than or equal to 2 M NaCl. Oxidation of 5 mu M C2S/C10N-RNase T1 by 8 mu M DsbA (at pH 7.0, 25 degrees C) is very rapid with a t1/2 of about 10 s (the second order rate constant is 7 x 10(3) s(-1) M(-1)), irrespective of whether the reduced molecules are unfolded or folded. When they are folded, the product of oxidation is the native protein. When they are denatured, first the disulfide bond is formed in the unfolded protein chains and then the native structure is acquired. This slow reaction is limited in rate by prolyl isomerization and catalyzed by prolyl isomerase. The efficiency of this catalysis is strongly decreased by the presence of the disulfide bond. Apparently, the rank order of chain folding, prolyl isomerization, and disulfide bond formation can vary in the oxidative folding of ribonuclease T1. Such a degeneracy could generally be an advantage for protein folding both in vitro and in vivo.	UNIV BAYREUTH, BIOCHEM LAB, D-95440 BAYREUTH, GERMANY	University of Bayreuth				Frech, Christian/0000-0002-8544-3278				AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; BALDWIN RL, 1993, CURR OPIN STRUC BIOL, V3, P84, DOI 10.1016/0959-440X(93)90206-Z; BALDWIN RL, 1991, CHEMTRACTS BIOCH MOL, V2, P379; BARDWELL JCA, 1993, CELL, V74, P769, DOI 10.1016/0092-8674(93)90455-Y; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; BREMS DN, 1983, J BIOL CHEM, V258, P3655; CREIGHTON TE, 1994, NAT STRUCT BIOL, V1, P135, DOI 10.1038/nsb0394-135; Creighton Thomas E., 1992, P301; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; EVANS PA, 1994, CURR OPIN STRUC BIOL, V4, P100, DOI 10.1016/S0959-440X(94)90066-3; FERSHT AR, 1993, FEBS LETT, V325, P5, DOI 10.1016/0014-5793(93)81405-O; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Freedman Robert B., 1992, P455; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; GOLDBERG ME, 1994, PROTEIN SCI, V3, P883; GOLDBERGER RF, 1963, J BIOL CHEM, V238, P628; GOTO Y, 1981, J MOL BIOL, V146, P321, DOI 10.1016/0022-2836(81)90391-0; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; HEINEMANN U, 1982, NATURE, V299, P27, DOI 10.1038/299027a0; IKAI A, 1973, J MOL BIOL, V73, P165, DOI 10.1016/0022-2836(73)90321-5; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KIEFHABER T, 1992, PROTEIN SCI, V1, P1162, DOI 10.1002/pro.5560010910; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023; KIEFHABER T, 1992, PROTEINS, V12, P171, DOI 10.1002/prot.340120210; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; MARTINEZOYANEDEL J, 1991, J MOL BIOL, V222, P335, DOI 10.1016/0022-2836(91)90215-R; MAYR LM, 1994, PROTEIN SCI, V3, P227; MAYR LM, 1993, PROTEIN EXPRES PURIF, V4, P52, DOI 10.1006/prep.1993.1008; MUCKE M, 1994, J MOL BIOL, V239, P713, DOI 10.1006/jmbi.1994.1408; MUCKE M, 1994, BIOCHEMISTRY-US, V33, P14608; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; MULLINS LS, 1993, BIOCHEMISTRY-US, V32, P6152, DOI 10.1021/bi00075a006; MURRYBRELIER A, 1989, PROTEINS, V6, P395, DOI 10.1002/prot.340060406; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; NEUBERT LA, 1974, J AM CHEM SOC, V96, P943, DOI 10.1021/ja00810a065; OOBATAKE M, 1979, J BIOCHEM-TOKYO, V86, P65; PACE CN, 1986, J MOL BIOL, V188, P477, DOI 10.1016/0022-2836(86)90169-5; PACE CN, 1988, J BIOL CHEM, V263, P11820; PACE CN, 1991, ANGEW CHEM INT EDIT, V30, P343, DOI 10.1002/anie.199103433; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Ptitsyn Oleg B., 1992, P243; QUAAS R, 1988, EUR J BIOCHEM, V173, P617, DOI 10.1111/j.1432-1033.1988.tb14043.x; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schmid Franz X., 1992, P197; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; SHIN HC, 1993, BIOCHEMISTRY-US, V32, P6356, DOI 10.1021/bi00076a008; SHIRLEY BA, 1989, J BIOL CHEM, V264, P11621; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; Takahashi K, 1970, Adv Biophys, V1, P53; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; VENETIANER P, 1963, BIOCHIM BIOPHYS ACTA, V67, P166; WALTHO JP, 1993, BIOCHEMISTRY-US, V32, P6337, DOI 10.1021/bi00076a006; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; WUNDERLICH M, 1993, BIOCHEMISTRY-US, V32, P12251, DOI 10.1021/bi00096a039; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P5202, DOI 10.1021/bi00183a025; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; ZHANG JX, 1993, BIOCHEMISTRY-US, V32, P14075, DOI 10.1021/bi00214a001	72	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5367	5374		10.1074/jbc.270.10.5367	http://dx.doi.org/10.1074/jbc.270.10.5367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890650	hybrid			2022-12-27	WOS:A1995QL58000064
J	KAWABATA, M; CHYTIL, A; MOSES, HL				KAWABATA, M; CHYTIL, A; MOSES, HL			CLONING OF A NOVEL TYPE-II SERINE THREONINE KINASE RECEPTOR THROUGH INTERACTION WITH THE TYPE-I TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; EXPRESSION CLONING; ACTIVIN RECEPTOR; COMPLEX; LIGAND	The transforming growth factor-beta (TGF-beta) superfamily comprises a number of molecules that are involved in a wide variety of biological processes. Specific receptors for several members of this family have been molecularly identified, forming a new category of transmembrane serine/threonine kinase receptors. The type I and type II receptor interact both physically and functionally, thereby cooperating to generate intracellular signals. The yeast two-hybrid system was used to identify proteins that can interact with the cytoplasmic region of the type I TGF-beta receptor. One of the proteins identified encodes a novel putative serine/threonine kinase receptor. Sequence analysis suggests that this molecule belongs to the type II receptor class. This receptor, however, is distinct from other type II receptors in having an extraordinarily long C-terminal tail region. The pattern of expression in adult tissues is different from that of other known type II receptors; it is highly expressed in heart and liver. In the yeast system, the cytoplasmic regions of different combinations of type I and type II receptors heterodimerize, providing a new cloning strategy for the large number of serine/threonine kinase receptors likely to exist for the many ligands of the TGF-beta superfamily.	VANDERBILT UNIV,DEPT CELL BIOL,NASHVILLE,TN 37232	Vanderbilt University					NCI NIH HHS [CA 42572] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042572] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AELST LV, 1994, P NATL ACAD SCI USA, V90, P6213; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BUCKBINDER L, 1989, EMBO J, V8, P4239, DOI 10.1002/j.1460-2075.1989.tb08609.x; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEN RH, 1994, J BIOL CHEM, V269, P22868; CHILDS SR, 1993, P NATL ACAD SCI USA, V90, P9475, DOI 10.1073/pnas.90.20.9475; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; ESTEVEZ M, 1994, NATURE, V365, P644; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LAWLER S, 1994, DEVELOPMENT, V120, P165; LIN HY, 1994, CELL MOL BIOL, V40, P337; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; SCHULER GD, 1994, PROTEIN-STRUCT FUNCT, V9, P180; Ten Dijke Peter, 1994, Progress in Growth Factor Research, V5, P55, DOI 10.1016/0955-2235(94)90017-5; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; ZERVOS AS, 1994, CELL, V72, P223	34	139	154	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5625	5630		10.1074/jbc.270.10.5625	http://dx.doi.org/10.1074/jbc.270.10.5625			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890683	hybrid			2022-12-27	WOS:A1995QL58000101
J	REEMS, JA; WOOD, S; MCHENRY, CS				REEMS, JA; WOOD, S; MCHENRY, CS			ESCHERICHIA-COLI DNA-POLYMERASE-III HOLOENZYME SUBUNIT-ALPHA, SUBUNIT-BETA, AND SUBUNIT-GAMMA DIRECTLY CONTACT THE PRIMER-TEMPLATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'->5' EXONUCLEASE ACTIVITY; INITIATION COMPLEX; REPLICATION PROTEINS; SPONTANEOUS MUTATION; PROCESSIVE SYNTHESIS; ACCESSORY PROTEINS; BINDING-PROTEIN; ATP ACTIVATION; SIZE CLASSES; GENE	Escherichia coli DNA polymerase III holoenzyme forms a stable initiation complex with RNA-primed template in the presence of ATP. To determine the linear arrangement of the holoenzyme subunits along the primer-template duplex region, we cross-linked holoenzyme to a series of photo-reactive primers. Site-specific photo-cross-linking revealed that the alpha, beta, and gamma subunits formed ATP-dependent contacts with the primer-template. The alpha polymerase catalytic subunit covalently attached to nucleotide positions -3, -9, and -13 upstream of the primer terminus, with the most efficient adduct formation occurring at position -9. The gamma subunit contacted the primer at positions -13, -18, and -22, with the strongest gamma-primer interactions occurring at position -18. The beta subunit predominated in crosslinking at position -22. Thus, within the initiation complex, alpha contacts roughly the first 13 nucleotides upstream of the 3'-primer terminus followed by gamma at -18 and beta at -22, and the gamma subunit remains a part of the initiation complex, bridging the alpha and beta subunits. Analyses of the interaction of photo-activatible primer-templates with the preinitiation complex proteins (gamma-complex (gamma-delta-delta'-chi-psi) and beta subunit) revealed the gamma subunit within the preinitiation complex covalently attached to primer at position -3. However, addition of core DNA polymerase III to preinitiation complex, fully reconstituting holoenzyme resulted in replacement of gamma by alpha at the primer terminus. These data indicate that assembly of holoenzyme onto a primer-template can occur in distinct stages and results in a structural rearrangement during initiation complex formation.	UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,PROGRAM MOLEC BIOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 35695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS B, 1975, DNA SYNTHESIS ITS RE, V3, P241; Atkinson T., 1984, OLIGONUCLEOTIDE SYNT, P35; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BARONE AD, 1984, NUCLEIC ACIDS RES, V12, P4051, DOI 10.1093/nar/12.10.4051; BEDINGER P, 1983, J BIOL CHEM, V258, P9649; BERKOWITZ SA, 1971, BIOCHEMISTRY-US, V13, P4825; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; CAPSON TL, 1991, CELL, V65, P249, DOI 10.1016/0092-8674(91)90159-V; CATALANO CE, 1990, BIOCHEMISTRY-US, V29, P3612, DOI 10.1021/bi00467a004; COX EC, 1983, P NATL ACAD SCI-BIOL, V80, P2295, DOI 10.1073/pnas.80.8.2295; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; CRUTE JJ, 1983, J BIOL CHEM, V258, P1344; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FAY PJ, 1981, J BIOL CHEM, V256, P976; FAY PJ, 1982, J BIOL CHEM, V257, P5692; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FERSHT AR, 1983, J MOL BIOL, V165, P669, DOI 10.1016/S0022-2836(83)80273-3; FOWLER RG, 1986, J BACTERIOL, V167, P130, DOI 10.1128/jb.167.1.130-137.1986; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; GIBSON KJ, 1987, NUCLEIC ACIDS RES, V15, P6455, DOI 10.1093/nar/15.16.6455; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; HORIUCHI T, 1978, MOL GEN GENET, V163, P277, DOI 10.1007/BF00271956; HUANG CC, 1981, J BIOL CHEM, V256, P4087; Ingraham J., 1987, ESCHERICHA COLI SALM, V2, P1543; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P555; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; JONES RA, 1984, OLIGONUCLEOTIDE SYNT, P23; KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LIVINGSTON DM, 1975, J BIOL CHEM, V250, P470; MAKI H, 1987, P NATL ACAD SCI USA, V84, P4389, DOI 10.1073/pnas.84.13.4389; MAKI S, 1988, J BIOL CHEM, V263, P6555; MANIATIS T, 1982, MOL CLONING LABORATO, P142; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MCHENRY CS, 1986, MECHANISMS DNA REPLI, P47; MEYER RR, 1980, J BIOL CHEM, V255, P2897; MOK M, 1987, J BIOL CHEM, V262, P16644; MOLINEUX IJ, 1975, NUCLEIC ACIDS RES, V2, P1821, DOI 10.1093/nar/2.10.1821; MUNN M, 1986, THESIS U CALIFORNIA; OBERFELDER R, 1987, J BIOL CHEM, V262, P4190; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Perrin D.D., 1988, PURIFICATION LAB CHE; REEMS JA, 1994, J BIOL CHEM, V269, P33091; RICHEY B, 1987, J BIOL CHEM, V262, P7157; ROBINS MJ, 1990, TETRAHEDRON LETT, V26, P3731; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4051; SLATER SC, 1994, J BACTERIOL, V176, P815, DOI 10.1128/jb.176.3.815-821.1994; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WASHBURN BK, 1991, J BACTERIOL, V178, P2569; WELCH MM, 1982, J BACTERIOL, V152, P351; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P3679, DOI 10.1073/pnas.70.12.3679; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	66	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5606	5613		10.1074/jbc.270.10.5606	http://dx.doi.org/10.1074/jbc.270.10.5606			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890680	hybrid			2022-12-27	WOS:A1995QL58000098
J	GLIBETIC, M; TAYLOR, L; LARSON, D; HANNAN, R; SELLS, B; ROTHBLUM, L				GLIBETIC, M; TAYLOR, L; LARSON, D; HANNAN, R; SELLS, B; ROTHBLUM, L			THE RNA POLYMERASE-I TRANSCRIPTION FACTOR UBF IS THE PRODUCT OF A PRIMARY RESPONSE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR-TIF-IA; RDNA; TRANSACTIVATION; CULTURE; CELLS	Transcription of the ribosomal RNA genes by RNA polymerase I is tightly coordinated with the rate of cell growth. The RNA polymerase I transcription factor, UBF, activates transcription by binding to elements within the promoter and enhancer elements within the intergenic spacer but is not required for basal transcription. To assess the role of UBF in modulating ribosomal DNA transcription, we studied its expression in NIH3T6 fibroblasts when transcription was repressed in response to serum starvation and stimulated following refeeding. Our results demonstrate a correlation be tween the amounts of UBF protein and the rates of ribosomal DNA transcription in quiescent and serum-stimulated cells. Nuclear run-on assays and Northern blot analyses demonstrated that the UBF gene was a primary response gene, exhibiting characteristics similar to those of c-myc and SRF. These results suggest that the regulation of transcription of the UBF gene by polymerase II represents a pathway by which cells modulate transcription by RNA polymerase I.	GEISINGER MED CLIN,SIGFRIED & JANET WEIS CTR RES,DANVILLE,PA 17822; UNIV GUELPH,DEPT MOLEC BIOL & GENET,GUELPH,ON N1G 2W1,CANADA	Geisinger Medical Center; University of Guelph				Hannan, Ross/0000-0002-2166-4493	NHLBI NIH HHS [HL47638] Funding Source: Medline; NIGMS NIH HHS [GM46991] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046991] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUN RP, 1994, MOL CELL BIOL, V14, P5010, DOI 10.1128/MCB.14.7.5010; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; CAVANAUGH AH, 1983, J BIOL CHEM, V258, P9768; DEAN M, 1986, J BIOL CHEM, V261, P9161; FINANCSEK I, 1982, P NATL ACAD SCI-BIOL, V79, P3092, DOI 10.1073/pnas.79.10.3092; GLIBETIC M, 1993, MOL CELL ENDOCRINOL, V94, P243, DOI 10.1016/0303-7207(93)90173-H; GRUMMT I, 1987, CELL NUCLEUS, V5, P373; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; KUHN A, 1994, EMBO J, V13, P416, DOI 10.1002/j.1460-2075.1994.tb06276.x; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; LARSON DE, 1991, BIOCHEM CELL BIOL, V69, P5, DOI 10.1139/o91-002; MAHAJAN P, 1990, J BIOL CHEM, V265, P16234; MOSS T, 1995, IN PRESS PROG NUCLEI; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OMAHONY DJ, 1991, P NATL ACAD SCI USA, V88, P3180, DOI 10.1073/pnas.88.8.3180; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; PAULE MR, 1984, NUCLEIC ACIDS RES, V12, P8161, DOI 10.1093/nar/12.21.8161; PAULE MR, 1994, TRANSCRIPTION MECHAN, P83; SCHNAPP A, 1993, MOL CELL BIOL, V13, P6723, DOI 10.1128/MCB.13.11.6723; SMITH SD, 1990, MOL CELL BIOL, V10, P3105, DOI 10.1128/MCB.10.6.3105; TOWER J, 1987, CELL, V50, P873, DOI 10.1016/0092-8674(87)90514-9; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; XIE WQ, 1993, TRENDS CARDIOVAS MED, V3, P7, DOI 10.1016/1050-1738(93)90021-W; XIE WQ, 1991, BIOTECHNIQUES, V11, P324	24	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4209	4212		10.1074/jbc.270.9.4209	http://dx.doi.org/10.1074/jbc.270.9.4209			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876178	hybrid			2022-12-27	WOS:A1995QK08400008
J	MENG, QH; SPARKS, DL; MARCEL, YL				MENG, QH; SPARKS, DL; MARCEL, YL			EFFECT OF LPA-I COMPOSITION AND STRUCTURE ON CHOLESTEROL TRANSFER BETWEEN LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; GRADIENT GEL-ELECTROPHORESIS; CELL-DERIVED CHOLESTEROL; HUMAN-PLASMA LECITHIN; MICELLAR COMPLEXES; PARTICLE-SIZE; ACYLTRANSFERASE; EXCHANGE; MECHANISM	The effect of high density lipoprotein composition on the rates of unesterified cholesterol exchange between low density lipoproteins (LDL) and well-defined homogeneous discoidal lipoproteins (LpA-I) reconstituted with phosphatidylcholine, cholesterol, and apolipoprotein A-I (apoA-I) has been investigated, LpA-I containing cholesterol and 2, 3, and 4 apoA-I molecules per particle differed in their ability to accept or donate cholesterol, A significant cholesterol exchange occurs between LDL and Lp2A-I (7.8 and 9.6 nm), while there is little or no cholesterol exchange detectable between LDL and Lp3A-I (10.8 and 13.4 nm) and Lp4A-I (17.0 nm) complexes, The cholesterol transfer from LDL to the cholesterol-free Lp2A-I (9.6 nm), Lp3A-I (13.4 nm), and Lp4A-I (17.0 nm) particles also shows significant cholesterol transfer to Lp2A-I, while there is no detectable transfer to Lp3- and 4A-I particles, The rates of cholesterol transfer to cholesterol-free and cholesterol-containing Lp2A-I appear to differ significantly, Cholesterol transfer from LDL to cholesterol-free Lp2A-I is zero order with respect to acceptor concentrations when the Lp2A-I/LDL ratio is above 10, Transfer rates from LDL to cholesterol-free Lp2A-I are faster for the smaller Lp2A-I (8.5 nn) than to the larger Lp2A-I (9.7 nm) and exhibit half-times (t(1/2)) at 25 degrees C of 4.0 and 5.3 h, respectively, In contrast, cholesterol transfer from LDL to cholesterol-containing Lp2A-I remains dependent upon acceptor concentrations to an acceptor/donor particle ratio of 80, In addition, transfer from LDL to cholesterol-containing Lp2A-I is faster to the 9.6 nm than to 7.8 nn particles, with t(1/2) of 1.4 and 2.3 h, respectively, The rates of cholesterol transfer from Lp2A-I to LDL are higher than in the opposite direction, in particular for the small Lp2A-I (7.8 nm), which has a t(1/2) of approximately 50 min, The results show that changes in the composition and structure of apoA-I-containing particles have a significant effect on inter-lipoprotein exchange of cholesterol. This suggests that the kinetics of cholesterol transfer to and from reconstituted discoidal LpA-I particles cannot be fully explained by passive aqueous diffusion.	UNIV OTTAWA, DEPT PATHOL & LAB MED, OTTAWA, ON K1Y 4E9, CANADA; UNIV OTTAWA, DEPT BIOCHEM, OTTAWA, ON K1Y 4E9, CANADA	University of Ottawa; University of Ottawa	MENG, QH (corresponding author), UNIV OTTAWA, INST HEART, LIPOPROT & ATHEROSCLEROSIS GRP, OTTAWA, ON K1Y 4E9, CANADA.							AGNANI G, 1993, BIOCHEMISTRY-US, V32, P2643, DOI 10.1021/bi00061a024; BACKER JM, 1981, BIOCHEMISTRY-US, V20, P3805, DOI 10.1021/bi00516a021; BAR LK, 1986, BIOCHEMISTRY-US, V25, P6701, DOI 10.1021/bi00369a056; BITTMAN R, 1984, BIOCHIM BIOPHYS ACTA, V772, P117, DOI 10.1016/0005-2736(84)90034-8; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; CALABRESI L, 1993, BIOCHEMISTRY-US, V32, P6477, DOI 10.1021/bi00076a023; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHEUNG MC, 1989, J LIPID RES, V30, P499; FIELDING CJ, 1981, J BIOL CHEM, V256, P2102; FIELDING PE, 1991, BIOCHEMISTRY-US, V30, P8551, DOI 10.1021/bi00099a009; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GURD FRN, 1960, LIPID CHEM, P208; HUANG YD, 1993, ARTERIOSCLER THROMB, V13, P445, DOI 10.1161/01.ATV.13.3.445; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1994, J LIPID RES, V35, P860; LETIZIA JY, 1991, BIOCHEMISTRY-US, V30, P866, DOI 10.1021/bi00217a041; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDKATZ S, 1984, BIOCHEMISTRY-US, V23, P1130, DOI 10.1021/bi00301a015; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; LUNDKATZ S, 1982, BIOCHEMISTRY-US, V21, P2964, DOI 10.1021/bi00541a025; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; MATZ CE, 1982, J BIOL CHEM, V257, P4541; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MAYFIELD C, 1979, CLIN CHEM, V25, P1309; McKay HAC, 1938, NATURE, V142, P997, DOI 10.1038/142997b0; MCKNIGHT GL, 1992, J BIOL CHEM, V267, P12131; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; MENG QH, 1993, J BIOL CHEM, V268, P16966; MIIDA T, 1990, BIOCHEMISTRY-US, V29, P10469, DOI 10.1021/bi00498a007; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; PARK MSC, 1987, ARCH BIOCHEM BIOPHYS, V258, P545, DOI 10.1016/0003-9861(87)90376-6; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1978, J BIOL CHEM, V253, P7069; TAJIMA S, 1983, J BIOL CHEM, V258, P73; TALL AR, 1978, BIOCHIM BIOPHYS ACTA, V513, P185, DOI 10.1016/0005-2736(78)90172-4; WILLIAMS PT, 1990, J LIPID RES, V31, P1131	41	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4280	4287		10.1074/jbc.270.9.4280	http://dx.doi.org/10.1074/jbc.270.9.4280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876187	hybrid			2022-12-27	WOS:A1995QK08400018
J	REHN, M; PIHLAJANIEMI, T				REHN, M; PIHLAJANIEMI, T			IDENTIFICATION OF 3 N-TERMINAL ENDS OF TYPE-XVIII COLLAGEN CHAINS AND TISSUE-SPECIFIC DIFFERENCES IN THE EXPRESSION OF THE CORRESPONDING TRANSCRIPTS - THE LONGEST FORM CONTAINS A NOVEL MOTIF HOMOLOGOUS TO RAT AND DROSOPHILA FRIZZLED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL REGION; MESSENGER-RNA; EXTENSIVE INTERRUPTIONS; GENE; VARIANTS; DOMAINS; EXON; SPECTRUM; SITES; LOCUS	Transcripts for the alpha 1 chain of mouse type XVIII collagen were found to be heterogeneous at their 5'-ends and to encode three variant N-terminal sequences of the ensuing 1315-, 1527-, or 1774-residue collagen chains. The variant mRNAs appeared to originate from the use of two alternate promoters of the alpha 1(XVIII) chain gene, resulting in the synthesis of either short or long N-terminal non-collagenous NC1 domains, the latter being further subject to modification due to alternative splicing of the transcripts. As a result, the 1527- and 1774-residue polypeptides share the same signal peptide, and the lengths of their NC1 domains are 517 or 764 amino acid residues, respectively, while the 1315-residue polypeptide has a different signal peptide and a 301-residue NC1 domain, The longest NC1 domain was strikingly characterized by a 110-residue sequence with 10 cysteines, which was found to be homologous with the previously identified frizzled proteins belonging to the family of G-protein-coupled membrane receptors. Thus, it is proposed that the cysteine-rich motif, termed fi, represents a new sequence motif that can be found in otherwise unrelated proteins, Tissues containing mainly one or two NC1 domain mRNA variants or all three NC1 domains were identified, indicating that there is tissue-specific utilization of two alternate promoters and alternative splicing of alpha 1(XVIII) transcripts.	UNIV OULU, DEPT MED BIOCHEM, SF-90220 OULU, FINLAND; UNIV OULU, BIOCTR, COLLAGEN RES UNIT, SF-90220 OULU, FINLAND	University of Oulu; University of Oulu				Pihlajaniemi, Taina/0000-0002-1664-9045				ABE N, 1993, BIOCHEM BIOPH RES CO, V196, P576, DOI 10.1006/bbrc.1993.2288; ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENNETT VD, 1990, J BIOL CHEM, V265, P2223; BORK P, 1992, FEBS LETT, V307, P49, DOI 10.1016/0014-5793(92)80900-2; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; Dayhoff M. O., 1979, ATLAS PROTEIN SEQUEN, P345; DELEAGE G, 1989, COMPUT APPL BIOSCI, V5, P159; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOLIANA R, 1990, J CELL BIOL, V111, P2197, DOI 10.1083/jcb.111.5.2197; FENG LL, 1994, J BIOL CHEM, V269, P2342; GERECKE DR, 1993, J BIOL CHEM, V268, P12177; HUEBNER K, 1992, GENOMICS, V14, P220, DOI 10.1016/S0888-7543(05)80209-5; JUVONEN M, 1992, J BIOL CHEM, V267, P24693; JUVONEN M, 1992, J BIOL CHEM, V267, P24700; JUVONEN M, 1993, LAB INVEST, V69, P541; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153; KIVIRIKKO S, 1994, J BIOL CHEM, V269, P4773; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S; MURAGAKI Y, 1994, J BIOL CHEM, V269, P4042; MYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144, DOI 10.1073/pnas.89.21.10144; NAH HD, 1994, J BIOL CHEM, V269, P16443; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; SAITTA B, 1992, J BIOL CHEM, V267, P6188; SAITTA B, 1990, J BIOL CHEM, V265, P6473; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STOKES DG, 1991, J BIOL CHEM, V266, P8626; TRUEB J, 1992, BIOCHIM BIOPHYS ACTA, V1171, P97, DOI 10.1016/0167-4781(92)90145-P; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALCHLI C, 1993, EUR J BIOCHEM, V212, P483, DOI 10.1111/j.1432-1033.1993.tb17685.x; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082	41	107	115	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4705	4711		10.1074/jbc.270.9.4705	http://dx.doi.org/10.1074/jbc.270.9.4705			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876242	hybrid			2022-12-27	WOS:A1995QK08400077
J	SUZUKI, JY; BAUER, CE				SUZUKI, JY; BAUER, CE			ALTERED MONOVINYL AND DIVINYL PROTOCHLOROPHYLLIDE POOLS IN BCHJ MUTANTS OF RHODOBACTER-CAPSULATUS - POSSIBLE MONOVINYL SUBSTRATE DISCRIMINATION OF LIGHT-INDEPENDENT PROTOCHLOROPHYLLIDE REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST BIOGENESIS; RHODOPSEUDOMONAS-CAPSULATA; HIGHER-PLANTS; QUANTITATIVE-DETERMINATION; BIOSYNTHESIS; GENES; PHOTOSYNTHESIS; CHLOROPHYLL; SPECTROFLUOROMETRY; MOBILIZATION	In land plants in particular, it has been well established that chlorophyll intermediates, Mg-protoporphyrin, Mg-protoporphyrin monomethylester, protochlorophyllide, and chlorophyllide occur as monovinyl and divinyl forms, The pool of monovinyl and divinyl intermediates differ according to species, age of tissue, and light regime, In this study, we investigated the monovinyl and divinyl characteristics of protochlorophyllide and chlorophyllide in the purple non-sulfur photosynthetic eubacterium Rhodobacter capsulatus. Our results indicate that mutations in genes known to completely block the reduction of protochlorophyllide to chlorophyllide (such as bchN, bchB, and bchL mutants), accumulate a pool of monovinyl and divinyl forms of protochlorophyllide just as observed in plants, However, we also observed that directed insertion and deletion mutations in bchJ, a gene located in the photosynthesis gene cluster, affected the ratio of monovinyl and divinyl protochlorophyllide, Specifically, bchJ-disrupted strains accumulate reduced levels of bacteriochlorophyll concomitant with the accumulation of divinyl protochlorophyllide, Mutants of bchJ in combination with a second mutation in bchL still produce a mixed pool of monovinyl and divinyl protochlorophyllide; however, the ratio of monovinyl to divinyl protochlorophyllide is skewed in favor of divinyl protochlorophyllide. These results thus identify bchJ as the first sequenced gene that affects the divinyl to monovinyl ratio of photopigment intermediates in any photosynthetic organism, In addition, the results of our study also suggest that light-independent protochlorophyllide reductase is discriminatory for a monovinyl substrate.	INDIANA UNIV,DEPT BIOL,MOLEC CELLULAR & DEV BIOL PROGRAM,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington					NIGMS NIH HHS [R01 GM053940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BAUER CE, 1993, J BACTERIOL, V175, P3919, DOI 10.1128/JB.175.13.3919-3925.1993; BAZZAZ MB, 1982, FEBS LETT, V138, P104, DOI 10.1016/0014-5793(82)80405-5; BELANGER FC, 1982, J BIOL CHEM, V257, P1360; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; CAREY EE, 1985, PLANT PHYSIOL, V79, P1, DOI 10.1104/pp.79.1.1; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; CHISHOLM SW, 1990, NATURE, V334, P340; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; IOANNIDES IM, 1992, PLANT PHYSL LIFE SCI, V11, P79; MARRS B, 1981, J BACTERIOL, V146, P1003, DOI 10.1128/JB.146.3.1003-1012.1981; PARHAM R, 1992, BIOCHEMISTRY-US, V31, P8460, DOI 10.1021/bi00151a011; PARTENSKY F, 1993, PLANT PHYSIOL, V101, P285, DOI 10.1104/pp.101.1.285; PONCE MR, 1992, NUCLEIC ACIDS RES, V20, P623, DOI 10.1093/nar/20.3.623; REBEIZ CA, 1988, CRIT REV PLANT SCI, V6, P384; REBEIZ CA, 1994, BIOSYNTHESIS TETRAPY, P177; SCOLNIK PA, 1984, NATURE, V307, P289, DOI 10.1038/307289a0; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SHIOI Y, 1992, PLANT PHYSIOL, V100, P1291, DOI 10.1104/pp.100.3.1291; SHIOI Y, 1988, ARCH BIOCHEM BIOPHYS, V267, P69, DOI 10.1016/0003-9861(88)90009-4; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH WL, 1991, TEACH SOCIOL, V19, P237, DOI 10.2307/1317856; SOJKA GA, 1970, ARCH BIOCHEM BIOPHYS, V136, P578, DOI 10.1016/0003-9861(70)90231-6; TAYLOR DP, 1983, J BACTERIOL, V154, P580, DOI 10.1128/JB.154.2.580-590.1983; TRIPATHY BC, 1985, ANAL BIOCHEM, V149, P43, DOI 10.1016/0003-2697(85)90475-0; TRIPATHY BC, 1988, PLANT PHYSIOL, V87, P89, DOI 10.1104/pp.87.1.89; TRIPATHY BC, 1986, J BIOL CHEM, V261, P3556; WHYTE BJ, 1993, BIOCHEM J, V291, P939, DOI 10.1042/bj2910939; WU SM, 1989, ANAL BIOCHEM, V178, P294, DOI 10.1016/0003-2697(89)90641-6; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YEN HC, 1976, J BACTERIOL, V126, P619, DOI 10.1128/JB.126.2.619-629.1976; YILDIZ FH, 1992, MOL MICROBIOL, V6, P2683, DOI 10.1111/j.1365-2958.1992.tb01445.x; YOUNG DA, 1989, MOL GEN GENET, V218, P1, DOI 10.1007/BF00330558; ZESBO KM, 1984, CELL, V37, P937	36	51	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3732	3740		10.1074/jbc.270.8.3732	http://dx.doi.org/10.1074/jbc.270.8.3732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876113	hybrid			2022-12-27	WOS:A1995QH68800043
J	ZHOU, Z; MISLER, S				ZHOU, Z; MISLER, S			ACTION POTENTIAL-INDUCED QUANTAL SECRETION OF CATECHOLAMINES FROM RAT ADRENAL CHROMAFFIN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET B-CELLS; TRANSMITTER RELEASE; CALCIUM CHANNELS; ELECTRICAL-ACTIVITY; NERVE-TERMINALS; ACETYLCHOLINE; FACILITATION; MEDULLA; STIMULATION; MUSCARINE	Using single rat adrenal chromaffin cells, we examined the coupling of action potential activity to quantal release of catecholamines by combining perforated patch current-clamp recording with electrochemical microcarbon fiber amperometry. Chromaffin cells display steeper dependence of quantal release on action potential frequency than many nerve terminals, as well as more desynchronized release following an action potential. Also in contrast to neurons, in chromaffin cells, a major chemical secretagogue (acetylcholine) triggers potent quantal release even in the absence of electrical activity. These findings are consistent with an hypothesis that a major component of exocytosis from chromaffin cells involves diffusion of Ca2+ to secretion sites which are less well co-localized with Ca2+ channels than those in nerve terminals.	WASHINGTON UNIV, JEWISH HOSP ST LOUIS, SCH MED, DEPT MED, DIV RENAL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT CELL BIOL PHYSIOL, ST LOUIS, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)			zhou, zhuan/A-8285-2011		NIDDK NIH HHS [DK37380] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037380] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; BOOKMAN RJ, 1991, ANN NY ACAD SCI, V635, P352, DOI 10.1111/j.1749-6632.1991.tb36504.x; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; BROCK JA, 1988, J PHYSIOL-LONDON, V399, P607; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CHOW RH, 1995, IN PRESS P NATL ACAD; COUTEAUX R, 1974, CR ACAD SCI D NAT, V278, P291; DUNN LA, 1983, J BIOL CHEM, V258, P4989; FALKE LC, 1989, FEBS LETT, V251, P167, DOI 10.1016/0014-5793(89)81448-6; Feldberg W, 1934, J PHYSIOL-LONDON, V81, P286, DOI 10.1113/jphysiol.1934.sp003136; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P599, DOI 10.1113/jphysiol.1982.sp014394; GERSDORFF HV, 1994, NATURE, V367, P735; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; HERRINGTON J, 1993, PULSE CONTROL DOCUME; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Katz B., 1969, RELEASE NEURAL TRANS; KIDOKORO Y, 1980, J PHYSIOL-LONDON, V307, P199, DOI 10.1113/jphysiol.1980.sp013431; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MAGLEBY KL, 1973, J PHYSIOL-LONDON, V234, P327, DOI 10.1113/jphysiol.1973.sp010348; MALHOTRA RK, 1988, NEUROSCIENCE, V26, P313, DOI 10.1016/0306-4522(88)90147-9; MISLER S, 1977, THESIS NEW YORK U; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; NEELY A, 1992, J PHYSIOL-LONDON, V453, P97, DOI 10.1113/jphysiol.1992.sp019220; NEELY A, 1992, J PHYSIOL-LONDON, V453, P133, DOI 10.1113/jphysiol.1992.sp019221; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; NOHMI M, 1992, J PHYSIOL-LONDON, V458, P171, DOI 10.1113/jphysiol.1992.sp019412; PRESSEL DM, 1991, J MEMBRANE BIOL, V124, P239, DOI 10.1007/BF01994357; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; RUDEN L, 1993, SCIENCE, V262, P1061; SACHI O, 1971, PFLUGERS ARCH, V329, P209; SCHROEDER TJ, 1994, J BIOL CHEM, V269, P17215; TOLEDO GA, 1993, NATURE, V363, P554; WAKADE AR, 1983, NEUROSCIENCE, V10, P973, DOI 10.1016/0306-4522(83)90235-X; WARASHINA A, 1989, BIOMED RES-TOKYO, V10, P157, DOI 10.2220/biomedres.10.157; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; ZHOU Z, 1994, J GEN PHYSIOL, V104, pA28; ZHOU Z, 1994, BIOPHYS J, V66, pA54; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	48	123	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3498	3505		10.1074/jbc.270.8.3498	http://dx.doi.org/10.1074/jbc.270.8.3498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876083	hybrid			2022-12-27	WOS:A1995QH68800010
J	HAHN, M; OLSEN, O; POLITZ, O; BORRISS, R; HEINEMANN, U				HAHN, M; OLSEN, O; POLITZ, O; BORRISS, R; HEINEMANN, U			CRYSTAL-STRUCTURE AND SITE-DIRECTED MUTAGENESIS OF BACILLUS-MACERANS ENDO-1,3-1,4-BETA-B-GLUCANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; BETA-GLUCANASE GENE; ACTIVE-SITE; TRICHODERMA-REESEI; MOLECULAR-CLONING; DNA-SEQUENCE; CONSTRUCTION; HYDROLASES; REFINEMENT; SUBTILIS	In beta-glucans those beta-1,4 glycosidic bonds which are adjacent to beta-1,3 bonds are cleaved by endo 1,3-1,4-beta-glucanases (beta-glucanases), Here, the relationship between structure and activity of the beta-glucanase of Bacillus macerans is studied by x-ray crystallography and site-directed mutagenesis of active site residues. Crystal structure analysis at 2.3-Angstrom resolution reveals a jelly-roll protein structure with a deep active site channel harboring the amino acid residues Trp(101) Glu(103), Asp(105), and Glu(107) as in the hybrid Bacillus beta-glucanase H(A16-M) (Keitel, T., Simon, O., Borriss, R, and Heinemann, U, (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 5287-5291). Different mutant proteins with substitutions in these residues are generated by site-directed mutagenesis, isolated, and characterized. Compared with the wild-type enzyme their activity is reduced to less than 1%. Several mutants with isosteric substitutions in Glu(103) and Glu(107) are completely inactive, suggesting a direct role of these residues in glycosyl bond hydrolysis. The kinetic properties of mutant beta-glucanases and the crystal structure of the wild-type enzyme are consistent with a mechanism where Glu(103) and Glu(107) are the catalytic amino acid residues responsible for cleavage of the beta-1,4 glycosidic bond within the substrate molecule.	MAX DELBRUCK CTR MOLEC MED,FORSCH GRP KRISTALLOG,D-13122 BERLIN,GERMANY; CARLSBERG LAB,DEPT PHYSIOL,DK-2500 COPENHAGEN,DENMARK; HUMBOLDT UNIV BERLIN,FACHBEREICH BIOL,D-10243 BERLIN,GERMANY	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin			Borriss, Rainer/C-5026-2012; Heinemann, Udo/AAH-4766-2019; Heinemann, Udo/S-3379-2016	Borriss, Rainer/0000-0003-3726-1004; Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850				ANDERSON MA, 1975, FEBS LETT, V52, P202, DOI 10.1016/0014-5793(75)80806-4; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BORRISS R, 1990, MOL GEN GENET, V222, P278, DOI 10.1007/BF00633829; BORRISS R, 1989, CARLSBERG RES COMMUN, V54, P41, DOI 10.1007/BF02907584; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; FLINT HJ, 1993, J BACTERIOL, V175, P2943, DOI 10.1128/JB.175.10.2943-2951.1993; GOSALBES MJ, 1991, J BACTERIOL, V173, P7705, DOI 10.1128/jb.173.23.7705-7710.1991; HAHN M, 1994, P NATL ACAD SCI USA, V91, P10417, DOI 10.1073/pnas.91.22.10417; Hahn T., 1992, INT TABLES CRYSTALLO; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOFEMEISTER J, 1986, GENE, V49, P177, DOI 10.1016/0378-1119(86)90278-7; HOJ PB, 1989, J BIOL CHEM, V264, P4939; HOJ PB, 1992, J BIOL CHEM, V26, P25059; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KADOWAKI H, 1989, GENE, V76, P161, DOI 10.1016/0378-1119(89)90018-8; KEITEL T, 1993, P NATL ACAD SCI USA, V90, P5287, DOI 10.1073/pnas.90.11.5287; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LLOBERAS J, 1991, EUR J BIOCHEM, V197, P337, DOI 10.1111/j.1432-1033.1991.tb15916.x; LOUW ME, 1993, APPL MICROBIOL BIOT, V38, P507, DOI 10.1007/BF00242946; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MACARRON R, 1993, FEBS LETT, V316, P137, DOI 10.1016/0014-5793(93)81202-B; MALET C, 1993, BIOCHEM J, V296, P753, DOI 10.1042/bj2960753; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MURPHY N, 1984, NUCLEIC ACIDS RES, V12, P5355, DOI 10.1093/nar/12.13.5355; OLSEN O, 1991, MOL GEN GENET, V225, P177, DOI 10.1007/BF00269845; OLSEN O, 1990, THESIS AARHUS U AARH; PLANAS A, 1992, FEBS LETT, V308, P141, DOI 10.1016/0014-5793(92)81262-K; POLITZ O, 1993, EUR J BIOCHEM, V216, P829, DOI 10.1111/j.1432-1033.1993.tb18204.x; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SCHIMMING S, 1992, EUR J BIOCHEM, V204, P13, DOI 10.1111/j.1432-1033.1992.tb16600.x; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; SPILLIAERT R, 1994, EUR J BIOCHEM, V224, P923, DOI 10.1111/j.1432-1033.1994.00923.x; SVENSSON B, 1993, J BIOTECHNOL, V29, P1, DOI 10.1016/0168-1656(93)90038-O; TEATHER RM, 1990, J BACTERIOL, V172, P3837, DOI 10.1128/jb.172.7.3837-3841.1990; TEZUKA H, 1989, AGR BIOL CHEM TOKYO, V53, P2335, DOI 10.1080/00021369.1989.10869684; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WELFLE K, 1994, J BIOMOL STRUCT DYN, V11, P1417, DOI 10.1080/07391102.1994.10508076; WHITHERS SG, 1990, J AM CHEM SOC, V112, P5887; YAHATA N, 1990, GENE, V86, P113, DOI 10.1016/0378-1119(90)90122-8	48	102	107	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3081	3088		10.1074/jbc.270.7.3081	http://dx.doi.org/10.1074/jbc.270.7.3081			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852389	hybrid			2022-12-27	WOS:A1995QG47100031
J	CROSS, AR; CURNUTTE, JT				CROSS, AR; CURNUTTE, JT			THE CYTOSOLIC ACTIVATING FACTORS P47(PHAX) AND P67(PHAX) HAVE DISTINCT ROLES IN THE REGULATION OF ELECTRON FLOW IN NADPH OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; SUPEROXIDE-GENERATING OXIDASE; CYTOCHROME-B; HUMAN-NEUTROPHILS; PLASMA-MEMBRANE; GALACTOSE-OXIDASE; BINDING-SITE; REDUCTION; PROTEIN	We have previously shown that the human neutrophil superoxide-generating NADPH oxidase possesses a novel dye reductase activity (Cross, A. R., Yarchover, J. L., and Curnutte, J. T. (1994) J. Biol. Chem. 269, 21448-21454). This activity exhibited an absolute requirement for the cytosolic activating factor p67(phox) but not far p47(phox), suggesting that p67(phox) and p47(phox) have individual roles in controlling electron flow from NADPH to oxygen. Here, we provide direct evidence that p67(phox) alone can facilitate electron flow from NADPH to the flavin center of NADPH oxidase in the absence of p47(phox), resulting in the reduction of enzyme FAD, whereas the presence of p47(phox) is required in order for electron transfer to proceed beyond the flavin center to the heme in cytochrome b(-245) and thence to oxygen.			CROSS, AR (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, CAL-1, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIAID NIH HHS [AI24838] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CROSS AR, 1984, BIOCHEM J, V223, P337, DOI 10.1042/bj2230337; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; CROSS AR, 1994, J BIOL CHEM, V269, P21448; CROSS AR, 1982, BIOCHEM J, V208, P758; CURNUTTE JT, 1993, CLIN IMMUNOL IMMUNOP, V67, pS2, DOI 10.1006/clin.1993.1078; CURNUTTE JT, 1989, P NATL ACAD SCI USA, V86, P825, DOI 10.1073/pnas.86.3.825; CURNUTTE JT, 1987, J BIOL CHEM, V262, P6450; DOUSSIERE J, 1993, BIOCHEMISTRY-US, V32, P8880, DOI 10.1021/bi00085a020; ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575; ENGLANDER SW, 1987, ANAL BIOCHEM, V161, P300, DOI 10.1016/0003-2697(87)90454-4; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; FORREST CB, 1988, HEMATOL ONCOL CLIN N, V2, P253, DOI 10.1016/S0889-8588(18)30619-1; HOOGLAND H, 1987, BIOCHIM BIOPHYS ACTA, V916, P76, DOI 10.1016/0167-4838(87)90212-3; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; KAKINUMA K, 1986, J BIOL CHEM, V2651, P9426; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; LAPORTE F, 1991, EUR J BIOCHEM, V196, P59, DOI 10.1111/j.1432-1033.1991.tb15785.x; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; MIKI T, 1992, J BIOL CHEM, V267, P18695; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; MUIRWOOD P, 1974, FEBS LETT, V44, P22, DOI 10.1016/0014-5793(74)80297-8; NAKANISHI A, 1992, J BIOL CHEM, V267, P19072; ODAJIMA T, 1970, BIOCHIM BIOPHYS ACTA, V206, P71, DOI 10.1016/0005-2744(70)90083-5; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; QUINN MT, 1992, BLOOD, V79, P2438; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; WEENING RS, 1985, J PEDIATR-US, V107, P102, DOI 10.1016/S0022-3476(85)80626-0; WHITTAKER MM, 1988, J BIOL CHEM, V263, P6074; YOSHIDA LS, 1992, BIOCHIM BIOPHYS ACTA, V1135, P245	40	94	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6543	6548		10.1074/jbc.270.12.6543	http://dx.doi.org/10.1074/jbc.270.12.6543			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896790	hybrid			2022-12-27	WOS:A1995QQ85500020
J	WITHERS, BE; DUNBAR, JC				WITHERS, BE; DUNBAR, JC			SEQUENCE-SPECIFIC DNA RECOGNITION BY THE SMAI ENDONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECORV RESTRICTION ENDONUCLEASE; RI ENDONUCLEASE; BASE ANALOG; CLEAVAGE; BINDING; CATALYSIS; REPRESSOR; DIFFUSION; SITE	SmaI endonuclease recognizes and cleaves the sequence CCC down arrow GGG. The enzyme requires magnesium for catalysis; however, equilibrium binding assays revealed that the enzyme binds specifically to DNA in the absence of magnesium. A specific association constant of 0.9 x 10(8) M(-1) was determined for SmaI binding to a 22-base duplex oligonucleotide. Furthermore, the K-A was a function of the length of the DNA substrate and the enzyme exhibited an affinity of 1.2 x 10(9) M(-1) for a 195-base pair fragment and which represented a 10(4)-fold increase in affinity over binding to nonspecific sequences. A K-m of 17.5 nM was estimated from kinetic assays based on cleavage of the 22 base oligonucleotide and is not significantly different from the K-D estimated from the thermodynamic analyses. Footprinting (dimethyl sulfate and missing nucleoside) analyses revealed that SmaI interacts with each of the base pairs within the recognition sequence. Ethylation interference assays suggested that the protein contacts three adjacent phosphates on each strand of the recognition sequence. Significantly, a predicted protein contact with the phosphate 3' of the scissile bond may have implications in the mechanism of catalysis by SmaI.	WAYNE STATE UNIV,SCH MED,CTR MOLEC MED & GENET,DETROIT,MI 48201	Wayne State University								AIKEN CR, 1991, J BIOL CHEM, V266, P19063; AIKEN CR, 1991, J BIOL CHEM, V266, P1070; ANDERSON JE, 1993, CURR OPIN STRUC BIOL, V3, P24, DOI 10.1016/0959-440X(93)90197-S; ATHANASIADIS A, 1994, NAT STRUCT BIOL, V1, P469, DOI 10.1038/nsb0794-469; BRENNAN CA, 1986, J BIOL CHEM, V261, P7270; BROOKS JE, 1991, NUCLEIC ACIDS RES, V19, P841, DOI 10.1093/nar/19.4.841; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; BURLEY SK, 1994, CURR OPIN STRUC BIOL, V4, P3, DOI 10.1016/S0959-440X(94)90053-1; CHENG XD, 1994, EMBO J, V13, P3927, DOI 10.1002/j.1460-2075.1994.tb06708.x; Fersht A., 1985, ENZYME STRUCTURE MEC; GHOSH SS, 1990, NUCLEIC ACIDS RES, V18, P5063, DOI 10.1093/nar/18.17.5063; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D; HARRAN TE, 1987, J BIOMOL STRUCT DYN, V5, P199; HEIDMANN S, 1989, NUCLEIC ACIDS RES, V23, P9783; HEITMAN J, 1992, BIOESSAYS, V14, P445, DOI 10.1002/bies.950140704; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; JELTSCH A, 1992, FEBS LETT, V304, P4, DOI 10.1016/0014-5793(92)80576-3; JELTSCH A, 1993, P NATL ACAD SCI USA, V90, P8499, DOI 10.1073/pnas.90.18.8499; JENJACOBSON L, 1986, CELL, V45, P619, DOI 10.1016/0092-8674(86)90294-1; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; MCLAUGHLIN LW, 1987, BIOCHEMISTRY-US, V26, P7238, DOI 10.1021/bi00397a007; MODRICH P, 1976, J BIOL CHEM, V251, P5866; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; NEWMAN PC, 1990, BIOCHEMISTRY-US, V29, P9902, DOI 10.1021/bi00494a021; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; Rosenberg JM, 1991, CURR OPIN STRUC BIOL, V1, P104, DOI 10.1016/0959-440X(91)90018-O; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; Segel I.H., 1975, ENZYME KINETICS; SELENT U, 1992, BIOCHEMISTRY-US, V31, P4801; SIEBENLIST U, 1980, P NATL ACAD SCI USA, V77, P121; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TAYLOR JD, 1991, BIOCHEMISTRY-US, V30, P8743, DOI 10.1021/bi00100a005; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; TERRY BJ, 1983, J BIOL CHEM, V258, P9820; THIELKING V, 1991, BIOCHEMISTRY-US, V30, P6416, DOI 10.1021/bi00240a011; THIELKING V, 1992, BIOCHEMISTRY-US, V15, P3727; VERMOTE CLM, 1992, BIOCHEMISTRY-US, V31, P6082, DOI 10.1021/bi00141a018; VONHIPPEL P, 1993, SCIENCE, V263, P769; WATERS TR, 1994, BIOCHEMISTRY-US, V33, P1812, DOI 10.1021/bi00173a026; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; WITHERS BE, 1993, NUCLEIC ACIDS RES, V21, P2571, DOI 10.1093/nar/21.11.2571; ZEBALA JA, 1992, J BIOL CHEM, V267, P8106	45	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6496	6504		10.1074/jbc.270.12.6496	http://dx.doi.org/10.1074/jbc.270.12.6496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896784	hybrid			2022-12-27	WOS:A1995QQ85500014
J	CHOUBEY, D; LENGYEL, P				CHOUBEY, D; LENGYEL, P			BINDING OF AN INTERFERON-INDUCIBLE PROTEIN (P202) TO THE RETINOBLASTOMA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; CELL-CYCLE; SUSCEPTIBILITY GENE; MURINE CHROMOSOME-1; ACTIVATABLE GENES; CLUSTER; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; CLONING	Many of the antimicrobial, immunomodulatory, and cell growth regulatory activities of the interferons are mediated by interferon-inducible proteins. One family of such murine proteins is encoded by six or more adjacent and structurally related genes (gene 200 cluster). Two homologous human genes have also been reported. p202, encoded by the Ifi202 gene in the gene 200 cluster, is a 52-kDa nuclear phosphoprotein. Constitutive overexpression of p202 in transfected cells is growth inhibitory, We report here that p202 binds the cell growth regulatory retinoblastoma protein (pRb) in vitro and in vivo. The binding is due to direct interaction between the two proteins, p202 has two nonoverlapping segments for binding pRb, and pRb has two nonoverlapping segments (one of them including the pocket region) for binding p202. The hypophosphorylated form of pRb binds to p202. p202 is the first interferon-inducible protein found to bind pRb.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06520; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CLIN IMMUNOL & BIOL THERAPY,HOUSTON,TX 77030	Yale University; University of Texas System; UTMD Anderson Cancer Center			Choubey, Divaker/A-4771-2008		NIAID NIH HHS [R37-AI12320] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012320] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARBACID M, 1981, J VIROL, V37, P518, DOI 10.1128/JVI.37.1.518-523.1981; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; BRIGGS JA, 1992, J CELL BIOCHEM, V49, P82, DOI 10.1002/jcb.240490114; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEMAEYER E, 1988, INTERFERONS OTHER RE, P488; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; EWEN ME, 1994, CANCER METAST REV, V13, P45, DOI 10.1007/BF00690418; FIGGE J, 1993, PROTEIN SCI, V2, P155; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HENSEY CE, 1994, J BIOL CHEM, V269, P1380; HERRMANN CH, 1991, J VIROL, V65, P5848, DOI 10.1128/JVI.65.11.5848-5859.1991; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KARANTZA V, 1993, MOL CELL BIOL, V13, P6640, DOI 10.1128/MCB.13.11.6640; KINGSMORE SF, 1990, IMMUNOGENETICS, V30, P169; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MITTNACHT S, 1994, EMBO J, V13, P118, DOI 10.1002/j.1460-2075.1994.tb06241.x; OPDENAKKER G, 1989, VIROLOGY, V171, P568, DOI 10.1016/0042-6822(89)90626-0; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; RAY SK, 1992, MOL CELL BIOL, V12, P4327, DOI 10.1128/MCB.12.10.4327; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; SEN GC, 1992, J BIOL CHEM, V267, P5017; Sherr Charles J., 1994, Trends in Cell Biology, V4, P15, DOI 10.1016/0962-8924(94)90033-7; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; TANNENBAUM CS, 1993, J LEUKOCYTE BIOL, V53, P563, DOI 10.1002/jlb.53.5.563; TEMPLETON DJ, 1992, MOL CELL BIOL, V12, P435, DOI 10.1128/MCB.12.2.435; TRAPANI JA, 1992, IMMUNOGENETICS, V36, P369; VILCEK J, 1990, PEPTIDE GROWTH FACTO, P3; WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	49	100	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6134	6140		10.1074/jbc.270.11.6134	http://dx.doi.org/10.1074/jbc.270.11.6134			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890747	hybrid			2022-12-27	WOS:A1995QM94500063
J	GUREVICH, VV; BENOVIC, JL				GUREVICH, VV; BENOVIC, JL			VISUAL ARRESTIN BINDING TO RHODOPSIN - DIVERSE FUNCTIONAL ROLES OF POSITIVELY CHARGED RESIDUES WITHIN THE PHOSPHORYLATION-RECOGNITION REGION OF ARRESTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							48-KDA PROTEIN; PHOTOEXCITED RHODOPSIN; BOVINE RHODOPSIN; BETA-ARRESTIN; RECEPTOR; ACTIVATION; DROSOPHILA; KINASE; SITES	Arrestin plays a critical role in quenching phototransduction via its ability to specifically interact with the phosphorylated light-activated form of the visual receptor rhodopsin. In an effort to identify the residues involved in interaction with the phosphorylated C terminus of rhodopsin, we introduced point mutations into a basic region in visual arrestin previously implicated in phosphorylation-recognition (residues 163-189). A total of nine point mutations were made, each substituting a neutral hydrophilic residue for a positively charged Lys, Arg, or His. The functional consequences of these mutations were then analyzed by comparing the binding of full-length and truncated wild-type and mutant arrestin to various functional forms of rhodopsin. These studies demonstrate that Arg-171, Arg-175, and Lys-176 in bovine arrestin play a primary role in phosphate interaction, while Lys-166 and Lys-167 likely play a minor role in phosphate binding. In contrast, Lys-163 and His-179 appear to play a regulatory role, while Arg-182 and Arg-189 are not directly involved in arrestin binding to rhodopsin, Arg-175 also appears to function as a phosphorylation-sensitive trigger since charge neutralization by mutagenesis enables arrestin-R175N to bind to light-activated rhodopsin as well as wild-type arrestin binds to phosphorylated light-activated rhodopsin. The implications of these findings for the sequential multisite binding of arrestin to rhodopsin are iscussed.			GUREVICH, VV (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON CANC CTR,DEPT PHARMACOL,233 S 10TH ST,PHILADELPHIA,PA 19107, USA.		Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NIGMS NIH HHS [GM44944, GM47417] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417, R01GM044944, R01GM047417] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; HARGRAVE PA, 1992, MOL BIOL RECEPTORS T, P49; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; MURAKAMI A, 1993, FEBS LETT, V334, P203, DOI 10.1016/0014-5793(93)81712-9; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; PLANGGER A, 1994, J BIOL CHEM, V269, P26969; RAMING K, 1993, CELL SIGNAL, V5, P69, DOI 10.1016/0898-6568(93)90009-B; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SMITH WC, 1995, J NEUROCHEM, V64, P1; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	22	128	131	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6010	6016		10.1074/jbc.270.11.6010	http://dx.doi.org/10.1074/jbc.270.11.6010			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890732	hybrid			2022-12-27	WOS:A1995QM94500047
J	NAKANO, T; HIGASHINO, K; KIKUCHI, N; KISHINO, J; NOMURA, K; FUJITA, H; OHARA, O; ARITA, H				NAKANO, T; HIGASHINO, K; KIKUCHI, N; KISHINO, J; NOMURA, K; FUJITA, H; OHARA, O; ARITA, H			VASCULAR SMOOTH-MUSCLE CELL-DERIVED, GLA-CONTAINING GROWTH-POTENTIATING FACTOR FOR CA2+-MOBILIZING GROWTH-FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GAMMA-CARBOXYGLUTAMIC ACID; SIGNAL TRANSDUCTION; PROTEIN-S; FIBROBLASTS; PROLIFERATION; EXPRESSION; BOVINE	Proliferation of vascular smooth muscle cells (VSMC) is triggered by two types of growth factors. One activates tyrosine kinase-type receptors and the other activates G-protein-coupled receptors. We found that a conditioned medium of rat VSMC contained a growth-potentiating activity for the latter type of growth factor, and we purified a 70-kDa growth-potentiating factor (GPF) from the conditioned medium. Analyses of GPF and its cDNA revealed GPF to be a gamma-carboxyglutamic acid-containing protein encoded by a growth arrest-specific gene, gas6, which related to protein S. GPF specifically potentiated cell proliferation mediated by Ca2+-mobilizing receptors. The presence of a specific binding site suggests that the effect of GPF is mediated by a receptor. Thus, GPF may be a new type of extracellular factor regulating VSMC proliferation.			NAKANO, T (corresponding author), SHIONOGI & CO LTD,SHIONOGI RES LABS,FUKUSHIMA KU,5-12-4 SAGISU,OSAKA 553,JAPAN.		Ohara, Osamu/G-5448-2015; Ohara, Osamu/A-9119-2012	Ohara, Osamu/0000-0002-3328-9571; 				BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; GOSPODAROWICZ D, 1988, EUR J CELL BIOL, V46, P144; HANASAKI K, 1992, J BIOL CHEM, V267, P6414; HOPP TP, 1991, P NATL ACAD SCI USA, V78, P3824; JALINK K, 1990, J BIOL CHEM, V265, P12232; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; NAKANO T, 1993, J BIOL CHEM, V268, P22941; PARIS S, 1988, J BIOL CHEM, V263, P12893; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; Raines E.W., 1990, PEPTIDE GROWTH FACTO, DOI [10.1007/978-3-642-49295-2_5, DOI 10.1007/978-3-642-49295-2_5]; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SAREMBOCK IJ, 1991, CIRCULATION, V84, P232, DOI 10.1161/01.CIR.84.1.232; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K	18	161	180	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5702	5705		10.1074/jbc.270.11.5702	http://dx.doi.org/10.1074/jbc.270.11.5702			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890695	hybrid			2022-12-27	WOS:A1995QM94500005
J	SHORE, P; BISSET, L; LAKEY, J; WALTHO, JP; VIRDEN, R; SHARROCKS, AD				SHORE, P; BISSET, L; LAKEY, J; WALTHO, JP; VIRDEN, R; SHARROCKS, AD			CHARACTERIZATION OF THE ELK-1 ETS DNA-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM; TRANSCRIPTIONAL ACTIVATION; NMR-SPECTRA; BEND DNA; C-FOS; COMPLEXES; SEQUENCE; FAMILY; MOTIF	The ETS domain family of transcription factors is comprised of several important proteins that are involved in controlling key cellular events such as proliferation, differentiation, and development, One such protein, Elk-1, regulates the activity of the c-fos promoter in response to extracellular stimuli. Elk-1 is representative of a subgroup of ETS domain proteins that utilize a bipartite recognition mechanism that is mediated by both protein-DNA and protein-protein interactions, In this study, we have overexpressed, purified, and characterized the ETS DNA-binding domain of Elk-1 (Elk-93), Elk-93 was expressed in Escherichia coli as a fusion protein with glutathione S-transferase and purified to homogeneity from both the soluble and insoluble fractions using a two-column protocol. A combination of CD, NMR, and fluorescence spectroscopy demonstrates that Elk-93 represents an independently folded domain of mixed alpha/beta structure in which the three conserved tryptophans appear to contribute to the hydrophobic core of the protein, Moreover, DNA binding studies demonstrate that Elk-93 binds DNA with both high affinity (K-d approximate to 0.85 x 10(-10) M) and specificity, Circular permutation analysis indicates that DNA binding by Elk-93 does not induce significant bending of the DNA. Our results are discussed with respect to predictive models for the structure of the ETS DNA-binding domain.	UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT BIOCHEM & GENET,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND; UNIV SHEFFIELD,KREBS INST,DEPT MOLEC BIOL & BIOTECHNOL,SHEFFIELD S10 2UH,S YORKSHIRE,ENGLAND	Newcastle University - UK; University of Sheffield				Waltho, Jonathan/0000-0002-7402-5492; Lakey, Jeremy/0000-0003-4646-9085; Shore, Paul/0000-0002-1832-5976	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERG JM, 1993, CURR OPIN STRUC BIOL, V3, P11, DOI 10.1016/0959-440X(93)90195-Q; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BOSSELUT R, 1993, NUCLEIC ACIDS RES, V21, P5184, DOI 10.1093/nar/21.22.5184; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; CAREY J, 1991, METHOD ENZYMOL, V208, P103; CHOU PY, 1978, ADV ENZYMOLOGY RELAT, V0047, P00145; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; DEGROOT RP, 1994, ONCOGENE, V9, P463; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GILLE H, 1992, NATURE, V358, P415; GUSTAFSON TA, 1989, P NATL ACAD SCI USA, V86, P2162, DOI 10.1073/pnas.86.7.2162; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HIPSKIND RA, 1991, NATURE, V354, P351; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KERPPOLA TK, 1991, SCIENCE, V254, P1210, DOI 10.1126/science.1957173; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KUMAR S, 1992, BIOCHEMISTRY-US, V31, P8648, DOI 10.1021/bi00151a035; LAGET MP, 1993, NUCLEIC ACIDS RES, V21, P5987, DOI 10.1093/nar/21.25.5987; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; LAUDET V, 1993, BIOCHEM BIOPH RES CO, V190, P8, DOI 10.1006/bbrc.1993.1002; LOPEZ M, 1994, MOL CELL BIOL, V14, P3292, DOI 10.1128/MCB.14.5.3292; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MAVROTHALASSITI.G, 1994, ONCOGENE, V9, P425; MURDOCH FE, 1991, BIOCHEMISTRY-US, V30, P10838, DOI 10.1021/bi00109a005; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; RANCE M, 1987, J MAGN RESON, V74, P557, DOI 10.1016/0022-2364(87)90277-0; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; RECORD MT, 1991, METHOD ENZYMOL, V208, P291; SAIKUMAR P, 1994, ONCOGENE, V9, P1279; SAMBROOK J, 1990, MOL CLONING LABORATO; SHARROCKS AD, 1993, NUCLEIC ACIDS RES, V21, P215, DOI 10.1093/nar/21.2.215; SHARROCKS AD, 1993, MOL CELL BIOL, V13, P123, DOI 10.1128/MCB.13.1.123; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; SMITH DB, 1985, GENE AMST, V67, P31; SZILAGYI L, 1994, IN PRESS PROG NMR SP, V27; TEI H, 1992, P NATL ACAD SCI USA, V89, P6856, DOI 10.1073/pnas.89.15.6856; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; VERRIJZER CP, 1991, EMBO J, V10, P3007, DOI 10.1002/j.1460-2075.1991.tb07851.x; WALTHO JP, 1993, J MAGN RESON SER A, V103, P338, DOI 10.1006/jmra.1993.1176; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZINCK R, 1993, EMBO J, V12, P2377, DOI 10.1002/j.1460-2075.1993.tb05892.x	63	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5805	5811		10.1074/jbc.270.11.5805	http://dx.doi.org/10.1074/jbc.270.11.5805			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890710				2022-12-27	WOS:A1995QM94500020
J	ALLEN, S; NAIM, HY; BULLEID, NJ				ALLEN, S; NAIM, HY; BULLEID, NJ			INTRACELLULAR FOLDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR - EFFECTS OF DISULFIDE BOND FORMATION ON N-LINKED GLYCOSYLATION AND SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; ENDOPLASMIC-RETICULUM; STRUCTURAL REQUIREMENTS; INTERFERON-GAMMA; AMINO-ACID; G-PROTEIN; SITES; TRANSPORT; GLYCOPROTEINS; MEMBRANE	The addition of N-linked core oligosaccharides to membrane and secretory glycoproteins occurs co-translationally at asparagine residues in the tripeptide sequon Asn-Xaa-Ser/Thr soon after translocation of the nascent polypeptide into the lumen of the endoplasmic reticulum. However, the presence of the sequon does not automatically ensure core glycosylation, as many proteins contain sequons that remain either unglycosylated or glycosylated to a variable extent. To investigate whether intracellular protein folding can influence sequon utilization, we have expressed tissue-type plasminogen activator (t-PA) in cell culture in the presence of mild concentrations of the reducing agent dithiothreitol to prevent cc-translational disulfide bond formation in the endoplasmic reticulum. We show that conditions that prevent disulfide bond formation lead to complete glycosylation of a sequon that otherwise undergoes variable glycosylation in untreated cells. This demonstrated that folding and disulfide bond formation of t-PA determines its extent of core N-linked glycosylation. When dithiothreitol was removed from the cells, the reduced and overglycosylated t-PA formed disulfide bonds, folded and was secreted We also show t-PA present within cells is more susceptible to reduction with low concentrations of dithiothreitol than secreted t-PA.	UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV DUSSELDORF,INST MIKROBIOL,W-4000 DUSSELDORF,GERMANY	University of Manchester; Heinrich Heine University Dusseldorf				Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BERG DT, 1993, BLOOD, V81, P1312; BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BULLEID NJ, 1992, BIOCHEM J, V286, P275, DOI 10.1042/bj2860275; BULLEID NJ, 1990, BIOCHEM J, V268, P777, DOI 10.1042/bj2680777; CARSON DD, 1981, J BIOL CHEM, V256, P1552; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; CURLING EMA, 1990, BIOCHEM J, V272, P333, DOI 10.1042/bj2720333; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; GALLAGHER PJ, 1992, J VIROL, V66, P7136, DOI 10.1128/JVI.66.12.7136-7145.1992; GUAN JL, 1985, CELL, V42, P489, DOI 10.1016/0092-8674(85)90106-0; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HANSEN L, 1988, J BIOL CHEM, V263, P15713; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HOTCHKISS A, 1988, THROMB HAEMOSTASIS, V60, P225; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; KONRAD M, 1994, J BIOL CHEM, V269, P8659; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LODISH HF, 1993, J BIOL CHEM, V268, P20598; LUI T, 1979, J BIOL CHEM, V254, P4554; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; MACHAMER CE, 1988, J BIOL CHEM, V263, P5948; Marshall R D, 1974, Biochem Soc Symp, P17; MONONEN I, 1984, BIOCHIM BIOPHYS ACTA, V788, P364, DOI 10.1016/0167-4838(84)90050-5; NAKAI K, 1988, J BIOCHEM-TOKYO, V104, P693, DOI 10.1093/oxfordjournals.jbchem.a122535; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; NILSSON I, 1993, J BIOL CHEM, V268, P5798; OPSTELTEN DJ, 1994, J VIROL, V67, P7394; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; PLUMMER TH, 1964, J BIOL CHEM, V239, P2530; POHL G, 1984, BIOCHEMISTRY-US, V23, P3701, DOI 10.1021/bi00311a020; POHL G, 1987, BLOOD, V81, P1312; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SAMBROOK J, 1985, EMBO J, V4, P91, DOI 10.1002/j.1460-2075.1985.tb02322.x; SAMBROOK J, 1986, MOL BIOL MED, V3, P459; Shakin-Eshleman W. H., 1993, TRENDS GLYCOSCI GLYC, V5, P355; SMEDSROD B, 1990, THROMB HAEMOSTASIS, V63, P60; SPELLMAN MW, 1989, J BIOL CHEM, V264, P14100; SRINIVASAN N, 1990, INT J PEPT PROT RES, V36, P147; STRUCK DK, 1978, J BIOL CHEM, V253, P5786; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; TAYLOR AK, 1988, MOL CELL BIOL, V8, P4197, DOI 10.1128/MCB.8.10.4197; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; WILLIAMS AM, 1993, J BIOL CHEM, V268, P12780; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022	54	107	108	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4797	4804		10.1074/jbc.270.9.4797	http://dx.doi.org/10.1074/jbc.270.9.4797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876253	hybrid			2022-12-27	WOS:A1995QK08400089
J	CHOI, YH; MATSUZAKI, R; FUKUI, T; SHIMIZU, E; YORIFUJI, T; SATO, H; OZAKI, Y; TANIZAWA, K				CHOI, YH; MATSUZAKI, R; FUKUI, T; SHIMIZU, E; YORIFUJI, T; SATO, H; OZAKI, Y; TANIZAWA, K			COPPER TOPA QUINONE-CONTAINING HISTAMINE OXIDASE FROM ARTHROBACTER-GLOBIFORMIS - MOLECULAR-CLONING AND SEQUENCING, OVERPRODUCTION OF PRECURSOR ENZYME, AND GENERATION OF TOPA QUINONE COFACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM AMINE OXIDASE; ACTIVE-SITE; ESCHERICHIA-COLI; STRUCTURAL GENE; EXPRESSION; 6-HYDROXYDOPA; MECHANISM; DNA	The gene coding for histamine oxidase has been cloned and sequenced from a Coryneform bacterium Arthrobacter globiformis, The deduced amino acid sequence consists of 684 residues with a calculated molecular mass of 75,109 daltons and shows a high overall identity (58%) with that of phenethylamine oxidase derived from the same bacterial strain, Although the sequence similarities are rather low when compared with copper amine oxidases from other organisms, the consensus Asn-Tyr-Asp/Glu sequence, in which the middle Tyr is the precursor to the quinone cofactor (the quinone of 2,4,5-trihydroxyphenylalanine, topa) covalently bound to this class of enzymes, is also conserved in the histamine oxidase sequence. To identify the quinone cofactor, an overexpression plasmid has been constructed for the recombinant histamine oxidase. The inactive enzyme purified from the transformed Escherichia coli cells grown in a copper-depleted medium gained maximal activity upon stoichiometric binding of cupric ions, Concomitantly with the enzyme activation by copper, a brownish pink compound was generated in the enzyme, which was identified as the quinone of topa by absorption and resonance Raman spectroscopies of the p-nitrophenylhydrazine-derivatized enzyme and found at the position corresponding to the precursor Tyr (Tyr-402). Therefore, the copper-dependent autoxidation of a specific tyrosyl residue operates on the formation of the topa quinone cofactor in this enzyme, as recently demonstrated with the precursor form of phenethylamine oxidase (Matsuzaki, R., Fukui, T., Sato, H., Ozaki, Y., and Tanizawa, K, (1994)FEBS Lett. 351, 360-364).	OSAKA UNIV,INST SCI & IND RES,IBARAKI,OSAKA 567,JAPAN; SHINSHU UNIV,DEPT BIOSCI & BIOTECHNOL,NAGANO 39945,JAPAN; KWANSEI GAKUIN UNIV,SCH SCI,DEPT CHEM,NISHINOMIYA,HYOGO 662,JAPAN	Osaka University; Shinshu University; Kwansei Gakuin University			Ozaki, Yukihiro/B-4760-2011					ALLAIN CC, 1974, CLIN CHEM, V20, P470; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; AZAKAMI H, 1994, J FERMENT BIOENG, V77, P315, DOI 10.1016/0922-338X(94)90241-0; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BARKER GJ, 1985, BIOCHEM J, V237, P609; BROWN DE, 1991, J BIOL CHEM, V266, P4049; BRUINENBERG PG, 1989, BIOCHIM BIOPHYS ACTA, V1008, P157, DOI 10.1016/0167-4781(80)90003-2; CAI DY, 1994, BIOCHEMISTRY-US, V33, P7647, DOI 10.1021/bi00190a019; COLLISON D, 1989, BIOCHEM J, V264, P663, DOI 10.1042/bj2640663; COOPER RA, 1992, BIOCHEM J, V288, P337, DOI 10.1042/bj2880337; HARTMANN C, 1991, BIOCHEMISTRY-US, V30, P4605, DOI 10.1021/bi00232a035; HARTMANN C, 1993, BIOCHEMISTRY-US, V32, P2234, DOI 10.1021/bi00060a015; JANES SM, 1991, BIOCHEMISTRY-US, V30, P4599, DOI 10.1021/bi00232a034; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JANES SM, 1992, BIOCHEMISTRY-US, V31, P12147, DOI 10.1021/bi00163a025; KUMAGAI H, 1985, STRUCTURE FUNCTION A, P37; MATSUZAKI R, 1994, FEBS LETT, V351, P360, DOI 10.1016/0014-5793(94)00884-1; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; McIntire W. S., 1993, COPPER CONTAINING AM, P97; MORPURGO L, 1992, BIOCHEMISTRY-US, V31, P2615, DOI 10.1021/bi00124a023; MU D, 1994, J BIOL CHEM, V269, P9926; MU D, 1992, J BIOL CHEM, V267, P7979; MURE M, 1993, J AM CHEM SOC, V115, P7117, DOI 10.1021/ja00069a008; NOVOTNY WF, 1994, J BIOL CHEM, V269, P9921; ROSSI A, 1992, FEBS LETT, V301, P253, DOI 10.1016/0014-5793(92)80251-B; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT RA, 1985, J AM CHEM SOC, V107, P4348, DOI 10.1021/ja00300a055; SHIMIZU E, 1994, BIOSCI BIOTECH BIOCH, V58, P2118, DOI 10.1271/bbb.58.2118; SHIMIZU E, 1990, AGR BIOL CHEM TOKYO, V54, P851, DOI 10.1080/00021369.1990.10870020; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; SUZUKI S, 1983, BIOCHEMISTRY-US, V22, P1630, DOI 10.1021/bi00276a016; TANIZAWA K, 1994, BIOCHEM BIOPH RES CO, V199, P1096, DOI 10.1006/bbrc.1994.1343; WARNCKE K, 1994, J AM CHEM SOC, V116, P4028, DOI 10.1021/ja00088a042; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993	38	72	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4712	4720		10.1074/jbc.270.9.4712	http://dx.doi.org/10.1074/jbc.270.9.4712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876243	hybrid			2022-12-27	WOS:A1995QK08400078
J	OBOYLE, DR; WAGERSMITH, K; STEVENS, JT; WEINHEIMER, SP				OBOYLE, DR; WAGERSMITH, K; STEVENS, JT; WEINHEIMER, SP			THE EFFECT OF INTERNAL AUTOCLEAVAGE OIL KINETIC-PROPERTIES OF THE HUMAN CYTOMEGALOVIRUS PROTEASE CATALYTIC DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; COMPLETE DNA-SEQUENCE; ASSEMBLY PROTEIN; READING FRAME; IDENTIFICATION; CLEAVAGE; GENE; UL26; EXPRESSION; PRODUCTS	The 28-kilodalton (kDa) catalytic domain of the human cytomegalovirus (HCMV) protease undergoes autoproteolytic cleavage at an internal site (I site), yielding amino terminal 15-kDa (N15) and carboxyl terminal 13-kDa (C13) fragments. I site autocleavage has been postulated to inactivate the protease and provide a mechanism for the negative regulation of enzyme activity during viral infection, We purified recombinant enzymes to demonstrate I site autocleavage in vitro and used site directed mutagenesis of the I site to stabilize the protease. No difference in the kinetic properties of wild type and stabilized mutant proteases were ob served in an in vitro peptide cleavage assay. The consequences of I site cleavage on enzyme activity were investigated two ways. First, autodigestion of the wild type enzyme converted the intact protease to N15 and C13 autocleavage products without a corresponding loss in enzyme activity. Second, genetic constructs encoding the N15 and C13 autocleavage products were generated and expressed separately in Escherichia coli, and each fragment was purified. An active enzyme was reconstituted by refolding a mixture of the purified fragments in vitro to form a noncovalent complex. The kinetic properties of this complex were very similar to the wild type and stabilized enzymes under optimal reaction conditions. We concluded from these studies that I site cleavage does not inactivate the HCMV protease, in the absence of other virally induced factors, and that limited potential exists for the regulation of catalytic activity by I site cleavage.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT VIROL, PRINCETON, NJ 08543 USA	Bristol-Myers Squibb								BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BAUM EZ, 1993, J VIROL, V67, P497, DOI 10.1128/JVI.67.1.497-506.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCK PJ, 1994, J VIROL, V68, P2937, DOI 10.1128/JVI.68.5.2937-2946.1994; CHEE MS, 1990, CURR TOP MICROBIOL I, V154, P126; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; DAVISON MD, 1992, J GEN VIROL, V73, P2709, DOI 10.1099/0022-1317-73-10-2709; DECKMAN IC, 1992, J VIROL, V66, P7362, DOI 10.1128/JVI.66.12.7362-7367.1992; DILANNI CL, 1993, J BIOL CHEM, V268, P2048; DUDA CT, 1982, J BIOL CHEM, V257, P9866; GAO M, 1994, J VIROL, V68, P3702, DOI 10.1128/JVI.68.6.3702-3712.1994; JONES TR, 1994, J VIROL, V68, P3742, DOI 10.1128/JVI.68.6.3742-3752.1994; LIU FY, 1991, J VIROL, V65, P5149, DOI 10.1128/JVI.65.10.5149-5156.1991; LIU FY, 1991, J VIROL, V65, P206, DOI 10.1128/JVI.65.1.206-212.1991; LIU FY, 1993, J VIROL, V67, P1300, DOI 10.1128/JVI.67.3.1300-1309.1993; LIU FY, 1992, P NATL ACAD SCI USA, V89, P2076, DOI 10.1073/pnas.89.6.2076; MCCANN PJ, 1994, J VIROL, V68, P526, DOI 10.1128/JVI.68.1.526-529.1994; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; NEURATH H, 1989, PROTEOLYTIC ENZYMES, P1; PERSON S, 1993, J GEN VIROL, V74, P2269, DOI 10.1099/0022-1317-74-10-2269; PRESTON VG, 1992, VIROLOGY, V186, P87, DOI 10.1016/0042-6822(92)90063-U; PRESTON VG, 1983, J VIROL, V45, P1056, DOI 10.1128/JVI.45.3.1056-1064.1983; RIXON FJ, 1988, J GEN VIROL, V69, P2879, DOI 10.1099/0022-1317-69-11-2879; Sambrook J, 1989, MOL CLONING LABORATO; SARDANA VV, 1994, J BIOL CHEM, V269, P14337; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHENK P, 1991, J VIROL, V65, P1525, DOI 10.1128/JVI.65.3.1525-1529.1991; STEVENS JT, 1994, EUR J BIOCHEM, V226, P361, DOI 10.1111/j.1432-1033.1994.tb20060.x; WEINHEIMER SP, 1993, J VIROL, V67, P5813, DOI 10.1128/JVI.67.10.5813-5822.1993; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; WELCH AR, 1993, J VIROL, V67, P7360, DOI 10.1128/JVI.67.12.7360-7372.1993	31	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4753	4758		10.1074/jbc.270.9.4753	http://dx.doi.org/10.1074/jbc.270.9.4753			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876248	hybrid			2022-12-27	WOS:A1995QK08400084
J	WARE, FE; VASSILAKOS, A; PETERSON, PA; JACKSON, MR; LEHRMAN, MA; WILLIAMS, DB				WARE, FE; VASSILAKOS, A; PETERSON, PA; JACKSON, MR; LEHRMAN, MA; WILLIAMS, DB			THE MOLECULAR CHAPERONE CALNEXIN BINDS GLC(1)MAN(9)GLCNAC(2) OLIGOSACCHARIDE AS AN INITIAL STEP IN RECOGNIZING UNFOLDED GLYCOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; IDENTIFICATION; PURIFICATION; MEMBRANE; PEPTIDE; LECTINS; CELLS; GENE; IP90	Calnexin is a molecular chaperone that resides in the membrane of the endoplasmic reticulum, Most proteins that calnexin binds are N-glycosylated, and treatment of cells with tunicamycin or inhibitors of initial glucose trimming steps interferes with calnexin binding. To test if calnexin is a lectin that binds early oligosaccharide processing intermediates, a recombinant soluble calnexin was created, Incubation of soluble calnexin with a mixture of Glc(0-3)Man(9)GlcNAc(2) oligosaccharides resulted in specific binding of the Glc(1)Man(9)GlcNAc(2) species, Furthermore, Glc(1)Man(5-7)GlcNAc(2) oligosaccharides bound relatively poorly, suggesting that, in addition to a requirement for the single terminal glucose residue, at least one of the terminal mannose residues was important for binding, To assess the involvement of oligosaccharide-protein interactions in complexes of calnexin and newly synthesized glycoproteins, alpha(1)-antitrypsin or the heavy chain of the class I histocompatibility molecule were purified as complexes with calnexin and digested with endoglycosidase H. All oligosaccharides on either glycoprotein were accessible to this probe and could be removed without disrupting the association with calnexin, Furthermore, the addition of 1 M alpha-methyl glucoside or alpha-methyl mannoside had no effect on complex stability, These findings suggest that once complexes between calnexin and glycoproteins are formed, oligosaccharide binding does not contribute significantly to the overall interaction, However, it is likely that the binding of Glc(1)Man(9)GlcNAc(2) oligosaccharides is a crucial event during the initial recognition of newly synthesized glycoproteins by calnexin.	UNIV TORONTO, DEPT BIOCHEM, TORONTO, ON M5S 1A8, CANADA; UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA; BW JOHNSON PHARMACEUT RES INST, LA JOLLA, CA 92121 USA	University of Toronto; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIGMS NIH HHS [GM38545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R56GM038545] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CALA SE, 1993, J BIOL CHEM, V268, P2969; CAMP LA, 1993, J BIOL CHEM, V268, P6721; Capps G. G., 1993, Molecular Biology of the Cell, V4, p206A; CAPPS GG, 1994, J BIOL CHEM, V269, P11634; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; GANAN S, 1991, BIOCHEMISTRY-US, V30, P3098, DOI 10.1021/bi00226a017; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUBBARD SC, 1979, J BIOL CHEM, V254, P4568; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LE AQ, 1994, J BIOL CHEM, V269, P7514; LENTER M, 1994, J BIOL CHEM, V269, P12263; LOO TW, 1994, J BIOL CHEM, V269, P28683; MARGOLESE L, 1993, J BIOL CHEM, V268, P17959; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; NOSSNER E, 1995, J EXP MED, V181, P327, DOI 10.1084/jem.181.1.327; OSAWA T, 1987, ANNU REV BIOCHEM, V56, P21, DOI 10.1146/annurev.biochem.56.1.21; OU WJ, 1992, J BIOL CHEM, V267, P23789; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; OU WJ, 1994, MOL BIOL CELL, V5, P202; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; SCHREIBER KL, 1994, INT IMMUNOL, V6, P101, DOI 10.1093/intimm/6.1.101; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; WADA I, 1994, J BIOL CHEM, V269, P7464; WADA I, 1991, J BIOL CHEM, V266, P19599; ZENG Y, 1991, ANAL BIOCHEM, V193, P266, DOI 10.1016/0003-2697(91)90020-T; ZHU XY, 1992, J BIOL CHEM, V267, P8895	42	384	387	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4697	4704		10.1074/jbc.270.9.4697	http://dx.doi.org/10.1074/jbc.270.9.4697			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876241	hybrid			2022-12-27	WOS:A1995QK08400076
J	KAPLAN, RS; MAYOR, JA; GREMSE, DA; WOOD, DO				KAPLAN, RS; MAYOR, JA; GREMSE, DA; WOOD, DO			HIGH-LEVEL EXPRESSION AND CHARACTERIZATION OF THE MITOCHONDRIAL CITRATE TRANSPORT PROTEIN FROM THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ASPARTATE GLUTAMATE CARRIER; BOVINE HEART-MITOCHONDRIA; BROWN FAT MITOCHONDRIA; ADP ATP TRANSLOCASE; TRICARBOXYLATE CARRIER; KINETIC CHARACTERIZATION; STRUCTURAL RELATIONSHIP; UNCOUPLING PROTEIN; ACID SYNTHESIS	The gene encoding the mitochondrial citrate transport protein (CTP) in the yeast Saccharomyces cerevisiae has been identified, and its protein product has been overexpressed in Escherichia coli, The expressed CTP accumulates in inclusion bodies and can be solubilized with sarkosyl, Approximately 25 mg of solubilized CTP at a purity of 75% is obtained per liter of E, coli culture, The function of the solubilized CTP has been reconstituted in a Liposomal system where both its kinetic parameters (i.e, K-m = 0.36 mM and V-max = 2.5 mu mol/ min/mg protein) and its substrate specificity have been determined, Notably, the yeast CTP displays a stricter specificity for tricarboxylates than do CTPs from higher eukaryotic organisms. Dot matrix analysis of the yeast CTP sequence indicates the presence of three homologous sequence domains (each approximately 100 residues in length), which are also related to domains in other CTPs, Thus, the yeast CTP displays the tripartite structure characteristic of other mitochondrial transporters, Alignment of the yeast CTP sequence with CTPs from other sources defines a consensus sequence that displays 89 positions of amino acid identity, as well as the more generalized mitochondrial transporter-associated sequence motif, Based on hydropathy analysis, the yeast CTP contains six putative membrane-spanning cy-helices, Finally, Southern blot analysis indicates that the yeast genome contains a single gene encoding the mitochondrial CTP, Our data indicate that, based on both its structural and functional properties, the expressed yeast CTP can be assigned membership in the mitochondrial carrier family, The identification of the yeast CTP gene, and the expression and purification of large quantities of its protein product, pave the way for investigations into the roles of specific amino acids in the CTP translocation mechanism, as well as for the initiation of crystallization trials.	UNIV SO ALABAMA,COLL MED,DEPT PEDIAT,MOBILE,AL 36688; UNIV SO ALABAMA,COLL MED,DEPT MICROBIOL & IMMUNOL,MOBILE,AL 36688	University of South Alabama; University of South Alabama	KAPLAN, RS (corresponding author), UNIV SO ALABAMA,COLL MED,DEPT PHARMACOL,MOBILE,AL 36688, USA.		Mayor, June/AAP-1544-2021					ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; BISACCIA F, 1992, BIOCHIM BIOPHYS ACTA, V1106, P291, DOI 10.1016/0005-2736(92)90008-A; BISACCIA F, 1990, BIOCHIM BIOPHYS ACTA, V1019, P250, DOI 10.1016/0005-2728(90)90201-E; BISACCIA F, 1989, BIOCHIM BIOPHYS ACTA, V977, P171, DOI 10.1016/S0005-2728(89)80068-4; BRUNENGR.H, 1973, FEBS LETT, V36, P130, DOI 10.1016/0014-5793(73)80353-9; CLAASSEN LA, 1991, J BIOL CHEM, V266, P11380; CLAEYS D, 1989, J BIOL CHEM, V264, P14627; CONOVER TE, 1987, TRENDS BIOCHEM SCI, V12, P88, DOI 10.1016/0968-0004(87)90042-9; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; EVANS CT, 1983, EUR J BIOCHEM, V130, P195; FERNANDEZ M, 1994, MOL GEN GENET, V242, P727; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; GLERUM DM, 1990, EUR J BIOCHEM, V194, P681, DOI 10.1111/j.1432-1033.1990.tb15668.x; HOLMSTROM K, 1994, YEAST, V10, pS47, DOI 10.1002/yea.320100007; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1993, J BIOENERG BIOMEMBR, V25, P503, DOI 10.1007/BF01108407; KAPLAN RS, 1985, J BIOL CHEM, V260, P293; KAPLAN RS, 1990, J BIOL CHEM, V265, P13379; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KOLAROV J, 1972, BIOCHIM BIOPHYS ACTA, V267, P457, DOI 10.1016/0005-2728(72)90173-9; KRAMER R, 1986, ARCH BIOCHEM BIOPHYS, V251, P166, DOI 10.1016/0003-9861(86)90063-9; Krumer R., 1992, MOL MECHANISMS BIOEN, P359, DOI DOI 10.1016/50167-7306(08)60184-2; KUAN J, 1993, RES MICROBIOL, V144, P671, DOI 10.1016/0923-2508(93)90073-B; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x; PERKINS M, 1973, BIOCHEM J, V134, P923, DOI 10.1042/bj1340923; PERSSON LO, 1992, BIOCHEM BIOPH RES CO, V183, P70, DOI 10.1016/0006-291X(92)91610-3; PHELPS A, 1991, BIOCHEMISTRY-US, V30, P248, DOI 10.1021/bi00215a035; ROISE D, 1988, J BIOL CHEM, V263, P4509; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; VINAS O, 1990, BIOCHEM J, V265, P321, DOI 10.1042/bj2650321; WATSON JA, 1970, J BIOL CHEM, V245, P5993; WOHLRAB H, 1994, BIOCHEMISTRY-US, V33, P9371, DOI 10.1021/bi00198a001	43	129	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4108	4114		10.1074/jbc.270.8.4108	http://dx.doi.org/10.1074/jbc.270.8.4108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876161				2022-12-27	WOS:A1995QH68800094
J	CZAJKOWSKI, C; KARLIN, A				CZAJKOWSKI, C; KARLIN, A			STRUCTURE OF THE NICOTINIC RECEPTOR ACETYLCHOLINE-BINDING SITE - IDENTIFICATION OF ACIDIC RESIDUES IN THE DELTA-SUBUNIT WITHIN 0.9-NM OF THE ALPHA-SUBUNIT-BINDING SITE DISULFIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MUTAGENESIS; TORPEDO-CALIFORNICA; LIGAND-BINDING; AMINO-ACIDS; PROTEINS; MEMBRANES; AFFINITY; INTERFACES; CLEAVAGE; SEQUENCE	In the nicotinic receptor, the quaternary ammonium group of acetylcholine (ACh) binds to a negative subsite at most 1 nm from a readily reducible disulfide formed between alpha-subunit residues Cys(192) and Cys(193). The cross-linker S-(2-[H-3]glycylamidoethyl)dithio-2-pyridine formed a disulfide bond with reduced alpha Cys(192)/Cys(193) and an amide bond with an acidic residue in the delta subunit (Czajkowski, C., and Karlin, A (1991) J. Biol. Chem. 266, 22603-22612). The fully extended cross-linking moiety -NRCH(2)CONHCH(2)CH(2)S- is 0.9 nm long. After the disulfide bond linking -NRCH(2)CONHCH(2)CH(2)S- to the alpha subunit was reduced, -NHCH2CONHCH2CH2SH remained linked to the delta subunit by an amide bond. The delta subunit was cleaved at Met residues, and the radioactive fragments were isolated and sequenced by automated Edman degradation. Additionally, the isolated radioactive fragments were further cleaved at Trp residues and sequenced. Peaks of release of radioactivity were obtained in the sequencing cycles corresponding to delta Asp(165), delta Asp(180) and delta Glu(182). The mutation of delta Asp(180) to Asn decreased the affinity of the receptor for ACh 100-fold, whereas the mutation of either delta Asp(165) delta Glu(182), Or 8 Other acidic residues in the same region of delta decreased the affinity by 3-fold or less (Czajkowski, C., Kaufmann, C., and Karlin, A. (1993) Proc. Natl. Acad. Sci. U. S. A 90, 6285-6289). Because delta Asp(180) both contributes to ACh binding and is suitably close to the binding site disulfide, it is likely to be part of the ACh-binding site formed in the interface between the alpha and the delta subunits.	COLUMBIA UNIV, COLL PHYS & SURG, CTR MOLEC RECOGNIT, NEW YORK, NY 10032 USA	Columbia University				KARLIN, ARTHUR/0000-0002-4813-752X	NINDS NIH HHS [NS07065, NS07258] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BRANDT WF, 1976, H-S Z PHYSIOL CHEM, V357, P1505, DOI 10.1515/bchm2.1976.357.2.1505; CHAK A, 1992, METHOD ENZYMOL, V207, P546; CHIARA DC, 1992, FASEB J, V6, pA106; COHEN JB, 1991, J BIOL CHEM, V266, P23354; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DAMLE VN, 1978, BIOCHEMISTRY-US, V17, P2039, DOI 10.1021/bi00604a002; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; DOWDING AJ, 1987, BIOCHEMISTRY-US, V26, P6372, DOI 10.1021/bi00394a010; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; KARLIN A, 1969, J GEN PHYSIOL, V54, pS245; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; NEUBIG RR, 1979, BIOCHEMISTRY-US, V18, P5464, DOI 10.1021/bi00591a032; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; PEDERSEN SE, 1990, P NATL ACAD SCI USA, V87, P2785, DOI 10.1073/pnas.87.7.2785; REITER MJ, 1972, P NATL ACAD SCI USA, V69, P1168, DOI 10.1073/pnas.69.5.1168; REYNOLDS JA, 1978, BIOCHEMISTRY-US, V17, P2035, DOI 10.1021/bi00604a001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3	39	89	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3160	3164		10.1074/jbc.270.7.3160	http://dx.doi.org/10.1074/jbc.270.7.3160			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852399	hybrid			2022-12-27	WOS:A1995QG47100042
J	FUJII, H; YONETANI, T; MIKI, T; KAKINUMA, K				FUJII, H; YONETANI, T; MIKI, T; KAKINUMA, K			MODULATION OF THE HEME ENVIRONMENT OF NEUTROPHIL CYTOCHROME B(558) TO A CYTOCHROME P450-LIKE STRUCTURE BY PYRIDINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ELECTRON-PARAMAGNETIC RESONANCE; NADPH OXIDASE SYSTEM; PORCINE NEUTROPHILS; RESPIRATORY BURST; PLASMA-MEMBRANES; INVOLVEMENT; SUBUNIT; CHAIN; GRANULOCYTES	The effect of pyridine on the heme environment of cytochrome b(558) was studied using ESR and optical absorption spectroscopy in relation to the O-2(-)-generating activity in the NADPH oxidase system of stimulated pig neutrophils. As the concentration of pyridine increased, the absorption maxima of the alpha- and gamma-bands of cytochrome b(558) shifted which correlated with a concomitant decrease in O, generating activity. In addition, the g = 3.2 signal of cytochrome b(558) decreased with the concomitant appearance of a new ESR spectrum that strikingly resembled that of cytochrome P450. The results suggest that pyridine induces a structural modification in the heme environment of cytochrome b(558) by shifting the 5th heme ligand (histidine) to a nearby thio late group without direct binding of pyridine to the heme. The existence of a reactive thiolate near the heme iron was confirmed by pretreatment of blocked cytochrome b(558) with p-chloromercuribenzoate, which completely inhibited the formation of the cytochrome P450-like ESR spectrum. The results provide further evidence that a low-spin heme iron of cytochrome b(558) with a g-value of 3.2 is essential to the O-2(-)-forming reaction of the NADPH oxidase system, From sequence alignments of cytochrome P450 with those of large and small subunits of cytochrome b(558) the heme in cytochrome b(588) appears to be specifically associated with the large subunit.	UNIV PENN,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104	University of Pennsylvania	FUJII, H (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT INFLAMMAT RES,BUNKYO KU,18-22 HONKOMAGOME 3-CHOME,TOKYO 113,JAPAN.							BABIOR BM, 1984, BLOOD, V64, P959; BOLSCHER BGJM, 1991, BLOOD, V77, P2482; CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CURNUTTE JT, 1993, CLIN IMMUNOL IMMUNOP, V67, pS2, DOI 10.1006/clin.1993.1078; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; FUJII H, 1990, J BIOCHEM-TOKYO, V108, P292, DOI 10.1093/oxfordjournals.jbchem.a123196; FUJII H, 1992, BIOCHIM BIOPHYS ACTA, V1136, P239, DOI 10.1016/0167-4889(92)90112-O; FUJII H, 1991, BIOCHIM BIOPHYS ACTA, V1095, P201, DOI 10.1016/0167-4889(91)90100-C; HASHIMOTO Y, 1962, J BIOL CHEM, V237, P3843; IIZUKA T, 1985, BIOCHEM BIOPH RES CO, V130, P621, DOI 10.1016/0006-291X(85)90462-0; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; ISOGAI Y, 1993, J BIOL CHEM, V268, P4025; ISOGAI Y, 1991, J BIOL CHEM, V266, P13481; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; MIKI T, 1992, J BIOL CHEM, V267, P18695; MIKI T, 1992, J BIOL CHEM, V267, P19673; NUGENT JHA, 1989, BIOCHEM J, V264, P921, DOI 10.1042/bj2640921; OMURA T, 1962, J BIOL CHEM, V237, P1375; ORKIN SH, 1989, ANNU REV IMMUNOL, V7, P277; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; POULOS TL, 1985, J BIOL CHEM, V260, P6122; QUINN MT, 1992, J BIOL CHEM, V267, P7303; SAKURAI H, 1981, BIOCHEM BIOPH RES CO, V101, P1102, DOI 10.1016/0006-291X(81)91561-8; SEGAL AW, 1978, NATURE, V276, P515, DOI 10.1038/276515a0; SEGAL AW, 1989, J CLIN INVEST, V83, P1785, DOI 10.1172/JCI114083; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; WAKEYAMA H, 1982, BIOCHEM J, V205, P593, DOI 10.1042/bj2050593; YAMAGUCHI T, 1989, J BIOL CHEM, V264, P112	30	10	10	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3193	3196		10.1074/jbc.270.7.3193	http://dx.doi.org/10.1074/jbc.270.7.3193			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852403	hybrid			2022-12-27	WOS:A1995QG47100047
J	MOURAO, PAS; ASSREUY, AMS				MOURAO, PAS; ASSREUY, AMS			TREHALOSE AS A POSSIBLE PRECURSOR OF THE SULFATED L-GALACTAN IN THE ASCIDIAN TUNIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHED CHONDROITIN SULFATE; PLICATA CHORDATA-TUNICATA; URONOSYL C-5 EPIMERASE; SEA-CUCUMBER; BODY WALL; GLYCANS; POLYSACCHARIDES; BIOSYNTHESIS; FRACTIONATION; HETEROGENEITY	Among sulfated polysaccharides, those in the tunic of ascidians are unique: their major constituent sugar is galactose, which occurs exclusively in the L-enantiomeric form. Incorporation of D-[C-14]glucose into tunic slices in. vitro revealed that the cells epimerize D-glucose into L-galactose during biosynthesis of the sulfated polysaccharides. The interconversion of these two sugars involves exchange of hydrogen atoms at the epimerization sites with protons of the medium. Tunic cells also synthesize trehalose, although this disaccharide is not a prominent constituent of the tissue. Pulse-chase experiments using D-[C-14]glucose reveal that incorporation of label into trehalose precedes the synthesis of the sulfated L-galactan. In addition, the loss of label from trehalose coincides with the appearance of label in the sulfated L-galactan. Based on these results, we speculate that trehalose in the ascidian tunic may be a precursor of the sulfated L-galactan.			MOURAO, PAS (corresponding author), UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,CAIXA POSTAL 68041,BR-21941590 RIO JANEIRO,BRAZIL.		Mourao, Paulo/AAA-5386-2020					ADAMS E, 1976, ADV ENZYMOL RAMB, V44, P69; ALBANO RM, 1983, BIOCHIM BIOPHYS ACTA, V760, P192, DOI 10.1016/0304-4165(83)90143-5; ALBANO RM, 1990, CARBOHYD RES, V208, P163, DOI 10.1016/0008-6215(90)80096-L; ALBANO RM, 1986, J BIOL CHEM, V261, P758; ANDERSON E, 1947, J BIOL CHEM, V168, P284; AVIGAD G, 1962, J BIOL CHEM, V237, P2736; BARBER GA, 1980, J BIOL CHEM, V254, P7600; BARNES RD, 1980, INVERTEBRATE ZOOLOGY, P1030; Bell DJ, 1941, J CHEM SOC, P125, DOI 10.1039/jr9410000125; CORREA JOAO BATISTA CHAVES, 1967, CARBOHYD RES, V3, P445, DOI 10.1016/S0008-6215(00)81676-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FEINGOLD DS, 1982, ENCY PLANT PHYS A, V13, P37; GABRIEL O, 1978, TRENDS BIOCHEM SCI, V3, P193, DOI 10.1016/S0968-0004(78)91666-3; JACOBSSON I, 1979, J BIOL CHEM, V254, P2975; LELOIR LF, 1960, COMP BIOCH, V2, P117; MALMSTROM A, 1980, J BIOL CHEM, V255, P3878; MAYER RM, 1987, METHOD ENZYMOL, V138, P648; MOURAO PAS, 1987, EUR J BIOCHEM, V166, P431, DOI 10.1111/j.1432-1033.1987.tb13534.x; MOURAO PAS, 1991, BIOCHEMISTRY-US, V30, P3458, DOI 10.1021/bi00228a016; MOURAO PAS, 1987, EUR J BIOCHEM, V166, P639, DOI 10.1111/j.1432-1033.1987.tb13561.x; MULLOY B, 1994, J BIOL CHEM, V269, P22113; Painter T.J., 1983, POLYSACCHARIDES, P196, DOI DOI 10.1016/B978-0-12-065602-8.50009-1; PANEK AD, 1991, YEASTS, V4, P655; PAVAO MSG, 1989, J BIOL CHEM, V264, P9972; PAVAO MSG, 1994, BBA-GEN SUBJECTS, V1199, P229, DOI 10.1016/0304-4165(94)90001-9; PAVAO MSG, 1989, CARBOHYD RES, V189, P374, DOI 10.1016/0008-6215(89)84115-1; PAVAO MSG, 1990, CARBOHYD RES, V208, P153, DOI 10.1016/0008-6215(90)80095-K; PRIHAR HS, 1980, BIOCHEMISTRY-US, V19, P495, DOI 10.1021/bi00544a016; RIBEIRO AC, 1994, CARBOHYD RES, V255, P225, DOI 10.1016/S0008-6215(00)90981-9; SANTOS JA, 1992, EUR J BIOCHEM, V204, P669, DOI 10.1111/j.1432-1033.1992.tb16680.x; SLEIN MW, 1955, METHOD ENZYMOL, V1, P299, DOI 10.1016/0076-6879(55)01041-0; STAMBUK BU, 1993, ANAL BIOCHEM, V212, P150, DOI 10.1006/abio.1993.1305; VIEIRA RP, 1993, BIOCHEMISTRY-US, V32, P2254, DOI 10.1021/bi00060a018; VIEIRA RP, 1988, J BIOL CHEM, V263, P18176; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530	36	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3132	3140		10.1074/jbc.270.7.3132	http://dx.doi.org/10.1074/jbc.270.7.3132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852395	hybrid			2022-12-27	WOS:A1995QG47100038
J	BHARADWAJ, D; HARRIS, RJ; KISIEL, W; SMITH, KJ				BHARADWAJ, D; HARRIS, RJ; KISIEL, W; SMITH, KJ			ENZYMATIC REMOVAL OF SIALIC-ACID FROM HUMAN FACTOR-IX AND FACTOR-X HAS NO EFFECT ON THEIR COAGULANT ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOTTING FACTOR-IX; STRUCTURAL-ANALYSIS; TISSUE FACTOR; ACTIVATION; IDENTIFICATION; PURIFICATION; SERINE-61; RESIDUES; CHAINS; FUCOSE	Factor IX and factor X have sialic acid in O-linked and N-linked oligosaccharides on their activation peptides, and a terminal sialic acid is found on a recently described O-linked tetrasaccharide at Ser-61 in the light chain of human factor Ma. In studies presented here, the potential role of sialic acid residues in mediating activity of human coagulation factors IX and X was tested after enzymatic removal of sialic acid residues. In contrast to previous reports, treatment of factor IX or factor Ma with recombinant sialidase did not decrease the rate of factor IX activation or proteolytic properties of human factor IXa. The activation rates of factor IX and desialated factor IX were indistinguishable when treated with factor XIa, with factor VIIa/tissue factor complex, and with the factor X activating enzyme from Russell's viper venom. Desialated human factor Ma showed full activity in the non-activated partial thromboplastin time assay and retained full ''tenase'' activity in a coupled amidolytic assay. Similar experiments with human factor X showed no detectable loss of clotting activity in the prothrombin time assay after desialation. Additionally, desialated human factor X was cleaved by the factor X activating enzyme from Russell's viper venom and intrinsic tenase at the same rate as untreated factor X when analyzed by SDS-polyacrylamide gel electrophoresis. These studies have shown that factor IX and factor X clotting activity are not dependent on sialic acid content. Further studies are needed to determine whether desialated factor IX binds to endothelial cells, and whether factors IX and X are more rapidly cleared from circulation or have altered susceptibility to proteolysis after enzymatic removal of sialic acid.	UNIV NEW MEXICO,SCH MED,DEPT PATHOL,ALBUQUERQUE,NM 87131; UNIV NEW MEXICO,SCH MED,DEPT BIOCHEM,ALBUQUERQUE,NM 87131; UNIV NEW MEXICO,SCH MED,DEPT MED,ALBUQUERQUE,NM 87131; GENENTECH INC,DEPT ANALYT CHEM,S SAN FRANCISCO,CA 94080	University of New Mexico; University of New Mexico; University of New Mexico; Roche Holding; Genentech				Bharadwaj, Dwaipayan/0000-0001-5268-8482				AGARWALA KL, 1994, BIOCHEMISTRY-US, V33, P5167, DOI 10.1021/bi00183a021; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BROZE GJ, 1985, J BIOL CHEM, V260, P917; CHAVIN SI, 1984, J BIOL CHEM, V259, P3387; DISCIPIO RG, 1978, J CLIN INVEST, V61, P1528, DOI 10.1172/JCI109073; DO SI, 1990, J BIOL CHEM, V265, P114; GIANNELLI F, 1993, NUCLEIC ACIDS RES, V21, P3075, DOI 10.1093/nar/21.13.3075; HAJJAR KA, 1994, J CLIN INVEST, V93, P703, DOI 10.1172/JCI117023; HAMAMOTO T, 1993, J BIOL CHEM, V268, P8704; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; INOUE K, 1993, EUR J BIOCHEM, V218, P153, DOI 10.1111/j.1432-1033.1993.tb18361.x; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; KURAYA N, 1993, J BIOCHEM-TOKYO, V114, P763, DOI 10.1093/oxfordjournals.jbchem.a124252; LIN SW, 1990, J BIOL CHEM, V265, P144; LINK RP, 1983, BIOCHEMISTRY-US, V22, P4033, DOI 10.1021/bi00286a007; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; MORELL AG, 1968, J BIOL CHEM, V243, P155; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; SINHA U, 1993, J BIOL CHEM, V268, P3048; SMITH KJ, 1988, BLOOD, V72, P1269; THOMPSON AR, 1986, BLOOD, V67, P565	23	16	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6537	6542		10.1074/jbc.270.12.6537	http://dx.doi.org/10.1074/jbc.270.12.6537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896789	hybrid			2022-12-27	WOS:A1995QQ85500019
J	PAJOR, AM				PAJOR, AM			SEQUENCE AND FUNCTIONAL-CHARACTERIZATION OF A RENAL SODIUM DICARBOXYLATE COTRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANES; EXPRESSION CLONING; CITRATE TRANSPORT; DICARBOXYLATE TRANSPORT; VESICLES; SYSTEM; IDENTIFICATION; SUCCINATE	The cDNA coding for a rabbit renal Na+/dicarboxylate cotransporter, designated NaDC-1, was isolated by functional expression in Xenopus oocytes, NaDC-1 cDNA is approximately 2.3 kilobases in length and codes for a protein of 593 amino acids, NaDC-1 protein contains eight putative transmembrane domains, and the sequence and secondary structure are related to the renal Na+/sulfate transporter, NaSi-1. Northern analysis shows that the NdDC-1 message is abundant in kidney and small intestine, and related transporters may be found in liver, lung, and adrenal. The transport of succinate by NaDC-1 was sodium-dependent, sensitive to inhibition by lithium, and inhibited by a range of di- and tricarboxylic acids, This transporter also carries citrate, but it does not transport lactate, In kinetic experiments, the K-m for succinate was around 0.4 mM and the V-max was 15 nmol/oocyte/h, while the Hill coefficient of Na+ activation of succinate transport was 1.9. The transport of succinate by NaDC-1 was insensitive to changes in pH, whereas the transport of citrate increased with decreasing pH, in parallel with the concentration of divalent citrate in the medium, The results of the functional characterization indicate that NaDC-1 likely corresponds to the renal brush-border Na+/dicarboxylate cotransporter.			PAJOR, AM (corresponding author), UNIV ARIZONA,COLL MED,DEPT PHYSIOL,TUCSON,AZ 85724, USA.				NIDDK NIH HHS [DK46269] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046269] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; BRENNAN TS, 1986, AM J PHYSIOL, V251, pF683, DOI 10.1152/ajprenal.1986.251.4.F683; BURCKHARDT G, 1984, PFLUG ARCH EUR J PHY, V401, P254, DOI 10.1007/BF00582592; BUSCH AE, 1994, J BIOL CHEM, V269, P12407; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COADY MJ, 1990, ARCH BIOCHEM BIOPHYS, V283, P130, DOI 10.1016/0003-9861(90)90622-6; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; KHATRI IA, 1993, BIOCHEM J, V294, P391, DOI 10.1042/bj2940391; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; MARKOVICH D, 1993, P NATL ACAD SCI USA, V90, P8073, DOI 10.1073/pnas.90.17.8073; McCormick M, 1987, Methods Enzymol, V151, P445, DOI 10.1016/S0076-6879(87)51036-9; MOSELEY RH, 1992, AM J PHYSIOL, V263, pG871, DOI 10.1152/ajpgi.1992.263.6.G871; PAJOR AM, 1992, BIOCHIM BIOPHYS ACTA, V1106, P216, DOI 10.1016/0005-2736(92)90241-D; PAJOR AM, 1994, J AM SOC NEPHROL, V5, P296; PAJOR AM, 1992, J BIOL CHEM, V267, P3557; Pritchard J.B., 1992, KIDNEY PHYSL PATHOPH, P2921; QUICK M W, 1992, Biotechniques, V13, P362; STEFFGEN J, 1994, BIOCHEM J, V297, P35, DOI 10.1042/bj2970035; ULLRICH KJ, 1994, BBA-REV BIOMEMBRANES, V1197, P45, DOI 10.1016/0304-4157(94)90018-3; VANDERREST ME, 1992, J BIOL CHEM, V267, P8971; WOLFFRAM S, 1994, EXP PHYSIOL, V79, P215, DOI 10.1113/expphysiol.1994.sp003754; WRIGHT EM, 1982, P NATL ACAD SCI-BIOL, V79, P7514, DOI 10.1073/pnas.79.23.7514; WRIGHT EM, 1985, ANNU REV PHYSIOL, V47, P127; WRIGHT EM, 1992, CURR OPIN CELL BIOL, V4, P896; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; WRIGHT SH, 1982, BIOCHIM BIOPHYS ACTA, V684, P287, DOI 10.1016/0005-2736(82)90019-0; WRIGHT SH, 1980, J MEMBRANE BIOL, V57, P73, DOI 10.1007/BF01868987; WRIGHT SH, 1987, AM J PHYSIOL, V253, pF432, DOI 10.1152/ajprenal.1987.253.3.F432; ZIMMERLI B, 1992, PFLUG ARCH EUR J PHY, V421, P329, DOI 10.1007/BF00374220	32	148	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5779	5785		10.1074/jbc.270.11.5779	http://dx.doi.org/10.1074/jbc.270.11.5779			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890707	hybrid			2022-12-27	WOS:A1995QM94500017
J	SOBOL, RW; HENDERSON, EE; KON, N; SHAO, J; HITZGES, P; MORDECHAI, E; REICHENBACH, NL; CHARUBALA, R; SCHIRMEISTER, H; PFLEIDERER, W; SUHADOLNIK, RJ				SOBOL, RW; HENDERSON, EE; KON, N; SHAO, J; HITZGES, P; MORDECHAI, E; REICHENBACH, NL; CHARUBALA, R; SCHIRMEISTER, H; PFLEIDERER, W; SUHADOLNIK, RJ			INHIBITION OF HIV-1 REPLICATION AND ACTIVATION OF RNASE-L BY PHOSPHOROTHIOATE PHOSPHODIESTER 2',5'-OLIGOADENYLATE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; BIOLOGICAL-ACTIVITIES; ENZYMATIC-SYNTHESIS; CHEMICAL SYNTHESIS; (2'-5')OLIGOADENYLATE SYNTHETASE; 2',5'-OLIGONUCLEOTIDE ANALOGS; 2-5A-DEPENDENT RNASE; CORDYCEPIN ANALOGS; CELL-CYCLE	2',5'-Oligoadenylate (2-5A) derivatives have been designed to act distal to the human immunodeficiency virus-1 (HIV-1)-induced blockade in the 2-5A synthetase/RNase L antiviral pathway. Stereochemical modification of individual internucleotide linkages of the 2-5A molecule was accomplished by phosphoramidite and phosphotriester chemical syntheses. Phosphorothioate/phosphodiester trimer and tetramer 2-5A derivatives revealed differences in the stereodynamics of activation of RNase L and inhibition of HIV-1 replication. The first and second internucleotide linkages are critical for activation of recombinant, human RNase L; A(R(p))ApA, A(S-p)ApA and ApA(R(p))A are agonists (IC50 = 2 x 10(-7), 2 x 10(-6), and 8 x 10(-6) M); ApA(S-p)A is an antagonist. The second and third internucleotide linkages are crucial for activation of murine RNase L; ApA(R(p))A, ApA(R(p))ApA, and ApApA(R(p))A are agonists (IC50 = 5 x 10(-7) M); ApA(S-p)A, ApA(S-p)ApA, and ApApA(S-p)A are antagonists. Inhibition of HIV-1-induced syncytia formation by the phosphorothioate/phosphodiester derivatives is specific for derivatives with substitution at the 2',3'-terminus. ApA(R(p))A, ApA(S-p)A, ApApA(R(p))A, and ApApA(S-p)A are potent inhibitors of HIV-1-induced syncytia formation (80-, 10-, 40-, and 15-fold more inhibitory, respectively, than solvent control). HIV-1 infection results in enhanced uptake and accumulation of ApA(R(p))A and ApA(S-p)A (7- and 10-fold, respectively). These stereochemically modified 2-5A derivatives are taken up preferentially by HIV-1-infected cells and show promise in anti-HIV-1 chemotherapy.	TEMPLE UNIV,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140; TEMPLE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140; UNIV KONSTANZ,FAK CHEM,W-7750 CONSTANCE,GERMANY	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Konstanz			Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563	NCI NIH HHS [P30-CA12227] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012227] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BATTISTINI C, 1992, TETRAHEDRON, V48, P3209, DOI 10.1016/S0040-4020(01)92259-8; CHARACHON G, 1990, BIOCHEMISTRY-US, V29, P2550, DOI 10.1021/bi00462a017; CHARUBALA R, 1981, LIEBIGS ANN CHEM, P2392; CHARUBALA R, 1991, NUCLEOS NUCLEOT, V10, P383, DOI 10.1080/07328319108046484; CHARUBALA R, 1989, HELV CHIM ACTA, V72, P1354, DOI 10.1002/hlca.19890720624; CHARUBALA R, 1992, HELV CHIM ACTA, V75, P471, DOI 10.1002/hlca.19920750206; CHARUBALA R, 1991, HELV CHIM ACTA, V74, P892; CHARUBALA R, 1987, NUCLEOS NUCLEOT, V6, P2314; DANI C, 1985, P NATL ACAD SCI USA, V82, P4895; DEMAEYER E, 1991, CYTOKINE HDB, P215; DONG BH, 1994, J BIOL CHEM, V269, P14153; FLOCKERZIE F, 1981, LIEBIGS ANN CHEM, P1568; GAO WY, 1990, J BIOL CHEM, V265, P20172; HAIGLER HT, 1990, J BIOL CHEM, V255, P1239; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; HENDERSON EE, 1991, VIROLOGY, V182, P186, DOI 10.1016/0042-6822(91)90662-U; HOVANESSIAN AG, 1991, J INTERFERON RES, V11, P199, DOI 10.1089/jir.1991.11.199; HUGHES BG, 1983, BIOCHEMISTRY-US, V22, P2116, DOI 10.1021/bi00278a011; HUGHES BG, 1983, BIOCHEMISTRY-US, V22, P2127, DOI 10.1021/bi00278a012; Johnston M. I., 1984, INTERFERON MECHANISM, V3, P189; JONES SS, 1980, TETRAHEDRON, V36, P3075, DOI 10.1016/0040-4020(80)88035-5; KANOU M, 1990, NUCLEIC ACIDS RES, V18, P4439, DOI 10.1093/nar/18.15.4439; KANOU M, 1991, BIOCHEM BIOPH RES CO, V176, P769, DOI 10.1016/S0006-291X(05)80251-7; KARIKO K, 1987, BIOCHEMISTRY-US, V26, P7136, DOI 10.1021/bi00396a040; KARIKO K, 1987, BIOCHEMISTRY-US, V26, P7127, DOI 10.1021/bi00396a039; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KRAEMER KH, 1980, MUTAT RES, V72, P285, DOI 10.1016/0027-5107(80)90043-3; KRASZEWSKI A, 1987, NUCLEIC ACIDS RES S, V18, P177; KROGER CF, 1969, Z CHEM, V9, P378; LEE CG, 1985, BIOCHEMISTRY-US, V24, P551, DOI 10.1021/bi00324a001; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; MCNAIR ANB, 1992, PHARMACOL THERAPEUT, V56, P79, DOI 10.1016/0163-7258(92)90038-2; MONTEFIORI DC, 1989, P NATL ACAD SCI USA, V86, P7191, DOI 10.1073/pnas.86.18.7191; MULLER WEG, 1991, BIOCHEMISTRY-US, V30, P2027, DOI 10.1021/bi00222a004; NELSON PS, 1984, J ORG CHEM, V49, P2314, DOI 10.1021/jo00187a003; NOTH H, 1982, CHEM BER-RECL, V115, P3011, DOI 10.1002/cber.19821150907; PESTKA S, 1981, METHOD ENZYMOL, V78, P79; SCHRODER HC, 1994, CHEM-BIOL INTERACT, V90, P169, DOI 10.1016/0009-2797(94)90101-5; SCHRODER HC, 1990, AIDS RES HUM RETROV, V6, P659, DOI 10.1089/aid.1990.6.659; SCHRODER HC, 1989, J BIOL CHEM, V264, P5669; SENGUPTA DN, 1989, NUCLEIC ACIDS RES, V17, P969, DOI 10.1093/nar/17.3.969; SHIMAZU M, 1993, ANGEW CHEM INT EDIT, V32, P870, DOI 10.1002/anie.199308701; SILVERMAN RH, 1985, ANAL BIOCHEM, V144, P450, DOI 10.1016/0003-2697(85)90141-1; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOBOL RW, 1993, BIOCHEMISTRY-US, V32, P12112, DOI 10.1021/bi00096a023; SPERLING J, 1991, P NATL ACAD SCI USA, V88, P10377, DOI 10.1073/pnas.88.23.10377; SUHADOLNIK RJ, 1988, BIOCHEMISTRY-US, V27, P8846, DOI 10.1021/bi00424a024; SUHADOLNIK RJ, 1983, NUCLEOS NUCLEOT NUCL, V2, P351, DOI 10.1080/07328318308078869; SUHADOLNIK RJ, 1987, BIOCHEMISTRY-US, V26, P7143, DOI 10.1021/bi00396a041; SUHADOLNIK RJ, 1988, BIOCHEMISTRY-US, V27, P8840, DOI 10.1021/bi00424a023; WELLS V, 1985, EXP CELL RES, V159, P27, DOI 10.1016/S0014-4827(85)80034-3; WELLS V, 1988, J INTERFERON RES, V8, P793, DOI 10.1089/jir.1988.8.793; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	57	35	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5963	5978		10.1074/jbc.270.11.5963	http://dx.doi.org/10.1074/jbc.270.11.5963			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890727	hybrid			2022-12-27	WOS:A1995QM94500041
J	WOO, SB; TIMM, DE; NEET, KE				WOO, SB; TIMM, DE; NEET, KE			ALTERATION OF NH2-TERMINAL RESIDUES OF NERVE GROWTH-FACTOR AFFECTS ACTIVITY AND TRK BINDING WITHOUT AFFECTING STABILITY OR CONFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROTROPHIC FACTOR; TYROSINE KINASE-ACTIVITY; BIOLOGICAL-ACTIVITY; MOLECULAR-CLONING; FACTOR RECEPTORS; CRYSTAL-STRUCTURE; FACTOR FAMILY; PC12 CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2; PROTOONCOGENE PRODUCT	The role of the NH2-terminal region of nerve growth factor (NGF) was studied with an NGF Delta 9/13 deletion mutant, overexpressed in a baculovirus system, and mouse NGF truncated at Met 9 by cleavage with CNBr (des-(1-9)-NGF). Structural studies have been performed on the purified proteins, in addition to biological activity assessment, in order to determine effects of such modifications on global conformation and stability. The activity of NGF Delta 9/13 was reduced below detectable levels, and the activity of the des-(l-g)-NGF form was decreased by at least a 50-fold in a PC12 bioassay. Competitive binding of NGF Delta 9/13 to low affinity receptors on PC12 cells was not impaired; however, the mutant was not capable of competing for the cold chase stable, high affinity binding of NGF to the cells. The binding of NGF Delta 9/13 to Sg21 cells ectopically expressing the TrkA NGF receptor was also abolished. Thus, deletion of residues 9-13 significantly altered the binding affinity for the high affinity receptors on PC12 cells and for the TrkA receptor, but not for the low affinity receptor. Neither the secondary structure, determined by circular dichroism, nor the conformational stability determined by equilibrium denaturation of NGF Delta 9/13 was altered as compared with wild type NGF. Slight conformational and stability perturbations of des-(1-9)-NGF were revealed by the same analysis; however, these changes were found to reflect the influence of the formic acid treatment, not the truncation of 9 residues. Our results support the conclusion that the NH2-terminal domain encompassing residues 1-9 and 9-13 is essential for maintaining the binding capability of NGF for high affinity TrkA receptors. Moreover, conformational and stability data show that the functional results of these modifications of the NH2-terminal region are directly due to receptor binding and not to secondary effects of improper folding or other indirect structural changes.	FINCH UNIV HLTH SCI,CHICAGO MED SCH,DEPT BIOL CHEM,N CHICAGO,IL 60064	Chicago Medical School					NIGMS NIH HHS [GM08056] Funding Source: Medline; NINDS NIH HHS [NS24380] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417; ANGELETT.RH, 1973, BIOCHEMISTRY-US, V12, P90, DOI 10.1021/bi00725a017; BARBACID M, 1993, ONCOGENE, V8, P2033; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BURTON LE, 1992, J NEUROCHEM, V59, P1937, DOI 10.1111/j.1471-4159.1992.tb11030.x; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; COHEN P, 1980, J BIOL CHEM, V255, P2949; DAOPIN S, 1992, SCIENCE, V258, P1161, DOI 10.1126/science.258.5085.1161; DRINKWATER CC, 1993, J BIOL CHEM, V268, P23202; DUNBAR JC, 1984, J PROTEIN CHEM, V3, P349, DOI 10.1007/BF01025171; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; FRAZIER WA, 1973, BIOCHEMISTRY-US, V12, P3281, DOI 10.1021/bi00741a021; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HOSANG M, 1985, J BIOL CHEM, V260, P655; HYNES MA, 1994, J NEUROSCI RES, V37, P144, DOI 10.1002/jnr.490370118; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; KAHLE P, 1992, J BIOL CHEM, V267, P22707; KAISHO Y, 1990, FEBS LETT, V266, P187, DOI 10.1016/0014-5793(90)81536-W; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LUO Y, 1992, J BIOL CHEM, V267, P12275; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MEAKIN SO, 1991, NEURON, V6, P153, DOI 10.1016/0896-6273(91)90130-R; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MOORE JB, 1974, BIOCHEMISTRY-US, V13, P833, DOI 10.1021/bi00701a030; NANDURI J, 1994, J NEUROSCI RES, V37, P433, DOI 10.1002/jnr.490370402; NEET KE, 1987, METHOD ENZYMOL, V147, P186; NEET KE, 1995, PROTEIN SCI, V3, P2167; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; REINHOLD DS, 1989, J BIOL CHEM, V264, P3538; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SCHMELZER CH, 1992, J NEUROCHEM, V59, P1675, DOI 10.1111/j.1471-4159.1992.tb10998.x; SHIH A, 1994, J BIOL CHEM, V269, P27679; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SNYDER SH, 1991, NATURE, V350, P195, DOI 10.1038/350195a0; SPRINGER CJ, 1987, BIOCHIM BIOPHYS ACTA, V916, P251, DOI 10.1016/0167-4838(87)90116-6; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; STACH RW, 1977, ANAL BIOCHEM, V83, P26, DOI 10.1016/0003-2697(77)90505-X; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SUTER U, 1992, J NEUROSCI, V12, P306; SUTTER A, 1979, J BIOL CHEM, V254, P5972; THOENEN H, 1987, REV PHYSIOL BIOCH P, V109, P145, DOI 10.1007/BFb0031026; TIMM DE, 1994, BIOCHEMISTRY-US, V33, P4667, DOI 10.1021/bi00181a602; TIMM DE, 1992, PROTEIN SCI, V1, P236; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WILLIAMS R, 1982, J BIOL CHEM, V257, P13321; WOODRUFF NR, 1986, BIOCHEMISTRY-US, V25, P7956, DOI 10.1021/bi00372a026	68	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6278	6285		10.1074/jbc.270.11.6278	http://dx.doi.org/10.1074/jbc.270.11.6278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890765	hybrid			2022-12-27	WOS:A1995QM94500085
J	KIM, S; LAKHANI, V; COSTA, DJ; SHARARA, AI; FITZ, JG; HUANG, LW; PETERS, KG; KINDMAN, LA				KIM, S; LAKHANI, V; COSTA, DJ; SHARARA, AI; FITZ, JG; HUANG, LW; PETERS, KG; KINDMAN, LA			SPHINGOLIPID-GATED CA2+ RELEASE FROM INTRACELLULAR STORES OF ENDOTHELIAL-CELLS IS MEDIATED BY A NOVEL CA2+-PERMEABLE CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; SARCOPLASMIC-RETICULUM; MOLECULAR-CLONING; CALCIUM RELEASE; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; PROLIFERATION; DERIVATIVES; SPHINGOSINE; CDNA	Sphingolipid gated Ca2+ signaling is mediated through Ca2+-permeable channels. In this report, we characterize the properties of the channel in a human endothelial cell line (EA.hy926). Ca2+ release from intracellular stores is not antagonized by nifedipine, omega conotoxin G-VIa, or heparin. To further characterize the molecular properties of the channel, we developed a novel assay to directly measure efflux of Ca2+ from intracellular stores of permeabilized Xenopus oocytes. Following size fractionation by sucrose gradient, poly(A)(+) RNA from EA,hy926 cells is microinjected into oocytes of Xenopus laevis. We find that the mRNA encoding Ca2+ release activity is similar to 1.5-2.0 kilobases in length. The sphingolipid gated Ca2+-permeable channel is thus likely to be a novel Ca2+-permeable channel distinct from other characterized intracellular Ca2+ channels such as the ryanodyne receptor and the inositol 1,4,5-trisphosphate receptor. The method described here provides a new approach to further characterizing this channel and other intracellular Ca2+ channels.	DUKE UNIV,MED CTR,DIV CARDIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DIV GASTROENTEROL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,PROGRAM MOLEC MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710	Duke University; Duke University; Duke University; Duke University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002361] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02361] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESAI NN, 1993, J CELL BIOL, V121, P1385, DOI 10.1083/jcb.121.6.1385; DETTBARN CA, 1994, J MOL CELL CARDIOL, V26, P229, DOI 10.1006/jmcc.1994.1026; DURIEUX ME, 1993, AM J PHYSIOL, V264, pC1360, DOI 10.1152/ajpcell.1993.264.5.C1360; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P418; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; KINDMAN LA, 1993, BIOCHEMISTRY-US, V32, P1270, DOI 10.1021/bi00056a011; KINDMAN LA, 1994, J BIOL CHEM, V269, P13088; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; MARKS AR, 1989, P NATL ACAD SCI USA, V86, P8683, DOI 10.1073/pnas.86.22.8683; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MCDONOUGH PM, 1994, CIRC RES, V75, P981, DOI 10.1161/01.RES.75.6.981; MUSLIN AJ, 1994, MOL CELL BIOL, V14, P3006, DOI 10.1128/MCB.14.5.3006; NAKAZAWA K, 1993, J GEN PHYSIOL, V101, P377, DOI 10.1085/jgp.101.3.377; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Rusakov S A, 1993, Biokhimiia, V58, P724; SABBADINI RA, 1992, J BIOL CHEM, V267, P15475; Sambrook J, 1989, MOL CLONING LABORATO; SCHMALZING G, 1990, BIOCHEM J, V269, P757, DOI 10.1042/bj2690757; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; SUMIKAWA K, 1982, NUCLEIC ACIDS RES, V10, P5809, DOI 10.1093/nar/10.19.5809; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WADA E, 1991, NEURON, V6; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	30	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5266	5269		10.1074/jbc.270.10.5266	http://dx.doi.org/10.1074/jbc.270.10.5266			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890637	hybrid			2022-12-27	WOS:A1995QL58000049
J	MAO, QC; SCHUNK, T; FLUKIGER, K; ERNI, E				MAO, QC; SCHUNK, T; FLUKIGER, K; ERNI, E			FUNCTIONAL RECONSTITUTION OF THE PURIFIED MANNOSE PHOSPHOTRANSFERASE SYSTEM OF ESCHERICHIA-COLI INTO PHOSPHOLIPID-VESICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-LAMBDA-DNA; SUGAR-TRANSPORT; STREPTOCOCCUS-LACTIS; GLUCOSE-TRANSPORT; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; MEMBRANE; PERMEASE; PROTEINS; PHOSPHOCYSTEINE	The mannose transporter complex acts by a mechanism which couples translocation with phosphorylation of the substrate. It consists of a hydrophilic subunit (IIAB(Man)) and two transmembrane subunits (IICMan, IIDMan). The purified complex was reconstituted into phospholipid vesicles by octyl glucoside dilution. Glucose export was measured with proteoliposomes which were loaded with radiolabeled glucose and to which purified ILAB(Man), cytoplasmic phosphorylcarrier proteins, and P-enolpyruvate were added from the outside. Vectorial transport was accompanied by stoichiometric phosphorylation of the transported sugar. Glucose added to the outside of the proteoliposomes was also phosphorylated rapidly but did not compete with vectorial export and phosphorylation of internal glucose. Glucose uptake was measured with proteoliposomes which were loaded with the cytoplasmic phosphoryl carrier proteins and P-enolpyruvate and to which glucose was added from the outside. Vectorial import and phosphorylation occurred with a higher specificity (K-m 30 +/- 6 mu M, k(cat) 401 +/- 32 pmol of Glc/mu g of IICDMan/min) than nonvectorial phosphorylation (K-m 201 +/- 43 mu M, k(cat) 975 +/- 88 pmol of Glc/mu g of IICDMan/min). A new plasmid pTSHIC9 for the controlled overexpression of the cytoplasmic phosphoryl carrier proteins, enzyme I, HPr, and IIA(Glc), and a simplified procedure for the purification of these proteins are also described.	UNIV BERN, INST BIOCHEM, CH-3012 BERN, SWITZERLAND; UNIV MARBURG, DEPT BIOL, W-3550 MARBURG, GERMANY	University of Bern; Philipps University Marburg								APELL HJ, 1985, J MEMBRANE BIOL, V85, P49, DOI 10.1007/BF01872005; BENESKI DA, 1982, J BIOL CHEM, V257, P4565; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; CHONN A, 1991, BIOCHIM BIOPHYS ACTA, V1070, P215, DOI 10.1016/0005-2736(91)90167-7; CONSLER TG, 1993, P NATL ACAD SCI USA, V90, P6934, DOI 10.1073/pnas.90.15.6934; DEREUSE H, 1988, J BACTERIOL, V170, P3827, DOI 10.1128/jb.170.9.3827-3837.1988; DEREUSE H, 1992, J MOL BIOL, V226, P623, DOI 10.1016/0022-2836(92)90620-Y; ELFERINK MGL, 1990, J BACTERIOL, V172, P7119, DOI 10.1128/jb.172.12.7119-7125.1990; ELLIOTT J, 1978, MOL GEN GENET, V161, P1, DOI 10.1007/BF00266608; ERNI B, 1992, INT REV CYTOL, V137A, P127; ERNI B, 1989, FEMS MICROBIOL LETT, V63, P13, DOI 10.1016/0168-6445(89)90004-1; ERNI B, 1982, J BIOL CHEM, V257, P13726; ERNI B, 1989, J BIOL CHEM, V264, P18733; ERNI B, 1987, J BIOL CHEM, V262, P5238; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; KUKURUZINSKA MA, 1982, METHOD ENZYMOL, V90, P431; KUNDIG W, 1971, J BIOL CHEM, V246, P1407; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P6716, DOI 10.1021/bi00241a012; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MEADOW ND, 1986, J BIOL CHEM, V261, P3504; MEADOW ND, 1982, METHOD ENZYMOL, V90, P439; NAKAZAWA A, 1982, METHOD ENZYMOL, V90, P436; NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804; NUOFFER C, 1988, J BIOL CHEM, V263, P6647; PAS HH, 1988, BIOCHEMISTRY-US, V27, P5835, DOI 10.1021/bi00416a002; PAS HH, 1991, J BIOL CHEM, V266, P6690; PEERCE BE, 1990, J BIOL CHEM, V265, P1731; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; REIDER E, 1979, P NATL ACAD SCI USA, V76, P5529, DOI 10.1073/pnas.76.11.5529; RHIEL E, 1994, BIOL CHEM H-S, V375, P551, DOI 10.1515/bchm3.1994.375.8.551; ROBILLARD GT, 1981, BIOCHEMISTRY-US, V20, P5025, DOI 10.1021/bi00520a032; ROBILLARD GT, 1982, EUR J BIOCHEM, V127, P597; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SCARBOROUGH GA, 1985, MICROBIOL REV, V49, P214, DOI 10.1128/MMBR.49.3.214-231.1985; SCHUNK T, 1992, THESIS U MARBURG GER; SINGH SP, 1985, J BACTERIOL, V164, P367, DOI 10.1128/JB.164.1.367-378.1985; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; STOLZ B, 1993, J BIOL CHEM, V268, P27094; THOMPSON J, 1985, J BACTERIOL, V162, P224, DOI 10.1128/JB.162.1.224-234.1985; THOMPSON J, 1985, J BACTERIOL, V162, P217, DOI 10.1128/JB.162.1.217-223.1985; WELCH GR, 1994, TRENDS BIOCHEM SCI, V19, P193; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	45	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5258	5265		10.1074/jbc.270.10.5258	http://dx.doi.org/10.1074/jbc.270.10.5258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890636	hybrid			2022-12-27	WOS:A1995QL58000048
J	SAXENA, M; HENDERSON, GB				SAXENA, M; HENDERSON, GB			ATP-DEPENDENT EFFLUX OF 2,4-DINITROPHENYL-S-GLUTATHIONE - PROPERTIES OF 2 DISTINCT TRANSPORT-SYSTEMS IN INSIDE-OUT VESICLES FROM L1210 CELLS AND A VARIANT SUBLINE WITH ALTERED EFFLUX OF METHOTREXATE AND CHOLATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-CONJUGATE; LIVER PLASMA-MEMBRANES; RAT-HEART SARCOLEMMA; HUMAN-ERYTHROCYTES; DINITROPHENYL GLUTATHIONE; MULTIDRUG-RESISTANCE; CYSTIC-FIBROSIS; BROMOSULFOPHTHALEIN; IDENTIFICATION; TRANSFERASES	The transport of 2,4-dinitrophenyl-S-glutathione (DNP-SG) into inside-out vesicles from L1210 cells was employed to identify and characterize ATP-dependent efflux routes for DNP SG. Measurements of ATP dependent uptake at varying concentrations of [H-3]DNP-SG revealed the presence of two distinct transport systems. Transport at low substrate concentrations occurred predominantly via a high affinity system (K-m = 0.63 mu M), whereas a low affinity system (K-m = 450 mu M) predominated at high concentrations of substrate, The high affinity system was characterized by a potent inhibition by the glutathione conjugates of bromosulfophthalein (K-i = 0.09 mu M) and ethacrynic acid (K-i = 0.44 mu M), leukotriene C-4 (K-i = 0.20 mu M), and the taurate diconjugate of bilirubin (K-i = 0.10 mu M). The low affinity transport system for DNP-SG exhibited a high affinity for bilirubin ditaurate (K-i = 1.8 mu M), indoprofen (K-i = 3.0 mu M), and biphenylacetic acid (K-i = 5.9 mu M). Different results were obtained with an L1210/C7 variant which has a defect in the efflux of methotrexate and cholate. Vesicles from the latter cells contain the same low affinity transport activity as parental cells, but the high affinity route is absent and has been replaced by a system with an intermediate affinity for DNP-SG (K-m = 4.5 mu M) These results indicate that L1210 cells contain two unidirectional efflux pumps for DNP-SG with substantial differences in inhibitor sensitivity, The high affinity system shows a binding preference for glutathione conjugates but can also accommodate large anionic conjugates, whereas the low affinity system has a binding preference for large organic anions. Results with the variant cells support the hypothesis that the high affinity transport system for DNP-SG also mediates the unidirectional efflux of methotrexate and cholate in intact L1210 cells.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED NX6, LA JOLLA, CA 92037 USA	Scripps Research Institute					NCI NIH HHS [CA23970] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA023970] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKERBOOM TPM, 1991, J BIOL CHEM, V266, P13147; AKERBOOM TPM, 1992, BIOCHIM BIOPHYS ACTA, V1103, P115, DOI 10.1016/0005-2736(92)90064-S; AWASTHI S, 1994, J CLIN INVEST, V93, P958, DOI 10.1172/JCI117102; AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; ECKERT KG, 1986, BIOCHEM PHARMACOL, V35, P325, DOI 10.1016/0006-2952(86)90533-2; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HENDERSON GB, 1993, BIOCHIM BIOPHYS ACTA, V1152, P91, DOI 10.1016/0005-2736(93)90235-R; HENDERSON GB, 1988, CANCER RES, V48, P5995; HENDERSON GB, 1990, BIOCHIM BIOPHYS ACTA, V1051, P60, DOI 10.1016/0167-4889(90)90174-C; HENDERSON GB, 1987, J BIOL CHEM, V262, P13571; HENDERSON GB, 1984, J BIOL CHEM, V259, P1526; HENDERSON GB, 1991, J BIOL CHEM, V266, P1641; HENDERSON GB, 1994, J BIOL CHEM, V269, P13382; HENDERSON GB, 1992, BIOCHIM BIOPHYS ACTA, V1110, P137, DOI 10.1016/0005-2736(92)90350-U; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; ISHIKAWA T, 1989, FEBS LETT, V246, P177, DOI 10.1016/0014-5793(89)80278-9; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; ISHIKAWA T, 1989, FEBS LETT, V259, P95, DOI 10.1016/0014-5793(89)81503-0; ISHIKAWA T, 1989, J BIOL CHEM, V264, P17343; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; ISHIKAWA T, 1993, STRUCTURE FUNCTION G, P211; ISHIKAWA T, 1990, TRENDS BIOCHEM SCI, V15, P217; JEDLITSCHKY G, 1994, CANCER RES, V54, P4833; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; KONDO T, 1981, BIOCHIM BIOPHYS ACTA, V645, P132, DOI 10.1016/0005-2736(81)90520-4; LABELLE EF, 1986, BIOCHEM J, V238, P443, DOI 10.1042/bj2380443; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mansur-Garza E. M., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P376; PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RINDLER MJ, 1978, J BIOL CHEM, V253, P5431; SCHAUB T, 1991, FEBS LETT, V279, P83, DOI 10.1016/0014-5793(91)80256-3; SIROTNAK FM, 1981, CANCER RES, V41, P966; SIROTNAK FM, 1991, CANCER RES, V51, P1412; Steck T L, 1974, Methods Enzymol, V31, P172; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; WHELAN G, 1970, J LAB CLIN MED, V75, P542; WIDDICOMBE JH, 1991, TRENDS BIOCHEM SCI, V16, P474, DOI 10.1016/0968-0004(91)90183-V; ZIMNIAK P, 1993, HEPATOLOGY, V17, P330, DOI 10.1002/hep.1840170226; ZIMNIAK P, 1993, TRENDS BIOCHEM SCI, V18, P164, DOI 10.1016/0968-0004(93)90106-W	47	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5312	5319		10.1074/jbc.270.10.5312	http://dx.doi.org/10.1074/jbc.270.10.5312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890643	hybrid			2022-12-27	WOS:A1995QL58000056
J	BANNO, Y; NAKASHIMA, S; HACHIYA, T; NOZAWA, Y				BANNO, Y; NAKASHIMA, S; HACHIYA, T; NOZAWA, Y			ENDOGENOUS CLEAVAGE OF PHOSPHOLIPASE C-BETA-3 BY AGONIST-INDUCED ACTIVATION OF CALPAIN IN HUMAN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; G-PROTEIN; C ISOZYMES; ALPHA-SUBUNITS; THROMBOXANE-A2 RECEPTOR; BINDING PROTEIN; PURIFICATION; STIMULATION; CELLS; FORMS	Two membrane-associated phosphoinositide-specific phospholipase Cs (mPI-PLC-1 and mPI-PLC-2) and a cytosolic enzyme (cPI-PLC) that were activated by brain G-protein beta gamma subunits have been isolated from human platelets. The truncation of mPI-PLC-1 that was mediated by mu-calpain induced much higher activation by beta gamma subunits (Banno, Y., Asano, T., and Nozawa, Y. (1994) FEES Lett. 340, 185-188). On the basis of size and immunological cross-reactivity, mPI-PLC-1 (155 kDa) was PLC-beta 3, and mPI-PLC-2 (100 kDa) was its truncated form. The cPI-PLC (140 kDa) was recognized by the antibody selective for internal sequences of PLC-beta 3 but not by the antibody raised against its carboxyl terminus, indicating that it may be related to PLC-beta 3. Treatment of human platelets with A23187 and dibucaine, activators of calpain, caused cleavage of actin-binding protein and talin in a time-dependent manner. At the same time, decrease of PLC-beta 3 (155 and 140 kDa) and concomitant increase of the 100-kDa product of cleavage were observed on immunoblots with the antibody to internal sequences of PLC-beta 3. Furthermore, stimulation of platelets by natural agonists, thrombin and collagen, caused the cleavage of PLC-beta 3 (155 and 140 kDa) and an increase of 100 kDa PLC-beta 3 in a time- and dose dependent manner. The cleavage of these PLC-beta 3 enzymes was completely blocked by calpain inhibitor, calpeptin, indicating that the PLC-beta 3 modification may be a consequence of platelet activation leading to activation of calpain. This is the first demonstration that PLC-beta 3 is indeed cleaved by calpain upon platelet activation by physiological agonists. The cleavage of PLC-beta 3 evoked by thrombin and collagen but not ADP was correlated with irreversible aggregation, suggesting that the PLC-beta 3 modification may play a role in secondary irreversible aggregation in agonist-stimulated human platelets.	GIFU UNIV, SCH MED, DEPT BIOCHEM, GIFU 500, JAPAN; MED & BIOL LABS CO LTD, NAKA KU, NAGOYA, AICHI 460, JAPAN	Gifu University								ANAGLI J, 1991, BIOCHEM J, V274, P497, DOI 10.1042/bj2740497; ANDO Y, 1987, BIOCHEM BIOPH RES CO, V144, P484, DOI 10.1016/S0006-291X(87)80535-1; ARIYOSHI H, 1991, BIOCHEM INT, V23, P1019; ASANO T, 1993, J BIOL CHEM, V268, P20512; BAHK YY, 1994, J BIOL CHEM, V269, P8240; BALDASSARE JJ, 1993, BIOCHEM J, V291, P235, DOI 10.1042/bj2910235; BANNO Y, 1994, FEBS LETT, V340, P185, DOI 10.1016/0014-5793(94)80134-7; BANNO Y, 1992, J BIOL CHEM, V267, P6488; BANNO Y, 1987, BIOCHEM BIOPH RES CO, V146, P861, DOI 10.1016/0006-291X(87)90610-3; BANNO Y, 1992, PLATELETS, V2, P69; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BLANK JL, 1993, J BIOL CHEM, V268, P25184; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; FOX JEB, 1990, BLOOD, V76, P2510; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FOX JEB, 1991, J BIOL CHEM, V266, P13289; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; ISHII H, 1990, THROMB RES, V57, P847, DOI 10.1016/0049-3848(90)90152-3; JHON DY, 1993, J BIOL CHEM, V268, P6654; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KRIZ R, 1990, CIBA F SYMP, V150, P112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CW, 1993, J BIOL CHEM, V268, P21318; LEE SB, 1993, J BIOL CHEM, V268, P25952; LOW MG, 1986, BIOCHEM J, V237, P139, DOI 10.1042/bj2370139; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MARTIN TFJ, 1991, BIOCHEM J, V280, P753, DOI 10.1042/bj2800753; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NOZAWA Y, 1993, ADV EXP MED BIOL, V344, P37; ODA A, 1993, J BIOL CHEM, V268, P12603; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SAIDO TC, 1993, J BIOL CHEM, V268, P7422; SHENKER A, 1991, J BIOL CHEM, V266, P9309; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; THUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201; TOSHIDA N, 1983, J BIOL CHEM, V258, P7168; TSUJINAKA T, 1982, THROMB RES, V28, P149, DOI 10.1016/0049-3848(82)90257-2; WAHL MI, 1990, J BIOL CHEM, V265, P3944; WU DQ, 1992, J BIOL CHEM, V267, P1811	52	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4318	4324		10.1074/jbc.270.9.4318	http://dx.doi.org/10.1074/jbc.270.9.4318			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876193	hybrid			2022-12-27	WOS:A1995QK08400024
J	KELLY, RJ; ROUQUIER, S; GIORGI, D; LENNON, GG; LOWE, JB				KELLY, RJ; ROUQUIER, S; GIORGI, D; LENNON, GG; LOWE, JB			SEQUENCE AND EXPRESSION OF A CANDIDATE FOR THE HUMAN SECRETOR BLOOD-GROUP ALPHA(1,2)FUCOSYLTRANSFERASE GENE (FUT2) - HOMOZYGOSITY FOR AN ENZYME-INACTIVATING NONSENSE MUTATION COMMONLY CORRELATES WITH THE NON-SECRETOR PHENOTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI INFECTION; GDP-L-FUCOSE; GASTRIC-CARCINOMA; HUMAN-SERUM; H-GENE; MOLECULAR-CLONING; ABO; SYSTEMS; LEWIS; PURIFICATION	Synthesis of soluble A, B, H, and Lewis b blood group antigens in humans is determined by the Secretor (Se) (FUT2) blood group locus. Genetic, biochemical, and molecular analyses indicate that this locus corresponds to an alpha(1,2)fucosyltransferase gene distinct from the genetically-linked H blood group alpha(1,2)fucosyltransferase lo cus. The accompanying paper (Rouquier, S., Lowe, J, B., Kelly, R. J., Fertitta, A L., Lennon, G. G., and Giorgi, D. (1995) J. Biol. Chem. 270, 4632-4639) describes the molecular cloning and mapping of two human DNA segments that are physically linked to, and cross-hybridize with, the H locus. We present here an analysis of these two new DNA segments. One of these, termed Sec1, is a pseudogene, because translational frameshifts and termination codons interrupt potential open reading frames that would otherwise share primary sequence similarity with the H alpha(1,2)fucosyltransferase. The other DNA segment, termed Seca, predicts a 332-amino acid-long polypeptide, and a longer isoform, that share 68% sequence identity with the COOH-terminal 292 residues of the human H blood group alpha(1,2)fucosyltransferase. Sec2 encodes an alpha(1,2)fucosyltransferase with catalytic properties that mirror those ascribed to the Secretor locus-encoded alpha(1,2)fucosyltransferase. Approximately 20% of randomly-selected individuals were found to be apparently homozygous for an enzyme-inactivating nonsense allele (Trp(143) --> ter) at this locus, in correspondence to the frequency of the non-secretor phenotype in most human populations. Furthermore, each of six unrelated non-secretor individuals are also apparentry homozygous for this null allele. These results indicate that Seca corresponds to the human Secretor blood group locus (FUT2) and indicate that homozygosity for a common nonsense allele is responsible for the nonsecretor phenotype in many non-secretor individuals.	UNIV MICHIGAN, MED CTR, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, DEPT PATHOL, ANN ARBOR, MI 48109 USA; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94550 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Lawrence Livermore National Laboratory			Lennon, Greg/T-4717-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048859] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00042] Funding Source: Medline; NHLBI NIH HHS [1R01HL48859] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER BK, 1994, CURR OPIN GENET DEV, V4, P316, DOI 10.1016/S0959-437X(05)80060-7; AUSUBEL BW, 1987, MOL BIOL LABORATORY, V2; AUSUBEL J, 1987, MOL BIOL LABORATORY, V1; BLASZCZYKTHURIN M, 1988, BIOCHEM BIOPH RES CO, V151, P100, DOI 10.1016/0006-291X(88)90564-5; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; CHA JHJ, 1994, MOL BRAIN RES, V22, P323, DOI 10.1016/0169-328X(94)90061-2; CHAN WY, 1991, HISTOPATHOLOGY, V19, P47, DOI 10.1111/j.1365-2559.1991.tb00893.x; CHESTER MA, 1976, EUR J BIOCHEM, V69, P583, DOI 10.1111/j.1432-1033.1976.tb10944.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DICKEY W, 1993, GUT, V34, P351, DOI 10.1136/gut.34.3.351; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; GAENSSLEN RE, 1987, J FORENSIC SCI, V32, P1016; HENRY SM, 1993, VOX SANG, V65, P62, DOI 10.1111/j.1423-0410.1993.tb04527.x; HENRY SM, 1990, VOX SANG, V58, P61, DOI 10.1111/j.1423-0410.1990.tb02057.x; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KUMAZAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P4193, DOI 10.1073/pnas.81.13.4193; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LEPENDU J, 1985, AM J HUM GENET, V37, P749; Lowe J B, 1991, Semin Cell Biol, V2, P289; MENTIS A, 1991, EPIDEMIOL INFECT, V106, P221, DOI 10.1017/S0950268800048366; MILNE RW, 1973, VOX SANG, V25, P298, DOI 10.1111/j.1423-0410.1973.tb04377.x; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; Mourant AE., 1976, DISTRIBUTION HUMAN B; MOURANT AE, 1978, BLOOD GROUPS DISEASE; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1990, J IMMUNOGENET, V17, P235; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; RAJAN VP, 1989, J BIOL CHEM, V264, P11158; RAJPUT B, 1994, J BIOL CHEM, V269, P9590; RIO DC, 1993, CURR OPIN GENET DEV, V3, P574, DOI 10.1016/0959-437X(93)90093-5; ROTH MS, 1990, TRANSPLANTATION, V49, P714, DOI 10.1097/00007890-199004000-00012; ROUQUIER S, 1995, J BIOL CHEM, V270, P4632, DOI 10.1074/jbc.270.9.4632; Sadler J. E., 1984, BIOL CARBOHYDRATES, V2, P199; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARNESTO A, 1990, J BIOL CHEM, V265, P15067; SARNESTO A, 1992, J BIOL CHEM, V267, P2737; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; WALKER RH, 1990, AM ASS BLOOD BANSK T; Watkins W M, 1980, Adv Hum Genet, V10, P1; WESTON BW, 1992, J BIOL CHEM, V267, P24575; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1993, VOX SANG, V64, P171, DOI 10.1111/j.1423-0410.1993.tb05157.x; YAMAMOTO FI, 1993, VOX SANG, V64, P120, DOI 10.1111/j.1423-0410.1993.tb02529.x; YAMAMOTO FI, 1993, VOX SANG, V64, P116, DOI 10.1111/j.1423-0410.1993.tb02528.x	53	415	448	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4640	4649		10.1074/jbc.270.9.4640	http://dx.doi.org/10.1074/jbc.270.9.4640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876235	hybrid			2022-12-27	WOS:A1995QK08400069
J	LUJAN, HD; MAROTTA, A; MOWATT, MR; SCIAKY, N; LIPPINCOTTSCHWARTZ, J; NASH, TE				LUJAN, HD; MAROTTA, A; MOWATT, MR; SCIAKY, N; LIPPINCOTTSCHWARTZ, J; NASH, TE			DEVELOPMENTAL INDUCTION OF GOLGI STRUCTURE AND FUNCTION IN THE PRIMITIVE EUKARYOTE GIARDIA-LAMBLIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; BREFELDIN-A; GUANINE-NUCLEOTIDE; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; ORGANELLE STRUCTURE; BINDING PROTEINS; CHOLERA-TOXIN	A fundamental characteristic of eukaryotic cells is the presence of membrane bound compartments and membrane transport pathways in which the Golgi complex plays a central role in the selective processing, sorting, and secretion of proteins. The parasitic protozoan Giardia lamblia belongs to the earliest identified Lineage among eukaryotes and therefore offers unique insight into the progression from primitive to more complex eukaryotic cells. Here, we report that Giardia trophozoites undergo a developmental induction of Golgi enzyme activities, which correlates with the appearance of a morphologically identifiable Golgi complex, as they differentiate to cysts. Prior to this induction, no morphologically or biochemically identifiable Golgi complex exists within nonencysting cells. Remarkably, protein secretion in both nonencysting and encysting trophozoites is inhibited by brefeldin A, and brefeldin A-sensitive membrane association of ADP-ribosylation factor and beta-COP is observed. These results suggest that the secretory machinery of Giardia resembles that of higher eukaryotes despite the absence of a Golgi complex in nonencysting trophozoites. These findings have implications both for defining the minimal machinery for protein secretion in eukaryotes and for examining the biogenesis of Golgi structure and function.	NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	LUJAN, HD (corresponding author), NIAID, PARASIT DIS LAB, 9000 ROCKVILLE PIKE, BLDG 4, RM 126, BETHESDA, MD 20892 USA.							ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; BALCH WE, 1992, J BIOL CHEM, V267, P13053; BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BOUCHER SEM, 1990, INFECT IMMUN, V58, P3516, DOI 10.1128/IAI.58.11.3516-3522.1990; BRACKER CE, 1967, ANNU REV PHYTOPATHOL, V5, P343, DOI 10.1146/annurev.py.05.090167.002015; BRESTSCHER MS, 1993, SCIENCE, V261, P1280; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Feely D.E., 1984, P3; FRIEND DS, 1966, J CELL BIOL, V29, P317, DOI 10.1083/jcb.29.2.317; GRIFFITHS G, 1986, SCIENCE, V234, P434; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; JARROLL EL, 1989, MOL BIOCHEM PARASIT, V32, P121, DOI 10.1016/0166-6851(89)90063-7; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KREIS TE, 1994, CURR OPIN CELL BIOL, V6, P533, DOI 10.1016/0955-0674(94)90073-6; KULDA J, 1978, PARASITIC PROTOZOA, P2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE FJS, 1992, J BIOL CHEM, V267, P24441; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LINDMARK DG, 1980, MOL BIOCHEM PARASIT, V1, P1, DOI 10.1016/0166-6851(80)90037-7; LINDMARK DG, 1988, EXP PARASITOL, V65, P141, DOI 10.1016/0014-4894(88)90116-6; Lippincott-Schwartz Jennifer, 1993, Trends in Cell Biology, V3, P81, DOI 10.1016/0962-8924(93)90078-F; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUJAN HD, 1994, J BIOL CHEM, V269, P13069; LUJAN HD, 1994, J EUKARYOT MICROBIOL, V41, P169, DOI 10.1111/j.1550-7408.1994.tb01491.x; MACECHKO PT, 1992, MOL BIOCHEM PARASIT, V56, P301, DOI 10.1016/0166-6851(92)90179-N; MANNING P, 1992, J PROTOZOOL, V39, P290, DOI 10.1111/j.1550-7408.1992.tb01317.x; MELLMAN L, 1992, CELL, V68, P829; MOSS J, 1993, CELL SIGNAL, V5, P367, DOI 10.1016/0898-6568(93)90076-X; MURTAGH JJ, 1992, J BIOL CHEM, V267, P9654; NASH TE, 1988, J IMMUNOL, V141, P636; NASH TE, 1983, J IMMUNOL, V131, P2004; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; NOTHWEHR SF, 1994, J BIOL CHEM, V269, P10185; ORCI L, 1991, CELL, V64, P1183; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; PAGANO RE, 1988, BIOCHEMISTRY-US, V27, P4439, DOI 10.1021/bi00412a034; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; PELHAM HRB, 1991, CELL, V67, P449, DOI 10.1016/0092-8674(91)90517-3; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; PIMENTA PFP, 1991, INFECT IMMUN, V59, P3989, DOI 10.1128/IAI.59.11.3989-3996.1991; RAMBOURG A, 1993, ANAT REC, V237, P441, DOI 10.1002/ar.1092370402; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; REINER DS, 1990, EUR J CELL BIOL, V53, P142; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SLUSAREWUCZ O, 1994, J CELL BIOL, V124, P405; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STIBBS HH, 1989, J CLIN MICROBIOL, V27, P2582, DOI 10.1128/JCM.27.11.2582-2588.1989; THOMPSON RCA, 1993, ADV PARASIT, V32, P71, DOI 10.1016/S0065-308X(08)60207-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI SC, 1993, J BIOL CHEM, V268, P10820; WATERS MG, 1991, NATURE, V339, P355	67	133	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4612	4618		10.1074/jbc.270.9.4612	http://dx.doi.org/10.1074/jbc.270.9.4612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876232	hybrid			2022-12-27	WOS:A1995QK08400065
J	MACDONALD, PN; SHERMAN, DR; DOWD, DR; JEFCOAT, SC; DELISLE, RK				MACDONALD, PN; SHERMAN, DR; DOWD, DR; JEFCOAT, SC; DELISLE, RK			THE VITAMIN-D-RECEPTOR INTERACTS WITH GENERAL TRANSCRIPTION FACTOR-IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-TFIIB; THYROID-HORMONE; RETINOIC ACID; EXPRESSION; ACTIVATION; PROTEIN; BINDING; CLONING; INVIVO; BETA	The vitamin D receptor (VDR) heterodimerizes with retinoid X receptors (RXR) on many vitamin D-responsive promoter elements, suggesting that this complex is the active factor in vitamin D-mediated transcription. However, the mechanism of transcriptional regulation following VDR . RXR binding to DNA is not well characterized, Using a yeast two-hybrid protein interaction assay, we demonstrate that VDR forms specific protein: protein contacts with the basal transcription factor TFIIB, Deletion analysis indicated that the carboxyl terminal ligand binding domain of VDR interacted with a 43-residue amino-terminal domain in TFIIB. The interaction with TFIIB showed selectivity for the ligand binding domain of VDR as similar regions of RXR alpha or of retinoic acid receptor cu did not couple with TFIIB. Binding assays with purified proteins showed a direct inter action between VDR and TFIIB in vitro. These data suggest a mechanism for VDR-dependent transcription in which protein contacts between VDR and TFIIB may impart regulatory information to the transcription preinitiation complex.	ST LOUIS UNIV,HLTH SCI CTR,EA DOISY DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104; PATHOGENESIS CORP,SEATTLE,WA 98119	Saint Louis University	MACDONALD, PN (corresponding author), ST LOUIS UNIV,HLTH SCI CTR,SCH MED,DEPT PHARMACOL & PHYSIOL SCI,1402 S GRAND BLVD,ST LOUIS,MO 63104, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047293] Funding Source: NIH RePORTER; NIDDK NIH HHS [R29DK47293] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANIAHMAD A, 1993, P NATL ACAD SCI USA, V90, P8832, DOI 10.1073/pnas.90.19.8832; BARBERIS A, 1993, P NATL ACAD SCI USA, V90, P5628, DOI 10.1073/pnas.90.12.5628; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; COLGAN J, 1993, NATURE, V362, P549, DOI 10.1038/362549a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FAGAN R, 1994, CELL, V78, P799, DOI 10.1016/S0092-8674(94)90522-3; GIETZ D, 1991, NUCLEIC ACIDS RES, V20, P1425; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; ING NH, 1992, J BIOL CHEM, V267, P17617; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LIAO J, 1990, P NATL ACAD SCI USA, V87, P9751, DOI 10.1073/pnas.87.24.9751; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MACDONALD PN, 1994, SEMIN NEPHROL, V14, P101; MACDONALD PN, 1991, J BIOL CHEM, V266, P18808; MACDONALD PN, 1993, MOL CELL BIOL, V13, P5907, DOI 10.1128/MCB.13.9.5907; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; NAKAJIMA S, 1994, MOL ENDOCRINOL, V8, P159, DOI 10.1210/me.8.2.159; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; SONE T, 1991, J BIOL CHEM, V266, P23296; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	29	141	142	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4748	4752		10.1074/jbc.270.9.4748	http://dx.doi.org/10.1074/jbc.270.9.4748			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876247	hybrid			2022-12-27	WOS:A1995QK08400083
J	MEINKE, A; DAMUDE, HG; TOMME, P; KWAN, E; KILBURN, DG; MILLER, RC; WARREN, RAJ; GILKES, NR				MEINKE, A; DAMUDE, HG; TOMME, P; KWAN, E; KILBURN, DG; MILLER, RC; WARREN, RAJ; GILKES, NR			ENHANCEMENT OF THE ENDO-BETA-1,4-GLUCANASE ACTIVITY OF AN EXOCELLOBIOHYDROLASE BY DELETION OF A SURFACE LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOMONAS-FIMI; BETA-GLUCOSIDASE; FAMILIES; BINDING; BETA-1,4-GLYCANASES; AGROBACTERIUM; CELLULASES; DOMAINS	In the commonly accepted mechanism for enzymatic hydrolysis of cellulose, endo-beta-1,4-glucanases randomly cleave glucosidic bonds within glucan polymers, providing sites for attack by exo-cellobiohydrolases (EC 3.2.1.91), It has been proposed that hydrolysis by Trichoderma reesei cellobiohydrolase II is restricted to the ends of cellulose polymers because two surface loops cover its active site to form a tunnel, In a closely related endoglucanase, E2 from Thermomonospora fusca, access to the substrate appears to be relatively unhindered because the carboxyl-proximal loop is shortened, and the amino-proximal loop is displaced, The hypothesis was examined by deletion of a region in Cellulomonas fimi cellobiohydrolase A corresponding to part of the carboxyl-proximal loop of T. reesei cellobiohydrolase II, The mutation enhanced the endoglucanase activity of the enzyme on soluble O-(carboxymethyl)cellulose and altered its activities on 2',4'-dinitrophenyl-beta-D-cellobioside, insoluble cellulose, and cellotetraose,	UNIV BRITISH COLUMBIA,DEPT MICROBIOL & IMMUNOL,VANCOUVER,BC V6T 1Z3,CANADA; UNIV BRITISH COLUMBIA,PROT ENGN NETWORK CTR EXCELLENCE,VANCOUVER,BC V6T 1Z3,CANADA	University of British Columbia; University of British Columbia								Chaplin M.F., 1986, MASS SPECTROM, P1; COUTINHO JB, 1992, MOL MICROBIOL, V6, P1243, DOI 10.1111/j.1365-2958.1992.tb01563.x; DAY AG, 1986, BIOCHEM CELL BIOL, V64, P914, DOI 10.1139/o86-122; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GILKES NR, 1984, J BIOL CHEM, V259, P455; GILKES NR, 1991, EUR J BIOCHEM, V202, P367, DOI 10.1111/j.1432-1033.1991.tb16384.x; GILKES NR, 1988, J BIOL CHEM, V263, P10401; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; MCGINNIS K, 1993, BIOCHEMISTRY-US, V32, P8151, DOI 10.1021/bi00083a014; MEINKE A, 1993, J BACTERIOL, V175, P1910, DOI 10.1128/JB.175.7.1910-1918.1993; MEINKE A, 1994, MOL MICROBIOL, V12, P413, DOI 10.1111/j.1365-2958.1994.tb01030.x; MEINKE A, 1993, GENETICS BIOCH ECOLO, P286; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; WAKARCHUK WW, 1986, MOL GEN GENET, V205, P146, DOI 10.1007/BF02428044	17	77	84	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4383	4386		10.1074/jbc.270.9.4383	http://dx.doi.org/10.1074/jbc.270.9.4383			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876202	hybrid			2022-12-27	WOS:A1995QK08400033
J	BOULARAND, S; DARMON, MC; RAVASSARD, P; MALLET, J				BOULARAND, S; DARMON, MC; RAVASSARD, P; MALLET, J			CHARACTERIZATION OF THE HUMAN TRYPTOPHAN-HYDROXYLASE GENE PROMOTER - TRANSCRIPTIONAL REGULATION BY CAMP REQUIRES A NEW MOTIF DISTINCT FROM THE CAMP-RESPONSIVE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCTAMER BINDING-PROTEINS; RAT PINEAL-GLAND; BETA-GLOBIN GENE; CYCLIC-AMP; DNA ELEMENTS; CCAAT BOX; EXPRESSION; CELLS; BRAIN; IDENTIFICATION	We isolated and sequenced 2,117 nucleotides of the promoter region of the human tryptophan hydroxylase (TPH) gene. Transient transfection in pinealocyte cultures and PC12 cells was used to investigate the human TPH (hTPH) gene promoter activity and its regulation by the cAMP signaling pathway. A region of 2,117 base pairs upstream of the transcription initiation site of the hTPH gene efficiently directed the transcription of a luciferase reporter gene but not in a cell-specific manner. The hTPH promoter activity was significantly enhanced by a cyclic AMP analog in the two cell types. Deletion analysis showed that the promoter region from -73 to +2 is sufficient to direct cAMP-dependent transcription, although it does not contain a motif exhibiting a significant identity to the cAMP-responsive element (CRE) or AP-2 binding site, Following site-directed mutagenesis of the region between -73 and -51, an inverted CCAAT box motif was identified as essential for cAMP inducibility of the hTPH promoter. This sequence between -73 and -51 alone allowed cAMP enhancement of transcription when fused to a heterologous promoter. Additionally, electrophoretic mobility shift assays showed that a specific protein-DNA complex is formed between an oligonucleotide corresponding to the inverted CCAAT box motif and nuclear proteins from pinealocytes treated or not treated with cAMP. Thus cAMP responsiveness of hTPH gene expression is mediated by a cis-acting element, which shares strong identitiy with an inverted CCAAT box and which binds to a constitutively produced nuclear factor.			BOULARAND, S (corresponding author), CNRS,GENET MOLEC NEUROTRANSMISS & PROC NEURODEGENERATI,F-91198 GIF SUR YVETTE,FRANCE.		Darmon, Michele/F-8708-2011	Darmon, Michele/0000-0001-9730-6273; ravassard, philippe/0000-0002-0393-9262				BEGEOT M, 1993, J BIOL CHEM, V268, P17317; BLUNDELL JE, 1984, NEUROPHARMACOLOGY, V23, P1537, DOI 10.1016/0028-3908(84)90098-4; BOULARAND S, 1995, J BIOL CHEM, V270, P3748, DOI 10.1074/jbc.270.8.3748; BUDA M, 1978, ENDOCRINOLOGY, V103, P1483, DOI 10.1210/endo-103-4-1483; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; DIERKS P, 1983, CELL, V32, P695, DOI 10.1016/0092-8674(83)90055-7; DYNAM WS, 1985, NATURE, V319, P246; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; EHRET M, 1991, J NEUROCHEM, V57, P1516, DOI 10.1111/j.1471-4159.1991.tb06346.x; EHRET M, 1989, J NEUROCHEM, V52, P1886, DOI 10.1111/j.1471-4159.1989.tb07272.x; FOGUET M, 1993, EMBO J, V12, P903, DOI 10.1002/j.1460-2075.1993.tb05731.x; FRAMPTON J, 1990, MOL CELL BIOL, V164, P149; GARBER SL, 1987, MOL BRAIN RES, V3, P1, DOI 10.1016/0169-328X(87)90038-6; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; HART R P, 1991, Molecular and Cellular Neuroscience, V2, P71, DOI 10.1016/1044-7431(91)90041-L; HASLINGER A, 1985, P NATL ACAD SCI USA, V82, P8572, DOI 10.1073/pnas.82.24.8572; Higuchi R., 1989, PCR TECHNOLOGY, P61; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; KINANE TB, 1993, J BIOL CHEM, V268, P24669; LERNER AB, 1959, J AM CHEM SOC, V80, P6084; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; LI XB, 1994, J NEUROCHEM, V63, P28; LOEFFLER JP, 1990, J NEUROCHEM, V54, P1815; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; LUND J, 1990, J BIOL CHEM, V265, P3304; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MIKUNI M, 1981, J NEUROCHEM, V36, P1295, DOI 10.1111/j.1471-4159.1981.tb01733.x; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURO AF, 1992, J BIOL CHEM, V267, P12767; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NAKAMURA N, 1989, P NATL ACAD SCI USA, V86, P56, DOI 10.1073/pnas.86.1.56; PARK K, 1993, J BIOL CHEM, V268, P17811; QUAY WB, 1963, GEN COMP ENDOCR, V3, P473, DOI 10.1016/0016-6480(63)90079-0; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1966, ENDOCRINOLOGY, V79, P1168, DOI 10.1210/endo-79-6-1168; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULE R, 1988, NATURE, V332, P87, DOI 10.1038/332087a0; SHEIN HM, 1971, LIFE SCI, V10, P935, DOI 10.1016/0024-3205(71)90358-4; SHIBUYA H, 1978, BRAIN RES, V138, P364; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; STOLL J, 1991, J NEUROSCI RES, V28, P457, DOI 10.1002/jnr.490280402; SZE PY, 1976, J NEUROCHEM, V26, P169; VRANA KE, 1994, LIFE SCI, V55, P1045, DOI 10.1016/0024-3205(94)00639-3	50	76	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3757	3764		10.1074/jbc.270.8.3757	http://dx.doi.org/10.1074/jbc.270.8.3757			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876116	hybrid			2022-12-27	WOS:A1995QH68800046
J	DEMCHYSHYN, LL; SUGAMORI, KS; LEE, FJS; HAMADANIZADEH, SA; NIZNIK, HB				DEMCHYSHYN, LL; SUGAMORI, KS; LEE, FJS; HAMADANIZADEH, SA; NIZNIK, HB			THE DOPAMINE D1D RECEPTOR - CLONING AND CHARACTERIZATION OF 3 PHARMACOLOGICALLY DISTINCT D1-LIKE RECEPTORS FROM GALLUS-DOMESTICUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; MOLECULAR-CLONING; CORTICAL MEMBRANES; PHOSPHOLIPASE-C; D(1) RECEPTORS; RAT-BRAIN; EXPRESSION; STIMULATION; AGONISTS; GENE	Three genomic clones encoding dopamine D1-like receptors were isolated from the avian species Gallus domesticus. Two of these genes encode proteins of 451 and 488 amino acids, which, based on deduced amino acid sequence identity and homology of exhibited pharmacological profiles, appear to be species homologs of mammalian and vertebrate D1/D1A and D5/D1B receptors, respectively, The third genomic clone, termed D1D, encodes a protein of 445 amino acids displaying a deduced amino acid sequence identity within putative transmembrane domains of 75% to mammalian D1/D1A and 77% to D5/D1B receptors with overall sequence homologies of only 49% and 46%, respectively, Membranes from COS-7 cells transfected with D1D DNA bound [H-3]SCH-23390 in a saturable manner with high affinity (similar to 300 pM) and with a pharmacological profile clearly indicative of a dopamine D1-like receptor, The DID receptor exhibited affinities for 6,7-dihydroxy-2-aminotetralin and dopamine 10-fold higher than D1/D1A receptors, characteristic of the D5/D1B receptor subfamily, In contrast, the D1D receptor bound dopaminergic agents, such as SKF-38393, apomorphine, pergolide, and lisuride, with affinities 10-fold higher than other cloned mammalian or vertebrate D1A/D1B receptor subtypes, while both clozapine and haloperidol displayed considerably lower affinity for the D1D receptor. Based on the low overall amino acid sequence identity (54%) and unique pharmacological profile, the avian dopamine D1D receptor does not appear to be a species homolog of the recently cloned vertebrate D1C receptor (Sugamori, K. S,, Demchyshyn, L, L,, Chung, M,, and Niznik, H, B, (1994) Proc. Natl. Acad. Sci, U. S. A. 91, 10536-10540), As with all cloned mammalian and vertebrate D1-like receptors, the D1D receptor stimulates adenylate cyclase activity in the presence of dopamine or SKF-82526. Northern blot analysis reveals the selective expression of both avian D1D and D1A receptor mRNAs only in brain with the D1B receptor more widely distributed and localized in tissues such as brain, kidney, and spleen, The isolation of four distinct vertebrate dopamine D1 receptor subtypes suggests the existence of additional mammalian D1 like receptor genes that may account for the observed pharmacological and biochemical multiplicity of dopamine D1-like receptor mediated events.	CLARKE INST PSYCHIAT,MOLEC NEUROBIOL LAB,TORONTO,ON M5T 1R8,CANADA; UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5S 1A8,CANADA; UNIV TORONTO,DEPT PSYCHIAT,TORONTO,ON M5S 1A8,CANADA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto			Lee, Frank J.S./D-5899-2017	Lee, Frank J.S./0000-0002-5768-3776				ANDERSEN PH, 1990, TRENDS PHARMACOL SCI, V11, P231, DOI 10.1016/0165-6147(90)90249-8; ARIASMONTANO JA, 1993, MOL BRAIN RES, V19, P233, DOI 10.1016/0169-328X(93)90033-L; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; BARONTI F, 1992, ANN NEUROL, V32, P776, DOI 10.1002/ana.410320611; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; BOUVIER C, 1993, J RECEPTOR RES, V13, P559, DOI 10.3109/10799899309073679; CASTO JM, 1994, J NEUROBIOL, V25, P767, DOI 10.1002/neu.480250703; CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281; DALY SA, 1993, PSYCHOPHARMACOLOGY, V113, P45, DOI 10.1007/BF02244332; DIETL MM, 1988, BRAIN RES, V439, P354, DOI 10.1016/0006-8993(88)91494-1; DOWNES RP, 1993, EUR J PHARMACOL, V234, P135, DOI 10.1016/0014-2999(93)90718-W; FELDER CC, 1989, J BIOL CHEM, V264, P8739; FELDER CC, 1993, AM J PHYSIOL, V264, pF1032, DOI 10.1152/ajprenal.1993.264.6.F1032; FRAIL DE, 1993, MOL PHARMACOL, V44, P1113; FRYXELL KJ, 1994, DOPAMINE RECEPTORS T, P237; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; HALL H, 1994, DOPAMINE RECEPTORS T, P3; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P2621, DOI 10.1073/pnas.91.7.2621; JARVIE KR, 1993, ADV NEUROL, V60, P325; JARVIE KR, 1993, J RECEPTOR RES, V13, P573, DOI 10.3109/10799899309073680; KATZ JL, 1993, PSYCHOPHARMACOLOGY, V118, P19; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; KOPIN IJ, 1993, ANN REV PHARM TOXICO, V32, P467; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAITINEN JT, 1993, J NEUROCHEM, V61, P1461, DOI 10.1111/j.1471-4159.1993.tb13641.x; LIU YF, 1992, MOL ENDOCRINOL, V6, P1815, DOI 10.1210/me.6.11.1815; MACHIDA CA, 1992, MOL PHARMACOL, V41, P652; MacKenzie R. G., 1994, DOPAMINE RECEPTORS T, P283; MAHAN LC, 1990, P NATL ACAD SCI USA, V87, P2196, DOI 10.1073/pnas.87.6.2196; MAILMAN RB, 1986, PSYCHOPHARMACOL BULL, V22, P593; MEYER ME, 1993, PHARMACOL BIOCHEM BE, V46, P269, DOI 10.1016/0091-3057(93)90352-T; MOONS L, 1994, J COMP NEUROL, V346, P97, DOI 10.1002/cne.903460107; NASH SR, 1993, MOL PHARMACOL, V44, P918; NIZNIK HB, 1987, MOL CELL ENDOCRINOL, V54, P1, DOI 10.1016/0303-7207(87)90134-1; NIZNIK HB, 1992, J PSYCHIATR NEUROSCI, V17, P158; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; OLANOW CW, 1994, MOVEMENT DISORD, V9, P40, DOI 10.1002/mds.870090107; PEDERSEN UB, 1994, EUR J PHARM-MOLEC PH, V267, P85, DOI 10.1016/0922-4106(94)90228-3; POLLOCK NJ, 1992, J BIOL CHEM, V267, P17780; ROSENGARTEN H, 1993, PHARMACOL BIOCHEM BE, V45, P921, DOI 10.1016/0091-3057(93)90140-O; ROSENZWEIGLIPSON S, 1993, J PHARMACOL EXP THER, V267, P765; SCHAMBRA UB, 1994, NEUROSCIENCE, V62, P66; SEEMAN P, 1988, ISI ATLAS-PHARMACOL, V2, P161; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SMEETS WJAJ, 1990, NEUROSCI LETT, V114, P248, DOI 10.1016/0304-3940(90)90571-P; SUGAMORI KS, 1994, P NATL ACAD SCI USA, V91, P10536, DOI 10.1073/pnas.91.22.10536; SUNAHARA RK, 1990, NATURE, V347, P80, DOI 10.1038/347080a0; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; UNDIE AS, 1990, J PHARMACOL EXP THER, V253, P987; UNDIE AS, 1994, J NEUROCHEM, V62, P2045; VENTURA ALM, 1990, BRAIN RES, V530, P301; VENTURA ALM, 1992, DEV BRAIN RES, V69, P199; VERNIER P, 1993, COMP MOL NEUROBIOLOG, P297; WALDMANN C, 1993, BRAIN RES, V600, P225, DOI 10.1016/0006-8993(93)91377-5; WALLACE MA, 1993, NEUROCHEM RES, V18, P139, DOI 10.1007/BF01474676; WEINSHANK RL, 1991, J BIOL CHEM, V266, P22427; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	57	96	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4005	4012		10.1074/jbc.270.8.4005	http://dx.doi.org/10.1074/jbc.270.8.4005			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876148	hybrid			2022-12-27	WOS:A1995QH68800081
J	RYTOMAA, M; KINNUNEN, PKJ				RYTOMAA, M; KINNUNEN, PKJ			REVERSIBILITY OF THE BINDING OF CYTOCHROME-C TO LIPOSOMES - IMPLICATIONS FOR LIPID-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRICYTOCHROME-C; PHOSPHOLIPID MONOLAYERS; CONFORMATIONAL-CHANGES; CARDIOLIPIN BILAYERS; NMR MEASUREMENTS; RESONANCE RAMAN; KINASE-C; MEMBRANES; FLUORESCENCE; ASSOCIATION	Studies on the membrane binding of cytochrome c revealed liposome-associated and soluble cytochrome c not to be in rapid equilibrium, In brief, cytochrome c attached to pyrene phospholipid labeled, fluorescent liposomes containing either 17.6 mol % cardiolipin (CL) or 30 mol % egg phosphatidylglycerol (PG) is practically not at all or very slowly, respectively, detached by a subsequently added excess (up to 20-fold) of nonlabeled liposomes containing these acidic lipids, Cytochrome c was fully dissociated from PG-containing liposomes by increasing the ionic strength by NaCl, whereas dissociation from CL-containing membranes was less complete, presumably because of the scavenging of the protein within inverted intramembrane micelles, Importantly, the apparent irreversibility of the binding of cytochrome c to liposomes is strongly dependent on the structure of the acidic phospholipid. Cytochrome c bound to lyso-PG/PC liposomes could be dissociated with an excess of nonlabeled PG-containing liposomes, Cytochrome c was also efficiently bound to membranes containing the negatively charged dicetylphosphate yet could be readily dissociated by nonlabeled PG-containing liposomes. We conclude both proper geometry of the phosphate group and the presence of two acyl chains to be required for the tight binding of cytochrome c to acidic phospholipids, These data provide evidence for the membrane association of cytochrome c by an acidic phospholipid in the extended conformation (Kinnunen, P. K. J., Koiv, A., Lehtonen, J, Y, A., Rytomaa, M., and Mustonen P, (1994) Chem, Phys. Lipids 73, 181-207) in which one of the acyl chains of the lipid becomes accommodated within a hydrophobic cavity of the protein, Based on the crystal structure of cytochrome c we putatively assign the invariant Asn-52 (horse heart cytochrome c) as the site liganding the protonated phosphate of the lipid, whereas Lys-72 and -73 should bind the deprotonated form.	UNIV HELSINKI, INST BIOMED, DEPT MED CHEM, SF-00014 HELSINKI, FINLAND	University of Helsinki								BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; BROWN LR, 1977, BIOCHIM BIOPHYS ACTA, V468, P389, DOI 10.1016/0005-2736(77)90290-5; DEKRUIJFF B, 1980, BIOCHIM BIOPHYS ACTA, V602, P477, DOI 10.1016/0005-2736(80)90327-2; DEMEL RA, 1989, J BIOL CHEM, V264, P3988; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; HAUSER H, 1988, BIOCHEMISTRY-US, V27, P9166, DOI 10.1021/bi00426a014; HEIMBURG T, 1991, BIOCHEMISTRY-US, V30, P9084, DOI 10.1021/bi00101a025; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; JORI G, 1974, PHOTOCHEM PHOTOBIOL, V19, P337, DOI 10.1111/j.1751-1097.1974.tb06521.x; KABACK HR, 1993, J BIOENERG BIOMEMBR, V25, P627; KAHANA E, 1992, BIOCHEM J, V282, P75, DOI 10.1042/bj2820075; KAIHOVAARA P, 1991, BIOCHEMISTRY-US, V30, P8380, DOI 10.1021/bi00098a015; KIMELBERG HK, 1969, BIOCHEM BIOPH RES CO, V34, P784, DOI 10.1016/0006-291X(69)90248-4; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; KINNUNEN PKJ, 1991, CHEM PHYS LIPIDS, V57, P375, DOI 10.1016/0009-3084(91)90087-R; KINNUNEN PKJ, 1994, CHEM PHYS LIPIDS, V73, P181, DOI 10.1016/0009-3084(94)90181-3; KINNUNEN PKJ, 1993, CHEM PHYS LIPIDS, V66, P75, DOI 10.1016/0009-3084(93)90033-Y; KINNUNEN PKJ, 1993, FLUORESCENCE SPECTRO, P159; KOIV A, 1994, CHEM PHYS LIPIDS, V70, P1, DOI 10.1016/0009-3084(94)90042-6; KOZARAC Z, 1988, FEBS LETT, V229, P372, DOI 10.1016/0014-5793(88)81159-1; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; LEE MH, 1989, J BIOL CHEM, V264, P14797; LETELLIER L, 1973, EUR J BIOCHEM, V40, P507, DOI 10.1111/j.1432-1033.1973.tb03220.x; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MEERS P, 1994, BIOCHEMISTRY-US, V33, P5829, DOI 10.1021/bi00185a022; MUGA A, 1991, BIOCHEMISTRY-US, V30, P7219, DOI 10.1021/bi00243a025; MUSTONEN P, 1987, BIOCHEMISTRY-US, V26, P2991, DOI 10.1021/bi00385a006; MUSTONEN P, 1993, BIOCHEMISTRY-US, V32, P5373, DOI 10.1021/bi00071a012; MUSTONEN P, 1993, J BIOL CHEM, V268, P1074; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NICHOLLS P, 1974, BIOCHIM BIOPHYS ACTA, V346, P261, DOI 10.1016/0304-4173(74)90003-2; PACHENCE JM, 1991, BIOPHYS J, V59, P894, DOI 10.1016/S0006-3495(91)82302-5; PINHEIRO TJT, 1994, BIOCHEMISTRY-US, V33, P2451, DOI 10.1021/bi00175a013; QI PX, 1994, NAT STRUCT BIOL, V1, P378, DOI 10.1038/nsb0694-378; QUINN PJ, 1969, BIOCHEM J, V115, P65, DOI 10.1042/bj1150065; QUINN PJ, 1969, BIOCHEM J, V113, P791, DOI 10.1042/bj1130791; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; SOUSSI B, 1990, BIOCHEM J, V265, P227, DOI 10.1042/bj2650227; SPECK SH, 1983, FEBS LETT, V164, P379, DOI 10.1016/0014-5793(83)80321-4; SPOONER PJR, 1991, BIOCHEMISTRY-US, V30, P3871, DOI 10.1021/bi00230a010; SPOONER PJR, 1991, BIOCHEMISTRY-US, V30, P3880, DOI 10.1021/bi00230a011; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; STEINEMANN A, 1971, J MEMBRANE BIOL, V4, P74, DOI 10.1007/BF02431963; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TEISSIE J, 1981, BIOCHEMISTRY-US, V20, P1554, DOI 10.1021/bi00509a023; THUREN T, 1985, CLIN CHEM, V31, P714; VANDERKOOI J, 1973, ARCH BIOCHEM BIOPHYS, V154, P219, DOI 10.1016/0003-9861(73)90052-0; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; VINCENT JS, 1986, J AM CHEM SOC, V108, P3551, DOI 10.1021/ja00273a001; VINCENT JS, 1987, BIOCHEMISTRY-US, V26, P2312, DOI 10.1021/bi00382a036; WALTHAM MC, 1986, BIOCHIM BIOPHYS ACTA, V862, P451, DOI 10.1016/0005-2736(86)90250-6	56	234	236	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3197	3202		10.1074/jbc.270.7.3197	http://dx.doi.org/10.1074/jbc.270.7.3197			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852404	hybrid			2022-12-27	WOS:A1995QG47100048
J	YAMADA, K; CARPENTIER, JL; CHEATHAM, B; GONCALVES, E; SHOELSON, SE; KAHN, CR				YAMADA, K; CARPENTIER, JL; CHEATHAM, B; GONCALVES, E; SHOELSON, SE; KAHN, CR			ROLE OF THE TRANSMEMBRANE DOMAIN AND FLANKING AMINO-ACIDS IN INTERNALIZATION AND DOWN-REGULATION OF THE INSULIN-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; JUXTAMEMBRANE REGION; MEDIATED INTERNALIZATION; POLYPEPTIDE HORMONES; DIABETIC RATS; ENDOCYTOSIS; BINDING; DEGRADATION; SEQUENCE; PROTEIN	We have characterized the internalization and downregulation of the insulin receptor and nine receptors with mutations in the transmembrane (TM) domain and/or flanking charged amino acids to define the role of this domain in receptor cycling, When expressed in Chinese hamster ovary cells, all had normal tetrameric structure and normal insulin-stimulated autophosphorylation/kinase activity, Replacement of the TM domain with that of the platelet derived growth factor receptor, insertion of 3 amino acids, and substitution of Asp for Val(938) or of Ala for either Gly(933) Or Pro(934) had no effect on internalization Replacement of the TER domain with that of c-neu or conversion of the charged amino acids on the cytoplasmic Bank to uncharged amino acids, on the other hand, resulted in a 40-60% decrease in insulin-dependent internalization rate constants, By contrast, substitution of Ala for both Gly(933) and Pro(934) increases lateral diffusion mobility and accelerates internalization rate, These changes in internalization were due to decreased or increased rates of redistribution of receptors from microvilli to the nonvillous cell surface, In all cases, receptor down-regulation and receptor-mediated insulin degradation paralleled the changes in internalization Thus, the structure of the transmembrane domain of the insulin receptor and flanking amino acids are major determinants of receptor internalization, insulin degradation, and receptor down-regulation.	JOSLIN DIABET CTR, DIV RES, BOSTON, MA 02215 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; UNIV GENEVA, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; University of Geneva; Harvard University; Harvard Medical School			Kahn, Ronald/AAY-2435-2021; Goncalves, Edison/AAR-3280-2020	Kahn, Ronald/0000-0002-7583-9228; Goncalves, Edison/0000-0002-7887-1231	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK031036, R37DK031036] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 31036, DK 36836] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDROLEWICZ MJ, 1989, BIOCHEMISTRY-US, V28, P9750, DOI 10.1021/bi00451a031; BACKER JM, 1989, J BIOL CHEM, V264, P1694; BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BERHANU P, 1990, J BIOL CHEM, V265, P9505; CARPENTIER JL, 1978, J CLIN INVEST, V61, P1057, DOI 10.1172/JCI109005; CARPENTIER JL, 1993, HISTOCHEMISTRY, V100, P169, DOI 10.1007/BF00269090; CARPENTIER JL, 1989, DIABETOLOGIA, V32, P627; CARPENTIER JL, 1986, J CLIN ENDOCR METAB, V63, P151, DOI 10.1210/jcem-63-1-151; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CARPENTIER JL, 1984, J BIOL CHEM, V259, P4190; CARPENTIER JL, 1979, J CLIN INVEST, V63, P1249, DOI 10.1172/JCI109420; CARPENTIER JL, 1993, J CELL BIOL, V118, P831; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHOU CK, 1987, J BIOL CHEM, V262, P1842; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; GEIGER D, 1989, EXP CELL RES, V185, P33, DOI 10.1016/0014-4827(89)90034-7; GONCALVES E, 1993, P NATL ACAD SCI USA, V90, P5762, DOI 10.1073/pnas.90.12.5762; GORDEN P, 1980, DIABETOLOGIA, V18, P263; GORDEN P, 1982, YALE J BIOL MED, V55, P101; GORDEN P, 1987, SCIENCE, V200, P782; HARI J, 1987, J BIOL CHEM, V262, P15341; JOCHEN AL, 1986, J CLIN ENDOCR METAB, V62, P268, DOI 10.1210/jcem-62-2-268; JUHANBAGUE I, 1986, DIABETOLOGIA, V29, P471; KANTAR A, 1991, BIOCHEM MED METAB B, V46, P422, DOI 10.1016/0885-4505(91)90090-8; KASUGA M, 1982, J BIOL CHEM, V257, P392; KRISCHER J, 1993, DIABETES, V42, P1303, DOI 10.2337/diabetes.42.9.1303; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LUND KA, 1990, J BIOL CHEM, V265, P15713; MASSAGUE J, 1980, P NATL ACAD SCI-BIOL, V77, P7137, DOI 10.1073/pnas.77.12.7137; MASUDA M, 1990, DIABETES, V39, P466, DOI 10.2337/diabetes.39.4.466; MCCLAIN DA, 1990, J BIOL CHEM, V265, P21363; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; PACCAUD JP, 1993, J BIOL CHEM, V268, P23191; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; THIES RS, 1990, J BIOL CHEM, V265, P10132; TRISCHITTA V, 1986, J CLIN ENDOCR METAB, V62, P522, DOI 10.1210/jcem-62-3-522; TRISCHITTA V, 1989, DIABETES, V38, P1579, DOI 10.2337/diabetes.38.12.1579; TRISCHITTA V, 1989, J BIOL CHEM, V264, P5041; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WHIE MF, 1994, J BIOL CHEM, V269, P1; YAMADA K, 1992, J BIOL CHEM, V267, P12452	51	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3115	3122		10.1074/jbc.270.7.3115	http://dx.doi.org/10.1074/jbc.270.7.3115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852393	hybrid			2022-12-27	WOS:A1995QG47100036
J	FULTON, C; LAI, EY; REMILLARD, SP				FULTON, C; LAI, EY; REMILLARD, SP			A FLAGELLAR CALMODULIN GENE OF NAEGLERIA, COEXPRESSED DURING DIFFERENTIATION WITH FLAGELLAR TUBULIN GENES, SHARES DNA, RNA, AND ENCODED PROTEIN-SEQUENCE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; TISSUE-SPECIFIC EXPRESSION; DIVERGENT MESSENGER-RNAS; AMINO-ACID-SEQUENCE; DROSOPHILA-MELANOGASTER; CELL-DIFFERENTIATION; ALPHA-TUBULIN; BETA-TUBULIN; DICTYOSTELIUM-DISCOIDEUM; STRUCTURAL ORGANIZATION	Two calmodulins are synthesized during differentiation of Naegleria gruberi from amoebae to flagellates; one remains in the cell body and the other becomes localized in the flagella, The single, intronless, expressed gene for flagellar calmodulin has been cloned and sequenced, The encoded protein is a typical calmodulin with four putative calcium-binding domains, but it has an amino-terminal extension of 10 divergent amino acids preceding conserved calmodulin residue 4. The transcripts encoding flagellar calmodulin and flagellate cell body calmodulin are clearly divergent, Expression of the flagellar calmodulin gene is differentiation specific; its mRNA appears and then disappears concurrently with those encoding flagellar alpha- and beta-tubulin, Three provocative sequence elements are shared among these unrelated coexpressed genes: (i) a palindromic DNA sequence element is found in duplicate or triplicate upstream to each transcribed region; (ii) a perfect 12-nucleotide match is found near the AUG start codon of flagellar calmodulin and alpha-tubulin; and (iii) the novel amino-terminal extension of flagellar calmodulin contains a 5-amino-acid element similar to the amino terminus of flagellar alpha-tubulin, These shared sequence elements are proposed to have roles in differentiation, possibly in regulation of transcription, mRNA stability, and localization of these proteins to flagella.			FULTON, C (corresponding author), BRANDEIS UNIV,DEPT BIOL,415 SOUTH ST,WALTHAM,MA 02254, USA.							BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BARTON PJR, 1985, BIOCHEM J, V231, P249, DOI 10.1042/bj2310249; BELTZ GA, 1983, METHOD ENZYMOL, V100, P266; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; BURGESS WH, 1982, J BIOL CHEM, V257, P1800; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; CLARK CG, 1990, J PROTOZOOL, V37, P400, DOI 10.1111/j.1550-7408.1990.tb01164.x; COLLINS JH, 1988, J BIOL CHEM, V263, P15378; CORNELISSEN AWCA, 1986, NUCLEIC ACIDS RES, V14, P5605, DOI 10.1093/nar/14.14.5605; COX JA, 1981, BIOCHEMISTRY-US, V20, P5430, DOI 10.1021/bi00522a012; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; DOYLE KE, 1990, J MOL BIOL, V213, P599, DOI 10.1016/S0022-2836(05)80245-1; FISCHER R, 1988, J BIOL CHEM, V263, P17055; FULTON C, 1993, J EUKARYOT MICROBIOL, V40, P520, DOI 10.1111/j.1550-7408.1993.tb04945.x; FULTON C, 1977, J SUPRAMOL STR CELL, V6, P13, DOI 10.1002/jss.400060103; FULTON C, 1977, ANNU REV MICROBIOL, V31, P597, DOI 10.1146/annurev.mi.31.100177.003121; FULTON C, 1986, J CELL BIOL, V102, P1671, DOI 10.1083/jcb.102.5.1671; GASCH A, 1988, MOL GEN GENET, V211, P8, DOI 10.1007/BF00338387; GAWIENOWSKI MC, 1993, PLANT MOL BIOL, V22, P215, DOI 10.1007/BF00014930; GOLDHAGEN H, 1986, MOL CELL BIOL, V6, P1851, DOI 10.1128/MCB.6.5.1851; HARDY DO, 1988, J MOL BIOL, V199, P223, DOI 10.1016/0022-2836(88)90392-0; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOWLEY PM, 1979, J BIOL CHEM, V254, P4876; HUANG B, 1988, J CELL BIOL, V107, P133, DOI 10.1083/jcb.107.1.133; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; KOBAYASHI T, 1984, EUR J BIOCHEM, V144, P401, DOI 10.1111/j.1432-1033.1984.tb08478.x; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAI EY, 1994, J MOL BIOL, V235, P377, DOI 10.1016/S0022-2836(05)80045-2; LAI EY, 1988, J CELL BIOL, V106, P2035, DOI 10.1083/jcb.106.6.2035; LAI EY, 1979, CELL, V17, P867, DOI 10.1016/0092-8674(79)90327-1; LEE JH, 1988, MOL CELL BIOL, V8, P2280, DOI 10.1128/MCB.8.6.2280; LEJOHN HB, 1989, J BIOL CHEM, V264, P19366; LIEBHABER SA, 1992, GENE REGULATION BIOL, P163; LIU TY, 1992, MOL BIOL CELL, V3, P1403, DOI 10.1091/mbc.3.12.1403; MATSUO K, 1992, GENE, V119, P279, DOI 10.1016/0378-1119(92)90283-U; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; NOJIMA H, 1989, J MOL BIOL, V208, P269, DOI 10.1016/0022-2836(89)90388-4; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; PERERA IY, 1992, PLANT MOL BIOL, V19, P649, DOI 10.1007/BF00026791; Prevelige P., 1989, PREDICTION PROTEIN S, P391; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; RASMUSSEN CD, 1990, J BIOL CHEM, V265, P13767; REMILLARD SP, 1995, GENE, V154, P39, DOI 10.1016/0378-1119(94)00860-U; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; RICCIARDI RP, 1979, P NATL ACAD SCI USA, V76, P4927, DOI 10.1073/pnas.76.10.4927; ROBSON KJH, 1991, MOL BIOCHEM PARASIT, V46, P19, DOI 10.1016/0166-6851(91)90195-C; SALVATO M, 1986, J MOL BIOL, V190, P281, DOI 10.1016/0022-2836(86)90002-1; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SHEA DK, 1987, J CELL BIOL, V105, P1303, DOI 10.1083/jcb.105.3.1303; SHEN P, 1986, GENETICS, V112, P441; SILFLOW CD, 1985, MOL CELL BIOL, V5, P2389, DOI 10.1128/MCB.5.9.2389; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; SMITH VL, 1987, J MOL BIOL, V196, P471, DOI 10.1016/0022-2836(87)90025-8; STEIN JP, 1983, P NATL ACAD SCI-BIOL, V80, P6485, DOI 10.1073/pnas.80.21.6485; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SWANSON ME, 1990, J MOL BIOL, V216, P545, DOI 10.1016/0022-2836(90)90382-V; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; THORNTON JM, 1983, J MOL BIOL, V167, P443, DOI 10.1016/S0022-2836(83)80344-1; TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998; TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YASWEN P, 1992, CELL GROWTH DIFFER, V3, P335; YASWEN P, 1990, P NATL ACAD SCI USA, V87, P7360, DOI 10.1073/pnas.87.19.7360; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; YOUNGBLOM J, 1984, MOL CELL BIOL, V4, P2686, DOI 10.1128/MCB.4.12.2686; ZIMMER WE, 1988, J BIOL CHEM, V263, P19370	71	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5839	5848		10.1074/jbc.270.11.5839	http://dx.doi.org/10.1074/jbc.270.11.5839			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890713	hybrid			2022-12-27	WOS:A1995QM94500025
J	GIMBLE, FS; STEPHENS, BW				GIMBLE, FS; STEPHENS, BW			SUBSTITUTIONS IN CONSERVED DODECAPEPTIDE MOTIFS THAT UNCOUPLE THE DNA-BINDING AND DNA CLEAVAGE ACTIVITIES OF PI-SCEI ENDONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; RESTRICTION ENDONUCLEASES; ADENOSINE-TRIPHOSPHATASE; INTERVENING SEQUENCES; ECORI ENDONUCLEASE; PROTEIN; GENE; RECOGNITION; INTRONS	The PI-SceI endonuclease from yeast belongs to a protein family whose members contain two conserved dodecapeptide motifs within their primary sequences, The function of two acidic residues within these motifs, Asp(218) and Asp(326), was examined by substituting alanine, asparagine, and glutamic acid residues at these positions, All of the purified mutant proteins bind to the PI-SceI recognition site with the same affinity and specificity as the wild-type enzyme, By contrast, substituting alanine or asparagine amino acids at the two positions completely eliminates strand cleavage of substrate DNA, whereas substitution with glutamic acid markedly reduces the cleavage activity. Experiments using nicked substrates demonstrate that the wild-type enzyme shows no strand preference during cleavage. These results are consistent with a model in which both acidic residues are part of a single catalytic center that cleaves both DNA strands. Furthermore, substrate binding by wild-type PI-SceI stimulates hydroxyl radical or hydroxide ion attack at the cleavage site while binding by the alanine-substituted proteins either stimulates this attack significantly less or protects the DNA at this position, These finding are discussed in terms of possible reaction mechanisms for PI-SceI-mediated endonucleolytic cleavage.	TEXAS A&M UNIV,DEPT BIOCHEM & BIOPHYS,HOUSTON,TX 77030	Texas A&M University System	GIMBLE, FS (corresponding author), TEXAS A&M UNIV,INST BIOSCI & TECHNOL,CTR MACROMOLEC DESIGN,2121 W HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050815] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50815] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JE, 1993, CURR OPIN STRUC BIOL, V3, P24, DOI 10.1016/0959-440X(93)90197-S; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BREMER MCD, 1992, NUCLEIC ACIDS RES, V20, P5484, DOI 10.1093/nar/20.20.5484; CHENG XD, 1994, EMBO J, V13, P3927, DOI 10.1002/j.1460-2075.1994.tb06708.x; COOPER AA, 1993, EMBO J, V12, P2575, DOI 10.1002/j.1460-2075.1993.tb05913.x; COOPER AA, 1993, BIOESSAYS, V15, P667, DOI 10.1002/bies.950151006; DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415; DUJON B, 1989, GENE, V82, P115, DOI 10.1016/0378-1119(89)90035-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; GIMBLE FS, 1993, J BIOL CHEM, V268, P21844; HAYES JJ, 1990, METHOD ENZYMOL, V186, P545; HENSGENS LAM, 1983, CELL, V32, P379, DOI 10.1016/0092-8674(83)90457-9; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HODGES RA, 1992, NUCLEIC ACIDS RES, V20, P6153, DOI 10.1093/nar/20.23.6153; JELTSCH A, 1992, FEBS LETT, V304, P4, DOI 10.1016/0014-5793(92)80576-3; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KING K, 1989, J BIOL CHEM, V264, P11807; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; LI L, 1992, P NATL ACAD SCI USA, V89, P4275, DOI 10.1073/pnas.89.10.4275; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MUELLER JE, 1993, NUCLEASES, P111; NEWMAN M, 1994, NATURE, V368, P660, DOI 10.1038/368660a0; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELENT U, 1992, BIOCHEMISTRY-US, V31, P4808, DOI 10.1021/bi00135a010; SKOWRON P, 1993, GENE, V125, P1, DOI 10.1016/0378-1119(93)90738-O; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; THIELKING V, 1991, BIOCHEMISTRY-US, V30, P6416, DOI 10.1021/bi00240a011; TULLIUS TD, 1985, SCIENCE, V230, P679, DOI 10.1126/science.2996145; WARING RB, 1982, P NATL ACAD SCI-BIOL, V79, P6332, DOI 10.1073/pnas.79.20.6332; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; WEAST RC, 1973, CRC HDB CHEM PHYSICS; Winkler F. K., 1992, CURR OPIN STRUC BIOL, V2, P93; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5	40	98	104	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5849	5856		10.1074/jbc.270.11.5849	http://dx.doi.org/10.1074/jbc.270.11.5849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890714	hybrid			2022-12-27	WOS:A1995QM94500026
J	HOFF, T; SCHNORR, KM; MEYER, C; CABOCHE, M				HOFF, T; SCHNORR, KM; MEYER, C; CABOCHE, M			ISOLATION OF 2 ARABIDOPSIS CDNAS INVOLVED IN EARLY STEPS OF MOLYBDENUM COFACTOR BIOSYNTHESIS BY FUNCTIONAL COMPLEMENTATION OF ESCHERICHIA-COLI MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATE REDUCTASE; MOLYBDOPTERIN PRECURSOR; CONVERTING FACTOR; INVITRO SYNTHESIS; GENETIC-ANALYSIS; PROTEINS; PURIFICATION; THALIANA; PEPTIDES; OXIDASE	Most organisms appear to have a molybdenum cofactor consisting of a complex of molybdenum and a pterin derivative. Very little is known about molybdenum cofactor biosynthesis in plants or other eukaryotes, because the instability of the cofactor and its precursors makes it difficult to analyze this pathway. We have isolated two cDNA clones from the higher plant Arabidopsis thaliana encoding genes involved in early steps of molybdenum cofactor biosynthesis, The cDNAs were obtained by functional complementation of two Escherichia coli mutants deficient in single steps of molybdenum cofactor biosynthesis, The two cDNAs, designated Cnx2 and Cnx3, encode proteins of 43 and 30 kDa, respectively. They have significant identity to the E. coli genes, moaA and moaC, involved in molybdenum cofactor biosynthesis, Both genes have N-terminal extensions that resemble targeting signals for the chloroplasts or the mitochondria, Import studies with the translated proteins and purified mitochondria and chloroplasts did not show import of these proteins to either of these organelles, Northern analysis show that Cnx2 is expressed in all organs and strongest in roots, Cnx3 is not expressed in abundant levels in any tissue but roots, For both genes there is no detectable difference in the expression level from plants grown with nitrate or with ammonium. The Cnx2 gene has been mapped to chromosome II. Southern analysis suggests that both genes exist as single copies in the genome.			HOFF, T (corresponding author), INRA,BIOL CELLULAIRE LAB,F-78026 VERSAILLES,FRANCE.			Meyer, Christian/0000-0002-7994-5693; Schnorr, Kirk Mtthew/0000-0002-2694-6772				CABOCHE M, 1994, PLANT MOL BIOL REP, V12, pS45; CLINE K, 1985, J BIOL CHEM, V260, P3691; Coughlan M.P., 1980, MOLYBDENUM MOLYBDENU; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GABARD J, 1988, MOL GEN GENET, V213, P206, DOI 10.1007/BF00339583; HOFF T, 1994, PLANT CELL ENVIRON, V17, P489, DOI 10.1111/j.1365-3040.1994.tb00145.x; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; JOHNSON JL, 1989, J BIOL CHEM, V264, P13440; KAMDAR PK, 1994, GENETICS, V137, P791; KLEINHOFS A, 1990, BIOCH PLANTS, P89; KRAMER SP, 1987, J BIOL CHEM, V262, P16357; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACGREGOR CH, 1974, J BIOL CHEM, V249, P5321; MENDEL RR, 1985, PLANTA, V163, P370, DOI 10.1007/BF00395145; NOHNO T, 1988, J BACTERIOL, V170, P4097, DOI 10.1128/jb.170.9.4097-4102.1988; PELSY F, 1992, ADV GENET, V30, P1, DOI 10.1016/S0065-2660(08)60317-X; PITTERLE DM, 1993, J BIOL CHEM, V268, P13499; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; RIVERS SL, 1993, MOL MICROBIOL, V8, P1071, DOI 10.1111/j.1365-2958.1993.tb01652.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNORR KM, 1994, PLANT J, V6, P113, DOI 10.1046/j.1365-313X.1994.6010113.x; SENECOFF JF, 1993, PLANT PHYSIOL, V102, P387, DOI 10.1104/pp.102.2.387; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WALKERSIMMONS M, 1989, PLANT PHYSIOL, V90, P728, DOI 10.1104/pp.90.2.728; WARNER CK, 1981, MOL GEN GENET, V184, P92, DOI 10.1007/BF00271201; WHITE JA, 1987, BIOCHIM BIOPHYS ACTA, V926, P16, DOI 10.1016/0304-4165(87)90178-4; Wray J.L., 1989, MOL GENETIC ASPECTS; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493	39	56	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6100	6107		10.1074/jbc.270.11.6100	http://dx.doi.org/10.1074/jbc.270.11.6100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890743	Green Submitted			2022-12-27	WOS:A1995QM94500059
J	POUPOT, R; MARTINEZROMERO, E; GAUTIER, N; PROME, JC				POUPOT, R; MARTINEZROMERO, E; GAUTIER, N; PROME, JC			WILD-TYPE RHIZOBIUM-ETLI, A BEAN SYMBIONT, PRODUCES ACETYL-FUCOSYLATED, N-METHYLATED, AND CARBAMOYLATED NODULATION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPO-OLIGOSACCHARIDE SIGNALS; PHASEOLUS-VULGARIS L; NOD GENE INDUCERS; HOST-SPECIFICITY; BRADYRHIZOBIUM-JAPONICUM; ROOT NODULE; MELILOTI; STRAINS; TROPICI; MOIETY	Phaseolus vulgaris (common bean) can be nodulated by different Rhizobium species. A new species has been recently proposed: Rhizobium etli. Following transcriptional activation of the bacterial nodulation genes using naringenin or bean seed exudate, we have isolated, purified, and characterized R. etli extracellular nodulation factors. They are chitopentameric compounds that are N-methyl-N-vaccenoylated at their non-reducing end. At position 6 of the reducing N-acetyl-D-glucosamine, they are 4-O-acetyl-L-fucosylated. Minor compounds bear a carbamate group on the terminal non-reducing saccharidic residue.	CNRS, PHARMACOL & TOXICOL FONDAMENTALES LAB, F-31077 TOULOUSE, FRANCE; UNIV NACL AUTONOMA MEXICO, CTR INVEST FIJAC NITROGENO, CUERNAVACA 62191, MORELOS, MEXICO	Centre National de la Recherche Scientifique (CNRS); Universidad Nacional Autonoma de Mexico				martinez-romero, esperanza/0000-0002-2295-2606				ALTONA C, 1980, ORG MAGN RESONANCE, V13, P417, DOI 10.1002/mrc.1270130606; BECFERTE MP, 1994, BIOCHEMISTRY-US, V33, P11782, DOI 10.1021/bi00205a014; CARLSON RW, 1993, J BIOL CHEM, V268, P18372; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DENARIE J, 1993, CELL, V74, P951, DOI 10.1016/0092-8674(93)90717-5; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; FISHER RF, 1992, NATURE, V357, P655, DOI 10.1038/357655a0; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; GOTTFERT M, 1993, FEMS MICROBIOL LETT, V104, P39, DOI 10.1016/0378-1097(93)90503-T; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P751, DOI 10.1104/pp.97.2.751; HUNGRIA M, 1991, PLANT PHYSIOL, V97, P759, DOI 10.1104/pp.97.2.759; ISONO K, 1968, TETRAHEDRON LETT, P1133, DOI 10.1016/S0040-4039(01)98906-3; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LEROUGE P, 1994, GLYCOBIOLOGY, V4, P127, DOI 10.1093/glycob/4.2.127; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MARTINEZ E, 1993, CURR PLANT SCI BIOT, V17, P171; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; MERGAERT P, 1993, P NATL ACAD SCI USA, V90, P1551, DOI 10.1073/pnas.90.4.1551; NAP JP, 1990, SCIENCE, V250, P948, DOI 10.1126/science.250.4983.948; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; POUPOT R, 1993, BIOCHEMISTRY-US, V32, P10430, DOI 10.1021/bi00090a019; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; PROME JC, 1987, RAPID COMMUN MASS SP, V1, P50; RELIC B, 1993, MOL PLANT MICROBE IN, V6, P764, DOI 10.1094/MPMI-6-764; ROCHE P, 1991, CELL, V67, P1131, DOI 10.1016/0092-8674(91)90290-F; SANJUAN J, 1992, P NATL ACAD SCI USA, V89, P8789, DOI 10.1073/pnas.89.18.8789; SEGOVIA L, 1993, INT J SYST BACTERIOL, V43, P374, DOI 10.1099/00207713-43-2-374; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; STOKKERMANS TJW, 1994, PLANTA, V193, P413, DOI 10.1007/BF00201821; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; YU RK, 1986, CHEM PHYS LIPIDS, V42, P27, DOI 10.1016/0009-3084(86)90041-1	31	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6050	6055		10.1074/jbc.270.11.6050	http://dx.doi.org/10.1074/jbc.270.11.6050			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890737	hybrid			2022-12-27	WOS:A1995QM94500053
J	PROSTKO, CR; DHOLAKIA, JN; BROSTROM, MA; BROSTROM, CO				PROSTKO, CR; DHOLAKIA, JN; BROSTROM, MA; BROSTROM, CO			ACTIVATION OF THE DOUBLE-STRANDED RNA-REGULATED PROTEIN-KINASE BY DEPLETION OF ENDOPLASMIC RETICULAR CALCIUM STORES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT EIF-2-ALPHA KINASE; MONOCLONAL-ANTIBODIES; CHAIN INITIATION; 3T3-F442A CELLS; MECHANISM; PHOSPHORYLATION; EXPRESSION; INHIBITION	Perturbants of the endoplasmic reticulum (ER), including Ca2+-mobilizing agents, provoke a rapid suppression of translational initiation in conjunction with an increased phosphorylation of the alpha-subunit of eukaryotic initiation factor (eIF)-2. Depletion of ER Ca2+ stores was found to signal the activation of a specific eIF-2 alpha kinase, Analysis of extracts derived from cultured cells that had been pretreated with Ca2+ ionophore A23187 or thapsigargin revealed a 2-3-fold increase in eIF-2 alpha kinase activity without detectable changes in eIF-2 alpha phosphatase activity. A peptide of 65-68 kDa, which was phosphorylated concurrently with eIF-2 alpha in extracts of pretreated cells, was identified as the interferon-inducible, double-stranded RNA (dsRNA)-regulated protein kinase (PKR). Depletion of ER Ca2+ stores did not alter the PKR contents of extracts. When incubated with reovirus dsRNA, extracts derived from cells with depleted ER Ca2+ stores displayed greater degrees of phosphorylation of PKR and of eIF-2 alpha than did control extracts, The enhanced dsRNA dependent phosphorylation of PKR was observed regardless of prior induction of the kinase with interferon. Lower concentrations of dsRNA were required for maximal phosphorylation of PKR in extracts of treated as compared to control preparations. These findings suggest that PKR mediates the translational suppression occurring in response to perturbation of ER Ca2+ homeostasis.	UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT PHARMACOL, PISCATAWAY, NJ 08854 USA; UNIV LOUISVILLE, SCH MED, DEPT BIOCHEM, LOUISVILLE, KY 40292 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035393] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 35393] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; BROSTROM CO, 1983, J BIOL CHEM, V258, P4390; BROSTROM MA, 1995, J BIOL CHEM, V270, P4127, DOI 10.1074/jbc.270.8.4127; DHOLAKIA JN, 1989, J BIOL CHEM, V264, P546; DUBOIS MF, 1989, J BIOL CHEM, V264, P12165; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; ITO T, 1994, P NATL ACAD SCI USA, V91, P7455, DOI 10.1073/pnas.91.16.7455; JUDWARE R, 1991, MOL CELL BIOL, V11, P3259, DOI 10.1128/MCB.11.6.3259; KIMBALL SR, 1991, J BIOL CHEM, V266, P1969; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LI JH, 1991, EUR J BIOCHEM, V195, P41, DOI 10.1111/j.1432-1033.1991.tb15673.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; MUNDSCHAU LJ, 1992, J BIOL CHEM, V267, P23092; PAL JK, 1991, BIOCHEMISTRY-US, V30, P2555, DOI 10.1021/bi00223a037; PATEL RC, 1994, J BIOL CHEM, V269, P18593; PETRYSHYN R, 1988, P NATL ACAD SCI USA, V85, P1427, DOI 10.1073/pnas.85.5.1427; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; SAMUEL CE, 1992, PHARMACOL THERAPEUT, V54, P307, DOI 10.1016/0163-7258(92)90005-K; THOMIS DC, 1992, VIROLOGY, V188, P33, DOI 10.1016/0042-6822(92)90732-5; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993	31	120	120	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6211	6215		10.1074/jbc.270.11.6211	http://dx.doi.org/10.1074/jbc.270.11.6211			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890757	hybrid			2022-12-27	WOS:A1995QM94500074
J	RUVINOV, SB; YANG, XJ; PARRIS, KD; BANIK, U; AHMED, SA; MILES, EW; SACKETT, DL				RUVINOV, SB; YANG, XJ; PARRIS, KD; BANIK, U; AHMED, SA; MILES, EW; SACKETT, DL			LIGAND-MEDIATED CHANGES IN THE TRYPTOPHAN SYNTHASE INDOLE TUNNEL PROBED BY NILE-RED FLUORESCENCE WITH WILD-TYPE, MUTANT, AND CHEMICALLY-MODIFIED ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; ESCHERICHIA-COLI; ALPHA-SUBUNIT; BETA-SUBUNIT; SALMONELLA-TYPHIMURIUM; BIENZYME COMPLEX; ALPHA-2-BETA-2 COMPLEX; FLEXIBLE LOOP; CONFORMATIONAL-CHANGES; ENZYMATIC-ACTIVITIES	The bacterial tryptophan synthase alpha(2) beta(2) complex contains an unusual structural feature: an intramolecular tunnel that channels indole from the active site of the alpha subunit to the active site of the beta subunit 25 Angstrom A away, Here we investigate the role of the tunnel in communication between the alpha and beta subunits using the polarity-sensitive fluorescent probe, Nile Red. Interaction of Nile Red in the nonpolar tunnel near beta subunit residues Cys-170 and Phe-280 is supported by studies with enzymes altered at these positions. Restricting the tunnel by enlarging Cys-170 by chemical modification or mutagenesis decreases the fluorescence of Nile Red by 30-70%. Removal of a partial restriction in the tunnel by replacing Phe-280 by Cys or Ser increases the fluorescence of Nile Red more than 2-fold. A binding site for Nile Red in this region near the pyridoxal phosphate coenzyme of the beta subunit is further supported by iodide quenching and fluorescence energy transfer experiments and by molecular modeling based on the three-dimensional structure of the alpha(2) beta(2) complex. Finally, studies using Nile Red as a sensitive probe of conformational changes in the tunnel reveal that allosteric ligands (alpha subunit) or active site ligands (beta subunit) decrease the fluorescence of Nile Red. We speculate that allosteric and active site ligands induce a tunnel restriction near Phe-280 that serves as a gate to control passage of indole through the tunnel.	NIH, NIDDK, BIOCHEM PHARMACOL LAB, BETHESDA, MD 20892 USA; NIH, NIDDK, MOLEC BIOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								AHMED SA, 1991, J BIOL CHEM, V266, P21548; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P3831, DOI 10.1021/bi00130a014; Cheung H.C., 1991, TOPICS FLUORESCENCE, P127; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Connors K. A., 1987, BINDING CONSTANTS; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; CREIGHTON TE, 1966, J BIOL CHEM, V241, P980; DEMOSS JA, 1962, BIOCHIM BIOPHYS ACTA, V62, P279, DOI 10.1016/0006-3002(62)90041-0; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; DUNN MF, 1991, INT UNION B, V199, P257; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLANAGAN MT, 1968, BIOCHIM BIOPHYS ACTA, V168, P16, DOI 10.1016/0005-2795(68)90229-8; FLURI R, 1971, J BIOL CHEM, V246, P6620; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; HABERLAND ME, 1973, P NATL ACAD SCI USA, V70, P2313, DOI 10.1073/pnas.70.8.2313; HIGGINS W, 1979, BIOCHEMISTRY-US, V18, P4827, DOI 10.1021/bi00589a010; HOUBEN KF, 1990, BIOCHEMISTRY-US, V29, P2421, DOI 10.1021/bi00461a028; HYDE CC, 1988, J BIOL CHEM, V263, P17857; JANSSON PA, 1984, DECONVOLUTION APPLIC; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KAWASAKI H, 1987, J BIOL CHEM, V262, P10678; KIRSCHNER K, 1975, EUR J BIOCHEM, V60, P513, DOI 10.1111/j.1432-1033.1975.tb21030.x; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; KIRSCHNER K, 1975, PROTEIN LIGAND INTER; KNUTSON JR, 1982, BIOCHEMISTRY-US, V21, P4671, DOI 10.1021/bi00262a024; KNUTSON JR, 1988, P SPIE INT SOC OPT E, V909, P51; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAHTI R, 1990, BIOCHEMISTRY-US, V29, P5761, DOI 10.1021/bi00476a017; LANE AN, 1991, BIOCHEMISTRY-US, V30, P479, DOI 10.1021/bi00216a025; LANE AN, 1983, EUR J BIOCHEM, V133, P531, DOI 10.1111/j.1432-1033.1983.tb07496.x; LANE AN, 1984, EMBO J, V3, P279, DOI 10.1002/j.1460-2075.1984.tb01797.x; MATCHETT WH, 1974, J BIOL CHEM, V249, P4041; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; Miles Edith Wilson, 1994, P127, DOI 10.1002/9783527615971.ch7; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MILES EW, 1980, BIOCHEM BIOPH RES CO, V93, P1152, DOI 10.1016/0006-291X(80)90610-5; MILES EW, 1978, J BIOL CHEM, V253, P6266; MILES EW, 1970, J BIOL CHEM, V245, P6016; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1977, J BIOL CHEM, V252, P6594; MILES EW, 1982, J BIOL CHEM, V257, P4203; MILES EW, 1991, J BIOL CHEM, V266, P10715; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; RUSSEL M, 1986, GENE, V45, P333, DOI 10.1016/0378-1119(86)90032-6; RUVINOV SB, 1992, FEBS LETT, V299, P197, DOI 10.1016/0014-5793(92)80246-D; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; SACKETT DL, 1990, J BIOL CHEM, V265, P14899; Sambrook J, 1989, MOL CLONING LABORATO; SCHLICHTING I, 1994, J BIOL CHEM, V269, P26591; SMITH DJ, 1975, BIOCHEMISTRY-US, V14, P766, DOI 10.1021/bi00675a019; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7535, DOI 10.1021/bi00148a014; STROUD RM, 1994, NAT STRUCT BIOL, V1, P131, DOI 10.1038/nsb0394-131; Swift S, 1991, Biotechnol Genet Eng Rev, V9, P229; YANG XJ, 1992, PROTEIN EXPRES PURIF, V3, P347, DOI 10.1016/1046-5928(92)90011-K; YANG XJ, 1992, J BIOL CHEM, V267, P7520; YANG XJ, 1993, J BIOL CHEM, V268, P22269; YANOFSKY C, 1958, BIOCHIM BIOPHYS ACTA, V28, P640, DOI 10.1016/0006-3002(58)90533-X; YANOFSKY C, 1972, ENZYMES, V7, P1	63	58	60	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6357	6369		10.1074/jbc.270.11.6357	http://dx.doi.org/10.1074/jbc.270.11.6357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890774	hybrid			2022-12-27	WOS:A1995QM94500096
J	TROTTER, PJ; VOELKER, DR				TROTTER, PJ; VOELKER, DR			IDENTIFICATION OF A NONMITOCHONDRIAL PHOSPHATIDYLSERINE DECARBOXYLASE ACTIVITY (PSD2) IN THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MEMBRANE LIPIDS; KEX2 PROTEASE; BIOGENESIS; MUTANTS; CLONING; GENE; SYNTHASE; ENZYMES; CHOLINE	Phosphatidylserine decarboxylase (PSD1) plays a central role in the biosynthesis of aminophospholipids in both prokaryotes and eukaryotes by catalyzing the synthesis of phosphatidylethanolamine. Recent reports (Trotter. P. J., Pedretti, J., and Voelker, D. R. (1993) J. Biol. Chem. 268, 21416-21424; Clancey, C. J., Chang, S. C., and Dowhan, W. (1993) J. Biol. Chem. 268, 24580-24590) described the cloning of a yeast structural gene for this enzyme (PSD1) and the creation of the null allele, Based on the phenotype of strains containing a null allele for PSD1 (psd1-Delta 1::TRP1) it was hypothesized that yeast have a second phosphatidylserine decarboxylase, The present studies demonstrate the presence of a second enzyme activity (denoted PSD2) which, depending on the method of evaluation, accounts for 4-12% of the total cellular phosphatidylserine decarboxylase activity found in wild type, Recessive mutations resulting in loss of this enzyme activity (denoted psd2) in cells containing the psd1-Delta 1::TRP1 null allele also result in ethanolamine auxotrophy. When incubated with [H-3] serine these double mutants accumulate label in phosphatidylserine, while very little (<5%) is converted to phosphatidylethanolamine. In addition, these mutants have a similar to 70% decrease in the amount of total phosphatidylethanolamine even when grown in the presence of exogenous ethanolamine. Strains containing psd1 or psd2 mutations were utilized for the subcellular localization of the PSD2 enzyme activity, Unlike the PSD1 activity, the PSD2 enzyme activity does not localize to the mitochondria, but to a low density subcellular compartment with fractionation properties similar to both vacuoles and Golgi.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DENVER, CO 80206 USA	National Jewish Health					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, F32GM016701, R01GM032453] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM032453, GM32453, GM16701] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGRANOFF BW, 1963, BIOCHEM PREP, V10, P46; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1984, GENETICS, V108, P533; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BERNINSONE P, 1994, J BIOL CHEM, V269, P207; BRANDAN E, 1983, BIOCHEMISTRY-US, V21, P4640; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; CUNNINGHAM KW, 1989, YEAST, V5, P25, DOI 10.1002/yea.320050105; DAUM G, 1982, J BIOL CHEM, V257, P3028; DENNIS EA, 1972, J LIPID RES, V13, P263; GOLDIN SM, 1977, J BIOL CHEM, V252, P5630; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HENNING R, 1969, H-S Z PHYSIOL CHEM, V350, P827, DOI 10.1515/bchm2.1969.350.2.827; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANFER J, 1964, J BIOL CHEM, V239, P1720; KANFER JN, 1980, CAN J BIOCHEM CELL B, V58, P1370, DOI 10.1139/o80-186; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; OHTA A, 1981, J BIOL CHEM, V256, P2219; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHATZ G, 1964, BIOCHIM BIOPHYS ACTA, V81, P448, DOI 10.1016/0926-6569(64)90130-0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; VOELKER DR, 1985, J BIOL CHEM, V260, P4671; WILLSKY GR, 1979, J BIOL CHEM, V254, P3326; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032	34	206	207	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6062	6070		10.1074/jbc.270.11.6062	http://dx.doi.org/10.1074/jbc.270.11.6062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890739	hybrid			2022-12-27	WOS:A1995QM94500055
J	GUAN, YH; RAWSTHORNE, S; SCOFIELD, G; SHAW, P; DOONAN, J				GUAN, YH; RAWSTHORNE, S; SCOFIELD, G; SHAW, P; DOONAN, J			CLONING AND CHARACTERIZATION OF A DIHYDROLIPOAMIDE ACETYLTRANSFERASE (E2) SUBUNIT OF THE PYRUVATE-DEHYDROGENASE COMPLEX FROM ARABIDOPSIS-THALIANA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEA-LEAF MITOCHONDRIA; GLYCINE DECARBOXYLASE; NUCLEOTIDE-SEQUENCE; PISUM-SATIVUM; PROTEIN-X; SERINE HYDROXYMETHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; MULTIENZYME COMPLEXES; PLANT-MITOCHONDRIA; ACETYL-COA	A cDNA encoding a dihydrolipoamide acetyltransferase (E2) subunit of the pyruvate dehydrogenase complex has been isolated from Arabidopsis thaliana. A cell culture cDNA expression library was screened with a monoclonal antibody (JIM 63) raised against nuclear matrix proteins, and four clones were isolated. One of these was 2175 base pairs in length, and it contained an open reading frame with an amino acid sequence and domain structure with strong similarity to the E2s of other eukaryotic and prokaryotic organisms. The organization and number of functional domains within the Arabidopsis protein are identical to those of the human E2, although the amino acid sequences within these domains are equally similar to those of the yeast and human proteins. The predicted amino acid sequence reveals the presence of a putative amino-terminal leader sequence with characteristics similar to those of other proteins, which are targeted to the plant mitochondrial matrix. The cross-reactivities of plant mitochondrial matrix proteins with JIM 63 and antibodies raised against the E2 and protein X components of eukaryotic pyruvate dehydrogenase complexes are consistent with the clone encoding a mitochondrial form of E2 and not the smaller protein X. The E2 mRNA of 2,2 kilobases was expressed in a range of Arabidopsis and Brassica napus tissues.	JOHN INNES CTR PLANT SCI RES, NORWICH NR4 7UH, NORFOLK, ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center			shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669; doonan, john/0000-0001-6027-1919				BEHAL RH, 1989, P NATL ACAD SCI USA, V86, P8732, DOI 10.1073/pnas.86.22.8732; BEVEN A, 1991, J CELL SCI, V98, P293; BOURGUIGNON J, 1988, BIOCHEM J, V255, P169, DOI 10.1042/bj2550169; BOURGUIGNON J, 1992, EUR J BIOCHEM, V204, P865, DOI 10.1111/j.1432-1033.1992.tb16706.x; CAMP PJ, 1985, PLANT PHYSIOL, V77, P571, DOI 10.1104/pp.77.3.571; DEMARCUCCI O, 1985, EUR J BIOCHEM, V149, P641, DOI 10.1111/j.1432-1033.1985.tb08972.x; DENYER K, 1988, PLANTA, V173, P172, DOI 10.1007/BF00403008; ELIAS BA, 1979, PLANT SCI LETT, V17, P115, DOI 10.1016/0304-4211(79)90170-6; FAN K, 1994, PLANT J, V6, P795; FUSSEY SPM, 1991, HEPATOLOGY, V13, P467, DOI 10.1016/0270-9139(91)90300-K; GUEST JR, 1987, FEMS MICROBIOL LETT, V44, P417, DOI 10.1111/j.1574-6968.1987.tb02324.x; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; JILKA JM, 1986, J BIOL CHEM, V261, P1858; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; Miernyk J. A., 1985, Current Topics in Plant Biochemistry and Physiology, V4, P175; Miernyk JA, 1987, PLANT MITOCHONDRIA, P189; MILES JS, 1988, BIOCH SOC S, V54, P45; PERHAM RN, 1989, ANN NY ACAD SCI, V573, P1, DOI 10.1111/j.1749-6632.1989.tb14983.x; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P2221; RANDALL DD, 1977, BIOCHIM BIOPHYS ACTA, V485, P336, DOI 10.1016/0005-2744(77)90169-3; RAPP BJ, 1980, PLANT PHYSIOL, V65, P314, DOI 10.1104/pp.65.2.314; REED LJ, 1990, J BIOL CHEM, V265, P8971; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; REID EE, 1977, PLANT PHYSIOL, V59, P842, DOI 10.1104/pp.59.5.842; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; RUBIN PM, 1977, ARCH BIOCHEM BIOPHYS, V178, P342, DOI 10.1016/0003-9861(77)90202-8; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; TABOR S, 1990, J BIOL CHEM, V265, P8322; TAYLOR AE, 1992, PLANTA, V188, P225, DOI 10.1007/BF00216817; THEKKUMKARA TJ, 1988, FEBS LETT, V240, P45, DOI 10.1016/0014-5793(88)80337-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER SR, 1992, J BIOL CHEM, V267, P7745; TURNER SR, 1992, J BIOL CHEM, V267, P5355; TURNER SR, 1992, J BIOL CHEM, V267, P13528; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WELLS B, 1985, MICRON MICROSC ACTA, V16, P49, DOI 10.1016/0739-6260(85)90031-0; WILLIAMS M, 1979, PLANT PHYSIOL, V64, P1099, DOI 10.1104/pp.64.6.1099	41	23	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5412	5417		10.1074/jbc.270.10.5412	http://dx.doi.org/10.1074/jbc.270.10.5412			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890655	hybrid			2022-12-27	WOS:A1995QL58000071
J	PERSSON, K; HOLM, I; HEBY, O				PERSSON, K; HOLM, I; HEBY, O			CLONING AND SEQUENCING OF AN INTRONLESS MOUSE S-ADENOSYLMETHIONINE DECARBOXYLASE GENE CODING FOR A FUNCTIONAL ENZYME STRONGLY EXPRESSED IN THE LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ORNITHINE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; PROCESSED PSEUDOGENES; NUCLEOTIDE-SEQUENCE; SECONDARY STRUCTURE; CELL-PROLIFERATION; ESCHERICHIA-COLI; PROENZYME FORM; ACID SEQUENCES	A genomic clon e for a mouse S-adenosylmethionine decarboxylase (AdoMetDC) gene was isolated from a cosmid library, Surprisingly, the gene proved to be intronless, With the exception of three base substitutions (changing 2 amino acids in the deduced protein), the 1002-nucleotide sequence of the open reading frame was identical to that of mouse AdoMetDC cDNA. Moreover, the gene contained a poly(dA) tract at the 3' end and was flanked by 13-base pair direct repeats. Our findings suggest that this gene has arisen by retroposition, in which a fully processed AdoMetDC mRNA has been reverse transcribed into a DNA copy and inserted into the genome. By polymerase chain reaction, we positively identified the intronless gene in the mouse genome, and, by primer extension analysis, we proved the gene to be functional. Thus, its transcripts were found in many cell lines and tissues of the mouse and were particularly abundant in the liver, When the open reading frame of the intronless gene was expressed in Escherichia coli HT551, a strain with no AdoMetDC activity, it was found to encode a 38-kDa protein, corresponding to AdoMetDC proenzyme. Although the change of methionine 70 to isoleucine was close to the cleavage site at serine 68, this protein underwent proenzyme processing, generating a 31-kDa alpha subunit and an 8-kDa beta subunit. Importantly, the protein encoded by the intronless gene was functional, i.e. it catalyzed the decarboxylation of S-adenosylmethionine, and its specific activity was comparable with that of recombinant human AdoMetDC purified according to the same procedure.	UMEA UNIV, DEPT CELLULAR & DEV BIOL, S-90187 UMEA, SWEDEN	Umea University			Holm, Ingvar/H-4735-2014	Holm, Ingvar/0000-0003-4155-6112				AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BALASUNDARAM D, 1993, P NATL ACAD SCI USA, V90, P4693, DOI 10.1073/pnas.90.10.4693; BHANDARI B, 1991, J BIOL CHEM, V266, P7784; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN SS, 1976, CANCER RES, V36, P2768; CRAXTON M, 1991, Methods (Orlando), V3, P20, DOI 10.1016/S1046-2023(05)80159-8; CYSTER J, 1990, EUR J IMMUNOL, V20, P875, DOI 10.1002/eji.1830200424; DEMCHYSHYN L, 1992, P NATL ACAD SCI USA, V89, P5522, DOI 10.1073/pnas.89.12.5522; DEVILAT I, 1993, FEBS LETT, V316, P114, DOI 10.1016/0014-5793(93)81197-8; DONOFRIO M, 1991, J BIOL CHEM, V266, P11980; FOUREL G, 1992, MOL CELL BIOL, V12, P5336, DOI 10.1128/MCB.12.12.5336; GILBERT W, 1986, CELL, V46, P151, DOI 10.1016/0092-8674(86)90730-0; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; HENCO K, 1985, J MOL BIOL, V185, P227, DOI 10.1016/0022-2836(85)90401-2; HILL JR, 1993, J BIOL CHEM, V268, P726; HILL JR, 1992, J BIOL CHEM, V267, P21886; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HUMPHREY T, 1988, TRENDS GENET, V4, P243, DOI 10.1016/0168-9525(88)90028-5; JACKMAN RW, 1987, P NATL ACAD SCI USA, V84, P6425, DOI 10.1073/pnas.84.18.6425; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; JASYS VJ, 1990, J AM CHEM SOC, V112, P6696, DOI 10.1021/ja00174a037; JOHANNES G, 1992, J BIOL CHEM, V267, P10108; KASHIWAGI K, 1990, J BIOL CHEM, V265, P22321; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; KOLLER M, 1993, BIOCHIM BIOPHYS ACTA, V1163, P1, DOI 10.1016/0167-4838(93)90271-R; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; LANS MS, 1994, J BIOL CHEM, V269, P14170; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; MACH M, 1986, J BIOL CHEM, V261, P1697; MARIC SC, 1992, J BIOL CHEM, V267, P18915; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; NOJIMA H, 1986, J MOL BIOL, V190, P391, DOI 10.1016/0022-2836(86)90010-0; OHNO S, 1981, P NATL ACAD SCI-BIOL, V78, P5305, DOI 10.1073/pnas.78.9.5305; OLIVA R, 1989, J BIOL CHEM, V264, P12472; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; PEGG AE, 1969, J BIOL CHEM, V244, P682; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1992, PHARMACOL THERAPEUT, V56, P359, DOI 10.1016/0163-7258(92)90025-U; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; POSO H, 1982, BIOCHEMISTRY-US, V21, P3116, DOI 10.1021/bi00256a013; PULKKA A, 1993, GENOMICS, V16, P342, DOI 10.1006/geno.1993.1195; PULKKA A, 1990, GENE, V86, P193, DOI 10.1016/0378-1119(90)90279-Z; PULKKA A, 1991, FEBS LETT, V291, P289, DOI 10.1016/0014-5793(91)81304-Q; Queen C, 1983, J Mol Appl Genet, V2, P1; RADFORD DM, 1988, CYTOGENET CELL GENET, V49, P285, DOI 10.1159/000132679; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RUAN HJ, 1994, J BIOL CHEM, V269, P17905; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFFNER W, 1978, CELL, V14, P655, DOI 10.1016/0092-8674(78)90249-0; SHANTZ LM, 1994, CANCER RES, V54, P2313; STANLEY BA, 1989, J BIOL CHEM, V264, P21073; SUZUKI T, 1993, EUR J BIOCHEM, V215, P247, DOI 10.1111/j.1432-1033.1993.tb18029.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1987, J BIOL CHEM, V262, P16037; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; TEKWANI BL, 1992, BIOCHIM BIOPHYS ACTA, V1130, P221, DOI 10.1016/0167-4781(92)90533-6; TIBERI M, 1991, P NATL ACAD SCI USA, V88, P7491, DOI 10.1073/pnas.88.17.7491; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; WAGNER M, 1986, TRENDS GENET, V2, P134, DOI 10.1016/0168-9525(86)90203-9; WARIS T, 1992, BIOCHEM BIOPH RES CO, V189, P424, DOI 10.1016/0006-291X(92)91575-B; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; YASWEN P, 1992, CELL GROWTH DIFFER, V3, P335	75	26	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5642	5648		10.1074/jbc.270.10.5642	http://dx.doi.org/10.1074/jbc.270.10.5642			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890685	hybrid			2022-12-27	WOS:A1995QL58000104
J	SHORE, JD; DAY, DE; FRANCISCHMURA, AM; VERHAMME, I; KVASSMAN, J; LAWRENCE, DA; GINSBURG, D				SHORE, JD; DAY, DE; FRANCISCHMURA, AM; VERHAMME, I; KVASSMAN, J; LAWRENCE, DA; GINSBURG, D			A FLUORESCENT-PROBE STUDY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 - EVIDENCE FOR REACTIVE CENTER LOOP INSERTION AND ITS ROLE IN THE INHIBITORY MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL CHANGE; ANTITHROMBIN; SERPINS; HEPARIN; SITE	A mutant recombinant plasminogen activator inhibitor 1 (PAI-1) was created (Ser-338 --> Cys) in which cysteine was placed at the P-9 position of the reactive center loop. Labeling this mutant with N,N'-dimethyl-N-(acetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylene diamine (NBD) provided a molecule with a fluorescent probe at that position. The NBD-labeled mutant was almost as reactive as wild type but was considerably more stable. Complex formation with tissue or urokinase type plasminogen activator (tPA or uPA), and cleavage between P-3 and P-4 with a catalytic concentration of elastase, all resulted in identical 13-nm blue shifts of the peak fluorescence emission wavelength and 6.2-fold fluorescence enhancements. Formation of latent PAI showed the same 13-nm spectral shift with a 6.7-fold fluorescence emission increase, indicating that the NBD probe is in a slightly more hydophobic milieu. These changes can be attributed to insertion of the reactive center loop into the beta sheet A of the inhibitor in a manner that exposes the NBD probe to a more hydrophobic milieu. The rate of loop insertion due to tPA complexation was followed using stopped flow fluorimetry. This rate showed a hyperbolic dependence on tPA concentration, with a half-saturation concentration of 0.96 mu M and a maximum rate constant of 3.4 s(-1), These results demonstrate experimentally that complexation with proteases is presumably associated with loop insertion. The identical fluorescence changes obtained with tPA . PAI-1 and uPA . PAI-1 complexes and elastase-cleaved PAI-1 strongly suggest that in the stable protease-PAI-1 complex the reactive center loop is cleaved and inserted into beta sheet A and that this process is central to the inhibition mechanism.	UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; HENRY FORD HOSP,HOWARD HUGHES MED INST,DETROIT,MI 48202	University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Howard Hughes Medical Institute	SHORE, JD (corresponding author), HENRY FORD HOSP,DIV BIOCHEM RES,E&R RM 3126 ,2799 W GRAND BLVD,DETROIT,MI 48202, USA.			Lawrence, Daniel/0000-0003-3126-1935	NHLBI NIH HHS [HL49184, HL45930] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045930, R01HL049184] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; GETTINS P, 1993, BIOESSAYS, V15, P461, DOI 10.1002/bies.950150705; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KEIJER J, 1991, BLOOD, V78, P1254; LAWRENCE D, 1987, EUR J BIOCHEM, V186, P523; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; LOBERMANN H, 1984, J MOL BIOL, V177, P531; LOBERMANN H, 1982, Z PHYSL CHEM, P1377; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SHORE JD, 1992, FIBRINOLYSIS S2, V6; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; STRANDBERG L, 1992, FIBRINOLYSIS S2, V6; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251	18	134	137	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5395	5398		10.1074/jbc.270.10.5395	http://dx.doi.org/10.1074/jbc.270.10.5395			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890653	hybrid			2022-12-27	WOS:A1995QL58000068
J	LIANG, QW; HE, JS; FULCO, AJ				LIANG, QW; HE, JS; FULCO, AJ			THE ROLE OF BARBIE BOX SEQUENCES AS CIS-ACTING ELEMENTS INVOLVED IN THE BARBITURATE-MEDIATED INDUCTION OF CYTOCHROMES P45(BM-1) AND P450(BM-3) IN BACILLUS-MEGATERIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID MONOOXYGENASE; PHENOBARBITAL INDUCTION; ESCHERICHIA-COLI; CYP2B2 GENE; EXPRESSION; PROTEIN; SYSTEM; CYTOCHROME-P-450BM-3; IDENTIFICATION; HYDROXYLATION	In a previous publication (He, J,-S,, and Fulco, A. J, (1991) J, Biol, Chem, 266, 7864-7869), we reported that a 15-17-base pair DNA sequence (designated a Barbie box element) in the 5'-regulatory regions of cytochrome P450(BM-1) and P450(BM-3) genes from Bacillus megaterium was recognized by a barbiturate-regulated protein. It is now recognized that essentially all eukaryotic and prokaryotic genes whose 5'-flanking regions are known and that encode barbiturate-inducible proteins contain the Barbie box element, A 4-base pair sequence (AAAG) is found in the same relative position in all Barbie box elements, In B. megaterium, mutation of the Barbie box located in the P450(BM-1) gene leads to the constitutive synthesis of cytochrome P450(BM-1) and a 10-fold increase of expression of Bm1P1, a small gene located upstream of the P450(BM-1) gene, that encodes a putative regulatory protein, Mutation of the P450(BM-3) Barbie box significantly increased the expression of both P450(BM-3) and Bm3P1 (another small gene located upstream of the P450(BM-3) gene that encodes a second putative regulatory protein) in response to pentobarbital induction but left the basal levels unaffected, In gel mobility shift assays, Bm3R1, a repressor of the P450(BM-3), gene, was found to specifically interact with the Barbie box sequences of the B, megaterium P450 genes, Mutated Barbie boxes showed a decreased binding affinity for Bm3R1 compared to their wild type (unmutated) counterparts, Barbie box sequences were also shown to specifically interact with putative positive regulatory factors of B. megaterium cells, These putative positive factors were induced by pentobarbital and were also present at high levels during late stationary phase of B, megaterium cell cultures grown in the absence of barbiturates, The mutated Barbie box sequences had greater binding affinity for these positive factors than did unmutated Barbie box sequences, DNase I footprinting analysis of the 5'-flanking region of the P450(BM-1) gene revealed that these positive factors protected a segment of DNA covering a portion of the Barbie box sequence and a small flanking region, Similar footprinting experiments with the 5'-flanking region of the P450(BM-3) gene failed, however, to unambiguously reveal protected sequences in the Barbie box region, The evidence suggests that the positive factors and Bm3R1 compete with each other for binding to the Barbie box region, especially in the 5'-flanking region of the P450(BM-1) gene, and for putative roles in the regulation of transcription from the B, megaterium P450 genes, This inference was further supported by evidence derived from a nested-deletion analysis in and around the Barbie box of the P450(BM-1) regulatory region that showed that a repressor binding site and a positive factor binding site overlap at the Barbie box sequence, In tote, these experimental results indicate that, in B. megaterium at least, the Barbie box sequences are important cis acting elements for coordinately regulating the barbiturate-mediated expression of the P450(BM-1) and P450(BM-3) genes and the genes encoding their positive regulatory factors.	UNIV CALIF LOS ANGELES,SCH MED,STRUCT BIOL & MOLEC MED LAB,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NIGMS NIH HHS [GM23913] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023913] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1989, CURRENT PROTOCOLS MO, V2, P1; FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177; FULCO AJ, 1987, LIFE SCI, V40, P1769, DOI 10.1016/0024-3205(87)90087-7; Gallaghar S.R., 1989, CURRENT PROTOCOLS MO, P1; HAHN CN, 1991, J BIOL CHEM, V266, P17031; HE JS, 1991, J BIOL CHEM, V266, P7864; HE JS, 1989, BIOCHIM BIOPHYS ACTA, V1009, P301, DOI 10.1016/0167-4781(89)90120-6; JAISWAL AK, 1990, NUCLEIC ACIDS RES, V18, P4237, DOI 10.1093/nar/18.14.4237; KIM BH, 1983, BIOCHEM BIOPH RES CO, V116, P843, DOI 10.1016/S0006-291X(83)80219-8; LIANG QW, 1992, BIOTECHNIQUES, V13, P730; MIURA Y, 1975, BIOCHIM BIOPHYS ACTA, V388, P305, DOI 10.1016/0005-2760(75)90089-2; MIURA Y, 1974, J BIOL CHEM, V249, P1880; NARHI LO, 1982, J BIOL CHEM, V257, P2147; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1988, MOL CELL BIOCHEM, V79, P63, DOI 10.1007/BF00229399; NARHI LO, 1987, J BIOL CHEM, V262, P6683; PATEL NV, 1992, GENE, V112, P67, DOI 10.1016/0378-1119(92)90304-8; RAMSDEN R, 1993, J BIOL CHEM, V268, P21722; RANGARAJAN PN, 1989, P NATL ACAD SCI USA, V86, P3963, DOI 10.1073/pnas.86.11.3963; RUETTINGER RT, 1989, J BIOL CHEM, V264, P10987; RUETTINGER RT, 1981, J BIOL CHEM, V256, P5728; SCHWALB H, 1985, BIOCHIM BIOPHYS ACTA, V838, P302, DOI 10.1016/0304-4165(85)90227-2; SHAW GC, 1992, J BIOL CHEM, V267, P5515; SHAW GC, 1993, J BIOL CHEM, V268, P2997; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; UPADHYA P, 1992, NUCLEIC ACIDS RES, V20, P557, DOI 10.1093/nar/20.3.557; WEN LP, 1989, J BIOL CHEM, V264, P10996; WEN LP, 1987, J BIOL CHEM, V262, P6676	28	86	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4438	4450		10.1074/jbc.270.9.4438	http://dx.doi.org/10.1074/jbc.270.9.4438			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876210	hybrid			2022-12-27	WOS:A1995QK08400042
J	SHERIDAN, PL; SCHORPP, M; VOZ, ML; JONES, KA				SHERIDAN, PL; SCHORPP, M; VOZ, ML; JONES, KA			CLONING OF AN SNF2/SWI2-RELATED PROTEIN THAT BINDS SPECIFICALLY TO THE SPH MOTIFS OF THE SV40 ENHANCER AND TO THE HIV-1 PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATOR; GLOBAL ACTIVATOR; GENE-EXPRESSION; SNF6 PROTEINS; T-ANTIGEN; SEQUENCE; CONTAINS; FAMILY	We have isolated a human cDNA clone encoding HIP116, a protein that binds to the SPH repeats of the SV40 enhancer and to the TATA/initiator region of the human immunodeficiency virus (HIV)-1 promoter. The predicted HIP116 protein is related to the yeast SNF2/SW12 transcription factor and to other members of this extended family and contains seven domains similar to those found in the vaccinia NTP1 ATPase. Interestingly, HIP116 also contains a C3HC4 zinc-binding motif (RING: finger) interspersed between the ATPase motifs in an arrangement similar to that found in the yeast RADS and RAD16 proteins. The HIP116 amino terminus is unique among the members of this family, and houses a specific DNA-binding domain, Antiserum raised against HIP116 recognizes a 116-kDa nuclear protein in Western blots and specifically supershifts SV40 and HIV-1 protein-DNA complexes in gel shift experiments. The binding site for HIP116 on the SV40 enhancer directly overlaps the site for TEF-1, and like TEF-1, binding of HIP116 to the SV40 enhancer is destroyed by mutations that inhibit SPH enhancer activity in vivo. Purified fractions of HIP116 display strong ATPase activity that is preferentially stimulated by SPH DNA and can be inhibited specifically by antibodies to HIP116. These findings suggest that HIP116 might affect transcription, directly or indirectly, by acting as a DNA binding site-specific ATPase.	SALK INST BIOL STUDIES, DEPT REGULAT BIOL, LA JOLLA, CA 92037 USA	Salk Institute					NIGMS NIH HHS [GM38166] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038166] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGEL P, 1989, New Biologist, V1, P35; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; DAVIS JL, 1992, MOL CELL BIOL, V12, P1879, DOI 10.1128/MCB.12.4.1879; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ELFRING LK, 1994, MOL CELL BIOL, V14, P2225, DOI 10.1128/MCB.14.4.2225; EMERY HS, 1991, GENE, V104, P103, DOI 10.1016/0378-1119(91)90473-O; EVERETT RD, 1988, J MOL BIOL, V202, P87, DOI 10.1016/0022-2836(88)90521-9; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; GIRDHAM CH, 1991, GENE DEV, V5, P1786, DOI 10.1101/gad.5.10.1786; GRUDA MC, 1991, J VIROL, V65, P3553, DOI 10.1128/JVI.65.7.3553-3558.1991; HENIKOFF S, 1993, TRENDS BIOCHEM SCI, V18, P291, DOI 10.1016/0968-0004(93)90037-N; HERR W, 1986, CELL, V45, P461, DOI 10.1016/0092-8674(86)90332-6; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; JONES JS, 1988, NUCLEIC ACIDS RES, V16, P7119, DOI 10.1093/nar/16.14.7119; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; Jones KA, 1993, CURR OPIN CELL BIOL, V5, P461, DOI 10.1016/0955-0674(93)90012-F; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KRUGER W, 1991, MOL CELL BIOL, V11, P4135, DOI 10.1128/MCB.11.8.4135; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAURENT BC, 1992, GENE DEV, V6, P1707, DOI 10.1101/gad.6.9.1707; LAURENT BC, 1990, MOL CELL BIOL, V10, P5616, DOI 10.1128/MCB.10.11.5616; LAURENT BC, 1991, P NATL ACAD SCI USA, V88, P2687, DOI 10.1073/pnas.88.7.2687; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; LIN Y, 1994, IN PRESS GENOMICS; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MANNHAUPT G, 1992, YEAST, V8, P397, DOI 10.1002/yea.320080507; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; MURCHARDT C, 1993, EMBO J, V12, P4279; OKABE I, 1992, NUCLEIC ACIDS RES, V20, P4649, DOI 10.1093/nar/20.17.4649; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; SARAGOSTI S, 1980, CELL, V20, P65, DOI 10.1016/0092-8674(80)90235-4; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	57	56	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4575	4587		10.1074/jbc.270.9.4575	http://dx.doi.org/10.1074/jbc.270.9.4575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876228	hybrid			2022-12-27	WOS:A1995QK08400061
J	TAIPALE, J; LOHI, J; SAARINEN, J; KOVANEN, PT; KESKIOJA, J				TAIPALE, J; LOHI, J; SAARINEN, J; KOVANEN, PT; KESKIOJA, J			HUMAN MAST-CELL CHYMASE AND LEUKOCYTE ELASTASE RELEASE LATENT TRANSFORMING GROWTH FACTOR-B1 FROM THE EXTRACELLULAR-MATRIX OF CULTURED HUMAN EPITHELIAL AND ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC ELASTASE; SMOOTH-MUSCLE CELLS; FACTOR-BETA; BINDING-PROTEIN; CATHEPSIN-G; TGF-BETA; PLASMINOGEN ACTIVATION; PERICELLULAR MATRIX; NEUTROPHIL ELASTASE; MOLECULAR-CLONING	Monolayer cultures of human epithelial and endothelial cells were used to study the association of latent transforming growth factor-beta 1 (TGF-beta 1) to extracellular matrices and its release and activation during matrix degradation, Human umbilical vein endothelial cells and embryonic lung fibroblasts produced relatively high revels of TGF-beta 1, its propeptide (beta 1-latency-associated protein), and latent TGF-beta-binding protein and incorporated latent TGF-beta 1 into their matrices as shown by immunoblotting, Amnion epithelial cells produced lower levels of these proteins, Confluent cultures of epithelial cells were exposed to matrix-degrading proteases and glycosidases, Mast cell chymase, leukocyte elastase, and plasmin efficiently released matrix-bound latent TGF-beta 1 complexes, while chondroitinase ABC and heparitinases were ineffective, The ability of the proteases to activate recombinant latent TGF-beta 1 was tested using growth inhibition assays and a novel sodium deoxycholate-polyacrylamide gel electrophoresis followed by immunoblotting. Sodium deoxycholate solubilized M(r) 25,000 TGF-beta 1 but did not dissociate high M(r) latent TGF-beta 1 complexes, allowing separation of these forms by polyacrylamide gel electrophoresis, Mast cell chymase and leukocyte elastase did not activate latent TGF-beta 1, suggesting that its release from matrix and activation are controlled by different mechanisms. The release of TGF-beta from the matrix by leukocyte and mast cell enzymes may contribute to the accumulation of connective tissue in inflammation.	UNIV HELSINKI, DEPT VIROL, SF-00014 HELSINKI, FINLAND; UNIV HELSINKI, DEPT DERMATOL & VENEREOL, SF-00014 HELSINKI, FINLAND; WIHURI RES INST, SF-00140 HELSINKI, FINLAND	University of Helsinki; University of Helsinki; Wihuri Research Institute								ALITALO K, 1980, CELL, V19, P1053, DOI 10.1016/0092-8674(80)90096-3; BENEZRA M, 1993, BLOOD, V81, P3324; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; Bosenberg MW, 1993, CURR OPIN CELL BIOL, V5, P832, DOI 10.1016/0955-0674(93)90032-L; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; BROMLEY M, 1984, ANN RHEUM DIS, V43, P76, DOI 10.1136/ard.43.1.76; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; COLOSETTI P, 1993, FEBS LETT, V320, P140, DOI 10.1016/0014-5793(93)80079-A; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; DABBOUS MK, 1986, BRIT J CANCER, V54, P459, DOI 10.1038/bjc.1986.198; DAYTON ET, 1989, J IMMUNOL, V142, P4307; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FALCONE DJ, 1993, J BIOL CHEM, V268, P11951; FLANDERS KC, 1989, J CELL BIOL, V108, P653, DOI 10.1083/jcb.108.2.653; FLAUMENHAFT R, 1992, MOL BIOL CELL, V3, P1057, DOI 10.1091/mbc.3.10.1057; FROMMHERZ KJ, 1991, J BIOL CHEM, V266, P15356; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRUHER BL, 1989, J CLIN INVEST, V84, P1657; HARPER JW, 1984, BIOCHEMISTRY-US, V23, P2995, DOI 10.1021/bi00308a023; HARVIMA IT, 1988, BIOCHIM BIOPHYS ACTA, V957, P71, DOI 10.1016/0167-4838(88)90158-6; HECHT P M, 1992, Trends in Cell Biology, V2, P197, DOI 10.1016/0962-8924(92)90246-J; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; HEIMARK RL, 1986, SCIENCE, V233, P1078, DOI 10.1126/science.3461562; HEINE UI, 1990, DEVELOPMENT, V109, P29; HUBER D, 1992, J IMMUNOL, V148, P277; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; JAFFE EA, 1976, J EXP MED, V144, P209, DOI 10.1084/jem.144.1.209; JULLIEN P, 1989, INT J CANCER, V43, P886, DOI 10.1002/ijc.2910430525; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KOVACS EJ, 1994, FASEB J, V8, P854, DOI 10.1096/fasebj.8.11.7520879; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; LAIHO M, 1992, Critical Reviews in Oncogenesis, V3, P1; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MALONE DG, 1987, ARTHRITIS RHEUM, V30, P130, DOI 10.1002/art.1780300202; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCRAE B, 1980, BIOCHEMISTRY-US, V19, P3973, DOI 10.1021/bi00558a013; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MIYAZONO K, 1993, ADV IMMUNOL, V55, P1994; MIZOI T, 1993, CANCER RES, V53, P183; MOSES HL, 1985, CANCER CELL, V3, P65; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; OKADA F, 1989, FEBS LETT, V242, P240, DOI 10.1016/0014-5793(89)80477-6; OLOFSSON A, 1992, J BIOL CHEM, V267, P19482; PAREKH T, 1994, J IMMUNOL, V152, P2456; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PENNINGTON DW, 1992, J CLIN INVEST, V90, P35, DOI 10.1172/JCI115853; PORTEU F, 1991, J BIOL CHEM, V266, P18846; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Robbins K. C., 1970, METHOD ENZYMOL, V19, P184; ROBERTS AB, 1980, P NATL ACAD SCI-BIOL, V77, P3494, DOI 10.1073/pnas.77.6.3494; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; SATO Y, 1993, J CELL BIOL, V123, P1249, DOI 10.1083/jcb.123.5.1249; SCHECHTER NM, 1989, J BIOL CHEM, V264, P21308; SCHECHTER NM, 1990, J IMMUNOL, V145, P2652; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; SCHWARTZ LB, 1984, PROG ALLERGY, V34, P271; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; TAIPALE J, 1994, MOL BIOL CELL, V5, P1808; TANAKA T, 1985, BIOCHEMISTRY-US, V24, P2040, DOI 10.1021/bi00329a036; TSUJI T, 1990, P NATL ACAD SCI USA, V87, P8835, DOI 10.1073/pnas.87.22.8835; VALLE M, 1962, ANN MED EXP BIOL FEN, V40, P342; VARTIO T, 1981, J BIOL CHEM, V256, P471; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WALTENBERGER J, 1993, J IMMUNOL, V151, P1147; WALTENBERGER J, 1993, AM J PATHOL, V142, P71; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	93	328	340	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4689	4696		10.1074/jbc.270.9.4689	http://dx.doi.org/10.1074/jbc.270.9.4689			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876240	hybrid			2022-12-27	WOS:A1995QK08400075
J	VIEILLEGROSJEAN, I; HUBER, P				VIEILLEGROSJEAN, I; HUBER, P			TRANSCRIPTION FACTOR GATA-1 REGULATES HUMAN HOXB2 GENE-EXPRESSION IN ERYTHROID-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHOBILINOGEN DEAMINASE GENE; DNA-BINDING PROTEIN; MAMMALIAN-CELLS; HOMEOBOX GENES; IMMUNOGLOBULIN GENES; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; NUCLEAR FACTOR; RETINOIC ACID; PROMOTER	The human HOXB2 gene is a member of the vertebrate Hox gene family that contains genes coding for specific developmental stage DNA-binding proteins. Remarkably, within the hematopoietic compartment, genes of the HOXB complex are expressed specifically in erythro-megakaryocytic cell lines and, for some of them, in hematopoietic progenitors, Here, we report the study of HOXB2 gene transcriptional regulation in hematopoietic cells, an initial step in understanding the lineage-specific expression of the whole HOXB complex in these cells. We have isolated the HOXB2 5'-flanking sequence and have characterized a promoter fragment extending 323 base pairs upstream from the transcriptional start site, which, in transfection experiments, was sufficient to direct the tissue specific expression of HOXB2 in the erythroid cell Line K562. In this fragment, we have identified a potential GATA-binding site that is essential to the promoter activity as demonstrated by point mutation experiments. Gel shift analysis revealed the formation of a specific complex in both erythroleukemic lines K562 and HEL that could be prevented by the addition of a specific antiserum raised against GATA-1 protein. These findings suggest a regulatory hierarchy in which GATA-1 is upstream of the HOXB2 gene in erythroid cells.	CEN GRENOBLE,DEPT BIOL MOLEC & STRUCT,INSERM,U217,HEMATOL LAB,F-38054 GRENOBLE 09,FRANCE	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)			Huber, Philippe/C-7971-2019	Huber, Philippe/0000-0002-4153-7694				ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; ARCIONI L, 1992, EMBO J, V11, P265, DOI 10.1002/j.1460-2075.1992.tb05049.x; BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; GALANG CK, 1993, MOL CELL BIOL, V13, P4609, DOI 10.1128/MCB.13.8.4609; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HALLIGAN BD, 1987, P NATL ACAD SCI USA, V84, P7019, DOI 10.1073/pnas.84.20.7019; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HUNT P, 1992, ANNU REV CELL BIOL, V8, P227, DOI 10.1146/annurev.cb.08.110192.001303; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KONDO T, 1992, NUCLEIC ACIDS RES, V20, P5729, DOI 10.1093/nar/20.21.5729; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; LAWRENCE HJ, 1992, BLOOD, V80, P2445; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; LEONARD M, 1993, BLOOD, V82, P1071; LUEKOW B, 1987, NUCLEIC ACIDS RES, V15, P1311; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MARTIN F, 1993, J BIOL CHEM, V268, P21606; MATHEWS CHE, 1991, BLOOD, V78, P2248; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; ORKIN SH, 1992, BLOOD, V80, P575; PAN JL, 1993, J BIOL CHEM, V268, P22600; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; RAVID K, 1991, MOL CELL BIOL, V11, P6116, DOI 10.1128/MCB.11.12.6116; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SENGUPTA PK, 1994, BLOOD, V83, P1420; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SHEN WF, 1992, EMBO J, V11, P983, DOI 10.1002/j.1460-2075.1992.tb05137.x; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VERRIJZER P, 1988, NUCLEIC ACIDS RES, V16, P2729, DOI 10.1093/nar/16.6.2729; VIEILLEGROSJEAN I, 1992, BIOCHEM BIOPH RES CO, V183, P1124, DOI 10.1016/S0006-291X(05)80307-9; VIEILLEGROSJEAN I, 1992, BIOCHEM BIOPH RES CO, V185, P785, DOI 10.1016/0006-291X(92)91694-L; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; ZAPPAVIGNA V, 1991, EMBO J, V10, P4177, DOI 10.1002/j.1460-2075.1991.tb04996.x; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638; ZON LI, 1993, BLOOD, V81, P3234	63	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4544	4550		10.1074/jbc.270.9.4544	http://dx.doi.org/10.1074/jbc.270.9.4544			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876223	hybrid			2022-12-27	WOS:A1995QK08400056
J	BALLATORI, N; TRUONG, AT				BALLATORI, N; TRUONG, AT			MULTIPLE CANALICULAR TRANSPORT MECHANISMS FOR GLUTATHIONE S-CONJUGATES - TRANSPORT ON BOTH ATP-DEPENDENT AND VOLTAGE-DEPENDENT CARRIERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE VESICLES; RAT-LIVER; HUMAN-ERYTHROCYTES; BILIARY TRANSPORT; ORGANIC-ANIONS; DINITROPHENYL GLUTATHIONE; OXIDIZED GLUTATHIONE; INHIBITION; SYSTEM; METABOLISM	A large number of structurally distinct electrophiles are conjugated to glutathione within hepatocytes, and the resulting glutathione S-conjugates are selectively transported across the canalicular membrane into bile. To test the hypothesis that a single multi-specific, ATP-dependent carrier mediates biliary secretion of glutathione S-conjugates, the present study compared the driving forces and substrate specificity for canalicular transport of S-ethylglutathione (ethyl-SG), a low molecular weight and relatively hydrophilic thioether, and S-(2,4-dinitrophenyl)-glutathione (DNP-SG), a larger and more hydrophobic anion, using isolated rat liver canalicular membrane vesicles. In agreement with previous findings, DNP-SG transport was stimulated by ATP, although there was considerable transport in the absence of ATP. ATP-independent DNP-SG transport was unaffected by a Na+ gradient, was enhanced by a valinomycin-induced K+ diffusion potential, and was saturable, with both high affinity (K-m = 8 +/- 2 mu M) and low affinity (K-m = 0.5 +/- 0.1 mM) components. High affinity ATP-independent DNP-SG uptake was cis-inhibited by GSH, GSH monoethyl ester, glutathione S-conjugates, other gamma-glutamyl compounds, sulfobromophthalein, and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS). In contrast, ATP-dependent DNP-SG uptake was unaffected by GSH, GSH ester, S-methyl glutathione, or S-carbamidomethyl glutathione, but was strongly inhibited by sulfobromophthalein, DIDS, and by high molecular weight and relatively hydrophobic glutathione S-conjugates. Transport of the low molecular weight ethyl SG conjugate was only minimally stimulated by ATP (10-20%). ATP-independent ethyl-SG uptake was electrogenic, saturable (K-m = 10 +/- 1 mu M) and was inhibited by GSH and all glutathione S-conjugates tested. These findings indicate the presence of multiple canalicular transport mechanisms for glutathione S-conjugates and demonstrate that the physicochemical properties of the S moiety are major determinants of transport. Relatively high molecular weight hydrophobic conjugates are substrates for both ATP-dependent and -independent mechanisms, whereas low molecular weight glutathione S-conjugates are transported largely by electrogenic carriers.			BALLATORI, N (corresponding author), UNIV ROCHESTER,SCH MED,DEPT ENVIRONM MED,ROCHESTER,NY 14642, USA.				NIEHS NIH HHS [ES-01247, ES-06484] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006484, P30ES001247] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKERBOOM T, 1984, EUR J BIOCHEM, V141, P211, DOI 10.1111/j.1432-1033.1984.tb08177.x; AKERBOOM TPM, 1991, J BIOL CHEM, V266, P13147; ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4; ANDERSON ME, 1983, ANNU REV BIOCHEM, V52, P711; ARIAS IM, 1993, HEPATOLOGY, V17, P318, DOI 10.1002/hep.1840170225; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; BALLATORI N, 1994, J BIOL CHEM, V269, P19731; BALLATORI N, 1986, J BIOL CHEM, V261, P6216; BARTOSZ G, 1993, BIOCHEM J, V292, P171, DOI 10.1042/bj2920171; BOARD P, 1992, HEPATOLOGY, V15, P722, DOI 10.1002/hep.1840150428; BOYLAND E, 1969, ADV ENZYMOL RELAT AR, V32, P172; BUTLER J, 1976, ANAL BIOCHEM, V75, P674, DOI 10.1016/0003-2697(76)90129-9; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; DUTCZAK WJ, 1994, J BIOL CHEM, V269, P9746; ELFERINK RPJO, 1991, BIOCHEM J, V274, P281, DOI 10.1042/bj2740281; ELFERINK RPJO, 1990, AM J PHYSIOL, V258, pG699, DOI 10.1152/ajpgi.1990.258.5.G699; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; Gibaldi M., 1975, PHARMACOKINETICS DRU; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HINCHMAN CA, 1994, J TOXICOL ENV HEALTH, V41, P387, DOI 10.1080/15287399409531852; HINCHMAN CA, 1991, J BIOL CHEM, V266, P22179; INOUE M, 1984, J BIOL CHEM, V259, P4998; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; ISHIKAWA T, 1989, FEBS LETT, V259, P95, DOI 10.1016/0014-5793(89)81503-0; ISHIKAWA T, 1989, J BIOL CHEM, V264, P17343; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; KOBAYASHI K, 1991, BIOCHEM BIOPH RES CO, V176, P622, DOI 10.1016/S0006-291X(05)80229-3; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; KONDO T, 1982, EUR J BIOCHEM, V125, P551, DOI 10.1111/j.1432-1033.1982.tb06717.x; LABELLE EF, 1986, BIOCHEM BIOPH RES CO, V139, P538, DOI 10.1016/S0006-291X(86)80024-9; LABELLE EF, 1986, BIOCHEM J, V238, P443, DOI 10.1042/bj2380443; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meier P J, 1993, Prog Liver Dis, V11, P27; MEIER PJ, 1984, J BIOL CHEM, V259, P614; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MOORE S, 1948, J BIOL CHEM, V176, P367; MULLER M, 1991, J BIOL CHEM, V266, P18920; NISHIDA T, 1992, J CLIN INVEST, V90, P2130, DOI 10.1172/JCI116098; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; NISHIDA T, 1992, AM J PHYSIOL, V262, pG629, DOI 10.1152/ajpgi.1992.262.4.G629; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P676; PLOEMEN JHTM, 1990, BIOCHEM PHARMACOL, V40, P1631, DOI 10.1016/0006-2952(90)90465-W; Saunders BC, 1934, BIOCHEM J, V28, P1977, DOI 10.1042/bj0281977; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SCHAUB T, 1991, FEBS LETT, V279, P83, DOI 10.1016/0014-5793(91)80256-3; SIMMONS TW, 1990, BIOCHIM BIOPHYS ACTA, V1023, P462, DOI 10.1016/0005-2736(90)90140-J; SIMMONS TW, 1992, J PHARMACOL EXP THER, V262, P1182; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; VORE M, 1993, TOXICOL APPL PHARM, V118, P2, DOI 10.1006/taap.1993.1002; WHELAN G, 1970, J LAB CLIN MED, V75, P542; ZIMNIAK P, 1993, HEPATOLOGY, V17, P330, DOI 10.1002/hep.1840170226	53	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3594	3601		10.1074/jbc.270.8.3594	http://dx.doi.org/10.1074/jbc.270.8.3594			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876095	hybrid			2022-12-27	WOS:A1995QH68800023
J	COTE, J; BEAUDOIN, J; TACKE, R; CHABOT, B				COTE, J; BEAUDOIN, J; TACKE, R; CHABOT, B			THE U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 5' SPLICE-SITE INTERACTION AFFECTS U2AF(65) BINDING TO THE DOWNSTREAM 3' SPLICE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; POLYPYRIMIDINE TRACT; BIOCHEMICAL-CHARACTERIZATION; MAMMALIAN SPLICEOSOME; AUXILIARY FACTOR; U2; PROTEIN; IDENTIFICATION; PURIFICATION; SELECTION	In the gene of the neural cell adhesion molecule, the 5' splice site of the alternate exon 18 plays an important role in establishing regulated splicing profiles, To understand how the 5' splice site of exon 18 contributes to splicing regulation, we have investigated the interaction of the U2AF(65) splicing factor to pre-mRNAs that contained portions of the constitutive exon 17 or the alternate exon 18 fused to exon 19 and separated by a shortened intron, Despite sharing an identical 3' splice site, only the pre-mRNA that contained a portion of exon 17 and its associated 5' splice site displayed efficient U2AF(65) cross-linking, Strikingly, a G --> U mutation at position +6 of the intron, converting the 5' splice site of exon 18 into that of exon 17, stimulated U2AF(65) crosslinking, The improved cross-linking efficiency of U2AF(65) to a pre-mRNA carrying the 5' splice site of exon 17 required the integrity of the 5' end of U1 but not of U2 small nuclear RNA, Our results indicate that neural cell adhesion molecule 5' splice site sequences influence U2AF(65) binding through a U1 small nuclear ribonucleoprotein/U2AF interaction that occurs at the commitment stage of spliceosome assembly, before stable binding of the U2 small nuclear ribonucleoprotein, Thus, the 5' splice sites of exons 17 and 18 differentially affect U2AF(65) binding to the 3' splice site of exon 19. Factors that modulate U1 small nuclear ribonucleoprotein binding to these 5' splice sites may play a critical role in regulating exon 18 skipping,	UNIV SHERBROOKE, FAC MED, DEPT MICROBIOL, SHERBROOKE, PQ J1H 5N4, CANADA; CNRS MARSEILLE LUMINY, CTR IMMUNOL, F-13288 MARSEILLE 9, FRANCE	University of Sherbrooke; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite			Cote, Jocelyn/O-2351-2018; Chabot, Benoit/A-8943-2008	Cote, Jocelyn/0000-0001-9551-2284; Chabot, Benoit/0000-0003-0994-0042				ABMAYR SM, 1988, P NATL ACAD SCI USA, V85, P7216, DOI 10.1073/pnas.85.19.7216; BARBAS JA, 1988, EMBO J, V7, P625, DOI 10.1002/j.1460-2075.1988.tb02856.x; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; CHABOT B, 1985, SCIENCE, V230, P1344, DOI 10.1126/science.2933810; CHABOT B, 1987, MOL CELL BIOL, V7, P281, DOI 10.1128/MCB.7.1.281; CHABOT B, 1992, NUCLEIC ACIDS RES, V20, P5197, DOI 10.1093/nar/20.19.5197; Chabot B., 1994, RNA PROCESSING PRACT, VI, P1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GRABOWSKI PJ, 1991, MOL CELL BIOL, V11, P5919, DOI 10.1128/MCB.11.12.5919; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; JAMISON SF, 1992, P NATL ACAD SCI USA, V89, P5482, DOI 10.1073/pnas.89.12.5482; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; LABRANCHE H, 1991, NUCLEIC ACIDS RES, V19, P4509, DOI 10.1093/nar/19.16.4509; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Moore MJ, 1993, RNA WORLD, P1; MULLIGAN GJ, 1992, J BIOL CHEM, V267, P25480; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; STAKNIS D, 1994, MOL CELL BIOL, V14, P2994, DOI 10.1128/MCB.14.5.2994; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; SWANSON MS, 1988, EMBO J, V7, P3519, DOI 10.1002/j.1460-2075.1988.tb03228.x; TACKE R, 1991, GENE DEV, V5, P1416, DOI 10.1101/gad.5.8.1416; TAZI J, 1986, CELL, V47, P755, DOI 10.1016/0092-8674(86)90518-0; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZUO P, 1994, P NATL ACAD SCI USA, V91, P3363, DOI 10.1073/pnas.91.8.3363	37	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4031	4036		10.1074/jbc.270.8.4031	http://dx.doi.org/10.1074/jbc.270.8.4031			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876151	hybrid			2022-12-27	WOS:A1995QH68800084
J	JAIN, JN; BURGEON, E; BADALIAN, TM; HOGAN, PG; RAO, A				JAIN, JN; BURGEON, E; BADALIAN, TM; HOGAN, PG; RAO, A			A SIMILAR DNA-BINDING MOTIF IN NFAT FAMILY PROTEINS AND THE REL HOMOLOGY REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; KAPPA-B; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; CYCLOSPORINE-A; C-REL; CALCINEURIN; FOS; JUN; PROMOTER	The cyclosporin-sensitive factor NFATp cooperates with Fos and Jun family proteins to regulate transcription of the interleukin 2 gene in activated T cells. We have defined a 187-amino acid fragment of NFATp, located centrally within the protein sequence, as the minimal region required for DNA binding and for complex formation with Fos and Jun. The sequence of this region of NFATp shows a low degree of similarity to the Rel homology region. One specific short sequence in NFATp (RAHYETEG), located near the NH, terminus of the DNA-binding domain, resembles a highly conserved sequence (RFRYxCEG) that is located near the NH, terminus of the Rel homology region and that has been implicated in DNA binding by Rel family proteins. Mutational analysis demonstrates that the residues in this sequence that are identical in NFATp, and Rel family proteins contribute to DNA binding by NFATp. Further, mutation of the threonine residue in this sequence to cysteine, as in Rel proteins, confers on NFATp a sensitivity to sulfhydryl modification similar to that of Rel family proteins. The results suggest that NFATp and Rel family proteins bind to DNA using similar structural motifs.	HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT NEUROBIOL, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School					NATIONAL CANCER INSTITUTE [R01CA042471, R37CA042471] Funding Source: NIH RePORTER; NCI NIH HHS [CA42471] Funding Source: Medline; NIGMS NIH HHS [GM46227] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABATE C, 1990, MOL CELL BIOL, V10, P5532, DOI 10.1128/MCB.10.10.5532; BRESSLER P, 1993, J VIROL, V67, P288, DOI 10.1128/JVI.67.1.288-293.1993; BUISE LH, 1993, MOL CELL BIOL, V13, P1911; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COLEMAN TA, 1993, MOL CELL BIOL, V13, P3850, DOI 10.1128/MCB.13.7.3850; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1993, J IMMUNOL, V151, P837; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1994, P NATL ACAD SCI USA, V91, P908, DOI 10.1073/pnas.91.3.908; LOGEAT F, 1991, EMBO J, V10, P1827, DOI 10.1002/j.1460-2075.1991.tb07708.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; NOLAN GP, 1994, CELL, V77, P1; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; YASEEN NR, 1994, MOL CELL BIOL, V14, P6886, DOI 10.1128/MCB.14.10.6886	41	128	129	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4138	4145		10.1074/jbc.270.8.4138	http://dx.doi.org/10.1074/jbc.270.8.4138			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876165	hybrid			2022-12-27	WOS:A1995QH68800099
J	KOBAYASHI, M; SHOUN, H				KOBAYASHI, M; SHOUN, H			THE COPPER-CONTAINING DISSIMILATORY NITRITE REDUCTASE INVOLVED IN THE DENITRIFYING SYSTEM OF THE FUNGUS FUSARIUM-OXYSPORUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHROMOBACTER-CYCLOCLASTES; INDUCIBLE CYTOCHROME-P-450; ALCALIGENES-FAECALIS; DENITRIFICATION; PURIFICATION; XYLOSOXIDANS; BACTERIUM; PROTEINS; TYPE-1	A copper-containing nitrite reductase (Cu-NiR) was purified to homogeneity from the denitrifying fungus Fusarium oxysporum. The enzyme seemed to consist of two subunits with almost the same M(r),value of 41,800 and contains two atoms of copper per subunit. The electron paramagnetic resonance spectrum showed that both type 1 and type 2 copper centers are present in the protein, whereas the visible absorption spectrum exhibited a sole and strong absorption maximum at 595 nm, causing a blue but not green color. The reaction product due to the Cu-NiR was mainly nitric oxide (NO), whereas a stoichiometric amount of nitrous oxide (N2O) was formed when cytochrome P-450nor was further added 60 the assay system. Therefore, the denitrifying (N2O forming) nitrite reductase activity that we had detected in the cell-free extract of the denitrifying cells (Shoun, Il., and Tanimoto, T. (1991) J. Biol. Chem. 266, 11078-11082) could be reconstituted upon combination of the purified Cu-NiR and P-450nor. The K-m, for nitrite and specific activity at pH 7.0 were estimated as 49 mu M and 447 mu mol NO.min(-1).mg protein(-1), respectively. Its activity was strongly inhibited by cyanide, carbon monoxide, and diethyldithiocarbamate, whereas enormously restored by the addition of cupric ions. An azurin-like blue copper protein (M(r) = 15,000) and a cytochrome c were also isolated from the same fungus, both of which together with cytochrome c of the yeast Saccharomyces cerevisiae were effective in donating electrons to the fungal Cu-NiR. The result suggested that the physiological electron donor of the Cu-NiR is the respiratory electron transport system. The intracellular localization of Cu-NiR was investigated, and it was suggested that the Cu-NiR localizes in an organelle such as mitochondrion. These findings showed the identity in many aspects between the fungal nitrite reductase and bacterial dissimilatory Cu-NiRs. This is the first isolation of dissimilatory NiR from a eukaryote.	UNIV TSUKUBA, INST APPL BIOCHEM, TSUKUBA, IBARAKI 305, JAPAN	University of Tsukuba								ABRAHAM ZHL, 1993, BIOCHEM J, V295, P587, DOI 10.1042/bj2950587; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; [Anonymous], 2002, HIST PHIL LIFE SCI; COYNE MS, 1990, J BACTERIOL, V172, P2558, DOI 10.1128/jb.172.5.2558-2562.1990; DENARIAZ G, 1991, BIOCHIM BIOPHYS ACTA, V1056, P225, DOI 10.1016/S0005-2728(05)80053-2; GODDEN JW, 1991, SCIENCE, V253, P438, DOI 10.1126/science.1862344; GORETSKI J, 1988, J BIOL CHEM, V263, P2316; GROSSMANN JG, 1993, BIOCHEMISTRY-US, V32, P7360, DOI 10.1021/bi00080a005; HOWES BD, 1994, BIOCHEMISTRY-US, V33, P3171, DOI 10.1021/bi00177a005; IWASAKI H, 1971, J BIOCHEM, V69, P847, DOI 10.1093/oxfordjournals.jbchem.a129536; IWASAKI H, 1972, J BIOCHEM, V71, P645; IWASAKI H, 1975, J BIOCHEM-TOKYO, V78, P355, DOI 10.1093/oxfordjournals.jbchem.a130915; JACKSON MA, 1991, FEBS LETT, V291, P41, DOI 10.1016/0014-5793(91)81099-T; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; KAKUTANI T, 1981, J BIOCHEM, V89, P453, DOI 10.1093/oxfordjournals.jbchem.a133220; KIZAWA H, 1991, J BIOL CHEM, V266, P10632; KNOWLES R, 1982, MICROBIOL REV, V46, P43, DOI 10.1128/MMBR.46.1.43-70.1982; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; LIU MY, 1986, J BACTERIOL, V166, P604, DOI 10.1128/jb.166.2.604-608.1986; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUKO M, 1984, J BIOCHEM, V96, P447, DOI 10.1093/oxfordjournals.jbchem.a134856; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; Payne W. J., 1981, DENITRIFICATION; SAWADA E, 1978, PLANT CELL PHYSIOL, V19, P1339; SHOUN H, 1983, J BIOCHEM, V94, P1219, DOI 10.1093/oxfordjournals.jbchem.a134467; SHOUN H, 1992, FEMS MICROBIOL LETT, V94, P277, DOI 10.1111/j.1574-6968.1992.tb05331.x; SHOUN H, 1989, FEBS LETT, V244, P11, DOI 10.1016/0014-5793(89)81151-2; SHOUN H, 1991, J BIOL CHEM, V266, P11078; SUZUKI S, 1993, INORG CHIM ACTA, V208, P107, DOI 10.1016/S0020-1693(00)82892-3; TOMURA D, 1994, J BIOCHEM-TOKYO, V116, P88, DOI 10.1093/oxfordjournals.jbchem.a124508; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMANAKA T, 1964, NATURE, V204, P253, DOI 10.1038/204253a0; ZUMFT WG, 1987, EUR J BIOCHEM, V168, P301, DOI 10.1111/j.1432-1033.1987.tb13421.x; Zumft WG, 1992, PROKARYOTES, P554	34	81	85	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4146	4151		10.1074/jbc.270.8.4146	http://dx.doi.org/10.1074/jbc.270.8.4146			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876166	hybrid			2022-12-27	WOS:A1995QH68800100
J	SHAO, HN; LOU, LD; PANDEY, A; VERDERAME, MF; SIEVER, DA; DIXIT, VM				SHAO, HN; LOU, LD; PANDEY, A; VERDERAME, MF; SIEVER, DA; DIXIT, VM			CDNA CLONING AND CHARACTERIZATION OF A CEK7 RECEPTOR PROTEIN-TYROSINE KINASE LIGAND THAT IS IDENTICAL TO THE LIGAND (ELF-1) FOR THE MEK-4 AND SEK RECEPTOR PROTEIN-TYROSINE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACID-REQUIREMENTS ADJACENT; MEMBRANE-PROTEINS; GENE; CLEAVAGE; ATTACHMENT; ENCODES; MOUSE; CELLS; SITE	We have isolated a murine cDNA encoding a ligand for the Cek7 receptor protein-tyrosine kinase (RPTK), a member of the Eph/Eck RPTK subfamily. Sequence analysis predicts an open reading frame of 209 amino acids with a predicted molecular mass of 24 kDa. The Cek7 ligand shows a 48% sequence identity at the protein level to B61, a ligand for the related Eck RPTK, 30% to the Cek5 ligand, 59% to the recently cloned Ehk1-L, and identity to ELF-1, a recently described ligand for the Mek4 and Sek RPTKs. The expressed Cek7 ligand is functionally active as it induces autophosphorylation of the Cek7 RPTK.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109; PENN STATE UNIV,COLL MED,DEPT MICROBIOL & IMMUNOL,HERSHEY,PA 17033	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health			Pandey, Akhilesh/B-4127-2009; dixit, vishva m/A-4496-2012	Pandey, Akhilesh/0000-0001-9943-6127; dixit, vishva m/0000-0001-6983-0326; Verderame, Michael F./0000-0001-7046-0879	NCI NIH HHS [CA60395, CA52791] Funding Source: Medline; NIDDK NIH HHS [DK39255] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA060395, R01CA052791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; BECKMANN MP, 1994, EMBO J, V13, P3757, DOI 10.1002/j.1460-2075.1994.tb06685.x; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; GERBER LD, 1992, J BIOL CHEM, V267, P12168; GILARDIHEBENSTREIT, 1992, ONCOGENE, V7, P2499; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KODUKULA K, 1993, J CELL BIOL, V120, P657, DOI 10.1083/jcb.120.3.657; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; LHOTAK V, 1991, MOL CELL BIOL, V11, P2496, DOI 10.1128/MCB.11.5.2496; LINDBERG RA, 1990, MOL CELL BIOL, V10, P6314; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; SAJJADI FG, 1991, NEW BIOL, V3, P769; SEED B, 1987, P NATL ACAD SCI USA, V87, P3365; SHAO HN, 1994, J BIOL CHEM, V269, P26606; SIEVER DA, 1994, GENE, V148, P219, DOI 10.1016/0378-1119(94)90692-0; SMITH PL, 1994, J BIOL CHEM, V269, P15162; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	25	38	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3467	3470		10.1074/jbc.270.8.3467	http://dx.doi.org/10.1074/jbc.270.8.3467			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876076	hybrid			2022-12-27	WOS:A1995QH68800002
J	CIOTTI, M; YEATMAN, MT; SOKOL, RJ; OWENS, IS				CIOTTI, M; YEATMAN, MT; SOKOL, RJ; OWENS, IS			ALTERED CODING FOR A STRICTLY CONSERVED DI-GLYCINE IN THE MAJOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE OF A CRIGLER-NAJJAR TYPE-I PATIENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UGT1 GENE-COMPLEX; CDNA SEQUENCE; COS-1 CELLS; CLONING; EXPRESSION; RAT; PHENOL; IDENTIFICATION; LOCUS; DEFICIENCIES	The characterization (Ritter, J.K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S., Yeatman, M. T., and Owens, I. S. (1992) J. Biol. Chem. 267, 3257-3261) of the single copy UGT1 gene complex locus encoding both bilirubin and phenol UDP-glucuronosyltransferases (transferase) has been critical to the determination of genetic defects in Crigler-Najjar patients. The complex (UGT1A-UGT1M) codes for at least two bilirubin, three bilirubin-like, and eight phenol transferase isozymes. In the 5' region, a minimum of 13 different exons 1, each with an upstream promoter, are arrayed in series with 4 common exons in the 3' region of the locus. Each exon 1 encodes the amino terminus of a transferase, and the common exons encode the common carboxyl terminus of each isoform. Although a deleterious mutation in a common exon inactivates the entire locus, a deleterious mutation in an exon 1, as we report here for the UGT1A gene in a Crigler-Najjar Type I patient, affects the amino terminus of that s ingle isoform. Recessively inherited mutant alleles for the predominant bilirubin isozyme, the HUG-Br1 protein, substituted Arg for Gly at codon 276 (G276R) in exon 1 of UGT1A abolishing a conserved di-glycine. The mutant HUG-Br1-G276R protein expressed in COS-1 cells had no detectable bilirubin glucuronidating activity at either pH 7.6 or 6.4. Although each of the bilirubin-type isozymes contains a conserved peptide between residues 270 and 288, all UDP-glucuronosyltransferases contain a di-glycine at approximately position 276-277, making it strictly conserved. Structure-func tion relationship was studied by site-directed mutations of the HUG-Br1 cDNA; G276A, G276Q, G276E, G276I, and P270G mutants were inactive, and V275I- and P285G-altered transferases expressed normal activity. Conservation of residues between the related baculoviral ecdysone UDP-glucosyltransferase and the UDP-glucuronosyltransferases confirms the critical role of the Gly-276 as well as other residues.	NICHHD,GENET DISORDERS DRUG METAB SECT,HUMAN GENET BRANCH,BETHESDA,MD 20892; CHILDRENS HOSP,CTR PEDIAT LIVER,DENVER,CO 80218	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's Hospital Colorado					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00069] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; BOSMA PJ, 1992, FASEB J, V6, P2859, DOI 10.1096/fasebj.6.10.1634050; BOSMA PJ, 1992, HEPATOLOGY, V15, P941, DOI 10.1002/hep.1840150531; CHOWDHURY JR, 1989, METABOLIC BASIS INHE, P1367; COFFMAN BL, 1990, ARCH BIOCHEM BIOPHYS, V281, P170, DOI 10.1016/0003-9861(90)90428-2; ERPS LT, 1994, J CLIN INVEST, V93, P564, DOI 10.1172/JCI117008; GONZALEZ FJ, 1983, J BIOL CHEM, V258, P1363; HARDING D, 1988, P NATL ACAD SCI USA, V85, P8381, DOI 10.1073/pnas.85.22.8381; HARDING D, 1990, ANN HUM GENET, V54, P17, DOI 10.1111/j.1469-1809.1990.tb00356.x; IYANAGI T, 1991, J BIOL CHEM, V266, P24048; IYANAGI T, 1986, J BIOL CHEM, V261, P5607; JACKSON MR, 1987, BIOCHEM J, V242, P581, DOI 10.1042/bj2420581; KIMURA T, 1987, EUR J BIOCHEM, V168, P515, DOI 10.1111/j.1432-1033.1987.tb13448.x; KONG ANT, 1993, PHARMACEUT RES, V10, P461, DOI 10.1023/A:1018965011846; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; MACKENZIE PI, 1990, J BIOL CHEM, V265, P8699; MACKENZIE PI, 1986, J BIOL CHEM, V261, P6119; MACKENZIE PI, 1987, J BIOL CHEM, V262, P9744; MACKENZIE PI, 1986, J BIOL CHEM, V261, P14112; MOGHRABI N, 1993, AM J HUM GENET, V53, P722; OREILLY DR, SCIENCE, V245, P1110; OWENS IS, 1992, PHARMACOGENETICS, V2, P93, DOI 10.1097/00008571-199206000-00001; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1993, J BIOL CHEM, V268, P23573; RITTER JK, 1992, J BIOL CHEM, V267, P3257; RITTER JK, 1991, J BIOL CHEM, V266, P1043; RITTER JK, 1990, J BIOL CHEM, V265, P7900; SATO H, 1990, BIOCHEM BIOPH RES CO, V169, P260, DOI 10.1016/0006-291X(90)91462-2; SIBANDA BL, 1993, J MOL BIOL, V24, P428; SIBANDA BL, 1993, J MOL BIOL, V24, P229; THORNTON JM, 1988, BIOESSAYS, V8, P63, DOI 10.1002/bies.950080205; TUKEY RH, 1993, J BIOL CHEM, V268, P15260; VANES HHG, 1990, J CLIN INVEST, V85, P1199, DOI 10.1172/JCI114553; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465	35	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3284	3291		10.1074/jbc.270.7.3284	http://dx.doi.org/10.1074/jbc.270.7.3284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852413	hybrid			2022-12-27	WOS:A1995QG47100060
J	FRANZUSOFF, A; VOLPE, AM; JOSSE, D; PICHUANTES, S; WOLF, JR				FRANZUSOFF, A; VOLPE, AM; JOSSE, D; PICHUANTES, S; WOLF, JR			BIOCHEMICAL AND GENETIC DEFINITION OF THE CELLULAR PROTEASE REQUIRED FOR HIV-1 GP160 PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; YEAST SACCHAROMYCES-CEREVISIAE; PSEUDOMONAS EXOTOXIN-A; ENVELOPE GLYCOPROTEIN; KEX2 PROTEASE; GOLGI-APPARATUS; ALPHA-FACTOR; PROHORMONE; EXPRESSION; PRECURSOR	The surface glycoproteins of enveloped viruses bind to target cell receptors and trigger membrane fusion for infection. The human immunodeficiency virus 1 (HIV-1) envelope glycoproteins gp120 (CD4 binding protein) and gp41 (transmembrane fusion protein) are initially synthesized as a gp160 precursor. The intracellular cleavage of gp160 by a host cell protease during transit through the secretory pathway is essential for viral activities such as infectivity, membrane fusion, and T-cell syncytium formation. We report that gp160 biogenesis, protein processing, and cell-surface expression have been successfully reproduced in the yeast Saccharomy cerevisiae. Genetic and biochemical approaches are used for defining that the unique cellular protease, Kex2p, is directly responsible for HIV-gp160 processing in yeast, in vivo and in vitro. The yeast system described in this report represents a powerful strategy for identifying, characterizing and inhibiting the host T-cell protease essential for HIV infectivity and AIDS.	UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	FRANZUSOFF, A (corresponding author), UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT CELLULAR & STRUCT BIOL,BOX B-111,4200 E 9TH AVE,DENVER,CO 80262, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034747, R21AI034747] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34747] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BARR PJ, 1987, VACCINE, V5, P90, DOI 10.1016/0264-410X(87)90053-3; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; BRENNER C, 1992, P NATL ACAD SCI USA, V89, P922, DOI 10.1073/pnas.89.3.922; DECROLY E, 1994, J BIOL CHEM, V269, P12240; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; EARL PL, 1991, J VIROL, V65, P31, DOI 10.1128/JVI.65.1.31-41.1991; FRANZUSOFF A, 1992, NATURE, V355, P173, DOI 10.1038/355173a0; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HASELTINE W, 1991, FASEB J, V5, P2849; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; INOCENCIO NM, 1993, J VIROL, V67, P593, DOI 10.1128/JVI.67.1.593-595.1993; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KIDO H, 1993, J BIOL CHEM, V268, P13406; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; OHNISHI Y, 1994, J VIROL, V68, P4075, DOI 10.1128/JVI.68.6.4075-4079.1994; PICHUANTES S, 1995, IN PRESS PRINCIPLES; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; RENNEISEN K, 1990, J BIOL CHEM, V265, P16337; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; SEIDAH NG, 1991, ENZYME, V45, P271, DOI 10.1159/000468901; STEINER DF, 1992, J BIOL CHEM, V267, P23435; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER BD, 1987, P NATL ACAD SCI USA, V84, P8120, DOI 10.1073/pnas.84.22.8120; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILCOX CA, 1991, J CELL BIOL, V115, P297, DOI 10.1083/jcb.115.2.297; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580	42	27	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3154	3159		10.1074/jbc.270.7.3154	http://dx.doi.org/10.1074/jbc.270.7.3154			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852398	hybrid			2022-12-27	WOS:A1995QG47100041
J	AIMES, RT; QUIGLEY, JP				AIMES, RT; QUIGLEY, JP			MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; HUMAN-SKIN; FIBROBLAST COLLAGENASE; SYNTHETIC PEPTIDES; NEUTRAL PROTEASE; GELATINASE; PURIFICATION; EXPRESSION; PROTEINS; COMPLEX	The 72-kDa gelatinase/type IV collagenase (MMP-2) is a member of the matrix metalloproteinase (MMP) family of enzymes. This enzyme is known to cleave type IV collagen as well as degrade denatured collagens. However, native interstitial collagens are reportedly resistant to MMP-2 and are thought to be susceptible only to the interstitial collagenases MMP-1 and MMP-8. In this study we report that both human and chicken MMP-8, free of tissue inhibitors of metalloproteinases (TIMPs) are capable of cleaving soluble, triple helical type I collagen generating the 3/4- and 1/4-length collagen fragments characteristic of vertebrate interstitial collagenases, MMP-2 cleaves at the same Gly-Ile/Leu bond in the collagen alpha chains as interstitial collagenases with k(cat) and K-m values similar to that of MMP-1. MMP-2 also is capable of degrading reconstituted type I collagen fibrils, The closely related 92-kDa gelatinase/type IV collagenase (MMP-9) is unable to cleave soluble or fibrillar collagen under identical conditions indicating that the specific collagenolytic activity of MMP-8 is not a general property of gelatinases. That MMP-2, a potent gelatinase, also can cleave fibrillar collagen provides an alternative to the proposal that two enzymes, an interstitial collagenase and a gelatinase, are required for the complete dissolution of stromal collagen during cellular invasion.	SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, DEPT BIOCHEM & CELL BIOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [R01CA055852] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55852] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMES RT, 1994, BIOCHEM J, V300, P729, DOI 10.1042/bj3000729; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BISWAS C, 1982, BIOCHEM BIOPH RES CO, V109, P1026, DOI 10.1016/0006-291X(82)92042-3; BROWN PD, 1990, CANCER RES, V50, P6184; BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cb.04.110188.003003; CHEN JM, 1991, J BIOL CHEM, V266, P5113; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CRAIG FM, 1991, BIOCHIM BIOPHYS ACTA, V1074, P243, DOI 10.1016/0304-4165(91)90159-E; DESROCHERS PE, 1991, J CLIN INVEST, V87, P2258, DOI 10.1172/JCI115262; FRIDMAN R, 1993, BIOCHEM J, V289, P411, DOI 10.1042/bj2890411; GLANVILLE RW, 1983, BIOCHEM J, V215, P183, DOI 10.1042/bj2150183; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; GROSS J, 1974, BIOCHEM BIOPH RES CO, V61, P605, DOI 10.1016/0006-291X(74)91000-6; Gross J, 1974, Harvey Lect, V68, P351; JOHNSONWINT B, 1980, ANAL BIOCHEM, V104, P175, DOI 10.1016/0003-2697(80)90295-X; KLEINER DE, 1993, BIOCHEMISTRY-US, V32, P1583, DOI 10.1021/bi00057a024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIOTTA LA, 1981, BIOCHEMISTRY-US, V20, P100, DOI 10.1021/bi00504a017; MACARTNEY HW, 1983, EUR J BIOCHEM, V130, P71; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; MOOKHTIAR KA, 1986, ANAL BIOCHEM, V158, P322, DOI 10.1016/0003-2697(86)90557-9; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; POLETTE M, 1993, INVAS METAST, V13, P31; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; SELTZER JL, 1981, J BIOL CHEM, V256, P4662; SELTZER JL, 1989, J BIOL CHEM, V264, P19583; STEFANSSON S, 1994, J CELL PHYSIOL, V161, P419, DOI 10.1002/jcp.1041610304; TEMPLETON NS, 1990, CANCER RES, V50, P5431; TRYGGVASON K, 1993, BREAST CANCER RES TR, V24, P209, DOI 10.1007/BF01833261; URBANSKI SJ, 1992, BRIT J CANCER, V66, P1188, DOI 10.1038/bjc.1992.434; WARD RV, 1991, BIOCHEM J, V278, P179, DOI 10.1042/bj2780179; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WILHELM SM, 1989, J BIOL CHEM, V264, P17213	39	796	818	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5872	5876		10.1074/jbc.270.11.5872	http://dx.doi.org/10.1074/jbc.270.11.5872			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890717				2022-12-27	WOS:A1995QM94500029
J	AITKEN, A; HOWELL, S; JONES, D; MADRAZO, J; PATEL, Y				AITKEN, A; HOWELL, S; JONES, D; MADRAZO, J; PATEL, Y			14-3-3-ALPHA AND 14-3-3-DELTA ARE THE PHOSPHORYLATED FORMS OF RAF-ACTIVATING 14-3-3-BETA AND 14-3-3-ZETA - IN-VIVO STOICHIOMETRIC PHOSPHORYLATION IN BRAIN AT A SER-PRO-GLU-LYS MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							C INHIBITOR PROTEINS; SHEEP BRAIN; KINASE-II; TYROSINE; PURIFICATION; SEQUENCE; ISOFORMS; FAMILY	The 14-3-3 protein family has received considerable attention recently in the literature, because of the finding that beta and zeta isoforms interact with and activate Raf. We had previously shown that these 14-3-3 isoforms also exist as phosphorylated forms in mammalian and avian brain. The presence of this modification enhances the activity of 14-3-3 as an inhibitor of protein kinase C nearly 2-fold. In this report we show by a combination of electrospray mass spectrometry and protein microsequencing that alpha and delta are in vivo post-translationally modified forms of beta and zeta, respectively, and the site of phosphorylation, serine 185, is in a consensus sequence motif for proline-directed kinases.	CIGB,HAVANA,CUBA		AITKEN, A (corresponding author), NATL INST MED RES,PROT STRUCT LAB,MILL HILL,LONDON NW7 1AA,ENGLAND.			Soneji, Yasmina/0000-0001-9189-6348	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AITKEN A, 1990, NATURE, V344, P594; AITKEN A, 1994, J PROTEIN CHEM, V13, P463; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; AITKEN A, 1990, IDENTIFICATION PROTE, P1; AITKEN A, 1989, PROTEIN SEQUENCING P, P43; AITKEN A, 1994, IN PRESS MOL CELL BI; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FERL RJ, 1994, GENETICA, V92, P129, DOI 10.1007/BF00163762; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; GEISOW MJ, 1989, PROTEIN SEQUENCING P, P85; HARDIE DG, 1993, PROTEIN PHOSPHORYLAT, P61; HIRSCH S, 1992, FEBS LETT, V296, P222, DOI 10.1016/0014-5793(92)80384-S; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; KAY I, 1993, RAPID COMMUN MASS SP, V7, P744, DOI 10.1002/rcm.1290070812; MARTENS GJM, 1992, BIOCHEM BIOPH RES CO, V184, P1456, DOI 10.1016/S0006-291X(05)80046-4; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; MOORE B W, 1968, PHYSIOLOGICAL AND BIOCHEMICAL ASPECTS OF NERVOUS INTEGRATION, P343; MORGAN A, 1992, NATURE, V355, P833, DOI 10.1038/355833a0; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; PALLAS DC, 1994, SCIENCE, V265, P535, DOI 10.1126/science.8036498; PARKER PJ, 1982, EUR J BIOCHEM, V124, P47, DOI 10.1111/j.1432-1033.1982.tb05904.x; PATEL Y, 1995, BIOCHIM BIOPHYS ACTA, V1222, P405; PEARSON RB, 1993, PROTEIN PHOSPHORYLAT, P265; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; ROBINSON K, 1994, BIOCHEM J, V299, P853, DOI 10.1042/bj2990853; ROSEBOOM PH, 1994, DNA CELL BIOL, V13, P629, DOI 10.1089/dna.1994.13.629; SHIMIZU K, 1994, J BIOL CHEM, V269, P22917; SWANSON KD, 1992, GENE, V113, P183, DOI 10.1016/0378-1119(92)90394-5; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; VANHEUSDEN GPH, 1992, FEBS LETT, V302, P145, DOI 10.1016/0014-5793(92)80426-H; WANG WF, 1994, GENE, V147, P215, DOI 10.1016/0378-1119(94)90068-X	37	164	172	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5706	5709		10.1074/jbc.270.11.5706	http://dx.doi.org/10.1074/jbc.270.11.5706			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890696	hybrid			2022-12-27	WOS:A1995QM94500006
J	HENDERSON, LM; BANTING, G; CHAPPELL, JB				HENDERSON, LM; BANTING, G; CHAPPELL, JB			THE ARACHIDONATE-ACTIVABLE, NADPH OXIDASE-ASSOCIATED H+ CHANNEL - EVIDENCE THAT GP91-PHOX FUNCTIONS AS AN ESSENTIAL PART OF THE CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL CYTOCHROME-B; HYDROGEN-ION CURRENTS; SUPEROXIDE GENERATION; PLASMA-MEMBRANE; POLYMORPHONUCLEAR LEUKOCYTES; RESPIRATORY BURST; INTRACELLULAR PH; CYTOPLASMIC PH; LYMPHOCYTES-B	The human neutrophil NADPH oxidase-associated H+ channel acts as a charge compensator for the electrogenic generation of superoxide (O-2(.-)). The expression of the channel activity was found to increase in parallel with that of the stimulatable generation of O-2(.-) in differentiated HL60 cells, HL60 cells induced to differentiate in the presence of succinyl acetone (a inhibitor of heme synthesis) were unable to generate O-2(.-), failed to express p22-phox but retained H+ channel activity. EBV transformed B lymphocyte cell lines from normal and CGD patients lacking expression of either p47-phox or p67-phox all expressed unaltered channel activity; however, the activity was completely absent in the lymphocyte cell line lacking gp91-phox. CHO cells and undifferentiated HL60 cells transfected with gp91-phox cDNA expressed H+ channel activity correlating with the expression of gp91-phox. We therefore conclude that the large subunit of the NADPH oxidase cytochrome b (gp91-phox) is the arachidonate activable H+ channel of human neutrophils.			HENDERSON, LM (corresponding author), UNIV BRISTOL,SCH MED SCI,DEPT BIOCHEM,UNIV WALK,BRISTOL BS8 1TD,AVON,ENGLAND.			Banting, George/0000-0001-8249-1621				ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BASHFORD CL, 1985, BIOCHIM BIOPHYS ACTA, V817, P174, DOI 10.1016/0005-2736(85)90080-X; BELETSKY IP, 1990, J IMMUNOL METHODS, V134, P201, DOI 10.1016/0022-1759(90)90381-5; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DEMAUREX N, 1993, J PHYSL, V466, P323; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; GRINSTEIN S, 1986, J BIOL CHEM, V261, P512; GRINSTEIN S, 1985, AM J PHYSIOL, V248, pC379, DOI 10.1152/ajpcell.1985.248.3.C379; HANCOCK JT, 1990, IMMUNOLOGY, V71, P213; HANCOCK JT, 1991, EUR J CLIN INVEST, V21, P208; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1992, BIOCHEM J, V283, P171, DOI 10.1042/bj2830171; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; HENDERSON LM, 1994, BLOOD, V84, P474; HURST JK, 1991, J BIOL CHEM, V266, P1627; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; KORCHAK HM, 1983, P NATL ACAD SCI-BIOL, V80, P4968, DOI 10.1073/pnas.80.16.4968; KUROKI M, 1982, BIOCHIM BIOPHYS ACTA, V693, P326, DOI 10.1016/0005-2736(82)90439-4; LEVY R, 1990, J IMMUNOL, V145, P2595; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MALY FE, 1989, J IMMUNOL, V142, P1260; MARIDONNEAUPARI.I, 1991, J CLIN INVEST, V87, P901; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; NANDA A, 1993, P NATL ACAD SCI USA, V90, P760, DOI 10.1073/pnas.90.2.760; NANDA A, 1994, J CLIN INVEST, V93, P1770, DOI 10.1172/JCI117162; NANDA A, 1994, J BIOL CHEM, V269, P27280; NEWBURGER PE, 1984, J BIOL CHEM, V259, P3771; NUGENT JHA, 1989, BIOCHEM J, V264, P921, DOI 10.1042/bj2640921; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; QUINN MT, 1992, J BIOL CHEM, V267, P7303; REAVES B, 1994, FEBS LETT, V351, P448, DOI 10.1016/0014-5793(94)00813-2; ROBERTS PJ, 1982, J CELL BIOL, V95, P720, DOI 10.1083/jcb.95.3.720; ROOS D, 1994, IMMUNOL REV, V138, P121, DOI 10.1111/j.1600-065X.1994.tb00850.x; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Sambrook J, 1989, MOL CLONING LABORATO; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SELIGMANN BE, 1980, J MEMBRANE BIOL, V52, P257, DOI 10.1007/BF01869194; SHOTTON D, 1989, TRENDS BIOCHEM SCI, V14, P435, DOI 10.1016/0968-0004(89)90096-0; SHOTTON DM, 1989, J CELL SCI, V94, P175; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; UENO I, 1991, FEBS LETT, V281, P130, DOI 10.1016/0014-5793(91)80375-D; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	53	98	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					5909	5916		10.1074/jbc.270.11.5909	http://dx.doi.org/10.1074/jbc.270.11.5909			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890722	hybrid			2022-12-27	WOS:A1995QM94500034
J	ISHIKAWA, K; TAKEUCHI, N; TAKAHASHI, S; MATERA, KM; SATO, M; SHIBAHARA, S; ROUSSEAU, DL; IKEDASAITO, M; YOSHIDA, T				ISHIKAWA, K; TAKEUCHI, N; TAKAHASHI, S; MATERA, KM; SATO, M; SHIBAHARA, S; ROUSSEAU, DL; IKEDASAITO, M; YOSHIDA, T			HEME OXYGENASE-2 - PROPERTIES OF THE HEME COMPLEX OF THE PURIFIED TRYPTIC FRAGMENT OF RECOMBINANT HUMAN HEME OXYGENASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; ESCHERICHIA-COLI; CARBON-MONOXIDE; PIG SPLEEN; PURIFICATION; DEGRADATION; EXPRESSION; MYOGLOBIN; FORM; COORDINATION	Recombinant human microsomal heme oxygenase-2 was expressed in Escherichia coli. Tryptic digestion of the membrane fraction, in which the wild-type enzyme was localized, yielded a soluble tryptic peptide of 28 kDa, which retained the ability to accept electrons from NADPH-cytochrome P-450 reductase and the enzymatic activity for conversion of heme to biliverdin. The tryptic fragment, when purified to apparent homogeneity, bound one equivalent of heme to form a substrate-enzyme complex that had spectroscopic properties characteristic of heme proteins, such as myoglobin and hemoglobin. Optical absorption, Raman scattering, and EPR studies of the heme-tryptic fragment complex revealed that the ferric heme was six coordinate high spin at neutral pH and six coordinate low spin at alkaline pH, with a pK(a) value of 8.5. EPR and Raman scattering studies indicated that a neutral imidazole of a histidine residue served as the proximal ligand in the heme-heme oxygenase-2 fragment complex. The reaction with hydrogen peroxide converted the heme of the heme oxygenase 2 fragment complex into a verdoheme-like intermedate, while the reaction with m-chloroperbenzoic acid yielded a oxoferryl species. These spectroscopic properties are similar to those obtained for heme oxygenase-1, and thus the catalytic mechanism of heme oxygenase-2 appears to be similar to that of heme oxygenase-1.	YAMAGATA UNIV,SCH MED,DEPT BIOCHEM,YAMAGATA 99023,JAPAN; YAMAGATA UNIV,SCH MED,CENT LAB RES & EDUCAT,YAMAGATA 99023,JAPAN; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106; AT&T BELL LABS,MURRAY HILL,NJ 07974; TOHOKU UNIV,SCH MED,DEPT APPL PHYSIOL & MOLEC BIOL,SENDAI,MIYAGI 980,JAPAN	Yamagata University; Yamagata University; Case Western Reserve University; AT&T; Nokia Corporation; Nokia Bell Labs; Tohoku University			Ikeda-Saito, Masao/A-5992-2008; Ikeda-Saito, Masao/K-2703-2015; Shibahara, Shigeki/M-3644-2014		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR005659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048714, R01GM039492] Funding Source: NIH RePORTER; NCRR NIH HHS [RR05659] Funding Source: Medline; NIGMS NIH HHS [GM48714, GM39492] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V21, P436, DOI 10.1126/science.178.4058.296; BRUNE B, 1987, MOL PHARMACOL, V32, P497; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; GIACOMETTI GM, 1981, J MOL BIOL, V146, P363, DOI 10.1016/0022-2836(81)90393-4; HERNANDEZ G, 1994, BIOCHEMISTRY-US, V33, P6631, DOI 10.1021/bi00187a033; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; ISHIKAWA K, 1992, BIOCHEM BIOPH RES CO, V182, P981, DOI 10.1016/0006-291X(92)91828-E; ISHIKAWA K, 1991, EUR J BIOCHEM, V202, P161, DOI 10.1111/j.1432-1033.1991.tb16357.x; ITOMAKI M, 1995, IN PRESS ARCH BIOPHY; KIKUCHI G, 1983, MOL CELL BIOCHEM, V53-4, P163; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1986, J BIOL CHEM, V261, P411; MCCOUBREY WK, 1993, ARCH BIOCHEM BIOPHYS, V302, P402, DOI 10.1006/abbi.1993.1231; MCCOUBREY WK, 1992, ARCH BIOCHEM BIOPHYS, V295, P13, DOI 10.1016/0003-9861(92)90481-B; MORIKIS D, 1990, J BIOL CHEM, V265, P12143; NOGUCHI M, 1983, J BIOCHEM, V93, P1027, DOI 10.1093/oxfordjournals.jbchem.a134226; NOGUCHI M, 1979, J BIOCHEM, V86, P833, DOI 10.1093/oxfordjournals.jbchem.a132615; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; ROTENBERG MO, 1991, ARCH BIOCHEM BIOPHYS, V290, P336, DOI 10.1016/0003-9861(91)90549-X; SHIBAHARA S, 1993, J BIOCHEM-TOKYO, V113, P214, DOI 10.1093/oxfordjournals.jbchem.a124028; SHIBAHARA S, 1979, ARCH BIOCHEM BIOPHYS, V197, P607, DOI 10.1016/0003-9861(79)90285-6; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; SUN J, 1994, BIOCHEMISTRY-US, V33, P13734, DOI 10.1021/bi00250a026; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; TRAKSHEL GM, 1986, J BIOL CHEM, V261, P1131; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; WILKS A, 1993, J BIOL CHEM, V268, P22357; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1984, J BIOCHEM-TOKYO, V96, P563, DOI 10.1093/oxfordjournals.jbchem.a134868; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; YOSHIDA T, 1978, J BIOL CHEM, V253, P4224; YOSHIDA T, 1979, J BIOL CHEM, V254, P4487; YOSHIDA T, 1982, J BIOL CHEM, V257, P9345; YOSHIDA T, 1980, J BIOCHEM-TOKYO, V88, P557, DOI 10.1093/oxfordjournals.jbchem.a133003	41	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6345	6350		10.1074/jbc.270.11.6345	http://dx.doi.org/10.1074/jbc.270.11.6345			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890772	hybrid			2022-12-27	WOS:A1995QM94500094
J	LEVITAN, ES; GEALY, R; TRIMMER, JS; TAKIMOTO, K				LEVITAN, ES; GEALY, R; TRIMMER, JS; TAKIMOTO, K			MEMBRANE DEPOLARIZATION INHIBITS KV1.5 VOLTAGE-GATED K+ CHANNEL GENE-TRANSCRIPTION AND PROTEIN EXPRESSION IN PITUITARY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; POTASSIUM CHANNEL; RAT-BRAIN; CALCIUM CHANNELS; DIFFERENTIAL EXPRESSION; NERVOUS-SYSTEM; MESSENGER-RNA; GH3 CELLS; CLONING; HEART	Voltage-gated K+ channels play an essential role in the production of action potential activity by excitable cells, Recent studies have suggested that expression of K+ channel genes may be regulated by stimuli that affect electrical activity. Elevating the concentration of extracellular KCl causes membrane depolarization and, thus, is widely used for studying electrical activity-dependent changes in neurons, muscle, and endocrine cells. Here we show that elevated KCl decreases Kv1.5 K+ channel mRNA expression in clonal pituitary cells without affecting Ev1.4 and Rv2.1 mRNA levels, K+ channel blockers, which cause depolarization, also produce down-regulation of Kv1.5 mRNA, while NaCl addition had no effect. Thus, the effect of KCl is mediated by K+-induced membrane depolarization. Unlike many known effects of K down-regulation of Kv1.5 mRNA does not require Ca2+ or Na+ influx, or Na+-H+ exchange. Furthermore, the decrease in Kv1.5 mRNA expression is due to inhibition of channel gene transcription and persists after inhibition of protein synthesis, excluding a role for induction of intermediary regulatory proteins. Finally, immunoblots with antibody specific for the Kv1.5 polypeptide show that depolarization for 8 h reduces the expression of Kv1.5 channel protein. The decrease in K+ channel protein expression caused by depolarization-induced Ca2+-independent inhibition of Kv1.5 gene transcription may produce a longterm enhancement of pituitary cell excitability and secretory activity.	SUNY STONY BROOK,DEPT BIOCHEM & CELL BIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	LEVITAN, ES (corresponding author), UNIV PITTSBURGH,DEPT PHARMACOL E1355BST,PITTSBURGH,PA 15261, USA.				NINDS NIH HHS [NS 29876, NS 29804] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS029876, R29NS029804] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERT PR, 1984, J BIOL CHEM, V259, P5827; ATTARDI B, 1993, RECEPTOR CHANNEL, V1, P287; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BLACK IB, 1987, SCIENCE, V236, P1263, DOI 10.1126/science.2884727; BONINI JA, 1991, BIOTECHNIQUES, V11, P708; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DREWE JA, 1992, J NEUROSCI, V12, P538; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FUJIMOTO J, 1992, ENDOCRINOLOGY, V130, P1879, DOI 10.1210/en.130.4.1879; GERSHENGORN MC, 1985, ENDOCRINOLOGY, V116, P591, DOI 10.1210/endo-116-2-591; HADCOCK JR, 1989, J BIOL CHEM, V264, P19928; HONORE E, 1994, P NATL ACAD SCI USA, V91, P1937, DOI 10.1073/pnas.91.5.1937; KRAMER RH, 1991, NEURON, V6, P557, DOI 10.1016/0896-6273(91)90058-8; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; LEVITAN ES, 1991, MOL ENDOCRINOL, V5, P1903, DOI 10.1210/mend-5-12-1903; LEVITAN ES, 1991, SOC NEUR ABSTR, V17, P1098; LOPEZBARNEO J, 1992, RECEPTOR CHANNEL, V1, P61; MARIOT P, 1993, ENDOCRINOLOGY, V132, P846, DOI 10.1210/en.132.2.846; MATSUBARA H, 1993, J CLIN INVEST, V92, P1659, DOI 10.1172/JCI116751; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MEYERHOF W, 1992, J NEUROENDOCRINOL, V4, P245, DOI 10.1111/j.1365-2826.1992.tb00166.x; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORI Y, 1993, J BIOL CHEM, V268, P26482; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; RAMPE D, 1993, MOL PHARMACOL, V44, P1240; RAMPE D, 1993, MOL PHARMACOL, V44, P642; RIHERA AG, 1990, NEURON, V5, P691; ROBERDS SL, 1991, P NATL ACAD SCI USA, V88, P1798, DOI 10.1073/pnas.88.5.1798; ROBERDS SL, 1991, FEBS LETT, V284, P152, DOI 10.1016/0014-5793(91)80673-Q; SIMASKO SM, 1988, AM J PHYSIOL, V254, pE328, DOI 10.1152/ajpendo.1988.254.3.E328; SNYDERS DJ, 1992, MOL PHARMACOL, V41, P322; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKIMOTO K, 1994, CIRC RES, V75, P1006, DOI 10.1161/01.RES.75.6.1006; TAKIMOTO K, 1993, NEURON, V11, P359, DOI 10.1016/0896-6273(93)90191-S; TAKIMOTO K, 1995, J NEUROSCI, V15, P449; TAKIMOTO K, IN PRESS BIOCH BIOPH; TORNQUIST K, 1991, ENDOCRINOLOGY, V128, P242; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117	43	63	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6036	6041		10.1074/jbc.270.11.6036	http://dx.doi.org/10.1074/jbc.270.11.6036			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890735	hybrid			2022-12-27	WOS:A1995QM94500051
J	ONO, SJ; SONG, Z				ONO, SJ; SONG, Z			MAPPING OF THE INTERACTION SITE OF THE DEFECTIVE TRANSCRIPTION FACTOR IN THE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX MUTANT-CELL LINE CLONE-13 TO THE DIVERGENT X2-BOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-BOX-BINDING; BARE LYMPHOCYTE SYNDROME; HLA-DRA GENE; B-CELL; INTERFERON-GAMMA; C-FOS; EXPRESSION; PROMOTERS; PROTEIN; CLONING	We have previously described a mutant B lymphoblastoid cell line, Clone-13, that expresses HLA-DQ in the absence of HLA-DR and -DP, Several criteria indicated that the defect in this cell line influences the activity of an isotype-specific transcription factor. Indeed, transient transfection of HLA-DRA and DQB reporter constructs indicated that the affected factor operates via cis-elements located between -141 base pairs and the transcription initiation site. A series of hybrid DRA/DQB reporter constructs was generated to further map the relevant cis-elements in this system, Insertion of oligonucleotides spanning the DQB X-box (but not the DQB-W region or the DQB Y-box) upstream of -141 in a DRA reporter plasmid rescued expression to nearly wild-type levels, Substitution promoters were then generated where the entire X-box, or only the X1- or X2-boxes of HLA-DRA were replaced with the analogous regions of HLA-DQB. The DQB X2-box was able to restore expression to the silent DRA reporter construct. Moreover, replacement of the DQB X2-box with the DRA X2-box markedly diminished the activity of the DQB promoter in the mutant cell, None of the hybrid reporter constructs were defective when transfected into the wild-type, HLA-DR/-DQ positive that the divergent X2-box of the class II major histocompatibility complex promoters plays an important role in influencing differential expression of the human class II isotypes.	JOHNS HOPKINS UNIV,SCH MED,LUCILLE P MARKEY GRAD PROGRAM CELLULAR MOLEC MED,BALTIMORE,MD 21224; JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT MOLEC MICROBIOL & IMMUNOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	ONO, SJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,5501 HOPKINS BAYVIEW CIR,RM 2A38,BALTIMORE,MD 21224, USA.							BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; BOOTHBY M, 1989, J IMMUNOL, V142, P1005; DAS HK, 1983, P NATL ACAD SCI-BIOL, V80, P3543, DOI 10.1073/pnas.80.12.3543; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINN PW, 1990, J EXP MED, V171, P2159, DOI 10.1084/jem.171.6.2159; FINN PW, 1990, EMBO J, V9, P1543, DOI 10.1002/j.1460-2075.1990.tb08273.x; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GLADSTONE P, 1978, NATURE, V271, P459, DOI 10.1038/271459a0; GLIMCHER LH, 1992, ANNU REV IMMUNOL, V10, P13, DOI 10.1146/annurev.iy.10.040192.000305; HENLE W, 1967, SCIENCE, V157, P1064, DOI 10.1126/science.157.3792.1064; HESTON L, 1982, NATURE, V295, P160, DOI 10.1038/295160a0; Hinuma Y, 1967, J Virol, V1, P1045; KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KOBR M, 1990, MOL CELL BIOL, V10, P965, DOI 10.1128/MCB.10.3.965; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4304, DOI 10.1073/pnas.88.10.4304; ONO SJ, 1991, P NATL ACAD SCI USA, V88, P4309, DOI 10.1073/pnas.88.10.4309; ONO SJ, 1991, J EXP MED, V173, P629, DOI 10.1084/jem.173.3.629; PUJOLBORRELL R, 1987, NATURE, V326, P304, DOI 10.1038/326304a0; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; SONG ZM, 1994, J EXP MED, V180, P1763, DOI 10.1084/jem.180.5.1763; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; SYMINGTON FW, 1985, J IMMUNOL, V135, P1026; TING JP, 1993, IMMUNOL RES, V12, P65, DOI 10.1007/BF02918369; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VILEN BJ, 1992, J BIOL CHEM, V267, P23728; VOLIVA CF, 1993, P NATL ACAD SCI USA, V90, P3408, DOI 10.1073/pnas.90.8.3408; WRIGHT KL, 1992, P NATL ACAD SCI USA, V89, P7601, DOI 10.1073/pnas.89.16.7601; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x	36	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6396	6402		10.1074/jbc.270.11.6396	http://dx.doi.org/10.1074/jbc.270.11.6396			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890777	hybrid			2022-12-27	WOS:A1995QM94500100
J	CARPENTIER, JL; MCCLAIN, D				CARPENTIER, JL; MCCLAIN, D			INSULIN-RECEPTOR KINASE ACTIVATION RELEASES A CONSTRAINT MAINTAINING THE RECEPTOR ON MICROVILLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; LIGAND-INDUCED INTERNALIZATION; CULTURED HUMAN-LYMPHOCYTES; LOW-DENSITY-LIPOPROTEIN; COATED PITS; MEDIATED ENDOCYTOSIS; JUXTAMEMBRANE REGION; RAT HEPATOCYTES; SURFACE REDISTRIBUTION; CLATHRIN	To examine whether the surface redistribution of the insulin receptor from microvilli, where it sits in its unoccupied form, to the nonvillous domain, where it is internalized through clathrin-coated pits, is an active movement or a passive redistribution linked to the release of a restraint maintaining it on microvilli, we have generated a mutated insulin receptor with a truncation of exons 17-22 and tracked it biochemically and morphologically. Biochemical analysis indicates that this mutated receptor is constitutively internalized and recycled even in the absence of ligand. Quantitative electron microscope autoradiography analysis reveals that it does not preferentially associate with microvilli in its unoccupied form but is normally segregated in clathrin-coated pits through the preserved signal sequence(s) of exon 16. We conclude that (a) insulin receptor internalization is initiated through receptor kinase activation and autophosphorylation, which free the receptor from constraints maintaining it on microvilli; (b) the signal sequences contained in exon 16 are entirely sufficient to promote clathrin coated pit-mediated internalization of insulin receptors; (c) these sequences are not uncovered by kinase activation; and (d) the ''code'' maintaining the unoccupied receptors on microvilli is contained within exons 17-21 of the receptor.	UNIV MISSISSIPPI, MED CTR, DEPT MED, JACKSON, MS 39218 USA; VET ADM MED CTR, DIV ENDOCRINOL, JACKSON, MS USA	University of Mississippi; University of Mississippi Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	CARPENTIER, JL (corresponding author), UNIV GENEVA, UNIV MED CTR, SCH MED, DEPT MORPHOL, 1 RUE MICHEL SERVET, CH-1211 GENEVA 4, SWITZERLAND.							AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; BACKER JM, 1992, J CELL BIOL, V118, P831, DOI 10.1083/jcb.118.4.831; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CARPENTIER JL, 1978, J CLIN INVEST, V61, P1057, DOI 10.1172/JCI109005; CARPENTIER JL, 1993, HISTOCHEMISTRY, V100, P169, DOI 10.1007/BF00269090; CARPENTIER JL, 1989, DIABETOLOGIA, V32, P627; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CARPENTIER JL, 1982, J CELL BIOL, V95, P73, DOI 10.1083/jcb.95.1.73; CARPENTIER JL, 1981, J CELL BIOL, V91, P17, DOI 10.1083/jcb.91.1.17; CARPENTIER JL, 1985, DIABETES, V34, P1002, DOI 10.2337/diabetes.34.10.1002; CARPENTIER JL, 1979, J CLIN INVEST, V63, P1249, DOI 10.1172/JCI109420; CARPENTIER JL, 1993, J CELL BIOL, V118, P831; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GRUNBERGER G, 1985, J LAB CLIN MED, V106, P211; HEIDENREICH KA, 1984, J BIOL CHEM, V259, P6511; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LECONTE I, 1994, J BIOL CHEM, V269, P18062; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LEVY JR, 1986, ENDOCRINOLOGY, V119, P572, DOI 10.1210/endo-119-2-572; MCCLAIN DA, 1990, J BIOL CHEM, V265, P21363; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; PACCAUD JP, 1993, J BIOL CHEM, V268, P23191; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PEELER JS, 1993, J CELL BIOL, V120, P47, DOI 10.1083/jcb.120.1.47; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; SCHMID SL, 1992, BIOESSAYS, V14, P589, DOI 10.1002/bies.950140903; SMITH RM, 1991, J BIOL CHEM, V266, P17522; SMITH RM, 1993, ENDOCRINOLOGY, V132, P1453, DOI 10.1210/en.132.4.1453; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; SOROKIN A, 1994, J BIOL CHEM, V269, P17056; THIES RS, 1990, J BIOL CHEM, V265, P10132; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; VANDEURS B, 1989, INT REV CYTOL, V117, P131; WELSH JB, 1994, MOL BIOL CELL, V5, P539, DOI 10.1091/mbc.5.5.539; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4	53	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5001	5006		10.1074/jbc.270.10.5001	http://dx.doi.org/10.1074/jbc.270.10.5001			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890606	hybrid			2022-12-27	WOS:A1995QL58000011
J	LEE, KD; HOLLENBECK, PJ				LEE, KD; HOLLENBECK, PJ			PHOSPHORYLATION OF KINESIN IN-VIVO CORRELATES WITH ORGANELLE ASSOCIATION AND NEURITE OUTGROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; LIGHT-CHAINS; PROTEIN-PHOSPHORYLATION; CYTOPLASMIC DYNEIN; AXONAL-TRANSPORT; PC12 CELLS; BINDING; MELANOPHORES; CYTOSKELETON; MOTILITY	The motor protein kinesin is implicated in organelle movement toward the plus ends of microtubules, but little is known about its interaction with organelle membranes or about the physiological role of the phosphorylation of kinesin and its associated protein kinectin seen in neurons in vivo (Hollenbeck, P. J. (1993) J. Neurochem, 60, 2265-2275). Here we have demonstrated that the kinesin heavy chain (KHC), light chain, and kinectin isolated from chick brain or sympathetic neurons exist in several isoelectric forms. Metabolic labeling followed by phosphatase treatment showed that these are phosphoisoforms, and that phosphorylation is reversible in vitro. To assess the capability of phosphorylation to regulate kinesin's state and/or activity, we performed P-32 and S-35 pulse-chase experiments with neuronal cultures and determined that kinesin-associated phosphate turns over 3-4 times faster than the proteins themselves. When the phosphoisoform distributions for different kinesin pools were analyzed, it was found that membrane associated KHC contained predominantly the most highly phosphorylated isoform, while soluble kinesin consisted of less phosphorylated KHC isoforms. Nerve growth factor-induced neurite outgrowth in PC12 cells was found to increase significantly kinesin's P-32 specific activity while doubling the relative abundance of the most highly phosphorylated IMC isoform. These results demonstrate that the phosphorylation state of kinesin is closely coupled to its organelle binding and to the magnitude of organelle transport in the cell. We propose that the phosphorylation state of kinesin and associated proteins may regulate motility via association with organelle membranes and, specifically, that KHC phosphorylation induces membrane association.	HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NINDS NIH HHS [NS27073] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS027073, R01NS027073] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARATUNGA A, 1993, J BIOL CHEM, V268, P17427; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; CITI S, 1987, BIOESSAYS, V7, P155, DOI 10.1002/bies.950070404; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; CYR JL, 1991, P NATL ACAD SCI USA, V88, P10114, DOI 10.1073/pnas.88.22.10114; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; HOLLENBECK PJ, 1986, J CELL BIOL, V103, P1539, DOI 10.1083/jcb.103.4.1539; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; JACOBS JR, 1986, J CELL BIOL, V103, P895, DOI 10.1083/jcb.103.3.895; JOHNSON CS, 1990, CELL MOTIL CYTOSKEL, V16, P204, DOI 10.1002/cm.970160307; KOTZ KJ, 1994, J CELL BIOL, V124, P463, DOI 10.1083/jcb.124.4.463; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN SXH, 1993, J CELL SCI, V105, P579; LYNCH TJ, 1986, J BIOL CHEM, V261, P4212; LYNCH TJ, 1986, J BIOL CHEM, V261, P4204; MATTHIES HJG, 1993, J BIOL CHEM, V268, P11176; MCILVAIN JM, 1994, J BIOL CHEM, V269, P19176; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PALAZZO RE, 1989, CELL MOTIL CYTOSKEL, V13, P21, DOI 10.1002/cm.970130104; RODIONOV VI, 1991, P NATL ACAD SCI USA, V88, P4956, DOI 10.1073/pnas.88.11.4956; ROZDZIAL MM, 1986, CELL, V47, P1061, DOI 10.1016/0092-8674(86)90821-4; ROZDZIAL MM, 1986, J CELL BIOL, V103, P2755, DOI 10.1083/jcb.103.6.2755; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Satir Peter, 1993, Trends in Cell Biology, V3, P409, DOI 10.1016/0962-8924(93)90092-F; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; SAWIN KE, 1993, BIOESSAYS, V15, P399, DOI 10.1002/bies.950150606; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; Skoufias DA, 1993, CURR OPIN CELL BIOL, V5, P95, DOI 10.1016/S0955-0674(05)80014-6; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TASH JS, 1989, CELL MOTIL CYTOSKEL, V14, P332, DOI 10.1002/cm.970140303; THALER CD, 1990, J CELL BIOL, V111, P1939, DOI 10.1083/jcb.111.5.1939; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; WALCZAK CE, 1994, CELL MOTIL CYTOSKEL, V27, P101, DOI 10.1002/cm.970270202; YU H, 1992, J BIOL CHEM, V267, P20457; ZHAO LP, 1993, MOL BIOL CELL, V4, P162	45	106	110	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5600	5605		10.1074/jbc.270.10.5600	http://dx.doi.org/10.1074/jbc.270.10.5600			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890679	hybrid			2022-12-27	WOS:A1995QL58000097
J	FUJITAYOSHIGAKI, J; SHIROUZU, M; ITO, Y; HATTORI, S; FURUYAMA, S; NISHIMURA, S; YOKOYAMA, S				FUJITAYOSHIGAKI, J; SHIROUZU, M; ITO, Y; HATTORI, S; FURUYAMA, S; NISHIMURA, S; YOKOYAMA, S			CONSTITUTIVE EFFECTOR REGION ON THE C-TERMINAL SIDE OF SWITCH-I OF THE RAS PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; GTPASE-ACTIVATING PROTEIN; AMINO-ACID-RESIDUES; MAP KINASE; HA-RAS; PC12 CELLS; SIGNAL TRANSDUCTION; GENE-PRODUCT; MOLECULAR-CLONING; NEURITE OUTGROWTH	The ''switch I'' region (Asp(30)-Asp(38)) of the Ras protein takes remarkably different conformations between the GDP- and GTP-bound forms and coincides with the so-called ''effector region.'' As for a region on the C-terminal side of switch I, the V45E and G48C mutants of Pas failed to promote neurite outgrowth of PC12 cells (Fujita-Yoshigaki, J., Shirouzu, Pd, Koide, H., Nishimura, S., and Yokoyama, S. (1991) FEBS Lett 294, 187-190). In the present study, we performed alanine-scanning mutagenesis within the region Lys(42)-Ile(55) Of Pas and found that the K42A, I46A, G48A, E49A, and L53A mutations significantly reduced the neurite-inducing activity. This is an effector region by definition, but its conformation is known to be unaffected by GDP --> GTP exchange. So, this region is referred to as a ''constitutive'' effector (E(c)) region, distinguished from switch I, a ''switch'' effector (E(s)) region. The E(c) region mutants exhibiting no neurite-inducing activity were found to be correlatably unable to activate mitogen-activated protein (MAP) kinase in PC12 cells. Therefore, the E(c) region is essential for the MAP kinase activation in PC12 cells, whereas mutations in this region only negligibly affect the binding of Ras to Raf-1 (Shirouzu, M., Koide, H., Fujita-Yoshigaki, J., Oshio, Il., Toyama, Y., Yamasaki, H., Fuhrman, S. A., Villafranca, E., Kaziro, Y., and Yokoyama, S. (1994) Oncogene 9, 2153-2157).	UNIV TOKYO, SCH SCI, DEPT BIOPHYS & BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN; NIHON UNIV, SCH DENT, DEPT PHYSIOL, MATSUDO, CHIBA 271, JAPAN; INST PHYS & CHEM RES, BIODESIGN RES GRP, WAKO, SAITAMA 35101, JAPAN; NATL CTR NEUROL & PSYCHIAT, NATL INST NEUROSCI, DIV BIOCHEM & CELLULAR BIOL, KODAIRA, TOKYO 187, JAPAN; BANYU PHARMACEUT CO LTD, MERCK SHARP & DOHME RES LABS, BANYU TSUKUBA RES INST, TSUKUBA, IBARAKI 30033, JAPAN	University of Tokyo; Nihon University; RIKEN; National Center for Neurology & Psychiatry - Japan; Merck & Company			Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016; Yoshigaki, Junko/AAE-6702-2020; Ito, Yutaka/P-2604-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Ito, Yutaka/0000-0002-1030-4660; Fujita-Yoshigaki, Junko/0000-0002-3271-6498				ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BIRCHMEIER C, 1985, CELL, V43, P615, DOI 10.1016/0092-8674(85)90233-8; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FARNSWORTH CL, 1991, CELL, V64, P625, DOI 10.1016/0092-8674(91)90246-U; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FUJITAYOSHIGAKI J, 1992, ONCOGENE, V7, P2019; FUJITAYOSHIGAKI J, 1991, FEBS LETT, V294, P187, DOI 10.1016/0014-5793(91)80665-P; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; ITO T, 1993, P NATL ACAD SCI USA, V90, P975; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; KIMURA K, 1994, J BIOL CHEM, V269, P18961; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MAEKAWA M, 1993, J BIOL CHEM, V268, P22948; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MILLER AF, 1993, BIOCHEMISTRY-US, V32, P7367, DOI 10.1021/bi00080a006; MIURA K, 1986, JPN J CANCER RES, V77, P45; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; NUREKAMAL MSA, 1992, J BIOL CHEM, V267, P1415; OSHIMA M, 1991, J BIOL CHEM, V266, P23753; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PIZON V, 1988, ONCOGENE, V3, P201; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SATOH T, 1987, MOL CELL BIOL, V7, P4553, DOI 10.1128/MCB.7.12.4553; SEGER R, 1992, J BIOL CHEM, V267, P25628; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; SHIROUZU M, 1994, ONCOGENE, V9, P2153; SHIROUZU M, 1992, ONCOGENE, V7, P475; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; STEIN RB, 1986, J VIROL, V60, P782, DOI 10.1128/JVI.60.2.782-786.1986; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WILLUMSEN BM, 1989, NATO ADV SCI I A-LIF, V165, P165; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; YAMASAKI K, 1989, BIOCHEM BIOPH RES CO, V162, P1054, DOI 10.1016/0006-291X(89)90780-8; YAMASAKI K, 1994, BIOCHEMISTRY-US, V33, P65, DOI 10.1021/bi00167a009; ZHANG K, 1990, SCIENCE, V249, P162, DOI 10.1126/science.2115210; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	71	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4661	4667		10.1074/jbc.270.9.4661	http://dx.doi.org/10.1074/jbc.270.9.4661			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876237	hybrid			2022-12-27	WOS:A1995QK08400071
J	HU, MJ; BIGGER, CB; GARDNER, PD				HU, MJ; BIGGER, CB; GARDNER, PD			A NOVEL REGULATORY ELEMENT OF A NICOTINIC ACETYLCHOLINE-RECEPTOR GENE INTERACTS WITH A DNA-BINDING ACTIVITY ENRICHED IN RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL EXPRESSION; ALPHA-SUBUNIT; GROWTH-FACTOR; FAMILY; DIVERSITY; PROMOTERS; SUBTYPES; ONCOGENE; MEMBERS	Nicotinic acetylcholine receptors are ligand-gated ion channels that play a critical role in signal transmission in the nervous system. The genes encoding the Various subunits that comprise functional acetylcholine receptors are expressed in distinct temporal and spatial patterns. Studies to understand the molecular mechanisms underlying the differential expression of the receptor subunit genes have led to the identification, in this report, of a 19-base pair cis-acting element that is required for transcriptional activation of the rat beta 4 subunit gene. Screening of computer data bases with the 19-base pair element revealed the sequence to be unique among known transcriptional regulatory elements. Loss of this element resulted in drastically reduced beta 4 promoter activity in transfected cholinergic SN17 cells. Furthermore, this element specifically interacts with nuclear proteins prepared from both SN17 cells and adult rat brain. UV cross-linking experiments indicated the presence, in SN17 nuclear extracts, of a prominent protein species (approximately 50 kDa) that interacts specifically with the Is-base pair element. These results lead us to hypothesize that interactions between the 50-kDa protein and the novel 19-base pair element are necessary for transcriptional activation of the beta 4 subunit gene.	UNIV TEXAS, HLTH SCI CTR, CTR MOLEC MED, INST BIOTECHNOL, SAN ANTONIO, TX 78245 USA; DARTMOUTH COLL SCH MED, BIOCHEM PROGRAM, HANOVER, NH 03755 USA	University of Texas System; University of Texas Health San Antonio; Dartmouth College					NINDS NIH HHS [NS30243, R01 NS030243] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030243] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ausubel FM, 1994, CURRENT PROTOCOLS MO; BESSIS A, 1993, NUCLEIC ACIDS RES, V21, P2185, DOI 10.1093/nar/21.9.2185; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREHM P, 1988, DEV BIOL, V129, P1, DOI 10.1016/0012-1606(88)90156-X; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CONROY WG, 1992, NEURON, V9, P679, DOI 10.1016/0896-6273(92)90031-8; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DAUBAS P, 1993, P NATL ACAD SCI USA, V90, P2237, DOI 10.1073/pnas.90.6.2237; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DINELEYMILLER K, 1992, MOL BRAIN RES, V16, P339, DOI 10.1016/0169-328X(92)90244-6; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; EVANS BA, 1985, EMBO J, V4, P133, DOI 10.1002/j.1460-2075.1985.tb02327.x; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; HEINEMANN S, 1990, PROG BRAIN RES, V86, P195; HU MJ, 1994, J NEUROCHEM, V62, P392; LAMAR E, 1990, SOC NEUR ABSTR, V16, P581; LUETJE CW, 1991, J NEUROSCI, V11, P837; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; MIHOVILOVIC M, 1993, SOC NEUR ABSTR, V123, P13; MORRIS BJ, 1990, MOL BRAIN RES, V7, P305, DOI 10.1016/0169-328X(90)90081-N; MULLE C, 1991, J NEUROSCI, V11, P2588; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PAPKE RL, 1989, NEURON, V3, P589, DOI 10.1016/0896-6273(89)90269-9; PATRICK J, 1993, PROG BRAIN RES, V98, P113; PEREIRA EFR, 1994, SOC NEUR ABSTR, V468, P12; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SCHUETZE SM, 1987, ANNU REV NEUROSCI, V10, P403, DOI 10.1146/annurev.ne.10.030187.002155; SEGUELA P, 1993, J NEUROSCI, V13, P596; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; van der Eb A J, 1980, Methods Enzymol, V65, P826; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307; YANG XD, 1994, J BIOL CHEM, V269, P10252	48	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4497	4502		10.1074/jbc.270.9.4497	http://dx.doi.org/10.1074/jbc.270.9.4497			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876217	hybrid			2022-12-27	WOS:A1995QK08400050
J	MAROTO, M; ARREDONDO, JJ; SANROMAN, M; MARCO, R; CERVERA, M				MAROTO, M; ARREDONDO, JJ; SANROMAN, M; MARCO, R; CERVERA, M			ANALYSIS OF THE PARAMYOSIN MINIPARAMYOSIN GENE - MINIPARAMYOSIN IS AN INDEPENDENTLY TRANSCRIBED, DISTINCT PARAMYOSIN ISOFORM, WIDELY DISTRIBUTED IN INVERTEBRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; DROSOPHILA-MELANOGASTER PARAMYOSIN; THICK FILAMENT STRUCTURE; INSECT FLIGHT MUSCLE; BOX-BINDING PROTEINS; CAENORHABDITIS-ELEGANS; MULTIPLE PROTEINS; MYOD FAMILY; EXPRESSION; IDENTIFICATION	Miniparamyosin, a distinct Drosophila melanogaster paramyosin isoform of 60 kDa, is shown here to be encoded by the same gene as paramyosin. The gene, located at 66D14, spans over 12.8 kilobases (kb) and is organized into 10 exons, 9 of which code for the paramyosin transcripts, An exon, located between exons 7 and 8, codes for the 5'-end of the miniparamyosin, and the two proteins share the two last exons of the gene, Mapping of the 5'-ends of these transcripts indicates that the paramyosin and miniparamyosin mRNAs arise from two overlapping transcriptional units; the miniparamyosin transcription initiation site is located inside a paramyosin intron, 8 kb downstream of the one used for paramyosin transcription, The existence of two differ ent promoters and the conserved and nonconserved features of their sequences suggest a very complex regulation of these two muscle proteins, In fact, while paramyosin is expressed at two distinct stages of development as most other Drosophila muscle proteins, miniparamyosin appears late in development, being present only in the adult musculature, The absence of exon 1B, the specific exon of miniparamyosin, in the nematode Caenorhabditis elegans, as web as additional lines of evidence support the lack of miniparamyosin in this particular organism, However, it is present in most invertebrate species examined, including different arthropod, annelid, mollusc, and echinoderm species.	UNIV AUTONOMA MADRID, FAC MED, CSIC, DEPT BIOQUIM, E-28029 MADRID, SPAIN; UNIV AUTONOMA MADRID, FAC MED, CSIC, INST INVEST BIOMED, E-28029 MADRID, SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)			Arredondo, Juan/L-2404-2013	Arredondo, Juan/0000-0002-6784-0990				BANDMAN E, 1992, DEV BIOL, V154, P273, DOI 10.1016/0012-1606(92)90067-Q; BECKER KD, 1992, J CELL BIOL, V116, P669, DOI 10.1083/jcb.116.3.669; BEINBRECH G, 1985, CELL TISSUE RES, V241, P607; BERNSTEIN SI, 1986, MOL CELL BIOL, V6, P2511, DOI 10.1128/MCB.6.7.2511; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; BULLARD B, 1973, J MOL BIOL, V75, P359, DOI 10.1016/0022-2836(73)90026-0; BULLARD B, 1973, BIOCHEM J, V135, P277, DOI 10.1042/bj1350277; CASTELLANI L, 1992, J MUSCLE RES CELL M, V13, P174, DOI 10.1007/BF01874154; CHERBAS L, 1993, INSECT BIOCHEM MOLEC, V23, P81, DOI 10.1016/0965-1748(93)90085-7; COHEN CAROLYN, 1963, JOUR MOLECULAR BIOL, V6, P423; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; DEITIKER PR, 1993, J CELL BIOL, V123, P303, DOI 10.1083/jcb.123.2.303; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EPSTEIN HF, 1985, J CELL BIOL, V100, P904, DOI 10.1083/jcb.100.3.904; EPSTEIN HF, 1986, J CELL BIOL, V103, P985, DOI 10.1083/jcb.103.3.985; EPSTEIN HF, 1991, SCIENCE, V251, P1039, DOI 10.1126/science.1998120; EPSTEIN HF, 1988, J CELL BIOL, V106, P1985, DOI 10.1083/jcb.106.6.1985; EPSTEIN HF, 1992, DEV BIOL, V154, P231, DOI 10.1016/0012-1606(92)90064-N; FALKENTHAL S, 1987, DEV BIOL, V121, P263, DOI 10.1016/0012-1606(87)90158-8; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; FYRBERG E, 1990, TRENDS GENET, V6, P126, DOI 10.1016/0168-9525(90)90127-R; GENYOANDO K, 1991, J MOL BIOL, V219, P429; GIL I, 1987, NUCLEIC ACIDS RES, V15, P6007, DOI 10.1093/nar/15.15.6007; HANKE PD, 1988, MOL CELL BIOL, V8, P3591, DOI 10.1128/MCB.8.9.3591; HARLOW E, 1988, ANTIBODIES LABORATOR; HONDA S, 1990, P NATL ACAD SCI USA, V87, P876, DOI 10.1073/pnas.87.3.876; KAGAWA H, 1989, J MOL BIOL, V207, P311, DOI 10.1016/0022-2836(89)90257-X; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; MACKENZIE JM, 1980, CELL, V22, P747, DOI 10.1016/0092-8674(80)90551-6; MAROTO M, 1992, J MOL BIOL, V224, P287, DOI 10.1016/0022-2836(92)90994-U; MICHELSON AM, 1990, GENE DEV, V4, P2086, DOI 10.1101/gad.4.12a.2086; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; NGUYEN HT, 1994, IN PRESS P NATL ACAD; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PARKER VP, 1985, MOL CELL BIOL, V5, P3058, DOI 10.1128/MCB.5.11.3058; PATERSON BM, 1991, P NATL ACAD SCI USA, V88, P3782, DOI 10.1073/pnas.88.9.3782; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Sambrook J, 1989, MOL CLONING LABORATO; SANCHEZ F, 1983, J MOL BIOL, V163, P533, DOI 10.1016/0022-2836(83)90111-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Smith D.S., 1984, P111; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TRIEZENBERG SJ, 1993, CURRENT PROTOCOLS MO; VIGOREAUX JO, 1993, J CELL BIOL, V121, P587, DOI 10.1083/jcb.121.3.587; VINOS J, 1992, MOL GEN GENET, V231, P385, DOI 10.1007/BF00292707; VINOS J, 1991, J MOL BIOL, V220, P687, DOI 10.1016/0022-2836(91)90110-R; WATERSTON RH, 1977, J MOL BIOL, V117, P679, DOI 10.1016/0022-2836(77)90064-X	54	36	37	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4375	4382		10.1074/jbc.270.9.4375	http://dx.doi.org/10.1074/jbc.270.9.4375			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876201	hybrid			2022-12-27	WOS:A1995QK08400032
J	ROLL, JT; SHAH, VK; DEAN, DR; ROBERTS, GP				ROLL, JT; SHAH, VK; DEAN, DR; ROBERTS, GP			CHARACTERISTICS OF NIFNE IN AZOTOBACTER-VINELANDII STRAINS - IMPLICATIONS FOR THE SYNTHESIS OF THE IRON-MOLYBDENUM COFACTOR OF DINITROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; NITROGEN-FIXATION; GENETIC-ANALYSIS; STRUCTURAL GENE; PROTEIN; BIOSYNTHESIS; HOMOCITRATE; PRODUCTS; CLUSTER	The products of the nifN and nifE genes of Azotobacter vinelandii function as a 200-kDa alpha 2 beta 2 tetramer (NIFNE) in the synthesis of the iron-molybdenum cofactor (FeMo-co) of nitrogenase, the enzyme system required for biological nitrogen fixation. NIFNE was purified using a modification of the published protocol. Immunoblot analysis of anoxic native gels indicated that distinct forms of NIFNE accumulate in strains deficient in either NIFB (Delta nifB::kan Delta nifDK) or NIFH (Delta nifHDK). During the purification of NIFNE from the Delta nifHDK mutant, its mobility in these gels changed, becoming similar to that of NIFNE from the Delta nifB::kan Delta nifDK mutant. While NIFB activity initially co-purified with the NIFNE activity from the Delta nifHDK mutant, further purification of NIFNE activity resulted in the loss of the co-purifying NIFB activity; this loss correlated with the change in NIFNE mobility on native gels. These results suggest that the form of NIFNE accumulated in the Delta nifHDK mutant is associated with NIFB activity in crude extract but loses this association during NIFNE purification. Addition of the purified metabolic product of NIFB, termed NifB-co, to either NIFNE purified from the Delta nifHDK strain or to the NIFNE in crude extract of the Delta nif::kan Delta DK strain caused a change in the mobility of NIFNE on anoxic native gels to that of the form accumulated in a Delta nifHDK mutant. These results support a model where both NifB-co and dinitrogenase reductase participate in FeMo-co synthesis through NIFNE, which serves as a scaffold for this process.	UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53706; UNIV WISCONSIN,COLL AGR & LIFE SCI,CTR STUDIES NITROGEN FIXAT,MADISON,WI 53706; VIRGINIA POLYTECH INST & STATE UNIV,DEPT BIOCHEM & ANAEROB MICROBIOL,BLACKSBURG,VA 24061	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University	ROLL, JT (corresponding author), UNIV WISCONSIN,DEPT BACTERIOL,MADISON,WI 53706, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035332, R01GM035332] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35332] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RM, 1993, J BIOL CHEM, V268, P23670; BISHOP PE, 1986, SCIENCE, V232, P92, DOI 10.1126/science.232.4746.92; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; DEAN DR, 1985, P NATL ACAD SCI USA, V82, P5720, DOI 10.1073/pnas.82.17.5720; DOWNS DM, 1990, J BACTERIOL, V172, P6084, DOI 10.1128/jb.172.10.6084-6089.1990; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HARLOW E, 1988, ANTIBODIES LABORATOR, P574; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; HOOVER TR, 1987, NATURE, V329, P855, DOI 10.1038/329855a0; IMPERIAL J, 1984, J BACTERIOL, V158, P187, DOI 10.1128/JB.158.1.187-194.1984; IMPERIAL J, 1988, NITROGEN FIXATION 10, P128; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KIM S, 1993, J BIOL CHEM, V269, P4215; LJONES T, 1978, BIOCHEM BIOPH RES CO, V80, P22, DOI 10.1016/0006-291X(78)91098-7; MACNEIL T, 1978, J BACTERIOL, V136, P253, DOI 10.1128/JB.136.1.253-266.1978; MASEPOHL B, 1993, MOL GEN GENET, V238, P369, DOI 10.1007/BF00291996; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; PAUSTIAN TD, 1989, P NATL ACAD SCI USA, V86, P6082, DOI 10.1073/pnas.86.16.6082; RAWLINGS J, 1978, J BIOL CHEM, V253, P1001; ROBINSON AC, 1986, J BACTERIOL, V166, P180, DOI 10.1128/jb.166.1.180-186.1986; ROBINSON AC, 1989, J BIOL CHEM, V264, P10088; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; Shah V. K., 1988, Nitrogen fixation: Hundred years after. Proceedings of the 7th International Congress on Nitrogen Fixation, Koln (Cologne), FRG, March 13-20, 1988., P115; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1978, BIOCHEM BIOPH RES CO, V81, P232, DOI 10.1016/0006-291X(78)91654-6; SHAH VK, 1986, P NATL ACAD SCI USA, V83, P1636, DOI 10.1073/pnas.83.6.1636; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; UGALDE RA, 1985, J BACTERIOL, V164, P1081, DOI 10.1128/JB.164.3.1081-1087.1985; UGALDE RA, 1984, J BACTERIOL, V159, P888, DOI 10.1128/JB.159.3.888-893.1984; WHITE TC, 1992, J BIOL CHEM, V267, P24007	41	56	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4432	4437		10.1074/jbc.270.9.4432	http://dx.doi.org/10.1074/jbc.270.9.4432			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876209	hybrid			2022-12-27	WOS:A1995QK08400041
J	TRAUB, LM; KORNFELD, S; UNGEWICKELL, E				TRAUB, LM; KORNFELD, S; UNGEWICKELL, E			DIFFERENT DOMAINS OF THE AP-1 ADAPTER COMPLEX ARE REQUIRED FOR GOLGI MEMBRANE-BINDING AND CLATHRIN RECRUITMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; ASSEMBLY PROTEIN AP-2; COATED VESICLE ADAPTERS; FACTOR-II RECEPTOR; PLASMA-MEMBRANE; SUBUNIT; PITS; IDENTIFICATION; POLYPEPTIDES; PURIFICATION	The assembly of clathrin-coated buds on the Golgi requires the recruitment of the heterotetrameric AP-1 adaptor complex, which is dependent on both guanine nucleotides and the small GTP-binding protein ADP-ribosylation factor (ARF). Here, we have investigated the structural domains of the AP-1 complex necessary for ARF-mediated translocation of the adaptor complex onto Golgi membranes and the subsequent recruitment of clathrin onto the membrane. Controlled proteolysis of purified AP-1, derived from bovine adrenal coated vesicles, was used to generate AP-1 core fragments composed of the amino-terminal trunk regions of the beta 1 and gamma subunits and associated mu 1 and sigma 1 subunits, and lacking either the beta 1 subunit carboxyl-terminal appendage or both beta 1 and gamma subunit appendages. On addition of these truncated fragments to AP-1-depleted adrenal cytosol, both types of core fragments were efficiently recruited onto Golgi membranes in the presence of GTP gamma S. Recruitment of both core fragments was inhibited by the fungal metabolite brefeldin A, indicative of an ARF-dependent process, Limited tryptic digestion of recruited, intact cytosolic AP-1 resulted in the quantitative release of the globular carboxyl-terminal appendage domains of the beta 1 and gamma subunits. The adaptor core complex remained associated with the Golgi membranes. Recruitment of cytosolic clathrin onto the Golgi membranes was strictly dependent on the presence of intact AP-1. Tryptic removal of the beta 1 subunit appendage prevented subsequent clathrin recruitment. We conclude that the structural determinants required for the ARF-mediated binding of cytosolic AP-1 onto Golgi membranes are contained within the adaptor core, and that the carboxyl-terminal appendage domains of the beta 1 and gamma subunits do not play any role in this process. Subsequent recruitment of cytosolic clathrin, however, requires an intact beta 1 subunit.	WASHINGTON UNIV, SCH MED, DEPT MED, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, CTR IMMUNOL, DEPT PATHOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)				Traub, Linton/0000-0002-1303-0298	NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [CA 08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHLE S, 1989, J BIOL CHEM, V264, P20089; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BELTZER JP, 1991, EMBO J, V10, P3739; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HARLOW E, 1988, ANTIBODIES LABORATOR; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; HINDSHAW JE, 1994, MOL BIOL CELL, V5, P75; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KEEN JH, 1989, BIOCHEM BIOPH RES CO, V158, P17, DOI 10.1016/S0006-291X(89)80170-6; KEEN JH, 1991, J BIOL CHEM, V266, P7950; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; LEBORGNE R, 1993, J BIOL CHEM, V268, P22552; MAHAFFEY DT, 1990, J BIOL CHEM, V265, P16514; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; MOREMEN KW, 1986, J BIOL CHEM, V261, P945; Morris SA, 1989, CURR OPIN CELL BIOL, V1, P684, DOI 10.1016/0955-0674(89)90034-3; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PEELER JS, 1993, J CELL BIOL, V120, P47, DOI 10.1083/jcb.120.1.47; PONNAMBALAM S, 1990, J BIOL CHEM, V265, P4814; PRASAD K, 1991, BIOCHEMISTRY-US, V30, P5590, DOI 10.1021/bi00236a036; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHRODER S, 1991, J BIOL CHEM, V266, P7910; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; SOSA MA, 1993, J BIOL CHEM, V268, P12537; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; TAYLOR TC, 1994, MOL BIOL CELL, V5, P237, DOI 10.1091/mbc.5.2.237; TEAL SB, 1994, J BIOL CHEM, V269, P3135; TRAUB LM, 1991, J BIOL CHEM, V266, P24642; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; UNGEWICKELL E, 1994, EUR J BIOCHEM, V222, P33, DOI 10.1111/j.1432-1033.1994.tb18838.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; ZAREMBA S, 1985, J CELL BIOCHEM, V28, P47, DOI 10.1002/jcb.240280108	50	86	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4933	4942		10.1074/jbc.270.9.4933	http://dx.doi.org/10.1074/jbc.270.9.4933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876268	hybrid			2022-12-27	WOS:A1995QK08400106
J	KATAYAMA, E; SCOTTWOO, G; IKEBE, M				KATAYAMA, E; SCOTTWOO, G; IKEBE, M			EFFECT OF CALDESMON ON THE ASSEMBLY OF SMOOTH-MUSCLE MYOSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN GIZZARD MYOSIN; VERTEBRATE NON-MUSCLE; LIGHT CHAIN KINASE; CALMODULIN-BINDING; NONMUSCLE CALDESMON; HEAVY-MEROMYOSIN; ACTIN-FILAMENTS; ATPASE ACTIVITY; CROSS-LINKING; SIDE-POLAR	Smooth muscle myosin filaments are much less stable than the skeletal muscle counterpart. Smooth myosin requires higher concentration of Mg2+ than skeletal myosin to form thick filaments and addition of ATP disassembles the dephosphorylated smooth muscle myosin filaments into monomers but not phosphorylated ones. We found that the addition of caldesmon to dephosphorylated myosin induced the formation of the filaments under the conditions where myosin by itself is soluble or disassembled. Although the induced filaments mere short at 1 mM Mg2+, they became medium sized and seemed like side polar filaments with prominent 14 nm periodicity at higher Mg2+ conditions (8 mM). In the presence of F-actin, myosin filaments induced by caldesmon were associated along actin filaments to form large structures. The association of actin and myosin filaments was observed only in the presence of caldesmon, suggesting that caldesmon cross-linked actin and myosin filaments. This cross-linking was disrupted by the addition of calmodulin. Caldesmon-induced filament formation of dephosphorylated myosin in the presence of Mg2+-ATP may explain the existence of myosin filaments in relaxed smooth muscle fibers. A similar effect of telokin on myosin filament assembly was also examined and is discussed.	UNIV TOKYO,INST MED SCI,DEPT FINE MORPHOL,MINATO KU,TOKYO 108,JAPAN	University of Tokyo	KATAYAMA, E (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44118, USA.				NHLBI NIH HHS [HL37117] Funding Source: Medline; NIAMS NIH HHS [AR41653, AR38888] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL037117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041653, R01AR038888] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARTEGI A, 1990, J BIOL CHEM, V265, P15231; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; COOKE PH, 1989, J MUSCLE RES CELL M, V10, P206, DOI 10.1007/BF01739811; CRAIG R, 1977, J CELL BIOL, V75, P990, DOI 10.1083/jcb.75.3.990; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; DABROWSKA R, 1985, BIOCHIM BIOPHYS ACTA, V842, P70, DOI 10.1016/0304-4165(85)90295-8; DINGUS J, 1986, J CELL BIOL, V102, P1748, DOI 10.1083/jcb.102.5.1748; FUJII T, 1987, J BIOL CHEM, V262, P2757; FURST DO, 1986, EMBO J, V5, P251, DOI 10.1002/j.1460-2075.1986.tb04206.x; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GRACEFFA P, 1987, FEBS LETT, V218, P139, DOI 10.1016/0014-5793(87)81034-7; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; HEMRIC ME, 1990, J BIOL CHEM, V265, P2929; HUBER PAJ, 1993, J MUSCLE RES CELL M, V14, P385, DOI 10.1007/BF00121289; IKEBE M, 1977, J BIOCHEM-TOKYO, V82, P299, DOI 10.1093/oxfordjournals.jbchem.a131684; IKEBE M, 1983, BIOCHEMISTRY-US, V22, P4580, DOI 10.1021/bi00288a036; IKEBE M, 1985, J BIOL CHEM, V260, P3146; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; IKEBE M, 1988, J BIOL CHEM, V263, P3055; ITO M, 1989, J BIOL CHEM, V264, P13971; ITO T, 1989, NATURE, V338, P164; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P751, DOI 10.1093/oxfordjournals.jbchem.a122928; KATAYAMA E, 1989, BIOCHEM BIOPH RES CO, V160, P1316, DOI 10.1016/S0006-291X(89)80147-0; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P988, DOI 10.1093/oxfordjournals.jbchem.a122987; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSTON S, 1992, J MUSCLE RES CELL M, V13, P206, DOI 10.1007/BF01874158; MARSTON SB, 1991, BIOCHEM J, V279, P1; MARSTON SB, 1989, BIOCHEM J, V259, P303, DOI 10.1042/bj2590303; MORNET D, 1988, BIOCHEM BIOPH RES CO, V154, P564, DOI 10.1016/0006-291X(88)90177-5; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; Sellers JR, 1987, ENZYMES, V18, ppp381, DOI 10.1016/S1874-6047(08)60264-4; SHIRINSKY VP, 1993, J BIOL CHEM, V268, P16578; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SOMLYO AV, 1981, NATURE, V294, P567, DOI 10.1038/294567a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTHERLAND C, 1989, J BIOL CHEM, V264, P578; SUZUKI H, 1978, J BIOCHEM, V84, P1529, DOI 10.1093/oxfordjournals.jbchem.a132278; Trybus KM, 1991, CURR OPIN CELL BIOL, V3, P105, DOI 10.1016/0955-0674(91)90172-U; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TRYBUS KM, 1987, J CELL BIOL, V105, P3021, DOI 10.1083/jcb.105.6.3021; TSUKITA S, 1982, EUR J CELL BIOL, V28, P195; WANG CLA, 1991, J BIOL CHEM, V266, P9166; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0	50	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3919	3925		10.1074/jbc.270.8.3919	http://dx.doi.org/10.1074/jbc.270.8.3919			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876138	hybrid			2022-12-27	WOS:A1995QH68800069
J	MOSCOSO, M; DELSOLAR, G; ESPINOSA, M				MOSCOSO, M; DELSOLAR, G; ESPINOSA, M			SPECIFIC NICKING-CLOSING ACTIVITY OF THE INITIATOR OF REPLICATION PROTEIN REPB OF PLASMID PMV158 ON SUPERCOILED OR SINGLE-STRANDED-DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROLLING-CIRCLE REPLICATION; PT181 PLASMID; ORIGIN RECOGNITION; FUNCTIONAL ORIGIN; SEQUENCE MOTIFS; PLS1; ELEMENT; FAMILY; MOBILIZATION; NUCLEOTIDE	Asymmetric rolling circle replication of the promiscuous replicon pMV158 is initiated by the plasmid-encoded RepB protein. In vitro, purified RepB protein introduces a nick within the leading strand origin of replication by a nucleophylic attack on the phosphodiester bond at the dinucleotide GpA. Some changes within and around this dinucleotide were recognized by the protein. RepB nicked and closed supercoiled pMV158 DNA, having an optimum activity at 60 degrees C. We have imitated, in vitro, a process of rolling circle replication, since RepB was able to nick (initiation) and to covalently close (termination) single-stranded oligonucleotides containing the protein cleavage sequence. Covalent DNA-protein complexes were not found, indicating that RepB has unique features among plasmid-encoded proteins involved in rolling circle replication or conjugative mobilization.	CSIC, CTR INVEST BIOL, E-28006 MADRID, SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)			Espinosa, Manuel/M-5282-2019; del Solar, Gloria/K-2485-2014; del Solar, Gloria/ABD-2668-2020	del Solar, Gloria/0000-0002-7356-9164; del Solar, Gloria/0000-0002-7356-9164; Moscoso, Miriam/0000-0001-8977-3269				AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; BAAS PD, 1988, CURR TOP MICROBIOL, V136, P31; BOWATER R, 1991, BIOCHEMISTRY-US, V30, P11495, DOI 10.1021/bi00113a003; DELACAMPA AG, 1990, J MOL BIOL, V213, P247, DOI 10.1016/S0022-2836(05)80188-3; DELSOLAR G, 1987, MOL GEN GENET, V206, P428, DOI 10.1007/BF00428882; DELSOLAR G, 1992, MOL MICROBIOL, V6, P83; DELSOLAR G, 1993, MOL MICROBIOL, V8, P789; DELSOLAR G, 1993, MOL GEN GENET, V237, P65, DOI 10.1007/BF00282785; DELSOLAR GH, 1990, J BIOL CHEM, V265, P12569; DEMPSEY LA, 1992, J BIOL CHEM, V267, P24538; GRUSS A, 1989, MICROBIOL REV, V53, P231, DOI 10.1128/MMBR.53.2.231-241.1989; HIGASHITANI A, 1994, J MOL BIOL, V237, P388, DOI 10.1006/jmbi.1994.1242; HORIUCHI K, 1986, J MOL BIOL, V188, P215, DOI 10.1016/0022-2836(86)90306-2; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; KHAN SA, 1982, P NATL ACAD SCI-BIOL, V79, P4580, DOI 10.1073/pnas.79.15.4580; KOEPSEL RR, 1987, NUCLEIC ACIDS RES, V15, P4085, DOI 10.1093/nar/15.10.4085; KORNBERG A, 1992, DNA REPLICATION, P311; LANGEVELD SA, 1978, NATURE, V271, P417, DOI 10.1038/271417a0; LEHMAN IR, 1974, SCIENCE, V186, P790; MEYER TF, 1979, J BIOL CHEM, V254, P2642; NOIROT P, 1990, P NATL ACAD SCI USA, V87, P8560, DOI 10.1073/pnas.87.21.8560; NOVICK RP, 1989, ANNU REV MICROBIOL, V43, P537, DOI 10.1146/annurev.micro.43.1.537; PANSEGRAU W, 1990, J BIOL CHEM, V265, P10637; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; PANSEGRAU W, 1991, NUCLEIC ACIDS RES, V19, P3455, DOI 10.1093/nar/19.12.3455; PRIEBE SD, 1989, J BACTERIOL, V171, P4778, DOI 10.1128/jb.171.9.4778-4784.1989; PUYET A, 1988, NUCLEIC ACIDS RES, V16, P115, DOI 10.1093/nar/16.1.115; RASOOLY A, 1993, SCIENCE, V262, P1048, DOI 10.1126/science.8235621; RASOOLY A, 1994, J BACTERIOL, V176, P2450, DOI 10.1128/JB.176.8.2450-2453.1994; RIELE HT, 1986, EMBO J, V5, P631, DOI 10.1002/j.1460-2075.1986.tb04257.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHERZINGER E, 1992, NUCLEIC ACIDS RES, V20, P41, DOI 10.1093/nar/20.1.41; THOMAS CD, 1990, J BIOL CHEM, V265, P5519; VANMANSFELD ADM, 1980, NATURE, V288, P561, DOI 10.1038/288561a0; WANG PZ, 1992, J MOL BIOL, V223, P145, DOI 10.1016/0022-2836(92)90722-V; WANG PZ, 1993, EMBO J, V12, P45, DOI 10.1002/j.1460-2075.1993.tb05630.x; WATERS VL, 1993, MOL MICROBIOL, V9, P1123, DOI 10.1111/j.1365-2958.1993.tb01242.x	37	32	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3772	3779		10.1074/jbc.270.8.3772	http://dx.doi.org/10.1074/jbc.270.8.3772			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876118	hybrid, Green Submitted			2022-12-27	WOS:A1995QH68800048
J	ISOM, LL; SCHEUER, T; BROWNSTEIN, AB; RAGSDALE, DS; MURPHY, BJ; CATTERALL, WA				ISOM, LL; SCHEUER, T; BROWNSTEIN, AB; RAGSDALE, DS; MURPHY, BJ; CATTERALL, WA			FUNCTIONAL COEXPRESSION OF THE BETA-1 AND TYPE IIA ALPHA-SUBUNITS OF SODIUM-CHANNELS IN A MAMMALIAN-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RAT-BRAIN; XENOPUS-OOCYTES; MESSENGER-RNA; NA CHANNELS; CLONED CDNA; INACTIVATION	Brain sodium channels are a complex of alpha (260 kDa), beta 1 (36 kDa), and beta 2 (33 kDa) subunits, a subunits are functional as voltage-gated sodium channels by themselves. When expressed in Xenopus oocytes, beta 1 subunits accelerate the time course of sodium channel activation and inactivation by shifting them to a fast gating mode, but alpha subunits expressed alone in mammalian cells activate and inactivate rapidly without co-expression of beta 1 subunits. In these experiments, we show that the Chinese hamster cell lines CHO and 1610 do not express endogenous beta 1 subunits as determined by Northern blotting, immunoblotting, and assay for beta 1 subunit function by expression of cellular mRNA in Xenopus oocytes. alpha subunits expressed alone in stable lines of these cells activate and inactivate rapidly. Co-expression of beta 1 subunits increases the level of sodium channels 2- to 4-fold as determined hom saxitoxin binding, but does not affect the K-d for saxitoxin. Co-expression of beta 1 subunits also shifts the voltage dependence of sodium channel inactivation to more negative membrane potentials by 10 to 12 mV and shifts the voltage dependence of channel activation to more negative membrane potentials by 2 to 11 mV. These effects of beta 1 subunits on sodium channel function in mammalian cells may be physiologically important determinants of sodium channel function in vivo.			ISOM, LL (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SJ-30, SEATTLE, WA 98195 USA.			Isom, Lori/0000-0002-9479-6729				AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOUCET JP, 1990, ANAL BIOCHEM, V190, P209, DOI 10.1016/0003-2697(90)90182-9; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; Hille B., 1992, IONIC CHANNELS EXCIT; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; MAKITA N, 1994, J BIOL CHEM, V269, P7571; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; MCPHERSON GA, 1987, LIGAND EBDA; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NUMA S, 1989, HARVEY LECT, V83, P121; PATTON DE, 1994, J BIOL CHEM, V269, P17649; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; QU YS, 1994, P NATL ACAD SCI USA, V91, P3289, DOI 10.1073/pnas.91.8.3289; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIMMER JS, 1989, ANNU REV PHYSIOL, V51, P401, DOI 10.1146/annurev.physiol.51.1.401; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; YANG JS, 1993, NEURON, V11, P915, DOI 10.1016/0896-6273(93)90121-7; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	33	189	192	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3306	3312		10.1074/jbc.270.7.3306	http://dx.doi.org/10.1074/jbc.270.7.3306			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852416	hybrid			2022-12-27	WOS:A1995QG47100063
J	LEE, GY; HE, DY; YU, L; YU, CA				LEE, GY; HE, DY; YU, L; YU, CA			IDENTIFICATION OF THE UBIQUINONE-BINDING DOMAIN IN QPS1 OF SUCCINATE-UBIQUINONE REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-REDUCTASE; DEHYDROGENASE; COMPLEX; PROTEIN; HEART; RECONSTITUTION; OXIDOREDUCTASE	An azidoubiquinone derivative, 3-azido-2-methyl-5-methoxy[H-3]-6-decyl-1,4-benzoquinone ([H-3]azido-Q), was used to study the ubiquinone-protein interaction and to identify ubiquinone-binding proteins in bovine heart mitochondrial succinate-ubiquinone reductase, When the reductase was incubated with [H-3]azido-Q and illuminated with long wavelength UV light, the decrease in the enzymatic activity correlated with the amount of azido-Q incorporated into the protein. When the illuminated, [H-3]azido-Q-treated reductase was extracted with organic solvent and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, radioactivity was found primarily in the QPs1 subunit. The [H-3]azido-Q-labeled QPs1 was purified from labeled reductase by a procedure involving ammonium sulfate fractionation, dialysis, organic solvent extraction, lyophilization, preparative sodium dodecyl sulfate polyacrylamide gel electrophoresis, and cold acetone precipitation, The purified, [H-3]azido-Q-labeled QPs1 protein was subjected to reductive carboxymethylation prior to digestion by trypsin, One azido-Q-linked peptide, with a retention time of 66.9 min, was obtained by high performance liquid chromatographic separation, The partial amino-terminal sequence of this peptide is GLTISQL-, indicating that this tryptic peptide comprises amino acid residues 113-140 of the revised amino acid sequence of QPs1. The Q-binding domain, using the proposed structure of QPs1, is probably located in the stretch connecting transmembrane helices 2 and 3 that extrude from the surface of the M side of the inner membrane.			LEE, GY (corresponding author), OKLAHOMA STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, STILLWATER, OK 74078 USA.				NIGMS NIH HHS [GM30721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; ACKRELL BAC, 1980, J BIOL CHEM, V255, P2761; BIRCHMACHIN MA, 1992, J BIOL CHEM, V267, P11553; CAMMACK R, 1986, IRON SULFUR PROTEIN, P40; DAVIS KA, 1971, BIOCHEMISTRY-US, V10, P2509; DOYLE MP, 1989, J BIOL CHEM, V264, P1387; HATEFI Y, 1980, J BIOL CHEM, V255, P5530; HE DY, 1994, J BIOL CHEM, V269, P2292; HEDERSTEDT L, 1992, MOL MECHANISMS BIOEN, P163; JENNER ER, 1973, Patent No. 3737516; KEILIN D, 1958, NATURE, V181, P1520, DOI 10.1038/1811520a0; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; LEGENDRE N, 1993, PRACTICAL GUIDE PROT, P71; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; WEBER K, 1969, J BIOL CHEM, V244, P4406; XU Y, 1987, BIOCHEM BIOPH RES CO, V144, P315, DOI 10.1016/S0006-291X(87)80512-0; YAO Y, 1986, IRON SULFUR PROTEIN, P240; YU CA, 1980, BIOCHEMISTRY-US, V19, P3579, DOI 10.1021/bi00556a025; YU L, 1985, J BIOL CHEM, V260, P963; YU L, 1982, J BIOL CHEM, V257, P2016; YU L, 1987, J BIOL CHEM, V262, P1137; YU L, 1987, BIOCHEMISTRY-US, V26, P3658, DOI 10.1021/bi00386a060; YU L, 1992, J BIOL CHEM, V267, P24508	24	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6193	6198		10.1074/jbc.270.11.6193	http://dx.doi.org/10.1074/jbc.270.11.6193			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890754	hybrid			2022-12-27	WOS:A1995QM94500071
J	JONES, MJ; MURRAY, AW				JONES, MJ; MURRAY, AW			EVIDENCE THAT CERAMIDE SELECTIVELY INHIBITS PROTEIN-KINASE C-ALPHA TRANSLOCATION AND MODULATES BRADYKININ ACTIVATION OF PHOSPHOLIPASE-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN FIBROBLASTS; PROGRAMMED CELL-DEATH; LEUKEMIA HL-60 CELLS; SPHINGOID BASES; GROWTH-FACTOR; PHOSPHATIDYLCHOLINE; SPHINGOMYELINASE; DIACYLGLYCEROL; PHOSPHATIDYLINOSITOL; PROLIFERATION	Sphingomyelinase (SMase) treatment (0.1 unit/ml for up to 30 min) of mouse epidermal (HEL 37) or human skin fibroblast (SF 3155) cells preincubated with [H-3]serine to label the sphingomyelin pool caused the accumulation of labeled ceramide but not sphingosine or ceramide 1-phosphate. Incubation of HEL-37 cells with dioctanoylglycerol (diC(8)) or SF 3155 cells with bradykinin caused translocation of calcium/phosphatidylserine-dependent protein kinase C (PKC) activity to particulate material. In both cell lines the translocation was blocked by SMase treatment of the cells or by incubation with the cell-permeable ceramide analogue N-acetylsphingosine (C-2-Cer). Western blot analysis indicated that treatment of HEL-37 cells with diC(8) or SF 3155 cells with bradykinin resulted in the translocation of both PKC-alpha and PKC-epsilon to particulate material. Treatment with SMase or C-2-Cer specifically blocked the translocation of PKC-alpha but not that of PKC-epsilon. Pretreatment of cells with SMase or C-2-Cer also inhibited the activation of phospholipase D activity induced by either diC(8) (HEL-37 cells) or bradykinin (SF 3155 cells). The data provide strong evidence that ceramide can negatively regulate the translocation of PKC-alpha but not PKC-epsilon and further suggest that PKC-alpha may be involved in regulating phospholipase D activity.			JONES, MJ (corresponding author), FLINDERS UNIV S AUSTRALIA,FAC SCI & ENGN,SCH BIOL SCI,GPO BOX 2100,ADELAIDE,SA 5001,AUSTRALIA.							BALBOA MA, 1994, J BIOL CHEM, V269, P10511; BALLOU LR, 1992, IMMUNOL TODAY, V13, P339, DOI 10.1016/0167-5699(92)90167-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAWSON RMC, 1967, BIOCHEM J, V102, P205, DOI 10.1042/bj1020205; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FU T, 1989, BIOCHEM BIOPH RES CO, V162, P1279, DOI 10.1016/0006-291X(89)90812-7; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; GODSON C, 1990, J BIOL CHEM, V265, P8369; GOLDKORN T, 1991, J BIOL CHEM, V266, P16092; HA KS, 1993, J BIOL CHEM, V268, P10534; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; IWATA M, 1994, INT IMMUNOL, V6, P431, DOI 10.1093/intimm/6.3.431; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KOLESNICK RN, 1988, J BIOL CHEM, V263, P6534; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; LEACH KL, 1991, J BIOL CHEM, V266, P3215; LISCOVITCH M, 1989, J BIOL CHEM, V264, P1450; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MERRILL AH, 1992, NUTR REV, V50, P78; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MURRAY AW, 1979, BIOCHEM BIOPH RES CO, V91, P395, DOI 10.1016/0006-291X(79)91535-3; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; RAINES MA, 1993, J BIOL CHEM, V268, P14572; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; TAPLEY PM, 1984, BIOCHEM BIOPH RES CO, V118, P835, DOI 10.1016/0006-291X(84)91470-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANBLITTERSWIJK WJ, 1991, J BIOL CHEM, V266, P10344; VANBLITTERSWIJK WJ, 1991, J BIOL CHEM, V266, P10337; VANNAM RR, 1979, BIOCHIM BIOPHYS ACTA, V573, P73; YANG SF, 1967, J BIOL CHEM, V242, P477; YOUNES A, 1992, J BIOL CHEM, V267, P842	45	146	147	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5007	5013		10.1074/jbc.270.10.5007	http://dx.doi.org/10.1074/jbc.270.10.5007			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890607	hybrid			2022-12-27	WOS:A1995QL58000012
J	KATZ, RW; SUBAUSTE, JS; KOENIG, RJ				KATZ, RW; SUBAUSTE, JS; KOENIG, RJ			THE INTERPLAY OF HALF-SITE SEQUENCE AND SPACING ON THE ACTIVITY OF DIRECT REPEAT THYROID-HORMONE RESPONSE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; VITAMIN-D RECEPTOR; DNA-BINDING; NUCLEAR RECEPTORS; AUXILIARY PROTEIN; HIGH-AFFINITY; X-RECEPTORS; PROMOTER; GENE; IDENTIFICATION	Direct repeats of the hexamer AGGTCA can serve as response elements for vitamin D, thyroid hormone, or retinoic acid. The specificity of the response appears to reside in the spacing between the hexamers, with response elements for vitamin D restricted to direct repeats separated by a 3-base pair (bp) spacer, thyroid hormone a 4-bp spacer, and retinoic acid a 5-bp spacer (3-4-5 rule). Recently we have shown that the optimum thyroid hormone receptor binding site consists of an 8-bp sequence (TAAGGTCA), not a hexamer. Therefore we tested whether the 3-4-5 rule is valid for octamer sequence direct repeats. In transfection experiments octamer direct repeats with 3-, 4-, or 5-bp spacers conferred equivalently strong thyroid hormone responses, although a repeat with a 9-bp spacer was substantially weaker. For the 4 and 5-bp spacer constructs, the 5' half-site octamer had as strong an influence on thyroid hormone induction as did the 3' half-site octamer, although for the 3-bp spacer construct the 5' octamer was marginally less potent than the 3' octamer. Transfection and gel shift experiments did not suggest a simple correlation between the binding of thyroid hormone receptor-retinoid X receptor heterodimers and thyroid hormone induction from these response elements. We conclude that half site sequence can override the effect of spacing in determining the hormone responsiveness of a direct repeat response element. In addition, the thyroid hormone response may not be due simply to the binding of thyroid hormone receptor-retinoid X receptor heterodimers to the DNA.			KATZ, RW (corresponding author), UNIV MICHIGAN,MED CTR,5560 MSRB II,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044155] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE00301] Funding Source: Medline; NIDDK NIH HHS [DK44155] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FREEDMAN LP, 1994, MOL ENDOCRINOL, V8, P265, DOI 10.1210/me.8.3.265; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KATZ RW, 1994, J BIOL CHEM, V269, P18915; KATZ RW, 1994, J BIOL CHEM, V269, P9500; KIM HS, 1992, MOL ENDOCRINOL, V6, P1489, DOI 10.1210/me.6.9.1489; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MADER S, 1993, J BIOL CHEM, V268, P591; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; MOORE DD, 1986, GENE AMST, V45, P107; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NISHIKAWA J, 1993, J BIOL CHEM, V268, P19739; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PROST E, 1988, NUCLEIC ACIDS RES, V16, P6248, DOI 10.1093/nar/16.13.6248; SCHRADER M, 1994, J BIOL CHEM, V269, P5501; SCHRADER M, 1994, J BIOL CHEM, V268, P6444; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SUBAUSTE JS, 1994, J BIOL CHEM, V269, P30232; SUGAWARA A, 1993, ENDOCRINOLOGY, V133, P965, DOI 10.1210/en.133.3.965; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WILLIAMS GR, 1991, J BIOL CHEM, V266, P19636; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	40	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5238	5242		10.1074/jbc.270.10.5238	http://dx.doi.org/10.1074/jbc.270.10.5238			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890633	hybrid			2022-12-27	WOS:A1995QL58000045
J	LOIDA, PJ; SLIGAR, SG; PAULSEN, MD; ARNOLD, GE; ORNSTEIN, RL				LOIDA, PJ; SLIGAR, SG; PAULSEN, MD; ARNOLD, GE; ORNSTEIN, RL			STEREOSELECTIVE HYDROXYLATION OF NORCAMPHOR BY CYTOCHROME P450(CAM) - EXPERIMENTAL-VERIFICATION OF MOLECULAR-DYNAMICS SIMULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTHETIC HEME ALKYLATION; ACTIVE-SITE; PRODUCT SPECIFICITY; SUBSTRATE MOBILITY; CRYSTAL-STRUCTURE; SPIN EQUILIBRIUM; AMINO-ACID; PROTEIN; CAMPHOR; REGIOSPECIFICITY	The stereoselectivity of cytochrome P450(cam) hydroxylation has been investigated with the enantiomerically pure substrate analog norcamphor, (1R)- and (1S)-norcamphor (>92 enantiomeric excess) were characterized in the hydroxylation reaction with cytochrome P450(cam) with respect to the product profile, steady state kinetics, coupling efficiency, and free energy of substrate dissociation. The experimental results demonstrate regiospecificity that is enantiomer-specific and confirm our previously reported prediction that (1R)-norcamphor is hydroxylated preferentially at the 5-carbon and (1S) norcamphor at the 6 carbon (Bass, M. B., and Ornstein, R, L, (1993) J. Comput. Chem, 14, 541-548); these simulation results are now compared with simulations involving a ferryl oxygen intermediate. Hydroxylation of (1R)-norcamphor was found at the 5, 6-, and S-carbons in a ratio of 65:30:5 (respectively), whereas (1S)-norcamphor was oxidized to produce a 28:62:10 ratio of the same products. With the exception of the re giospecificity, all of the reaction and physical parameters are similar for each enantiomer of norcamphor. These results show that the position of the carbonyl group on the hydrocarbon skeleton of norcamphor plays a role in determining the average orientation of this substrate in the active site and suggests that hydrogen bonding interactions can aid in directing the regiospecificity and stereospecificity of the hydroxylation reaction catalyzed by cytochrome P450(cam).	UNIV ILLINOIS, SCH CHEM SCI, URBANA, IL 61801 USA; UNIV ILLINOIS, BECKMAN INST ADV SCI & TECHNOL, URBANA, IL 61801 USA; PACIFIC NW LAB, ENVIRONM MOLEC SCI LAB, RICHLAND, WA 99352 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Pacific Northwest National Laboratory					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033775] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 33775] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA T, 1989, J BIOL CHEM, V264, P21327; ATKINS WM, 1987, J AM CHEM SOC, V109, P3754, DOI 10.1021/ja00246a038; ATKINS WM, 1988, BIOCHEMISTRY-US, V27, P1610, DOI 10.1021/bi00405a033; ATKINS WM, 1989, J AM CHEM SOC, V111, P2715, DOI 10.1021/ja00189a057; ATKINS WM, 1988, J BIOL CHEM, V263, P18842; BASS MB, 1993, J COMPUT CHEM, V14, P541, DOI 10.1002/jcc.540140506; BASS MB, 1992, PROTEINS, V13, P26, DOI 10.1002/prot.340130103; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLACK SD, 1987, ADV ENZYMOL RAMB, V60, P35; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; COLLINS JR, 1991, J AM CHEM SOC, V113, P2736, DOI 10.1021/ja00007a057; COLLINS JR, 1988, J BIOL CHEM, V263, P3164; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DAVIES MD, 1990, J AM CHEM SOC, V112, P7396, DOI 10.1021/ja00176a050; FASCO MJ, 1977, ARCH BIOCHEM BIOPHYS, V182, P379, DOI 10.1016/0003-9861(77)90518-5; FILIPOVIC D, 1992, BIOCHEM BIOPH RES CO, V189, P488, DOI 10.1016/0006-291X(92)91584-D; FISHER MT, 1987, BIOCHEMISTRY-US, V26, P4797, DOI 10.1021/bi00389a029; FRUETEL JA, 1992, J AM CHEM SOC, V114, P6987, DOI 10.1021/ja00044a006; GELB MH, 1982, BIOCHEMISTRY-US, V21, P370, DOI 10.1021/bi00531a026; GELB MH, 1982, BIOCHEM BIOPH RES CO, V104, P853, DOI 10.1016/0006-291X(82)91327-4; GOTOH O, 1992, J BIOL CHEM, V267, P83; GOULD PV, 1981, J BIOL CHEM, V256, P6686; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; GUENGERICH FP, 1992, LIFE SCI, V50, P1471; GUENGERICH FP, 1990, FASEB J, V4, P2453, DOI 10.1096/fasebj.4.8.2185971; Gunsalus I. C., 1973, OXIDASES RELATED RED, P583; HAGLER AT, 1985, PEPTIDES, P213; HEWICK DS, 1970, BIOCHEM J, V117, P833, DOI 10.1042/bj1170833; HSE MH, 1993, J BIOL CHEM, V268, P6939; JONES JP, 1993, J AM CHEM SOC, V115, P381, DOI 10.1021/ja00055a002; KUNZE KL, 1983, J BIOL CHEM, V258, P4202; LOIDA PJ, 1993, PROTEIN ENG, V6, P207, DOI 10.1093/protein/6.2.207; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; MARTINIS SA, 1990, THEIS U ILLINOIS; MARYNIAK DM, 1993, TETRAHEDRON, V49, P9373, DOI 10.1016/0040-4020(93)80022-L; OGURI K, 1994, ANNU REV PHARMACOL, V34, P251; Ortiz de Montellano PR, 1986, CYTOCHROME P450 STRU, P217; PAULSEN MD, 1993, PROTEIN ENG, V6, P359, DOI 10.1093/protein/6.4.359; PAULSEN MD, 1992, J COMPUT AID MOL DES, V6, P449, DOI 10.1007/BF00130396; PAULSEN MD, 1991, PROTEINS, V11, P184, DOI 10.1002/prot.340110304; PAULSEN MD, 1991, J BIOMOL STRUCT DYN, V9, P187, DOI 10.1080/07391102.1991.10507906; PAULSEN MD, 1995, J COMPUT AID MOL DES, V8, P389; POULOS TL, 1988, PHARMACEUT RES, V5, P67, DOI 10.1023/A:1015920931701; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; SLIGAR SG, 1986, CYTOCHROME P450 STRU, P429; SLIGAR SG, 1982, MICROSOMES DRUG OXID, P155; TUCK SF, 1993, J BIOL CHEM, V268, P269; WHITE PW, 1990, BIOORG CHEM, V18, P440, DOI 10.1016/0045-2068(90)90027-3; WHITE RE, 1984, ARCH BIOCHEM BIOPHYS, V228, P493, DOI 10.1016/0003-9861(84)90015-8; WHITE RE, 1991, PHARMACOL THERAPEUT, V49, P21, DOI 10.1016/0163-7258(91)90020-M	53	43	43	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5326	5330		10.1074/jbc.270.10.5326	http://dx.doi.org/10.1074/jbc.270.10.5326			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890644	hybrid			2022-12-27	WOS:A1995QL58000058
J	DANAIE, P; WITTMER, B; ALTMANN, M; TRACHSEL, H				DANAIE, P; WITTMER, B; ALTMANN, M; TRACHSEL, H			ISOLATION OF A PROTEIN COMPLEX CONTAINING TRANSLATION INITIATION-FACTOR PRT1 FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE GELS; YEAST; TEMPERATURE; REGULATORS; GENES; GCN4	Translation initiation factor Prt1 was purified from a ribosomal salt wash fraction of Saccharomyces cerevisiae cells by ammonium sulfate precipitation, DEAE chromatography, phosphocellulose chromatography, sucrose density gradient centrifugation, and non-denaturing polyacrylamide gel electrophoresis. Prt1 protein cofractionates with four other polypeptides during all steps of purification suggesting that it is part of a protein complex containing polypeptide subunits with apparent molecular masses of 130, 80, 75 (Prt1), 40, and 32 kDa. Deletion of the first AUG codon in the published sequence of the PRT1 gene results in the synthesis of functional Prt1 protein indicating that the actual molecular mass of the Prt1 subunit is 82.7 kDa. This is in agreement with results from primer extension experiments reported earlier by Keierleber ct al, (Keierleber, C., Wittekind, M., Qin, S., and McLaughlin, C. S. (1986) Mol. Cell. Biol. 6, 4419-4424). The Prt1-containing protein complex is an active translation factor as shown by its ability to restore translation in a cell-free system derived from a temperature sensitive prt1 mutant strain in which endogenous Prt1 activity is inactivated by heating the extract to 37 degrees C. The question of whether the Prt1-containing protein complex represents the yeast homologue of mammalian translation initiation factor eIF-3 is discussed.	UNIV BERN,INST BIOCHEM & MOLEC BIOL,CH-3012 BERN,SWITZERLAND	University of Bern								ACHSTETTER T, 1984, J BIOL CHEM, V259, P3334; ALTMANN M, 1985, BIOCHEMISTRY-US, V24, P6085, DOI 10.1021/bi00343a009; ALTMANN M, 1989, J BIOL CHEM, V264, P12145; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; CIGAN AM, 1993, P NATL ACAD SCI USA, V90, P5350, DOI 10.1073/pnas.90.11.5350; FEINBERG B, 1982, J BIOL CHEM, V257, P846; FENG L, 1993, TRANSLATIONAL REGULA, V2, P69; GASIOR E, 1979, J BIOL CHEM, V254, P3965; HANICJOYCE PJ, 1987, J BIOL CHEM, V262, P2845; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HINNEBUSCH AG, 1993, TRANSLATIONAL REGULA, V2, P87; KEIERLEBER C, 1986, MOL CELL BIOL, V6, P4419, DOI 10.1128/MCB.6.12.4419; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LINDER P, 1992, ANTON LEEUW INT J G, V62, P47, DOI 10.1007/BF00584462; MANDEL T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P80, DOI 10.1016/0167-4781(89)90133-4; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MOLDAVE K, 1988, NATO ASI SER, V14, P271; MULLER PP, 1990, EUR J BIOCHEM, V191, P257, DOI 10.1111/j.1432-1033.1990.tb19118.x; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8; Tuite M F, 1986, Yeast, V2, P35, DOI 10.1002/yea.320020103; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	27	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4288	4292		10.1074/jbc.270.9.4288	http://dx.doi.org/10.1074/jbc.270.9.4288			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876188	hybrid			2022-12-27	WOS:A1995QK08400019
J	LU, G; KOCHOUMIAN, L; KING, TP				LU, G; KOCHOUMIAN, L; KING, TP			SEQUENCE IDENTITY AND ANTIGENIC CROSS-REACTIVITY OF WHITE FACE HORNET VENOM ALLERGEN, ALSO A HYALURONIDASE, WITH OTHER PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM SURFACE PROTEIN; YELLOW JACKET VENOM; MOLECULAR-STRUCTURE; HYMENOPTERA VENOM; CDNA CLONING; BEE VENOM; T-CELL; SIMILARITY; MELITTIN; GENE	White face hornet (Dolichovespula maculata) venom has three known protein allergens which induce IgE response in susceptible people, They are antigen 5, phospholipase A(1), and hyaluronidase, also known as Dol m 5, 1, and 2, respectively, We have cloned Dol m 2, a protein of 331 residues, When expressed in bacteria, a mixture of recombinant Dol m 2 and its fragments was obtained, The fragments were apparently generated by proteolysis of a Met-Met bond at residue 122, as they were not observed for a Dol m 2 mutant with a Leu-Met bond. Dol m 2 has 56% sequence identity with the honey bee venom allergen hyaluronidase and 27% identity with PH-20, a human sperm protein with hyaluronidase activity, A common feature of hornet venom allergens is their sequence identity with other proteins in our environment, We showed previously the sequence identity of Dol m 5 with a plant protein and a mammalian testis protein and of Dol m 1 with mammalian lipases. In BALB/c mice, Dol m 2 and bee hyaluronidase showed cross-reactivity at both antibody and T cell levels, These findings are relevant to some patients' multiple sensitivity to hornet and bee stings.			LU, G (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017021] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-17021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRINER TJ, 1993, P NATL ACAD SCI USA, V90, P7608, DOI 10.1073/pnas.90.16.7608; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; CLARK MA, 1987, J BIOL CHEM, V262, P4402; DEVRIES JE, 1994, ALLERGY CLIN IMMUNOL, V6, P49; DORFMAN A, 1955, METHOD ENZYMOL, V1, P166, DOI 10.1016/0076-6879(55)01023-9; FANG KSY, 1988, P NATL ACAD SCI USA, V85, P895, DOI 10.1073/pnas.85.3.895; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROHMAN MA, 1990, AMPLIFICATIONS, V5, P11; GEFTER ML, 1992, CURRENT THERAPY ALLE, P376; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; GMACHL M, 1993, FEBS LETT, V336, P545, DOI 10.1016/0014-5793(93)80873-S; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMAN DR, 1984, ANN ALLERGY, V52, P276; HOFFMAN DR, 1984, J ALLERGY CLIN IMMUN, V74, P93, DOI 10.1016/0091-6749(84)90094-0; HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V91, P187; HOYNE GF, 1993, J EXP MED, V178, P1783, DOI 10.1084/jem.178.5.1783; KAETZEL MA, 1987, J BIOL CHEM, V262, P3726; KING TP, 1985, J ALLERGY CLIN IMMUN, V75, P621, DOI 10.1016/0091-6749(85)90040-5; KING TP, 1978, BIOCHEMISTRY-US, V17, P5165, DOI 10.1021/bi00617a016; KING TP, 1984, ARCH BIOCHEM BIOPHYS, V230, P1, DOI 10.1016/0003-9861(84)90080-8; KING TP, 1976, ARCH BIOCHEM BIOPHYS, V172, P661, DOI 10.1016/0003-9861(76)90121-1; KING TP, 1995, J IMMUNOL, V154, P577; KING TP, 1994, WHO B, V72, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAINE RO, 1989, J IMMUNOL, V143, P553; LATHROP WF, 1990, J CELL BIOL, V111, P2939, DOI 10.1083/jcb.111.6.2939; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LIN Y, 1993, P NATL ACAD SCI USA, V90, P10071, DOI 10.1073/pnas.90.21.10071; LU G, 1993, J IMMUNOL, V150, P2823; MIZUKI N, 1992, MAMM GENOME, V3, P274, DOI 10.1007/BF00292155; NORMAN PS, 1993, CURR OPIN IMMUNOL, V5, P968, DOI 10.1016/0952-7915(93)90114-8; REISMAN RE, 1994, NEW ENGL J MED, V331, P523, DOI 10.1056/NEJM199408253310808; SOLDATOVA L, 1993, J ALLERGY CLIN IMMUN, V91, P283; SOLDATOVA L, 1993, FEBS LETT, V320, P145, DOI 10.1016/0014-5793(93)80080-E; VERHEIJ HM, 1983, BIOCHIM BIOPHYS ACTA, V747, P93, DOI 10.1016/0167-4838(83)90126-7; WYPCH J, 1989, INT ARCH ALLER A IMM, V89, P60	40	69	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4457	4465		10.1074/jbc.270.9.4457	http://dx.doi.org/10.1074/jbc.270.9.4457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876212	hybrid			2022-12-27	WOS:A1995QK08400044
J	ODERMATT, A; SOLIOZ, M				ODERMATT, A; SOLIOZ, M			2 TRANS-ACTING METALLOREGULATORY PROTEINS CONTROLLING EXPRESSION OF THE COPPER-ATPASES OF ENTEROCOCCUS-HIRAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSON DISEASE GENE; CANDIDATE GENE; MENKES DISEASE; BACILLUS-LICHENIFORMIS; TRANSCRIPTION FACTOR; TRANSPORTING ATPASE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; BINDING-PROTEIN; RESISTANCE	Enterococcus hirae possesses two P-type ATPases, CopA and CopB, that are involved in copper homeostasis. These enzymes are induced by extracellular copper concentrations that are either tao low or too high for optimal growth, To identify the regulatory proteins involved in induction, the DNA upstream of copA was cloned and sequenced. Following a putative promoter region, it contains two genes, copY and copZ, that encode proteins of 145 and 69 amino acids, respectively. Both proteins contain metal binding motifs and exhibit significant sequence similarity to known regulatory proteins, Gene disruption of CopY by reverse genetics caused constitutive overexpression of CopA and CopB, generating a copper-dependent phenotype, In contrast, disruption of copZ suppressed the expression of the two copper-ATPases, rendering the cells copper-sensitive. Both null mutations could be complemented in trans with plasmids bearing copY or copZ. Thus, copY and copZ encode trans acting metalloregulatory proteins that are required for induction of the cop operon by copper. In this mechanism, CopY apparently acts as a metal-fist type repressor and CopZ as an activator.	UNIV BERN,DEPT CLIN PHARMACOL,CH-3010 BERN,SWITZERLAND	University of Bern			Solioz, Marc/I-3162-2013	Solioz, Marc/0000-0002-7989-6721; Odermatt, Alex/0000-0002-6820-2712				ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DODD IB, 1987, J MOL BIOL, V194, P557, DOI 10.1016/0022-2836(87)90681-4; FURST P, 1989, P NATL ACAD SCI USA, V86, P5267, DOI 10.1073/pnas.86.14.5267; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; HIMENO T, 1986, J BACTERIOL, V168, P1128, DOI 10.1128/jb.168.3.1128-1132.1986; INOUE C, 1989, GENE, V84, P47, DOI 10.1016/0378-1119(89)90138-8; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; Maniatis T., 1982, MOL CLONING; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MILLS SD, 1994, MOL GEN GENET, V244, P341, DOI 10.1007/BF00286685; MILLS SD, 1993, J BACTERIOL, V175, P1656, DOI 10.1128/JB.175.6.1656-1664.1993; MISRA TK, 1984, P NATL ACAD SCI USA, V81, P5974; NUCIFORA G, 1989, J BACTERIOL, V171, P4241, DOI 10.1128/JB.171.8.4241-4247.1989; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; ODERMATT A, 1992, ANN NY ACAD SCI, V671, P484, DOI 10.1111/j.1749-6632.1992.tb43836.x; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVER S, 1993, CHEM COPPER ZINC TRI; SOLIOZ M, 1994, FEBS LETT, V346, P44, DOI 10.1016/0014-5793(94)00316-5; SOLIOZ M, 1990, BIOCHIMIE, V72, P279, DOI 10.1016/0300-9084(90)90084-T; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WITTMAN V, 1988, J BACTERIOL, V170, P3206, DOI 10.1128/jb.170.7.3206-3212.1988; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; ZHOU PB, 1991, P NATL ACAD SCI USA, V88, P6112, DOI 10.1073/pnas.88.14.6112	36	134	140	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4349	4354		10.1074/jbc.270.9.4349	http://dx.doi.org/10.1074/jbc.270.9.4349			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876197	hybrid			2022-12-27	WOS:A1995QK08400028
J	OKAMOTO, T; TAKEDA, S; MURAYAMA, Y; OGATA, E; NISHIMOTO, I				OKAMOTO, T; TAKEDA, S; MURAYAMA, Y; OGATA, E; NISHIMOTO, I			LIGAND-DEPENDENT G-PROTEIN COUPLING FUNCTION OF AMYLOID TRANSMEMBRANE PRECURSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FAMILIAL ALZHEIMERS-DISEASE; NUCLEOTIDE-BINDING PROTEINS; ISLET-ACTIVATING PROTEIN; GROWTH-FACTOR; REGULATORY COMPONENT; SIGNAL-TRANSDUCTION; MISSENSE MUTATION; ADENYLYL CYCLASE; HORMONE RECEPTOR; PERTUSSIS TOXIN	Amyloid precursor protein (APP), a transmembrane precursor of beta-amyloid, possesses a function whereby it associates with G(o) through its cytoplasmic His(657)- Lys(676). Here we demonstrate that APP has a receptor function. In phospholipid vesicles consisting of baculovirally made APP(695) and brain trimeric G(o), 22C11, a monoclonal antibody against the extracellular domain of APP, increased GTP gamma S binding and the turnover number of GTPase of G(o) without affecting its intrinsic GTPase activity. This effect of 22C11 was specific among various antibodies and was observed neither in G(o) vesicles nor in APP(695)/G(i2) vesicles. In APP(695)/G(o) vesicles, synthetic APP(66-81), the epitope of 22C11, competitively antagonized the action of 22C11. Monoclonal antibody against APP(657-676), the G(o) binding domain of APP(695), specifically blocked 22C11-dependent activation of G(o). Therefore, APP has a potential receptor function whereby it specifically activates G(o) in a ligand-dependent and ligand-specific manner.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02129; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,BUNKYO KU,TOKYO 112,JAPAN; CANC RES INST,TOSHIMA KU,TOKYO 170,JAPAN	Harvard University; Harvard Medical School; University of Tokyo	OKAMOTO, T (corresponding author), MASSACHUSETTS GEN HOSP E,CARDIOVASC RES CTR,149 13TH ST,BOSTON,MA 02129, USA.							BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BODMER S, 1990, BIOCHEM BIOPH RES CO, V171, P890, DOI 10.1016/0006-291X(90)91229-L; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHEN M, 1991, NEUROSCI LETT, V125, P223, DOI 10.1016/0304-3940(91)90034-Q; COWBURN RF, 1992, J NEUROCHEM, V58, P1409, DOI 10.1111/j.1471-4159.1992.tb11357.x; COWBURN RF, 1993, NEUROSCI LETT, V155, P163, DOI 10.1016/0304-3940(93)90698-K; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; FLYNN DD, 1991, ANN NEUROL, V29, P256, DOI 10.1002/ana.410290305; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GIBSON GE, 1992, MECH AGEING DEV, V63, P1, DOI 10.1016/0047-6374(92)90012-3; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HILBICH C, 1993, J BIOL CHEM, V268, P26571; HUANG HM, 1993, J BIOL CHEM, V268, P14616; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; IYENGAR R, 1982, P NATL ACAD SCI-BIOL, V79, P5179, DOI 10.1073/pnas.79.17.5179; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KARLINSKY H, 1992, NEUROLOGY, V42, P1445, DOI 10.1212/WNL.42.8.1445; KATADA T, 1986, J BIOL CHEM, V261, P8182; KATADA T, 1987, FEBS LETT, V213, P353, DOI 10.1016/0014-5793(87)81521-1; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; KNOPS J, 1991, J BIOL CHEM, V266, P7285; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MOIR RD, 1992, J NEUROCHEM, V59, P1490, DOI 10.1111/j.1471-4159.1992.tb08465.x; MONNING U, 1992, J BIOL CHEM, V267, P23950; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SMITH CJ, 1989, BIOCHEM SOC T, V17, P202, DOI 10.1042/bst0170202; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; UEDA K, 1989, ANN NEUROL, V25, P246, DOI 10.1002/ana.410250307; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	49	149	154	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4205	4208		10.1074/jbc.270.9.4205	http://dx.doi.org/10.1074/jbc.270.9.4205			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876177	hybrid			2022-12-27	WOS:A1995QK08400007
J	ROS, R; ROMIEU, C; GIBRAT, R; GRIGNON, C				ROS, R; ROMIEU, C; GIBRAT, R; GRIGNON, C			THE PLANT INORGANIC PYROPHOSPHATASE DOES NOT TRANSPORT K+ IN VACUOLE MEMBRANE-VESICLES MULTILABELED WITH FLUORESCENT-PROBES FOR H+,K+, AND MEMBRANE-POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TONOPLAST VESICLES; PROTON TRANSPORT; ANION TRANSPORT; OAT ROOTS; PUMPING PYROPHOSPHATASE; H+; POTASSIUM; ACTIVATION; CELLS	It has been claimed that the inorganic pyrophosphatase (PPase) of the plant vacuolar membrane transports K+ in addition to H+ in intact vacuoles (Davies, J. M., Poole, R. J., Rea, P. A., and Sanders, D. (1992) Proc. Natl. Acad. Sci. U. S. A, 89, 11701-11705). Since this was not confirmed using the purified and reconstituted PPase consisting of a 75-kDa polypeptide (Sate, M, H,, Kasahara, M., Ishii, N., Homareda, H., Matsui, H., and Yoshida, M. (1994) J. Biol. Chem. 269, 6725-6728), these authors proposed that K+ transport by the PPase is dependent on its association with other membrane components lost during purification. We have examined the hypothesis of K+ translocation by the PPase using native vacuolar membrane vesicles from Vitis vinifera suspension cells, multilabeled with fluorescent probes for K+, H+, and membrane potential. This material con contained a high proportion of right-side-out, tightly sealed vesicles, exhibiting high PPase activity which was strongly stimulated by uncouplers and K+. Proton pumping occurred in response to pyrophosphate addition in the absence of K+. No K+ incorporation into the vesicles could be observed after PPase energization in the presence of K+, although H+ transport was highly stimulated. The hydrolytic activity was stimulated by a protonophore and by a H+/B+ exchanger but not by the K+ ionophore valinomycin. No evidence could be obtained supporting the operation of an endogenous K+/H+ exchanger capable to dissipate the putative active K+ flux generated by the PPase, We conclude that PPase in native vacuolar membrane vesicles does not transport K+.	INRA,ENSA M,INST PROD VIGNE,CNRS,URA 573,F-34060 MONTPELLIER 1,FRANCE; UNIV VALENCIA,FAC CIENCIES BIOL,DEPT BIOL VEGETAL,E-46100 BURJASSOT,SPAIN	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Montpellier; University of Valencia			Ros, Roc/F-3033-2015; romieu, charles/C-2115-2015	Ros, Roc/0000-0003-4254-8368; romieu, charles/0000-0003-2607-8335				AMBID C, 1983, PHYSIOL VEG, V21, P87; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BRAUER D, 1988, PLANT PHYSIOL, V87, P598, DOI 10.1104/pp.87.3.598; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; COOPER S, 1991, PLANT PHYSIOL, V97, P1212, DOI 10.1104/pp.97.3.1212; DAVIES JM, 1992, P NATL ACAD SCI USA, V89, P11701, DOI 10.1073/pnas.89.24.11701; DAVIES JM, 1991, FEBS LETT, V278, P66, DOI 10.1016/0014-5793(91)80085-H; GIANNINI JL, 1987, PLANT PHYSIOL, V84, P613, DOI 10.1104/pp.84.3.613; GIBRAT R, 1990, PLANT PHYSIOL, V93, P1183, DOI 10.1104/pp.93.3.1183; HEDRICH R, 1989, ANNU REV PLANT PHYS, V40, P539, DOI 10.1146/annurev.pp.40.060189.002543; KAESTNER KH, 1987, PLANT PHYSIOL, V83, P483, DOI 10.1104/pp.83.3.483; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LUTTGE U, 1979, TRANSPORT PLANTS, P124; MACROBBIE E A C, 1970, Quarterly Reviews of Biophysics, V3, P251; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; MARQUARDTJARCZYK G, 1990, J PLANT PHYSIOL, V136, P129, DOI 10.1016/S0176-1617(11)81654-8; POPE AJ, 1987, PLANTA, V172, P91, DOI 10.1007/BF00403033; REA PA, 1992, PLANT PHYSIOL, V100, P723, DOI 10.1104/pp.100.2.723; REA PA, 1987, PHYSIOL PLANTARUM, V71, P131, DOI 10.1111/j.1399-3054.1987.tb04630.x; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SATO MH, 1994, J BIOL CHEM, V269, P6725; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SZE H, 1985, ANNU REV PLANT PHYS, V36, P175, DOI 10.1146/annurev.pp.36.060185.001135; TAKESHIGE K, 1988, PLANT CELL PHYSIOL, V29, P649; VENEMA K, 1993, BIOCHIM BIOPHYS ACTA, V1146, P87, DOI 10.1016/0005-2736(93)90342-W; WANG YZ, 1986, PLANT PHYSIOL, V81, P497, DOI 10.1104/pp.81.2.497; WHITE PJ, 1990, PLANT PHYSIOL, V93, P1063, DOI 10.1104/pp.93.3.1063	28	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4368	4374		10.1074/jbc.270.9.4368	http://dx.doi.org/10.1074/jbc.270.9.4368			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876200	hybrid, Green Submitted			2022-12-27	WOS:A1995QK08400031
J	YOSHIKAWA, S; MOCHIZUKI, M; ZHAO, XJ; CAUGHEY, WS				YOSHIKAWA, S; MOCHIZUKI, M; ZHAO, XJ; CAUGHEY, WS			EFFECTS OF OVERALL OXIDATION-STATE ON INFRARED-SPECTRA OF HEME A(3) CYANIDE IN BOVINE HEART CYTOCHROME-C-OXIDASE - EVIDENCE OF NOVEL MECHANISTIC ROLES FOR CU-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; PRIMARY OXYGEN INTERMEDIATE; OUTER CATION INTERACTIONS; ELECTRON-TRANSFER; DIOXYGEN REDUCTION; BRIDGED COPPER(II); MAGNETIC EXCHANGE; BINDING; LIGAND; TEMPERATURE	Effects of changes in oxidation state at the other metal centers on oxidized heme alpha(3) cyanide of bovine heart cytochrome c oxidase have been investigated. Only one CN- binds, giving Fea33+CN, in fully-oxidized cytochrome c oxidase and its 1-, 2-, and 3-electron reduction products. Soret/visible spectra for the heme alpha(3) cyanide are independent of overall redox level, whereas distinct shifts in C-N infrared stretch band frequency occur upon reduction, reflecting changes in the polarity of the ligand (CN-) environment. Catalysis of O-2 reduction can be critically dependent upon such changes in polarity at the reduction site. These findings indicate that Cu-B, when reduced, exists in two forms whose relative stabilities are independent of Fe-a and Cu-A oxidation states and, when oxidized, is in only one stable form. These results are consistent with the oxidation of Cu-B(+) triggering proton pumping and with the involvement of a Cu-B Ligand in respiratory control. Electron equivalents introduced into the enzyme are distributed equally among Fe-a, Cu-A, and Cu-B, which raises the possibility that ah four electrons used in O-2 reduction are donated via Cu-B(+), which is favorably positioned with respect to Fe-a3 (the O-2 binding site) in order to carry out this role in electron transfers.	HIMEJI INST TECHNOL, DEPT LIFE SCI, AKOH, HYOGO 67812, JAPAN	University of Hyogo	YOSHIKAWA, S (corresponding author), COLORADO STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, FT COLLINS, CO 80523 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM030306, R01GM030306] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 30306] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BERRY KJ, 1980, NOUV J CHIM, V4, P581; BERTRAN JF, 1990, SPECTROCHIM ACTA A, V46, P685, DOI 10.1016/0584-8539(90)80023-R; BERTRAN JF, 1990, SPECTROCHIM ACTA A, V46, P1679, DOI 10.1016/0584-8539(90)80237-S; BLACKMORE RS, 1991, J BIOL CHEM, V266, P19245; CALHOUN MW, 1994, TRENDS BIOCHEM SCI, V19, P325, DOI 10.1016/0968-0004(94)90071-X; Caughey W. S., 1980, METHODS DETERMINING, P95; CAUGHEY WS, 1993, J BIOENERG BIOMEMBR, V25, P81, DOI 10.1007/BF00762850; CAUGHEY WS, 1976, ENZYMES, V13, P299; COPELAND RA, 1991, P NATL ACAD SCI USA, V88, P7281, DOI 10.1073/pnas.88.16.7281; DOORN SK, 1993, J AM CHEM SOC, V115, P6398, DOI 10.1021/ja00067a065; DUGGAN DM, 1974, J AM CHEM SOC, V96, P3443, DOI 10.1021/ja00818a017; DUGGAN DM, 1974, INORG CHEM, V13, P1911, DOI 10.1021/ic50138a024; EINARSDOTTIR O, 1988, J BIOL CHEM, V263, P13641; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; GUNTER MJ, 1984, J AM CHEM SOC, V106, P4227, DOI 10.1021/ja00327a027; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; HILL BC, 1984, BIOCHEM J, V218, P913, DOI 10.1042/bj2180913; HILL BC, 1994, J BIOL CHEM, V269, P2419; HILL BC, 1983, BIOCHEM J, V215, P57, DOI 10.1042/bj2150057; HILL BC, 1986, BIOCHIM BIOPHYS ACTA, V256, P258; JOHNSON MK, 1981, BIOCHEM J, V193, P699, DOI 10.1042/bj1930699; Keilin D, 1939, PROC R SOC SER B-BIO, V127, P167, DOI 10.1098/rspb.1939.0016; LANDEE CP, 1979, INORG CHEM, V18, P2317, DOI 10.1021/ic50198a055; LI WB, 1993, BIOCHEMISTRY-US, V32, P1833, DOI 10.1021/bi00058a018; MALMSTROM BG, 1990, CHEM REV, V90, P1247, DOI 10.1021/cr00105a008; Nakamoto K., 1978, INFRARED RAMAN SPECT; OGURA T, 1991, B CHEM SOC JPN, V64, P2901, DOI 10.1246/bcsj.64.2901; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OLIVEBERG M, 1992, BIOCHEMISTRY-US, V31, P3560, DOI 10.1021/bi00129a002; ORII Y, 1988, ANN NY ACAD SCI, V550, P105, DOI 10.1111/j.1749-6632.1988.tb35327.x; SCOTT RA, 1989, ANNU REV BIOPHYS BIO, V18, P137, DOI 10.1146/annurev.bb.18.060189.001033; SHERMAN D, 1991, P NATL ACAD SCI USA, V88, P4265, DOI 10.1073/pnas.88.10.4265; THOMSON AJ, 1982, BIOCHEM J, V207, P167, DOI 10.1042/bj2070167; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P9262, DOI 10.1021/bi00086a038; TSUBAKI M, 1993, BIOCHEMISTRY-US, V32, P164, DOI 10.1021/bi00052a022; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; Warburg O, 1929, BIOCHEM Z, V214, P64; WEINTRAUB ST, 1981, J BIOL CHEM, V256, P1669; WIKSTROM M, 1992, J BIOL CHEM, V267, P10266; WOODRUFF WH, 1991, P NATL ACAD SCI USA, V88, P2588, DOI 10.1073/pnas.88.6.2588; YOSHIKAWA S, 1985, J BIOL CHEM, V260, P3518; YOSHIKAWA S, 1982, J BIOL CHEM, V257, P412; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; YOSHIKAWA S, 1988, P NATL ACAD SCI USA, V85, P1354, DOI 10.1073/pnas.85.5.1354; YOSHIKAWA S, 1990, J BIOL CHEM, V265, P7945; YOSHIKAWA S, 1973, J BIOCHEM, V73, P637, DOI 10.1093/oxfordjournals.jbchem.a130122; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P9757	50	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4270	4279		10.1074/jbc.270.9.4270	http://dx.doi.org/10.1074/jbc.270.9.4270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876186	hybrid			2022-12-27	WOS:A1995QK08400017
J	HABUCHI, H; HABUCHI, O; KIMATA, K				HABUCHI, H; HABUCHI, O; KIMATA, K			PURIFICATION AND CHARACTERIZATION OF HEPARAN-SULFATE 6-SULFOTRANSFERASE FROM THE CULTURE-MEDIUM OF CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; D-GLUCOSAMINYLTRANSFERASE REACTIONS; CHICK-EMBRYO CHONDROCYTES; RAT-LIVER; CHONDROITIN 6-SULFOTRANSFERASE; POLYMER-MODIFICATION; MOLECULAR-CLONING; O-SULFATION; BIOSYNTHESIS; SULFOTRANSFERASE	Heparan sulfate 6-sulfotransferase, which catalyzes the transfer of sulfate from S'-phosphoadenylyl sulfate to position 6 of N-sulfoglucosamine in heparan sulfate, was purified 10,700-fold to apparent homogeneity with a 40% yield from the serum-free culture medium of Chinese hamster ovary cells. The isolation procedure included affinity chromatography of the first heparin-Sepharose CL-GB column (stepwise elution), 3',5'-ADP-agarose, and the second heparin-Sepharose CL-6B column (gradient elution). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the purified enzyme showed two protein bands with molecular masses of 52 and 45 kDa. Both proteins appeared to be glycoproteins, because their molecular masses decreased after N-glycanase digestion. When completely desulfated and N-resulfated heparin was used as acceptor, the purified enzyme transferred sulfate to position 6 of N-sulfoglucosamine residue but did not transfer sulfate to the amino group of glucosamine residue or to position 2 of the iduronic acid residue. Heparan sulfate was also sulfated by the purified enzyme at position 6 of N-sulfoglucosamine residue. Chondroitin and chondroitin sulfate did not serve as accepters. The optimal pH for enzyme activity was around 6.3. The enzyme activity was inhibited by dithiothreitol and was stimulated strongly by protamine. The K-m, value for adenosine S'-phosphate 5'-phosphosulfate was 0.44 mu M.	AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN; AICHI UNIV EDUC,DEPT LIFE SCI,KARIYA,AICHI 448,JAPAN	Aichi Medical University; Aichi University Education								AVIEZER D, 1994, J BIOL CHEM, V269, P114; BENDIAK B, 1987, J BIOL CHEM, V262, P5775; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; GOHLER D, 1984, EUR J BIOCHEM, V138, P301, DOI 10.1111/j.1432-1033.1984.tb07915.x; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HABUCHI O, 1980, BIOCHIM BIOPHYS ACTA, V616, P208, DOI 10.1016/0005-2744(80)90139-4; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; HABUCHI O, 1991, BIOCHIM BIOPHYS ACTA, V1133, P9; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; INOUE H, 1986, J BIOL CHEM, V261, P4460; ISHIHARA M, 1993, J BIOL CHEM, V268, P20091; ISHIHARA M, 1992, GLYCOBIOLOGY, V3, P400; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JACOBSSON I, 1980, J BIOL CHEM, V255, P5094; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KUSCHE M, 1988, J BIOL CHEM, V263, P15474; KUSCHE M, 1991, J BIOL CHEM, V266, P7400; KUSCHE M, 1990, J BIOL CHEM, V265, P15403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMMERS G, 1989, BIOCHEM J, V261, P389, DOI 10.1042/bj2610389; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; LIND T, 1993, J BIOL CHEM, V268, P20705; Lindahl U., 1989, HEPARIN, P159; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; MANDON E, 1994, J BIOL CHEM, V269, P11729; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; SARKAR M, 1991, P NATL ACAD SCI USA, V88, P234, DOI 10.1073/pnas.88.1.234; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; STROMINGER JL, 1959, J BIOL CHEM, V234, P3263; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885; WEINSTEIN J, 1987, J BIOL CHEM, V263, P17735; WLAD H, 1994, J BIOL CHEM, V269, P24538; YAMADA S, 1994, GLYCOBIOLOGY, V4, P69, DOI 10.1093/glycob/4.1.69	44	73	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					4172	4179		10.1074/jbc.270.8.4172	http://dx.doi.org/10.1074/jbc.270.8.4172			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876170	hybrid			2022-12-27	WOS:A1995QH68800104
J	AMIRHAERI, S; WOHLRAB, F; WELLS, RD				AMIRHAERI, S; WOHLRAB, F; WELLS, RD			DIFFERENTIAL-EFFECTS OF SIMPLE REPEATING DNA-SEQUENCES ON GENE-EXPRESSION FROM THE SV40 EARLY PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEGMENT INVERSION SITE; B-DNA; TRINUCLEOTIDE REPEAT; SECONDARY STRUCTURE; MUSCULAR-ATROPHY; POLY(DG) REGION; ENDONUCLEASE-G; TELOMERIC DNA; FRAGILE-X; MUTATIONS	The influence of simple repeat sequences, cloned into different positions relative to the SV40 early promoter/enhancer, on the transient expression of the chloramphenicol acetyltransferase (CAT) gene was investigated. Insertion of (G)(29).(C)(29) in either orientation into the 5'-untranslated region of the CAT gene reduced expression in CV-1 cells 50-100 fold when compared with controls with random sequence inserts. Analysis of CAT-specific mRNA levels demonstrated that the effect was due to a reduction of CAT mRNA production rather than to posttranscriptional events. In contrast, insertion of the same insert in either orientation upstream of the promoter enhancer or downstream of the gene stimulated gene expression 2-3-fold. These effects could be reversed by cotransfection of a competitor plasmid carrying (G)(25).(C)(25) sequences. The results suggest that a G.C-binding transcription factor modulates gene expression in this system and that promoter strength can be regulated by providing protein binding sites in trans. Although constructs containing longer tracts of alternating (C-G), (T-G), or (A-T) sequences inhibited CAT expression when inserted in the 5'-untranslated region of the CAT gene, the amount of CAT mRNA was unaffected. Hence, these inhibitions must be due to posttranscriptional events, presumably at the level of translation. These effects of microsatellite sequences on gene expression are discussed with respect to recent data on related simple repeat sequences which cause several human genetic diseases.	UNIV ALABAMA,SCH MED,DEPT BIOCHEM,BIRMINGHAM,AL 35294; UNIV ALABAMA,SCH DENT,BIRMINGHAM,AL 35294; TEXAS A&M UNIV,TEXAS MED CTR,INST BIOSCI & TECHNOL,HOUSTON,TX 77030	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Texas A&M University System					NIGMS NIH HHS [GM 30822] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030822] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; BERGER SL, 1987, METHOD ENZYMOL, V152, P182; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BLAHO JA, 1988, J BIOL CHEM, V263, P14446; BOLES TC, 1987, BIOCHEMISTRY-US, V26, P367, DOI 10.1021/bi00376a006; CASASNOVAS JM, 1987, EUR J BIOCHEM, V167, P489, DOI 10.1111/j.1432-1033.1987.tb13363.x; CASKEY CT, 1991, SCIENCE, V256, P784; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK SP, 1990, NUCLEIC ACIDS RES, V18, P5119, DOI 10.1093/nar/18.17.5119; COTE J, 1989, J BIOL CHEM, V264, P3301; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOTTLIEB J, 1988, MOL CELL BIOL, V6, P2513; HAPGOOD J, 1994, MOL CELL BIOL, V14, P1402, DOI 10.1128/MCB.14.2.1402; HIGGINS GJ, 1992, NAT GENET, V2, P186; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOWARD H, 1984, MOL CELL BIOL, V4, P2622; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; KOHWI Y, 1991, GENE DEV, V5, P2547, DOI 10.1101/gad.5.12b.2547; KOHWI Y, 1989, NUCLEIC ACIDS RES, V17, P4493, DOI 10.1093/nar/17.12.4493; KOHWISHIGEMATSU T, 1986, CELL, V43, P199; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; LU GH, 1993, INT J BIOCHEM, V25, P1529, DOI 10.1016/0020-711X(93)90508-C; LUKOMSKI S, 1994, P NATL ACAD SCI USA, V91, P9980, DOI 10.1073/pnas.91.21.9980; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCARTHY JG, 1987, NUCLEIC ACIDS RES, V15, P8069, DOI 10.1093/nar/15.19.8069; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; MIVA S, 1994, NAT GENET, V6, P3; MURCHIE AIH, 1992, BIOCHIM BIOPHYS ACTA, V1131, P1, DOI 10.1016/0167-4781(92)90091-D; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PANYUTIN IG, 1990, P NATL ACAD SCI USA, V87, P867, DOI 10.1073/pnas.87.3.867; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; USSERY DW, 1993, BIOCHEMISTRY-US, V32, P6206, DOI 10.1021/bi00075a013; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS R D, 1990, P25; WELLS RD, 1982, J BIOL CHEM, V257, P166; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; WOHLRAB F, 1989, J BIOL CHEM, V264, P8207; WOHLRAB F, 1991, P NATL ACAD SCI USA, V88, P6432, DOI 10.1073/pnas.88.15.6432; WOHLRAB F, 1987, J BIOL CHEM, V262, P6407; YEE CJ, 1994, CANCER RES, V54, P1641; ZACHARIAS W, 1988, P NATL ACAD SCI USA, V85, P7069, DOI 10.1073/pnas.85.19.7069; ZHENG GX, 1991, J MOL BIOL, V221, P107, DOI 10.1016/0022-2836(91)80208-C; ZHU QS, 1990, NUCLEIC ACIDS RES, V18, P7119, DOI 10.1093/nar/18.23.7119; 1993, CELL, V72, P971	61	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3313	3319		10.1074/jbc.270.7.3313	http://dx.doi.org/10.1074/jbc.270.7.3313			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852417				2022-12-27	WOS:A1995QG47100064
J	INAGAKI, Y; TRUTER, S; TANAKA, S; DILIBERTO, M; RAMIREZ, F				INAGAKI, Y; TRUTER, S; TANAKA, S; DILIBERTO, M; RAMIREZ, F			OVERLAPPING PATHWAYS MEDIATE THE OPPOSING ACTIONS OF TUMOR-NECROSIS-FACTOR-ALPHA AND TRANSFORMING GROWTH-FACTOR-BETA ON ALPHA-2(I) COLLAGEN GENE-TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; FUNCTIONAL-ANALYSIS; DNA-SEQUENCES; KAPPA-B; EXPRESSION; FIBROBLASTS; ACTIVATION; ELEMENTS; PROMOTER; STIMULATION	Transforming growth factor-beta (TGF-beta) and tumor necrosis factor-alpha (TNF-alpha) are multifunctional peptides intimately involved in the process of exhacellular matrix remodeling. We recently showed that TGF-beta stimulates the human alpha 2(I) collagen gene by increasing the affinity of an Sp1-containing transcriptional complex bound to an upstream sequence termed the TbRE (Inagaki, Y., Truter, S, and Ramirez, F. (1994) J. Biol, Chem. 269, 14828-14834). Here, we report that the TbRE-bound complex also mediates the inhibitory signal of TNF-alpha. Nuclear proteins from cells treated with TNF-alpha bind to the TbRE sequence substantially more strongly than those from untreated cells. Additionally, TNF-alpha increases binding of a second protein complex that recognizes the negatively cis-acting element located immediately next to the TbRE. Thus, we postulate that TNF-alpha counteracts the TGF-beta-elicited stimulation of collagen gene expression through overlapping nuclear signaling pathways. One modifies the TGF-beta-targeted transcrip tional complex, probably by reducing its stimulatory effect on collagen transcription. The other acts on the binding of the adjacent factor, presumably by increasing its effectiveness in repressing the activity of the collagen promoter. The convergence of the TGF-beta and TNF-alpha pathways on the same sequence of the alpha 2(I) collagen promoter is yet another example of combinatorial gene regulation achieved through composite response elements.	CUNY MT SINAI SCH MED, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA; KANAZAWA UNIV, SCH MED, DEPT INTERNAL MED 1, KANAZAWA, ISHIKAWA 920, JAPAN	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Kanazawa University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038648, R37AR038648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BOAST S, 1990, J BIOL CHEM, V265, P13351; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; BUTLER DM, 1988, J RHEUMATOL, V15, P1463; DIEGELMANN RF, 1988, COLLAGEN BIOCH BIOME, V2, P113; EDWARDS DR, 1987, EMBO J, V7, P2977; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hay E.D., 1991, CELL BIOL EXTRACELLU, P419; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; HILL DJ, 1986, J CELL PHYSIOL, V128, P322, DOI 10.1002/jcp.1041280226; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; Johnson A. A, 1992, TRANSCRIPTIONAL REGU, P975; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; KARSENTY G, 1988, J BIOL CHEM, V263, P13909; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; MURATA Y, 1994, J BIOL CHEM, V269, P20674; NIEDERREITHER K, 1992, J CELL BIOL, V119, P1361, DOI 10.1083/jcb.119.5.1361; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; YAMAMOTO KR, 1992, TRANSCRIPTIONAL REGU, P1169	34	98	108	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3353	3358		10.1074/jbc.270.7.3353	http://dx.doi.org/10.1074/jbc.270.7.3353			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852421	hybrid			2022-12-27	WOS:A1995QG47100069
J	PARKER, EM; SWIGART, P; NUNNALLY, MH; PERKINS, JP; ROSS, EM				PARKER, EM; SWIGART, P; NUNNALLY, MH; PERKINS, JP; ROSS, EM			CARBOXYL-TERMINAL DOMAINS IN THE AVIAN BETA(1)-ADRENERGIC RECEPTOR THAT REGULATE AGONIST-PROMOTED ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; INDUCED DOWN-REGULATION; ASTROCYTOMA-CELLS; DESENSITIZATION; MEMBRANE; INTERNALIZATION; CATECHOLAMINE; BINDING; TRANSFERRIN	Most G protein-coupled receptors, including the mammalian beta(2)-adrenergic receptor, are endocytosed to an intracellular, vesicular compartment upon continued exposure to agonist. The long form of the avian beta(1)-adrenergic receptor, which contains a carboxyl-terminal 59-amino acid extension, does not undergo agonist-promoted endocytosis. We constructed and expressed turkey beta(1)-adrenergic receptor cDNAs with regularly spaced carboxyl-terminal truncations and studied their agonist-promoted endocytosis. Removal of 34-86 amino acids from the carboxyl terminus of the turkey receptor allowed its efficient endocytosis, with optimal endocytosis observed upon re moval of 59 residues. Removal of only 18 residues allowed some endocytosis. A receptor that lacks the entire carboxyl-terminal region (124 residues) was not endocytosed. We also constructed a chimeric hamster beta(2)-adrenergic recep tor with the added 59-residue carboxyl-terminal domain of the turkey receptor. The chimera was not significantly endocytosed. These data indicate that residues 450-465 in the carboxyl-terminal region of the beta(1)-adrenergic receptor can act independently to block agonist-promoted endocytosis and that other carboxyl-terminal structures nearer to the seventh membrane span are required for endocytosis.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIGMS NIH HHS [GM36254, GM 30355] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030355, R01GM030355, R01GM036254] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; CLARK RB, 1989, MOL PHARMACOL, V36, P343; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOSS RC, 1981, J BIOL CHEM, V256, P2281; FREDERICH RC, 1983, J CYCLIC NUCL PROT, V9, P103; HADCOCK JR, 1989, J BIOL CHEM, V264, P19928; HANSKI E, 1978, LIFE SCI, V22, P53, DOI 10.1016/0024-3205(78)90411-3; HARDEN TK, 1980, SCIENCE, V210, P441, DOI 10.1126/science.6254143; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HERTEL C, 1984, N-S ARCH PHARMACOL, V328, P51, DOI 10.1007/BF00496106; HERTEL C, 1983, J CYCLIC NUCL PROT, V9, P119; HERTEL C, 1990, J BIOL CHEM, V265, P17988; HERTEL C, 1983, BIOCHEM J, V216, P669, DOI 10.1042/bj2160669; INSEL PA, 1982, J BIOL CHEM, V257, P9717; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LIAO JF, 1993, MOL PHARMACOL, V44, P364; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; MINNEMAN KP, 1980, MOL PHARMACOL, V17, P1; MUNTZ KH, 1994, CIRC RES, V74, P369, DOI 10.1161/01.RES.74.3.369; NANTEL F, 1993, MOL PHARMACOL, V43, P548; NEVE KA, 1985, J PHARMACOL EXP THER, V235, P657; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PARKER EM, 1991, J BIOL CHEM, V266, P9987; PERKINS JP, 1990, BETA ADRENERGIC RECE, P73; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; RUDOLPH SA, 1977, P NATL ACAD SCI USA, V74, P3404, DOI 10.1073/pnas.74.8.3404; Sambrook J., 1989, MOL CLONING; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; SIMANTOV R, 1978, FEBS LETT, V90, P69, DOI 10.1016/0014-5793(78)80300-7; SIMPSON IA, 1980, FEBS LETT, V115, P113, DOI 10.1016/0014-5793(80)80738-1; SUZUKI T, 1992, MOL PHARMACOL, V412, P542; VALIQUETTE M, 1990, P NATL ACAD SCI USA, V87, P5089, DOI 10.1073/pnas.87.13.5089; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WALDO GL, 1984, MOL PHARMACOL, V26, P424; WANG J, 1982, J BIOL CHEM, V270, P6488; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795; YU SS, 1993, J BIOL CHEM, V268, P337; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	40	33	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 24	1995	270	12					6482	6487		10.1074/jbc.270.12.6482	http://dx.doi.org/10.1074/jbc.270.12.6482			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QQ855	7896782	hybrid			2022-12-27	WOS:A1995QQ85500012
J	FUKUNAGA, K; MULLER, D; MIYAMOTO, E				FUKUNAGA, K; MULLER, D; MIYAMOTO, E			INCREASED PHOSPHORYLATION OF CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE-II AND ITS ENDOGENOUS SUBSTRATES IN THE INDUCTION OF LONG-TERM POTENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MESSENGER-RNA; CA-2+-INDEPENDENT ACTIVITY; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; DENTATE GYRUS; NITRIC-OXIDE; SYNAPSIN-I; CALMODULIN; CALCIUM	Induction of long term potentiation in the CA1 region of hippocampal slices is associated with increased activity of Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) (Fukunaga, K., Stoppini, L., Miyamoto, E., and Muller, D. (1993) J. Biol. Chem. 268, 7863-7867), Here we report that application of high but not low frequency stimulation to two groups of afferents in the CA1 region of P-32-labeled slices resulted in the phosphorylation of two major substrates of this enzyme, synapsin I and microtubule-associated protein 2, as well as in the autophosphorylation of CaM kinase II, Furthermore, immunoblotting analysis revealed that long term potentiation induction was associated with an increase in the amount of CaM kinase II in the same region. All these changes were prevented when high frequency stimulation was applied in the presence of the N-methyl-D-aspartate receptor antagonist, D-2-amino-B-phosphonopentanoate. These results indicate that activation of CaM kinase II is involved in the induction of synaptic potentiation in both the postsynaptic and presynaptic regions,	CTR MED UNIV GENEVA,DEPT PHYSIOL,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva	FUKUNAGA, K (corresponding author), KUMAMOTO UNIV,SCH MED,DEPT PHARMACOL,KUMAMOTO 860,JAPAN.							BENSON DL, 1992, NEUROSCIENCE, V46, P851, DOI 10.1016/0306-4522(92)90189-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CHARRIAUTMARLANGUE, 1991, P NATL ACAD SCI USA, V88, P10232; CHICUREL ME, 1993, J NEUROSCI, V13, P4054; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FIGUROV A, 1993, EUR J NEUROSCI, V5, P1035, DOI 10.1111/j.1460-9568.1993.tb00956.x; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1990, Molecular and Cellular Neuroscience, V1, P133; GEINISMAN Y, 1992, HIPPOCAMPUS, V2, P445, DOI 10.1002/hipo.450020412; GIANOTTI C, 1992, NEURON, V8, P843, DOI 10.1016/0896-6273(92)90198-M; HUTTNER WB, 1979, P NATL ACAD SCI USA, V76, P5402, DOI 10.1073/pnas.76.10.5402; KITANO T, 1987, J NEUROSCI, V7, P1520; KLANN E, 1992, J NEUROCHEM, V58, P1576, DOI 10.1111/j.1471-4159.1992.tb11382.x; KLANN E, 1991, J BIOL CHEM, V266, P24253; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; MACKLER SA, 1992, NEURON, V9, P539, DOI 10.1016/0896-6273(92)90191-F; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; REYMANN KG, 1988, BRAIN RES, V461, P388, DOI 10.1016/0006-8993(88)90274-0; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SILVA AJ, 1993, SCIENCE, V257, P201; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; YANO S, 1994, J BIOL CHEM, V269, P5428	40	192	199	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6119	6124		10.1074/jbc.270.11.6119	http://dx.doi.org/10.1074/jbc.270.11.6119			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890745	hybrid			2022-12-27	WOS:A1995QM94500061
J	JIANG, H; LU, ZM; LUO, JQ; WOLFMAN, A; FOSTER, DA				JIANG, H; LU, ZM; LUO, JQ; WOLFMAN, A; FOSTER, DA			RAS MEDIATES THE ACTIVATION OF PHOSPHOLIPASE-D BY V-SRC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; INDUCED TRANSFORMATION; TYROSINE KINASES; GROWTH; RAF-1; MEMBRANE; CELLS; PHOSPHATIDYLCHOLINE; INHIBITION; FAMILY	We demonstrated previously that v-Src activates a phospholipase D (PLD) activity (Song, J., Pfeffer, L. M., and Foster, D. A. (1991) Mol. Cell. Biol. 11, 4903-4908) and that this activation is dependent upon a G protein(s) (Jiang, H., Alexandropoulos, K., Song, J., and Foster, D. A, (1994) Mol. Cell. Biol. 14, 3676-3682). An in vitro PLD assay was developed to study G protein involvement in v-Src-induced PLD activity. Maximal PLD activity in membranes isolated from v-Src-transformed cells was dependent upon both GTP and cytosol. In this report, we present three lines of evidence demonstrating that v-Src-induced PLD activity is mediated by Ras. First, a neutralizing Ras monoclonal antibody (Y13-259) inhibits PLD activity in membranes isolated from v-Src-transformed Balb/c 3T3 cells. Second, immobilized Ras protein depleted cytosol of the ability to stimulate PLD activity. This effect was dependent upon preloading immobilized Ras with GTP. Last, expression of a dominant negative Ras mutant in v-Src-transformed cells reduced PLD activity to the level observed in the nontransformed parental cells. These data establish a novel role for Ras in the regulation of PLD activity.	CUNY HUNTER COLL,INST BIOMOLEC STRUCT & FUNCT,NEW YORK,NY 10021; CUNY HUNTER COLL,DEPT BIOL SCI,NEW YORK,NY 10021; CLEVELAND CLIN FDN,CLEVELAND,OH 44195	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); Cleveland Clinic Foundation					NATIONAL CANCER INSTITUTE [R29CA046677, R01CA046677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM049652, R01GM049652] Funding Source: NIH RePORTER; NCI NIH HHS [CA46677] Funding Source: Medline; NCRR NIH HHS [RR 03037] Funding Source: Medline; NIGMS NIH HHS [GM49652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOARDER MR, 1994, TRENDS PHARMACOL SCI, V15, P57, DOI 10.1016/0165-6147(94)90111-2; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CARNERO A, 1994, ONCOGENE, V9, P1387; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; DECLUE JE, 1991, MOL CELL BIOL, V11, P2819, DOI 10.1128/MCB.11.5.2819; DIBATTISTE D, 1993, ONCOGENE, V8, P637; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FOSTER DA, 1993, CELL SIGNAL, V5, P389, DOI 10.1016/0898-6568(93)90078-Z; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; JIANG H, 1994, MOL CELL BIOL, V14, P3676, DOI 10.1128/MCB.14.6.3676; JIANG YW, 1994, BIOCHEM BIOPH RES CO, P1195; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; KASZKIN M, 1992, BIOCHEM J, V287, P51, DOI 10.1042/bj2870051; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NORI M, 1991, MOL CELL BIOL, V11, P2812, DOI 10.1128/MCB.11.5.2812; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PLEVIN R, 1991, BIOCHEM J, V279, P559, DOI 10.1042/bj2790559; QURESHI SA, 1992, J BIOL CHEM, V267, P17635; QURESHI SA, 1993, BIOCHEM BIOPH RES CO, V192, P969, DOI 10.1006/bbrc.1993.1510; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; SONG JG, 1993, BIOCHEM J, V294, P711, DOI 10.1042/bj2940711; SONG JG, 1994, CELL GROWTH DIFFER, V5, P79; VANCORVEN EJ, 1990, CELL, V59, P45; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	38	89	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6006	6009		10.1074/jbc.270.11.6006	http://dx.doi.org/10.1074/jbc.270.11.6006			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890731	hybrid			2022-12-27	WOS:A1995QM94500046
J	TREUMANN, A; LIFELY, MR; SCHNEIDER, P; FERGUSON, MAJ				TREUMANN, A; LIFELY, MR; SCHNEIDER, P; FERGUSON, MAJ			PRIMARY STRUCTURE OF CD52	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; VARIANT SURFACE GLYCOPROTEIN; CAMPATH-1 CDW52 ANTIGEN; PHOSPHOLIPASE-C; PEPTIDE BACKBONE; CELL ACTIVATION; LYMPHOMA-CELLS; ACETYLCHOLINESTERASE; BIOSYNTHESIS; SENSITIVITY	The CD52 antigen was extracted from human spleens with organic solvents and purified by immunoaffinity and reverse-phase chromatography, The latter step resolved two CD52 species, called CD52-I and CD52-II. Both species were found to contain similar N-linked oligosaccharides and glycosylphosphatidylinositol (GPI) anchor glycans, The N-linked oligosaccharides were characterized by methylation linkage analysis and, following exhaustive neuraminidase and endo-beta-galactosidase digestion, by the reagent array analysis method TM. The results showed that the single CD52 N-glycosylation site is occupied by large sialylated, polylactosamine-containing, core-fucosylated tetraantennary oligosaccharides. The locations of the phosphoryl substituents on the GPI anchor glycan were determined using a new and sensitive method based upon partial acid hydrolysis of the GPI glycan. The difference between CD52-I and CD52-II was in the phosphatidylinositol (PI) moieties of the GPI anchors. The phosphatidylinositol-specific phospholipase C-sensitive CD52-I contained exclusively distearoyl-PI, while the PI-phospholipase C-resistant CD52-II contained predominantly a palmitoylated stearoyl-arachidonoyl-PI, as judged by electrospray ionization mass spectrometry. Tandem mass spectrometric studies indicated that the palmitoyl residue of the CD52-II anchor is attached to the S-position of the myo inositol ring, Both the CD52-I and CD52-II PI structures are unusual for GPI anchors and the possible significance of this is discussed. The alkali-lability of the CD52 epitope recognized by the Campath-1H monoclonal antibody was studied. The data suggest that the alkali-labile hydroxyester-linked fatty acids of the GPI anchor are necessary for antibody binding.	UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND; WELLCOME FDN RES LABS,DEPT CELL BIOL,BECKENHAM BR3 3BS,KENT,ENGLAND	University of Dundee; GlaxoSmithKline			Ferguson, Michael A. J./F-7829-2010; Treumann, Achim/H-1295-2013	Ferguson, Michael A. J./0000-0003-1321-8714; Treumann, Achim/0000-0002-9417-3505; Schneider, Pascal/0000-0003-0677-9409				ANUMULA KR, 1991, EUR J BIOCHEM, V195, P269, DOI 10.1111/j.1432-1033.1991.tb15703.x; BUTIKOFER P, 1990, J BIOL CHEM, V265, P18983; DEEG MA, 1992, J BIOL CHEM, V267, P18573; DOERING TL, 1994, BIOCHEM J, V299, P741, DOI 10.1042/bj2990741; EDGE CJ, 1992, P NATL ACAD SCI USA, V89, P6338, DOI 10.1073/pnas.89.14.6338; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1992, BIOCHEM J, V284, P297, DOI 10.1042/bj2840297; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; GUTHER MLS, 1992, J BIOL CHEM, V267, P6820; HALE G, 1990, TISSUE ANTIGENS, V35, P118, DOI 10.1111/j.1399-0039.1990.tb01767.x; HALE G, 1983, BLOOD, V62, P873; HALE G, 1994, BONE MARROW TRANSPL, V13, P597; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; KANNAGI R, 1983, CANCER RES, V43, P4997; KAY R, 1990, J IMMUNOL, V145, P1952; KAY R, 1991, J IMMUNOL, V147, P1412; KERWIN JL, 1994, J LIPID RES, V35, P1102; KIARASH A, 1994, J BIOL CHEM, V269, P11138; KIRCHHOFF C, 1994, BIOL REPROD, V50, P896, DOI 10.1095/biolreprod50.4.896; KIRCHHOFF C, 1993, MOL REPROD DEV, V34, P8, DOI 10.1002/mrd.1080340103; KUBOTA H, 1990, J IMMUNOL, V145, P3924; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; NYHOLM PG, 1993, BIOCHEMISTRY-US, V32, P1225, DOI 10.1021/bi00056a005; PUOTI A, 1993, J BIOL CHEM, V268, P7215; REDMAN CA, 1994, BIOCHEM J, V302, P861, DOI 10.1042/bj3020861; RICHIER P, 1992, BIOCHIM BIOPHYS ACTA, V1112, P83, DOI 10.1016/0005-2736(92)90257-M; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SCHNEIDER P, 1993, ANAL BIOCHEM, V210, P106, DOI 10.1006/abio.1993.1158; SCHNEIDER P, 1995, IN PRESS METHODS ENZ, V250; SHERMAN WR, 1985, BIOMED MASS SPECTROM, V12, P409, DOI 10.1002/bms.1200120810; SINGH N, 1994, MOL CELL BIOL, V14, P21, DOI 10.1128/MCB.14.1.21; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; TOUTANT JP, 1990, EUR J BIOCHEM, V187, P31, DOI 10.1111/j.1432-1033.1990.tb15274.x; VALENTIN H, 1992, TRANSPLANTATION, V54, P97, DOI 10.1097/00007890-199207000-00018; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; WALTER EI, 1990, J IMMUNOL, V144, P1030; WONG YW, 1994, BIOCHEM J, V301, P205, DOI 10.1042/bj3010205; XIA MQ, 1991, EUR J IMMUNOL, V21, P1677, DOI 10.1002/eji.1830210714; XIA MQ, 1993, MOL IMMUNOL, V30, P1089; XIA MQ, 1993, BIOCHEM J, V293, P633, DOI 10.1042/bj2930633; YOSHINO T, 1982, BIOCHEMISTRY-US, V21, P928, DOI 10.1021/bi00534a018	46	217	223	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 17	1995	270	11					6088	6099		10.1074/jbc.270.11.6088	http://dx.doi.org/10.1074/jbc.270.11.6088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QM945	7890742				2022-12-27	WOS:A1995QM94500058
J	WEIR, L; CHEN, DF; PASTORE, C; ISNER, JM; WALSH, K				WEIR, L; CHEN, DF; PASTORE, C; ISNER, JM; WALSH, K			EXPRESSION OF GAX, A GROWTH ARREST HOMEOBOX GENE, IS RAPIDLY DOWN-REGULATED IN THE RAT CAROTID-ARTERY DURING THE PROLIFERATIVE RESPONSE TO BALLOON INJURY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; PROTEIN; SYSTEM; ATHEROSCLEROSIS; TRANSCRIPTION; PATHOGENESIS; QUANTITATION; MARKERS	gax is a recently described homeobox gene whose expression in the adult is largely confined to cardiovascular tissues. gax has been shown to be rapidly down-regulated in cultured vascular smooth muscle cells (VSMC) upon stimulation by serum or platelet-derived growth factor. The temporal profile of gax expression in vitro matches that of two families of growth arrest genes: the gas genes and the gadd genes. All of these genes are expressed at their highest levels in quiescent cells and are down-regulated following mitogen activation. Here we report that gax is also down-regulated in vivo in the vascular wall in response to endothelial denudation by balloon angioplasty. The reduction in steady state levels of gax mRNA is transient and occurs with a similar time course to that seen in vitro. The down-regulation of gax in response to balloon injury mirrors the up-regulation seen in a number of early response genes such as c-myc and c-fos. This report is the first to document the in vivo expression of a growth arrest gene which regulates proliferation of vascular smooth muscle cells. In addition, in contrast with previous reports which have demonstrated up-regulation of several genes following balloon injury and/or angioplasty, the present report demonstrates the down-regulation of a regulatory gene within hours of balloon injury. The characteristics of gax suggest it may be required to maintain the gene expression of proteins in VSMC that are associated with the nonproliferative or contractile phenotype in smooth muscle cells.	TUFTS UNIV,ST ELIZABETHS MED CTR,SCH MED,DEPT MED CARDIOL,BOSTON,MA 02135; TUFTS UNIV,ST ELIZABETHS MED CTR,SCH MED,DEPT BIOMED RES,BOSTON,MA 02135	St. Elizabeth's Medical Center; Tufts University; St. Elizabeth's Medical Center; Tufts University					NHLBI NIH HHS [HL 02428, HL 40518] Funding Source: Medline; NIAMS NIH HHS [AR 40580] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002428, R01HL040518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040580] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CICCARELLI C, 1990, MOL CELL BIOL, V10, P1525, DOI 10.1128/MCB.10.4.1525; CLOWES AW, 1983, LAB INVEST, V49, P327; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DILLEY RJ, 1988, ARCH SURG-CHICAGO, V123, P691; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GABBIANI G, 1984, J CLIN INVEST, V73, P148, DOI 10.1172/JCI111185; GALLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; GORSKI DH, 1993, TRENDS CARDIOVAS MED, V3, P184, DOI 10.1016/1050-1738(93)90004-P; KAWAMOTO S, 1987, J BIOL CHEM, V262, P7282; KIM DK, 1994, J CLIN INVEST, V93, P355, DOI 10.1172/JCI116967; KOCHER O, 1984, LAB INVEST, V50, P645; KOCHER O, 1985, CIRC RES, V56, P829, DOI 10.1161/01.RES.56.6.829; KUROO M, 1989, J BIOL CHEM, V264, P18292; LECLERC G, 1992, CIRCULATION, V85, P543, DOI 10.1161/01.CIR.85.2.543; MAJESKY MW, 1992, CIRC RES, V71, P759, DOI 10.1161/01.RES.71.4.759; MANIFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924; MIANO JM, 1990, AM J PATHOL, V137, P761; MIANO JM, 1993, ARTERIOSCLER THROMB, V13, P211, DOI 10.1161/01.ATV.13.2.211; MUNRO JM, 1988, LAB INVEST, V58, P249; MURPHY LD, 1990, BIOCHEMISTRY-US, V29, P10351, DOI 10.1021/bi00497a009; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PASTORE C, 1993, CIRCULATION, V88, P1658; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SALOMON RS, 1991, P NATL ACAD SCI USA, V89, P2814; Sambrook J, 1989, MOL CLONING LABORATO; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; TAUBMAN M, 1991, CIRC RES, V70, P314; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	44	89	101	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 10	1995	270	10					5457	5461		10.1074/jbc.270.10.5457	http://dx.doi.org/10.1074/jbc.270.10.5457			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QL580	7890661	hybrid			2022-12-27	WOS:A1995QL58000077
J	HARRINGTON, JJ; LIEBER, MR				HARRINGTON, JJ; LIEBER, MR			DNA STRUCTURAL ELEMENTS REQUIRED FOR FEN-1 BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION	In eukaryotic cells, a 5'-flap DNA endonuclease and a double-stranded DNA 5'-exonuclease activity reside within a 42-kDa enzyme called FEN-1 (flap endonuclease-1 and 5(five)'-exonuclease), This endo/exonuclease has been shown to be highly homologous to human XP-G, Saccharomyces cerevisiae RAD2, and S. cerevisiae YKL510. Like FEN-1, these related structure-specific nucleases recognize and cleave a branched DNA structure called a DNA flap and its derivative, called a pseudo Y-structure, To dissect the important structural components of the DNA flap structure, we have developed a mobility shift assay, We find that the F-adj strand (located adjacent to the displaced flap strand) is necessary for efficient binding and cleavage of flap structures by FEN-1. When this strand is absent or when it is present, but recessed from the elbow of the flap strand, binding efficiency drops, Further investigation of the role of the F-adj strand using double flap structures reveals that the F-adj strand is necessary to provide a double-stranded template upon which FEN-1 can bind near the elbow of the flap strand, These results provide a basis for understanding how this structure-specific nuclease recognizes a variety of DNA substrates.	STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,PROGRAM CANC BIOL,STANFORD,CA 94305; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110	Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)				Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; HABER J E, 1992, Current Opinion in Cell Biology, V4, P401, DOI 10.1016/0955-0674(92)90005-W; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HIRAOKA LR, 1995, GENOMICS, V25, P220, DOI 10.1016/0888-7543(95)80129-A; KORNBERG A, 1992, DNA REPLICATION, P931; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; PONTKINGDON G, 1993, EMBO J, V12, P23, DOI 10.1002/j.1460-2075.1993.tb05628.x; ROBINS P, 1994, J BIOL CHEM, V269, P28535; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; WAGA S, 1994, J BIOL CHEM, V269, P10923; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0	13	81	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4503	4508		10.1074/jbc.270.9.4503	http://dx.doi.org/10.1074/jbc.270.9.4503			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876218	hybrid			2022-12-27	WOS:A1995QK08400051
J	LEDUC, I; MELOCHE, S				LEDUC, I; MELOCHE, S			ANGIOTENSIN-II STIMULATES TYROSINE PHOSPHORYLATION OF THE FOCAL ADHESION-ASSOCIATED PROTEIN PAXILLIN IN AORTIC SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; KINASE-C; RECEPTOR ANTAGONISTS; BOMBESIN; VASOPRESSIN; ENDOTHELIN; EXPRESSION; INHIBITION; CLONING; GROWTH	Treatment of vascular smooth muscle cells (SMC) with angiotensin II (AII) leads to an increase in the tyrosine phosphorylation of multiple cellular substrates. Here, we have demonstrated that All stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in rat aortic SMC. AII-induced phosphorylation of paxillin was detectable within 1 min and was sustained up to 60 min. Preincubation with the AT(1)-selective antagonist losartan abolished this response. The stimulatory effect of AII on paxillin tyrosine phosphorylation was observed only in aortic SMC and not in other target cells such as adrenal zona glomerulosa cells, chromaffin cells, or hepatocytes. The effect of AII was dependent on the activation of phospholipase C. Chelation of intracellular calcium completely inhibited the ability of AII to stimulate paxillin tyrosine phosphorylation, while selective inhibition of protein kinase C partially attenuated the response. in contrast, treatment of the cells with pertussis toxin had no effect on AII-induced paxillin tyrosine phosphorylation. These findings identify paxillin as a new substrate for AII-stimulated tyrosine phosphorylation and suggest a role for cytoskeleton-associated proteins in the growth response of aortic SMC.	HOTEL DIEU MONTREAL, CTR RECH, MONTREAL, PQ H2W 1T8, CANADA; UNIV MONTREAL, DEPT PHARMACOL, MONTREAL, PQ H2W 1T8, CANADA	Universite de Montreal; Universite de Montreal								BABINSKI K, 1992, FEBS LETT, V313, P300, DOI 10.1016/0014-5793(92)81214-7; BALLA T, 1991, MOL PHARMACOL, V40, P401; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; CRAWFORD KW, 1992, MOL PHARMACOL, V41, P154; DELEAN A, 1984, ENDOCRINOLOGY, V115, P485, DOI 10.1210/endo-115-2-485; FORCE T, 1991, J BIOL CHEM, V266, P6650; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; HADRAVA V, 1989, HYPERTENSION, V13, P589, DOI 10.1161/01.HYP.13.6.589; HAIMOVICI J, 1994, AM J PHYSIOL, V267, pG364, DOI 10.1152/ajpgi.1994.267.3.G364; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; LEEBLUNDBERG LMF, 1991, J BIOL CHEM, V266, P7746; MEYER T, 1989, INT J CANCER, V43, P851, DOI 10.1002/ijc.2910430519; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; OWENS GK, 1989, AM J PHYSIOL, V257, pH1755, DOI 10.1152/ajpheart.1989.257.6.H1755; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SCHELLING P, 1991, J HYPERTENS, V9, P3; SECKL M, 1993, J BIOL CHEM, V268, P9548; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; WEISS RH, 1992, J BIOL CHEM, V267, P5608; WONG PC, 1992, TRENDS ENDOCRIN MET, V3, P211, DOI 10.1016/1043-2760(92)90030-5; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	33	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4401	4404		10.1074/jbc.270.9.4401	http://dx.doi.org/10.1074/jbc.270.9.4401			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876204	hybrid			2022-12-27	WOS:A1995QK08400036
J	LINNEKIN, D; MOU, SM; GREER, P; LONGO, DL; FERRIS, DK				LINNEKIN, D; MOU, SM; GREER, P; LONGO, DL; FERRIS, DK			PHOSPHORYLATION OF A FES-RELATED PROTEIN IN RESPONSE TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HL-60 LEUKEMIA-CELLS; TYROSINE KINASE; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; INTERLEUKIN-3; EXPRESSION; DIFFERENTIATION; GENE; IDENTIFICATION; ASSOCIATION	Previous work has suggested that a 97-kDa protein (p97) is involved in the signal transduction pathway of granulocyte-macrophage colony stimulating factor (GMCSF) as well as interleukin 3, erythropoietin, and interleukin 2, We have examined the relationship of p97 to the protein tyrosine kinase Fes in the GM-CSF signal transduction pathway in erythroid and myeloid cell lines. GM-CSF stimulation of three different cell lines induced tyrosine phosphorylation of p97 as well as a number of other phosphotyrosylproteins. Although each cell Line expressed the proto-oncogene product Fes, antisera specific for Pes did not recognize p97 in immunoblotting experiments. Furthermore, immunodepletion of Fes did not reduce the amount of p97 in GM-CSF treated cells. Two dimensional gel electrophoresis demonstrated that p97 and Fes have similar charge to mass ratios, and limited proteolytic mapping of p97 and Fes suggested that these proteins may be related but are not identical. Our studies demonstrate that p97 is not Fes but is probably a Fes related protein.	NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; QUEENS UNIV,DEPT PATHOL,CANC RES LABS,KINGSTON,ON K7L 3N6,CANADA; QUEENS UNIV,DEPT BIOCHEM,CANC RES LABS,KINGSTON,ON K7L 3N6,CANADA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Queens University - Canada; Queens University - Canada	LINNEKIN, D (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RECOURSES INC DYNCORP,DIV CANC TREATMENT,FREDERICK,MD 21702, USA.		Longo, Dan L./F-6022-2011					ARECES LB, 1994, MOL CELL BIOL, V14, P4606, DOI 10.1128/MCB.14.7.4606; CARE A, 1994, ONCOGENE, V9, P739; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; FERRIS DK, 1989, LYMPHOKINE RES, V8, P215; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GEARING D, 1988, EMBO J, V8, P3667; HANAZONO Y, 1993, BLOOD, V81, P3193; HANAZONO Y, 1993, EMBO J, V12, P1641, DOI 10.1002/j.1460-2075.1993.tb05809.x; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; KANAKURA Y, 1990, BLOOD, V76, P706; LESHET E, 1990, MOL CELL BIOL, V10, P5021; LINNEKIN D, 1992, J BIOL CHEM, V267, P23993; LINNEKIN D, 1994, BLOOD, V84, P94, DOI 10.1182/blood.V84.1.94.bloodjournal84194; LINNEKIN D, 1992, P NATL ACAD SCI USA, V89, P6237, DOI 10.1073/pnas.89.14.6237; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; MANFREDINI R, 1993, J EXP MED, V178, P381, DOI 10.1084/jem.178.2.381; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; PAWSON T, 1989, MOL CELL BIOL, V9, P5722, DOI 10.1128/MCB.9.12.5722; QUELLE FW, 1992, J BIOL CHEM, V267, P17055; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; TORIGOE T, 1992, BLOOD, V80, P617; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YU G, 1989, J BIOL CHEM, V264, P10276; YU G, 1987, J BIOL CHEM, V262, P17543	31	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4950	4954		10.1074/jbc.270.9.4950	http://dx.doi.org/10.1074/jbc.270.9.4950			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876270	hybrid			2022-12-27	WOS:A1995QK08400108
J	OPRESKO, LK; CHANG, CP; WILL, BH; BURKE, PM; GILL, GN; WILEY, HS				OPRESKO, LK; CHANG, CP; WILL, BH; BURKE, PM; GILL, GN; WILEY, HS			ENDOCYTOSIS AND LYSOSOMAL TARGETING OF EPIDERMAL GROWTH-FACTOR RECEPTORS ARE MEDIATED BY DISTINCT SEQUENCES INDEPENDENT OF THE TYROSINE KINASE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; EGF RECEPTOR; MULTIVESICULAR BODY; CYTOPLASMIC DOMAIN; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; DOWN-REGULATION; BETA-RECEPTOR; BINDING; CELLS	Ligand-induced internalization of the epidermal growth factor receptor (EGFR) leads to accelerated receptor degradation, Two models have been proposed to explain this. In the first model, induced internalization expands the intracellular pool of receptors, leading to enhanced lysosomal targeting. The second model proposes that activation of intrinsic receptor kinase activity induces inward vesiculation of endosomes, thus interrupting receptor recycling. To test these models, we created EGFR mutants that lack the conserved tyrosine kinase domain, but retain different parts of the distal carboxyl terminus regulatory region. Mutants lacking all distal regulatory sequences underwent slow internalization (0.02 min(-1)) and turnover (t(1/2) similar to 24 h), similar to unoccupied, holo-EGFR. Mutant receptors that lacked the kinase domain, but retained the entire distal regulatory domain, were constitutively internalized and targeted to lysosomes, even in the absence of EGF. The turnover of these receptors (t(1/2) similar to 11 h) was similar to that of occupied, kinase-active holo-EGFR (t(1/2) similar to 9.5 h). These results show that receptor tyrosine kinase activity is not required for the targeting of EGFR to lysosomes, Receptor mutants which expressed previously identified endocytic sequences underwent rapid internalization. Unexpectedly, enhanced turnover of EGFR mutants required additional sequences located between residues 945 and 991 in the holo-EGFR. Thus, internalization and lysosomal targeting of EGFR are separate processes mediated by distinct sequences. Our results indicate that induced internalization is necessary, but not sufficient, for enhanced EGFR degradation. Instead, down-regulation requires exposure of previously cryptic internalization and lysosomal targeting sequences. Occupied EGFR thus appear to be handled by the endocytic machinery in the same fashion as other constitutively internalized or lysosomally targeted receptors.	UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego	OPRESKO, LK (corresponding author), UNIV UTAH, SCH MED, DEPT PATHOL, SALT LAKE CITY, UT 84132 USA.			Wiley, Steven/0000-0003-0232-6867	NCI NIH HHS [P01CA 58689] Funding Source: Medline; NICHD NIH HHS [P01HD28528] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD028528] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERLIN CM, 1965, MOL PHARMACOL, V1, P149; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHANG CP, 1991, J BIOL CHEM, V266, P23467; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN S, 1982, J BIOL CHEM, V257, P1523; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; GAMOU S, 1987, J BIOL CHEM, V262, P6708; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GILL GN, 1988, COLD SPRING HARB SYM, V53, P467, DOI 10.1101/SQB.1988.053.01.054; GILL GN, 1984, J BIOL CHEM, V259, P7755; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GRAKO KA, 1992, ENDOCRINOLOGY, V130, P3441, DOI 10.1210/en.130.6.3441; GREEN SA, 1994, J CELL BIOL, V124, P435, DOI 10.1083/jcb.124.4.435; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KAMPS MP, 1988, ONCOGENE, V2, P305; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KNIGHTON DR, 1993, P NATL ACAD SCI USA, V90, P5001, DOI 10.1073/pnas.90.11.5001; KORC M, 1985, P NATL ACAD SCI USA, V82, P6172, DOI 10.1073/pnas.82.18.6172; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LAMAZE C, 1993, MOL BIOL CELL, V4, P715, DOI 10.1091/mbc.4.7.715; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LUND KA, 1990, J BIOL CHEM, V265, P15713; LUND KA, 1990, J BIOL CHEM, V265, P20517; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MORI S, 1993, J BIOL CHEM, V268, P577; MOSTOV K, 1993, J CELL SCI, P21; OGATA S, 1994, J BIOL CHEM, V269, P5210; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1991, J BIOL CHEM, V266, P8355; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; SWANSON JA, 1992, J CELL SCI, V103, P201; WEBER W, 1984, J BIOL CHEM, V259, P4631; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WELSH JB, 1994, MOL BIOL CELL, V5, P539, DOI 10.1091/mbc.5.5.539; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WILEY HS, 1985, CURR TOP MEMBR TRANS, V24, P369; WILEY HS, 1985, J BIOL CHEM, V260, P5290; WINKLER ME, 1989, BIOCHEMISTRY-US, V28, P6373, DOI 10.1021/bi00441a033; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42	64	135	140	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4325	4333		10.1074/jbc.270.9.4325	http://dx.doi.org/10.1074/jbc.270.9.4325			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876194	hybrid			2022-12-27	WOS:A1995QK08400025
J	PARK, CH; MU, D; REARDON, JT; SANCAR, A				PARK, CH; MU, D; REARDON, JT; SANCAR, A			THE GENERAL TRANSCRIPTION-REPAIR FACTOR TFIIH IS RECRUITED TO THE EXCISION-REPAIR COMPLEX BY THE XPA PROTEIN INDEPENDENT OF THE TFIIE TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; STRANDED-DNA ENDONUCLEASE; XERODERMA-PIGMENTOSUM; COCKAYNE SYNDROME; DAMAGED DNA; MINIMAL SET; IDENTIFICATION; INITIATION; AFFINITY; EXTRACTS	Recent studies have revealed that the general transcription factor TFIIH is also a general excision repair factor which, along with several other proteins, is required for transcription-independent excision reaction, As a general transcription factor, TFIIH is recruited to RNA polymerase II-promoter complex by another general transcription factor called TFIIE, We were interested in knowing whether TFIIE is also involved in recruiting TFIIH to the excision repair complex, We found that cell-free extract depleted of TFIIE carried out excision repair at a normal rate, leading us to conclude that TFIIE is not involved in recruiting TFIIH to the damage site and has no role in general excision repair, In contrast, the human damage recognition protein XPA specifically binds to TFIIH and apparently recruits it to the damage site. The carboxyl-terminal half of XPA is responsible for specific interaction with TFIIH. The C261S/C264S mutant of XPA bound the ERCC1 . XPF complex normally, but failed to bind TFIIH and failed to complement an XP-A mutant cell-free extract indicating that the XPA-TFIIH interaction is essential to effecting the excision reaction. Interestingly, XPA also binds to the p34 subunit of TFIIE specifically and in competition with the p56 subunit of TFIIE, This latter interaction has no apparent role in general excision repair but may be relevant in the transcription-coupled repair reaction.	UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine			Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; CLEAVER JE, 1989, METABOLIC BASIS INHE, P2959; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DRAPKIN R, 1994, CELL, V77, P9, DOI 10.1016/0092-8674(94)90228-3; FLORES O, 1989, J BIOL CHEM, V264, P8913; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; HABRAKEN Y, 1994, NATURE, V371, P531, DOI 10.1038/371531a0; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12095; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1991, NATURE, V354, P398, DOI 10.1038/354398a0; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; PARK CH, 1993, NUCLEIC ACIDS RES, V21, P5110, DOI 10.1093/nar/21.22.5110; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PETERSON MG, 1991, NATURE, V354, P369; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; REARDON JT, 1993, COLD SPRING HARB SYM, V58, P605, DOI 10.1101/SQB.1993.058.01.067; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SUMIMOTO H, 1991, NATURE, V354, P401, DOI 10.1038/354401a0; TANAKA K, 1994, TRENDS BIOCHEM SCI, V19, P83, DOI 10.1016/0968-0004(94)90040-X; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; ZAWEL L, 1995, IN PRESS ANN REV BIO, V64	48	180	182	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4896	4902		10.1074/jbc.270.9.4896	http://dx.doi.org/10.1074/jbc.270.9.4896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876263	hybrid, Green Published			2022-12-27	WOS:A1995QK08400101
J	SHIMEKAKE, Y; NAGATA, K; OHTA, S; KAMBAYASHI, Y; TERAOKA, H; KITAMURA, K; ETO, T; KANGAWA, K; MATSUO, H				SHIMEKAKE, Y; NAGATA, K; OHTA, S; KAMBAYASHI, Y; TERAOKA, H; KITAMURA, K; ETO, T; KANGAWA, K; MATSUO, H			ADRENOMEDULLIN STIMULATES 2 SIGNAL-TRANSDUCTION PATHWAYS, CAMP ACCUMULATION AND CA2+ MOBILIZATION, IN BOVINE AORTIC ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED RAT SOMATOTROPHS; SMOOTH-MUSCLE CELLS; GH-RELEASING FACTOR; PROTEIN-KINASE; NITRIC-OXIDE; HYPOTENSIVE PEPTIDE; NATRIURETIC PEPTIDE; MOLECULAR-CLONING; GROWTH-FACTOR; RECEPTOR	The biological action of adrenomedullin, a novel hypotensive peptide, on bovine aortic endothelial cells, was examined. The specific binding of adrenomedullin to these cells was observed, and adrenomedullin was found to induce intracellular cAMP accumulation in a dose-dependent manner. EC(50) for the cAMP accumulation was about 100 times lower than the apparent IC50 for the binding assay. Adrenomedullin also induced increase of intracellular free Ca2+ in endothelial cells in a dose-dependent manner. The Ca2+ response to adrenomedullin was biphasic with an initial transient increase due to the release from thapsigargin-sensitive intracellular Ca2+ storage and a prolonged increase by influx through the ion channel on the plasma membrane. This intracellular free Ca2+ increase resulted from phospholipase C activation and inositol 1,4,5-trisphosphate formation, and seemed to cause nitric oxide synthase activation by monitoring intracellular cGMP accumulation. Both cAMP accumulation and Ca2+ increased responses to adrenomedullin were mediated by cholera toxin-sensitive G protein, but the two signal transduction pathways were independent. Thus, the results suggest that adrenomedullin elicits the hypotensive effect through at least two mechanisms, a direct action on vascular smooth muscle cells to increase intracellular cAMP and an action on endothelial cells to stimulate nitric oxide release, with both leading to vascular relaxation.	SHIONOGI & CO LTD,SHIONOGI RES LABS,FUKUSHIMA KU,OSAKA 553,JAPAN; MIYAZAKI MED COLL,DEPT INTERNAL MED 1,MIYAZAKI 88916,JAPAN; NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 564,JAPAN	Shionogi & Company Limited; University of Miyazaki; National Cerebral & Cardiovascular Center - Japan			Ohta, shigeki/L-1677-2013; Ohta, Shigeki/Y-4455-2019	Ohta, Shigeki/0000-0003-2994-4278				ADAMS DJ, 1994, TRENDS CARDIOVAS MED, V4, P18, DOI 10.1016/1050-1738(94)90021-3; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; EGUCHI S, 1994, FEBS LETT, V340, P226, DOI 10.1016/0014-5793(94)80143-6; EMORI T, 1991, BIOCHEM BIOPH RES CO, V174, P228, DOI 10.1016/0006-291X(91)90510-E; EMORI T, 1991, HYPERTENSION, V18, P165, DOI 10.1161/01.HYP.18.2.165; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FUKAMI K, 1989, J BIOL CHEM, V264, P14985; GEILEN CC, 1992, FEBS LETT, V309, P381, DOI 10.1016/0014-5793(92)80811-T; GILLONGO J, 1993, EUR J PHARM-MOLEC PH, V247, P119, DOI 10.1016/0922-4106(93)90068-K; HIRANO K, 1993, EUR J PHARM-MOLEC PH, V244, P133, DOI 10.1016/0922-4106(93)90018-5; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; IGNARRO LJ, 1993, THROMB HAEMOSTASIS, V70, P148; ISHIZAKA Y, 1994, BIOCHEM BIOPH RES CO, V200, P642, DOI 10.1006/bbrc.1994.1496; ITAZAKI K, 1993, EUR J PHARM-MOLEC PH, V245, P147, DOI 10.1016/0922-4106(93)90122-P; KAMBAYASHI Y, 1989, FEBS LETT, V248, P28, DOI 10.1016/0014-5793(89)80425-9; KITAMURA K, 1994, FEBS LETT, V338, P306, DOI 10.1016/0014-5793(94)80289-0; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KUBALAK SW, 1993, AM J PHYSIOL, V264, pH86, DOI 10.1152/ajpheart.1993.264.1.H86; LAMPUGNANI MG, 1989, THROMB RES, V54, P75, DOI 10.1016/0049-3848(89)90338-1; LIANO JK, 1993, CIRC RES, V70, P1018; LIU YF, 1992, MOL ENDOCRINOL, V6, P1815, DOI 10.1210/me.6.11.1815; LUSSIER BT, 1991, ENDOCRINOLOGY, V128, P570, DOI 10.1210/endo-128-1-570; LUSSIER BT, 1991, ENDOCRINOLOGY, V128, P592, DOI 10.1210/endo-128-1-592; MACHRTHUR H, 1993, BRIT J PHARMACOL, V108, P100; MYERS DE, 1989, CELL SIGNAL, V1, P335, DOI 10.1016/0898-6568(89)90052-1; NAMBA T, 1994, J BIOL CHEM, V269, P9986; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; ODA K, 1992, FEBS LETT, V299, P187, DOI 10.1016/0014-5793(92)80244-B; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; SHIMEKAKE Y, 1994, EUR J BIOCHEM, V222, P645, DOI 10.1111/j.1432-1033.1994.tb18908.x; SHIMEKAKE Y, 1992, FEBS LETT, V309, P185, DOI 10.1016/0014-5793(92)81091-Y; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; YU YM, 1992, J CELL PHYSIOL, V150, P559, DOI 10.1002/jcp.1041500317; ZIEGELSTEIN RC, 1994, CIRC RES, V74, P151, DOI 10.1161/01.RES.74.1.151	35	334	343	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4412	4417		10.1074/jbc.270.9.4412	http://dx.doi.org/10.1074/jbc.270.9.4412			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876206	hybrid			2022-12-27	WOS:A1995QK08400038
J	THOMPSON, MA; GINTY, DD; BONNI, A; GREENBERG, ME				THOMPSON, MA; GINTY, DD; BONNI, A; GREENBERG, ME			L-TYPE VOLTAGE-SENSITIVE CA2+ CHANNEL ACTIVATION REGULATES C-FOS TRANSCRIPTION AT MULTIPLE LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; IMMEDIATE EARLY GENES; AMP-RESPONSIVE ELEMENT; CYCLIC-AMP; SUPRACHIASMATIC NUCLEUS; MEMBRANE DEPOLARIZATION; PHOSPHORYLATED CREB; SOMATOSTATIN GENE; SERUM STIMULATION; NERVOUS-SYSTEM	A mechanism by which voltage-sensitive Ca2+ channel (VSCC) activation triggers c-fos transcription has been characterized, Ca2+ influx through VSCCs stimulates phosphorylation of the transcription factor cAMP response element-binding protein (CREB) on serine 133 leading to an increase in the formation of transcription complexes that can elongate through a transcription pause site within the c-fos gene, Ca2+-stimulated CREB serine 133 phosphorylation is mediated by a Ca2+-activated kinase and is not dependent on the cAMP-dependent protein kinase (PKA), While necessary for c-fos transcriptional induction following VSCC opening, CREB serine 133 phosphorylation is not sufficient for transcriptional activation. A second, PKA-dependent event is required. Following induction, c-fos transcription is rapidly down-regulated, Dephosphorylation of CREB serine 133 parallels and likely mediates the transcriptional shut-off event, These results suggest that the phosphorylation and dephosphorylation of CREB controls its ability to regulate transcription in membrane-depolarized cells and that multiple pathways contribute to Ca2+-activated gene expression.	HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School					NINDS NIH HHS [NS28829] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; CELANO P, 1989, BIOTECHNIQUES, V7, P942; CHARNAY P, 1984, CELL, V38, P251, DOI 10.1016/0092-8674(84)90547-6; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; FOULKES NS, 1991, P NATL ACAD SCI USA, V88, P5448, DOI 10.1073/pnas.88.12.5448; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1991, J BIOL CHEM, V266, P15325; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; LAMB NJC, 1990, CELL, V61, P485, DOI 10.1016/0092-8674(90)90530-R; MACNICOL M, 1990, J BIOL CHEM, V265, P18055; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; MISRA RP, 1994, J BIOL CHEM, V269, P25483; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NGUYEN TV, 1992, P NATL ACAD SCI USA, V89, P4270, DOI 10.1073/pnas.89.10.4270; NGUYEN TV, 1990, J NEUROSCI, V10, P2825; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SCHWANINGER M, 1993, J BIOL CHEM, V268, P5168; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SPENCER CA, 1990, ONCOGENE, V5, P777; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WERLEN G, 1993, J BIOL CHEM, V268, P16596; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2	63	138	138	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4224	4235		10.1074/jbc.270.9.4224	http://dx.doi.org/10.1074/jbc.270.9.4224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876182	hybrid			2022-12-27	WOS:A1995QK08400012
J	WANG, JZ; GONG, CX; ZAIDI, T; GRUNDKEIQBAL, I; IQBAL, K				WANG, JZ; GONG, CX; ZAIDI, T; GRUNDKEIQBAL, I; IQBAL, K			DEPHOSPHORYLATION OF ALZHEIMER PAIRED HELICAL FILAMENTS BY PROTEIN PHOSPHATASE-2A AND PHOSPHATASE-2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; SKELETAL-MUSCLE; DISEASE BRAIN; NORMAL-TAU; IDENTIFICATION; LOCALIZATION; POLYPEPTIDES; PURIFICATION; RABBIT	Microtubule associated protein tau is abnormally hyperphosphorylated in the brain of patients with Alzheimer disease and in this form is the major protein subunit of the paired helical filaments (PHF), the most prominent lesion of the disease. In this study the dephosphorylation of sparingly soluble PHF, PHF II-tau by brain protein phosphatase (PP)-2A(1) and PP-2B, and the resulting biochemical, biological, and structural alterations were investigated. Both of the phosphatases dephosphorylated PHF II-tau at the sites of Ser-199/Ser-202 and partially dephosphorylated it at Ser-396/Ser-404; in addition, PHF II-tau was dephosphorylated at Ser-46 by PP-2A(1) and Ser-235 by PP-2B. The relative electrophoretic mobility of PHF II-tau increased after dephosphorylation by either enzyme. Bivalent cations, manganese, and magnesium increased the activities of PP-2A(1) and PP-SB toward PHF II-tau. Dephosphorylation both by PP-2B and PP-2A(1) decreased the resistance of PHF II-tau to proteolysis by the brain calcium-activated neutral proteases (CANP). The ability of PHF II-tau to promote the in vitro microtubule assembly was restored after dephosphorylation by PP-2A(1) and PP-2B. Microtubules assembled by the dephosphorylated PHF II-tau were structurally identical to those assembled by bovine tau used as a control, The dephosphorylation both by PP-2A(1) and PP-2B caused dissociation of the tangles and the PHF; some of the PHF dissociated into straight protofilaments/subfilaments. Approximately 25% of the total tau was released from PHF on dephosphorylation by PP-2A(1). These observations demonstrate that PHF II-tau is accessible to dephospho rylation by PP-2A(1) and PP-2B, and dephosphorylation makes PHF dissociate, accessible to proteolysis by CANP, and biologically active in promoting the assembly of tubulin into microtubules.	NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314	Institute for Basic Research in Developmental Disabilities					NIA NIH HHS [AG 05892, AG 08076] Funding Source: Medline; NINDS NIH HHS [NS 18105] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005892, R01AG008076] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; COHEN P, 1988, METHOD ENZYMOL, V159, P390; COHEN P, 1989, ANN REV BIOCH, V58, P543; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; FRIBERG L, 1986, HDB TOXICOLOGY METHO, V2, P364; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GONG CX, 1994, J NEUROCHEM, V62, P803; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1984, ACTA NEUROPATHOL, V62, P259, DOI 10.1007/BF00687607; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KAWASHIMA S, 1984, J BIOCHEM-TOKYO, V95, P95, DOI 10.1093/oxfordjournals.jbchem.a134608; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAA.B, 1992, P NATL ACAD SCI USA, V82, P5384; MALIK MN, 1983, J BIOL CHEM, V258, P8955; MORISHIMAKAWASH.M, 1993, NEURON, V10, P1151; MORISHIMAKAWASHIMA, 1995, J BIOL CHEM, V270, P823; PEI JJ, 1994, BRAIN RES, V655, P70, DOI 10.1016/0006-8993(94)91598-9; SHARMA RK, 1983, METHOD ENZYMOL, V102, P210; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SLOBODA RD, 1979, BIOCHEMISTRY-US, V18, P48, DOI 10.1021/bi00568a008; SORIMACHI H, 1994, FEBS LETT, V343, P1, DOI 10.1016/0014-5793(94)80595-4; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WISNIEWSKI HM, 1984, J NEUROPATH EXP NEUR, V43, P643, DOI 10.1097/00005072-198411000-00008	44	251	283	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 3	1995	270	9					4854	4860		10.1074/jbc.270.9.4854	http://dx.doi.org/10.1074/jbc.270.9.4854			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QK084	7876258	hybrid			2022-12-27	WOS:A1995QK08400095
J	HAUCK, W; STANNERS, CP				HAUCK, W; STANNERS, CP			TRANSCRIPTIONAL REGULATION OF THE CARCINOEMBRYONIC ANTIGEN GENE - IDENTIFICATION OF REGULATORY ELEMENTS AND MULTIPLE NUCLEAR FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE; CARCINOMA CELL-LINE; COLON-CARCINOMA; DNA-BINDING; FACTOR USF; BILIARY GLYCOPROTEIN; FACTOR SP1; EXPRESSION; FAMILY; PROMOTER	Human carcinoembryonic antigen (CEA) belongs to a family of membrane glycoproteins that are overexpressed in many carcinomas; CEA functions in vitro as a homotypic intercellular adhesion molecule and can inhibit differentiation when expressed ectopically in myoblasts. The regulation of expression of CEA is therefore of considerable interest. The CEA gene promoter region between -403 and -124 base pairs upstream of the translation initiation site directed high levels of expression in CEA-expressing SW403 cells and was 3 times more active in differentiated than in undifferentiated Caco-2 cells, correlating exactly with the 3-fold increase in CEA mRNA seen in differentiated Caco-2 cells. Inclusion of additional upstream sequences between -1098 and -403 base pairs repressed all activity. By in vitro footprinting and deletion analyses, four cis-acting elements were mapped within the positive regulatory region, and one element within the silencing region. Several nuclear factors binding to these domains were identified: USF, Spl, and an Spl-like factor. By co-transfection, USF directly activated the CEA gene promoter in vivo in both SW403 and Caco-2 cells. In addition, the levels of factors binding to each positively acting element increased dramatically with differentiation in Caco-2 cells. Thus the transcriptional control of the CEA gene depends on the interaction of several regulatory elements that bind multiple specific factors.	MCGILL UNIV, MCGILL CANC CTR, MONTREAL, PQ H3G 1Y6, CANADA; MCGILL UNIV, DEPT BIOCHEM, MONTREAL, PQ H3G 1Y6, CANADA	McGill University; McGill University								ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; AHNEN DJ, 1982, CANCER, V49, P2077, DOI 10.1002/1097-0142(19820515)49:10<2077::AID-CNCR2820491020>3.0.CO;2-X; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; BASERGA R, 1980, INTRO MACROMOLECULES, V1; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOUCHER D, 1989, CANCER RES, V49, P847; BRAM RJ, 1987, MOL CELL BIOL, V7, P403, DOI 10.1128/MCB.7.1.403; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROPHY BK, 1992, BIOCHIM BIOPHYS ACTA, V1131, P119, DOI 10.1016/0167-4781(92)90110-L; DEAN DC, 1987, P NATL ACAD SCI USA, V84, P1876, DOI 10.1073/pnas.84.7.1876; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; FINLEY GG, 1989, ONCOGENE, V4, P963; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HAUCK W, 1991, CANCER RES, V51, P3526; HAUCK W, 1994, EUR J BIOCHEM, V223, P529, DOI 10.1111/j.1432-1033.1994.tb19022.x; HOPPESEYLER F, 1992, NUCLEIC ACIDS RES, V20, P6701, DOI 10.1093/nar/20.24.6701; HOWELL BW, 1989, MOL CELL BIOL, V9, P2928, DOI 10.1128/MCB.9.7.2928; JESSUP JM, 1989, CANCER METAST REV, V8, P263; JOTHY S, 1993, AM J PATHOL, V143, P250; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; MELHEM MF, 1992, CANCER RES, V52, P5853; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V146, P464, DOI 10.1016/0006-291X(87)90552-3; PINTO M, 1983, BIOL CELL, V47, P323; POGNONEC P, 1992, J BIOL CHEM, V267, P24563; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sambrook J, 1989, MOL CLONING LABORATO; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; TRAN R, 1988, CANCER RES, V48, P5674; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247; WILLCOCKS TC, 1990, GENOMICS, V8, P492, DOI 10.1016/0888-7543(90)90036-T; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557	56	60	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	1995	270	8					3602	3610		10.1074/jbc.270.8.3602	http://dx.doi.org/10.1074/jbc.270.8.3602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QH688	7876096				2022-12-27	WOS:A1995QH68800024
J	FARRELL, CM; LUKENS, LN				FARRELL, CM; LUKENS, LN			NATURALLY-OCCURRING ANTISENSE TRANSCRIPTS ARE PRESENT IN CHICK-EMBRYO CHONDROCYTES SIMULTANEOUSLY WITH THE DOWN-REGULATION OF THE ALPHA-1(I) COLLAGEN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; II COLLAGEN; C-ELEGANS; RNA; EXPRESSION; PROMOTER; DNA; SWITCH; 5-BROMO-2'-DEOXYURIDINE; CHONDROGENESIS	It has previously been shown that very low steady state levels of alpha 1(I) collagen mRNA are present in chick embryo sternal chondrocytes (Askew, G. R., Wang, S., and Lukens, L. N. (1991) J. Biol. Chem. 266, 16834-16841), yet nuclear run-on experiments with double-stranded cDNA probes indicated a high transcription rate at this locus. These findings were investigated in this study using single-stranded probes, where nuclear run on experiments showed that antisense transcription of the alpha 1(I) collagen gene was occurring in chondrocytes, while sense strand transcription was down-regulated. Treatment of these chondrocytes with 5-bromo-2'-deoxyuridine (BrdU), which causes the cells to resemble their mesenchymal precursors, resulted in an antiparallel situation, where antisense transcription was lost, and instead, sense strand transcription was acquired, suggesting that the reverse switch from sense to antisense transcription occurs during chondrogenesis. Very large (> 10 kilobases) and heterogeneous antisense transcripts of moderate stability were shown to span both ends of the gene in chondrocytes, while their absence was shown in BrdU-treated chondrocytes, chick embryo fibroblasts, and a variety of other tissues. The function of these antisense transcripts is so far unknown, but their unusual chondrocyte-specific appearance, concurrent with little or no sense strand transcription, suggests a possible functional role in the down-regulation of the alpha 1(I) collagen gene.			FARRELL, CM (corresponding author), WESLEYAN UNIV, DEPT MOLEC BIOL & BIOCHEM, MIDDLETOWN, CT 06459 USA.							ABBOTT J, 1968, P NATL ACAD SCI USA, V59, P1144, DOI 10.1073/pnas.59.4.1144; ADAMS SL, 1982, CELL, V30, P373, DOI 10.1016/0092-8674(82)90235-5; ALLEBACH ES, 1985, MOL CELL BIOL, V5, P1002, DOI 10.1128/MCB.5.5.1002; ASKEW GR, 1991, J BIOL CHEM, V266, P16834; BECK KM, 1991, NUCLEIC ACIDS RES, V19, P4975, DOI 10.1093/nar/19.18.4975; BENNETT VD, 1989, J BIOL CHEM, V264, P8402; BENNETT VD, 1990, J BIOL CHEM, V265, P2223; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CHU ML, 1984, NATURE, V310, P337, DOI 10.1038/310337a0; CORBIN V, 1989, NATURE, V337, P279, DOI 10.1038/337279a0; FINER MH, 1984, P NATL ACAD SCI-BIOL, V81, P1659, DOI 10.1073/pnas.81.6.1659; FINER MH, 1985, MOL CELL BIOL, V5, P1415, DOI 10.1128/MCB.5.6.1415; FINER MH, 1987, J BIOL CHEM, V262, P13323; FOCHT RJ, 1984, MOL CELL BIOL, V4, P1843, DOI 10.1128/MCB.4.9.1843; FREMEAU RT, 1990, EMBO J, V9, P3533, DOI 10.1002/j.1460-2075.1990.tb07562.x; GERSTENFELD LC, 1984, MOL CELL BIOL, V4, P1483, DOI 10.1128/MCB.4.8.1483; GERSTENFELD LC, 1989, J BIOL CHEM, V264, P5112; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; HILDEBRANDT M, 1992, CELL, V69, P197, DOI 10.1016/0092-8674(92)90130-5; KHOCHBIN S, 1989, EMBO J, V8, P4107, DOI 10.1002/j.1460-2075.1989.tb08595.x; Kimelman D., 1992, Gene regulation: biology of antisense RNA and DNA., P1; Krystal G. W., 1992, Gene regulation: biology of antisense RNA and DNA., P11; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MAYNE R, 1975, P NATL ACAD SCI USA, V72, P4511, DOI 10.1073/pnas.72.11.4511; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NELLEN W, 1993, TRENDS BIOCHEM SCI, V18, P419, DOI 10.1016/0968-0004(93)90137-C; NOWAK R, 1994, SCIENCE, V263, P608, DOI 10.1126/science.7508142; PACIFICI M, 1977, AM J ANAT, V150, P207, DOI 10.1002/aja.1001500116; PACIFICI M, 1977, CELL, V11, P891, DOI 10.1016/0092-8674(77)90300-2; PAWLOWSKI PJ, 1982, BIOCHEMISTRY-US, V21, P34, DOI 10.1021/bi00530a006; Sambrook J, 1989, MOL CLONING LABORATO; SAXE SA, 1985, J BIOL CHEM, V260, P3812; Schiltz J., 1973, DIFFERENTIATION, V1, P97; TAKAYAMA KM, 1990, CRIT REV BIOCHEM MOL, V25, P155, DOI 10.3109/10409239009090608; VALES LD, 1989, GENE DEV, V3, P49, DOI 10.1101/gad.3.1.49; von der Mark K, 1980, Curr Top Dev Biol, V14, P199; WANG S, 1994, MATRIX BIOL, V14, P313, DOI 10.1016/0945-053X(94)90197-X; WICKENS M, 1994, NATURE, V367, P17, DOI 10.1038/367017a0; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; YOSHIDA H, 1994, NUCLEIC ACIDS RES, V22, P41, DOI 10.1093/nar/22.1.41; 1991, PROTOCOLS APPLICATIO, P125	44	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3400	3408		10.1074/jbc.270.7.3400	http://dx.doi.org/10.1074/jbc.270.7.3400			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852426	hybrid			2022-12-27	WOS:A1995QG47100076
J	MOREL, C; CORDIERBUSSAT, M; PHILIPPE, J				MOREL, C; CORDIERBUSSAT, M; PHILIPPE, J			THE UPSTREAM PROMOTER ELEMENT OF THE GLUCAGON GENE, G1, CONFERS PANCREATIC ALPHA CELL-SPECIFIC EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; INSULIN GENE; IDENTIFICATION; TRANSCRIPTION; SEQUENCES; NEURONS	The glucagon gene is expressed in the endocrine pancreas, the intestine, and the brain. In the endocrine pancreas, expression of the glucagon gene is restricted to the alpha cells of the islets of Langerhans. We previously showed that 168 base pairs of the promoter was critical for this restricted expression. To further characterize the mechanisms involved in alpha cell specificity, we analyzed the responsible DNA sequences by transient transfection studies into glucagon- and insulin-producing cell Lines. We localized alpha cell-specific sequences between nt 100 and 52, a region that corresponds to the upstream promoter element G1. Four protein complexes, B1, B2, B3, and B6 interact with G1; B6 requires most of G1 to be formed. B1, B2, and B3, by contrast, bind on closely overlapping sequences, display similar methylation interference patterns, and appear to be related complexes. Point mutations of G1 indicate, however, that their binding specificities are different. All four complexes are islet-specific, and impairment of their binding results in decreased transcription. We conclude that G1 interacts with islet cell-specific proteins to restrict glucagon gene expression to the alpha cells.	CTR MED UNIV GENEVA,DEPT GENET & MICROBIOL,CH-1211 GENEVA 4,SWITZERLAND; CTR MED UNIV GENEVA,DEPT MED,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva; University of Geneva			Cordier-Bussat, Martine/G-4019-2014					ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ARONHEIM A, 1993, NUCLEIC ACIDS RES, V7, P1601; BALL DW, 1992, NUCLEIC ACIDS RES, V20, P117, DOI 10.1093/nar/20.1.117; DRUCKER DJ, 1987, J BIOL CHEM, V262, P15659; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; KOBR M, 1990, MOL CELL BIOL, V10, P965, DOI 10.1128/MCB.10.3.965; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Maxam A M, 1980, Methods Enzymol, V65, P499; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1994, MOL CELL BIOL, V14, P3514, DOI 10.1128/MCB.14.5.3514; PHILIPPE J, 1990, DNA CELL BIOL, V10, P119; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; TAKAKI R, 1985, IN VITRO CELL DEV, V22, P120; WANG TC, 1990, J BIOL CHEM, V265, P8908; WHEELER MB, 1992, MOL CELL BIOL, V12, P3531, DOI 10.1128/MCB.12.8.3531; Wright WE, 1992, CURR OPIN GENET DEV, V2, P243, DOI 10.1016/S0959-437X(05)80280-1	32	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3046	3055		10.1074/jbc.270.7.3046	http://dx.doi.org/10.1074/jbc.270.7.3046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852385	hybrid			2022-12-27	WOS:A1995QG47100026
J	WILLIAMS, PF; MYNARCIK, DC; YU, GQ; WHITTAKER, J				WILLIAMS, PF; MYNARCIK, DC; YU, GQ; WHITTAKER, J			MAPPING OF AN NH2-TERMINAL LIGAND-BINDING SITE OF THE INSULIN-RECEPTOR BY ALANINE SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ALPHA-SUBUNIT; GROWTH-FACTOR; HORMONE; DOMAIN; IDENTIFICATION; DETERMINANTS; SPECIFICITY; ECTODOMAIN; AFFINITY	Affinity labeling studies and mutational analyses have implicated the involvement of a predicted domain of the insulin receptor (L1, amino acids 1-119) in ligand binding. In order to obtain a higher resolution localization of this ligand binding site, we have performed alanine scanning mutagenesis of this domain. Alanine mutant cDNAs encoding a secreted recombinant insulin receptor extracellular domain were expressed transiently in adenovirus transformed human embryonic kidney cells and the affinity of the expressed receptor for insulin was determined. Mutation of 14 amino acids located in four discontinuous peptide segments to alanine was disruptive of insulin binding: Segment 1 amino acids 12-15; Segment 2, amino acids 34-44; Segment 3, amino acids 64-67; and Segment 4, amino acids 89-91. The quantitative contribution of the four segments to the free energy of insulin binding was 1 > 3 > 2 > 4. Of the 14 amino acids whose mutation compromised insulin binding, 3 are charged, 3 hydrophobic, 5 aromatic, and 3 are amides.	SUNY STONY BROOK, HLTH SCI CTR, DEPT MED, DIV ENDOCRINOL, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, DEPT PHYSIOL & BIOPHYS, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042171] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42171] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DESILVA AM, 1990, J CELL BIOL, V111, P857, DOI 10.1083/jcb.111.3.857; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FABRY M, 1992, J BIOL CHEM, V267, P8950; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; MARKUSSEN J, 1991, J BIOL CHEM, V266, P18814; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHAEFER EM, 1992, J BIOL CHEM, V267, P23393; SCHAEFER EM, 1990, J BIOL CHEM, V265, P13248; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SHIER P, 1989, J BIOL CHEM, V264, P14605; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WHITTAKER J, 1987, P NATL ACAD SCI USA, V84, P5237, DOI 10.1073/pnas.84.15.5237	29	87	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3012	3016		10.1074/jbc.270.7.3012	http://dx.doi.org/10.1074/jbc.270.7.3012			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852381	hybrid			2022-12-27	WOS:A1995QG47100021
J	WONG, K; LI, XB; HUNCHUK, N				WONG, K; LI, XB; HUNCHUK, N			N-ACETYLSPHINGOSINE (C-2-CERAMIDE) INHIBITED NEUTROPHIL SUPEROXIDE FORMATION AND CALCIUM INFLUX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTRACELLULAR CALCIUM; HUMAN-PLATELETS; CA2+ INFLUX; STORES; SPHINGOSINE; MESSENGER; CERAMIDE; LYSOSPHINGOLIPIDS; INVOLVEMENT	Ceramide, a product arising from sphingomyelinase activity, has been shown to act as an intracellular second messenger in effecting growth inhibition, cellular differentiation, and apoptosis, In the present study, the relative effects of cell-permeable ceramides, N-acetylsphingosine (C-2-ceramide) and N-hexanoylsphingosine (C-2-ceramide), on neutrophil responses were measured, When cells were activated with fMet-Leu-Phe, C-2-ceramide both potentiated (<1 mu M) and inhibited (>1 mu M) superoxide generation, C-2- and C-6-ceramide inhibited phorbol ester induced superoxide release from neutrophils at IC50 values of 5 and 120 mu M, respectively. C-2-ceramide had no effect on semipurified protein kinase C activity, Neither ceramide affected significantly the general level of phosphorylated proteins in phorbol ester-treated cells, C-2-ceramide (1-20 mu M) alone did not change cytosolic free Ca2+ levels but inhibited Ca2+ and Mn2+ influx in fMet-Leu-Phe-activated neutrophils. In contrast, sphingosine enhanced Ca2+ entry; thus, ceramide conversion to sphingosine was not significant, Unlike C-2-ceramide, C-2-dihydroceramide failed to block superoxide generation or Ca2+ influx, Preincubation of cells with 10 nM okadaic acid reversed slightly the effects of C-2-ceramide, Calyculin A, tautomycin, and much higher concentrations of okadaic acid inhibited agonist-induced Ca2+ influx. We postulate that C-2-ceramide may inhibit neutrophil superoxide release by activation of type 2A protein phosphatases. Results suggest that protein phosphatase type 1 up-regulates Ca2+ entry, whereas type 2A (or a ceramide-activated subtype) forestalls Ca2+ entry by inactivating a calcium influx factor.	UNIV CALGARY,DEPT PHARMACOL & THERAPEUT,CALGARY,AB T2N 4N1,CANADA	University of Calgary	WONG, K (corresponding author), CANADIAN RED CROSS SOC,CTR BLOOD TRANSFUS,737 13 AVE SW,CALGARY,AB T2R 1J1,CANADA.							BERLIN RD, 1993, CELL CALCIUM, V14, P379, DOI 10.1016/0143-4160(93)90042-5; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; DELLABIANCA V, 1986, BIOCHEM BIOPH RES CO, V135, P556; DING JB, 1992, J BIOL CHEM, V267, P6442; DIVIRGILIO F, 1990, CURR TOP MEMBR TRANS, V35, P180; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FASOLATO C, 1993, J BIOL CHEM, V268, P20737; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; HANNUN YA, 1993, ADV LIPID RES, V25, P43; LAGAST H, 1984, J CLIN INVEST, V73, P878, DOI 10.1172/JCI111284; LU DJ, 1992, AM J PHYSIOL, V262, pC39, DOI 10.1152/ajpcell.1992.262.1.C39; MATHIAS S, 1993, ADV LIPID RES, V25, P65; MELDOLESI J, 1991, TRENDS PHARMACOL SCI, V12, P289, DOI 10.1016/0165-6147(91)90577-F; MONTERO M, 1993, BIOCHIM BIOPHYS ACTA, V1177, P127, DOI 10.1016/0167-4889(93)90031-J; MONTERO M, 1994, J BIOL CHEM, V269, P3963; MURATA K, 1993, J CELL BIOCHEM, V51, P442, DOI 10.1002/jcb.2400510409; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PARENTE JE, 1989, MOL PHARMACOL, V35, P26; Pittet D, 1992, Adv Second Messenger Phosphoprotein Res, V26, P369; Putney J W Jr, 1991, Adv Pharmacol, V22, P251, DOI 10.1016/S1054-3589(08)60037-X; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; SNYDERMAN R, 1991, AGENT ACTION SUPPL, V35, P3; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; TYAGT SR, 1985, J BIOL CHEM, V263, P12191; Walker Blair A. M., 1992, Biological Signals, V1, P237; WONG K, 1993, CELL CALCIUM, V14, P493, DOI 10.1016/0143-4160(93)90008-T; WONG K, 1990, J BIOL CHEM, V265, P21454; WONG K, 1992, BIOCHEM J, V283, P499, DOI 10.1042/bj2830499; YANAGA F, 1994, BIOCHEM J, V298, P733, DOI 10.1042/bj2980733	38	70	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					3056	3062		10.1074/jbc.270.7.3056	http://dx.doi.org/10.1074/jbc.270.7.3056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852386	hybrid			2022-12-27	WOS:A1995QG47100027
